PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	EY	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Chalwe, V				Chalwe, V.			HIV-1 infection increases the risk of severe malaria in semi-immune adults in Zambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Chalwe, V.] Inst Trop Med, B-2000 Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2010	15	8					S19	S19						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	626BE	WOS:000279939900067					2019-04-02	
J	D'Alessandro, U				D'Alessandro, U.			Artemisinin combination therapies (ACTs) for uncomplicated malaria in African children: The 4ABC trial, preliminary results	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[D'Alessandro, U.] Inst Trop Med, ABC Study Grp 4, B-2000 Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2010	15	8					S13	S13						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	626BE	WOS:000279939900045					2019-04-02	
J	Van Geertruyden, JP				Van Geertruyden, J. -P.			Risk of hemolysis after chlorproguanil-dapsone plus artesunate treatment in G6pd deficient infants	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van Geertruyden, J. -P.] Inst Trop Med, B-2000 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2010	15	8					S21	S22						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	626BE	WOS:000279939900077					2019-04-02	
J	Gillet, P; Mori, M; Van den Ende, J; Jacobs, J				Gillet, Philippe; Mori, Marcella; Van den Ende, Jef; Jacobs, Jan			Buffer substitution in malaria rapid diagnostic tests causes false-positive results	MALARIA JOURNAL			English	Article							ANTIGEN-DETECTION TESTS; INSTRUCTIONS	Background: Malaria rapid diagnostic tests (RDTs) are kits that generally include 20 to 25 test strips or cassettes, but only a single buffer vial. In field settings, laboratory staff occasionally uses saline, distilled water (liquids for parenteral drugs dilution) or tap water as substitutes for the RDT kit's buffer to compensate for the loss of a diluent bottle. The present study assessed the effect of buffer substitution on the RDT results. Methods: Twenty-seven RDT brands were run with EDTA-blood samples of five malaria-free subjects, who were negative for rheumatoid factor and antinuclear antibodies. Saline, distilled water and tap water were used as substitute liquids. RDTs were also run with distilled water, without adding blood. Results were compared to those obtained with the RDT kit's buffer and Plasmodium positive samples. Results: Only eight cassettes (in four RDT brands) showed no control line and were considered invalid. Visible test lines occurred for at least one malaria-free sample and one of the substitutes in 20/27 (74%) RDT brands (saline: n = 16; distilled water: n = 17; and tap water: n = 20), and in 15 RDTs which were run with distilled water only. They occurred for all Plasmodium antigens and RDT formats (two-, three-and four-band RDTs). Clearance of the background of the strip was excellent except for saline. The aspects (colour, intensity and crispness) of the control and the false-positive test lines were similar to those obtained with the RDT kits' buffer and Plasmodium positive samples. Conclusion: Replacement of the RDT kit's dedicated buffer by saline, distilled water and tap water can cause false-positive test results.	[Gillet, Philippe; Mori, Marcella; Van den Ende, Jef; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Jacobs, Jan] Fac Hlth Med & Life Sci, Dept Med Microbiol, Maastricht, Netherlands	Gillet, P (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	pgillet@itg.be	Mori, Marcella/U-3810-2018	Mori, Marcella/0000-0002-7191-9191; gillet, philippe/0000-0001-5878-6446			Bell D, 2008, T ROY SOC TROP MED H, V102, P1064, DOI 10.1016/j.trstmh.2008.05.007; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI 10.1038/nrmico1524; Bharti PK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-126; Chiodini PL, 2007, T ROY SOC TROP MED H, V101, P331, DOI 10.1016/j.trstmh.2006.09.007; Drakeley C, 2009, T ROY SOC TROP MED H, V103, P333, DOI 10.1016/j.trstmh.2008.10.003; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-262; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-129; Grobusch MP, 1999, J CLIN MICROBIOL, V37, P3781; Grobusch MP, 1999, LANCET, V353, P297, DOI 10.1016/S0140-6736(05)74930-8; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Iqbal J, 2000, J CLIN MICROBIOL, V38, P1184; MILLIPORE T, 2002, RAPID LATERAL FLOW T; Moody A H, 2002, Br J Biomed Sci, V59, P228; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Seidahmed OME, 2008, TROP MED INT HEALTH, V13, P406, DOI 10.1111/j.1365-3156.2008.02015.x; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; van Dijk DPJ, 2010, EUR J CLIN MICROBIOL, V29, P577, DOI 10.1007/s10096-010-0898-y; van Dijk DPJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-293; Veron V, 2006, AM J TROP MED HYG, V74, P941, DOI 10.4269/ajtmh.2006.74.941; WHO, 2010, INF NOT INT SEL CRIT; *WHO, 2010, US RAP DIAGN TEST RD; Wiese L, 2006, SCAND J INFECT DIS, V38, P1063, DOI 10.1080/00365540600818011; World Health Organization, 2012, MAL RAP DIAGN TEST P; World Health Organization, 2009, MAL RAP DIAGN TEST P	27	10	10	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 22	2010	9								215	10.1186/1475-2875-9-215				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	657LI	WOS:000282413800005	20650003	DOAJ Gold, Green Published			2019-04-02	
J	Jansen, FH				Jansen, Frans Herwig			The pharmaceutical death-ride of dihydroartemisinin	MALARIA JOURNAL			English	Editorial Material							PIPERAQUINE; ARTESUNATE; MALARIA	In the 2010 second edition of WHO's guidelines for the treatment of malaria, the relatively new fixed dose combination dihydroartemisinin-piperaquine is included as one of the recommended artemisinin combination therapies. However, experimental testing demonstrates that, due to its intrinsic chemical instability, dihydroartemisinin is not suitable to be used in pharmaceutical formulations. In addition, data show that the currently available dihydroartemisinin preparations fail to meet the internationally accepted stability requirements. At a time when many efforts aim to ban counterfeit and substandard drugs from the malaria market, the obvious question rises how WHO and public-private partnerships, such as Medicine for Malaria venture (MMV), can support the production and marketing of anti-malarial drugs that do not even meet the International Pharmacopoeia requirements?	Fdn ACT Ion Afr, Brussels, Belgium	Jansen, FH (reprint author), Fdn ACT Ion Afr, Brussels, Belgium.	fhjansen@actionafrique.com					Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871; Dhooghe L, 2007, PHARMAZIE, V62, P900, DOI 10.1691/ph.2007.12.7087; Haynes RK, 2007, CHEMMEDCHEM, V2, P1448, DOI 10.1002/cmdc.200700064; Jansen FH, 2007, CURR MED CHEM, V14, P3243, DOI 10.2174/092986707782793844; JANSEN FH, 2006, AM J TROP MED HYG, V75, P55; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; SCHMID G, 1983, J AM CHEM SOC, V105, P624, DOI 10.1021/ja00341a054; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; Tran Tinh Hien, 2004, Lancet (North American Edition), V363, P18; World Health Organization, 2010, GUID TREAT MAL	10	13	13	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 22	2010	9								212	10.1186/1475-2875-9-212				5	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	657LI	WOS:000282413800002	20649950	DOAJ Gold, Green Published			2019-04-02	
J	Verhaeghen, K; Van Bortel, W; Ho, DT; Sochantha, T; Keokenchanh, K; Coosemans, M				Verhaeghen, Katrijn; Van Bortel, Wim; Ho Dinh Trung; Sochantha, Tho; Keokenchanh, Kalouna; Coosemans, Marc			Knockdown resistance in Anopheles vagus, An. sinensis, An. paraliae and An. peditaeniatus populations of the Mekong region	PARASITES & VECTORS			English	Article							SODIUM-CHANNEL GENE; PYRETHROID INSECTICIDES; MALARIA VECTORS; MOLECULAR CHARACTERIZATION; REDUCED SUSCEPTIBILITY; MOSQUITOS DIPTERA; GAMBIAE; KDR; CULICIDAE; IDENTIFICATION	Background: In the Mekong region (Vietnam, Cambodia and Laos), a large investigation was conducted to assess the susceptibility of Anopheles species against DDT and pyrethroids. In this study, the resistance status of the potential malaria vectors An. vagus, An. sinensis, An. paraliae and An. peditaeniatus was assessed. Methods: Bioassays were performed on field collected unfed female mosquitoes using the standard WHO susceptibility tests. In addition, the DIIS6 region of the para-type sodium channel gene was amplified and sequenced and four allele-specific PCR assays were developed to assess the kdr frequencies. Results: In Southern Vietnam all species were DDT and pyrethroid resistant, which might suggest the presence of a kdr resistance mechanism. Sequence-analysis of the DIIS6 region of the para-type sodium channel gene revealed the presence of a L1014S kdr mutation in An. vagus, An. sinensis and An. paraliae. In An. peditaeniatus, a low frequency L1014S kdr mutation was found in combination with a high frequency L1014F kdr mutation. For pyrethroids and DDT, no genotypic differentiation was found between survivors and non-survivors for any of these species. In the two widespread species, An. vagus and An. sinensis, kdr was found only in southern Vietnam and in Cambodia near the Vietnamese border. Conclusions: Different levels of resistance were measured in Laos, Cambodia and Vietnam. The kdr mutation in different Anopheles species seems to occur in the same geographical area. These species breed in open agricultural lands where malaria endemicity is low or absent and vector control programs less intensive. It is therefore likely that the selection pressure occurred on the larval stages by insecticides used for agricultural purposes.	[Verhaeghen, Katrijn; Van Bortel, Wim; Coosemans, Marc] Inst Trop Med Antwerp, Dept Biol, B-2000 Antwerp, Belgium; [Ho Dinh Trung] Natl Inst Malariol Parasitol & Entomol, Dept Entomol, Hanoi, Vietnam; [Sochantha, Tho] Natl Ctr Malaria Control Parasitol & Entomol, Dept Entomol, Phnom Penh, Cambodia; [Keokenchanh, Kalouna] Ctr Malariol Parasitol & Entomol, Dept Entomol, Viangchan, Laos; [Coosemans, Marc] Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, Dept Biomed Sci, B-2610 Antwerp, Belgium	Coosemans, M (reprint author), Inst Trop Med Antwerp, Dept Biol, Natl Str 155, B-2000 Antwerp, Belgium.	mcoosemans@itg.be		Van Bortel, Wim/0000-0002-6644-518X	Belgian Cooperation (Directoraat-Generaal voor Internationale Samenwerking, DGIS) [IC4-CT2002-10041]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT - Vlaanderen)	We acknowledge the excellent technical support of the entomological teams of the National Institute of Malariology, Parasitology and Entomology (NIMPE), Hanoi, Vietnam; the National Centre for Malaria Control, Parasitology and Entomology (NCMC), Phnom Penh, Cambodia and the Centre of Malariology, Parasitology and Entomology (CMPE), Vientiane, Laos; as well as the provincial malaria centers for their full and constant support to this study. We are grateful to the Ministries of Public Health of Vietnam, Laos and Cambodia for facilitating this research. We thank Valerie Obsomer (Universite Catholique de Louvain, Louvain-la-Neuve, Belgium) for providing maps of the Mekong region. This work was carried out within the framework of the INCO research project IC4-CT2002-10041 and was supported by the Belgian Cooperation (Directoraat-Generaal voor Internationale Samenwerking, DGIS) in the framework of the Institutional Collaboration between ITM, Antwerp and NIMPE, Hanoi. This research was funded by a Ph.D. grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT - Vlaanderen)	Alam MS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-15; Amerasinghe PH, 1999, AM J TROP MED HYG, V60, P421, DOI 10.4269/ajtmh.1999.60.421; Brogdon WG, 1999, PESTIC BIOCHEM PHYS, V64, P101, DOI 10.1006/pest.1999.2415; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; COOSEMANS M, 2007, P INT C HUBS HARB DE, P551; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Etang J, 2006, AM J TROP MED HYG, V74, P795, DOI 10.4269/ajtmh.2006.74.795; GINGRICH JB, 1990, J MED ENTOMOL, V27, P1016, DOI 10.1093/jmedent/27.6.1016; Guerrero FD, 1997, INSECT BIOCHEM MOLEC, V27, P745, DOI 10.1016/S0965-1748(97)00057-X; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hodjati MH, 1999, B ENTOMOL RES, V89, P329; Kim H, 2007, PESTIC BIOCHEM PHYS, V87, P54, DOI 10.1016/j.pestbp.2006.06.009; Kostaropoulos I, 2001, INSECT BIOCHEM MOLEC, V31, P313, DOI 10.1016/S0965-1748(00)00123-5; Lee JS, 2002, AM J TROP MED HYG, V66, P13, DOI 10.4269/ajtmh.2002.66.13; MAHESWARY NP, 1994, INDIAN J MALARIOL, V24, P776; MANGUIN S, 2008, BIODIVERSITY MALARIA, P427; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10<1012::AID-PS39>3.0.CO;2-5; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; *MIN HLTH NAT I MA, 2008, KEYST AN VIETN, P68; MOGI M, 1990, J MED ENTOMOL, V27, P530, DOI 10.1093/jmedent/27.4.530; Moreno M, 2008, TROP MED INT HEALTH, V13, P430, DOI 10.1111/j.1365-3156.2008.02010.x; Mzilahowa T, 2008, MED VET ENTOMOL, V22, P258, DOI 10.1111/j.1365-2915.2008.00736.x; Pinto J, 2006, MED VET ENTOMOL, V20, P27, DOI 10.1111/j.1365-2915.2006.00611.x; Prakash A, 2004, ANN TROP MED PARASIT, V98, P559, DOI 10.1179/000349804225021361; QUYEN PB, 1995, TRAC-TREND ANAL CHEM, V14, P383, DOI 10.1016/0165-9936(95)90916-B; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; SCANLON J E, 1968, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale, V6, P237; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Stoops CA, 2007, J MED ENTOMOL, V44, P543, DOI 10.1603/0022-2585(2007)44[543:EFAWSA]2.0.CO;2; SUZUKI T, 1981, Southeast Asian Journal of Tropical Medicine and Public Health, V12, P47; Tenenbaum D, 1996, ENVIRON HEALTH PERSP, V104, P1280, DOI 10.2307/3432962; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Van Bortel W, 2000, INSECT MOL BIOL, V9, P335, DOI 10.1046/j.1365-2583.2000.00192.x; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Verhaeghen K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-84; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; WHO, 1998, WHOCDSCPCMAL9812; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; ZHANG SQ, 1994, T ROY SOC TROP MED H, V88, P510	43	40	44	0	16	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUL 21	2010	3								59	10.1186/1756-3305-3-59				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	658MW	WOS:000282495100001	20646327	DOAJ Gold, Green Published			2019-04-02	
J	Twagirumukiza, M; Kayumba, PC; Kips, JG; Vrijens, B; Stichele, RV; Vervaet, C; Remon, JP; Van Bortel, ML				Twagirumukiza, Marc; Kayumba, Pierre Claver; Kips, Jan G.; Vrijens, Bernard; Stichele, Robert Vander; Vervaet, Chris; Remon, Jean Paul; Van Bortel, M. Luc			Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SULFADOXINE-PYRIMETHAMINE; ARTEMETHER-LUMEFANTRINE; COMBINATION; HYPERTENSION; VALIDATION; ARTESUNATE; CHILDREN; THERAPY; PATIENT	Objectives: To compare three methods for evaluating treatment adherence in a 7-day controlled treatment period for malaria in children in Rwanda. Methods: Fifty-six children (< 5 years) with malaria were recruited at the University Hospital of Butare, Rwanda. Patients were treated with quinine sulfate, taste-masked, pellets during seven days: three days in hospital (in-patient) followed by a four-day out-patient period. Three methods to evaluate medication adherence among patients were compared: manual pill count of returned tablets, patient self-report and electronic pill-box monitoring. These pill-boxes were equipped with a microchip registering date and time of every opening. Medication adherence was defined as the proportion of prescribed doses taken. The inter-dose intervals were analysed as well. Results: Medication adherence data were available for 54 of the 56 patients. Manual pill count and patient self-report yielded a medication adherence of 100% for the in-and out-patient treatment periods. Based on electronic pill-box monitoring, medication adherence during the seven-day treatment period was 90.5 +/- 8.3%. Based on electronic pillbox monitoring inpatient medication adherence (99.3 +/- 2.7%) was markedly higher (p < 0.03) than out-patient adherence (82.7 +/- 14.7%), showing a clear difference between health workers' and consumers' medication adherence. Conclusion: Health workers' medication adherence was good. However, a significant lower medication adherence was observed for consumers' adherence in the outpatient setting. This was only detected by electronic pill-box monitoring. Therefore, this latter method is more accurate than the two other methods used in this study.	[Twagirumukiza, Marc; Kips, Jan G.; Stichele, Robert Vander; Van Bortel, M. Luc] Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium; [Twagirumukiza, Marc] Univ Hosp, Dept Internal Med, Butare, Rwanda; [Kayumba, Pierre Claver; Vervaet, Chris; Remon, Jean Paul] Univ Ghent, Fac Pharmaceut Sci, Pharmaceut Technol Lab, B-9000 Ghent, Belgium; [Kayumba, Pierre Claver] Fac Med, Dept Pharm, Butare, Rwanda; [Vrijens, Bernard] Univ Liege, Dept Biostat & Med Informat, Liege, Belgium	Van Bortel, ML (reprint author), Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium.	Luc.VanBortel@UGent.be	Vander Stichele, Robert/K-7203-2015	Vander Stichele, Robert/0000-0001-9118-9651; Vrijens, Bernard/0000-0002-9090-1253; Twagirumukiza, Marc/0000-0003-1378-6922			Bell DJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-204; Byerly M, 2005, PSYCHIAT RES, V133, P129, DOI 10.1016/j.psychres.2004.11.002; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Cramer JA, 1999, TRANSPLANT P, V31, p7S, DOI 10.1016/S0041-1345(99)00112-8; DEKLERK E, 2001, ADV BEHAV MED ASSESM; Depoortere E, 2004, TROP MED INT HEALTH, V9, P62, DOI 10.1046/j.1365-3156.2003.01157.x; Diaz E, 2001, J PSYCHIATR NEUROSCI, V26, P325; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Hugen PWH, 2002, J ACQ IMMUN DEF SYND, V30, P324, DOI 10.1097/01.QAI.0000014768.35851.DB; JEFFREY HS, 2001, AIDS BEHAV, V5, P21; Kachur SP, 2004, AM J TROP MED HYG, V71, P715, DOI 10.4269/ajtmh.2004.71.715; Kayumba PC, 2008, ANN TROP PAEDIATR, V28, P103, DOI 10.1179/146532808X302116; Kokwaro G, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S2; Lee JY, 1996, AM J HYPERTENS, V9, P719, DOI 10.1016/0895-7061(96)00056-8; Mallion JM, 1996, J HYPERTENS, V14, P137; Namkoong K, 1999, J CLIN PSYCHIAT, V60, P449, DOI 10.4088/JCP.v60n0706; Nshakira N, 2002, TROP MED INT HEALTH, V7, P309, DOI 10.1046/j.1365-3156.2002.00858.x; Rosen MI, 2004, BEHAV RES THER, V42, P409, DOI 10.1016/S0005-7967(03)00149-9; RUDD P, 1979, ARCH INTERN MED, V139, P627, DOI 10.1001/archinte.139.6.627; Souares A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-118; Wetzels G, 2006, PATIENT EDUC COUNS, V64, P151, DOI 10.1016/j.pec.2005.12.010; Wetzels GEC, 2007, AM J HYPERTENS, V20, P119, DOI 10.1016/j.amjhyper.2006.07.018; *WHO, 2001, MON ANT DRUG RSIST R; WHO, 2010, GUID TREATM MAL	24	10	10	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 16	2010	9								209	10.1186/1475-2875-9-206				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	657KB	WOS:000282410500001	20637094	DOAJ Gold, Green Published			2019-04-02	
J	Maltha, J; Gillet, P; Cnops, L; van den Ende, J; van Esbroeck, M; Jacobs, J				Maltha, Jessica; Gillet, Philippe; Cnops, Lieselotte; van den Ende, Jef; van Esbroeck, Marjan; Jacobs, Jan			Malaria rapid diagnostic tests: Plasmodium falciparum infections with high parasite densities may generate false positive Plasmodium vivax pLDH lines	MALARIA JOURNAL			English	Article							TRAVELERS; MICROSCOPY; ACCURACY	Background: Most malaria rapid diagnostic tests (RDTs) detect Plasmodium falciparum and an antigen common to the four species. Plasmodium vivax-specific RDTs target P. vivax-specific parasite lactate dehydrogenase (Pv-pLDH). Previous observations of false positive Pv-pLDH test lines in P. falciparum samples incited to the present study, which assessed P. vivax-specific RDTs for the occurrence of false positive Pv-pLDH lines in P. falciparum samples. Methods: Nine P. vivax-specific RDTs were tested with 85 P. falciparum samples of high (>= 2%) parasite density. Mixed P. falciparum/P. vivax infections were ruled out by real-time PCR. The RDTs included two-band (detecting Pv-pLDH), three-band (detecting P. falciparum-antigen and Pv-pLDH) and four-band RDTs (detecting P. falciparum, Pv-pLDH and pan-pLDH). Results: False positive Pv-pLDH lines were observed in 6/9 RDTs (including two-three-and four-band RDTs). They occurred in the individual RDT brands at frequencies ranging from 8.2% to 29.1%. For 19/85 samples, at least two RDT brands generated a false positive Pv-pLDH line. Sixteen of 85 (18.8%) false positive lines were of medium or strong line intensity. There was no significant relation between false positive results and parasite density or geographic origin of the samples. Conclusion: False positive Pv-pLDH lines in P. falciparum samples with high parasite density occurred in 6/9 P. vivax-specific RDTs. This is of concern as P. falciparum and P. vivax are co-circulating in many regions. The diagnosis of life-threatening P. falciparum malaria may be missed (two-band Pv-pLDH RDT), or the patient may be treated incorrectly with primaquine (three-or four-band RDTs).	[Maltha, Jessica; Jacobs, Jan] Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Gillet, Philippe; Cnops, Lieselotte; van den Ende, Jef; van Esbroeck, Marjan; Jacobs, Jan] Inst Trop Med, Unit Trop Lab Med, Dept Clin Sci, B-2000 Antwerp, Belgium	Maltha, J (reprint author), Fac Hlth Med & Life Sci, Maastricht, Netherlands.	j.maltha@student.maastrichtuniversity.nl		gillet, philippe/0000-0001-5878-6446			Chiodini PL, 2007, T ROY SOC TROP MED H, V101, P331, DOI 10.1016/j.trstmh.2006.09.007; Cho D, 2001, PARASITOL RES, V87, P445, DOI 10.1007/s004360000360; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-262; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-129; Habib AG, 2004, INFECTION, V32, P356, DOI 10.1007/s15010-004-4060-6; Kim SH, 2008, TROP MED INT HEALTH, V13, P1495, DOI 10.1111/j.1365-3156.2008.02163.x; Leslie T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002861; Makler MT, 2009, AM J TROP MED HYG, V81, P921, DOI 10.4269/ajtmh.2009.09-0202; Marx A, 2005, ANN INTERN MED, V142, P836, DOI 10.7326/0003-4819-142-10-200505170-00009; Mason DP, 2002, ACTA TROP, V82, P51, DOI 10.1016/S0001-706X(02)00031-1; Mekonnen Z, 2010, ACTA TROP, V113, P285, DOI 10.1016/j.actatropica.2009.12.001; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Pieroni P, 1998, T ROY SOC TROP MED H, V92, P166, DOI 10.1016/S0035-9203(98)90730-1; Rakotonirina H, 2008, AM J TROP MED HYG, V78, P217, DOI 10.4269/ajtmh.2008.78.217; Rogerson SJ, 2008, PLOS MED, V5, P875, DOI 10.1371/journal.pmed.0050136; Sharew B, 2009, ACTA TROP, V111, P321, DOI 10.1016/j.actatropica.2009.05.014; SINA B, 2007, AM J TROP MED HYG, V77, P779; Tarazona Alonso Soto, 2004, Braz J Infect Dis, V8, P151, DOI 10.1590/S1413-86702004000200005; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; van Dijk DPJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-293; WHO, 2006, GUID TREATM MAL; *WHO, LIST KNOWN COMM AV A; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2009, MAL RAP DIAGN TEST P; COMPOSITION MACRO GE	27	16	17	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 10	2010	9								198	10.1186/1475-2875-9-198				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	657JT	WOS:000282409700001	20618990	DOAJ Gold, Green Published			2019-04-02	
J	Bisoffi, Z; Sirima, SB; Menten, J; Pattaro, C; Angheben, A; Gobbi, F; Tinto, H; Lodesani, C; Neya, B; Gobbo, M; Van den Ende, J				Bisoffi, Zeno; Sirima, Sodiomon B.; Menten, Joris; Pattaro, Cristian; Angheben, Andrea; Gobbi, Federico; Tinto, Halidou; Lodesani, Claudia; Neya, Bouma; Gobbo, Maria; Van den Ende, Jef			Accuracy of a rapid diagnostic test on the diagnosis of malaria infection and of malaria - attributable fever during low and high transmission season in Burkina Faso	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CLINICAL CASE DEFINITIONS; RANDOMIZED-TRIAL; ENDEMIC AREAS; MICROSCOPY; PARACHECK-PF(R); MANAGEMENT; FIELD; RELIABILITY; POPULATION	Background: Malaria management policies currently recommend that the treatment should only be administered after laboratory confirmation. Where microscopy is not available, rapid diagnostic tests (RDTs) are the usual alternative. Conclusive evidence is still lacking on the safety of a test-based strategy for children. Moreover, no formal attempt has been made to estimate RDTs accuracy on malaria-attributable fever. This study aims at estimating the accuracy of a RDT for the diagnosis of both malaria infection and malaria-attributable fever, in a region of Burkina Faso with a typically seasonal malaria transmission pattern. Methods: Cross-sectional study. Subjects: all patients aged > 6 months consulting during the study periods. Gold standard for the diagnosis of malaria infection was microscopy. Gold standard for malaria-attributable fever was the number of fevers attributable to malaria, estimated by comparing parasite densities of febrile versus non-febrile subjects. Exclusion criteria: severe clinical condition needing urgent care. Results: In the dry season, 186/852 patients with fever (22%) and 213/1,382 patients without fever (15%) had a Plasmodium falciparum infection. In the rainy season, this proportion was 841/1,317 (64%) and 623/1,669 (37%), respectively. The attributable fraction of fever to malaria was 11% and 69%, respectively. The RDT was positive in 113/ 400 (28.3%) fever cases in the dry season, and in 443/650 (68.2%) in the rainy season. In the dry season, the RDT sensitivity and specificity for malaria infection were 86% and 90% respectively. In the rainy season they were 94% and 78% respectively. In the dry season, the RDT sensitivity and specificity for malaria-attributable fever were 94% and 75%, the positive predictive value (PPV) was 9% and the negative predictive value (NPV) was 99.8%. In the rainy season the test sensitivity for malaria-attributable fever was 97% and specificity was 55%. The PPV ranged from 38% for adults to 82% for infants, while the NPV ranged from 84% for infants to over 99% for adults. Conclusions: In the dry season the RDT has a low positive predictive value, but a very high negative predictive value for malaria-attributable fever. In the rainy season the negative test safely excludes malaria in adults but not in children.	[Bisoffi, Zeno; Angheben, Andrea; Gobbi, Federico; Gobbo, Maria] S Cuore Hosp, Ctr Trop Dis, I-37024 Verona, Italy; [Bisoffi, Zeno; Gobbi, Federico; Neya, Bouma] Projet AnKaHeresso, Bobo Dioulasso, Burkina Faso; [Sirima, Sodiomon B.] Ctr Natl Rech & Format Paludisme, Minist Hlth, Ouagadougou 01, Burkina Faso; [Menten, Joris] Inst Trop Med Prince Leopold, Clin Trials Unit, B-2000 Antwerp, Belgium; [Pattaro, Cristian] European Acad EURAC, Inst Med Genet, I-39100 Bozen Bolzano, Italy; [Tinto, Halidou] Ctr Muraz, Bobo Dioulasso 01, Burkina Faso; [Lodesani, Claudia] Med Sans Frontieres Italy, I-00185 Rome, Italy; [Van den Ende, Jef] Inst Trop Med Prince Leopold, Dept Clin Sci, B-2000 Antwerp, Belgium	Bisoffi, Z (reprint author), S Cuore Hosp, Ctr Trop Dis, I-37024 Verona, Italy.	zeno.bisoffi@sacrocuore.it	Bisoffi, Zeno/B-6438-2013	Tinto, Halidou/0000-0002-0472-3586	UNIDEA-UNICREDIT Foundation	The authors thank the patients who accepted to participate in the study, the personnel of the health centres involved and all the research assistants, as well as all the health staff of the "An Ka Heresso" Project (Progetto Mondo - MLAL) at the time of the field survey: Giuseppe Baracca (who first suggested a study on RDT), Klara Van den Ende, Annalisa Romeo, Mamadou Traore and Rosalie Midjour. We also thank Monica Degani and Barbara Paiola for their active collaboration to the training of the research assistants, Marleen Boelaert for support to data analysis and interpretation and Chris Whitty for critical reading of the manuscript. This study was funded by UNIDEA-UNICREDIT Foundation.	Bejon P, 2007, VACCINE, V25, P8198, DOI 10.1016/j.vaccine.2007.07.057; Belizario V. Y., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P552; Bisoffi Z, 2008, BRIT MED J, V336, P168, DOI 10.1136/bmj.39401.486655.80; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; Drakeley C, 2009, T ROY SOC TROP MED H, V103, P333, DOI 10.1016/j.trstmh.2008.10.003; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Gogtay N J, 2003, J Assoc Physicians India, V51, P762; Guthmann JP, 2002, T ROY SOC TROP MED H, V96, P254, DOI 10.1016/S0035-9203(02)90091-X; Hawkes M, 2007, EXPERT REV ANTI-INFE, V5, P485, DOI 10.1586/14787210.5.3.485; Huong NM, 2002, TROP MED INT HEALTH, V7, P304, DOI 10.1046/j.1365-3156.2002.00869.x; Lubell Y, 2008, BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Mboera LEG, 2006, ANN TROP MED PARASIT, V100, P115, DOI 10.1179/136485906X78571; McGuinness D, 1998, T ROY SOC TROP MED H, V92, P527, DOI 10.1016/S0035-9203(98)90902-6; Mendiratta D K, 2006, Indian J Med Microbiol, V24, P49; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Mwangi TW, 2005, TROP MED INT HEALTH, V10, P530, DOI 10.1111/j.1365-3156.2005.01439.x; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Nicastri E, 2009, AM J TROP MED HYG, V80, P712, DOI 10.4269/ajtmh.2009.80.712; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Proux S, 2001, TROP MED INT HEALTH, V6, P99, DOI 10.1046/j.1365-3156.2001.00694.x; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Risch L, 1999, SCHWEIZ MED WSCHR, V129, P1002; Rogers WO, 2006, J INFECT DIS, V193, P467, DOI 10.1086/499314; Rolland E, 2006, TROP MED INT HEALTH, V11, P398, DOI 10.1111/j.1365-3156.2006.01580.x; ROUGEMONT A, 1991, LANCET, V338, P1292, DOI 10.1016/0140-6736(91)92592-P; Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; Singh DP, 2002, CURR MICROBIOL, V45, P165, DOI 10.1007/s00284-001-0112-7; Singh N, 2005, AM J TROP MED HYG, V72, P26, DOI 10.4269/ajtmh.2005.72.26; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Stauffer WM, 2009, CLIN INFECT DIS, V49, P908, DOI 10.1086/605436; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; Wang SJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-43; WHO, 2010, GUID TREATM MAL; Willcox ML, 2009, ANN TROP MED PARASIT, V103, P3, DOI 10.1179/136485909X384983; 2009, TDR-DRAMA REV-J PERF, P100, DOI DOI 10.2471/TDR.09.978-924-1598071	43	38	38	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 7	2010	9								192	10.1186/1475-2875-9-192				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	657JO	WOS:000282409200001	20609211	DOAJ Gold, Green Published			2019-04-02	
J	Maheu-Giroux, M; Casapia, M; Soto-Calle, VE; Ford, LB; Buckeridge, DL; Coomes, OT; Gyorkos, TW				Maheu-Giroux, Mathieu; Casapia, Martin; Soto-Calle, Veronica E.; Ford, Lea Berrang; Buckeridge, David L.; Coomes, Oliver T.; Gyorkos, Theresa W.			Risk of malaria transmission from fish ponds in the Peruvian Amazon	ACTA TROPICA			English	Article						Aquaculture; Cohort study; Geographic information systems; Plasmodium falciparum; Plasmodium vivax	PLASMODIUM-VIVAX-MALARIA; ANOPHELES-DARLINGI; CENTRAL-AMERICA; FALCIPARUM; VECTOR; DEFORESTATION; CULICIDAE; HABITATS; DIPTERA; REGION	Background: The contribution made by fish ponds (pisciculture) to malaria transmission in the Peruvian Amazon remains to be confirmed. Recent entomological evidence indicates that Anopheles darlingi, the main malaria vector in the region, is frequently found in fish ponds along the Iquitos-Nauta road (Loreto, Peru). The aim of this study was to quantify the effect of fish pond density on malaria occurrence. Methods: A retrospective 30-month cohort study was conducted in eight communities along the Iquitos-Nauta road. Malaria incidence was ascertained from malaria registries of the local health post, which consist of data from both active and passive surveillance (247 cases). Fish pond density was measured using an interpreted satellite image and information on potential confounders was collected through interviewer-administered questionnaires. Results: A total of 1018 individuals from 234 eligible households (90% of the 259 total number of households in the study area) provided complete information on exposures and outcome. Fish pond density was found to be a significant predictor of malaria occurrence (aOR = 1.23; 95% Cl: 1.09-1.38). Conclusion: The association between fish pond density and malaria suggests that fish ponds contribute to malaria transmission in the region. These results have important implications for the prevention and control of malaria and the development of pisciculture as an important economic activity in Amazonia and beyond. (C) 2010 Published by Elsevier B.V.	[Maheu-Giroux, Mathieu; Gyorkos, Theresa W.] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Res Inst, Montreal, PQ H3A 1A1, Canada; [Maheu-Giroux, Mathieu; Buckeridge, David L.; Gyorkos, Theresa W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Casapia, Martin] Asociac Civil Selva Amazon, Cuadra, Iquitos, Peru; [Soto-Calle, Veronica E.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Ford, Lea Berrang; Coomes, Oliver T.] McGill Univ, Dept Geog, Montreal, PQ H3A 2K6, Canada	Gyorkos, TW (reprint author), McGill Univ, Ctr Hlth, Div Clin Epidemiol, Res Inst, Royal Victoria Hosp Campus V Bldg,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	theresa.gyorkos@mcgill.ca	Berrang Ford, Lea/H-5965-2013	Berrang Ford, Lea/0000-0001-9216-8035; Maheu-Giroux, Mathieu/0000-0002-8363-4388	International Development Research Centre; McGill University; 'Fonds de la recherche en sante du Quebec' (FRSQ)	MMG was awarded an 'Ecosystem Approaches to Human Health Graduate Award' from the International Development Research Centre, a Principal's Graduate Fellowship from McGill University, and a scholarship from the 'Fonds de la recherche en sante du Quebec' (FRSQ). FRSQ also provides partial institutional support to TWG's research program.	Achee NL, 2006, J MED ENTOMOL, V43, P382, DOI 10.1603/0022-2585(2006)043[0382:UORSAG]2.0.CO;2; ALCANTARA F, 2001, PISCICULTURE FOOD SE, P83; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; CONSOLI RAG, 1994, PRINCIPAL MOSQUITOES; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; De Jesus MJ, 2004, FISHERIES, V29, P10, DOI 10.1577/1548-8446(2004)29[10:TCFOTP]2.0.CO;2; FARAN M E, 1981, Mosquito Systematics, V13, P1; FERNANDEZ R, 1996, SOC PERUANA ENFERM I, V5, P10; Garcia A, 2009, FISH PHYSIOL BIOCHEM, V35, P53, DOI 10.1007/s10695-008-9212-7; Garrett ES, 1997, EMERG INFECT DIS, V3, P453, DOI 10.3201/eid0304.970406; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Hox J., 2002, MULTILEVEL ANAL TECH; HUDSON JE, 1984, B ENTOMOL RES, V74, P129, DOI 10.1017/S0007485300010002; Junk WJ, 2007, AQUAT ECOSYST HEALTH, V10, P153, DOI 10.1080/14634980701351023; Maki S, 2001, ENVIRON CONSERV, V28, P199; Manguin S, 1996, J MED ENTOMOL, V33, P205, DOI 10.1093/jmedent/33.2.205; Matthys B, 2006, AM J TROP MED HYG, V75, P1223, DOI 10.4269/ajtmh.2006.75.1223; Miglioretti DL, 2007, AM J EPIDEMIOL, V165, P453, DOI 10.1093/aje/kwk020; MOLNAR JL, 2000, 17 OR STAT U, P139; Molyneux DH, 2003, T ROY SOC TROP MED H, V97, P129, DOI 10.1016/S0035-9203(03)90097-6; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Norris DE, 2004, ECOHEALTH, V1, P19, DOI DOI 10.1007/S10393-004-0008-7; OOMEN JMV, 1988, HLTH IRRIGATION INCO; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Parekh FK, 2007, AM J TROP MED HYG, V77, P451, DOI 10.4269/ajtmh.2007.77.451; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Ripley B, 2008, BOOT BOOTSTRAP R S P; Roberts DR, 1997, EMERG INFECT DIS, V3, P295, DOI 10.3201/eid0303.970305; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; SIMPSON JM, 2006, THESIS COLUMBIA U NE, P47; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; VITTOR AY, 2003, THESIS J HOPKINS U B, P480	35	21	21	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JUL-AUG	2010	115	1-2			SI		112	118		10.1016/j.actatropica.2010.02.011				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	613IU	WOS:000278973400015	20188688				2019-04-02	
J	Yewhalaw, D; Van Bortel, W; Denis, L; Coosemans, M; Duchateau, L; Speybroeck, N				Yewhalaw, Delenasaw; Van Bortel, Wim; Denis, Leen; Coosemans, Marc; Duchateau, Luc; Speybroeck, Niko			First Evidence of High Knockdown Resistance Frequency in Anopheles arabiensis (Diptera: Culicidae) from Ethiopia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SODIUM-CHANNEL GENE; KDR MUTATION; INSECTICIDE RESISTANCE; GAMBIAE COMPLEX; PYRETHROID INSECTICIDES; BURKINA-FASO; TREATED NETS; COTE-DIVOIRE; POPULATIONS; MALARIA	The status of knockdown resistance (kdr) mutation was investigated in the major malaria vector Anopheles arabiensis Patton (Diptera: Culicidae) from Ethiopia. Among 240 mosquito samples from 15 villages of southwestern Ethiopia that were screened by allele-specific polymerase chain reaction for kdr mutations, the West African kdr mutation (L1014F) was detected in almost all specimens (98.5%), whereas the East African kdr mutation (L1014S) was absent. Moreover, the mortality of An. gambiae s.l. to diagnostic dosages of 4% DDT, 0.75% permethrin, and 0.05% deltamethrin from bioassay results was 1.0%, 18.1%, and 82.2%, respectively. We report here the highest kdr allele frequency ever observed in An. arabiensis and its implications in malaria vector control in Ethiopia are discussed.	[Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc, Sch Publ Hlth, B-1200 Brussels, Belgium; [Speybroeck, Niko] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Duchateau, Luc] Univ Ghent, Dept Physiol & Biometr, B-9000 Ghent, Belgium; [Van Bortel, Wim; Denis, Leen; Coosemans, Marc] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Yewhalaw, Delenasaw] Jimma Univ, Dept Biol, Jimma, Ethiopia	Speybroeck, N (reprint author), Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium.	delenasaw.yewhalaw@ju.edu.et; nspeybroeck@itg.be		Van Bortel, Wim/0000-0002-6644-518X	Flemish Interuniversity Council (VLIR-IUC)	The study received financial support from Flemish Interuniversity Council (VLIR-IUC).	Abdalla H, 2008, T ROY SOC TROP MED H, V102, P263, DOI 10.1016/j.trstmh.2007.10.008; ABOSE T, 1998, REORIENTATION DEFINI, P19; AMENESHEWA B, 1995, THESIS U LIVERPOOL L; Asidi AN, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-25; Balkew M., 2003, Parassitologia (Rome), V45, P1; Brooke BD, 2008, T ROY SOC TROP MED H, V102, P524, DOI 10.1016/j.trstmh.2008.01.001; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P1; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Diabate A, 2004, J AM MOSQUITO CONTR, V20, P195; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Gillies M, 1987, ANOPHELINAE AFRICA S, P55; Hargreaves K, 2003, MED VET ENTOMOL, V17, P417, DOI 10.1111/j.1365-2915.2003.00460.x; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; Kulkarni MA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-56; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Matambo TS, 2007, MED VET ENTOMOL, V21, P97, DOI 10.1111/j.1365-2915.2007.00671.x; Ministry of Health Uganda, 2005, HLTH SECT STRAT PLAN; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Pinto J, 2006, MED VET ENTOMOL, V20, P27, DOI 10.1111/j.1365-2915.2006.00611.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Verhaeghen Katrijn, 2006, Malaria Journal, V5, P1; WHITE GB, 1980, T ROY SOC TROP MED H, V74, P683; WHO, 1975, MAN PRACT ENT MAL 2; WHO, 1998, WHOCDSCPCMAL9812; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Yawson AE, 2004, MED VET ENTOMOL, V18, P372, DOI 10.1111/j.0269-283X.2004.00519.x; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21	32	35	37	0	8	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUL	2010	83	1					122	125		10.4269/ajtmh.2010.09-0738				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	618OU	WOS:000279366300025	20595490	Green Published, Bronze			2019-04-02	
J	Van den Ende, J; Jacobs, J; Bisoffi, Z				Van den Ende, J.; Jacobs, Jan; Bisoffi, Zeno			Utility of Point-of-Care Malaria Rapid Diagnostic Tests	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Letter									[Van den Ende, J.; Jacobs, Jan] Inst Trop Med, B-2000 Antwerp, Belgium; [Bisoffi, Zeno] Sacro Cuore Hosp, Ctr Trop Dis, Verona, Italy	Van den Ende, J (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.	jvdende@itg.be	Bisoffi, Zeno/B-6438-2013				Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Mills LA, 2010, AM J TROP MED HYG, V82, P145, DOI 10.4269/ajtmh.2010.09-0408	3	1	1	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUL	2010	83	1					207	207		10.4269/ajtmh.2010.10-0114a				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	618OU	WOS:000279366300038	20595503	Green Published, Bronze			2019-04-02	
J	Yates, VM; Lebas, E; Orpiay, R; Bale, BJ				Yates, V. M.; Lebas, E.; Orpiay, R.; Bale, B. J.			Management of snakebites by the staff of a rural clinic: the impact of providing free antivenom in a nurse-led clinic in Meserani, Tanzania	ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY			English	Article							SEEKING BEHAVIOR; BITE; ENVENOMATION	In Tanzania, the impact, on clinical outcomes and treatment-seeking behaviour, of a rural, nurse-led clinic that provides free, antivenom-based treatment of snakebite envenomation was recently assessed. Data on all 85 patients who, between April 2007 and the end of 2009, received treatment for snakebite envenomation at the Snake Park clinic in Meserani, Tanzania, were collected prospectively. Although only four cases of snakebite envenomation were treated in the last 9 months of 2007, 34 such cases were treated in 2008 and 47 in 2009. The 85 snakebite cases had a mean age of 23 years and a male: female ratio of 1.4. Most of the bites occurred in the evening or at night and most also occurred during the rainy season. In some cases, the seeking of treatment from traditional healers delayed treatment at the clinic. After being bitten, the snakebite cases travelled a mean of 82 km (range = 2-550 km) to reach the clinic. Thirty-two (37%) of the cases were each unable to identify the snake that had bit them. Of the bites in which the snake was identified, the puff adder (Bitis arietans) caused more (24) than any other snake. Forty-two of the snakebite cases received antivenom. Only one patient (1%), a 12-year-old girl, was believed to have died as the result of a snakebite but another six (7%) each required a skin graft or the amputation of a limb or digit. Establishment of the Snake Park clinic appears to have improved access to snakebite treatment, with cases of snakebite travelling long distances to reach the clinic (because of the lack of any other source of antivenom in Tanzania). Although the clinic is nurse-led, treatment outcomes among the snakebite victims who attend the clinic appear to be good.	[Yates, V. M.; Lebas, E.] Kilimanjaro Christian Med Ctr, Reg Dermatol Training Ctr, Moshi, Tanzania; [Lebas, E.] Univ Hosp Liege, Dept Dermatol, B-4000 Liege, Belgium; [Orpiay, R.; Bale, B. J.] Meserani Snake Pk, Arusha 13669, Tanzania	Yates, VM (reprint author), 40 Leighton Beck Rd, Slackhead LA7 7AX, Milnthorpe, England.	vicky@vmyates.co.uk					Ahmed Syed Moied, 2008, J Emerg Trauma Shock, V1, P97, DOI 10.4103/0974-2700.43190; CHIPPAUX JP, 1998, PLOS MED, V5, pE221; Coombs MD, 1997, T ROY SOC TROP MED H, V91, P319, DOI 10.1016/S0035-9203(97)90091-2; Cruz LS, 2009, ETHNIC DIS, V19, P42; GARG A, 2009, J INFECT DEV COUNTRI, V30, P221; Ghosh S, 2008, WILD ENVIRON MED, V19, P267, DOI 10.1580/08-WEME-OR-219.1; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kumar N V Girish, 2007, J Indian Med Assoc, V105, P655; Muguti G. I., 1994, Central African Journal of Medicine, V40, P83; Newman WJ, 1997, ANN TROP MED PARASIT, V91, P967, DOI 10.1080/00034983.1997.11813228; NHACI CFB, 2006, J APPL TOXICOL, V14, P191; Sharma N, 2005, EMERG MED J, V22, P118, DOI 10.1136/emj.2003.008458; Simpson ID, 2009, WILD ENVIRON MED, V20, P275, DOI 10.1580/08-WEME-CON-296R1.1; Sloan DJ, 2007, TROP MED INT HEALTH, V12, P1386, DOI 10.1111/j.1365-3156.2007.01924.x; SNOW RW, 1994, ANN TROP MED PARASIT, V88, P665, DOI 10.1080/00034983.1994.11812919; Spawls S., 2004, FIELD GUIDE REPTILES; Suleman M M, 1998, J Pak Med Assoc, V48, P306; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; *WHO, 2009, WHO GUID PROD CONTR; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4	22	8	8	0	5	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0003-4983			ANN TROP MED PARASIT	Ann. Trop. Med. Parasitol.	JUL	2010	104	5					439	448		10.1179/136485910X12743554760306				10	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	642HE	WOS:000281196000010	20819312				2019-04-02	
J	Kibadi, K; Boelaert, M; Fraga, AG; Kayinua, M; Longatto, A; Minuku, JB; Mputu-Yamba, JB; Muyembe-Tamfum, JJ; Pedrosa, J; Roux, JJ; Meyers, WM; Portaels, F				Kibadi, Kapay; Boelaert, Marleen; Fraga, Alexandra G.; Kayinua, Makanzu; Longatto-Filho, Adhemar; Minuku, Jean-Bedel; Mputu-Yamba, Jean-Baptiste; Muyembe-Tamfum, Jean-Jacques; Pedrosa, Jorge; Roux, Jean-Jacques; Meyers, Wayne M.; Portaels, Francoise			Response to Treatment in a Prospective Cohort of Patients with Large Ulcerated Lesions Suspected to Be Buruli Ulcer (Mycobacterium ulcerans Disease)	PLOS NEGLECTED TROPICAL DISEASES			English	Article							INFECTION; STREPTOMYCIN; DIAGNOSIS; COMBINATION; EFFICACY; BENIN; GHANA; PCR	Background: The World Health Organization (WHO) advises treatment of Mycobacterium ulcerans disease, also called "Buruli ulcer'' (BU), with a combination of the antibiotics rifampicin and streptomycin (R+S), whether followed by surgery or not. In endemic areas, a clinical case definition is recommended. We evaluated the effectiveness of this strategy in a series of patients with large ulcers of >= 10 cm in longest diameter in a rural health zone of the Democratic Republic of Congo (DRC). Methods: A cohort of 92 patients with large ulcerated lesions suspected to be BU was enrolled between October 2006 and September 2007 and treated according to WHO recommendations. The following microbiologic data were obtained: Ziehl-Neelsen (ZN) stained smear, culture and PCR. Histopathology was performed on a sub-sample. Directly observed treatment with R+S was administered daily for 12 weeks and surgery was performed after 4 weeks. Patients were followed up for two years after treatment. Findings: Out of 92 treated patients, 61 tested positive for M. ulcerans by PCR. PCR negative patients had better clinical improvement than PCR positive patients after 4 weeks of antibiotics (54.8% versus 14.8%). For PCR positive patients, the outcome after 4 weeks of antibiotic treatment was related to the ZN positivity at the start. Deterioration of the ulcers was observed in 87.8% (36/41) of the ZN positive and in 12.2% (5/41) of the ZN negative patients. Deterioration due to paradoxical reaction seemed unlikely. After surgery and an additional 8 weeks of antibiotics, 98.4% of PCR positive patients and 83.3% of PCR negative patients were considered cured. The overall recurrence rate was very low (1.1%). Interpretation: Positive predictive value of the WHO clinical case definition was low. Low relapse rate confirms the efficacy of antibiotics. However, the need for and the best time for surgery for large Buruli ulcers requires clarification. We recommend confirmation by ZN stain at the rural health centers, since surgical intervention without delay may be necessary on the ZN positive cases to avoid progression of the disease. PCR negative patients were most likely not BU cases. Correct diagnosis and specific management of these non-BU ulcers cases are urgently needed.	[Kibadi, Kapay] PNLUB, Kinshasa, Zaire; [Kibadi, Kapay; Muyembe-Tamfum, Jean-Jacques] Inst Natl Rech Biomed, Kinshasa, Zaire; [Kibadi, Kapay; Mputu-Yamba, Jean-Baptiste] Univ Kinshasa, Dept Surg, Kinshasa, Zaire; [Boelaert, Marleen] Inst Trop Med, Epidemiol Unit, B-2000 Antwerp, Belgium; [Fraga, Alexandra G.; Longatto-Filho, Adhemar; Pedrosa, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Kayinua, Makanzu] Gen Reference Hosp Nsona Mpangu, Lower Congo, Zaire; [Kayinua, Makanzu; Minuku, Jean-Bedel] Rural Hlth Zone Nsona Mpangu, Lower Congo, Zaire; [Longatto-Filho, Adhemar] Sao Paulo State Univ, Fac Med, Dept Pathol, LIM 14, Sao Paulo, Brazil; [Roux, Jean-Jacques] Assoc Pathol Cytol Dev, Hosp Chambery, Anat Pathol Unit, Chambery, France; [Meyers, Wayne M.] Armed Forces Inst Pathol, Washington, DC 20306 USA; [Portaels, Francoise] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium	Kibadi, K (reprint author), PNLUB, Kinshasa, Zaire.	portaels@itg.be	Longatto Filho, Adhemar/A-2889-2016; Boelaert, Marleen/E-2698-2012; Fraga, Alexandra/T-5174-2018; longatto-filho, adhemar/D-7039-2013; Pedrosa, Jorge/H-4877-2011	Boelaert, Marleen/0000-0001-8051-6776; Fraga, Alexandra/0000-0003-2029-1629; longatto-filho, adhemar/0000-0002-5779-9752; Pedrosa, Jorge/0000-0002-8204-4888	Directorate-General for Development and Cooperation (DGDC), Brussels, Belgium; European Commission [INCO-CT-2005-051476-BURULICO]; Health Services of Fundacao Calouste Gulbenkian	This study was supported by the Directorate-General for Development and Cooperation (DGDC), Brussels, Belgium, the European Commission (International Science and Technology Cooperation Development Program) (project no. INCO-CT-2005-051476-BURULICO), and by a grant from the Health Services of Fundacao Calouste Gulbenkian. K.K. was supported by a grant from DGDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar J, 1997, Med Trop (Mars), V57, P83; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P145; BUNTINE J, 2001, WHOCDSCPEGBUI20013; CHAUTY A, 2005, B ALLF, V17, P40; CHAUTY A, 2009, WHO ANN M BUR ULC CO, P42; Chauty A, 2007, ANTIMICROB AGENTS CH, V51, P4029, DOI 10.1128/AAC.00175-07; CONNOR DH, 1966, ARCH PATHOL, V81, P183; Debacker M, 2004, EMERG INFECT DIS, V10, P1391, DOI 10.3201/eid1008.030886; DODGE OG, 1964, J PATHOL BACTERIOL, V88, P167, DOI 10.1002/path.1700880122; Eddyani M, 2008, J CLIN MICROBIOL, V46, P69, DOI 10.1128/JCM.00301-07; Espey David K., 2002, International Journal of Infectious Diseases, V6, P60, DOI 10.1016/S1201-9712(02)90138-4; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.; Guarner J, 2003, EMERG INFECT DIS, V9, P651; HAYMAN J, 1993, J CLIN PATHOL, V46, P5, DOI 10.1136/jcp.46.1.5; JANSSENS PG, 2005, B SEANCES ACAD R SCI, V51, P165; Johnson PDR, 2010, LANCET, V375, P618, DOI 10.1016/S0140-6736(10)60169-9; Johnson RC, 2008, AIDS, V22, P901, DOI 10.1097/QAD.0b013e3282f7690a; Kibadi K, 2005, Med Trop (Mars), V65, P444; KIBADI K, 2006, EMERG INFECT DIS, V14, P1790; Kibadi K, 2010, EMERG INFECT DIS, V16, P738, DOI 10.3201/eid1604.091343; Lagarrigue V, 2000, Med Trop (Mars), V60, P262; Mensah-Quainoo E, 2008, TROP MED INT HEALTH, V13, P191, DOI 10.1111/j.1365-3156.2007.01990.x; Meyers W M, 1974, Ann Soc Belg Med Trop, V54, P147; NIENHUIS W, 2009, WHO ANN M BUR ULC CO; Nienhuis WA, 2010, LANCET, V375, P664, DOI 10.1016/S0140-6736(09)61962-0; OBRIEN DP, 2009, MED J AUSTRALIA, V192, P564; Phanzu DM, 2006, AM J TROP MED HYG, V75, P311, DOI 10.4269/ajtmh.2006.75.311; *PNMLS PRES REP RE, 2007, PUBL PNMLS; Portaels F, 2001, WHOCDSCPEGBUI4; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; Pszolla N, 2003, CLIN INFECT DIS, V37, P78; Ross BC, 1997, J CLIN MICROBIOL, V35, P1696; Schutte D, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000002; Stienstra Y, 2003, J CLIN MICROBIOL, V41, P794, DOI 10.1128/JCM.41.2.794-797.2003; *WHO, 2004, WHOCDSCPEGBUI200410	35	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2727			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2010	4	7							e736	10.1371/journal.pntd.0000736				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	632HC	WOS:000280412300007	20625556	DOAJ Gold, Green Published			2019-04-02	
J	Matovu, E; Mugasa, CM; Ekangu, RA; Deborggraeve, S; Lubega, GW; Laurent, T; Schoone, GJ; Schallig, HD; Buscher, P				Matovu, Enock; Mugasa, Claire M.; Ekangu, Rosine Ali; Deborggraeve, Stijn; Lubega, George W.; Laurent, Thierry; Schoone, Gerard J.; Schallig, Henk D.; Buescher, Philippe			Phase II Evaluation of Sensitivity and Specificity of PCR and NASBA Followed by Oligochromatography for Diagnosis of Human African Trypanosomiasis in Clinical Samples from D. R. Congo and Uganda	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; RHODESIENSE SLEEPING SICKNESS; SEQUENCE-BASED AMPLIFICATION; LEISHMANIA PARASITES; BRUCEI-GAMBIENSE; CATT; QUANTIFICATION; CENTRIFUGATION; CONFIRMATION	Background: The polymerase chain reaction (PCR) and nucleic acid sequence-based amplification (NASBA) have been recently modified by coupling to oligochromatography (OC) for easy and fast visualisation of products. In this study we evaluate the sensitivity and specificity of the PCR-OC and NASBA-OC for diagnosis of Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense human African trypanosomiasis (HAT). Methodology and Results: Both tests were evaluated in a case-control design on 143 HAT patients and 187 endemic controls from the Democratic Republic of Congo (DRC) and Uganda. The overall sensitivity of PCR-OC was 81.8% and the specificity was 96.8%. The PCR-OC showed a sensitivity and specificity of 82.4% and 99.2% on the specimens from DRC and 81.3% and 92.3% on those from Uganda. NASBA-OC yielded an overall sensitivity of 90.2%, and a specificity of 98.9%. The sensitivity and specificity of NASBA-OC on the specimens from DRC was 97.1% and 99.2%, respectively. On the specimens from Uganda we observed a sensitivity of 84.0% and a specificity of 98.5%. Conclusions/Significance: The tests showed good sensitivity and specificity for the T. b. gambiense HAT in DRC but rather a low sensitivity for T. b. rhodesiense HAT in Uganda.	[Matovu, Enock; Mugasa, Claire M.; Lubega, George W.] Makerere Univ, Dept Vet Parasitol & Microbiol, Kampala, Uganda; [Mugasa, Claire M.; Schoone, Gerard J.; Schallig, Henk D.] Royal Trop Inst, Dept Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Ekangu, Rosine Ali] INRB, Dept Parasitol, Kinshasa, Zaire; [Deborggraeve, Stijn; Buescher, Philippe] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Deborggraeve, Stijn] Katholieke Univ Leuven, Rega Inst, Leuven, Belgium; [Laurent, Thierry] Coris BioConcept, Gembloux, Belgium	Matovu, E (reprint author), Makerere Univ, Dept Vet Parasitol & Microbiol, Kampala, Uganda.	matovue@vetmed.mak.ac.ug	Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472; Deborggraeve, Stijn/0000-0003-1501-5355; Matovu, Enock/0000-0003-0714-7032	European Communities [015379]	This study was financed by the commission of the European Communities Sixth Framework Programme, priority INCO-DEV, Project TRYLEIDIAG, contract 015379. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akol MN, 1999, E AFR MED J, V76, P38; Barrett MP, 2006, LANCET, V367, P1377, DOI 10.1016/S0140-6736(06)68591-7; BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Deborggraeve S, 2006, J CLIN MICROBIOL, V44, P2884, DOI 10.1128/JCM.02594-05; DEBORGGRAEVE S, LANCET INFE IN PRESS; Deborggraeve S, 2008, DIAGN MICR INFEC DIS, V61, P428, DOI 10.1016/j.diagmicrobio.2008.03.006; DUKES P, 1992, ACTA TROP, V51, P123, DOI 10.1016/0001-706X(92)90054-2; Enyaru JCK, 1998, ANN TROP MED PARASIT, V92, P845; Kuboki N, 2003, J CLIN MICROBIOL, V41, P5517, DOI 10.1128/JCM.41.12.5517-5524.2003; Legros D, 2002, LANCET INFECT DIS, V2, P437, DOI 10.1016/S1473-3099(02)00321-3; LUMSDEN WHR, 1979, T ROY SOC TROP MED H, V73, P312, DOI 10.1016/0035-9203(79)90092-0; Lutumba P, 2007, EMERG INFECT DIS, V13, P1484, DOI 10.3201/eid1310.060358; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Miezan TW, 2000, T ROY SOC TROP MED H, V94, P293, DOI 10.1016/S0035-9203(00)90327-4; Mugasa CM, 2009, J CLIN MICROBIOL, V47, P630, DOI 10.1128/JCM.01430-08; NGAIRA JM, 1992, TROP MED PARASITOL, V43, P29; NGOYI DM, J INFECT DI IN PRESS; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; PRIOTO G, 2009, LANCET, DOI DOI 10.1016/S0140-6736909)61117-X; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Simarro PP, 1999, TROP MED INT HEALTH, V4, P858, DOI 10.1046/j.1365-3156.1999.00494.x; SIMMARO PP, 2009, PLOS MED, V5, pE55; Truc P, 2002, B WORLD HEALTH ORGAN, V80, P882; van der Meide W, 2008, J CLIN MICROBIOL, V46, P73, DOI 10.1128/JCM.01416-07; van der Meide WF, 2005, J CLIN MICROBIOL, V43, P5560, DOI 10.1128/JCM.43.11.5560-5566.2005; von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P71; Woo P. T. K., 1970, Acta trop., V27, P384	29	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2727			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2010	4	7							e737	10.1371/journal.pntd.0000737				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	632HC	WOS:000280412300008	20625557	DOAJ Gold, Green Published			2019-04-02	
J	Sopoh, GE; Barogui, YT; Johnson, RC; Dossou, AD; Makoutode, M; Anagonou, SY; Kestens, L; Portaels, F				Sopoh, Ghislain Emmanuel; Barogui, Yves Thierry; Johnson, Roch Christian; Dossou, Ange Dodji; Makoutode, Michel; Anagonou, Severin Y.; Kestens, Luc; Portaels, Francoise			Family Relationship, Water Contact and Occurrence of Buruli Ulcer in Benin	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MYCOBACTERIUM-ULCERANS; RISK-FACTORS; INFECTIOUS-DISEASES; GENETIC DISSECTION; SUSCEPTIBILITY; LEPROSY; GHANA; INTERLEUKIN-10; CONSANGUINITY; TUBERCULOSIS	Background: Mycobacterium ulcerans disease (Buruli ulcer) is the most widespread mycobacterial disease in the world after leprosy and tuberculosis. How M. ulcerans is introduced into the skin of humans remains unclear, but it appears that individuals living in the same environment may have different susceptibilities. Objectives: This study aims to determine whether frequent contacts with natural water sources, family relationship or the practice of consanguineous marriages are associated with the occurrence of Buruli ulcer (BU). Design: Case control study. Setting: Department of Atlantique, Benin. Subjects: BU-confirmed cases that were diagnosed and followed up at the BU detection and treatment center (CDTUB) of Allada (Department of the Atlantique, Benin) during the period from January 1st, 2006, to June 30th, 2008, with three matched controls (persons who had no signs or symptoms of active or inactive BU) for age, gender and village of residence per case. Main Outcomes Measured: Contact with natural water sources, BU history in the family and the practice of consanguineous marriages. Results: A total of 416 participants were included in this study, including 104 cases and 312 controls. BU history in the family (p < 0.001), adjusted by daily contact with a natural water source (p = 0.007), was significantly associated with higher odds of having BU (OR; 95% CI = 5.5; 3.0-10.0). The practice of consanguineous marriage was not associated with the occurrence of BU (p = 0.40). Mendelian disorders could explain this finding, which may influence individual susceptibility by impairing immunity. Conclusion: This study suggests that a combination of genetic factors and behavioral risk factors may increase the susceptibility for developing BU.	[Sopoh, Ghislain Emmanuel; Dossou, Ange Dodji] CDTUB Allada, Allada, Benin; [Barogui, Yves Thierry] CDTUB Lalo, Lalo, Benin; [Johnson, Roch Christian] PNLLUB, Cotonou, Benin; [Makoutode, Michel] IRSP, Ouidah, Benin; [Anagonou, Severin Y.] PNT, LRM, Cotonou, Benin; [Kestens, Luc] Inst Trop Med, Dept Microbiol, Immunol Unit, B-2000 Antwerp, Belgium; [Portaels, Francoise] Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium	Sopoh, GE (reprint author), CDTUB Allada, Allada, Benin.	portaels@itg.be		SOPOH, Ghislain Emmanuel/0000-0003-1237-1047	Government of Benin; Raoul Follereau Foundation of Luxembourg; European Union [INCO-CT-2005-051476]; UBS Optimus Foundation, Switzerland; Damien Action, Brussels, Belgium; Directorate-General for Development and Cooperation (DGDC), Brussels, Belgium; World Health Organization (WHO), Geneva, Switzerland	The authors are grateful to all the partners who support the PNLLUB and the CDTUB Allada, in particular the following: 1. Government of Benin; 2. Raoul Follereau Foundation of Luxembourg; 3. Burulico Project (European Union project INCO-CT-2005-051476); 4. Stop Buruli project (UBS Optimus Foundation), Switzerland; 5. Damien Action, Brussels, Belgium; 6. Directorate-General for Development and Cooperation (DGDC), Brussels, Belgium; 7. World Health Organization (WHO), Geneva, Switzerland. The funders had no role in study design, data collection, data analysis, data interpretation, decisions to publish or preparation of the manuscript.	Aiga H, 2004, AM J TROP MED HYG, V71, P387, DOI 10.4269/ajtmh.2004.71.387; Alcais A, 2005, CURR OPIN IMMUNOL, V17, P44, DOI 10.1016/j.coi.2004.11.006; Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Asiedu K, 1998, AM J TROP MED HYG, V59, P1015, DOI 10.4269/ajtmh.1998.59.1015; ASIEDU K, 2000, BURULI ULCER, P1; Awomoyi AA, 2002, J INFECT DIS, V186, P1808, DOI 10.1086/345920; BAI PVA, 1981, TROP GEOGR MED, V33, P275; BARKER DJP, 1972, T ROY SOC TROP MED H, V66, P867, DOI 10.1016/0035-9203(72)90121-6; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Casanova JL, 2001, SWISS MED WKLY, V131, P445; Catherinot E, 2005, REV MAL RESPIR, V22, P767, DOI 10.1019/200530081; Debacker M, 2006, EMERG INFECT DIS, V12, P1325, DOI 10.3201/eid1209.050598; Drummond C, 2004, EMERG INFECT DIS, V10, P1038, DOI 10.3201/eid1006.030428; Duker AA, 2006, ENVIRON INT, V32, P567, DOI 10.1016/j.envint.2006.01.002; Eddyani M, 2004, APPL ENVIRON MICROB, V70, P5679, DOI 10.1128/AEM.70.9.5679-5681.2004; El Baghdadi J, 2006, J EXP MED, V203, P1679, DOI 10.1084/jem.20060269; Gooding TM, 2002, INFECT IMMUN, V70, P5562, DOI 10.1128/IAI.70.10.5562-5567.2002; Gooding TM, 2001, INFECT IMMUN, V69, P1704, DOI 10.1128/IAI.69.3.1704-1707.2001; Janssens P, 2005, B SEANCES ACAD R SCI, V51, P265; Johnson RC, 2005, EMERG INFECT DIS, V11, P500, DOI 10.3201/eid1103.040597; Kilbadi K, 2008, EMERG INFECT DIS, V14, P1790, DOI 10.3201/eid1411.071649; Kotlowski R, 2004, J MED MICROBIOL, V53, P927, DOI 10.1099/jmm.0.45593-0; LAROSA FMD, 2008, B ALLF, V23, P60; LUNN H F, 1965, East Afr Med J, V42, P275; Lyons EJ, 2009, BIOL LETTERS, V5, P574, DOI 10.1098/rsbl.2009.0133; MARSTON BJ, 1995, AM J TROP MED HYG, V52, P219, DOI 10.4269/ajtmh.1995.52.219; Merritt RW, 2005, FRONT ECOL ENVIRON, V3, P323, DOI 10.1890/1540-9295(2005)003[0323:UAEDAW]2.0.CO;2; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Nackers F, 2007, AM J TROP MED HYG, V77, P834, DOI 10.4269/ajtmh.2007.77.834; Okenu DMN, 2004, CLIN DIAGN LAB IMMUN, V11, P387, DOI 10.1128/CDLI.11.2.387-391.2004; OLUWASANMI JO, 1976, AM J TROP MED HYG, V25, P122, DOI 10.4269/ajtmh.1976.25.122; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; Portaels F, 2001, REV SCI TECH OIE, V20, P252, DOI 10.20506/rst.20.1.1270; PORTAELS F, 2001, BURULI ULCER DIAGNOS, P92; Portaels F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000178; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; Pouillot R, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000101; Prevot G, 2004, INFECT IMMUN, V72, P958, DOI 10.1128/IAI.72.2.958-965.2004; Raghunathan PL, 2005, CLIN INFECT DIS, V40, P1445, DOI 10.1086/429623; RAVISSE P, 1977, B SOC PATHOL EXOT, V70, P109; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Silva MT, 2009, LANCET INFECT DIS, V9, P699, DOI 10.1016/S1473-3099(09)70234-8; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; Stienstra Y, 2006, GENES IMMUN, V7, P185, DOI 10.1038/sj.gene.6364281; Stienstra Y, 2001, TROP MED INT HEALTH, V6, P554, DOI 10.1046/j.1365-3156.2001.00746.x; Stinear T, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000216; World Health Organization, 2004, WHOCDSCPEGBUI10	50	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2010	4	7							e746	10.1371/journal.pntd.0000746				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	632HC	WOS:000280412300015	20644620	DOAJ Gold, Green Published			2019-04-02	
J	Gloriani, NG; Srinivasa, K; Bock, HL; Hoet, B				Gloriani, Nina G.; Srinivasa, Karthik; Bock, Hans L.; Hoet, Bernard			IMMUNOGENICITY OF HBV VACCINE DURING STATED SHELF-LIFE	SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH			English	Article						HBV vaccine; immunogenicity; shelf-life; preservative	HEPATITIS-B-VACCINE; FORMULATIONS; EFFICACY; ADULTS	Thiomersal has been used as preservative in multi-dose vials of hepatitis B vaccine (Engerix (TM)-B). Due to safety concerns, thiomersal was replaced with 2-phenoxyethanol (2PE) as preservative in multi-dose vials. The potency of 2PE preserved hepatitis B vaccine multiple use vials was measured over the shelf-life in terms of immunogenicity, reactogenicity and safety. This single-blind, randomized study was conducted with the assistance of employees of GlaxoSmithKline Biologicals, makers of the Engerix (TM)-B vaccine. Four hundred twenty subjects aged years were randomized to receive three doses (0, 1, 6 months) of 2PE preserved hepatitis B vaccine kept on the shelf <12 months (2PE New group), 2PE preserved hepatitis B vaccine kept on the shelf >18 months (2PE Old group), or thiomersal preserved hepatitis B vaccine [HBV(Thio) group]. Anti-HBs was measured by GlaxoSmithKline Biologicals post-vaccination; the reactogenicity and safety of the vaccines were assessed. Protective anti-HBs levels (>= 10 mIU/ml) were measured one month after dose 3. The results showed protective levels in 86.8% (2PE New), 89% (2PE Old) and 95.3% [HBV(Thio)]. There was no difference detected between the 2PE New and 2PE Old groups in terms of anti-HBs seroprotection rates and geometric mean concentrations one month after dose 3. However, both 2PE groups had significantly lower seroprotection rates than the HBV(Thio) group and the number of non-responders was higher in the 2PE groups than in the Thio group. A antibody response rates over time were similar between the 2PE New and Old groups. The reactogenicity profiles were acceptable and the ranges were similar for each group. The shelf-life of the vaccines had no impact on immunogenicity or reactogenicity and 2PE preserved hepatitis B vaccine can be considered stable over time.	[Gloriani, Nina G.] Univ Philippines, Coll Publ Hlth, Dept Microbiol, Manila 1000, Philippines; [Srinivasa, Karthik; Bock, Hans L.; Hoet, Bernard] GlaxoSmithKline Biol, Wavre, Belgium	Gloriani, NG (reprint author), Univ Philippines, Coll Publ Hlth, Dept Microbiol, 625 Pedro Gil St, Manila 1000, Philippines.	ninagloriani@yahoo.com					American Academy of Pediatrics, 1999, PEDIATRICS, V104, P568; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P642; Clements CJ, 2005, EXPERT REV VACCINES, V4, P281, DOI 10.1586/14760584.4.3.281; *EMEA, 1999, PUBL EMEA; *EMEA, 2001, CPMPEWPQWP140198 EME, P1; Keating GM, 2003, DRUGS, V63, P1021, DOI 10.2165/00003495-200363100-00006; POOVORAWAN Y, 1992, PEDIATR INFECT DIS J, V11, P816, DOI 10.1097/00006454-199210000-00002; POOVORAWAN Y, 1990, VACCINE, V8, pS56, DOI 10.1016/0264-410X(90)90237-G; Rebedea I, 2006, VACCINE, V24, P5320, DOI 10.1016/j.vaccine.2006.04.018; Van Damme P, 2009, J MED VIROL, V81, P1710, DOI 10.1002/jmv.21568; *WHO, 204 WHO; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P255; World Health Organization, 1998, SAF SAF PROM CONC OP, P1; World Health Organization (WHO), 2006, TEMP SENS VACC, P1; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	15	1	2	0	0	SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION	BANGKOK	SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND	0125-1562			SE ASIAN J TROP MED	Southeast Asian J. Trop. Med. Public Health	JUL	2010	41	4					876	882						7	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	633RK	WOS:000280521900013	21073062				2019-04-02	
J	Meheus, F; Boelaert, M				Meheus, F.; Boelaert, M.			The burden of visceral leishmaniasis in South Asia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material							INDIA; DISEASE; BIHAR; ELIMINATION; HOUSEHOLDS; MANAGEMENT; COMMUNITY; POVERTY; NEPAL		[Meheus, F.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Meheus, F (reprint author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	fmeheus@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776			Ahluwalia IB, 2003, AM J TROP MED HYG, V69, P624, DOI 10.4269/ajtmh.2003.69.624; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x; Das P, 2010, TROP MED INT HEALTH, V15, P4, DOI 10.1111/j.1365-3156.2010.02517.x; Hasker E, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02562.x; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; Lutumba P, 2007, EMERG INFECT DIS, V13, P248, DOI 10.3201/eid1302.060075; MEHEUS F, 2010, P AM SOC TROP MED HY; Meheus F, 2006, TROP MED INT HEALTH, V11, P1715, DOI 10.1111/j.1365-3156.2006.01732.x; Mishra RN, 2010, TROP MED INT HEALTH, V15, P36, DOI 10.1111/j.1365-3156.2010.02544.x; Mondal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000355; Reithinger R, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000285; Rijal S, 2006, T ROY SOC TROP MED H, V100, P838, DOI 10.1016/j.trstmh.2005.09.017; Rijal S, 2010, TROP MED INT HEALTH, V15, P21, DOI 10.1111/j.1365-3156.2010.02518.x; Sarnoff R, 2010, TROP MED INT HEALTH, V15, P42, DOI 10.1111/j.1365-3156.2010.02516.x; SHARMA AD, 2006, TROP MED INT HEALTH, V11, P757; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh SP, 2010, TROP MED INT HEALTH, V15, P29, DOI 10.1111/j.1365-3156.2010.02515.x; Singh SP, 2010, TROP MED INT HEALTH, V15, P12, DOI 10.1111/j.1365-3156.2010.02519.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Sundar S, 2010, TROP MED INT HEALTH, V15, P50, DOI 10.1111/j.1365-3156.2010.02520.x; *WHO TDR, 2009, RES SUPP EL VISC LEI; World Health Organization, 2005, REG STRAT FRAM EL KA	24	2	2	0	4	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2010	15			2			1	3		10.1111/j.1365-3156.2010.02564.x				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	604ZB	WOS:000278315900001	20591079	Bronze			2019-04-02	
J	Singh, SP; Picado, A; Boelaert, M; Gidwani, K; Andersen, EW; Ostyn, B; Meheus, F; Rai, M; Chappuis, F; Davies, C; Sundar, S				Singh, Shri P.; Picado, Albert; Boelaert, Marleen; Gidwani, Kamlesh; Andersen, Elisabeth W.; Ostyn, Bart; Meheus, Filip; Rai, Madhukar; Chappuis, Francois; Davies, Clive; Sundar, Shyam			The epidemiology of Leishmania donovani infection in high transmission foci in India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						epidemiology; kala-azar; India; Leishmania donovani; infection; direct agglutination test (DAT)	DIRECT AGGLUTINATION-TEST; AZAR DERMAL LEISHMANIASIS; VISCERAL LEISHMANIASIS; KALA-AZAR; ENDEMIC AREA; RISK-FACTORS; SUBCONTINENT; PREVALENCE; ANTIBODIES; DISEASE	P>Objective Visceral Leishmaniasis (VL) is highly prevalent in Bihar, India. India and its neighbours aim at eliminating VL, but several knowledge gaps in the epidemiology of VL may hamper that effort. The prevalence of asymptomatic infections with Leishmania donovani and their role in transmission dynamics are not well understood. We report data from a sero-survey in Bihar. Methods Demographic and immunological surveys were carried out in July and November 2006, respectively in 16 highly VL endemic foci in Muzaffarpur district in Bihar. Household and individual information was gathered and capillary blood samples were collected on filter papers. Direct agglutination test (DAT) was used to determine infected individuals (cut-off titre 1:1600). DAT results were tabulated against individual and household variables. A multivariate generalized estimating equation (GEE) model was used to study the prevalence of serologically positive individuals taking into account the clustering at household and cluster levels. Results Of study subjects 18% were DAT positive, and this proportion increased with age. Women had a significantly lower prevalence than men > 14 years old. Owning domestic animals (cows, buffaloes or goats) was associated with a higher risk of being DAT positive [OR 1.16 (95% CI 1.01-1.32)], but socio-economic status was not. Conclusions Prevalence of leishmanial antibodies was high in these communities, but variable. Demographic factors (i.e. marriage) may explain the lower DAT positivity in women > 14 years of age. Within these homogeneously poor communities, socio-economic status was not linked to L. donovani infection risk at the individual level, but ownership of domestic animals was.	[Singh, Shri P.; Gidwani, Kamlesh; Rai, Madhukar; Sundar, Shyam] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India; [Picado, Albert; Andersen, Elisabeth W.; Davies, Clive] London Sch Hyg & Trop Med, London WC1, England; [Boelaert, Marleen; Ostyn, Bart; Meheus, Filip] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Chappuis, Francois] Univ Hosp Geneva, Div Int & Humanitarian Med, Geneva, Switzerland	Singh, SP (reprint author), Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India.	drspsingh_vns@yahoo.com		Picado, Albert/0000-0001-7344-628X; Boelaert, Marleen/0000-0001-8051-6776	European Union [015374]	This study received financial support from the KALANET project funded by the European Union DG Research Sixth Framework Programme/INCODEV (Proposal Contract No.: 015374). The funding source had no role in the study design; collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The author's work was independent of the funders (the funding source had no involvement).	ADDY M, 1992, B WORLD HEALTH ORGAN, V70, P341; ALI A, 1994, ANN TROP MED PARASIT, V88, P289, DOI 10.1080/00034983.1994.11812869; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2000, AM J TROP MED HYG, V63, P184, DOI 10.4269/ajtmh.2000.63.184; Bhattarai NR, 2009, TROP MED INT HEALTH, V14, P404, DOI 10.1111/j.1365-3156.2009.02242.x; Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x; Chappuis F, 2006, BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; CHELALA C, 2004, BOSTON GLOBE NE 0426; CHOWDHURY MS, 1993, PARASITOL RES, V79, P444, DOI 10.1007/BF00931580; Davies CR, 1999, PARASITOLOGY, V119, P247, DOI 10.1017/S0031182099004680; Davies CR, 2003, BRIT MED J, V326, P377, DOI 10.1136/bmj.326.7385.377; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124; Gidwani K, 2009, TROP MED INT HEALTH, V14, P187; International Institute for Population Sciences & Macro International, 2007, NAT FAM HLTH SURV NF; Jacquet D, 2006, TROP MED INT HEALTH, V11, P1777, DOI 10.1111/j.1365-3156.2006.01743.x; OFFICE OF THE REGISTRAR GENERAL AND CENSUS COMMISSIONER, 2001, CENS IND 2001; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; Rijal S, 2010, TROP MED INT HEALTH, V15, P21, DOI 10.1111/j.1365-3156.2010.02518.x; Saha S, 2009, T ROY SOC TROP MED H, V103, P737, DOI 10.1016/j.trstmh.2008.10.006; Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh SP, 2010, TROP MED INT HEALTH, V15, P29, DOI 10.1111/j.1365-3156.2010.02515.x; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826; ZIJLSTRA EE, 1991, T ROY SOC TROP MED H, V85, P474, DOI 10.1016/0035-9203(91)90224-M	29	35	38	0	8	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2010	15			2			12	20		10.1111/j.1365-3156.2010.02519.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	604ZB	WOS:000278315900003	20487420	Bronze			2019-04-02	
J	Rijal, S; Uranw, S; Chappuis, F; Picado, A; Khanal, B; Paudel, IS; Andersen, EW; Meheus, F; Ostyn, B; Das, ML; Davies, C; Boelaert, M				Rijal, Suman; Uranw, Surendra; Chappuis, Francois; Picado, Albert; Khanal, Basudha; Paudel, Ishwari S.; Andersen, Elisabeth W.; Meheus, Filip; Ostyn, Bart; Das, Murari L.; Davies, Clive; Boelaert, Marleen			Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Leishmania donovani; infection; epidemiology; Nepal; kala-azar; DAT	DIRECT AGGLUTINATION-TEST; VISCERAL LEISHMANIASIS; KALA-AZAR; RISK-FACTORS; INDIA; POVERTY; BIHAR	P>Objective Nepal reports a visceral leishmaniasis (VL) incidence of 5 per 10 000 per year on the basis of notification by health facilities, but little community-based epidemiological information exists. We report data on prevalence rates of Leishmania donovani infection in ten communities in East Nepal. Methods Ten clusters with highest VL incidence rates were purposefully selected in Nepal. All households were mapped and socio-demographic data and data on past VL incidence were collected. An exhaustive serological survey was performed of individuals aged > 2 years, by collecting finger prick blood on filter paper in November-December 2006. The samples were tested by direct agglutination, and a titre >= 1:1600 was taken as marker of infection. A generalized estimating equation (GEE) model was used to assess risk factors for Direct Agglutination Test (DAT) positivity taking into account the clustering at household and village level. Results The sero-survey (n = 5397) showed an infection prevalence rate of 9%, (range 5-15% per cluster) with higher prevalence in men (9.9%) than in women (8.3%) (P = 0.049). Male gender, increasing age and poverty were significant risk factors in the final GEE model. Conclusion Leishmania infection rate in high-transmission areas in Nepal is associated with gender, age and socio-economic status.	[Rijal, Suman; Uranw, Surendra; Khanal, Basudha; Paudel, Ishwari S.; Das, Murari L.] BP Koirala Inst Hlth Sci, Ghopa, Dharan, Nepal; [Chappuis, Francois] Univ Hosp Geneva, Div Int & Humanitarian Med, Geneva, Switzerland; [Picado, Albert; Andersen, Elisabeth W.; Davies, Clive] London Sch Hyg & Trop Med, London WC1, England; [Meheus, Filip; Ostyn, Bart; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Rijal, S (reprint author), BP Koirala Inst Hlth Sci, Ghopa, Dharan, Nepal.	sumanrijal2@yahoo.com	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Das, Murari/0000-0001-6816-2389; Picado, Albert/0000-0001-7344-628X	European Union [015374]	This article is dedicated to the life and work of Prof. Clive Davies who passed away in March 2009. The authors gratefully acknowledge the financial support by the European Union for this study, (Proposal Contract No.: 015374; FP6/INCO-DEV). We are also grateful to the people of the study area for their active participation in the study and the project field staff for their hard work in the collection of data. This study received financial support from the KALANET project funded by the European Union DG Research Sixth Framework Programme/INCODEV. (Proposal Contract No.: 015374). The funding source had no role in the study design; collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The author's work was independent of the funders (the funding source had no involvement).	Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bhattarai NR, 2009, TROP MED INT HEALTH, V14, P404, DOI 10.1111/j.1365-3156.2009.02242.x; Bista MB, 1998, KALA AZAR NEPAL PRIN, P1; Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x; CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030; Fakhar M, 2008, ANN TROP MED PARASIT, V102, P577, DOI 10.1179/136485908X337526; Gidwani K, 2009, AM J TROP MED HYG, V80, P345, DOI 10.4269/ajtmh.2009.80.345; Jacquet D, 2006, TROP MED INT HEALTH, V11, P1777, DOI 10.1111/j.1365-3156.2006.01743.x; Koirala S, 2004, TROP MED INT HEALTH, V9, P533, DOI 10.1111/j.1365-3156.2004.01212.x; LAWYER PG, 1992, 81324 VBC USAID; Moshfe A, 2009, ACTA TROP, V112, P101, DOI 10.1016/j.actatropica.2009.07.004; PETERS W, 1981, INDIAN J MED RES, V73, P1; Picado A, 2010, J MED ENTOMOL, V47, P283, DOI 10.1603/ME09175; Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x; Shrestha S. L., 1994, JNMA, Journal of the Nepal Medical Association, V32, P237; SUNDAR S, 2009, TROPICAL MED INT S24, V11; *TDR, 2005, EL KAL AZ END COUNTR; *WHO, 1990, WHO TECH REP SER, V793, P1, DOI DOI 10.3201/EID1105.040718; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	22	34	35	0	9	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2010	15			2			21	28		10.1111/j.1365-3156.2010.02518.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	604ZB	WOS:000278315900004	20487421	Bronze			2019-04-02	
J	Singh, SP; Hasker, E; Picado, A; Gidwani, K; Malaviya, P; Singh, RP; Boelaert, M; Sundar, S				Singh, S. P.; Hasker, E.; Picado, A.; Gidwani, K.; Malaviya, P.; Singh, R. P.; Boelaert, M.; Sundar, S.			Risk factors for visceral leishmaniasis in India: further evidence on the role of domestic animals	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						leishmaniasis; visceral; risk factors; disease transmission; infectious	PHLEBOTOMUS-PAPATASI; KALA-AZAR; BIHAR; PREFERENCE; ARGENTIPES; NEPAL	P>Objective Studies investigating risk factors for visceral leishmaniasis (VL) on the Indian Subcontinent have shown contradictory results related to the role of domestic animals. In some studies having animals in or around the house was a risk factor, in others it was protective. We investigated the specific hypothesis that keeping domestic animals inside the house at night is a risk factor for VL. Methods Individually matched case-control study. All patients with VL diagnosed in the study area in Bihar, India between March 1st, 2007 and December 1st, 2008 were eligible. For each case, we selected two random controls, with no history of previous VL; matched on sex, age group and neighbourhood. Patients and controls were subjected to a structured interview on the main exposure of interest and potential confounders; a conditional logistic regression model was used to analyse the data. Results We enrolled 141 patients and 282 controls. We found no significant associations between VL and keeping domestic animals inside the house (OR of 0.88 for bovines and 1.00 for 'any animal') or ownership of domestic animals (OR of 0.97 for bovines and 1.02 for 'any animal'). VL was associated with housing conditions. Living in a thatched house (OR 2.60, 95% CI 1.50-4.48) or in a house with damp floors (OR 2.60, 95% CI 1.25-5.41) were risk factors, independently from socio economic status. Conclusion Keeping animals inside the house is not a risk factor for VL in Bihar, India. Improving housing conditions for the poor has the potential to reduce VL incidence.	[Singh, S. P.; Gidwani, K.; Malaviya, P.; Singh, R. P.; Sundar, S.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Hasker, E.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Picado, A.] London Sch Hyg & Trop Med, London, England	Sundar, S (reprint author), Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	Boelaert, Marleen/E-2698-2012; Malaviya, Paritosh/B-1819-2012	Boelaert, Marleen/0000-0001-8051-6776; Malaviya, Paritosh/0000-0002-7558-152X; Picado, Albert/0000-0001-7344-628X	NIAID, NIH TMRC [1P50AI074321]	This work was supported by NIAID, NIH TMRC Grant No. 1P50AI074321.	Barnett PG, 2005, AM J TROP MED HYG, V73, P720, DOI 10.4269/ajtmh.2005.73.720; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2000, AM J TROP MED HYG, V63, P184, DOI 10.4269/ajtmh.2000.63.184; Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x; Chelbi I, 2008, VECTOR-BORNE ZOONOT, V8, P741, DOI 10.1089/vbz.2007.0265; Gidwani K, 2009, AM J TROP MED HYG, V80, P345, DOI 10.4269/ajtmh.2009.80.345; *GOV BIH, POP SCHEM IND AAW YO; MUKHOPADHYAY AK, 1987, INDIAN J MED RES, V86, P475; Palit A, 2005, INT J ENVIRON HEAL R, V15, P449, DOI 10.1080/09603120500392525; Ranjan A, 2005, AM J TROP MED HYG, V73, P74, DOI 10.4269/ajtmh.2005.73.74; SAHA S, 2008, T ROY SOC TROP MED H, V103, P737; Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x; Singh R, 2008, ACTA TROP, V107, P117, DOI 10.1016/j.actatropica.2008.04.025; Sivagnaname N., 1997, Journal of Communicable Diseases, V29, P153; *WHO, 1990, WHO TECH REP SER, V793, P1, DOI DOI 10.3201/EID1105.040718; *WHO, 1982, 66 WHO, P159	16	22	23	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2010	15			2			29	35		10.1111/j.1365-3156.2010.02515.x				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	604ZB	WOS:000278315900005	20487424	Bronze, Green Accepted			2019-04-02	
J	Mishra, RN; Singh, SP; Vanlerberghe, V; Sundar, S; Boelaert, M; Lefevre, P				Mishra, Rabindra N.; Singh, S. P.; Vanlerberghe, Veerle; Sundar, Shyam; Boelaert, Marleen; Lefevre, Pierre			Lay perceptions of kala-azar, mosquitoes and bed nets in Bihar, India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						visceral leishmaniasis; kala-azar; disease perception; bed nets; India; sand fly	VISCERAL LEISHMANIASIS; ENDEMIC AREAS; KNOWLEDGE; SUBCONTINENT; DIAGNOSIS; VECTOR; NEPAL	P>Objective To describe the lay perception of kala-azar (KA) in an endemic area of Muzaffarpur District, Bihar, India: local names, symptoms, affected persons, perceived severity and modes of transmission, as well as perceived mosquito nuisance, modes of protection and use of bed nets. Methods We held 16 focus group discussions (FGD) in eight remote villages with altogether 157 participants in March 2008. Separate FGDs were held according to gender, socio-economic status (SES) and with key informants. Results Kala-azar is most commonly named pilahi. Poor people were said to be the most affected. Knowledge about symptoms was satisfactory. Fever and prolonged fever were the most stated symptoms. KA was perceived as a life-threatening disease with a heavy economic burden. Mosquito bites were perceived as the main mode of transmission but in lower socio-economic groups, non-vector-related explanations were also provided. The main modes of protection from mosquitoes mentioned were the use of fumes and bed nets. Season was the strongest factor influencing the use of bed nets and non-affordability for not owning them. Conclusions Although the sand fly is not recognised as the vector, the relatively good awareness of disease transmission by mosquitoes and the nuisance caused by their high density might be an entry point for adopting preventive measures to protect from mosquito bite and thereby indirectly preventing from KA. Educational campaigns targeted to the poorer segments of society are needed to enhance knowledge about KA, its mode of transmission, risks of getting infected and to increase bed net use.	[Mishra, Rabindra N.] Banaras Hindu Univ, Dept Community Med, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Vanlerberghe, Veerle; Boelaert, Marleen; Lefevre, Pierre] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Mishra, RN (reprint author), Banaras Hindu Univ, Dept Community Med, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	rnmishra_prem@rediffmail.com	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776	European Union [015374]	We gratefully acknowledge the role played by all field research staff involved in the KALANET project. We also thank the people of the concerned localities in India who participated in the study. We received financial support from the European Union, Proposal Contract No. 015374 (KALANET). The funding source was not involved in any stage of the research process.	Adongo PB, 2005, TROP MED INT HEALTH, V10, P366, DOI 10.1111/j.1365-3156.2005.01361.x; Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x; Boelaert M, 2000, T ROY SOC TROP MED H, V94, P465, DOI 10.1016/S0035-9203(00)90055-5; Das ML, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000100; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Koirala S, 1998, B WORLD HEALTH ORGAN, V76, P485; Lal S, 1996, MANUAL VISCERAL LEIS, P167; Murray HW, 2002, NEW ENGL J MED, V347, P1793, DOI 10.1056/NEJMe020133; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; Singh SP, 2006, AM J TROP MED HYG, V75, P505, DOI 10.4269/ajtmh.2006.75.505; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar S, 2008, TROP MED INT HEALTH, V13, P2, DOI 10.1111/j.1365-3156.2007.01974.x; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P60, DOI 10.1111/j.1365-3156.2009.02433.x	14	7	7	0	4	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2010	15			2			36	41		10.1111/j.1365-3156.2010.02544.x				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	604ZB	WOS:000278315900006	20591080	Bronze			2019-04-02	
J	Sundar, S; Arora, R; Singh, SP; Boelaert, M; Varghese, B				Sundar, Shyam; Arora, Rakesh; Singh, S. P.; Boelaert, Marleen; Varghese, Beena			Household cost-of-illness of visceral leishmaniasis in Bihar, India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						cost of illness; visceral leishmaniasis; economic evaluation; direct costs; cost analysis	LIPOSOMAL AMPHOTERICIN-B; DRUG-RESISTANCE; INFUSIONS	P>Objective To determine the cost of kala-azar (KA) to patients in Bihar, India. Method A semi-structured questionnaire was used to collect costs of illness - direct (medical; non-medical) and indirect costs (work days lost). After screening the community known to be endemic for visceral leishmaniasis (VL), households (HHs) with VL were recruited which reported a case of KA who received treatment between September 2005 and September 2006. The total costs were calculated as a summation of individual costs category. Medians were estimated for the total and for each of the cost categories. Result Data from 171 HHs and 183 patients revealed that median age of patients with KA was 18; 59% were men; 33% were employed; household size was 7; household median monthly income was $38. The median total costs per patient were $127, equal to > 3 months of income, of which medical care comprised $83 (provider fees $13, medicines $50, diagnostics $9, hospital stay $30); and food and transport comprised $33. Patients also lost almost 2 weeks of work time during illness and even after recovery. Conclusion Despite provision of free/subsidized medicines, diagnostics, and hospital stay at public and Non-Governmental Organization facilities, the impoverished HHs of Bihar with a case of KA incur high expenditures. Easier access to, and more use of free public health services, plus innovative health financing schemes, are urgently required.	[Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Varghese, Beena] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	Sundar, S (reprint author), Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776	European Union [015374]	The authors gratefully acknowledge the financial support by the European Union for this study (proposal Contract No.: 015374; FP6/INCO-DEV). We are also grateful to the people of the study area for their active participation in the study.	Bern C, 2006, CLIN INFECT DIS, V43, P917, DOI 10.1086/507530; BOELAERT M, 2009, TROP MED INT HEALTH, V14, P1; Bryceson A, 2001, TROP MED INT HEALTH, V6, P928, DOI 10.1046/j.1365-3156.2001.00795.x; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; Meheus F, 2006, TROP MED INT HEALTH, V11, P1715, DOI 10.1111/j.1365-3156.2006.01732.x; Olliaro P, 2009, TROP MED INT HEALTH, V14, P88, DOI 10.1111/j.1365-3156.2008.02195.x; Rijal S, 2006, T ROY SOC TROP MED H, V100, P838, DOI 10.1016/j.trstmh.2005.09.017; Sharma DA, 2006, TROP MED INT HEALTH, V11, P757, DOI 10.1111/j.1365-3156.2006.01604.x; Sundar S, 2005, B WORLD HEALTH ORGAN, V83, P394; Sundar S, 2001, BRIT MED J, V323, P419, DOI 10.1136/bmj.323.7310.419; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar S, 2007, CLIN INFECT DIS, V45, P556, DOI 10.1086/520665; World Bank, 2005, BIH DEV STRAT	13	11	11	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2010	15			2			50	54		10.1111/j.1365-3156.2010.02520.x				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	604ZB	WOS:000278315900008	20487419	Bronze			2019-04-02	
J	Hasker, E; Singh, SP; Malaviya, P; Singh, RP; Shankar, R; Boelaert, M; Sundar, S				Hasker, E.; Singh, S. P.; Malaviya, P.; Singh, R. P.; Shankar, R.; Boelaert, M.; Sundar, S.			Management of visceral leishmaniasis in rural primary health care services in Bihar, India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						leishmaniasis; Visceral Primary Health Care Treatment Outcome Patient Acceptance of Health Care	KALA-AZAR	P>Objective In 2005 a visceral leishmaniasis (VL) elimination initiative was launched on the Indian subcontinent, with early diagnosis based on a rapid diagnostic test and treatment with the oral drug miltefosine as its main strategy. Several recent studies have signaled underreporting of VL cases in the region. Information on treatment outcomes is scanty. Our aim was to document VL case management by the primary health care services in India. Methods We took a random sample of all VL patients registered in rural primary health care (PHC) facilities of Muzaffarpur district, Bihar, India during 2008. Patients were traced at home for an interview and their records were reviewed. We recorded patient and doctor delay, treatment regimens, treatment outcomes and costs incurred by patients. Results We could review records of all 150 patients sampled and interview 139 patients or their guardian. Most patients (81%) had first presented to unqualified practitioners; median delay before reaching the appropriate primary healthcare facility was 40 days (IQR 31-59 days). Existing networks of village health workers were under-used. 48% of VL patients were treated with antimonials; 40% of those needed a second treatment course. Median direct expenditure by patients was 4000 rupees per episode (IQR 2695-5563 rupees), equivalent to almost 2 months of household income. Conclusion In 2008 still critical flaws remained in VL case management in the primary health care services in Bihar: obsolete use of antimonials with high failure rates and long patient delay. To meet the target of the VL elimination, more active case detection strategies are needed, and village health worker networks could be more involved. Costs to patients remain an obstacle to early case finding.	[Singh, S. P.; Malaviya, P.; Singh, R. P.; Shankar, R.; Sundar, S.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Hasker, E.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium	Sundar, S (reprint author), Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	Malaviya, Paritosh/B-1819-2012; Boelaert, Marleen/E-2698-2012	Malaviya, Paritosh/0000-0002-7558-152X; Boelaert, Marleen/0000-0001-8051-6776	NIAID, NIH TMRC [1P50AI074321]; European Commission [HEALTH-F3-2008-222895 KALADRUG]	This work was supported by NIAID, NIH TMRC Grant No. 1P50AI074321 and the European Commission, grant HEALTH-F3-2008-222895 KALADRUG.	[Anonymous], 2005, REG STRAT FRAM EL KA; Barnett PG, 2005, AM J TROP MED HYG, V73, P720, DOI 10.4269/ajtmh.2005.73.720; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x; Boelaert M, 2000, T ROY SOC TROP MED H, V94, P465, DOI 10.1016/S0035-9203(00)90055-5; Elnaiem DEA, 2003, AM J TROP MED HYG, V68, P10, DOI 10.4269/ajtmh.2003.68.1.0680010; Joshi A., 2008, Journal of Vector Borne Diseases, V45, P105; Kumar R, 2007, HEALTH CARE ANAL, V15, P223, DOI 10.1007/s10728-007-0060-x; Lockwood DNJ, 2006, BMJ-BRIT MED J, V333, P711, DOI 10.1136/bmj.38989.567083.BE; Meheus F, 2006, TROP MED INT HEALTH, V11, P1715, DOI 10.1111/j.1365-3156.2006.01732.x; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; SBARBARO J, 2004, TOMANS TUBERCULOSIS, P181; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Sundar S, 2001, AM J TROP MED HYG, V65, P193, DOI 10.4269/ajtmh.2001.65.193; *WHO, 2003, WHOCDSTB20031313; *WHO, 2010, COUNTR OFF IND OR EV; *WHO, COUNTR OFF IND PRIM	18	21	21	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2010	15			2			55	62		10.1111/j.1365-3156.2010.02562.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	604ZB	WOS:000278315900009	20591081	Green Accepted, Bronze			2019-04-02	
J	Mugasa, CM; Deborggraeve, S; Schoone, GJ; Laurent, T; Leeflang, MM; Ekangu, RA; El Safi, S; Saad, AA; Basiye, FL; De Doncker, S; Lubega, GW; Kager, PA; Buscher, P; Schallig, HDFH				Mugasa, Claire M.; Deborggraeve, Stijn; Schoone, Gerard J.; Laurent, Thierry; Leeflang, Mariska M.; Ekangu, Rosine A.; El Safi, Sayda; Saad, Al-farazdag A.; Basiye, Frank L.; De Doncker, Simone; Lubega, George W.; Kager, Piet A.; Buscher, Philippe; Schallig, Henk D. F. H.			Accordance and concordance of PCR and NASBA followed by oligochromatography for the molecular diagnosis of Trypanosoma brucei and Leishmania	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						leishmaniasis; trypanosomiais; diagnostics; nucleic acid sequence-based amplification; polymerase chain reaction; oligochromatography	SEQUENCE-BASED AMPLIFICATION; CLINICAL-SAMPLES; PARASITES; QUANTIFICATION; TRIALS	OBJECTIVE To evaluate the repeatability and reproducibility of four simplified molecular assays for the diagnosis of Trypanosoma brucei spp. or Leishmania ssp. in a multicentre ring trial with seven participating laboratories. METHODS The tests are based on PCR or NASBA amplification of the parasites nucleic acids followed by rapid read-out by oligochromatographic dipstick (PCR-OC and NASBA-OC). RESULTS On purified nucleic acid specimens, the repeatability and reproducibility of the tests were Tryp-PRC-OC, 91.7% and 95.5%; Tryp-NASBA-OC, 95.8% and 100%; Leish-PCR-OC, 95.9% and 98.1%; Leish-NASBA-OC, 92.3% and 98.2%. On blood specimens spiked with parasites, the repeatability and reproducibility of the tests were Tryp-PRC-OC, 78.4% and 86.6%; Tryp-NASBA-OC, 81.5% and 89.0%; Leish-PCR-OC, 87.1% and 91.7%; Leish-NASBA-OC, 74.8% and 86.2%. CONCLUSION As repeatability and reproducibility of the tests were satisfactory, further phase IT and III evaluations in clinical and population specimens from disease endemic countries are justified.	[Schallig, Henk D. F. H.] KIT, Parasitol Unit, NL-1105 AZ Amsterdam, Netherlands; [Mugasa, Claire M.; Lubega, George W.] Makerere Univ, Dept Vet Parasitol & Microbiol, Kampala, Uganda; [Deborggraeve, Stijn; De Doncker, Simone; Buscher, Philippe] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Laurent, Thierry] Coris BioConcept, Gembloux, Belgium; [Leeflang, Mariska M.] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, NL-1012 WX Amsterdam, Netherlands; [Ekangu, Rosine A.] Inst Natl Rech Biomed, Dept Parasitol, Kinshasa, Zaire; [El Safi, Sayda; Saad, Al-farazdag A.] Univ Khartoum, Fac Med, Khartoum, Sudan; [Basiye, Frank L.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Kager, Piet A.] Univ Amsterdam, Acad Med Ctr, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands	Schallig, HDFH (reprint author), KIT, Parasitol Unit, Meibergdreef 39, NL-1105 AZ Amsterdam, Netherlands.	h.schallig@kit.nl	Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472; Leeflang, Mariska/0000-0001-5960-0471	Commission of the European Community [015379]	We thank all our partners in the TRYLEIDIAG consortium for the input towards this study and Ronald Geskus (Department of Clinical Epidemiology, Biostatistics and Bioinformatics; Academic Medical Center; University of Amsterdam; Amsterdam; The Netherlands) for performing bootstrap analyses. This work was supported by the Commission of the European Communities' Sixth Framework Programme, priority INCO-DEV, project TRYLEIDIAG, contract 015379. Stijn Deborggraeve is a postdoctoral fellow of the Research Foundation Flanders (FWO, Belgium).	BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Claes F, 2007, J CLIN MICROBIOL, V45, P3785, DOI 10.1128/JCM.01244-07; Davison A. C., 1997, BOOTSTRAP METHODS TH; Deborggraeve S, 2006, J CLIN MICROBIOL, V44, P2884, DOI 10.1128/JCM.02594-05; Deborggraeve S, 2008, J INFECT DIS, V198, P1565, DOI 10.1086/592509; Langton SD, 2002, INT J FOOD MICROBIOL, V79, P175, DOI 10.1016/S0168-1605(02)00107-1; Mugasa CM, 2008, DIAGN MICR INFEC DIS, V61, P440, DOI 10.1016/j.diagmicrobio.2008.03.019; Mugasa CM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-13; Mugasa CM, 2009, J CLIN MICROBIOL, V47, P630, DOI 10.1128/JCM.01430-08; van der Meide W, 2008, J CLIN MICROBIOL, V46, P73, DOI 10.1128/JCM.01416-07; van der Meide WF, 2005, J CLIN MICROBIOL, V43, P5560, DOI 10.1128/JCM.43.11.5560-5566.2005; van der Voet H, 2004, INT J FOOD MICROBIOL, V95, P231, DOI 10.1016/j.ijfoodmicro.2004.03.013	12	13	13	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2010	15	7					800	805		10.1111/0365-3156.2010.02547.x				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	616XW	WOS:000279245800003	20487429				2019-04-02	
J	Basiye, FL; Mbuchi, M; Magiri, C; Kirigi, G; Deborggraeve, S; Schoone, GJ; Saad, AA; El-Safi, S; Matovu, E; Wasunna, MK				Basiye, Frank L.; Mbuchi, Margaret; Magiri, Charles; Kirigi, George; Deborggraeve, Stijn; Schoone, Gerard J.; Saad, Alfarazdeg A.; El-Safi, Sayda; Matovu, Enock; Wasunna, Monique K.			Sensitivity and specificity of the Leishmania OligoC-TesT and NASBA-oligochromatography for diagnosis of visceral leishmaniasis in Kenya	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						visceral leishmaniasis; diagnosis; polymerase chain reaction; nucleic acid sequence-based amplification; sensitivity; specificity	DIRECT AGGLUTINATION-TEST; KALA-AZAR; PCR; ACCURACY; SAMPLES	OBJECTIVE To estimate the sensitivity and specificity of the OligoC-TesT and nucleic acid sequence-based amplification coupled to oligochromatography (NASBA-OC) for molecular detection of Leishmania in blood from patients with confirmed visceral leishmaniasis (VL) and healthy endemic controls from Kenya. METHODS Blood specimens of 84 patients with confirmed VL and 98 endemic healthy controls from Baringo district in Kenya were submitted to both assays. RESULTS The Leishmania OligoC-TesT showed a sensitivity of 96.4% (95% confidence interval [CI]: 90-98.8%) and a specificity of 88.8% (95% CI: 81-93.6%), while the sensitivity and specificity of the NASBA-OC were 79.8% (95% CI: 67-87%) and 100% (95% CI: 96.3-100%), respectively. CONCLUSION Our findings indicate high sensitivity of the Leishmania OligoC-TesT on blood while the NASBA-OC is a better marker for active disease.	[Deborggraeve, Stijn] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Basiye, Frank L.; Mbuchi, Margaret; Magiri, Charles; Kirigi, George; Wasunna, Monique K.] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya; [Deborggraeve, Stijn] Katholieke Univ Leuven, Rega Inst, Leuven, Belgium; [Schoone, Gerard J.] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Saad, Alfarazdeg A.; El-Safi, Sayda] Univ Khartoum, Fac Med, Khartoum, Sudan; [Matovu, Enock] Makerere Univ, Fac Vet Med, Kampala, Uganda	Deborggraeve, S (reprint author), Inst Trop Med, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	sdeborggraeve@itg.be		Matovu, Enock/0000-0003-0714-7032; Deborggraeve, Stijn/0000-0003-1501-5355	commission of the European community [015379]	The study received financial support from the commission of the European communities' Sixth Framework Programme, priority INCO-DEV, project TRYLEIDIAG, contract 015379. S. Deborggraeve is a postdoctoral fellow of the Research Foundation Flanders (FWO). OligoC-TesT and NASBA-OC kits used in this evaluation study were provided by Cons Bioconcept, Gembloux, Belgium. We further acknowledge Dr. Seuleiman Hussein, Director Soba Teaching Hospital, Khartoum, Sudan for the laboratory facilities. We are also grateful to all study participants and field workers from KEMRI who efficiently mobilised the participants.	ANDERSON K, 1994, TROP MED INT HEALTH, V2, P440; Antinori S, 2007, CLIN INFECT DIS, V44, P1602, DOI 10.1086/518167; Bhattarai NR, 2009, TROP MED INT HEALTH, V14, P404, DOI 10.1111/j.1365-3156.2009.02242.x; Boelaert M, 1999, AM J TROP MED HYG, V60, P129, DOI 10.4269/ajtmh.1999.60.129; Boelart M, 2007, NATURE REV MICROBIOL, V1, pS30, DOI DOI 10.1038/NRMICRO1766; BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Chappuis F, 2005, J CLIN MICROBIOL, V43, P5973, DOI 10.1128/JCM.43.12.5973-5977.2005; Deborggraeve S, 2008, TROP MED INT HEALTH, V13, P1378, DOI 10.1111/j.1365-3156.2008.02154.x; Deborggraeve S, 2008, J INFECT DIS, V198, P1565, DOI 10.1086/592509; HAILU A, 1990, T ROY SOC TROP MED H, V84, P673, DOI 10.1016/0035-9203(90)90141-Z; HARITH AE, 1988, J CLIN MICROBIOL, V26, P1321; Hunt P, 2007, NEGLECTED DIS HUMAN; Maurya R, 2005, J CLIN MICROBIOL, V43, P3038, DOI 10.1128/JCM.43.7.3038-3041.2005; MUGASA C, 2010, TROPICAL ME IN PRESS; Mugasa CM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-13; Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76; SALOTRA P, 2001, J CLIN MICROBIOL, V39, P357; ter Horst R, 2009, AM J TROP MED HYG, V80, P929, DOI 10.4269/ajtmh.2009.80.929; WHO, 1996, MICR MALN HALF WORLD, P1	21	14	14	0	2	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2010	15	7					806	810		10.1111/j.1365-3156.2010.02548.x				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	616XW	WOS:000279245800004	20487428				2019-04-02	
J	Maltha, J; Gillet, P; Bottieau, E; Cnops, L; van Esbroeck, M; Jacobs, J				Maltha, Jessica; Gillet, Philippe; Bottieau, Emmanuel; Cnops, Lieselotte; van Esbroeck, Marjan; Jacobs, Jan			Evaluation of a rapid diagnostic test (CareStart (TM) Malaria HRP-2/pLDH (Pf/pan) Combo Test) for the diagnosis of malaria in a reference setting	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM MALARIA; POLYMERASE-CHAIN-REACTION; ANTIGEN-DETECTION TESTS; RETURNED TRAVELERS; EXPERT MICROSCOPY; PERFORMANCE; FIELD; PCR; INSTRUCTIONS; ACCURACY	Background: Malaria Rapid Diagnostic Tests (RDTs) are widely used for diagnosing malaria. The present retrospective study evaluated the CareStart (TM) Malaria HRP-2/pLDH (Pf/pan) Combo Test targeting the Plasmodium falciparum specific antigen histidine-rich protein (HRP-2) and the pan-Plasmodium antigen lactate dehydrogenase (pLDH) in a reference setting. Methods: The CareStart (TM) Malaria HRP-2/pLDH (Pf/pan) Combo Test was evaluated on a collection of samples obtained in returned international travellers using microscopy corrected by PCR as the reference method. Included were P. falciparum (n = 320), Plasmodium vivax (n = 76), Plasmodium ovale (n = 76), Plasmodium malariae (n = 23) and Plasmodium negative samples (n = 95). Results: Overall sensitivity for the detection of P. falciparum was 88.8%, increasing to 94.3% and 99.3% at parasite densities above 100 and 1,000/mu l respectively. For P. vivax, P. ovale and P. malariae, overall sensitivities were 77.6%, 18.4% and 30.4% respectively. For P. vivax sensitivity reached 90.2% for parasite densities above 500/mu l. Incorrect species identification occurred in 11/495 samples (2.2%), including 8/320 (2.5%) P. falciparum samples which generated only the pan-pLDH line. For P. falciparum samples, 205/284 (72.2%) HRP-2 test lines had strong or medium line intensities, while for all species the pan-pLDH lines were less intense, especially in the case of P. ovale. Agreement between observers was excellent (kappa values > 0.81 for positive and negative readings) and test results were reproducible. The test was easy to perform with good clearing of the background. Conclusion: The CareStart (TM) Malaria HRP-2/pLDH (Pf/pan) Combo Test performed well for the detection of P. falciparum and P. vivax, but sensitivities for P. ovale and P. malariae were poor.	[Gillet, Philippe; Bottieau, Emmanuel; Cnops, Lieselotte; van Esbroeck, Marjan; Jacobs, Jan] ITM, Dept Clin Sci, Antwerp, Belgium; [Maltha, Jessica; Jacobs, Jan] FHML, Dept Med Microbiol, Maastricht, Netherlands	Gillet, P (reprint author), ITM, Dept Clin Sci, Antwerp, Belgium.	pgillet@itg.be		gillet, philippe/0000-0001-5878-6446			Ashley EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-241; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; Bossuyt PM, 2003, CROAT MED J, V44, P639; Craig MH, 2002, T ROY SOC TROP MED H, V96, P258, DOI 10.1016/S0035-9203(02)90092-1; De Monbrison F, 2004, EUR J CLIN MICROBIOL, V23, P784, DOI 10.1007/s10096-004-1202-9; Farcas GA, 2003, AM J TROP MED HYG, V69, P589, DOI 10.4269/ajtmh.2003.69.6.0690589; Fogg C, 2008, T ROY SOC TROP MED H, V102, P25, DOI 10.1016/j.trstmh.2007.09.014; Gatti S, 2007, ANN TROP MED PARASIT, V101, P195, DOI 10.1179/136485907X156997; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-129; Grobusch MP, 2003, PARASITOL RES, V89, P354, DOI 10.1007/s00436-002-0764-7; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Jelinek T, 2000, J TRAVEL MED, V7, P175, DOI 10.2310/7060.2000.00055; Marx A, 2005, ANN INTERN MED, V142, P836, DOI 10.7326/0003-4819-142-10-200505170-00009; Mason DP, 2002, ACTA TROP, V82, P51, DOI 10.1016/S0001-706X(02)00031-1; Mayxay M, 2004, TROP MED INT HEALTH, V9, P325, DOI 10.1111/j.1365-3156.2004.01199.x; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Pieroni P, 1998, T ROY SOC TROP MED H, V92, P166, DOI 10.1016/S0035-9203(98)90730-1; Ratsimbasoa A, 2007, AM J TROP MED HYG, V76, P481, DOI 10.4269/ajtmh.2007.76.481; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Richardson DC, 2002, J CLIN MICROBIOL, V40, P4528, DOI 10.1128/JCM.40.12.4528-4530.2002; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Sharew B, 2009, ACTA TROP, V111, P321, DOI 10.1016/j.actatropica.2009.05.014; United Nations, 2010, COMP MACR CONT REG G; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; Whitty CJM, 2000, AM J TROP MED HYG, V63, P295, DOI 10.4269/ajtmh.2000.63.295; WHO, 2006, GUID TREATM MAL; WHO, 2008, WORLD MAL REP 2008; *WHO, 2003, MAL RAP DIAGN MAK IT; Wiese L, 2006, SCAND J INFECT DIS, V38, P1063, DOI 10.1080/00365540600818011; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2009, MAL RAP DIAGN TEST P; World Health Organization Malaria Rapid Diagnostic Test Performance, 2009, MAL RAP DIAGN TEST P, P2010	35	38	39	1	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUN 18	2010	9								171	10.1186/1475-2875-9-171				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	629BV	WOS:000280169900001	20565816	DOAJ Gold, Green Published			2019-04-02	
J	Van den Eede, P; Van der Auwera, G; Delgado, C; Huyse, T; Soto-Calle, VE; Gamboa, D; Grande, T; Rodriguez, H; Llanos, A; Anne, J; Erhart, A; D'Alessandro, U				Van den Eede, Peter; Van der Auwera, Gert; Delgado, Christopher; Huyse, Tine; Soto-Calle, Veronica E.; Gamboa, Dionicia; Grande, Tanilu; Rodriguez, Hugo; Llanos, Alejandro; Anne, Jozef; Erhart, Annette; D'Alessandro, Umberto			Multilocus genotyping reveals high heterogeneity and strong local population structure of the Plasmodium vivax population in the Peruvian Amazon	MALARIA JOURNAL			English	Article							GENETIC DIFFERENTIATION MEASURE; RURAL AMAZONIA; MALARIA; FALCIPARUM; TRANSMISSION; DYNAMICS; EPIDEMIOLOGY; INFECTIONS; DIVERSITY; COMMUNITY	Background: Peru is one of the Latin American countries with the highest malaria burden, mainly due to Plasmodium vivax infections. However, little is known about P. vivax transmission dynamics in the Peruvian Amazon, where most malaria cases occur. The genetic diversity and population structure of P. vivax isolates collected in different communities around Iquitos city, the capital of the Peruvian Amazon, was determined. Methods: Plasmodium vivax population structure was determined by multilocus genotyping with 16 microsatellites on 159 P. vivax infected blood samples (mono-infections) collected in four sites around Iquitos city. The population characteristics were assessed only in samples with monoclonal infections (n = 94), and the genetic diversity was determined by calculating the expected heterozygosity and allelic richness. Both linkage disequilibrium and the genetic differentiation (.) were estimated. Results: The proportion of polyclonal infections varied substantially by site (11% - 70%), with the expected heterozygosity ranging between 0.44 and 0.69; no haplotypes were shared between the different populations. Linkage disequilibrium was present in all populations (I(A)(S) 0.14 - 0.61) but was higher in those with fewer polyclonal infections, suggesting inbreeding and a clonal population structure. Strong population differentiation (theta = 0.45) was found and the Bayesian inference cluster analysis identified six clusters based on distinctive allele frequencies. Conclusion: The P. vivax populations circulating in the Peruvian Amazon basin are genetically diverse, strongly differentiated and they have a low effective recombination rate. These results are in line with the low and clustered pattern of malaria transmission observed in the region around Iquitos city.	[Van den Eede, Peter; Van der Auwera, Gert; Huyse, Tine; Erhart, Annette; D'Alessandro, Umberto] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Delgado, Christopher; Soto-Calle, Veronica E.; Gamboa, Dionicia; Llanos, Alejandro] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Dept Bioquim Biol Mol & Farmacol, Fac Ciencias, Lima, Peru; [Grande, Tanilu; Rodriguez, Hugo] Organismo Andinode Salud Convenio Hipolito Unanue, PAMAFRO, Multicountry Malaria Project Malaria Control Cros, Lima, Peru; [Anne, Jozef] Catholic Univ Louvain, Dept Microbiol & Immunol, B-3000 Louvain, Belgium	Van den Eede, P (reprint author), Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium.	pvandeneede@itg.be	D'Alessandro, Umberto/D-3457-2015; Delgado Ratto, Christopher/D-3838-2013	D'Alessandro, Umberto/0000-0001-6341-5009; Delgado-Ratto, Christopher/0000-0003-2300-5181; Anne, Jozef/0000-0002-0493-2644; Gamboa, Dionicia/0000-0002-1420-7729	"Fonds voor Wetenschappelijk Onderzoek" (FWO); "Institute for the Promotion of Innovation by Science, and Technology in Flanders" (IWT)	We thank Jean-Claude Dujardin (ITMA, Antwerp, Belgium) for his useful comments in preparing the manuscript. This study was funded by the Flemish government funds: "Fonds voor Wetenschappelijk Onderzoek" (FWO), and the "Institute for the Promotion of Innovation by Science, and Technology in Flanders" (IWT, PhD grant). The sample collection was funded by the Directorate General for Development Cooperation (DGCD) of the Belgian Government (framework agreement 2 and 3; project 95501 and 95502 respectively) and The Global Fund to fight AIDS, Tuberculosis and Malaria TM through Organismo Andino de Salud - Convenio Hipolito Unanue (Principal Recipient of Multi-Country Malaria Project "Malaria control on the cross border areas of the Andean Region: A community based approach"-PAMAFRO), Grant Number MAA-305-G01-M" http://www.orasconhu.org/index.php?IDIOMA=SP&plantilla=contenido&ncategoria1=141.	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; ANTONIO MR, 2009, AM J TROP MED HYG, V80, P729; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Awadalla P, 2001, TRENDS PARASITOL, V17, P351, DOI 10.1016/S1471-4922(01)02034-7; Bautista CT, 2006, AM J TROP MED HYG, V75, P1216, DOI 10.4269/ajtmh.2006.75.1216; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Buckling A, 2001, P ROY SOC B-BIOL SCI, V268, P2325, DOI 10.1098/rspb.2001.1808; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Durand P, 2003, AM J TROP MED HYG, V68, P345, DOI 10.4269/ajtmh.2003.68.345; EEDE PV, 2010, AM J TROP MED HYG, V82, P223; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1996, GENETICS, V144, P1933; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Orjuela-Sanchez P, 2009, PARASITOLOGY, V136, P1097, DOI 10.1017/S0031182009990539; Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337; *PAHO, MAL AM TIM SER EP DA; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Pritchard JK, 2000, GENETICS, V155, P945; Roper MH, 2000, AM J TROP MED HYG, V62, P247, DOI 10.4269/ajtmh.2000.62.247; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199, DOI 10.1016/S0035-9203(02)90077-5; Ruebush TK, 2003, AM J TROP MED HYG, V69, P548, DOI 10.4269/ajtmh.2003.69.548; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Sutton PL, 2009, AM J TROP MED HYG, V81, P950, DOI 10.4269/ajtmh.2009.09-0132; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; INTERNAL REPORT NATL	36	52	52	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUN 3	2010	9								151	10.1186/1475-2875-9-151				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	629BD	WOS:000280168100001	20525233	DOAJ Gold, Green Published			2019-04-02	
J	Amin, DN; Ngoyi, DM; Nhkwachi, GM; Palomba, M; Rottenberg, M; Buscher, P; Kristensson, K; Masocha, W				Amin, Daniel Ndem; Ngoyi, Dieudonne Mumba; Nhkwachi, Gondwe-Mphepo; Palomba, Maria; Rottenberg, Martin; Buescher, Philippe; Kristensson, Krister; Masocha, Willias			Identification of Stage Biomarkers for Human African Trypanosomiasis	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							BLOOD-BRAIN-BARRIER; SLEEPING SICKNESS; VERVET MONKEYS; LIPOCALIN-2; MODEL; IMMUNOGLOBULINS; EXPRESSION; INVASION; DISEASE; BIOLOGY	Human African trypanosomiasis (HAT), caused by infection with sub-species of Trypanosoma brucei (T. b.), manifests as a hemolymphatic stage followed by an encephalitic stage. The distinction of the two stages needs improvement as drugs used for the late stage are highly toxic. Transcripts encoding 16 secreted proteins differentially expressed in the brains of mice at late stage T b. brucei infection when the early stage drug suramin is no longer effective and different to immunoglobulins, chemokines, and cytokines, were selected by microarray analysis. Lipocalin 2 and secretory leukocyte peptidase inhibitor (SLPI) mRNA showed the highest differential expression in mice. These transcripts were also upregulated in brains from infected rats. Lipocalin 2 was increased in cerebrospinal fluid (CSF) from rats during late stage T b. brucei infection. Protein levels of lipocalin 2, SLPI, and the chemokine CXCL10 were found increased in CSF from Trypunosoma brucei gambiense and Trypanosoma brucei rhodesiense late stage HAT compared to early stage.	[Amin, Daniel Ndem; Rottenberg, Martin; Kristensson, Krister] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; [Ngoyi, Dieudonne Mumba] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Palomba, Maria] Univ Verona, Sect Anat & Histol, Fac Med, I-37100 Verona, Italy; [Nhkwachi, Gondwe-Mphepo] Ctr Ticks & Tick Borne Dis, Lilongwe, Malawi; [Buescher, Philippe] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Masocha, Willias] Kuwait Univ, Dept Appl Therapeut, Fac Pharm, Safat, Kuwait	Amin, DN (reprint author), Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden.	ndemamin@yahoo.co.uk; mumbadieudonne@yahoo.fr; ncgondwe@yahoo.com; mariella@anatomy.univr.it; martinrottenberg@ki.se; PBuscher@itg.be; krister.kristensson@ki.se; masocha@hsc.edu.kw	Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472; Masocha, Willias/0000-0003-3132-5935	European Union [FP6-2004-INCO-DEV-3 032324]; International Brain Research Organization; Belgian Directorate General for Development Cooperation	This work was supported by a grant from the European Union (FP6-2004-INCO-DEV-3 032324; NEUROTRYP). DNA received a post-doctoral research fellowship from the International Brain Research Organization. DMN received a PhD grant from the Belgian Directorate General for Development Cooperation.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Amin DN, 2009, J INFECT DIS, V200, P1556, DOI 10.1086/644597; Amin DN, 2008, ACTA TROP, V106, P72, DOI 10.1016/j.actatropica.2008.01.005; [Anonymous], 1998, WHO TECH REP SER, V881, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bisser S, 2002, J NEUROL SCI, V193, P127, DOI 10.1016/S0022-510X(01)00655-4; Bouteille B, 2003, FUND CLIN PHARMACOL, V17, P171, DOI 10.1046/j.1472-8206.2003.00167.x; Courtioux B, 2009, TROP MED INT HEALTH, V14, P529, DOI 10.1111/j.1365-3156.2009.02263.x; Dumas M, 2009, Med Trop (Mars), V69, P5; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hainard A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000459; Kennedy PGE, 2008, ANN NEUROL, V64, P116, DOI 10.1002/ana.21429; Kennedy PGE, 2004, J CLIN INVEST, V113, P496, DOI 10.1172/JCI200421052; Kristensson K, 2002, CURR TOP MICROBIOL, V265, P227; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Lejon V, 2001, Med Trop (Mars), V61, P355; Lejon V, 2008, CLIN INFECT DIS, V47, P15, DOI 10.1086/588668; Lejon V, 2007, CLIN VACCINE IMMUNOL, V14, P732, DOI 10.1128/CVI.00103-07; Lindberg J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1903; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; Masocha W, 2006, ANTIMICROB AGENTS CH, V50, P1798, DOI 10.1128/AAC.50.5.1798-1804.2006; Masocha W, 2004, J CLIN INVEST, V114, P689, DOI 10.1172/JCI200422104; Mulenga C, 2001, NEUROPATH APPL NEURO, V27, P77, DOI 10.1046/j.0305-1846.2001.00306.x; Ngotho M, 2009, TROP MED INT HEALTH, V14, P736, DOI 10.1111/j.1365-3156.2009.02285.x; Ngoyi DM, 2010, J INFECT DIS, V201, P453, DOI 10.1086/649917; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Smyth GK, 2004, STAT APPL GENET MOL, V3, P1, DOI DOI 10.2202/1544-6115.1027; Thuita JK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000238; Wang XK, 2003, MOL PHARMACOL, V64, P833, DOI 10.1124/mol.64.4.833; Zhang YH, 1997, J CLIN INVEST, V99, P894, DOI 10.1172/JCI119254	33	24	27	0	7	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUN	2010	82	6					983	990		10.4269/ajtmh.2010.09-0770				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	606XP	WOS:000278462600004	20519589	Green Published			2019-04-02	
J	Grietens, KP; Soto, V; Erhart, A; Ribera, JM; Toomer, E; Tenorio, A; Montalvo, TG; Rodriguez, H; Cuentas, AL; D'Alessandro, U; Gamboa, D				Grietens, Koen Peeters; Soto, Veronica; Erhart, Annette; Ribera, Joan Muela; Toomer, Elizabeth; Tenorio, Alex; Grande Montalvo, Tanilu; Rodriguez, Hugo; Llanos Cuentas, Alejandro; D'Alessandro, Umberto; Gamboa, Dionicia			Adherence to 7-Day Primaquine Treatment for the Radical Cure of P-vivax in the Peruvian Amazon	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							ANOPHELES-DARLINGI; MALARIA; REGION; FALCIPARUM; HEALTH	Despite being free of charge, treatment adherence to 7-day primaquine for the radical cure of Plasmodium vivax was estimated at 62.2% among patients along the Iquitos-Nauta road in the Peruvian Amazon. The principal reason for non-adherence was the perceived adverse effects related to local humoral illness conceptions that hold that malaria produces a hot state of body, which is further aggravated by the characteristically hot medical treatment. Notably, patients were willing to adhere to the first 3 days of treatment during which symptoms are most apparent and include the characteristic chills. Nevertheless, as symptoms abate, the perceived aggravating characteristics of the medication outweigh the perceived advantages of treatment adherence. Improving community awareness about the role of primaquine to prevent further malaria transmission and fostering a realistic system of direct observed treatment intake, organized at community level, can be expected to improve adherence to the radical cure of P. vivax in this area.	[Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Dept Bioquim Biol Mol & Farmacol, Fac Ciencias, Lima, Peru; [Ribera, Joan Muela; Toomer, Elizabeth] PASS Int, Partners Appl Social Sci, Tessenderlo, Belgium; [Rodriguez, Hugo] Organism Andino Salud Convenio Hipolito Unanue, PAMAFRO, Multi Country Malaria Project, Lima, Peru; [Grietens, Koen Peeters; Erhart, Annette; D'Alessandro, Umberto] Prins Leopold Inst Trop Geneeskunde, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium	Grietens, KP (reprint author), Prins Leopold Inst Trop Geneeskunde, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	kpeeters@itg.be; vescwslc@yahoo.com; aerhart@itg.be; joan.muela@pass-international.org; elizabeth.toomer@pass-international.org; alextenorio78@yahoo.es; tanilu_grande@yahoo.com; udalessandro@itg.be; dionigamboa@yahoo.com	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Peeters Grietens, Koen/0000-0001-6570-9887; Gamboa, Dionicia/0000-0002-1420-7729	Belgian Cooperation of Institute of Tropical Medicine (ITM), AntwerpBelgium; ITM Alexander van Humbold (ITM-AvH) in Lima, Peru; National Institute of Health/National Institute of Allergy and Infectious Diseases [95502, RO1-AI067727-03]	The study was funded by the Belgian Cooperation within the Framework Agreement 3 consisting of a bilateral cooperation between the Institute of Tropical Medicine (ITM), AntwerpBelgium, and the ITM Alexander van Humbold (ITM-AvH) in Lima, Peru. Project 95502 DG is supported by National Institute of Health/National Institute of Allergy and Infectious Diseases (RO1-AI067727-03).	American Anthropological Association, 2004, AM ANTHR ASS STAT ET; American Anthropological Association, 1998, COD ETH AM ANTHR ASS; Baird JK, 2003, TRENDS PARASITOL, V19, P115, DOI [10.1016/S1471-4922(03)00005-9, 10.1016/S1471-4922(03)0005-9]; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; BURKE L, 2001, COMPLIANCE HLTH CARE; CRABTREE B, 1992, RES METHODS PRIMARY; EINARSON TR, 1993, ANN PHARMACOTHER, V27, P832, DOI 10.1177/106002809302700702; Foster G, 1993, HIPPOCRATES LATIN AM; *GLOB FUND, 2009, PER GLOB FUND FIGHT; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Harvey SA, 2008, AM J TROP MED HYG, V79, P834, DOI 10.4269/ajtmh.2008.79.834; *I TROP MED, 2009, ANN ACT REP 2008; MAYS N, 1995, BRIT MED J, V311, P182, DOI 10.1136/bmj.311.6998.182; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; *MIN SAL, 2007, NORM TECN SAL AT MAL; *OFF GEN EP DIRESA, 2008, AN SIT SDAL REG LOR; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Ragin Charles C., 1994, CONSTRUCTING SOCIAL; Roper MH, 2000, AM J TROP MED HYG, V62, P247, DOI 10.4269/ajtmh.2000.62.247; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Schoeler GB, 2003, J AM MOSQUITO CONTR, V19, P286; Seale C, 1999, QUALITY QUALITATIVE; TASHAKKORI A, 1998, APPL SOCIAL RES METH; VANDULMEN S, 2007, BMC HLTH SERV RES, V55; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Yepez M C, 2000, Rev Cubana Med Trop, V52, P81; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x; ZAVAKAGAL FL, 2001, REV PERUANA MED EXPT, V18, P63	28	36	36	1	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUN	2010	82	6					1017	1023		10.4269/ajtmh.2010.09-0521				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	606XP	WOS:000278462600009	20519594	Green Published, Bronze			2019-04-02	
J	Mahendradhata, Y; Probandari, A; Ahmad, RA; Utarini, A; Trisnantoro, L; Lindholm, L; van der Werf, MJ; Kimerling, M; Boelaert, M; Johns, B; van der Stuyft, P				Mahendradhata, Yodi; Probandari, Ari; Ahmad, Riris A.; Utarini, Adi; Trisnantoro, Laksono; Lindholm, Lars; van der Werf, Marieke J.; Kimerling, Michael; Boelaert, Marleen; Johns, Benjamin; van der Stuyft, Patrick			The Incremental Cost-Effectiveness of Engaging Private Practitioners to Refer Tuberculosis Suspects to DOTS Services in Jogjakarta, Indonesia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							TB CONTROL; INDIA; PARTNERSHIP; NEPAL; MIX; COLLABORATION; PROGRAM; CARE	We aimed to evaluate the incremental cost-effectiveness of engaging private practitioners (PPs) to refer tuberculosis (TB) suspects to public health centers in Jogjakarta, Indonesia. Effectiveness was assessed for TB suspects notified between May 2004 and April 2005. Private practitioners referred 1,064 TB suspects, of which 57.5% failed to reach a health center. The smear-positive rate among patients reaching a health center was 61.8%. Two hundred eighty (280) out of a total of 1,306 (21.4%) new smear-positive cases were enrolled through the PPs strategy. The incremental cost-effectiveness ratio per smear-positive case successfully treated for the PPs strategy was US$351.66 (95% CI 322.84-601.33). On the basis of an acceptability curve using the National TB control program's willingness-to-pay threshold (US$448.61), we estimate the probability that the PPs strategy is cost-effective at 66.8%. The strategy of engaging PPs was incrementally cost-effective, although under specific conditions, most importantly a well-functioning public directly observed treatment, short-course (DOTS) program.	[Mahendradhata, Yodi; Ahmad, Riris A.; Utarini, Adi; Trisnantoro, Laksono] Gadjah Mada Univ, Dept Publ Hlth, Fac Med, Sekip Utara 55281, Jogjakarta, Indonesia; Gadjah Mada Univ, Ctr Hlth Serv Management, Fac Med, Sekip Utara 55281, Jogjakarta, Indonesia; [Boelaert, Marleen; van der Stuyft, Patrick] Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Probandari, Ari] Sebelas Maret Univ, Dept Publ Hlth, Fac Med, Surakarta, Indonesia; [Lindholm, Lars] Umea Univ, Umea, Sweden; [van der Werf, Marieke J.] KNCV TB Fdn, The Hague, Netherlands; Univ Amsterdam, Dept Infect Dis Trop Med & AIDS, Ctr Infect & Immun Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Kimerling, Michael] UAB, Gorgas TB Initiat, Sch Med, Div Infect Dis, Birmingham, AL USA; [Johns, Benjamin] WHO Country Off Indonesia, Jakarta, Indonesia	Mahendradhata, Y (reprint author), Gadjah Mada Univ, Dept Publ Hlth, Fac Med, Sekip Utara 55281, Jogjakarta, Indonesia.	yodi_mahendradhata@yahoo.co.uk; ariprobandari@yahoo.com; risandono.ahmad@gmail.com; adiutarini@gmail.com; trisnantoro@yahoo.com; lars.lindholm@epiph.umu.se; vanderWerfM@kncvtbc.nl; kimerlin@uab.edu; mboelaert@itg.be; benpj@yahoo.com; pvds@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Probandari, Ari/0000-0003-3171-5271; van der Werf, Marieke J./0000-0001-8021-1358; Mahendradhata, Yodi/0000-0002-4522-1785	Belgium Directorate-General; CIDA through FIDELIS; National TB control program; KNCV Tuberculosis Foundation; WHO; USAID through the TB Coalition of Technical Assistance	The set up of the intervention was funded by CIDA through FIDELIS. The cost-effectiveness study was jointly funded by the National TB control program, KNCV Tuberculosis Foundation, WHO, and USAID through the TB Coalition of Technical Assistance. Additional funding was provided by the Belgium Directorate-General for Development Cooperation.	*BPS STAT IND, 2007, HLTH STAT 2004; Briggs AH, 2002, ANNU REV PUBL HEALTH, V23, P377, DOI 10.1146/annurev.publhealth.23.100901.140534; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Drummond M, 2005, METHODS EC EVALUATIO; Dye C, 2006, INT J TUBERC LUNG D, V10, P460; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Ferroussier O, 2007, INT J TUBERC LUNG D, V11, P755; Floyd K, 2006, B WORLD HEALTH ORGAN, V84, P437, DOI 10.2471/BLT.05.024109; Irawati SR, 2007, INT J TUBERC LUNG D, V11, P33; Karki DK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-84; Kelkar-Khambete A, 2008, INT J TUBERC LUNG D, V12, P87; Krishnan A, 2006, INT J TUBERC LUNG D, V10, P264; Lambert ML, 2005, TROP MED INT HEALTH, V10, P246, DOI 10.1111/j.1365-3156.2004.01383.x; Lonnroth K, 2004, B WORLD HEALTH ORGAN, V82, P580; Lonnroth K, 2007, HEALTH POLICY PLANN, V22, P156, DOI 10.1093/heapol/czm007; Mahendradhata Y, 2007, TROP MED INT HEALTH, V12, P1218, DOI 10.1111/j.1365-3156.2007.01946.x; Mahendradhata Y, 2007, TROP MED INT HEALTH, V12, P315, DOI 10.1111/j.1365-3156.2007.01816.x; *MOH STOP TB PARTN, 2007, REP JOINT EXT TB MON; Newell JN, 2005, INT J TUBERC LUNG D, V9, P1013; Newell JN, 2004, B WORLD HEALTH ORGAN, V82, P92; *NIHRD, 2005, TUB PREV SURV IND 20; Quy HT, 2003, INT J TUBERC LUNG D, V7, P464; Sinanovic Edina, 2006, Cost Eff Resour Alloc, V4, P11, DOI 10.1186/1478-7547-4-11; *STAT IND BPS, 2008, IMPR DAT DEC PLANN; Stop TB Partnership. The Stop TB Strategy, 2006, STOP TB STRAT BUILD; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Uplekar M, 2007, TROP MED INT HEALTH, V12, P473, DOI 10.1111/j.1365-3156.2007.01839.x; UTARINI A, 2006, FIDELIS PROJECT REPO; WHO, 2008, GLOB TUB CONTR SURV; WHO, 2006, ENG ALL HLTH CAR PRO; Yassin MA, 2003, TROP MED INT HEALTH, V8, P927, DOI 10.1046/j.1365-3156.2003.01107.x	31	10	10	0	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUN	2010	82	6					1131	1139		10.4269/ajtmh.2010.09-0447				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	606XP	WOS:000278462600028	20519613	Bronze, Green Published			2019-04-02	
J	Harries, AD; Zachariah, R; Lawn, SD; Rosen, S				Harries, Anthony D.; Zachariah, Rony; Lawn, Stephen D.; Rosen, Sydney			Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						HIV; AIDS; antiretroviral therapy; retention; treatment outcomes; lost to follow-up; Africa	RESOURCE-LIMITED COUNTRIES; SOUTH-AFRICA; FOLLOW-UP; COTRIMOXAZOLE PROPHYLAXIS; TREATMENT SERVICE; INCOME COUNTRIES; EARLY MORTALITY; MALAWI; HIV; CARE	P>The scale-up of antiretroviral therapy (ART) has been one of the success stories of sub-Saharan Africa, where coverage has increased from about 2% in 2003 to more than 40% 5 years later. However, tempering this success is a growing concern about patient retention (the proportion of patients who are alive and remaining on ART in the health system). Based on the personal experience of the authors, 10 key interventions are presented and discussed that might help to improve patient retention. These are (1) the need for simple and standardized monitoring systems to track what is happening, (2) reliable ascertainment of true outcomes of patients lost to follow-up, (3) implementation of measures to reduce early mortality in patients both before and during ART, (4) ensuring uninterrupted drug supplies, (5) consideration of simple, non-toxic ART regimens, (6) decentralization of ART care to health centres and the community, (7) a reduction in indirect costs for patients particularly in relation to transport to and from clinics, (8) strengthening links within and between health services and the community, (9) the use of ART clinics to deliver other beneficial patient or family-orientated packages of care such as insecticide-treated bed nets, and (10) innovative (thinking 'out of the box') interventions. High levels of retention on ART are vital for individual patients, for credibility of programmes and for on-going resource and financial support.	[Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.; Lawn, Stephen D.] London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1, England; [Zachariah, Rony] Med Sans Frontieres, Dept Med, Brussels, Belgium; [Lawn, Stephen D.] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Rosen, Sydney] Boston Univ, Ctr Int Hlth & Dev, Boston, MA 02215 USA; [Rosen, Sydney] Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa	Harries, AD (reprint author), Old Inn Cottage, Vears Lane, Winchester SO21 1TQ, Hants, England.	adharries@theunion.org		Rosen, Sydney/0000-0002-6560-2964			Ait-Mohand H, 2008, HIV MED, V9, P738, DOI 10.1111/j.1468-1293.2008.00616.x; Boyer S, 2009, B WORLD HEALTH ORGAN, V87, P279, DOI 10.2471/BLT.07.049643; Braitstein P, 2006, LANCET, V367, P817; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; BRINKHOF MWG, 2009, PLOS ONE, V6, pE5790; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Harries AD, 2007, B WORLD HEALTH ORGAN, V85, P152, DOI 10.2471/BLT.06.032060; Harries AD, 2009, JAIDS-J ACQ IMM DEF, V52, pS14, DOI 10.1097/QAI.0b013e3181bbc99e; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2007, CLIN INFECT DIS, V45, P803, DOI 10.1086/522413; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Lester RT, 2006, AIDS, V20, P2242, DOI 10.1097/QAD.0b013e3280108508; Libamba E, 2006, B WORLD HEALTH ORGAN, V84, P320, DOI 10.2471/BLT.05.023952; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Makombe Sd, 2007, Malawi Med J, V19, P111; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Renaud-Thery F, 2007, AIDS, V21, pS89, DOI 10.1097/01.aids.0000279711.54922.f0; Rivett U., 2008, S AFR J HIV MED, V9, P44; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Souteyrand YP, 2008, AIDS, V22, pS161, DOI 10.1097/01.aids.0000327637.59672.02; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; WHO, 2009, UN ACC SCAL PRIOR HI; World Health Organization, 2009, RAP ADV ANT THER HIV; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	38	76	76	0	5	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUN	2010	15			1			70	75		10.1111/j.1365-3156.2010.02506.x				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	590DZ	WOS:000277205500007	20586963	Bronze, Green Published			2019-04-02	
J	Michielsen, JJA; Meulemans, H; Soors, W; Ndiaye, P; Devadasan, N; De Herdt, T; Verbist, G; Criel, B				Michielsen, Joris J. A.; Meulemans, Herman; Soors, Werner; Ndiaye, Pascal; Devadasan, Narayanan; De Herdt, Tom; Verbist, Gerlinde; Criel, Bart			Social protection in health: the need for a transformative dimension	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						social protection; social transformation; social exclusion; health inequity; health policy; health care economics and organisation	EQUITY		[Michielsen, Joris J. A.; Meulemans, Herman] Univ Antwerp, Res Ctr Longitudinal & Life Course Studies, Antwerp, Belgium; [Soors, Werner; Ndiaye, Pascal; Criel, Bart] Inst Trop Med, Unit Hlth Policy & Financing, B-2000 Antwerp, Belgium; [Devadasan, Narayanan] Inst Publ Hlth, Bangalore, India; [De Herdt, Tom] Univ Antwerp, Inst Dev Policy & Management, Antwerp, Belgium; [Verbist, Gerlinde] Univ Antwerp, Herman Deleeck Ctr Social Policy, Antwerp, Belgium	Michielsen, JJA (reprint author), Univ Antwerp, Res Ctr Longitudinal & Life Course Studies, Antwerp, Belgium.	joris.michielsen@ua.ac.be		de herdt, tom/0000-0002-5288-7446			AGRAWAL S, 2008, COMMUNITY LEVEL PROC; Agyepong IA, 2008, HEALTH POLICY PLANN, V23, P150, DOI 10.1093/heapol/czn002; Barrientos A, 2009, GLOB SOC POLICY, V9, P165, DOI 10.1177/14680181090090020102; BASTAGLI F, 2009, 60 CTR INCL GROWTH I; Bastiaensen J, 2005, WORLD DEV, V33, P979, DOI 10.1016/j.worlddev.2004.09.019; Criel B, 2005, TROP MED INT HEALTH, V10, P450, DOI 10.1111/j.1365-3156.2005.01410.x; CRIEL B, 2008, INT ENCY PUBLIC HLTH, V1, P782; CRIEL B, 2010, EXPERIENCE PROTECTIO, P26; CSDH (Commission on Social Determinants of Health), 2008, CLOS GAP GEN HLTH EQ; *DESA, 2007, REP WORLD SOC 2007 S; *DESA, 2010, REP WORLD SOC SIT 20; DEVADASAN N, 2008, INSURANCE REGULATORY, V4, P33; Devereux S., 2004, 232 I DEV STUD; ESCOBAR A, 2003, EVALUACION CUALITATI, P3; Fonteneau B., 2006, PROTECTING POOR MICR, VI, P378; *ILO, 2008, SCO HLTH PROT ILO ST; *ILO GTZ WHO, 2007, EXT SOC PROT HLTH DE; ILO/WHO (World Health Organization), 2009, SOC PROT FLOOR JOINT; International Labour Organization (ILO), 2010, WORLD SOC SEC REP 20; Mackintosh M, 2004, SOC POL DEV CONTEXT, P143; MICHIELSEN J, 2009, ISA C HLTH ENCE HLTH; MOORE C, 2009, NICARAGUAS RED PROTE, P17; NDIAYE P, 2008, INT WORKSH PRIM HLTH; Noirhomme M, 2007, HEALTH POLICY PLANN, V22, P246, DOI 10.1093/heapol/czm015; PAL K, 2005, 13 INT LAB OFF SOC S; Sen A., 1999, DEV FREEDOM; SOORS W, 2009, INTERFACE ENTRE MUTU; VANGINNEKEN W, 1999, INT SOCIAL SECURITY, V52, P49, DOI DOI 10.1111/1468-246X.00033; VRANKEN J, 2009, SOCIAL SPATIAL EXPLO, pR17; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; *WHO, 2004, 115 SESS GEN; World Health Organization, 2008, WORLD HLTH REP 2008	32	5	5	0	6	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUN	2010	15	6					654	658		10.1111/j.1365-3156.2010.02529.x				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	594IC	WOS:000277529100001	20374560	Bronze			2019-04-02	
J	Harries, AD; Murray, MB; Jeon, CY; Ottmani, SE; Lonnroth, K; Barreto, ML; Billo, N; Brostrom, R; Bygbjerg, IC; Fisher-Hoch, S; Mori, T; Ramaiya, K; Roglic, G; Strandgaard, H; Unwin, N; Viswanathan, V; Whiting, D; Kapur, A				Harries, Anthony D.; Murray, Megan B.; Jeon, Christie Y.; Ottmani, Salah-Eddine; Lonnroth, Knut; Barreto, Mauricio L.; Billo, Nils; Brostrom, Richard; Bygbjerg, Ib Christian; Fisher-Hoch, Susan; Mori, Toru; Ramaiya, Kaushik; Roglic, Gojka; Strandgaard, Hanne; Unwin, Nigel; Viswanathan, Vijay; Whiting, David; Kapur, Anil			Defining the research agenda to reduce the joint burden of disease from Diabetes mellitus and Tuberculosis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						research; diabetes mellitus; tuberculosis; screening; treatment outcomes	HIV; EPIDEMICS; TB	The steadily growing epidemic of diabetes mellitus poses a threat for global tuberculosis (TB) control. Previous studies have identified an important association between diabetes mellitus and TB. However, these studies have limitations: very few were carried out in low-income countries, with none in Africa, raising uncertainty about the strength of the diabetes mellitus-TB association in these settings, and many critical questions remain unanswered. An expert meeting was held in November 2009 to discuss where there was sufficient evidence to make firm recommendations about joint management of both diseases, to address research gaps and to develop a research agenda. Ten key research questions were identified, of which 4 were selected as high priority: (i) whether, when and how to screen for TB in patients with diabetes mellitus and vice versa; (ii) the impact of diabetes mellitus and non-diabetes mellitus hyperglycaemia on TB treatment outcomes and deaths, and the development of strategies to improve outcomes; (iii) implementation and evaluation of the tuberculosis 'DOTS' model for diabetes mellitus management; and (iv) the development and evaluation of better point-of-care diagnostic and monitoring tests, including measurements of blood glucose and glycated haemoglobin A(1c) (HbA(1c)) for patients with diabetes mellitus. Implementation of this research agenda will benefit the control of both diseases.	[Harries, Anthony D.; Billo, Nils] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England; [Murray, Megan B.; Jeon, Christie Y.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Murray, Megan B.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Ottmani, Salah-Eddine; Lonnroth, Knut] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; [Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, BR-41170290 Salvador, BA, Brazil; [Brostrom, Richard] CNMI Div Publ Hlth, TB Control Programme, Saipan, CM USA; [Bygbjerg, Ib Christian] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Fisher-Hoch, Susan] Univ Texas Houston, Div Epidemiol, Houston, TX USA; [Mori, Toru] Res Inst TB, Kiyose, Japan; [Ramaiya, Kaushik] Shree Hindu Mandal Hosp, Dar Es Salaam, Tanzania; [Ramaiya, Kaushik] Muhimbili Univ Hlth & Allied Sci, Dept Med, Dar Es Salaam, Tanzania; [Roglic, Gojka] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [Strandgaard, Hanne; Kapur, Anil] World Diabet Fdn, Lyngby, Denmark; [Unwin, Nigel] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Viswanathan, Vijay] MV Hosp Diabetes & Res Ctr, Chennai, Tamil Nadu, India; [Whiting, David] Int Diabet Federat, Brussels, Belgium	Harries, AD (reprint author), Old Inn Cottage,Vears Lane, Winchester SO21 1TQ, Hants, England.	adharries@theunion.org	Barreto, Mauricio/B-1752-2008; Lonnroth, Knut/H-5470-2017; Lonnroth, Knut/L-2339-2014	Barreto, Mauricio/0000-0002-0215-4930; Lonnroth, Knut/0000-0001-6944-0256; Lonnroth, Knut/0000-0001-5054-8240; Bygbjerg, Ib/0000-0001-9100-2754	NIMHD NIH HHS [P20 MD000170, P20 MD000170-08]		De Cock KM, 2006, TROP DOCT, V36, P71, DOI 10.1258/004947506776593495; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Drabo KM, 2006, INT J TUBERC LUNG D, V10, P93; EDGINTON ME, 1990, INT J TUBERC LUNG D, V3, P445; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Harries AD, 2009, T ROY SOC TROP MED H, V103, P537, DOI 10.1016/j.trstmh.2008.12.008; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; International Diabetes Federation, 2009, IDF DIAB ATL; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; LESNICHII A V, 1969, Problemy Tuberkuleza, V47, P1; PFAFFENBERG R, 1958, Z Tuberk, V111, P167; SMART T, 2009, HATIP           1015, P2; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; WHO (World Health Organization), 2006, GLOB PLAN STOP TB 20; World Health Organization, 2009, GLOB TUB CONTR 2009	17	59	59	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUN	2010	15	6					659	663		10.1111/j.1365-3156.2010.02523.x				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	594IC	WOS:000277529100002	20406430	Green Accepted			2019-04-02	
J	Clements, MF; Gidwani, K; Kumar, R; Hostomska, J; Dinesh, DS; Kumar, V; Das, P; Muller, I; Hamilton, G; Volfova, V; Boelaert, M; Das, M; Rijal, S; Picado, A; Volf, P; Sundar, S; Davies, CR; Rogers, ME				Clements, Meredith F.; Gidwani, Kamlesh; Kumar, Rajiv; Hostomska, Jitka; Dinesh, Diwakar S.; Kumar, Vijay; Das, Pradeep; Mueller, Ingrid; Hamilton, Gordon; Volfova, Vera; Boelaert, Marleen; Das, Murari; Rijal, Suman; Picado, Albert; Volf, Petr; Sundar, Shyam; Davies, Clive R.; Rogers, Matthew E.			Measurement of Recent Exposure to Phlebotomus argentipes, the Vector of Indian Visceral Leishmaniasis, by Using Human Antibody Responses to Sand Fly Saliva	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							LUTZOMYIA-LONGIPALPIS SALIVA; IMMUNE-RESPONSE; GLAND ANTIGENS; CHAGASI; MARKER	Antibody (IgG) responses to the saliva of Phlebotomus argentipes were investigated using serum samples from regions of India endemic and non-endemic for visceral leishmaniasis (VL). By pre-adsorbing the sera against the saliva of the competing human-biting but non-VL vector P.papatasi. we significantly improved the specificity of a P.argentipes saliva enzyme-linked immunosorbent assay. Using this method, we observed a statistically significant correlation between antibodies to P argenitpes saliva and the average indoor density of female sand flies. Additionally, the method was able to detect recent changes in vector exposure when sera from VL patients were assayed before, during, and after hospitalization and protected from sand fly bites under untreated bed nets. Collectively, these results highlight the utility of antibodies to P.argentipes saliva as an important tool to evaluate VL vector control programs.	[Mueller, Ingrid; Rogers, Matthew E.] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Div Investigat Sci, London W2 1PG, England; [Gidwani, Kamlesh; Kumar, Rajiv; Sundar, Shyam] Banaras Hindu Univ, Kala Azar Med Res Ctr, Varanasi 221005, Uttar Pradesh, India; [Hostomska, Jitka; Volfova, Vera; Volf, Petr] Charles Univ Prague, Dept Parasitol, Prague, Czech Republic; Rajendra Mem Res Inst, Patna, Bihar, India; [Boelaert, Marleen] Inst Trop Med, Unit Epidemiol & Dis Control, B-2000 Antwerp, Belgium; [Hamilton, Gordon] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England; [Das, Murari; Rijal, Suman] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Clements, Meredith F.; Picado, Albert; Davies, Clive R.] London Sch Hyg & Trop Med, Dept Dis Vector Biol & Control, London, England; [Dinesh, Diwakar S.; Kumar, Vijay; Das, Pradeep] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Patna, Bihar, India	Rogers, ME (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Div Investigat Sci, St Marys Campus,Norfolk Pl, London W2 1PG, England.	j.g.c.hamilton@biol.keele.ac.uk; mboelaert@itg.be; clasp@cal2.vsnl.net.in; sumanrijal2@yahoo.com; albert.picado@lshtm.ac.uk; volf@cesnet.cz; drshvamsundar@hotmail.com; matthew.rogers@imperial.ac.uk	Boelaert, Marleen/E-2698-2012; Volf, Petr/C-4300-2012; Stafkova, Jitka/H-5775-2016; Volfova, Vera/H-1055-2017	Boelaert, Marleen/0000-0001-8051-6776; Volf, Petr/0000-0003-1790-1123; Stafkova, Jitka/0000-0002-7346-5445; Volfova, Vera/0000-0002-7189-1483; Das, Murari/0000-0001-6816-2389; Kumar, Rajiv/0000-0003-2338-1494; Picado, Albert/0000-0001-7344-628X	Wellcome Trust, UK [WT078223MA]; Indian Council of Medical Research; Czech Republic Ministry of Education [LC 06009, MSM0021620828]; European Union [015374]	Financial support: This study was supported by the Wellcome Trust, UK (advanced training fellowship, project WT078223MA to Matthew E. Rogers), the Indian Council of Medical Research (junior fellowship to Rajiv Kumar), the Czech Republic Ministry of Education (LC 06009 and MSM0021620828), and the European Union (Project 015374, KALANET).	Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; [Anonymous], 1998, LIF 21 CENT VIS ALL; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Billingsley PF, 2006, PARASITE IMMUNOL, V28, P143, DOI 10.1111/j.1365-3024.2006.00805.x; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Davies CR, 2003, BRIT MED J, V326, P377, DOI 10.1136/bmj.326.7385.377; Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x; Gomes RB, 2002, J INFECT DIS, V186, P1530, DOI 10.1086/344733; Gomes RB, 2007, T ROY SOC TROP MED H, V101, P127, DOI 10.1016/j.trstmh.2006.06.002; Hostomska J, 2008, VECTOR-BORNE ZOONOT, V8, P443, DOI 10.1089/vbz.2007.0214; Kumar V., 2001, Journal of Communicable Diseases, V33, P102; Peng ZK, 2004, ANN ALLERG ASTHMA IM, V93, P553, DOI 10.1016/S1081-1206(10)61262-8; Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI [10.1017/S003118200400681X, 10.1017/S00311200400681X]; Rohousova I, 2006, FOLIA PARASIT, V53, P161, DOI 10.14411/fp.2006.022; SCHWARTZ BS, 1991, AM J EPIDEMIOL, V134, P86, DOI 10.1093/oxfordjournals.aje.a115996; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; SWAMINATH C. S., 1942, Indian Journal of Medical Research, V30, P473; Volf P, 2001, PARASITOLOGY, V122, P37, DOI 10.1017/S0031182000007046; VOLF P, 1993, VET PARASITOL, V47, P327, DOI 10.1016/0304-4017(93)90033-J	19	48	48	1	13	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAY	2010	82	5					801	807		10.4269/ajtmh.2010.09-0336				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	592UQ	WOS:000277406500010	20439958	Green Published			2019-04-02	
J	Dewals, BG; Marillier, RG; Hoving, JC; Leeto, M; Schwegmann, A; Brombacher, F				Dewals, Benjamin G.; Marillier, Reece G.; Hoving, Jennifer C.; Leeto, Mosiuoa; Schwegmann, Anita; Brombacher, Frank			IL-4R alpha-Independent Expression of Mannose Receptor and Ym1 by Macrophages Depends on their IL-10 Responsiveness	PLOS NEGLECTED TROPICAL DISEASES			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; L-ARGININE METABOLISM; SCHISTOSOMA-MANSONI; T-CELLS; DIFFERENTIATION ANTIGENS; GRANULOMATOUS PATHOLOGY; MONOCLONAL-ANTIBODIES; TYPE-2 INFLAMMATION; MAMMALIAN LECTIN; IN-VITRO	IL-4R alpha-dependent responses are essential for granuloma formation and host survival during acute schistosomiasis. Previously, we demonstrated that mice deficient for macrophage-specific IL-4R alpha (LysM(cre) Il4ra(-/lox)) developed increased hepatotoxicity and gut inflammation; whereas inflammation was restricted to the liver of mice lacking T cell-specific IL-4R alpha expression (iLck(cre) Il4ra(-/lox)). In the study presented here we further investigated their role in liver granulomatous inflammation. Frequencies and numbers of macrophage, lymphocyte or granulocyte populations, as well as Th1/Th2 cytokine responses were similar in Schistosoma mansoni-infected LysM(cre) Il4ra(-/lox) liver granulomas, when compared to Il4ra(-/lox) control mice. In contrast, a shift to Th1 responses with high IFN-gamma and low IL-4, IL-10 and IL-13 was observed in the severely disrupted granulomas of iLck(cre) Il4ra(-/lox) and Il4ra(-/)-mice. As expected, alternative macrophage activation was reduced in both LysM(cre) Il4ra(-/lox) and iLck(cre) Il4ra(-/lox) granulomas with low arginase 1 and heightened nitric oxide synthase RNA expression in granuloma macrophages of both mouse strains. Interestingly, a discrete subpopulation of SSC(high) CD11b(+)I-A/I-E(high)CD204(+) macrophages retained expression of mannose receptor (MMR) and Ym1 in LysM(cre)Il4ra(-/lox) but not in iLck(cre)Il4ra(-/lox) granulomas. While aaM circle dot were in close proximity to the parasite eggs in Il4ra(-/lox) control mice, MMR(+)Ym1(+) macrophages in LysM(cre)Il4ra(-/lox) mice were restricted to the periphery of the granuloma, indicating that they might have different functions. In vivo IL-10 neutralisation resulted in the disappearance of MMR+Ym1+ macrophages in LysM(cre)Il4ra(-/lox) mice. Together, these results show that IL-4R alpha-responsive T cells are essential to drive alternative macrophage activation and to control granulomatous inflammation in the liver. The data further suggest that in the absence of macrophage-specific IL-4R alpha signalling, IL-10 is able to drive mannose receptor-and Ym1-positive macrophages, associated with control of hepatic granulomatous inflammation.	[Dewals, Benjamin G.; Marillier, Reece G.; Hoving, Jennifer C.; Leeto, Mosiuoa; Schwegmann, Anita; Brombacher, Frank] Univ Cape Town, ICGEB, ZA-7925 Cape Town, South Africa; [Dewals, Benjamin G.; Marillier, Reece G.; Hoving, Jennifer C.; Leeto, Mosiuoa; Schwegmann, Anita; Brombacher, Frank] Univ Cape Town, Div Immunol, IIDMM, ZA-7925 Cape Town, South Africa	Dewals, BG (reprint author), Univ Liege, Dept Infect & Parasit Dis, Fac Vet Med, B-4000 Liege, Belgium.	fbrombac@mweb.co.za	Hoving, Jennifer/J-8379-2012	Dewals, Benjamin G./0000-0003-1497-0799	Wellcome Trust [080921/Z/06/Z]		Atochina O, 2001, J IMMUNOL, V167, P4293, DOI 10.4049/jimmunol.167.8.4293; ATOCHINA O, 2008, IMMUNOLOGY; Baumgart M, 2006, J IMMUNOL, V176, P5374, DOI 10.4049/jimmunol.176.9.5374; BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; DEVILLIERS WJS, 1994, IMMUNOL LETT, V43, P73, DOI 10.1016/0165-2478(94)00148-0; Dewals B, 2009, AM J PATHOL, V175, P706, DOI 10.2353/ajpath.2009.090137; ELLIOTT DE, 1990, INFECT IMMUN, V58, P1577; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; GORDON S, 1982, ADV EXP MED BIOL, V155, P391; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GORDON S, 1988, CURR OPIN IMMUNOL, V1, P26, DOI 10.1016/0952-7915(88)90047-7; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Harbord M, 2002, J BIOL CHEM, V277, P5468, DOI 10.1074/jbc.M110635200; Herbert DR, 2008, J IMMUNOL, V181, P7214, DOI 10.4049/jimmunol.181.10.7214; Herbert DR, 2008, J IMMUNOL, V180, P4948, DOI 10.4049/jimmunol.180.7.4948; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Holscher C, 2006, J IMMUNOL, V176, P1115, DOI 10.4049/jimmunol.176.2.1115; Jankovic D, 1999, J IMMUNOL, V163, P337; Keating P, 2009, IMMUNOL CELL BIOL, V87, P534, DOI 10.1038/icb.2009.37; King CH, 2009, NEW ENGL J MED, V360, P106, DOI 10.1056/NEJMp0808041; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Leeto M, 2006, AM J PATHOL, V169, P1701, DOI 10.2353/ajpath.2006.060346; Linehan SA, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-4; Linehan SA, 2003, LAB INVEST, V83, P1223, DOI 10.1097/01.LAB.0000081392.93701.6F; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez-Pomares L, 2003, J LEUKOCYTE BIOL, V73, P604, DOI 10.1189/jlb.0902450; Mckee AS, 2008, INT IMMUNOL, V20, P659, DOI 10.1093/intimm/dxn025; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Smith P, 2004, J IMMUNOL, V173, P1240, DOI 10.4049/jimmunol.173.2.1240; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Terrazas LI, 2001, J IMMUNOL, V167, P5294, DOI 10.4049/jimmunol.167.9.5294; Tomokiyo R, 2002, ATHEROSCLEROSIS, V161, P123, DOI 10.1016/S0021-9150(01)00624-4; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; VILLANUEVA POF, 1994, J IMMUNOL, V152, P1847; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723	57	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2727			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2010	4	5							e689	10.1371/journal.pntd.0000689				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	608QO	WOS:000278601000019	20502521	DOAJ Gold, Green Published			2019-04-02	
J	Tayler-Smith, K; Zachariah, R; Massaquoi, M; Manzi, M; Pasulani, O; van den Akker, T; Bemelmans, M; Bauernfeind, A; Mwagomba, B; Harries, AD				Tayler-Smith, Katie; Zachariah, Rony; Massaquoi, Moses; Manzi, Marcel; Pasulani, Olesi; van den Akker, Thomas; Bemelmans, Marielle; Bauernfeind, Ariane; Mwagomba, Beatrice; Harries, Anthony D.			Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system?	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						HIV/AIDS; CD4 count; WHO stages 1 and 2; Follow-up; Attrition; Malawi	RESOURCE-POOR SETTINGS; SUB-SAHARAN AFRICA; ANTIRETROVIRAL TREATMENT; EARLY MORTALITY; SOUTH-AFRICA; THERAPY; OUTCOMES; COUNTRIES; SURVIVAL; DISTRICT	A study conducted among HIV-positive adults in WHO clinical stages 1 and 2 was followed up at Thyolo District Hospital (rural Malawi) to report on: (1) retention and attrition before and while on antiretroviral treatment (ART); and (2) the criteria used for initiating ART. Between June 2008 and January 2009, 1633 adults in WHO stages 1 and 2 were followed up for a total of 282 person-years. Retention in care at 1, 2, 3 and 6 months for those not on ART (n = 1078) was 25, 18, 11 and 4% vs. 99, 97, 95 and 90% for patients who started ART (n = 555, P = 0.001). Attrition rates were 31 times higher among patients not started on ART compared with those started on ART (adjusted hazard ratio, 31.0, 95% CI 22-44). Ninety-two patients in WHO stage 1 or 2 were started on ART without the guidance of a CD4 count, and 11 were incorrectly started on ART with CD4 count >= 250 cells/mm(3). In a rural district hospital setting in Malawi, attrition of individuals in WHO stages 1 and 2 is unacceptably high, and specific operational strategies need to be considered to retain such patients in the health system. (C) 2010 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Tayler-Smith, Katie; Zachariah, Rony; Manzi, Marcel] Brussels Operat Ctr, Med Dept Operat Res, L-1617 Luxembourg, Luxembourg; [Massaquoi, Moses; Pasulani, Olesi; van den Akker, Thomas; Bemelmans, Marielle] Med Sans Frontieres, Thyolo, Malawi; [Bauernfeind, Ariane] Brussels Operat Ctr, Operat Dept, Brussels, Belgium; [Mwagomba, Beatrice] Minist Hlth & Populat, Thyolo, Malawi; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England	Zachariah, R (reprint author), Brussels Operat Ctr, Med Dept Operat Res, 68 Rue Gasperich, L-1617 Luxembourg, Luxembourg.	zachariah@internet.lu; zachariah@internet.lu					Braitstein P, 2006, LANCET, V367, P817; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; COETZEE A, 2004, AIDS S3, V18, pS27; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Hermann K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-31; Kober K, 2006, EXPERT PATIENTS AIDS; KUMPHITAK A, 2004, PERSPECTIVES PRACTIC; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; *MIN HLTH, 2008, ART PUBL PRIV SECT M; *MIN HLTH POP NAT, 2008, GUID US ANT THER MAL; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Simon S, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-13; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019; ZACHARIAH R, 2006, PLOS ONE, V27, P121; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	22	38	38	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAY	2010	104	5					313	319		10.1016/j.trstmh.2010.01.007				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	599AD	WOS:000277881200002	20138323	Green Published			2019-04-02	
J	Gerstl, S; Dunkley, S; Mukhtar, A; Baker, S; Maikere, J				Gerstl, Sibylle; Dunkley, Sophie; Mukhtar, Ahmed; Baker, Samuel; Maikere, Jacob			Successful introduction of artesunate combination therapy is not enough to fight malaria: results from an adherence study in Sierra Leone	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Malaria; Treatment; Artemisinin; Combination drug therapy; Medication adherence; Patient compliance; Sierra Leone	SULFADOXINE-PYRIMETHAMINE; UNCOMPLICATED MALARIA; ANTIMALARIAL-DRUGS; CHILDREN; LUMEFANTRINE; ARTEMETHER; TANZANIA; UGANDA	A study to measure adherence to artesunate and amodiaquine (AS+AQ) therapy in patients treated for uncomplicated malaria in community health centres (CHC) was conducted in Sierra Leone. Patients/caretakers were interviewed and remaining AS+AQ tablets at home after the last treatment dose were counted. Persons leaving CHCs with an AS+AQ prescription were also interviewed (exit interviews). In total, 118 patients were visited at home: 27 (22.9%) had one or more tablets left and were classed as certainly non-adherent; 34(28.8%) were probably non-adherent [reported incorrect (n=27) or incomplete (n=7) intake]; and 57(48.3%) were probably adherent. The main reasons for incomplete intake were sickness after one dose of AS+AQ no food available for drug intake and forgetting to take them. For incorrect intake, reasons were vomiting after drug intake and incorrect instructions given by the CHC. Eighty-one percent of probably adherent patients reported following instructions given to them. In exit interviews, 82% of patients or caretakers of patients were able to repeat AS+AQ intake instructions correctly. Adherence to antimalarial treatment should not be taken for granted. Instructions on correct AS+AQ use should include discussion of disease symptoms as well as possible treatment side effects and how to manage them. Other factors are more difficult to influence, such as patients forgetting to take the treatment. (C) 2010 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Gerstl, Sibylle] MSF UK, London EC1N 8QX, England; [Dunkley, Sophie; Mukhtar, Ahmed] Med Sans Frontieres Belgium, Bo, Sierra Leone; [Baker, Samuel] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Maikere, Jacob] Med Sans Frontieres Belgium, B-1090 Jette, Belgium	Gerstl, S (reprint author), MSF UK, 67-74 Saffron Hill, London EC1N 8QX, England.	sibylle.gerstl@london.msf.org			Medecins Sans Frontieres	This study was funded by Medecins Sans Frontieres.	Adjuik M, 2004, LANCET, V363, P9; Agyepong IA, 2002, SOC SCI MED, V55, P2215, DOI 10.1016/S0277-9536(01)00366-5; Ansah EK, 2001, TROP MED INT HEALTH, V6, P496, DOI 10.1046/j.1365-3156.2001.00740.x; BAUME C, 2008, ETHIOPIA BEDNET UTIL; Beer N, 2009, TROP MED INT HEALTH, V14, P766, DOI 10.1111/j.1365-3156.2009.02289.x; Conteh L, 2007, TROP MED INT HEALTH, V12, P382, DOI 10.1111/j.1365-3156.2006.01806.x; Depoortere E, 2004, ANN TROP MED PARASIT, V98, P635, DOI 10.1179/000349804225021271; Depoortere E, 2004, TROP MED INT HEALTH, V9, P62, DOI 10.1046/j.1365-3156.2003.01157.x; Duarte EC, 2003, TROP MED INT HEALTH, V8, P518, DOI 10.1046/j.1365-3156.2003.01042.x; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Kachur SP, 2004, AM J TROP MED HYG, V71, P715, DOI 10.4269/ajtmh.2004.71.715; Khantikul N, 2009, J HEALTH POPUL NUTR, V27, P4; Kolaczinski JH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-40; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Qingjun L, 1998, Bull World Health Organ, V76 Suppl 1, P21; Reilley B, 2002, TROP MED INT HEALTH, V7, P744, DOI 10.1046/j.1365-3156.2002.00919.x; Souares A, 2008, T ROY SOC TROP MED H, V102, P751, DOI 10.1016/j.trstmh.2008.05.016; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; *WHO, 2009, MAL DIAGN TREATM; *WHO, 2008, WORLD MAL REP; Yeboah-Antwi K, 2001, B WORLD HEALTH ORGAN, V79, P394; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x	22	22	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAY	2010	104	5					328	335		10.1016/j.trstmh.2009.12.008				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	599AD	WOS:000277881200004	20129636	Green Published			2019-04-02	
J	Alvarez, AMM; Nodarse, JF; Goodridge, IM; Fidalgo, LM; Marin, M; Van der Auwera, G; Dujardin, JC; Bernal, IDV; Muskus, C				Montalvo Alvarez, Ana Margarita; Fraga Nodarse, Jorge; Montano Goodridge, Ivon; Monzote Fidalgo, Lianet; Marin, Marcel; Van der Auwera, Gert; Dujardin, Jean-Claude; Velez Bernal, Ivan Dario; Muskus, Carlos			Differentiation of Leishmania (Viannia) panamensis and Leishmania (V.) guyanensis using Bccl for hsp70 PCR-RFLP	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Leishmaniasis; Leishmania; PCR; Restriction Fragment Length Polymorphism; hsp70; Cuba	CUTANEOUS LEISHMANIASIS; GEOGRAPHIC-DISTRIBUTION; MUCOSAL LEISHMANIASIS; COLOMBIA; ASSAY	Leishmania panamensis and Leishmania guyanensis are two species of the subgenus Viannia that are genetically very similar. Both parasites are usually associated with cutaneous leishmaniasis, but also have the potential to cause the mucocutaneous form of the disease. In addition, the study of foci and consequently the identification of vectors and probable reservoirs involved in transmission require a correct differentiation between both species, which is important at epidemiological level. We explored the possibility of identifying these species by using restriction fragment length polymorphisms (RFLP) in the gene coding for heat-shock protein 70 (hsp70). Previously, an hsp70 PCR-RFLP assay proved to be very effective in differentiating other Leishmania species when Haelll is used as restriction enzyme. Based on hsp70 sequences analysis, Bccl was found to generate species-specific fragments that can easily be recognized by agarose gel electrophoresis. Using the analysis of biopsies, scrapings, and parasite isolates previously grouped in a cluster comprising both L. panamensis and L. guyanensis, we showed that our approach allowed differentiation of both entities. This offers the possibility not only for identification of parasites in biological samples, but also to apply molecular epidemiology in certain countries of the New World, where several Leishmania species could coexist. (C) 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Montalvo Alvarez, Ana Margarita] Inst Med Trop Pedro Kouri, Dept Parasitol, Havana, Cuba; [Marin, Marcel; Velez Bernal, Ivan Dario; Muskus, Carlos] Univ Antioquia, Programa Estudio & Control Enfermedades Trop, Medellin, Colombia; [Van der Auwera, Gert; Dujardin, Jean-Claude] Inst Trop Med, B-2000 Antwerp, Belgium	Alvarez, AMM (reprint author), Inst Med Trop Pedro Kouri, Dept Parasitol, Autopista Novia Mediodia Km 6Y 1-2, Havana, Cuba.	amontalvo@ipk.sld.cu			Belgian Program of Cooperation and Development with Cuba	This work was financially supported by the Belgian Program of Cooperation and Development with Cuba.	ALVAR J, 2006, ADV PARASIT, V61, P227; Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041; Banuls AL, 1999, AM J TROP MED HYG, V61, P838, DOI 10.4269/ajtmh.1999.61.838; Calvopina M, 2005, AM J TROP MED HYG, V73, P281, DOI 10.4269/ajtmh.2005.73.281; Christensen HA, 1999, AM J TROP MED HYG, V60, P54, DOI 10.4269/ajtmh.1999.60.54; CORREDOR A, 1990, AM J TROP MED HYG, V42, P206; Perez JE, 2007, MEM I OSWALDO CRUZ, V102, P655, DOI 10.1590/S0074-02762007005000077; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Lainson R., 1987, LEISHMANIASES BIOL M, V1, P1; Lucas CM, 1998, AM J TROP MED HYG, V59, P312, DOI 10.4269/ajtmh.1998.59.312; MARSDEN PD, 1986, T ROY SOC TROP MED H, V80, P859, DOI 10.1016/0035-9203(86)90243-9; Osorio LE, 1998, AM J TROP MED HYG, V59, P49, DOI 10.4269/ajtmh.1998.59.49; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; RODRIGUEZBARRAQ.I, 2008, COLOMBIA AM J TROP M, V78, P270; Romero Gustavo A. S., 2001, Clinical Infectious Diseases, V32, P1304, DOI 10.1086/319990; Rotureau B, 2006, J CLIN MICROBIOL, V44, P459, DOI 10.1128/JCM.44.2.459-467.2006; Sambrook J., 1989, MOL CLONING LAB MANU; SANTRICH C, 1990, AM J TROP MED HYG, V42, P51, DOI 10.4269/ajtmh.1990.42.51; SARAVIA NG, 1985, AM J TROP MED HYG, V34, P714, DOI 10.4269/ajtmh.1985.34.714; Saravia NG, 2002, AM J TROP MED HYG, V66, P738, DOI 10.4269/ajtmh.2002.66.738; *WHO, 1990, CONTR LEISHM REP WHO, V793	22	14	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAY	2010	104	5					364	367		10.1016/j.trstmh.2009.12.002				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	599AD	WOS:000277881200009	20227738				2019-04-02	
J	Verweij, JJ; Canales, M; Polman, K; Ziem, J; Brienen, EAT; Polderman, AM; van Lieshout, L				Verweij, Jaco J.; Canales, Marco; Polman, Katja; Ziem, Juventus; Brienen, Eric A. T.; Polderman, Anton M.; van Lieshout, Lisette			Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR (vol 103, pg 342, 2009)	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Correction									[Verweij, Jaco J.; Brienen, Eric A. T.; Polderman, Anton M.; van Lieshout, Lisette] Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands; [Canales, Marco] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Polman, Katja] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Ziem, Juventus] Univ Dev Studies, Sch Med & Hlth Sci, Tamale, Ghana	Verweij, JJ (reprint author), Leiden Univ, Med Ctr, Dept Parasitol, Postbus 9600, NL-2300 RC Leiden, Netherlands.	j.j.verweij@lumc.nl					Verweij JJ, 2009, T ROY SOC TROP MED H, V103, P342, DOI 10.1016/j.trstmh.2008.12.001	1	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAY	2010	104	5					378	378		10.1016/j.trstmh.2010.02.010				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	599AD	WOS:000277881200014		Bronze			2019-04-02	
J	Chapman, R; White, RG; Shafer, LA; Pettifor, A; Mugurungi, O; Ross, D; Pascoe, S; Cowan, FM; Grosskurth, H; Buve, A; Hayes, RJ				Chapman, R.; White, R. G.; Shafer, L. A.; Pettifor, A.; Mugurungi, O.; Ross, D.; Pascoe, S.; Cowan, F. M.; Grosskurth, H.; Buve, A.; Hayes, R. J.			Do behavioural differences help to explain variations in HIV prevalence in adolescents in sub-Saharan Africa?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						HIV prevalence; adolescents; sexual behaviour; epidemiology; sub-Saharan Africa; age mixing	HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED-DISEASES; COMMUNITY-RANDOMIZED-TRIAL; SOUTH-AFRICA; 1ST SEX; HEALTH INTERVENTION; URBAN POPULATIONS; RURAL TANZANIA; RISK BEHAVIOR; YOUNG-PEOPLE	P>Objective To compare adolescent risk factors for HIV infection in two countries with high adolescent HIV prevalence and two lower prevalence countries with the aim of identifying risk factors that may help explain differences in adolescent HIV prevalence. Methods Data were available from two nationally representative surveys (South Africa, Zimbabwe), two behavioural intervention trials (Tanzania, Zimbabwe) and one population-based cohort (Uganda). Data on variables known or postulated to be risk factors for HIV infection were compared. Results Few risk behaviours were markedly more common in the high HIV prevalence populations. Risk factors more common in high HIV prevalence settings were genital ulcers and discharge, and women were more likely to report older male partners. Discussion Age mixing may be an important determinate of HIV prevalence in adolescents. Potential reasons for the general lack of association between other adolescent risk factors and adolescent HIV prevalence include adult HIV prevalence, misreported behaviour, different survey methods and other unmeasured adolescent behaviours. If adult factors dominate adolescent HIV risk, it would help explain the failure of behavioural interventions targeted at adolescents and suggests future interventions should include adults.	[Chapman, R.; White, R. G.; Ross, D.; Pascoe, S.; Hayes, R. J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Shafer, L. A.; Grosskurth, H.] UVRI Uganda Res Unit AIDS, MRC, Entebbe, Uganda; [Pettifor, A.] Univ Witwatersrand, Reprod Hlth & HIV Res Unit, Johannesburg, South Africa; [Mugurungi, O.] Minist Hlth & Child Welf, AIDS&TB Unit, Harare, Zimbabwe; [Cowan, F. M.] UCL, Ctr Sexual Hlth & HIV Res, London WC1E 6BT, England; [Grosskurth, H.] Inst Trop Med, B-2000 Antwerp, Belgium	Chapman, R (reprint author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	ruth.chapman@lshtm.ac.uk	White, Richard/D-5407-2009	White, Richard/0000-0003-4410-6635; Grosskurth, Heiner/0000-0001-9960-7280; Cowan, Frances/0000-0003-3087-4422; Hayes, Richard/0000-0002-1729-9892; Pascoe, Sophie/0000-0002-9199-8333	NICHD NIH HHS [R24 HD050924]; Medical Research Council [G0700837, G0802414, G0901756]		Allen S, 2003, AIDS, V17, P733, DOI [10.1097/00002030-200303280-00012, 10.1097/01.aids.0000050867.71999.ed]; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Benedetti JK, 1999, ANN INTERN MED, V131, P14, DOI 10.7326/0003-4819-131-1-199907060-00004; Boerma JT, 2003, SEX TRANSM DIS, V30, P779, DOI 10.1097/01.OLQ.0000078820.62897.A6; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Buve A, 2001, AIDS, V15, pS117, DOI 10.1097/00002030-200108004-00013; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Clark S, 2006, INT FAM PLAN PERSPEC, V32, P79, DOI 10.1363/3207906; Cowan FM, 2002, AIDS, V16, P1673, DOI 10.1097/00002030-200208160-00013; Dickerson MC, 1996, SEX TRANSM DIS, V23, P429, DOI 10.1097/00007435-199609000-00015; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gallant M, 2004, SOC SCI MED, V58, P1337, DOI 10.1016/S0277-9536(03)00331-9; Glynn JR, 2004, TROP MED INT HEALTH, V9, P4, DOI 10.1046/j.1365-3156.2003.01168.x; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2004, SEX TRANSM INFECT, V80, P36, DOI 10.1136/sti.2004.012088; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; GREGSON S, 2009, SEX TRANSM INFECT S1, V85, P1; Hallett TB, 2007, SEX TRANSM INFECT S1, V83, pi50, DOI DOI 10.1136/STI.2006.023606; Hallett TB, 2006, SEX TRANSM INFECT S1, V82, pi1, DOI 10.1136/sti.2005.016014; Hallett TB, 2007, STUD FAMILY PLANN, V38, P1, DOI 10.1111/j.1728-4465.2007.00111.x; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Hartell CG, 2005, ADOLESCENCE, V40, P171; Hayes RJ, 2005, CONTEMP CLIN TRIALS, V26, P430, DOI 10.1016/j.cct.2005.04.006; Hosegood V, 2007, POP STUD-J DEMOG, V61, P327, DOI 10.1080/00324720701524292; *HSRC, 2002, S AFR NAT HIV PREV B; Huang E, 2002, STEREOT FUNCT NEUROS, V79, P44, DOI 10.1159/000069503; Hunter M, 2005, CULT HEALTH SEX, V7, P389, DOI 10.1080/13691050412331293458; Jemmott JB, 2000, AIDS, V14, pS40; Johnson BT, 2003, ARCH PEDIAT ADOL MED, V157, P381, DOI 10.1001/archpedi.157.4.381; Katz I, 2008, SEX TRANSM DIS, V35, P837, DOI 10.1097/OLQ.0b013e31817c0be5; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; KondeLule JK, 1997, AIDS, V11, P791, DOI 10.1097/00002030-199706000-00012; *MACR INT, 2004, ZIMB YOUNG AD SURV 2; MAHOMVA A, 2006, SEX TRANSM INFECT S1, V82, P42; MARSTON M, 2009, SEX TRANSM INFECT S1, V85, P64; McGrath Nuala, 2009, SEX TRANSM INFECT S1, V85, pi49; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Mwaluko G, 2003, AIDS, V17, P2645, DOI 10.1097/01.aids.0000088225.55968.9d; NUNN AJ, 1994, AIDS, V8, P81, DOI 10.1097/00002030-199401000-00012; Pettifor AE, 2005, TROP MED INT HEALTH, V10, P971, DOI 10.1111/j.1365-3156.2005.01483.x; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Rehle T., 2006, SEX TRANSM INFECT S1, V82, P57; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Robin L, 2004, J ADOLESCENT HEALTH, V34, P3, DOI 10.1016/S1054-139X(03)00244-1; Rosenberg MD, 1999, SEX TRANSM DIS, V26, P208, DOI 10.1097/00007435-199904000-00004; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Todd J, 2004, SEX TRANSM INFECT, V80, P35, DOI 10.1136/sti.2003.005413; Todd J., 2009, SEXUALLY TRANSMITTED, V85, pi72; *UN, 2003, DEM YB UN; *UNAIDS, 2006, UPD GLOB AIDS EP; UNAIDS, 2008, REP GLOB AIDS EP; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Whitworth JAG, 2002, TROP MED INT HEALTH, V7, P1047, DOI 10.1046/j.1365-3156.2002.00973.x; Zaba B, 2004, SEX TRANSM INFECT, V80, P28, DOI 10.1136/sti.2004.012674; Zaba B, 2005, AIDS, V19, pS39, DOI 10.1097/01.aids.0000172876.74886.86	65	28	28	0	5	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2010	15	5					554	566		10.1111/j.1365-3156.2010.02483.x				13	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	581BN	WOS:000276496100009	20345559	Bronze			2019-04-02	
J	Delva, W; Yard, E; Luchters, S; Chersich, MF; Muigai, E; Oyier, V; Temmerman, M				Delva, W.; Yard, E.; Luchters, S.; Chersich, M. F.; Muigai, E.; Oyier, V.; Temmerman, M.			A Safe Motherhood project in Kenya: assessment of antenatal attendance, service provision and implications for PMTCT	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						nevirapine; prenatal care; maternal health services; HIV; Kenya	CHILD HIV TRANSMISSION; IMMUNODEFICIENCY-VIRUS TRANSMISSION; SINGLE-DOSE NEVIRAPINE; MATERNAL HEALTH-CARE; SUB-SAHARAN AFRICA; PREVENTION; PROGRAM; IMPLEMENTATION; COUNTRIES; PARTICIPATION	P>Objectives To investigate uptake and provision of antenatal care (ANC) services in the Uzazi Bora project: a demonstration-intervention project for Safe Motherhood and prevention of mother-to-child transmission of HIV in Kenya. Methods Data were extracted from antenatal clinic, laboratory and maternity ward registers of all pregnant women attending ANC from January 2004 until September 2006 at three antenatal clinics in Mombasa and two in rural Kwale district of Coast Province, Kenya (n = 25 364). Multiple logistic and proportional odds logistic regression analyses assessed changes over time, and determinants of the frequency and timing of ANC visits, uptake of HIV testing, and provision of iron sulphate, folate and single-dose nevirapine (sd-NVP). Results About half of women in rural and urban settings (52.2% and 49.2%, respectively) attended antenatal clinics only once. Lower parity, urban setting, older age and having received iron sulphate and folate supplements during the first ANC visit were independent predictors of more frequent visits. The first ANC visit occurred after 28 weeks of pregnancy for 30% (5894/19 432) of women. By mid-2006, provision of nevirapine to HIV-positive women had increased from 32.5% and 11.7% in rural and urban clinics, to 67.0% and 74.6%, respectively. Equally marked improvements were observed in the uptake of HIV testing and the provision of iron sulphate and folate. Conclusion Provision of ANC services, including sd-NVP, increased markedly over time. While further improvements in quality are necessary, particular attention is needed to implement evidence-based interventions to alter ANC utilization patterns. Encouragingly, improved provision of basic essential obstetric care may increase attendance.	[Delva, W.; Luchters, S.; Chersich, M. F.; Temmerman, M.] Univ Ghent, Dept Obstet & Gynaecol, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Delva, W.] Univ Stellenbosch, S African Ctr Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa; [Yard, E.; Luchters, S.; Muigai, E.; Oyier, V.] Int Ctr Reprod Hlth, Mombasa, Kenya; [Chersich, M. F.] Univ Witwatersrand, Dept Obstet & Gynaecol, Reprod Hlth & HIV Res Unit, Johannesburg, South Africa	Delva, W (reprint author), Univ Ghent, Dept Obstet & Gynaecol, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium.	wim.delva@ugent.be	Delva, Wim/E-9950-2012	chersich, matthew/0000-0002-4320-9168; Delva, Wim/0000-0001-8054-1904	European Union [KE/AIDCO/2001/460]	This study was funded by the European Union grant KE/AIDCO/2001/460 as part of the Uzazi Bora project.	Abou-Zahr C, 2003, ANTENATAL CARE DEV C; Adamu Y M, 2002, J Obstet Gynaecol, V22, P600, DOI 10.1080/0144361021000020349; Addai I, 2000, J BIOSOC SCI, V32, P1; [Anonymous], 2000, LOC MON EV INT PREV; Behets FMTF, 2006, B WORLD HEALTH ORGAN, V84, P969, DOI 10.2471/BLT.05.028217; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Bolu OO, 2007, AM J OBSTET GYNECOL, V197, pS83, DOI 10.1016/j.ajog.2007.03.006; Brown Celia A, 2008, BMC Pregnancy Childbirth, V8, P2, DOI 10.1186/1471-2393-8-2; Delva W, 2006, AIDS CARE, V18, P189, DOI 10.1080/09540120500456425; Delva W, 2006, SAMJ S AFR MED J, V96, P706; Delvaux T, 2008, TROP MED INT HEALTH, V13, P970, DOI 10.1111/j.1365-3156.2008.02105.x; Delvaux T, 2009, JAIDS-J ACQ IMM DEF, V50, P223, DOI 10.1097/QAI.0b013e31819001a3; Doherty Tanya M, 2005, Afr Health Sci, V5, P213; Druce N, 2007, REPROD HEALTH MATTER, V15, P190, DOI 10.1016/S0968-8080(07)30337-6; Fowler MG, 2007, AM J OBSTET GYNECOL, V197, pS3, DOI 10.1016/j.ajog.2007.06.048; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Gage AJ, 2007, SOC SCI MED, V65, P1666, DOI 10.1016/j.socscimed.2007.06.001; Gharoro EP, 1999, INT J GYNECOL OBSTET, V67, P179, DOI 10.1016/S0020-7292(99)00107-1; Gies S, 2009, AM J TROP MED HYG, V80, P460, DOI 10.4269/ajtmh.2009.80.460; Gloyd S, 2007, SEX TRANSM DIS, V34, pS31, DOI 10.1097/olq.0000264586.49616.72; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; *HOR PROGR, 2002, NDOL DEM PROJ MIDT A; *INT TASK TEAM PRE, 2007, GUID GLOB SCAL UP PR; Jimoh A A, 2003, Afr J Reprod Health, V7, P49, DOI 10.2307/3583288; Karamagi Charles A S, 2006, BMC Int Health Hum Rights, V6, P6, DOI 10.1186/1472-698X-6-6; Kebaabetswe PM, 2007, AIDS CARE, V19, P355, DOI 10.1080/09540120600942407; Kone-Pefoyo A, 2006, REV EPIDEMIOL SANTE, V54, P485, DOI 10.1016/S0398-7620(06)76748-7; Lagarde M, 2008, B WORLD HEALTH ORGAN, V86, P839, DOI 10.2471/BLT.07.049197; Magadi MA, 2007, SOC SCI MED, V64, P1311, DOI 10.1016/j.socscimed.2006.11.004; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Mrisho M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-10; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; National AIDS Control Council, 2005, KEN NAT HIV AIDS STR; Nuwagaba-Biribonwoha H, 2007, J PUBLIC HEALTH-UK, V29, P269, DOI 10.1093/pubmed/fdm025; Perez F, 2004, TROP MED INT HEALTH, V9, P774, DOI 10.1111/j.1365-3156.2004.01264.x; Perez F, 2004, BRIT MED J, V329, P1147, DOI 10.1136/bmj.329.7475.1147; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/01.aids.0000060351.78202.a2; Theuring S, 2009, AIDS BEHAV, V13, pS92, DOI 10.1007/s10461-009-9543-0; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Waiswa Peter, 2008, BMC Pregnancy Childbirth, V8, P21, DOI 10.1186/1471-2393-8-21; Westaway M S, 1998, Curationis, V21, P57; *WHO, 2006, ANT DRUGS TREAT PREG; Wildman K, 2003, EUR J OBSTET GYN R B, V111, pS53, DOI 10.1016/j.ejogrb.2003.09.006; World Health Organization, 1997, MON REPR HLTH SEL SH; World Health Organization, 2009, RAP ADV US ANT DRUGS; World Health Organization, 2006, REPR HLTH IND GUID T; 2007, KENYA WAIVER MATERNI	50	16	17	0	10	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2010	15	5					584	591		10.1111/j.1365-3156.2010.02499.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	581BN	WOS:000276496100013	20230571				2019-04-02	
J	Corbel, V; Chabi, J; Dabire, RK; Etang, J; Nwane, P; Pigeon, O; Akogbeto, M; Hougard, JM				Corbel, Vincent; Chabi, Joseph; Dabire, Roch K.; Etang, Josiane; Nwane, Philippe; Pigeon, Olivier; Akogbeto, Martin; Hougard, Jean-Marc			Field efficacy of a new mosaic long-lasting mosquito net (PermaNet (R) 3.0) against pyrethroid-resistant malaria vectors: a multi centre study in Western and Central Africa	MALARIA JOURNAL			English	Article							INSECTICIDE-TREATED NETS; ANOPHELES-GAMBIAE COMPLEX; CULEX-QUINQUEFASCIATUS; IMPREGNATED BEDNETS; BURKINA-FASO; COTE-DIVOIRE; SOUTH-AFRICA; BED NETS; CAMEROON; TRANSMISSION	Background: Due to the spread of pyrethroid-resistance in malaria vectors in Africa, new strategies and tools are urgently needed to better control malaria transmission. The aim of this study was to evaluate the performances of a new mosaic long-lasting insecticidal net (LLIN), i.e. PermaNet (R) 3.0, against wild pyrethroid-resistant Anopheles gambiae s.l. in West and Central Africa. Methods: A multi centre experimental hut trial was conducted in Malanville (Benin), Vallee du Kou (Burkina Faso) and Pitoa (Cameroon) to investigate the exophily, blood feeding inhibition and mortality induced by PermaNet (R) 3.0 (i.e. a mosaic net containing piperonyl butoxide and deltamethrin on the roof) comparatively to the WHO recommended PermaNet (R) 2.0 (unwashed and washed 20-times) and a conventionally deltamethrin-treated net (CTN). Results: The personal protection and insecticidal activity of PermaNet 3.0 and PermaNet (R) 2.0 were excellent (>80%) in the "pyrethroid-tolerant" area of Malanville. In the pyrethroid-resistance areas of Pitoa (metabolic resistance) and Vallee du Kou (presence of the L1014F kdr mutation), PermaNet (R) 3.0 showed equal or better performances than PermaNet (R) 2.0. It should be noted however that the deltamethrin content on PermaNet (R) 3.0 was up to twice higher than that of PermaNet (R) 2.0. Significant reduction of efficacy of both LLIN was noted after 20 washes although PermaNet (R) 3.0 still fulfilled the WHO requirement for LLIN. Conclusion: The use of combination nets for malaria control offers promising prospects. However, further investigations are needed to demonstrate the benefits of using PermaNet (R) 3.0 for the control of pyrethroid resistant mosquito populations in Africa.	[Corbel, Vincent; Chabi, Joseph] IRD, UR016, Cotonou, Benin; [Corbel, Vincent; Chabi, Joseph; Akogbeto, Martin] CREC, Cotonou, Benin; [Dabire, Roch K.] Ctr Muraz, IRSS, Bobo Dioulasso, Burkina Faso; [Etang, Josiane; Nwane, Philippe] Org Coordinat Lutte Contre Endemies Afr Cent, Yaounde, Cameroon; [Pigeon, Olivier] CRA W, Agr & Nat Environm Dept, Plant Protect Prod & Biocides Physicochem & Resid, B-5030 Gembloux, Belgium; [Hougard, Jean-Marc] IRD, Dakar, Senegal	Corbel, V (reprint author), IRD, UR016, 01 BP 4414 RP, Cotonou, Benin.	vincent.corbel@ird.fr	Corbel, VIncent/G-9576-2016		Vestergaard Frandsen SA, (Switzerland)	The experimental hut trial performed in Malanville (Benin) was carried out within the framework of the WHO Pesticide Evaluation Scheme (WHOPES) initiative for research and development of alternative insecticides for vector control. Trials carried out in Pitoa (Cameroon) and the Vallee du Kou (Burkina Faso) were supported by a grant from Vestergaard Frandsen SA, (Switzerland). We are grateful to the team of Malanville, Pitoa and the Vallee du Kou for their excellence during field work, and the people of these villages for their hospitality. We also thank Mr. Nicolas Moiroux for having set up of the map of the ABC network and Dr. Pennetier Cedric for revising the manuscript.	Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bingham G, 2007, PEST MANAG SCI, V63, P276, DOI 10.1002/ps.1336; Carnevale P., 2009, ANOPHELES BIOL TRANS; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Chandre F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P319; Chouaibou M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-77; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Corbel V, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-22; Dabire KR, 2008, J VECTOR ECOL, V33, P70, DOI 10.3376/1081-1710(2008)33[70:YTYASV]2.0.CO;2; DABIRE KR, 2009, T R SOC TROP MED HYG; Dabire RK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-12; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Diabate A, 2006, TROP MED INT HEALTH, V11, P597, DOI 10.1111/j.1365-3156.2006.01605.x; Djenontin A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-233; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Etang J, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-46; Etang J, 2003, J MED ENTOMOL, V40, P491, DOI 10.1603/0022-2585-40.4.491; Etang J, 2007, J VECTOR ECOL, V32, P123, DOI 10.3376/1081-1710(2007)32[123:SOMRTD]2.0.CO;2; Etang J, 2006, AM J TROP MED HYG, V74, P795, DOI 10.4269/ajtmh.2006.74.795; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; Hardstone MC, 2009, J EVOLUTION BIOL, V22, P416, DOI 10.1111/j.1420-9101.2008.01661.x; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hargreaves K, 2003, MED VET ENTOMOL, V17, P417, DOI 10.1111/j.1365-2915.2003.00460.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hougard JM, 2003, B ENTOMOL RES, V93, P491, DOI 10.1079/BER2003261; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Lapied B, 2009, TRENDS BIOTECHNOL, V27, P190, DOI 10.1016/j.tibtech.2008.12.005; Lehane M, 2005, BIOL BLOOD SUCKING I; Lengeler C., 2009, COCHRANE DB SYST REV, V2, P1; Martinez Torres D, 1998, INSECT MOL BIOL, V7, P179; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Pennetier C, 2005, AM J TROP MED HYG, V72, P739, DOI 10.4269/ajtmh.2005.72.739; Pennetier C, 2008, EMERG INFECT DIS, V14, P1707, DOI 10.3201/eid1411.071575; Pennetier C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-38; Pennetier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007896; PIGEON OVJ, 2009, CIPAC TECHN M SAN SA; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; TUNGU P, 2010, MALARIA J, V3, P9; Van Bortel W, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-248; Vulule JM, 1999, MED VET ENTOMOL, V13, P239, DOI 10.1046/j.1365-2915.1999.00177.x; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; WHO, 2006, GUID TEST MOSQ AD IN; WHO, WHO REC LONG LAST IN; WHO, 2009, 12 WHOPED WORK GROUP, P1; WHO, 2008, WORLD MAL REP 2008, P215; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x	58	51	51	0	11	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 27	2010	9								113	10.1186/1475-2875-9-113				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	604SH	WOS:000278298300001	20423479	DOAJ Gold, Green Published			2019-04-02	
J	Lempereur, L; Geysen, D; Madder, M				Lempereur, Laetitia; Geysen, Dirk; Madder, Maxime			Development and validation of a PCR-RFLP test to identify African Rhipicephalus (Boophilus) ticks	ACTA TROPICA			English	Article						Rhipicephalus (Boophilus); Identification; PCR-RFLP; Second internal transcribed spacer (ITS2); Africa	MICROPLUS; DECOLORATUS; CLIMATE; CATTLE	The cattle tick Rhipicephalus (Boophilus) microplus has recently invaded West Africa and caused anxiety amongst farmers in Ivory Coast, as livestock production was severely affected. The introduction of this tick species has remained unnoticed for several years, as all the members of this genus are very similar in appearance. To overcome the cumbersome morphological identification of the four closely related R. (Boophilus) spp. in the region, a PCR-RFLP test, based on a part of the second internal transcribed spacer ribosomal DNA (ITS2), was developed. The molecular tool was successfully validated with a large number of ticks recently collected from West Africa and that were identified both morphologically and genetically. The tool developed is simple, fast, reliable and reproducible; hence it can be routinely applied for species identification. (C) 2010 Elsevier B.V. All rights reserved.	[Lempereur, Laetitia; Geysen, Dirk; Madder, Maxime] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium	Lempereur, L (reprint author), Inst Trop Med, Dept Anim Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	llempereur@ulg.ac.be; mmadder@itg.be			Camille Hela Foundation of Liege University Belgium	Camille Hela Foundation of Liege University Belgium are acknowledged for their financial support.; The members of the ITM alumni network are thanked for the collections of ticks in the respective countries: Kokou Emmanuel Deka (Benin), Therese Roseline Sidpayete Nana (Burkina Faso), Roger Ngambia Funkeu (Cameroon), Arss Secka (The Gambia), Barry Alpha Madiou (Republic of Guinea), Barry Yahya (Mauritania), Ibrahima Mahamadou (Niger), Ibrahima Deme, Souaibou Diouf and Amadou Sow (Senegal).; Prof. Ivan Horak, Department of Veterinary Tropical Diseases, University of Pretoria, South Africa, is acknowledged for the morphological confirmation of a subset of the collected ticks.	BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Estrada-Pena A, 2006, J VECTOR ECOL, V31, P158, DOI 10.3376/1081-1710(2006)31[158:CICAHS]2.0.CO;2; Estrada-Pena A, 2006, VET PARASITOL, V142, P350, DOI 10.1016/j.vetpar.2006.07.003; George JE, 2004, PARASITOLOGY, V129, pS353, DOI 10.1017/S0031182003004682; Hoogstraal H., 1956, AFRICAN IXODOIDEA TI, VI, pii + 1101; Labruna MB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-46; Lynen G, 2008, EXP APPL ACAROL, V44, P147, DOI 10.1007/s10493-008-9134-1; Madder M, 2007, EXP APPL ACAROL, V43, P233, DOI 10.1007/s10493-007-9110-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonnesen MH, 2004, EXP APPL ACAROL, V32, P199, DOI 10.1023/B:APPA.0000021789.44411.b5; WALKER AR, 2003, BIOSCIENCE REPORTS, V1	11	20	22	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X			ACTA TROP	Acta Trop.	APR	2010	114	1					55	58		10.1016/j.actatropica.2010.01.004				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	580AP	WOS:000276419100008	20080073	Green Published			2019-04-02	
J	Verhaeghen, K; Van Bortel, W; Roelants, P; Okello, PE; Talisuna, A; Coosemans, M				Verhaeghen, Katrijn; Van Bortel, Wim; Roelants, Patricia; Okello, Paul Edward; Talisuna, Ambrose; Coosemans, Marc			Spatio-Temporal Patterns in kdr Frequency in Permethrin and DDT Resistant Anopheles gambiae s.s. from Uganda	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							COTE-DIVOIRE; PYRETHROID INSECTICIDES; KNOCKDOWN RESISTANCE; IMPREGNATED BEDNETS; SODIUM-CHANNEL; VECTOR CONTROL; TREATED NETS; MALARIA; IDENTIFICATION; EFFICACY	The planned upscaling of vector control strategies requires insight into the epidemiological consequences of vector resistance. Therefore, the pyrethroid and DDT resistance status of Anopheles gambiae s.l. was assessed in Uganda from 2004 to 2006, and spatial and seasonal variations in knockdown resistance (kdr) frequencies were analyzed in terms of epidemiological significance. Anopheles gambiae s.l. was DDT and pyrethroid resistant in central and eastern Uganda. The L1014S kdr allele frequencies varied from 3% to 48% in An. gambiae s.s. Although the homozygous resistant genotype was the most prevalent genotype among survivors, the genotypes could not entirely explain the bioassay results. In the dry season, the kdr frequency was significantly higher in Plasmodium falciparum-infected mosquitoes, indicating that mosquitoes bearing a kdr mutation have a better adult survival, hence a higher likelihood of becoming infectious. This study showed that kdr might have an epidemiological impact that could jeopardize the vector control strategies.	[Verhaeghen, Katrijn; Van Bortel, Wim; Roelants, Patricia; Coosemans, Marc] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; [Talisuna, Ambrose] Minist Hlth, Epidemiol Surveillance Div, Kampala, Uganda; [Coosemans, Marc] Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, Dept Biomed Sci, B-2020 Antwerp, Belgium	Verhaeghen, K (reprint author), Inst Trop Med Prince Leopold, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	kverhaeghen@itg.be; wvbortel@itg.be; proelants@itg.be; okellopaul2000@yahoo.co.uk; atalisuna@yahoo.com; mcoosemans@itg.be		Van Bortel, Wim/0000-0002-6644-518X	Belgian Directorate-General for Development Co-operation; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)	This research was financed by the Belgian Directorate-General for Development Co-operation and was funded by a Ph.D. grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen).	Asidi AN, 2004, MED VET ENTOMOL, V18, P134, DOI 10.1111/j.0269-283X.2004.00485.x; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P181; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Darriet F, 2000, B SOC PATHOL EXOT, V93, P131; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Etang J, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-46; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Garros C, 2004, AM J TROP MED HYG, V70, P260, DOI 10.4269/ajtmh.2004.70.260; GILLIES MT, 1987, PUBLICATION S AFRICA, V55; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Hougard JM, 2003, B ENTOMOL RES, V93, P491, DOI 10.1079/BER2003261; John R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-92; Mahama T, 2007, J MED ENTOMOL, V44, P498, DOI 10.1603/0022-2585(2007)44[498:EOPICD]2.0.CO;2; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10<1012::AID-PS39>3.0.CO;2-5; MARTINEZTORRES D, 1998, MOL BIOL, V7, P179; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Penilla RP, 1998, MED VET ENTOMOL, V12, P217; *PRES MAL IN UG, 2009, MAL OP PLAN; Protopopoff N, 2008, TROP MED INT HEALTH, V13, P1479, DOI 10.1111/j.1365-3156.2008.02164.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROUSH RT, 1987, ANNU REV ENTOMOL, V32, P361, DOI 10.1146/annurev.ento.32.1.361; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Vais H, 2000, J GEN PHYSIOL, V115, P305, DOI 10.1085/jgp.115.3.305; Vais H, 2003, MOL PHARMACOL, V64, P914, DOI 10.1124/mol.64.4.914; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Vulule JM, 1999, MED VET ENTOMOL, V13, P239, DOI 10.1046/j.1365-2915.1999.00177.x; *WHO, 2005, ATL INS RES MAL VEC; *WHO, 1998, REP WHO INF CONS TES	36	33	35	0	11	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	APR	2010	82	4					566	573		10.4269/ajtmh.2010.08-0668				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	577JR	WOS:000276219700011	20348500	Green Published, Bronze			2019-04-02	
J	van Olmen, J; Criel, B; Devadasan, N; Pariyo, G; De Vos, P; Van Damme, W; Van Dormael, M; Marchal, B; Kegels, G				van Olmen, Josefien; Criel, Bart; Devadasan, Narayanan; Pariyo, George; De Vos, Pol; Van Damme, Wim; Van Dormael, Monique; Marchal, Bruno; Kegels, Guy			Primary Health Care in the 21st century: primary care providers and people's empowerment	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						primary health care; empowerment; physician patient relations; chronic disease; editorial; low income population	QUALITY-OF-CARE; ALMA-ATA; DEVELOPING-COUNTRIES; PATIENT EMPOWERMENT; CHRONIC DISEASE; SYSTEMS; REBIRTH; INTERVENTIONS; PARTNERSHIP; INFORMATION		[van Olmen, Josefien; Criel, Bart; De Vos, Pol; Van Damme, Wim; Van Dormael, Monique; Marchal, Bruno; Kegels, Guy] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Devadasan, Narayanan] Inst Publ Hlth, Bangalore, Karnataka, India; [Pariyo, George] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	van Olmen, J (reprint author), Inst Trop Med, Dept Publ Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	jvanolmen@itg.be	Pariyo, George/K-2335-2017; De Vos, Pol/D-3370-2009; Van Damme, Wim/F-7404-2011	Pariyo, George/0000-0002-4411-2309; van Olmen, Josefien/0000-0001-9724-1887			Anderson RM, 2005, PATIENT EDUC COUNS, V57, P153, DOI 10.1016/j.pec.2004.05.008; ARNOLD MS, 1995, DIABETES EDUCATOR, V21, P308, DOI 10.1177/014572179502100408; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Blaise P, 2004, INT J HEALTH PLAN M, V19, P337, DOI 10.1002/hpm.769; BLOOM G, 2004, PRIVATE PROVISION IT; Bloom GHS, 2001, PLURALISM MARKETISAT; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Chan M, 2008, LANCET, V372, P865, DOI 10.1016/S0140-6736(08)61372-0; Criel B, 2005, TROP MED INT HEALTH, V10, P450, DOI 10.1111/j.1365-3156.2005.01410.x; De Vos Pol, 2009, Health Hum Rights, V11, P23; DIETRICH M, 2005, ONLINE SPOT PRAKTIJK; FESTE C, 1995, PATIENT EDUC COUNS, V26, P139, DOI 10.1016/0738-3991(95)00730-N; Frenk J, 2009, LANCET, V374, P170, DOI 10.1016/S0140-6736(09)60693-0; Fung CSC, 2009, FAM PRACT, V26, P398, DOI 10.1093/fampra/cmp044; Gilson L, 2007, CHALLENGING INEQUITY; Griffin SJ, 2004, ANN FAM MED, V2, P595, DOI 10.1370/afm.142; Hanson C, 2009, TROP MED INT HEALTH, V14, P710, DOI 10.1111/j.1365-3156.2009.02296.x; Herbert Rosemary J, 2009, Res Theory Nurs Pract, V23, P107; Holman H, 2000, BRIT MED J, V320, P526, DOI 10.1136/bmj.320.7234.526; Howie JGR, 2000, FAM PRACT, V17, P455, DOI 10.1093/fampra/17.6.455; *I TROP MED, 2009, PRIM HLTH CAR 21 CEN; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Lucas H, 2008, SOC SCI MED, V66, P2122, DOI 10.1016/j.socscimed.2008.01.033; Meessen B, 2006, TROP MED INT HEALTH, V11, P1303, DOI 10.1111/j.1365-3156.2006.01680.x; *MIN HLTH FAM WELF, 2005, NAT RUR HLTH MISS MI; Perez D, 2009, HEALTH POLICY PLANN, V24, P335, DOI 10.1093/heapol/czp028; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; Segall M, 2000, INT J HEALTH PLAN M, V15, P61, DOI 10.1002/(SICI)1099-1751(200001/03)15:1<61::AID-HPM573>3.0.CO;2-4; Shaw J, 2004, BMJ-BRIT MED J, V328, P723, DOI 10.1136/bmj.328.7442.723; Tomasi E, 2004, B WORLD HEALTH ORGAN, V82, P867; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; Van Dormael M, 2007, FAM PRACT, V24, P102, DOI 10.1093/fampra/cml070; Van Dormael M, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-25; Van Eygen L, 2007, INT J HEALTH PLAN M, V22, P63, DOI 10.1002/hpm.859; Wallerstein N, 2006, WHAT IS EVIDENCE EFF; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; *WHO, 2007, INN CAR CHRON COND B; Wientjens W., 2008, DIABETES VOICE, V53, P45; World Health Organization, 2008, WORLD HLTH REP 2008; Yamin Alicia Ely, 2009, Health Hum Rights, V11, P5	40	10	10	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2010	15	4					386	390		10.1111/j.1365-3156.2010.02475.x				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	568NY	WOS:000275530600001	20149164				2019-04-02	
J	Borrmann, S; Sallas, WM; Machevo, S; Gonzalez, R; Bjorkman, A; Martensson, A; Hamel, M; Juma, E; Peshu, J; Ogutu, B; Djimde, A; D'Alessandro, U; Marrast, AC; Lefevre, G; Kern, SE				Borrmann, Steffen; Sallas, William M.; Machevo, Sonia; Gonzalez, Raquel; Bjorkman, Anders; Martensson, Andreas; Hamel, Mary; Juma, Elizabeth; Peshu, Judy; Ogutu, Bernhards; Djimde, Abdoulaye; D'Alessandro, Umberto; Marrast, Anne-Claire; Lefevre, Gilbert; Kern, Steven E.			The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem (R)) for acute uncomplicated Plasmodium falciparum malaria	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						lumefantrine; artemether; Coartem; pharmacokinetics; food; bioavailability	CLINICAL PHARMACOKINETICS; THERAPEUTIC RESPONSE; 6-DOSE REGIMEN; EFFICACY; TRIAL; BENFLUMETOL; SAFETY; PHARMACODYNAMICS; INFANTS; UGANDA	OBJECTIVES Artemether-lumefantrine (AL) is first-line treatment for uncomplicated malaria in many African countries. Concomitant food consumption may affect absorption of lumefantrine but data in the most important target population, i.e. children, are lacking. Therefore, we evaluated the effect of food intake on oral lumefantrine bioavailability in African children with malaria. METHODS In a randomised, investigator-blinded, multicentre phase III efficacy trial, 899 infants and children with acute uncomplicated Plasmodium falciparum malaria received six doses of AL according to body weight over 3 days either as crushed tablets (Coartem (R)) or as dispersible tablets. Single blood samples were obtained for lumefantrine plasma concentration determination in a subset of 621 patients, and a two-compartment pharmacokinetic model was constructed. RESULTS The mean observed lumefantrine plasma concentration for crushed tablet and dispersible tablet, respectively, was 100% and 55% higher with a concomitant meal at the time of dose intake than when taken alone. Similarly, consumption of milk (the most common meal) increased model-estimated lumefantrine bioavailability by 57% (90% CI: 29-96%) with crushed tablets and 65% (90% CI: 28-109%) with dispersible tablets compared to no food. The 28-day PCR-corrected cure rate (primary study endpoint) in the evaluable population was 582/587 [99.1% (95% CI: 98.0-99.7%)] and was not related to food intake. CONCLUSIONS AL was highly efficacious. Concomitant food intake increased lumefantrine absorption in children with malaria.	[Borrmann, Steffen] Univ Heidelberg, Sch Med, Inst Hyg, D-69120 Heidelberg, Germany; [Borrmann, Steffen; Peshu, Judy] Wellcome Trust Res Programme, Kenya Med Res Inst, Kilifi, Kenya; [Sallas, William M.] Nova Pharmaceut Corp, Dept Modeling & Simulat, E Hanover, NJ USA; [Machevo, Sonia; Gonzalez, Raquel] Manhica Hlth Res Ctr, Manhica, Mozambique; [Gonzalez, Raquel] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Bjorkman, Anders; Martensson, Andreas] Karolinska Univ Hosp, Karolinska Inst, Infect Dis Unit, Stockholm, Sweden; [Martensson, Andreas] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth, Stockholm, Sweden; [Hamel, Mary; Juma, Elizabeth] Ctr Vector Biol & Control Res, Kenya Med Res Inst, Kisumu, Kenya; [Ogutu, Bernhards] Walter Reed US Army Inst, Kenya Med Res Inst, Kisumu, Kenya; [Djimde, Abdoulaye] Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Mol Epidemiol & Drug Resistance Unit, Bamako, Mali; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [Marrast, Anne-Claire] Novartis Pharma AG, Global Program Trop Med, Basel, Switzerland; [Lefevre, Gilbert] Novartis NIBR, Basel, Switzerland; [Kern, Steven E.] Novartis Pharma AG, Dept Modeling & Simulat, Basel, Switzerland; [Kern, Steven E.] Univ Utah, Dept Pharmaceut, Salt Lake City, UT USA	Borrmann, S (reprint author), Univ Heidelberg, Sch Med, Inst Hyg, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	steffen.borrmann@urz.uni-heidelberg.de	Borrmann, Steffen/G-1838-2013; D'Alessandro, Umberto/D-3457-2015; Gonzalez, Raquel/J-3604-2017	Borrmann, Steffen/0000-0001-9189-4393; D'Alessandro, Umberto/0000-0001-6341-5009; Gonzalez, Raquel/0000-0001-5487-801X	Novartis Pharma AG, Basel, Switzerland; German Research Foundation	We thank Salim Abdulla and John Lyimo of the Ifakara Health Institute, Dar es Salaam, Tanzania; Zulfikarali Premji of Muhimbili University of Health and Allied Sciences, Dar es Salaam; Issaka Sagara and Hamma Maiga of the Malaria Research and Training Centre, University of Bamako; Alain Nahum of the Centre de Recherche Entomologique de Cotonou; Quique Bassat of the Barcelona Centre for International Health Research; Lucas Otieno of the Walter Reed Project, Kenya Medical Research Institute, Kisumu; Peter Ouma of Kenya Medical Research Institute, Kisumu; David Ubben of Medicines for Malaria Venture, Geneva; Nathan Mulure from Novartis Kenya; Obiyo Nwaiwu from Novartis Nigeria; Marc Cousin, Novartis Basle. The study from which these data were derived was funded by Novartis Pharma AG, Basel, Switzerland. SB is funded by a German Research Foundation Junior Group grant.	Abdulla S, 2008, LANCET, V372, P1819, DOI 10.1016/S0140-6736(08)61492-0; Anderson BJ, 2008, ANNU REV PHARMACOL, V48, P303, DOI 10.1146/annurev.pharmtox.48.113006.094708; Checchi F, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-59; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Ezzet F, 1998, BRIT J CLIN PHARMACO, V46, P553, DOI 10.1046/j.1365-2125.1998.00830.x; Falade C, 2005, T ROY SOC TROP MED H, V99, P459, DOI 10.1016/j.trstmh.2004.09.013; Lefevre G, 2001, AM J TROP MED HYG, V64, P247, DOI 10.4269/ajtmh.2001.64.247; Lefevre G, 1999, CLIN DRUG INVEST, V18, P467; Makanga M, 2006, AM J TROP MED HYG, V74, P991, DOI 10.4269/ajtmh.2006.74.991; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; Premji ZG, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-244; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Roll Back Malaria, 2008, MAL AFR; van Vugt M, 2000, T ROY SOC TROP MED H, V94, P545, DOI 10.1016/S0035-9203(00)90082-8; van Vugt M, 1999, AM J TROP MED HYG, V60, P936, DOI 10.4269/ajtmh.1999.60.936; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; *WHO, 2008, WORLD MAL REP; [World Health Organization Severe falciparum malaria], 2000, T R SOC TROP MED S1, V94, pS1, DOI DOI 10.1016/S0035-9203(00)90300-6	20	32	33	0	12	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2010	15	4					434	441		10.1111/j.1365-3156.2010.02477.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	568NY	WOS:000275530600007	20180933	Bronze			2019-04-02	
J	Nguyen, TGT; Le, TH; De, NV; Doan, TT; Dao, THT; Vercruysse, J; Dorny, P				Nguyen, T. G. T.; Le, T. H.; De, N. V.; Doan, T. T.; Dao, T. H. T.; Vercruysse, J.; Dorny, P.			Assessment of a 27-kDa antigen in Enzyme-Linked Immunosorbent Assay for the diagnosis of fasciolosis in Vietnamese patients	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Fasciolosis; diagnosis; Enzyme-linked immunosorbent assay; hepatic disease; Vietnam	HEPATICA; GIGANTICA; SERODIAGNOSIS; CHOLANGIOCARCINOMA; TRICLABENDAZOLE; SHEEP	Fasciolosis has emerged as an important zoonotic disease in many parts of the world. In recent years, an increasing number of human cases were reported in Vietnam. In this study, the 27-kDa component protein from the excretory/secretory production of adult Fasciola gigantica, purified by high performance liquid chromatography, was assessed in an enzyme-linked immunosorbent assay (ELISA) to detect antibodies against Fasciola spp. for diagnosis of human fasciolosis. The ELISA showed a high sensitivity (100%) and specificity (97.67%) when tested on patients with fasciolosis, other parasitic infections, cholangiocarcinoma and on healthy controls. The assay was applied for diagnosis on 143 patients in the Viet Duc-Hanoi hospital who presented with clinical signs of liver disease and lesions in their livers as shown by imaging techniques. Antibodies were found in 37 (25.9%) of these patients, of whom only 3 shed Fasciola eggs in their stools (2.1%). The excellent response to triclabendazole treatment of 37 sero-positive patients confirmed the diagnosis of fasciolosis. This study demonstrated the diagnostic potential for human fasciolosis of the 27-kDa antigen ELISA. Fasciolosis should be considered in the differential diagnosis of hepatic disease in Vietnam.	[Dorny, P.] Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium; [Nguyen, T. G. T.; Dao, T. H. T.] Natl Inst Vet Res, Hanoi, Vietnam; [Le, T. H.] Inst Biotechnol, Dept Immunol, Hanoi, Vietnam; [De, N. V.] Hanoi Med Univ, Dept Parasitol, Hanoi, Vietnam; [Doan, T. T.] Hanoi Med Univ, Viet Duc Hosp, Hanoi, Vietnam; [Vercruysse, J.; Dorny, P.] Univ Ghent, Fac Vet Med, Parasitol Lab, Merelbeke, Belgium	Dorny, P (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	PDorny@itg.be			Flemish Inter-University Council, Belgium	This study was financially supported by the Flemish Inter-University Council (VLIR) PhD programme, Belgium. The authors wish to thank the staff of the Parasitology Department of NIVR, the clinical Department of NIMPE, Viet Duc-Hanoi hospital, the Department of Animal Health of ITM and the Laboratory Department of Parasitology, Faculty of Veterinary Medicine, Ghent University, for technical help.	Adachi S, 2005, INTERNAL MED, V44, P1013, DOI 10.2169/internalmedicine.44.1013; Almazan C, 2001, VET PARASITOL, V97, P101, DOI 10.1016/S0304-4017(01)00376-4; Andrews SJ, 1999, FASCIOLOSIS, P1; [Anonymous], 1995, World Health Organ Tech Rep Ser, V849, P1; Choi BI, 2004, CLIN MICROBIOL REV, V17, P540, DOI 10.1128/CMR.17.3.540-552.2004; Dalimi A, 2004, ANN SAUDI MED, V24, P18, DOI 10.5144/0256-4947.2004.18; De N.V., 2006, 5 SEM FOOD WAT BORN; De Nguyen Van, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 1, P12; DE NV, 2005, J MALARIA PARASITIC, V6, P54; Dixit AK, 2002, VET PARASITOL, V109, P233, DOI 10.1016/S0304-4017(02)00202-9; Espino AM, 1998, J CLIN MICROBIOL, V36, P2723; Esteban JG, 1999, T ROY SOC TROP MED H, V93, P151, DOI 10.1016/S0035-9203(99)90289-4; Graham CS, 2001, CLIN INFECT DIS, V33, P1, DOI 10.1086/320870; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Lee OJ, 2006, J GASTROEN HEPATOL, V21, P1631, DOI 10.1111/1440-1746.2006.03185.x; Maleewong W., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P566; Maleewong W, 1999, AM J TROP MED HYG, V61, P648, DOI 10.4269/ajtmh.1999.61.648; Marcos LA, 2008, AM J TROP MED HYG, V78, P222, DOI 10.4269/ajtmh.2008.78.222; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Mas-Coma S, 1999, B WORLD HEALTH ORGAN, V77, P340; Mas-Coma S, 1999, FASCIOLOSIS, P411; Mezo M, 2003, J PARASITOL, V89, P843, DOI 10.1645/GE-74RI.1; Mungube EO, 2006, TROP ANIM HEALTH PRO, V38, P475, DOI 10.1007/s11250-006-4394-4; Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188; Silva E, 2004, J PARASITOL, V90, P746, DOI 10.1645/GE-136R; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; TESANA S, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P447; Wongkham C, 2005, CLIN DIAGN LAB IMMUN, V12, P1152, DOI 10.1128/CDLI.12.10.1152-1156.2005; Ying M, 2007, T ROY SOC TROP MED H, V101, P1051, DOI 10.1016/j.trstmh.2007.05.013	29	10	14	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2010	15	4					462	467		10.1111/j.1365-3156.2010.02468.x				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	568NY	WOS:000275530600010	20149166				2019-04-02	
J	Secka, A; Grimm, F; Victor, B; Marcotty, T; De Deken, R; Nyan, O; Herera, O; Van Marck, E; Geerts, S				Secka, A.; Grimm, F.; Victor, B.; Marcotty, T.; De Deken, R.; Nyan, O.; Herera, O.; Van Marck, E.; Geerts, S.			Epilepsy is not caused by cysticercosis in The Gambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						The Gambia; neurocysticercosis; antigen-ELISA; electro-immunotransfer blot; computed tomography; epilepsy; case-control study	LINKED IMMUNOELECTROTRANSFER BLOT; TAENIA-SOLIUM CYSTICERCOSIS; NEUROCYSTICERCOSIS; ANTIGENS; SEROPREVALENCE; BURUNDI; AFRICA; ELISA; ASSAY; SERUM	OBJECTIVE To determine whether epilepsy is caused by Taenia solium cysticercosis in The Gambia. METHODS Case-control study testing samples collected from 210 people with epilepsy and 420 matched controls by sex and age +/- 5 years from 69 different places around the country during the period October 2008-March 2009. All serum samples were subjected to an antigen detection ELISA (Ag-ELISA) and electro-immunotransfer blot (EITB), and the seropositives were further CT-scanned to determine the presence of cysticerci in the brain. RESULTS Although not significantly different (P = 0.668), circulating Taenia antigen was found by Ag-ELISA in 1.4% (95% CI: 0.3-4.1) of people with epilepsy and in 1.9% (95% CI: 0.8-3.7) of the controls. A non-significant (P = 0.4718) odds ratio of association 0.75 (95% CI: 0.13-3.15) between epilepsy and the presence of Taenia antigens was found. All 630 serum samples turned out seronegative by the EITB test. There were no intracranial cysts or cyst-like structures detected among the nine CT-scanned Ag-ELISA seropositives. CONCLUSION Epilepsy appears not to be caused by cysticercosis in The Gambia.	[Victor, B.; Marcotty, T.; De Deken, R.; Geerts, S.] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Secka, A.] Int Trypanotolerance Ctr, Banjul, Gambia; [Grimm, F.] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Nyan, O.; Herera, O.] Royal Victoria Teaching Hosp, Banjul, Gambia; [Van Marck, E.] Univ Antwerp, Pathol Lab, B-2020 Antwerp, Belgium	Geerts, S (reprint author), Inst Trop Med, Dept Anim Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	s.geerts@itg.be		Geerts, Stanny/0000-0001-9885-8846	Flemish Inter-University Council (VLIR, Brussels, Belgium)	This study was funded by the Flemish Inter-University Council (VLIR, Brussels, Belgium). The help offered by the neurologist and radiologist at RVTH, the psychiatric unit staff at the polyclinic unit of RVTH and the technical/administrative staffs of ITC is gratefully acknowledged. The participation of the Gambia Epilepsy Association and study volunteers was very much appreciated.	BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; Carabin H, 2006, TROP MED INT HEALTH, V11, P906, DOI 10.1111/j.1365-3156.2006.01627.x; Carpio A, 2002, NEUROLOGY, V59, P1730, DOI 10.1212/01.WNL.0000036320.69823.EA; Commission on classification and terminology of the International League Against Epilepsy (ILAE), 1989, EPILEPSIA, V30, P389, DOI DOI 10.1111/J.1528-1157.1989.TB05316.X; Erhart A, 2002, T ROY SOC TROP MED H, V96, P270, DOI 10.1016/S0035-9203(02)90095-7; Garcia HH, 2000, T ROY SOC TROP MED H, V94, P673, DOI 10.1016/S0035-9203(00)90228-1; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Houinato D, 1998, T ROY SOC TROP MED H, V92, P621, DOI 10.1016/S0035-9203(98)90785-4; Nash T.E., 2005, WHO FAO OIE GUIDELIN, P11; Nguekam, 2003, PARASITE, V10, P65, DOI 10.1051/parasite/2003101p65; NORLINAH I, 2003, NEUROL J S E ASIA, V8, P45; Nsengiyumva G, 2003, EPILEPSIA, V44, P950, DOI 10.1046/j.1528-1157.2003.55302.x; Prado-Jean A, 2007, TROP MED INT HEALTH, V12, P895, DOI 10.1111/j.1365-3156.2007.01860.x; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Rodriguez S, 2009, J INFECT DIS, V199, P1345, DOI 10.1086/597757; SOKAL RR, 1981, BIOMETRY, P229; TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50; Vondou L, 2002, PARASITE, V9, P271, DOI 10.1051/parasite/2002093271; WILSON M, 1991, J INFECT DIS, V164, P1007, DOI 10.1093/infdis/164.5.1007	19	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2010	15	4					476	479		10.1111/j.1365-3156.2010.02470.x				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	568NY	WOS:000275530600012	20180937	Bronze			2019-04-02	
J	Gerstl, S; Dunkley, S; Mukhtar, A; Maes, P; De Smet, M; Baker, S; Maikere, J				Gerstl, Sibylle; Dunkley, Sophie; Mukhtar, Ahmed; Maes, Peter; De Smet, Martin; Baker, Samuel; Maikere, Jacob			Long-lasting insecticide-treated net usage in eastern Sierra Leone - the success of free distribution	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						malaria; Sierra Leone; prevention; bed nets; long-lasting insecticide-treated net; mass distribution; antenatal care; Abuja target; Roll Back Malaria	MALARIA CONTROL; RURAL KENYA; COVERAGE; CHILDREN; OWNERSHIP; TANZANIA; AFRICA; NIGERIA; POSSESSION; CAMPAIGN	OBJECTIVE Medecins Sans Frontieres (MSF) runs a malaria control project in Bo and Pujehun districts (population 158 000) that includes the mass distribution, routine delivery and demonstration of correct use of free, long-lasting insecticide-treated nets (LLINs). In 2006/2007, around 65 000 LLINs were distributed. The aim of this follow-up study was to measure LLIN usage and ownership in the project area. METHODS Heads of 900 randomly selected households in 30 clusters were interviewed, using a standardized questionnaire, about household use of LLINs. The condition of any LLIN was physically assessed. RESULTS Of the 900 households reported, 83.4% owning at least one LLIN. Of the 16.6% without an LLIN, 91.9% had not participated in the MSF mass distribution. In 94.1% of the households reporting LLINs, the nets were observed hanging correctly over the beds. Of the 1135 hanging LLINs, 75.2% had no holes or 10 or fewer finger-size holes. The most common source of LLINs was MSF (75.2%). Of the 4997 household members, 67.2% reported sleeping under an LLIN the night before the study, including 76.8% of children under 5 years and 73.0% of pregnant women. CONCLUSION Our results show that MSF achieved good usage with freely distributed LLINs. It is one of the few areas where results almost achieve the new targets set in 2005 by Roll Back Malaria to have at least 80% of pregnant women and children under 5 years using LLINs by 2010.	[Gerstl, Sibylle] Med Sans Frontieres United Kingdom, London EC1N 8QX, England; [Dunkley, Sophie; Mukhtar, Ahmed] Med Sans Frontieres Belgium, Bo, Sierra Leone; [Maes, Peter; De Smet, Martin; Maikere, Jacob] Med Sans Frontieres Belgium, Brussels, Belgium; [Baker, Samuel] Minist Hlth & Sanitat, Freetown, Sierra Leone	Gerstl, S (reprint author), Med Sans Frontieres United Kingdom, 67-74 Saffron Hill, London EC1N 8QX, England.	sgerstl@aol.com			Medecins Sans Frontieres teams in Bo, Freetown and Brussels	We thank the study teams for their enthusiasm and diligence when carrying out the study. We also thank the Medecins Sans Frontieres teams in Bo, Freetown and Brussels for their support. Many thanks to Sarah Venis (Medecins Sans Frontieres-United Kingdom) for reviewing the manuscript. Finally, this study would not have been possible without the cooperation and generosity of the people of the villages of Bo and Pujehun districts.	[Anonymous], 2008, LANCET, V372, P1193; Baume CA, 2007, AM J TROP MED HYG, V77, P963, DOI 10.4269/ajtmh.2007.77.963; Baume CA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-153; Bernard J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-65; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; COHEN J, 2008, 169 BREAD; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Fettene M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-114; GERSTL S, 2008, STUDY REPORT RETROSP; GERSTL S, 2009, STUDY REPORT ADHEREN; Gikandi PW, 2008, TROP MED INT HEALTH, V13, P208, DOI 10.1111/j.1365-3156.2007.01992.x; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; Hanson K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2434; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Khatib RA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-98; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; Macintyre K, 2006, TROP MED INT HEALTH, V11, P824, DOI 10.1111/j.1365-3156.2006.01637.x; Matovu F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-109; Miller JM, 2007, JAMA-J AM MED ASSOC, V297, P2241, DOI 10.1001/jama.297.20.2241; *MIN HLTH SAN, 2007, SURV REP COV MAL CON; Mueller DH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-73; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Oresanya OB, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-145; PETTIFOR A, 2009, TROP MED INT HEALTH, V80, P14; Roll Back Malaria, 2005, GLOB STRAT PLAN 2005; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dy1027; Sachs JD, 2005, NEW ENGL J MED, V352, P115, DOI 10.1056/NEJMp048319; SELD H, 2008, MALARIA J, V7, P85; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S01406736(07)60951-9; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; *UNICEF SIERR LEON, 2007, SIERR LEON MULT IND; WHO, 2008, WORLD MAL REP 2008; *WHO, 2007, REP 11 WHOPES WORK G; World Health Organization, 2000, AFR SUMM ROLL BACK M	41	23	23	0	11	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2010	15	4					480	488		10.1111/j.1365-3156.2010.02478.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	568NY	WOS:000275530600013	20149163				2019-04-02	
J	Mekonnen, Z; Ali, S; Belay, G; Suleman, S; Chatterjee, S				Mekonnen, Zeleke; Ali, Solomon; Belay, Getachew; Suleman, Sultan; Chatterjee, Shyama			Evaluation of the performance of CareStart (TM) Malaria Pf/Pv Combo rapid diagnostic test for the diagnosis of malaria in Jimma, southwestern Ethiopia	ACTA TROPICA			English	Article						Malaria; CareStart (TM) Malaria RDT; Plasmodium; Ethiopia	EXPERT MICROSCOPY; CHILDREN; UGANDA; FIELD; RISK	Objective: To evaluate the diagnostic performance of CareStart (TM) Malaria Pf/Pv Combo test relative to microscopy, for the diagnosis of falciparum and vivax malaria in Ethiopia. Methods: Two hundred and forty febrile patients visiting the Serbo health center in Jimma zone, southwestern Ethiopia, were involved in this study in 2008. Giemsa-stained thin and thick blood smears were prepared and microscopically examined under a 100x oil immersion microscope objective for Plasmodium species identification and determination of parasitemia respectively. CareStart (TM) Malaria Pf/Pv Combo test was performed as per the manufacturers' instruction. Findings: The validity of CareStart (TM) Malaria Pf/Pv Combo test for the diagnosis of Plasmodium was very good with a sensitivity of 95.8%, specificity of 100%, positive predictive value of 100% and negative predictive value of 96%. The test performed equally well for the identification of Plasmodium falciparum and P. vivax. The diagnostic performance of this CareStart (TM) test is comparable to light microscopy of thin and thick blood smears. Conclusion: Although CareStart (TM) Malaria Pf/Pv Combo test and blood microscopy have comparable diagnostic performance for Plasmodium detection, the CareStart (TM) test has the added advantage of being simple to interpret, cost-efficient, and hence it is preferable to use this rapid diagnostic test for malaria diagnosis in areas where microscopy is not accessible and during times of malaria epidemics that are observed approximately every 4-5 years in Ethiopia. (C) 2009 Elsevier B.V. All rights reserved.	[Chatterjee, Shyama] Univ Antwerp, Fac Med, Pathol Lab, B-2610 Antwerp, Belgium; [Mekonnen, Zeleke; Ali, Solomon; Belay, Getachew] Jimma Univ, Fac Med Sci, Sch Med Lab Sci, Jimma, Ethiopia; [Suleman, Sultan] Jimma Univ, Fac Med Sci, Sch Pharm, Jimma, Ethiopia	Chatterjee, S (reprint author), Univ Antwerp, Fac Med, Pathol Lab, Campus Drie Eiken S3-53,Univ Pl 1, B-2610 Antwerp, Belgium.	Shyama.Chatterjee@ua.ac.be			School of Laboratory Studies of the Jimma University; VLIR-IUC program between Flanders and Jimma University	The study received financial support from the School of Laboratory Studies of the Jimma University and the VLIR-IUC program between Flanders and Jimma University. We acknowledge with gratitude Access Bio, Inc. for the donation of CareStart (TM) Malaria Pf/Pv Combo test kit.	Adhanom T, 2006, EPIDEMIOLOGY ECOLOGY, P556; ALLEN C, 2006, J TROP PEDIATRICS, V52, P386; ANTHONY M, 2002, CLIN MICROBIOL REV, V15, P66; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; *CNHDE, 2007, MAL TREATM; Deressa W, 2003, B WORLD HEALTH ORGAN, V81, P261; *FED MIN HLTH, 2004, GUID MAL EP PREV CON; *FED MIN HLTH, 2006, NAT 5 YEAR STRAT PLA; Fogg C, 2008, T ROY SOC TROP MED H, V102, P25, DOI 10.1016/j.trstmh.2007.09.014; Gatti S, 2002, ANN TROP MED PARASIT, V96, P15, DOI 10.1179/000349802125000457; Ghebreyesus TA, 1996, ACTA TROP, V61, P145, DOI 10.1016/0001-706X(95)00107-P; GIRUM T, 2001, ETHIOP J HLTH SCI, V11, P5; Guthmann JP, 2002, T ROY SOC TROP MED H, V96, P254, DOI 10.1016/S0035-9203(02)90091-X; Hopkins H, 2007, AM J TROP MED HYG, V76, P1092, DOI 10.4269/ajtmh.2007.76.1092; Jima D, 2005, ETHIOP J HEALTH DEV, V19, P16; KAKLCIAYA BS, 2003, LAB MED, V8, P602; Kloos H, 1993, ECOLOGY HLTH DIS ETH, P341; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; Mendiratta D K, 2006, Indian J Med Microbiol, V24, P49; OLIVAR M, 1991, T ROY SOC TROP MED H, V85, P729, DOI 10.1016/0035-9203(91)90432-X; Ratsimbasoa A, 2007, AM J TROP MED HYG, V76, P481, DOI 10.4269/ajtmh.2007.76.481; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; Tagbor Harry, 2008, Ther Clin Risk Manag, V4, P631; *WHO, 2000, JOINT WHO USAID INF; *WHO, 1993, WHO TECHN REP SER, V839; *WHO, 2003, M JAN 20 23 WHO MAN	26	14	14	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	MAR	2010	113	3					285	288		10.1016/j.actatropica.2009.12.001				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	570KZ	WOS:000275677700013	20005196				2019-04-02	
J	Phanzu, MD; Bafende, AE; Imposo, BBD; Meyers, WM; Portaels, F				Phanzu, Mavinga D.; Bafende, Aombe E.; Imposo, Bofunga B. D.; Meyers, Wayne M.; Portaels, Francoise			Short Report: Under Treated Necrotizing Fasciitis Masquerading as Ulcerated Edematous Mycobacterium ulcerans Infection (Buruli Ulcer)	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							TROPICAL ULCER; DISEASE; SKIN	We report a case of under treated necrotizing fasciitis (NF) in a 65-year-old woman with diabetes misdiagnosed as Mycobacterium ulcerans infection. She came to the Institut Medical Evangelique (IME) with an extensive painful edematous ulcerated lesion on the dorsum of the right foot and ankle. The diagnosis of Buruli ulcer (BU) was based initially on clinical findings and place of residence (Songololo Territory, the largest known focus of BU in Bas-Congo province). Tissue specimens gave negative results for acid-fast bacilli (AFB), culture, and polymerase chain reaction (PCR) for M. ulcerans. Histopathologic analysis revealed marked necrosis of the lower dermis and subcutaneous tissue. No AFB was found. Later, scattered foci of intracellular gram-positive cocci typical of streptococci were seen. Clinicopathologic correlation of these findings strongly supported the diagnosis of NF. This patient shows the difficulties that may be encountered even in known endemic areas in recognizing BU cases purely on clinical findings.	[Portaels, Francoise] ITM, Antwerp, Belgium; [Meyers, Wayne M.] AFIP, Washington, DC USA; [Phanzu, Mavinga D.; Bafende, Aombe E.; Imposo, Bofunga B. D.] IME, Kimpese, Bas Congo, Zaire	Portaels, F (reprint author), ITM, Antwerp, Belgium.	dmavingaphanzu@yahoo.fr; eric.bafende@sam-ame.org; imposodesire@yahoo.fr; wmekmeyers@comcast.net; portaels@itg.be			European Commission [INCO-CT-2005-05-051476-BURULICO]	This study was supported by the European Commission (International Science and Technology Cooperation Development Program), Project No. INCO-CT-2005-05-051476-BURULICO.	Abalos F M, 2000, Ann Diagn Pathol, V4, P386, DOI 10.1053/adpa.2000.19372; Aiga H, 2004, AM J TROP MED HYG, V71, P387, DOI 10.4269/ajtmh.2004.71.387; Angoules AG, 2007, INJURY S, V38, pS18; Asiedu K, 2000, BURULI ULCER MYCOBAC; BRAUNWALD E, 2001, HARRISONS MANUAL MED, P176; BULTO T, 1993, ETHIOPIAN MED J, V31, P75; Cox NH, 1999, BRIT J DERMATOL, V141, P613; Dahl PR, 2002, J AM ACAD DERMATOL, V47, P489, DOI 10.1067/mjd.2002.120536; Debacker M, 2004, EMERG INFECT DIS, V10, P1391, DOI 10.3201/eid1008.030886; Debacker M, 2003, CLIN INFECT DIS, V36, pE67, DOI 10.1086/367660; FLEMING R A, 1962, J Int Coll Surg, V38, P120; Hasham S, 2005, BMJ-BRIT MED J, V330, P830, DOI 10.1136/bmj.330.7495.830; Janssens P, 2005, B SEANCES ACAD R SCI, V51, P265; Meyers W M, 1974, Ann Soc Belg Med Trop, V54, P147; MEYERS WM, 1974, AM J TROP MED HYG, V23, P919, DOI 10.4269/ajtmh.1974.23.919; Ogundiran TO, 2004, TROP DOCT, V34, P175, DOI 10.1177/004947550403400320; Phanzu DM, 2006, AM J TROP MED HYG, V75, P311, DOI 10.4269/ajtmh.2006.75.311; Portaels F, 2001, BURULI ULCER DIAGNOS; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; ROBINSON DC, 1988, INT J DERMATOL, V27, P49, DOI 10.1111/j.1365-4362.1988.tb02339.x; Siegmund V, 2007, CLIN INFECT DIS, V45, P68, DOI 10.1086/518604; Smeets L, 2007, ACTA CHIR BELG, V107, P29, DOI 10.1080/00015458.2007.11680007; Turner S. M., 1989, PSYCHOL ASSESSMENT J, V1, P35, DOI [10.1037/1040-3590.1.1.35, DOI 10.1037/1040-3590.1.1.35]; van der Werf TS, 1999, LANCET, V354, P1013, DOI 10.1016/S0140-6736(99)01156-3; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P816; Walsh DS, 2008, T ROY SOC TROP MED H, V102, P969, DOI 10.1016/j.trstmh.2008.06.006; *WHO, 2004, WHOCDSCPEGBUI200410	27	4	4	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAR	2010	82	3					478	481		10.4269/ajtmh.2010.09-0256				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	564LE	WOS:000275215000024	20207877	Bronze, Green Published			2019-04-02	
J	Eren, M; Dinleyici, EC; Vandenplas, Y				Eren, Makbule; Dinleyici, Ener C.; Vandenplas, Yvan			Clinical Efficacy Comparison of Saccharomyces boulardii and Yogurt Fluid in Acute Non-Bloody Diarrhea in Children: A Randomized, Controlled, Open Label Study	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							ACUTE GASTROENTERITIS; INFECTIOUS DIARRHEA; PROBIOTICS; METAANALYSIS; PREVENTION; MANAGEMENT; THERAPY; TRIAL	The purpose of this trial is to evaluate the clinical efficacy and cost/effectiveness of Saccharomyces boulardii compared with yogurt fluid (YF) in acute non-bloody diarrhea in children. This randomized, prospective open-label clinical trial includes 55 children (36 boys, 19 girls; mean age 21.2 +/- 28.2 months). Group A (N = 28) received lyophilized S. boulardii and group B (N = 27) received YE The duration of diarrhea was shorter with S. boidardii but the hospital stay was reduced with YF, although these differences were not significant. However, diarrhea had resolved in significantly more children on day 3 in the S. boulardii group (48.5% versus 25.5%; P < 0.05). In outpatient cases, yogurt treatment was cheaper than S. boulardii whereas in hospitalized patients, treatment cost was similar. In conclusion, the effect of daily freshly prepared YF was comparable to S. boulardii in the treatment of acute non-bloody diarrhea in children. ne duration of diarrhea was shorter in the S boulardii group, expressed as a significantly higher number of patients with normal stools on day 3.	[Eren, Makbule] Eskisehir Osmangazi Univ, Fac Med, Dept Pediat Gastroenterol & Hepatol, TR-26480 Eskisehir, Turkey; [Vandenplas, Yvan] Vrije Univ Brussels, Univ Ziekenhuis Brussel, B-1090 Brussels, Belgium; [Dinleyici, Ener C.] Eskisehir Osmangazi Univ, Fac Med, Dept Pediat, Eskisehir, Turkey	Eren, M (reprint author), Eskisehir Osmangazi Univ, Fac Med, Dept Pediat Gastroenterol & Hepatol, TR-26480 Eskisehir, Turkey.	makbule99@yahoo.com; timboothtr@yahoo.com; Yvan.Vandenplas@uzbrussel.de					Adolfsson O, 2004, AM J CLIN NUTR, V80, P245; Billoo AG, 2006, WORLD J GASTROENTERO, V12, P4557, DOI 10.3748/wjg.v12.i28.4557; Boudraa G, 2001, J PEDIATR GASTR NUTR, V33, P307, DOI 10.1097/00005176-200109000-00015; Burkhardt O, 2005, SCAND J INFECT DIS, V37, P69, DOI 10.1080/00365540510026454; Canani RB, 2006, J PEDIATR GASTR NUTR, V42, P253, DOI 10.1097/01.mpg.0000214159.60445.9a; Canani RB, 2007, BMJ-BRIT MED J, V335, P340, DOI 10.1136/bmj.39272.581736.55; Conway S, 2007, BRIT J GEN PRACT, V57, P953, DOI 10.3399/096016407782604811; Dinleyici EC, 2009, AM J TROP MED HYG, V80, P953, DOI 10.4269/ajtmh.2009.80.953; Gaon D, 2003, MEDICINA-BUENOS AIRE, V63, P293; GREENBAUM L, 2008, TXB PEDIAT, P313; Guandalini S, 2006, J CLIN GASTROENTEROL, V40, P244, DOI 10.1097/00004836-200603000-00016; Guarino A, 2008, J PEDIATR GASTR NUTR, V46, pS81, DOI 10.1097/MPG.0b013e31816f7b16; Gueimonde M, 2004, FOOD RES INT, V37, P839, DOI 10.1016/j.foodres.2004.04.006; Htwe K, 2008, AM J TROP MED HYG, V78, P214, DOI 10.4269/ajtmh.2008.78.214; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Kurugol Z, 2005, ACTA PAEDIATR, V94, P44, DOI 10.1080/08035250410022521; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Pashapour N, 2006, TURKISH J PEDIATR, V48, P115; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Szajewska H, 2007, ALIMENT PHARM THER, V25, P257, DOI 10.1111/j.1365-2036.2006.03202.x; Van Niel CW, 2002, PEDIATRICS, V109, P678, DOI 10.1542/peds.109.4.678; Vandenplas Y, 2007, EUR J PEDIATR, V166, P1211, DOI 10.1007/s00431-007-0497-9; Vandenplas Y, 2009, EUR J PEDIATR, V168, P253, DOI 10.1007/s00431-008-0879-7; Veereman-Wauters G, 2006, PEDIAT GASTROINTESTI, P151; WATERLOW JC, 1972, BRIT MED J, V3, P566, DOI 10.1136/bmj.3.5826.566	25	19	21	2	6	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAR	2010	82	3					488	491		10.4269/ajtmh.2010.09-0529				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	564LE	WOS:000275215000026	20207879	Green Published, Bronze			2019-04-02	
J	Neerinckx, S; Peterson, AT; Gulinck, H; Deckers, J; Kimaro, D; Leirs, H				Neerinckx, Simon; Peterson, A. Townsend; Gulinck, Hubert; Deckers, Jozef; Kimaro, Didas; Leirs, Herwig			Predicting Potential Risk Areas of Human Plague for the Western Usambara Mountains, Lushoto District, Tanzania	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SOUTHWESTERN UNITED-STATES; SPATIAL EPIDEMIOLOGIC DATA; ECOLOGICAL NICHE; SPECIES DISTRIBUTIONS; GEOGRAPHIC DISTRIBUTIONS; VECTORBORNE DISEASES; YERSINIA-PESTIS; NEW-MEXICO; CLIMATE; MODELS	A natural focus of plague exists in the Western Usambara Mountains of Tanzania. Despite intense research, questions remain as to why and how plague emerges repeatedly in the same suite of villages. We used human plague incidence data for 1986-2003 in an ecological-niche modeling framework to explore the geographic distribution and ecology of human plague. Our analyses indicate that plague Occurrence is related directly to landscape-scale environmental features, yielding a predictive understanding of one set of environmental factors affecting plague transmission in East Africa. Although many environmental variables contribute significantly to these models, the most important are elevation and Enhanced Vegetation Index derivatives. Projections of these models across broader regions predict only 15.5% (under a majority-rule threshold) or 31,997 km(2) of East Africa as suitable for plague transmission, but they successfully anticipate most known foci in the region, making possible the development of a risk map of plague.	[Neerinckx, Simon; Leirs, Herwig] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Gulinck, Hubert; Deckers, Jozef] Katholieke Univ Leuven, Dept Earth & Environm Sci, B-3001 Heverlee, Belgium; Katholieke Univ Leuven, Dept Earth & Environm Sci, Louvain, Belgium; [Peterson, A. Townsend] Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; [Peterson, A. Townsend] Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA; [Kimaro, Didas] Sokoine Univ Agr, Dept Agr Engn & Land Planning, Morgoro, Tanzania; [Leirs, Herwig] Univ Aarhus, Fac Agr Sci, Dept Integrated Pest Management, Danish Pest Infestat Lab, DK-2800 Lyngby, Denmark	Neerinckx, S (reprint author), Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	simon.neerinckx@ua.ac.be	Peterson, A. Townsend/I-5697-2013; Leirs, Herwig/B-8197-2008	Peterson, A. Townsend/0000-0003-0243-2379; Leirs, Herwig/0000-0002-7612-5024	NIDDK NIH HHS [K24 DK002800]		Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Ben Ari T, 2008, BIOL LETTERS, V4, P737, DOI 10.1098/rsbl.2008.0363; Davis D. H. S., 1953, Bulletin of the World Health Organization, V9, P665; Davis S, 2006, ACTA TROP, V100, P133, DOI 10.1016/j.actatropica.2006.10.006; Dennis D. T., 1999, PLAGUE MANUAL EPIDEM; Eisen L, 2007, EMERG INFECT DIS, V13, P1816, DOI 10.3201/eid1312.070211; Eisen RJ, 2007, AM J TROP MED HYG, V77, P121, DOI 10.4269/ajtmh.2007.77.121; Eisen RJ, 2007, J MED ENTOMOL, V44, P530, DOI 10.1603/0022-2585(2007)44[530:HPITSU]2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Enscore RE, 2002, AM J TROP MED HYG, V66, P186, DOI 10.4269/ajtmh.2002.66.186; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Kausrud KL, 2007, P R SOC B, V274, P1963, DOI 10.1098/rspb.2007.0568; Kilonzo BS, 1997, ACTA TROP, V68, P215, DOI 10.1016/S0001-706X(97)00096-X; KILONZO BS, 1982, T ROY SOC TROP MED H, V76, P172, DOI 10.1016/0035-9203(82)90269-3; Kilonzo BS, 2000, P 19 ANN SCI C TANZ, p172 ; Krasnov BR, 2001, J MED ENTOMOL, V38, P629, DOI 10.1603/0022-2585-38.5.629; Laudisoit A., 2009, Current Zoology, V55, P199; Laudisoit A, 2007, EMERG INFECT DIS, V13, P687, DOI 10.3201/eid1305.061084; LYAMUYA EF, 1992, J TROP MED HYG, V95, P335; MAKUNDI RH, 2003, RATS MICE PEOPLE ROD, P20; Migliani R, 2006, TROP MED INT HEALTH, V11, P1228, DOI 10.1111/j.1365-3156.2006.01677.x; MISONNE X, 1920, ANN SOC BELG MED TR, V39, P437; Nakazawa Y, 2007, VECTOR-BORNE ZOONOT, V7, P529, DOI 10.1089/vbz.2007.0125; Neerinckx S, 2010, T ROY SOC TROP MED H, V104, P97, DOI 10.1016/j.trstmh.2009.07.028; Neerinckx SB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-54; ORACH SO, 2002, PLAGUE OUTBREAKS GEN; Parmenter RR, 1999, AM J TROP MED HYG, V61, P814, DOI 10.4269/ajtmh.1999.61.814; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2008, EMERG INFECT DIS, V14, P1335, DOI 10.3201/eid1408.080145; Peterson AT, 2008, NATURWISSENSCHAFTEN, V95, P483, DOI 10.1007/s00114-008-0352-5; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Roberts JI., 1935, E AFR MED J, V12, P200; *SMART, 2008, 90 M DIG EL DAT; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Stenseth NC, 2006, P NATL ACAD SCI USA, V103, P13110, DOI 10.1073/pnas.0602447103; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; *WHO, 2008, P INT M PREV CONTR P; Winters AM, 2009, AM J TROP MED HYG, V80, P1014, DOI 10.4269/ajtmh.2009.80.1014	46	12	14	0	11	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAR	2010	82	3					492	500		10.4269/ajtmh.2010.09-0426				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	564LE	WOS:000275215000027	20207880	Green Published, Bronze			2019-04-02	
J	Rijal, S; Bhandari, S; Koirala, S; Singh, R; Khanal, B; Loutan, L; Dujardin, JC; Boelaert, M; Chappuis, F				Rijal, S.; Bhandari, S.; Koirala, S.; Singh, R.; Khanal, B.; Loutan, L.; Dujardin, J. C.; Boelaert, M.; Chappuis, F.			Clinical risk factors for therapeutic failure in kala-azar patients treated with pentavalent antimonials in Nepal	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Kala-azar; Therapeutic failure; Risk factors; Pentavalent antimonials; Control programme; Nepal	INDIAN VISCERAL LEISHMANIASIS; SODIUM STIBOGLUCONATE; ORAL MILTEFOSINE; DRUG-RESISTANCE; AMPHOTERICIN-B; DONOVANI; ASSAYS; TRIAL; SUDAN	Drug-related factors and parasite resistance have been implicated in the failure of pentavalent antimonials (Sb(v)) in the Indian subcontinent; however, little information is available on host-related factors. Parasitologically confirmed kala-azar patients, treatment naive to Sbv, were prospectively recruited at a referral hospital in Nepal and were treated under supervision with 30 closes of quality-assured sodium stibogluconate (SSG) 20 mg/kg/day and followed for 12 months to assess cure. Analysis of risk factors for treatment failure was assessed in those receiving >= 25 doses and completing 12 months of follow-up. One hundred and ninety-eight cases were treated with SSG and the overall cure rate was 77.3% (153/198). Of the 181 cases who received >= 25 doses, 12-month follow-up data were obtained in 169, comprising 153 patients (90.5%) with definite cure and 16(9.5%) treatment failures. In the final logistic regression model, increased failure to SSG was significantly associated with fever for >= 12 weeks [odds ratio (OR) = 7.4], living in districts bordering the high SSG resistance zone in Bihar (OR = 6.1), interruption of treatment (OR = 4.3) and ambulatory treatment (OR = 10.2). Early diagnosis and supervised treatment is of paramount importance to prevent treatment failures within the control programme. (C) 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Rijal, S.; Bhandari, S.; Koirala, S.] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan 056700, Nepal; [Singh, R.] BP Koirala Inst Hlth Sci, Dept Paediat, Dharan 056700, Nepal; [Khanal, B.] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan 056700, Nepal; [Loutan, L.; Chappuis, F.] Univ Hosp Geneva, Div Int & Humanitarian Med, CH-1211 Geneva 14, Switzerland; [Dujardin, J. C.] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Boelaert, M.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Rijal, S (reprint author), BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan 056700, Nepal.	sumanrijal2@yahoo.com	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776	European Commission Community Research [ICA-CT-2001-10076]	Acknowledgements: The authors are grateful to Dr Jo Robays from ITM for data analysis, Mr Kamal Parajuli, and the sisters and staff of the Tropical Ward, BPKIHS. They are also grateful to the European Union who supported this project through the Fifth Framework Programme of the European Commission Community Research (contract ICA-CT-2001-10076).	Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; Anoopa SD, 2006, TROP MED INT HEALTH, V11, P757; Bhattacharya SK, 2006, INDIAN J MED RES, V123, P195; Bhattacharya SK, 2007, J INFECT DIS, V196, P591, DOI 10.1086/519690; Boelaert M, 2000, T ROY SOC TROP MED H, V94, P465, DOI 10.1016/S0035-9203(00)90055-5; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203; DAS VN, 2005, NATL MED J INDIA, V8, P131; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Laguna F, 1999, AIDS, V13, P1063, DOI 10.1097/00002030-199906180-00009; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; Respess RA, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200104003-00007; Rijal S, 2006, T ROY SOC TROP MED H, V100, P838, DOI 10.1016/j.trstmh.2005.09.017; Rijal S, 2003, T ROY SOC TROP MED H, V97, P597, DOI 10.1016/S0035-9203(03)80043-3; Rijal S, 2003, T ROY SOC TROP MED H, V97, P350, DOI 10.1016/S0035-9203(03)90167-2; Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009; Ritmeijer K, 2006, CLIN INFECT DIS, V43, P357, DOI 10.1086/505217; Sundar S, 2005, B WORLD HEALTH ORGAN, V83, P394; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; SUNDAR S, 1994, BRIT MED J, V308, P307, DOI 10.1136/bmj.308.6924.307; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar S, 2008, CLIN INFECT DIS, V47, P1000, DOI 10.1086/591972; Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536; Thakur CP, 2000, T ROY SOC TROP MED H, V94, P156, DOI 10.1016/S0035-9203(00)90255-4; Veeken H, 2000, TROP MED INT HEALTH, V5, P312, DOI 10.1046/j.1365-3156.2000.00555.x; *WHO, 1996, WHOLEISH9640; *WHO, 2000, 116 WHO; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176; Yamey G, 2002, BMJ-BRIT MED J, V325, P352	31	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAR	2010	104	3					225	229		10.1016/j.trstmh.2009.08.002				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	574OJ	WOS:000276000000009	19726065	Green Published			2019-04-02	
J	Sochantha, T; Van Bortel, W; Savonnaroth, S; Marcotty, T; Speybroeck, N; Coosemans, M				Sochantha, T.; Van Bortel, W.; Savonnaroth, S.; Marcotty, T.; Speybroeck, N.; Coosemans, M.			Personal protection by long-lasting insecticidal hammocks against the bites of forest malaria vectors	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						malaria; prevention; hammock; long-lasting insecticidal net; Southeast Asia; Cambodia	ANOPHELES-DIRUS COMPLEX; RANDOMIZED TRIAL; TREATED HAMMOCK; IDENTIFICATION; CAMBODIA; REGION	OBJECTIVE In Southeast Asia, malaria vectors bite outside the houses before bedtime, and forest dwellers rarely use insecticide-treated nets (ITNs). Thus, we tested the protection of long-lasting insecticidal hammocks (LLIH) using Olyset (TM) technology against exophagic vectors in two forest villages of Cambodia. METHODS In each village, we conducted two entomological surveys ( middle and end of the rainy season), each lasting 10 consecutive nights. These comprised human landing collections during the whole night by people sitting outside in the hammocks. Five households were selected per village, and for each household, two fixed positions were allocated: one for the control and one for the treated hammock. RESULTS In total, 6449 mosquitoes were collected from control hammocks compared to 4481 in treated hammocks. Personal protection conferred by the hammocks was 46% (CI 95%: 35-55%) against the bites of Anopheles minimus. A significant reduction of An. dirus bites ( 46% CI 95%: 25-62%) was only observed at the end of the rainy season. An. maculatus and culicines bites were only reduced in one of the two study sites. CONCLUSION Even if this LLIH is not inducing full protection against the bites of malaria vectors, it could prove effective in protecting forest workers and villagers before sleeping time. LLIH can be an additional and valuable tool in eliminating artemisinin-resistant malaria in the region.	[Van Bortel, W.; Marcotty, T.; Speybroeck, N.; Coosemans, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Sochantha, T.; Savonnaroth, S.] Natl Ctr Malaria Control Parasitol & Entomol, Phnom Penh, Cambodia	Coosemans, M (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	mcoosemans@itg.be		Van Bortel, Wim/0000-0002-6644-518X	Belgian Co-operation	We are grateful to the manufacturer Sumitomo Chemical Co., Inc. (Tokyo, Japan) for providing the experimental LLIH. This study was conducted within the framework of the Institutional collaboration between CNM-Cambodia and the Institute of Tropical Medicine of Antwerp Belgium, supported by the Belgian Co-operation.	COOSEMANS M, 2007, P INT C HUBS HARB DE, P551; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716; Hougard JM, 2007, J MED ENTOMOL, V44, P651, DOI 10.1603/0022-2585(2007)44[651:PFTOAL]2.0.CO;2; Magris M, 2007, TROP MED INT HEALTH, V12, P392, DOI 10.1111/j.1365-3156.2006.01801.x; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; NGO DT, 2008, MALARIA J, V7, P28; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Rubio-Palis Yasmin, 1995, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V35, P66; Sochantha T, 2006, TROP MED INT HEALTH, V11, P1166, DOI 10.1111/j.1365-3156.2006.01673.x; Thang Ngo Duc, 2009, PLoS One, V4, pe7369, DOI 10.1371/journal.pone.0007369; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Van Bortel W, 2000, INSECT MOL BIOL, V9, P335, DOI 10.1046/j.1365-2583.2000.00192.x; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102; Walton C, 1999, MED VET ENTOMOL, V13, P24, DOI 10.1046/j.1365-2915.1999.00142.x; WHO, 2008, GLOB MAL CONTR EL RE	16	28	28	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAR	2010	15	3					336	341		10.1111/j.1365-3156.2009.02457.x				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	554MX	WOS:000274440200009	20070632	Bronze			2019-04-02	
J	Twagirumukiza, M; Annemans, L; Kips, JG; Bienvenu, E; Van Bortel, LM				Twagirumukiza, Marc; Annemans, Lieven; Kips, Jan G.; Bienvenu, Emile; Van Bortel, Luc M.			Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						sub-Saharan Africa; drug costs; antihypertensive agents; hypertension; drugs; essential medicines; World Health Organization	HEALTH-CARE; HYPERTENSION TREATMENT; DEVELOPING-COUNTRIES; COST; DRUGS; AFFORDABILITY; MANAGEMENT; HYDROCHLOROTHIAZIDE; MULTICENTER; EXPENDITURE	OBJECTIVE To investigate compliance of National Essential Medicines Lists (NEMLs) with the WHO Essential Medicines List (WHO/EML) in 2007 and to compare prices of antihypertensive drugs in and between 13 sub-Saharan African countries. METHODOLOGY Data on NEMLs and drug prices were collected from 65 public and 65 private pharmacies ( five of each per country). Prices were compared with the International Drug Price Indicator Guide (IDPIG). The cost of drug treatment within a country was calculated using defined daily doses (DDD) and between countries using DDD prices adjusted for purchasing power parity-based gross domestic product per capita. RESULTS All surveyed countries had a NEML. However, none of these lists were in complete alignment with the 2007 WHO/EML, and 38% had not been updated in the last 5 years. Surveyed medicines were cheaper when on the NEMLs; they were also cheaper in public than in private pharmacies. Prices varied greatly per medicine. A large majority of the public prices were higher than those indicated by the IDPIG. Overall, hydrochlorothiazide is the cheapest drug. CONCLUSION There are substantial differences in NEML composition between the 13 countries. The proportion of NEMLs not regularly updated was double the global United Nations estimates. Prices of WHO/EML-advised drugs differ greatly between drugs and for each drug within and between countries. In general, the use of drugs on the NEML improves financial accessibility, and these drugs should be prescribed preferentially.	[Van Bortel, Luc M.] Univ Ghent, Fac Med & Hlth Sci, Heymans Inst Pharmacol, B-9000 Ghent, Belgium; [Twagirumukiza, Marc] Natl Univ Rwanda, Fac Med, Dept Internal Med, Butare, Rwanda; [Annemans, Lieven] Univ Ghent, Dept Publ Hlth, Ctr Hlth Econ, B-9000 Ghent, Belgium; [Bienvenu, Emile] Natl Univ Rwanda, Fac Med, Dept Pharm, Butare, Rwanda	Van Bortel, LM (reprint author), Univ Ghent, Fac Med & Hlth Sci, Heymans Inst Pharmacol, B-9000 Ghent, Belgium.	Luc.VanBortel@UGent.be		Twagirumukiza, Marc/0000-0003-1378-6922			AASERUD M, 2006, COCHRANE DB SYST REV, V19; Anis AH, 2003, MED CARE, V41, P135, DOI 10.1097/00005650-200301000-00015; Annemans L, 1997, PHARMACOECONOMICS, V11, P203, DOI 10.2165/00019053-199711030-00001; BALASUBRAMANIAM K, 1996, HLTH PHARM DEV COUNT; Bloor K, 1996, BRIT MED J, V313, P33, DOI 10.1136/bmj.313.7048.33; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, 2009, LANCET, V373, P1081, DOI 10.1016/S0140-6736(09)60650-4; Cooper RS, 1998, BRIT MED J, V316, P614, DOI 10.1136/bmj.316.7131.614; COURTOIS X, 1995, HEALTH POLICY PLANN, V10, P181, DOI 10.1093/heapol/10.2.181; Costa Juvenal Soares Dias da, 2002, Sao Paulo Med. J., V120, P100, DOI 10.1590/S1516-31802002000400002; Elliott WJ, 1996, POSTGRAD MED, V99, P241; EWEN M, 2007, MED TOO COSTLY TOO S; Fischer MA, 2004, JAMA-J AM MED ASSOC, V291, P1850, DOI 10.1001/jama.291.15.1850; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Gelders S, 2006, PRICE AVAILABILITY A; Guimier Jean Marc, 2005, Sante, V15, P41; *HAI, 2008, MON MED PRIC AV AFF; HELGELAND A, 1986, LANCET, V1, P872, DOI 10.1016/S0140-6736(86)90985-2; HUGHES D, 1989, BRIT MED J, V299, P683, DOI 10.1136/bmj.299.6700.683-a; Jayasinghe S, 2003, BMJ-BRIT MED J, V326, P553, DOI 10.1136/bmj.326.7388.553; KAPLAN NM, 1990, JAMA-J AM MED ASSOC, V263, P2888, DOI 10.1001/jama.1990.03440210038023; Kindermans JM, 2001, TROP MED INT HEALTH, V6, P955, DOI 10.1046/j.1365-3156.2001.00797.x; Laing R, 1991, Afr Health, V14, P32; Levison L., 2003, ESSENT DRUGS MONIT, V33, P20; Lindholm LH, 1996, BRIT MED J, V313, P1203, DOI 10.1136/bmj.313.7066.1203b; Linjer E, 2005, BLOOD PRESSURE, V14, P107, DOI 10.1080/08037050510008940; Mallet H P, 2001, Sante, V11, P185; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a; Mayor Susan, 2003, BMJ, V327, P521, DOI 10.1136/bmj.327.7414.521-a; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Montgomery RW, 1998, BRIT MED J, V317, P76; *MSH, 2007, INT GRUG PRIC IND GU; Mugisha F, 2002, TROP MED INT HEALTH, V7, P187, DOI 10.1046/j.1365-3156.2002.00835.x; Niens LM, 2009, LANCET, V373, P1081, DOI 10.1016/S0140-6736(09)60649-8; Odell TW, 1995, J GEN INTERN MED, V10, P686, DOI 10.1007/BF02602764; Pardell H, 2000, DRUGS, V59, P13, DOI 10.2165/00003495-200059002-00002; Perez-Casas C, 2001, TROP MED INT HEALTH, V6, P960, DOI 10.1046/j.1365-3156.2001.00801.x; Philipp T, 1997, BRIT MED J, V315, P154, DOI 10.1136/bmj.315.7101.154; Quick JD, 2005, BRIT MED J, V331, P709, DOI 10.1136/bmj.331.7519.709; Quick JD, 2002, B WORLD HEALTH ORGAN, V80, P913; Reidenberg MM, 2007, CLIN PHARMACOL THER, V81, P603, DOI 10.1038/sj.clpt.6100106; Richard V, 2004, Med Trop (Mars), V64, P337; RICHARDS T, 1986, BRIT MED J, V292, P1347, DOI 10.1136/bmj.292.6532.1347; Seedat Y K, 2007, Cardiovasc J Afr, V18, P316; SHULMAN NB, 1986, AM J PUBLIC HEALTH, V76, P1105, DOI 10.2105/AJPH.76.9.1105; Smith MK, 2003, T ROY SOC TROP MED H, V97, P2, DOI 10.1016/S0035-9203(03)90001-0; Spurgeon D, 2004, BRIT MED J, V328, P539, DOI 10.1136/bmj.328.7439.539; The world medicines situation, 2004, WORLD MED SIT; Turshen M, 2001, J PUBLIC HEALTH POL, V22, P198, DOI 10.2307/3343460; *UN, 2008, MILL DEV GOAL MDG GA; Walker ARP, 2000, J R SOC PROMO HEALTH, V120, P152, DOI 10.1177/146642400012000303; WALLER PC, 1989, J HUM HYPERTENS, V3, P457; WHO, 2006, WHO TECH REP SER, V936, P1; *WHO, 2003, WHO TECHNICAL REPORT, V914, P58; WHO, 1999, OP PRINC GOOD PHARM; *WHO, 2007, WHO TECHNICAL REPORT, V946, P104; *WHO, 2004, WHO TECHNICAL REPORT, V920, P80; *WHO, 2008, ATC DDD IND 2008; *WHO, 2009, MEAS MED PRIC AV AFF; *WHO, 2008, MED PRIC NEW APPR ME; *WORLD BANK, 2007, WORLD DEV IND WDI DA	61	11	11	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAR	2010	15	3					350	361		10.1111/j.1365-3156.2009.02453.x				12	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	554MX	WOS:000274440200011	20070634	Bronze			2019-04-02	
J	Koole, O; Van den Ende, J				Koole, O.; Van den Ende, J.			"Absolute'' or "added'' predictive value?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Letter									[Koole, O.; Van den Ende, J.] Inst Trop Med, Antwerp, Belgium	Koole, O (reprint author), Inst Trop Med, Antwerp, Belgium.	jvdende@itg.be		Koole, Olivier/0000-0002-1122-5382			Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x	1	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAR	2010	15	3					382	382		10.1111/j.1365-3156.2009.02465.x				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	554MX	WOS:000274440200013	20074084	Bronze			2019-04-02	
J	Yewhalaw, D; Kassahun, W; Woldemichael, K; Tushune, K; Sudaker, M; Kaba, D; Duchateau, L; Van Bortel, W; Speybroeck, N				Yewhalaw, Delenasaw; Kassahun, Wondwossen; Woldemichael, Kifle; Tushune, Kora; Sudaker, Morankar; Kaba, Daniel; Duchateau, Luc; Van Bortel, Wim; Speybroeck, Niko			The influence of the Gilgel-Gibe hydroelectric dam in Ethiopia on caregivers' knowledge, perceptions and health-seeking behaviour towards childhood malaria	MALARIA JOURNAL			English	Article							SOUTH-AFRICA; PLASMODIUM-FALCIPARUM; COMMUNITY KNOWLEDGE; VECTOR CONTROL; TRANSMISSION; ATTITUDES; TANZANIA; MOTHERS; BURDEN; CARE	Background: Malaria remains the most important public health problem in tropical and subtropical areas. Mothers' or caregivers' ability to recognize childhood malaria-related morbidity is crucial as knowledge, attitudes and health seeking behavior of caregivers towards childhood malaria could influence response to signs of the disease. Methods: A total of 1,003 caregivers in 'at-risk' villages in close proximity to the Gilgel-Gibe hydroelectric dam in south-western Ethiopia, and 953 caregivers in 'control' villages further away from the dam were surveyed using structured questionnaires to assess their knowledge, perceptions and health seeking behaviour about childhood malaria. Results: Malaria (busa) was ranked as the most serious health problem. Caregivers perceived childhood malaria as a preventable ('at-risk' 96%, 'control' 86%) and treatable ('at-risk' 98% and 'control' 96%) disease. Most caregivers correctly associated the typical clinical manifestations with malaria attacks. The use of insecticide-treated nets (ITNs) was mentioned as a personal protective measure, whereas the role of indoor residual spraying (IRS) in malaria prevention and control was under-recognized. Most of the caregivers would prefer to seek treatment in health-care services in the event of malaria and reported the use of recommended anti-malarials. Conclusion: Health education to improve knowledge, perceptions and health-seeking behaviour related to malaria is equally important for caregivers in 'at risk' villages and caregivers in 'control' villages as minimal differences seen between both groups. Concluding, there may be a need of more than one generation after the introduction of the dam before differences can be noticed. Secondly, differences in prevalence between 'control' and 'at-risk' villages may not be sufficient to influence knowledge and behaviour.	[Speybroeck, Niko] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Yewhalaw, Delenasaw] Jimma Univ, Dept Biol, Jimma, Ethiopia; [Kassahun, Wondwossen] Jimma Univ, Dept Stat, Jimma, Ethiopia; [Woldemichael, Kifle] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Tushune, Kora] Jimma Univ, Dept Hlth Planning & Hlth Management, Jimma, Ethiopia; [Sudaker, Morankar] Jimma Univ, Dept Hlth Educ, Jimma, Ethiopia; [Kaba, Daniel] Minist Hlth, Jimma Zone Hlth Bur, Jimma, Ethiopia; [Duchateau, Luc] Univ Ghent, Dept Physiol & Biometr, B-9000 Ghent, Belgium; [Van Bortel, Wim] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Speybroeck, Niko] Univ Catholique Louvain, Sch Publ Hlth, B-1200 Brussels, Belgium	Speybroeck, N (reprint author), Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium.	nspeybroeck@itg.be		Van Bortel, Wim/0000-0002-6644-518X	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland [A50881]; Institutional University Cooperation of the Council of Flemish Universities (VLIR-IUC)	The authors are grateful to Sekoru, Tiro-Afeta, Omo-Nada and Kerssa district officials for giving permission to undertake this study. All the caregivers of the 16 villages are highly acknowledged for cooperation and kindly giving consent to participate in the study. We also thank the community health extension workers of the four districts who were involved in data collection. We are especially grateful to Jimma zone health department for assisting in the selection of study villages and Jimma University for logistical support. The study received core financial support from UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland (project ID: A50881). Part of the study was also funded by the Institutional University Cooperation of the Council of Flemish Universities (VLIR-IUC)	Adera TD, 2003, ETHIOPIAN MED J, V41, P25; Akenji TKN, 2005, T ROY SOC TROP MED H, V99, P325, DOI 10.1016/j.trstmh.2003.12.016; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Baume C, 2000, SOC SCI MED, V51, P1491, DOI 10.1016/S0277-9536(00)00049-6; BRINKMANN U, 1991, TROP MED PARASITOL, V42, P204; Brooker S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-99; CASTILLA REF, 1993, SOC SCI MED, V37, P1137; CHIBSA S, 2007, 4 WIN M BAS SWITZ 24; D'Alessandro U, 1997, T ROY SOC TROP MED H, V91, P638, DOI 10.1016/S0035-9203(97)90502-2; Deressa W., 2003, ETHIOP J HEALTH DEV, V17, P99; Deressa W, 2007, ACTA TROP, V102, P1, DOI 10.1016/j.actatropica.2007.02.009; Fawole O I, 2001, West Afr J Med, V20, P152; Fettene M, 2004, AFR ENTOMOL, V12, P83; FOSTER S, 1995, J TROP MED HYG, V98, P29; Govere J, 2000, S AFR MED J, V90, P611; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/01.aids.0000096909.73209.14; JEFFERY GM, 1984, B WORLD HEALTH ORGAN, V62, P49; JENKINS C, 1998, REV 4 ETHNOGRAPHIC S; Jima D, 2005, ETHIOP J HEALTH DEV, V19, P16; Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Kouznetsov R L, 1977, Trop Doct, V7, P81; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P865, DOI 10.1046/j.1365-3156.2000.00651.x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; *MIN HLTH, 2005, HSDP 3 HLTH SECT STR; *MIN HLTH, 2001, NAT 5 YEAR STRAT PLA; *MIN HLTH, 2004, METH MAN GLAUC SURV, P2; *MIN HLTH, 2004, NAT STRAT PLAN GOING; Ministry of Health, 2007, HLTH EXT PROGR ETH; Minja H, 2001, TROP MED INT HEALTH, V6, P614, DOI 10.1046/j.1365-3156.2001.00755.x; MWENESI H, 1995, SOC SCI MED, V40, P1271, DOI 10.1016/0277-9536(94)00250-W; NATACHA P, 2007, MALARIA J, V6, P158; Njama D, 2003, TROP MED INT HEALTH, V8, P685, DOI 10.1046/j.1365-3156.2003.01060.x; Nyamongo IK, 2002, SOC SCI MED, V54, P377, DOI 10.1016/S0277-9536(01)00036-3; Oberlander L, 2000, B WORLD HEALTH ORGAN, V78, P1352; Oguonu T, 2005, PUBLIC HEALTH, V119, P409, DOI 10.1016/j.puhe.2004.05.008; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Paulander J, 2009, GLOBAL HLTH ACTION; Sanjana P, 2006, AM J TROP MED HYG, V75, P783, DOI 10.4269/ajtmh.2006.75.783; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tanner M, 1998, SOC SCI MED, V46, P523, DOI 10.1016/S0277-9536(97)00195-0; Tarimo DS, 2000, TROP MED INT HEALTH, V5, P179, DOI 10.1046/j.1365-3156.2000.00537.x; THANG DC, 2009, MALARIA J, V8, P3; THORA MA, 2000, TROP MED INT HEALTH, V5, P876; *WHO, 2005, WHOHTMMAL20051101; *WHO, 2008, WORLD MAL REP COUNTR; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; YENENEH H, 1993, B WORLD HEALTH ORGAN, V71, P763; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21	52	21	21	0	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	FEB 11	2010	9								47	10.1186/1475-2875-9-47				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	567RE	WOS:000275463500001	20146830	DOAJ Gold, Green Published			2019-04-02	
J	Das, ML; Roy, L; Rijal, S; Paudel, IS; Picado, A; Kroeger, A; Petzold, M; Davies, C; Boelaert, M				Das, M. L.; Roy, L.; Rijal, S.; Paudel, I. S.; Picado, A.; Kroeger, A.; Petzold, M.; Davies, C.; Boelaert, M.			Comparative study of kala-azar vector control measures in eastern Nepal	ACTA TROPICA			English	Article						Visceral leishmaniasis elimination; Vector control; Indoor residual spraying; Long lasting insecticidal nets; Ecological vector management; Nepal	DELTAMETHRIN-IMPREGNATED BEDNETS; PHLEBOTOMUS-ARGENTIPES; SANDFLY VECTOR; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; TRIAL; CURTAINS; INDIA	This study was conducted to explore the most effective vector control tool among indoor residual spraying (IRS), long lasting insecticidal nets (LLINs) and ecological vector management (EVM) as a part of the regional visceral leishmaniasis elimination initiative. Alpha-cypermethrin as IRS, PermaNet (R) as LLINs and plastering the inner walls of houses with lime as EVM were the interventions. One baseline and three follow-up entomological surveys were carried out in all arms using CDC miniature light traps (LT) and mouth aspirators. Comparisons were made between intervention arms and control arms with pre-intervention and post-intervention vector densities. Light traps were found more efficient in the collection of Phlebotomus argentipes in comparison with aspiration. Vector densities were significantly low in both IRS arm (p=0.009 in LT and p<0.001 in aspirator collections) and LLIN arm (p=0.019 in LT and p = 0.023 in aspirator collections) in comparison with control arm. However, in EVM arm, there was no significant difference in P. argentipes sand fly density in comparison with control arm (p = 0.785) in LT collections in follow-up surveys. Hence, IRS was found most effective control measure to decrease vector density. LLINs were also found effective and can be considered as a promising alternative vector control tool in VL elimination initiative. (C) 2009 Elsevier B.V. All rights reserved.	[Das, M. L.] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal; [Roy, L.] BP Koirala Inst Hlth Sci, KALANET Project, Dharan, Nepal; [Rijal, S.] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Paudel, I. S.] BP Koirala Inst Hlth Sci, Dept Community Med, Dharan, Nepal; [Picado, A.; Davies, C.] London Sch Hyg & Trop Med, London WC1, England; [Kroeger, A.] WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland; [Kroeger, A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Petzold, M.] Nord Sch Publ Hlth, Gothenburg, Sweden; [Boelaert, M.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Das, ML (reprint author), BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal.	mldas_29@yahoo.com; roy_lalita@yahoo.com; sumanrijal2@yahoo.com; is_paudel@yahoo.com; Albert.Picado@lshtm.ac.uk; kroegera@who.int; max@nhv.se; mboelaert@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Das, Murari/0000-0001-6816-2389; Picado, Albert/0000-0001-7344-628X; Kroeger, Axel/0000-0001-8438-2904	UNICEF/UNDP/World Bank/WHO; European Union; LLINs	This investigation received financial support from the UNICEF/UNDP/World Bank/WHO special program for Research and Training in Tropical Diseases (TDR). The European Union FP6 INCODEV - funded KALANET project supported the LLINs.	ALEXANDER B, 1995, MED VET ENTOMOL, V9, P279, DOI 10.1111/j.1365-2915.1995.tb00134.x; Binka FN, 1997, TROP MED INT HEALTH, V2, P499, DOI 10.1046/j.1365-3156.1997.d01-299.x; Bista MB, 2005, ANN INTERNAL ASSESSM; Courtenay O, 2007, MED VET ENTOMOL, V21, P168, DOI 10.1111/j.1365-2915.2007.00678.x; DAS ML, 2007, INDIAN J PRACTISING, V4; Das ML, 2008, INT J TROP AGRIC, V26, P323; Das ML, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000100; Dinesh DS, 2008, MED VET ENTOMOL, V22, P120, DOI 10.1111/j.1365-2915.2008.00724.x; Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x; Jalouk L, 2007, T ROY SOC TROP MED H, V101, P360, DOI 10.1016/j.trstmh.2006.07.011; Joshi AB, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-54; Kesari S., 2000, Journal of Communicable Diseases, V32, P284; Kishore K, 2006, INDIAN J MED RES, V123, P467; Koirala S, 1998, B WORLD HEALTH ORGAN, V76, P485; Kroeger A, 2002, BRIT MED J, V325, P810, DOI 10.1136/bmj.325.7368.810; KUMAR V, 1995, INDIAN J MED RES, V101, P154; LAWYER PG, 1992, 81324 USAID VBC; LEWIS DJ, 1978, ENTO SERIES B BRIT M, V37; Ritmeijer K, 2007, TROP MED INT HEALTH, V12, P404, DOI 10.1111/j.1365-3156.2006.01807.x; TAYEH A, 1997, WHOLEISH9741; THAPA LB, 2009, INTERNAL ASSESSMENT; *WHO, 2004, 7 WHOPES WORK GROUP, P29	22	17	18	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X			ACTA TROP	Acta Trop.	FEB	2010	113	2					162	166		10.1016/j.actatropica.2009.10.012				5	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	559JV	WOS:000274821300011	19879851				2019-04-02	
J	Masumu, J; Akoda, K; Van den Bossche, P				Masumu, J.; Akoda, K.; Van den Bossche, P.			Transmissibility, by Glossina morsitans morsitans, of Trypanosoma congolense strains during the acute and chronic phases of infection	ACTA TROPICA			English	Article						Trypanosoma congolense; Glossina morsitans morsitans; Acute phase; Chronic phase; Transmissibility	EASTERN ZAMBIA; ENDEMIC AREA; TSETSE; TRYPANOSOMA-(NANNOMONAS)-CONGOLENSE; SUSCEPTIBILITY; PARASITEMIA; PALLIDIPES; VIRULENCE; CATTLE; BRUCEI	In order to verify whether chronic trypanosomal infections can affect the transmissibility of Trypanosoma congolense by tsetse flies, batches of Glossina morsitans morsitans were fed on mice infected with the same level of parasitemia (10(8.1) trypanosomes/ml of blood) of two cloned low virulent T. congolense strains during the acute and the chronic phases of infection. Results showed that the proportions of procyclic infections in flies that were fed during the acute phase (32.6% and 45.4% for isolates I and 2. respectively) were significantly higher(chi(2) = 4.7, P<0.05 and chi(2) = 23.7, P<0.0001, respectively) compared to the proportions of procyclic infections of flies fed during the chronic phase of infection (18.8% and 14.9% for isolates I and 2, respectively). Similarly the proportions of metacyclic infections in flies fed during the acute phase (32.6% and 45.4% for isolates I and 2, respectively) were significantly higher (chi(2) = 6.3, P<0.05 and chi(2) = 23.7, P<0.0001, respectively) compared to the proportions of metacyclic infections in flies fed during the chronic phase of infection (16.8% and 14.9% for isolates I and 2, respectively). No significant difference was found in the maturation rate of both strains during the acute phase compared to the chronic phase of infection (P>0.05). The results of this study suggest that T. congolense loses part of its transmissiblity by tsetse flies during the chronic phase of infection. (C) 2009 Published by Elsevier B.V.	[Akoda, K.; Van den Bossche, P.] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Masumu, J.; Van den Bossche, P.] Univ Pretoria, Dept Vet Trop Dis, ZA-0110 Onderstepoort, Gauteng, South Africa; [Masumu, J.] Cent Vet Lab, Kinshasa, Zaire	Van den Bossche, P (reprint author), Inst Trop Med, Dept Anim Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	pvdbossche@itg.be			DGDC (Directory General for Development Cooperation)	The authors acknowledge the DGDC (Directory General for Development Cooperation) for financially Supporting this work.	Akoda K, 2008, ACTA TROP, V107, P17, DOI 10.1016/j.actatropica.2008.04.002; Caldas S, 2008, EXP PARASITOL, V118, P315, DOI 10.1016/j.exppara.2007.08.016; Elsen Pierre, 1993, Journal of African Zoology, V107, P439; Geysen D, 2003, VET PARASITOL, V110, P171, DOI 10.1016/S0304-4017(02)00313-8; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; HINTZE J, 2007, NCSS GESS; JOSHUA RA, 1990, VET PARASITOL, V36, P303, DOI 10.1016/0304-4017(90)90042-A; Kazadi JM, 1998, PARASITE, V5, P159, DOI 10.1051/parasite/1998052159; Leak S. G. A., 1999, TSETSE BIOL ECOLOGY; LEEFLANG P, 1976, INT J PARASITOL, V6, P413, DOI 10.1016/0020-7519(76)90027-8; Lloyd LL, 1924, B ENTOMOL RES, V14, P225; MAMMAN M, 1993, VET PARASITOL, V50, P1, DOI 10.1016/0304-4017(93)90002-5; Masumu J, 2006, PARASITOLOGY, V133, P331, DOI 10.1017/S0031182006000369; Masumu J, 2006, J BIOTECHNOL, V125, P22, DOI 10.1016/j.jbiotec.2006.01.016; Masumu J, 2006, INT J PARASITOL, V36, P497, DOI 10.1016/j.ijpara.2006.01.003; Matthews KR, 1999, PARASITOL TODAY, V15, P76, DOI 10.1016/S0169-4758(98)01381-7; MOHAMEDAHMED MM, 1989, TROP ANIM HEALTH PRO, V21, P239, DOI 10.1007/BF02261101; MOLOO SK, 1981, ACTA TROP, V38, P125; MOLOO SK, 1995, MED VET ENTOMOL, V9, P224, DOI 10.1111/j.1365-2915.1995.tb00126.x; NANTULYA VM, 1978, ACTA TROP, V35, P329; NANTULYA VM, 1978, ACTA TROP, V35, P339; Reifenberg JM, 1997, MED VET ENTOMOL, V11, P246, DOI 10.1111/j.1365-2915.1997.tb00402.x; Stephen LE, 1986, TRYPANOSOMIASIS VET; VANDENBOSSCHE P, 2006, VET PARASITOL, V18, P365; Welburn SC, 1995, EXP PARASITOL, V81, P404, DOI 10.1006/expr.1995.1131; Wijers D. J. B., 1960, Annals of Tropical Medicine and Parasitology, V54, P341; WOOLHOUSE MEJ, 1994, INT J PARASITOL, V24, P987, DOI 10.1016/0020-7519(94)90164-3	27	3	4	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	FEB	2010	113	2					195	198		10.1016/j.actatropica.2009.09.002				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	559JV	WOS:000274821300016	19765543				2019-04-02	
J	Van den Eede, P; Erhart, A; Van der Auwera, G; Van Overmeir, C; Ngo, DT; Le, XH; Anne, J; D'Alessandro, U				Van den Eede, Peter; Erhart, Annette; Van der Auwera, Gert; Van Overmeir, Chantal; Ngo Duc Thang; Le Xuan Hung; Anne, Jozef; D'Alessandro, Umberto			High Complexity of Plasmodium vivax Infections in Symptomatic Patients from a Rural Community in Central Vietnam Detected by Microsatellite Genotyping	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							TANDEM REPEATS; MALARIA; MARKERS; FALCIPARUM; TRANSMISSION; HYPNOZOITES; RELAPSES; AREAS; ASIA	Fourteen published and three newly identified polymorphic microsatellites were used to genotype 69 Plasmodium vivax samples obtained from 39 patients detected over a period of two years who lived in it rural community Of central Vietnam. All samples were polyclonal with in average expected heterozygosity of 0.86. Among the 39 patients, 16 experienced 1-5 recurrent episodes of P. vivax malaria, most of them (83%) with a different genotype profile compared with previous infections. The minimal Set of microsatellites required for differentiating the genotype profiles of the recurrent infections compared with the full set of 17 microsatellites was explored. A combination of five markers was sufficient to identify all recurrent infections with an unrelated or different genotype profile compared with an previous episodes.	[Van den Eede, Peter; Erhart, Annette; Van der Auwera, Gert; Van Overmeir, Chantal; D'Alessandro, Umberto] Inst Trop Med Antwerp, Dept Parasitol, Antwerp, Belgium; [Ngo Duc Thang; Le Xuan Hung] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Anne, Jozef] Katholieke Univ Leuven, Bacteriol Lab, Louvain, Belgium	Van den Eede, P (reprint author), Inst Trop Med Antwerp, Dept Parasitol, Natl Str 155, Antwerp, Belgium.	pvandeneede@itg.be; aerhart@itg.be; gvdauwera@itg.be; cvovermeir@itg.be; thangnimpevn@yahoo.com; lxhung1952@yahoo.com; jozef.anne@rega.kuleuven.be; udalessandro@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Anne, Jozef/0000-0002-0493-2644	Fonds voor Wetenschappelijk Onderzoek; Institute for the Promotion of Innovation by Science; Technology in Flanders; Institute of Tropical Medicine Antwerp; Belgian Technical Cooperation	This study was supported by the Flemish government funds (Fonds voor Wetenschappelijk Onderzoek) and the Institute for the Promotion of Innovation by Science, and Technology in Flanders (PhD grant). The field study in Vietnam was supported by thee Framework Agreement 2 between the Institute of Tropical Medicine Antwerp, and the Belgian Technical Cooperation.	ALAM MZ, 2008, INFECT GENET EVOL, V9, P24; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chen NH, 2007, J INFECT DIS, V195, P934, DOI 10.1086/512242; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Havryliuk T, 2008, EXP PARASITOL, V120, P330, DOI 10.1016/j.exppara.2008.08.012; Havryliuk T, 2009, MEM I OSWALDO CRUZ, V104, P67, DOI 10.1590/S0074-02762009000100011; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Rezende AM, 2009, AM J TROP MED HYG, V80, P729, DOI 10.4269/ajtmh.2009.80.729; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199, DOI 10.1016/S0035-9203(02)90077-5; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; GENOME P VIVAX	22	41	41	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	FEB	2010	82	2					223	227		10.4269/ajtmh.2010.09-0458				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	552CC	WOS:000274263300010	20133996	Green Published, Bronze			2019-04-02	
J	Neerinckx, S; Bertherat, E; Leirs, H				Neerinckx, Simon; Bertherat, Eric; Leirs, Herwig			Human plague occurrences in Africa: an overview from 1877 to 2008	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Review						Plague; Yersinia pestis; Review; Overview; History; Africa	MADAGASCAR	Plague remains a public health concern worldwide, but particularly in Africa. Despite the long-standing history of human plague, it is difficult to get a historical and recent overview of the general situation. We searched and screened available information sources oil human plague occurrences in African countries and compiled information on when, where and how many cases occurred in a centralised database. We found records that plague was probably already present before the third pandemic and that hundreds of thousands of human infections have been reported in 26 Countries since 1877. In the first 30 years of the 20th century, the number of human cases steadily increased to reach a maximum in 1929. From then on the number decreased and fell below 250 after 1945. Since the 1980s, again increasingly more human infections have been reported with the vast majority of cases notified in East Africa and Madagascar. We show that public health concerns regarding the current plague Situation are justified and that the disease should not be neglected, despite the sometimes questionability of the numbers of cases. We conclude that improving plague surveillance strategies is absolutely necessary to obtain a clear picture of the plague situation in endemic regions. (C) 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Neerinckx, Simon; Leirs, Herwig] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Neerinckx, Simon] Katholieke Univ Leuven, Dept Earth & Environm Sci, B-3001 Heverlee, Belgium; [Bertherat, Eric] WHO HQ, Dept Epidem & Pandem Alert & Response EPR, Geneva, Switzerland; [Leirs, Herwig] Univ Aarhus, Fac Agr Sci, Dept Integrated Pest Management, Danish Pest Infestat Lab, DK-2800 Kongens Lyngby, Denmark	Neerinckx, S (reprint author), Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	simon.neerinckx@ua.ac.be	Leirs, Herwig/B-8197-2008	Leirs, Herwig/0000-0002-7612-5024	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)	SN was supported by a PhD grant from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen).	AKIEV AK, 1982, B WORLD HEALTH ORGAN, V60, P165; BARRETT R. E., 1933, East African Medical Journal, V10, P160; Begier EM, 2006, EMERG INFECT DIS, V12, P460, DOI 10.3201/eid1203.051051; Bertherat E, 2007, EMERG INFECT DIS, V13, P1459, DOI 10.3201/eid1310.070284; Boisier P, 1997, TROP MED INT HEALTH, V2, P422, DOI 10.1046/j.1365-3156.1997.d01-292.x; Chanteau S, 1998, EMERG INFECT DIS, V4, P101, DOI 10.3201/eid0401.980114; Chanteau S., 2006, ATLAS PESTE MADAGASC; CHRISTIE AB, 1980, J INFECT DIS, V141, P724, DOI 10.1093/infdis/141.6.724; Dennis D. T., 1999, PLAGUE MANUAL EPIDEM; DENYS C, 2001, GEOGRAPHIC VARIATION; Duplantier JM, 2005, VET RES, V36, P437, DOI 10.1051/vetres:2005007; Echenberg Myron J., 2007, PLAGUE PORTS GLOBAL; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; GUIYOULE A, 1994, J CLIN MICROBIOL, V32, P634; HUSSEIN A G, 1955, Bull World Health Organ, V13, P27; KARIMI Y, 1974, B WORLD HEALTH ORGAN, V50, P564; Kilonzo B. S., 1999, Central African Journal of Medicine, V45, P70; KILONZO BS, 1976, E AFR MED J, V53, P117; KILONZO BS, 1991, HLTH DIS TANZANIA, P98; KUMARESAN JA, 1991, CENT AFR J MED, V37, P271; Mafart B, 2004, Bull Soc Pathol Exot, V97, P306; MAKUNDI RH, 2007, PRELIMINARY REPORT O; MISONNE X, 1977, ANN SOC BELG MED TR, V57, P163; MITCHELL JA, 1927, S AFR I MED RES, V3, P89; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1168; Neerinckx SB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-54; ORACH SO, 2002, PLAGUE OUTBREAKS GEN; Pollitzer R, 1954, PLAGUE; RAETTIG H, 1961, WORLD ATLAS EPIDEMIC, P5; Roberts JI., 1935, E AFR MED J, V12, P200; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; TWIGG GI, 1978, MAMMAL REV, V8, P78; WITMER GW, 2007, INVASIVE RATS BUBONI; World Health Organization, 2008, INT M PREV CONTR PLA	34	29	29	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	FEB	2010	104	2					97	103		10.1016/j.trstmh.2009.07.028				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	563TP	WOS:000275157600003	19716148				2019-04-02	
J	van Griensven, J; Zachariah, R; Rasschaert, F; Mugabo, J; Atte, EF; Reid, T				van Griensven, Johan; Zachariah, Rony; Rasschaert, Freya; Mugabo, Jules; Atte, Edi F.; Reid, Tony			Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						HIV; Antiretroviral; Toxicity; Stavudine; Nevirapine; Africa	SYMPTOMATIC HYPERLACTATEMIA; THERAPY; HEPATOTOXICITY; LIPODYSTROPHY	This cohort study was conducted to report on the incidence, timing and risk factors for stavudine (d4T)- and nevirapine (NVP)-related severe drug toxicity (requiring substitution) with a generic fixed-dose combination under program conditions in Kigali, Rwanda. Probability of 'time to first toxicity-related drug substitution' was estimated using the Kaplan-Meier method and Cox-proportional hazards modeling was used to identify risk factors. Out of 2190 adults (median follow-up: 1.5 years), d4T was replaced in 175 patients (8.0%) for neuropathy, 69 (3.1%) for lactic acidosis and 157 (7.2%) for lipoatrophy, which was the most frequent toxicity by 3 years of antiretroviral treatment (ART). NVP was substituted in 4.9 and 1.3% of patients for skin rash and hepatotoxicity, respectively. Use of d4T 40 mg was associated with increased risk of lipoatrophy and early (<6 months) neuropathy. Significant risk factors associated with lactic acidosis and late neuropathy included higher baseline body weight. Older age and advanced HIV disease increased the risk of neuropathy. Elevated baseline liver tests and older age were identified as risk factors for NVP-related hepatotoxicity. d4T is associated with significant long-term toxicity. d4T-dose reduction, increased access to safer ART in low-income countries and close monitoring for those at risk are all relevant strategies. (C) 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[van Griensven, Johan; Zachariah, Rony; Rasschaert, Freya; Atte, Edi F.; Reid, Tony] Operat Ctr Brussels, Dept Med, B-1090 Brussels, Belgium; [Mugabo, Jules] Ctr Treatment & Res AIDS Malaria TB & Other Epid, Kigali 2717, Rwanda	van Griensven, J (reprint author), Operat Ctr Brussels, Dept Med, Duprestr 94, B-1090 Brussels, Belgium.	jvgrie@yahoo.com			European Union; Belgian Development Cooperation (DGCD); Global Fund	The MSF project received funding from the European Union, the Belgian Development Cooperation (DGCD) and the Global Fund to fight AIDS, Tuberculosis and Malaria.	Bolhaar MG, 2007, CLIN INFECT DIS, V45, P254, DOI 10.1086/518976; Boulle A, 2007, ANTIVIR THER, V12, P753; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Carr A, 2003, JAIDS-J ACQ IMM DEF, V33, P571, DOI 10.1097/00126334-200308150-00004; Hill A, 2007, EXPERT OPIN PHARMACO, V8, P679, DOI 10.1517/14656566.8.5.679; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Lichtenstein KA, 2001, AIDS, V15, P1389, DOI 10.1097/00002030-200107270-00008; Makinson A, 2008, EXPERT OPIN DRUG SAF, V7, P283, DOI [10.1517/14740330802049781, 10.1517/14740338.7.3.283 ]; Murphy RA, 2007, J INFECT DIS, V196, pS449, DOI 10.1086/521112; Rivero A, 2007, J ANTIMICROB CHEMOTH, V59, P342, DOI 10.1093/jac/dkl524; Sanne I, 2005, J INFECT DIS, V191, P825, DOI 10.1086/428093; Subbaraman R, 2007, CLIN INFECT DIS, V45, P1093, DOI 10.1086/521150; van Griensven J, 2008, CLIN INFECT DIS, V46, P320, DOI 10.1086/524085; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; van Griensven J, 2009, T ROY SOC TROP MED H, V103, P613, DOI 10.1016/j.trstmh.2008.08.015; VANGRIENSVEN J, 2007, 2007 HIV AIDS IMPL M; WHO, 2008, UN ACC SCAL PRIOR HI; *WHO, 2006, REP WHO UNAIDS M FOR; WHO, 2006, ANT THER HIV INF AD	19	33	34	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	FEB	2010	104	2					148	153		10.1016/j.trstmh.2009.07.009				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	563TP	WOS:000275157600012	19732926	Green Published			2019-04-02	
J	Harries, K; Zachariah, R; Manzi, M; Firmenich, P; Mathela, R; Drabo, J; Onadja, G; Arnould, L; Harries, A				Harries, Katie; Zachariah, Rony; Manzi, Marcel; Firmenich, Peter; Mathela, Richard; Drabo, Joseph; Onadja, G.; Arnould, Line; Harries, Anthony			Baseline characteristics, response to and outcome of antiretroviral therapy among patients with HIV-1, HIV-2 and dual infection in Burkina Faso	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						HIV-1; HIV-2; Antiretroviral therapy; Treatment response; Treatment outcome; Burkina Faso	IMMUNODEFICIENCY-VIRUS TYPE-2; POLYMERASE-CHAIN-REACTION; TO-CHILD TRANSMISSION; PLASMA VIRAL LOAD; COTE-DIVOIRE; GUINEA-BISSAU; HIV-2-INFECTED PATIENTS; DRUG-RESISTANCE; PREGNANT-WOMEN; SOUTH-AFRICA	In an urban district hospital in Burkina Faso we investigated the relative proportions of HIV-1, HIV-2 and HIV-1/2 among those tested, the baseline sociodemographic and clinical characteristics, and the response to and outcome of antiretroviral therapy (ART). A total of 7368 individuals (male = 32%; median age = 34 years) were included in the analysis over a 6 year period (2002-2008). The proportions of HIV-1, HIV-2 and dual infection were 94%, 2.5% and 3.6%, respectively. HIV-1-infected individuals were younger, whereas HIV-2-infected individuals were more likely to be male, have higher CD4 Counts and be asymptomatic on presentation. ART was started in 4255 adult patients who were followed up for a total of 8679 person-years, during which time 469 deaths occurred. Mortality differences by serotype were not statistically significant, but were generally worse for HIV-2 and HIV-1/2 after controlling for age, CD4 count and WHO stage. Among severely immunedeficient patients, mortality was higher for HIV-2 than HIV-1. CD4 count recovery was poorest for HIV-2. HIV-2 and dually infected patients appeared to do less well on ART than HIV-1 patients. Reasons may include differences in age at baseline, lower intrinsic immune recovery in HIV-2, use of ineffective ART regimens (inappropriate prescribing) by clinicians, and Poor drug adherence. (C) 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Harries, Katie; Zachariah, Rony; Manzi, Marcel] Brussels Operat Ctr, Med Dept Operat Res, L-1617 Luxembourg, Luxembourg; [Firmenich, Peter] Brussels Operat Ctr, Operat Dept, Brussels, Belgium; [Mathela, Richard] Med Sans Frontieres, Ougadugo, Burkina Faso; [Drabo, Joseph] CHU Yalgado, Ouagadougou, Burkina Faso; [Onadja, G.] Ministerial Coordinat Comm HIV AIDS, Ouagadougou, Burkina Faso; [Arnould, Line] Brussels Operat Ctr, Med Dept HIV AIDS Unit, Brussels, Belgium; [Harries, Anthony] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony] London Sch Hyg & Trop Med, London WC1, England	Zachariah, R (reprint author), Brussels Operat Ctr, Med Dept Operat Res, 68 Rue Gasperich, L-1617 Luxembourg, Luxembourg.	zachariah@internet.lu			Ministry of Cooperation-Luxembourg (MAE-Lux); Medecins Sans Frontieres; Ministry of Health of Burkina Faso	The district hospital HIV/AIDS programme is supported by the Ministry of Cooperation-Luxembourg (MAE-Lux), Medecins Sans Frontieres and the Ministry of Health of Burkina Faso.	Adje-Toure CA, 2003, AIDS, V17, pS49, DOI 10.1097/00002030-200317003-00007; ADJORLOLOJOHNSON G, 1994, JAMA-J AM MED ASSOC, V272, P462, DOI 10.1001/jama.272.6.462; Ampofo W K, 1999, J Med Dent Sci, V46, P53; Andersson S, 2000, ARCH INTERN MED, V160, P3286, DOI 10.1001/archinte.160.21.3286; ANDREASSON PA, 1993, AIDS, V7, P989; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Chimirri A, 1999, ANTIVIR CHEM CHEMOTH, V10, P211, DOI 10.1177/095632029901000405; Coetzee D, 2004, AIDS, V18, P887, DOI [10.1097/01.aids.0000125925.87797.38, 10.1097/00002030-200406003-00006]; COURTOIS F, 1990, LANCET, V335, P1103, DOI 10.1016/0140-6736(90)92681-7; DECOCK KM, 1994, BMJ-BRIT MED J, V308, P441, DOI 10.1136/bmj.308.6926.441; Drylewicz J, 2008, AIDS, V22, P457, DOI 10.1097/QAD.0b013e3282f4ddfc; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; GEORGE JR, 1992, LANCET, V340, P337, DOI 10.1016/0140-6736(92)91406-X; HORSBURGH CR, 1988, TRANSFUSION, V28, P192, DOI 10.1046/j.1537-2995.1988.28288179031.x; Jaffar S, 1997, J ACQ IMMUN DEF SYND, V16, P327, DOI 10.1097/00042560-199712150-00003; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; LoussertAjaka I, 1995, RES VIROLOGY, V146, P409, DOI 10.1016/0923-2516(96)80900-9; Marlink R, 1996, AIDS, V10, P689, DOI 10.1097/00002030-199606001-00002; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; MARLINK RG, 1988, AIDS RES HUM RETROV, V4, P137, DOI 10.1089/aid.1988.4.137; Matheron S, 2006, AIDS, V20, P459, DOI 10.1097/01.aids.0000199829.57112.2f; MORGAN G, 1990, AIDS, V4, P879, DOI 10.1097/00002030-199009000-00008; Ndour CT, 2006, MED MALADIES INFECT, V36, P111, DOI 10.1016/j.medmal.2005.11.012; Norrgren H, 1997, J ACQ IMMUN DEF SYND, V16, P31, DOI 10.1097/00042560-199709010-00005; Norrgren H, 1999, AIDS, V13, P701, DOI 10.1097/00002030-199904160-00011; Parkin NT, 2004, ANTIVIR THER, V9, P3; PEETERS M, 1992, LANCET, V340, P339, DOI 10.1016/0140-6736(92)91407-Y; PEETERS M, 1994, J VIROL METHODS, V48, P23, DOI 10.1016/0166-0934(94)90085-X; POUSLEN AG, 1993, J ACQ IMMUN DEF SYND, V6, P941; Rouet F, 2004, J CLIN MICROBIOL, V42, P4147, DOI 10.1128/JCM.42.9.4147-4153.2004; Sagoe Kwc, 2008, Ghana Med J, V42, P16; Smith NA, 2001, J INFECTION, V42, P126, DOI 10.1053/jinf.2001.0792; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; van der Loeff MFS, 2002, AIDS, V16, P1775; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; WHITTLE H, 1994, AIDS, V8, P1617, DOI 10.1097/00002030-199411000-00015; Witvrouw M, 2004, ANTIVIR THER, V9, P57	41	13	14	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	FEB	2010	104	2					154	161		10.1016/j.trstmh.2009.08.012				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	563TP	WOS:000275157600013	19783268	Green Published			2019-04-02	
J	Sanchez, L; Cortinas, J; Pelaez, O; Gutierrez, H; Concepcion, D; Van der Stuyft, P				Sanchez, L.; Cortinas, J.; Pelaez, O.; Gutierrez, H.; Concepcion, D.; Van der Stuyft, P.			Breteau Index threshold levels indicating risk for dengue transmission in areas with low Aedes infestation	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Aedes aegypti control; larval indices; dengue; transmission risk; surveillance; Cuba	HEMORRHAGIC-FEVER	We used Breteau Indices to - retrospectively - predict dengue transmission. The presence of one house block (on average about 50 houses) with a Breteau Index >= 4 in a neighbourhood (a block plus the surrounding blocks in a radius of 100 m) predicted transmission at the latter level with 81.8% sensitivity and 73.3% specificity during the first month of the Havana 2001 dengue outbreak. This result corroborates the external validity of this threshold, at least in situations with low infestations levels.	[Sanchez, L.; Pelaez, O.; Gutierrez, H.; Concepcion, D.] Trop Med Inst Pedro Kouri, Havana, Cuba; [Cortinas, J.] Hasselt Univ, Ctr Stat, Diepenbeek, Belgium; [Van der Stuyft, P.] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium	Sanchez, L (reprint author), Trop Med Inst Pedro Kouri, Havana, Cuba.	lsanchez@ipk.sld.cu					Farrar J, 2007, TROP MED INT HEALTH, V12, P695, DOI 10.1111/j.1365-3156.2007.01838; Focks DA, 2003, REV ENTOMOLOGICAL SA; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Nathan MB, 2006, ANN TROP MED PARASIT, V100, pS1, DOI 10.1179/136485906X105462; Pelaez O, 2004, EMERG INFECT DIS, V10, P719, DOI 10.3201/eid1004.030271; Sanchez L, 2006, EMERG INFECT DIS, V12, P800; Sternberg MR, 2001, STAT MED, V20, P1529, DOI 10.1002/sim.688; Sulaiman S, 1996, J AM MOSQUITO CONTR, V12, P494; Thammapalo S, 2008, EPIDEMIOL INFECT, V136, P135, DOI 10.1017/S0950268807008126	9	30	32	1	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2010	15	2					173	175		10.1111/j.1365-3156.2009.02437.x				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	543SS	WOS:000273599400004	20409286				2019-04-02	
J	Hasker, E; Mitashi, P; Baelmans, R; Lutumba, P; Jacquet, D; Lejon, V; Kande, V; Declercq, J; Van der Veken, W; Boelaert, M				Hasker, E.; Mitashi, P.; Baelmans, R.; Lutumba, P.; Jacquet, D.; Lejon, V.; Kande, V.; Declercq, J.; Van der Veken, W.; Boelaert, M.			A new format of the CATT test for the detection of Human African Trypanosomiasis, designed for use in peripheral health facilities	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						trypanosomiasis; Trypanosoma brucei gambiense; agglutination tests; mass screening; primary health care; communicable disease control	GAMBIENSE; DIAGNOSIS; AGREEMENT	OBJECTIVES To test the reproducibility and thermostability of a new format of the Card-Agglutination Test for Trypanosomiasis (CATT) test for Human African Trypanosomiasis (HAT), designed for use at primary health care facility level in endemic countries. METHODS A population of 4217 from highly endemic villages was screened using the existing format of the CATT test (CATT-R250) on whole blood. All those testing positive (220) and a random sample of negatives (555) were retested in the field with the new format (CATT-D10). Inter-format reproducibility was assessed by calculating kappa. All samples testing positive on whole blood with either method were further evaluated in Belgium by CATT titration of serum by two observers, using both old and new format. CATT-D10 test kits were incubated under four temperature regimens (4, 37, 45 degrees C and fluctuating) with regular assessments of reactivity over 18 months. RESULTS Inter-format reproducibility of CATT-D10 vs. CATT-R250 on whole blood performed by laboratory technicians in the field was excellent with kappa values of 0.83-0.89. Both inter- and intra-format reproducibility assessed by CATT titration were excellent, with 96.5-100% of all differences observed falling within the limits of +/- 1 titration step. After 18 months, reactivity of test kits incubated under all four temperature regimens was still well above the minimum threshold considered acceptable. CONCLUSION The CATT-D10 is thermostable and can be used interchangeably with the old format of the CATT test. It is highly suitable for use in peripheral health facilities in HAT-endemic countries.	[Hasker, E.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Mitashi, P.; Lutumba, P.] Univ Kinshasa, Fac Med, Kinshasa, Zaire; [Baelmans, R.] Inst Trop Med, Appl Technol & Prod Unit, B-2000 Antwerp, Belgium; [Jacquet, D.; Lejon, V.] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Kande, V.] Natl Program Control Human African Trypanosomiasi, Kinshasa, Zaire; [Declercq, J.; Van der Veken, W.] Belgian Tech Cooperat, Kinshasa, Zaire	Hasker, E (reprint author), Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, Natl Str 155, B-2000 Antwerp, Belgium.	ehasker@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Lejon, Veerle/0000-0002-6795-0962			Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lutumba P, 2005, TROP MED INT HEALTH, V10, P347, DOI 10.1111/j.1365-3156.2005.01391.x; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Wembonyama S, 2007, Med Trop (Mars), V67, P447; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P71	7	12	12	0	3	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2010	15	2					263	267		10.1111/j.1365-3156.2009.02446.x				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	543SS	WOS:000273599400016	20002614	Bronze			2019-04-02	
J	Gerstl, S; Dunkley, S; Mukhtar, A; De Smet, M; Baker, S; Maikere, J				Gerstl, Sibylle; Dunkley, Sophie; Mukhtar, Ahmed; De Smet, Martin; Baker, Samuel; Maikere, Jacob			Assessment of two malaria rapid diagnostic tests in children under five years of age, with follow-up of false-positive pLDH test results, in a hyperendemic falciparum malaria area, Sierra Leone	MALARIA JOURNAL			English	Review							PARASITE LACTATE-DEHYDROGENASE; HISTIDINE-RICH PROTEIN-2; ANTIGEN REACTIVITY; EXPERT MICROSCOPY; PLASMODIUM-VIVAX; ASSAYS; FIELD; PANMALARIAL; ACCURACY; UGANDA	Background: Most malaria rapid diagnostic tests (RDTs) use HRP2 detection, including Paracheck-Pf (R), but their utility is limited by persistent false positivity after treatment. PLDH-based tests become negative more quickly, but sensitivity has been reported below the recommended standard of 90%. A new pLDH test, CareStart (TM) three-line P. f/PAN-pLDH, claims better sensitivity with continued rapid conversion to negative. The study aims were to 1) compare sensitivity and specificity of CareStart (TM) to Paracheck-Pf (R) to diagnose falciparum malaria in children under five years of age, 2) assess how quickly false-positive CareStart (TM) tests become negative and 3) evaluate ease of use and inter-reader agreement of both tests. Methods: Participants were included if they were aged between two and 59 months, presenting to a Medecins Sans Frontieres community health centre in eastern Sierra Leone with suspected malaria defined as fever ( axillary temperature > 37.5 degrees C) and/or history of fever in the previous 72 hours and no signs of severe disease. The same capillary blood was used for the RDTs and the blood slide, the latter used as the gold standard reference. All positive participants were treated with supervised artesunate and amodiaquine treatment for three days. Participants with a persistent false-positive CareStart (TM), but a negative blood slide on Day 2, were followed with repeated CareStart (TM) and blood slide tests every seven days until CareStart (TM) became negative or a maximum of 28 days. Results: Sensitivity of CareStart (TM) was 99.4% (CI 96.8-100.0, 168/169) and of Paracheck-Pf (R), 98.8% (95% CI 95.8-99.8, 167/169). Specificity of CareStart (TM) was 96.0% ( CI 91.9-98.4, 167/174) and of Paracheck-Pf (R), 74.7% ( CI 67.6-81.0, 130/174) ( p < 0.001). Neither test showed any change in sensitivity with decreasing parasitaemia. Of the 155 eligible follow-up CareStart (TM) participants, 63.9% (99/155) had a false-positive test on day 2, 21.3% (33/155) on day 7, 5.8% (9/155) on day 14, 1.9% (3/155) on day 21 and 0.6% (1/155) on day 28. The median time for test negativity was seven days. CareStart (TM) was as easy to use and interpret as Paracheck-Pf (R) with excellent inter-reader agreement. Conclusions: Both RDTs were highly sensitive, met WHO standards for the detection of falciparum malaria monoinfections where parasitaemia was > 100 parasites/mu l and were easy to use. CareStart (TM) persistent false positivity decreased quickly after successful anti-malarial treatment, making it a good choice for a RDT for a hyperendemic falciparum malaria area.	[Gerstl, Sibylle] MSF UK, London EC1N 8QX, England; [Dunkley, Sophie; Mukhtar, Ahmed] MSF OCB, Bo, Sierra Leone; [De Smet, Martin; Maikere, Jacob] Med Sans Frontieres, B-1090 Brussels, Belgium; [Baker, Samuel] Minist Hlth & Sanitat, Freetown, Sierra Leone	Gerstl, S (reprint author), MSF UK, 67-74 Saffron Hill, London EC1N 8QX, England.	sgerstl@aol.com					Ashley EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-241; BELL D, 2006, NAT REV MICROBIOL, V4, pS34, DOI DOI 10.1038/NRMICO1524; Bell DR, 2005, AM J TROP MED HYG, V73, P199, DOI 10.4269/ajtmh.2005.73.199; Bisoffi Z, 2008, BRIT MED J, V336, P168, DOI 10.1136/bmj.39401.486655.80; Bisoffi Z, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000063; BROEK V, 2006, AM J TROP MED HYG, V75, P1209; Chiodini PL, 2007, T ROY SOC TROP MED H, V101, P331, DOI 10.1016/j.trstmh.2006.09.007; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; de Oliveira AM, 2009, AM J TROP MED HYG, V80, P470, DOI 10.4269/ajtmh.2009.80.470; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Fogg C, 2008, T ROY SOC TROP MED H, V102, P25, DOI 10.1016/j.trstmh.2007.09.014; Forney JR, 2003, J CLIN MICROBIOL, V41, P2358, DOI 10.1128/JCM.41.6.2358-2366.2003; Guthmann JP, 2002, T ROY SOC TROP MED H, V96, P254, DOI 10.1016/S0035-9203(02)90091-X; Huong NM, 2002, TROP MED INT HEALTH, V7, P304, DOI 10.1046/j.1365-3156.2002.00869.x; Iqbal J, 2002, J CLIN MICROBIOL, V40, P4675, DOI 10.1128/JCM.40.12.4675-4678.2002; Iqbal J, 2004, J CLIN MICROBIOL, V42, P4237, DOI 10.1128/JCM.42.9.4237-4241.2004; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; McCutchan TF, 2008, EMERG INFECT DIS, V14, P1750, DOI 10.3201/eid1411.080840; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Pattanasin S, 2003, T ROY SOC TROP MED H, V97, P672, DOI 10.1016/S0035-9203(03)80100-1; Piper R, 1999, AM J TROP MED HYG, V60, P109, DOI 10.4269/ajtmh.1999.60.109; Ratsimbasoa A, 2007, AM J TROP MED HYG, V76, P481, DOI 10.4269/ajtmh.2007.76.481; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; Tjitra E, 2001, J CLIN MICROBIOL, V39, P1025, DOI 10.1128/JCM.39.3.1025-1031.2001; *WHO, LIST PROD SUBM WHO M; WHO, 2008, WORLD MAL REP 2008; *WHO, MAL RAP DIAGN TEST W; World Health Organization, 2009, MAL RAP DIAGN TEST P; World Health Organization (WHO), GUID TREATM MAL	33	39	39	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 21	2010	9								28	10.1186/1475-2875-9-28				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	567MZ	WOS:000275452300001	20092620	DOAJ Gold, Green Published			2019-04-02	
J	Grietens, KP; Xa, NX; Van Bortel, W; Thang, ND; Ribera, JM; Truong, BN; Ky, PV; Hung, LX; D'Alessandro, U; Erhart, A				Grietens, Koen Peeters; Xa Nguyen Xuan; Van Bortel, Wim; Thang Ngo Duc; Ribera, Joan Muela; Truong Ba Nhat; Ky Pham Van; Hung Le Xuan; D'Alessandro, Umberto; Erhart, Annette			Low perception of malaria risk among the Ra-glai ethnic minority in south-central Vietnam: implications for forest malaria control	MALARIA JOURNAL			English	Article							BED-NETS	Background: Despite Vietnam's success in reducing malaria mortality and morbidity over the last decade, malaria persists in the forested and mountainous areas of the central and southern provinces, where more than 50% of the clinical cases and 90% of severe cases and malaria deaths occur. Methods: Between July 2005 and September 2006, a multi-method study, triangulating a malariometric cross-sectional survey and qualitative data from focused ethnography, was carried out among the Ra-glai ethnic minority in the hilly forested areas of south-central Vietnam. Results: Despite the relatively high malaria burden among the Ra-glai and their general awareness that mosquitoes can transmit an unspecific kind of fever (84.2%), the use of bed nets, distributed free of charge by the national malaria control programme, remains low at the farmers' forest fields where the malaria risk is the highest. However, to meet work requirements during the labour intensive malaria transmission and rainy season, Ra-glai farmers combine living in government supported villages along the road with a second home or shelter at their slash and burn fields located in the forest. Bed net use was 84.6% in the villages but only 52.9% at the forest fields; 20.6% of the respondents slept unprotected in both places. Such low use may be explained by the low perception of the risk for malaria, decreasing the perceived need to sleep protected. Several reasons may account for this: (1) only 15.6% acknowledged the higher risk of contracting malaria in the forest than in the village; (2) perceived mosquito biting times only partially coincided with Anopheles dirus ss and Anopheles minimus A true biting times; (3) the disease locally identified as 'malaria' was hardly perceived as having an impact on forest farmers' daily lives as they were unaware of the specific kind of fevers from which they had suffered even after being diagnosed with malaria at the health centre (20.9%). Conclusions: The progressive confinement of malaria to minority groups and settings in the Greater Mekong sub-region implies that further success in malaria control will be linked to research into these specific socio-cultural contexts. Findings highlight the need for context sensitive malaria control policies; not only to reduce the local malaria burden but also to minimize the risk of malaria spreading to other areas where transmission has virtually ceased.	[Grietens, Koen Peeters; Van Bortel, Wim; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med, B-2000 Antwerp, Belgium; [Grietens, Koen Peeters; Ribera, Joan Muela] PASS Int, B-3980 Tessenderlo, Belgium; [Xa Nguyen Xuan; Thang Ngo Duc; Hung Le Xuan] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Truong Ba Nhat; Ky Pham Van] Prov Malaria Stn, Phan Rang City, Ninh Thuan Prov, Vietnam	Grietens, KP (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	kpeeters@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Van Bortel, Wim/0000-0002-6644-518X; Peeters Grietens, Koen/0000-0001-6570-9887			Agypeong I, 1999, J BIOSOC SCI, V31, P79; AIKINS MK, 1994, J TROP MED HYG, V97, P81; *AM ANTHR ASS, AM ANTHR ASS STAT ET; Brieger W, 1994, HLTH ED RES, V11, P133; BRUNELLE M, 2005, MON KHMER STUDIES, V35, P121; CHU T. S., 2000, ETHNIC MINORITIES VI; ERHARL A, 2006, THESIS ANTWERP U; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; GRIETENS KP, 2009, TROP MED INT HLTH; Harvey SA, 2008, AM J TROP MED HYG, V79, P834, DOI 10.4269/ajtmh.2008.79.834; *I TROP MED ANTW, 2007, ITM ANN C MAL MEK DE; KING V, 2002, MODERN ANTHR SE ASIA; Manderson L, 1998, TROP MED INT HEALTH, V3, P1020, DOI 10.1046/j.1365-3156.1998.00334.x; Mbonye AK, 2006, HEALTH POLICY PLANN, V21, P17, DOI 10.1093/heapol/czj002; Minja H, 2001, TROP MED INT HEALTH, V6, P614, DOI 10.1046/j.1365-3156.2001.00755.x; *NAT I MAL PAR ENT, 1987, KEYS AN VIETN AD PUP; NIMPE, 2003, ANN REP NAT MAL CONT; *NIMPE, 2004, ANN REP NAT MAL CONT; *NIMPE, 2005, ANN REP NAT MAL CONT; Peeters Grietens K, 2005, SOCIOCULTURAL STUDY; Ragin Charles C., 1994, CONSTRUCTING SOCIAL; Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092; Seale C, 1999, QUALITY QUALITATIVE; SEXTON JD, 1990, AM J TROP MED HYG, V43, P11, DOI 10.4269/ajtmh.1990.43.11; Thang Ngo Duc, 2009, PLoS One, V4, pe7369, DOI 10.1371/journal.pone.0007369; Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; *WHO, 2003, HLTH ETHN MIN VIETN; WINCH PJ, 1994, SOC SCI MED, V39, P63, DOI 10.1016/0277-9536(94)90166-X; ZIMICKI S, 1996, PROMOTION SUBSAHARAN, P111	31	17	18	2	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 20	2010	9								23	10.1186/1475-2875-9-23				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	559OG	WOS:000274834500001	20089152	DOAJ Gold, Green Published			2019-04-02	
J	Tungu, P; Magesa, S; Maxwell, C; Malima, R; Masue, D; Sudi, W; Myamba, J; Pigeon, O; Rowland, M				Tungu, Patrick; Magesa, Stephen; Maxwell, Caroline; Malima, Robert; Masue, Dennis; Sudi, Wema; Myamba, Joseph; Pigeon, Olivier; Rowland, Mark			Evaluation of PermaNet 3.0 a deltamethrin-PBO combination net against Anopheles gambiae and pyrethroid resistant Culex quinquefasciatus mosquitoes: an experimental hut trial in Tanzania	MALARIA JOURNAL			English	Article							INSECTICIDE-TREATED NETS; FALCIPARUM-MALARIA; WEST-AFRICA; EFFICACY; DIPTERA; BEDNETS; MANAGEMENT; CULICIDAE; MIXTURES; TACTICS	Background: Combination mosquito nets incorporating two unrelated insecticides or insecticide plus synergist are designed to control insecticide resistant mosquitoes. PermaNet 3.0 is a long-lasting combination net incorporating deltamethrin on the side panels and a mixture of deltamethrin and synergist piperonyl butoxide (PBO) on the top panel. PBO is an inhibitor of mixed function oxidases implicated in pyrethroid resistance. Method: An experimental hut trial comparing PermaNet 3.0, PermaNet 2.0 and a conventional deltamethrin-treated net was conducted in NE Tanzania using standard WHOPES procedures. The PermaNet arms included unwashed nets and nets washed 20 times. PermaNet 2.0 is a long-lasting insecticidal net incorporating deltamethrin as a single active. Results: Against pyrethroid susceptible Anopheles gambiae the unwashed PermaNet 3.0 showed no difference to unwashed PermaNet 2.0 in terms of mortality (95% killed), but showed differences in blood-feeding rate (3% blood-fed with PermaNet 3.0 versus 10% with PermaNet 2.0). After 20 washes the two products showed no difference in feeding rate (10% with 3.0 and 9% with 2.0) but showed small differences in mortality (95% with 3.0 and 87% with 2.0). Against pyrethroid resistant Culex quinquefasciatus, mediated by elevated oxidase and kdr mechanisms, the unwashed PermaNet 3.0 killed 48% and PermaNet 2.0 killed 32% but after 20 washes there was no significant difference in mortality between the two products (32% killed by 3.0 and 30% by 2.0). For protecting against Culex PermaNet 3.0 showed no difference to PermaNet 2.0 when either unwashed or after 20 washes; both products were highly protective against biting. Laboratory tunnel bioassays confirmed the loss of biological activity of the PBO/deltamethrin-treated panel after washing. Conclusion: Both PermaNet products were highly effective against susceptible Anopheles gambiae. As a long-lasting net to control or protect against pyrethroid resistant mosquitoes PermaNet 3.0 showed limited improvement over PermaNet 2.0 against Culex quinquefasciatus.	[Tungu, Patrick; Magesa, Stephen; Maxwell, Caroline; Malima, Robert; Masue, Dennis; Sudi, Wema; Myamba, Joseph] Natl Inst Med Res, Amani Med Res Ctr, Muheza, Tanzania; [Pigeon, Olivier] Walloon Agr Res Ctr, Pesticides Res Dept, B-5030 Gembloux, Belgium; [Maxwell, Caroline; Rowland, Mark] Univ London London Sch Hyg & Trop Med, Dept Infect Dis, London WC1E 7HT, England		mark.rowland@lshtm.ac.uk			WHO Pesticide Evaluation Scheme	This study was commissioned and financially supported by the WHO Pesticide Evaluation Scheme.	AGUAS R, PLOS ONE, V3, pE1767; [Anonymous], 2007, LANCET, V370, P1459; Armitage P, 1987, STAT METHODS MED RES, P559; Asidi AN, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-25; BHATTARAI A, 2007, PLOS MED, V4, P309; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chandre F, 1998, MED VET ENTOMOL, V12, P359, DOI 10.1046/j.1365-2915.1998.00120.x; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Feachem R, 2008, LANCET, V371, P1633, DOI [10.1016/S0140-6736(08)60424-9, 10.1016/S1473-3099(08)70045-8]; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Georghiou G. P., 1972, ANNU REV ECOL SYST, V3, P133, DOI DOI 10.1146/ANNUREV.ES.03.110172.001025; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; HILL I, 2006, AD PARASITOL, V61, P77; Hougard JM, 2003, B ENTOMOL RES, V93, P491, DOI 10.1079/BER2003261; KHAYRANDISH A, 1993, B ENTOMOL RES, V83, P75, DOI 10.1017/S0007485300041808; Kolaczinski JH, 2000, B ENTOMOL RES, V90, P125; *MAL, MAL ER RES AG; MCKENZIE CL, 1993, J ECON ENTOMOL, V86, P1040, DOI 10.1093/jee/86.4.1040; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Oxborough RM, 2008, ANN TROP MED PARASIT, V102, P717, DOI 10.1179/136485908X337553; ROUSH RT, 1987, ANNU REV ENTOMOL, V32, P361, DOI 10.1146/annurev.ento.32.1.361; ROUSH RT, 1989, PESTIC SCI, V26, P423, DOI 10.1002/ps.2780260409; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; SMITH A, 1965, B ENTOMOL RES, V56, P161, DOI 10.1017/S0007485300057114; TABASHNIK BE, 1989, J ECON ENTOMOL, V82, P1263, DOI 10.1093/jee/82.5.1263; Tanner M, 2008, B WORLD HEALTH ORGAN, V86, P82, DOI 10.2471/BLT.07.050633; WHO, 2009, 13 WHOPES WORK GROUP; WHO, 2008, WORLD MAL REP 2008; WHO, 2006, WHOCDSNTDWHOPESGCDPP; *WHO, 2008, WHO PEST EV SCHEM; *WHO, 2009, 12 WORK GROUP M WHO; WHO [World Health Organization], 2006, WHOCDSNTDWHOPESGCDPP; World Health Organization, WHOCDSWHOPESGCDPP200	42	53	53	1	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 19	2010	9								21	10.1186/1475-2875-9-21				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	553PU	WOS:000274380100001	20085631	DOAJ Gold, Green Published			2019-04-02	
J	Van den Eede, P; Vythilingam, I; Thang, ND; Hong, NV; Le, XH; D'Alessandro, U; Erhart, A				Van den Eede, Peter; Vythilingam, Indra; Thang Ngo Duc; Hong Nguyen Van; Le Xuan Hung; D'Alessandro, Umberto; Erhart, Annette			Plasmodium knowlesi malaria in Vietnam: some clarifications	MALARIA JOURNAL			English	Article							INFECTIONS	A recently published comment on a report of Plasmodium knowlesi infections in Vietnam states that this may not accurately represent the situation in the study area because the PCR primers used may cross-hybridize with Plasmodium vivax. Nevertheless, P. knowlesi infections have been confirmed by sequencing. In addition, a neighbour-joining tree based on the 18S S-Type SSUrRNA gene shows that the Vietnamese samples clearly cluster with the P. knowlesi isolates identified in Malaysia and are distinct from the corresponding P. vivax sequences. All samples came from asymptomatic individuals who did not consult for fever during the months preceding or following the survey, indicating that asymptomatic P. knowlesi infections occur in this population, although this does not exclude the occurrence of symptomatic cases. Large-scale studies to determine the extent and the epidemiology of P. knowlesi malaria in Vietnam are further needed.	[Van den Eede, Peter; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Vythilingam, Indra; Hong Nguyen Van] Inst Med Res, Kuala Lumpur 50588, Malaysia; [Thang Ngo Duc; Le Xuan Hung] Natl Inst Malariol, Hanoi, Vietnam	Van den Eede, P (reprint author), Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium.	pvandeneede@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009	Institute of Tropical Medicine, Antwerp; Belgian Cooperation	PVDE is a research fellow of the Institute for the Promotion of Innovation by Science and Technology in Flanders. This project was funded by the Framework Agreement between the Institute of Tropical Medicine, Antwerp, and the Belgian Cooperation.	Cox-Singh J, 2008, TRENDS PARASITOL, V24, P406, DOI 10.1016/j.pt.2008.06.001; Cox-Singh J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-269; IMWONG M, 2009, J CLIN MICROBIOL; Nakazawa S, 2009, INT J PARASITOL, V39, P1533, DOI 10.1016/j.ijpara.2009.08.005; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Van den Eede P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-249; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569	7	8	8	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 18	2010	9								20	10.1186/1475-2875-9-20				3	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	553PT	WOS:000274380000001	20082717	DOAJ Gold, Green Published			2019-04-02	
J	Van der Auwera, G; Bhattarai, NR; Odiwuor, S; Vuylsteke, M				Van der Auwera, Gert; Bhattarai, Narayan Raj; Odiwuor, Samwel; Vuylsteke, Marnik			Remarks on identification of amplified fragment length poly-morphisms linked to SAG resistance in Leishmania	ACTA TROPICA			English	Letter						AFLP; Leishmania; Drug resistance; Antimony	DONOVANI COMPLEX; REVEALS; AFLP; PCR		[Van der Auwera, Gert] Inst Trop Med Antwerp, Dept Parasitol, B-2000 Antwerp, Belgium; [Bhattarai, Narayan Raj] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Odiwuor, Samwel] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya; [Vuylsteke, Marnik] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Vuylsteke, Marnik] Univ Ghent, Dept Mol Genet, B-9000 Ghent, Belgium	Van der Auwera, G (reprint author), Inst Trop Med Antwerp, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	gvdauwera@itg.be					Alam MZ, 2009, INFECT GENET EVOL, V9, P24, DOI 10.1016/j.meegid.2008.09.005; Kumar A, 2009, ACTA TROP, V110, P80, DOI 10.1016/j.actatropica.2009.01.005; Laurent T, 2007, INFECT GENET EVOL, V7, P206, DOI 10.1016/j.meegid.2006.08.005; Manna M, 2005, MED SCI MONITOR, V11, pBR220; Mauricio IL, 2004, PARASITOLOGY, V128, P263, DOI 10.1017/S0031182003004578; Mauricio IL, 2001, PARASITOLOGY, V122, P393, DOI 10.1017/S0031182001007466; Pandey K, 2007, PARASITOL RES, V100, P1361, DOI 10.1007/s00436-007-0464-4; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Singh N, 1999, ACTA TROP, V73, P313, DOI 10.1016/S0001-706X(99)00036-4; Vuylsteke M, 2007, NAT PROTOC, V2, P1387, DOI 10.1038/nprot.2007.175	10	1	1	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X			ACTA TROP	Acta Trop.	JAN	2010	113	1					92	93		10.1016/j.actatropica.2009-09-010				2	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	534RX	WOS:000272916100017	19800857				2019-04-02	
J	Lejon, V; Ngoyi, DM; Boelaert, M; Buscher, P				Lejon, Veerle; Ngoyi, Dieudonne Mumba; Boelaert, Marleen; Buscher, Philippe			A CATT Negative Result after Treatment for Human African Trypanosomiasis Is No Indication for Cure	PLOS NEGLECTED TROPICAL DISEASES			English	Article							GAMBIENSE; DIAGNOSIS	Background: Cure after treatment for human African trypanosomiasis (HAT) is assessed by examination of the cerebrospinal fluid every 6 months, for a total period of 2 years. So far, no markers for cure or treatment failure have been identified in blood. Trypanosome-specific antibodies are detectable in blood by the Card Agglutination Test for Trypanosomiasis (CATT). We studied the value of a normalising, negative post-treatment CATT result in treated Trypanosoma brucei (T.b.) gambiense sleeping sickness patients as a marker of cure. Methodology/Principal Findings: The CATT/T.b. gambiense was performed on serum of a cohort of 360 T.b. gambiense patients, consisting of 242 primary and 118 retreatment cases. The CATT results during 2 years of post-treatment follow-up were studied in function of cure or treatment failure. At inclusion, sensitivity of CATT was 98% (234/238) in primary cases and only 78% (91/117) in retreatment cases. After treatment, the CATT titre decreased both in cured patients and in patients experiencing treatment failure. Conclusions/Significance: Though CATT is a good test to detect HAT in primary cases, a normalising or negative CATT result after treatment for HAT does not indicate cure, therefore CATT cannot be used to monitor treatment outcome.	[Lejon, Veerle; Buscher, Philippe] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Ngoyi, Dieudonne Mumba] Inst Natl Rech Biomed, Kinshasa, Zaire; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Lejon, V (reprint author), Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium.	vlejon@itg.be	Boelaert, Marleen/E-2698-2012; Buscher, Philippe/B-9956-2012	Boelaert, Marleen/0000-0001-8051-6776; Buscher, Philippe/0000-0002-1926-7472; Lejon, Veerle/0000-0002-6795-0962	Belgian Directorate-General for International Co-operation; Fund for Scientific Research Flanders (FWO)	This study received financial support from the Belgian Directorate-General for International Co-operation and from the Fund for Scientific Research Flanders (FWO, www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish,	[Anonymous], 2007, WHOCDSNTDIDM20071; [Anonymous], 1998, WHO TECH REP SER, V881, P1; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; FREZIL JL, 1978, B SOC PATHOL EXOT, V71, P440; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Miezan TW, 2003, B SOC PATHOL EXOT, V95, P362; NGAMPO S, 1992, THESIS I TROPISCHE G; NGOYI DM, 2009, J INFECT DI IN PRESS; PAQUET C, 1992, LANCET, V340, P250, DOI 10.1016/0140-6736(92)90524-7; PEPIN J, 1986, ANN SOC BELG MED TR, V66, P213; Robays J, 2007, TROP MED INT HEALTH, V12, P290, DOI 10.1111/j.1365-3165.2006.01768.x; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055	12	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2010	4	1							e590	10.1371/journal.pntd.0000590				4	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	551BE	WOS:000274179500016	20126270	DOAJ Gold, Green Published			2019-04-02	
J	Picado, A; Das, ML; Kumar, V; Kesari, S; Dinesh, DS; Roy, L; Rijal, S; Das, P; Rowland, M; Sundar, S; Coosemans, M; Boelaert, M; Davies, CR				Picado, Albert; Das, Murari L.; Kumar, Vijay; Kesari, Shreekant; Dinesh, Diwakar S.; Roy, Lalita; Rijal, Suman; Das, Pradeep; Rowland, Mark; Sundar, Shyam; Coosemans, Marc; Boelaert, Marleen; Davies, Clive R.			Effect of Village-wide Use of Long-Lasting Insecticidal Nets on Visceral Leishmaniasis Vectors in India and Nepal: A Cluster Randomized Trial	PLOS NEGLECTED TROPICAL DISEASES			English	Article							ANTHROPONOTIC CUTANEOUS LEISHMANIASIS; PHLEBOTOMUS-ARGENTIPES DIPTERA; TREATED BEDNETS; IMPREGNATED BEDNETS; EASTERN SUDAN; BED-NETS; MALARIA; DONOVANI; PROGRAM; PSYCHODIDAE	Background: Visceral leishmaniasis (VL) control in the Indian subcontinent is currently based on case detection and treatment, and on vector control using indoor residual spraying (IRS). The use of long-lasting insecticidal nets (LN) has been postulated as an alternative or complement to IRS. Here we tested the impact of comprehensive distribution of LN on the density of Phlebotomus argentipes in VL-endemic villages. Methods: A cluster-randomized controlled trial with household P. argentipes density as outcome was designed. Twelve clusters from an ongoing LN clinical trial-three intervention and three control clusters in both India and Nepal-were selected on the basis of accessibility and VL incidence. Ten houses per cluster selected on the basis of high pre-intervention P. argentipes density were monitored monthly for 12 months after distribution of LN using CDC light traps (LT) and mouth aspiration methods. Ten cattle sheds per cluster were also monitored by aspiration. Findings: A random effect linear regression model showed that the cluster-wide distribution of LNs significantly reduced the P. argentipes density/house by 24.9% (95% CI 1.80%-42.5%) as measured by means of LTs. Interpretation: The ongoing clinical trial, designed to measure the impact of LNs on VL incidence, will confirm whether LNs should be adopted as a control strategy in the regional VL elimination programs. The entomological evidence described here provides some evidence that LNs could be usefully deployed as part of the VL control program.	[Picado, Albert; Rowland, Mark; Davies, Clive R.] London Sch Hyg & Trop Med, London WC1, England; [Das, Murari L.; Roy, Lalita; Rijal, Suman] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Kumar, Vijay; Kesari, Shreekant; Dinesh, Diwakar S.; Das, Pradeep] Rajendra Mem Res Inst Med Sci, Patna, Bihar, India; [Sundar, Shyam] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India; [Coosemans, Marc; Boelaert, Marleen] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium	Picado, A (reprint author), London Sch Hyg & Trop Med, London WC1, England.	albert.picado@lshtm.ac.uk	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Picado, Albert/0000-0001-7344-628X; Das, Murari/0000-0001-6816-2389	European Commission [INCO-CT 2005-01537]	European Commission Contract no INCO-CT 2005-01537, KALANET project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alten B, 2003, J VECTOR ECOL, V28, P97; Basak Basab, 1995, Journal of Communicable Diseases, V27, P122; Curtis CF, 2006, J AM MOSQUITO CONTR, V22, P501, DOI 10.2987/8756-971X(2006)22[501:IBFMMC]2.0.CO;2; DAS ML, 2007, HLTH RENAISSANCE, V1, P26; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dinesh DS, 2008, MED VET ENTOMOL, V22, P120, DOI 10.1111/j.1365-2915.2008.00724.x; Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x; Dinesh DS, 2000, ANN TROP MED PARASIT, V94, P447, DOI 10.1080/00034983.2000.11813563; Dinesh DS, 2001, ANN TROP MED PARASIT, V95, P197, DOI 10.1080/00034980120041071; ELNAIEM DA, 1996, L3188147 WHO ID; EMAMI MM, 2004, IMPACT OLYSET LONG L; Ghosh K, 1999, J MED ENTOMOL, V36, P588, DOI 10.1093/jmedent/36.5.588; GHOSH K N, 1990, Journal of Communicable Diseases, V22, P67; Hassan MM, 2004, ACTA TROP, V92, P77, DOI 10.1016/j.actatropicaa.2004.06.001; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Jalouk L, 2007, T ROY SOC TROP MED H, V101, P360, DOI 10.1016/j.trstmh.2006.07.011; JANAKARA BR, 1995, J TROP MED HYG, V98, P73; Joshi AB, 2003, J NEPAL HLTH RES COU, V1, P1; Maxwell CA, 2002, TROP MED INT HEALTH, V7, P1003, DOI 10.1046/j.1365-3156.2002.00966.x; Mondal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000355; Mondal D, 2008, HEALTH POLICY, V87, P369, DOI 10.1016/j.healthpol.2008.01.011; Moosa-Kazemi SH, 2007, ANN SAUDI MED, V27, P6, DOI 10.4103/0256-4947.51543; MUKHOPADHYAY AK, 1987, INDIAN J MED RES, V86, P475; NADIM A, 2000, WHOLEISH9537; OSTYN B, 2008, TROP MED INT HLTH; Ritmeijer K, 2007, TROP MED INT HEALTH, V12, P404, DOI 10.1111/j.1365-3156.2006.01807.x; Shrestha S. L., 1994, JNMA, Journal of the Nepal Medical Association, V32, P237; Soremekun S, 2004, TROP MED INT HEALTH, V9, P664, DOI 10.1111/j.1365-3156.2004.01250.x; TAYEH A, 1997, WHOLEISH9741; Yadav RS, 2001, J MED ENTOMOL, V38, P613, DOI 10.1603/0022-2585-38.5.613; Yaghoobi-Ershadi M R, 2006, Bull Soc Pathol Exot, V99, P43, DOI 10.3185/pathexo2818	31	40	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2010	4	1							e587	10.1371/journal.pntd.0000587				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	551BE	WOS:000274179500015	20126269	DOAJ Gold, Green Published			2019-04-02	
J	Romero, GAS; Boelaert, M				Romero, Gustavo A. S.; Boelaert, Marleen			Control of Visceral Leishmaniasis in Latin America-A Systematic Review	PLOS NEGLECTED TROPICAL DISEASES			English	Review							DIRECT AGGLUTINATION-TEST; IMPREGNATED DOG COLLARS; LUTZOMYIA-LONGIPALPIS DIPTERA; LINKED-IMMUNOSORBENT-ASSAY; B CHOLESTEROL DISPERSION; KALA-AZAR; CANINE LEISHMANIASIS; ENDEMIC AREA; CHAGASI INFECTION; NORTHEAST BRAZIL	Background: While three countries in South Asia decided to eliminate anthroponotic visceral leishmaniasis (VL) by 2015, its control in other regions seems fraught with difficulties. Is there a scope for more effective VL control in the Americas where transmission is zoonotic? We reviewed the evidence on VL control strategies in Latin America-diagnosis, treatment, veterinary interventions, vector control-with respect to entomological and clinical outcomes. Methodology/Principal Findings: We searched the electronic databases of MEDLINE, LILACS, and the Cochrane Central Register of Controlled Trials, from 1960 to November 2008 and references of selected articles. Intervention trials as well as observational studies that evaluated control strategies of VL in the Americas were included. While the use of rapid diagnostic tests for VL diagnosis seems well established, there is a striking lack of evidence from clinical trials for drug therapy and few well designed intervention studies for control of vectors or canine reservoirs. Conclusion: Elimination of zoonotic VL in the Americas does not seem a realistic goal at this point given the lack of political commitment, gaps in scientific knowledge, and the weakness of case management and surveillance systems. Research priorities and current strategies should be reviewed with the aim of achieving better VL control.	[Romero, Gustavo A. S.] Univ Brasilia, Fac Med, Nucleo Med Trop, Brasilia, DF, Brazil; [Boelaert, Marleen] Inst Trop Med, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium	Romero, GAS (reprint author), Univ Brasilia, Fac Med, Nucleo Med Trop, Brasilia, DF, Brazil.	gromero@unb.br	Romero, Gustavo/F-7214-2012; Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Romero, Gustavo/0000-0003-1425-926X	Pan American Health Organization; BIREME/OPAS/OMS	Authors thank to Ms. Anne Marie Trooskens for her assistance with the bibliography, and Dr. Daniel Salomon and Dr. Ana Rabello for reviewing the manuscript. This review is based on an evidence report that was requested by the Pan American Health Organization to support cooperative action for neglected infectious diseases in Latin America.; This review has partial financial support from BIREME/OPAS/OMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso DP, 2007, J INFECT DIS, V195, P1212, DOI 10.1086/512683; ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879; Andrade AM, 2007, REV SOC BRAS MED TRO, V40, P594, DOI 10.1590/S0037-86822007000500021; ANDRADE CR, 1989, BRAZ J MED BIOL RES, V22, P611; Borges BKA, 2008, CAD SAUDE PUBLICA, V24, P777, DOI 10.1590/S0102-311X2008000400007; Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; Bejarano EE, 2001, T ROY SOC TROP MED H, V95, P27, DOI 10.1016/S0035-9203(01)90320-7; Berman JD, 1998, B WORLD HEALTH ORGAN, V76, P25; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Bhattacharya SK, 2006, INDIAN J MED RES, V123, P195; Braga M D, 1998, Rev Soc Bras Med Trop, V31, P419; BRAGA RR, 1986, T ROY SOC TROP MED H, V80, P143, DOI 10.1016/0035-9203(86)90214-2; CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364; Carr-Hill RA, 1999, BRIT J SOC WORK, V29, P679, DOI 10.1093/bjsw/29.5.679; Carranza-Tamayo CO, 2009, T ROY SOC TROP MED H, V103, P743, DOI 10.1016/j.trstmh.2009.01.014; Carrasco J, 1998, ANN TROP MED PARASIT, V92, P869; Carvalho SFG, 2003, AM J TROP MED HYG, V68, P321; CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030; Chappuis F, 2006, TROP MED INT HEALTH, V11, P31, DOI 10.1111/j.1365-3156.2005.01533.x; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chappuis F, 2006, BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; Costa C H, 2001, Rev Soc Bras Med Trop, V34, P223; Costa CHN, 2005, ANN TROP MED PARASIT, V99, P229, DOI 10.1179/136485905X28018; Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334; Courtenay O, 2007, MED VET ENTOMOL, V21, P168, DOI 10.1111/j.1365-2915.2007.00678.x; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; Courtenay O, 2002, PARASITOLOGY, V125, P407, DOI 10.1017/S0031182002002238; COUSINO B, 2006, VIGILANCIA CONTROL L, P34; Coutinho MTZ, 2005, VET PARASITOL, V128, P149, DOI 10.1016/j.vetpar.2004.11.011; Da Costa RT, 2003, T ROY SOC TROP MED H, V97, P678; da Silva ES, 2006, VET RES COMMUN, V30, P637, DOI 10.1007/s11259-006-3324-2; da Silva VO, 2000, VACCINE, V19, P1082, DOI 10.1016/S0264-410X(00)00339-X; David JR, 2001, MEM I OSWALDO CRUZ, V96, P839, DOI 10.1590/S0074-02762001000600018; Camargo-Neves Vera Lucia Fonseca de, 2003, Rev. Soc. Bras. Med. Trop., V36, P27, DOI 10.1590/S0037-86822003000700009; de Oliveira JF, 2006, REV SOC BRAS MED TRO, V39, P146, DOI 10.1590/S0037-86822006000500005; Oliveira Simone Souza de, 2003, Cad. Saúde Pública, V19, P1681, DOI 10.1590/S0102-311X2003000600012; De Silans LNMP, 1998, MEM I OSWALDO CRUZ, V93, P339; Deborggraeve S, 2008, TROP MED INT HEALTH, V13, P1378, DOI 10.1111/j.1365-3156.2008.02154.x; Delgado O, 2001, PARASITE, V8, P355, DOI 10.1051/parasite/2001084355; Delgado O, 1998, PARASITE, V5, P317, DOI 10.1051/parasite/1998054317; DIETZE R, 1995, AM J TROP MED HYG, V53, P40, DOI 10.4269/ajtmh.1995.53.40; Dietze R, 2001, AM J TROP MED HYG, V65, P685, DOI 10.4269/ajtmh.2001.65.685; Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096; DIETZE R, 1995, T ROY SOC TROP MED H, V89, P309, DOI 10.1016/0035-9203(95)90557-X; DIETZE R, 1993, CLIN INFECT DIS, V17, P981, DOI 10.1093/clinids/17.6.981; DIMIERDAVID L, 1991, ANN SOC BELG MED TR, V71, P275; do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015; Santos Soraya Oliveira dos, 2003, Rev. Soc. Bras. Med. Trop., V36, P633, DOI 10.1590/S0037-86822003000500017; Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; DYE C, 1993, P ROY SOC B-BIOL SCI, V254, P33, DOI 10.1098/rspb.1993.0123; EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124; EVANS TG, 1990, AM J TROP MED HYG, V42, P118, DOI 10.4269/ajtmh.1990.42.118; Feliciangeli MD, 2005, TROP MED INT HEALTH, V10, P444, DOI 10.1111/j.1365-3156.2005.01408.x; Feliciangeli MD, 2003, TROP MED INT HEALTH, V8, P1131; Feliciangeli MD, 1999, PARASITE, V6, P113, DOI 10.1051/parasite/1999062113; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Fernández José, 2006, Biomédica, V26, P121; Ferreira ED, 2007, VET PARASITOL, V146, P235, DOI 10.1016/j.vetpar.2007.02.015; Freire M., 1997, BRAZ J INFECT DIS, V1, P230; Garcez Lourdes M., 1996, Revista da Sociedade Brasileira de Medicina Tropical, V29, P165; Gavgani ASM, 2002, LANCET, V360, P374, DOI 10.1016/S0140-6736(02)09609-5; Giffoni Juliana Haddad, 2002, Vet Ther, V3, P485; Hashiguchi Y., 1991, Bulletin of the Pan American Health Organization, V25, P64; Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357; Jeronimo SMB, 2007, GENES IMMUN, V8, P539, DOI 10.1038/sj.gene.6364422; Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682; JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; LAINSON R, 1990, MEM I OSWALDO CRUZ, V85, P135, DOI 10.1590/S0074-02761990000100027; Lemos EM, 2008, ACTA TROP, V107, P205, DOI 10.1016/j.actatropica.2008.04.023; Luz Zelia Maria Profeta da, 2005, Cad Saude Publica, V21, P606; de Assis TSM, 2008, EPIDEMIOL SERV SAUDE, V17, P107; MAGALHAES P A, 1980, Revista do Instituto de Medicina Tropical de Sao Paulo, V22, P197; Mazzarri MB, 1997, J AM MOSQUITO CONTR, V13, P335; de Souza VMM, 2008, EPIDEMIOL SERV SAUDE, V17, P97; MEREDITH SEO, 1995, J CLIN MICROBIOL, V33, P1742; *MIN HLTH BRAZ, 2008, CAS CONF LEISHM VISC; *MIN HLTH BRAZ, 2006, MAN VIG CONTR LEISHM, P1; Moreira ED, 2004, VET PARASITOL, V122, P245, DOI 10.1016/j.vetpar.2004.05.019; MORRISON AC, 1995, J MED ENTOMOL, V32, P538, DOI 10.1093/jmedent/32.4.538; NAVIN TR, 1985, AM J TROP MED HYG, V34, P1069, DOI 10.4269/ajtmh.1985.34.1069; Costa CHN, 2007, REV SOC BRAS MED TRO, V40, P415, DOI 10.1590/S0037-86822007000400009; Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005; NUNES MP, 1991, MEM I OSWALDO CRUZ, V86, P411, DOI 10.1590/S0074-02761991000400006; Oliveira CD, 2006, REV PANAM SALUD PUBL, V20, P369, DOI 10.1590/S1020-49892006001100002; OSORIO G, 1984, REV MED CHILE, V112, P261; Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510; Paranhos-Silva M, 1998, ACTA TROP, V69, P75, DOI 10.1016/S0001-706X(97)00116-2; ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39, DOI 10.4269/ajtmh.1996.55.39; Parra LE, 2007, VACCINE, V25, P2180, DOI 10.1016/j.vaccine.2006.11.057; Pedras MJ, 2008, T ROY SOC TROP MED H, V102, P172, DOI 10.1016/j.trstmh.2007.11.004; Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06; Profeta da Luz Z M, 2001, Rev Soc Bras Med Trop, V34, P249, DOI 10.1590/S0037-86822001000300004; Quinnell RJ, 1997, PARASITOLOGY, V115, P143, DOI 10.1017/S0031182097001200; Quinnell RJ, 2001, PARASITOLOGY, V122, P253, DOI 10.1017/S0031182001007363; Rabello A, 2003, ANN TROP MED PARASIT, V97, P17, DOI 10.1179/000349803225002507; Reithinger R, 2002, J CLIN MICROBIOL, V40, P2352, DOI 10.1128/JCM.40.7.2352-2356.2002; Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI [10.1016/j.ijpara.2003.09.006, 10.1016/j.ipara.2003.09.006]; Rijal S, 2004, TROP MED INT HEALTH, V9, P724, DOI 10.1111/j.1365-3156.2004.01251.x; Rosypal AC, 2005, J PARASITOL, V91, P1113, DOI 10.1645/GE-586R.1; Rotureau B, 2006, J CLIN MICROBIOL, V44, P1120, DOI 10.1128/JCM.44.3.1120-1122.2006; Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P109, DOI 10.1590/S0074-02762008000100018; Salomon OD, 2005, MEM I OSWALDO CRUZ, V100, P475, DOI 10.1590/S0074-02762005000500005; Sanchez-Robert E, 2008, VET RES, V39, DOI 10.1051/vetres:2008013; Santos Mácia A., 2002, Rev. Soc. Bras. Med. Trop., V35, P629, DOI 10.1590/S0037-86822002000600014; Schallig HDFH, 2002, MEM I OSWALDO CRUZ, V97, P1015, DOI 10.1590/S0074-02762002000700015; Sherlock I. A., 1969, Revista Brasileira de Malariologia e Doencas Tropicais, V21, P535; SILVA FL, 2008, VET PARASITOL; Silveira Fernando T., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P177, DOI 10.1590/S0036-46651993000200010; Maia-Elkhoury ANS, 2007, REV SAUDE PUBL, V41, P929; Sundar S, 2008, TROP MED INT HEALTH, V13, P2, DOI 10.1111/j.1365-3156.2007.01974.x; Teran-Angel G, 2007, BIOMEDICA, V27, P447, DOI 10.7705/biomedica.v27i3.207; TRAVI BL, 1994, AM J TROP MED HYG, V50, P557, DOI 10.4269/ajtmh.1994.50.557; Travi BL, 2001, AM J TROP MED HYG, V64, P119, DOI 10.4269/ajtmh.2001.64.119; Trejo-Perez J A, 1993, Bol Med Hosp Infant Mex, V50, P662; Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007; Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9; Werneck GL, 2002, ACTA TROP, V83, P13, DOI 10.1016/S0001-706X(02)00058-X; Werneck Guilherme L., 2002, Cad. Saúde Pública, V18, P633, DOI 10.1590/S0102-311X2002000300007; Zeledon R., 1984, Memorias do Instituto Oswaldo Cruz, V79, P455; Zerpa Olga, 2003, Rev Panam Salud Publica, V13, P239, DOI 10.1590/S1020-49892003000300006	123	173	178	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2010	4	1							e584	10.1371/journal.pntd.0000584				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	551BE	WOS:000274179500012	20098726	DOAJ Gold, Green Published			2019-04-02	
J	Vanderelst, D; Speybroeck, N				Vanderelst, Dieter; Speybroeck, Niko			Quantifying the Lack of Scientific Interest in Neglected Tropical Diseases	PLOS NEGLECTED TROPICAL DISEASES			English	Article							GLOBAL BURDEN; FRAMEWORK; HEALTH		[Vanderelst, Dieter] Univ Antwerp, Fac Appl Econ, B-2020 Antwerp, Belgium; [Speybroeck, Niko] Inst Trop Med, B-2000 Antwerp, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Inst Rech Sante & Soc, B-1200 Brussels, Belgium	Vanderelst, D (reprint author), Univ Antwerp, Fac Appl Econ, B-2020 Antwerp, Belgium.	dieter.vanderelst@ua.ac.be					Chirac P, 2006, LANCET, V367, P1560, DOI 10.1016/S0140-6736(06)68672-8; Engels D, 2006, TRENDS PARASITOL, V22, P363, DOI 10.1016/j.pt.2006.06.004; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; HOLLAND L, 1991, SCIENTIST, V5, P14; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000279; Hunter PR, 2009, LANCET, V373, P630, DOI 10.1016/S0140-6736(09)60397-4; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Moran Mary, 2005, PLoS Med, V2, pe302, DOI 10.1371/journal.pmed.0020302; Swingler GH, 2003, BRIT MED J, V327, P1083, DOI 10.1136/bmj.327.7423.1083; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176	13	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2727			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2010	4	1							e576	10.1371/journal.pntd.0000576				3	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	551BE	WOS:000274179500004	20126268	DOAJ Gold, Green Published			2019-04-02	
J	Vanlerberghe, V; Singh, SP; Paudel, IS; Ostyn, B; Picado, A; Sanchez, A; Rijal, S; Sundar, S; Davies, C; Boelaert, M				Vanlerberghe, V.; Singh, S. P.; Paudel, I. S.; Ostyn, B.; Picado, A.; Sanchez, A.; Rijal, S.; Sundar, S.; Davies, C.; Boelaert, M.			Determinants of bednet ownership and use in visceral leishmaniasis-endemic areas of the Indian subcontinent	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						visceral leishmaniasis; India; Nepal; bednet use; bednet ownership; poverty	INSECTICIDE-TREATED NETS; RANDOMIZED CONTROLLED-TRIAL; KALA-AZAR; IMPREGNATED BEDNETS; MASS-DISTRIBUTION; RISK-FACTORS; RURAL AREA; NEPAL; VECTOR; AFGHANISTAN	OBJECTIVE To document ownership and use of bednets with its determinants in the visceral leishmaniasis (VL)-endemic region where mainly non-insecticide impregnated nets are available through commercial channels, and bednets are being considered as a leishmaniasis vector control measure. METHODS In August-September 2006, semi-structured household (HH) questionnaires and observation guides were used in a random sample of 1330 HHs in VL-endemic districts of India and Nepal to collect data on VL knowledge, HH socio-economic status, bednet ownership and use patterns. An asset index was constructed to allow wealth ranking of the HH. A binary logistic response General Estimating Equations model was fitted to evaluate the determinants of bednet ownership and use. RESULTS The proportion of HHs with at least one bednet purchased on the commercial market was 81.5% in India and 70.2% in Nepal. The bednets were used in all seasons by 50.6% and 54.1% of the Indian and Nepalese HH owning a bed net. There was striking inequity in bednet ownership: only 38.3% of the poorest quintile in Nepal owned at least one net, compared to 89.7% of the wealthiest quintile. In India, the same trend was observed though somewhat less pronounced (73.6% vs. 93.7%). Multivariate analysis showed that poverty was an important independent predictor for not having a bednet in the HH [OR 5.39 (2.90-10.03)]. CONCLUSION Given the inequity in commercial bednet ownership, free distribution of insecticide-treated bednets to the general population seems imperative to achieve a mass effect on vector density.	[Vanlerberghe, V.; Ostyn, B.; Sanchez, A.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Singh, S. P.; Sundar, S.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Paudel, I. S.; Rijal, S.] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Picado, A.] London Sch Hyg & Trop Med, London WC1, England	Vanlerberghe, V (reprint author), Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, Natl Str 155, B-2000 Antwerp, Belgium.	vvanlerberghe@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Picado, Albert/0000-0001-7344-628X	European Union [015374]	We gratefully acknowledge the role played by all field research staff involved in the KALANET project. We also thank the people of the concerned districts in India and Nepal who participated in the study. We received financial support from the European Union, Proposal Contract No. 015374 (KALANET). The funding source was not involved in any stage of the research process.	AIKINS MK, 1993, T ROY SOC TROP MED H, V87, P25, DOI 10.1016/0035-9203(93)90172-M; Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; Alten B, 2003, J MED ENTOMOL, V40, P930, DOI 10.1603/0022-2585-40.6.930; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2000, AM J TROP MED HYG, V63, P184, DOI 10.4269/ajtmh.2000.63.184; BOELAERT M, 2009, TROP MED INT HEALTH, V14, P1; Das ML, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000100; Elnaiem DA, 1999, MED VET ENTOMOL, V13, P310, DOI 10.1046/j.1365-2915.1999.00191.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P846, DOI 10.1046/j.1365-3156.2002.00929.x; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Howard N, 2003, TROP MED INT HEALTH, V8, P1043, DOI 10.1046/j.1365-3156.2003.01163.x; Joshi A., 2008, Journal of Vector Borne Diseases, V45, P105; Koirala S, 1998, B WORLD HEALTH ORGAN, V76, P485; Mathanga DP, 2006, TROP MED INT HEALTH, V11, P1367, DOI 10.1111/j.1365-3156.2006.01684.x; Nuwaha F, 2001, AM J TROP MED HYG, V65, P877, DOI 10.4269/ajtmh.2001.65.877; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; Pardo Raúl H, 2006, Biomédica, V26, P167; Reyburn H, 2000, T ROY SOC TROP MED H, V94, P361, DOI 10.1016/S0035-9203(00)90104-4; Ritmeijer K, 2007, TROP MED INT HEALTH, V12, P404, DOI 10.1111/j.1365-3156.2006.01807.x; Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x; Singh SP, 2006, AM J TROP MED HYG, V75, P505, DOI 10.4269/ajtmh.2006.75.505; Skarbinski J, 2007, AM J TROP MED HYG, V76, P1100, DOI 10.4269/ajtmh.2007.76.1100; Sundar S, 2008, TROP MED INT HEALTH, V13, P2, DOI 10.1111/j.1365-3156.2007.01974.x; Tayeh A, 1997, CUTANEOUS LEISHMANIA; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S01406736(07)60951-9; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Webster J, 2005, LANCET INFECT DIS, V5, P709, DOI 10.1016/S1473-3099(05)70269-3	29	11	11	0	6	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2010	15	1					60	67		10.1111/j.1365-3156.2009.02433.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	531JU	WOS:000272662600009	19917036				2019-04-02	
J	Wanyenze, RK; Nawavvu, C; Ouma, J; Namale, A; Colebunders, R; Kamya, MR				Wanyenze, Rhoda K.; Nawavvu, Cecilia; Ouma, Joseph; Namale, Alice; Colebunders, Robert; Kamya, Moses R.			Provider-initiated HIV testing for paediatric inpatients and their caretakers is feasible and acceptable	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						provider initiated HIV testing and counselling (PITC); hospital; children; HIV prevalence; Africa	EARLY INFANT DIAGNOSIS; UGANDA; MORTALITY; KAMPALA; MOTHERS	OBJECTIVES Early diagnosis of HIV-infected children remains a major challenge in Africa. Children who are hospitalised represent an opportunity for HIV diagnosis and appropriate treatment. We introduced HIV Counselling and Testing (HCT) for hospitalised children and their caretakers in Mulago teaching hospital in Uganda to assess its feasibility. METHODS We analysed routine program data for children and caretakers who were tested between February 2005 and February 2008 to assess the proportion of children and caretakers who were HIV-infected. We also assessed the level of immune suppression (CD4 percentage) in a subset of HIV infected children tested between January 2007 and December 2007. RESULTS Caretakers agreed to HIV testing for 8990 (92.8%) of the 9687 children who were offered HIV testing. Among the caretakers, 89.8% agreed to be tested. At the time of hospitalization, 41.3% of the caretakers had previously tested for HIV. Although 313 parents (mothers and fathers) reported that they had previously tested HIV positive, only 113 (36.3%) of these had tested their children prior to hospitalization. Overall HIV prevalence among caretakers was 16.7%. HIV prevalence among children was 12.4%, highest on the nutrition ward (30.8%). Of those children who underwent CD4 counts, 56.4% had a CD4 percentage of <20%. CONCLUSION HCT for hospitalized children and their caretakers identified a significant number of HIV infected children and caretakers. More than half of the children had advanced HIV disease. More intensive efforts are needed to ensure earlier diagnosis and linkage to care for HIV infected children.	[Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Nawavvu, Cecilia; Ouma, Joseph; Kamya, Moses R.] Mulago Mbarara Teaching Hosp, Joint AIDS Program, Kampala, Uganda; [Namale, Alice] Mulago Hosp, Kampala, Uganda; [Colebunders, Robert] Inst Trop Med, B-2000 Antwerp, Belgium; [Kamya, Moses R.] Makerere Univ, Sch Med, Kampala, Uganda	Wanyenze, RK (reprint author), Makerere Univ, Sch Publ Hlth, POB 7072, Kampala, Uganda.	rwanyenze@hotmail.com			Centers for Disease Control and Prevention (CDC), Department of Health and Human Services/PEPFAR	We received funding from the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services/PEPFAR. The content and views in this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of CDC.	[Anonymous], 2009, 2008 UNAIDS ANN REP; Brahmbhatt H, 2006, JAIDS-J ACQ IMM DEF, V41, P504, DOI 10.1097/01.qai.0000188122.15493.0a; Cherutich P, 2008, B WORLD HEALTH ORGAN, V86, P155, DOI 10.2471/BLT.07.040402; Helleringer S, 2009, JAIDS-J ACQ IMM DEF, V51, P185, DOI 10.1097/QAI.0b013e31819c1726; MBORINGACHA D, 2006, 2006 HIV AIDS IMPL M; *MOH UG, 2009, NAT ANT TREATM GUID; *MOH UG, 2005, UG NAT POL HIV COUNS; NAIDOO V, 2007, 3 S AFR AIDS C DURB; Nakanjako D, 2007, AIDS BEHAV, V11, P753, DOI 10.1007/s10461-006-9180-9; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Uganda AIDS Commission (UAC), 2008, REP IMPL NAT HIV AID; UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNICEF, 2008, CHILDR AIDS 3 STOCKT; Wanyenze R, 2006, AIDS BEHAV, V10, P361, DOI 10.1007/s10461-005-9035-9; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28; Wong V, 2006, VULNERABLE CHILD YOU, V1, P44, DOI 10.1080/17450120600700004; World Health Organization, 2008, REP WHO TECHN REF GR	18	22	22	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2010	15	1					113	119		10.1111/j.1365-3156.2009.02417.x				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	531JU	WOS:000272662600016	19891756	Bronze			2019-04-02	
J	van Dijk, DPJ; Gillet, P; Vlieghe, E; Cnops, L; van Esbroeck, M; Jacobs, J				van Dijk, David P. J.; Gillet, Philippe; Vlieghe, Erika; Cnops, Lieselotte; van Esbroeck, Marjan; Jacobs, Jan			Evaluation of the Palutop+4 malaria rapid diagnostic test in a non-endemic setting	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM; RETURNED TRAVELERS; VIVAX; PERFORMANCE; ACCURACY; REACTIVITY; ASSAY; ICT	Background: Palutop+4 (All. Diag, Strasbourg, France), a four-band malaria rapid diagnostic test (malaria RDT) targeting the histidine-rich protein 2 (HRP-2), Plasmodium vivax-specific parasite lactate dehydrogenase (Pv-pLDH) and pan Plasmodium-specific pLDH (pan-pLDH) was evaluated in a non-endemic setting on stored whole blood samples from international travellers suspected of malaria. Methods: Microscopy corrected by PCR was the reference method. Samples include those infected by Plasmodium falciparum (n = 323), Plasmodium vivax (n = 97), Plasmodium ovale (n = 73) and Plasmodium malariae (n = 25) and 95 malaria negative samples. Results: The sensitivities for the diagnosis of P. falciparum, P. vivax, P. malariae and P. ovale were 85.1%, 66.0%, 32.0% and 5.5%. Sensitivities increased at higher parasite densities and reached 90.0% for P. falciparum >100/mu l and 83.8% for P. vivax >500/mu l. Fourteen P. falciparum samples reacted with the Pv-pLDH line, one P. vivax sample with the HRP-2 line, and respectively two and four P. ovale and P. malariae samples reacted with the HRP-2 line. Two negative samples gave a signal with the HRP-2 line. Faint and weak line intensities were observed for 129/289 (44.6%) HRP-2 lines in P. falciparum samples, for 50/64 (78.1%) Pv-pLDH lines in P. vivax samples and for 9/13 (69.2%) pan-pLDH lines in P. ovale and P. malariae samples combined. Inter-observer reliabilities for positive and negative readings were excellent for the HRP-2 and Pv-pLDH lines (overall agreement >92.0% and kappa-values for each pair of readers >= 0.88), and good for the pan-pLDH line (85.5% overall agreement and kappa-values >= 0.74). Conclusions: Palutop+4 performed moderately for the detection of P. falciparum and P. vivax, but sensitivities were lower than those of three-band malaria RDTs.	[Gillet, Philippe; Vlieghe, Erika; Cnops, Lieselotte; van Esbroeck, Marjan; Jacobs, Jan] Inst Trop Med ITM, Dept Clin Sci, Unit Trop Lab Med, B-2000 Antwerp, Belgium; [van Dijk, David P. J.; Jacobs, Jan] Fac Hlth Med & Life Sci FHML, Maastricht, Netherlands	Gillet, P (reprint author), Inst Trop Med ITM, Dept Clin Sci, Unit Trop Lab Med, Natl Str 155, B-2000 Antwerp, Belgium.	D.vanDijk@student.maastrichtuniversity.nl; pgillet@itg.be; evlieghe@itg.be; lcnops@itg.be; mvesbroeck@itg.be; jjacobs@itg.be		gillet, philippe/0000-0001-5878-6446			BELL D, 2006, NAT REV MICROBIOL, V4, pS34, DOI DOI 10.1038/NRMICO1524; Bossuyt PM, 2003, CROAT MED J, V44, P639; De Monbrison F, 2004, EUR J CLIN MICROBIOL, V23, P784, DOI 10.1007/s10096-004-1202-9; Durand F, 2005, CLIN MICROBIOL INFEC, V11, P903, DOI 10.1111/j.1469-0691.2005.01253.x; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-129; Grobusch MP, 2003, PARASITOL RES, V89, P354, DOI 10.1007/s00436-002-0764-7; Hanscheid T, 2003, CLIN MICROBIOL INFEC, V9, P497, DOI 10.1046/j.1469-0691.2003.00640.x; Iqbal J, 2000, J CLIN MICROBIOL, V38, P1184; Kim SH, 2008, TROP MED INT HEALTH, V13, P1495, DOI 10.1111/j.1365-3156.2008.02163.x; Lee SW, 2008, J CLIN MICROBIOL, V46, P939, DOI 10.1128/JCM.02110-07; Marx A, 2005, ANN INTERN MED, V142, P836, DOI 10.7326/0003-4819-142-10-200505170-00009; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Rakotonirina H, 2008, AM J TROP MED HYG, V78, P217, DOI 10.4269/ajtmh.2008.78.217; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Richardson DC, 2002, J CLIN MICROBIOL, V40, P4528, DOI 10.1128/JCM.40.12.4528-4530.2002; Richter J, 2004, PARASITOL RES, V94, P384, DOI 10.1007/s00436-004-1213-6; Tjitra E, 1999, J CLIN MICROBIOL, V37, P2412; Van der Palen M, 2009, MALARIA J, V8, P90; WHO, 2009, LIST KNOWN COMM AV A; *WHO, 2009, INT TRAV HLTH SIT 1; *WHO, 2003, MAL RAP DIAGN MAK IT; Wiese L, 2006, SCAND J INFECT DIS, V38, P1063, DOI 10.1080/00365540600818011; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2009, MAL RAP DIAGN TEST P	26	22	22	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	DEC 12	2009	8								293	10.1186/1475-2875-8-293				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	536OY	WOS:000273054900001	20003378	DOAJ Gold, Green Published			2019-04-02	
J	Proano-Perez, F; Benitez-Ortiz, W; Celi-Erazo, M; Ron-Garrido, L; Benitez-Capistros, R; Portaels, F; Rigouts, L; Linden, A				Proano-Perez, Freddy; Benitez-Ortiz, Washington; Celi-Erazo, Maritza; Ron-Garrido, Lenin; Benitez-Capistros, Ricardo; Portaels, Francoise; Rigouts, Leen; Linden, Annick			Comparative Intradermal Tuberculin Test in Dairy Cattle in the North of Ecuador and Risk Factors Associated with Bovine Tuberculosis	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							MYCOBACTERIUM-BOVIS; TRANSMISSION; PREVALENCE; INFECTION; COUNTRIES; TANZANIA; SLAUGHTER; SEVERITY; ANIMALS; IRELAND	We studied the prevalence of bovine tuberculosis (BTB) in Mejia canton, the major dairy cattle production area in northern Ecuador. Twenty dairy herds comprising 2,022 cattle were selected. In 2007, each animal was tested using the comparative intradermal tuberculin test (CITT). In 2008, a follow-up test was performed in the same herds. The true annual incidence was 1.70%, and the true prevalence was 7.41% and 7.13% in 2007 and 2008, respectively. The prevalence was 0.27% and 0.57% in medium-sized herds in 2007 and 2008, respectively, compared with 8.63% and 8.43% in large herds (P < 0.01). The number of skin test-positive cases also increased significantly with age (P = 0.03), contacts with other species of animals (P < 0.01), and introduction of new cattle (P = 0.04). Herd prevalence was 55% in 2007 and 65% in 2008. This study shows the lack of knowledge in cattle farmers about this zoonosis and the necessity for a national BTB control program in Ecuador.	[Linden, Annick] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Liege, Belgium; [Proano-Perez, Freddy; Benitez-Ortiz, Washington; Celi-Erazo, Maritza; Ron-Garrido, Lenin; Benitez-Capistros, Ricardo] Cent Univ Ecuador, Int Ctr Zoonoses, Quito, Ecuador; [Portaels, Francoise; Rigouts, Leen] Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium; Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Liege, Belgium; Cent Univ Ecuador, Fac Vet Med, Quito, Ecuador	Linden, A (reprint author), Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Bat B43A, Liege, Belgium.	fproano-ciz@ac.uce.edu.ec; wbenitez-ciz@ac.uce.edu.ec; mceli-ciz@ac.uce.edu.ec; lron-ciz@ac.uce.edu.ec; fportaels@itg.be; lrigouts@itg.be; a.linden@ulg.ac.be		Linden, Annick/0000-0002-8957-0573	"Commission universitaire pour le Developpement" (CUD), University of Liege, Project PIC	The authors gratefully acknowledge the financial support from "Commission universitaire pour le Developpement" (CUD), University of Liege, Project PIC.	Abalos P, 2004, REV SCI TECH OIE, V23, P583, DOI 10.20506/rst.23.2.1502; Acha P.N., 2001, ZOONOSES COMMUNICABL; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; [Anonymous], 2008, MANUAL DIAGNOSTIC TE; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Biet F, 2005, VET RES, V36, P411, DOI 10.1051/vetres:2005001; Brown WH, 1998, J AM VET MED ASSOC, V212, P557; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Collins JD, 2006, VET MICROBIOL, V112, P369, DOI 10.1016/j.vetmic.2005.11.041; Cook AJC, 1996, BRIT VET J, V152, P37, DOI 10.1016/S0007-1935(96)80084-4; COONEY R, 1997, IRISH VET J, V41, P363; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Cousins D. V., 2004, Infectious diseases of livestock. Volume Three, P1973; de Kantor IN, 2006, VET MICROBIOL, V112, P111, DOI 10.1016/j.vetmic.2005.11.033; Denny GO, 1999, VET REC, V144, P305, DOI 10.1136/vr.144.12.305; GIL A, 2001, 2 FAO; Goodchild AV, 2001, TUBERCULOSIS, V81, P23, DOI 10.1054/tube.2000.0256; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Gormley E, 2006, VET MICROBIOL, V112, P171, DOI 10.1016/j.vetmic.2005.11.029; GROOMS D, 2000, EXTENSION B MICHIG E, V2731; Kaneene JB, 2002, J AM VET MED ASSOC, V221, P837, DOI 10.2460/javma.2002.221.837; Kazwala RR, 2001, VET RES COMMUN, V25, P609, DOI 10.1023/A:1012757011524; Lindeboom JA, 2006, CLIN INFECT DIS, V43, P1547, DOI 10.1086/509326; Marangon S, 1998, PREV VET MED, V34, P87, DOI 10.1016/S0167-5877(97)00087-1; Menzies FD, 2000, VET J, V160, P92, DOI 10.1053/tvjl.2000.0482; Milian-Suazo F, 2000, AM J VET RES, V61, P86, DOI 10.2460/ajvr.2000.61.86; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; Munroe FA, 1999, PREV VET MED, V41, P119, DOI 10.1016/S0167-5877(99)00051-3; Munyeme M, 2008, PREV VET MED, V85, P317, DOI 10.1016/j.prevetmed.2008.03.006; NEILL SD, 1991, VET MICROBIOL, V28, P103, DOI 10.1016/0378-1135(91)90102-L; Olea-Popelka FJ, 2004, PREV VET MED, V63, P163, DOI 10.1016/j.prevetmed.2004.03.001; Oloya J, 2007, PREV VET MED, V80, P318, DOI 10.1016/j.prevetmed.2007.03.004; Oloya J, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-95; Omer MK, 2001, TROP ANIM HEALTH PRO, V33, P295, DOI 10.1023/A:1010531802372; Parra A, 2005, VET MICROBIOL, V110, P293, DOI 10.1016/j.vetmic.2005.07.013; Pavlik I, 2002, VET MED-CZECH, V47, P45, DOI 10.17221/5802-VETMED; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; Proano-Perez F, 2006, AM J TROP MED HYG, V75, P318, DOI 10.4269/ajtmh.2006.75.318; Shirima GM, 2003, PREV VET MED, V57, P167, DOI 10.1016/S0167-5877(02)00214-3; *SICA, 2000, SERV INF CENS AGR MI; Suazo FM, 2003, PREV VET MED, V58, P1, DOI 10.1016/S0167-5877(03)00003-5	42	7	7	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2009	81	6					1103	1109		10.4269/ajtmh.2009.09-0182				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	531YN	WOS:000272709600028	19996444	Bronze, Green Published			2019-04-02	
J	Walsh, DS; Eyase, F; Onyango, D; Odindo, A; Otieno, W; Waitumbi, JN; Bulimo, WD; Schnabel, DC; Meyers, WM; Portaels, F				Walsh, Douglas S.; Eyase, Fredrick; Onyango, David; Odindo, Alfred; Otieno, Walter; Waitumbi, John N.; Bulimo, Wallace D.; Schnabel, David C.; Meyers, Wayne M.; Portaels, Francoise			Short Report: Clinical and Molecular Evidence for a Case of Buruli Ulcer (Mycobacterium ulcerans Infection) in Kenya	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							RISK-FACTORS; PCR; IS2404; DISEASE; BENIN; SKIN	Mycobacterium ulcerans infection is an emerging disease that causes indolent, necrotizing skin lesions known as Buruli ulcer (BU) and occasional contiguous or metastatic bone lesions. Buruli ulcer is named after Buruli County in Uganda (east Africa), where an epidemic occurred in the 1960s. Today, BU is most common in central and west Africa. We describe clinical and molecular evidence for a case of BU in Kenya.	[Walsh, Douglas S.] USN, Med Res Unit, Walter Reed Project, Kenya Med Res Inst, Kisumu 10400, Kenya; [Bulimo, Wallace D.; Schnabel, David C.] USN, Med Res Unit, Global Emerging Infect Syst Program, Nairobi, Kenya; [Bulimo, Wallace D.; Schnabel, David C.] Walter Reed Project, Nairobi, Kenya; [Meyers, Wayne M.] USAF, Inst Pathol, Dept Environm & Infect Dis Sci, Washington, DC 20306 USA; [Portaels, Francoise] Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium	Walsh, DS (reprint author), USN, Med Res Unit, Walter Reed Project, Kenya Med Res Inst, POB 54, Kisumu 10400, Kenya.	douglas.s.walsh@us.army.mil; wbulimo@wrp-nbo.org; dschnabel@wrp-nbo.org; wmekmeyers@comcast.net; portaels@itg.be	Bulimo, Wallace/B-1982-2014	Bulimo, Wallace/0000-0001-8475-0586	Global Emerging Infections System (Silver Spring, MD); United States Army Medical Research Unit-Kenya (Nairobi, Kenya)	This study was supported by the Global Emerging Infections System (Silver Spring, MD) and the United States Army Medical Research Unit-Kenya (Nairobi, Kenya).	Ablordey A, 2005, J CLIN MICROBIOL, V43, P448, DOI 10.1128/JMC.43.1.448-451.2005; Demangel C, 2009, NAT REV MICROBIOL, V7, P50, DOI 10.1038/nrmicro2077; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Guimaraes-Peres A, 1999, J CLIN MICROBIOL, V37, P206; Johnson RC, 2008, AIDS, V22, P901, DOI 10.1097/QAD.0b013e3282f7690a; MEYERS WM, 1974, AM J TROP MED HYG, V23, P919, DOI 10.4269/ajtmh.1974.23.919; Meyers WM, 1996, BRIT J DERMATOL, V134, P1116, DOI 10.1111/j.1365-2133.1996.tb07955.x; Nackers F, 2007, AM J TROP MED HYG, V77, P834, DOI 10.4269/ajtmh.2007.77.834; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; Pouillot R, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000101; Rondini S, 2003, J CLIN MICROBIOL, V41, P4231, DOI 10.1128/JCM.41.9.4231-4237.2003; Stinear T, 1999, J CLIN MICROBIOL, V37, P1018; Stinear T, 2000, J CLIN MICROBIOL, V38, P1482; Stragier P, 2006, EMERG INFECT DIS, V12, P844, DOI 10.3201/eid1205.051191; Stragier P, 2007, SYST APPL MICROBIOL, V30, P525, DOI 10.1016/j.syapm.2007.06.001; Walsh DS, 2008, T ROY SOC TROP MED H, V102, P969, DOI 10.1016/j.trstmh.2008.06.006; Walsh DS, 2005, AM J TROP MED HYG, V73, P410, DOI 10.4269/ajtmh.2005.73.410	19	8	8	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2009	81	6					1110	1113		10.4269/ajtmh.2009.09-0313				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	531YN	WOS:000272709600029	19996445	Bronze			2019-04-02	
J	Barbour, AG; Bunikis, J; Travinsky, B; Hoen, AG; Diuk-Wasser, MA; Fish, D; Tsao, JI				Barbour, Alan G.; Bunikis, Jonas; Travinsky, Bridgit; Hoen, Anne Gatewood; Diuk-Wasser, Maria A.; Fish, Durland; Tsao, Jean I.			Niche Partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the Same Tick Vector and Mammalian Reservoir Species	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							IXODES-RICINUS TICKS; NORTHEASTERN UNITED-STATES; POLYMERASE-CHAIN-REACTION; DISEASE ENDEMIC AREA; WHITE-FOOTED MICE; BLACK-LEGGED TICK; LONE-STAR TICKS; LYME-DISEASE; SENSU-LATO; NORTH-AMERICA	The Lyme borreliosis agent Borrelia burgdorferi and the relapsing fever group species Borrelia miyamotoi co-occur in the United States. We used species-specific, quantitative polymerase chain reaction to study both species in the blood and skin of Peromyscus leucopus mice and host-seeking Ixodes scapularis nymphs at a Connecticut site. Bacteremias with R burgdorferi or B. miyamotoi were most prevalent during periods of greatest activity for nymphs or larvae, respectively. Whereas B. burgdorferi was 30-fold more frequent than B. miyamotoi in skin biopsies and mice had higher densities of B. burgdorferi densities in the skin than in the blood, B. miyamotoi densities were higher in blood than skin. In a survey of host-seeking nymphs in 11 northern states, infection prevalences for B. burgdorferi and B. miyamotoi averaged similar to 0.20 and similar to 0.02, respectively. Co-infections of P. leucopus or L. scapularis with both B. burgdorferi and B. miyamotoi were neither more nor less common than random expectations.	[Barbour, Alan G.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; [Bunikis, Jonas] CDMA, B-1050 Brussels, Belgium; [Hoen, Anne Gatewood] Harvard MIT, Div Hlth Sci, Childrens Hosp, Informat Program, Boston, MA 02215 USA; [Diuk-Wasser, Maria A.; Fish, Durland] Yale Univ, Dept Epidemiol & Publ Hlth, Sch Publ Hlth, New Haven, CT 06520 USA; [Tsao, Jean I.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Tsao, Jean I.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	Barbour, AG (reprint author), Univ Calif Irvine, Dept Microbiol & Mol Genet, 3012 Hewitt, Irvine, CA 92697 USA.	abarbour@uci.edu; Jonas.BUNIKIS@ec.europa.eu; btravins@uci.edu; anne.gatewood@childrens.harvard.edu; maria.diuk@yale.edu; Durland.Fish@yale.edu; tsao@msu.edu		Barbour, Alan/0000-0002-0719-5248	NIH [AI24424, AI37248]; USDA-ARS [58-0790-5-068]; G. Harold and Leila Y. Mathers Charitable Foundation; Centers for Disease Control Fellowship Training Program in Vector-Borne Diseases	This work was supported by NIH Grants AI24424 and AI37248 (A.G.B.), CDC cooperative agreement CI 00171-01 (D.F.), USDA-ARS cooperative agreement # 58-0790-5-068 (D.F) G. Harold and Leila Y. Mathers Charitable Foundation (D.F), a Centers for Disease Control Fellowship Training Program in Vector-Borne Diseases (A.G.H.), and patent royalties donated for research (A.G.B.)	ANDERSON JF, 1983, AM J TROP MED HYG, V32, P818, DOI 10.4269/ajtmh.1983.32.818; Anderson JF, 1996, J CLIN MICROBIOL, V34, P524; Armstrong PM, 1996, LANCET, V347, P67, DOI 10.1016/S0140-6736(96)91604-9; Barbour AG, 2005, TICK-BORNE DISEASES OF HUMANS, P268; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barbour AG, 1996, J INFECT DIS, V173, P403, DOI 10.1093/infdis/173.2.403; BARBOUR AG, 2001, EMERG INFECT DIS, V5, P153; Beati L, 2001, J PARASITOL, V87, P32, DOI 10.1007/s004360000288; BRUNET LR, 1995, AM J TROP MED HYG, V53, P300, DOI 10.4269/ajtmh.1995.53.300; Bunikis J, 2005, EMERG INFECT DIS, V11, P1150; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; Bunikis J, 2004, EMERG INFECT DIS, V10, P1661, DOI 10.3201/eid1009.040236; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; BURGDORFER W, 1987, AM J TROP MED HYG, V37, P624, DOI 10.4269/ajtmh.1987.37.624; BURGDORFER W, 1985, AM J TROP MED HYG, V34, P925, DOI 10.4269/ajtmh.1985.34.925; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; BURKOT TR, 1994, AM J TROP MED HYG, V50, P354, DOI 10.4269/ajtmh.1994.50.354; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; DESILVA AM, 1995, AM J TROP MED HYG, V53, P397, DOI 10.4269/ajtmh.1995.53.397; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; FALCO RC, 1992, EXP APPL ACAROL, V14, P165, DOI 10.1007/BF01219108; FINE PEM, 1975, ANN NY ACAD SCI, V266, P173, DOI 10.1111/j.1749-6632.1975.tb35099.x; Fraenkel CJ, 2002, J CLIN MICROBIOL, V40, P3308, DOI 10.1128/JCM.40.9.3308-3312.2002; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Gatewood AG, 2009, APPL ENVIRON MICROB, V75, P2476, DOI 10.1128/AEM.02633-08; Goethert HK, 2003, AM J TROP MED HYG, V69, P455, DOI 10.4269/ajtmh.2003.69.455; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P153, DOI 10.1128/AEM.01567-07; Hulinska D, 2007, FOLIA MICROBIOL, V52, P315, DOI 10.1007/BF02932085; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; KRAMPITZ HE, 1986, ZBL BAKT-INT J MED M, V263, P21; Kurtenbach K, 2001, APPL ENVIRON MICROB, V67, P4926, DOI 10.1128/AEM.67.10.4926-4929.2001; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; LANE RS, 1987, AM J TROP MED HYG, V37, P188, DOI 10.4269/ajtmh.1987.37.188; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; Nefedova VV, 2004, FOLIA PARASIT, V51, P67, DOI 10.14411/fp.2004.010; Ornstein K, 2006, VECTOR-BORNE ZOONOT, V6, P103, DOI 10.1089/vbz.2006.6.103; Patrican LA, 1997, J MED ENTOMOL, V34, P52, DOI 10.1093/jmedent/34.1.52; Pennington PM, 1997, INFECT IMMUN, V65, P285; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; RAMAKRISHNAN U, 2001, FRONT PLANT SCI, V53, P7; Rich SM, 2001, J CLIN MICROBIOL, V39, P494, DOI 10.1128/JCM.39.2.494-497.2001; Richter D, 2004, INFECT IMMUN, V72, P2442, DOI 10.1128/IAI.72.4.2442-2444.2004; Richter D, 2003, EMERG INFECT DIS, V9, P697; Richter D, 2006, EMERG INFECT DIS, V12, P1919; Rijpkema S, 1996, EXP APPL ACAROL, V20, P23; Schneider BS, 2000, J CLIN MICROBIOL, V38, P3103; Schwan TG, 2003, J BACTERIOL, V185, P1346, DOI 10.1128/JB.185.4.1346-1356.2003; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723; STANEK G, 1986, ZBL BAKT-INT J MED M, V263, P29; Steere AC, 2005, TICK-BORNE DISEASES OF HUMANS, P176; Tsao J, 2001, VECTOR-BORNE ZOONOT, V1, P65, DOI 10.1089/153036601750137705; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Ullmann AJ, 2005, J MED ENTOMOL, V42, P1057, DOI 10.1603/0022-2585(2005)042[1057:TMAFDO]2.0.CO;2; Varela AS, 2004, J CLIN MICROBIOL, V42, P1163, DOI 10.1128/JCM.42.3.1163-1169.2004; Varela-Stokes AS, 2007, J MED ENTOMOL, V44, P478, DOI 10.1603/0022-2585(2007)44[478:TOBAFL]2.0.CO;2; Vennestrom J, 2008, PARASITOL INT, V57, P32, DOI 10.1016/j.parint.2007.07.004; WALKER ED, 1994, J MED ENTOMOL, V31, P524, DOI 10.1093/jmedent/31.4.524; Wang GQ, 2003, APPL ENVIRON MICROB, V69, P4561, DOI 10.1128/AEM.69.8.4561-4565.2003; Wodecka Beata, 2007, Wiadomosci Parazytologiczne, V53, P231; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; ZHIOUA E, 1994, J MED ENTOMOL, V31, P763, DOI 10.1093/jmedent/31.5.763	64	134	140	0	28	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2009	81	6					1120	1131		10.4269/ajtmh.2009.09-0208				12	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	531YN	WOS:000272709600031	19996447	Green Accepted, Bronze			2019-04-02	
J	Declercq, E				Declercq, Etienne			Leprosy global statistics: beware of traps	LEPROSY REVIEW			English	Editorial Material									Damien Fdn, B-1081 Brussels, Belgium	Declercq, E (reprint author), Damien Fdn, Blvd Leopold 2,263, B-1081 Brussels, Belgium.						[Anonymous], 2009, WEEKLY EPIDEMIOLOGIC, V84, P333; World Health Organization, GLOB STRAT FURTH RED	2	4	4	0	4	LEPRA	COLCHESTER	28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND	0305-7518			LEPROSY REV	Lepr. Rev.	DEC	2009	80	4					350	352						3	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	655JB	WOS:000282244900001	20306633				2019-04-02	
J	Picado, A; Kumar, V; Das, M; Burniston, I; Roy, L; Suman, R; Dinesh, D; Coosemans, M; Sundar, S; Shreekant, K; Boelaert, M; Davies, C; Cameron, M				Picado, Albert; Kumar, Vijay; Das, Murari; Burniston, Ian; Roy, Lalita; Suman, Rijal; Dinesh, Diwakar; Coosemans, Marc; Sundar, Shyam; Shreekant, Kesari; Boelaert, Marleen; Davies, Clive; Cameron, Mary			Effect of untreated bed nets on blood-fed Phlebotomus argentipes in kala-azar endemic foci in Nepal and India	MEMORIAS DO INSTITUTO OSWALDO CRUZ			English	Article						untreated nets; Phlebotomus argentipes; visceral leishmaniasis; HBI	VISCERAL LEISHMANIASIS; VECTOR-CONTROL; RISK-FACTORS; INFECTION; DONOVANI	Observational studies in the Indian subcontinent have shown that untreated nets may be protective against visceral leishmaniasis (VL). In this study, we evaluated the effect of untreated nets on the blood feeding rates of Phlebotomus argentipes as well as the human blood index (HBI) in VL endemic villages in India and Nepal. The study had a "before and after intervention" design in 58 households in six clusters. The use of untreated nets reduced the blood feeding rate by 85% (95% CI 76.5-91.1%) and the HBI by 42.2% (95% CI 11.1-62.5%). These results provide circumstantial evidence that untreated nets may provide some degree of personal protection against sand fly bites.	[Picado, Albert; Burniston, Ian; Davies, Clive; Cameron, Mary] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Coosemans, Marc; Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [Das, Murari; Roy, Lalita; Suman, Rijal] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Kumar, Vijay; Dinesh, Diwakar; Shreekant, Kesari] Rajendra Mem Res Inst Med Sci, Patna, Bihar, India; [Sundar, Shyam] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India	Picado, A (reprint author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	albert.picado@lshtm.ac.uk	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Das, Murari/0000-0001-6816-2389	EU [015374]	EU-funded INCO-DEV KALANET project (015374)	Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2000, AM J TROP MED HYG, V63, P184, DOI 10.4269/ajtmh.2000.63.184; BOREHAM PFL, 1975, J TROP MED HYG, V78, P83; Dinesh DS, 2000, ANN TROP MED PARASIT, V94, P447, DOI 10.1080/00034983.2000.11813563; Githeko AK, 1996, PARASITOL TODAY, V12, P127, DOI 10.1016/0169-4758(96)30001-X; Maroli M, 1991, Parassitologia, V33 Suppl, P399; OLIVEIRA AM, 1994, MEM I OSWALDO CRUZ, V89, P451, DOI 10.1590/S0074-02761994000300029; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; PICADO A, 2009, PLOS NEGL T IN PRESS; Sampath TRR, 1998, J AM MOSQUITO CONTR, V14, P437; Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x; Svobodova M, 2003, AM J TROP MED HYG, V68, P6, DOI 10.4269/ajtmh.2003.68.6; WHO, 2005, REG TECHN ADV GROUP; WHO, 2006, GUID TEST MOSQ AD IN	14	10	11	0	8	FUNDACO OSWALDO CRUZ	RIO DE JANEIRO, RJ	AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL	0074-0276			MEM I OSWALDO CRUZ	Mem. Inst. Oswaldo Cruz	DEC	2009	104	8					1183	1186		10.1590/S0074-02762009000800018				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	554CO	WOS:000274413300018	20140382	DOAJ Gold, Green Published			2019-04-02	
J	Dauby, N; Alonso-Vega, C; Suarez, E; Flores, A; Hermann, E; Cordova, M; Tellez, T; Torrico, F; Truyens, C; Carlier, Y				Dauby, Nicolas; Alonso-Vega, Cristina; Suarez, Eduardo; Flores, Amilcar; Hermann, Emmanuel; Cordova, Marisol; Tellez, Tatiana; Torrico, Faustino; Truyens, Carine; Carlier, Yves			Maternal Infection with Trypanosoma cruzi and Congenital Chagas Disease Induce a Trend to a Type 1 Polarization of Infant Immune Responses to Vaccines	PLOS NEGLECTED TROPICAL DISEASES			English	Article							BACILLUS-CALMETTE-GUERIN; T-CELL RESPONSE; IN-UTERO; INTERFERON-GAMMA; HUMAN NEWBORNS; VACCINATION; TRANSMISSION; ANTIBODY; CD8(+); TUBERCULOSIS	Background: We previously showed that newborns congenitally infected with Trypanosoma cruzi (M+B+) display a strong type 1 parasite-specific T cell immune response, whereas uninfected newborns from T. cruzi-infected mothers (M+B-) are prone to produce higher levels of proinflammatory cytokines than control neonates (M-B-). The purpose of the present study was to determine if such fetal/neonatal immunological environments could alter the response to standard vaccines administered in early life. Methodology: Infants (6-7 months old) living in Bolivia, an area highly endemic for T. cruzi infection, and having received Bacillus Calmette Guerin (BCG), hepatitis B virus (HBV), diphtheria and tetanus vaccines, were enrolled into the M+B+, M+B-, M-B- groups mentioned above. The production of IFN-gamma and IL-13, as markers of Th1 and Th2 responses respectively, by peripherical blood mononuclear cells stimulated with tuberculin purified protein derivative of Mycobacterium tuberculosis (PPD) or the vaccinal antigens HBs, diphtheria toxoid (DT) or tetanus toxoid (TT), as well as circulating levels of IgG antibodies against HBsAg, DT and TT were analyzed in infants. Cellular responses to the superantigen SEB were also monitored in M+B+, M+B-, M-B-infants and newborns. Principal Findings: M+B+ infants developed a stronger IFN-gamma response to hepatitis B, diphtheria and tetanus vaccines than did M+B- and M-B- groups. They also displayed an enhanced antibody production to HBsAg. This was associated with a type 1-biased immune environment at birth, since cells of M+B+ newborns produced higher IFN-gamma levels in response to SEB. M+B- infants produced more IFN-gamma in response to PPD than the other groups. IL-13 production remained low and similar in all the three groups, whatever the subject's ages or vaccine status. Conclusion: These results show that: i) both maternal infection with T. cruzi and congenital Chagas disease do not interfere with responses to BCG, hepatitis B, diphtheria and tetanus vaccines in the neonatal period, and ii) the overcoming of immunological immaturity by T. cruzi infection in early life is not limited to the development of parasite-specific immune responses, but also tends to favour type 1 immune responses to vaccinal antigens.	[Dauby, Nicolas; Hermann, Emmanuel; Truyens, Carine; Carlier, Yves] Univ Libre Bruxelles, Fac Med, Parasitol Lab, Brussels, Belgium; [Alonso-Vega, Cristina; Suarez, Eduardo; Flores, Amilcar; Cordova, Marisol; Tellez, Tatiana; Torrico, Faustino] Univ Mayor San Simon, Fac Med, Cochabamba, Bolivia	Dauby, N (reprint author), Univ Libre Bruxelles, Fac Med, Parasitol Lab, Brussels, Belgium.	ctruyens@ulb.ac.be	Dauby, Nicolas/F-1235-2011; Hermann, Emmanuel/C-6376-2008	Dauby, Nicolas/0000-0002-7697-6849; Hermann, Emmanuel/0000-0003-0971-4918	Region Wallonne; Glaxo-Smithkline Biologicals; Conseil Interuniversitaire de la Communaute francaise de Belgique; Fonds Emile Defay; Fondation Van Buuren; Fond National de la Recherche Scientifique [3461505F, 9-452804, 1.5.284.08F]	The study was supported by the Centre de Recherche Interuniversitaire en Vaccinologie (CRIV) sponsored by the Region Wallonne (http://recherchetechnologie.wallonie.be) and Glaxo-Smithkline Biologicals (Rixensart, Belgium, http://www.gsk-bio.com), the Conseil Interuniversitaire de la Communaute francaise de Belgique (CIUF, http://www.cud.be), the Fonds Emile Defay (ULB, ulb.ac.be), the Fondation Van Buuren (ULB), and the Fond National de la Recherche Scientifique (http://www1.frs-fnrs.be/) (FNRS, grants 3461505F, 9-452804 and 1.5.284.08F). CA-V is a research fellow of the Association pour la promotion de l'education et la formation a l'etranger(APEFE, Communaute Francaise de Belgique, http://portail.apefe.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Serrano A, 2001, MOL BIOCHEM PARASIT, V114, P143, DOI 10.1016/S0166-6851(01)00245-6; Almeida IC, 2001, J LEUKOCYTE BIOL, V70, P467; Carlier Yves, 2003, Rev. Soc. Bras. Med. Trop., V36, P767, DOI 10.1590/S0037-86822003000600024; Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Brustoski K, 2006, J INFECT DIS, V193, P146, DOI 10.1086/498578; Buekens P, 2008, MATERN CHILD HLTH J, V12, P283, DOI 10.1007/s10995-007-0246-8; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; CARLIER Y, 1995, PARASITOL TODAY, V11, P94, DOI 10.1016/0169-4758(95)80165-0; Carlier Y., 2002, ENCY MED CHIR MALADI; Doherty TM, 2005, CLIN MICROBIOL REV, V18, P687, DOI 10.1128/CMR.18.4.687-702.2005; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI [10.1016/j.trstmh.2004.08.006, 10.1019/j.trstmh.2004.08.006]; Garraud O, 2003, TRENDS PARASITOL, V19, P300, DOI 10.1016/S1471-4922(03)00139-9; Gregorek H, 2000, VACCINE, V18, P1210, DOI 10.1016/S0264-410X(99)00394-1; Hasselhorn HM, 1998, VACCINE, V16, P70, DOI 10.1016/S0264-410X(97)00148-5; Hermann E, 2002, BLOOD, V100, P2153; Hermann E, 2006, PEDIATR RES, V60, P38, DOI 10.1203/01.pdr.0000220335.05588.ea; Jackson Y, 2009, EMERG INFECT DIS, V15, P601, DOI 10.3201/eid1504.080438; Jannin J, 2006, ESTIMACION CUANTITAT; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Kaur K, 2007, BLOOD, V110, P2948, DOI 10.1182/blood-2007-01-069245; LaBeaud AD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000442; Malhotra I, 1999, J IMMUNOL, V162, P6843; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.111/j.1365.2249.2005.02799.x; Marchant A, 2003, J CLIN INVEST, V111, P1747, DOI 10.1172/JCI200317470; Mascart F, 2007, VACCINE, V25, P391, DOI 10.1016/j.vaccine.2006.06.046; Mascart F, 2003, J IMMUNOL, V170, P1504, DOI 10.4049/jimmunol.170.3.1504; Munoz J, 2007, T ROY SOC TROP MED H, V101, P1161, DOI 10.1016/j.trstmh.2007.06.011; Murray RA, 2006, J IMMUNOL, V177, P5647, DOI 10.4049/jimmunol.177.8.5647; Neves SF, 1999, PARASITE IMMUNOL, V21, P631, DOI 10.1046/j.1365-3024.1999.00262.x; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Ouaissi A, 2002, J IMMUNOL, V168, P6366, DOI 10.4049/jimmunol.168.12.6366; Riera C, 2006, AM J TROP MED HYG, V75, P1078, DOI 10.4269/ajtmh.2006.75.1078; ROSSI ME, 1998, CLIN EXP IMMUNOL, V72, P196; Sadeghi K, 2007, J INFECT DIS, V195, P296, DOI 10.1086/509892; Saffar MJ, 2008, SWISS MED WKLY, V138, P256, DOI 2008/17/smw-11840; Sathler-Avelar R, 2008, MICROBES INFECT, V10, P103, DOI 10.1016/j.micinf.2007.10.009; Schmunis GA, 2007, MEM I OSWALDO CRUZ, V102, P75, DOI 10.1590/S0074-02762007005000093; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; SIMONSEN O, 1986, J BIOL STAND, V14, P231, DOI 10.1016/0092-1157(86)90008-9; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Torrico F, 2004, AM J TROP MED HYG, V70, P201, DOI 10.4269/ajtmh.2004.70.201; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Vekemans J, 2000, INFECT IMMUN, V68, P5430, DOI 10.1128/IAI.68.9.5430-5434.2000; Virreira M, 2007, AM J TROP MED HYG, V77, P102, DOI 10.4269/ajtmh.2007.77.102; West DJ, 1996, VACCINE, V14, P1019, DOI 10.1016/0264-410X(96)00062-X; WHO, 2005, WORLD HLTH REP	50	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2009	3	12							e571	10.1371/journal.pntd.0000571				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	536RB	WOS:000273060400014	20041029	DOAJ Gold, Green Published			2019-04-02	
J	Gillet, P; Mori, M; Van Esbroeck, M; Van den Ende, J; Jacobs, J				Gillet, Philippe; Mori, Marcella; Van Esbroeck, Marjan; Van den Ende, Jef; Jacobs, Jan			Assessment of the prozone effect in malaria rapid diagnostic tests	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM MALARIA; POLYMERASE-CHAIN-REACTION; ANTIGEN-DETECTION TESTS; RETURNED TRAVELERS; EXPERT MICROSCOPY; PERFORMANCE; FIELD; ACCURACY; INSTRUCTIONS; BINAX	Background: The prozone effect (or high doses-hook phenomenon) consists of false-negative or false-low results in immunological tests, due to an excess of either antigens or antibodies. Although frequently cited as a cause of false-negative results in malaria rapid diagnostic tests (RDTs), especially at high parasite densities of Plasmodium falciparum, it has been poorly documented. In this study, a panel of malaria RDTs was challenged with clinical samples with P. falciparum hyperparasitaemia (> 5% infected red blood cells). Methods: Twenty-two RDT brands were tested with seven samples, both undiluted and upon 10 x, 50 x and 100 x dilutions in NaCl 0.9%. The P. falciparum targets included histidine-rich protein-2 (HRP-2, n = 17) and P. falciparum-specific parasite lactate dehydrogenase (Pf-pLDH, n = 5). Test lines intensities were recorded in the following categories: negative, faint, weak, medium or strong. The prozone effect was defined as an increase in test line intensity of at least one category after dilution, if observed upon duplicate testing and by two readers. Results: Sixteen of the 17 HRP-2 based RDTs were affected by prozone: the prozone effect was observed in at least one RDT sample/brand combination for 16/17 HRP-2 based RDTs in 6/7 samples, but not for any of the Pf-pLDH tests. The HRP-2 line intensities of the undiluted sample/brand combinations with prozone effect (n = 51) included a single negative (1.9%) and 29 faint and weak readings (56.9%). The other target lens (P. vivax-pLDH, pan-specific pLDH and aldolase) did not show a prozone effect. Conclusion: This study confirms the prozone effect as a cause of false-negative HRP-2 RDTs in samples with hyperparasitaemia.	[Gillet, Philippe; Mori, Marcella; Van Esbroeck, Marjan; Van den Ende, Jef; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Jacobs, Jan] Fac Hlth Med & Life Sci, Maastricht, Netherlands	Gillet, P (reprint author), Inst Trop Med, Dept Clin Sci, Natl Str 155, B-2000 Antwerp, Belgium.	pgillet@itg.be; mmori@itg.be; mvesbroeck@itg.be; jvdende@itg.be; jjacobs@itg.be	Mori, Marcella/U-3810-2018	Mori, Marcella/0000-0002-7191-9191; gillet, philippe/0000-0001-5878-6446			Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bell D, 2008, T ROY SOC TROP MED H, V102, P1064, DOI 10.1016/j.trstmh.2008.05.007; Chilton D, 2006, J CLIN PATHOL, V59, P862, DOI 10.1136/jcp.2005.032904; Chiodini PL, 2007, T ROY SOC TROP MED H, V101, P331, DOI 10.1016/j.trstmh.2006.09.007; Craig MH, 2002, T ROY SOC TROP MED H, V96, P258, DOI 10.1016/S0035-9203(02)90092-1; Drakeley C, 2009, T ROY SOC TROP MED H, V103, P333, DOI 10.1016/j.trstmh.2008.10.003; Erdman Laura K, 2008, Travel Med Infect Dis, V6, P82, DOI 10.1016/j.tmaid.2007.10.001; Farcas GA, 2003, AM J TROP MED HYG, V69, P589, DOI 10.4269/ajtmh.2003.69.6.0690589; Forney JR, 2001, J CLIN MICROBIOL, V39, P2884, DOI 10.1128/JCM.39.8.2884-2890.2001; Gaye O, 1998, PARASITE, V5, P189, DOI 10.1051/parasite/1998052189; *GLOB FUND FIGHT A, 2008, TUB MAL PRM FULL PUR; Grobusch MP, 2003, PARASITOL RES, V89, P354, DOI 10.1007/s00436-002-0764-7; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Hawkes M, 2007, EXPERT REV ANTI-INFE, V5, P485, DOI 10.1586/14787210.5.3.485; Heidelberger M, 1935, J EXP MED, V62, P697, DOI 10.1084/jem.62.5.697; Humar A, 1997, AM J TROP MED HYG, V56, P44, DOI 10.4269/ajtmh.1997.56.44; Huong NM, 2002, TROP MED INT HEALTH, V7, P304, DOI 10.1046/j.1365-3156.2002.00869.x; Jelinek T, 1999, J CLIN MICROBIOL, V37, P721; Jelinek T, 2002, CLIN INFECT DIS, V34, P572, DOI 10.1086/338235; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Marx A, 2005, ANN INTERN MED, V142, P836, DOI 10.7326/0003-4819-142-10-200505170-00009; Mayxay M, 2004, TROP MED INT HEALTH, V9, P325, DOI 10.1111/j.1365-3156.2004.01199.x; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Moody A H, 2002, Br J Biomed Sci, V59, P228; Moonasar D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-74; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Ohrt C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-79; Peeling RW, 2006, NAT REV MICROBIOL, pS2, DOI [10.1038/nrmicro1568, 10.1038/nrmico1522]; Pieroni P, 1998, T ROY SOC TROP MED H, V92, P166, DOI 10.1016/S0035-9203(98)90730-1; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Risch L, 1999, SCHWEIZ MED WSCHR, V129, P1002; Risch L, 2000, LANCET, V355, P237, DOI 10.1016/S0140-6736(05)72117-6; Stow NW, 1999, T ROY SOC TROP MED H, V93, P519, DOI 10.1016/S0035-9203(99)90359-0; Trachsler M, 1999, TROP MED INT HEALTH, V4, P442, DOI 10.1046/j.1365-3156.1999.00419.x; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; *WHO, 2003, M REP 20 23 JAN 2003; *WHO, 2005, LIST KNOWN COMM AV A; Wiese L, 2006, SCAND J INFECT DIS, V38, P1063, DOI 10.1080/00365540600818011; Wongsrichanalai C, 1999, ACTA TROP, V73, P263, DOI 10.1016/S0001-706X(99)00040-6	40	66	66	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 30	2009	8								271	10.1186/1475-2875-8-271				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	530JF	WOS:000272585000001	19948018	DOAJ Gold, Green Published			2019-04-02	
J	Gillet, P; van Dijk, DPJ; Bottieau, E; Cnops, L; Van Esbroeck, M; Jacobs, J				Gillet, Philippe; van Dijk, David P. J.; Bottieau, Emmanuel; Cnops, Lieselotte; Van Esbroeck, Marjan; Jacobs, Jan			Test characteristics of the SD FK80 Plasmodium falciparum/Plasmodium vivax malaria rapid diagnostic test in a non-endemic setting	MALARIA JOURNAL			English	Article							HISTIDINE-RICH PROTEIN-2; ANTIGEN-DETECTION TESTS; FALCIPARUM-MALARIA; RETURNED TRAVELERS; MICROSCOPY; AREA; ICT; SENSITIVITY; CHLOROQUINE; PERFORMANCE	Background: The SD FK80 P. f/P. v Malaria Antigen Rapid Test (Standard Diagnostics, Korea) (FK80) is a three-band malaria rapid diagnostic test detecting Plasmodium falciparum histidine-rich protein-2 (HRP-2) and Plasmodium vivax-specific lactate dehydrogenase (Pv-pLDH). The present study assessed its performance in a non-endemic setting. Methods: Stored blood samples (n = 416) from international travellers suspected of malaria were used, with microscopy corrected by PCR as the reference method. Samples infected by Plasmodium falciparum (n = 178), Plasmodium vivax (n = 99), Plasmodium ovale (n = 75) and Plasmodium malariae (n = 24) were included, as well as 40 malaria negative samples. Results: Overall sensitivities for the diagnosis of P. falciparum and P. vivax were 91.6% (95% confidence interval (CI): 86.2% - 95.0%) and 75.8% (65.9% - 83.6%). For P. falciparum, sensitivity at parasite densities >= 100/mu l was 94.6% (88.8% - 97.6%); for P. vivax, sensitivity at parasite densities >= 500/mu l was 86.8% (75.4% - 93.4%). Four P. falciparum samples showed a Pv-pLDH line, three of them had parasite densities exceeding 50.000/mu l. Two P. vivax samples, one P. ovale and one P. malariae sample showed a HRP-2 line. For the HRP-2 and Pv-pLDH lines, respectively 81.4% (136/167) and 55.8% (43/77) of the true positive results were read as medium or strong line intensities. The FK80 showed good reproducibility and reliability for test results and line intensities (kappa values for both exceeding 0.80). Conclusion: The FK80 test performed satisfactorily in diagnosing P. falciparum and P. vivax infections in a non-endemic setting.	[Gillet, Philippe; Bottieau, Emmanuel; Cnops, Lieselotte; Van Esbroeck, Marjan; Jacobs, Jan] ITM, Dept Clin Med, B-2000 Antwerp, Belgium; [van Dijk, David P. J.; Jacobs, Jan] Fac Hlth Med & Life Sci, Maastricht, Netherlands	Gillet, P (reprint author), ITM, Dept Clin Med, Natl Str 155, B-2000 Antwerp, Belgium.	pgillet@itg.be; D.vanDijk@student.maastrichtuniversity.nl; ebottieau@itg.be; lcnops@itg.be; mvesbroeck@itg.be; jjacobs@itg.be		gillet, philippe/0000-0001-5878-6446			Barnadas C, 2008, ANTIMICROB AGENTS CH, V52, P4233, DOI 10.1128/AAC.00578-08; BELL D, 2006, NAT REV MICROBIOL, V4, pS34, DOI DOI 10.1038/NRMICO1524; Bell DR, 2005, AM J TROP MED HYG, V73, P199, DOI 10.4269/ajtmh.2005.73.199; Bossuyt PM, 2003, CROAT MED J, V44, P639; Coleman RE, 2002, AM J TROP MED HYG, V66, P379, DOI 10.4269/ajtmh.2002.66.379; De Monbrison F, 2004, EUR J CLIN MICROBIOL, V23, P784, DOI 10.1007/s10096-004-1202-9; Durand F, 2005, CLIN MICROBIOL INFEC, V11, P903, DOI 10.1111/j.1469-0691.2005.01253.x; Farcas GA, 2003, AM J TROP MED HYG, V69, P589, DOI 10.4269/ajtmh.2003.69.6.0690589; Gatti S, 2007, ANN TROP MED PARASIT, V101, P195, DOI 10.1179/136485907X156997; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-129; Grobusch MP, 2003, PARASITOL RES, V89, P354, DOI 10.1007/s00436-002-0764-7; Hanscheid T, 2003, CLIN MICROBIOL INFEC, V9, P497, DOI 10.1046/j.1469-0691.2003.00640.x; Jelinek T, 1999, J CLIN MICROBIOL, V37, P721; Kim SH, 2008, TROP MED INT HEALTH, V13, P1495, DOI 10.1111/j.1365-3156.2008.02163.x; Lee SW, 2008, J CLIN MICROBIOL, V46, P939, DOI 10.1128/JCM.02110-07; Marx A, 2005, ANN INTERN MED, V142, P836, DOI 10.7326/0003-4819-142-10-200505170-00009; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Richter J, 2004, PARASITOL RES, V94, P384, DOI 10.1007/s00436-004-1213-6; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Seidahmed OME, 2008, TROP MED INT HEALTH, V13, P406, DOI 10.1111/j.1365-3156.2008.02015.x; Teka H, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-220; Van den Ende J, 1998, T ROY SOC TROP MED H, V92, P285, DOI 10.1016/S0035-9203(98)91013-6; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; *WHO REG OFF W PAC, 2003, MAL RAP DIAGN MAK IT; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119	29	18	18	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 22	2009	8								262	10.1186/1475-2875-8-262				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	525ZG	WOS:000272256200002	19930609	DOAJ Gold, Green Published			2019-04-02	
J	Van Geertruyden, JP; Van Eijk, E; Yosaatmadja, F; Kasongo, W; Mulenga, M; D'Alessandro, U; Rogerson, S				Van Geertruyden, Jean-Pierre; Van Eijk, Erika; Yosaatmadja, Francisca; Kasongo, Webster; Mulenga, Modest; D'Alessandro, Umberto; Rogerson, Stephen			The relationship of Plasmodium falciparum humeral immunity with HIV-1 immunosuppression and treatment efficacy in Zambia	MALARIA JOURNAL			English	Article							VARIANT SURFACE-ANTIGENS; ANTIBODY-RESPONSES; CLINICAL MALARIA; UNCOMPLICATED MALARIA; INFECTED ERYTHROCYTES; HUMORAL IMMUNITY; PREGNANT-WOMEN; BURKINA-FASO; CELL COUNTS; ADULTS	Background: HIV-1 infection affects malaria humeral immunity during pregnancy, but data for non-pregnant adults are lacking. This study reports the impact of HIV-1 infection and other variables on the level of malaria humeral immunity in adults with clinical malaria and whether humeral immune suppression was a risk factor for treatment failure. Methods: Sera of 224 HIV-1 infected and 115 uninfected adults were compared for IgG to merozoite antigens AMA-1 and MSP2 (3D7 and FC27 types) determined by ELISA, and for IgG to the Variant Surface Antigens (VSA) of three different parasite line E8B, A4 and HCD6 determined by flow cytometry. Results: Compared to HIV-1 uninfected adults, AMA-1 IgG was lower in HIV-1 infected (P = 0.02) and associated with low CD4 count AMA-1 IgG (P = 0.003). Low IgG to all three merozoite antigens was associated with less anemia ( P = 0.03). High parasite load was associated with low MSP2 IgG 3D7 and FC27 types ( P = 0.02 and P = 0.08). Antibody levels to VSA did not differ between HIV-1 infected and uninfected adults. However, low VSA IgGs were associated with high parasite load ( P = 0.002 for each parasite line) and with treatment failure ( P = 0.04 for each parasite line). Conclusion: HIV-1 affects humeral responses to AMA-1, but seems to marginally or not affect humeral responses to other merozoite antigens and VSAs. The latter were important for controlling parasite density and predict treatment outcome.	[Van Geertruyden, Jean-Pierre] Univ Antwerp, Unit Int Hlth Epidemiol & Social Med, Antwerp, Belgium; [Van Eijk, Erika] Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands; [Yosaatmadja, Francisca; Rogerson, Stephen] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Kasongo, Webster; Mulenga, Modest] Trop Dis Res Ctr, Ndola, Zambia; [Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium	Van Geertruyden, JP (reprint author), Univ Antwerp, Unit Int Hlth Epidemiol & Social Med, Antwerp, Belgium.	jean-pierre.vangeertruyden@ua.ac.be; erikavaneijk@hotmail.com; fyo@unimelb.edu.au; kwebsterngo@yahoo.com; MulengaM@tdrc.org.zm; UDAlessandro@itg.be; sroger@unimelb.edu.au	Van geertruyden, Jean-Pierre/K-6425-2014; D'Alessandro, Umberto/D-3457-2015	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; D'Alessandro, Umberto/0000-0001-6341-5009; Rogerson, Stephen/0000-0003-4287-1982	Belgian Development Co-operation; National Health and Medical Research Council of Australia	Funding was received by the Belgian Development Co-operation in the framework of an institutional collaboration between the TDRC in Ndola and the ITM in Antwerp, and from the National Health and Medical Research Council of Australia. We would like to thank all the patients and their families who contributed to this study. Sincere thanks also to the staff of the health centers where the study was carried out. We are also grateful to the Director TDRC for his support and to the Director DHMT for offering his clinic facilities to the study.	Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Ayisi JG, 2003, J INFECTION, V46, P164, DOI 10.1053/jinf.2002.1088; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Chalwe V, 2009, EMERG INFECT DIS, V15, P749, DOI 10.3201/eid1505.081009; de Souza W, 2008, CURR PHARM DESIGN, V14, P822; Deitsch KW, 2004, TRENDS PARASITOL, V20, P562, DOI 10.1016/j.pt.2004.09.002; Dembo EG, 2008, CLIN VACCINE IMMUNOL, V15, P617, DOI 10.1128/CVI.00378-07; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Hewitt K, 2006, AIDS, V20, P1993, DOI 10.1097/01.aids.0000247572.95880.92; Hviid L, 1997, INFECT IMMUN, V65, P4090; Janossy G, 2000, BRIT J HAEMATOL, V111, P1198, DOI 10.1046/j.1365-2141.2000.02433.x; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Juliano JJ, 2009, J INFECT DIS, V200, P5, DOI 10.1086/599379; Kats LM, 2008, TRAFFIC, V9, P176, DOI 10.1111/j.1600-0854.2007.00681.x; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mayxay M, 2001, AM J TROP MED HYG, V65, P918, DOI 10.4269/ajtmh.2001.65.918; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; MIEDEMA F, 1988, J CLIN INVEST, V82, P1908, DOI 10.1172/JCI113809; Migot F, 1996, PARASITE IMMUNOL, V18, P333, DOI 10.1046/j.1365-3024.1996.d01-116.x; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mouala C, 2009, AIDS, V23, P1997, DOI 10.1097/QAD.0b013e32832f4215; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Mulenga M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-73; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Tebo AE, 2002, CLIN EXP IMMUNOL, V130, P300, DOI 10.1046/j.1365-2249.2002.01972.x; Van Geertruyden JP, 2007, TRENDS PARASITOL, V23, P465, DOI 10.1016/j.pt.2007.08.006; Van Geertruyden JP, 2006, J INFECT DIS, V194, P917, DOI 10.1086/507310; Van Geertruyden JP, 2006, JAIDS-J ACQ IMM DEF, V43, P363; WABWIREMANGEN F, 1989, AM J TROP MED HYG, V41, P504, DOI 10.4269/ajtmh.1989.41.504; WHITE NJ, 1998, MALARIA PARASITE BIO, P378; WHO, 2003, ASS MON ANT DRUG EFF	42	13	13	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 18	2009	8								258	10.1186/1475-2875-8-258				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	525ZC	WOS:000272255800001	19922664	DOAJ Gold, Green Published			2019-04-02	
J	Adoke, Y; Talisuna, AO; D'Alessandro, U				Adoke, Yeka; Talisuna, Ambrose O.; D'Alessandro, Umberto			THE BEST APPROACH TO RETREATING PATIENTS WITH RECURRENT MALARIA IN THE ERA OF ARTEMISININ BASED COMBINATION THERAPY	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Adoke, Yeka; Talisuna, Ambrose O.] Uganda Malaria Surveillance Project, Kampala, Uganda; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		25	7	8						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956700026					2019-04-02	
J	Maheu-Giroux, M; Casapia, M; Soto-Calle, VE; Ford, LB; Buckeridge, DL; Coomes, OT; Gyorkos, TW				Maheu-Giroux, Mathieu; Casapia, Martin; Soto-Calle, Veronica E.; Ford, Lea Berrang; Buckeridge, David L.; Coomes, Oliver T.; Gyorkos, Theresa W.			ARE FISH FARMING ACTIVITIES CONTRIBUTING TO MALARIA TRANSMISSION IN THE PERUVIAN AMAZON?	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Maheu-Giroux, Mathieu; Ford, Lea Berrang; Buckeridge, David L.; Coomes, Oliver T.; Gyorkos, Theresa W.] McGill Univ, Montreal, PQ, Canada; [Casapia, Martin] Asociac Civil Selva Amazon, Iquitos, Peru; [Soto-Calle, Veronica E.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium								0	0	0	1	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		187	52	53						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956700187					2019-04-02	
J	Gerstl, S; Dunkley, S; Mukhtar, A; Maes, P; De Smet, M; Baker, S; Maikere, J				Gerstl, Sibylle; Dunkley, Sophie; Mukhtar, Ahmed; Maes, Peter; De Smet, Martin; Baker, Samuel; Maikere, Jacob			LONG-LASTING INSECTICIDAL MOSQUITO NET USAGE IN EASTERN SIERRA LEONE - THE SUCCESS OF FREE DISTRIBUTION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Gerstl, Sibylle] Med Sans Frontieres UK, London, England; Med Sans Frontieres Brussels, Bo, Sierra Leone; [Maes, Peter; De Smet, Martin; Maikere, Jacob] Med Sans Frontieres Brussels, Brussels, Belgium; [Baker, Samuel] Minist Hlth & Sanitat, Freetown, Sierra Leone								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		222	63	63						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956700222					2019-04-02	
J	Bendezu, J; Soto-Cornejo, K; Torres, K; D'Alessandro, U; Gamboa, D				Bendezu, Jorge; Soto-Cornejo, Katherine; Torres, Katherine; D'Alessandro, Umberto; Gamboa, Dionicia			PRESENCE OF MULTIDRUG RESISTANCE GENE 1 (PFMDR1) ALLELES IN PLASMODIUM FALCIPARUM SAMPLES FROM A CLINICAL TRIAL TO TEST TWO ANTIMALARIAL DRUGS IN THE PERUVIAN AMAZON	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Bendezu, Jorge; Torres, Katherine; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru; [Soto-Cornejo, Katherine] Inst Trop Med, Lima, Peru; [D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		376	107	108						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956700376					2019-04-02	
J	Beatty, ME; Beutels, P; Meltzer, MI; Wichmann, O; Hombach, J; Hutubessy, R; Dessis, D; Coudeville, L; Dervaux, B; Shepard, DS; Margolis, HS; Kuritsky, J				Beatty, Mark E.; Beutels, Philippe; Meltzer, Martin I.; Wichmann, Ole; Hombach, Joachim; Hutubessy, Raymond; Dessis, Damien; Coudeville, Laurent; Dervaux, Benoit; Shepard, Donald S.; Margolis, Harold S.; Kuritsky, Joel			A SYSTEMATIC LITERATURE REVIEW AND EXPERT PANEL'S ASSESSMENT HEALTH ECONOMICS OF DENGUE	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Beatty, Mark E.; Wichmann, Ole; Margolis, Harold S.; Kuritsky, Joel] Int Vaccine Inst, Seoul, South Korea; [Beutels, Philippe] Univ Antwerp, Ctr Hlth Econ Res & Modeling Infect Dis, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium; [Meltzer, Martin I.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Hombach, Joachim; Hutubessy, Raymond] WHO, CH-1211 Geneva, Switzerland; [Dessis, Damien] GlaxoSmithKline Biol, Wavre, Belgium; [Coudeville, Laurent] Sanofi Pasteur, Lyon, France; [Dervaux, Benoit] Univ Catholique Lille, Lille, France; [Shepard, Donald S.] Brandeis Univ, Waltham, MA USA			Dervaux, Benoit/A-7161-2014; Beutels, Philippe/A-1919-2010	Beutels, Philippe/0000-0001-5034-3595				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		399	115	115						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956700399					2019-04-02	
J	van Herpen, T; Bouwmeester, H; Beekwilder, J; Jansen, H				van Herpen, Teun; Bouwmeester, Harro; Beekwilder, Jules; Jansen, Herwig			INDUSTRIAL CHICORY AS PRODUCTION PLATFORM FOR ARTEMISININ	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[van Herpen, Teun; Bouwmeester, Harro; Beekwilder, Jules] Wageningen Univ, Wageningen, Netherlands; [Jansen, Herwig] Dafra Pharma Int, Turnhout, Belgium			Beekwilder, Jules/A-6802-2011	Beekwilder, Jules/0000-0003-3238-4427				0	1	1	0	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		513	146	146						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956700511					2019-04-02	
J	Gerstl, S; Dunkley, S; Mukhtar, A; Baker, S; Maikere, J				Gerstl, Sibylle; Dunkley, Sophie; Mukhtar, Ahmed; Baker, Samuel; Maikere, Jacob			SUCCESSFUL INTRODUCTION OF ARTESUNATE AND AMODIAQUINE IS NOT ENOUGH TO FIGHT MALARIA - RESULTS FROM AN ADHERENCE STUDY IN SIERRA LEONE	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Gerstl, Sibylle] Med Sans Frontieres, London, England; [Dunkley, Sophie; Mukhtar, Ahmed] Med Sans Frontieres Brussels, Bo, Sierra Leone; [Baker, Samuel] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Maikere, Jacob] Med Sans Frontieres Brussels, Brussels, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		546	155	155						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956700544					2019-04-02	
J	Torres, K; Villasis, E; Bendezu, J; Erhart, A; D'Alessandro, U; Gamboa, D				Torres, Katherine; Villasis, Elizabeth; Bendezu, Jorge; Erhart, Annette; D'Alessandro, Umberto; Gamboa, Dionicia			SEROPREVALENCE OF IGG ANTIBODIES TO PLASMODIUM VIVAX MSP-1 ANTIGEN AND PLASMODIUM FALCIPARUM GLURP R2 ANTIGEN IN THE AMAZON AREA, IQUITOS-PERU	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Torres, Katherine; Villasis, Elizabeth; Bendezu, Jorge; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Erhart, Annette; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		558	159	159						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956700556					2019-04-02	
J	Gerstl, S; Dunkley, S; Mukhtar, A; De Smet, M; Baker, S; Maikere, J				Gerstl, Sibylle; Dunkley, Sophie; Mukhtar, Ahmed; De Smet, Martin; Baker, Samuel; Maikere, Jacob			ASSESSMENT OF TWO MALARIA RAPID DIAGNOSTIC TESTS, WITH FOLLOW-UP OF POSITIVE PLDH TEST RESULTS, IN A HYPERENDEMIC FALCIPARUM MALARIA AREA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Gerstl, Sibylle] Med Sans Frontieres UK, London, England; [Dunkley, Sophie; Mukhtar, Ahmed] Med Sans Frontieres Brussels, Bo, Sierra Leone; [De Smet, Martin; Maikere, Jacob] Med Sans Frontieres Brussels, Brussels, Belgium; [Baker, Samuel] Minist Hlth & Sanitat, Freetown, Sierra Leone								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S			194	194						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956701094					2019-04-02	
J	Meheus, F; Sundar, S; Rijal, S; Faiz, A; Balasegaram, M; Alvar, J; Olliaro, P; Boelaert, M				Meheus, Filip; Sundar, Shyam; Rijal, Suman; Faiz, A.; Balasegaram, Manica; Alvar, Jorge; Olliaro, Piero; Boelaert, Marleen			COST-EFFECTIVENESS ANALYSIS OF COMBINATION THERAPIES FOR VISCERAL LEISHMANIASIS ON THE INDIAN SUBCONTINENT	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Meheus, Filip; Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [Sundar, Shyam] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India; [Rijal, Suman] BP Koirala Inst Med Sci, Dharan, Nepal; [Faiz, A.] Minist Hlth & Family Welf, Dhaka, Bangladesh; [Balasegaram, Manica] Drugs Neglected Dis Initiat, Geneva, Switzerland; [Alvar, Jorge; Olliaro, Piero] WHO, CH-1211 Geneva, Switzerland			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		830	239	239						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956701245					2019-04-02	
J	Ayede, AI; Falade, AG; Sowumi, A; Jansen, H				Ayede, Adejumoke I.; Falade, Adegoke G.; Sowumi, Akintunde; Jansen, Herwig			AN OPEN RANDOMIZED CLINICAL TRIAL IN COMPARING TWO ARTESUNATE-BASED COMBINATION TREATMENTS [ARTESUNATE/SULFAMETHOXYPYRAZINE/PYRIMETHAMINE (FIXED DOSE OVER 24 HOURS) AND ARTESUNATE/AMODIAQUINE (FIXED DOSE OVER 48 HOURS)] ON PLASMODIUM FALCIPARUM MALARIA IN NIGERIAN CHILDREN	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Ayede, Adejumoke I.; Falade, Adegoke G.] Univ Ibadan, Coll Med, Dept Pediat, Ibadan, Nigeria; [Sowumi, Akintunde] Univ Ibadan, Coll Med, Inst Adv Med Res & Training, Ibadan, Nigeria; [Jansen, Herwig] Dafra Pharma, Slachuistraat, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		851	245	245						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956701266					2019-04-02	
J	Min-Oo, G; Ayi, K; Bongfen, SE; Fortin, A; Tam, M; Stevenson, MM; Kain, KC; Gros, P				Min-Oo, Gundula; Ayi, Kodjo; Bongfen, Silayuv E.; Fortin, Anny; Tam, Mifong; Stevenson, Mary M.; Kain, Kevin C.; Gros, Philippe			LOW DOSE CYSTEAMINE POTENTIATES THE ANTI-MALARIAL ACTIVITY OF ARTEMISININ DERIVATIVES IN VIVO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Min-Oo, Gundula; Bongfen, Silayuv E.; Tam, Mifong; Stevenson, Mary M.; Gros, Philippe] McGill Univ, Montreal, PQ, Canada; [Ayi, Kodjo; Kain, Kevin C.] Univ Toronto, Toronto, ON, Canada; [Fortin, Anny] Dafra Pharma, Turnhout, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S			252	252						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956701292					2019-04-02	
J	Fortin, A; Soomro, S; Stoppie, P; Cauwenbergh, S; Ruesch-Gerdes, S; Jansen, FH				Fortin, Anny; Soomro, Shahid; Stoppie, Paul; Cauwenbergh, Sarah; Ruesch-Gerdes, Sabine; Jansen, Frans Herwig			DF152 AS A NEW MOLECULE TO TREAT TUBERCULOSIS AND OTHER NEGLECTED MYCOBACTERIAL INFECTIONS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Fortin, Anny; Soomro, Shahid; Stoppie, Paul; Cauwenbergh, Sarah; Jansen, Frans Herwig] Dafra Pharma R&D Bvba, Turnhout, Belgium; [Ruesch-Gerdes, Sabine] Res Ctr Borstel, Natl Reference Ctr Mycobacteria, Borstel, Germany			Soomro, Shahid/C-1095-2008					0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		988	284	284						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956701402					2019-04-02	
J	Lumsden, J; Schwenk, RJ; Egner, L; Cohen, J; Ballou, R; Ofori-Anyinam, O; Moris, P; Kester, KE; Heppner, DG; Krzych, U				Lumsden, Joanne; Schwenk, Robert J.; Egner, Lisa; Cohen, Joe; Ballou, Ripley; Ofori-Anyinam, Opokua; Moris, Philippe; Kester, Kent E.; Heppner, D. Gray; Krzych, Urszula			IL-2-PRODUCING EFFECTOR MEMORY AND CENTRAL MEMORY CD4(+) T CELL SUBSETS ARE ASSOCIATED WITH PROTECTIVE IMMUNITY IN RTS,S-IMMUNIZED SUBJECTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Lumsden, Joanne; Schwenk, Robert J.; Egner, Lisa; Kester, Kent E.; Heppner, D. Gray; Krzych, Urszula] Walter Reed Army Inst Res, Silver Spring, MD USA; [Cohen, Joe; Ballou, Ripley; Ofori-Anyinam, Opokua; Moris, Philippe] GSK Biol, Rixensart, Belgium			Kester, Kent/A-2114-2011; Lumsden, Joanne/B-6475-2009	Kester, Kent/0000-0002-5056-0802; 				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		1010	291	291						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956701424					2019-04-02	
J	Vanloubbeeck, Y; Pichyangkul, S; Bayat, B; Yongvanitchit, K; Srichairatanakul, U; Chluaydumrong, A; Donner, MN; Garze, V; Afsar, A; Ware, L; Dubois, MC; Mettens, P; Lemiale, L; Polhemus, M; House, B; Sattabongkot, J; Schaecher, K; Ockenhouse, C; Cohen, J; Yadava, A				Vanloubbeeck, Yannick; Pichyangkul, Sathit; Bayat, Babak; Yongvanitchit, Kosol; Srichairatanakul, Utaiwan; Chluaydumrong, Amporn; Donner, Marie-Noelle; Garze, Virginie; Afsar, Aram; Ware, Lisa; Dubois, Marie-Claude; Mettens, Pascal; Lemiale, Laurence; Polhemus, Mark; House, Brent; Sattabongkot, Jetsumon; Schaecher, Kurt; Ockenhouse, Christian; Cohen, Joe; Yadava, Anjali			INDUCTION OF VACCINE-SPECIFIC T CELL AND ANTIBODY RESPONSES IN RHESUS MACAQUES IMMUNIZED WITH TWO PLASMODIUM VIVAX CIRCUMSPOROZOITE-BASED VACCINE ANTIGEN CANDIDATES FORMULATED IN AS01(B)	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Vanloubbeeck, Yannick; Bayat, Babak; Donner, Marie-Noelle; Garze, Virginie; Afsar, Aram; Dubois, Marie-Claude; Mettens, Pascal; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Pichyangkul, Sathit; Yongvanitchit, Kosol; Srichairatanakul, Utaiwan; Chluaydumrong, Amporn; Sattabongkot, Jetsumon] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Ware, Lisa; Polhemus, Mark; House, Brent; Schaecher, Kurt; Ockenhouse, Christian; Yadava, Anjali] Walter Reed Army Inst Res, Silver Spring, MD USA; [Lemiale, Laurence] PATH Malaria Vaccine Initiat, Bethesda, MD USA								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		1032	297	297						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956701446					2019-04-02	
J	Thera, MA; Doumbo, OK; Coulibaly, D; Laurens, MB; Kone, A; Guindo, A; Diallo, DA; Traore, K; Kouriba, B; Diarra, I; Dolo, A; Niangaly, A; Daou, M; Sissoko, M; Traore, D; Lyke, KE; Takala, S; Godeaux, O; Thonnard, J; Cohen, J; Lanar, D; Diggs, C; Soisson, L; Heppner, DG; Plowe, CV				Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Laurens, Matthew B.; Kone, Abdoulaye; Guindo, Ando; Diallo, Dapa A.; Traore, Karim; Kouriba, Bourema; Diarra, Issa; Dolo, Amagana; Niangaly, Amadou; Daou, Modibo; Sissoko, Mady; Traore, Drissa; Lyke, Kirsten E.; Takala, Shannon; Godeaux, Olivier; Thonnard, Joelle; Cohen, Joe; Lanar, David; Diggs, Carter; Soisson, Lorraine; Heppner, Donald G.; Plowe, Christopher V.			RANDOMIZED, CONTROLLED, PHASE 2B CLINICAL TRIAL TO EVALUATE THE SAFETY, IMMUNOGENICITY AND EFFICACY OF WRAIR'S AMA-1 MALARIA VACCINE (FMP2.1) ADJUVANTED IN GSK BIOLOGICALS' AS02A VS. RABIES VACCINE IN 1-6 YEAR OLD CHILDREN IN BANDIAGARA, MALI	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	58th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 18-22, 2009	Washington, DC	Amer Soc Trop Med & Hyg					[Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Kone, Abdoulaye; Guindo, Ando; Diallo, Dapa A.; Traore, Karim; Kouriba, Bourema; Diarra, Issa; Dolo, Amagana; Niangaly, Amadou; Daou, Modibo; Sissoko, Mady; Traore, Drissa] Univ Bamako, MRTC DEAP FMPOS, Bamako, Mali; [Laurens, Matthew B.; Lyke, Kirsten E.; Takala, Shannon; Plowe, Christopher V.] Univ Maryland, CVD, Baltimore, MD 21201 USA; [Godeaux, Olivier; Thonnard, Joelle; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Lanar, David; Heppner, Donald G.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Diggs, Carter; Soisson, Lorraine] US Agcy Int Dev, Washington, DC 20523 USA			Lanar, David/B-3560-2011					0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5		S		1074	310	310						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WK	WOS:000271956701488					2019-04-02	
J	Twagirumukiza, M; Cosijns, A; Pringels, E; Remon, JP; Vervaet, C; Van Bortel, L				Twagirumukiza, Marc; Cosijns, An; Pringels, Eveline; Remon, Jean Paul; Vervaet, Chris; Van Bortel, Luc			Influence of Tropical Climate Conditions on the Quality of Antihypertensive Drugs from Rwandan Pharmacies	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							IN-VITRO DISSOLUTION; SUB-SAHARAN AFRICA; VIVO BIOAVAILABILITY; ANTIMALARIAL-DRUGS; STORAGE-CONDITIONS; SUBSTANDARD DRUGS; GLOBAL BURDEN; FAKE DRUGS; STABILITY; COUNTERFEIT	The objective of this study was to assess the quality of antihypertensive drugs and to investigate the influence of tropical storage conditions. Drug content and in vitro dissolution tests were performed on 10 test formulations (from Rwanda) and 6 reference formulations (from Belgium or France) after purchase and after 6-month storage under long-term (25 +/- 2 degrees C and 60 +/- 5% relative humidity [RH]) and accelerated (40 +/- 2 degrees C and 75 +/- 5% RH) testing conditions. Twenty percent of test formulations were of substandard content at the time of purchase. After 6 months at accelerated testing conditions, 7 of 10 test formulations were substandard in content and 8 were substandard for the combined criteria of drug content and dissolution, whereas no reference drug became substandard. This study shows that, apart from some drugs being already substandard from purchase, accelerated testing conditions (simulating tropical climate) have deleterious effects on the majority of antihypertensive drug formulations found in the Rwandan market.	[Twagirumukiza, Marc; Van Bortel, Luc] Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium; Univ Ghent, Pharmaceut Technol Lab, Fac Pharmaceut Sci, B-9000 Ghent, Belgium; Univ Hosp, Dept Internal Med, Kigali, Rwanda	Van Bortel, L (reprint author), Univ Ghent, Heymans Inst Pharmacol, Pintelaan 185,Block B,1st Floor, B-9000 Ghent, Belgium.	Marc.Twagirumukiza@UGent.be; Chris.Vervaet@UGent.be; Luc.VanBortel@UGent.be		Twagirumukiza, Marc/0000-0003-1378-6922	VLIR (Vlaamse Interuniversitaire Raad: Flemish Interuniversity Council); Ghent University; National University of Rwanda	Marc Twagirumukiza has a PhD Fellowship sponsored by VLIR (Vlaamse Interuniversitaire Raad: Flemish Interuniversity Council) in Belgium through Ghent University and the National University of Rwanda. All standards and reagents were kindly supplied by the laboratory of pharmaceutical technology at Ghent University.	AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Ballereau F, 1997, AM J TROP MED HYG, V57, P31, DOI 10.4269/ajtmh.1997.57.31; Behrens RH, 2002, TROP DOCT, V32, P1; Bott RF, 2007, DRUG DEV IND PHARM, V33, P393, DOI 10.1080/03639040600975022; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; *FDA CTR DRUG EV R, 1997, FDA GUID IND DISS TE; HOGERZEIL HV, 1991, LANCET, V338, P754, DOI 10.1016/0140-6736(91)91470-F; *ICH, 2003, ICHQ1AR2; Kayumba PC, 2004, J CLIN PHARM THER, V29, P331, DOI 10.1111/j.1365-2710.2004.00568.x; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)17741-1; KIBWAGE IO, 1992, E AFR MED J, V69, P577; Kommanaboyina B, 1999, DRUG DEV IND PHARM, V25, P857, DOI 10.1081/DDC-100102246; Matthews BR, 1999, DRUG DEV IND PHARM, V25, P831, DOI 10.1081/DDC-100102245; Moore J.W., 1996, PHARM TECH, V20, P64; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; PETRALANDA I, 1995, LANCET, V345, P1433, DOI 10.1016/S0140-6736(95)92620-8; Po ALW, 2001, LANCET, V357, P1904, DOI 10.1016/S0140-6736(00)05092-3; Raufu A, 2002, BRIT MED J, V324, P698, DOI 10.1136/bmj.324.7339.698; Raufu Abiodun, 2003, BMJ, V326, P1234, DOI 10.1136/bmj.326.7401.1234-d; Reidenberg MM, 2001, CLIN PHARMACOL THER, V69, P189, DOI 10.1067/mcp.2001.114672; Risha P, 2006, J AOAC INT, V89, P1300; Risha PG, 2003, EUR J CLIN PHARMACOL, V59, P135, DOI 10.1007/s00228-003-0587-1; Risha PG, 2002, TROP MED INT HEALTH, V7, P701, DOI 10.1046/j.1365-3156.2002.00937.x; Roy J, 1994, World Health Forum, V15, P406; Shah VP, 1998, PHARMACEUT RES, V15, P889, DOI 10.1023/A:1011976615750; Taylor RB, 2001, LANCET, V357, P1933, DOI 10.1016/S0140-6736(00)05065-0; Unwin N, 2001, HEALTH POLICY PLANN, V16, P351, DOI 10.1093/heapol/16.4.351; Uppoor VRS, 2001, J CONTROL RELEASE, V72, P127, DOI 10.1016/S0168-3659(01)00268-1; *US PHARM, 2006, 29NF24 USP; van der Sande MAB, 2003, NETH J MED, V61, P32; Videau Jean-Yves, 2000, WHO DRUG INFORM, V14, P77; *WHO, 2006, WHO DRUG INFORM, V20, P22; Zahn M, 2006, J PHARM SCI-US, V95, P946, DOI 10.1002/jps.20584	35	15	15	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5					776	781		10.4269/ajtmh.2009.09-0109				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WI	WOS:000271956500010	19861610	Bronze, Green Published			2019-04-02	
J	Suykerbuyk, P; Wambacq, J; Phanzu, DM; Haruna, H; Nakazawa, Y; Ooms, K; Kamango, K; Stragier, P; Singa, JN; Ekwanzala, F; De Herdt, E; De Maeyer, P; Kestens, L; Portaels, F				Suykerbuyk, Patrick; Wambacq, Julie; Phanzu, Delphin M.; Haruna, Hemedi; Nakazawa, Yoshinori; Ooms, Kristien; Kamango, Kalambo; Stragier, Pieter; Singa, Jackie N.; Ekwanzala, Florent; De Herdt, Eric; De Maeyer, Philippe; Kestens, Luc; Portaels, Francoise			Persistence of Mycobacterium ulcerans Disease (Buruli Ulcer) in the Historical Focus of Kasongo Territory, the Democratic Republic of Congo	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							INFECTION; BENIN; SPECIMENS; DIAGNOSIS; OUTBREAK; NIGERIA; GHANA	Fifty years after the last report of Mycobacterium ulcerans infections (Buruli ulcer [BU]) in Kasongo Territory, Maniema Province, Democratic Republic of Congo (DRC), we conducted a small-scale cross-sectional survey to assess if this historical BU focus was still active and if so to explore the disease epidemiology. Seventy-five active and inactive BU cases were identified on clinical grounds of which two of 28 BU active cases were laboratory confirmed. We used a modified BU02 form to reconstruct the local disease dynamics and we believe that the horrific conflict in eastern DRC and exceptional flooding were the most likely causes of the re-emergence of the disease. There is a need in the DRC to decentralize and integrate surveillance and control activities at local level to increase the effectiveness of patient management.	[Suykerbuyk, Patrick; Stragier, Pieter; Portaels, Francoise] Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Kestens, Luc] Inst Trop Med, Dept Microbiol, Immunol Unit, B-2000 Antwerp, Belgium; Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Lab Microbiol Parasitol & Hyg, Antwerp, Belgium; [Wambacq, Julie; De Herdt, Eric] Assoc KU Leuven, Leuven Engn Coll, Grp T, B-3000 Leuven, Belgium; [Phanzu, Delphin M.] Kimpese Hosp, Inst Med Evangel, Projet UB, Kimpese, Bas Congo Prov, Zaire; [Nakazawa, Yoshinori] Nat Hist Museum, Lawrence, KS 66045 USA; [Nakazawa, Yoshinori] Univ Kansas, Biodivers Res Ctr, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Univ Ghent, Dept Geog, Cartog Geog Informat Syst Unit, B-9000 Ghent, Belgium; [Singa, Jackie N.] Inst Natl Rech Biomed, Programme Natl Lutte Ulcere Buruli, Kinshasa, Zaire; [Ekwanzala, Florent] WHO, Dis Control & Prevent Program, Kinshasa, Zaire	Portaels, F (reprint author), Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	portaels@itg.be	De Maeyer, Philippe/F-2985-2011; Stragier, Pieter/G-9414-2012	De Maeyer, Philippe/0000-0001-8902-3855; Stragier, Pieter/0000-0002-6369-341X	European Commission [INCO-CT-2005-051476-BURULICO]; Flemish Interuniversity Council (VLIR) [NDOC2005UA0006]	This study was supported by the European Commission (international Science and Technology Cooperation Development Program), project no. INCO-CT-2005-051476-BURULICO. Patrick Suykerbuyk is currently supported by a PhD grant (no. NDOC2005UA0006) of the Flemish Interuniversity Council (VLIR). Julie Wambacq was Supported by a research travel grant of VLIR.	Amofah G, 2002, EMERG INFECT DIS, V8, P167, DOI 10.3201/eid0802.010119; [Anonymous], 1971, T ROY SOC TROP MED H, V65, P763; *ASS BRIT PHARM IN, 2006, COD PRACT PHARM IND, P1; BARKER DJP, 1971, J TROP MED HYG, V74, P260; BENOIT PL, 1964, ANN MUSEE R AFRIQUE, V132, P7; *BUR COORD AFF HUM, 2005, MISS EV BES HUM PROV, P1; Chukwuekezie O, 2007, EMERG INFECT DIS, V13, P782, DOI 10.3201/eid1305.070065; Cleaveland S, 2007, CURR TOP MICROBIOL, V315, P85; Debacker M, 2005, EMERG INFECT DIS, V11, P584, DOI 10.3201/eid1104.041000; Debacker M, 2004, TROP MED INT HEALTH, V9, P1297, DOI 10.1111/j.1365-3156.2004.01339.x; Debacker M, 2004, EMERG INFECT DIS, V10, P1391, DOI 10.3201/eid1008.030886; Depoortere E, 2006, LANCET, V367, P7, DOI 10.1016/S0140-6736(06)67900-2; Duker AA, 2006, ENVIRON INT, V32, P567, DOI 10.1016/j.envint.2006.01.002; Eddyani M, 2008, J CLIN MICROBIOL, V46, P69, DOI 10.1128/JCM.00301-07; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Janssens P, 2005, B SEANCES ACAD R SCI, V51, P265; JANSSENS P G, 1959, Trop Geogr Med, V11, P293; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Johnson RC, 2005, TROP MED INT HEALTH, V10, P863, DOI 10.1111/j.1365-3156.2005.01465.x; Johnson RC, 2005, EMERG INFECT DIS, V11, P500, DOI 10.3201/eid1103.040597; Kilbadi K, 2008, EMERG INFECT DIS, V14, P1790, DOI 10.3201/eid1411.071649; Merritt RW, 2005, FRONT ECOL ENVIRON, V3, P323, DOI 10.1890/1540-9295(2005)003[0323:UAEDAW]2.0.CO;2; Meyers W M, 1974, Ann Soc Belg Med Trop, V54, P147; Nackers F, 2007, AM J TROP MED HYG, V77, P834, DOI 10.4269/ajtmh.2007.77.834; Noeske J, 2004, AM J TROP MED HYG, V70, P520, DOI 10.4269/ajtmh.2004.70.520; OLUWASANMI JO, 1976, AM J TROP MED HYG, V25, P122, DOI 10.4269/ajtmh.1976.25.122; PANGU KA, 1990, ANN SOC BELG MED TR, V1, P23; Phanzu DM, 2006, AM J TROP MED HYG, V75, P311, DOI 10.4269/ajtmh.2006.75.311; Phillips R, 2005, J CLIN MICROBIOL, V43, P3650, DOI 10.1128/JCM.43.8.3650-3656.2005; Portaels F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000178; QUERTINMONT MJ, 1959, ACTA CHIR BELG, V58, P862; RAUCQ P, 1952, MEM I R COLON BEL SN, V821, P1; *RELIEFWEB, 1998, CONG FLOOD EM UPD; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; Stienstra Y, 2006, GENES IMMUN, V7, P185, DOI 10.1038/sj.gene.6364281; Stienstra Y, 2002, AM J TROP MED HYG, V67, P207, DOI 10.4269/ajtmh.2002.67.207; Stragier P, 2007, SYST APPL MICROBIOL, V30, P525, DOI 10.1016/j.syapm.2007.06.001; Van Herp M, 2003, DISASTERS, V27, P141, DOI 10.1111/1467-7717.00225; VANBALEN H, 1994, TROP DOCT, V24, P13, DOI 10.1177/004947559402400106; Veitch MGK, 1997, EPIDEMIOL INFECT, V119, P313, DOI 10.1017/S0950268897008273; Walsh DS, 2008, T ROY SOC TROP MED H, V102, P969, DOI 10.1016/j.trstmh.2008.06.006; *WHO, 2004, WKLY EPIDEMIOL REC, V14, P194; *WHO, 2008, BUR ULC OBJ STRAT CO; *WHO, 2001, WHOCDSGBUI20014; *WHO, 2008, WKLY EPIDEMIOL REC, V17, P145	45	4	4	0	5	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2009	81	5					888	894		10.4269/ajtmh.2009.09-0049				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	521WI	WOS:000271956500027	19861627	Bronze			2019-04-02	
J	Buscher, P; Ngoyi, DM; Kabore, J; Lejon, V; Robays, J; Jamonneau, V; Bebronne, N; Van der Veken, W; Bieler, S				Buescher, Philippe; Ngoyi, Dieudonne Mumba; Kabore, Jacques; Lejon, Veerle; Robays, Jo; Jamonneau, Vincent; Bebronne, Nicolas; Van der Veken, Wim; Bieler, Sylvain			Improved Models of Mini Anion Exchange Centrifugation Technique (mAECT) and Modified Single Centrifugation (MSC) for Sleeping Sickness Diagnosis and Staging	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; BRUCEI		[Buescher, Philippe; Lejon, Veerle; Robays, Jo; Bebronne, Nicolas] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Buescher, Philippe; Lejon, Veerle; Robays, Jo; Bebronne, Nicolas] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Ngoyi, Dieudonne Mumba] Inst Nacl Rech Biomed, Kinshasa, Zaire; [Kabore, Jacques; Jamonneau, Vincent] CIRDES, IRD, UMR 177, Bobo Dioulasso, Burkina Faso; [Van der Veken, Wim] Belgain Tech Cooperat, Kinshasa, Zaire; [Bieler, Sylvain] Fdn Innovat New Diagnost, Geneva, Switzerland	Buscher, P (reprint author), Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium.	pbuscher@itg.be	Jamonneau, Vincent/K-1124-2016; Buscher, Philippe/B-9956-2012	Jamonneau, Vincent/0000-0001-8427-0769; Buscher, Philippe/0000-0002-1926-7472; Lejon, Veerle/0000-0002-6795-0962	Belgian Directorate General for Development Co-operation; World Health Organization HTM/NTD/IDM; Foundation for Innovative New Diagnostics	This work was supported by the Belgian Directorate General for Development Co-operation, World Health Organization HTM/NTD/IDM, and Foundation for Innovative New Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BAILEY JW, 1994, TROP DOCT, V24, P54, DOI 10.1177/004947559402400204; Buscher P., 2004, The trypanosomiases, P203, DOI 10.1079/9780851994758.0203; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; *FDN INN NEW DIAGN, 2009, MAECT STAND OP PROC; Gutierrez C, 2004, ANN NY ACAD SCI, V1026, P149, DOI 10.1196/annals.1307.020; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; LUMSDEN WHR, 1979, T ROY SOC TROP MED H, V73, P312, DOI 10.1016/0035-9203(79)90092-0; Miezan TW, 2000, T ROY SOC TROP MED H, V94, P293, DOI 10.1016/S0035-9203(00)90327-4; MIEZAN TW, 1994, B SOC PATHOL EXOT, V87, P101; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Woo P. T. K., 1970, Acta trop., V27, P384	12	63	64	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2009	3	11							e471	10.1371/journal.pntd.0000471				3	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	522XG	WOS:000272032900001	19936296	DOAJ Gold, Green Published			2019-04-02	
J	Carabin, H; Millogo, A; Praet, N; Hounton, S; Tarnagda, Z; Ganaba, R; Dorny, P; Nitiema, P; Cowan, LD				Carabin, Helene; Millogo, Athanase; Praet, Nicolas; Hounton, Sennen; Tarnagda, Zekiba; Ganaba, Rasmane; Dorny, Pierre; Nitiema, Pascal; Cowan, Linda D.		EFECAB Faso	Seroprevalence to the Antigens of Taenia solium Cysticercosis among Residents of Three Villages in Burkina Faso: A Cross-Sectional Study	PLOS NEGLECTED TROPICAL DISEASES			English	Article							CIRCULATING ANTIGEN; NEUROCYSTICERCOSIS; EPILEPSY; BENIN; PREVALENCE; CAMEROON; AFRICA; ELISA; ASSAY	Background: There is limited published information on the prevalence of human cysticercosis in West Africa. The aim of this pilot study was to estimate the prevalence of Taenia solium cysticercosis antigens in residents of three villages in Burkina Faso. Methods/Principal Findings: Three villages were selected: The village of Batondo, selected to represent villages where pigs are allowed to roam freely; the village of Pabre, selected to represent villages where pigs are usually confined; and the village of Nyonyogo, selected because of a high proportion of Muslims and limited pig farming. Clustered random sampling was used to select the participants. All participants were asked to answer an interview questionnaire on socio-demographic characteristics and to provide a blood sample. The sera were analysed using an AgELISA. The prevalence of "strong'' seropositive results to the presence of antigens of the larval stages of T. solium was estimated as 10.3% (95% CI: 7.1%-14.3%), 1.4% (0.4%-3.5%) and 0.0% (0.0%-2.1%) in the 763 participants who provided a blood sample in Batondo, Pabre and Nyonyogo, respectively. The prevalence of "weak'' seropositive test results to the presence of antigens of the larval stages of T. solium was 1.3% (0.3%-3.2%), 0.3% (0.0%-1.9%) and 4.5% (2.0%-8.8%) in Batondo, Pabre and Nyonyogo, respectively. The multivariate logistic regression, which included only Batondo and Pabre, showed that village, gender, and pork consumption history were associated with AgELISA seroprevalence. Conclusions/Significance: This study illustrates two major points: 1) there can be large variation in the prevalence of human seropositivity to the presence of the larval stages of T. solium cysticercosis among rural areas of the same country, and 2) the serological level of the antigen, not just whether it is positive or negative, must be considered when assessing prevalence of human cysticercosis antigens.	[Carabin, Helene; Nitiema, Pascal; Cowan, Linda D.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Millogo, Athanase] CHU Souro Sanou, Bobo Dioulasso, Burkina Faso; [Praet, Nicolas; Dorny, Pierre] Inst Trop Med, B-2000 Antwerp, Belgium; [Hounton, Sennen] WHO, Multi Dis Surveillance Ctr, Ouagadougou, Burkina Faso; [Tarnagda, Zekiba] Inst Natl Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Ganaba, Rasmane] GREFSaD, Bobo Dioulasso, Burkina Faso	Carabin, H (reprint author), Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK USA.	helene-carabin@ouhsc.edu	Carabin, Helene/B-7600-2016		National Institute for Neurological Disorders and Stroke ( NINDS) of the US National Institutes of Health [R21 NS055353]	This study was funded by the National Institute for Neurological Disorders and Stroke ( NINDS) of the US National Institutes of Health ( Epidemiology and Burden of Neurocysticercosis in Bukina Faso ( R21 NS055353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjide CC, 1996, B SOC PATHOL EXOT, V89, P24; Arruda GC, 2005, TROP MED INT HEALTH, V10, P1005, DOI 10.1111/j.1365-3156.2005.01480.x; Avode DG, 1996, B SOC PATHOL EXOT, V89, P45; BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; Carpio Arturo, 2002, P211, DOI 10.1079/9780851996288.0211; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Erhart A, 2002, T ROY SOC TROP MED H, V96, P270, DOI 10.1016/S0035-9203(02)90095-7; Houinato D, 1998, T ROY SOC TROP MED H, V92, P621, DOI 10.1016/S0035-9203(98)90785-4; Kabore J, 1995, AFR J NEUROL SCI, V14, P24; Krecek RC, 2008, VET PARASITOL, V154, P38, DOI 10.1016/j.vetpar.2008.03.005; Nguekam JP, 2003, TROP MED INT HEALTH, V8, P144, DOI 10.1046/j.1365-3156.2003.01000.x; Prado-Jean A, 2007, TROP MED INT HEALTH, V12, P895, DOI 10.1111/j.1365-3156.2007.01860.x; PREUX PM, 1996, NEUROL INFECT EPIDEM, V1, P63; Sakande B, 1998, B SOC PATHOL EXOT, V91, P217; TCHAMDJA E, 2007, THESIS IMTA; TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50; Van Kerckhoven I, 1998, VET PARASITOL, V76, P269, DOI 10.1016/S0304-4017(97)00226-4; Wallin MT, 2004, NEUROLOGY, V63, P1559, DOI 10.1212/01.WNL.0000142979.98182.FF; Zoli A, 2003, ACTA TROP, V87, P35, DOI 10.1016/S0001-706X(02)00289-9; Zoli AP, 2003, T ROY SOC TROP MED H, V97, P683, DOI 10.1016/S0035-9203(03)80103-7	20	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2009	3	11							e555	10.1371/journal.pntd.0000555				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	522XG	WOS:000272032900015	19936298	DOAJ Gold, Green Published			2019-04-02	
J	Kerneis, S; Koivogui, L; Magassouba, N; Koulemou, K; Lewis, R; Aplogan, A; Grais, RF; Guerin, PJ; Fichet-Calvet, E				Kerneis, Solen; Koivogui, Lamine; Magassouba, N'Faly; Koulemou, Kekoura; Lewis, Rosamund; Aplogan, Aristide; Grais, Rebecca F.; Guerin, Philippe J.; Fichet-Calvet, Elisabeth			Prevalence and Risk Factors of Lassa Seropositivity in Inhabitants of the Forest Region of Guinea: A Cross-Sectional Study	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SIERRA-LEONE; WEST-AFRICA; EPIDEMIOLOGICAL ASPECTS; MASTOMYS-NATALENSIS; EASTERN PROVINCE; FEVER; VIRUS; NIGERIA; RODENTS; ANTIBODIES	Background: Lassa fever is a viral hemorrhagic fever endemic in West Africa. The reservoir host of the virus is a multimammate rat, Mastomys natalensis. Prevalence estimates of Lassa virus antibodies in humans vary greatly between studies, and the main modes of transmission of the virus from rodents to humans remain unclear. We aimed to (i) estimate the prevalence of Lassa virus-specific IgG antibodies (LV IgG) in the human population of a rural area of Guinea, and (ii) identify risk factors for positive LV IgG. Methods and Findings: A population-based cross-sectional study design was used. In April 2000, all individuals one year of age and older living in three prefectures located in the tropical secondary forest area of Guinea (Gueckedou, Lola and Yomou) were sampled using two-stage cluster sampling. For each individual identified by the sampling procedure and who agreed to participate, a standardized questionnaire was completed to collect data on personal exposure to potential risk factors for Lassa fever (mainly contact with rodents), and a blood sample was tested for LV IgG. A multiple logistic regression model was used to determine risk factors for positive LV IgG. A total of 1424 subjects were interviewed and 977 sera were tested. Prevalence of positive LV Ig was of 12.9% [10.8%-15.0%] and 10.0% [8.1%-11.9%] in rural and urban areas, respectively. Two risk factors of positive LV IgG were identified: to have, in the past twelve months, undergone an injection (odds ratio [OR] = 1.8 [1.1-3.1]), or lived with someone displaying a haemorrhage (OR = 1.7 [1.1-2.9]). No factors related to contacts with rats and/or mice remained statistically significant in the multivariate analysis. Conclusions: Our study underlines the potential importance of person-to-person transmission of Lassa fever, via close contact in the same household or nosocomial exposure.	[Kerneis, Solen; Lewis, Rosamund; Aplogan, Aristide; Grais, Rebecca F.; Guerin, Philippe J.] Epicentre, Paris, France; [Koivogui, Lamine; Magassouba, N'Faly; Koulemou, Kekoura] Surveillance & Res Project Viral Hemorrhag Fevers, Conakry, Guinea; [Fichet-Calvet, Elisabeth] Univ Antwerp, Evolutionary Biol Grp, B-2020 Antwerp, Belgium	Kerneis, S (reprint author), Epicentre, Paris, France.	solen.kerneis@cch.aphp.com		Guerin, Philippe/0000-0002-6008-2963	European Union-project [ERBIC18 CT980382]	This work was part of a European Union-project [ ERBIC18 CT980382 "Surveillance and Research Project on Viral Hemorrhagic Fevers ( Lassa, Ebola and Yellow fever) in West Africa'']. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoua-Koffi C, 2006, Med Trop (Mars), V66, P465; Atkin S., 2009, EUROSURVEILL, V14, P19145; Bajani MD, 1997, T ROY SOC TROP MED H, V91, P379, DOI 10.1016/S0035-9203(97)90247-9; Bausch DG, 2001, VECTOR-BORNE ZOONOT, V1, P269, DOI 10.1089/15303660160025903; BOWEN GS, 1975, B WORLD HEALTH ORGAN, V52, P599; CAREY DE, 1972, T ROY SOC TROP MED H, V66, P402, DOI 10.1016/0035-9203(72)90271-4; EMOND RTD, 1982, BRIT MED J, V285, P1001, DOI 10.1136/bmj.285.6347.1001; Fichet-Calvet E, 2007, VECTOR-BORNE ZOONOT, V7, P119, DOI 10.1089/vbz.2006.0520; Fichet-Calvet E, 2005, BELG J ZOOL, V135, P63; Fisher-Hoch SP, 2005, BRIT MED BULL, V73-74, P123, DOI 10.1093/bmb/ldh054; FISHERHOCH SP, 1995, BRIT MED J, V311, P857, DOI 10.1136/bmj.311.7009.857; FRAME JD, 1970, AM J TROP MED HYG, V19, P670, DOI 10.4269/ajtmh.1970.19.670; FRASER DW, 1974, AM J TROP MED HYG, V23, P1131, DOI 10.4269/ajtmh.1974.23.1131; Gunther S, 2000, EMERG INFECT DIS, V6, P466, DOI 10.3201/eid0605.000504; Gunther S, 2004, CRIT REV CL LAB SCI, V41, P339, DOI 10.1080/10408360490497456; Jay MT, 2005, JAVMA-J AM VET MED A, V227, P904, DOI 10.2460/javma.2005.227.904; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Lecompte E, 2006, EMERG INFECT DIS, V12, P1971; Lukashevich IS, 2008, VACCINE, V26, P5246, DOI 10.1016/j.vaccine.2008.07.057; LUKASHEVICH IS, 1993, J MED VIROL, V40, P210, DOI 10.1002/jmv.1890400308; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; McCormick JB, 1999, EMERGENCE AND CONTROL OF RODENT-BORNE VIRAL DISEASES (HANTAVIRAL AND ARENAL DISEASES), P177; MONATH TP, 1973, AM J TROP MED HYG, V22, P773, DOI 10.4269/ajtmh.1973.22.773; MONATH TP, 1974, AM J TROP MED HYG, V23, P1140, DOI 10.4269/ajtmh.1974.23.1140; MONSON MH, 1984, T ROY SOC TROP MED H, V78, P549, DOI 10.1016/0035-9203(84)90082-8; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; SALTZMANN S, 1978, FIEVRE LASSA; STEPHENSON EH, 1984, J MED VIROL, V14, P295, DOI 10.1002/jmv.1890140402; ter Meulen J, 2001, TROP MED INT HEALTH, V6, P83, DOI 10.1046/j.1365-3156.2001.00676.x; terMeulen J, 1996, AM J TROP MED HYG, V55, P661; World Health Organization, 1991, WHOEPIMLM9110; WULFF H, 1975, B WORLD HEALTH ORGAN, V52, P609	33	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2009	3	11							e548	10.1371/journal.pntd.0000548				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	522XG	WOS:000272032900009	19924222	DOAJ Gold, Green Published			2019-04-02	
J	Bhattarai, NR; Das, ML; Rijal, S; van der Auwera, G; Picado, A; Khanal, B; Roy, L; Speybroeck, N; Berkvens, D; Davies, CR; Coosemans, M; Boelaert, M; Dujardin, JC				Bhattarai, Narayan Raj; Das, Murari Lal; Rijal, Suman; van der Auwera, Gert; Picado, Albert; Khanal, Basudha; Roy, Lalita; Speybroeck, Niko; Berkvens, Dirk; Davies, Clive R.; Coosemans, Marc; Boelaert, Marleen; Dujardin, Jean-Claude			Natural infection of Phlebotomus argentipes with Leishmania and other trypanosomatids in a visceral leishmaniasis endemic region of Nepal	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Leishmania; Phlebotomus argentipes; PCR; Kala-azar; Ribosomal DNA; Nepal	SANDFLIES DIPTERA; SAND FLIES; PCR; IDENTIFICATION; PSYCHODIDAE; PREVALENCE; DONOVANI; DNA	Monitoring Leishmania infection in sand flies is important for understanding the eco-epidemiology of kala-azar and assessing the impact of the recently launched kala-azar control programme in the Indian subcontinent. We applied a PCR technique that targets rRNA genes to estimate the natural incidence of Leishmania infection in sand flies sampled in six villages of the Terai region of Nepal. Amplifications were made on 135 pools of sand flies and confirmed by sequencing. Seven pools were found to be PCR positive: in five of them we identified the rDNA signature found in Leishmania spp., whereas two other pools revealed a sequence compatible with other trypanosomatids. Different methodologies were applied to evaluate the infection rate from pools of unequal size and estimated the infection rate to range from 0.468% to 0.578% for the Leishmania group and from 0.185% to 0.279% for the non-Leishmania group. Our results highlight the diversity of flagellate infections likely to be encountered in Phlebotomus argentipes populations. Our methodology allows clear discrimination of Leishmania from other trypanosomatids and should be applied on larger insect samples or in longitudinal studies. (C) 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Bhattarai, Narayan Raj; van der Auwera, Gert; Speybroeck, Niko; Berkvens, Dirk; Coosemans, Marc; Boelaert, Marleen; Dujardin, Jean-Claude] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Bhattarai, Narayan Raj; van der Auwera, Gert; Speybroeck, Niko; Berkvens, Dirk; Coosemans, Marc; Boelaert, Marleen; Dujardin, Jean-Claude] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Bhattarai, Narayan Raj; van der Auwera, Gert; Speybroeck, Niko; Berkvens, Dirk; Coosemans, Marc; Boelaert, Marleen; Dujardin, Jean-Claude] Inst Trop Med, Dept Vet & Anim Sci, B-2000 Antwerp, Belgium; [Bhattarai, Narayan Raj; Das, Murari Lal; Rijal, Suman; Khanal, Basudha; Roy, Lalita] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Bhattarai, Narayan Raj; Dujardin, Jean-Claude] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Picado, Albert; Davies, Clive R.] London Sch Hyg & Trop Med, London WC1, England; [Speybroeck, Niko] Catholic Univ Louvain, Ecole Sante Publ, B-1348 Louvain, Belgium	Dujardin, JC (reprint author), Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium.	jcdujardin@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Picado, Albert/0000-0001-7344-628X; Das, Murari/0000-0001-6816-2389	EU [INCO-CT 2005-01537]	EU-funded KALANET project (contract no. INCO-CT 2005-01537).	Aransay AM, 2000, APPL ENVIRON MICROB, V66, P1933, DOI 10.1128/AEM.66.5.1933-1938.2000; BHATTARAI NR, 2009, TROP MED IN IN PRESS; Carvalho GML, 2008, VECTOR-BORNE ZOONOT, V8, P407, DOI 10.1089/vbz.2007.0180; Deborggraeve S, 2008, TROP MED INT HEALTH, V13, P1378, DOI 10.1111/j.1365-3156.2008.02154.x; Dinesh DS, 2008, MED VET ENTOMOL, V22, P120, DOI 10.1111/j.1365-2915.2008.00724.x; Dinesh DS, 2000, ANN TROP MED PARASIT, V94, P447, DOI 10.1080/00034983.2000.11813563; Esseghir S, 2000, BIOL J LINN SOC, V70, P189, DOI 10.1006/bijl.1999.0393; FARRINGTON CP, 1992, STAT MED, V11, P1591, DOI 10.1002/sim.4780111206; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Joshi A., 2008, Journal of Vector Borne Diseases, V45, P105; Kato H, 2005, AM J TROP MED HYG, V72, P87, DOI 10.4269/ajtmh.2005.72.87; Kato H, 2007, AM J TROP MED HYG, V77, P324, DOI 10.4269/ajtmh.2007.77.324; KILLICKKENDRICK R, 1981, PARASITOLOGY, V82, P143; Kumar V., 2001, Journal of Communicable Diseases, V33, P102; LEWIS DJ, 1987, SYST ENTOMOL, V12, P163, DOI 10.1111/j.1365-3113.1987.tb00194.x; Martin-Sanchez J, 2006, T ROY SOC TROP MED H, V100, P527, DOI 10.1016/j.trstmh.2005.08.005; Noyes H, 2002, PARASITOLOGY, V124, P17, DOI 10.1017/S0031182001008927; Pandey K, 2008, PARASITOL RES, V103, P293, DOI 10.1007/s00436-008-0967-7; THAPA LB, 2009, INTERNAL ASSESSMENT; WALLACE FG, 1968, J PARASITOL, V54, P606, DOI 10.2307/3277094; WILLIAMS P, 1976, B ENTOMOL RES, V65, P615, DOI 10.1017/S0007485300006313	21	26	27	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	NOV	2009	103	11					1087	1092		10.1016/j.trstmh.2009.03.008				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	519OP	WOS:000271776800003	19345387				2019-04-02	
J	Fernandez, MAL; Bauernfeind, A				Luque Fernandez, Miguel Angel; Bauernfeind, Ariane			Reply to comment on: Influence of temperature and rainfall on the evolution of cholera epidemics in Lusaka, Zambia, 2003-2006: analysis of a time series	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Editorial Material									[Luque Fernandez, Miguel Angel; Bauernfeind, Ariane] Med Sans Frontieres, Brussels Operat Ctr, B-1090 Brussels, Belgium; [Luque Fernandez, Miguel Angel] Inst Salud Carlos III, Natl Ctr Epidemiol, Programa Epidemiol Aplicada Campo, Madrid 28029, Spain	Fernandez, MAL (reprint author), Med Sans Frontieres, Brussels Operat Ctr, Rue Dupre 94, B-1090 Brussels, Belgium.	fmiguelangel@isciii.es	LUQUE FERNANDEZ, MIGUEL ANGEL/L-4053-2015	LUQUE FERNANDEZ, MIGUEL ANGEL/0000-0001-6683-5164			Depoortere E, 2005, TROP MED INT HEALTH, V10, P139, DOI 10.1111/j.1365-3156.2004.01363.x; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Fernandez MAL, 2009, T ROY SOC TROP MED H, V103, P137, DOI 10.1016/j.trstmh.2008.07.017; MEIER B, 2009, NY TIMES        0605	4	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	NOV	2009	103	11					1183	1184		10.1016/j.trstmh.2009.06.009				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	519OP	WOS:000271776800020					2019-04-02	
J	Beutels, P; Jia, N; Zhou, QY; Smith, R; Cao, WC; de Vlas, SJ				Beutels, Philippe; Jia, Na; Zhou, Qing-Yi; Smith, Richard; Cao, Wu-Chun; de Vlas, Sake J.			The economic impact of SARS in Beijing, China	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						severe acute respiratory syndrome; economic impact; leisure industry; postponed consumption; losses; People's Republic of China		P>Objective To document the impact of the severe acute respiratory syndrome (SARS) outbreak in Beijing on indicators of social and economic activity. Methods Associations between time series of daily and monthly SARS cases and deaths and volume of public train, airplane and cargo transport, tourism, household consumption patterns and gross domestic product growth in Beijing were investigated using the cross-correlation function. Results Significant correlation coefficients were found for all indicators except wholesale accounts and expenditures on necessities, with the most significant correlations occurring with a delay of 1 day to 1 month. Conclusions Especially leisure activities, local and international transport and tourism were affected by SARS particularly in May 2003. Much of this consumption was merely postponed; but irrecoverable losses to the tourist sector alone were estimated at about US$ 1.4 bn, or 300 times the cost of treatment for SARS cases in Beijing.	[Jia, Na; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Beutels, Philippe] Univ Antwerp, Fac Med, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modeling Infect Dis, Antwerp, Belgium; [Zhou, Qing-Yi] Capital Med Univ, Dept Publ Hlth, Beijing, Peoples R China; [Smith, Richard] London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1, England; [de Vlas, Sake J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Beutels, Philippe] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	Cao, WC (reprint author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dong Da St, Beijing 100071, Peoples R China.	caowc@nic.bmi.ac.cn	Beutels, Philippe/A-1919-2010	Beutels, Philippe/0000-0001-5034-3595; Smith, Richard/0000-0003-3837-6559	Commission of the European Community [SP22-CT-2004-003824]	This study was supported by the Commission of the European Community under the Sixth Framework Program Specific Targeted Research Project, SARS Control 'Effective and Acceptable Strategies for the Control of SARS and new emerging infections in China and Europe' (Contract No. SP22-CT-2004-003824).	Beutels P, 2008, HEALTH ECON, V17, P1317, DOI 10.1002/hec.1339; Donnelly CA, 2004, LANCET INFECT DIS, V4, P672, DOI 10.1016/S1473-3099(04)01173-9; HAMORI S, 2003, BUSINESS EC, V8, P17; *HSYND, 2008, BEIJ HOT MARK OV; Keogh-Brown MR, 2008, HEALTH POLICY, V88, P110, DOI 10.1016/j.healthpol.2008.03.003; *MIN PUBL HLTH, 2003, STAT B SARS; Noipoth Helmut, 1984, POLITICAL BEHAVIOR, V6, p[253, 253]; Sadique MZ, 2007, EMERG INFECT DIS, V13, P1307, DOI 10.3201/eid1309.070372; SMITH RD, 2006, RAPID ASSESSMENT EC; Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004; *WHO, 2008, SEV AC RESP SYNDR SA; Xiao Feng, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P312	12	16	19	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2009	14			1			85	91		10.1111/j.1365-3156.2008.02210.x				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	505CW	WOS:000270667100012	19508435				2019-04-02	
J	Sanchez, L; Perez, D; Cruz, G; Castro, M; Kouri, G; Shkedy, Z; Vanlerberghe, V; Van der Stuyft, P				Sanchez, L.; Perez, D.; Cruz, G.; Castro, M.; Kouri, G.; Shkedy, Z.; Vanlerberghe, V.; Van der Stuyft, P.			Intersectoral coordination, community empowerment and dengue prevention: six years of controlled interventions in Playa Municipality, Havana, Cuba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Aedes aegypti; dengue; prevention and control; participation; evaluation studies; Cuba	AEDES-AEGYPTI CONTROL; INTEGRATED CONTROL; COST-EFFECTIVENESS; CONTROL PROGRAMS; VECTOR CONTROL; PARTICIPATION; SANTIAGO; HEALTH; INVOLVEMENT; EPIDEMIC	OBJECTIVE To document the process, outcome and effectiveness of a community-based intervention for dengue control. METHODS The primary intervention, focused on strengthening intersectoral coordination, was initiated by researchers in January 2000 in a pilot area in Playa municipality, Havana. In August 2002 health authorities extended the intervention to neighbouring areas, one of which was selected for evaluation. In August 2003 a complementary strategy, focused on community empowerment, was initiated in half of the pilot area. In our control area, routine dengue activities continued throughout the study period. Longitudinal process assessment was carried out using document analysis, interviews and group discussions. Random population surveys in 1999, 2002 and 2005 assessed levels of participation and behavioural changes. Entomological surveillance data from 1999 to 2005 were used to determine effectiveness. RESULTS Mean scores for participation in the pilot area were 1.6, 3.4 and 4.4 at baseline, and 2 years after initiating intersectoral coordination and intersectoral coordination plus community empowerment interventions, respectively. While in the control area little behavioural change was observed over time, changes were considerable in the pilot and extension areas, with 80% of households involved in the community empowerment intervention showed adequate behavioural patterns. The pilot and extension areas attained comparable entomological effectiveness with significantly lower Breteau indices (BIs) than the control area. The pilot (sub-) area with the community empowerment intervention reached BIs below 0.1 that continued to be significantly lower than the one in the control area until the end of the study. CONCLUSION The study showed a trend in the levels and quality of participation, behavioural change and effectiveness of Aedes control from the routine activities only over an intervention with intersectoral coordination to one that combined intersectoral coordination and community empowerment approach.	[Sanchez, L.] Trop Med Inst Pedro Kouri, Div Epidemiol, Havana, Cuba; [Cruz, G.] Hyg & Epidemiol Ctr, Div Epidemiol, Havana, Cuba; [Shkedy, Z.] Hasselt Univ, Ctr Stat, Diepenbeek, Belgium; [Vanlerberghe, V.; Van der Stuyft, P.] Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium	Sanchez, L (reprint author), Trop Med Inst Pedro Kouri, Div Epidemiol, Km 6,La Lisa AP 601,Marianao 13, Havana, Cuba.	lsanchez@ipk.sld.cu			Cuban Ministry of Health; Institute of Tropical Medicine (Antwerp); Belgium Directorate-General for Development Cooperation	We gratefully acknowledge the family doctors, formal and informal leaders and residents of Playa Municipality who participated in the study. We thank Linda Lloyd for helpful comments on the final draft of the manuscript and Marleen Boelaert for her observations and recommendations during the execution of the project. The research was funded by the Cuban Ministry of Health and through a framework agreement between the Institute of Tropical Medicine 'Pedro Kouri', the Institute of Tropical Medicine (Antwerp) and the Belgium Directorate-General for Development Cooperation.	Baly A, 2007, T ROY SOC TROP MED H, V101, P578, DOI 10.1016/j.trstmh.2007.01.002; Baly A, 2009, AM J TROP MED HYG, V81, P88, DOI 10.4269/ajtmh.2009.81.88; Lazcano JAB, 2006, REV PANAM SALUD PUBL, V19, P379, DOI 10.1590/S1020-49892006000600003; de Oliveira R M, 1998, Cad Saude Publica, V14 Suppl 2, P69; Farrar J, 2007, TROP MED INT HEALTH, V12, P695, DOI 10.1111/j.1365-3156.2007.01838; Freire P., 1972, PEDAGOGY OPPRESSED; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Guzman Maria, 2004, Expert Rev Vaccines, V3, P511, DOI 10.1586/14760584.3.5.511; Guzman Maria G, 2004, Expert Rev Anti Infect Ther, V2, P895, DOI 10.1586/14789072.2.6.895; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Kay B H, 1994, Gaoxiong Yi Xue Ke Xue Za Zhi, V10 Suppl, pS56; Kouri G, 1998, EMERG INFECT DIS, V4, P89; Kouri G, 2006, REV PANAM SALUD PUBL, V19, P143; Lardeux F, 2002, J MED ENTOMOL, V39, P493, DOI 10.1603/0022-2585-39.3.493; LEONTSINI E, 1993, T ROY SOC TROP MED H, V87, P267, DOI 10.1016/0035-9203(93)90120-F; LIBORIO M, 2004, REV BRAS EPIDEMIOL, V7, P311; Nam V, 2005, DENGUE B, V28, P57; Parks W. J., 2004, Dengue Bulletin, V28, P1; Pelaez O, 2004, EMERG INFECT DIS, V10, P719, DOI 10.3201/eid1004.030271; Perez D, 2007, TROP MED INT HEALTH, V12, P664, DOI 10.1111/j.1365-3156.2007.01833.x; Perez T., 2003, REV CUBANA SALUD PUB, V29, P11; REYES I, 1996, REV CUBANA SALUD PUB, V22, P5; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; Roussos ST, 2000, ANNU REV PUBL HEALTH, V21, P369, DOI 10.1146/annurev.publhealth.21.1.369; Sanchez L, 2004, REV PANAM SALUD PUBL, V15, P19, DOI 10.1590/S1020-49892004000100004; Sanchez L, 2005, TROP MED INT HEALTH, V10, P82, DOI 10.1111/j.1365-3156.2004.01347.x; Spiegel Jerry, 2005, EcoHealth, V2, P273, DOI 10.1007/s10393-005-8388-x; Toledo ME, 2007, T ROY SOC TROP MED H, V101, P56, DOI 10.1016/j.trstmh.2006.03.006; Toledo ME, 2008, TROP MED INT HEALTH, V13, P728, DOI 10.1111/j.1365-3156.2008.02046.x; Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959; Wang CH, 2000, J AM MOSQUITO CONTR, V16, P93	32	28	30	0	12	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2009	14	11					1356	1364		10.1111/j.1365-3156.2009.02379.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	505XI	WOS:000270734300007	19840350	Bronze			2019-04-02	
J	Van den Eede, P; Hong, NV; Van Overmeir, C; Vythilingam, I; Thang, ND; Le, XH; Hung, NM; Anne, J; D'Alessandro, U; Erhart, A				Van den Eede, Peter; Hong Nguyen Van; Van Overmeir, Chantal; Vythilingam, Indra; Thang Ngo Duc; Le Xuan Hung; Hung Nguyen Manh; Anne, Jozef; D'Alessandro, Umberto; Erhart, Annette			Human Plasmodium knowlesi infections in young children in central Vietnam	MALARIA JOURNAL			English	Article							HUMAN MALARIA PARASITE; ANOPHELES-LATENS; MALAYSIAN-BORNEO; TRANSMISSION; THAILAND; TRAVELER; SARAWAK	Background: Considering increasing reports on human infections by Plasmodium knowlesi in Southeast Asian countries, blood samples collected during two large cross-sectional malariometric surveys carried out in a forested area of central Vietnam in 2004 and 2005 were screened for this parasite. Methods: Blood samples collected at the 2004 survey and positive for Plasmodium malariae were randomly selected for PCR analysis detecting P. knowlesi. Blood samples collected in 2005 from the same individuals were screened again for P. knowlesi. Positive samples were confirmed by sequencing. Family members of positive cases who participated in both surveys were also screened. Results: Ninety-five samples with P. malariae mono- or mixed infections identified by species-specific PCR were screened for P. knowlesi. Among the five (5.2%) positive samples by PCR, three were confirmed to be P. knowlesi infections by sequencing, two young children (<5 years old) and a young man, all asymptomatic at the time of the survey and for the next six months after the survey. One of the two children was still positive one year later. No infection was found among the family members. Conclusion: Plasmodium knowlesi infections in humans can be found in central Vietnam. A small child was positive for P. knowlesi in both surveys at one year interval, though it is unclear whether it was the same or a new infection.	[Van den Eede, Peter; Van Overmeir, Chantal; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Hong Nguyen Van; Thang Ngo Duc; Le Xuan Hung; Hung Nguyen Manh] Natl Inst Malariol, Dept Parasitol & Entomol, Hanoi, Vietnam; [Vythilingam, Indra] Inst Med Res, Kuala Lumpur 50588, Malaysia; [Anne, Jozef] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium	Van den Eede, P (reprint author), Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium.	pvandeneede@itg.be; nvhong1982@yahoo.com; cvovermeir@itg.be; indra@imr.gov.my; thangnimpe@yahoo.com; lxhung1952@yahoo.com; drmanhhung@gmail.com; jozef.anne@rega.kuleuven.be; udalessandro@itg.be; aerhart@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Anne, Jozef/0000-0002-0493-2644	Science and Technology in Flanders; Institute of Tropical Medicine, Antwerp; Belgian Cooperation	We would like to thank Gert van der Auwera and Jean-Claude Dujardin for their useful comments in the revision of the paper. PVDE is a research fellow of the Institute for the Promotion of Innovation by Science and Technology in Flanders. This project was funded by the Framework Agreement between the Institute of Tropical Medicine, Antwerp, and the Belgian Cooperation.	Bronner U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-15; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; COLLINS WE, 1967, J PARASITOL, V53, P841, DOI 10.2307/3276783; Cox-Singh J, 2008, TRENDS PARASITOL, V24, P406, DOI 10.1016/j.pt.2008.06.001; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Dang Nghiem Van, 2000, ETHNIC MINORITIES VI; *EMBL EBI, EMBL EBI WEBS SEQ AN; Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293; Kantele A, 2008, EMERG INFECT DIS, V14, P1434, DOI 10.3201/eid1409.080170; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; Nakazawa S, 2009, INT J PARASITOL, V39, P1533, DOI 10.1016/j.ijpara.2009.08.005; Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; *PRIM, PRIM INF NET; Putaporntip C, 2009, J INFECT DIS, V199, P1143, DOI 10.1086/597414; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199, DOI 10.1016/S0035-9203(02)90077-5; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Tan CH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-52; Thang Ngo Duc, 2009, PLoS One, V4, pe7369, DOI 10.1371/journal.pone.0007369; Thang Ngo Duc, 2009, Malar J, V8, P3, DOI 10.1186/1475-2875-8-3; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889; Zhu Huai-min, 2006, Chinese Journal of Parasitology and Parasitic Diseases, V24, P70	26	80	82	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 30	2009	8								249	10.1186/1475-2875-8-249				5	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	517HJ	WOS:000271603600001	19878553	DOAJ Gold, Green Published			2019-04-02	
J	Van Bortel, W; Vu, DC; Berkvens, D; Speybroeck, N; Ho, DT; Coosemans, M				Van Bortel, Wim; Vu Duc Chinh; Berkvens, Dirk; Speybroeck, Niko; Ho Dinh Trung; Coosemans, Marc			Impact of insecticide-treated nets on wild pyrethroid resistant Anopheles epiroticus population from southern Vietnam tested in experimental huts	MALARIA JOURNAL			English	Article							COTE-DIVOIRE; CULEX-QUINQUEFASCIATUS; MALARIA VECTORS; MEKONG REGION; EFFICACY; GAMBIAE	Background: In this study, the efficacy of insecticide-treated nets was evaluated in terms of deterrence, blood-feeding inhibition, induced exophily and mortality on a wild resistant population of Anopheles epiroticus in southern Vietnam, in order to gain insight into the operational consequences of the insecticide resistance observed in this malaria vector in the Mekong delta. Method: An experimental station, based on the model of West Africa and adapted to the behaviour of the target species, was built in southern Vietnam. The study design was adapted from the WHO phase 2 guidelines. The study arms included a conventionally treated polyester net (CTN) with deltamethrin washed just before exhaustion, the WHO recommended long-lasting insecticidal net (LLIN) PermaNet 2.0(R) unwashed and 20 times washed and PermaNet 3.0(R), designed for the control of pyrethroid resistant vectors, unwashed and 20 times washed. Results: The nets still provided personal protection against the resistant An. epiroticus population. The personal protection ranged from 67% for deltamethrin CTN to 85% for unwashed PermaNet 3.0. Insecticide resistance in the An. epiroticus mosquitoes did not seem to alter the deterrent effect of pyrethroids. A significant higher mortality was still observed among the treatment arms despite the fact that the An. epiroticus population is resistant against the tested insecticides. Conclusion: This study shows that CTN and LLINs still protect individuals against a pyrethroid resistant malaria vector from the Mekong region, where insecticide resistance is caused by a metabolic mechanism. In the light of a possible elimination of malaria from the Mekong region these insights in operational consequences of the insecticide resistance on control tools is of upmost importance.	[Van Bortel, Wim; Coosemans, Marc] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Vu Duc Chinh; Ho Dinh Trung] Natl Inst Malariol Parasitol & Entomol, Dept Entomol, Hanoi, Vietnam; [Berkvens, Dirk; Speybroeck, Niko] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Coosemans, Marc] Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, Dept Biomed Sci, B-2610 Antwerp, Belgium	Van Bortel, W (reprint author), Inst Trop Med, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	wvbortel@itg.be; chinh_vu99@yahoo.com; dberkvens@itg.be; nspeybroeck@itg.be; hodinhtrung@fpt.vn; mcoosemans@itg.be		Van Bortel, Wim/0000-0002-6644-518X	Belgian Co-operation; WHOPES	We acknowledge Vestegaard-Frandsen for providing PermaNet. This study was conducted in the framework of the Institutional Collaboration between NIMPE and the Institute of Tropical Medicine, Belgium, supported by the Belgian Co-operation (Directorate-General for Development Cooperation) and WHOPES.	Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Darriet F, 2002, B SOC PATHOL EXOT, V95, P299; Darriet F, 2000, B SOC PATHOL EXOT, V93, P131; Erhart A, 2006, MALARIA CONTROL VIET; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Hougard JM, 2003, B ENTOMOL RES, V93, P491, DOI 10.1079/BER2003261; *IMPE, 1987, KEYS AN VIETN AD PUP; MITTAL PK, 2004, STATUS INSECTICIDE R, V129, P1; N'Guessan R, 2001, MED VET ENTOMOL, V15, P97, DOI 10.1046/j.1365-2915.2001.00284.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; *RBM, 2008, ROLL BACK MAL PARTN, P1; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; TRUNG HD, 2003, MALARIA VECTORS SE A; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102; Verhaeghen K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-84; WHO, 1998, WHOCDSCPCMAL9812; WHO, 2006, WHOCDSNTDWHOPESGCDPP, P1; WHO, 2005, WHO TECH REP SER, P1; WHO Expert Committee, 2007, World Health Organ Tech Rep Ser, P1; World Health Organization, 2009, WHO GLOB DAT VIT A D, P1	23	26	26	0	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 29	2009	8								248	10.1186/1475-2875-8-248				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	525YU	WOS:000272254900001	19874581	DOAJ Gold, Green Published			2019-04-02	
J	Mutesa, L; Bours, V				Mutesa, Leon; Bours, Vincent			Diagnostic Challenges of Cystic Fibrosis in Patients of African Origin	JOURNAL OF TROPICAL PEDIATRICS			English	Editorial Material							TRANSMEMBRANE-CONDUCTANCE REGULATOR; PROTEIN-ENERGY MALNUTRITION; AIRWAY SURFACE DEHYDRATION; CFTR MUTATIONS; MISSENSE MUTATION; GENETIC-ANALYSIS; SODIUM-CHANNELS; LUNG-DISEASE; SOUTH-AFRICA; IDENTIFICATION		[Mutesa, Leon; Bours, Vincent] Univ Liege, CHU Sart Tilman, Ctr Human Genet, B-4000 Liege, Belgium	Bours, V (reprint author), Univ Liege, CHU Sart Tilman, Ctr Human Genet, B-4000 Liege, Belgium.	vbours@ulg.ac.be					Alibakhshi R, 2008, J CYST FIBROS, V7, P102, DOI 10.1016/j.jcf.2007.06.001; Alper Ozgul M, 2004, Hum Mutat, V24, P353, DOI 10.1002/humu.9281; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Boelaert JR, 2002, LANCET, V360, P1102, DOI 10.1016/S0140-6736(02)11169-X; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Cabello GMK, 2001, HUM BIOL, V73, P403, DOI 10.1353/hub.2001.0031; Carles S, 1996, J MED GENET, V33, P802, DOI 10.1136/jmg.33.9.802; Collazo T, 2009, J CYST FIBROS, V8, P47, DOI 10.1016/j.jcf.2008.09.004; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; CUTTING GR, 1992, AM J HUM GENET, V50, P1185; DEMAY G, 1984, ARCH FR PEDIATR, V41, P370; DEONIS M, 1993, B WORLD HEALTH ORGAN, V71, P703; des Georges MD, 2008, J MOL DIAGN, V10, P544, DOI 10.2353/jmoldx.2008.080028; Dodge JA, 2006, BEST PRACT RES CL GA, V20, P531, DOI 10.1016/j.bpg.2005.11.006; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/cliest.07-0288; Dork T, 1998, AM J HUM GENET, V63, P656, DOI 10.1086/301950; El-Harith EA, 1997, J MED GENET, V34, P996, DOI 10.1136/jmg.34.12.996; Felley C, 2004, AIDS, V18, P1521, DOI 10.1097/01.aids.0000131356.52457.7a; Feuillet-Fieux MN, 2004, CLIN GENET, V65, P284, DOI 10.1111/j.1399-0004.2004.00230.x; Friedman KJ, 1998, AM J HUM GENET, V62, P195, DOI 10.1086/301681; Frizzell RA, 2004, NAT MED, V10, P452, DOI 10.1038/nm0504-452; Gernaat HBPE, 1998, J TROP PEDIATRICS, V44, P211, DOI 10.1093/tropej/44.4.211; Goldman A, 2003, SAMJ S AFR MED J, V93, P518; Goldman A, 2001, CLIN GENET, V59, P37, DOI 10.1034/j.1399-0004.2001.590106.x; GROVE S S, 1959, S Afr J Lab Clin Med, V5, P113; Hamosh A, 1998, J PEDIATR-US, V132, P255, DOI 10.1016/S0022-3476(98)70441-X; Hoyer HX, 2004, CLIN INFECT DIS, V39, P438, DOI 10.1086/422149; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Levin S E, 1967, S Afr Med J, V41, P482; Macallan DC, 1999, DIAGN MICR INFEC DIS, V34, P153, DOI 10.1016/S0732-8893(99)00007-3; Macek M, 1997, AM J HUM GENET, V60, P1122; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Monaghan KG, 2004, GENET MED, V6, P141, DOI 10.1097/01.GIM.0000127269.42279.83; Monnier N, 2001, J Med Genet, V38, pE4, DOI 10.1136/jmg.38.1.e4; Mutesa L, 2009, CHEST, V135, P1233, DOI 10.1378/chest.08-2246; NUNES V, 1991, HUM GENET, V87, P737; OBER C, 1992, AM J HUM GENET, V51, P1344; Olson Diane L, 2004, Nutr Clin Pract, V19, P575, DOI 10.1177/0115426504019006575; Padoa C, 1999, J MED GENET, V36, P41; PHILLIPS RJ, 1993, ARCH DIS CHILD, V69, P446, DOI 10.1136/adc.69.4.446; Raskin S, 2003, GENET TEST, V7, P213, DOI 10.1089/109065703322537223; Rippon I, 2005, THORAX, V60, P63, DOI 10.1136/thx.2004.031229; RODRIGUES MESM, 1994, ARCH DIS CHILD, V71, P141, DOI 10.1136/adc.71.2.141; Romey MC, 1999, J MED GENET, V36, P263; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenstein BJ, 1998, CLIN CHEST MED, V19, P423, DOI 10.1016/S0272-5231(05)70091-5; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; Sheridan MB, 2005, HUM MOL GENET, V14, P3493, DOI 10.1093/hmg/ddi374; SMIT LS, 1995, HUM MOL GENET, V4, P269, DOI 10.1093/hmg/4.2.269; SMIT LS, 1993, HUM MUTAT, V2, P148, DOI 10.1002/humu.1380020217; Strandvik B, 2001, GENET TEST, V5, P235, DOI 10.1089/10906570152742290; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Sugarman EA, 2004, GENET MED, V6, P392, DOI 10.1097/01.GIM.0000139503.22088.66; Tzetis M, 1997, HUM GENET, V99, P121; Viel M, 2008, J CYST FIBROS, V7, P23, DOI 10.1016/j.jcf2007.04.003; WANG CI, 1968, NEW ENGL J MED, V279, P1216, DOI 10.1056/NEJM196811282792209; Wang YL, 1997, MOL DIAGN, V2, P205; Westwood T, 2006, SAMJ S AFR MED J, V96, P304; Westwood T, 2006, SAMJ S AFR MED J, V96, P288; WHITE MB, 1991, GENOMICS, V10, P266, DOI 10.1016/0888-7543(91)90510-L; Yigit H, 2003, J PEDIATR GASTR NUTR, V37, P242	63	6	6	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	OCT	2009	55	5					281	286		10.1093/tropej/fmp064				6	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	516XY	WOS:000271577900001	19625487	Bronze			2019-04-02	
J	Ribera, JM; Grietens, KP; Toomer, E; Hausmann-Muela, S				Ribera, Joan Muela; Grietens, Koen Peeters; Toomer, Elizabeth; Hausmann-Muela, Susanna			A Word of Caution against the Stigma Trend in Neglected Tropical Disease Research and Control	PLOS NEGLECTED TROPICAL DISEASES			English	Article							ONCHOCERCAL SKIN-DISEASE; BURULI ULCER; LEPROSY; HEALTH; INFECTIONS; ILLNESS; BURDEN; GENDER; IMPACT; NEPAL		[Ribera, Joan Muela; Grietens, Koen Peeters; Toomer, Elizabeth; Hausmann-Muela, Susanna] PASS Int Vzw, Tessenderlo, Belgium	Ribera, JM (reprint author), PASS Int Vzw, Tessenderlo, Belgium.	susanna.hausmann_muela@yahoo.es					Barrett R, 2005, MED ANTHROPOL Q, V19, P216, DOI 10.1525/maq.2005.19.2.216; Brieger WR, 2001, TROP DOCT, V31, P96, DOI 10.1177/004947550103100214; Brieger WR, 1998, SOC SCI MED, V47, P841, DOI 10.1016/S0277-9536(98)00007-0; Castro A, 2005, AM J PUBLIC HEALTH, V95, P53, DOI 10.2105/AJPH.2003.028563; Coleman C, 2007, J ADV NURS, V58, P35, DOI 10.1111/j.1365-2648.2007.04193.x; Debacker M, 2005, EMERG INFECT DIS, V11, P584, DOI 10.3201/eid1104.041000; DILORIO C, 2003, EPILEPSY BEHAV, V4, P259; FIGEROA JP, 2004, W INDIAN MED J, V53, P277; Floyd-Richard M, 2000, LEPROSY REV, V71, P499; Goffmann E, 1968, STIGMA NOTES MANAGEM; Grietens KP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000321; Hagan M, 1998, ANN TROP MED PARASIT, V92, pS85, DOI 10.1080/00034983.1998.11813371; Heukelbach J, 2006, LANCET, V367, P1767, DOI 10.1016/S0140-6736(06)68772-2; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000230; Kassi M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000259; Kleinman A., 1995, WRITING MARGIN DISCO; Lichtenstein B, 2003, SOC SCI MED, V57, P2435, DOI 10.1016/j.socscimed.2003.08.002; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Low N, 2006, LANCET, V368, P2001, DOI 10.1016/S0140-6736(06)69482-8; Marshall R, 1995, Commun Dis Rep CDR Rev, V5, pR90; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Opala J, 1996, SOC SCI MED, V42, P3, DOI 10.1016/0277-9536(95)00026-7; PEARSON M, 1988, SOC SCI MED, V26, P25, DOI 10.1016/0277-9536(88)90042-1; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Sen Amartya, 2000, SOCIAL DEV PAPERS, V1; Sontag S., 1988, AIDS ITS METAPHORS; Stienstra Y, 2002, AM J TROP MED HYG, V67, P207, DOI 10.4269/ajtmh.2002.67.207; Takougang Innocent, 2004, Afr J Health Sci, V11, P111; Tsutsumi A, 2008, SOC SCI MED, V66, P1841, DOI 10.1016/j.socscimed.2007.12.025; van Brakel WH, 2003, INT J LEPROSY, V71, P190, DOI 10.1489/1544-581X(2003)71<190:MLSPRO>2.0.CO;2; Vlassoff C, 2000, SOC SCI MED, V50, P1353, DOI 10.1016/S0277-9536(99)00389-5; Weiss MG, 2006, LANCET, V367, P536, DOI 10.1016/S0140-6736(06)68189-0; Weiss MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000237; Yang LH, 2007, SOC SCI MED, V64, P1524, DOI 10.1016/j.socscimed.2006.11.013	34	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2009	3	10							e445	10.1371/journal.pntd.0000445				4	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	522XF	WOS:000272032800001		DOAJ Gold, Green Published			2019-04-02	
J	Olsen, A; van Lieshout, L; Marti, H; Polderman, T; Polman, K; Steinmann, P; Stothard, R; Thybo, S; Verweij, JJ; Magnussen, P				Olsen, Annette; van Lieshout, Lisette; Marti, Hanspeter; Polderman, Ton; Polman, Katja; Steinmann, Peter; Stothard, Russell; Thybo, Soren; Verweij, Jaco J.; Magnussen, Pascal			Strongyloidiasis - the most neglected of the neglected tropical diseases?	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Review						Strongyloides stercoralis; Diagnosis; Morbidity; Treatment; Control; Neglected tropical disease	TRANSMITTED HELMINTH INFECTIONS; STERCORALIS; HOOKWORM; THERAPY; ANTIGEN	Soil-transmitted helminths of the genus Strongyloides (S. fuelleborni and the more prevalent S. stercoralis) are currently believed to infect an estimated 30-100 million people worldwide. The health consequences of S. stercoralis infections range from asymptomatic light infections to chronic symptomatic strongyloidiasis. Uncontrolled multiplication of the parasite (hyperinfection) and potentially Life-threatening dissemination of larvae to all internal organs is found among individuals with compromised immune system functions. This paper provides an overview of the current state of the art in relation to diagnostic methods for detecting the infection, the morbidity caused by the infection and the recommended treatment. It further discusses some of the reasons why this infection is so neglected and the consequence of this for the estimated global prevalence. The paper finally points to the gaps in our knowledge and future research needs related to this infection. As Strongyloides infections have the potential to develop into severe disease in certain population subgroups, untreated infections could cause serious problems in the community. Therefore, we need to carefully investigate this parasite in order to develop and implement effective control programmes. (c) 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Olsen, Annette; Magnussen, Pascal] Univ Copenhagen, DBL, Ctr Hlth Res & Dev, Copenhagen, Denmark; [Thybo, Soren] Rigshosp, Dept Epidemiol, DK-2100 Copenhagen, Denmark; [van Lieshout, Lisette; Polderman, Ton; Verweij, Jaco J.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Marti, Hanspeter] Swiss Trop Inst, Dept Med & Diagnost Serv, CH-4002 Basel, Switzerland; [Polman, Katja] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; [Steinmann, Peter] Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland; [Steinmann, Peter] China CDC, Natl Inst Parasit Dis, Shanghai, Peoples R China; [Stothard, Russell] Nat Hist Museum, Dept Zool, London SW7 5BD, England	Olsen, A (reprint author), Univ Copenhagen, DBL, Ctr Hlth Res & Dev, Copenhagen, Denmark.	aol@life.ku.dk	Stothard, Russell/I-9717-2016	Stothard, Russell/0000-0002-9370-3420; Olsen, Annette/0000-0001-9352-621X; Magnussen, Pascal/0000-0001-7372-0250			[Anonymous], 2006, PREV CHEM HUM HELM C; Ashford R.W., 1989, P271; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brown M, 2006, INT J STD AIDS, V17, P560, DOI 10.1258/095646206778145712; BUNDY DAP, 1987, PARASITOLOGY, V95, P623, DOI 10.1017/S0031182000058042; Carvalho EM, 2004, PARASITE IMMUNOL, V26, P487, DOI 10.1111/j.0141-9838.2004.00726.x; CHEESBROUGH M, 1987, MED LAB MANUAL TROPI, V1; Dreyfuss ML, 2001, AM J CLIN NUTR, V74, P814; Fardet L, 2006, CLIN MICROBIOL INFEC, V12, P945, DOI 10.1111/j.1469-0691.2006.01443.x; Genta R. M., 1989, Strongyloidiasis: a major roundworm infection of man., P133; Ghosh K, 2007, T ROY SOC TROP MED H, V101, P1163, DOI 10.1016/j.trstmh.2007.05.021; Grove D. I., 1989, Strongyloidiasis: a major roundworm infection of man., P155; HALL A, 1994, T ROY SOC TROP MED H, V88, P527, DOI 10.1016/0035-9203(94)90146-5; Hirata T, 2006, AM J TROP MED HYG, V74, P246, DOI 10.4269/ajtmh.2006.74.246; Keiser PB, 2004, CLIN MICROBIOL REV, V17, P208, DOI 10.1128/CMR.17.1.208-217.2004; Marcos LA, 2008, T ROY SOC TROP MED H, V102, P314, DOI 10.1016/j.trstmh.2008.01.020; Marti H, 1996, AM J TROP MED HYG, V55, P477, DOI 10.4269/ajtmh.1996.55.477; Mendonca SCL, 2006, ACTA TROP, V99, P102, DOI 10.1016/j.actatropica.2006.06.006; MORGAN JS, 1986, TRANSPLANTATION, V42, P518, DOI 10.1097/00007890-198611000-00016; Olsen A, 2007, T ROY SOC TROP MED H, V101, P747, DOI 10.1016/j.trstmh.2007.03.006; Page WA, 2006, T ROY SOC TROP MED H, V100, P1056, DOI 10.1016/j.trstmh.2005.12.006; Rodrigues RM, 2007, PARASITOL RES, V101, P1209, DOI 10.1007/s00436-007-0602-z; Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707; Silva LP, 2003, MEM I OSWALDO CRUZ, V98, P687, DOI 10.1590/S0074-02762003000500017; SPEARE P, 1989, STRONGYLOIDIASIS MAJ, P11; Steinmann P, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000075; Streit A, 2008, PARASITOLOGY, V135, P285, DOI 10.1017/S003118200700399X; Sudarshi S, 2003, TROP MED INT HEALTH, V8, P728, DOI 10.1046/j.1365-3156.2003.01069.x; Viney Mark E, 2007, WormBook, P1; Viney ME, 2004, J INFECT DIS, V190, P2175, DOI 10.1086/425935; WHO, 2005, WHOCDSPVC200514; *WHO, 2002, TECHN REP SER WHO, V912; Yelifari L, 2005, T ROY SOC TROP MED H, V99, P32, DOI 10.1016/j.trstmh.2004.02.007; Yori PP, 2006, AM J TROP MED HYG, V74, P97, DOI 10.4269/ajtmh.2006.74.97	34	249	259	3	28	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	OCT	2009	103	10					967	972		10.1016/j.trstmh.2009.02.013				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	540CV	WOS:000273309300001	19328508	Green Published	Y	N	2019-04-02	
J	White, LJ; Maude, RJ; Pongtavornpinyo, W; Saralamba, S; Aguas, R; Van Effelterre, T; Day, NPJ; White, NJ				White, Lisa J.; Maude, Richard J.; Pongtavornpinyo, Wirichada; Saralamba, Sompob; Aguas, Ricardo; Van Effelterre, Thierry; Day, Nicholas P. J.; White, Nicholas J.			The role of simple mathematical models in malaria elimination strategy design	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SUB-SAHARAN AFRICA; VACCINE; TRANSMISSION; ERADICATION; RESISTANCE; CAMBODIA; IMPACT; TRIAL	Background: Malaria has recently been identified as a candidate for global eradication. This process will take the form of a series of national eliminations. Key issues must be considered specifically for elimination strategy when compared to the control of disease. Namely the spread of drug resistance, data scarcity and the adverse effects of failed elimination attempts. Mathematical models of various levels of complexity have been produced to consider the control and elimination of malaria infection. If available, detailed data on malaria transmission (such as the vector life cycle and behaviour, human population behaviour, the acquisition and decay of immunity, heterogeneities in transmission intensity, age profiles of clinical and subclinical infection) can be used to populate complex transmission models that can then be used to design control strategy. However, in many malaria countries reliable data are not available and policy must be formed based on information like an estimate of the average parasite prevalence. Methods: A simple deterministic model, that requires data in the form of a single estimate of parasite prevalence as an input, is developed for the purpose of comparison with other more complex models. The model is designed to include key aspects of malaria transmission and integrated control. Results: The simple model is shown to have similar short-term dynamic behaviour to three complex models. The model is used to demonstrate the potential of alternative methods of delivery of controls. The adverse effects on clinical infection and spread of resistance are predicted for failed elimination attempts. Since elimination strategies present an increased risk of the spread of drug resistance, the model is used to demonstrate the population level protective effect of multiple controls against this very serious threat. Conclusion: A simple model structure for the elimination of malaria is suitable for situations where data are sparse yet strategy design requirements are urgent with the caveat that more complex models, populated with new data, would provide more information, especially in the long-term.	[White, Lisa J.; Maude, Richard J.; Day, Nicholas P. J.; White, Nicholas J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford OX3 9DU, England; [White, Lisa J.; Maude, Richard J.; Pongtavornpinyo, Wirichada; Saralamba, Sompob; Day, Nicholas P. J.; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Aguas, Ricardo] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Van Effelterre, Thierry] GlaxoSmithKline Biol, Rixensart, Belgium	White, LJ (reprint author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford OX3 9DU, England.	lisa@tropmedres.ac; richard@tropmedres.ac; pan@tropmedres.ac; sompob@tropmedres.ac; ricaguas@igc.gulbenkian.pt; thierry.van-effelterre@gskbio.com; nickd@tropmedres.ac; nickw@tropmedres.ac	White, Nicholas/I-4629-2012	Maude, Richard/0000-0002-5355-0562; White, Lisa/0000-0002-6523-185X; Saralamba, Sompob/0000-0002-5460-8447	Wellcome Trust of Great Britain	Mahidol-Oxford Tropical medicine Research Unit is funded by the Wellcome Trust of Great Britain. The authors thank anonymous Reviewer 1 for insightful comments and suggestions for revision.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Boni MF, 2008, P NATL ACAD SCI USA, V105, P14216, DOI 10.1073/pnas.0804628105; Crockett M, 2007, EXPERT OPIN INV DRUG, V16, P705, DOI 10.1517/13543784.16.5.705; CROSS AP, 1991, T ROY SOC TROP MED H, V85, P349, DOI 10.1016/0035-9203(91)90286-8; Greenwood Brian, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS2, DOI 10.1016/j.trstmh.2008.10.027; Gu WD, 2003, T ROY SOC TROP MED H, V97, P43, DOI 10.1016/S0035-9203(03)90018-6; Hommel M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S1; Killeen GF, 2000, AM J TROP MED HYG, V62, P545, DOI 10.4269/ajtmh.2000.62.545; Mackinnon MJ, 2005, ACTA TROP, V94, P207, DOI 10.1016/j.actatropica.2005.04.006; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; Maire N, 2006, AM J TROP MED HYG, V75, P104, DOI 10.4269/ajtmh.2006.75.104; Maude RJ, 2009, T ROY SOC TROP MED H, V103, P643, DOI 10.1016/j.trstmh.2009.01.027; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; MCKENZIE FE, 2002, AM J TROP MED HYG, V67, P517; Molyneux DH, 2004, TRENDS PARASITOL, V20, P347, DOI 10.1016/j.pt.2004.06.004; Osborne K, 2000, INT J EPIDEMIOL, V29, P362, DOI 10.1093/ije/29.2.362; Rieckmann KH, 2006, ANN TROP MED PARASIT, V100, P647, DOI 10.1179/136485906X112185; Ross R., 1911, PREVENTION MALARIA; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Sochantha T, 2006, TROP MED INT HEALTH, V11, P1166, DOI 10.1111/j.1365-3156.2006.01673.x; MALARIA ELIMINATION	22	41	41	0	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 14	2009	8								212	10.1186/1475-2875-8-212				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	508WP	WOS:000270969200001	19747403	DOAJ Gold, Green Published			2019-04-02	
J	Akoda, K; Van Den Abbeele, J; Marcotty, T; De Deken, R; Sidibe, I; Van den Bossche, P				Akoda, K.; Van Den Abbeele, J.; Marcotty, T.; De Deken, R.; Sidibe, I.; Van den Bossche, P.			Nutritional stress of adult female tsetse flies (Diptera: Glossinidae) affects the susceptibility of their offspring to trypanosomal infections	ACTA TROPICA			English	Article						Glossina morsitans; Trypanosoma congolense; Tryponosoma brucei brucei; Starvation; Offspring; Vectorial capacity	MORSITANS-MORSITANS; IMMUNE-RESPONSES; G-BREVIPALPIS; FLY; RATES; TRANSMISSION; PALLIDIPES; FUSCIPES; BRUCEI; SIZE	The epidemiology of tsetse-transmitted trypanosomiasis depends, among other factors, on the proportion of infected flies in a tsetse population. A wide range of intrinsic and extrinsic factors seem to determine the ability of a tsetse fly to become infected and to transmit the parasite. In this paper, we investigated the effect of nutritional stress of reproducing female Glossina morsitans morsitans on the susceptibility of their offspring to trypanosomal infections. Adult female flies that were nutritionally stressed by feeding only once a week, produced pupae with a significant lower weight and offspring with a significant lower fat content as well as a lower baseline immune peptide gene expression. Moreover, infection experiments showed that the emerging teneral flies were significantly more susceptible to a Trypanosoma congolense or Trypanosoma brucei brucei infection than flies emerging from non-starved adult females. These findings suggest that in the field, substantial nutritional stress of adult tsetse flies, as is often experienced during the hot dry season, can increase significantly the vectorial capacity of the emerging teneral flies and thus result in an increased infection rate of the tsetse population. (C) 2009 Elsevier B.V. All rights reserved.	[Marcotty, T.; De Deken, R.; Van den Bossche, P.] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Akoda, K.; Van Den Abbeele, J.] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Sidibe, I.] Ctr Int Rech Dev Elevage Zone Subhumide, Bobo Dioulasso, Burkina Faso; [Van den Bossche, P.] Univ Pretoria, Dept Vet Trop Dis, Onderstepoort, South Africa	Van den Bossche, P (reprint author), Inst Trop Med Prince Leopold, Dept Anim Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	pvdbossche@itg.be		Van Den Abbeele, Jan/0000-0002-4533-4480			Abubakar LU, 2006, INSECT BIOCHEM MOLEC, V36, P344, DOI 10.1016/j.ibmb.2006.01.010; Aksoy S, 2003, ADV PARASIT, V53, P1, DOI 10.1016/S0065-308X(03)53002-0; Attardo GM, 2006, INSECT MOL BIOL, V15, P411, DOI 10.1111/j.1365-2583.2006.00649.x; Boulanger N, 2002, INSECT BIOCHEM MOLEC, V32, P369, DOI 10.1016/S0965-1748(02)00029-2; BURTT E, 1946, ANN TROP MED PARASIT, V40, P18, DOI 10.1080/00034983.1946.11685259; DENLINGER DL, 1974, J INSECT PHYSIOL, V20, P1015, DOI 10.1016/0022-1910(74)90143-7; DRANSFIELD RD, 1989, MED VET ENTOMOL, V3, P83, DOI 10.1111/j.1365-2915.1989.tb00478.x; Elsen Pierre, 1993, Journal of African Zoology, V107, P439; Fairbairn H., 1948, Tropical Diseases Bulletin London, V45, P1; Fairbairn H., 1950, Acta Tropica, V7, P19; FAIRBAIRN H., 1955, ANN TROP MED AND PARASITOL, V49, P250; FORD J., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P383, DOI 10.1016/0035-9203(61)90108-0; GEIGY R, 1973, Acta Tropica, V30, P12; GLASGOW JP, 1960, B ENTOMOL RES, V51, P705; Hao ZR, 2001, P NATL ACAD SCI USA, V98, P12648, DOI 10.1073/pnas.221363798; HARLEY JMB, 1967, B ENTOMOL RES, V57, P459, DOI 10.1017/S0007485300050203; JACKSON CHN, 1952, B ENTOMOL RES, V43, P703; JORDAN AM, 1965, T ROY SOC TROP MED H, V59, P423, DOI 10.1016/0035-9203(65)90060-X; Kinghorn A., 1912, Annals of Tropical Medicine Liverpool, V6; Koella JC, 2002, MED VET ENTOMOL, V16, P316, DOI 10.1046/j.1365-2915.2002.00381.x; Kubi C, 2006, MED VET ENTOMOL, V20, P388, DOI 10.1111/j.1365-2915.2006.00644.x; LANGLEY PA, 1990, PHYSIOL ENTOMOL, V15, P179, DOI 10.1111/j.1365-3032.1990.tb00505.x; LEAK SGA, 1998, TSETSE BIOL ECOLOGY, P592; Lehane MJ, 2004, TRENDS PARASITOL, V20, P433, DOI 10.1016/j.pt.2004.07.002; LERAY D, 1977, ANN SOC BELG MED TR, V57, P369; LLYOD L, 1924, B ENTOMOL RES, V14, P265; MacLeod ET, 2007, PARASITOLOGY, V134, P827, DOI 10.1017/S0031182007002247; Munks RJL, 2005, INSECT MOL BIOL, V14, P483, DOI 10.1111/j.1365-2583.2005.00579.x; NDEGWA PN, 1992, MED VET ENTOMOL, V6, P127, DOI 10.1111/j.1365-2915.1992.tb00588.x; PHELPS RJ, 1974, B ENTOMOL RES, V64, P313, DOI 10.1017/S0007485300031205; Roditi I, 2008, CURR OPIN MICROBIOL, V11, P345, DOI 10.1016/j.mib.2008.06.006; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; StataCorp, 2006, STAT STAT SOFTW REL; TAYLOR A. W., 1932, PARASITOLOGY, V24, P401; Van den Bossche P, 1999, B ENTOMOL RES, V89, P381; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	36	6	6	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	SEP	2009	111	3					263	267		10.1016/j.actatropica.2009.05.005				5	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	483PK	WOS:000268979500010	19445895	Green Published			2019-04-02	
J	Giroud, C; Ottones, F; Coustou, V; Dacheux, D; Biteau, N; Miezan, B; Van Reet, N; Carrington, M; Doua, F; Baltz, T				Giroud, Christiane; Ottones, Florence; Coustou, Virginie; Dacheux, Denis; Biteau, Nicolas; Miezan, Benjamin; Van Reet, Nick; Carrington, Mark; Doua, Felix; Baltz, Theo			Murine Models for Trypanosoma brucei gambiense Disease Progression-From Silent to Chronic Infections and Early Brain Tropism	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; POLYMERASE-CHAIN-REACTION; MEDIATED ISOTHERMAL AMPLIFICATION; SURFACE GLYCOPROTEIN ISG75; SLEEPING SICKNESS PATIENTS; RECENTLY ISOLATED STOCKS; CEREBROSPINAL-FLUID; ANIMAL TRYPANOSOMES; LABORATORY RODENTS; PARAFLAGELLAR ROD	Background: Human African trypanosomiasis (HAT) caused by Trypanosoma brucei gambiense remains highly prevalent in west and central Africa and is lethal if left untreated. The major problem is that the disease often evolves toward chronic or asymptomatic forms with low and fluctuating parasitaemia producing apparently aparasitaemic serological suspects who remain untreated because of the toxicity of the chemotherapy. Whether the different types of infections are due to host or parasite factors has been difficult to address, since T.b. gambiense isolated from patients is often not infectious in rodents thus limiting the variety of isolates. Methodology/Principal findings: T.b. gambiense parasites were outgrown directly from the cerebrospinal fluid of infected patients by in vitro culture and analyzed for their molecular polymorphisms. Experimental murine infections showed that these isolates could be clustered into three groups with different characteristics regarding their in vivo infection properties, immune response and capacity for brain invasion. The first isolate induced a classical chronic infection with a fluctuating blood parasitaemia, an invasion of the central nervous system (CNS), a trypanosome specific-antibody response and death of the animals within 6 -8 months. The second group induced a sub-chronic infection resulting in a single wave of parasitaemia after infection, followed by a low parasitaemia with no parasites detected by microscope observations of blood but detected by PCR, and the presence of a specific antibody response. The third isolate induced a silent infection characterised by the absence of microscopically detectable parasites throughout, but infection was detectable by PCR during the whole course of infection. Additionally, specific antibodies were barely detectable when mice were infected with a low number of this group of parasites. In both sub-chronic and chronic infections, most of the mice survived more than one year without major clinical symptoms despite an early dissemination and growth of the parasites in different organs including the CNS, as demonstrated by bioluminescent imaging. Conclusions/Significance: Whereas trypanosome characterisation assigned all these isolates to the homogeneous Group I of T.b. gambiense, they clearly induce very different infections in mice thus mimicking the broad clinical diversity observed in HAT due to T.b. gambiense. Therefore, these murine models will be very useful for the understanding of different aspects of the physiopathology of HAT and for the development of new diagnostic tools and drugs.	[Giroud, Christiane; Ottones, Florence; Coustou, Virginie; Dacheux, Denis; Biteau, Nicolas; Baltz, Theo] Univ Bordeaux 2, CNRS, UMR 5234, IFR66, F-33076 Bordeaux, France; [Miezan, Benjamin; Doua, Felix] PRCT, Daloa, Cote Ivoire; [Van Reet, Nick] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Giroud, C (reprint author), Univ Bordeaux 2, CNRS, UMR 5234, IFR66, F-33076 Bordeaux, France.	theo.baltz@u-bordeaux2.fr	Van Reet, Nick/D-8406-2011; Carrington, Mark/N-4892-2018	Carrington, Mark/0000-0002-6435-7266	Centre National de la Recherche Scientifique; Ministere de l'Education Nationale	Centre National de la Recherche Scientifique and The Ministere de l'Education Nationale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ER, 2008, FUTURE MICROBIOL, V3, P167, DOI 10.2217/17460913.3.2.167; Antoine-Moussiaux N, 2008, TRENDS PARASITOL, V24, P411, DOI 10.1016/j.pt.2008.05.010; BALTZ T, 1981, INFECT IMMUN, V32, P979; BALTZ T, 1985, EMBO J, V4, P1273, DOI 10.1002/j.1460-2075.1985.tb03772.x; BECKERS A, 1981, Z PARASITENKD, V64, P285; Berberof M, 2001, MOL BIOCHEM PARASIT, V113, P127, DOI 10.1016/S0166-6851(01)00208-0; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Biteau N, 2000, MOL BIOCHEM PARASIT, V105, P187, DOI DOI 10.1016/S0166-6851(99)00171-1; Blum J, 2005, T ROY SOC TROP MED H, V99, P795, DOI 10.1016/j.trstmh.2005.04.010; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Checchi F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000303; CLAES F, 2009, PLOS NEGL T IN PRESS; CLAYTON CE, 1990, MOL CELL BIOL, V10, P3036, DOI 10.1128/MCB.10.6.3036; Courtioux B, 2006, INT J PARASITOL, V36, P1057, DOI 10.1016/j.ijpara.2006.04.011; Deborggraeve S, 2006, J CLIN MICROBIOL, V44, P2884, DOI 10.1128/JCM.02594-05; Desquesnes M, 2002, VET PARASITOL, V109, P213, DOI 10.1016/S0304-4017(02)00270-4; Desquesnes M, 2001, INT J PARASITOL, V31, P610, DOI 10.1016/S0020-7519(01)00161-8; Dumartin B, 2007, NEUROSCI LETT, V419, P273, DOI 10.1016/j.neulet.2007.04.034; Fevre EM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000333; Garcia A, 2000, TROP MED INT HEALTH, V5, P786, DOI 10.1046/j.1365-3156.2000.00623.x; Gibson W, 2007, INT J PARASITOL, V37, P829, DOI 10.1016/j.ijpara.2007.03.002; Grab DJ, 2008, J NEUROVIROL, V14, P344, DOI 10.1080/13550280802282934; Holzmuller P, 2008, MICROBES INFECT, V10, P79, DOI 10.1016/j.micinf.2007.10.008; HUDSON KM, 1976, NATURE, V264, P256, DOI 10.1038/264256a0; Hunger-Glaser I, 1997, MOL BIOCHEM PARASIT, V90, P347, DOI 10.1016/S0166-6851(97)00139-4; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Inoue N, 1998, TROP MED INT HEALTH, V3, P408; Jamonneau V, 2003, TROP MED INT HEALTH, V8, P589, DOI 10.1046/j.1365-3156.2003.01079.x; Kanmogne GD, 1996, ANN TROP MED PARASIT, V90, P475, DOI 10.1080/00034983.1996.11813072; Keita M, 1997, EXP PARASITOL, V85, P183, DOI 10.1006/expr.1996.4136; Kennedy PGE, 2008, ANN NEUROL, V64, P116, DOI 10.1002/ana.21429; Kennedy PGE, 2007, T ROY SOC TROP MED H, V101, P1061, DOI 10.1016/j.trstmh.2007.05.001; Kennedy PGE, 2006, INT J PARASITOL, V36, P505, DOI 10.1016/j.ijpara.2006.01.012; Koffi M, 2006, ACTA TROP, V98, P183, DOI 10.1016/j.actatropica.2006.04.001; KRONENBERGER P, 1988, ACTA TROP, V45, P181; Kuboki N, 2003, J CLIN MICROBIOL, V41, P5517, DOI 10.1128/JCM.41.12.5517-5524.2003; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Lejon V, 2002, TROP MED INT HEALTH, V7, P685, DOI 10.1046/j.1365-3156.2002.00917.x; Lejon V, 2008, CLIN INFECT DIS, V47, P15, DOI 10.1086/588668; Marcipar IS, 2005, J CLIN MICROBIOL, V43, P5498, DOI 10.1128/JCM.43.11.5498-5503.2005; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; Masocha W, 2004, J CLIN INVEST, V114, P689, DOI 10.1172/JCI200422104; McLaughlin GL, 1996, PARASITOLOGY FOR THE 21ST CENTURY, P261; MEHLITZ D, 1978, TROPENMED PARASITOL, V29, P101; Mendoza-Palomares C, 2008, EUKARYOT CELL, V7, P684, DOI 10.1128/EC.00405-07; Miezan TW, 1998, TROP MED INT HEALTH, V3, P571, DOI 10.1046/j.1365-3156.1998.00267.x; MOSER DR, 1989, PARASITOLOGY, V99, P57, DOI 10.1017/S0031182000061023; Ngaira JM, 2005, EXP PARASITOL, V110, P30, DOI 10.1016/j.exppara.2005.01.001; NGOYI DM, 2009, TROP MED INT HLTH; Nikolskaia OV, 2006, J CLIN INVEST, V116, P2739, DOI 10.1172/JC127798; Nikolskaia OV, 2006, INT J PARASITOL, V36, P513, DOI 10.1016/j.ijpara.2006.01.011; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; OKA M, 1988, MICROBIOL IMMUNOL, V32, P1175, DOI 10.1111/j.1348-0421.1988.tb01481.x; OVERATH P, 1994, PARASITOL TODAY, V10, P53, DOI 10.1016/0169-4758(94)90393-X; Penchenier L, 1996, PARASITE, V3, P387, DOI 10.1051/parasite/1996034387; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; SCHLAEPPI K, 1989, J CELL BIOL, V109, P1695, DOI 10.1083/jcb.109.4.1695; SEYFANG A, 1993, EUR J BIOCHEM, V214, P593, DOI 10.1111/j.1432-1033.1993.tb17958.x; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Solano P, 2002, ACTA TROP, V82, P349, DOI 10.1016/S0001-706X(02)00029-3; Tran T, 2006, PARASITOLOGY, V133, P613, DOI 10.1017/S0031182006000953; Tran T, 2008, J BIOTECHNOL, V135, P247, DOI 10.1016/j.jbiotec.2008.04.012; VANDERPLOEG LHT, 1982, NUCLEIC ACIDS RES, V10, P5905, DOI 10.1093/nar/10.19.5905; VANMARCK EAE, 1981, Z PARASITENKD, V64, P187; VANMEIRVENNE N, 1992, ANN SOC BELG MED TR, V72, P53; VANMEIRVENNE N, 1999, BIOL DIAGNOSIS HUMAN, P235; WHITTLE HC, 1977, AM J TROP MED HYG, V26, P1129, DOI 10.4269/ajtmh.1977.26.1129	67	42	42	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2009	3	9							e509	10.1371/journal.pntd.0000509				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	506ZP	WOS:000270818900005	19721701	DOAJ Gold, Green Published			2019-04-02	
J	Hadinegoro, SRH; Hindra, IS; Han, HH; Gatchalian, S; Bock, HL				Hadinegoro, S. R. H.; Hindra, I. S.; Han, H. H.; Gatchalian, S.; Bock, H. L.			REACTOGENICITY AND IMMUNOGENICITY OF A LIVE-ATTENUATED REFRIGERATOR-STABLE VARICELLA VACCINE (OKA STRAIN) IN HEALTHY SERONEGATIVE SUBJECTS AGE 10 MONTHS TO 12 YEARS	SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH			English	Article							CHILDREN; VARILRIX(TM); SAFETY; TOLERABILITY	This study assessed the immunogenicity and reactogenicity of a live-attenuated varicella vaccine (Oka strain), Varilrix (TM) in Indonesian children age 10 months to 12 years. A total of 300 seronegative subjects were stratified into three age subgroups (10 months to < 3 years, 3 years to < 7 years and 7 to 12 years) and all received a single-dose of Oka strain varicella vaccine. One solicited local symptom (injection site soreness) was reported during the 43-day post-vaccination follow-up period. Fever (29/295; 10%) was more prevalent than rash (3/295; 1%,) but the incidence of grade 3 fever (defined as axillary temperature of > 39 degrees C) was infrequent. No grade 3 unsolicited events and no serious adverse events were reported. The vaccine proved to be immunogenic in all age groups; all but one subject seroconverted for anti-varicella antibodies 43-days post-vaccination. This study demonstrated that the live-attenuated varicella vaccine (Oka strain) was well tolerated and immunogenic with no safety issues when administered as a single dose primary vaccination to healthy, seronegative Indonesian subjects age 10 months to 12 years.	[Hadinegoro, S. R. H.] Univ Indonesia, Div Infect & Trop Pediat, Dept Child Hlth, Ciptomangunkusumo Gen Hosp,Med Sch, Jakarta 10430, Indonesia; [Han, H. H.; Gatchalian, S.; Bock, H. L.] GlaxoSmithKline Biol, Rixensart, Belgium	Hadinegoro, SRH (reprint author), Univ Indonesia, Div Infect & Trop Pediat, Dept Child Hlth, Ciptomangunkusumo Gen Hosp,Med Sch, Jl Salemba 6, Jakarta 10430, Indonesia.	srh3546@centrin.net.id			GlaxoSmithKline Biologicals	This study was funded by GlaxoSmithKline Biologicals. The authors would like to thank Sarah Benns and Geetha Subramanyarn for providing writing assistance in the preparation of this manuscript and Martine Douha for providing statistical input. Varilrix (R) is a trademark of the GlaxoSmithKline group of companies.	Ampofo K, 2002, CLIN INFECT DIS, V34, P774, DOI 10.1086/338959; Barzaga N. G., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P259; Chiu SS, 2005, EXPERT REV VACCINES, V4, P629, DOI 10.1586/14760584.4.5.629; Clements DA, 2000, BIODRUGS, V14, P49, DOI 10.2165/00063030-200014010-00005; DEMOIRA AP, 2005, EUROSURVEILLANCE, V10, P43; Diaz C, 2006, VACCINE, V24, P6875, DOI 10.1016/j.vaccine.2006.06.030; Diaz-Mitoma F, 2000, Can J Infect Dis, V11, P97; Kreth HW, 2008, BIODRUGS, V22, P387, DOI 10.2165/0063030-200822060-00005; Lau YL, 2002, VACCINE, V20, P2942, DOI 10.1016/S0264-410X(02)00245-1; Lee BW, 1998, TROP MED INT HEALTH, V3, P886; LICHENSTEIN R, PEDIAT CHICKEN POX V; LIEU TA, 1994, JAMA-J AM MED ASSOC, V271, P375, DOI 10.1001/jama.271.5.375; Lopez AS, 2006, PEDIATRICS, V117, P1070; Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1; MEURICE F, 1996, J INFECT DIS S3, V174, P324; MILLER E, 1993, LANCET, V341, P309; Offit PA, 2008, NEW ENGL J MED, V358, P2089, DOI 10.1056/NEJMp0802904; Ramkissoon A, 1995, S AFR MED J, V85, P1295; SLOAN DSG, 1992, LANCET, V340, P974, DOI 10.1016/0140-6736(92)92860-I; Tan AYS, 1996, EUR J PEDIATR, V155, P706; VARIS T, 1996, J INFECT DIS S, V174, P342	21	4	4	0	0	SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION	BANGKOK	SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND	0125-1562			SE ASIAN J TROP MED	Southeast Asian J. Trop. Med. Public Health	SEP	2009	40	5					991	999						9	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	503FW	WOS:000270519800016	19842382				2019-04-02	
J	Van den Ende, J				Van den Ende, J.			The Kabisa computer training program for tropical medicine	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van den Ende, J.] Inst Trop Geneeskunde, Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						2	2						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000004					2019-04-02	
J	Roddy, P; Sterk, E; Van Herp, M; Calain, P; Sprecher, A; Jeffs, B; de la Rosa, O; Lokuge, K; Palma, PP				Roddy, P.; Sterk, E.; Van Herp, M.; Calain, P.; Sprecher, A.; Jeffs, B.; de la Rosa, O.; Lokuge, K.; Palma, P. P.			Clinical manifestations and supportive treatment outcomes: ebola haemorrhagic fever data from Bundibugyo, Uganda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Roddy, P.; Sterk, E.; Jeffs, B.; de la Rosa, O.; Palma, P. P.] Med Sans Frontieres, Barcelona, Spain; [Sterk, E.; Van Herp, M.; Sprecher, A.] Med Sans Frontieres, Brussels, Belgium; [Calain, P.] Med Sans Frontieres, Geneva, Switzerland; [Lokuge, K.] Med Sans Frontieres, Amsterdam, Netherlands								0	0	0	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						4	4						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000009					2019-04-02	
J	Marchal, B; Kegels, G				Marchal, B.; Kegels, G.			Stimulating health workers to provide responsive care in low-resource settings: paying for performance won't do the job on its own	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									Inst Trop Med, B-2000 Antwerp, Belgium; Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						5	6						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000013					2019-04-02	
J	Ablefoni, S; Yondo, D; Schnellbach, KP; Knobloch, U; Schneider, A; Belkaab, N; Dujardin, B; Bin Shujaa, RS; Bilivogui, P				Ablefoni, S.; Yondo, D.; Schnellbach, K. P.; Knobloch, U.; Schneider, A.; Belkaab, N.; Dujardin, B.; Bin Shujaa, R. Sheikh; Bilivogui, P.			What is systemic quality improvement? Objectives and principles, values, methods and results	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ablefoni, S.] German Dev Agcy GTZ, Dakar, Senegal; [Yondo, D.; Schneider, A.] German Dev Agcy GTZ, Hlth Program DRC, Kinshasa, Zaire; [Schnellbach, K. P.; Knobloch, U.] German Dev Agcy GTZ, Dept Hlth, Eschborn, Germany; [Belkaab, N.] Hosp & Ambulant Care, Minist Hlth, Rabat, Morocco; [Dujardin, B.] Univ Libre Bruxelles, Polit & Programmes Sante Int, Brussels, Belgium; [Bin Shujaa, R. Sheikh] Minist Hlth, Sanaa, Yemen; [Bilivogui, P.] Minist Hlth, Reg Dept Labe, Conakry, Guinea								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						12	12						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000033					2019-04-02	
J	Dujardin, B; Schnellbach, KP; Knobloch, U; Schneider, A; Yondo, D; Belkaab, N; Bilivogui, P; Bin Shujaa, RGS; Albefoni, S				Dujardin, B.; Schnellbach, K. P.; Knobloch, U.; Schneider, A.; Yondo, D.; Belkaab, N.; Bilivogui, P.; Bin Shujaa, R. G. Sheikh; Albefoni, S.			The systemic quality improvement network: a new experience in coordinating and strengthening international and national expertise promoting systemic quality improvement approaches	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dujardin, B.] Univ Libre Bruxelles, Polit & Programmes Sante Int, Brussels, Belgium; [Schnellbach, K. P.; Knobloch, U.] German Dev Agcy GTZ, Eschborn, Germany; [Schneider, A.; Yondo, D.] German Dev Agcy GTZ, Hlth Program DRC, Kinshasa, Zaire; [Belkaab, N.] Minist Hlth, Hosp & Ambulant Care, Rabat, Morocco; [Bilivogui, P.] Minist Hlth, Reg Dept Labe, Conakry, Guinea; [Bin Shujaa, R. G. Sheikh] Minist Publ Hlth & Populat, Sanaa, Yemen; [Albefoni, S.] German Dev Agcy GTZ, Dakar, Senegal								0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						14	14						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000038					2019-04-02	
J	Kade, M; Bin Shujaa, RGS; Dujardin, B; Jahhaf, A; Salah, B				Kade, M.; Bin Shujaa, R. G. Sheikh; Dujardin, B.; Jahhaf, A.; Salah, B.			The Quality Improvement Programme (QIP) in Yemen: a successful experience to step up health providers behavior and to increase health services results	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kade, M.] German Dev Agcy GTZ, MOPHP Yemen, Sanaa, Yemen; [Bin Shujaa, R. G. Sheikh] Minist Publ Hlth & Populat, Sanaa, Yemen; [Dujardin, B.] Univ Libre Bruxelles, Polit & Programmes Sante Int, Brussels, Belgium; [Jahhaf, A.; Salah, B.] German Dev Agcy GTZ, Yemeni German Reprod Hlth Program, Sanaa, Yemen								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						14	14						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000037					2019-04-02	
J	De Brouwere, V; Richard, F; Witter, S				De Brouwere, V.; Richard, F.; Witter, S.			Access to maternal and perinatal health services: successful and less successful examples of improving access to safe delivery and care of the newborn	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Brouwere, V.] Inst Natl Adm Sanitaire, Rabat, Belgium; [De Brouwere, V.; Richard, F.] Inst Trop Med, B-2000 Antwerp, Belgium; [Witter, S.] Univ Aberdeen, Aberdeen, Scotland								0	0	0	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						16	17						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000047					2019-04-02	
J	Dujardin, B				Dujardin, B.			Sector-wide approach and health policy reforms: SWAP is the answer, but what is the question?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dujardin, B.] ESP, ULB, Brussels, Belgium								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						17	18						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000050					2019-04-02	
J	Van den Ende, J				Van den Ende, J.			The Kabisa travel expert program	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van den Ende, J.] Inst Trop Geneeskunde, Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						17	17						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000048					2019-04-02	
J	Paul, E; Dujardin, B; Zinnen, V; Laokri, S; Robert, A				Paul, E.; Dujardin, B.; Zinnen, V.; Laokri, S.; Robert, A.			SWAPs in motion: lessons from case studies in six African countries	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Paul, E.] Univ Liege, Liege, Belgium; [Dujardin, B.; Laokri, S.] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium; [Zinnen, V.; Robert, A.] Catholic Univ Louvain, Sch Publ Hlth, Brussels, Belgium								0	1	1	1	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						18	19						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000052					2019-04-02	
J	Van der Roost, D				Van der Roost, D.			Be-cause Health, Belgian initiative for international health	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van der Roost, D.] Inst Trop Med, B-2000 Antwerp, Belgium								0	0	0	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						18	18						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000051					2019-04-02	
J	Bosmans, M; Temmerman, M				Bosmans, M.; Temmerman, M.			A rights-based approach to prevention and response to gender-based violence in conflict settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bosmans, M.; Temmerman, M.] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium								0	0	0	0	3	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						20	20						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000056					2019-04-02	
J	Temmerman, M; Maternowska, C; Othigo, MJ				Temmerman, M.; Maternowska, C.; Othigo, M. J.			Organising referral and health care for survivors of sexual violence; an example from Mombasa, Kenya	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Temmerman, M.] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Maternowska, C.] ICRH Kenya, Mombasa, Kenya; [Othigo, M. J.] Coast Gen Hosp, Mombasa, Kenya								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						20	20						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000057					2019-04-02	
J	Cohen, J				Cohen, J.			The vaccine RTS,S/AS: from the original insight to the development of the most promising candidate	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cohen, J.] GlaxoSmithKline Biol, R&D, Rixensart, Belgium								0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						21	21						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000059					2019-04-02	
J	Keygnaert, I; Keygnaert, J; Vettenburg, N; Bosmans, M; Temmerman, M				Keygnaert, I.; Keygnaert, J.; Vettenburg, N.; Bosmans, M.; Temmerman, M.			Sexual violence against and among sub-Saharan transmigrants in Morocco: a participatory assessment of determinants	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Keygnaert, I.; Bosmans, M.; Temmerman, M.] Univ Ghent, ICRH, B-9000 Ghent, Belgium; [Keygnaert, J.] Partners Reprod Hlth ICRH Global, Ghent, Belgium								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						25	26						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000073					2019-04-02	
J	Philips, M				Philips, M.			Removing user fees: selective or comprehensive?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Philips, M.] Med Sans Frontieres, Anal & Advocacy Unit, Brussels, Belgium								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						26	27						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000076					2019-04-02	
J	Ponsar, F; Mancini, S; Van Herp, M; Firmenich, P; Kakudji, L; Philips, M				Ponsar, F.; Mancini, S.; Van Herp, M.; Firmenich, P.; Kakudji, L.; Philips, M.			Reducing mortality in Mali through free health care for children and pregnant women and enhanced malaria care	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ponsar, F.; Mancini, S.; Van Herp, M.; Firmenich, P.; Kakudji, L.; Philips, M.] Dept Med, MSF, Brussels, Belgium								0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						31	31						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000090					2019-04-02	
J	Zinnen, V; Mwisongo, A; Robert, A				Zinnen, Veronique; Mwisongo, A.; Robert, A.			Health sector reforms and quality of care at the district level in Tanzania	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Zinnen, Veronique; Robert, A.] Catholic Univ Louvain, Ecole Sante Publ, Unite Epidemiol & Biostat, Brussels, Belgium; [Mwisongo, A.] Natl Inst Med Res, Dar Es Salaam, Tanzania								0	1	1	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						32	32						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000093					2019-04-02	
J	Guerra, M; Rodriguez, A; De Vos, P; Bonet, M; Van der Stuyft, P				Guerra, M.; Rodriguez, A.; De Vos, P.; Bonet, M.; Van der Stuyft, P.			Ensuring access to first line care in a changing environment: the experience of the Dragones-area in CentroHabana, Cuba (2004-2007)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Guerra, M.; Rodriguez, A.; Bonet, M.] INHEM, Havana, Cuba; [De Vos, P.; Van der Stuyft, P.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium			De Vos, Pol/D-3370-2009					0	1	1	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						33	33						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000095					2019-04-02	
J	Philips, M; Ponsar, F; Simons, S				Philips, M.; Ponsar, F.; Simons, S.			Abolish user fees: a major difference in increased coverage of essential reproductive health care	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Philips, M.; Ponsar, F.; Simons, S.] Med Sans Frontieres, Anal & Advocacy Unit, Brussels, Belgium								0	0	0	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						33	33						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000094					2019-04-02	
J	Schirvel, C; Bahizire, E; Bahati, E; Bisimwa, G; Dramaix, M; Donnen, P				Schirvel, C.; Bahizire, E.; Bahati, E.; Bisimwa, G.; Dramaix, M.; Donnen, P.			How to improve women's and partner's participation to prenatal HIV counseling in rural and urban areas in Kivu, democratic republic of Congo?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Schirvel, C.; Dramaix, M.] SSPN, Cemubac, Brussels, Belgium; [Bahizire, E.; Bisimwa, G.] Cemubac, Bukavu, Zaire; [Bahati, E.] CRSN Lwiro, Lwiro, Zaire; [Dramaix, M.; Donnen, P.] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium								0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						34	34						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000099					2019-04-02	
J	Affolabi, D; Sanoussi, N; Senou, N; Portaels, F; Anagonou, S				Affolabi, D.; Sanoussi, N.; Senou, N.; Portaels, F.; Anagonou, S.			Cost-effective strategy for confirmation of Mycobacterium ulcerans disease (Buruli ulcer) in low-resource and endemic settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Affolabi, D.; Sanoussi, N.; Senou, N.; Anagonou, S.] PNT, LRM, Cotonou, Benin; [Portaels, F.] Inst Trop Med, B-2000 Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						36	37						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000106					2019-04-02	
J	Yemoa, A; Martin, A; Gbenou, J; Affolabi, D; Johnson, RC; Djego, J; Moudachirou, M; Bigot, A; Anagonou, S; Portaels, F; Quetin-Leclercq, J				Yemoa, A.; Martin, A.; Gbenou, J.; Affolabi, D.; Johnson, R. C.; Djego, J.; Moudachirou, M.; Bigot, A.; Anagonou, S.; Portaels, F.; Quetin-Leclercq, J.			Antimycobacterial efficacy of plants from Benin against Mycobacterium ulcerans	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Yemoa, A.; Bigot, A.] Univ Abomey Calavi, UFR Pharm, Cotonou, Benin; [Martin, A.; Portaels, F.] Inst Trop Med, B-2000 Antwerp, Belgium; [Affolabi, D.; Anagonou, S.] Univ Abomey Calavi, Fac Sci Sante, Lab Reference Mycobacteries, Cotonou, Benin; [Johnson, R. C.] Minist Sante, Programme Natl Lutte Ulcere Buruli, Cotonou, Benin; [Djego, J.] Univ Abomey Calavi, Fac Sci Agron, Lab Ecol Appl, Cotonou, Benin; [Quetin-Leclercq, J.] Univ Catholique Louvain, Louvain Drug Res Inst, Unite CHAM, Lab Pharmacognosie, B-1200 Brussels, Belgium								0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						36	36						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000105					2019-04-02	
J	Hasker, E; Mitashi, P; Baelmans, R; Lutumba, P; Jacquet, D; Lejon, V; Kande, V; Van der Veken, W; Declercq, J; Boelaert, M; Mitashi, P				Hasker, E.; Mitashi, P.; Baelmans, R.; Lutumba, P.; Jacquet, D.; Lejon, V.; Kande, V.; Van der Veken, W.; Declercq, J.; Boelaert, M.; Mitashi, P.			A new format of the CATT test for the detection of Human African Trypanosomiasis, designed for use in peripheral health facilities	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Baelmans, R.; Jacquet, D.] ITM, Appl Technol & Prod Unit, Antwerp, Belgium; [Mitashi, P.; Lutumba, P.; Mitashi, P.] Univ Kinshasa, Fac Med, Kinshasa, Zaire; [Lejon, V.] ITM, Dept Parasitol, Antwerp, Belgium; [Kande, V.] Natl Program Control HAT, Kinshasa, Zaire; [Van der Veken, W.; Declercq, J.] Belgian Tech Cooperat, Kinshasa, Zaire			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						42	43						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000125					2019-04-02	
J	Mpanya, A; Hendrickx, D; Mitashi, P; Lutumba, P; Boelaert, M; Lefevre, P				Mpanya, A.; Hendrickx, D.; Mitashi, P.; Lutumba, P.; Boelaert, M.; Lefevre, P.			Perception of Human African Trypanosomiasis and participation in the control programme in the Kasai Oriental province of DRCongo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mpanya, A.] Programme Natl Lutte THA, Kinshasa, Zaire; [Hendrickx, D.; Boelaert, M.; Lefevre, P.] Inst Trop Med, B-2000 Antwerp, Belgium; [Mitashi, P.] Univ Kinshasa, Kinshasa, Zaire; [Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, Zaire			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						43	43						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000127					2019-04-02	
J	Priotto, G; Kasparian, S; Mutombo, W; Ngouama, D; Ghorashian, S; Arnold, U; Ghabri, S; Baudin, E; Buard, V; Kazadi-Kyanza, S; Ilunga, M; Mutangala, W; Pohlig, G; Schmid, C; Karunakara, U; Torreele, E; Kande, V				Priotto, G.; Kasparian, S.; Mutombo, W.; Ngouama, D.; Ghorashian, S.; Arnold, U.; Ghabri, S.; Baudin, E.; Buard, V.; Kazadi-Kyanza, S.; Ilunga, M.; Mutangala, W.; Pohlig, G.; Schmid, C.; Karunakara, U.; Torreele, E.; Kande, V.			Multicentre clinical trial of nifurtimox-eflornithine combination therapy for second-stage sleeping sickness	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Priotto, G.; Kasparian, S.; Ghabri, S.; Baudin, E.] Epictr, Paris, France; [Mutombo, W.; Ilunga, M.; Mutangala, W.; Kande, V.] DRC, PNLTHA, Kinshasa, DEM REP CONGO; [Ngouama, D.] Minist Hlth, Brazzaville, Rep Congo; [Ghorashian, S.; Arnold, U.] Med Sans Frontieres, Amsterdam, Netherlands; [Buard, V.; Kazadi-Kyanza, S.] Med Sans Frontieres, Brussels, Belgium; [Pohlig, G.; Schmid, C.] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Torreele, E.] Drugs Neglected Dis Initiat, Geneva, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14			2			43	43						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000126					2019-04-02	
J	D'Alessandro, U; Nahum, A; Lyimo, J; Otieno, L; Maiga, H; Bashraheil, M; Machevo, S; Ouma, P; Makame, H; Mulure, N; Nwaiwu, O; Cousin, M				D'Alessandro, U.; Nahum, A.; Lyimo, J.; Otieno, L.; Maiga, H.; Bashraheil, M.; Machevo, S.; Ouma, P.; Makame, H.; Mulure, N.; Nwaiwu, O.; Cousin, M.			Efficacy and safety of artemether-lumefantrine dispersible tablet according to body weight in African infants and children with uncomplicated malaria: results of a multinational, randomised trial	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[D'Alessandro, U.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [D'Alessandro, U.; Nahum, A.] Ctr Rech Entomol, Cotonou, Benin; [Lyimo, J.] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Otieno, L.] Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya; [Maiga, H.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Bashraheil, M.] Kenya Govt Med Res Ctr, Kilifi, Kenya; [Machevo, S.] Manhica Hlth Res Ctr CISM, Manhica, Mozambique; [Ouma, P.] Ctr Dis Control, Kenya Med Res Inst, Kisumu, Kenya; [Makame, H.] Karolinska Inst, Zanzibar Malaria Res Unit, Zanzibar, Tanzania; [Mulure, N.] Novartis Pharma AG, Nairobi, Kenya; [Nwaiwu, O.] Novartis Pharma AG, Lagos, Nigeria; [Cousin, M.] Novartis Pharma AG, Basel, Switzerland			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						45	45						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000132					2019-04-02	
J	Roels, B				Roels, B.			Ethical principles and practices in clinical research: an explorative survey	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Roels, B.] Inst Trop Med, B-2000 Antwerp, Belgium								0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						46	47						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000137					2019-04-02	
J	Halidou, T; Talisuna, A; Rouamba, N; Adoke, Y; Grietens, KP; D'Alessandro, U; Ravinetto, R				Halidou, T.; Talisuna, A.; Rouamba, N.; Adoke, Y.; Grietens, K. Peeters; D'Alessandro, U.; Ravinetto, R.			Informed consent, decision-making capacity and vulnerability in resource constrained settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Halidou, T.; Rouamba, N.] Ctr Muraz, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Talisuna, A.; Rouamba, N.] Uganda Malaria Surveillance Project, Kampala, Uganda; [Grietens, K. Peeters; D'Alessandro, U.; Ravinetto, R.] Inst Trop Med Price Leopold, Clin Trial Unit, Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						47	47						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000138					2019-04-02	
J	Ravinetto, R; Buve, A; Lutumba, P; Maketa, V; Kadima, AE; Cras, P; Crawley, FP				Ravinetto, R.; Buve, A.; Lutumba, P.; Maketa, V.; Kadima, A. Ebeja; Cras, P.; Crawley, F. P.			Rationalising international approaches to ethical review: examining and revising the ethical review practices for clinical research funded, sponsored or carried out by Northern organizations in developing countries	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ravinetto, R.] Inst Trop Med Price Leopold, Clin Trial Unit, Antwerp, Belgium; [Buve, A.] Inst Trop Med Pronce Leopold, Dept Microbiol, Antwerp, Belgium; [Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, Zaire; [Maketa, V.] Univ Kinshasa, Fac Med, Dept Trop Med, Kinshasa, Zaire; [Kadima, A. Ebeja] DNDi, Kinshasa, Zaire; [Cras, P.] Univ Antwerp Hosp, Eth Comm, Antwerp, Belgium; [Crawley, F. P.] Good Clin Practice Alliance Europe, Kessel Lo, Belgium								0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						47	48						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000139					2019-04-02	
J	Maketa, V; Ebeja, A; Boelaert, M; Ravinetto, R; Lutumba, P				Maketa, V.; Ebeja, A.; Boelaert, M.; Ravinetto, R.; Lutumba, P.			Ethics and clinical research in Democratic Republic of Congo (DRC)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Maketa, V.; Lutumba, P.] Univ Kinshasa, Kinshasa, Zaire; [Ebeja, A.] DNDI & Partenaires, Plateforme Reg Essais Clin THA, Kinshasa, Zaire; [Boelaert, M.; Ravinetto, R.; Lutumba, P.] Inst Trop Med, B-2000 Antwerp, Belgium			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						48	48						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000140					2019-04-02	
J	Philips, M; Dahmane, A; Callewaert, A; Reid, T				Philips, M.; Dahmane, A.; Callewaert, A.; Reid, T.			HIV-positive migrants face important problems of access to care in Thailand	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Philips, M.; Dahmane, A.; Callewaert, A.; Reid, T.] Med Sans Frontieres, Dept Med, Brussels, Belgium								0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						52	52						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000152					2019-04-02	
J	Gies, S; Coulibaly, SO; Ouattara, FT; D'Alessandro, U				Gies, S.; Coulibaly, S. O.; Ouattara, F. T.; D'Alessandro, U.			Malaria control in pregnancy: monitoring the effectiveness of IPTp-SP beyond the coverage with >= 2 doses	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gies, S.; D'Alessandro, U.] Inst Trop Med, B-2000 Antwerp, Belgium; [Coulibaly, S. O.] Lab Natl Sante Publ, Ouagadougou, Burkina Faso			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						57	57						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000166					2019-04-02	
J	Ostyn, B; Gidwani, K; Picado, A; Chappuis, F; Khanal, B; Singh, S; Rijal, S; Sundar, S; Boelaert, M				Ostyn, B.; Gidwani, K.; Picado, A.; Chappuis, F.; Khanal, B.; Singh, S.; Rijal, S.; Sundar, S.; Boelaert, M.			Incidence of asymptomatic infection with L. donovani and their evolution in high endemic villages in India and Nepal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ostyn, B.; Boelaert, M.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Gidwani, K.; Singh, S.; Sundar, S.] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India; [Picado, A.] London Sch Hyg & Trop Med, London WC1, England; [Chappuis, F.] Univ Geneva, Geneva, Switzerland; [Khanal, B.; Rijal, S.] BP Koirala Inst Hlth Sci, Dharan, Nepal			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	3	3	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						60	61						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000176					2019-04-02	
J	Rijal, S; Chappuis, F; Uranw, S; Picado, A; Khanal, B; Paudel, I; Ostyn, B; Das, M; Anderson, E; Davies, C; Boelaert, M				Rijal, S.; Chappuis, F.; Uranw, S.; Picado, A.; Khanal, B.; Paudel, I.; Ostyn, B.; Das, M.; Anderson, E.; Davies, C.; Boelaert, M.			The epidemiology of Leishmania donovani infection in a high transmission foci in Nepal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Rijal, S.; Uranw, S.; Khanal, B.; Paudel, I.; Das, M.] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Chappuis, F.] Univ Hosp Geneva, Travel & Migrat Unit, Geneva, Switzerland; [Picado, A.; Anderson, E.; Davies, C.] London Sch Hyg & Trop Med, London WC1, England; [Ostyn, B.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						60	60						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000175					2019-04-02	
J	Alvar, J; Hendrickx, D; Pickering, J; Dujardin, JC				Alvar, J.; Hendrickx, D.; Pickering, J.; Dujardin, J-C.			The e-compendium: a geo-referenced bibliographical database on leishmaniasis epidemiology	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									World Hlth Org, Neglected Trop Dis HTM NTD IDM, Geneva, Switzerland; [Hendrickx, D.; Dujardin, J-C.] Inst Trop Med, B-2000 Antwerp, Belgium; [Pickering, J.] World Hlth Org, Publ Hlth Mapping Grp, Geneva, Switzerland								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						62	62						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000180					2019-04-02	
J	Gerstl, S; Dunkley, S; Mukhtar, A; Baker, S; Maikere, J				Gerstl, S.; Dunkley, S.; Mukhtar, A.; Baker, S.; Maikere, J.			Successful introduction of artesunate and amodiaquine is not enough to fight malaria - results from an adherence study in Sierra Leone	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gerstl, S.] Med Sans Frontieres, London, Germany; [Dunkley, S.; Mukhtar, A.; Baker, S.; Maikere, J.] Med Sans Frontieres, Bo, Sierra Leone, Belgium; [Baker, S.] Minist Hlth & Sanitat, Freetown, Sierra Leone, Belgium								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						62	63						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000181					2019-04-02	
J	Picado, A; Das, M; Kumar, V; Kesari, S; Dinesh, D; Roy, L; Rijal, S; Das, P; Rowland, M; Boelaert, M; Coosemans, M; Davies, C				Picado, A.; Das, M.; Kumar, V.; Kesari, S.; Dinesh, D.; Roy, L.; Rijal, S.; Das, P.; Rowland, M.; Boelaert, M.; Coosemans, M.; Davies, C.			Mass effect of village-wide use of long lasting impregnated nets on visceral leishmaniasis vectors in India and Nepal: cluster randomized trial	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Picado, A.; Rowland, M.; Davies, C.] London Sch Hyg & Trop Med, London WC1, England; [Das, M.; Roy, L.; Rijal, S.] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Kumar, V.; Kesari, S.; Dinesh, D.; Das, P.] Rajendra Mem Res Inst Med Sci, Patna, Bihar, India; [Boelaert, M.; Coosemans, M.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						62	62						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000179					2019-04-02	
J	D'Alessandro, U; Nahum, A; Juma, E; Sallas, WM; Lyimo, J; Marrast, AC; Lefevre, G; Djimde, A				D'Alessandro, U.; Nahum, A.; Juma, E.; Sallas, W. M.; Lyimo, J.; Marrast, A-C.; Lefevre, G.; Djimde, A.			Exposure to lumefantrine in infants and children receiving artemether-lumefantrine for acute uncomplicated malaria: impact of African diet components	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[D'Alessandro, U.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [D'Alessandro, U.; Nahum, A.] Ctr Rech Entomol Cotonou, Cotonou, Benin; [Juma, E.] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Sallas, W. M.] Novartis Pharmaceut, E Hanover, NJ USA; [Lyimo, J.] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Marrast, A-C.] Novartis Pharma AG, Dept Trop & Infect Dis, Basel, Switzerland; [Djimde, A.] Univ Bamako, Fac Med Pharm & Odontostomatol, Bamako, Mali			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						63	64						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000184					2019-04-02	
J	De Smet, M; Philips, M; Ponsar, F; Gerard, S; Van Herp, M				De Smet, M.; Philips, M.; Ponsar, F.; Gerard, S.; Van Herp, M.			Increased access to malaria diagnosis and treatment through free care provided in health centres and by malaria village workers in Chad, Mali and Sierra Leone	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Smet, M.; Philips, M.; Ponsar, F.; Gerard, S.; Van Herp, M.] MSF, Dept Med, Brussels, Belgium								0	1	1	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						63	63						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000182					2019-04-02	
J	Demeester, R; Bottieau, E; Bisoffi, Z; Pini, A; Wetsteyn, J; Visser, L; Tendero, DT; Delgado, MJP; Van den Ende, J				Demeester, R.; Bottieau, E.; Bisoffi, Z.; Pini, A.; Wetsteyn, J.; Visser, L.; Tendero, D. T.; Delgado, M. -J. P.; Van den Ende, J.			Prospective multicentre evaluation of the expert system Kabisa Travel in diagnosing febrile illnesses occurring after a stay in the tropics	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Demeester, R.; Bottieau, E.; Van den Ende, J.] Inst Trop Med, B-2000 Antwerp, Belgium; [Demeester, R.; Van den Ende, J.] Univ Antwerp Hosp, Unit Trop Dis, Antwerp, Belgium; [Demeester, R.] Univ Hosp St Pierre, Dept Infect Dis, Brussels, Belgium; [Bisoffi, Z.] Sacro Cuore Don Calabria Hosp, Ctr Trop Dis, Negrar, Italy; [Pini, A.] Univ Brescia, Inst Infect & Trop Dis, Brescia, Italy; [Wetsteyn, J.] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Visser, L.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Tendero, D. T.] Univ Gen Hosp Alicante, Dept Internal Med Imported Dis & Clin Parasitol C, Alicante, Spain; [Delgado, M. -J. P.] Hosp Clin Barcelona, Dept Trop Med, Ctr Int Hlth, Barcelona, Spain			Torrus, Diego/D-6145-2019	Torrus, Diego/0000-0002-5694-8162				0	0	0	1	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						78	79						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000225					2019-04-02	
J	Peeters, K; Xuan, XN; Erhart, A; Duc, TN; Le Xuan, H; Le Khan, T; D'Alessandro, U				Peeters, K.; Xuan, X. Nguyen; Erhart, A.; Duc, T. Ngo; Le Xuan, H.; Le Khan, T.; D'Alessandro, U.			The relevance of understanding residence and mobility patterns for forest malaria control in south east asia: the case of the Ra-glai in Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Peeters, K.; Erhart, A.; Duc, T. Ngo; Le Xuan, H.; Le Khan, T.; D'Alessandro, U.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Xuan, X. Nguyen; Erhart, A.; Duc, T. Ngo; Le Xuan, H.; Le Khan, T.; D'Alessandro, U.] NIMPE, Hanoi, Vietnam			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						81	82						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000232					2019-04-02	
J	Duc, TN; Erhart, A; Speybroeck, N; Xuan, XN; Ngoc, TN; Van, KP; Le Xuan, H; Le Khanh, T; Coosemans, M; D'Alessandro, U				Duc, T. Ngo; Erhart, A.; Speybroeck, N.; Xuan, X. Nguyen; Ngoc, T. Nguyen; Van, K. Pham; Le Xuan, H.; Le Khanh, T.; Coosemans, M.; D'Alessandro, U.			Long-lasting insecticidal hammocks for controlling forest malaria: a community-based trial in a rural area of Central Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Duc, T. Ngo; Xuan, X. Nguyen; Ngoc, T. Nguyen; Le Xuan, H.; Le Khanh, T.] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Erhart, A.; Speybroeck, N.; Coosemans, M.; D'Alessandro, U.] Inst Trop Med, B-2000 Antwerp, Belgium; [Van, K. Pham] Prov Ctr Malariol, Ninh Thuan, Phan Rang, Vietnam			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	4	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						85	86						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000244					2019-04-02	
J	Gerstl, S; Dunkley, S; Mukhtar, A; Maes, P; De Smet, M; Baker, S; Maikere, J				Gerstl, S.; Dunkley, S.; Mukhtar, A.; Maes, P.; De Smet, M.; Baker, S.; Maikere, J.			Long-lasting insecticidal mosquito net usage in eastern Sierra Leone - the success of free distribution	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gerstl, S.; Dunkley, S.] Med Sans Frontieres, London, Sierra Leone; [Dunkley, S.; Mukhtar, A.] Med Sans Frontieres, Bo, Sierra Leone; [Maes, P.; De Smet, M.; Maikere, J.] Med Sans Frontieres, Brussels, Belgium; [Baker, S.] Minist Hlth & Sanitat, Freetown, Sierra Leone								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						86	86						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000245					2019-04-02	
J	Grietens, KP; Erhart, A; D'Alessandro, U; Cuentas, AL; Gamboa, D				Grietens, K. Peeters; Erhart, A.; D'Alessandro, U.; Llanos Cuentas, A.; Gamboa, D.			Housing structure, poverty and the acceptability of long lasting insecticidal bed nets in the Peruvian Amazon	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Grietens, K. Peeters; Erhart, A.; D'Alessandro, U.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Llanos Cuentas, A.; Gamboa, D.] Univ Peruana Cayetano Heredia, Lima, Peru			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						87	87						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000250					2019-04-02	
J	Hazeleger, F; Sochantha, T; Erhart, A; Coosemans, M; Van Geertruyden, JP				Hazeleger, F.; Sochantha, T.; Erhart, A.; Coosemans, M.; Van Geertruyden, J. -P.			Risk factors for Malaria in an area with Artemisinine resistance in the forests of Cambodia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hazeleger, F.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Sochantha, T.] Natl Ctr Parasitol Entomol & Malaria Control, CNM, P Penh, Cambodia; [Erhart, A.; Coosemans, M.; Van Geertruyden, J. -P.] Inst Trop Med, B-2000 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	6	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						89	89						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000253					2019-04-02	
J	Sosa, I; Guerra, M; Ferrer, L; Abreu, I; Rodriguez, A; De Vos, P; Lefevre, P; Bonet, M; Van der Stuyft, P				Sosa, I.; Guerra, M.; Ferrer, L.; Abreu, I.; Rodriguez, A.; De Vos, P.; Lefevre, P.; Bonet, M.; Van der Stuyft, P.			Implementation of a participatory method for planning, implementation and evaluation of community health actions in Centro Habana, Cuba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sosa, I.; Guerra, M.; Ferrer, L.; Abreu, I.; Rodriguez, A.; Bonet, M.] INHEM, Havana, Cuba; [De Vos, P.; Lefevre, P.; Van der Stuyft, P.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium			De Vos, Pol/D-3370-2009					0	0	0	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						90	90						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000256					2019-04-02	
J	Gerstl, S; Dunkley, S; Mukhtar, A; De Smet, M; Baker, S; Maikere, J				Gerstl, S.; Dunkley, S.; Mukhtar, A.; De Smet, M.; Baker, S.; Maikere, J.			Assessment of two malaria rapid diagnostic tests, with follow-up of positive pLDH test results, in a hyperendemic falciparum malaria area	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gerstl, S.] Med Sans Frontieres, London, Germany; [Dunkley, S.; Mukhtar, A.] Med Sans Frontieres, Bo, Sierra Leone, Sierra Leone; [De Smet, M.; Maikere, J.] Med Sans Frontieres, Brussels, Belgium; [Baker, S.] Minist Hlth & Sanitat, Freetown, Sierra Leone								0	4	4	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						92	92						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000262					2019-04-02	
J	Grietens, KP; Erhart, A; D'Alessandro, U; Cuentas, AL; Gamboa, D				Grietens, K. Peeters; Erhart, A.; D'Alessandro, U.; Llanos Cuentas, A.; Gamboa, D.			Adherence to 7 day primaquine treatment for Plasmodium vivax in the Peruvian Amazon	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Grietens, K. Peeters; Erhart, A.; D'Alessandro, U.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Llanos Cuentas, A.; Gamboa, D.] Univ Peruana Cayetano Heredia, Lima, Peru			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						94	94						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000268					2019-04-02	
J	Van Den Eede, P; Van, HN; Van Overmeir, C; Vythilingam, I; Duc, TN; Xuan, XN; Le Xuan, H; Manh, HN; Anne, J; D'Alessandro, U; Erhart, A				Van Den Eede, P.; Van, H. Nguyen; Van Overmeir, C.; Vythilingam, I.; Duc, T. Ngo; Xuan, X. Nguyen; Le Xuan, H.; Manh, H. Nguyen; Anne, J.; D'Alessandro, U.; Erhart, A.			Human Plasmodium knowlesi infections in Central Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van Den Eede, P.; Van, H. Nguyen; Van Overmeir, C.; Duc, T. Ngo; D'Alessandro, U.; Erhart, A.] Inst Trop Med, B-2000 Antwerp, Belgium; [Van, H. Nguyen; Duc, T. Ngo] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Vythilingam, I.] Inst Med Res, Kuala Lumpur 50588, Malaysia; [Xuan, X. Nguyen; Le Xuan, H.; Manh, H. Nguyen] NIMPE, Hanoi, Vietnam; [Anne, J.] Catholic Univ Louvain, B-3000 Leuven, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						94	94						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000266					2019-04-02	
J	Casas, EC; De Weggheleire, A; Decroo, T; Maria, BJ; Cumba, L; Maendaenda, R; Das Dores, C; Bottieau, E				Casas, E. Carrillo; De Weggheleire, A.; Decroo, T.; Maria, B. Jesus; Cumba, L.; Maendaenda, R.; Das Dores, C.; Bottieau, E.			Caring for African caregivers: morbidity profile among the hospital staff in Tete, Mozambique	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Casas, E. Carrillo; De Weggheleire, A.; Bottieau, E.] Inst Trop Med, B-2000 Antwerp, Belgium; [Casas, E. Carrillo; Maria, B. Jesus; Maendaenda, R.] Prov Hosp Tete, Tete, Mozambique; [Cumba, L.; Das Dores, C.] Prov Hlth Directorate, Tete, Mozambique								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						96	97						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000274					2019-04-02	
J	Casas, EC; Dos Santos, OA; De Weggheleire, A; Cumba, L; Maendaenda, R; Das Dores, C; Bottieau, E				Casas, E. Carrillo; Dos Santos, O. Artur; De Weggheleire, A.; Cumba, L.; Maendaenda, R.; Das Dores, C.; Bottieau, E.			Implementing opt-out testing strategy in a provincial hospital in Mozambique	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Casas, E. Carrillo; De Weggheleire, A.; Bottieau, E.] Inst Trop Med, B-2000 Antwerp, Belgium; [Casas, E. Carrillo; Dos Santos, O. Artur; Maendaenda, R.] Prov Hosp Tete, Tete, Mozambique; [Cumba, L.; Das Dores, C.] Prov Hlth Directorate, Tete, Mozambique								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						97	97						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000275					2019-04-02	
J	Alvarez, A; Alegret, M; Leyva, A; Rodriguez, A; Bonet, M; De Vos, P; Van der Stuyft, P				Alvarez, A.; Alegret, M.; Leyva, A.; Rodriguez, A.; Bonet, M.; De Vos, P.; Van der Stuyft, P.			Differences in health determinants and in health within Cuba (1989-2000)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Alvarez, A.; Alegret, M.; Leyva, A.; Rodriguez, A.; Bonet, M.] INHEM, Havana, Cuba; [De Vos, P.; Van der Stuyft, P.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium			De Vos, Pol/D-3370-2009					0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						99	99						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000279					2019-04-02	
J	Ponsar, F; Kakudji, L; Firmenich, P; Van Herp, M; Philips, M				Ponsar, F.; Kakudji, L.; Firmenich, P.; Van Herp, M.; Philips, M.			Ensuring that malaria treatment is accessible through the existing health services: MSF experience in Mali	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ponsar, F.; Kakudji, L.; Firmenich, P.; Van Herp, M.; Philips, M.] MSF, Dept Med, Brussels, Belgium								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						102	103						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000289					2019-04-02	
J	De Vos, P; Santos-Pena, M; Ordunez-Garcia, P; Van der Stuyft, P				De Vos, P.; Santos-Pena, M.; Ordunez-Garcia, P.; Van der Stuyft, P.			Public hospital management in times of crisis: lessons learned from Cienfuegos, Cuba (1996-2008)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Vos, P.; Van der Stuyft, P.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Santos-Pena, M.; Ordunez-Garcia, P.] Univ Hosp, Cienfuegos, Cuba			De Vos, Pol/D-3370-2009					0	0	0	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						109	109						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000305					2019-04-02	
J	Lefevre, P; Sosa, I; Guerra, M; Rodriguez, A; De Vos, P; Van der Stuyft, P				Lefevre, P.; Sosa, I.; Guerra, M.; Rodriguez, A.; De Vos, P.; Van der Stuyft, P.			Usefulness of a wedge design to study the implementation of a pilot methodological innovation in the Cuban first line health services	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lefevre, P.; De Vos, P.; Van der Stuyft, P.] Inst Trop Med, B-2000 Antwerp, Belgium; [Sosa, I.; Guerra, M.; Rodriguez, A.] Inst Nacl Higiene Epidemiol & Microbiol, Havana, Cuba			De Vos, Pol/D-3370-2009					0	0	0	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						109	109						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000306					2019-04-02	
J	De Vos, P; Alvarez, A; Rodriguez, A; Bonet, M; Van der Stuyft, P				De Vos, P.; Alvarez, A.; Rodriguez, A.; Bonet, M.; Van der Stuyft, P.			The resilience of Cuba's public health system: How first line health services respond to economic crisis (1990s) and to massive international collaboration (2000s)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Vos, P.; Van der Stuyft, P.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Alvarez, A.; Rodriguez, A.; Bonet, M.] INHEM, Havana, Cuba			De Vos, Pol/D-3370-2009					0	2	2	0	9	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						113	114						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000318					2019-04-02	
J	Bisoffi, Z; Sodiomont, SB; Pattaro, C; Menten, J; Gobbi, F; Angheben, A; Tinto, H; Duffini, C; Van den Ende, J				Bisoffi, Z.; Sodiomont, S. B.; Pattaro, C.; Menten, J.; Gobbi, F.; Angheben, A.; Tinto, H.; Duffini, C.; Van den Ende, J.			Prevalence of malaria infection and of malaria-attributable fever in adult and children attending health facilities in rural Burkina Faso, in dry and rainy season	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bisoffi, Z.; Gobbi, F.; Angheben, A.] Osped Sacrocuore, Verona, Italy; [Sodiomont, S. B.] Ctr Natl Paludisme, Minist Hlth, Ouagadougou, Burkina Faso; [Pattaro, C.] EURAC, Bolzano, Italy; [Menten, J.; Van den Ende, J.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Tinto, H.] Ctr Muraz, Dioulasso, Burkina Faso; [Duffini, C.] Med Sans Frontieres, Kinshasa, Zaire								0	1	1	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						122	122						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000341					2019-04-02	
J	Stokx, J; Casas, E; Beulane, AJ; Gillet, P; Maendaenda, R; Cumba, L; De, A; Bottieau, E; Jacobs, J				Stokx, J.; Casas, E.; Beulane, A. J.; Gillet, P.; Maendaenda, R.; Cumba, L.; De, A.; Bottieau, E.; Jacobs, J.			Seroprevalence of Major Blood-borne Infections among Blood Donors in Tete, Mozambique	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Stokx, J.; Casas, E.; Gillet, P.; De, A.; Bottieau, E.; Jacobs, J.] Inst Trop Med, B-2000 Antwerp, Belgium; [Stokx, J.; Casas, E.; Beulane, A. J.; Maendaenda, R.] Prov Hosp Tete, Tete, Mozambique; [Cumba, L.] Prov Hlth Directorate, Tete, Mozambique								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						139	139						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000392					2019-04-02	
J	Van Belle, S				Van Belle, S.			The role of non-state actors in framing global sexual and reproductive health policy: a historical perspective	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van Belle, S.] Inst Trop Med Prince Leopold, Dept Publ Hlth, B-2000 Antwerp, Belgium								0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						147	147						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000415					2019-04-02	
J	Nathalie, M; Jean, M				Nathalie, M.; Jean, M.			Learning from patients with obstetric fistula unsuccessful repairs	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Nathalie, M.; Jean, M.] Univ Catholique Louvain, Inst Rech Sante & Soc, B-1200 Brussels, Belgium								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						152	153						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000425					2019-04-02	
J	Dorny, P; Kanobana, K; Kabwe, C; Lutumba, P; Polman, K; Praet, N; Sumbu, J				Dorny, P.; Kanobana, K.; Kabwe, C.; Lutumba, P.; Polman, K.; Praet, N.; Sumbu, J.			Taenia solium cysticercosis in the Democratic Republic of Congo: emerging or neglected?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kanobana, K.; Polman, K.] Inst Trop Med, Unit Helminthol, B-2000 Antwerp, Belgium; [Kabwe, C.; Lutumba, P.] Inst Rech Biomed, Kinshasa, Zaire; [Sumbu, J.] Labovet, Kinshasa, Zaire								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						163	164						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000458					2019-04-02	
J	Perez, D; Lefevre, P; Castro, M; Sanchez, L; Toledo, ME; Baly, A; Reyes, A; Perez, K; Vanlerberghe, V; Polo, V; Garcia, A; Lopez, M; Brooks, M; Van der Stuyft, P				Perez, D.; Lefevre, P.; Castro, M.; Sanchez, L.; Toledo, M. E.; Baly, A.; Reyes, A.; Perez, K.; Vanlerberghe, V.; Polo, V.; Garcia, A.; Lopez, M.; Brooks, M.; Van der Stuyft, P.			Fidelity research assists in evaluation, adjustment and scaling-up of community-based interventions in Cuba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Perez, D.; Castro, M.; Sanchez, L.; Toledo, M. E.; Baly, A.; Reyes, A.; Perez, K.] Inst Pedro Kouri, Havana, Cuba; [Lefevre, P.; Vanlerberghe, V.; Van der Stuyft, P.] Inst Trop Med, B-2000 Antwerp, Belgium; [Lopez, M.] Community Ctr, Havana, Cuba								0	1	1	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						167	167						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000467					2019-04-02	
J	Baly, A; Toledo, ME; Rodriguez, K; Benitez, JR; Rodriguez, M; Vanlerberghe, V; Boelaert, M; Van der Stuyft, P				Baly, A.; Toledo, M. E.; Rodriguez, K.; Benitez, J. R.; Rodriguez, M.; Vanlerberghe, V.; Boelaert, M.; Van der Stuyft, P.			The incremental economic cost of controlling Dengue disease in Guantanamo, Cuba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Baly, A.; Toledo, M. E.] Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba; [Rodriguez, K.; Benitez, J. R.; Rodriguez, M.] Prov Unit Aedes Aegypti Control, Guantanamo, Cuba; [Vanlerberghe, V.; Boelaert, M.; Van der Stuyft, P.] Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						168	168						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000471					2019-04-02	
J	Toledo, ME; Baly, A; Vanlerberghe, V; Benitez, JR; Gomez, D; Rodriguez, M; Rodriguez, A; Banderas, D; Ceballos, E; Van der Stuyft, P				Toledo, M. E.; Baly, A.; Vanlerberghe, V.; Benitez, J. R.; Gomez, D.; Rodriguez, M.; Rodriguez, A.; Banderas, D.; Ceballos, E.; Van der Stuyft, P.			The added value of community involvement strategies in the control of Aedes aegypti: from design to translation into practice	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Toledo, M. E.; Baly, A.] Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba; [Vanlerberghe, V.; Van der Stuyft, P.] Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Benitez, J. R.; Gomez, D.; Rodriguez, M.] Prov Unit Aedes Aegypti Control, Guantanamo, Cuba; [Rodriguez, A.; Banderas, D.; Ceballos, E.] Prov Unit Aedes Aegypti Control, Santiago De Cuba, Cuba								0	1	1	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						168	168						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000470					2019-04-02	
J	Reyes, A; Baly, A; Torres, D; Toledo, ME; Polo, V; Garcia, L; Cepero, B; Zamora, G; Vanlerberghe, V; Van der Stuyft, P				Reyes, A.; Baly, A.; Torres, D.; Toledo, M. E.; Polo, V.; Garcia, L.; Cepero, B.; Zamora, G.; Vanlerberghe, V.; Van der Stuyft, P.			Social costs of dengue and Aedes aegypti control in La Lisa, Cuba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Reyes, A.; Baly, A.; Torres, D.; Toledo, M. E.; Cepero, B.] Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba; [Polo, V.; Garcia, L.] Municipal Unit Aedes Aegypti Control, Havana, Cuba; [Zamora, G.] Natl Aedes Aegypti Control Programme, Havana, Cuba; [Vanlerberghe, V.; Van der Stuyft, P.] Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium								0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						169	169						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000472					2019-04-02	
J	Vanlerberghe, V; Villegas, E; Oviedo, M; Baly, A; Lenhart, A; McCall, PJ; Van der Stuyft, P				Vanlerberghe, V.; Villegas, E.; Oviedo, M.; Baly, A.; Lenhart, A.; McCall, P. J.; Van der Stuyft, P.			Effectiveness of insecticide treated materials for Aedes aegypti control in Venezuela	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vanlerberghe, V.; Van der Stuyft, P.] Inst Trop Med, Unit Epidemiol & Dis Control, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Villegas, E.; Oviedo, M.] Univ Los Andes, Inst Witremundo Torrealba, Trujillo, Venezuela; [Baly, A.] Inst Trop Med, Dept Epidemiol, Havana, Cuba; [Lenhart, A.; McCall, P. J.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England								0	2	2	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						169	169						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000473					2019-04-02	
J	Singh, S; Hasker, E; Picado, A; Gidwani, K; Malaviya, P; Singh, R; Boelaert, M; Sundar, S				Singh, S.; Hasker, E.; Picado, A.; Gidwani, K.; Malaviya, P.; Singh, R.; Boelaert, M.; Sundar, S.			Risk factors for visceral leishmaniasis in India: the role of domestic animals	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Singh, S.; Gidwani, K.; Malaviya, P.; Singh, R.; Sundar, S.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Hasker, E.; Boelaert, M.] ITM, Antwerp, Belgium; [Picado, A.] London Sch Hyg & Trop Med, London WC1, England			Boelaert, Marleen/E-2698-2012; Malaviya, Paritosh/B-1819-2012	Boelaert, Marleen/0000-0001-8051-6776; Malaviya, Paritosh/0000-0002-7558-152X				0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						182	182						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000508					2019-04-02	
J	Das, M; Rijal, S; Roy, L; Picado, A; Coosemans, M; Kroeger, A; Boelaert, M				Das, M.; Rijal, S.; Roy, L.; Picado, A.; Coosemans, M.; Kroeger, A.; Boelaert, M.			Assessment of the insecticide residual effect of LNs and IRS used for the control of Phlebotomus argentipes in Nepal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Das, M.; Rijal, S.] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Roy, L.] BPKIHS, Kalanet Project, Dharan, Nepal; [Picado, A.] London Sch Hyg & Trop Med, London WC1, England; [Coosemans, M.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Kroeger, A.] World Hlth Org, Special Programme Res & Training Trop Dis, Geneva, Switzerland			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						184	184						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000516					2019-04-02	
J	Sundar, S; Gidwani, K; Anderson, E; Davies, C; Picado, A; Meheus, F; Chappuis, F; Boelaert, M; Singh, S				Sundar, S.; Gidwani, K.; Anderson, E.; Davies, C.; Picado, A.; Meheus, F.; Chappuis, F.; Boelaert, M.; Singh, S.			The epidemiology of Leishmania donovani infection in high transmission foci in India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sundar, S.; Gidwani, K.; Singh, S.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Anderson, E.; Davies, C.; Picado, A.] Laondon Sch Hyg & Trop Med, London, England; [Meheus, F.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Chappuis, F.] Hop Univ Geneve, Geneva, Switzerland			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						186	186						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000518					2019-04-02	
J	Gidwani, K; Ostyn, B; Picado, A; Chappuis, F; Khanal, B; Singh, SP; Rijal, S; Boelaert, M; Sundar, S				Gidwani, K.; Ostyn, B.; Picado, A.; Chappuis, F.; Khanal, B.; Singh, S. P.; Rijal, S.; Boelaert, M.; Sundar, S.			Persistence of human Leishmania antibodies in past Kala azar cases in the Indian subcontinent	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gidwani, K.; Singh, S. P.; Sundar, S.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Ostyn, B.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Picado, A.] London Sch Hyg & Trop Med, London WC1, England; [Chappuis, F.] Univ Hosp Geneva, Geneva, Switzerland; [Khanal, B.; Rijal, S.] BP Koirala Inst Hlth Sci, Dharan, Nepal			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	1	1	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						187	187						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000521					2019-04-02	
J	Van den Broeck, F; Huyse, T; Meurs, L; Polman, K; Volckaert, F				Van den Broeck, F.; Huyse, T.; Meurs, L.; Polman, K.; Volckaert, F.			Do host-specific factors drive population genetics of human Schistosoma spp.? A molecular study in Pakh, Senegal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van den Broeck, F.; Huyse, T.; Volckaert, F.] Katholieke Univ Leuven, Lab Anim Divers & Systemat, Leuven, Belgium; [Huyse, T.; Meurs, L.; Polman, K.] Inst Trop Med, B-2000 Antwerp, Belgium								0	0	0	0	5	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						188	188						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000526					2019-04-02	
J	Meurs, L; Labuda, L; Amoah, AS; Mbow, M; Ateba, U; Polman, K; Yazdanbakhsh, M; Boakye, D; Mboup, S; Dieye, TN; Mountford, A; Adegnika, AA				Meurs, L.; Labuda, L.; Amoah, A. S.; Mbow, M.; Ateba, U.; Polman, K.; Yazdanbakhsh, M.; Boakye, D.; Mboup, S.; Dieye, T. N.; Mountford, A.; Adegnika, A. A.			S. haematobium-infected Gabonese schoolchildren have elevated pro-inflammatory cytokine responses to single Toll-like-receptor ligands	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Meurs, L.; Polman, K.] Inst Trop Med, B-2000 Antwerp, Belgium; [Labuda, L.; Yazdanbakhsh, M.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Amoah, A. S.; Boakye, D.] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Mbow, M.; Mboup, S.; Dieye, T. N.] Ctr Hosp Univ Le Dantec, Immunol Lab, Dakar, Senegal; [Ateba, U.; Adegnika, A. A.] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Mountford, A.] Univ York, York YO10 5DD, N Yorkshire, England								0	1	1	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						192	192						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000536					2019-04-02	
J	Vereecken, K; Kanobana, K; Woerdemann, M; Heredia, LM; Diaz, RJ; Espinosa, AR; Rivero, LR; Gorbea, MB; Polman, K				Vereecken, K.; Kanobana, K.; Woerdemann, M.; Menocal Heredia, L.; Junco Diaz, R.; Ruiz Espinosa, A.; Rojas Rivero, L.; Bonet Gorbea, M.; Polman, K.			The influence of atopy and helminth infection on total IgE in Cuban schoolchildren	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vereecken, K.; Kanobana, K.; Woerdemann, M.; Polman, K.] Inst Trop Med, B-2000 Antwerp, Belgium; [Menocal Heredia, L.; Junco Diaz, R.; Bonet Gorbea, M.] Natl Inst Hyg Epidemiol & Microbiol, Havana, Cuba; [Rojas Rivero, L.] Inst Pedro Kouri, Havana, Cuba								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						196	196						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000548					2019-04-02	
J	Habimana, L; De Ravestein, CD; Van Malderen, C; De Jaegere, A; Glorieux, C; Lambot, L; Rycken, L; Kalenga, P; Robert, A				Habimana, L.; De Ravestein, C. De Meester; Van Malderen, C.; De Jaegere, A.; Glorieux, C.; Lambot, L.; Rycken, L.; Kalenga, P.; Robert, A.			Goitre and iodine deficiency in Kapolowe district, in Republic Democratic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Habimana, L.; De Ravestein, C. De Meester; Van Malderen, C.; De Jaegere, A.; Glorieux, C.; Lambot, L.; Rycken, L.; Robert, A.] Univ Catholique Louvain, Ecole Sante Publ, B-1200 Brussels, Belgium; [Kalenga, P.] Univ Lubumbashi, Lubumbashi, Zaire								0	0	0	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14						223	223						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HZ	WOS:000269264000625					2019-04-02	
J	Thai, S; Koole, O; Un, P; Ros, S; Munter, P; Damme, W; Jacques, G; Colebunders, R; Lynen, L				Thai, Sopheak; Koole, Olivier; Un, Phally; Ros, Seilavath; De Munter, Paul; Van Damme, Wim; Jacques, Gary; Colebunders, Robert; Lynen, Lutgarde			Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						ART; ART coverage scale-up; survival; loss to follow-up; programme indicators; Cambodia	RESOURCE-POOR SETTINGS; SOUTH-AFRICA; INFECTED PATIENTS; INCOME COUNTRIES; EARLY MORTALITY; THERAPY; SURVIVAL; OUTCOMES; ADULTS; MALAWI	OBJECTIVES To evaluate a 5-year HIV care programme (2003-2007) in the Sihanouk Hospital Center of HOPE, Phnom Penh, Cambodia. METHODS Analysis of routine programme indicators per year: number of new patients, active patients, antiretroviral therapy (ART) coverage in the cohort, mortality and loss to follow-up. Comparison of mortality before and after the start of ART using Kaplan-Meier survival curves. Analysis of risk factors using Cox regression for the combined endpoint of mortality and loss to follow-up in patients on ART. RESULTS 3844 patients were registered in the hospital between March 2003 and December 2007. The mortality and loss to follow-up rate fell and paralleled the rise of ART coverage from 23% in 2003 to 90% in 2007. The mortality and the loss to follow-up rate was significantly higher in patients not on ART but eligible (Log rank P < 0.001). The combined endpoint of mortality and loss to follow-up was 48.7% after one year in patients who were waiting for ART. 1667 patients were started on ART. The combined endpoint (mortality and loss to follow-up) in this group was 11.5% at 12 months and 14.2% at 24 months. Risk factors for mortality in the ART group were male sex, CD4 count < 50 cells/mu l, BMI < 18 and haemoglobin levels < 10 g/dl. CONCLUSION Better access to ART is associated with lower mortality and fewer losses to follow-up. Pre-ART attrition remains significant. Strategies are needed to enable an earlier start of ART and to promote retention in care.	[Koole, Olivier; Van Damme, Wim; Colebunders, Robert; Lynen, Lutgarde] Inst Trop Med, B-2000 Antwerp, Belgium; [Thai, Sopheak; Un, Phally; Ros, Seilavath] Sihanouk Hosp Ctr HOPE, Dept Infect Dis, Phnom Penh, Cambodia; [De Munter, Paul] Univ Ziekenhuizen Leuven, Louvain, Belgium; [Jacques, Gary] Global Programs HOPE Worldwide Ltd, Wayne, PA USA; [Colebunders, Robert] Univ Antwerp, Fac Med, Antwerp, Belgium	Lynen, L (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	llynen@itg.be	Van Damme, Wim/F-7404-2011; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Koole, Olivier/0000-0002-1122-5382	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine, Antwerp; Global Fund to fight AIDS, Tuberculosis and Malaria; Hope World Wide; ITM Secondary Research Fund, Flemish government (SOFI-A grant)	We thank Joris Menten for statistical support, Veerle Huyst and Delphine Sculier for training the doctors of SHCH in the use and implementation of the data collection tools. We are grateful to the doctors and patients of SHCH for their contribution to the data collection. The project was supported by the Belgian Directorate General of Development Cooperation through the framework agreement with the Institute of Tropical Medicine, Antwerp, the Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide. LL received a grant from the ITM Secondary Research Fund, Flemish government (SOFI-A grant).	Badri M, 2006, LANCET, V368, P1254, DOI 10.1016/S0140-6736(06)69117-4; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2006, LANCET, V367, P817; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Coetzee D, 2004, AIDS, V18, P887, DOI [10.1097/01.aids.0000125925.87797.38, 10.1097/00002030-200406003-00006]; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Harries AD, 2004, T ROY SOC TROP MED H, V98, P695, DOI 10.1016/j.trstmh.2004.05.002; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; IVE P, 2009, 16 ANN CROI M MONTR; KEISER O, 2009, 16 ANN CROI M MONTR; KHAIM S, 2004, 15 INT AIDS C BANGK; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; KNOBEL H, 2002, J ACQ IMMUN DEF SYND, V16, P605; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2007, AIDS, V21, P121, DOI 10.1097/QAD.0b013e3280117fa5; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; LYNEN L, 2009, J ACQUIRED IN PRESS; Madec Y, 2007, AIDS, V21, P351, DOI 10.1097/QAD.0b013e328012c54f; *MIN HLTH CAMB NCH, 2008, REP CONS WORKSH HIV; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; *NAT AIDS AUT, 2008, UNGASS COUNTR PROGR; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Royston P., 2004, STATA J, V4, P227, DOI DOI 10.1037//1082-989X.7.2.147; SOK S, 2008, 17 INT AIDS C MEX CI; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; THAI S, 2006, 16 INT AIDS C TOR; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; *WHO, 2003, SCAL ANTR THER RES L; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	39	39	39	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14	9					1048	1058		10.1111/j.1365-3156.2009.02334.x				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HY	WOS:000269263800011	19573140				2019-04-02	
J	Kibadi, K; Boelaert, M; Kayinua, M; Minuku, JB; Muyembe-Tamfum, JJ; Portaels, F; Lefevre, P				Kibadi, Kapay; Boelaert, Marleen; Kayinua, Makanzu; Minuku, Jean-Bedel; Muyembe-Tamfum, Jean-Jacques; Portaels, Francoise; Lefevre, Pierre			Therapeutic itineraries of patients with ulcerated forms of Mycobacterium ulcerans (Buruli ulcer) disease in a rural health zone in the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Mycobacterium ulcerans; Buruli ulcer; disease perception; health seeking behaviour; therapeutic itineraries; Democratic Republic of Congo	SOUTHERN BENIN; STREPTOMYCIN; COMBINATION; EFFICACY; GHANA; MODEL	OBJECTIVE To describe lay perceptions of the ulcerated forms of Mycobacterium ulcerans, commonly called Buruli ulcer (BU), and therapeutic itineraries of BU patients in a rural area of the Democratic Republic of Congo. METHODS Qualitative research consisting of semi-structured interviews of 19 patients with clinical signs of BU and 12 in-depth interviews of confirmed cases allowing for a detailed reconstruction of the itineraries followed. RESULTS The first symptoms of BU are perceived as mild. The perceived seriousness of the disease increases as the ulceration persists, increases in size or results in complications. Knowledge about the biomedical aetiology of the disease is scarce; it is commonly believed to be due to witches' attacks or bad fate. Four therapeutic paths are taken: self-medication, traditional therapy, the church and the health centre. However lay perception, recourse to traditional treatments and self-medication only partially explain the long delays in diagnosis (on average 6 months); the main problem lies with health providers, particularly the lack of proper diagnostic capability. CONCLUSIONS Diagnostic capabilities at health centre level need to be strengthened through training and supervision. Engaging with the population and the traditional healers would render health promotion messages on BU more relevant and culturally acceptable.	[Kibadi, Kapay; Boelaert, Marleen; Portaels, Francoise; Lefevre, Pierre] Inst Trop Med, B-2000 Antwerp, Belgium; [Kibadi, Kapay; Kayinua, Makanzu] Gen Reference Hosp Nsona Mpangu, Lower Congo, Zaire; [Minuku, Jean-Bedel] Cent Off Rural Hlth Zone Nsona Mpangu, Lower Congo, Zaire; [Muyembe-Tamfum, Jean-Jacques] Inst Natl Rech Biomed, Kinshasa, Zaire; [Muyembe-Tamfum, Jean-Jacques] Univ Kinshasa, Kinshasa, Zaire	Lefevre, P (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	plefevre@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776			Asiedu K, 1998, AM J TROP MED HYG, V59, P1015, DOI 10.4269/ajtmh.1998.59.1015; Aujoulat I, 2003, TROP MED INT HEALTH, V8, P750, DOI 10.1046/j.1365-3156.2003.01089.x; BENOIST J, 1996, SOIGNER PLURIEL ESSA, P491; Chauty A, 2007, ANTIMICROB AGENTS CH, V51, P4029, DOI 10.1128/AAC.00175-07; Debacker M, 2004, EMERG INFECT DIS, V10, P1391, DOI 10.3201/eid1008.030886; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.; GOOD BJ, 1996, MED RATIONALITY EXPE; Jaffre Y., 1999, CONSTRUCTION SOCIALE; Janssens P, 2005, B SEANCES ACAD R SCI, V51, P265; Johnson R C, 2004, Med Trop (Mars), V64, P145; Kibadi K, 2005, Med Trop (Mars), V65, P444; Kibadi K, 2008, MED MALADIES INFECT, V38, P156, DOI 10.1016/j.medmal.2007.09.009; Kibadi K, 2007, Med Trop (Mars), V67, P241; KIBADI K, 2004, B SOC PATHOL EXOT, V97, P302; KIBADI K, 2003, CAHIERS SANTE, V13, P39; KIBADI K, 2009, WHOCDSCPEGBUI2009; KIBADI K, 2006, B ALLF, V18, P24; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; Kleinman A., 1980, PATIENTS HEALERS CON; Meyers W M, 1974, Ann Soc Belg Med Trop, V54, P147; Mulder AA, 2008, T ROY SOC TROP MED H, V102, P912, DOI 10.1016/j.trstmh.2008.05.026; Phanzu DM, 2006, AM J TROP MED HYG, V75, P311, DOI 10.4269/ajtmh.2006.75.311; Portaels F., 2003, Bulletin des Seances, Academie Royale des Sciences d'Outre- Mer, V49, P161; SMITH JH, 1970, AM J TROP MED HYG, V19, P657, DOI 10.4269/ajtmh.1970.19.657; Stienstra Y, 2002, AM J TROP MED HYG, V67, P207, DOI 10.4269/ajtmh.2002.67.207; van OYE E, 1950, Ann Soc Belg Med Trop (1920), V30, P619; *WHO, 2008, RAPP REC REUN ANN UL; *WHO, 2004, WHOCDSCPEGBUI200410; *WHO, 2001, BUR ULC DIAGN MYC UL; World Health Organization, 2000, BUR ULC MYC ULC INF	30	24	24	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14	9					1110	1116		10.1111/j.1365-3156.2009.02324.x				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HY	WOS:000269263800019	19563476	Bronze			2019-04-02	
J	Tun-Lin, W; Lenhart, A; Nam, VS; Rebollar-Tellez, E; Morrison, AC; Barbazan, P; Cote, M; Midega, J; Sanchez, F; Manrique-Saide, P; Kroeger, A; Nathan, MB; Meheus, F; Petzold, M				Tun-Lin, W.; Lenhart, A.; Nam, V. S.; Rebollar-Tellez, E.; Morrison, A. C.; Barbazan, P.; Cote, M.; Midega, J.; Sanchez, F.; Manrique-Saide, P.; Kroeger, A.; Nathan, M. B.; Meheus, F.; Petzold, M.			Reducing costs and operational constraints of dengue vector control by targeting productive breeding places: a multi-country non-inferiority cluster randomized trial	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						dengue; vector control; targeted intervention; efficiency of interventions	WATER-STORAGE CONTAINERS; AEDES-AEGYPTI DIPTERA; COMMUNITY PARTICIPATION; SURVEILLANCE; VIETNAM; CAMBODIA; RELEASE; COVERS	OBJECTIVES To test the non-inferiority hypothesis that a vector control approach targeting only the most productive water container types gives the same or greater reduction of the vector population as a non-targeted approach in different ecological settings and to analyse whether the targeted intervention is less costly. METHODS Cluster randomized trial in eight study sites (Venezuela, Mexico, Peru, Kenya, Thailand, Myanmar, Vietnam, Philippines), with each study area divided into 18-20 clusters (sectors or neighbourhoods) of approximately 50-100 households each. Using a baseline pupal-demographic survey, the most productive container types were identified which produced >= 55% of all Ae. aegypti pupae. Clusters were then paired based on similar pupae per person indices. One cluster from each pair was randomly allocated to receive the targeted vector control intervention; the other received the 'blanket' (non-targeted) intervention attempting to reach all water holding containers. RESULTS The pupal-demographic baseline survey showed a large variation of productive container types across all study sites. In four sites the vector control interventions in both study arms were insecticidal and in the other four sites, non-insecticidal (environmental management and/or biological control methods). Both approaches were associated with a reduction of outcome indicators in the targeted and non-targeted intervention arm of the six study sites where the follow up study was conducted (PPI, Pupae per Person Index and BI, Breteau Index). Targeted interventions were as effective as non-targeted ones in terms of PPI. The direct costs per house reached were lower in targeted intervention clusters than in non-targeted intervention clusters with only one exception, where the targeted intervention was delivered through staff-intensive social mobilization. CONCLUSIONS Targeting only the most productive water container types ( roughly half of all water holding container types) was as effective in lowering entomological indices as targeting all water holding containers at lower implementation costs. Further research is required to establish the most efficacious method or combination of methods for targeted dengue vector interventions.	[Tun-Lin, W.] Dept Med Res, Yangon, Myanmar; [Lenhart, A.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Nam, V. S.] Minist Hlth, Gen Dept Prevent Med & Environm Hlth, Hanoi, Vietnam; [Rebollar-Tellez, E.] Univ Autonoma Nuevo Leon, Dept Zool Invertebrados, Lab Entomol Med, Nuevo Leon, Mexico; [Morrison, A. C.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Barbazan, P.] Mahidol Univ, Fac Sci, Ctr Excellence Vectors & Vector Borne Dis, MU IRD Collaborating Res Unit, Salaya, Nathon Pathom, Thailand; [Cote, M.] Univ Los Andes, Nucleo Univ Rafael Rangel, Inst Expt Jose W Torrealba, Trujillo, Venezuela; [Midega, J.] Ctr Geog Med, Kenya Med Res Inst, Kilifi, Kenya; [Sanchez, F.] Univ E Ramon, Magsaysay Mem Med Ctr, Quezon City, Philippines; [Manrique-Saide, P.] Univ Autonoma Yucatan, Dept Zool, Merida, Mexico; [Kroeger, A.] World Hlth Org, Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland; [Kroeger, A.; Nathan, M. B.] World Hlth Org, Dept Neglected Trop Dis, Geneva, Switzerland; [Meheus, F.] Inst Trop Med Prince Leopold, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Petzold, M.] Nord Sch Publ Hlth, Gothenburg, Sweden	Tun-Lin, W (reprint author), Dept Med Res Lower Myanmar, 5 Ziwaka Rd, Yangon 11191, Myanmar.	wtunlin@mptmail.net.mm		REBOLLAR-TELLEZ, EDUARDO/0000-0002-8173-3550; Kroeger, Axel/0000-0001-8438-2904	Special Programme for Research and Training in Tropical Diseases (TDR/WHO)	The research was supported by the Special Programme for Research and Training in Tropical Diseases (TDR/WHO). Permanet water container covers in Venezuela were donated by Vestergaard-Frandsen company in Lausanne, Switzerland. Without a large number of dedicated researchers and field staff this study would not have been possible. In their representation we would like to mention: Myanmar: Pe Than Htun, Tin Oo, Than Win; Venezuela: Milagros Oviedo, Elci Villegas; Mexico: Alejandra Gonzalez-Moreno, Adan Zapata-Peniche, Laura Buenfil-Silva; Peru: Greg Devine, Helvio Astete, David Florin; Kenya: Charles Mbogo, Joseph Mwangangi, Rosemary Sang; Vietnam: Nguyen Thi Yen, Vu Bich Diep, Le Trung Nghia; Philippines: Grace Encelan-Brizuela, Ephraim M. Brizuela, Ferdinand V. Salazar. We also thank the many families who accepted to be part of the study and contributed to its success.	Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x; CLARK GG, 1994, J AM MOSQUITO CONTR, V10, P119; Focks D, 2003, TDRIDEDEN031 UNICEF; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Focks DA, 2006, TDRIRMDEN061; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; Kay BH, 2002, AM J TROP MED HYG, V66, P40, DOI 10.4269/ajtmh.2002.66.40; KAY BH, 1992, J AM MOSQUITO CONTR, V8, P375; Knox TB, 2007, J MED ENTOMOL, V44, P192, DOI 10.1603/0022-2585(2007)44[192:CEOQSM]2.0.CO;2; Kroeger A, 2006, BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Mulla MS, 2004, J AM MOSQUITO CONTR, V20, P64; Nam VS, 1998, AM J TROP MED HYG, V59, P657, DOI 10.4269/ajtmh.1998.59.657; Nathan MB, 2006, ANN TROP MED PARASIT, V100, pS1, DOI 10.1179/136485906X105462; NATHAN MB, 2006, WP31 WHO SCI WORK GR; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; SEBASTIAN A, 1990, B ENTOMOL RES, V80, P223, DOI 10.1017/S0007485300013468; Seng CM, 2008, J VECTOR ECOL, V33, P333, DOI 10.3376/1081-1710-33.2.333; Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x; Tun-Lin W., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P754; TUNLIN W, 1994, J AM MOSQUITO CONTR, V10, P390; TunLin W, 1995, AM J TROP MED HYG, V53, P595, DOI 10.4269/ajtmh.1995.53.595; *WHO, 2006, TDRSWG08 WHO SCI WOR	26	73	74	1	15	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2009	14	9					1143	1153		10.1111/j.1365-3156.2009.02341.x				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	487HY	WOS:000269263800024	19624476	Bronze			2019-04-02	
J	Zwang, J; Olliaro, P; Barennes, H; Bonnet, M; Brasseur, P; Bukirwa, H; Cohuet, S; D'Alessandro, U; Djimde, A; Karema, C; Guthmann, JP; Hamour, S; Ndiaye, JL; Martensson, A; Rwagacondo, C; Sagara, I; Same-Ekobo, A; Sirima, SB; van den Broek, I; Yeka, A; Taylor, WRJ; Dorsey, G; Randrianarivelojosia, M				Zwang, Julien; Olliaro, Piero; Barennes, Hubert; Bonnet, Maryline; Brasseur, Philippe; Bukirwa, Hasifa; Cohuet, Sandra; D'Alessandro, Umberto; Djimde, Abdulaye; Karema, Corine; Guthmann, Jean-Paul; Hamour, Sally; Ndiaye, Jean-Louis; Martensson, Andreas; Rwagacondo, Claude; Sagara, Issaka; Same-Ekobo, Albert; Sirima, Sodiomon B.; van den Broek, Ingrid; Yeka, Adoke; Taylor, Walter R. J.; Dorsey, Grant; Randrianarivelojosia, Milijaona			Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis	MALARIA JOURNAL			English	Article							ARTEMISININ COMBINATION THERAPIES; PLUS SULFADOXINE-PYRIMETHAMINE; PLASMODIUM-FALCIPARUM; CLINICAL-TRIALS; ARTEMETHER-LUMEFANTRINE; MOLECULAR MARKERS; RANDOMIZED-TRIAL; CENTRAL ANGOLA; IN-VIVO; CHILDREN	Background: Artesunate and amodiaquine (AS&AQ) is at present the world's second most widely used artemisinin-based combination therapy (ACT). It was necessary to evaluate the efficacy of ACT, recently adopted by the World Health Organization (WHO) and deployed over 80 countries, in order to make an evidence-based drug policy. Methods: An individual patient data (IPD) analysis was conducted on efficacy outcomes in 26 clinical studies in sub-Saharan Africa using the WHO protocol with similar primary and secondary endpoints. Results: A total of 11,700 patients (75% under 5 years old), from 33 different sites in 16 countries were followed for 28 days. Loss to follow-up was 4.9% (575/11,700). AS&AQ was given to 5,897 patients. Of these, 82% (4,826/5,897) were included in randomized comparative trials with polymerase chain reaction (PCR) genotyping results and compared to 5,413 patients (half receiving an ACT). AS& AQ and other ACT comparators resulted in rapid clearance of fever and parasitaemia, superior to non- ACT. Using survival analysis on a modified intent- to- treat population, the Day 28 PCR- adjusted efficacy of AS& AQ was greater than 90% (the WHO cut- off) in 11/16 countries. In randomized comparative trials (n = 22), the crude efficacy of AS&AQ was 75.9% (95% CI 74.6-77.1) and the PCR-adjusted efficacy was 93.9% (95% CI 93.2-94.5). The risk (weighted by site) of failure PCR-adjusted of AS&AQ was significantly inferior to non-ACT, superior to dihydroartemisinin-piperaquine (DP, in one Ugandan site), and not different from AS+SP or AL (artemether-lumefantrine). The risk of gametocyte appearance and the carriage rate of AS&AQ was only greater in one Ugandan site compared to AL and DP, and lower compared to non-ACT (p = 0.001, for all comparisons). Anaemia recovery was not different than comparator groups, except in one site in Rwanda where the patients in the DP group had a slower recovery. Conclusion: AS& AQ compares well to other treatments and meets the WHO efficacy criteria for use against falciparum malaria in many, but not all, the sub-Saharan African countries where it was studied. Efficacy varies between and within countries. An IPD analysis can inform general and local treatment policies. Ongoing monitoring evaluation is required.	[Zwang, Julien] SMRU, Mae Sot, Thailand; [Olliaro, Piero; Taylor, Walter R. J.] UNICEF UNDP WB WHO Special Programme Res & Train, Geneva, Switzerland; [Barennes, Hubert] Inst Francophonie Med Trop, Viangchan, Laos; [Bonnet, Maryline; Cohuet, Sandra; Guthmann, Jean-Paul; Hamour, Sally] Epictr, Paris, France; [Brasseur, Philippe] IRD, Dakar, Senegal; [Bukirwa, Hasifa; Yeka, Adoke] Uganda Malaria Surveillance Project, Kampala, Uganda; [D'Alessandro, Umberto] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Djimde, Abdulaye; Sagara, Issaka] Univ Bamako, Fac Med & Pharm, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali; [Karema, Corine; Rwagacondo, Claude] Natl Malaria Control Programme, Kigali, Rwanda; [Guthmann, Jean-Paul] Cheikh Anta Diop Univ, Fac Med, Dept Parasitol, Dakar, Senegal; [Martensson, Andreas] Karolinska Univ Hosp, Karolinska Inst, Infect Dis Unit, Dept Med, Stockholm, Sweden; [Same-Ekobo, Albert] CHU, Parasitol Lab, Yaounde, Cameroon; [Sirima, Sodiomon B.] Minist Sante, Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Randrianarivelojosia, Milijaona] Inst Pasteur, Unite Rech Paludisme, Antananarivo, Madagascar; [van den Broek, Ingrid] Med Sans Frontieres, London, England	Zwang, J (reprint author), SMRU, Mae Sot, Thailand.	jul@shoklo-unit.com; olliarop@who.int; barenneshub@yahoo.fr; maryline.bonnet@geneva.msf.org; brasseur@ird.sn; hbukirwa@muucsf.org; s.cohuet@invs.sante.fr; UDAlessandro@itg.be; adjimde@mrtcbko.org; ckarema@gmail.com; jp.guthmann@invs.sante.fr; s.hamour@imperial.ac.uk; jlndiaye@yahoo.com; Andreas.Martensson@ki.se; crwagacondo@hotmail.com; isagara@mrtcbko.org; seko180@hotmail.com; s.sirima.cnlp@fasonet.bf; Ingrid.van.den.Broek@rivm.nl; yadoke@muucsf.org; bobtaylor@oucru.netnam.vn; gdorsey@medsfgh.ucsf.edu; milijaon@pasteur.mg	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Ndiaye, Jean/0000-0003-0450-5551; Randrianarivelojosia, Milijaona/0000-0003-2767-0349			Abacassamo F, 2004, TROP MED INT HEALTH, V9, P200, DOI 10.1046/j.1365-3156.2003.01182.x; Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Agnamey P, 2005, TROP MED INT HEALTH, V10, P926, DOI 10.1111/j.1365-3156.2005.01482.x; Ashley EA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-154; Barennes H, 2004, TROP MED INT HEALTH, V9, P438, DOI 10.1111/j.1365-3156.2004.01224.x; Bonnet M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-54; Brasseur P, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-150; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Bukirwa H, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010007; Carneiro IA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-67; Djimde AA, 2008, AM J TROP MED HYG, V78, P455, DOI 10.4269/ajtmh.2008.78.455; Dorsey G, 2004, AM J TROP MED HYG, V71, P531, DOI 10.4269/ajtmh.2004.71.531; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Durrani N, 2005, TROP MED INT HEALTH, V10, P521, DOI 10.1111/j.1365-3156.2005.01429.x; Grandesso F, 2006, TROP MED INT HEALTH, V11, P1017, DOI 10.1111/j.1365-3156.2006.01655.x; Greenhouse B, 2006, AM J TROP MED HYG, V75, P836, DOI 10.4269/ajtmh.2006.75.836; Guthmann JP, 2006, AM J TROP MED HYG, V75, P143, DOI 10.4269/ajtmh.2006.75.143; Guthmann JP, 2005, T ROY SOC TROP MED H, V99, P485, DOI 10.1016/j.trstmh.2004.11.010; Hamour S, 2005, T ROY SOC TROP MED H, V99, P548, DOI 10.1016/j.trstmh.2004.10.003; Hasugian AR, 2007, CLIN INFECT DIS, V44, P1067, DOI 10.1086/512677; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Irion A, 1998, TROP MED INT HEALTH, V3, P490, DOI 10.1046/j.1365-3156.1998.00253.x; Juni P, 2001, BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001; Kimbi HK, 2007, ANN TROP MED PARASIT, V101, P95, DOI 10.1179/136485907X156942; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; Meremikwu M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-43; *NAT CANC I, COMM TOX CRIT VERS 2; Ndayiragije A, 2004, TROP MED INT HEALTH, V9, P673, DOI 10.1111/j.1365-3156.2004.01255.x; Ndiaye JL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-125; Ndiaye JLA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-16; Osorio L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-25; Pocock SJ, 2008, BMJ-BRIT MED J, V336, P1166, DOI 10.1136/bmj.39561.548924.94; Price RN, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-119; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Rwagacondo CE, 2004, TROP MED INT HEALTH, V9, P1091, DOI 10.1111/j.1365-3156.2004.01316.x; Sibley CH, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-118; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Sirima SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-48; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; Swarthout TD, 2006, TROP MED INT HEALTH, V11, P1503, DOI 10.1111/j.1365-3156.2006.01710.x; Taylor WRJ, 2006, B WORLD HEALTH ORGAN, V84, P956; van den Broek I, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-14; van den Broek I, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-113; WHO, 2006, GUID TREATM MAL; *WHO, GLOB ANT DRUG POL DA; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; SANOFI AVENTIS	49	49	50	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 23	2009	8								203	10.1186/1475-2875-8-203				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	495FH	WOS:000269875500002	19698172	DOAJ Gold, Green Published			2019-04-02	
J	Bonnet, M; van den Broek, I; van Herp, M; Urrutia, PPP; van Overmeir, C; Kyomuhendo, J; Ndosimao, CN; Ashley, E; Guthmann, JP				Bonnet, Maryline; van den Broek, Ingrid; van Herp, Michel; Palma Urrutia, Pedro Pablo; van Overmeir, Chantal; Kyomuhendo, Juliet; Ndosimao, Celestin Nsibu; Ashley, Elizabeth; Guthmann, Jean-Paul			Varying efficacy of artesunate plus amodiaquine and artesunate plus sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM; MOLECULAR MARKERS; ARTEMETHER-LUMEFANTRINE; RANDOMIZED-TRIAL; ANTIMALARIAL; RESISTANCE; CHILDREN; SURVEILLANCE; COMBINATIONS; BRAZZAVILLE	Background: Very few data on anti-malarial efficacy are available from the Democratic Republic of Congo (DRC). DRC changed its anti-malarial treatment policy to amodiaquine (AQ) and artesunate (AS) in 2005. Methods: The results of two in vivo efficacy studies, which tested AQ and sulphadoxine-pyrimethamine (SP) monotherapies and AS+SP and AS+AQ combinations in Boende (Equatorial province), and AS+SP, AS+AQ and SP in Kabalo (Katanga province), between 2003 and 2004 are presented. The methodology followed the WHO 2003 protocol for assessing the efficacy of anti-malarials in areas of high transmission. Results: Out of 394 included patients in Boende, the failure rates on day 28 after PCR-genotyping adjustment of AS+SP and AS+AQ were estimated as 24.6% [95% CI: 16.6-35.5] and 15.1% [95% CI: 8.6-25.7], respectively. For the monotherapies, failure rates were 35.9% [95% CI: 27.0-46.7] for SP and 18.3% [95% CI: 11.6-28.1] for AQ. Out of 207 patients enrolled in Kabalo, the failure rate on day 28 after PCR-genotyping adjustment was 0 [1-sided 95% CI: 5.8] for AS+SP and AS+AQ [1-sided 95% CI: 6.2]. It was 19.6% [95% CI: 11.4-32.7] for SP monotherapy. Conclusion: The finding of varying efficacy of the same combinations at two sites in one country highlights one difficulty of implementing a uniform national treatment policy in a large country. The poor efficacy of AS+AQ in Boende should alert the national programme to foci of resistance and emphasizes the need for systems for the prospective monitoring of treatment efficacy at sentinel sites in the country.	[Bonnet, Maryline] Epictr, CH-1211 Geneva 21, Switzerland; [van den Broek, Ingrid; Ashley, Elizabeth; Guthmann, Jean-Paul] Epictr, F-70011 Paris, France; [van den Broek, Ingrid] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van Herp, Michel] Med Sans Frontieres, Dept Med, Brussels, Belgium; [Palma Urrutia, Pedro Pablo] Med Sans Frontieres, Dept Med, E-08003 Barcelona, Spain; [van Overmeir, Chantal] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; [Kyomuhendo, Juliet] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Ndosimao, Celestin Nsibu] Natl Malaria Control Programme, Kinshasa, Zaire; [Guthmann, Jean-Paul] Inst Veille Sanit INVS, Dept Malad Infect, Unite Malad Prevent Vaccinale, F-94415 St Maurice, France	Bonnet, M (reprint author), Epictr, Rue Lausanne 78, CH-1211 Geneva 21, Switzerland.	maryline.bonnet@geneva.msf.org; ingrid_vandenbroek@yahoo.com; michel.van.herp@brussels.msf.org; PedroPablo.PALMA@barcelona.msf.org; CVOvermeir@itg.be; uganda@epicentre.msf.org; celnsibu@hotmail.fr; elizabeth.ashley@epicentre.msf.org; jp.guthmann@invs.sante.fr					Alker AP, 2008, TROP MED INT HEALTH, V13, P1384, DOI 10.1111/j.1365-3156.2008.02150.x; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Cohuet S, 2006, AM J TROP MED HYG, V75, P152, DOI 10.4269/ajtmh.2006.75.152; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07; Guthmann JP, 2005, T ROY SOC TROP MED H, V99, P485, DOI 10.1016/j.trstmh.2004.11.010; GUTHMANN JP, 2008, PLOS MED, V5, P169; Kabanywanyi AM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-146; Kamya MR, 2007, PLOS CLIN TRIALS, V2, DOI 10.1371/journal.pctr.0020020; Kublin JG, 1998, LANCET, V351, P1629, DOI 10.1016/S0140-6736(98)24022-0; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Nahum A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-170; Ndayiragije A, 2004, TROP MED INT HEALTH, V9, P673, DOI 10.1111/j.1365-3156.2004.01255.x; Ndounga M, 2007, TROP MED INT HEALTH, V12, P1164, DOI 10.1111/j.1365-3156.2007.01904.x; Ndounga M, 2007, ACTA TROP, V103, P163, DOI 10.1016/j.actatropica.2007.06.002; Pearce RJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000055; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Price RN, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-119; RANFORDCARTWRIGHT LC, 1993, PARASITOLOGY, V107, P11, DOI 10.1017/S003118200007935X; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Swarthout TD, 2006, TROP MED INT HEALTH, V11, P1503, DOI 10.1111/j.1365-3156.2006.01710.x; Talisuna AO, 2004, INFECT GENET EVOL, V4, P321, DOI 10.1016/j.meegid.2004.04.002; *WHO, WHOHTMMAL2006110; *WHO, 2008, WORLD MAL REP 2008 C; World Health Organization, ASS MON ANT DRUG EFF	26	23	23	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 10	2009	8								192	10.1186/1475-2875-8-192				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	495EW	WOS:000269874400002	19664280	DOAJ Gold, Green Published			2019-04-02	
J	Nwaka, S; Ramirez, B; Brun, R; Maes, L; Douglas, F; Ridley, R				Nwaka, Solomon; Ramirez, Bernadette; Brun, Reto; Maes, Louis; Douglas, Frank; Ridley, Robert			Advancing Drug Innovation for Neglected Diseases-Criteria for Lead Progression	PLOS NEGLECTED TROPICAL DISEASES			English	Review							PUBLIC-PRIVATE PARTNERSHIPS; PLASMODIUM-FALCIPARUM; GENOME SEQUENCE; CHAGAS-DISEASE; DISCOVERY; MALARIA; PARASITE; HEALTH; CHALLENGES	The current drug R&D pipeline for most neglected diseases remains weak, and unlikely to support registration of novel drug classes that meet desired target product profiles in the short term. This calls for sustained investment as well as greater emphasis in the risky upstream drug discovery. Access to technologies, resources, and strong management as well as clear compound progression criteria are factors in the successful implementation of any collaborative drug discovery effort. We discuss how some of these factors have impacted drug discovery for tropical diseases within the past four decades, and highlight new opportunities and challenges through the virtual North-South drug discovery network as well as the rationale for greater participation of institutions in developing countries in product innovation. A set of criteria designed to facilitate compound progression from screening hits to drug candidate selection is presented to guide ongoing efforts.	[Nwaka, Solomon; Ramirez, Bernadette; Ridley, Robert] WHO, Special Programme Res & Training Trop Dis TDR, CH-1211 Geneva, Switzerland; [Brun, Reto] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Maes, Louis] Univ Antwerp, B-2020 Antwerp, Belgium; [Douglas, Frank] Ewing Marion Kauffman Fdn, Kansas City, MO USA	Nwaka, S (reprint author), WHO, Special Programme Res & Training Trop Dis TDR, CH-1211 Geneva, Switzerland.	nwakas@who.int	Maes, Louis/A-2384-2017	Maes, Louis/0000-0002-2324-9509	WHO/TDR	This work was supported by WHO/TDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; [Anonymous], 2006, PUBL HLTH INN INT PR; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; BAJORATH J, 2002, NAT REV DRUG DISCOV, V1, P882, DOI DOI 10.1038/NRD941; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; *BILL MEL GAT FDN, 2008, GRAND CHALL GLOB HLT; *BIO VENT GLOB HLT, 2007, CLOS GLOB HLTH INN G; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Blundell TL, 2002, NAT REV DRUG DISCOV, V1, P45, DOI 10.1038/nrd706; Boatin BA, 2006, ADV PARASIT, V61, P349, DOI 10.1016/S0065-308X(05)61009-3; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Casenghi M, 2007, PLOS MED, V4, P1722, DOI 10.1371/journal.pmed.0040293; Croft SL, 2006, T ROY SOC TROP MED H, V100, pS4, DOI 10.1016/j.trstmh.2006.03.009; Croft SL, 2005, T ROY SOC TROP MED H, V99, pS9, DOI 10.1016/j.trstmh.2005.06.008; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Duschak Vilma G, 2007, Recent Pat Antiinfect Drug Discov, V2, P19, DOI 10.2174/157489107779561625; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Gribbon P, 2005, DRUG DISCOV TODAY, V10, P17, DOI 10.1016/S1359-6446(04)03275-1; Gutteridge WE, 2006, T ROY SOC TROP MED H, V100, pS21, DOI 10.1016/j.trstmh.2006.02.013; Haas BJ, 2007, EXP PARASITOL, V117, P225, DOI 10.1016/j.exppara.2007.06.005; Holloway GA, 2007, BIOORG MED CHEM LETT, V17, P1422, DOI 10.1016/j.bmcl.2006.11.090; Hopkins AL, 2003, E SCHERING RES FDN W, V42, P11; Hopkins AL, 2007, NATURE, V449, P166, DOI 10.1038/449166a; Horton J, 2003, TRENDS PARASITOL, V19, pP06; Hudson A, 2007, EXPERT OPIN DRUG DIS, V2, pS3, DOI 10.1517/17460441.2.S1.S3; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; JANSSENS PG, 1992, MED HYGIENE AFRIQUE; LEPAPE P, 2008, J ENZYM INHIB MED CH, V1, P1; Lipinski CA, 2000, J PHARMACOL TOXICOL, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Masum H., 2007, Innovations: Technology / Governance / Globalisation, V2, P129, DOI 10.1162/itgg.2007.2.4.129; McKerrow JH, 2005, PLOS MED, V2, P712, DOI 10.1371/journal.pmed.0020210; Moran Mary, 2005, PLoS Med, V2, pe302, DOI 10.1371/journal.pmed.0020302; Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nwaka S, 2005, T ROY SOC TROP MED H, V99, pS20, DOI 10.1016/j.trstmh.2005.06.003; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd.1230; NWAKA S, 2004, COMBATING DIS ASS PO, P164; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; PERRIN D, 2006, EUR PHARM REV, V3, P52; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038//nrd1824; Prichard RK, 2007, PARASITOLOGY, V134, P1073, DOI 10.1017/S0031182007000078; Prichard RK, 2007, EXPERT OPIN DRUG DIS, V2, pS41, DOI 10.1517/17460441.2.S1.S41; Ramirez B, 2007, EXPERT OPIN DRUG DIS, V2, pS53, DOI 10.1517/17460441.2.S1.S53; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; *SPEC PROGR RES TR, 2007, MAK DIFF 30 YEARS RE; *TDR, 2008, LEAD DISC DRUGS INF; Teixeira ARL, 2006, POSTGRAD MED J, V82, P788, DOI 10.1136/pgmj.2006.047357; Townson S, 2007, EXPERT OPIN DRUG DIS, V2, pS63, DOI 10.1517/17460441.2.S1.S63; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; VENNERSTROM JL, 2004, NATURE, V430, P838; *WHO, 2008, 61 WORLD HLTH ASS AG; *WHO TDR, 2008, P IN M A6 8 OCT 20 1; *WHO TDR, 2008, WHO TDR TARG DAT; *WHO TDR JPS, 2007, EXPERT OPIN DRUG DIS, V2, pS99; World Health Organization, 2004, WORLD HLTH REP 2004	61	97	98	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2009	3	8							e440	10.1371/journal.pntd.0000440				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	486TL	WOS:000269220900004	19707561	DOAJ Gold, Green Published			2019-04-02	
J	Vodnala, SK; Ferella, M; Lunden-Miguel, H; Betha, E; van Reet, N; Amin, DN; Oberg, B; Andersson, B; Kristensson, K; Wigzell, H; Rottenberg, ME				Vodnala, Suman K.; Ferella, Marcela; Lunden-Miguel, Hilda; Betha, Evans; van Reet, Nick; Amin, Daniel Ndem; Oberg, Bo; Andersson, Bjorn; Kristensson, Krister; Wigzell, Hans; Rottenberg, Martin E.			Preclinical Assessment of the Treatment of Second-Stage African Trypanosomiasis with Cordycepin and Deoxycoformycin	PLOS NEGLECTED TROPICAL DISEASES			English	Article							ADENOSINE-DEAMINASE; NUCLEOSIDE TRANSPORTER; BRUCEI-BRUCEI; RESISTANCE; KINASE; TRYPANOCIDE; APOPTOSIS; ANALOGS; PURINE; DRUGS	Background: There is an urgent need to substitute the highly toxic compounds still in use for treatment of the encephalitic stage of human African trypanosomiasis (HAT). We here assessed the treatment with the doublet cordycepin and the deaminase inhibitor deoxycoformycin for this stage of infection with Trypanosoma brucei (T.b.). Methodology/Principal Findings: Cordycepin was selected as the most efficient drug from a direct parasite viability screening of a compound library of nucleoside analogues. The minimal number of doses and concentrations of the drugs effective for treatment of T.b. brucei infections in mice were determined. Oral, intraperitoneal or subcutaneous administrations of the compounds were successful for treatment. The doublet was effective for treatment of late stage experimental infections with human pathogenic T.b. rhodesiense and T.b. gambiense isolates. Late stage infection treatment diminished the levels of inflammatory cytokines in brains of infected mice. Incubation with cordycepin resulted in programmed cell death followed by secondary necrosis of the parasites. T.b. brucei strains developed resistance to cordycepin after culture with increasing concentrations of the compound. However, cordycepin-resistant parasites showed diminished virulence and were not cross-resistant to other drugs used for treatment of HAT, i.e. pentamidine, suramin and melarsoprol. Although resistant parasites were mutated in the gene coding for P2 nucleoside adenosine transporter, P2 knockout trypanosomes showed no altered resistance to cordycepin, indicating that absence of the P2 transporter is not sufficient to render the trypanosomes resistant to the drug. Conclusions/Significance: Altogether, our data strongly support testing of treatment with a combination of cordycepin and deoxycoformycin as an alternative for treatment of second-stage and/or melarsoprol-resistant HAT.	[Vodnala, Suman K.; Lunden-Miguel, Hilda; Wigzell, Hans; Rottenberg, Martin E.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Ferella, Marcela; Andersson, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Betha, Evans] Trop Dis Res Ctr, Ndola, Zambia; [van Reet, Nick] Inst Trop Med, B-2000 Antwerp, Belgium; [Amin, Daniel Ndem; Kristensson, Krister] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Oberg, Bo] Medivir AB, Huddinge, Sweden	Vodnala, SK (reprint author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Martin.Rottenberg@ki.se	Van Reet, Nick/D-8406-2011; Andersson, Bjorn/G-9832-2013	Andersson, Bjorn/0000-0002-4624-0259	Swedish International Development Cooperation Agency (SIDA) [SWE-2005-016]; European Union [FP62004-INCO-DEV-3032324]; World Health Organization/TDR	This study was funded by grants from the Swedish International Development Cooperation Agency (SIDA) SWE-2005-016, the European Union (FP62004-INCO-DEV-3032324; NEUROTRYP) and the World Health Organization/TDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON RH, 1977, PHARMACOLOGY, V15, P84, DOI 10.1159/000136666; AGARWAL RP, 1975, BIOCHEM PHARMACOL, V24, P693, DOI 10.1016/0006-2952(75)90245-2; AIYEDUN B A, 1973, Acta Tropica, V30, P276; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; CARTER NS, 1995, J BIOL CHEM, V270, P28153; CARTER NS, 1993, NATURE, V361, P173, DOI 10.1038/361173a0; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; de Koning HP, 2004, ANTIMICROB AGENTS CH, V48, P1515, DOI 10.1128/AAC.48.5.1515-1519.2004; de Koning HP, 2001, ACTA TROP, V80, P245, DOI 10.1016/S0001-706X(01)00177-2; Drew ME, 2003, J BIOL CHEM, V278, P46596, DOI 10.1074/jbc.M309320200; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Geiser F, 2005, MOL PHARMACOL, V68, P589, DOI 10.1124/mol.104.010298; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; HOMBURG CHE, 1995, BLOOD, V85, P532; Kyambadde JW, 2000, B WORLD HEALTH ORGAN, V78, P119; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; LIVAK KJ, 2001, METHOD METHODS, V4, P402; Luscher A, 2007, ANTIMICROB AGENTS CH, V51, P3895, DOI 10.1128/AAC.00458-07; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; Masocha W, 2006, ANTIMICROB AGENTS CH, V50, P1798, DOI 10.1128/AAC.50.5.1798-1804.2006; Matovu E, 2003, EUKARYOT CELL, V2, P1003, DOI 10.1128/EC.2.5.1003-1008.2003; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Rodman LE, 1997, TOXICOL APPL PHARM, V147, P39, DOI 10.1006/taap.1997.8264; Rottenberg ME, 2005, J INFECT DIS, V192, P1658, DOI 10.1086/496896; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Vodnala M, 2008, J BIOL CHEM, V283, P5380, DOI 10.1074/jbc.M705603200; WALTER RD, 1977, H-S Z PHYSIOL CHEM, V358, P23, DOI 10.1515/bchm2.1977.358.1.23; Welburn SC, 2006, PARASITOLOGY, V132, pS7, DOI 10.1017/S0031182006000825; WILLIAMSON J, 1976, T ROY SOC TROP MED H, V70, P130, DOI 10.1016/0035-9203(76)90174-7; WILLIAMSON J, 1972, T ROY SOC TROP MED H, V66, P354, DOI 10.1016/0035-9203(72)90244-1; Yoshikawa Noriko, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS51, DOI 10.1111/j.1440-1681.2004.04108.x	33	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2009	3	8							e495	10.1371/journal.pntd.0000495				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	486TL	WOS:000269220900016	19652702	DOAJ Gold, Green Published			2019-04-02	
J	Baly, A; Toledo, ME; Vanlerberghe, V; Ceballos, E; Reyes, A; Sanchez, I; Carvajal, M; Maso, R; La Rosa, M; Denis, O; Boelaert, M; Van der Stuyft, P				Baly, Alberto; Toledo, Maria Eugenia; Vanlerberghe, Veerle; Ceballos, Enrique; Reyes, Alicia; Sanchez, Idalmis; Carvajal, Marinelli; Maso, Rizel; La Rosa, Maite; Denis, Orestes; Boelaert, Marleen; Van der Stuyft, Patrick			Cost-Effectiveness of a Community-Based Approach Intertwined with a Vertical Aedes Control Program	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							AEGYPTI CONTROL; DENGUE-3 EPIDEMIC; CUBA; SUSTAINABILITY; SANTIAGO; BEHAVIOR; VECTORS; HAVANA; IMPACT	We compared in a 5-year intervention study the cost-effectiveness of community-based environmental management intertwined with routine vertical Aedes control and of routine vertical control only. At baseline (year 2000), Aedes infestation levels and economic costs for vector control were comparable in intervention and control areas (house index, 2.23% versus 2.21% and US$21 versus US$24/yr/inhabitant, respectively). By 2004, house indices became 0.22% versus 2.36% and the costs were 29.8 US$ versus 36.7 US$/yr/inhabitant, respectively. The community cost made up 38.6% of the total economic cost in 2004 in the intervention areas against 23.5% in 2000. The average cost-effectiveness ratio for the intervention period 2001-2004, expressed as the societal cost incurred for the reduction (from baseline) of Aedes foci, was US$831.1 per focus in the intervention areas versus US$2,465.6 in the control areas. The intervention produced economic savings and health benefits that were sustained over the whole observation period.	[Baly, Alberto] Inst Med Trop Pedro Kouri, Dept Epidemiol, Havana, Cuba; Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium; Prov Unit Surveillance & Vector Control, Santiago De Cuba, Cuba; Inst Med Trop Pedro Kouri, Dept Econ, Havana, Cuba	Baly, A (reprint author), Inst Med Trop Pedro Kouri, Dept Epidemiol, Km 6 1-2 La Lisa, Havana, Cuba.	baly@ipk.sld.cu; mariaeugeniatoledo@yahoo.es; vvanlerberghe@itg.be; pvdstuyft@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776	Cuban Ministry of Health [95900]	The study was funded by the Cuban Ministry of Health and through the framework agreement between the Institute of Tropical Medicine and the Belgian Directorate-General for Development Cooperation (Project 95900).	Armien B, 2008, AM J TROP MED HYG, V79, P364, DOI 10.4269/ajtmh.2008.79.364; Baly A, 2007, T ROY SOC TROP MED H, V101, P578, DOI 10.1016/j.trstmh.2007.01.002; BOSSERT TJ, 1990, SOC SCI MED, V30, P1015, DOI 10.1016/0277-9536(90)90148-L; CHIARAVALLOTI NF, 1998, CAD SAUDE PUBLICA S2, V14, P101; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P282, DOI 10.1590/S1020-49892006000400014; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; JENSEN ER, 1991, COST EFFECTIVENESS F; Johns B, 2003, COST EFF RESOUR ALLO, V1, P1; Kay BH, 2002, AM J TROP MED HYG, V66, P40, DOI 10.4269/ajtmh.2002.66.40; LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635; Pai HH, 2006, J ENVIRON HEALTH, V68, P35; PARKS W, 2005, DENGUE B S, V28, P1; Pelaez O, 2004, EMERG INFECT DIS, V10, P719, DOI 10.3201/eid1004.030271; Reiter Paul, 1997, P425; Renganathan E., 2003, Dengue Bulletin, V27, P6; RIERA P, 2004, MANUAL VALORACION CO; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; Sanchez L, 2006, EMERG INFECT DIS, V12, P800; Sanchez L, 2005, TROP MED INT HEALTH, V10, P82, DOI 10.1111/j.1365-3156.2004.01347.x; Shediac-Rizkallah MC, 1998, HEALTH EDUC RES, V13, P87, DOI 10.1093/her/13.1.87; Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x; Toledo ME, 2007, T ROY SOC TROP MED H, V101, P56, DOI 10.1016/j.trstmh.2006.03.006; TOLEDO ME, 2006, REV SALUD PUBL MEX, V48, P1; Valdes L, 1999, Rev Panam Salud Publica, V6, P16, DOI 10.1590/S1020-49891999000600003; Wiesemann A, 2004, SOZ PRAVENTIV MED, V49, P254, DOI 10.1007/s00038-004-3039-5; Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363; 2004, NACIONES UNIDAS CEPA, V15, P2004	29	23	24	0	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUL	2009	81	1					88	93		10.4269/ajtmh.2009.81.88				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	464SI	WOS:000267526500017	19556572	Green Published			2019-04-02	
J	Marcotty, T; Matthys, F; Godfroid, J; Rigouts, L; Ameni, G; Gey van Pittius, NC; Kazwala, R; Muma, J; van Helden, P; Walravens, K; de Klerk, LM; Geoghegan, C; Mbotha, D; Otte, M; Amenu, K; Abu Samra, N; Botha, C; Ekron, M; Jenkins, A; Jori, F; Kriek, N; McCrindle, C; Michel, A; Morar, D; Roger, F; Thys, E; van den Bossche, P				Marcotty, T.; Matthys, F.; Godfroid, J.; Rigouts, L.; Ameni, G.; Gey van Pittius, N. C.; Kazwala, R.; Muma, J.; van Helden, P.; Walravens, K.; de Klerk, L. M.; Geoghegan, C.; Mbotha, D.; Otte, M.; Amenu, K.; Abu Samra, N.; Botha, C.; Ekron, M.; Jenkins, A.; Jori, F.; Kriek, N.; McCrindle, C.; Michel, A.; Morar, D.; Roger, F.; Thys, E.; van den Bossche, P.			Zoonotic tuberculosis and brucellosis in Africa: neglected zoonoses or minor public-health issues? The outcomes of a multi-disciplinary workshop	ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY			English	Article							MYCOBACTERIUM-BOVIS INFECTION; ANIMAL BRUCELLOSIS; SEROLOGICAL TESTS; DISEASE; CATTLE; DIAGNOSIS; WILDLIFE; VACCINES; SYSTEMS; HUMANS	Late in 2007, veterinary, medical and anthropological professionals from Europe and Africa met in a 2-day workshop in Pretoria, South Africa, to evaluate the burden, surveillance and control of zoonotic tuberculosis and brucellosis in sub-Saharan Africa. Keynote presentations reviewed the burden of these diseases on human and livestock health, the existing diagnostic tools, and the available control methods. These presentations were followed by group discussions and the formulation of recommendations. The presence of Mycobacterium bovis and Brucella spp. in livestock was considered to be a serious threat to public health, since livestock and animal products are the only source of such infections in human beings. The impact of these pathogens on human health appears to be relatively marginal, however, when compared with Mycobacterium tuberculosis infections and drug resistance, HIV and malaria. Appropriate diagnostic tools are needed to improve the detection of M. bovis and Brucella spp. in humans. In livestock, the 'test-and-slaughter' approach and the pasteurization of milk, which have been used successfully in industrialized countries, might not be the optimal control tools in Africa. Control strategies should fit the needs and perceptions of local communities. Improved intersectoral and international collaboration in surveillance, diagnosis and control, and in the education of medical and veterinary personnel, are advocated.	[Marcotty, T.; Thys, E.; van den Bossche, P.] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Matthys, F.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Godfroid, J.; Jenkins, A.; Morar, D.; van den Bossche, P.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa; [Rigouts, L.] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium; [Ameni, G.] Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Gey van Pittius, N. C.; van Helden, P.] Univ Stellenbosch, Div Mol Biol & Human Genet, ZA-7602 Stellenbosch, South Africa; [Kazwala, R.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Muma, J.] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Walravens, K.] Vet & Agrochem Res Ctr, B-1180 Brussels, Belgium; [de Klerk, L. M.] Mil Vet Inst, ZA-2522 Noordbrug, South Africa; [Geoghegan, C.] Univ Pretoria, Fac Nat & Agr Sci, Dept Zool, ZA-0002 Pretoria, South Africa; [Mbotha, D.] Analabs Ltd, Nairobi, Kenya; [Otte, M.] Leiden Univ, Fac Social & Behav Sci, Dept Cultural Anthropol and Dev Sociol, NL-2300 RB Leiden, Netherlands; [Amenu, K.] Hawassa Univ, Fac Vet Med, Dept Vet Epidemiol Microbiol & Publ Hlth, Hawassa, Ethiopia; [Abu Samra, N.; Jori, F.] Univ Pretoria, Fac Vet Sci, Dept Prod Anim Studies, ZA-0110 Onderstepoort, South Africa; [Botha, C.; McCrindle, C.] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0110 Onderstepoort, South Africa; [Ekron, M.] Chief Directorate Vet Serv, Dept Agr & Land Adm, ZA-2350 Ermelo, South Africa; [Jori, F.; Roger, F.] French Agr Res Ctr Int Dev CIRAD, Dept Environm & Soc, F-34398 Montpellier, France; [Kriek, N.] Univ Pretoria, Fac Vet Sci, Ctr Vet Wildlife Studies, ZA-0110 Onderstepoort, South Africa; [Michel, A.] Onderstepoort Vet Inst, ZA-0110 Onderstepoort, South Africa	Marcotty, T (reprint author), Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium.	tmarcotty@itg.be	Gey van Pittius, Nicolaas/D-3434-2015; Michel, Anita/N-8996-2014; Ejeta, Kebede Amenu/E-6876-2018; godfroid, jacques/U-3524-2017	Gey van Pittius, Nicolaas/0000-0002-8807-4105; Michel, Anita/0000-0001-9240-2653; Ejeta, Kebede Amenu/0000-0002-0985-2950; godfroid, jacques/0000-0002-0782-7858; Morar-Leather, Darshana/0000-0002-7696-8574; Botha, Christo/0000-0003-1535-9270	Belgian Direction Generale de la Cooperation au Developpement ( DGCD)	The Belgian Direction Generale de la Cooperation au Developpement ( DGCD) is thanked for funding the workshop and some of the research activities that were discussed. The workshop was part of a study conducted in the framework of the DGCD's Policy Supporting Research programme ( project 9740X). The workshop's participants are grateful to the University of Pretoria's Department of Veterinary Tropical Diseases for hosting the workshop.	Acha PN, 2003, ZOONOSES COMMUNICABL, V1; Al-Ani FK, 2004, REV SCI TECH OIE, V23, P831, DOI 10.20506/rst.23.3.1528; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Beers M. H., 2006, MERCK MANUAL; Cheville NF, 2000, ANN NY ACAD SCI, V916, P147; COSIVI O, 1995, REV SCI TECH OIE, V14, P733, DOI 10.20506/rst.14.3.875; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Edginton ME, 2002, INT J TUBERC LUNG D, V6, P1075; Endsley JJ, 2007, VACCINE, V25, P8384, DOI 10.1016/j.vaccine.2007.10.011; Etter E, 2006, ANN NY ACAD SCI, V1081, P61, DOI 10.1196/annals.1373.006; FOSTER GM, 1976, AM ANTHROPOL, V78, P773, DOI 10.1525/aa.1976.78.4.02a00030; Fretin D, 2008, VET MICROBIOL, V131, P376, DOI 10.1016/j.vetmic.2008.04.003; Godfroid J, 2002, REV SCI TECH OIE, V21, P277, DOI 10.20506/rst.21.2.1333; Grange JM, 2001, INT J TUBERC LUNG D, V5, P208; Green E. C., 1998, Agriculture and Human Values, V15, P127, DOI 10.1023/A:1007430926620; Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953; HOPE JC, 2007, COMP IMMUNOL MICROB, V31, P77; Huygen K, 2006, FUTURE MICROBIOL, V1, P63, DOI 10.2217/17460913.1.1.63; Jennings GJ, 2007, T ROY SOC TROP MED H, V101, P707, DOI 10.1016/j.trstmh.2007.02.027; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Konstantinidis A, 2007, EUR J CLIN MICROBIOL, V26, P715, DOI 10.1007/s10096-007-0363-8; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; McNair J, 2007, VACCINE, V25, P5504, DOI 10.1016/j.vaccine.2007.02.037; Michel AL, 2006, VET MICROBIOL, V112, P91, DOI 10.1016/j.vetmic.2005.11.035; Moda G, 1996, TUBERCLE LUNG DIS, V77, P103, DOI 10.1016/S0962-8479(96)90022-2; Moriyon I, 2004, VET RES, V35, P1, DOI 10.1051/vetres:2003037; Muma JB, 2007, VET MICROBIOL, V125, P187, DOI 10.1016/j.vetmic.2007.05.012; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Nielsen K, 2002, VET MICROBIOL, V90, P447, DOI 10.1016/S0378-1135(02)00229-8; Rigouts L, 1996, TUBERCLE LUNG DIS, V77, P264, DOI 10.1016/S0962-8479(96)90011-8; Rigouts L, 2007, J CLIN MICROBIOL, V45, P252, DOI 10.1128/JCM.01489-06; SCHWABE C. W., 1984, VET MED HUMAN HLTH; Sheik-Mohamed A, 1999, TROP MED INT HEALTH, V4, P695, DOI 10.1046/j.1365-3156.1999.00473.x; Smits HL, 2003, CLIN DIAGN LAB IMMUN, V10, P1141, DOI 10.1128/CDLI.10.6.1141-1146.2003; Steinfeld H, 2006, LIVESTOCKS LONG SHAD; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Todorov SD, 2008, J APPL MICROBIOL, V104, P465, DOI 10.1111/j.1365-2672.2007.03558.x; van Helden Paul D, 2006, Expert Rev Anti Infect Ther, V4, P759, DOI 10.1586/14787210.4.5.759; Van Helden PD, 2006, SCIENCE, V314, P419; WHO, 2006, JOINT WHO DFID AHP M; Wilkins MJ, 2008, EMERG INFECT DIS, V14, P657, DOI 10.3201/eid1404.070408; Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8; Zinsstag J, 2001, SCIENCE, V294, P477, DOI 10.1126/science.294.5542.477; Zinsstag J, 2007, EMERG INFECT DIS, V13, P527, DOI 10.3201/eid1304.060381; 2004, MANUAL STANDARDS DIA	45	41	43	2	40	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0003-4983	1364-8594		ANN TROP MED PARASIT	Ann. Trop. Med. Parasitol.	JUL	2009	103	5					401	411		10.1179/136485909X451771				11	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	468LI	WOS:000267819500004	19583911				2019-04-02	
J	Claes, F; Vodnala, SK; van Reet, N; Boucher, N; Lunden-Miguel, H; Baltz, T; Goddeeris, BM; Buscher, P; Rottenberg, ME				Claes, Filip; Vodnala, Suman K.; van Reet, Nick; Boucher, Nathalie; Lunden-Miguel, Hilda; Baltz, Theo; Goddeeris, Bruno Maria; Buescher, Philippe; Rottenberg, Martin E.			Bioluminescent Imaging of Trypanosoma brucei Shows Preferential Testis Dissemination Which May Hamper Drug Efficacy in Sleeping Sickness	PLOS NEGLECTED TROPICAL DISEASES			English	Article							GENE-EXPRESSION; IN-VIVO; AFRICAN TRYPANOSOMIASIS; LIVING MICE; LUCIFERASE; RECEPTOR; DIFFERENTIATION; DIVISION; BARRIER; SYSTEM	Monitoring Trypanosoma spread using real-time imaging in vivo provides a fast method to evaluate parasite distribution especially in immunoprivileged locations. Here, we generated monomorphic and pleomorphic recombinant Trypanosoma brucei expressing the Renilla luciferase. In vitro luciferase activity measurements confirmed the uptake of the coelenterazine substrate by live parasites and light emission. We further validated the use of Renilla luciferase-tagged trypanosomes for real-time bioluminescent in vivo analysis. Interestingly, a preferential testis tropism was observed with both the monomorphic and pleomorphic recombinants. This is of importance when considering trypanocidal drug development, since parasites might be protected from many drugs by the blood-testis barrier. This hypothesis was supported by our final study of the efficacy of treatment with trypanocidal drugs in T. brucei-infected mice. We showed that parasites located in the testis, as compared to those located in the abdominal cavity, were not readily cleared by the drugs.	[Claes, Filip; van Reet, Nick; Buescher, Philippe] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Claes, Filip; Goddeeris, Bruno Maria] Katholieke Univ Leuven, Dept Biosyst, Louvain, Belgium; [Vodnala, Suman K.; Lunden-Miguel, Hilda; Rottenberg, Martin E.] Karolinska Inst, Microbiol & Tumorbiol Ctr, Stockholm, Sweden; [Boucher, Nathalie; Baltz, Theo] Univ Victor Segalen Bordeaux II, CNRS, UMR 5234, Lab Microbiol Cellulaire & Mol & Pathogenicite, Bordeaux, France	Claes, F (reprint author), Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium.	fclaes@itg.be	Van Reet, Nick/D-8406-2011; Goddeeris, Bruno/L-2440-2015; Buscher, Philippe/B-9956-2012	Goddeeris, Bruno/0000-0003-3729-7592; Buscher, Philippe/0000-0002-1926-7472	Commission of the European Communities' Sixth Framework Program [032324]; Research Foundation Flanders (FWO); Centre National de la Recherche Scientifique (CNRS)	This work was supported by the Commission of the European Communities' Sixth Framework Program, priority INCO-DEV, project NEUROTRYP, contract 032324. FC is a Postdoctoral Fellow of the Research Foundation Flanders (FWO). NB is a Postdoctoral Fellow of the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANOSA VO, 1984, VET PATHOL, V21, P238, DOI 10.1177/030098588402100217; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; BLACK SJ, 1983, ACTA TROP, V40, P11; Boucher N, 2007, J BIOL CHEM, V282, P13780, DOI 10.1074/jbc.M700780200; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; Breidbach T, 2002, EXP PARASITOL, V101, P223, DOI 10.1016/S0014-4894(02)00133-9; Buckley SMK, 2008, HUM GENE THER, V19, P1050, DOI 10.1089/hum.2008.023; Claes F, 2005, TRENDS PARASITOL, V21, P316, DOI 10.1016/j.pt.2005.05.010; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Dellacasa-Lindberg I, 2007, MICROBES INFECT, V9, P1291, DOI 10.1016/j.micinf.2007.06.003; Deroose CM, 2006, MOL THER, V14, P423, DOI 10.1016/j.ymthe.2006.05.007; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Hitziger N, 2005, CELL MICROBIOL, V7, P837, DOI 10.1111/j.1462-5822.2005.00517.x; HOLASH JA, 1993, P NATL ACAD SCI USA, V90, P11069, DOI 10.1073/pnas.90.23.11069; Kadurugamuwa Jagath L, 2005, Mol Imaging, V4, P137; KIMATA DM, 1994, ACTA TROP, V57, P69, DOI 10.1016/0001-706X(94)90094-9; Lang T, 2005, CELL MICROBIOL, V7, P383, DOI 10.1111/j.1462-5822.2004.00468.x; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Masocha W, 2004, J CLIN INVEST, V114, P689, DOI 10.1172/JCI200422104; Rottenberg ME, 2005, J INFECT DIS, V192, P1658, DOI 10.1086/496896; SOMMER JM, 1992, MOL BIOL CELL, V3, P749; SOUDAN B, 1992, ACTA ENDOCRINOL-COP, V127, P86, DOI 10.1530/acta.0.1270086; Stephen LE, 1986, TRYPANOSOMIASIS VET; Tyler KM, 1997, P ROY SOC B-BIOL SCI, V264, P1481, DOI 10.1098/rspb.1997.0205; WIRTZ E, 1994, NUCLEIC ACIDS RES, V22, P3887, DOI 10.1093/nar/22.19.3887; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	26	41	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2009	3	7							e486	10.1371/journal.pntd.0000486				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	476OP	WOS:000268452200016	19621071	DOAJ Gold, Green Published			2019-04-02	
J	Hanson, C; Van Damme, W; Van Dormael, M; Van der Roost, D; Songane, F				Hanson, Claudia; Van Damme, Wim; Van Dormael, Monique; Van der Roost, Dirk; Songane, Francisco			Three global health reports: towards a growing consensus?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						health policy; primary health care; financing; integration			[Hanson, Claudia; Van Damme, Wim; Van Dormael, Monique; Van der Roost, Dirk] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Songane, Francisco] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland	Hanson, C (reprint author), Inst Trop Med Prince Leopold, Natl Str 155, B-2000 Antwerp, Belgium.	claudia.hanson@gmx.de	Van Damme, Wim/F-7404-2011				*CSDC, 2008, CSDC FIN REP CLOS GA; *ITG, 2008, PRIM HLTH CAR TIM GL; People's Health Movement Medact and Global Equity Gauge Alliance, 2008, GLOB HLTH WATCH; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; World Health Organization, 2008, WORLD HLTH REP 2008	5	5	5	0	3	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2009	14	7					710	712		10.1111/j.1365-3156.2009.02296.x				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	469HB	WOS:000267886000001	19392736	Bronze			2019-04-02	
J	Zachariah, R; Harries, K; Moses, M; Manzi, M; Line, A; Mwagomba, B; Harries, AD				Zachariah, Rony; Harries, Katie; Moses, Massaquoi; Manzi, Marcel; Line, Arnould; Mwagomba, Beatrice; Harries, Anthony D.			Very early mortality in patients starting antiretroviral treatment at primary health centres in rural Malawi	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Malawi; HIV/AIDS; antiretroviral treatment; early mortality; health centres	VIRUS-INFECTED PATIENTS; SUB-SAHARAN AFRICA; SOUTH-AFRICA; HIV-1-INFECTED PATIENTS; ESOPHAGEAL SYMPTOMS; ORAL CANDIDIASIS; AIDS PATIENTS; TUBERCULOSIS; THERAPY; BACTEREMIA	OBJECTVES To report on the cumulative proportion of deaths occurring within 3 months of starting antiretroviral treatment (ART) and to identify factors associated with such deaths, among adults at primary health centres in a rural district of Malawi. methods Retrospective cohort study: from June 2006 to April 2008, deaths occurring over a 3-month period were determined and risk factors examined. RESULTS A total of 2316 adults (706 men and 1610 women; median age 35 years) were included in the analysis and followed up for a total of 1588 person-years (PY); 277 (12%) people died, of whom 206 (74%) people died within 3 months of initiating ART (cumulative incidence: 13.0; 95% confidence interval: 11.3-14.8 per 100 PY of follow-up). Significant risk factors associated with early deaths included male sex, WHO stage 4 disease, oesophageal or persistent oral candidiasis and unexplained presumed or measured weight loss >10%. One in every 3 patients who either died or was lost to follow up had unexplained weight loss >10%, and survival in this group was significantly different from patients without this condition. CONCLUSIONS Seven of 10 patients who die after initiating ART at primary health centres die early. Specific groups of patients are at higher risk of such mortality and should receive priority attention, care and support.	[Zachariah, Rony; Harries, Katie; Manzi, Marcel] Med Sans Frontieres, Med Dept Operat Res, Brussels, Belgium; [Line, Arnould] Med Sans Frontieres, Dept Med, Brussels, Belgium; [Mwagomba, Beatrice] Minist Hlth & Populat, Thyolo, Malawi; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England	Zachariah, R (reprint author), Med Sans Frontieres Brussels Operat Ctr, Med Dept Operat Res, 68 Rue Gasperich, L-1617 Luxembourg, Luxembourg.	zachariah@internet.lu			Medecins Sans Frontieres [09_NAT_ERB_002]		Ayisi NK, 1997, E AFR MED J, V74, P784; Braitstein P, 2006, LANCET, V367, P817; CHEN SC, 2008, TROP MED INT HEALTH, V19, P513; Coetzee D, 2004, AIDS, V18, P887, DOI [10.1097/01.aids.0000125925.87797.38, 10.1097/00002030-200406003-00006]; CONNOLLY GM, 1989, GUT, V30, P1033, DOI 10.1136/gut.30.8.1033; Deribe K, 2008, TROP MED INT HEALTH, V13, P328, DOI 10.1111/j.1365-3156.2008.02006.x; DODD CL, 1991, AIDS, V5, P1339, DOI 10.1097/00002030-199111000-00009; Dromer F, 1997, AIDS, V11, P1095, DOI 10.1097/00002030-199709000-00003; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Harries AD, 2004, T ROY SOC TROP MED H, V98, P695, DOI 10.1016/j.trstmh.2004.05.002; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lewis DK, 2002, INT J TUBERC LUNG D, V6, P1067; Libamba E, 2005, INT J TUBERC LUNG D, V9, P1062; Lowrance DW, 2008, JAIDS-J ACQ IMM DEF, V49, P287, DOI 10.1097/QAI.0b013e3181893ef0; LUCAS SB, 1994, BRIT MED J, V308, P1531, DOI 10.1136/bmj.308.6943.1531; MCCARTHY GM, 1992, ORAL SURG ORAL MED O, V73, P181, DOI 10.1016/0030-4220(92)90192-S; McDonald LC, 1999, LANCET, V354, P1159, DOI 10.1016/S0140-6736(98)12325-5; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; *MOHP NAC, 2006, GUID US ANT THER MAL; Morgan D, 2000, SEX TRANSM INFECT, V76, P193, DOI 10.1136/sti.76.3.193; *NAC, 2007, HIV SYPH SER NAT HIV; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Ravera M, 1999, EMERG INFECT DIS, V5, P274, DOI 10.3201/eid0502.990214; *USDHH, 2003, CLIN GUID SUPP PALL; WHO, 2006, TAK STOCK HLTH WORK; *WHO, 2006, PROGR GLOB ACC HIV A; WHO, 2006, ANT THER HIV INF AD; *WIK, 2008, PLUMP NUT; Wilcox CM, 1996, GASTROENTEROLOGY, V110, P1803, DOI 10.1053/gast.1996.v110.pm8964406; WILCOX CM, 1995, AM J GASTROENTEROL, V90, P1938; Yu JKL, 2008, INT J TUBERC LUNG D, V12, P692; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010; ZACHARIAH R, 2006, PLOS ONE, V27, P1; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	39	30	30	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2009	14	7					713	721		10.1111/j.1365-3156.2009.02291.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	469HB	WOS:000267886000002	19497082	Bronze			2019-04-02	
J	Rusa, L; Ngirabega, JD; Janssen, W; Van Bastelaere, S; Porignon, D; Vandenbulcke, W				Rusa, Louis; Ngirabega, Jean de Dieu; Janssen, Willy; Van Bastelaere, Stefaan; Porignon, Denis; Vandenbulcke, Werner			Performance-based financing for better quality of services in Rwandan health centres: 3-year experience	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						internal contracting; performance-based financing; supervision		In 2005, the Ministry of Health in Rwanda, with the support of the Belgian Technical Cooperation, launched a strategy of performance-based financing (PBF) in a group of 74 health centres (HCs), covering 2-m inhabitants. In 2006, PBF was extended to an additional group of 85 HCs, thus reaching 3.8-m inhabitants. This study evaluates the effect of PBF on HC performance from 2005 to 2007. Composite indicators for measuring quantity and quality of services were developed and evaluated through monthly formative supervisions by qualified and well-trained district supervisors. The strategy was based on a fixed fee per quality-approved service. The entire budget spent on the implementation of PBF amounted to $0.25/cap/year, of which $0.20/cap/year for subsidies and an estimated $0.05/cap/year for administration, supervision and training. A positive effect on utilization rates was only seen for activities that were previously less well organized; in this case, growth monitoring services and institutional deliveries. The quality of services, defined as the compliance rate with national and international norms, rose considerably for all services in both groups. A sustained level of quality between 80% and 95% was reached within 18 months in the first group. A similar result was reached in the second group in 8 months.	[Rusa, Louis; Ngirabega, Jean de Dieu] Minist Hlth, Kigali, Rwanda; [Janssen, Willy; Van Bastelaere, Stefaan; Vandenbulcke, Werner] Belgian Tech Cooperat, Kigali, Rwanda; [Porignon, Denis] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium	Vandenbulcke, W (reprint author), CTB, BP 6089, Kigali, Rwanda.	wvandenbulcke@gmail.com					Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; MEESSEN B, 2006, B WORLD HEALTH ORGAN, V85, P108; *MOH, 2007, INT DEM HLTH SURV; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Soeters R, 2006, B WORLD HEALTH ORGAN, V84, P884; *WHO, 2005, APPL CONTR HLTH SYST; *WHO, 2003, WHA5625 WHO	7	46	46	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2009	14	7					830	837		10.1111/j.1365-3156.2009.02292.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	469HB	WOS:000267886000016	19497081				2019-04-02	
J	Gillet, P; Bosselaers, K; Cnops, L; Bottieau, E; Van Esbroeck, M; Jacobs, J				Gillet, Philippe; Bosselaers, Katrien; Cnops, Lieselotte; Bottieau, Emmanuel; Van Esbroeck, Marjan; Jacobs, Jan			Evaluation of the SD FK70 Malaria Ag Plasmodium vivax rapid diagnostic test in a non-endemic setting	MALARIA JOURNAL			English	Article							IMPORTED MALARIA; FALCIPARUM; INSTRUCTIONS; CHLOROQUINE; COMMUNITY; THAILAND; DEVICES; ANTIGEN; HUMANS; UPDATE	Background: For clinical and epidemiological reasons, it is interesting to diagnose non-falciparum malaria to the species level. This retrospective study assessed the performance of the SD BIOLINE Malaria Antigen Pv test (FK70), a two-band immunochromatographic test detecting Plasmodium vivax-specific lactate dehydrogenase, on samples of international travellers in a non-endemic setting. Methods: Stored blood samples from international travellers suspected of malaria were used, with microscopy corrected by PCR as the reference method. Samples infected by Plasmodium vivax (n = 100), Plasmodium falciparum ( n = 75), Plasmodium ovale ( n = 75) and Plasmodium malariae (n = 25) were included, as well as 100 malaria-negative samples. End points were sensitivity, specificity, inter-reader reliability and reproducibility. Results: The overall sensitivity of the FK70 for the diagnosis of P. vivax was 88.0% (95% confidence interval (CI): 83.6% - 90.3%). For parasite densities > 500/mu l, a sensitivity of 97.2% ( CI: 92.6% - 99.1%) was obtained. Specificity was 98.5%, with 4 out of 75 P. falciparum samples testing positive. None of the P. ovale samples tested positive. Nearly two-thirds (57/88, 64.7%) of positive P. vivax samples showed faint or weak line intensities, with stronger line intensities at higher parasite densities. The test showed excellent reproducibility and reliability for test results and line intensities (kappa values exceeding 0.98 and 0.87 respectively). Conclusion: The FK70 test performed well in diagnosing P. vivax infections in a non-endemic reference setting. It can be of added value to microscopy in species differentiation of malaria infections, especially at parasite densities > 500/mu l.	[Gillet, Philippe; Bosselaers, Katrien; Cnops, Lieselotte; Bottieau, Emmanuel; Van Esbroeck, Marjan; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Jacobs, Jan] Fac Hlth Med & Life Sci FHML, Dept Med Microbiol, Maastricht, Netherlands	Jacobs, J (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	pgillet@itg.be; katrien.bosselaers@gmail.com; lcnops@itg.be; ebottieau@itg.be; mvesbroeck@itg.be; jjacobs@itg.be		gillet, philippe/0000-0001-5878-6446			Barnadas C, 2008, ANTIMICROB AGENTS CH, V52, P4233, DOI 10.1128/AAC.00578-08; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI 10.1038/nrmico1524; Bell DR, 2005, AM J TROP MED HYG, V73, P199, DOI 10.4269/ajtmh.2005.73.199; Coleman RE, 2002, AM J TROP MED HYG, V66, P379, DOI 10.4269/ajtmh.2002.66.379; Craig MH, 2002, T ROY SOC TROP MED H, V96, P258, DOI 10.1016/S0035-9203(02)90092-1; Culleton RL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-174; Forney JR, 2003, J CLIN MICROBIOL, V41, P2358, DOI 10.1128/JCM.41.6.2358-2366.2003; Habib AG, 2004, INFECTION, V32, P356, DOI 10.1007/s15010-004-4060-6; Hanscheid T, 2003, CLIN MICROBIOL INFEC, V9, P497, DOI 10.1046/j.1469-0691.2003.00640.x; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Iqbal J, 2000, J CLIN MICROBIOL, V38, P1184; Kettelhut MM, 2003, J CLIN PATHOL, V56, P927, DOI 10.1136/jcp.56.12.927; Kim SH, 2008, TROP MED INT HEALTH, V13, P1495, DOI 10.1111/j.1365-3156.2008.02163.x; Lee SW, 2008, J CLIN MICROBIOL, V46, P939, DOI 10.1128/JCM.02110-07; Marx A, 2005, ANN INTERN MED, V142, P836, DOI 10.7326/0003-4819-142-10-200505170-00009; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Rogerson SJ, 2008, PLOS MED, V5, P875, DOI 10.1371/journal.pmed.0050136; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001; Seidahmed OME, 2008, TROP MED INT HEALTH, V13, P406, DOI 10.1111/j.1365-3156.2008.02015.x; Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120; Teka H, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-220; WHO, 2009, LIST KNOWN COMM AV A; *WHO, 2009, GEN INSTR MAL RAP TE; *WHO, 2009, INT NOT SEL TYP MAL; Wongsrichanalai C, 2002, TRENDS PARASITOL, V18, P107, DOI 10.1016/S1471-4922(01)02175-4; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119	32	21	21	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUN 11	2009	8								129	10.1186/1475-2875-8-129				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	461FB	WOS:000267248900001	19519915	DOAJ Gold, Green Published			2019-04-02	
J	Dinleyici, EC; Eren, M; Yargic, ZA; Dogan, N; Vandenplas, Y				Dinleyici, Ener C.; Eren, Makbule; Yargic, Zeynel A.; Dogan, Nihal; Vandenplas, Yvan			Clinical Efficacy of Saccharomyces boulardii and Metronidazole Compared to Metronidazole Alone in Children with Acute Bloody Diarrhea Caused by Amebiasis: A Prospective, Randomized, Open Label Study	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							METAANALYSIS; PROBIOTICS; YEAST	The aim was to evaluate the efficacy of Saccharomyces boulardii (Sb) in addition to metronidazole in amebiasis. A prospective, randomized, open clinical trial was performed in 50 children presenting with acute bloody diarrhea caused by Entameba histolytica. Group A and B (each N = 25) was treated with metronidazole, but Sb (250 mg, twice daily) during the 7 days was added to Group B patients who were re-evaluated 2, 3, 51 10, and 30 days after diagnosis. Duration of bloody diarrhea was significantly longer in Group A (72.0 +/- 28.5 versus 42.2 +/- 17.4 hours, P < 0.001). On day 5, amebic cysts had disappeared in all children in Group B, whereas in Group A, amebic cysts were still present in 6 children (P < 0.05). On day 10, all children were cured and cysts had disappeared in all. The addition of Sb to metronidazole in amebiasis significantly decreases duration of (bloody) diarrhea and enhances clearance of cysts.	[Dinleyici, Ener C.; Eren, Makbule] Eskisehir Osmangazi Univ, Dept Pediat, Fac Med, Div Pediat Gastroenterol & Hepatol, TR-26480 Eskisehir, Turkey; [Dogan, Nihal] Eskisehir Osmangazi Univ, Dept Parasitol, Fac Med, TR-26480 Eskisehir, Turkey; [Vandenplas, Yvan] Vrije Univ Brussel, Univ Ziekenhuis Brussel Kinderen, Brussels, Belgium	Dinleyici, EC (reprint author), Eskisehir Osmangazi Univ, Dept Pediat, Fac Med, Div Pediat Gastroenterol & Hepatol, TR-26480 Eskisehir, Turkey.	timboothtr@yahoo.com; makbule99@yahoo.com; z_a_judge@yahoo.com; ndogan@ogu.edu.tr; yuan.vandenplas@uzbrussel.be					Bercu Tracy E, 2007, Curr Gastroenterol Rep, V9, P429, DOI 10.1007/s11894-007-0054-8; Besirbellioglu BA, 2006, SCAND J INFECT DIS, V38, P479, DOI 10.1080/00365540600561769; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Guandalini S, 2000, J PEDIATR GASTR NUTR, V30, P486, DOI 10.1097/00005176-200005000-00004; Guandalini S, 2008, J CLIN GASTROENTEROL, V42, pS53, DOI 10.1097/MCG.0b013e3181674087; Htwe K, 2008, AM J TROP MED HYG, V78, P214, DOI 10.4269/ajtmh.2008.78.214; Kurugol Z, 2005, ACTA PAEDIATR, V94, P44, DOI 10.1080/08035250410022521; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Mansour-Ghanaei F, 2003, WORLD J GASTROENTERO, V9, P1832, DOI 10.3748/wjg.v9.i8.1832; RIGOTHIER MC, 1994, PARASITOL RES, V80, P10, DOI 10.1007/BF00932617; Szajewska H, 2007, ALIMENT PHARM THER, V25, P257, DOI 10.1111/j.1365-2036.2006.03202.x; Szajewska H, 2005, ALIMENT PHARM THER, V22, P365, DOI 10.1111/j.1365-2036.2005.02624.x; Tanyuksel M, 2003, CLIN MICROBIOL REV, V16, P713, DOI 10.1128/CMR.16.4.713-729.2003; Villarruel G, 2007, ACTA PAEDIATR, V96, P538, DOI 10.1111/j.1651-2227.2007.00191.x; Zanello G, 2009, CURR ISSUES MOL BIOL, V11, P47	15	23	25	3	5	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUN	2009	80	6					953	955		10.4269/ajtmh.2009.80.953				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	453XI	WOS:000266645800017	19478257				2019-04-02	
J	Woods, ME; Montenieri, JA; Eisen, RJ; Zeidner, NS; Borchert, JN; Laudisoit, A; Babi, N; Atiku, LA; Enscore, RE; Gage, KL				Woods, Michael E.; Montenieri, John A.; Eisen, Rebecca J.; Zeidner, Nordin S.; Borchert, Jeff N.; Laudisoit, Anne; Babi, Nackson; Atiku, Linda A.; Enscore, Russell E.; Gage, Kenneth L.			Identification of Flea Blood Meals Using Multiplexed Real-Time Polymerase Chain Reaction Targeting Mitochondrial Gene Fragments	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							EARLY-PHASE TRANSMISSION; YERSINIA-PESTIS; PLAGUE; MOSQUITOS; EPIDEMICS; TANZANIA; FELINE	Human plague is found in the West Nile region of Uganda and Democratic Republic of the Congo where flea vectors are often found inhabiting homes. We have developed a multiplexed, real-time polymerase chain reaction assay targeting mitochondrial genes that is capable of detecting blood meal sources in fleas collected off-host in East Africa. Laboratory tests showed that the assay is specific for the intended targets and has a detection limit below one picogram of DNA. Testing of wild-caught fleas from the Democratic Republic of Congo suggests that humans are at significant risk from flea-borne disease and implicates domestic animals including cats, chickens, and the black rat as potential sources of human exposure to fleas and flea-borne diseases. Future application of the assay will help us better define the ecology of plague in East Africa to implement effective control measures to combat the spread of disease.	[Woods, Michael E.; Montenieri, John A.; Eisen, Rebecca J.; Zeidner, Nordin S.; Borchert, Jeff N.; Enscore, Russell E.; Gage, Kenneth L.] CDC, Bacterial Dis Branch, Div Vector Borne Infect Dis, NCZVED, Ft Collins, CO 80521 USA; [Laudisoit, Anne] CERVA CODA, B-1180 Brussels, Belgium; [Laudisoit, Anne] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Laudisoit, Anne] Univ Liege, Zoogeog Res Unit, B-4000 Liege, Belgium; [Babi, Nackson; Atiku, Linda A.] Uganda Virus Res Inst, Entebbe, Uganda	Woods, ME (reprint author), CDC, Bacterial Dis Branch, Div Vector Borne Infect Dis, NCZVED, 3150 Rampart Rd, Ft Collins, CO 80521 USA.	gvi1@cdc.gov; anne.laudisoit@var.fgov.be; plague@ug.cdc.gov	Laudisoit, Anne/F-2646-2017	Laudisoit, Anne/0000-0001-7626-9426	Association of Public Health Laboratories Emerging Infectious Diseases Post-Doctoral Research Fellowship Program; Funds for Research in Industry and Agriculutre, Belgium	Financial support: We acknowledge support from the Association of Public Health Laboratories Emerging Infectious Diseases Post-Doctoral Research Fellowship Program (M.E.W.) and Funds for Research in Industry and Agriculutre, Belgium (A.L.).	BURKOT TR, 1981, AM J TROP MED HYG, V30, P1336, DOI 10.4269/ajtmh.1981.30.1336; CHRISTIE AB, 1980, J INFECT DIS, V141, P724, DOI 10.1093/infdis/141.6.724; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; EIDSON M, 1988, AM J PUBLIC HEALTH, V78, P1333, DOI 10.2105/AJPH.78.10.1333; Eisen RJ, 2008, AM J TROP MED HYG, V78, P949, DOI 10.4269/ajtmh.2008.78.949; Eisen RJ, 2007, J MED ENTOMOL, V44, P678, DOI 10.1603/0022-2585(2007)44[678:ETOYPB]2.0.CO;2; Gage KL, 2000, CLIN INFECT DIS, V30, P893, DOI 10.1086/313804; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Gomes LAM, 2001, MEM I OSWALDO CRUZ, V96, P693, DOI 10.1590/S0074-02762001000500020; HEISCH RB, 1953, T ROY SOC TROP MED H, V47, P503, DOI 10.1016/S0035-9203(53)80004-0; HOPKINS GHE, 1949, REPORT RATS FLEAS PL, P52; Humair PF, 2007, J MED ENTOMOL, V44, P869, DOI 10.1603/0022-2585(2007)44[869:MIOBSI]2.0.CO;2; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; KILONZO BS, 1992, E AFR MED J, V69, P494; KILONZO BS, 2000, TROP PESTS MANAGE B, V1, P11; Kilpatrick AM, 2006, P R SOC B, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Laudisoit A, 2007, EMERG INFECT DIS, V13, P687, DOI 10.3201/eid1305.061084; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; PERROW C, 1997, ORG ENV, V10, P66; Reeves W. C, 1944, AMER JOUR TROP MED, V24, P131; Sackal C, 2008, EMERG INFECT DIS, V14, P1972, DOI 10.3201/eid1412.080610; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P301; *WHO, 2005, WKLY EPIDEMIOL REC, V80, P433; Wilson D.E., 2005, MAMMAL SPECIES WORLD, V2, P142	25	13	13	0	7	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUN	2009	80	6					998	1003		10.4269/ajtmh.2009.80.998				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	453XI	WOS:000266645800025	19478265				2019-04-02	
J	Portaels, F				Portaels, Francoise			Professor SR Pattyn MD 1927-2008 Obituary	LEPROSY REVIEW			English	Biographical-Item									[Portaels, Francoise] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium; [Portaels, Francoise] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium	Portaels, F (reprint author), Inst Trop Med, Dept Microbiol, Natl Str 155, B-2000 Antwerp, Belgium.							0	0	0	0	0	LEPRA	COLCHESTER	28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND	0305-7518			LEPROSY REV	Lepr. Rev.	JUN	2009	80	2					221	223						3	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	489EL	WOS:000269402700016					2019-04-02	
J	Deborggraeve, S; Coronado, X; Solari, A; Zulantay, I; Apt, W; Mertens, P; Laurent, T; Leclipteux, T; Stessens, T; Dujardin, JC; Herdewijn, P; Buscher, P				Deborggraeve, Stijn; Coronado, Ximena; Solari, Aldo; Zulantay, Ines; Apt, Werner; Mertens, Pascal; Laurent, Thierry; Leclipteux, Thierry; Stessens, Tim; Dujardin, Jean-Claude; Herdewijn, Piet; Buscher, Philippe			T. cruzi OligoC-TesT: A Simplified and Standardized Polymerase Chain Reaction Format for Diagnosis of Chagas Disease	PLOS NEGLECTED TROPICAL DISEASES			English	Article							DETECT TRYPANOSOMA-CRUZI; SATELLITE DNA; BLOOD-SAMPLES; PCR; AMPLIFICATION; RANGELI; ASSAY; STRATEGIES; DIPSTICK	Background: PCR has evolved into one of the most promising tools for T. cruzi detection in the diagnosis and control of Chagas disease. However, general use of the technique is hampered by its complexity and the lack of standardization. Methodology: We here present the development and phase I evaluation of the T. cruzi OligoC-TesT, a simple and standardized dipstick format for detection of PCR amplified T. cruzi DNA. The specificity and sensitivity of the assay were evaluated on blood samples from 60 Chagas non-endemic and 48 endemic control persons and on biological samples from 33 patients, 7 reservoir animals, and 14 vectors collected in Chile. Principal Findings: The lower detection limits of the T. cruzi OligoC-TesT were 1 pg and 1 to 10 fg of DNA from T. cruzi lineage I and II, respectively. The test showed a specificity of 100% (95% confidence interval [CI]: 96.6%-100%) on the control samples and a sensitivity of 93.9% (95% CI: 80.4%-98.3%), 100% (95% CI: 64.6%-100%), and 100% (95% CI: 78.5%-100%) on the human, rodent, and vector samples, respectively. Conclusions: The T. cruzi OligoC-TesT showed high sensitivity and specificity on a diverse panel of biological samples. The new tool is an important step towards simplified and standardized molecular diagnosis of Chagas disease.	[Deborggraeve, Stijn; Stessens, Tim; Dujardin, Jean-Claude; Buscher, Philippe] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Deborggraeve, Stijn; Herdewijn, Piet] Katholieke Univ Leuven, Rega Inst Med Res, Med Chem Lab, Leuven, Belgium; [Coronado, Ximena; Solari, Aldo; Zulantay, Ines; Apt, Werner] Univ Chile, Fac Med, Program Mol & Cellular Biol, Santiago 7, Chile; [Mertens, Pascal; Laurent, Thierry; Leclipteux, Thierry] Coris BioConcept, Gembloux, Belgium	Deborggraeve, S (reprint author), Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium.	sdeborggraeve@itg.be	Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472; Deborggraeve, Stijn/0000-0003-1501-5355; Herdewijn, Piet/0000-0003-3589-8503	Flemish Government; European Union's Sixth Framework Programme [015379]	This study received financial support from the Flemish Government in the framework of the Bilateral Scientific Collaboration Flanders-Chile 2006-2007. Salary support for SD was from the European Union's Sixth Framework Programme (priority INCO-DEV, project TRYLEIDIAG, contract 015379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HM, 2007, MEM I OSWALDO CRUZ, V102, P47, DOI 10.1590/S0074-02762007005000098; Akinwale OP, 2008, MOL BIOCHEM PARASIT, V160, P167, DOI 10.1016/j.molbiopara.2008.04.003; BRENIERE SF, 1993, MEM I OSWALDO CRUZ, V88, P163, DOI 10.1590/S0074-02761993000100027; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Carolina M, 2003, MOL BIOCHEM PARASIT, V129, P1, DOI 10.1016/S0166-6851(03)00054-9; Carriazo CS, 1998, DIAGN MICR INFEC DIS, V30, P183, DOI 10.1016/S0732-8893(97)00238-1; Chan AB, 1999, REV MED MICROBIOL, V10, P185; Cuba Cuba A, 1998, Rev Soc Bras Med Trop, V31, P207; Deborggraeve S, 2006, J CLIN MICROBIOL, V44, P2884, DOI 10.1128/JCM.02594-05; Deborggraeve S, 2008, J INFECT DIS, V198, P1565, DOI 10.1086/592509; DIAZ C, 1992, AM J TROP MED HYG, V46, P616, DOI 10.4269/ajtmh.1992.46.616; Diez M, 2007, AM J TRANSPLANT, V7, P1633, DOI 10.1111/j.1600-6143.2007.01820.x; Edvinsson B, 2004, APMIS, V112, P342, DOI 10.1111/j.1600-0463.2004.apm1120604.x; Eger-Mangrich I, 2001, PARASITOL RES, V87, P505, DOI 10.1007/s004360000356; Le Ray D, 1975, Ann Soc Belg Med Trop, V55, P129; Leiby DA, 2000, J CLIN MICROBIOL, V38, P639; MERTENS P, 2004, CLIN MICROBIOL INFEC, V10, P526; Miles MA, 2003, BRIT MED J, V326, P1444, DOI 10.1136/bmj.326.7404.1444; MOSER DR, 1989, J CLIN MICROBIOL, V27, P1477; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ochs DE, 1996, AM J TROP MED HYG, V54, P526, DOI 10.4269/ajtmh.1996.54.526; OSORIO Y, 1995, J PARASITOL, V81, P687, DOI 10.2307/3283955; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; RENUART I, 2004, Patent No. 2004099438; Rozas M, 2007, AM J TROP MED HYG, V77, P647, DOI 10.4269/ajtmh.2007.77.647; Sanchez G, 2005, PARASITE, V12, P353, DOI 10.1051/parasite/2005124353; Schenone H, 1999, MEM I OSWALDO CRUZ, V94, P289, DOI 10.1590/S0074-02761999000700052; SLOOF P, 1983, J MOL BIOL, V167, P1, DOI 10.1016/S0022-2836(83)80031-X; Virreira M, 2003, AM J TROP MED HYG, V68, P574, DOI 10.4269/ajtmh.2003.68.574; *WHO, 2002, TECHN REP SER WHO, V905; *WHO, 2000, WHO REP 2002 RED RIS; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Zulantay I, 2004, DIAGN MICR INFEC DIS, V48, P253, DOI 10.1016/j.diagmicrobio.2003.10.011	34	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2009	3	6							e450	10.1371/journal.pntd.0000450				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	475XS	WOS:000268401000020	19503815	DOAJ Gold, Green Published			2019-04-02	
J	Hainard, A; Tiberti, N; Robin, X; Lejon, V; Ngoyi, DM; Matovu, E; Enyaru, JC; Fouda, C; Ndung'u, JM; Lisacek, F; Muller, M; Turck, N; Sanchez, JC				Hainard, Alexandre; Tiberti, Natalia; Robin, Xavier; Lejon, Veerle; Ngoyi, Dieudonne Mumba; Matovu, Enock; Enyaru, John Charles; Fouda, Catherine; Ndung'u, Joseph Mathu; Lisacek, Frederique; Mueller, Markus; Turck, Natacha; Sanchez, Jean-Charles			A Combined CXCL10, CXCL8 and H-FABP Panel for the Staging of Human African Trypanosomiasis Patients	PLOS NEGLECTED TROPICAL DISEASES			English	Article							CENTRAL-NERVOUS-SYSTEM; ACID-BINDING-PROTEIN; POSTMORTEM CEREBROSPINAL-FLUID; GAMMA-INDUCIBLE PROTEIN-10; BLOOD-BRAIN-BARRIER; CHEMOKINE RECEPTORS; CEREBRAL MALARIA; SLEEPING SICKNESS; IMMUNE-RESPONSE; CELL-DEATH	Background: Human African trypanosomiasis ( HAT), also known as sleeping sickness, is a parasitic tropical disease. It progresses from the first, haemolymphatic stage to a neurological second stage due to invasion of parasites into the central nervous system (CNS). As treatment depends on the stage of disease, there is a critical need for tools that efficiently discriminate the two stages of HAT. We hypothesized that markers of brain damage discovered by proteomic strategies and inflammation-related proteins could individually or in combination indicate the CNS invasion by the parasite. Methods: Cerebrospinal fluid (CSF) originated from parasitologically confirmed Trypanosoma brucei gambiense patients. Patients were staged on the basis of CSF white blood cell (WBC) count and presence of parasites in CSF. One hundred samples were analysed: 21 from stage 1 (no trypanosomes in CSF and <= 5 WBC/mu L) and 79 from stage 2 (trypanosomes in CSF and/or >5 WBC/mu L) patients. The concentration of H-FABP, GSTP-1 and S100 beta in CSF was measured by ELISA. The levels of thirteen inflammation-related proteins (IL-1ra, IL-1 beta, IL-6, IL-9, IL-10, G-CSF, VEGF, IFN-gamma, TNF-alpha, CCL2, CCL4, CXCL8 and CXCL10) were determined by bead suspension arrays. Results: CXCL10 most accurately distinguished stage 1 and stage 2 patients, with a sensitivity of 84% and specificity of 100%. Rule Induction Like (RIL) analysis defined a panel characterized by CXCL10, CXCL8 and H-FABP that improved the detection of stage 2 patients to 97% sensitivity and 100% specificity. Conclusion: This study highlights the value of CXCL10 as a single biomarker for staging T. b. gambiense-infected HAT patients. Further combination of CXCL10 with H-FABP and CXCL8 results in a panel that efficiently rules in stage 2 HAT patients. As these molecules could potentially be markers of other CNS infections and disorders, these results should be validated in a larger multi-centric cohort including other inflammatory diseases such as cerebral malaria and active tuberculosis.	[Hainard, Alexandre; Tiberti, Natalia; Robin, Xavier; Fouda, Catherine; Turck, Natacha; Sanchez, Jean-Charles] Med Univ Ctr, Biomed Prote Res Grp, Geneva, Switzerland; [Lejon, Veerle] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Ngoyi, Dieudonne Mumba] Inst Natl Rech Biomed, Kinshasa, Zaire; [Matovu, Enock] Makerere Univ, Fac Sci, Dept Vet Parasitol & Microbiol, Kampala, Uganda; [Enyaru, John Charles] Makerere Univ, Fac Sci, Dept Biochem, Kampala, Uganda; [Ndung'u, Joseph Mathu] FIND, Geneva, Switzerland; [Lisacek, Frederique; Mueller, Markus] Med Univ Ctr, Swiss Inst Bioinformat, Geneva, Switzerland	Hainard, A (reprint author), Med Univ Ctr, Biomed Prote Res Grp, Geneva, Switzerland.	Jean-Charles.Sanchez@unige.ch	Tiberti, Natalia/I-7928-2018; Robin, Xavier/A-1680-2009	Tiberti, Natalia/0000-0002-2981-5233; Robin, Xavier/0000-0002-6813-3200; Lejon, Veerle/0000-0002-6795-0962; Muller, Markus/0000-0003-0907-3583; LISACEK, Frederique/0000-0002-0948-4537; Matovu, Enock/0000-0003-0714-7032	Foundation for Innovative New Diagnostics (FIND)	This work is supported by the Foundation for Innovative New Diagnostics (FIND). The THARSAT study, including a PhD grant of DMN, received financial support from the Belgian Ministry of Foreign Affairs, Directorate General for Development Co-operation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Allard L, 2007, BIOMARK INSIGHTS, V2, P155; AMIN DN, 2009, P NATL ACAD IN PRESS; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Burgess JA, 2006, J PROTEOME RES, V5, P1674, DOI 10.1021/pr060160v; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Ching S, 2005, BRAIN BEHAV IMMUN, V19, P127, DOI 10.1016/j.bbi.2004.06.001; Courtioux B, 2006, INT J PARASITOL, V36, P1057, DOI 10.1016/j.ijpara.2006.04.011; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; Girard M, 2005, MOL BIOCHEM PARASIT, V139, P41, DOI 10.1016/j.molbiopara.2004.09.008; GLATZ JFC, 1988, BIOCHIM BIOPHYS ACTA, V961, P148, DOI 10.1016/0005-2760(88)90141-5; Gotsch F, 2007, J MATERN-FETAL NEO M, V20, P777, DOI 10.1080/14767050701483298; Guillaume E, 2003, PROTEOMICS, V3, P1495, DOI 10.1002/pmic.200300478; HANUM PS, 2003, INT IMMUNOL, V15, P633, DOI DOI 10.1093/INTIMM/DXG065; Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284; Huang DR, 2000, IMMUNOL REV, V177, P52, DOI 10.1034/j.1600-065X.2000.17709.x; HUNTER CA, 1992, LAB INVEST, V67, P635; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; John CC, 2008, AM J TROP MED HYG, V78, P198, DOI 10.4269/ajtmh.2008.78.198; Kennedy PGE, 2008, ANN NEUROL, V64, P116, DOI 10.1002/ana.21429; Kennedy PGE, 2008, T ROY SOC TROP MED H, V102, P306, DOI 10.1016/j.trstmh.2007.11.011; Kennedy PGE, 2009, T ROY SOC TROP MED H, V103, P213, DOI 10.1016/j.trstmh.2008.08.013; Kennedy PGE, 2006, INT J PARASITOL, V36, P505, DOI 10.1016/j.ijpara.2006.01.012; KNOWLTON AA, 1989, J MOL CELL CARDIOL, V21, P577, DOI 10.1016/0022-2828(89)90823-7; Lahrtz F, 1997, EUR J IMMUNOL, V27, P2484, DOI 10.1002/eji.1830271004; Lejon V, 2005, TROP MED INT HEALTH, V10, P395, DOI 10.1111/j.1365-3156.2005.01403.x; Lejon V, 2001, Med Trop (Mars), V61, P355; Lejon V, 2003, J INFECT DIS, V187, P1475, DOI 10.1086/374645; Lejon V, 2002, T ROY SOC TROP MED H, V96, P329, DOI 10.1016/S0035-9203(02)90115-X; Lescuyer P, 2004, PROTEOMICS, V4, P2234, DOI 10.1002/pmic.200300822; Lescuyer Pierre, 2005, Mol Diagn, V9, P1, DOI 10.2165/00066982-200509010-00001; MacLean L, 2007, J INFECT DIS, V196, P1620, DOI 10.1086/522011; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.ccn.2003.12.008; Masocha W, 2007, PHYSIOL BEHAV, V92, P110, DOI 10.1016/j.physbeh.2007.05.045; Miezan TW, 2000, T ROY SOC TROP MED H, V94, P293, DOI 10.1016/S0035-9203(00)90327-4; Ngotho M, 2006, PARASITOL INT, V55, P243, DOI 10.1016/j.parint.2006.06.004; R Development Core Team, 2008, R LANG ENV STAT COMP; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Sternberg JM, 2005, J NEUROIMMUNOL, V167, P81, DOI 10.1016/j.jneuroim.2005.06.017; Sternberg JM, 2004, PARASITE IMMUNOL, V26, P469, DOI 10.1111/j.0141-9838.2004.00731.x; Sui YJ, 2006, EUR J NEUROSCI, V23, P957, DOI 10.1111/j.1460-9568.2006.04631.x; THEODORE C, 1985, BIOCHEM J, V225, P375, DOI 10.1042/bj2250375; van Heteren JT, 2008, GLIA, V56, P568, DOI 10.1002/glia.20639; Weng YM, 1998, J BIOL CHEM, V273, P18288, DOI 10.1074/jbc.273.29.18288; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; WHO, 2006, WKLY EPIDEMIOL REC, V81, P69; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP20; 1998, TECH REP SER WHO, V881, pR1	52	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2009	3	6							e459	10.1371/journal.pntd.0000459				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	475XS	WOS:000268401000011	19554086	DOAJ Gold, Green Published			2019-04-02	
J	Montes, M; Sanchez, C; Verdonck, K; Lake, JE; Gonzalez, E; Lopez, G; Terashima, A; Nolan, T; Lewis, DE; Gotuzzo, E; White, AC				Montes, Martin; Sanchez, Cesar; Verdonck, Kristien; Lake, Jordan E.; Gonzalez, Elsa; Lopez, Giovanni; Terashima, Angelica; Nolan, Thomas; Lewis, Dorothy E.; Gotuzzo, Eduardo; White, A. Clinton, Jr.			Regulatory T Cell Expansion in HTLV-1 and Strongyloidiasis Co-infection Is Associated with Reduced IL-5 Responses to Strongyloides stercoralis Antigen	PLOS NEGLECTED TROPICAL DISEASES			English	Article							LEUKEMIA-VIRUS TYPE-1; PROTECTIVE IMMUNITY; BALB/CBYJ MICE; PROVIRAL LOAD; INFECTION; HYPERINFECTION; EXPRESSION; EOSINOPHIL; FREQUENCY; CARRIERS	Background: Human strongyloidiasis varies from a chronic but limited infection in normal hosts to hyperinfection in patients treated with corticosteroids or with HTLV-1co-infection. Regulatory T cells dampen immune responses to infections. How human strongyloidiasis is controlled and how HTLV-1 infection affects this control are not clear. We hypothesize that HTLV-1 leads to dissemination of Strongyloides stercoralis infection by augmenting regulatory T cell numbers, which in turn down regulate the immune response to the parasite. Objective: To measure peripheral blood T regulatory cells and Strongyloides stercoralis larval antigen-specific cytokine responses in strongyloidiasis patients with or without HTLV-1 co-infection. Methods: Peripheral blood mononuclear cells (PBMCs) were isolated from newly diagnosed strongyloidiasis patients with or without HTLV-1 co-infection. Regulatory T cells were characterized by flow cytometry using intracellular staining for CD4, CD25 and FoxP3. PBMCs were also cultured with and without Strongyloides larval antigens. Supernatants were analyzed for IL-5 production. Results: Patients with HTLV-1 and Strongyloides co-infection had higher parasite burdens. Eosinophil counts were decreased in the HTLV-1 and Strongyloides co-infected subjects compared to strongyloidiasis-only patients (70.0 vs. 502.5 cells/mm(3), p = 0.09, Mann-Whitney test). The proportion of regulatory T cells was increased in HTLV-1 positive subjects co-infected with strongyloidiasis compared to patients with only strongyloidiasis or asymptomatic HTLV-1 carriers (median = 17.9% vs. 4.3% vs. 5.9 p<0.05, One-way ANOVA). Strongyloides antigen-specific IL-5 responses were reduced in strongyloidiasis/ HTLV-1 coinfected patients (5.0 vs. 187.5 pg/ml, p = 0.03, Mann-Whitney test). Reduced IL-5 responses and eosinophil counts were inversely correlated to the number of CD4+CD25+FoxP3+ cells. Conclusions: Regulatory T cell counts are increased in patients with HTLV-1 and Strongyloides stercoralis co-infection and correlate with both low circulating eosinophil counts and reduced antigen-driven IL-5 production. These findings suggest a role for regulatory T cells in susceptibility to Strongyloides hyperinfection.	[Montes, Martin; Sanchez, Cesar; Verdonck, Kristien; Gonzalez, Elsa; Lopez, Giovanni; Terashima, Angelica; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Montes, Martin; Verdonck, Kristien] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX USA; [Lake, Jordan E.] Inst Trop Med, Dept Microbiol, Virol Unit, B-2000 Antwerp, Belgium; [Nolan, Thomas] Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA; [Lewis, Dorothy E.; White, A. Clinton, Jr.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Montes, M (reprint author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.	montes@bcm.edu		White, A Clinton/0000-0002-9668-4632; Nolan, Thomas/0000-0002-6860-7947; sanchez, cesar/0000-0001-7300-0085	NIH [RO1 TW007642, TW006569]	This work was supported by NIH Research Grant No. RO1 TW007642 funded by the Fogarty International Center to MM, NIH Frant No. D43 TW006569 funded by the Fogarty International Center to ACW, and the Directorate-General for Development Cooperation (DGDC) of the Belgian Government ( framework agreement 02, project 95501) and the Flemish Interuniversity Council (VLIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, EUR J HAEMATOL, V81, P209, DOI 10.1111/j.1600-0609.2008.01105.x; ABRAHAM D, 1995, EXP PARASITOL, V80, P297, DOI 10.1006/expr.1995.1036; Adaui V, 2006, J NEUROVIROL, V12, P456, DOI 10.1080/13550280601039634; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Carvalho EM, 2004, PARASITE IMMUNOL, V26, P487, DOI 10.1111/j.0141-9838.2004.00726.x; Carvalho EM, 2001, J ACQ IMMUN DEF SYND, V27, P1; DAWKINS HJS, 1982, J HELMINTHOL, V56, P23, DOI 10.1017/S0022149X00034957; Ding W, 2003, J VIROL, V77, P11027, DOI 10.1128/JVI.77.20.11027-11039.2003; Gill GV, 2004, QJM-INT J MED, V97, P789, DOI 10.1093/qjmed/hch133; Gotuzzo E, 1999, AM J TROP MED HYG, V60, P146, DOI 10.4269/ajtmh.1999.60.146; Herbert DR, 2000, J IMMUNOL, V165, P4544, DOI 10.4049/jimmunol.165.8.4544; Herbert DR, 2002, PARASITE IMMUNOL, V24, P95, DOI 10.1046/j.0141-9838.2001.00441.x; INOUE J, 1986, EMBO J, V5, P2883, DOI 10.1002/j.1460-2075.1986.tb04583.x; Keiser PB, 2004, CLIN MICROBIOL REV, V17, P208, DOI 10.1128/CMR.17.1.208-217.2004; Kerepesi LA, 2004, J INFECT DIS, V189, P1282, DOI 10.1086/382484; Klion AD, 2004, J ALLERGY CLIN IMMUN, V113, P30, DOI 10.1016/j.jaci.2003.10.050; Ligas JA, 2003, INFECT IMMUN, V71, P6835, DOI 10.1128/IAI.71.12.6835-6843.2003; Marcos Luis, 2005, Rev. gastroenterol. Perú, V25, P341; Marcos LA, 2008, T ROY SOC TROP MED H, V102, P314, DOI 10.1016/j.trstmh.2008.01.020; Mercado Rubén, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P247, DOI 10.1590/S0036-46652007000400010; Michaelsson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-41; Mir A, 2006, PARASITE IMMUNOL, V28, P397, DOI 10.1111/j.1365-3024.2006.00826.x; Neva FA, 1998, J INFECT DIS, V178, P1856, DOI 10.1086/314507; Padigel UM, 2007, J INFECT DIS, V196, P1844, DOI 10.1086/522968; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; PHELPS KR, 1993, AM J MED, V94, P447, DOI 10.1016/0002-9343(93)90163-J; Porto AF, 2001, PARASITE IMMUNOL, V23, P503, DOI 10.1046/j.1365-3024.2001.00407.x; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rotman HL, 1997, PARASITE IMMUNOL, V19, P29, DOI 10.1046/j.1365-3024.1997.d01-142.x; Rotman HL, 1996, EXP PARASITOL, V82, P267, DOI 10.1006/expr.1996.0034; Safdar A, 2004, CANCER-AM CANCER SOC, V100, P1531, DOI 10.1002/cncr.20120; Satoh M, 2002, CLIN EXP IMMUNOL, V127, P354, DOI 10.1046/j.1365-2249.2002.01733.x; Siddiqui AA, 2006, TROPICAL INFECT DIS, P1274; Toulza F, 2008, BLOOD, V111, P5047, DOI 10.1182/blood-2007-10-118539; Vadlamudi Raja S, 2006, Clin Mol Allergy, V4, P8, DOI 10.1186/1476-7961-4-8; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; Viney ME, 2006, MED MICROBIOL IMMUN, V195, P49, DOI 10.1007/s00430-006-0013-2; Viney ME, 2004, J INFECT DIS, V190, P2175, DOI 10.1086/425935	40	53	53	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2009	3	6							e456	10.1371/journal.pntd.0000456				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	475XS	WOS:000268401000016	19513105	DOAJ Gold, Green Published			2019-04-02	
J	Harries, AD; Zachariah, R; Kapur, A; Jahn, A; Enarson, DA				Harries, Anthony D.; Zachariah, Rony; Kapur, Anil; Jahn, Andreas; Enarson, Donald A.			The vital signs of chronic disease management	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Review						Chronic disease; Disease management; Vital signs; Tuberculosis; Antiretroviral therapy; Diabetes mellitus	ANTIRETROVIRAL THERAPY; COUNTRIES; CARE	The vital signs of pulse rate, blood pressure, temperature and respiratory rate are the 'nub' of individual patient management. At the programmatic level, vital signs could also be used to monitor the burden and treatment outcome of chronic disease. Case detection and treatment outcome constitute the vital signs of tuberculosis control within the WHO's 'DOTS' framework, and similar vital signs could be adapted and used for management of chronic diseases. The numbers of new patients started on therapy in each month or quarter (new incident cases) are sensitive indicators for programme performance and access to services. Using similar reporting cycles, treatment outcomes for all patients can be assessed, the vital signs being: alive and retained on therapy at the respective facility; died; stopped therapy; lost to follow-up; and transferred out to another facility. Retention on treatment constitutes the prevalent number of cases, the burden of disease, and this provides important strategic information for rational. drug forecasting and logistic planning. If case numbers and outcomes of chronic diseases were measured reliably and consistently as part of an integrated programmatic approach, this would strengthen the ability of resource-poor countries to monitor and assess their response to these growing epidemics. (C) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Harries, Anthony D.; Enarson, Donald A.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England; [Zachariah, Rony] Med Sans Frontieres, Dept Med, Brussels Operat Ctr, Brussels, Belgium; [Kapur, Anil] World Diabet Fdn, Lyngby, Denmark; [Jahn, Andreas] Lighthouse Trust, Lilongwe, Malawi; [Jahn, Andreas] Int Training & Educ Ctr HIV, Seattle, WA USA	Harries, AD (reprint author), Old Inn Cottage,Vears Lane, Winchester SO21 1TQ, Hants, England.	adharries@theunion.org					Ait-Khaled N, 2008, MANAGEMENT ASTHMA GU, P58; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Mamo Y, 2007, CLIN MED, V7, P228, DOI 10.7861/clinmedicine.7-3-228; MASOLI M, GLOBAL BURDEN ASTHMA; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; WHO (World Health Organization), 2006, STOP TB PARTN GLOB P; *WORLD DIAB FDN, CHENN CALL ACT; World Health Organization, 2008, WHOHTMTB2008393; World Health Organization, 2004, WHOHTMTB2004330; World Health Organization, 2006, WHOHTMTB2006368; World Health Organization, 1994, WHOTB94179; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Yu JKL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002065	16	24	24	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUN	2009	103	6					537	540		10.1016/j.trstmh.2008.12.008				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	456ZJ	WOS:000266893300001	19155031	Green Published			2019-04-02	
J	Zachariah, R; Ford, N; Philips, M; Lynch, S; Massaquoi, M; Janssens, V; Harries, AD				Zachariah, R.; Ford, N.; Philips, M.; Lynch, S.; Massaquoi, M.; Janssens, V.; Harries, A. D.			Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Review						Task shifting; Human resources; HIV; AIDS; Review; Sub-Saharan Africa	TUBERCULOSIS-CONTROL PROGRAMS; RESOURCE-POOR SETTINGS; HEALTH-CARE WORKERS; ANTIRETROVIRAL-TREATMENT; SOUTH-AFRICA; SCALING-UP; RURAL DISTRICT; MEDICAL ASSISTANTS; MALAWI; THERAPY	Sub-Saharan Africa is facing a crisis in human health resources due to a critical shortage of health workers. The shortage is compounded by a high burden of infectious diseases; emigration of trained professionals; difficult working conditions and low motivation. In particular, the burden of HIV/AIDS has led to the concept of task shifting being increasingly promoted as a way of rapidly expanding human resource capacity. This refers to the delegation of medical and health service responsibilities from higher to lower cadres of health staff, in some cases non-professionals. This paper, drawing on Medecins Sans Frontieres' experience of scaling-up antiretroviral treatment in three sub-Saharan African countries (Malawi, South Africa and Lesotho) and supplemented by a review of the literature, highlights the main opportunities and challenges posed by task shifting and proposes specific actions to tackle the challenges. The opportunities include: increasing access to life-saving treatment; improving the workforce skills mix and health-system efficiency; enhancing the role of the community; cost advantages and reducing attrition and international 'brain drain'. The challenges include: maintaining quality and safety; addressing professional and institutional resistance; sustaining motivation and performance and preventing deaths of health workers from HIV/AIDS. Task shifting should not undermine the primary objective of improving patient benefits and public health outcomes. (C) 2008 Published by Elsevier Ltd on behalf of Royal Society of Tropical Medicine and Hygiene.	[Zachariah, R.; Janssens, V.] Med Sans Frontieres, Dept Med, Brussels Operat Ctr, L-1617 Luxembourg, Luxembourg; [Ford, N.; Lynch, S.] Med Sans Frontieres, SAMU, Johannesburg, South Africa; [Philips, M.] Med Sans Frontieres, Anal & Advocacy Unit, Brussels Operat Ctr, Brussels, Belgium; [Massaquoi, M.] Med Sans Frontieres, Blantyre, Malawi; [Harries, A. D.] Int Union TB & Lung Dis, Paris, France; [Harries, A. D.] London Sch Hyg & Trop Med, London WC1, England	Zachariah, R (reprint author), Med Sans Frontieres, Dept Med, Brussels Operat Ctr, 68 Rue Gosperich, L-1617 Luxembourg, Luxembourg.	zachariah@internet.lu					Aja G, 2005, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004015.PUB2; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; BERMAN PA, 1987, SOC SCI MED, V25, P443, DOI 10.1016/0277-9536(87)90168-7; Buchan J, 2002, B WORLD HEALTH ORGAN, V80, P575; Calmy A, 2004, AIDS, V18, P2353; Chopra M, 2008, LANCET, V371, P668, DOI 10.1016/S0140-6736(08)60305-0; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/01.aids.0000131322.13515.e2; Daviauda E, 2008, B WORLD HEALTH ORGAN, V86, P46, DOI 10.2471/BLT.07.042283; Department of Health, 2007, HIV AIDS STI STRAT P; Deribe K, 2008, TROP MED INT HEALTH, V13, P328, DOI 10.1111/j.1365-3156.2008.02006.x; DOVLO D, 2004, HUMAN RESOURCES HLTH, V2, P1; Dovlo Delanyo, 2005, PLoS Med, V2, pe109, DOI 10.1371/journal.pmed.0020109; EGGER D, 2007, WHOHSSHEALTHSYSTEMS2; Feeley F, 2006, LANCET, V368, P435, DOI 10.1016/S0140-6736(06)69133-2; GIMBELSHERR S, 2007, HUMAN RES HLTH, V5, P1; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Harries AD, 2005, INT J TUBERC LUNG D, V9, P138; Harries AD, 2002, T ROY SOC TROP MED H, V96, P34, DOI 10.1016/S0035-9203(02)90231-2; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Kironde S, 2002, INT J TUBERC LUNG D, V6, P104; KNIPPENBERG R, 1997, INT J HEALTH PLAN MA, V12, P29; KUMPHITAK A, 2004, PERSPECTIVES PRACTIC; Lanata CF, 2007, LANCET, V369, P1238, DOI 10.1016/S0140-6736(07)60573-X; LEHMAN U, 2004, 41 JLI GLOB HLTH TRU; Lehmann S, 2007, COMMUNITY HLTH WORKE; Libamba E, 2005, INT J TUBERC LUNG D, V9, P1062; LIN Y, 2000, ASSESSING MALARIA TR; Makombe SD, 2007, B WORLD HEALTH ORGAN, V85, P851; Mccoy D, 2008, LANCET, V371, P675, DOI 10.1016/S0140-6736(08)60306-2; Medecins Sans Frontieres, 2008, HELP WANT CONFR HEAL; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; OforiAdjei D, 1996, SOC SCI MED, V42, P1169, DOI 10.1016/0277-9536(95)00389-4; Pereira C, 2007, BJOG-INT J OBSTET GY, V114, P1530, DOI 10.1111/j.1471-0528.2007.01489.x; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2003, INT J EPIDEMIOL, V32, P296, DOI 10.1093/ije/dyg063; Rowe AK, 2001, AM J PUBLIC HEALTH, V91, P1625, DOI 10.2105/AJPH.91.10.1625; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; SIBBALD B, 2004, J HLTH SERVICES R S1, V9, pS28; Tawfik L, 2003, IMPACT HIV AIDS HLTH; *UNAIDS, 2000, AIDS AFR COUNTR COUN; Van Damme W, 2006, AIDS, V20, P653, DOI 10.1097/01.aids.0000216364.44409.b1; Vaz F, 1999, B WORLD HEALTH ORGAN, V77, P688; Vujicic M, 2004, HUMAN RESOURCES HLTH, V2, P3, DOI DOI 10.1186/1478-4491-2-3; WALT G, 1989, SOC SCI MED, V29, P599, DOI 10.1016/0277-9536(89)90179-2; WHITE SM, 1987, LANCET, V2, P612; WHO, 2007, TREAT TRAIN RETR TAS; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; World Health Organization, 2007, WORLD HLTH STAT 2007; World Health Organization, 2006, WORLD HLTH REP 2006; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010; Zachariah R, 2006, T ROY SOC TROP MED H, V100, P167, DOI 10.1016/j.trstmh.2005.07.008; Zachariah R, 2003, TROP DOCT, V33, P88, DOI 10.1177/004947550303300211	57	219	223	1	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUN	2009	103	6					549	558		10.1016/j.trstmh.2008.09.019				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	456ZJ	WOS:000266893300003	18992905	Green Published	Y	N	2019-04-02	
J	van Griensven, J; Zachariah, R; Rasschaert, F; Atte, EF; Reid, T				van Griensven, Johan; Zachariah, Rony; Rasschaert, Freya; Atte, Edi F.; Reid, Tony			Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						HIV; Stavudine; Lipoatrophy; Body weight; Substitution; Africa	ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED ADULTS; THYMIDINE ANALOG; ABACAVIR; LIPODYSTROPHY; TOXICITY; COHORT; TRIAL	This cohort study was conducted amongst female patients manifesting lipoatrophy while receiving stavudine-containing first-Line antiretroviral treatment regimens at two urban health centres in Rwanda. The objectives were to assess weight evolution after stavudine substitution and to describe any significant difference in weight evolution when zidovudine or tenofovir/abacavir was used for substitution. All adult patients on stavudine-containing first-line regimens who developed lipoatrophy (diagnosed using a lipodystrophy case definition study-based questionnaire) and whose treatment regimen was changed were included (n = 114). In the most severe cases stavudine was replaced with tenofovir or abacavir (n = 39), and in the remainder with zidovudine (n = 75). For patients changed to zidovudine a progressive weight toss was seen, while those on tenofovir/abacavir showed a progressive weight increase from six months. The between-group difference in weight evolution was significant from nine months (difference at 12 months: 2.3 kg, P = 0.02). These differences were confirmed by follow-up lipoatrophy scores. In multivariate analysis, substitution with tenofovir/abacavir remained significantly associated with weight gain. This is the first study in Africa assessing weight gain as a proxy for recovery after stavudine substitution due to lipoatrophy, providing supporting evidence that tenofovir/abacavir is superior to zidovudine. The weight toss with zidovudine might justify earlier substitution and access to better alternatives like tenofovir/abacavir. (C) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[van Griensven, Johan; Atte, Edi F.] Med Sans Frontieres, Kigali 7089, Rwanda; [Zachariah, Rony; Reid, Tony] Med Sans Frontieres Brussels, Med Dept Operat Res, B-1090 Brussels, Belgium	van Griensven, J (reprint author), Med Sans Frontieres, Kigali 7089, Rwanda.	jvgrie@yahoo.com			European Union; Belgian Development Cooperation (DGCD); Global Fund to fight AIDS, Tuberculosis and Malaria; Medecins Sans Frontieres [09_NAT_ERB_007]	The MSF project received funding from the European Union, the Belgian Development Cooperation (DGCD) and the Global Fund to fight AIDS, Tuberculosis and Malaria.	Ananworanich J, 2008, J ANTIMICROB CHEMOTH, V61, P1340, DOI 10.1093/jac/dkn097; Bacchetti P, 2006, JAIDS-J ACQ IMM DEF, V42, P562; Boulle A, 2007, ANTIVIR THER, V12, P753; Brown TT, 2007, AIDS, V21, P1731, DOI 10.1097/QAD.0b013e328270356a; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; CARR A, 2000, AIDS, V14, P25; Gerrior Jul L, 2005, Nutr Clin Care, V8, P6; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Justman JE, 2008, JAIDS-J ACQ IMM DEF, V47, P312, DOI 10.1097/QAI.0b013e318162f597; Kennedy N, 1996, T ROY SOC TROP MED H, V90, P162, DOI 10.1016/S0035-9203(96)90123-6; Lichtenstein KA, 2001, AIDS, V15, P1389, DOI 10.1097/00002030-200107270-00008; Mallon PWG, 2003, AIDS, V17, P971, DOI [10.1097/00002030-200305020-00005, 10.1097/01.aids.0000060348.78202.74]; Mangili A, 2006, CLIN INFECT DIS, V42, P836, DOI 10.1086/500398; Martin A, 2004, AIDS, V18, P1029, DOI 10.1097/01.aids.0000125923.10668.da; MCCOMSEY G, 2006, 13 C RETR OPP INF 5; McComsey GA, 2004, CLIN INFECT DIS, V38, P263, DOI 10.1086/380790; *MED SANS FRONT, 2007, ANT THER PRIM HEALTH; Moyle GJ, 2006, AIDS, V20, P2043, DOI 10.1097/01.aids.0000247574.33998.03; Murphy RA, 2007, J INFECT DIS, V196, pS449, DOI 10.1086/521112; Mutimura Eugene, 2007, AIDS Res Ther, V4, P19, DOI 10.1186/1742-6405-4-19; Subbaraman R, 2007, CLIN INFECT DIS, V45, P1093, DOI 10.1086/521150; Tien PC, 2007, JAIDS-J ACQ IMM DEF, V44, P43, DOI 10.1097/01.qai.0000248353.56125.43; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; *WHO, 2006, ANT TREATM HIV INF A; *WHO, 2005, REP WHO UNAIDS M FOR; Wohl DA, 2006, CLIN INFECT DIS, V43, P645, DOI 10.1086/507333; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea	27	6	6	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUN	2009	103	6					613	619		10.1016/j.trstmh.2008.08.015				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	456ZJ	WOS:000266893300013	18835003	Green Published			2019-04-02	
J	Boelaert, M; Meheus, F; Sanchez, A; Singh, SP; Vanlerberghe, V; Picado, A; Meessen, B; Sundar, S				Boelaert, M.; Meheus, F.; Sanchez, A.; Singh, S. P.; Vanlerberghe, V.; Picado, A.; Meessen, B.; Sundar, S.			The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						visceral leishmaniasis; poverty; vulnerability; wealth distribution; Bihar	ECONOMIC BURDEN; KALA-AZAR; INFECTION; DISEASE; NEPAL; SUDAN	OBJECTIVE To provide data about wealth distribution in visceral leishmanisis (VL)-affected communities compared to that of the general population of Bihar State, India. METHODS After extensive disease risk mapping, 16 clusters with high VL transmission were selected in Bihar. An exhaustive census of all households in the clusters was conducted and socio-economic household characteristics were documented by questionnaire. Data on the general Bihar population taken from the National Family Health Survey of India were used for comparison. An asset index was developed based on Principal Components Analysis and the distribution of this asset index for the VL communities was compared with that of the general population of Bihar. RESULTS 83% of households in communities with high VL attack rates belonged to the two lowest quintiles of the Bihar wealth distribution. All socio-economic indicators showed significantly lower wealth for those households. CONCLUSION Visceral leishmanisis clearly affects the poorest of the poor in India. They are most vulnerable, as this vector-born disease is linked to poor housing and unhealthy habitats. The disease leads the affected households to more destitution because of its impact on household income and wealth. Support for the present VL elimination initiative is important in the fight against poverty.	[Meheus, F.] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Singh, S. P.; Sundar, S.] Banaras Hindu Univ, Inst Med Sci, Dept Community Med, Varanasi 221005, Uttar Pradesh, India; [Picado, A.] London Sch Hyg & Trop Med, London WC1, England	Meheus, F (reprint author), Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, Natl Str 155, B-2000 Antwerp, Belgium.	fmeheus@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Picado, Albert/0000-0001-7344-628X; Meessen, Bruno/0000-0002-0359-8621	European Union [015374]	This study received financial support from the KALANET project funded by the European Union DG Research Sixth Framework Programme/INCODEV. (Proposal Contract No.: 015374). The funding source had no role in the study design; collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The author's work was independent of the funders (the funding source had no involvement).	Adhikari SR, 2003, ACTA TROP, V88, P1, DOI 10.1016/S0001-706X(03)00156-6; ALI A, 1994, ANN TROP MED PARASIT, V88, P289, DOI 10.1080/00034983.1994.11812869; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Bloom D., 2003, J HUMAN DEV, V4, P47, DOI DOI 10.1080/1464988032000051487; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; FALKINGHAM J, 2002, MEASURING HLTH POVER, P71; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Howe L. D., 2008, EMERGING THEMES EPID, V5; International Institute for Population Sciences & Macro International, 2007, NAT FAM HLTH SURV NF; Kleinbaum D.G., 1988, APPL REGRESSION ANAL; McKenzie DJ, 2005, J POPUL ECON, V18, P229, DOI 10.1007/s00148-005-0224-7; Meheus F, 2006, TROP MED INT HEALTH, V11, P1715, DOI 10.1111/j.1365-3156.2006.01732.x; MORRIS SS, 2007, CONT CLIN TRIALS, V283, P382; Rijal S, 2006, T ROY SOC TROP MED H, V100, P838, DOI 10.1016/j.trstmh.2005.09.017; SCHAEFER KU, 1995, T ROY SOC TROP MED H, V89, P471, DOI 10.1016/0035-9203(95)90070-5; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Trouiller P, 2001, TROP MED INT HEALTH, V6, P945, DOI 10.1046/j.1365-3156.2001.00803.x; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; WIJEYARATNE PM, 1994, ACTA TROP, V56, P349, DOI 10.1016/0001-706X(94)90106-6; Zeller M, 2006, WORLD DEV, V34, P446, DOI 10.1016/j.worlddev.2005.07.020; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	23	88	90	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUN	2009	14	6					639	644		10.1111/j.1365-3156.2009.02279.x				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	462CI	WOS:000267323200006	19392741				2019-04-02	
J	Van der Palen, M; Gillet, P; Bottieau, E; Cnops, L; Van Esbroeck, M; Jacobs, J				Van der Palen, Mirna; Gillet, Philippe; Bottieau, Emmanuel; Cnops, Lieselotte; Van Esbroeck, Marjan; Jacobs, Jan			Test characteristics of two rapid antigen detection tests (SD FK50 and SD FK60) for the diagnosis of malaria in returned travellers	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM MALARIA; POLYMERASE-CHAIN-REACTION; HISTIDINE-RICH PROTEIN-2; REAL-TIME PCR; PARASIGHT(TM)-F TEST; MICROSCOPY; ICT; PERFORMANCE; SENSITIVITY; ACCURACY	Background: Two malaria rapid diagnostic tests were evaluated in a travel clinic setting: the SD FK50 Malaria Ag Plasmodium falciparum test (a two-band test) and the SD FK60 Malaria Ag P. falciparum/Pan test (a three-band test). Methods: A panel of stored whole blood samples (n = 452 and n = 614 for FK50 and FK60, respectively) from returned travellers was used. The reference method was microscopy with PCR in case of discordant results. Results: For both tests, overall sensitivity for the detection of P. falciparum was 93.5%, reaching 97.6% and 100% at parasite densities above 100 and 1,000/mu l respectively. Overall sensitivities for Plasmodium vivax, Plasmodium ovale and Plasmodium malariae for the FK60 test were 87.5%, 76.3% and 45.2%, but they reached 92.6% and 90.5% for P. vivax and P. ovale at parasite densities above 500/mu l. Specificities were above 95% for all species and both tests when corrected by PCR, with visible histidine-rich protein-2 lines for P. malariae (n = 3) and P. vivax and P. ovale (1 sample each). Line intensities were reproducible and correlated to parasite densities. The FK60 tests provided clues to estimate parasite densities for P. falciparum below or above 1,000/mu l. Conclusion: Both the FK50 and FK60 performed well for the diagnosis of P. falciparum in the present setting, and the FK60 for the diagnosis of P. vivax and P. ovale at parasite densities > 500/mu l. The potential use of the FK60 as a semi-quantitative estimation of parasite density needs to be further explored.	[Van der Palen, Mirna; Jacobs, Jan] Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Gillet, Philippe; Bottieau, Emmanuel; Cnops, Lieselotte; Van Esbroeck, Marjan; Jacobs, Jan] Inst Trop Med, Dept Clin Med, B-2000 Antwerp, Belgium	Jacobs, J (reprint author), Fac Hlth Med & Life Sci, Maastricht, Netherlands.	mirna_palen@yahoo.com; pgillet@itg.be; ebottieau@itg.be; lcnops@itg.be; mvesbroeck@itg.be; jjacobs@itg.be		gillet, philippe/0000-0001-5878-6446			Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; BELL D, 2006, NAT REV MICROBIOL, V4, pS34, DOI DOI 10.1038/NRMICO1524; Bell DR, 2005, AM J TROP MED HYG, V73, P199, DOI 10.4269/ajtmh.2005.73.199; Craig MH, 2002, T ROY SOC TROP MED H, V96, P258, DOI 10.1016/S0035-9203(02)90092-1; Cruciani M, 2004, MED SCI MONITOR, V10, pMT81; De Monbrison F, 2004, EUR J CLIN MICROBIOL, V23, P784, DOI 10.1007/s10096-004-1202-9; Durand F, 2005, CLIN MICROBIOL INFEC, V11, P903, DOI 10.1111/j.1469-0691.2005.01253.x; Farcas GA, 2003, AM J TROP MED HYG, V69, P589, DOI 10.4269/ajtmh.2003.69.6.0690589; Gatti S, 2007, ANN TROP MED PARASIT, V101, P195, DOI 10.1179/136485907X156997; Grobusch MP, 2003, PARASITOL RES, V89, P354, DOI 10.1007/s00436-002-0764-7; Grobusch MP, 2002, EUR J CLIN MICROBIOL, V21, P818, DOI 10.1007/s10096-002-0831-0; Hanscheid T, 2003, CLIN MICROBIOL INFEC, V9, P497, DOI 10.1046/j.1469-0691.2003.00640.x; Iqbal Jamshaid, 2001, American Journal of Tropical Medicine and Hygiene, V64, P20; Jelinek T, 1999, J CLIN MICROBIOL, V37, P721; Marx A, 2005, ANN INTERN MED, V142, P836, DOI 10.7326/0003-4819-142-10-200505170-00009; Mason DP, 2002, ACTA TROP, V82, P51, DOI 10.1016/S0001-706X(02)00031-1; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; Moody A H, 2002, Br J Biomed Sci, V59, P228; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Pieroni P, 1998, T ROY SOC TROP MED H, V92, P166, DOI 10.1016/S0035-9203(98)90730-1; Piper R, 1999, AM J TROP MED HYG, V60, P109, DOI 10.4269/ajtmh.1999.60.109; Playford EG, 2002, J CLIN MICROBIOL, V40, P4166, DOI 10.1128/JCM.40.11.4166-4171.2002; Richter J, 2004, PARASITOL RES, V94, P384, DOI 10.1007/s00436-004-1213-6; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Stamatopoulos B, 2007, CLIN CHEM, V53, P1757, DOI 10.1373/clinchem.2007.089326; Van den Ende J, 1998, T ROY SOC TROP MED H, V92, P285, DOI 10.1016/S0035-9203(98)91013-6; *WHO, LIST KNOWN COMM AV A; Wiese L, 2006, SCAND J INFECT DIS, V38, P1063, DOI 10.1080/00365540600818011; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119	29	39	39	1	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAY 5	2009	8								90	10.1186/1475-2875-8-90				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	461CY	WOS:000267243400001	19416497	DOAJ Gold, Green Published			2019-04-02	
J	Garcia, AL; Parrado, R; Rojas, E; Delgado, R; Dujardin, JC; Reithinger, R				Garcia, Ana L.; Parrado, Rudy; Rojas, Ernesto; Delgado, Raul; Dujardin, Jean-Claude; Reithinger, Richard			Leishmaniases in Bolivia: Comprehensive Review and Current Status	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Review							AMERICAN TEGUMENTARY LEISHMANIASIS; WORLD CUTANEOUS LEISHMANIASIS; POLYMERASE-CHAIN-REACTION; SUB ANDEAN REGION; MUCOCUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; ISOENZYME CHARACTERIZATION; BRAZILIENSIS-BRAZILIENSIS; VIANNIA LAINSONI; RISK-FACTORS	The leishmaniases are protozoan, zoonotic diseases transmitted to human and other mammal hosts by the bite of phlebotomine sandflies. Bolivia has the highest incidence of cutaneous leishmaniasis (CL) in Latin America (LA), with 33 cases per 100,000 population reported in 2006. CL is endemic in seven of the country's nine administrative departments. Visceral leishmaniasis (VL) is comparatively rare and is restricted to one single focus. Most CL cases are caused by Leishmania (Viannia) braziliensis (85% cases); VL is caused by L. (L.) infantum. Seven sandfly species are incriminated as vectors and Leishmania infections have been detected in several non-human mammal hosts. Transmission is associated with forest-related activities, but recently, cases of autochthonous, urban transmission were reported. Because most cases are caused by L. (V) braziliensis, Bolivia reports the greatest ratio (i.e., up to 20% of all cases) of mucosal leishmaniasis to localized CL cases in LA. Per national guidelines, both CL and VL cases are microscopically diagnosed and treated with pentavalent antimony.	[Reithinger, Richard] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, London WC1E 7HT, England; [Garcia, Ana L.; Parrado, Rudy; Rojas, Ernesto; Delgado, Raul] Univ Mayor San Simon, IIBISMED CUMETROP, Fac Med, Cochabamba, Bolivia; [Dujardin, Jean-Claude] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; Inst Trop Med, Dept Mol Parasitol, B-2000 Antwerp, Belgium; George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA	Reithinger, R (reprint author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, Keppel St, London WC1E 7HT, England.	rreithinger@yahoo.co.uk			Belgian Agency for Cooperation and Development; European Commission; UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases; Wellcome Trust	Previous and Current CUMETROP work on the leishmaniases has been supported by the Belgian Agency for Cooperation and Development. the European Commission, the UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases, and the Wellcome Trust.	Alcais A, 1997, AM J HUM GENET, V61, P968, DOI 10.1086/514882; Alcais A, 1997, AM J TROP MED HYG, V57, P79, DOI 10.4269/ajtmh.1997.57.79; Altamirano-Enciso Alfredo J, 2003, Hist Cienc Saude Manguinhos, V10, P852; Bastrenta B, 2003, MEM I OSWALDO CRUZ, V98, P255, DOI 10.1590/S0074-02762003000200015; Bastrenta B, 2002, ACTA TROP, V83, P249, DOI 10.1016/S0001-706X(02)00129-8; Bermudez H, 2006, ANN TROP MED PARASIT, V100, P591, DOI 10.1179/136485906X118495; Bermudez H., 1993, Archives de l'Institut Pasteur de Tunis, V70, P455; Bermudez H., 1993, Archives de l'Institut Pasteur de Tunis, V70, P443; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; COPELAND HW, 1990, AM J TROP MED HYG, V43, P257, DOI 10.4269/ajtmh.1990.43.257; Davies C R, 2000, Cad Saude Publica, V16, P925, DOI 10.1590/S0102-311X2000000400013; Deborggraeve S, 2008, J INFECT DIS, V198, P1565, DOI 10.1086/592509; DEDET JP, 1995, B WORLD HEALTH ORGAN, V73, P39; DEMUYNCK A, 1979, ANN SOC BELG MED TR, V59, P325; DESJEUX P, 1987, T ROY SOC TROP MED H, V81, P742, DOI 10.1016/0035-9203(87)90014-9; DESJEUX P, 1983, T ROY SOC TROP MED H, V77, P851, DOI 10.1016/0035-9203(83)90305-X; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; DESJEUX P, 1986, LEISHMANIA TAXONOMIE, P401; Dimier-David L, 1991, Rev Soc Bras Med Trop, V24, P231; DIMIERDAVID L, 1993, B SOC PATHOL EXOT, V86, P106; DIMIERDAVID L, 1991, ANN SOC BELG MED TR, V71, P275; ESCOBAR MA, 1992, TROP DOCT, V22, P69, DOI 10.1177/00494755920220S110; ESPEJO JMT, 1989, MEM I OSWALDO CRUZ, V84, P583; ESPEJO JMT, 1989, ANN SOC BELG MED TR, V69, P297; FLORES MD, 2003, REV CHIL PEDIATR, V75, P285; FOURNET A, 1992, J ETHNOPHARMACOL, V37, P159, DOI 10.1016/0378-8741(92)90074-2; FOURNET A, 1994, J ETHNOPHARMACOL, V41, P19, DOI 10.1016/0378-8741(94)90054-X; FOURNET A, 1994, PLANTA MED, V60, P8, DOI 10.1055/s-2006-959397; Garcia A. L., 2005, Infection Genetics and Evolution, V5, P109, DOI 10.1016/j.meegid.2004.07.003; Garcia AL, 2007, T ROY SOC TROP MED H, V101, P1208, DOI 10.1016/j.trstmh.2007.09.002; Garcia AL, 2007, T ROY SOC TROP MED H, V101, P368, DOI 10.1016/j.trstmh.2006.06.009; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; GARRETT AJ, 1983, B INFORM CENETROP, V9, P1; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687; Kerr SF, 2006, AM J TROP MED HYG, V75, P1069, DOI 10.4269/ajtmh.2006.75.1069; LAFUENTE C, 1986, B CIENTIFICO CENETRO, V12, P1; Lawn SD, 2004, QJM-INT J MED, V97, P781, DOI 10.1093/qjmed/hch127; le Pont F., 1986, Memorias do Instituto Oswaldo Cruz, V81, P311; LEPONT F, 1989, ANN SOC BELG MED TR, V69, P223; LEPONT F, 1989, MEM I OSWALDO CRUZ, V84, P575, DOI 10.1590/S0074-02761989000400017; LEPONT F, 1989, MEM I OSWALDO CRUZ, V84, P417, DOI 10.1590/S0074-02761989000300019; LEPONT F, 1989, ANN SOC BELG MED TR, V69, P307; LEPONT F, 1988, CR ACAD SCI III-VIE, V307, P279; LEPONT F, 1985, T ROY SOC TROP MED H, V79, P227, DOI 10.1016/0035-9203(85)90341-4; LEPONT F, 1989, MEM I OSWALDO CRUZ, V84, P277, DOI 10.1590/S0074-02761989000200021; LERAY D, 1990, ANN SOC BELG MED  S1, V70, pS39; Marcondes CB, 1998, MEM I OSWALDO CRUZ, V93, P203, DOI 10.1590/S0074-02761998000200013; Martinez E, 1999, AM J TROP MED HYG, V61, P846, DOI 10.4269/ajtmh.1999.61.846; Martinez E, 1998, ACTA TROP, V71, P97, DOI 10.1016/S0001-706X(98)00049-7; Martinez E, 2002, T ROY SOC TROP MED H, V96, P529, DOI 10.1016/S0035-9203(02)90428-1; Martinez E, 2001, T ROY SOC TROP MED H, V95, P375, DOI 10.1016/S0035-9203(01)90185-3; MOLLINEDO S, 2000, 7 I NAC LAB SAL, P1; Reithinger R, 2003, AM J TROP MED HYG, V69, P473, DOI 10.4269/ajtmh.2003.69.473; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; REVOLLO S, 1992, T ROY SOC TROP MED H, V86, P388, DOI 10.1016/0035-9203(92)90231-Z; RODRIGUEZ LV, 1995, MEM I OSWALDO CRUZ, V90, P525, DOI 10.1590/S0074-02761995000400020; Rojas E, 2009, EMERG INFECT DIS, V15, P678, DOI 10.3201/eid1504.081257; SAGARNAGA E, 1909, RECUERDOS CAMPANA AC; Soto J, 2007, CLIN INFECT DIS, V44, P350, DOI 10.1086/510588; Soto J, 2004, AM J TROP MED HYG, V71, P577, DOI 10.4269/ajtmh.2004.71.577; Soto J, 2008, AM J TROP MED HYG, V78, P210, DOI 10.4269/ajtmh.2008.78.210; Telleria J, 1999, MEM I OSWALDO CRUZ, V94, P5, DOI 10.1590/S0074-02761999000100002; Torrez M, 1998, ACTA TROP, V71, P311, DOI 10.1016/S0001-706X(98)00068-0; URJEL R, 1983, T ROY SOC TROP MED H, V77, P882, DOI 10.1016/0035-9203(83)90325-5; URJEL R, 1987, B CIENTIFICO CTR ENF, V13, P38; WALTON BC, 1979, ANN TROP MED PARASIT, V73, P23, DOI 10.1080/00034983.1979.11687222; Weigle K, 1996, CLIN DERMATOL, V14, P433, DOI 10.1016/0738-081X(96)00036-3; World Health Organization, 2004, WORLD HLTH REP 2004; Yadon ZE, 2001, AM J TROP MED HYG, V65, P27, DOI 10.4269/ajtmh.2001.65.27; Yardley V, 2006, J INFECT DIS, V194, P1168, DOI 10.1086/507710; 2007, DOCUMENTOS TECNICONO; COMPUTER AIDED IDENT; 1998, MANUAL PROCEDIMIENTO	74	31	34	0	5	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAY	2009	80	5					704	711		10.4269/ajtmh.2009.80.704				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	443GS	WOS:000265898800005	19407110	Green Published			2019-04-02	
J	Zachariah, R; Ford, N; Philips, M; Draguez, B; Harries, AD				Zachariah, R.; Ford, N.; Philips, M.; Draguez, B.; Harries, A. D.			Reply to: What about health system strengthening and internal brain drain?	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Letter									[Zachariah, R.; Draguez, B.] Brussels Operat Ctr, Med Sans Frontieres Med Dept Operat Res, Brussels, Belgium; [Ford, N.] S African Med Unit SAMU, Johannesburg, South Africa; [Philips, M.] Brussels Operat Ctr, Anal & Advocacy Unit, Brussels, Belgium; [Harries, A. D.] London Sch Hyg & Trop Med, London WC1, England; [Harries, A. D.] Int Union TB & Lung Dis, Paris, France	Zachariah, R (reprint author), Brussels Operat Ctr, Med Sans Frontieres Med Dept Operat Res, 68 Rue Gasper,L-1617, Brussels, Belgium.	zachariah@internet.lu					Guthmann JP, 2008, PLOS MED, V5, P1191, DOI 10.1371/journal.pmed.0050169; Harries AD, 2008, INT J TUBERC LUNG D, V12, P1347; *MED SANS FRONT, 2008, CAMP ACC ESS MED UNT; MSF Field Research, MSF FIELD RES; O'Brien DP, 2006, AIDS, V20, P1955, DOI 10.1097/01.aids.0000247117.66585.ce; OOMS G, 2008, EQUINET NEWSLET 0701; OOMS G, 2008, GLOBAL HLTH, V4, P1; Ooms G, 2007, PLOS MED, V4, P605, DOI 10.1371/journal.pmed.0040128; van Rensburg DHCJ, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-15; Zachariah R, 2004, INT J TUBERC LUNG D, V8, P1058; ZACHARIAH R, 2009, T R SOC TRO IN PRESS	11	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAY	2009	103	5					534	535		10.1016/j.trstmh.2009.01.012				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	442EI	WOS:000265822400019					2019-04-02	
J	Bisoffi, Z; Sirima, BS; Angheben, A; Lodesani, C; Gobbi, F; Tinto, H; Van den Ende, J				Bisoffi, Zeno; Sirima, Bienvenu Sodiomon; Angheben, Andrea; Lodesani, Claudia; Gobbi, Federico; Tinto, Halidou; Van den Ende, Jef			Rapid malaria diagnostic tests vs. clinical management of malaria in rural Burkina Faso: safety and effect on clinical decisions. A randomized trial	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						malaria management; malaria diagnosis; fever management; rapid diagnostic test; RDT safety; clinical decision	PLASMODIUM-FALCIPARUM; FEBRILE ILLNESS; TANZANIA; PATTERNS; INDIA; FIELD; RISK	To assess if the clinical outcome of patients treated after performing a Rapid Diagnostic Test for malaria (RDT) is at least equivalent to that of controls (treated presumptively without test) and to determine the impact of the introduction of a malaria RDT on clinical decisions. Randomized, multi-centre, open clinical trial in two arms in 2006 at the end of the dry and of the rainy season in 10 peripheral health centres in Burkina Faso: one arm with use of RDT before treatment decision, one arm managed clinically. Primary endpoint: persistence of fever at day 4. Secondary endpoints: frequency of malaria treatment and of antibiotic treatment. A total of 852 febrile patients were recruited in the dry season and 1317 febrile patients in the rainy season, and randomized either to be submitted to RDT (P_RTD) or to be managed presumptively (P_CLIN). In both seasons, no significant difference was found between the two randomized groups in the frequency of antimalarial treatment, nor of antibiotic prescription. In the dry season, 80.8% and 79.8% of patients with a negative RDT were nevertheless diagnosed and treated for malaria, and so were 85.0% and 82.6% negative patients in the rainy season. In the rainy season only, both diagnosis and treatment of other conditions were significantly less frequent in RDT positive vs. negative patients (48.3%vs. 61.4% and 46.2%vs. 59.9%, P = 0.00 and 0.00, respectively). Our study was inconclusive on RDT safety (clinical outcome in the two randomized groups), because of an exceedingly and unexpectedly low compliance with the negative test result. Further research is needed on best strategies to promote adherence and on the safety of a test based strategy compared with the current, presumptive treatment strategy.	[Bisoffi, Zeno; Angheben, Andrea; Gobbi, Federico] Sacro Cuore Hosp, Ctr Trop Dis, Verona, Italy; [Sirima, Bienvenu Sodiomon] Minist Hlth, Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Tinto, Halidou] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Bisoffi, Zeno] Projet AnKaHeresso, Bobo Dioulasso, Burkina Faso; [Van den Ende, Jef] Inst Trop Med Prince Leopold, Dept Clin Sci, B-2000 Antwerp, Belgium	Bisoffi, Z (reprint author), Sacro Cuore Hosp, Ctr Trop Dis, Verona, Italy.	zeno.bisoffi@sacrocuore.it	Bisoffi, Zeno/B-6438-2013	Tinto, Halidou/0000-0002-0472-3586	UNIDEA-UNICREDIT Foundation	We thank the patients who participated in the study, the personnel of the health centres involved and all the investigation staff, as well as all the health staff of the 'An Ka Heresso' Project at the time of the field survey: Giuseppe Baracca (who first suggested a study on RDT), Klara Van den Ende, Annalisa Romeo, Bouma Neya, Mamadou Traore and Rosalie Midjour. We also thank Maria Gobbo, Monica Degani and Barbara Paiola for their active collaboration to the training of the investigational staff, Marleen Boelaert for support to data analysis and interpretation and Marco Albonico for critical reading of the manuscript. This study was funded by UNIDEA - UNICREDIT Foundation.	Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Bisoffi Z, 2008, BRIT MED J, V336, P168, DOI 10.1136/bmj.39401.486655.80; Guthmann JP, 2002, T ROY SOC TROP MED H, V96, P254, DOI 10.1016/S0035-9203(02)90091-X; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Kynast-Wolf G, 2006, INT J EPIDEMIOL, V35, P427, DOI 10.1093/ije/dyi150; Lubell Y, 2008, BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Ogbonna A, 2008, T ROY SOC TROP MED H, V102, P621, DOI 10.1016/j.trstmh.2008.03.024; Pfeiffer K, 2008, TROP MED INT HEALTH, V13, P418, DOI 10.1111/j.1365-3156.2008.02017.x; Reyburn H, 2004, BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; Singh N, 2005, AM J TROP MED HYG, V72, P26, DOI 10.4269/ajtmh.2005.72.26; Singh N, 2005, AM J TROP MED HYG, V73, P855, DOI 10.4269/ajtmh.2005.73.855; Some D T, 2007, Med Trop (Mars), V67, P43; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; Van den Broek I, 2006, AM J TROP MED HYG, V75, P1209, DOI 10.4269/ajtmh.2006.75.1209; *WHO, 2006, WHOHTMMAL20061108; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x	20	76	77	0	4	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2009	14	5					491	498		10.1111/j.1365-3156.2009.02246.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	445EN	WOS:000266032700002	19222821	Bronze			2019-04-02	
J	Verhaeghen, K; Van Bortel, W; Ho, DT; Sochantha, T; Coosemans, M				Verhaeghen, Katrijn; Van Bortel, Wim; Ho Dinh Trung; Sochantha, Tho; Coosemans, Marc			Absence of knockdown resistance suggests metabolic resistance in the main malaria vectors of the Mekong region	MALARIA JOURNAL			English	Article							GUATEMALAN ANOPHELES-ALBIMANUS; PYRETHROID RESISTANCE; INSECTICIDE RESISTANCE; SOUTHEAST-ASIA; KDR MUTATION; IMPREGNATED BEDNETS; SUNDAICUS COMPLEX; DIRUS COMPLEX; TREATED NETS; COTE-DIVOIRE	Background: As insecticide resistance may jeopardize the successful malaria control programmes in the Mekong region, a large investigation was previously conducted in the Mekong countries to assess the susceptibility of the main malaria vectors against DDT and pyrethroid insecticides. It showed that the main vector, Anopheles epiroticus, was highly pyrethroid-resistant in the Mekong delta, whereas Anopheles minimus sensu lato was pyrethroid-resistant in northern Vietnam. Anopheles dirus sensu stricto showed possible resistance to type II pyrethroids in central Vietnam. Anopheles subpictus was DDT- and pyrethroid-resistant in the Mekong Delta. The present study intends to explore the resistance mechanisms involved. Methods: By use of molecular assays and biochemical assays the presence of the two major insecticide resistance mechanisms, knockdown and metabolic resistance, were assessed in the main malaria vectors of the Mekong region. Results: Two FRET/MCA assays and one PCR-RFLP were developed to screen a large number of Anopheles populations from the Mekong region for the presence of knockdown resistance (kdr), but no kdr mutation was observed in any of the study species. Biochemical assays suggest an esterase mediated pyrethroid detoxification in An. epiroticus and An. subpictus of the Mekong delta. The DDT resistance in An. subpictus might be conferred to a high GST activity. The pyrethroid resistance in An. minimus s.l. is possibly associated with increased detoxification by esterases and P450 monooxygenases. Conclusion: As different metabolic enzyme systems might be responsible for the pyrethroid and DDT resistance in the main vectors, each species may have a different response to alternative insecticides, which might complicate the malaria vector control in the Mekong region.	[Verhaeghen, Katrijn; Van Bortel, Wim; Coosemans, Marc] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Ho Dinh Trung] Natl Inst Malariol Parasitol & Entomol, Dept Entomol, Hanoi, Vietnam; [Sochantha, Tho] Natl Ctr Malaria Control Parasitol & Entomol, Dept Entomol, Phnom Penh, Cambodia; [Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Vet & Biomed Sci, B-2610 Antwerp, Belgium	Verhaeghen, K (reprint author), Inst Trop Med, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	kverhaeghen@itg.be; wvbortel@itg.be; entomology@fpt.vn; sochanthat@cnm.gov.kh; mcoosemans@itg.be		Van Bortel, Wim/0000-0002-6644-518X	Institute for the Promotion of Innovation through Science and Technology in Flander	We acknowledge the excellent technical support of the entomology teams of the National Institute of Malariology, Parasitology and Entomology (NIMPE, Hanoi, Vietnam), the National Centre of Malariology, Parasitology and Entomology (NCMP, Vientiane, Laos) and the National Malaria Centre (NMC, Phnom Phen, Cambodia). We are grateful to the Ministries of Public Health of Vietnam, Laos and Cambodia for facilitating this research. The authors are grateful to Thierry Backeljau for reading and providing useful comments to this manuscript. This work was carried out within the framework of the INCO research project IC-4CT-2002-10041 and the Institutional Collaboration between NIMPE and the Institute of Tropical Medicine, Belgium, supported by the Belgian Co-operation (Directorate-General for Development Co-operation). This research was funded by a Ph. D. grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen).	Abhayawardana T. A., 1996, Indian Journal of Malariology, V33, P53; Brogdon WG, 1999, J ECON ENTOMOL, V92, P298, DOI 10.1093/jee/92.2.298; Brogdon WG, 1999, PESTIC BIOCHEM PHYS, V64, P101, DOI 10.1006/pest.1999.2415; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Chareonviriyaphap T, 2003, J VECTOR ECOL, V28, P108; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Dabire RK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-12; Darriet F, 2000, B SOC PATHOL EXOT, V93, P131; Diabate A, 2004, J AM MOSQUITO CONTR, V20, P195; Dusfour I, 2004, AM J TROP MED HYG, V71, P518, DOI 10.4269/ajtmh.2004.71.518; Enayati AA, 2003, MED VET ENTOMOL, V17, P138, DOI 10.1046/j.1365-2915.2003.00418.x; Etang J, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-46; Garros C, 2006, TROP MED INT HEALTH, V11, P102, DOI 10.1111/j.1365-3156.2005.01536.x; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Hoti SL, 2006, CURR SCI INDIA, V91, P658; Hung DQ, 2002, CHEMOSPHERE, V47, P357, DOI 10.1016/S0045-6535(01)00342-3; Karunaratne SHPP, 2007, PESTIC BIOCHEM PHYS, V88, P108, DOI 10.1016/j.pestbp.2006.10.001; Kim H, 2007, PESTIC BIOCHEM PHYS, V87, P54, DOI 10.1016/j.pestbp.2006.06.009; Linton YM, 2005, B ENTOMOL RES, V95, P329, DOI 10.1079/BER2005364; Luleyap HU, 2002, J MED ENTOMOL, V39, P870, DOI 10.1603/0022-2585-39.6.870; Mahama T, 2007, J MED ENTOMOL, V44, P498, DOI 10.1603/0022-2585(2007)44[498:EOPICD]2.0.CO;2; Manguin S, 2002, MED VET ENTOMOL, V16, P46, DOI 10.1046/j.0269-283x.2002.00344.x; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; MOURYA DT, 1993, MED VET ENTOMOL, V7, P11, DOI 10.1111/j.1365-2915.1993.tb00645.x; Nabeshima T, 2003, BIOCHEM BIOPH RES CO, V307, P15, DOI 10.1016/S0006-291X(03)01101-X; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Penilla RP, 1998, MED VET ENTOMOL, V12, P217; Prapanthadara LA, 1998, INSECT BIOCHEM MOLEC, V28, P321, DOI 10.1016/S0965-1748(98)00006-X; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Spillings BL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-226; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; TRUNG HD, 2003, THESIS U ANTWERP; Van Bortel W, 2000, INSECT MOL BIOL, V9, P335, DOI 10.1046/j.1365-2583.2000.00192.x; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; VERHAEGHEN K, 2002, THESIS U ANTWERP; Vulule JM, 1999, MED VET ENTOMOL, V13, P239, DOI 10.1046/j.1365-2915.1999.00177.x; *WHO, 1998, REP WHO INF CONS TES	43	20	22	0	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 28	2009	8								84	10.1186/1475-2875-8-84				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	449JU	WOS:000266327700001	19400943	DOAJ Gold, Green Published			2019-04-02	
J	Sagara, I; Rulisa, S; Mbacham, W; Adam, I; Sissoko, K; Maiga, H; Traore, OB; Dara, N; Dicko, YT; Dicko, A; Djimde, A; Jansen, FH; Doumbo, OK				Sagara, Issaka; Rulisa, Stephen; Mbacham, Wilfred; Adam, Ishag; Sissoko, Kourane; Maiga, Hamma; Traore, Oumar B.; Dara, Niawanlou; Dicko, Yahia T.; Dicko, Alassane; Djimde, Abdoulaye; Jansen, F. Herwig; Doumbo, Ogobara K.			Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial	MALARIA JOURNAL			English	Article							SULFADOXINE-PYRIMETHAMINE; EASTERN SUDAN; DOUBLE-BLIND; CHILDREN; AMODIAQUINE; COMBINATION; RESISTANCE; DRUG; EPIDEMIOLOGY; MEFLOQUINE	Background: The efficacy of artemisinin-based combination therapy has already been demonstrated in a number of studies all over the world, and some of them can be regarded as comparably effective. Ease of administration of anti-malarial treatments with shorter courses and fewer tablets may be key determinant of compliance. Methods: Patients with uncomplicated falciparum malaria and over six months of age were recruited in Cameroon, Mali, Rwanda and Sudan. 1,384 patients were randomly assigned to receive artesunate-sulphamethoxypyrazine-pyrimethamine (AS-SMP) three-day (once daily for 3 days) regimen (N = 476) or AS-SMP 24-hour (0 h, 12 h, 24 h) regimen (N = 458) or artemether-lumefantrine (AL), the regular 6 doses regimen (N = 450). The primary objective was to demonstrate non-inferiority (using a margin of -6%) of AS-SMP 24 hours or AS-SMP three days versus AL on the PCR-corrected 28-day cure rate. Results: The PCR-corrected 28-day cure rate on the intention to treat (ITT) analysis population were: 96.0%(457/476) in the AS-SMP three-day group, 93.7%(429/458) in the AS-SMP 24-hour group and 92.0%(414/450) in the AL group. Likewise, the cure rates on the PP analysis population were high: 99.3%(432/437) in the AS-SMP three-day group, 99.5%(416/419) in the AS-SMP 24-hour group and 99.7(391/394)% in the AL group. Most common drug-related adverse events were gastrointestinal symptoms (such as vomiting and diarrhea) which were slightly higher in the AS-SMP 24-hour group. Conclusion: AS-SMP three days or AS-SMP 24 hours are safe, are as efficacious as AL, and are well tolerated.	[Sagara, Issaka; Sissoko, Kourane; Maiga, Hamma; Traore, Oumar B.; Dara, Niawanlou; Dicko, Yahia T.; Dicko, Alassane; Djimde, Abdoulaye; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med Pharm & Odonto Stomatol, Bamako, Mali; [Rulisa, Stephen] Kigali Cent Univ Hosp, Kigali, Rwanda; [Mbacham, Wilfred] Univ Yaounde 1, Ctr Biotechnol, Lab Publ Hlth Biotechnol, Yaounde, Cameroon; [Adam, Ishag] Univ Khartoum, Khartoum, Sudan; [Jansen, F. Herwig] Dafra Pharma NV SA, B-2300 Turnhout, Belgium	Sagara, I (reprint author), Univ Bamako, Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med Pharm & Odonto Stomatol, Bamako, Mali.	isagara@mrtcbko.org; stevenruse@yahoo.com; wfmbacham@yahoo.com; ishagadam@hotmail.com; kouranes@mrtcbko.org; hmaiga@mrtcbko.org; bila@mrtcbko.org; niawanlou@mrtcbko.org; yahia@mrtcbko.org; adicko@mrtcbko.org; adjimde@mrtcbko.org; fhj@dafra.be; okd@mrtcbko.org	Rulisa, Stephen/E-3914-2018	Rulisa, Stephen/0000-0002-5357-7626; Mbacham, Wilfred/0000-0002-3934-3233			A-Elbasit IE, 2006, TROP MED INT HEALTH, V11, P604, DOI 10.1111/j.1365-3156.2006.01616.x; Adam Ishag, 2006, Ann Clin Microbiol Antimicrob, V5, P18, DOI 10.1186/1476-0711-5-18; Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Basco LK, 2002, B WORLD HEALTH ORGAN, V80, P538; Djimde AA, 2004, J INFECT DIS, V190, P853, DOI 10.1086/422758; Djimde AA, 2003, AM J TROP MED HYG, V69, P558, DOI 10.4269/ajtmh.2003.69.558; Elamin S. B., 2007, Eastern Mediterranean Health Journal, V13, P25; Falade C, 2005, T ROY SOC TROP MED H, V99, P459, DOI 10.1016/j.trstmh.2004.09.013; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Haynes RK, 2007, CHEMMEDCHEM, V2, P1448, DOI 10.1002/cmdc.200700064; Jansen FH, 2007, CURR MED CHEM, V14, P3243, DOI 10.2174/092986707782793844; Jansen FH, 2007, AM J TROP MED HYG, V77, P1005, DOI 10.4269/ajtmh.2007.77.1005; Kamya MR, 2007, PLOS CLIN TRIALS, V2, DOI 10.1371/journal.pctr.0020020; Kremsner PG, 2004, LANCET, V364, P285, DOI 10.1016/S0140-6736(04)16680-4; LOOAREESUWAN S, 1992, LANCET, V339, P821, DOI 10.1016/0140-6736(92)90276-9; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; Mukhtar EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-92; Nahum A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-170; Omari AA, 2004, TROP MED INT HEALTH, V9, P192, DOI 10.1046/j.1365-3156.2003.01186.x; Penali LK, 2008, INT J INFECT DIS, V12, P430, DOI 10.1016/j.ijid.2007.12.006; Priotto G, 2003, T ROY SOC TROP MED H, V97, P325, DOI 10.1016/S0035-9203(03)90161-1; Rapuoda B, 2003, TROP MED INT HEALTH, V8, P860; Rulisa S, 2007, AM J TROP MED HYG, V77, P612, DOI 10.4269/ajtmh.2007.77.612; Sagara I, 2008, AM J TROP MED HYG, V79, P655, DOI 10.4269/ajtmh.2008.79.655; Sagara I, 2006, AM J TROP MED HYG, V75, P630, DOI 10.4269/ajtmh.2006.75.630; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tahar R, 2007, ACTA TROP, V103, P81, DOI 10.1016/j.actatropica.2007.04.008; *WHO, ASS MON ANT DRUG EFF, V50, P1; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; [World Health Organization Severe falciparum malaria], 2000, T R SOC TROP MED S1, V94, pS1, DOI DOI 10.1016/S0035-9203(00)90300-6; World Health Organization (WHO), GUID TREATM MAL	32	35	35	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 14	2009	8								63	10.1186/1475-2875-8-63				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	449JF	WOS:000266326100001	19366448	DOAJ Gold, Green Published			2019-04-02	
J	Gidwani, K; Rai, M; Chakravarty, J; Boelaert, M; Sundar, S				Gidwani, Kamlesh; Rai, Madhukar; Chakravarty, Jaya; Boelaert, Marleen; Sundar, Shyam			Short Report: Evaluation of Leishmanin Skin Test in Indian Visceral Leishmaniasis	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							CUTANEOUS LEISHMANIASIS; CONTROLLED-TRIAL; MAJOR VACCINE; EASTERN SUDAN; DOUBLE-BLIND; KALA-AZAR; INFECTION; RESPONSES; BCG	We evaluated the performance of the leishmanin skin test (LST) in 50 patients with visceral leishmaniasis (VL), 124 cured VL patients at different time intervals, 125 healthy controls from an endemic region (HEC), and 14 healthy controls from a non-endemic region (NEHC). The leishmanin antigen used was based on Leishmania major and was obtained from the Pasteur Institute (Iran). A positive LST was found in 14.0% of patients with active VL, 40.3% of cured patients, 21.6% of HECs, and 0% in NEHCs. The 14% positivity in patients with active VL conflicts with the widely held opinion that such patients should be negative because of anergy. Also, a lack of sensitivity of the LST was observed in cured VL patients. An LST antigen produced from L. donovani strains from India should be explored.	[Gidwani, Kamlesh; Rai, Madhukar; Chakravarty, Jaya; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Sundar, S (reprint author), Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776	European Commission [INCO-CT-2005-015374]; Kala-azar Medical Research Center; Sitaram Memorial Trust, Muzaffarpur, India	This project was supported by a grant from the DG Research of the European Commission (Contract INCO-CT-2005-015374, Kalanet) and the Kala-azar Medical Research Center, Sitaram Memorial Trust, Muzaffarpur, India.	ANTUNES CM, 1986, INT J EPIDEMIOL, V15, P572, DOI 10.1093/ije/15.4.572; Bern C, 2006, AM J TROP MED HYG, V75, P744, DOI 10.4269/ajtmh.2006.75.744; CARVALHO EM, 1989, J CLIN INVEST, V83, P860, DOI 10.1172/JCI113969; Desjeux P., 1992, World Health Statistics Quarterly, V45, P267; el-Safi SH, 2004, TROP MED INT HEALTH, V9, P1305, DOI 10.1111/j.1365-3156.2004.01337.x; Khalil EAG, 2005, CLIN EXP IMMUNOL, V140, P349, DOI 10.1111/j.1365-2249.2005.02768.x; Khalil EAG, 2000, LANCET, V356, P1565, DOI 10.1016/S0140-6736(00)03128-7; MANSON-BAHR P. E. C., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P550, DOI 10.1016/0035-9203(61)90078-5; Mol Christopher J, 2006, AAOHN J, V54, P245; Momeni AZ, 1999, VACCINE, V17, P466, DOI 10.1016/S0264-410X(98)00220-5; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; SACKS DL, 1987, J IMMUNOL, V138, P908; SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013; Zhou X-H, 2002, STAT METHODS DIAGNOS; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	15	26	28	0	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	APR	2009	80	4					566	567		10.4269/ajtmh.2009.80.566				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	432CK	WOS:000265110900013	19346376				2019-04-02	
J	Callens, SFJ; Westreich, D; Kitetele, F; Lusiama, J; Shabani, N; Belhorn, T; Colebunders, R; Behets, F; Van Rie, A				Callens, Steven F. J.; Westreich, Daniel; Kitetele, Faustin; Lusiama, Jean; Shabani, Nicole; Belhorn, Tom; Colebunders, Robert; Behets, Frieda; Van Rie, Annelies			A Visual Dosing Aid for First-line Pediatric Antiretroviral Treatment in Resource-poor Settings	JOURNAL OF TROPICAL PEDIATRICS			English	Article						children; resource-poor setting; antiretroviral treatment; drug dosing	CHILDREN; LAMIVUDINE; ZIDOVUDINE; DIDANOSINE; INFECTION; THERAPY	The visual dosing aid (VDA) was developed to facilitate dosing calculations in response to children's growth and weight during antiretroviral treatment. The theoretical accuracy of the VDA was assessed using anthropometric data from 55 children receiving care in the USA and 324 children in the Democratic Republic of the Congo. The VDA dose was similar to the WHO recommended dose. A potentially significant relative dosing difference of >= 20% occurred in <3% of children for NVP, AZT and d4T, but was observed in 20% for 3TC, overdosing being more frequent. The VDA compared well with generic pediatric fixed dose combination tablets. Results did not differ between sites. The VDA enables accurate dosing of pediatric ART in distinct populations and could facilitate roll-out of pediatric ART in resource-poor settings.	[Callens, Steven F. J.; Westreich, Daniel; Behets, Frieda; Van Rie, Annelies] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27599 USA; [Kitetele, Faustin; Lusiama, Jean; Shabani, Nicole] Univ Kinhasa, Sch Publ Hlth, Kinshasa, Zaire; [Belhorn, Tom] Univ N Carolina, Sch Med, Dept Pediat, Div Pediat Infect Dis & Immunol, Chapel Hill, NC 27599 USA; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium; [Colebunders, Robert] Inst Trop Med, B-2000 Antwerp, Belgium	Callens, SFJ (reprint author), Univ N Carolina, Sch Publ Hlth, 2102-D McGavran Greenberg Hall, Chapel Hill, NC 27599 USA.	callens@email.unc.edu	Van Rie, Annelies/C-2082-2017	Van Rie, Annelies/0000-0001-7666-3263; Callens, Steven/0000-0002-7245-527X			Lewis LL, 1996, J INFECT DIS, V174, P16, DOI 10.1093/infdis/174.1.16; McKinney RE, 1998, J PEDIATR-US, V133, P500, DOI 10.1016/S0022-3476(98)70057-5; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098; Ponnet M, 2005, INT J STD AIDS, V16, P420, DOI 10.1258/0956462054094114; Saez-Llorens X, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e4; Weidle PJ, 2006, PEDIATR INFECT DIS J, V25, P59, DOI 10.1097/01.inf.0000195619.76277.3f	6	0	0	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338			J TROP PEDIATRICS	J. Trop. Pediatr.	APR	2009	55	2					135	137		10.1093/tropej/fmn095				3	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	425TJ	WOS:000264659700014	19022850	Bronze			2019-04-02	
J	Verweij, JJ; Canales, M; Polman, K; Ziem, J; Brienen, EAT; Polderman, AM; van Lieshout, L				Verweij, Jaco J.; Canales, Marco; Polman, Katja; Ziem, Juventus; Brienen, Eric A. T.; Polderman, Anton M.; van Lieshout, Lisette			Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Strongyloides stercoralis; Strongyloidiasis; Parasitic intestinal disease; Diagnosis; Baermann sedimentation; Real-time PCR	OESOPHAGOSTOMUM-BIFURCUM; NORTHERN GHANA; ENTAMOEBA-HISTOLYTICA; NECATOR-AMERICANUS; INFECTIONS; QUANTIFICATION; PREVALENCE; HOOKWORM; DNA	A real-time PCR method targeting the small subunit of the rRNA gene was developed for the detection of Strongyloides stercoralis DNA in faecal samples, including an internal control to detect inhibition of the amplification process. The assay was performed on a range of well-defined control samples (n=145), known positive faecal samples (n=38) and faecal samples from a region in northern Ghana where S. stercoralis infections are highly endemic (n=212), and achieved 100% specificity and high sensitivity. The use of this assay could facilitate monitoring the prevalence and intensity of S. stercoralis infections during helminth intervention programs. Moreover, the use of this assay in diagnostic laboratories could make the introduction of molecular diagnostics feasible in the routine diagnosis of S. stercoralis infections, with a two-fold increase in the detection rate as compared with the commonly used Baermann sedimentation method. (C) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Verweij, Jaco J.; Brienen, Eric A. T.; Polderman, Anton M.; van Lieshout, Lisette] Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands; [Canales, Marco] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Polman, Katja] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Ziem, Juventus] Univ Dev Studies, Sch Med & Hlth Sci, Tamale, Ghana	Verweij, JJ (reprint author), Leiden Univ, Med Ctr, Dept Parasitol, Postbus 9600, NL-2300 RC Leiden, Netherlands.	j.j.vetweij@lumc.nl		Ziem, Juventus/0000-0002-5130-8764	Directorate-General for Development Cooperation (DGDC); Dutch Foundation; Oesophagostomum Research Intervention	Funding: Sample collection in Peru was supported by the Directorate-General for Development Cooperation (DGDC) of the Belgian Government through a framework agreement with the Institute of Tropical Medicine of Antwerp. Financial support was provided by the Dutch Foundation for the Advancement of Tropical Research WOTRO-NWO and the Oesophagostomum Research Intervention Project in Northern Ghana.	Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Grove DI, 1989, STRONGYLOIDIASIS MAJ; Intapan PM, 2005, J CLIN MICROBIOL, V43, P1932, DOI 10.1128/JCM.43.4.1932-1933.2005; KREPEL HP, 1995, TROP GEOGR MED, V47, P157; LIU LX, 1993, INFECT DIS CLIN N AM, V7, P655; Niesters HGM, 2002, J CLIN VIROL, V25, pS3; Page WA, 2006, T ROY SOC TROP MED H, V100, P1056, DOI 10.1016/j.trstmh.2005.12.006; Pecson BM, 2006, APPL ENVIRON MICROB, V72, P7864, DOI 10.1128/AEM.01983-06; POLDERMAN AM, 1991, AM J TROP MED HYG, V44, P336, DOI 10.4269/ajtmh.1991.44.336; Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707; Sudarshi S, 2003, TROP MED INT HEALTH, V8, P728, DOI 10.1046/j.1365-3156.2003.01069.x; ten Hove R, 2007, CLIN MICROBIOL INFEC, V13, P1001, DOI 10.1111/j.1469-0691.2007.01788.x; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Uparanukraw P, 1999, AM J TROP MED HYG, V60, P967, DOI 10.4269/ajtmh.1999.60.967; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; Verweij JJ, 2007, DIAGN MICR INFEC DIS, V57, P163, DOI 10.1016/j.diagmicrobio.2006.08.009; Verweij JJ, 2001, TROP MED INT HEALTH, V6, P726, DOI 10.1046/j.1365-3156.2001.00770.x; Verweij JJ, 2003, TROP MED INT HEALTH, V8, P1153, DOI 10.1046/j.1360-2276.2003.01145.x; Verweij JJ, 2004, J CLIN MICROBIOL, V42, P1220, DOI 10.1128/JCM.42.3.1220-1223.2004; Yelifari L, 2005, T ROY SOC TROP MED H, V99, P32, DOI 10.1016/j.trstmh.2004.02.007; Yori PP, 2006, AM J TROP MED HYG, V74, P97, DOI 10.4269/ajtmh.2006.74.97; Ziem JB, 2006, PARASITOLOGY, V132, P525, DOI 10.1017/S0031182005009418	22	132	136	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	APR	2009	103	4					342	346		10.1016/j.trstmh.2008.12.001				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	430GK	WOS:000264976700005	19195671		Y	N	2019-04-02	
J	Verdonck, K; Gonzalez, E; Maldonado, F; Agapito, D; Van Dooren, S; Vandamme, AM; Silva-Santisteban, A; Vanham, G; Clark, D; Gotuzzo, E				Verdonck, Kristien; Gonzalez, Elsa; Maldonado, Fernando; Agapito, Doris; Van Dooren, Sonia; Vandamme, Anne-Mieke; Silva-Santisteban, Alfonso; Vanham, Guido; Clark, Daniel; Gotuzzo, Eduardo			Comparison of three ELISAs for the routine diagnosis of human T-lymphotropic virus infection in a high-prevalence setting in Peru	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Human T-lymphotropic virus 1; Human T-lymphotropic virus 2; Diagnosis; ELISA; Predictive value of tests; Peru		To compare three human T-lymphotropic virus (HTLV) ELISAs in a high-prevalence setting, we recruited 300 adults: 125 relatives of HTLV-infected subjects and 175 patients with possible diagnoses of HTLV-associated diseases. Sera were tested with Platelia, Murex, and Ortho ELISA. Samples with positive or discordant ELISA underwent confirmatory Inno-Lia testing. Inno-Lia gave 85/300 HTLV-1-positive and 1/300 HTLV-2-positive results. The positive predictive value was 98% for Platelia, and 100% for Murex and Ortho. Six samples had discordant ELISA; Murex gave one false-negative result, Ortho two and Platelia one. In high-prevalence settings, it is recommended to test samples with two ELISAs before considering them HTLV-seronegative. (C) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Verdonck, Kristien; Gonzalez, Elsa; Maldonado, Fernando; Agapito, Doris; Silva-Santisteban, Alfonso; Clark, Daniel; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru; [Verdonck, Kristien; Vanham, Guido] Inst Trop Med, Dept Microbiol, Virol Unit, B-2000 Antwerp, Belgium; [Gonzalez, Elsa] Univ Peruana Cayetano Heredia, Dept Med, Fac Med, Lima 31, Peru; [Van Dooren, Sonia; Vandamme, Anne-Mieke] Katholieke Univ Leuven, Rega Inst, B-3000 Louvain, Belgium; [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Biomed & Vet Sci, B-2610 Antwerp, Belgium; [Clark, Daniel] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Labs Invest & Desarrollo, Lima 31, Peru; [Gotuzzo, Eduardo] Hosp Nacl Cayetano Heredia, Dept Enfermedades Infecciosas Trop & Dermatol, Lima 31, Peru	Verdonck, K (reprint author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Av Honorio Delgado 430, Lima 31, Peru.	tverdonck@itg.be	santos, sofia/I-1637-2012; Vandamme, Anne-Mieke/I-4127-2012	Vandamme, Anne-Mieke/0000-0002-6594-2766; Silva-Santisteban, Alfonso/0000-0001-7225-3515	Directorate-General of Development Co-operation; Flemish Interuniversity Council (VLIR)	This study was financed by the Directorate-General of Development Co-operation of the Belgian Government through a project of the Flemish Interuniversity Council (VLIR) and through the Framework Agreement with the Institute of Tropical Medicine of Antwerp.	Alarcon JO, 2006, JAIDS-J ACQ IMM DEF, V42, P604, DOI 10.1097/01.qai.0000221680.52563.d5; Jacob Fabrício, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P361, DOI 10.1590/S0036-46652007000600005; Roucoux DF, 2004, AIDS REV, V6, P144; Thorstensson R, 2002, TRANSFUSION, V42, P780, DOI 10.1046/j.1537-2995.2002.00114.x; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6	5	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	APR	2009	103	4					420	422		10.1016/j.trstmh.2008.12.002				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	430GK	WOS:000264976700018	19155035				2019-04-02	
J	Bhattarai, NR; Van der Auwera, G; Khanal, B; De Doncker, S; Rijal, S; Das, ML; Uranw, S; Ostyn, B; Praet, N; Speybroeck, N; Picado, A; Davies, C; Boelaert, M; Dujardin, JC				Bhattarai, Narayan Raj; Van der Auwera, Gert; Khanal, Basudha; De Doncker, Simonne; Rijal, Suman; Das, Murari Lal; Uranw, Surendra; Ostyn, Bart; Praet, Nicolas; Speybroeck, Niko; Picado, Albert; Davies, Clive; Boelaert, Marleen; Dujardin, Jean-Claude			PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Kala-azar; Nepal; PCR; DAT; asymptomatic infections	VISCERAL LEISHMANIASIS; DONOVANI INFECTION; BALEARIC-ISLANDS; BLOOD-DONORS; INFANTUM; TESTS; SPAIN; CURE	To compare a PCR assay and direct agglutination test (DAT) for the detection of potential markers of Leishmania infection in 231 healthy subjects living in a kala-azar endemic focus of Nepal. The sample was composed of 184 (80%) persons without any known history of KA and not living in the same house as known kala-azar cases (HNK), 24 (10%) Healthy Household Contacts (HHC) and 23 (10%) past kala-azar cases which had been successfully treated (HPK). PCR and DAT positivity scores were, respectively: HNK, 17.6% and 5.6%; HHC, 12.5% and 20.8%; HPK, 26.1% and 95.7%. The ratio PCR-positives/DAT-positives was significantly higher in HNK (ratio = 3.1) than in HHC (ratio = 0.6, P = 0.036) and in HPK (ratio = 0.2, P = 0.012). The ratio PCR-positives/DAT-positives did not significantly differ between HHC (ratio = 0.6) and HPK (ratio = 0.2, P = 0.473). The positive agreement index between PCR and DAT in HNK was 5%; in HHC, 0%; in HPK, 43%. Our study highlights the specific character of PCR and DAT for the exploration of Leishmania asymptomatic infections. PCR is probably more informative for very recent infections among HNK, while DAT provides more information among HHC and HPK, a feature likely related to the power of serology to track less recent infections.	[Bhattarai, Narayan Raj; Van der Auwera, Gert; De Doncker, Simonne; Dujardin, Jean-Claude] Inst Trop Med, Unit Mol Parasitol, B-2000 Antwerp, Belgium; [Bhattarai, Narayan Raj; Khanal, Basudha; Das, Murari Lal] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal; [Rijal, Suman; Uranw, Surendra] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Ostyn, Bart; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Praet, Nicolas; Speybroeck, Niko] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Speybroeck, Niko] Univ Catholique Louvain, Ecole Sante Publ, B-1200 Brussels, Belgium; [Picado, Albert; Davies, Clive] London Sch Hyg & Trop Med, London WC1, England; [Bhattarai, Narayan Raj; Dujardin, Jean-Claude] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium	Dujardin, JC (reprint author), Inst Trop Med, Unit Mol Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	jcdujardin@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Das, Murari/0000-0001-6816-2389; Picado, Albert/0000-0001-7344-628X	EU	We thank Suman Rijal supervising the fieldwork; Simonne De Doncker for technical support, Basudha Khanal and Murari Lal Das for DAT analyses; Surendra Uranw and Albert Picado for collecting samples; Bart Ostyn for quality control of DAT analysis; Nicolas Praet and Niko Speybroeck for statistical analysis; Suman Rijal, Albert Picado, Clive Davies and Marleen Boelaert for selecting study sites. The authors specially thank Ganesh Saha and Iccha Ghale for their technical help during the processing of field samples in Nepal; and Tushar Neupane to update the database during the study. We acknowledge all staff members of tropical ward at BPKIHS and field enumerators of Kalanet project in Nepal. This study was conducted with the support of EU funded INCO-Dev KALANET project.; Besides their individual technical contribution to the study, the following authors Narayan Raj Bhattarai, Gert Van der Auwera, Suman Rijal, Simonne De Doncker, Basudha Khanal, Murari Lal Das, Surendra Uranw, Bart Ostyn, Nicolas Praet, Niko Speybroeck, Albert Picado, Clive Davies, Marleen Boelaert, Jean-Claude Dujardin are contributed to the design of the study, writing of the manuscript and reviewed the final version of the manuscript.	Bern C, 2007, AM J TROP MED HYG, V76, P909; BHANDARI GP, 2008, KALA AZAR CONT UNPUB; Bimal S, 2005, ANN TROP MED PARASIT, V99, P743, DOI 10.1179/136485905X65107; Chapman D, 2007, EJC SUPPL, V5, P7, DOI 10.1016/S1359-6349(07)71713-5; Chappuis F, 2006, BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; DEBORGGRAEVE S, 2008, TROP MED INT HEALTH, V13, P1; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; GIDWANI K, AM J TROPIC IN PRESS; Graham P, 1998, J CLIN EPIDEMIOL, V51, P763, DOI 10.1016/S0895-4356(98)00048-1; HAILU A, 1990, T ROY SOC TROP MED H, V84, P673, DOI 10.1016/0035-9203(90)90141-Z; HARITH AE, 1988, J CLIN MICROBIOL, V26, P1321; Jacquet D, 2006, TROP MED INT HEALTH, V11, P1777, DOI 10.1111/j.1365-3156.2006.01743.x; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Maurya R, 2005, J CLIN MICROBIOL, V43, P3038, DOI 10.1128/JCM.43.7.3038-3041.2005; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; PAMPIGLIONE S, 1975, T ROY SOC TROP MED H, V69, P60, DOI 10.1016/0035-9203(75)90012-7; Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005; Riera C, 2004, T ROY SOC TROP MED H, V98, P102, DOI 10.1016/S0035-9203(03)00015-4; Riera C, 2008, TRANSFUSION, V48, P1383, DOI 10.1111/j.1537-2995.2008.01708.x; Rijal S, 2003, T ROY SOC TROP MED H, V97, P350, DOI 10.1016/S0035-9203(03)90167-2; Rodriguez-Cortes A, 2007, INT J PARASITOL, V37, P683, DOI 10.1016/j.ijpara.2006.11.007; Salotra P, 2001, J CLIN MICROBIOL, V39, P849, DOI 10.1128/JCM.39.3.849-854.2001; Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x; Silva LD, 2006, AM J TROP MED HYG, V75, P739, DOI 10.4269/ajtmh.2006.75.739; Sinha PK, 2008, ANN TROP MED PARASIT, V102, P119, DOI 10.1179/136485908X252278; Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x	26	33	34	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2009	14	4					404	411		10.1111/j.1365-3156.2009.02242.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	418RN	WOS:000264166200006	19228350	Bronze			2019-04-02	
J	Ngoyi, DM; Lejon, V; N'Siesi, F; Boelaert, M; Buscher, P				Ngoyi, D. Mumba; Lejon, V.; N'Siesi, F. X.; Boelaert, M.; Buscher, P.			Comparison of operational criteria for treatment outcome in gambiense human African trypanosomiasis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						African trypanosomiasis; African sleeping sickness; Trypanosoma brucei gambiense; treatment outcome; cerebrospinal fluid; white blood cell count; sensitivity; specificity; relapse	SLEEPING SICKNESS; BRUCEI-GAMBIENSE; COMBINATION THERAPY; CEREBROSPINAL-FLUID; CLINICAL-TRIAL; EFLORNITHINE; MELARSOPROL; NIFURTIMOX; EFFICACY; CONGO	To develop a simple and standard operational decision tool for the diagnosis of relapse after treatment for human African trypanosomiasis (HAT), by evaluating the performance of several criteria currently used by HAT control programs and research projects. We identified 10 different criteria for relapse, based on trypanosome presence and/or white blood cell count in cerebrospinal fluid, and compared their specificity, sensitivity and time to diagnosis on a data set containing 63 relapsed and 247 cured T.b. gambiense patients. At any time point, the criterion 'Trypanosomes present and/or a cerebrospinal white blood cell count >= 50/mu l' allowed accurate and timely detection of HAT relapse, irrespective of disease stage. This criterion was 13-25% more sensitive (P <= 0.013) than trypanosome detection alone and was > 97% specific. Lumbar punctures at the end of treatment and at 3-month post-treatment provided limited clinical information. Adequate detection of relapse was possible with a simple criterion but these findings should be validated in a prospective study before adoption in clinical practice.	[Lejon, V.; Boelaert, M.; Buscher, P.] Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium; [N'Siesi, F. X.] Minist Hlth, Kinshasa, Zaire; [Ngoyi, D. Mumba] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO	Lejon, V (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	vlejon@itg.be	Buscher, Philippe/B-9956-2012; Boelaert, Marleen/E-2698-2012	Buscher, Philippe/0000-0002-1926-7472; Boelaert, Marleen/0000-0001-8051-6776; Lejon, Veerle/0000-0002-6795-0962	Belgian Ministry of Foreign Affairs, Directorate General for Development Cooperation	The Centre de DEveloppement IntEgral (Bwamanda, D.R. Congo), Medische Missie Samenwerking (Itterbeek, Belgium), and the staff of Bwamanda Hospital, in particular the late sister J. Verbunt provided logistic, medical, and laboratory support in D.R. Congo. Joris Menten (ITM) is thanked for statistical support. This study received financial support from the Belgian Ministry of Foreign Affairs, Directorate General for Development Cooperation.	[Anonymous], 2007, WHOCDSNTDIDM20071; [Anonymous], 1998, WHO TECHN REP SER, V881; BALASEGARAM M, 2004, SLEEPING SICKNESS PR, P1; Balasegaram M, 2006, B WORLD HEALTH ORGAN, V84, P777, DOI 10.2471/BLT.05.028399; Bisser S, 2007, J INFECT DIS, V195, P322, DOI 10.1086/510534; Burri C, 2000, LANCET, V355, P1419, DOI 10.1016/S0140-6736(00)02141-3; CATTAND P, 1988, B WORLD HEALTH ORGAN, V66, P83; Emerson JF, 2005, J CLIN LAB ANAL, V19, P267, DOI 10.1002/jcla.20089; Epidemiology and control of African trypanosomiasis, 1986, WHO TECHN REP SER, V739, P40; Lejon V, 2008, CLIN INFECT DIS, V47, P15, DOI 10.1086/588668; Lejon V, 2007, CLIN VACCINE IMMUNOL, V14, P732, DOI 10.1128/CVI.00103-07; Lourie E. M., 1942, ANN TROP MED AND PARASITOL, V36, P113; MILORD F, 1992, LANCET, V340, P652, DOI 10.1016/0140-6736(92)92180-N; PEPIN J, 1989, T ROY SOC TROP MED H, V83, P514, DOI 10.1016/0035-9203(89)90270-8; Pepin J, 2000, B WORLD HEALTH ORGAN, V78, P1284; PEPIN J, 1994, ADV PARASIT, V33, P2; Priotto G, 2007, CLIN INFECT DIS, V45, P1435, DOI 10.1086/522982; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Priotto G, 2008, BMJ-BRIT MED J, V336, P705, DOI 10.1136/bmj.39485.592674.BE; Robays J, 2008, EMERG INFECT DIS, V14, P966, DOI 10.3201/eid1406.071266; Schmid C, 2004, LANCET, V364, P789, DOI 10.1016/S0140-6736(04)16940-7; VANNIEUWENHOVE S, 1999, PROGR HUMAN AFRICAN, P253	22	6	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2009	14	4					438	444		10.1111/j.1365-3156.2009.02248.x				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	418RN	WOS:000264166200010	19228348				2019-04-02	
J	Nahum, A; Erhart, A; Ahounou, D; Bonou, D; Van Overmeir, C; Menten, J; Akogbeto, M; Coosemans, M; Massougbodji, A; D'Alessandro, U				Nahum, Alain; Erhart, Annette; Ahounou, Daniel; Bonou, Desire; Van Overmeir, Chantal; Menten, Joris; Akogbeto, Martin; Coosemans, Marc; Massougbodji, Achille; D'Alessandro, Umberto			Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa	MALARIA JOURNAL			English	Article							ARTEMISININ-BASED COMBINATIONS; PLASMODIUM-FALCIPARUM; ARTEMETHER-LUMEFANTRINE; MOLECULAR MARKERS; DIHYDROFOLATE-REDUCTASE; PEDIATRIC MALARIA; UGANDAN CHILDREN; DRUG-RESISTANCE; SULFADOXINE/PYRIMETHAMINE; AMODIAQUINE	Background: A study carried out in 2003-2005 in Southern Benin showed a day-28 sulphadoxine-pyrimethamine (SP) monotherapy failure rate greater than 40%, while for SP combined with artesunate (SP-AS) the failure rate was 5.3%. Such a large difference could be explained by the relatively short 28-day follow-up period, with a substantial number of recurrent infections possibly occurring after day 28. This paper reports the treatment outcome observed in the same study cohort beyond the initial 28-day follow-up. Methods: After the 28-day follow-up, children treated with either chloroquine alone (CQ), SP or SP-AS, were visited at home twice a week until day 90 after treatment. A blood sample was collected if the child had fever (axillary temperature >= 37.5 degrees C). Total clinical failure for each treatment group was estimated by combining all the early treatment failures and late clinical failures that occurred over the whole follow-up period, i.e. from day 0 up to day 90. Pre-treatment randomly selected blood samples were genotyped for the dhfr gene (59) and the dhps gene (437 and 540) point mutations related to SP resistance. Results: The PCR-corrected clinical failure at day 90 was significantly lower in the SP-AS group (SP-AS: 2.7%, SP alone: 38.2%; CQ: 41.1%) (Log-Rank p < 0,001). The most prevalent haplotype was dhfr Arg-59 with the dhps Gly-437 mutant and the dhps 540 wild type (85.5%). The dhps 540 mutation could be found in only three (8.3%) samples. Conclusion: Combining artesunate to SP dramatically increased the treatment efficacy, even when extending the follow-up to day 90 post-treatment, and despite the high percentage of failures following treatment with SP alone. Such a good performance may be explained by the low prevalence of the dhps 540 mutation, by the rapid parasite clearance with artesunate and by the level of acquired immunity.	[Nahum, Alain; Ahounou, Daniel; Bonou, Desire; Van Overmeir, Chantal] Ctr Rech Entomol Cotonou, Cotonou, Benin; [Erhart, Annette; Van Overmeir, Chantal; Menten, Joris; Coosemans, Marc; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Massougbodji, Achille] Univ Natl Benin, Fac Sci Sante, Parasitol Lab, Cotonou, Benin	Nahum, A (reprint author), Ctr Rech Entomol Cotonou, Cotonou, Benin.	nahum_alain@yahoo.fr; aerhart@itg.be; danahoun@yahoo.fr; bondesire@yahoo.fr; cvovermeir@itg.be; jmenten@itg.be; akogbetom@yahoo.fr; mcoosemans@itg.be; massougbodjiachille@yahoo.fr; udalessandro@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009	Benin Ministry of Health	We are very grateful to the children and parents who participated in the study. The authors thank the staff of Population Health Project, particularly its coordinator, Dr. Olivier Capo-Chichi. We would like to express our sincere appreciation to all the members of the study team including Agbowai Carine, Adjeniya Achille, Bocovo Charles, Tohon Honesty, Chabi do Aboudou, Djidonou Gilbert, for their commitment, technical support and high quality work related to the data entry. We would also like to thank Dr. Albertine Traore of the A Aidjedo district health centre, Dr. Theophile Hounhouedo and the staff of the NGO Vie Nouvelle.; This study was funded by the Benin Ministry of Health through the Population Health Project. Finally, we would like to thank all the members of the Malaria Epidemiology & Control Unit at unit at the Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium.	Akogbeto M., 1992, Parassitologia (Rome), V34, P147; AKOGBETO M, 1992, THESIS U PARIS 11; BISWAS S, 2000, TROP MED INT HEALTH, V10, P773; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; BUKIRWA H, 2006, COCHRANE DB SYST REV, V1, P4966; Depoortere E, 2005, TROP MED INT HEALTH, V10, P139, DOI 10.1111/j.1365-3156.2004.01363.x; Djimde AA, 2003, AM J TROP MED HYG, V69, P558, DOI 10.4269/ajtmh.2003.69.558; Dorsey G, 2004, AM J TROP MED HYG, V71, P758, DOI 10.4269/ajtmh.2004.71.758; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; Enevold A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-153; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; Jansen FH, 2007, AM J TROP MED HYG, V77, P1005, DOI 10.4269/ajtmh.2007.77.1005; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Kyabayinze D, 2003, AM J TROP MED HYG, V69, P247, DOI 10.4269/ajtmh.2003.69.247; Malik EM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-65; *MIN SANT, 1992, PROGR NAT LUTT PAL C; Ministerio de Agricultura y Desarrollo Rural Instituto Interamericano de Cooperacion para la Agricultura Banco Mundial, 2005, PHYS STRENGTH MOV AB, P1; Ministerio de Cultura Juventud y Deportes-Costa Rica, 2004, ACC DEATHS SUIC IND, P1; Missinou MA, 2003, CLIN INFECT DIS, V36, P1198, DOI 10.1086/374555; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Nahum A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-170; Njama-Meya D, 2004, TROP MED INT HEALTH, V9, P862, DOI 10.1111/j.1365-3156.2004.01277.x; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Obonyo CO, 2007, T ROY SOC TROP MED H, V101, P117, DOI 10.1016/j.trstmh.2006.07.001; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; RANFORDCARTWRIGHT LC, 1993, PARASITOLOGY, V107, P11, DOI 10.1017/S003118200007935X; Rulisa S, 2007, AM J TROP MED HYG, V77, P612, DOI 10.4269/ajtmh.2007.77.612; Rwagacondo CE, 2003, AM J TROP MED HYG, V68, P743, DOI 10.4269/ajtmh.2003.68.743; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Vestergaard LS, 2008, INFECT IMMUN, V76, P2706, DOI 10.1128/IAI.01401-06; White NJ, 1996, PARASITOL TODAY, V12, P399, DOI 10.1016/0169-4758(96)10055-7; WHO, 2006, GUID TREATM MAL; WHO, 2003, ASS MON ANT DRUG EFF; *WHO, 2000, T R SOC TROP MED S1, V94, P1; Wongsrichanalai C, 2000, LANCET, V355, P2245, DOI 10.1016/S0140-6736(00)02416-8; World Health Organization, 2001, WHOCDSRBM200135; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x; Zurovac D, 2005, BRIT MED J, V331, P734, DOI 10.1136/bmj.331.7519.734; Zurovac D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-31	43	8	8	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAR 3	2009	8								37	10.1186/1475-2875-8-37				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	424SE	WOS:000264587500001	19257898	DOAJ Gold, Green Published			2019-04-02	
J	Castillo, Y; Rodriguez, S; Garcia, HH; Brandt, J; Van Hul, A; Silva, M; Rodriguez-Hidalgo, R; Portocarrero, M; Melendez, DP; Gonzalez, AE; Gilman, RH; Dorny, P				Castillo, Yesenia; Rodriguez, Silvia; Garcia, Hector H.; Brandt, Jef; Van Hul, Alike; Silva, Maria; Rodriguez-Hidalgo, Richar; Portocarrero, Mylagritos; Melendez, D. Paolo; Gonzalez, Armando E.; Gilman, Robert H.; Dorny, Pierre		Cysticercosis Working Grp Peru	Urine Antigen Detection for the Diagnosis of Human Neurocysticercosis	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							TAENIA-SAGINATA CYSTICERCOSIS; INTRAVENTRICULAR HUMAN NEUROCYSTICERCOSIS; EXCRETORY-SECRETORY ANTIGENS; MONOCLONAL-ANTIBODIES; FOLLOW-UP; PORCINE CYSTICERCOSIS; HP10 ANTIGEN; DISEASE; SERUM; METACESTODES	Neurocysticercosis (NCC) is a major cause of seizures and epilepsy. Diagnosis is based on brain imaging, supported by immunodiagnosis in serum or cerebrospinal fluid (CSF). Lumbar puncture is invasive and painful. Blood sampling is slightly painful and poorly accepted. Urine antigen detection has been used for other parasites and tried in NCC with suboptimal performance. We used a monoclonal antibody-based ELISA to detect Taenia solium antigens in urine from 87 Peruvian neurocysticercosis patients (viable cysts,N = 34;subarachnoid cysticercosis, N = 10;degenerating parasites, N = 7; calcified lesions, N = 36) and 32 volunteers from a non-endemic area of Peru. Overall sensitivity of urine antigen detection for viable parasites was 92%, which decreased to 62.5% in patients with a single cyst. Most patients (30/36, 83%) with only calcified cysticercosis were urine antigen negative. Antigen levels in paired serum/urine samples (evaluated in 19 patients) were strongly correlated. Non-invasive urine testing for T solium antigens provides a useful alternative for NCC diagnosis.	[Garcia, Hector H.] Inst Ciencias Neurol, Cysticercosis Unit, Lima, Peru; Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru; Inst Peruano Parasitol Clin & Expt, Lima, Peru; Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; Univ Nacl Mayor San Marcos, Sch Vet Med, Lima 14, Peru; Univ Cent Ecuador, Ctr Int Zoonosis, Quito, Ecuador; Johns Hopkins Univ, Bloomberg Sch Publ llealth, Dept Int Hlth, Baltimore, MD USA	Garcia, HH (reprint author), Inst Ciencias Neurol, Cysticercosis Unit, Jr Ancash 1271, Lima, Peru.	hgarcia@jhsph.edu	Rodriguez-Hidalgo, Richar/P-8877-2015	Rodriguez-Hidalgo, Richar/0000-0002-9338-1062; Gonzalez, Armando/0000-0003-1909-1873	National Institute of Allergy and Infectious Diseases, [D43 TW01140, TW06581]; Wellcome Trust [063109]; Bill and Melinda Gates Foundation [23981]	This work was partly funded by Grants D43 TW01140 and TW06581 from the National Institute of Allergy and Infectious Diseases, 063109 from The Wellcome Trust, and 23981 from the Bill and Melinda Gates Foundation (to RG, VT, AG, and HG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bern C, 1999, CLIN INFECT DIS, V29, P1203, DOI 10.1086/313470; Bobes RJ, 2006, TROP MED INT HEALTH, V11, P943, DOI 10.1111/j.1365-3156.2006.01642.x; Bosompem KM, 1996, ACTA TROP, V62, P91, DOI 10.1016/S0001-706X(96)00040-X; BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; *COMM TROP DIS INT, 1994, EPILEPSIA, V35, P89; CORREA D, 1989, T ROY SOC TROP MED H, V83, P814, DOI 10.1016/0035-9203(89)90340-4; Deckers N, 2008, INT J PARASITOL, V38, P1191, DOI 10.1016/j.ijpara.2008.01.005; Dorny P, 2003, ACTA TROP, V87, P79, DOI 10.1016/S0001-706X(03)00058-5; Dorny P, 2000, VET PARASITOL, V88, P43, DOI 10.1016/S0304-4017(99)00196-X; Dorny P., 2005, WHO FAO OIE GUIDELIN, P45; DRAELANTS E, 1995, PARASITE IMMUNOL, V17, P119, DOI 10.1111/j.1365-3024.1995.tb01013.x; Fleury A, 2007, J NEUROL NEUROSUR PS, V78, P970, DOI 10.1136/jnnp.2006.107243; FREILIJ HL, 1987, J CLIN MICROBIOL, V25, P133; GAMZE H, 2007, ANAL BIOANAL CHEM, V387, P1815; Garcia HH, 2007, NAT CLIN PRACT NEURO, V3, P488, DOI 10.1038/ncpneuro0563; Garcia HH, 2001, AM J TROP MED HYG, V65, P31, DOI 10.4269/ajtmh.2001.65.31; Garcia HH, 2005, LANCET NEUROL, V4, P653, DOI 10.1016/S1474-4422(05)70194-0; Garcia HH, 1997, J INFECT DIS, V175, P486, DOI 10.1093/infdis/175.2.486; Garcia HH, 2004, NEW ENGL J MED, V350, P249, DOI 10.1056/NEJMoa031294; Garcia HH, 2003, ACTA TROP, V87, P71, DOI 10.1016/S0001-706X(03)00057-3; Garcia HH, 2002, AM J TROP MED HYG, V66, P427, DOI 10.4269/ajtmh.2002.66.427; HARRISON LJS, 1989, PARASITE IMMUNOL, V11, P351, DOI 10.1111/j.1365-3024.1989.tb00673.x; KOOLMAN J, 1986, INSECT BIOCHEM, V16, P287, DOI 10.1016/0020-1790(86)90108-3; KREMSNER PG, 1993, T ROY SOC TROP MED H, V87, P167, DOI 10.1016/0035-9203(93)90474-5; Parija M, 2004, ACTA TROP, V92, P253, DOI 10.1016/j.actatropica.2004.08.007; Parija SC, 1997, J CLIN MICROBIOL, V35, P1571; Roman G, 2000, B WORLD HEALTH ORGAN, V78, P399; TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50; Van Kerckhoven I, 1998, VET PARASITOL, V76, P269, DOI 10.1016/S0304-4017(97)00226-4; Wiederkehr F, 1991, Schweiz Arch Neurol Psychiatr (1985), V142, P126; Zamora H, 2005, AM J TROP MED HYG, V73, P41; ZHENG HJ, 1987, AM J TROP MED HYG, V36, P554	32	15	17	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAR	2009	80	3					379	383		10.4269/ajtmh.2009.80.379				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	417EH	WOS:000264058800011	19270285				2019-04-02	
J	Gies, S; Coulibaly, SO; Ky, C; Ouattara, FT; Brabin, BJ; D'Alessandro, U				Gies, Sabine; Coulibaly, Sheick O.; Ky, Clolilde; Ouattara, Florence T.; Brabin, Bernard J.; D'Alessandro, Umberto			Community-Based Promotional Campaign to Improve Uptake of Intermittent Preventive Antimalarial Treatment in Pregnancy in Burkina Faso	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SULFADOXINE-PYRIMETHAMINE; DISEASE BURDEN; MALARIA; WOMEN; DISTRICT; KENYA; IMPLEMENTATION; CHALLENGES; DELIVERY; THERAPY	Malaria preventive strategies in pregnancy were assessed in a health center randomized trial comparing intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) with and without community based promotional activities in rural Burkina Faso. The study involved 2,240 secundigravidae and secundigravidae and evaluated factors associated with antenatal clinic (ANC) attendance and uptake of IPTp-SP With promotion, 64.2% completed >= 3 ANC visits compared with 44.7% without (P = 0.05). Complete uptake of IPTp-SP was 71.8% with and 49.1.% without promotion (P = 0.008). The IPTp-SP uptake was lowest in adolescents delivering during high malaria transmission with (29%) or without promotion (30%). Uptake of SP was higher during the low transmission season than in the high transmission season (adjusted odds ratio = 2.17, 95% confidence interval = 1.59-3.03). Community sensitization increased ANC attendance and IPTp-SP uptake. Adolescents were the most difficult to reach, particularly during the high malaria transmission period. The impact of IPTp-SP will be limited unless this high risk group is protected.	Inst Trop Med, Dept Parasitol, Epidemiol & Control Parasit Dis Unit, B-2000 Antwerp, Belgium; Dist Sanitaire Boromo, Boromo, Burkina Faso; Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England; Univ Amsterdam, Acad Med Ctr, Emma Kinderziekenhuis, NL-1105 AZ Amsterdam, Netherlands	Gies, S (reprint author), Inst Trop Med Prince Leopold, Dept Parasitol, Epidemiol & Control Parasit Dis Unit, Natl Str 155, B-2000 Antwerp, Belgium.	sgies@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009	European Union [IC4-CT-2002-10022]; Belgian co-operation (DGDC)	This study was supported by the European Union INCO-DEV programme (contract IC4-CT-2002-10022). Sabine Gies was partly supported by the Belgian co-operation (DGDC) through the framework agreement ITM-Centre Muraz.	Abou-Zahr C, 2003, ANTENATAL CARE DEV C; Anders K, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-79; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Brabin L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-2; BRADBURY RH, 2007, TOP MED CHEM, V1, P1; Brown Celia A, 2008, BMC Pregnancy Childbirth, V8, P2, DOI 10.1186/1471-2393-8-2; Crawley J, 2007, LANCET INFECT DIS, V7, P145, DOI 10.1016/S1473-3099(07)70026-9; Gikandi PW, 2008, TROP MED INT HEALTH, V13, P208, DOI 10.1111/j.1365-3156.2007.01992.x; Gill CJ, 2007, J INFECT DIS, V196, P1577, DOI 10.1086/522137; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Kiwuwa MS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-44; Mbonye AK, 2007, TROP MED INT HEALTH, V12, P519, DOI 10.1111/j.1365-3156.2007.01819.x; *MIN SANT, 2005, REUN CONS NAT SUR CH; Ministerio da Agricultura Pecuaria e Abastecimento, 2006, DIR NAT POUR PRIS CH, P1; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; MSYAMBOZA K, 2009, TROP MED INT HEALTH, DOI DOI 10.1111/J.1365-3156.2008.02197.X.; Nikiema B, 2008, WORLD DEV, V36, P608, DOI 10.1016/j.worlddev.2007.04.019; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Sirima SB, 2006, AM J TROP MED HYG, V75, P205, DOI 10.4269/ajtmh.2006.75.205; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; ter Kuile FO, 2007, J INFECT DIS, V196, P1574, DOI 10.1086/522233; Tiono AB, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-201; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P630, DOI 10.1111/j.1365-3156.2004.01242.x; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Verhoeff FH, 1998, ANN TROP MED PARASIT, V92, P141, DOI 10.1080/00034983.1998.11813273; *WHO, 2005, GLOB STRAT PLAN 2005; *WHO, 2004, AFRMAI0401 WHO; WHO, 2007, AD PREGN UNM NEEDS U	31	21	21	0	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAR	2009	80	3					460	469		10.4269/ajtmh.2009.80.460				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	417EH	WOS:000264058800025	19270299				2019-04-02	
J	Jongert, E; Roberts, CW; Gargano, N; Forster-Wald, E; Petersen, E				Jongert, Erik; Roberts, Craig W.; Gargano, Nicola; Foerster-Wald, Elisabeth; Petersen, Eskild			Vaccines against Toxoplasma gondii: challenges and opportunities	MEMORIAS DO INSTITUTO OSWALDO CRUZ			English	Article; Proceedings Paper	Meeting on Toxoplasma Centennial Congress from Discovery to Public Health Management	SEP, 2008	Buzios, BRAZIL			Toxoplasma gondii; vaccine models; vaccines; virulence; genotype	ATTENUATED SALMONELLA-TYPHIMURIUM; MULTIANTIGENIC DNA VACCINE; CRUDE RHOPTRY PROTEINS; BRAIN CYST FORMATION; CD8(+) T-CELLS; PROTECTIVE IMMUNITY; CONGENITAL TOXOPLASMOSIS; INTRANASAL IMMUNIZATION; BALB/C MICE; ORAL INFECTION	Development of vaccines against Toxoplasma gondii infection in humans is of high priority, given the high burden of disease in some areas of the world like South America, and the lack of effective drugs with few adverse effects. Rodent models have been used in research on vaccines against T. gondii over the past decades. However, regardless of the vaccine construct, the vaccines have not been able to induce protective immunity when the organism is challenged with T. gondii, either directly or via a vector. Only a few live, attenuated T. gondii strains used for immunization have been able to confer protective immunity, which is measured by a lack of tissue cysts after challenge. Furthermore, challenge with low virulence strains, especially strains with genotype II, will probably be insufficient to provide protection against the more virulent T. gondii strains, such as those with genotypes I or II, or those genotypes from South America not belonging to genotype I, II or III. Future studies should use animal models besides rodents, and challenges should be performed with at least one genotype II T. gondii and one of the more virulent genotypes. Endpoints like maternal-foetal transmission and prevention of eye disease are important in addition to the traditional endpoint of survival or reduction in numbers of brain cysts after challenge.	[Gargano, Nicola] Aarhus Univ Hosp Skejby, Dept Infect Dis, DK-8200 Aarhus, Denmark; [Jongert, Erik] Sci Inst Publ Hlth, Pasteur Inst Brussels, Lab Toxoplasmosis, Brussels, Belgium; [Roberts, Craig W.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Gargano, Nicola] Sigma Tau Ind Farmaceutiche Riunite, Rome, Italy; [Foerster-Wald, Elisabeth] Med Univ Vienna, Dept Pediat, Vienna, Austria	Petersen, E (reprint author), Aarhus Univ Hosp Skejby, Dept Infect Dis, DK-8200 Aarhus, Denmark.	eskildp@dadlnet.dk	Roberts, Craig/B-8016-2008	Roberts, Craig/0000-0002-0653-835X; Forster-Waldl, Elisabeth/0000-0002-8484-9890			Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Angus CW, 2000, J INFECT DIS, V181, P317, DOI 10.1086/315186; Aosai F, 2006, CELL STRESS CHAPERON, V11, P13, DOI 10.1379/CSC-138R.1; Aosai F, 1999, MICROBIOL IMMUNOL, V43, P87, DOI 10.1111/j.1348-0421.1999.tb02378.x; AWAN KJ, 1978, ANN OPHTHALMOL, V10, P459; Beghetto E, 2005, J INFECT DIS, V191, P637, DOI 10.1086/427660; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Bonenfant C, 2001, INFECT IMMUN, V69, P1605, DOI 10.1128/IAI.69.3.1605-1612.2001; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; BRINKMANN V, 1993, MOL IMMUNOL, V30, P353, DOI 10.1016/0161-5890(93)90064-I; BULOW R, 1991, J IMMUNOL, V147, P3496; BUXTON D, 1991, VET REC, V129, P89, DOI 10.1136/vr.129.5.89; Caetano BC, 2006, HUM GENE THER, V17, P415, DOI 10.1089/hum.2006.17.415; Conacher M, 2001, VACCINE, V19, P2965, DOI 10.1016/S0264-410X(00)00537-5; Cong H, 2005, PARASITE IMMUNOL, V27, P29, DOI 10.1111/j.1365-3024.2005.00738.x; Cong H, 2008, VACCINE, V26, P3913, DOI 10.1016/j.vaccine.2008.04.046; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Couper KN, 2003, VACCINE, V21, P2813, DOI 10.1016/S0264-410X(03)00163-4; Cui YL, 2008, PARASITE IMMUNOL, V30, P309, DOI 10.1111/j.1365-3024.2008.01025.x; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Curtsinger JM, 2005, J IMMUNOL, V175, P4392, DOI 10.4049/jimmunol.175.7.4392; CUTCHINS EC, 1956, AM J TROP MED HYG, V5, P197, DOI 10.4269/ajtmh.1956.5.197; DARCY F, 1992, J IMMUNOL, V149, P3636; Dautu G, 2007, EXP PARASITOL, V116, P273, DOI 10.1016/j.exppara.2007.01.017; De Gregorio E, 2008, EUR J IMMUNOL, V38, P2068, DOI 10.1002/eji.200838648; Debard N, 1996, INFECT IMMUN, V64, P2158; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; DENKERS EY, 1993, RES IMMUNOL, V144, P51, DOI 10.1016/S0923-2494(05)80099-9; Desolme B, 2000, VACCINE, V18, P2512, DOI 10.1016/S0264-410X(00)00035-9; DUQUESNE V, 1991, CLIN EXP IMMUNOL, V84, P527; Echeverria PC, 2006, VACCINE, V24, P4102, DOI 10.1016/j.vaccine.2006.02.039; ESCAJADILLO A, 1991, AM J TROP MED HYG, V44, P382, DOI 10.4269/ajtmh.1991.44.382; Fachado A, 2003, INFECT IMMUN, V71, P5407, DOI 10.1128/IAI.71.9.5407-5411.2003; Fachado A, 2003, VACCINE, V21, P1327, DOI 10.1016/S0264-410X(02)00692-8; Cuppari AF, 2008, VACCINE, V26, P5040, DOI 10.1016/j.vaccine.2008.07.031; Flori P, 2006, PARASITOL RES, V98, P511, DOI 10.1007/s00436-005-0074-y; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; FRENKEL JK, 1991, AM J VET RES, V52, P759; Garcia JL, 2005, VET PARASITOL, V129, P209, DOI 10.1016/j.vetpar.2005.01.006; Garcia JL, 2007, VET PARASITOL, V145, P197, DOI 10.1016/j.vetpar.2007.01.007; Gatkowska J, 2008, EXP PARASITOL, V118, P266, DOI 10.1016/j.exppara.2007.07.003; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; Golkar M, 2007, VACCINE, V25, P4301, DOI 10.1016/j.vaccine.2007.02.057; HAKIM FT, 1991, J IMMUNOL, V147, P2310; Igarashi M, 2008, EXP PARASITOL, V118, P386, DOI 10.1016/j.exppara.2007.10.002; Innes EA, 2006, PARASITOLOGY, V133, pS145, DOI 10.1017/S0031182006001855; Ishii K, 2006, MICROBES INFECT, V8, P1045, DOI 10.1016/j.micinf.2005.10.023; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Ismael AB, 2003, INFECT IMMUN, V71, P6222, DOI 10.1128/IAI.71.11.6222-6228.2003; Ismael AB, 2006, J INFECT DIS, V194, P1176, DOI 10.1086/507706; Johnson LL, 2004, VACCINE, V22, P4054, DOI 10.1016/j.vaccine.2004.03.056; Jongert E, 2008, VACCINE, V26, P5289, DOI 10.1016/j.vaccine.2008.07.032; Jongert E, 2008, VACCINE, V26, P1025, DOI 10.1016/j.vaccine.2007.11.058; Jongert E, 2007, PARASITE IMMUNOL, V29, P445, DOI 10.1111/j.1365-3024.2007.00961.x; KASPER LH, 1985, J IMMUNOL, V134, P3426; KHAN IA, 1991, J IMMUNOL, V147, P3501; Kijlstra A, 2008, INT J PARASITOL, V38, P1359, DOI 10.1016/j.ijpara.2008.06.002; Kodjikian L, 2004, PEDIATR INFECT DIS J, V23, P272, DOI 10.1097/01.inf.0000115949.12206.69; KRAHENBUHL JL, 1972, J IMMUNOL, V108, P425; Kringel H, 2004, VET PARASITOL, V123, P55, DOI 10.1016/j.vetpar.2004.01.021; Letscher-Bru V, 2003, INFECT IMMUN, V71, P6615, DOI 10.1128/IAI.71.11.6615-6619.2003; Letscher-Bru V, 1998, INFECT IMMUN, V66, P4503; Leyva R, 2001, PARASITOL RES, V87, P70, DOI 10.1007/s004360000296; LINDSAY DS, 1993, J PARASITOL, V79, P71, DOI 10.2307/3283280; Liu Q, 2008, MICROBES INFECT, V10, P1355, DOI 10.1016/j.micinf.2008.08.002; Lourenco EV, 2006, MICROBES INFECT, V8, P1244, DOI 10.1016/j.micinf.2005.11.013; Martin V, 2004, CLIN DIAGN LAB IMMUN, V11, P704, DOI 10.1128/CDLI.11.4.704-710.2004; MCLEOD R, 1988, J IMMUNOL, V140, P1632; Mevelec MN, 2005, VACCINE, V23, P4489, DOI 10.1016/j.vaccine.2005.04.025; Mevelec MN, 1998, PARASITE IMMUNOL, V20, P183; Mishima M, 2001, J VET MED SCI, V63, P433, DOI 10.1292/jvms.63.433; Mishima M, 2001, MOL BIOCHEM PARASIT, V117, P103, DOI 10.1016/S0166-6851(01)00325-5; Mohamed RM, 2003, VACCINE, V21, P2852, DOI 10.1016/s0264-410X(03)00157-9; Nielsen HV, 1999, INFECT IMMUN, V67, P6358; Nielsen HV, 2006, EXP PARASITOL, V112, P274, DOI 10.1016/j.exppara.2005.11.009; Petersen E, 1998, VACCINE, V16, P1283, DOI 10.1016/S0264-410X(98)00039-5; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.1440-1711.2004.01272.x; PETTERSEN EK, 1988, APMIS, V96, P820, DOI 10.1111/j.1699-0463.1988.tb00949.x; PFEFFERKORN ER, 1976, EXP PARASITOL, V129, P25; Qu DF, 2008, VACCINE, V26, P4541, DOI 10.1016/j.vaccine.2008.06.030; REIKVAM A, 1976, NATURE, V261, P508, DOI 10.1038/261508a0; Roque-Resendiz JL, 2004, PARASITOLOGY, V128, P397, DOI 10.1017/S0031182003004761; Sabin AB, 1941, J AMER MED ASSOC, V116, P801, DOI 10.1001/jama.1941.02820090001001; Sayles PC, 2000, INFECT IMMUN, V68, P1026, DOI 10.1128/IAI.68.3.1026-1033.2000; Schaap D., 2007, P721, DOI 10.1016/B978-012369542-0/50026-X; Scorza T, 2003, INFECT IMMUN, V71, P309, DOI 10.1128/IAI.71.1.309-316.2003; Siachoque H, 2006, EXP PARASITOL, V114, P62, DOI 10.1016/j.exppara.2006.02.005; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Silveira C, 2003, AM J OPHTHALMOL, V136, P370, DOI 10.1016/S0002-9394(03)00191-0; Stanley AC, 2004, VACCINE, V22, P3929, DOI 10.1016/j.vaccine.2004.04.022; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Supply P, 1999, VACCINE, V17, P705, DOI 10.1016/S0264-410X(98)00255-2; Taneja V, 1998, J CLIN INVEST, V101, P921, DOI 10.1172/JCI2860; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038; Velge-Roussel F, 1997, MOL IMMUNOL, V34, P1045, DOI 10.1016/S0161-5890(97)00133-8; Velge-Roussel F, 2000, INFECT IMMUN, V68, P969, DOI 10.1128/IAI.68.2.969-972.2000; Vercammen M, 2000, INFECT IMMUN, V68, P38, DOI 10.1128/IAI.68.1.38-45.2000; Vogel N, 1996, CLIN INFECT DIS, V23, P1055, DOI 10.1093/clinids/23.5.1055; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; WALDELAND H, 1983, J PARASITOL, V69, P60, DOI 10.2307/3281275; Wang HF, 2007, PARASITOL INT, V56, P263, DOI 10.1016/j.parint.2007.04.003; WILKINS MF, 1988, NEW ZEAL VET J, V36, P86, DOI 10.1080/00480169.1988.35489; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Xue MF, 2008, PARASITOL INT, V57, P424, DOI 10.1016/j.parint.2008.05.001; Xue MF, 2008, EXP PARASITOL, V119, P352, DOI 10.1016/j.exppara.2008.03.005; Yang CD, 2004, PARASITOL RES, V92, P58, DOI 10.1007/s00436-003-0992-5; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zenner L, 1999, PARASITE IMMUNOL, V21, P261, DOI 10.1046/j.1365-3024.1999.00229.x; Zhang G, 2007, PARASITOLOGY, V134, P1339, DOI 10.1017/S0031182007002892; Zhang J, 2007, PARASITOL RES, V101, P331, DOI 10.1007/s00436-007-0465-3; Zimmermann S, 2008, INT J MED MICROBIOL, V298, P39, DOI 10.1016/j.ijmm.2007.07.011	112	105	118	2	22	FUNDACO OSWALDO CRUZ	RIO DE JANEIRO, RJ	AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL	0074-0276	1678-8060		MEM I OSWALDO CRUZ	Mem. Inst. Oswaldo Cruz	MAR	2009	104	2					252	266		10.1590/S0074-02762009000200019				15	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	458UT	WOS:000267051500019	19430651	DOAJ Gold			2019-04-02	
J	Fichet-Calvet, E; Rogers, DJ				Fichet-Calvet, Elisabeth; Rogers, David John			Risk Maps of Lassa Fever in West Africa	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MARCH-APRIL 1972; MASTOMYS-NATALENSIS; SIERRA-LEONE; HEMORRHAGIC-FEVER; VIRUS ACTIVITY; HOSPITAL EPIDEMIC; EASTERN PROVINCE; LIBERIA; GUINEA; NIGERIA	Background: Lassa fever is caused by a viral haemorrhagic arenavirus that affects two to three million people in West Africa, causing a mortality of between 5,000 and 10,000 each year. The natural reservoir of Lassa virus is the multi-mammate rat Mastomys natalensis, which lives in houses and surrounding fields. With the aim of gaining more information to control this disease, we here carry out a spatial analysis of Lassa fever data from human cases and infected rodent hosts covering the period 1965-2007. Information on contemporary environmental conditions (temperature, rainfall, vegetation) was derived from NASA Terra MODIS satellite sensor data and other sources and for elevation from the GTOPO30 surface for the region from Senegal to the Congo. All multi-temporal data were analysed using temporal Fourier techniques to generate images of means, amplitudes and phases which were used as the predictor variables in the models. In addition, meteorological rainfall data collected between 1951 and 1989 were used to generate a synoptic rainfall surface for the same region. Methodology/Principal Findings: Three different analyses (models) are presented, one superimposing Lassa fever outbreaks on the mean rainfall surface (Model 1) and the other two using non-linear discriminant analytical techniques. Model 2 selected variables in a step-wise inclusive fashion, and Model 3 used an information-theoretic approach in which many different random combinations of 10 variables were fitted to the Lassa fever data. Three combinations of absence: presence clusters were used in each of Models 2 and 3, the 2 absence: 1 presence cluster combination giving what appeared to be the best result. Model 1 showed that the recorded outbreaks of Lassa fever in human populations occurred in zones receiving between 1,500 and 3,000 mm rainfall annually. Rainfall, and to a much lesser extent temperature variables, were most strongly selected in both Models 2 and 3, and neither vegetation nor altitude seemed particularly important. Both Models 2 and 3 produced mean kappa values in excess of 0.91 (Model 2) or 0.86 (Model 3), making them 'Excellent'. Conclusion/Significance: The Lassa fever areas predicted by the models cover approximately 80% of each of Sierra Leone and Liberia, 50% of Guinea, 40% of Nigeria, 30% of each of Cote d'Ivoire, Togo and Benin, and 10% of Ghana.	[Fichet-Calvet, Elisabeth] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Rogers, David John] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England	Fichet-Calvet, E (reprint author), Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium.	ecalvet@club-internet.fr			UK's Joint Environment and Human Health Programme (funded by NERC, Defra, EA, MOD and the MRC); EU FP6 project [GOCE-2003-010284]	We are grateful for the support of the UK's Joint Environment and Human Health Programme (funded by NERC, Defra, EA, MOD and the MRC). The statistical models were developed as part of the EU FP6 project grant code GOCE-2003-010284 EDEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoua-Koffi C, 2006, Med Trop (Mars), V66, P465; Allan R, 1999, EMERGENCE AND CONTROL OF RODENT-BORNE VIRAL DISEASES (HANTAVIRAL AND ARENAL DISEASES), P197; Bajani MD, 1997, T ROY SOC TROP MED H, V91, P379, DOI 10.1016/S0035-9203(97)90247-9; Bausch DG, 2001, VECTOR-BORNE ZOONOT, V1, P269, DOI 10.1089/15303660160025903; BLOCH A, 1978, B WORLD HEALTH ORGAN, V56, P811; BOIRO I, 1987, B SOC PATHOL EXOT, V80, P607; BOTTINEAU MC, 2003, LASSA FEVER SUMMARY; BOWEN GS, 1975, B WORLD HEALTH ORGAN, V52, P599; Burnham KP, 2002, MODEL SELECTION MULT; CAREY DE, 1972, T ROY SOC TROP MED H, V66, P402, DOI 10.1016/0035-9203(72)90271-4; Clegg JCS, 2002, CURR TOP MICROBIOL, V262, P1; Demby AH, 2001, VECTOR-BORNE ZOONOT, V1, P283, DOI 10.1089/15303660160025912; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fichet-Calvet E, 2008, VECTOR-BORNE ZOONOT, V8, P41, DOI 10.1089/vbz.2007.0118; Fichet-Calvet E, 2007, VECTOR-BORNE ZOONOT, V7, P119, DOI 10.1089/vbz.2006.0520; FISHERHOCH SP, 1995, BRIT MED J, V311, P857, DOI 10.1136/bmj.311.7009.857; FRAME JD, 1984, T ROY SOC TROP MED H, V78, P761, DOI 10.1016/0035-9203(84)90012-9; FRAME JD, 1970, AM J TROP MED HYG, V19, P670, DOI 10.4269/ajtmh.1970.19.670; FRAME JD, 1979, T ROY SOC TROP MED H, V73, P219, DOI 10.1016/0035-9203(79)90218-9; FRAME JD, 1984, T ROY SOC TROP MED H, V78, P656, DOI 10.1016/0035-9203(84)90232-3; FRAME JD, 1975, B WORLD HEALTH ORGAN, V52, P593; FRASER DW, 1974, AM J TROP MED HYG, V23, P1131, DOI 10.4269/ajtmh.1974.23.1131; GEORGES AJ, 1985, T ROY SOC TROP MED H, V79, P78, DOI 10.1016/0035-9203(85)90242-1; Glass GE, 2002, P NATL ACAD SCI USA, V99, P16817, DOI 10.1073/pnas.252617999; Glass GE, 2000, EMERG INFECT DIS, V6, P238, DOI 10.3201/eid0603.000303; GONZALEZ JP, 1983, INTERVIROLOGY, V19, P105, DOI 10.1159/000149344; GONZALEZ JP, 1989, RES VIROLOGY, V140, P319, DOI 10.1016/S0923-2516(89)80112-8; Granjon L, 2004, ACTA THERIOL, V49, P215, DOI 10.1007/BF03192522; GREIN T, 2004, LASSA FEVER OUTBREAK; Gunther S, 2004, CRIT REV CL LAB SCI, V41, P339, DOI 10.1080/10408360490497456; HENDERSON BE, 1972, T ROY SOC TROP MED H, V66, P409, DOI 10.1016/0035-9203(72)90272-6; JOHNSON KM, 1981, AM J TROP MED HYG, V30, P1291, DOI 10.4269/ajtmh.1981.30.1291; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Justice CO, 1998, IEEE T GEOSCI REMOTE, V36, P1228, DOI 10.1109/36.701075; KEANE E, 1977, BRIT MED J, V1, P1399, DOI 10.1136/bmj.1.6073.1399; Klempa B, 2006, EMERG INFECT DIS, V12, P838, DOI 10.3201/eid1205.051487; LANDIS JR, 1977, BIOMETRICS, V33, P174; Lecompte E, 2007, VIROLOGY, V364, P178, DOI 10.1016/j.virol.2007.02.008; Lecompte E, 2006, EMERG INFECT DIS, V12, P1971; LHOTE Y, 1995, W CENTRAL AFRICA MEA, P1951; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; LUKASHEVICH IS, 1993, J MED VIROL, V40, P210, DOI 10.1002/jmv.1890400308; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; MCCORMICK JB, 1987, J INFECT DIS, V155, P445, DOI 10.1093/infdis/155.3.445; McCormick JB, 1999, EMERGENCE AND CONTROL OF RODENT-BORNE VIRAL DISEASES (HANTAVIRAL AND ARENAL DISEASES), P177; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; *MERL, 2002, LISK LASS FEV STRAT; MERTENS PE, 1973, AM J TROP MED HYG, V22, P780, DOI 10.4269/ajtmh.1973.22.780; MONATH TP, 1973, AM J TROP MED HYG, V22, P773, DOI 10.4269/ajtmh.1973.22.773; MONATH TP, 1974, AM J TROP MED HYG, V23, P1140, DOI 10.4269/ajtmh.1974.23.1140; MONATH TP, 1974, SCIENCE, V185, P263, DOI 10.1126/science.185.4147.263; Musser G. G., 2005, MAMMAL SPECIES WORLD, P894; Nakounne E, 2001, B SOC PATHOL EXOT, V93, P340; Omilabu SA, 2005, EMERG INFECT DIS, V11, P1642, DOI 10.3201/eid1110.041343; Rogers DJ, 2006, ADV PARASIT, V62, P1, DOI 10.1016/S0065-308X(05)62001-5; Rogers David J., 1994, P247; Rogers DJ, 2000, ADV PARASIT, V47, P129, DOI 10.1016/S0065-308X(00)47008-9; SALTZMANN S, 1978, FIEVRE LASSA; Sauvage F, 2003, J ANIM ECOL, V72, P1, DOI 10.1046/j.1365-2656.2003.00675.x; SAUVAGE F, 2004, SYNERGIE ENTRE DYNAM; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; STEPHENSON EH, 1984, J MED VIROL, V14, P295, DOI 10.1002/jmv.1890140402; TALANI P, 1999, MED AFRIQUE NOIRE, V46, P424; ter Meulen J, 2001, TROP MED INT HEALTH, V6, P83, DOI 10.1046/j.1365-3156.2001.00676.x; terMeulen J, 1996, AM J TROP MED HYG, V55, P661; TOMORI O, 1988, AM J TROP MED HYG, V38, P407, DOI 10.4269/ajtmh.1988.38.407; Vieth S, 2007, T ROY SOC TROP MED H, V101, P1253, DOI 10.1016/j.trstmh.2005.03.018; Wan ZM, 1997, IEEE T GEOSCI REMOTE, V35, P980, DOI 10.1109/36.602541; WULFF H, 1977, B WORLD HEALTH ORGAN, V55, P441; WULFF H, 1975, B WORLD HEALTH ORGAN, V52, P609; YALLEYOGUNRO JE, 1984, T ROY SOC TROP MED H, V78, P764, DOI 10.1016/0035-9203(84)90013-0; 2006, GTOPO30 GLOBAL 30 2	74	115	115	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2009	3	3							e388	10.1371/journal.pntd.0000388				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	438DT	WOS:000265536800005	19255625	DOAJ Gold, Green Published			2019-04-02	
J	Praet, N; Speybroeck, N; Manzanedo, R; Berkvens, D; Nforninwe, DN; Zoli, A; Quet, F; Preux, PM; Carabin, H; Geerts, S				Praet, Nicolas; Speybroeck, Niko; Manzanedo, Rafael; Berkvens, Dirk; Nforninwe, Denis Nsame; Zoli, Andre; Quet, Fabrice; Preux, Pierre-Marie; Carabin, Helene; Geerts, Stanny			The Disease Burden of Taenia solium Cysticercosis in Cameroon	PLOS NEGLECTED TROPICAL DISEASES			English	Article							WEST-CAMEROON; PORCINE CYSTICERCOSIS; TIBETAN PLATEAU; ENDEMIC REGION; EPILEPSY; AFRICA; PROVINCE; NEUROCYSTICERCOSIS; ECHINOCOCCOSIS; PREVALENCE	Background: Taenia solium cysticercosis is an important zoonosis in many developing countries. Human neurocysticercosis is recognised as an important cause of epilepsy in regions where the parasite occurs. However, it is largely underreported and there is a lack of data about the disease burden. Because a body of information on human and porcine cysticercosis in Cameroon is becoming available, the present study was undertaken to calculate the impact of this neglected zoonosis. Methods: Both the cost and Disability Adjusted Life Year (DALY) estimations were applied. All necessary parameters were collected and imported in R software. Different distributions were used according to the type of information available for each of the parameters. Findings: Based on a prevalence of epilepsy of 3.6%, the number of people with neurocysticercosis-associated epilepsy was estimated at 50,326 (95% CR 37,299-65,924), representing 1.0% of the local population, whereas the number of pigs diagnosed with cysticercosis was estimated at 15,961 (95% CR 12,320-20,044), which corresponds to 5.6% of the local pig population. The total annual costs due to T. solium cysticercosis in West Cameroon were estimated at 10,255,202 Euro (95% CR 6,889,048-14,754,044), of which 4.7% were due to losses in pig husbandry and 95.3% to direct and indirect losses caused by human cysticercosis. The monetary burden per case of cysticercosis amounts to 194 Euro (95% CR 147-253). The average number of DALYs lost was 9.0 per thousand persons per year (95% CR 2.8-20.4). Interpretation: This study provides an estimation of the costs due to T. solium cysticercosis using country-specific parameters and including the human as well as the animal burden of the zoonotic disease. A comparison with a study in South Africa indicates that the cost of inactivity, influenced by salaries, plays a predominant role in the monetary burden of T. solium cysticercosis. Therefore, knowing the salary levels and the prevalence of the disease might allow a rapid indication of the total cost of T. solium cysticercosis in a country. Ascertaining this finding with additional studies in cysticercosis-endemic countries could eventually allow the estimation of the global disease burden of cysticercosis. The estimated number of DALYs lost due to the disease was higher than estimates already available for some other neglected tropical diseases. The total estimated cost and number of DALYs lost probably underestimate the real values because the estimations have been based on epilepsy as the only symptom of cysticercosis.	[Praet, Nicolas; Speybroeck, Niko; Manzanedo, Rafael; Berkvens, Dirk; Geerts, Stanny] Inst Trop Med, B-2000 Antwerp, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc, B-1200 Brussels, Belgium; [Nforninwe, Denis Nsame] Batibo Dist Hosp, Batibo, Cameroon; [Zoli, Andre] Univ Dschang, Dschang, Cameroon; [Quet, Fabrice; Preux, Pierre-Marie] Inst Neuroepidemiol & Trop Neurol, Limoges, France; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA	Praet, N (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.	npraet@itg.be	Carabin, Helene/B-7600-2016; PREUX, Pierre-Marie/B-8393-2014	PREUX, Pierre-Marie/0000-0002-2171-2977; Geerts, Stanny/0000-0001-9885-8846			Bern C, 1999, CLIN INFECT DIS, V29, P1203, DOI 10.1086/313470; Boussinesq M, 2002, T ROY SOC TROP MED H, V96, P537, DOI 10.1016/S0035-9203(02)90433-5; Budke CM, 2005, AM J TROP MED HYG, V73, P2, DOI 10.4269/ajtmh.2005.73.2; Budke CM, 2004, AM J TROP MED HYG, V71, P56, DOI 10.4269/ajtmh.2004.71.56; Carabin H, 2006, TROP MED INT HEALTH, V11, P906, DOI 10.1111/j.1365-3156.2006.01627.x; Ding D, 2006, EPILEPSIA, V47, P2032, DOI 10.1111/j.1528-1167.2006.00802.x; Diop AG, 2003, ACTA TROP, V87, P149, DOI 10.1016/S0001-706X(03)00038-X; DONGMO L, 2000, B SOC PATHOL EXOT, V93, P266; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Engels D, 2003, ACTA TROP, V87, P177, DOI [10.1016/S0001-706X(03)00064-0, 10.1016/j.actatropica.2003.05.001]; *FAO, 2007, GLOB LIV PROD; FREEMAN J, 1980, AM J EPIDEMIOL, V112, P707, DOI 10.1093/oxfordjournals.aje.a113043; Garcia HH, 2001, AM J TROP MED HYG, V65, P31, DOI 10.4269/ajtmh.2001.65.31; Geerts S, 2004, SE ASIAN J TROP MED, V35, P262; Gelman A., 2004, BAYESIAN DATA ANAL; Havelaar AH, 2000, EPIDEMIOL INFECT, V125, P505, DOI 10.1017/S0950268800004933; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.1080/10618600.1996.10474713; *INS, 2006, ANN STAT CAM 2006; Kamgno J, 2003, EPILEPSIA, V44, P956, DOI 10.1046/j.1528-1157.2003.59302.x; Murray J. L., 1996, GLOBAL BURDEN DIS CO; NASH TE, 2005, CLIN CYSTICERCOSIS D, P11; Nguekam JP, 2003, TROP MED INT HEALTH, V8, P144, DOI 10.1046/j.1365-3156.2003.01000.x; NKWI PN, 1989, CULT MED PSYCHIAT, V13, P437; Nsengiyumva G, 2004, EPILEPSIA, V45, P673, DOI 10.1111/j.0013-9580.2004.36303.x; Nsoso S. J., 2006, Livestock Research for Rural Development, V18, P125; Pouedet MSR, 2002, VET PARASITOL, V106, P45, DOI 10.1016/S0304-4017(02)00035-3; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Preux PM, 2000, EPILEPSIA, V41, P432, DOI 10.1111/j.1528-1157.2000.tb00185.x; QUET F, 2005, QUESTIONNAIRE INVEST; R Development Core Team, 2007, R LANG ENV STAT COMP; Shey-Njila O, 2003, J HELMINTHOL, V77, P351, DOI 10.1079/JOH2003179; Taylor MA, 2007, VET PARASITOLOGY; *WHO, 2005, WHO DFID AHP M 20 21; World Health Organization, 2008, GBD 2004 SUMM TABL; Zoli A, 2003, ACTA TROP, V87, P35, DOI 10.1016/S0001-706X(02)00289-9; Zoli A., 1987, Helminth zoonoses., P85; Zoli AP, 2003, T ROY SOC TROP MED H, V97, P683, DOI 10.1016/S0035-9203(03)80103-7	37	57	60	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2009	3	3							e406	10.1371/journal.pntd.0000406				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	438DT	WOS:000265536800021	19333365	DOAJ Gold, Green Published			2019-04-02	
J	Balasegaram, M; Young, H; Chappluis, F; Priotto, G; Raguenaud, ME; Checchi, F				Balasegaram, Manica; Young, Heather; Chappluis, Francois; Priotto, Gerardo; Raguenaud, Marie-Eve; Checchi, Francesco			Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Medecins Sans Frontieres programmes	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Melarsoprol; Eflornithine; Treatment outcome; Trypanosoma brucei gambiense; Sleeping sickness; Trypanosomiasis	HUMAN AFRICAN TRYPANOSOMIASIS; RISK-FACTORS; LATE-STAGE; GAMBIAN TRYPANOSOMIASIS; COMBINATION THERAPY; FAILURE; TRIAL; CONGO; EFFICACY; RELAPSE	This paper describes the effectiveness of first-line regimens for stage 2 human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense infection in nine Medecins Sans Frontieres HAT treatment programmes in Angola, Republic of Congo, Sudan and Uganda. Regimens included eflornithine and standard- and short-course melarsoprol. Outcomes for 10461 naive stage 2 patients fitting a standardised case definition and allocated to one of the above regimens were analysed by intention-to-treat analysis. Effectiveness was quantified by the case fatality rate (CFR) during treatment, the proportion probably and definitely cured and the Kaplan-Meier probability of relapse-free survival at 12 months and 24 months post admission. The CFR was similar for the standard- and short-course metarsoprol regimens (4.9% and 4.2%, respectively). The CFR for eflornithine was 1.2%. Kaplan-Meier survival probabilities varied from 71.4-91.8% at 1 year and 56.5-87.9% at 2 years for standard-course melarsoprol, to 73.0-91.1% at 1 year for short-course melarsoprol, and 79.9-97.4% at 1 year and 68.6-93.7% at 2 years for eflornithine. With the exception of one programme, survival at 12 months was >90% for eflornithine, whilst for metarsoprol it was <90% except in two sites. Eflornithine is recommended where feasible, especially in areas with tow melarsoprol effectiveness. (C) 2008 Royal Society of Tropical. Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Young, Heather; Checchi, Francesco] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; [Balasegaram, Manica] Med Sans Frontieres United Kingdom, London EC1N 8QX, England; [Chappluis, Francois] Med Sans Frontieres Swiss Sect, CH-1211 Geneva 21, Switzerland; [Chappluis, Francois] Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland; [Chappluis, Francois] Univ Geneva, Travel & Migrat Med Unit, CH-1211 Geneva 14, Switzerland; [Priotto, Gerardo] Epictr, F-75011 Paris, France; [Raguenaud, Marie-Eve] Med Sans Frontieres Belgian Sect, B-1090 Brussels, Belgium	Checchi, F (reprint author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Room 51G6,49-51 Bedford Sq, London WC1B 3DP, England.	francesco.checchi@lshtm.ac.uk					ASKONAS BA, 1985, CURR TOP MICROBIOL, V117, P119; Balasegaram M, 2006, B WORLD HEALTH ORGAN, V84, P783, DOI 10.2471/BLT.06.031955; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Bisser S, 2007, J INFECT DIS, V195, P322, DOI 10.1086/510534; Blum J, 2001, TROP MED INT HEALTH, V6, P390, DOI 10.1046/j.1365-3156.2001.00710.x; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; Burri C, 2003, PARASITOL RES, V90, pS49, DOI 10.1007/s00436-002-0766-5; Chappuis F, 2005, CLIN INFECT DIS, V41, P748, DOI 10.1086/432576; Cross P, 2006, TROP DOCT, V36, P90, DOI 10.1258/004947506776593350; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Legros D, 1999, B SOC PATHOL EXOT, V92, P171; Legros D, 1999, T ROY SOC TROP MED H, V93, P439, DOI 10.1016/S0035-9203(99)90151-7; Louis F J, 2003, Med Trop (Mars), V63, P559; MILORD F, 1993, T ROY SOC TROP MED H, V87, P473, DOI 10.1016/0035-9203(93)90044-Q; MILORD F, 1992, LANCET, V340, P652, DOI 10.1016/0140-6736(92)92180-N; MOORE A, 2002, MISSION REPORT INFOR; Pepin J, 2005, EMERG INFECT DIS, V11, P921; PEPIN J, 1992, AM J TROP MED HYG, V47, P133, DOI 10.4269/ajtmh.1992.47.133; PEPIN J, 1994, T ROY SOC TROP MED H, V88, P447, DOI 10.1016/0035-9203(94)90430-8; Pepin J, 2000, B WORLD HEALTH ORGAN, V78, P1284; Priotto G, 2007, CLIN INFECT DIS, V45, P1435, DOI 10.1086/522982; Priotto G, 2008, BMJ-BRIT MED J, V336, P705, DOI 10.1136/bmj.39485.592674.BE; Schmid C, 2004, LANCET, V364, P789, DOI 10.1016/S0140-6736(04)16940-7; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x	25	51	51	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAR	2009	103	3					280	290		10.1016/j.trstmh.2008.09.005				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	421BP	WOS:000264333200012	18947846	Green Published			2019-04-02	
J	Valea, I; Tinto, H; Nikiema, M; Yamuah, L; Rouamba, N; Drabo, M; Guiguemde, RT; d'Alessandro, U				Valea, Innocent; Tinto, Halidou; Nikiema, Madi; Yamuah, Lawrence; Rouamba, Noel; Drabo, Maxime; Guiguemde, Robert T.; d'Alessandro, Umberto			Performance of OptiMAL-IT (R) compared to microscopy, for malaria detection in Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						malaria; diagnosis; rapid test; Burkina Faso	LACTATE-DEHYDROGENASE; DIAGNOSTIC-TEST; RAPID TEST; TESTS; FIELD	To compare the performance of OptiMAL-IT (R), a rapid diagnostic test for malaria, with that of microscopy in Burkina Faso. Finger-prick blood samples of 464 children attending hospital for suspected malaria were tested for malaria by microscopy and OptiMAL-IT (R). The sensitivity and specificity of OptiMAL-IT (R) were 98.7% (CI 95% = 97.6-99.8) and 96.2% (CI 95% = 94.3-98.1) respectively, with a high positive likelihood ratio (25.97). OptiMAL-IT (R) can be considered a good method to diagnose malaria in Burkina Faso, particularly in remote areas with little or no access to microscopy services.	[Valea, Innocent; Nikiema, Madi; Guiguemde, Robert T.] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Tinto, Halidou; Rouamba, Noel; Drabo, Maxime] IRSS DRO, Bobo Dioulasso, Burkina Faso; [Yamuah, Lawrence] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [d'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium	Valea, I (reprint author), Ctr Muraz, Ctr Muraz 01 BP 390, Bobo Dioulasso, Burkina Faso.	valinno@yahoo.fr	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Tinto, Halidou/0000-0002-0472-3586			Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Bell DR, 2005, AM J TROP MED HYG, V73, P199, DOI 10.4269/ajtmh.2005.73.199; Ghosh K, 2001, BRIT J BIOMED SCI, V58, P20; Haditsch M, 2004, Travel Med Infect Dis, V2, P149, DOI 10.1016/j.tmaid.2004.03.001; Makler MT, 1998, PARASITOL TODAY, V14, P376, DOI 10.1016/S0169-4758(98)01284-8; Mboera LEG, 2006, ANN TROP MED PARASIT, V100, P115, DOI 10.1179/136485906X78571; Moody A H, 2002, Br J Biomed Sci, V59, P228; Palmer CJ, 1999, T ROY SOC TROP MED H, V93, P517, DOI 10.1016/S0035-9203(99)90357-7; Pattanasin S, 2003, T ROY SOC TROP MED H, V97, P672, DOI 10.1016/S0035-9203(03)80100-1; Ratsimbasoa A, 2007, AM J TROP MED HYG, V76, P481, DOI 10.4269/ajtmh.2007.76.481; Tham JM, 1999, J CLIN MICROBIOL, V37, P1269; VanderJagt TA, 2005, TROP MED INT HEALTH, V10, P39, DOI 10.1111/j.1365-3156.2004.01349.x; Warhurst DC, 1996, J CLIN PATHOL, V49, P533, DOI 10.1136/jcp.49.7.533; *WHO, 1988, B WORLD HEALTH ORGAN, V66, P575; World Health Organization, 2003, M REP JAN 20 23 MAN	15	14	14	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAR	2009	14	3					338	340		10.1111/j.1365-3156.2009.02228.x				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	408WV	WOS:000263467200011	19187517	Bronze			2019-04-02	
J	Fernandez, MAL; Bauernfeind, A; Jimenez, JD; Gil, CL; El Omeiri, N; Guibert, DH				Luque Fernandez, Miguel Angel; Bauernfeind, Ariane; Diaz Jimenez, Julio; Linares Gil, Cristina; El Omeiri, Nathalie; Herrera Guibert, Dionisio			Influence of temperature and rainfall on the evolution of cholera epidemics in Lusaka, Zambia, 2003-2006: analysis of a time series	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Cholera; Epidemics; Climate; Mathematical modelling; Zambia; Africa	VIBRIO-CHOLERAE; CLIMATE-CHANGE; INFECTIOUS-DISEASE; GLOBAL CLIMATE; EL-NINO; ADMISSIONS; BANGLADESH; AFRICA; MODELS	In this study, we aimed to describe the evolution of three cholera epidemics that occurred in Lusaka, Zambia, between 2003 and 2006 and to analyse the association between the increase in number of cases and climatic factors. A Poisson autoregressive model controlling for seasonality and trend was built to estimate the association between the increase in the weekly number of cases and weekly means of daily maximum temperature and rainfall. AR epidemics showed a seasonal trend coinciding with the rainy season (November to March). A 1 degrees C rise in temperature 6 weeks before the onset of the outbreak explained 5.2% [relative risk (RR) 1.05, 95% Cl 1.04-1.06] of the increase in the number of cholera cases (2003-2006). In addition, a 50mm increase in rainfall 3 weeks before explained an increase of 2.5% (RR 1.02, 95% Cl 1.01-1.04). The attributable risks were 4.9% for temperature and 2.4% for rainfall. If 6 weeks prior to the beginning of the rainy season an increase in temperature is observed followed by an increase in rainfall 3 weeks later, both exceeding expected levels, an increase in the number of cases of cholera within the following 3 weeks could be expected. Our explicative model could contribute to developing a warning signal to reduce the impact of a presumed cholera epidemic. (C) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All. rights reserved.	[Luque Fernandez, Miguel Angel; Linares Gil, Cristina; El Omeiri, Nathalie] Inst Salud Carlos III, PEAC, CNE, Natl Ctr Epidemiol, Madrid 28029, Spain; [Bauernfeind, Ariane] Brussels Operat Ctr, B-1090 Brussels, Belgium; [Diaz Jimenez, Julio] Inst Salud Carlos III, ENS, Madrid 28029, Spain; [El Omeiri, Nathalie] EPIET, Stockholm, Sweden	Fernandez, MAL (reprint author), Inst Salud Carlos III, PEAC, CNE, Natl Ctr Epidemiol, C Sinesio Delgado 6,Pabellon 12, Madrid 28029, Spain.	fmiguelangel@isciii.es	LUQUE FERNANDEZ, MIGUEL ANGEL/L-4053-2015	LUQUE FERNANDEZ, MIGUEL ANGEL/0000-0001-6683-5164			BLAKE PA, 1980, NEW ENGL J MED, V302, P305, DOI 10.1056/NEJM198002073020601; Bosch A., 2005, OCEANS HLTH PATHOGEN, P109; Boyle P, 1997, INT J EPIDEMIOL, V26, P651, DOI 10.1093/ije/26.3.651; Checkley W, 2000, LANCET, V355, P442; COLWELL RR, 1994, ANN NY ACAD SCI, V740, P44, DOI 10.1111/j.1749-6632.1994.tb19852.x; COSTE J, 1991, REV EPIDEMIOL SANTE, V39, P399; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Gaffga NH, 2007, AM J TROP MED HYG, V77, P705, DOI 10.4269/ajtmh.2007.77.705; Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007; HUQ A, 1984, APPL ENVIRON MICROB, V48, P420; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; ISLAM S, 1990, J TROP MED HYG, V93, P133; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Mendelsohn J, 2008, INT J HYG ENVIR HEAL, V211, P156, DOI 10.1016/j.ijheh.2006.12.002; Nyati H, 2004, WATER SCI TECHNOL, V50, P99; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; Patz JA, 2002, P NATL ACAD SCI USA, V99, P12506, DOI 10.1073/pnas.212467899; Richard V, 1999, Med Trop (Mars), V59, P169; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Sattenspiel L, 2000, YEARB PHYS ANTHROPOL, V43, P3; SENIOR K, 2007, LANCET, V370, P1840; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977; Tobias A, 2001, EUR J EPIDEMIOL, V17, P765, DOI 10.1023/A:1015663013620; TWEDT RM, 1981, APPL ENVIRON MICROB, V41, P1475; *UNFPA, 2005, EST POBL MUND 2005 P; WHO, 2004, WHOCDSCPEZFK20044; World Health Organization, 2007, WKLY EPIDEMIOL REC, V31, P273; World Health Organization (WHO), 2004, US CLIM PRED INF DIS	31	45	45	1	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	FEB	2009	103	2					137	143		10.1016/j.trstmh.2008.07.017				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	407XD	WOS:000263396700005	18783808	Green Published			2019-04-02	
J	Gonzalez-Ochoa, E; Brooks, JL; Matthys, F; Caliste, P; Armas, L; Van der Stuyft, P				Gonzalez-Ochoa, Edilberto; Brooks, Jorge L.; Matthys, Francine; Caliste, Pausides; Armas, Luisa; Van der Stuyft, Patrick			Pulmonary tuberculosis case detection through fortuitous cough screening during home visits	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						tuberculosis; active case finding; risk groups; Cuba	RANDOMIZED CONTROLLED-TRIAL; EDUCATIONAL OUTREACH; PRIMARY-CARE; ELIMINATION; CUBA	To compare the yield of active tuberculosis (TB) case detection among risk groups during home visits with passive detection among patients at health services. In April 2004, in a first phase, we introduced, active screening for coughing among all family members of patients that were visited at home by their family doctor or nurse for other reasons. Subsequently, from October 2004 onwards, active screening was restricted to family members belonging to groups at risk of TB. The overall detection rate of TB increased from 6.7/100 000 during passive detection at health services before the intervention to 26.2/100 000 inhabitants when passive detection was complemented by active case finding. Active screening among risk groups yielded 35 TB cases per 1000 persons screened compared to 20 TB cases per 1000 persons passively screened at health services. Active case finding was particularly efficient in those coughing for 3 weeks or more (107/1000 screened). This study demonstrates that active case finding in groups at risk during home visits increases the case detection rate in the population and permits the identification of cases that may not be detected through passive case finding at health facility level.	[Gonzalez-Ochoa, Edilberto; Armas, Luisa] Inst Trop Med Pedro Kouri, Res & Surveillance Grp TB Leprosy & ARI, Havana, Cuba; [Brooks, Jorge L.] Municipal Ctr Hyg & Epidemiol, Majibacoa, Las Tunas, Cuba; [Matthys, Francine; Van der Stuyft, Patrick] Inst Trop Med, Epidemiol & Dis Control Unit, Antwerp, Belgium; [Caliste, Pausides] Prov Ctr Hyg & Epidemiol, Las Tunas, Cuba	Gonzalez-Ochoa, E (reprint author), Inst Trop Med Pedro Kouri, Res & Surveillance Grp TB Leprosy & ARI, Autopista Novia Mediodia Km 6, Havana, Cuba.	ochoa@ipk.sld.cu			Institute of Tropical Medicine in Antwerp and the Belgian Belgium Directorate-General for Development Co-operation	We thank the health staff of the Municipality of LasTunas who was involved in the TB detection and control activities and the health and government authorities. The study was partly funded through the framework agreement between the Institute of Tropical Medicine in Antwerp and the Belgian Belgium Directorate-General for Development Co-operation.	Broekmans JF, 2002, EUR RESPIR J, V19, P765, DOI 10.1183/09031936.02.00261402; BROOKS J, 2006, REV PANAMERICANA INF, V8, P25; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P1; DENBOON S, 2008, EPIDEMIOLOGY INFECT, V4, P1; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Gonzalez E, 2007, INT J TUBERC LUNG D, V11, P405; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; Marrero A, 2000, THORAX, V55, P39, DOI 10.1136/thorax.55.1.39; *MIN SAL PUBL, 1999, MAN NORM PROC; Murray CJL, 1998, INT J TUBERC LUNG D, V2, pS9; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P611; *WHO, 2002, GLOB TUB CONTR SURV; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization; Stop TB Partnership, 2006, WHOHTMSTB200635	15	13	19	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2009	14	2					131	135		10.1111/j.1365-3156.2008.02201.x				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	409HL	WOS:000263496700002	19236664	Bronze			2019-04-02	
J	Gies, S; Coulibaly, SO; Ouattara, FT; D'Alessandro, U				Gies, Sabine; Coulibaly, Sheick Oumar; Ouattara, Florence Tiemegna; D'Alessandro, Umberto			Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						malaria; pregnancy; birth weight; intermittent preventive treatment; sulfadoxine-pyrimethamine; Burkina Faso	PLACEBO-CONTROLLED TRIAL; PREGNANT-WOMEN; PLACENTAL MALARIA; WESTERN KENYA; IMPLEMENTATION; BURDEN; MALAWI; PREVALENCE; INFECTION; REGIMENS	To assess the efficacy at individual level of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) in primi- and secundigravidae in rural Burkina Faso. Data of 1441 women enrolled in a health centre randomized trial and delivering a live-singleton between September 2004 and October 2006 were analysed at individual level. Prevalence of peripheral and placental parasitaemia, anaemia (PCV < 33%), low-birth weight (< 2500 g; LBW), mean packed cell volume (PCV) and birth weight were compared in relation to the number of directly observed SP doses. Two or more doses of SP significantly reduced the risk of placental parasitaemia [adjusted odds ratio (AOR) = 0.04, 95%CI = 0.003-0.60, P = 0.023] and anaemia at delivery (AOR = 0.31, 95%CI = 0.18-0.52, P < 0.001). IPTp was associated with reduced risk of LBW in primigravidae (AOR = 0.11, 95%CI = 0.07-0.17, P < 0.001) but not secundigravidae (AOR = 0.70, 95%CI = 0.26-1.91, P = 0.452). For each increment in number of SP doses mean PCV increased by 1.0% (95%CI = 0.4-1.7, P = 0.005) at 32 weeks gestation, by 1.2% (95%CI = 0.2-2.2, P = 0.025) at delivery and mean birth weight by 220 g (95%CI = 134-306 P < 0.001) in primigravidae and by 102 g (95%CI = 55-148, P = 0.001) in secundigravidae. The risk of malaria infection was significantly reduced by IPTp with SP in primi- and secundigravidae in rural Burkina Faso. The impact on clinical outcomes is lower and mainly limited to primigravidae for LBW. Incomplete uptake of IPTp-SP and limited effect in low risk groups together may substantially dilute the measurable impact of effective interventions. This needs to be taken into account when evaluating interventions at community level.	[Gies, Sabine; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, Dept Parasitol, Epidemiol & Control Parasit Dis Unit, B-2000 Antwerp, Belgium; [Coulibaly, Sheick Oumar] Univ Ouagadougou, UFR Sci Sante, Ouagadougou, Burkina Faso; [Coulibaly, Sheick Oumar] Lab Natl Sante Publ, Ouagadougou, Burkina Faso; [Ouattara, Florence Tiemegna] Dist Sanitaire Boromo, Boromo, Burkina Faso	Gies, S (reprint author), Inst Trop Med Prince Leopold, Dept Parasitol, Epidemiol & Control Parasit Dis Unit, Nationalestr 155, B-2000 Antwerp, Belgium.	sgies@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009	European Union INCO-DEV programme [IC4-CT-2002-10022]; Belgian co-operation (DGDC)	This study was supported by the European Union INCO-DEV programme (contract IC4-CT-2002-10022). SG was partly supported by the Belgian co-operation (DGDC) through the framework agreement ITM, Antwerp - Centre Muraz, Bobo-Dioulasso.	BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Challis K, 2004, TROP MED INT HEALTH, V9, P1066, DOI 10.1111/j.1365-3156.2004.01307.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; GIES S, 2009, AM J TROPIC IN PRESS; Gies S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-180; Gill CJ, 2007, J INFECT DIS, V196, P1577, DOI 10.1086/522137; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Hommerich L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-144; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Mbaye A, 2006, TROP MED INT HEALTH, V11, P992, DOI 10.1111/j.1365-3156.2006.01649.x; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; *MIN SANTE, 2006, DIR NAT PRIS CHARG P; *MIN SANTE, 2006, ANN STAT SANTE 2005; Njagi JK, 2003, T ROY SOC TROP MED H, V97, P277, DOI 10.1016/S0035-9203(03)90141-6; Ouedraogo A, 2008, MED MALADIES INFECT, V38, P180, DOI 10.1016/j.medmal.2007.10.012; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Ramharter M, 2007, AM J TROP MED HYG, V77, P418, DOI 10.4269/ajtmh.2007.77.418; Rogerson SJ, 2000, T ROY SOC TROP MED H, V94, P549, DOI 10.1016/S0035-9203(00)90083-X; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; SCHULTZ LJ, 1994, AM J TROP MED HYG, V51, P515, DOI 10.4269/ajtmh.1994.51.515; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Sirima SB, 2006, AM J TROP MED HYG, V75, P205, DOI 10.4269/ajtmh.2006.75.205; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Tinto H, 2007, AM J TROP MED HYG, V76, P608, DOI 10.4269/ajtmh.2007.76.608; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P630, DOI 10.1111/j.1365-3156.2004.01242.x; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P351, DOI 10.1111/j.1365-3156.2004.01196.x; Verhoeff FH, 1998, ANN TROP MED PARASIT, V92, P141, DOI 10.1080/00034983.1998.11813273; *WHO, 2005, GLOB STRAT PLAN 2005; *WHO, 2003, WHOCDSRBM200017; *WHO, 2004, AFRMAL0401 WHO REG O	31	25	27	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2009	14	2					174	182		10.1111/j.1365-3156.2008.02215.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	409HL	WOS:000263496700008	19171009	Bronze			2019-04-02	
J	Msyamboza, KP; Savage, EJ; Kazembe, PN; Gies, S; Kalanda, G; D'Alessandro, U; Brabin, BJ				Msyamboza, K. P.; Savage, E. J.; Kazembe, P. N.; Gies, S.; Kalanda, G.; D'Alessandro, U.; Brabin, B. J.			Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						malaria; pregnancy; birthweight; anaemia; sulfadoxine-pyrimethamine; antenatal attendance; Malawi	LOW-BIRTH-WEIGHT; WOMEN; UGANDA; INDICATOR; TRIAL; RISK	To evaluate the impact of a 2-year programme for community-based delivery of sulfadoxine-pyremethamine (SP) on intermittent preventive treatment during pregnancy coverage, antenatal clinic attendance and pregnancy outcome. Fourteen intervention and 12 control villages in the catchment areas of Chikwawa and Ngabu Government Hospitals, southern Malawi, were selected. Village-based community health workers were trained in information, education and counselling on malaria control in pregnancy and the importance of attending antenatal clinics and promoted these messages to pregnant women. In the intervention group community health workers also distributed SP to pregnant women. In the control area, coverage of intermittent preventive treatment during pregnancy (> 2 doses) was low before (44.1%) and during the intervention (46.1%). In the intervention area, coverage increased from 41.5% to 82.9% (P < 0.01). Antenatal clinic attendance (> 2 visits) was maintained in control villages at above 90%, but fell in intervention villages from 87.3% to 51.5% (P < 0.01). Post-natal malaria parasitaemia prevalence fell in women from both study areas during the intervention phase (P < 0.05). Increasing the coverage of intermittent preventive treatment during pregnancy to > 40% did not significantly improve maternal haemoglobin or reduce low birthweight prevalence. Better coverage of community-based intermittent preventive treatment during pregnancy can lower attendance at antenatal clinics; thus its effect on pregnancy outcome and antenatal attendance need to be monitored.	[Savage, E. J.; Kalanda, G.; Brabin, B. J.] Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England; [Kazembe, P. N.] Baylor Coll Med, Childrens Clin Ctr Excellence, Lilongwe, Malawi; [Gies, S.; D'Alessandro, U.] Inst Trop Med, Epidemiol & Control Parasit Dis Unit, Antwerp, Belgium; Univ Amsterdam, Acad Med Ctr, EmmaKinderziekenhuis, Amsterdam, Netherlands; [Brabin, B. J.] Royal Liverpool Childrens Hosp NHS Trust, Dept Community Paediat, Liverpool, Merseyside, England; [Msyamboza, K. P.] Coll Med, Malaria Alert Ctr, Blantyre, Malawi	Brabin, BJ (reprint author), Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	brabinbj@liverpool.ac.uk	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009	European Commission Research Directorate [ICA4-CT-2002-10022]	This study was supported by a grant from the European Commission Research Directorate (Contract ICA4-CT-2002-10022).	Ashwood-Smith Hannah, 2002, Malawi Med J, V14, P8; BRABIN B, 1991, INT J EPIDEMIOL, V20, P276, DOI 10.1093/ije/20.1.276; Brabin BJ, 1999, ANN TROP MED PARASIT, V93, pS43, DOI 10.1080/00034983.1999.11813503; Filler SJ, 2006, J INFECT DIS, V194, P286, DOI 10.1086/505080; Gies S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-180; GREENWOOD BM, 1989, T ROY SOC TROP MED H, V83, P589, DOI 10.1016/0035-9203(89)90362-3; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Hogg A, 2005, DEV PRACT, V15, P655, DOI 10.1080/09614520500128844; Holtz TH, 2004, TROP MED INT HEALTH, V9, P77, DOI 10.1046/j.1365-3156.2003.01170.x; KASEJE D C O, 1987, Annals of Tropical Medicine and Parasitology, V81, P77; Mbonye AK, 2008, INT J INFECT DIS, V12, P22, DOI 10.1016/j.ijid.2006.10.008; Mbonye AK, 2007, TROP MED INT HEALTH, V12, P519, DOI 10.1111/j.1365-3156.2007.01819.x; Mbonye AK, 2007, HEALTH POLICY, V81, P228, DOI 10.1016/j.healthpol.2006.05.018; *MIN HLTH POP, 2005, ROLL BACK MAL MON EV; Msyamboza K, 2007, Malawi Med J, V19, P11; SAVAGE EJ, 2007, BRIT J OBSTET GYNAEC, V121, P861; *STAT CORP, 2003, REL 9; Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; UDDENFELDTWORT U, 2006, MALARIA J, V5, P89; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P630, DOI 10.1111/j.1365-3156.2004.01242.x; Verhoeff FH, 1998, ANN TROP MED PARASIT, V92, P141, DOI 10.1080/00034983.1998.11813273; *WHO, 2005, WORLD MAL REP; *WHO GLOB STRAT, 2005, WHO GLOB STRAT PLAN; Wort UU, 2008, PUBLIC HEALTH, V122, P923, DOI 10.1016/j.puhe.2007.12.012	26	21	21	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2009	14	2					183	189		10.1111/j.1365-3156.2008.02197.x				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	409HL	WOS:000263496700009	19207178	Bronze			2019-04-02	
J	Yewhalaw, D; Legesse, W; Van Bortel, W; Gebre-Selassie, S; Kloos, H; Duchateau, L; Speybroeck, N				Yewhalaw, Delenasaw; Legesse, Worku; Van Bortel, Wim; Gebre-Selassie, Solomon; Kloos, Helmut; Duchateau, Luc; Speybroeck, Niko			Malaria and water resource development: the case of Gilgel-Gibe hydroelectric dam in Ethiopia	MALARIA JOURNAL			English	Article							RISK-FACTORS; GLOBAL DISTRIBUTION; CHILDREN; MORTALITY; BURDEN; POPULATION; MANAGEMENT; AFRICA; AREA; IRRIGATION	Background: Ethiopia plans to increase its electricity power supply by five-fold over the next five years to fulfill the needs of its people and support the economic growth based on large hydropower dams. Building large dams for hydropower generation may increase the transmission of malaria since they transform ecosystems and create new vector breeding habitats. The aim of this study was to assess the effects of Gilgel-Gibe hydroelectric dam in Ethiopia on malaria transmission and changing levels of prevalence in children. Methods: A cross-sectional, community-based study was carried out between October and December 2005 in Jimma Zone, south-western Ethiopia, among children under 10 years of age living in three 'at-risk' villages (within 3 km from dam) and three 'control' villages (5 to 8 km from dam). The man-made Gilgel-Gibe dam is operating since 2004. Households with children less than 10 years of age were selected and children from the selected households were sampled from all the six villages. This included 1,081 children from 'at-risk' villages and 774 children from 'control' villages. Blood samples collected from children using finger prick were examined microscopically to determine malaria prevalence, density of parasitaemia and identify malarial parasite species. Results: Overall 1,855 children (905 girls and 950 boys) were surveyed. A total of 194 (10.5%) children were positive for malaria, of which, 117 (60.3%) for Plasmodium vivax, 76 (39.2%) for Plasmodium falciparum and one (0.5%) for both P. vivax and P. falciparum. A multivariate design-based analysis indicated that, while controlling for age, sex and time of data collection, children who resided in 'at-risk' villages close to the dam were more likely to have P. vivax infection than children who resided farther away (odds ratio (OR) = 1.63, 95% CI = 1.15, 2.32) and showed a higher OR to have P. falciparum infection than children who resided in 'control' villages, but this was not significant (OR = 2.40, 95% CI = 0.84, 6.88). A classification tree revealed insights in the importance of the dam as a risk factor for malaria. Assuming that the relationship between the dam and malaria is causal, 43% of the malaria occurring in children was due to living in close proximity to the dam. Conclusion: This study indicates that children living in close proximity to a man-made reservoir in Ethiopia are at higher risk of malaria compared to those living farther away. It is recommended that sound prevention and control programme be designed and implemented around the reservoir to reduce the prevalence of malaria. In this respect, in localities near large dams, health impact assessment through periodic survey of potential vectors and periodic medical screening is warranted. Moreover, strategies to mitigate predicted negative health outcomes should be integral parts in the preparation, construction and operational phases of future water resource development and management projects.	[Speybroeck, Niko] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Yewhalaw, Delenasaw] Jimma Univ, Dept Biol, Jimma, Ethiopia; [Legesse, Worku] Jimma Univ, Sch Environm Hlth, Jimma, Ethiopia; [Van Bortel, Wim] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Gebre-Selassie, Solomon] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Kloos, Helmut] Univ Calif San Francisco, Dept Epidemiol & Biostat, Med Ctr, San Francisco, CA 94143 USA; [Duchateau, Luc] Univ Ghent, Dept Physiol & Biometr, B-9000 Ghent, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Sch Publ Hlth, B-1200 Brussels, Belgium	Speybroeck, N (reprint author), Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium.	delenasaw.yewhalaw@ju.edu.et; workuu@gmail.com; wvbortel@itg.be; solomongst@yahoo.com; helmutk@comcast.net; Luc.Duchateau@UGent.be; nspeybroeck@itg.be		Van Bortel, Wim/0000-0002-6644-518X			ADHANOM T, 2007, EPIDEMIOLOGY ECOLOGY, P556; Bruce-Chwatt LJ, 1985, ESSENTIAL MALARIOLOG; Cheesbrough M, 1987, MED LAB MANUAL TROPI; DEMEILLON B, 1947, PUBLICATIONS S AFRIC, P160; Erlanger TE, 2005, AM J TROP MED HYG, V73, P523, DOI 10.4269/ajtmh.2005.73.523; GEBREMARIAM N., 1988, ECOLOGY HLTH DIS ETH, P136; Ghebreyesus TA, 1998, J PUBLIC HEALTH MED, V20, P238, DOI 10.1093/oxfordjournals.pubmed.a024754; Ghebreyesus TA, 1999, BRIT MED J, V319, P663, DOI 10.1136/bmj.319.7211.663; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Gillies M. T., 1988, Malaria: principles and practice of malariology. Volume 1., P453; Gratz N. G., 1988, Vector-borne disease control in humans through rice agroecosystem management. Proceedings of the Workshop on Research and Training Needs in the Field of Integrated Vector-borne Disease Control in Riceland Agroecosystems of Developing Countries, 9-14 March 1987., P7; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; HOLDING PA, 2001, AM J TROP MED HYG, V64, P568; HORSEFALL WR, 1955, MOSQUITOES THEIR BIO; Hunter J, 1993, PARASITIC DIS WATER; Issifou S, 2007, AM J TROP MED HYG, V77, P1015, DOI 10.4269/ajtmh.2007.77.1015; Jobin W., 1999, DAMS DIS ECOLOGICAL; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392; Keiser J, 2005, ACTA TROP, V95, P40, DOI 10.1016/j.actatropica.2005.04.012; Kloos H, 1993, ECOLOGY HLTH DIS ETH, P341; LINDSAY SW, 1995, MED VET ENTOMOL, V9, P50, DOI 10.1111/j.1365-2915.1995.tb00116.x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; *MOH, 2000, P NAT C ROLL BACK MA; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Ramos JM, 2005, J TRAVEL MED, V12, P155; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dy1027; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; Singh N, 1999, ANN TROP MED PARASIT, V93, P477, DOI 10.1080/00034983.1999.11813447; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Speybroeck N, 2004, AGR SYST, V80, P133, DOI 10.1016/j.agsy.2003.06.006; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28; TRAPE JF, 1987, T R SOC TROP MED S2, V81, P27; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; WHO, 1996, FIGHT DIS FOST DEV; [World Health Organization Severe falciparum malaria], 2000, T R SOC TROP MED S1, V94, pS1, DOI DOI 10.1016/S0035-9203(00)90300-6; Woyessa A, 2004, ETHIOP J HEALTH DEV, V18, P2; WOYESSA A, 2002, ETHIOP J HLTH DEV, V16, P47; 1999, GUIDELINES MALARIA D; ETHIOPIA ELECT 24 MI	44	52	53	0	28	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 29	2009	8								21	10.1186/1475-2875-8-21				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	424OD	WOS:000264575100001	19178727	DOAJ Gold, Green Published			2019-04-02	
J	Ngo, DT; Erhart, A; Le, XH; Le, KT; Nguyen, XX; Nguyen, NT; Pham, VK; Coosemans, M; Speybroeck, N; D'Alessandro, U				Ngo Duc Thang; Erhart, Annette; Le Xuan Hung; Le Khanh Thuan; Nguyen Xuan Xa; Nguyen Ngoc Thanh; Pham Van Ky; Coosemans, Marc; Speybroeck, Nico; D'Alessandro, Umberto			Rapid decrease of malaria morbidity following the introduction of community-based monitoring in a rural area of central Vietnam	MALARIA JOURNAL			English	Article							SOUTHEAST-ASIA; FOREST MALARIA; SCHOOLCHILDREN; CHALLENGE	Background: Despite a successful control programme, malaria has not completely disappeared in Vietnam; it remains endemic in remote areas of central Vietnam, where standard control activities seem to be less effective. The evolution of malaria prevalence and incidence over two and half years in a rural area of central Vietnam, after the introduction of community-based monitoring of malaria cases, is presented. Methods: After a complete census, six cross-sectional surveys and passive detection of malaria cases (by village and commune health workers using rapid diagnostic tests) were carried out between March 2004 and December 2006 in Ninh-Thuan province, in a population of about 10,000 individuals. The prevalence of malaria infection and the incidence of clinical cases were estimated. Results: Malaria prevalence significantly decreased from 13.6% (281/2,068) in December 2004 to 4.0% (80/2,019) in December 2006. Plasmodium falciparum and Plasmodium vivax were the most common infections with few Plasmodium malariae mono-infections and some mixed infections. During the study period, malaria incidence decreased by more than 50%, from 25.7/1,000 population at risk in the second half of 2004 to 12.3/1,000 in the second half of 2006. The incidence showed seasonal variations, with a yearly peak between June and December, except in 2006 when the peak observed in the previous years did not occur. Conclusion: Over a 2.5-year follow-up period, malaria prevalence and incidence decreased by more than 70% and 50%, respectively. Possibly, this could be attributed to the setting up of a passive case detection system based on village health workers, indicating that a major impact on the malaria burden can be obtained whenever prompt diagnosis and adequate treatment are available.	[Ngo Duc Thang; Le Xuan Hung; Le Khanh Thuan; Nguyen Xuan Xa; Nguyen Ngoc Thanh] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Erhart, Annette; Coosemans, Marc; Speybroeck, Nico; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Pham Van Ky] Prov Ctr Malariol Parasitol & Entomol, Phan Rang, Ninh Thuan, Vietnam; [Speybroeck, Nico] Univ Catholique Louvain, Ecole Sante Publ, B-1200 Brussels, Belgium	Ngo, DT (reprint author), Natl Inst Malariol Parasitol & Entomol, Luong Vinh St 245, Hanoi, Vietnam.	thangnimpevn@yahoo.com; aerhart@itg.be; lxhung1952@yahoo.com; nimpe@netnam.org.vn; ngxxa@yahoo.com; thanhnimpe@yahoo.com.vn; phamvankynt@hotmail.com; mcoosemans@itg.be; nspeybroeck@itg.be; udalessandro@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009	provincial health authorities; People Committee of Ninh Thuan province	We would like to thank all the health staff and the hamlet health workers involved in the present study for their enthusiasm and dedication during the whole study period. The study would not have been possible without the generous and willing cooperation of the study population, and the strong and constant support from provincial health authorities as well as People Committee of Ninh Thuan province.	Al Serouri AW, 2000, PARASITOLOGY, V121, P337, DOI 10.1017/S0031182099006502; Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; Bell D., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P578; *CTR NAT MAL, 2008, ANN MAL REP 2007; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; Ghebreyesus TA, 1996, ACTA TROP, V61, P145, DOI 10.1016/0001-706X(95)00107-P; *IMPE, 2006, IMPE QUY NHON REP; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Kurtzhals JAL, 1999, T ROY SOC TROP MED H, V93, P623, DOI 10.1016/S0035-9203(99)90073-1; NGO DT, 2008, MALARIA J, V7, P28; *NIMPE, 2006, ANN REP NAT MAL CONT; *NIMPE, 2007, ANN REP NAT MAL CONT; *NIMPE, 2008, ANN REP NAT MAL CONT; Okanurak K, 1996, ACTA TROP, V61, P157, DOI 10.1016/0001-706X(95)00115-U; Osorio Lyda, 2004, Biomédica, V24, P13; Richards Adam K, 2007, Confl Health, V1, P9, DOI 10.1186/1752-1505-1-9; Schuftan C., 2000, WHO WPRO GLOBAL ROLL; Syafruddin D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-116; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; Wise J, 2004, B WORLD HEALTH ORGAN, V82, P884	22	3	3	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 5	2009	8								3	10.1186/1475-2875-8-3				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	424MU	WOS:000264571600002		DOAJ Gold, Green Published			2019-04-02	
J	Kouanda, S; Doulougou, B; De Coninck, V; Habimana, L; Sondo, B; Tonglet, R; Ketelslegers, JM; Robert, A				Kouanda, S.; Doulougou, B.; De Coninck, V.; Habimana, L.; Sondo, B.; Tonglet, R.; Ketelslegers, J. M.; Robert, A.			Insulin Growth Factor-I in Protein-Energy Malnutrition during Rehabilitation in Two Nutritional Rehabilitation Centres in Burkina Faso	JOURNAL OF TROPICAL MEDICINE			English	Article								Objective. To investigate the relationship between IGF-I and the nutritional status of West-African children hospitalised for nutritional rehabilitation. Patients and methods. A cohort study was performed in two centres for nutritional rehabilitation and education (CREN) in Burkina Faso. Children were followed and the anthropometric data as well as the capillary blood samples were taken on the 7th and on the 14th days after their admission. IGF-I levels were determined from dried blood spots on filter paper on IGF-I RIA, after separation of the IGF-I from its binding proteins, using Sep-Pak chromatography. Results. A total of 59 children was included in the cohort. The IGF-I mean geometric values (SD) were 6.3 (1.4) mu g/L on admission, 8.6 (1.8) mu g/L at day 7 and 13.6 (2.0) mu g/L at day 14. The differences between these values were statistically significant (P < .001). There is a significant correlation between the changes of IGF-I with the change of weight for height Z-score (P = .01). Conclusion. These results suggest that IGF-I can be considered as a potential marker to follow the nutritional status of children admitted in hospital for protein and energy malnutrition. Copyright (C) 2009 S. Kouanda et al.	[Kouanda, S.; Doulougou, B.; Sondo, B.] Minist Enseignements Secondaire Supe & Rech Sci, CNRS, Inst Rech Sci Sante, BP 7192, Ouagadougou, Burkina Faso; [De Coninck, V.; Ketelslegers, J. M.] Unit Diabetol & Nutr, Ave Hippocrate 54, B-1200 Brussels, Belgium; [Habimana, L.; Tonglet, R.; Robert, A.] Unit Epidemiol Biostat & Methodes Operat Sante Pu, B-1200 Brussels, Belgium	Kouanda, S (reprint author), Minist Enseignements Secondaire Supe & Rech Sci, CNRS, Inst Rech Sci Sante, BP 7192, Ouagadougou, Burkina Faso.	skouanda@irss.bf			Fonds de la Recherche Scientifique Medicale [FRSM 3.4561.04]; Belgian Cooperation Universitaire pour le Developpement (CUD)	This research was supported by grants from Fonds de la Recherche Scientifique Medicale (convention FRSM 3.4561.04) and the Belgian Cooperation Universitaire pour le Developpement (CUD). The authors also thank Dr. Lassana Zalla of "Centre Medical Persis" and the paediatric staff of CHR of Ouahigouya.	BEAU JP, 1987, J TROP PEDIATRICS, V33, P4, DOI 10.1093/tropej/33.1.4; Bhutta ZA, 1999, ARCH DIS CHILD, V80, P438, DOI 10.1136/adc.80.5.438; BRIEND A, 1986, BRIT MED J, V293, P373, DOI 10.1136/bmj.293.6543.373; CLEMMONS DR, 1981, J CLIN ENDOCR METAB, V53, P1247, DOI 10.1210/jcem-53-6-1247; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; Defalque D, 1999, AM J PHYSIOL-ENDOC M, V276, pE565; DEONIS M, 1993, B WORLD HEALTH ORGAN, V71, P703; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736; Dramaix M, 1996, AM J EPIDEMIOL, V143, P1235; FURLANETTO RW, 1977, J CLIN INVEST, V60, P648, DOI 10.1172/JCI108816; HILL KK, 1993, J AM COLL NUTR, V12, P475, DOI 10.1080/07315724.1993.10718338; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Institut National de la Statistique et de la Demographie Macro International Inc, 2003, ENQ DEM SANT; ISLEY WL, 1984, JPEN-PARENTER ENTER, V8, P407, DOI 10.1177/0148607184008004407; Ketelslegers JM, 1996, HORM RES, V45, P252, DOI 10.1159/000184797; Kouanda S, 2008, GROWTH HORM IGF RES, V18, P345, DOI 10.1016/j.ghir.2008.01.008; MCCONAGHEY P, 1970, NATURE, V225, P1249, DOI 10.1038/2251249b0; MILLER LL, 1981, ENDOCRINOLOGY, V108, P1265, DOI 10.1210/endo-108-4-1265; OMS. Obesite, 1995, SER RAPP TECHN; Palacio AC, 2002, NUTRITION, V18, P17, DOI 10.1016/S0899-9007(01)00690-6; RECHLER MM, 1985, ANNU REV PHYSIOL, V47, P425; SCHWANDER JC, 1983, ENDOCRINOLOGY, V113, P297, DOI 10.1210/endo-113-1-297; Smith W. J., 1995, PEDIATR RES, V20, P1122; SMITH WJ, 1995, J CLIN ENDOCR METAB, V80, P443, DOI 10.1210/jc.80.2.443; SULLIVAN DH, 1994, J AM COLL NUTR, V13, P184; Thissen JP, 1999, NUTR REV, V57, P167, DOI 10.1111/j.1753-4887.1999.tb06939.x; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; UNDERWOOD LE, 1994, HORM RES, V42, P145, DOI 10.1159/000184187; VANWYK JJ, 1984, HORMONAL PROTEINS PE, P81; Yumet G, 2006, CRIT CARE MED, V34, P1420, DOI 10.1097/01.CCM.0000215113.66070.E0; Zamboni G, 1996, PEDIATR RES, V39, P410, DOI 10.1203/00006450-199603000-00006	31	2	2	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-9686	1687-9694		J TROP MED	J. Trop. Med.		2009									832589	10.1155/2009/832589				7	Tropical Medicine	Tropical Medicine	V15WT	WOS:000214579400010	20339465	DOAJ Gold, Green Published			2019-04-02	
J	Levecke, B; De Wilde, N; Vandenhoute, E; Vercruysse, J				Levecke, Bruno; De Wilde, Nathalie; Vandenhoute, Els; Vercruysse, Jozef			Field Validity and Feasibility of Four Techniques for the Detection of Trichuris in Simians: A Model for Monitoring Drug Efficacy in Public Health?	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRANSMITTED HELMINTH INFECTIONS; NONHUMAN-PRIMATES; PARASITES; HOOKWORM; EGGS; ALBENDAZOLE; ASCARIS	Background: Soil-transmitted helminths, such as Trichuris trichiura, are of major concern in public health. Current efforts to control these helminth infections involve periodic mass treatment in endemic areas. Since these large-scale interventions are likely to intensify, monitoring the drug efficacy will become indispensible. However, studies comparing detection techniques based on sensitivity, fecal egg counts (FEC), feasibility for mass diagnosis and drug efficacy estimates are scarce. Methodology/Principal Findings: In the present study, the ether-based concentration, the Parasep Solvent Free (SF), the McMaster and the FLOTAC techniques were compared based on both validity and feasibility for the detection of Trichuris eggs in 100 fecal samples of nonhuman primates. In addition, the drug efficacy estimates of quantitative techniques was examined using a statistical simulation. Trichuris eggs were found in 47% of the samples. FLOTAC was the most sensitive technique (100%), followed by the Parasep SF (83.0% [95% confidence interval (CI): 82.4-83.6%]) and the ether-based concentration technique (76.6% [ 95% CI: 75.8-77.3%]). McMaster was the least sensitive (61.7% [ 95% CI: 60.7-62.6%]) and failed to detect low FEC. The quantitative comparison revealed a positive correlation between the four techniques (Rs = 0.85-0.93; p < 0.0001). However, the ether-based concentration technique and the Parasep SF detected significantly fewer eggs than both the McMaster and the FLOTAC (p < 0.0083). Overall, the McMaster was the most feasible technique (3.9 min/sample for preparing, reading and cleaning of the apparatus), followed by the ether-based concentration technique (7.7 min/sample) and the FLOTAC (9.8 min/sample). Parasep SF was the least feasible (17.7 min/ sample). The simulation revealed that the sensitivity is less important for monitoring drug efficacy and that both FLOTAC and McMaster were reliable estimators. Conclusions/Significance: The results of this study demonstrated that McMaster is a promising technique when making use of FEC to monitor drug efficacy in Trichuris.	[Levecke, Bruno; De Wilde, Nathalie; Vandenhoute, Els; Vercruysse, Jozef] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium	Levecke, B (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	Bruno.Levecke@ugent.be		Levecke, Bruno/0000-0001-8912-5595	Ghent University	This investigation was supported by the Department of Virology, Parasitology & Immunology, Faculty of Veterinary Medicine (Ghent University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Albonico M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000126; Albonico M, 2007, T ROY SOC TROP MED H, V101, P454, DOI 10.1016/j.trstmh.2006.09.003; ALLEN AVH, 1970, J CLIN PATHOL, V23, P545, DOI 10.1136/jcp.23.6.545; Bennett A, 2000, PARASITOL TODAY, V16, P71, DOI 10.1016/S0169-4758(99)01544-6; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2007, T ROY SOC TROP MED H, V101, P146, DOI 10.1016/j.trstmh.2006.05.012; Cringoli G., 2006, Parassitologia (Rome), V48, P381; GEERTS S, 2000, CLIN MICROBIOL REV, V13, P202; Goodman D, 2007, AM J TROP MED HYG, V76, P725, DOI 10.4269/ajtmh.2007.76.725; Katz N, 1972, REV INST MED TROP SP, V14, P379; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Montresor A, 1998, GUIDELINES EVALUATIO, P1; Munene E, 1998, VET PARASITOL, V78, P195, DOI 10.1016/S0304-4017(98)00143-5; Muriuki SMK, 1998, ACTA TROP, V71, P73, DOI 10.1016/S0001-706X(98)00040-0; NICHOLLS J, 1994, VET PARASITOL, V52, P337, DOI 10.1016/0304-4017(94)90125-2; Pereckiene A, 2007, VET PARASITOL, V149, P111, DOI 10.1016/j.vetpar.2007.04.014; Ramsan M, 1999, TROP MED INT HEALTH, V4, P46, DOI 10.1046/j.1365-3156.1999.00356.x; ROSSANIGO CE, 1991, VET PARASITOL, V39, P115, DOI 10.1016/0304-4017(91)90067-6; Thienpont D, 1986, DIAGNOSING HELMINTHI, P35; Utzinger J, 2008, T ROY SOC TROP MED H, V102, P84, DOI 10.1016/j.trstmh.2007.09.009; Vercruysse J, 2001, VET PARASITOL, V96, P171, DOI 10.1016/S0304-4017(00)00443-X; WHO, 1991, BAS LAB METH MED PAR, P25; *WHO, 2007, WHO GLOB DAT BANK SC	24	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2009	3	1							e366	10.1371/journal.pntd.0000366				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	406NB	WOS:000263301100015	19172171	DOAJ Gold, Green Published			2019-04-02	
J	Mondal, D; Singh, SP; Kumar, N; Joshi, A; Sundar, S; Das, P; Siddhivinayak, H; Kroeger, A; Boelaert, M				Mondal, Dinesh; Singh, Shri Prakash; Kumar, Narendra; Joshi, Anand; Sundar, Shyam; Das, Pradeep; Siddhivinayak, Hirve; Kroeger, Axel; Boelaert, Marleen			Visceral Leishmaniasis Elimination Programme in India, Bangladesh, and Nepal: Reshaping the Case Finding/Case Management Strategy	PLOS NEGLECTED TROPICAL DISEASES			English	Article							DIRECT AGGLUTINATION-TEST; KALA-AZAR; ECONOMIC BURDEN; STRIP-TEST; DIAGNOSIS; MILTEFOSINE; HOUSEHOLDS; BIHAR	Objective: We sought to estimate visceral leishmaniasis (VL) burden in Bangladesh, India, and Nepal and document care-seeking behaviour for VL to provide baseline information for monitoring the VL elimination program and identify options for improved case finding and management. Design: A cross-sectional study using cluster sampling (clusters being villages) of 4 VL endemic districts was used in order to document all current and existing VL cases over the preceding 12 mo. Extended (in-depth) interviews were conducted in a subsample of households to explore (a) VL-related knowledge, attitudes, and practices of the population; (b) use of VL care by patients; and (c) delay between onset of symptoms, diagnosis, and start of treatment, as well as treatment interruption. Findings were discussed with national program managers and policy makers to develop improved strategies. Results: Screening for VL was done in 18,933 households (106,425 inhabitants). The estimated annual incidence of VL in the endemic districts was on average 22 times higher than the elimination target of less than one case per 10,000 inhabitants in 2015. This incidence varied widely between study sites, from 9.0 to 29.8 per 10,000 inhabitants. The percentage of newly detected cases through the household screening was high in the districts least covered by health-care services (particularly Rajshahi, Bangladesh, 49%; and to a lesser extent Vaishali in Bihar, India, 32.5%), and much lower in districts with greater availability of VL care (Muzaffarpur, India, 3.8%). On average 267 houses had to be visited, i.e., at least three to four working days per health worker, to identify a new VL (ranging from 1,432 houses in Muzaffarpur, India to only 166 houses in Rajshahi, Bangladesh). Knowledge of the disease and its vectors was good in India and Nepal but poor in Bangladesh (Rajshahi) where very little attention has been given to VL over the last decades. Although all socio-demographic indicators showed high levels of poverty, people in India preferred private medical practitioners for the treatment of VL, whereas in Nepal, and even more in Bangladesh, the public health-care sector was preferred. Delays between onset of symptoms and diagnosis as well as start of treatment was high. Reported non-adherence to treatment was particularly high in the more under-served districts and was mainly due to lack of resources. Discussion: The findings suggest that (a) house-to-house screening may be useful in highly endemic districts with a poor passive case detection system, but further evidence on case finding adapted to local conditions has to be collected; (b) strengthening the quality of the public health sector is imperative in the three countries, especially in India, with its largely unregulated private-sector provision of VL care.	[Mondal, Dinesh] Int Ctr Diarrhoeal Dis Res, Div Sci Lab, Dhaka 1000, Bangladesh; [Singh, Shri Prakash; Sundar, Shyam] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India; [Joshi, Anand] Tribhuvan Univ, Inst Med, Kathmandu, Nepal; [Siddhivinayak, Hirve] Vadu Rural Hlth Programme, Pune, Maharashtra, India; [Kroeger, Axel] World Hlth Org, Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland; [Kroeger, Axel] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Boelaert, Marleen] Inst Trop Med Prince Leopold, Dept Publ Hlth, B-2000 Antwerp, Belgium	Mondal, D (reprint author), Int Ctr Diarrhoeal Dis Res, Div Sci Lab, GPO Box 128, Dhaka 1000, Bangladesh.	din63d@icddrb.org	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Kroeger, Axel/0000-0001-8438-2904	World Health Organization	The research initiative was funded by the Special Programme for Research and Training in Tropical Diseases (TDR) at the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari SR, 2003, ACTA TROP, V88, P1, DOI 10.1016/S0001-706X(03)00156-6; BERN C, 2006, INDIAN J MED RES, V23, P275; Bhattacharya SK, 2007, J INFECT DIS, V196, P591, DOI 10.1086/519690; Chappuis F, 2006, BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; *DIM RES, 2008, CONF INT PROP CALC; Joshi A., 2008, Journal of Vector Borne Diseases, V45, P105; JOSHI A, 2008, KALA AZAR STATUS SEA; Joshi A B, 2006, Kathmandu Univ Med J (KUMJ), V4, P488; Mondal D, 2008, HEALTH POLICY, V87, P369, DOI 10.1016/j.healthpol.2008.01.011; Rijal S, 2006, T ROY SOC TROP MED H, V100, P838, DOI 10.1016/j.trstmh.2005.09.017; SHARMA AD, 2006, TROP MED INT HEALTH, V11, pN57; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh SP, 2006, AM J TROP MED HYG, V75, P505, DOI 10.4269/ajtmh.2006.75.505; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Sundar S, 2007, TROP MED INT HEALTH, V12, P284, DOI 10.1111/j.1356-3156.2006.01775.x; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; Sundar S, 2005, B WORLD HEALTH ORGAN, V83, P394; Sundar S, 2002, ANN TROP MED PARASIT, V96, P19, DOI 10.1179/000349802125000466; SUNDAR S, 2006, INDIAN J MED RES, V9, P26; Sundar S, 2008, TROP MED INT HEALTH, V13, P2, DOI 10.1111/j.1365-3156.2007.01974.x; Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536; Sundar S, 2006, T ROY SOC TROP MED H, V100, pS26, DOI 10.1016/j.trstmh.2006.02.011; *WHO, 2007, 2 M KATHM NEP 20 OCT; *WHO, 2005, 1 M MAN HAR 20 23 DE; WHO, 2004, REG STRAT FRAM EL KA	26	70	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2009	3	1							e355	10.1371/journal.pntd.0000355				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	406NB	WOS:000263301100004	19159009	DOAJ Gold, Green Published			2019-04-02	
J	Matthys, F; Perez, MP; Diaz, SV; Silvera, EG; Diaz, TC; Perez, LA; Ochoa, EG; Van der Stuyft, P				Matthys, F.; Peralta Perez, M.; Valdes Diaz, S.; Garcia Silvera, E.; Crespo Diaz, T.; Armas Perez, L.; Gonzalez Ochoa, E.; Van der Stuyft, P.			Diagnostic validity of an expert tuberculosis commission that assists the diagnosis of bacteriologically negative suspected TB cases in Havana, Cuba	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Tuberculosis; Bacteriologically negative tuberculosis; Sputum; Diagnosis; Signs and symptoms; Cuba	ACID-FAST BACILLI; PULMONARY TUBERCULOSIS; MICROSCOPY; ELIMINATION; COUNTRIES	The Provincial Tuberculosis Commission of Havana, Cuba, a multi-speciality committee, assists clinicians in diagnosing bacteriologically negative tuberculosis (TB). At its weekly meetings, clinicians present the files of suspected TB cases for discussion, diagnosis and recommendations. This prospective study assessed the validity of the diagnoses made by the Commission by comparing the diagnoses made with diagnoses ascertained after one year of follow-up. Between October 2002 and December 2003, 126 patients suspected to have TB but who were bacteriologically negative completed diagnostic work at the Commission. Fifty-three (42%) were diagnosed as TB cases. The definite diagnosis of 116 patients (92%) was ascertained after one year of follow-up. Six patients diagnosed by the Commission as TB cases were suffering from other diseases, while one patient diagnosed with pneumonia had a definite diagnosis of pulmonary TB. The diagnostic sensitivity and specificity of the Commission were 98% (95% CI 93-100) and 92% (95% CI 85-98), respectively. The Provincial Tuberculosis Commission of Havana can be considered a valuable toot for the diagnosis of TB in patients suspected of TB but who are bacteriologically negative. A comparable approach, adapted to the local conditions, could prove useful in other epidemiological and healthcare settings. (c) 2008 Published by Elsevier Ltd on behalf of Royal Society of Tropical Medicine and Hygiene.	[Matthys, F.; Van der Stuyft, P.] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Peralta Perez, M.; Armas Perez, L.; Gonzalez Ochoa, E.] Pedro Kouri Inst Trop Med, Leprosy & ARI, Surveillance & Res Grp TB, Havana, Cuba; [Valdes Diaz, S.; Garcia Silvera, E.; Crespo Diaz, T.] Benef Jurid Hosp, Havana, Cuba	Ochoa, EG (reprint author), POB 601,Marianao 13, Havana, Cuba.	ochoa@ipk.sld.cu			Belgian Directorate for Development Cooperation [FA 11.5.13\3]	The research received partial financial support through an institutional collaboration agreement between IPK and ITM funded by the Belgian Directorate for Development Cooperation (nr. FA 11.5.13\3).	Addo KK, 2006, INT J TUBERC LUNG D, V10, P870; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Court JIS, 2003, REV SAUDE PUBL, V37, P326, DOI 10.1590/S0034-89102003000300010; FRIEDEN T, 2004, TOMANS TUBERCULOSIS, P35; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gonzalez E, 2007, INT J TUBERC LUNG D, V11, P405; Gonzalez E, 2000, Cad Saude Publica, V16, P687, DOI 10.1590/S0102-311X2000000300017; Greco S, 2006, THORAX, V61, P783, DOI 10.1136/thx.2005.054908; LEVY H, 1989, CHEST, V95, P1193, DOI 10.1378/chest.95.6.1193; Long R, 2001, CHEST, V120, P330, DOI 10.1378/chest.120.2.330; Marrero A, 2000, THORAX, V55, P39, DOI 10.1136/thorax.55.1.39; *MIN SAL PUBL DIR, 1995, ACT PROGR NAC CONTR; *MIN SAL PUBL DIR, 1999, PROGR NAC TUB MAN NO; Montoro E, 2006, TUBERCULOSIS, V86, P319, DOI 10.1016/j.tube.2006.01.013; *PAHO, 2002, HLTH AM, V1, P198; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Sevy Court José I., 2004, Rev Cubana Med Trop, V56, P234; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Van Deun A, 1999, INT J TUBERC LUNG D, V3, P823; *WHO, 2003, WHOGDCTB20033; *WHO, 2006, WHOHTMTB2006362	22	2	5	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JAN	2009	103	1					52	58		10.1016/j.trstmh.2008.07.021				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	386YO	WOS:000261918700010	18814892				2019-04-02	
J	Sieleunou, I; Souleymanou, M; Schonenberger, AM; Menten, J; Boelaert, M				Sieleunou, Isidore; Souleymanou, Mohamadou; Schoenenberger, Anne-Marie; Menten, Joris; Boelaert, Marleen			Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						antiretroviral therapy; Africa; HIV/AIDS; treatment; survival analysis	FIXED-DOSE COMBINATION; RESOURCE-POOR SETTINGS; HIV-INFECTED PATIENTS; SOUTH-AFRICA; HIV-1-INFECTED PATIENTS; PROSPECTIVE COHORT; INCOME COUNTRIES; DRUG-RESISTANCE; EARLY MORTALITY; PILOT PROJECT	To analyse the outcomes of antiretroviral therapy (ART) in routine conditions in a rural hospital in the Far-North province of Cameroon. Retrospective cohort study of 1187 patients > 15 years who started ART between July 2001 and December 2006. The survival time was estimated by Kaplan-Meier analysis and Cox proportional hazard models were fitted to explain survival. Upon enrolment, 90.4% patients were in WHO stage III or IV and 56.1% had a BMI < 18.5. Median CD4 count was 105 cells/mm(3) (IQR 40-173). At the end of the study period, 338/1187 had died and 59/1187 were lost to follow-up. The survival probability was 77% at 1 year [95% CI: 75-80] and 47% at 5 years [95% CI: 40-55]. The median survival time was 58 months. CD4 count, haemoglobin, BMI, sex and clinical stage at enrolment were independent predictors of mortality. This study confirms the clinical benefit of ART programs in a remote and resource-constrained setting operating in routine conditions. The challenge ahead is to secure earlier access to ART and to maintain its longer-term benefit.	[Boelaert, Marleen] Inst Trop Med, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Sieleunou, Isidore] Approved Treatment Ctr HIV AIDS, Maroua, Cameroon; [Souleymanou, Mohamadou; Schoenenberger, Anne-Marie] Dist Hosp, Pette, Cameroon	Boelaert, M (reprint author), Inst Trop Med, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium.	mboelaert@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776			Akileswaran C, 2005, CLIN INFECT DIS, V41, P376, DOI 10.1086/431482; Bekker LG, 2003, SAMJ S AFR MED J, V93, P458; Bourgeois A, 2005, ANTIVIR THER, V10, P335; Braitstein P, 2006, LANCET, V367, P817; Coetzee D, 2004, AIDS, V18, P887, DOI [10.1097/01.aids.0000125925.87797.38, 10.1097/00002030-200406003-00006]; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/01.aids.0000131322.13515.e2; Crane JT, 2006, AIDS BEHAV, V10, P437, DOI 10.1007/s10461-006-9080-z; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Dabis F, 2005, INT J EPIDEMIOL, V34, P979, DOI 10.1093/ije/dyi164; Djomand G, 2003, AIDS, V17, pS5, DOI 10.1097/00002030-200317003-00002; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 2007, 14 C RETR OPP INF 25; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kabugo C, 2005, JAIDS-J ACQ IMM DEF, V38, P578, DOI 10.1097/01.qai.0000134742.26338.2f; Kremer H, 2003, EUR J MED RES, V8, P8; Laniece I, 2003, AIDS, V17, pS103, DOI 10.1097/00002030-200317003-00014; Laurent C, 2006, EMERG INFECT DIS, V12, P1001, DOI 10.3201/eid1206.050860; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Laurent C, 2004, LANCET, V364, P29, DOI 10.1016/S0140-6736(04)16586-0; Laurent C, 2005, CLIN INFECT DIS, V41, P108, DOI 10.1086/430712; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Laurent C, 2007, AIDS, V21, P768, DOI 10.1097/QAD.0b013e328045c4d7; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Mannheimer K, 2006, COMP LITERATURE STUD, V43, P1, DOI 10.1353/cls.2006.0036; Moore AL, 2002, J ACQ IMMUN DEF SYND, V29, P197; MOSOKO JJ, 2005, ENQUETE DEMOGRAPHIQU, P293; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; *OMS ONUSIDA, 2006, EL ACC TRAIT ANT MON; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Perez-Hoyos S, 2003, AIDS, V17, P353, DOI 10.1097/01.aids.0000050782.28043.77; Robbins GK, 2007, JAIDS-J ACQ IMM DEF, V44, P30, DOI 10.1097/01.qai.0000248351.10383.b7; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; SCHNEIDER M, 2004, HQ03463871 UNAIDS; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Stevens G, 2005, J CLIN MICROBIOL, V43, P857, DOI 10.1128/JCM.43.2.857-861.2005; Tassie JM, 2003, AIDS, V17, P1995, DOI 10.1097/01.aids.0000088165.01779.77; Van Vaerenbergh K, 2002, AIDS RES HUM RETROV, V18, P419, DOI 10.1089/088922202753614182; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2006, UN ACC 2010 WHO WORK; *WHO, 2003, SCAL ANT THER RES LT; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	49	52	58	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2009	14	1					36	43		10.1111/j.1365-3156.2008.02183.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	395IN	WOS:000262517900006	19017309	Bronze			2019-04-02	
J	Thera, MA; Doumbo, OK; Coulibaly, D; Laurens, MB; Kone, AK; Guindo, AB; Diallo, DA; Traore, K; Diarra, I; Niangaly, A; Dolo, A; Daou, M; Sissoko, M; Sissoko, MS; Kouriba, B; Traore, D; Lyke, KE; Takala, SL; Godeaux, O; Diggs, C; Dutta, S; Stewart, VA; House, B; Heppner, DG; Plowe, CV; Cohen, J; Ballou, WR; Thonnard, J; Dubois, MC; Soisson, L; Ware, LA; Lanar, DE				Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Laurens, Matthew B.; Kone, Abdoulaye K.; Guindo, Ando B.; Diallo, Dapa A.; Traore, Karim; Diarra, Issa; Niangaly, Amadou; Dolo, Amagana; Daou, Modibo; Sissoko, Mady; Sissoko, Mahamadou S.; Kouriba, Bourema; Traore, Drissa; Lyke, Kirsten E.; Takala, Shannon L.; Godeaux, Olivier; Diggs, Carter; Dutta, Sheetij; Stewart, V. Ann; House, Brent; Heppner, D. Gray; Plowe, Christopher V.; Cohen, Joe; Ballou, W. Ripley; Thonnard, Joelle; Dubois, Marie-Claude; Soisson, Lorraine; Ware, Lisa A.; Lanar, David E.			RANDOMIZED, CONTROLLED, PHASE 2B CLINICAL TRIAL TO EVALUATE THE SAFETY, IMMUNOGENICITY AND EFFICACY OF WALTER REED ARMY INSTITUTE OF RESEARCH'S AMA-1 MALARIA VACCINE (FMP2.1) ADJUVANTED IN GSK BIOLOGICALS' AS02 VS. RABIES VACCINE IN 1-6 YEAR OLD CHILDREN IN BANDIAGARA, MALI	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Kone, Abdoulaye K.; Guindo, Ando B.; Diallo, Dapa A.; Traore, Karim; Diarra, Issa; Niangaly, Amadou; Dolo, Amagana; Daou, Modibo; Sissoko, Mady; Sissoko, Mahamadou S.; Kouriba, Bourema; Traore, Drissa] Univ Bamako, Fac Med, Bamako, Mali; [Laurens, Matthew B.; Lyke, Kirsten E.; Takala, Shannon L.; Plowe, Christopher V.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Godeaux, Olivier; Cohen, Joe; Ballou, W. Ripley; Dubois, Marie-Claude] GlaxoSmithKline Biol, Rixensart, Belgium; [Diggs, Carter] US Agcy Int Dev, Washington, DC 20523 USA; [Dutta, Sheetij; Stewart, V. Ann; House, Brent; Heppner, D. Gray; Ware, Lisa A.; Lanar, David E.] Walter Reed Army Inst Res, Silver Spring, MD USA			Lanar, David/B-3560-2011					0	0	0	0	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				25	8	8						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600026					2019-04-02	
J	Abdulla, S; Oberholzer, R; Juma, O; Leach, A; Vekemans, J; Lievens, M; Kuboja, S; Salim, N; Carter, T; Demoitie, MA; Dubois, MC; Jumanne, A; Machel, F; Membi, C; Shomari, M; Aebi, T; Mshinda, H; Villafana, T; Cohen, J; Ballou, WR; Tanner, M				Abdulla, Salim; Oberholzer, R.; Juma, O.; Leach, A.; Vekemans, J.; Lievens, M.; Kuboja, S.; Salim, N.; Carter, T.; Demoitie, M. A.; Dubois, M. C.; Jumanne, A.; Machel, F.; Membi, C.; Shomari, M.; Aebi, T.; Mshinda, H.; Villafana, T.; Cohen, J.; Ballou, W. R.; Tanner, M.			PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE SAFETY, IMMUNOGENICITY AND EFFICACY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS02 WHEN ADMINISTERED ACCORDING TO THE EXPANDED PROGRAM ON IMMUNIZATION SCHEDULE	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Abdulla, Salim; Juma, O.; Kuboja, S.; Salim, N.; Jumanne, A.; Machel, F.; Membi, C.; Shomari, M.; Mshinda, H.] Ifakara Hlth Res & Dev Ctr, Bagamoyo Res & Training Ctr, Dar Es Salaam, Tanzania; [Oberholzer, R.; Aebi, T.; Tanner, M.] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Leach, A.; Vekemans, J.; Lievens, M.; Demoitie, M. A.; Dubois, M. C.; Cohen, J.; Ballou, W. R.] GlaxoSmithKline Biol, Rixensart, Belgium; [Carter, T.; Villafana, T.] PATH Malaria Vaccine Initiat, Bethesda, MD USA								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				27	9	9						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600028					2019-04-02	
J	Bejon, P; Lusingu, J; Olotu, A; Leach, A; Lievens, M; Vekemans, J; Msham, S; Lang, T; Gould, J; Dubois, MC; Demoitie, MA; Vansadia, P; Carter, T; Njuguna, P; Kawuondo, K; Gesase, S; Drakeley, C; Savarese, B; Villafana, T; Ballou, WR; Cohen, J; Riley, E; Lemnge, M; Marsh, K; von Seidlein, L				Bejon, P.; Lusingu, J.; Olotu, Ally; Leach, A.; Lievens, M.; Vekemans, J.; Msham, S.; Lang, T.; Gould, J.; Dubois, M. C.; Demoitie, M. A.; Vansadia, P.; Carter, T.; Njuguna, P.; Kawuondo, K.; Gesase, S.; Drakeley, C.; Savarese, B.; Villafana, T.; Ballou, W. R.; Cohen, J.; Riley, E.; Lemnge, M.; Marsh, K.; von Seidlein, L.			PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Bejon, P.; Olotu, Ally; Msham, S.; Lang, T.; Njuguna, P.; Kawuondo, K.; Marsh, K.] KEMRI Wellcome Collaborat Res Programme, Kilifi, Kenya; [Lusingu, J.; Gould, J.; Gesase, S.; Lemnge, M.; von Seidlein, L.] Joint Malaria Project, Korogwe, Tanzania; [Leach, A.; Lievens, M.; Vekemans, J.; Dubois, M. C.; Demoitie, M. A.; Ballou, W. R.; Cohen, J.] GlaxoSmithKline Biol, Rixensart, Belgium; [Vansadia, P.; Carter, T.; Savarese, B.; Villafana, T.] PATH Malaria Vaccine Initiat, Bethesda, MD USA; [Drakeley, C.; Riley, E.] London Sch Hyg & Trop Med, London WC1, England								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				26	9	9						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600027					2019-04-02	
J	Owusu-Agyei, S; Ansong, D; Asante, KP; Owusu-Kwarteng, S; Owusu, R; Brobby, NAW; Dosoo, D; Akoto, AYO; Osei-Kwakye, K; Adjei, EA; Boahen, KO; Sylverken, J; Adjei, G; Sambian, D; Vekemans, J; Ofori-Anyinam, O; Lievens, M; Demoitie, M; Cohen, J; Ballou, WR; Savarese, B; Greenwood, B; Bawa, T; Evans, J; Agbenyega, T				Owusu-Agyei, Seth; Ansong, D.; Asante, K. P.; Owusu-Kwarteng, S.; Owusu, R.; Brobby, N. A. Wireko; Dosoo, D.; Akoto, A. Y. Osei; Osei-Kwakye, K.; Adjei, E. Asafo; Boahen, K. Owusu; Sylverken, J.; Adjei, G.; Sambian, D.; Vekemans, J.; Ofori-Anyinam, O.; Lievens, M.; Demoitie, M.; Cohen, J.; Ballou, W. R.; Savarese, B.; Greenwood, B.; Bawa, T.; Evans, J.; Agbenyega, T.			PHASE II, RANDOMIZED TRIAL TO ASSESS THE SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINES RTS,S/AS02 AND RTS,S/AS01 WHEN GIVEN ACCORDING TO DIFFERENT VACCINATION SCHEDULES IN CHILDREN IN GHANA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Owusu-Agyei, Seth; Asante, K. P.; Owusu, R.; Dosoo, D.; Osei-Kwakye, K.; Boahen, K. Owusu; Adjei, G.] Kintampo Hlth Res Ctr, Kintampo WC1, Ghana; [Ansong, D.; Owusu-Kwarteng, S.; Brobby, N. A. Wireko; Akoto, A. Y. Osei; Adjei, E. Asafo; Sylverken, J.; Sambian, D.; Agbenyega, T.] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Vekemans, J.; Ofori-Anyinam, O.; Lievens, M.; Demoitie, M.; Cohen, J.; Ballou, W. R.] GlaxoSmithKline Biol, Rixensart, Belgium; [Savarese, B.] PATH Malaria Vaccine Initiat, Bethesda, MD USA; [Greenwood, B.] London Sch Hyg & Trop Med, London, England; [Bawa, T.; Evans, J.] Kumasi Ctr Collaborat Res, Kumasi, Ghana								0	0	0	0	5	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				28	9	9						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600029					2019-04-02	
J	Carabin, H; Millogo, A; Hounton, S; Praet, N; Cowan, LD; Nitiema, P; Dorny, P; Tarnagda, Z; Ganaba, R				Carabin, Helene; Millogo, Athanase; Hounton, Sennen; Praet, Nicolas; Cowan, Linda D.; Nitiema, Pascal; Dorny, Pierre; Tarnagda, Zekiba; Ganaba, Rasmane			PREVALENCE OF EPILEPSY, CYSTICERCOSIS AND NEUROCYSTICERCOSIS IN BURKINA FASO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Carabin, Helene; Cowan, Linda D.; Nitiema, Pascal] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Millogo, Athanase] Ctr Univ Hosp Souro Sanous, Bobo Dioulasso, Burkina Faso; [Hounton, Sennen] W Africa Field Epidemiol & Lab Training Program, Ouagadougou, Burkina Faso; [Praet, Nicolas; Dorny, Pierre] Inst Trop Med, B-2000 Antwerp, Belgium; [Tarnagda, Zekiba] IRSS, Bobo Dioulasso, Burkina Faso; [Ganaba, Rasmane] GREFSaD, Bobo Dioulasso, Burkina Faso			Carabin, Helene/B-7600-2016					0	0	0	0	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				41	13	13						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600042					2019-04-02	
J	Achan, JW; Kyabayinze, D; Adoke, Y; Kamya, M; Mangeni, FW; D'Alessandro, U; Tibenderana, J; Talisuna, AO				Achan, Jane W.; Kyabayinze, Daniel; Adoke, Yeka; Kamya, Moses; Mangeni, Fred W.; D'Alessandro, Umberto; Tibenderana, James; Talisuna, Ambrose O.			EFFECTIVENESS OF ORAL QUININE AND ARTEMETHER-LUMEFANTRINE IN THE TREATMENT OF UNCOMPLICATED FALCIPARUM MALARIA IN UGANDAN CHILDREN: A RANDOMIZED TRIAL	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Achan, Jane W.; Kamya, Moses; Mangeni, Fred W.] Makerere Univ, Kampala, Uganda; [Kyabayinze, Daniel; Tibenderana, James] Malaria Consortium, Kampala, Uganda; [Adoke, Yeka; Talisuna, Ambrose O.] Ugnada Malaria Surveillance Project, Kampala, Uganda; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				177	53	53						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600178					2019-04-02	
J	Huyse, T; Maes, GE; Geldof, S; Vereecken, K; Djibril, D; Rollinson, D; Webster, BL; Polman, K				Huyse, Tine; Maes, Gregory E.; Geldof, Sarah; Vereecken, Kim; Djibril, Djibril; Rollinson, David; Webster, Bonnie L.; Polman, Katja			HIGH GENETIC DIVERSITY IN SCHISTOSOMA MANSONI IN THE SENEGAL RIVER BASIN, A POPULATION GENETIC ANALYSIS 20 YEARS AFTER THE EPIDEMIC OUTBREAK	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Huyse, Tine; Vereecken, Kim; Djibril, Djibril; Polman, Katja] Inst Trop Med, B-2000 Antwerp, Belgium; [Maes, Gregory E.; Geldof, Sarah] Katholieke Univ Leuven, Leuven, Belgium; [Rollinson, David; Webster, Bonnie L.] Nat Hist Museum, London SW7 5BD, England			Maes, Gregory/C-5450-2008; Rollinson, David/C-7406-2009	Maes, Gregory/0000-0002-1531-7321; 				0	1	1	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				296	86	87						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600297					2019-04-02	
J	Van Eijk, E; Van Geertruyden, JP; Yosaatmadja, F; Kasongo, W; Mulenga, M; D'Alessandro, U; Rogerson, S				Van Eijk, Erica; Van Geertruyden, Jean-Pierre; Yosaatmadja, Francisca; Kasongo, Webster; Mulenga, Modest; D'Alessandro, Umberto; Rogerson, Stephen			IMPACT OF HIV-1 ON HUMORAL IMMUNITY TO PLASMODIUM FALCIPARUM MALARIA IN NON-PREGNANT ADULTS WITH UNCOMPLICATED MALARIA IN ZAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Van Eijk, Erica] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto] Prince Leopold Inst Trop Geneeskunde, Antwerp, Belgium; [Yosaatmadja, Francisca; Rogerson, Stephen] Univ Melbourne, Melbourne, Vic, Australia; [Kasongo, Webster; Mulenga, Modest] Trop Dis Res Ctr, Ndola, Zambia			Van geertruyden, Jean-Pierre/K-6425-2014; D'Alessandro, Umberto/D-3457-2015	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				323	94	95						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600323					2019-04-02	
J	de Vlas, SJ; Sow, S; Vereecken, K; Vercruysse, J; Gryseels, B; Polman, K				de Vlas, Sake J.; Sow, Seydou; Vereecken, Kim; Vercruysse, Jozef; Gryseels, Bruno; Polman, Katja			THE ROLE OF HYGIENIC BATHING AFTER DEFECATION IN THE TRANSMISSION OF SCHISTOSOMA MANSONI	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[de Vlas, Sake J.] Erasmus MC, Rotterdam, Netherlands; [Sow, Seydou] Reg Med St Louis, St Louis, Senegal; [Vereecken, Kim; Gryseels, Bruno; Polman, Katja] Inst Trop Med, B-2000 Antwerp, Belgium; [Vercruysse, Jozef] Univ Ghent, Fac Vet Med, B-9000 Ghent, Belgium								0	0	0	0	5	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				360	106	106						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600360					2019-04-02	
J	van den Eede, P; Van Der Auwera, G; Erhart, A; Van Overmeir, C; Ann, J; D'Alessandro, U				Van den Eede, Peter; Van Der Auwera, Gert; Erhart, Annette; Van Overmeir, Chantal; Ann, Jozef; D'Alessandro, Umberto			PLASMODIUM VIVAX POPULATION GENETICS IN PERU AND VIETNAM: A COMPARATIVE STUDY USING MICROSATELLITES MARKERS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Van den Eede, Peter; Van Der Auwera, Gert; Erhart, Annette; Van Overmeir, Chantal; D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [Ann, Jozef] Catholic Univ Louvain, B-3000 Louvain, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				409	121	121						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600409					2019-04-02	
J	Priotto, G; Kasparian, S; Ngouama, D; Ghorashian, S; Arnold, U; Ghabri, S; Baudin, E; Buard, V; Kazadi-Kyanza, S; Kande, V; Mutombo, W; Llunga, M; Mutangala, W; Schmid, C; Torreele, E; Karunakara, U				Priotto, Gerardo; Kasparian, Serena; Ngouama, Daniel; Ghorashian, Sara; Arnold, Ute; Ghabri, Salah; Baudin, Elisabeth; Buard, Vincent; Kazadi-Kyanza, Serge; Kande, Victor; Mutombo, Wilfried; Llunga, Medard; Mutangala, Willy; Schmid, Caecilia; Torreele, Els; Karunakara, Unni			MULTICENTER CLINICAL TRIAL OF NIFURTIMOX-EFLORNITHINE COMBINATION THERAPY FOR SECOND-STAGE SLEEPING SICKNESS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Priotto, Gerardo; Kasparian, Serena; Ghabri, Salah; Baudin, Elisabeth] Epicentre, Paris, France; [Ngouama, Daniel] Minist Hlth, Nkayi, Rep Congo; [Ghorashian, Sara; Arnold, Ute; Karunakara, Unni] Med Sans Frontieres, Amsterdam, Netherlands; [Buard, Vincent; Kazadi-Kyanza, Serge] Med Sans Frontieres, Brussels, Belgium; [Kande, Victor] Minist Hlth, Kinshasa, DEM REP CONGO; [Mutombo, Wilfried; Llunga, Medard] Minist Hlth, Mbuji Mayi, DEM REP CONGO; [Mutangala, Willy] Minist Hlth, Katanda, DEM REP CONGO; [Schmid, Caecilia] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Torreele, Els] Drugs Neglected Dis Initiat, Geneva, Switzerland								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6		S		424	126	126						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600424					2019-04-02	
J	Bohorquez, EB; Juliano, JJ; Buscher, P; Brun, R; Meshnick, SR				Bohorquez, Elaine B.; Juliano, Jonathan J.; Buescher, Philippe; Brun, Reto; Meshnick, Steven R.			REAL-TIME PCR ASSAY FOR TRYPANOSOMA BRUCEI DETECTION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Bohorquez, Elaine B.; Juliano, Jonathan J.; Meshnick, Steven R.] Univ N Carolina, Chapel Hill, NC USA; [Buescher, Philippe] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Brun, Reto] Swiss Trop Inst, CH-4002 Basel, Switzerland			Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				539	159	159						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600538					2019-04-02	
J	Nahum, AM; Erhart, A; Ahounou, D; van Overmeir, C; Menten, J; Akogbeto, M; Coosemans, M; Massougbodji, A; D'Alessandro, U				Nahum, Alain M.; Erhart, Annette; Ahounou, Daniel; van Overmeir, Chantal; Menten, Joris; Akogbeto, Martin; Coosemans, Marc; Massougbodji, Achille; D'Alessandro, Umberto			EXTENDED HIGH EFFICACY (90 DAYS FOLLOW UP) OF THE COMBINATION SULPHADOXINE-PYRIMETHAMINE WITH ARTESUNATE IN CHILDREN WITH UNCOMPLICATED FALCIPARUM MALARIA ON THE BENIN COAST, WEST AFRICA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Nahum, Alain M.; Ahounou, Daniel; Akogbeto, Martin] Ctr Rech Entomol Cotonou, Cotonou, Benin; [Erhart, Annette; van Overmeir, Chantal; Menten, Joris; Coosemans, Marc; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Massougbodji, Achille] Univ Natl Benin, Lab Parasitol, Fac Sci Sante, Cotonou, Benin			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				567	167	167						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600566					2019-04-02	
J	Bukirwa, H; Mwebaza, N; Nayiga, S; Hopkins, H; D'Alessandro, U; Talisuna, AO; Staedke, SG				Bukirwa, Hasifa; Mwebaza, Norah; Nayiga, Susan; Hopkins, Heidi; D'Alessandro, Umberto; Talisuna, Ambrose O.; Staedke, Sarah G.			PHARMACOVIGILANCE AND ANTIMALARIAL TREATMENT IN UGANDA: A PILOT SYSTEM OF ENHANCED PASSIVE SURVEILLANCE	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Bukirwa, Hasifa; Nayiga, Susan] Uganda Malaria Surveillance Project, Kampala, Uganda; [Mwebaza, Norah] Makerere Univ, Kampala, Uganda; [Hopkins, Heidi] Univ Calif San Francisco, San Francisco, CA 94143 USA; [D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Talisuna, Ambrose O.] Minist Hlth, Kampala, Uganda; [Staedke, Sarah G.] London Sch Hyg & Trop Med, London WC1, England			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				576	170	170						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600575					2019-04-02	
J	Gies, S; Coulibaly, SO; Ouattara, FT; Ky, C; Brabin, BJ; D'Alessandro, U				Gies, Sabine; Coulibaly, Sheick O.; Ouattara, Florence T.; Ky, Clotilde; Brabin, Bernard J.; D'Alessandro, Umberto			A COMMUNITY EFFECTIVENESS TRIAL ON STRATEGIES PROMOTING INTERMITTENT PREVENTIVE ANTIMALARIAL TREATMENT IN PREGNANT WOMEN IN RURAL BURKINA FASO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Gies, Sabine; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Coulibaly, Sheick O.] Univ Ouagadougou, UFR Sci Sante, Ouagadougou, Burkina Faso; [Ouattara, Florence T.] Dist Sanitaire Boromo, Boromo, Burkina Faso; [Ky, Clotilde] Lab Natl Sante Publ, Ouagadougou, Burkina Faso; [Brabin, Bernard J.] Child & Reproduct Hlth Grp, Liverpool, Merseyside, England			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6		S		605	179	179						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600604					2019-04-02	
J	Gies, S; Coulibaly, SO; Ky, C; Ouattara, FT; Brabin, BJ; D'Alessandro, U				Gies, Sabine; Coulibaly, Sheick O.; Ky, Clotilde; Ouattara, Florence T.; Brabin, Bernard J.; D'Alessandro, Umberto			IMPROVING UPTAKE OF INTERMITTENT PREVENTIVE ANTIMALARIAL TREATMENT IN ANTENATAL CLINICS THROUGH COMMUNITY BASED PROMOTION IN RURAL BURKINA FASO: A HEALTH CENTRE RANDOMIZED TRIAL	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Gies, Sabine; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Coulibaly, Sheick O.] Univ Ouagadougou, UFR Sci Sante, Ouagadougou, Burkina Faso; [Ky, Clotilde] Lab Natl Sante Publ, Ouagadougou, Burkina Faso; [Ouattara, Florence T.] Dist Sanitaire Boromo, Boromo, Burkina Faso; [Brabin, Bernard J.] Child & Reprod Hlth Grp, Liverpool, Merseyside, England			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6		S		606	179	179						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600605					2019-04-02	
J	Peeters, K; Gies, S; Coulibaly, SO; Ky, C; D'Alessandro, U				Peeters, Koen; Gies, S.; Coulibaly, S. O.; Ky, C.; D'Alessandro, U.			BOTTLENECKS FOR HIGH COVERAGE OF INTERMITTENT PREVENTIVE TREATMENT IN PREGNANCY IN A RURAL AREA IN BURKINA FASO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Peeters, Koen; Gies, S.; Coulibaly, S. O.; Ky, C.; D'Alessandro, U.] ITM, Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				619	183	183						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644600618					2019-04-02	
J	McGrath, S; Cummings, J; Kortepeter, M; Nielsen, R; Tierney, E; Ware, L; Ofori-Anyinam, O; Dutta, S; Lanar, D; Sedegah, M; Kester, K; Malkin, E; Diggs, C; Soisson, L; Dubois, MC; Ballou, R; Cohen, J; Krzych, U; Ockenhouse, C; Heppner, G; Spring, M				McGrath, Shannon; Cummings, James; Kortepeter, Mark; Nielsen, Robin; Tierney, Ev; Ware, Lisa; Ofori-Anyinam, Opokua; Dutta, Sheetij; Lanar, David; Sedegah, Martha; Kester, Kent; Malkin, Elissa; Diggs, Carter; Soisson, Lorraine; Dubois, Marie-Claude; Ballou, Ripley; Cohen, Joe; Krzych, Urszula; Ockenhouse, Chris; Heppner, Gray; Spring, Michele			MULTI-FUNCTIONAL T-CELL RESPONSES INDUCED BY THE AS01 OR AS02 ADJUVANTED MALARIA VACCINE CANDIDATE APICAL MEMBRANE ANTIGEN-1 (AMA-1) ADMINISTERED TO MALARIA-NAIVE ADULTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[McGrath, Shannon; Cummings, James; Nielsen, Robin; Ware, Lisa; Dutta, Sheetij; Lanar, David; Sedegah, Martha; Krzych, Urszula; Ockenhouse, Chris; Heppner, Gray; Spring, Michele] US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Kortepeter, Mark] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Tierney, Ev; Malkin, Elissa] PATH Malaria Vaccine Initiat, Bethesda, MD USA; [Ofori-Anyinam, Opokua; Dubois, Marie-Claude; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Kester, Kent] Walter Reed Army Inst Res, Silver Spring, MD USA; [Diggs, Carter; Soisson, Lorraine] US Agcy Int Dev, Washington, DC 20523 USA; [Ballou, Ripley] Bill & Melinda Gates Fdn, Seattle, WA USA			Lanar, David/B-3560-2011; Kester, Kent/A-2114-2011	Kester, Kent/0000-0002-5056-0802				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				646	191	191						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601011					2019-04-02	
J	Spring, M; Bergmann-Leitner, E; James, C; House, B; Krzych, U; Tosh, D; Miller, L; Ware, L; Godeaux, O; Dubois, MC; Lyons, J; Ballou, R; Soisson, L; Diggs, C; Cohen, J; Heppner, G; Ockenhouse, C; Angov, E				Spring, Michele; Bergmann-Leitner, Elke; James, Cummings; House, Brent; Krzych, Urszula; Tosh, Donna; Miller, Lori; Ware, Lisa; Godeaux, Olivier; Dubois, Marie-Claude; Lyons, Jeffrey; Ballou, Ripley; Soisson, Lorraine; Diggs, Carter; Cohen, Joe; Heppner, Gray; Ockenhouse, Chris; Angov, Evelina			PHASE 1A OPEN-LABEL DOSE ESCALATION STUDY TO EVALUATE THE SAFETY, REACTOGENICITY, AND IMMUNOGENICITY OF THE CANDIDATE PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEIN-1 (MSP-1(42)) ADMINISTERED INTRAMUSCULARLY WITH GSK BIOLOGICALS' ADJUVANT SYSTEM AS01B IN HEALTHY MALARIA-NAIVE ADULTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Spring, Michele; Bergmann-Leitner, Elke; James, Cummings; House, Brent; Krzych, Urszula; Tosh, Donna; Ware, Lisa; Heppner, Gray; Ockenhouse, Chris; Angov, Evelina] US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Miller, Lori; Lyons, Jeffrey] Walter Reed Army Inst Res, Silver Spring, MD USA; [Godeaux, Olivier; Dubois, Marie-Claude; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Ballou, Ripley] Bill & Melinda Gates Fdn, Seattle, WA USA; [Soisson, Lorraine; Diggs, Carter] US Agcy Int Dev, Washington, DC 20523 USA			Bergmann-Leitner, Elke/B-3548-2011	Bergmann-Leitner, Elke/0000-0002-8571-8956				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6		S		647	191	192						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601012					2019-04-02	
J	Van Doren, W; Ngamije, D; Karema, CK; Nyitegeka, F; Ahoranayezu, JB; Van Geertruyden, JP				Van Doren, Waltruda; Ngamije, Daniel; Karema, Corine K.; Nyitegeka, Francois; Ahoranayezu, Jean B.; Van Geertruyden, Jean-Pierre			THE IMPACT OF HOME BASED MANAGEMENT OF MALARIA (HMM) ON UNDER FIVE MALARIA MORTALITY: THE RWANDAN EXPERIENCE	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Van Doren, Waltruda] Belgian Tech Cooperat, Malaria Control Programme Rwanda, Kigali, Rwanda; [Ngamije, Daniel; Karema, Corine K.; Nyitegeka, Francois] Natl Malaria Control Programme Rwanda, Kigali, Rwanda; [Ahoranayezu, Jean B.] WHO, Kigali, Rwanda; [Van Geertruyden, Jean-Pierre] Prince Leopold Inst Trop Geneeskunde, Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				791	233	233						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601156					2019-04-02	
J	Gies, S; Coulibaly, SO; Ouattara, FT; D'Alessandro, U				Gies, Sabine; Coulibaly, Sheick O.; Ouattara, Florence T.; D'Alessandro, Umberto			EFFICACY OF INTERMITTENT PREVENTIVE TREATMENT WITH SULFADOXINE-PYRIMETHAMINE IN PRIMI- AND SECUNDIGRAVIDAE IN RURAL BURKINA FASO: IMPACT ON PARASITAEMIA, ANAEMIA AND BIRTH WEIGHT	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Gies, Sabine; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Coulibaly, Sheick O.] Univ Ouagadougou, UFR Sci Sante, Ouagadougou, Burkina Faso; [Ouattara, Florence T.] Dist Sanitaire Boromo, Boromo, Burkina Faso			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				821	242	243						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601186					2019-04-02	
J	Chalwe, V; Van Geertruyden, JP; Mutale, F; Mukwamataba, D; Menten, J; Kamalamba, J; Mulenga, M; D'Alessandro, U				Chalwe, Victor; Van Geertruyden, Jean-Pierre; Mutale, Felix; Mukwamataba, Doreen; Menten, Joris; Kamalamba, John; Mulenga, Modest; D'Alessandro, Umberto			HIV-1 INFECTION INCREASES THE RISK OF SEVERE MALARIA IN SEMI-IMMUNE ADULTS IN ZAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Chalwe, Victor; Mulenga, Modest] Trop Dis Res Ctr, Ndola, Zambia; [Van Geertruyden, Jean-Pierre; Menten, Joris; D'Alessandro, Umberto] Prince Leopold Inst Trop Geneeskunde, Antwerp, Belgium; [Mutale, Felix; Kamalamba, John] Thomson Hosp, Luanshya, Zambia; [Mukwamataba, Doreen] Trop Dis Res Ctr, Nola, Zambia			D'Alessandro, Umberto/D-3457-2015; Van geertruyden, Jean-Pierre/K-6425-2014	D'Alessandro, Umberto/0000-0001-6341-5009; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				823	243	243						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601188					2019-04-02	
J	Van Geertruyden, JP; Mulenga, M; Chalwe, V; Nambozi, M; Moerman, F; Mukwamataba, D; D'Alessandro, U				Van Geertruyden, Jean-Pierre; Mulenga, Modest; Chalwe, Victor; Nambozi, Michael; Moerman, Filip; Mukwamataba, Doreen; D'Alessandro, Umberto			IMPACT OF HIV-1 INFECTION ON THE HEMATOLOGICAL RECOVERY AFTER CLINICAL MALARIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Van Geertruyden, Jean-Pierre; Moerman, Filip; D'Alessandro, Umberto] Prince Leopold Inst Trop Geneeskunde, Antwerp, Belgium; [Mulenga, Modest; Chalwe, Victor; Nambozi, Michael; Mukwamataba, Doreen] Trop Dis Res Ctr, Ndola, Zambia			Van geertruyden, Jean-Pierre/K-6425-2014; D'Alessandro, Umberto/D-3457-2015	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				829	245	245						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601194					2019-04-02	
J	Van den Eede, P; Erhart, A; Van Overmeir, C; Anne, J; D'Alessondro, U				Van den Eede, Peter; Erhart, Annette; Van Overmeir, Chantal; Anne, Jozef; D'Alessondro, Umberto			MALARIA EPIDEMIOLOGY IN VIETNAM: LOW INTENSITY OF TRANSMISSION AND HIGHLY COMPLEX PARASITE POPULATION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Anne, Jozef] Catholic Univ Louvain, B-3000 Louvain, Belgium; [Van den Eede, Peter; Erhart, Annette; Van Overmeir, Chantal; D'Alessondro, Umberto] Inst Trop Med Antwerp, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				994	292	292						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601358					2019-04-02	
J	Thera, MA; Doumbo, OK; Coulibaly, D; Laurens, MB; Kone, AK; Guindo, AB; Diallo, DA; Traore, K; Diarra, I; Niangaly, A; Dolo, A; Daou, M; Sissoko, M; Sagara, I; Sissoko, MS; Kouriba, B; Lyke, KE; Takala, SL; Godeaux, O; Soisson, L; Lanar, DE; Dutta, S; House, B; Heppner, DG; Plowe, CV; Baby, M; Thonnard, J; Leach, A; Dubois, MC; Cohen, J; Ballou, WR; Diggs, C; Ware, LA; Cummings, JF; Stewart, VA				Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Laurens, Matthew B.; Kone, Abdoulaye K.; Guindo, Ando B.; Diallo, Dapa A.; Traore, Karim; Diarra, Issa; Niangaly, Amadou; Dolo, Amagana; Daou, Modibo; Sissoko, Mady; Sagara, Issaka; Sissoko, Mahamadou S.; Kouriba, Bourema; Lyke, Kirsten E.; Takala, Shannon L.; Godeaux, Olivier; Soisson, Lorraine; Lanar, David E.; Dutta, Sheetij; House, Brent; Heppner, D. Gray; Plowe, Christopher V.; Baby, Mounirou; Thonnard, Joelle; Leach, Amanda; Dubois, Marie-Claude; Cohen, Joe; Ballou, W. Ripley; Diggs, Carter; Ware, Lisa A.; Cummings, James F.; Stewart, V. Ann			RANDOMIZED, CONTROLLED, DOSE ESCALATION PHASE 1 CLINICAL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF WALTER REED ARMY INSTITUTE OF RESEARCH'S AMA-1 MALARIA VACCINE (FMP2.1) ADJUVANTED IN GSK BIOLOGICALS' AS02 VS. RABIES VACCINE IN 1-6 YEAR OLD CHILDREN IN BANDIAGARA, MALI	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Kone, Abdoulaye K.; Guindo, Ando B.; Diallo, Dapa A.; Traore, Karim; Diarra, Issa; Niangaly, Amadou; Dolo, Amagana; Daou, Modibo; Sissoko, Mady; Sagara, Issaka; Sissoko, Mahamadou S.; Kouriba, Bourema; Baby, Mounirou] Univ Bamako, Fac Med, Bamako, Mali; [Laurens, Matthew B.; Lyke, Kirsten E.; Takala, Shannon L.; Plowe, Christopher V.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Godeaux, Olivier; Leach, Amanda; Dubois, Marie-Claude; Cohen, Joe; Ballou, W. Ripley] GlaxoSmithKline Biol, Rixensart, Belgium; [Soisson, Lorraine; Diggs, Carter] US Agcy Int Dev, Washington, DC 20523 USA; [Lanar, David E.; Dutta, Sheetij; House, Brent; Heppner, D. Gray; Ware, Lisa A.; Cummings, James F.; Stewart, V. Ann] Walter Reed Army Inst Res, Silver Spring, MD USA			Lanar, David/B-3560-2011					0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				1036	304	305						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601400					2019-04-02	
J	Kilian, A; Nery, S; Casimiro, S; Cuamba, N; Pigeon, O; Gimnig, J				Kilian, Albert; Nery, Susana; Casimiro, Sonia; Cuamba, Nelson; Pigeon, Olivier; Gimnig, John			FIELD PERFORMANCE OF A WASH RESISTANT INSECTICIDE TREATMENT KIT FOR MOSQUITO NETS IN THREE DIFFERENT SETTINGS IN UGANDA AND MOZAMBIQUE	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Kilian, Albert] Malaria Consortium, Montagut, Spain; [Nery, Susana] Malaria Consortium, Maputo, Mozambique; [Casimiro, Sonia; Cuamba, Nelson] Natl Inst Hlth, Maputo, Mozambique; [Pigeon, Olivier] Ctr Wallon Rech Agron, Gembloux, Belgium; [Gimnig, John] Ctr Dis Control & Prevent, Atlanta, GA USA			Vaz Nery, Susana/P-4518-2014					0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				1052	309	309						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601416					2019-04-02	
J	Ngo, TD; Erhart, A; Le, HX; Le, TK; Xa, NX; Coosemans, M; D'Alessandro, U				Ngo, Thang D.; Erhart, Annette; Le, Hung X.; Le, Thuan K.; Xa, Nguyen X.; Coosemans, Marc; D'Alessandro, Umberto			LONG-LASTING INSECTICIDAL HAMMOCK NETS (LLIHN) FOR CONTROLLING FOREST MALARIA IN VIETNAM	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Ngo, Thang D.; Le, Hung X.; Le, Thuan K.; Xa, Nguyen X.] Natl Inst Malariol Parasitol & Entomoll, Hanoi, Vietnam; [Erhart, Annette; Coosemans, Marc; D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				1051	309	309						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601415					2019-04-02	
J	Woerdemann, M; Menten, J; Diaz, RJ; Heredia, LM; Espinosa, AR; Gryseels, B; Gorbea, MB; Polman, K				Woerdemann, Meike; Menten, Joris; Junco Diaz, Raquel; Menocal Heredia, Lenina; Ruiz Espinosa, Aniran; Gryseels, Bruno; Bonet Gorbea, Mariano; Polman, Katja			EFFECT OF DEWORMING AND INTESTINAL HELMINTH (RE)INFECTIONS ON ATOPY AND ATOPIC DISEASE: LONGITUDINAL ANTHELMINTHIC TREATMENT STUDIES IN CUBAN SCHOOLCHILDREN	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Woerdemann, Meike; Menten, Joris; Gryseels, Bruno; Polman, Katja] Inst Trop Med, B-2000 Antwerp, Belgium; [Junco Diaz, Raquel; Menocal Heredia, Lenina; Bonet Gorbea, Mariano] Natl Inst Hyg Epidemiol & Microbiol, Havana, Cuba; [Ruiz Espinosa, Aniran] Inst Pedro Kouri, Havana, Cuba								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6		S		1150	337	337						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601513					2019-04-02	
J	Cavalli, A; Polman, K; Pirard, M; Boelaert, M; Van Dormael, M				Cavalli, Anna; Polman, Katja; Pirard, Marjan; Boelaert, Marleen; Van Dormael, Monique			HOW DO MASS CAMPAIGNS AFFECT DISTRICT HEALTH SERVICES? THE CASE OF A NATIONAL CAMPAIGN FOR NEGLECTED TROPICAL DISEASES IN MALI	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Cavalli, Anna; Polman, Katja; Pirard, Marjan; Boelaert, Marleen; Van Dormael, Monique] Inst Trop Med, B-2000 Antwerp, Belgium			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				1180	346	346						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601543					2019-04-02	
J	Espinosa, D; Boggild, AK; Deborggraeve, S; Laurent, T; Valencia, C; Miranda-Verstegui, C; Llanos-Cuentas, A; Leclipteux, T; Dujardin, JC; Buscher, P; Arevalo, J				Espinosa, Diego; Boggild, Andrea K.; Deborggraeve, Stijn; Laurent, Thierry; Valencia, Cristian; Miranda-Verstegui, Cesar; Llanos-Cuentas, Alejandro; Leclipteux, Thierry; Dujardin, Jean-Claude; Buescher, Philippe; Arevalo, Jorge			DIAGNOSTIC ACCURACY OF LEISHMANIA OLIGOC-TEST FOR THE DIAGNOSIS OF CUTANEOUS LEISHMANIASIS IN PERU	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Espinosa, Diego; Valencia, Cristian; Miranda-Verstegui, Cesar; Llanos-Cuentas, Alejandro; Arevalo, Jorge] Univ Peruana Cayetano Heredia, Inst Med Trop Trop Alexander von Humboldt, Lima, Peru; [Boggild, Andrea K.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Deborggraeve, Stijn; Dujardin, Jean-Claude; Buescher, Philippe] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Laurent, Thierry; Leclipteux, Thierry] Coris BioConcept, Gembloux, Belgium			Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				1202	353	354						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601565					2019-04-02	
J	Freund, YR; Plattner, J; Abdulla, M; McKerrow, J; Bowling, T; Mercer, L; Nare, B; Wring, S; Jacobs, R; Yarlett, N; Bacchi, C; Maes, L; Don, R				Freund, Yvonne R.; Plattner, Jacob; Abdulla, Maha; McKerrow, James; Bowling, Tana; Mercer, Luke; Nare, Bakela; Wring, Steven; Jacobs, Robert; Yarlett, Nigel; Bacchi, Cyrus; Maes, Louis; Don, Robert			AN2920, A NOVEL OXABORALE, SHOWS IN VITRO AND IN VIVO ACTIVITY AGAINST TRYPANOSOMA BRUCEI	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Freund, Yvonne R.; Plattner, Jacob] Anacor Pharmaceut Inc, Palo Alto, CA USA; [Abdulla, Maha; McKerrow, James] Univ Calif San Francisco, Sandler Ctr, San Francisco, CA 94143 USA; [Bowling, Tana; Mercer, Luke; Nare, Bakela; Wring, Steven; Jacobs, Robert] Scynexis Inc, Res Triangle Pk, NC USA; [Yarlett, Nigel; Bacchi, Cyrus] Pace Univ, Haskins Lab, New York, NY 10038 USA; [Maes, Louis] Univ Antwerp, B-2020 Antwerp, Belgium; [Don, Robert] Drugs Neglected Dis Initiat, Geneva, Switzerland			Maes, Louis/A-2384-2017	Maes, Louis/0000-0002-2324-9509				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				1205	354	354						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601568					2019-04-02	
J	Bockstal, V; Guirnalda, P; Frenkel, D; Magez, S; Black, S				Bockstal, Viki; Guirnalda, Patrick; Frenkel, Deborah; Magez, Stefan; Black, Samuel			THE ROLE OF TNF AND MYD88 IN THE INDUCTION OF B CEL PATHOLOGY FOLLOWING TRYPANOSOMA BRUCEI INFECTION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	57th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	DEC 07-11, 2008	New Orleans, LA	Amer Soc Trop Med & Hyg					[Bockstal, Viki; Guirnalda, Patrick; Frenkel, Deborah; Black, Samuel] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Magez, Stefan] Vrije Univ Brussel VIB, Dept Mol & Cellular Recognit, B-1050 Brussels, Belgium			Magez, Stefan/D-9497-2014	Magez, Stefan/0000-0003-3760-7968				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2008	79	6				1240	364	365						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	382ZT	WOS:000261644601603					2019-04-02	
J	Montalvo, AM; Monzote, L; Fraga, J; Montano, I; Muskus, C; Marin, M; de Doncker, S; Velez, ID; Dujardin, JC				Margarita Montalvo, Ana; Monzote, Lianet; Fraga, Jorge; Montano, Ivon; Muskus, Carlos; Marin, Marcel; de Doncker, Simonne; Dario Velez, Ivan; Claude Dujardin, Jean			PCR-RFLP and RAPD for typing neotropical Leishmania	BIOMEDICA			Spanish	Article						Leishmania; leishmaniasis/diagnosis; polymerase chain reaction; polymorphism; restriction fragment length	POLYMERASE-CHAIN-REACTION; FRAGMENT LENGTH POLYMORPHISM; MOLECULAR DIAGNOSIS; IDENTIFICATION; PRIMERS; ASSAY; PARASITES; COMPLEX; REGION	Introduction. The analysis of the PCR-restriction fragment length polymorphism and random amplified polymorphic DNA have been useful tools for Leishmania identification. Objectives. Molecular procedures were demonstrated for identification and typing of reference strains of New World Leishmania and their applicability was validated for clinical samples. Materials and methods. DNA was extracted from 16 reference strains of Latin American Leishmania as well as from clinical samples of leishmaniasis patients. A sequence coding for cysteine proteinase B was amplified by PCR and subjected to restriction fragment length polymorphism analysis. The enzyme used was Taq1. For eight of the reference strains, the random amplified polymorphic desoxyribonucleic acid technique (RAPD) was applied. Band patterns for Leishmania species differentiation were established each each method. The sample size of the clinical sample was of 5. Results. PCR products of the cysteine proteinase B gene were obtained for L. braziliensis, L. peruviana, L. panamensis and L. guyanensis. For the other species, L. mexicana, L. amazonensis, L. garnhami, L. lainsoni, L. chagasi, L. naiffi, no amplification occurred. The patterns of restriction fragments revealed band patterns in common for L. peruviana, L. guyanensis and L. panamensis, whereas L. braziliensis had a distinctive pattern. When human samples were examined, amplification occurred for all cases, and the profiles corresponded to the common profile of L. peruviana, L. guyanensis and L. panamensis. The RAPD technique demonstrated reproducible and distinctive patterns for each of the 8 reference strains, L. mexicana, L. amazonensis, L. gamhami, L. lainsoni, L. chagasi, L. naiffi, making possible to differentiate all them. The advantages and limitations of each procedure are discussed. Conclusions. The combination of RFP and RAPID methodologies provide useful tools to identify medical important species of Leishmania by recognizing DNA sequences characteristic of each species.	[Margarita Montalvo, Ana; Monzote, Lianet; Fraga, Jorge; Montano, Ivon] Inst Pedro Kouri, Dept Parasitol, Havana, Cuba; [Muskus, Carlos; Marin, Marcel; Dario Velez, Ivan] Univ Antioquia, PECET, Medellin, Colombia; [de Doncker, Simonne; Claude Dujardin, Jean] Inst Trop Med, Mol Parasitol Lab, B-2000 Antwerp, Belgium	Montalvo, AM (reprint author), Inst Pedro Kouri, Dept Parasitol, Autopista Novia Mediodia Km 6 1-2 La Lisa,Apartad, Havana, Cuba.	amontalvo@ipk.sld.cu					BANULS AL, 1999, AM J TROP MED HYG, V61, P828; Berman JD, 1997, CLIN INFECT DIS, V24, P684, DOI 10.1093/clind/24.4.684; BHATTACHARYYA R, 1993, FEMS MICROBIOL LETT, V114, P99, DOI 10.1111/j.1574-6968.1993.tb06557.x; Croft S.L., 2002, T R SOC TROP MED HYG, V96, P127; CUPOLILLO E, 1995, MOL BIOCHEM PARASIT, V73, P145, DOI 10.1016/0166-6851(95)00108-D; Diakou A, 2001, ANAL BIOCHEM, V288, P195, DOI 10.1006/abio.2000.4896; Garcia A. L., 2005, Infection Genetics and Evolution, V5, P109, DOI 10.1016/j.meegid.2004.07.003; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; Hanafi R, 2001, EXP PARASITOL, V98, P90, DOI 10.1006/expr.2001.4617; Martinez E, 2003, PARASITOLOGY, V127, P513, DOI 10.1017/S0031182003004104; MONTALVO AM, 2006, REV CUB MED TROP, V58; Noyes HA, 1996, AM J TROP MED HYG, V55, P98, DOI 10.4269/ajtmh.1996.55.98; ORDENANAPILOTOS R, 2005, THESIS I PEDRO KOURI; Pavlicek A, 1999, FOLIA BIOL-PRAGUE, V45, P97; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Rodriguez-Bonfante C, 2003, INFECT GENET EVOL, V3, P119, DOI 10.1016/S1567-1348(03)00012-1; Rotureau B, 2006, J CLIN MICROBIOL, V44, P459, DOI 10.1128/JCM.44.2.459-467.2006; Sambrook J, 1989, MOL CLONING LAB MANU; Serin MS, 2005, DIAGN MICR INFEC DIS, V53, P209, DOI 10.1016/j.diagmicrobio.2005.05.007; Singh S, 2003, J Postgrad Med, V49, P55; Sneath P. H. A., 1973, NUMERICAL TAXONOMY; Tavares CAP, 2003, EXPERT REV MOL DIAGN, V3, P657, DOI 10.1586/14737159.3.5.657; TIBAYRENC M, 1993, P NATL ACAD SCI USA, V90, P1335, DOI 10.1073/pnas.90.4.1335; Victoir K, 2003, T ROY SOC TROP MED H, V97, P80, DOI 10.1016/S0035-9203(03)90031-9; *WHO, 1995, 12 UNDP WHO WORLD BA, P135; Zemanova E, 2004, AM J TROP MED HYG, V70, P613, DOI 10.4269/ajtmh.2004.70.613	26	7	9	1	1	INST NACIONAL SALUD	BOGOTA D C	AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C, 00000, COLOMBIA	0120-4157			BIOMEDICA	Biomedica	DEC	2008	28	4					597	606		10.7705/biomedica.v28i4.66				10	Tropical Medicine	Tropical Medicine	400UM	WOS:000262894600014	19462565	DOAJ Gold			2019-04-02	
J	Ouedraogo, HZ; Zeba, A; Dramaix-Wilmet, M; Donnen, P				Ouedraogo, Hermann Z.; Zeba, Augustin; Dramaix-Wilmet, Michele; Donnen, Philippe			Moderate-to-Severe Anaemia due to Afebrile Plasmodium falciparum Infection in Children aged 623 Months from the Rural District of Kongoussi, Burkina Faso	JOURNAL OF TROPICAL PEDIATRICS			English	Article							YOUNG-CHILDREN; WESTERN KENYA; PRESCHOOL-CHILDREN; MALARIA; AREA; TRANSMISSION; PREVALENCE; INFANTS; IMPACT	A population-based cross-sectional study was conducted to investigate the association of haemoglobin concentration and moderate-to-severe anaemia with afebrile Plasmodium falciparum (PF) infection in 456 rural children aged 623 months. Capillary blood was obtained for haemoglobin concentration measurement by HemoCue and malaria detection by blood smear microscopy. Anaemia was noted in 444 (97.4) children with 194 (42.5) being moderate-to-severe anaemia. PF infection was noted in 240 (52.6) children with 117 (25.6) being afebrile and 123 (27.0) being febrile. Children with afebrile and those with febrile PF infection were more likely to have moderate-to-severe anaemia than children who were PF-free, with odds ratio (95 confidence interval) of 1.86 (1.073.23), p 0.028 and 2.40 (1.294.48), p 0.001, respectively. These results underline the high burden of both anaemia and PF infection in this population. Strategies aiming at controlling malarial anaemia and based on malaria case-treatment should consider both febrile and afebrile PF infection to allow for a better impact.	[Ouedraogo, Hermann Z.; Zeba, Augustin] Inst Rech Sci Sante, Ouagadougou, Burkina Faso; [Dramaix-Wilmet, Michele; Donnen, Philippe] ULB, Ecole Sante Publ, B-1070 Brussels, Belgium	Ouedraogo, HZ (reprint author), Inst Rech Sci Sante, 02 BP 5608, Ouagadougou, Burkina Faso.	ouedher68@yahoo.fr			Fonds pour la Recherche Scientifique Medicale' FRSM of Belgium [3.4534.03]	This study was funded by the 'Fonds pour la Recherche Scientifique Medicale' FRSM of Belgium (Convention no 3.4534.03).	Asobayire FS, 2001, AM J CLIN NUTR, V74, P776; BRABIN BJ, 2001, J NUTR, V131, P636; Cornet M, 1998, AM J TROP MED HYG, V58, P606, DOI 10.4269/ajtmh.1998.58.606; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; Desai MR, 2005, AM J TROP MED HYG, V72, P47, DOI 10.4269/ajtmh.2005.72.47; Dewey Kathryn G., 2003, Food and Nutrition Bulletin, V24, P5; DUNN JT, 1990, PRACTICAL GUIDE CORR; Eliades MJ, 2006, AM J TROP MED HYG, V75, P622, DOI 10.4269/ajtmh.2006.75.622; Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698; Gentilini M, 1993, MED TROPICALE; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Lemeshow S, 1985, World Health Stat Q, V38, P65; *MEAS, BURK FAS ENQ DEM SAN; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Stich A, 2006, PARASITOL RES, V98, P596, DOI 10.1007/s00436-005-0104-9; Stoltzfus RJ, 2000, J NUTR, V130, P1724; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P68, DOI 10.4269/ajtmh.2003.68.68; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; *WHO, 2004, IR SUPPL YOUNG CHILD; *WHO, 2007, LESS LEARN HOM MAN M; WHO, 2000, NEW PERSP MAL DIAGN; WHO, 2001, IR DEF AN ASS PREV C; *WHO UN CHILD FUND, 2005, WORLD MAL REP 2005; *WHO UN CHILD FUND, 2004, FOC AN INT APPR EFF; WHO(World Health Organ.), 1995, PHYS STAT US INT ANT; World Health Organization, 2004, SCAL HOM BAS MAN MAL	27	9	9	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	DEC	2008	54	6					395	400		10.1093/tropej/fmn049				6	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	380JM	WOS:000261462000008	18599531	Bronze			2019-04-02	
J	Schoonbaert, D; Demedts, V				Schoonbaert, Dirk; Demedts, Veerle			Analysis of the leprosy literature indexed in Medline (1950-2007)	LEPROSY REVIEW			English	Review								Some 19 204 leprosy-related articles were identified in the Medline database for the period 1950 2007. These were analysed for distribution and evolution of a number of variables: publication years, languages, document types, journals, authors, major aspects and countries involved, and author addresses. Next to a number of tables presenting the actual results, some noteworthy trends and possible pitfalls ill the interpretation of these results are discussed. The analysis shows that the number of leprosy-related articles peaked in the 1980s and has been in decline ever since, as well in absolute as in relative numbers. Coverage of non-English language literature has decreased far more strongly than that of English language articles. The scholarly input of a number of countries where the leprosy burden is the highest, such as India and Brazil, is clearly visible in the distribution of journals, authors, and for some, language, but this is certainly not the case for all countries afflicted.	[Schoonbaert, Dirk; Demedts, Veerle] Inst Trop Med, B-2000 Antwerp, Belgium	Schoonbaert, D (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	bib@itg.be					[Anonymous], 2005, INT J LEPROSY, V73, P25; Cronin B, 2001, J AM SOC INF SCI TEC, V52, P558, DOI 10.1002/asi.1097; DYSINGER W, 1992, LEPROSY LIT 1913 199; Falagas ME, 2006, ACTA TROP, V99, P155, DOI 10.1016/j.actatropica.2006.07.010; KEFFER L, 1944, INDICE BIBLIO LEPRA, P1936; REMME JHF, 2006, DIS CONTROL PRIORITI, P1433; *WHO, 2007, WKLY EPIDEMIOL REC, V82, P225	7	10	10	0	4	LEPRA	COLCHESTER	28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND	0305-7518	2162-8807		LEPROSY REV	Lepr. Rev.	DEC	2008	79	4					387	400						14	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	412FR	WOS:000263710300006	19274985				2019-04-02	
J	Fevre, EM; von Wissmann, B; Welburn, SC; Lutumba, P				Fevre, Eric M.; v. Wissmann, Beatrix; Welburn, Susan C.; Lutumba, Pascal			The Burden of Human African Trypanosomiasis	PLOS NEGLECTED TROPICAL DISEASES			English	Review							RHODESIENSE SLEEPING SICKNESS; NEGLECTED TROPICAL DISEASES; WORLD DEVELOPMENT REPORT; ADJUSTED LIFE YEARS; BRUCEI-RHODESIENSE; COST-EFFECTIVENESS; EASTERN UGANDA; GLOBAL BURDEN; CLINICAL-ASPECTS; HEALTH-POLICY	Human African trypanosomiasis (HAT, or sleeping sickness) is a protozoan parasitic infection caused by Trypanosoma brucei rhodesiense or Trypanosoma brucei gambiense. These are neglected tropical diseases, and T.b. rhodesiense HAT is a zoonosis. We review current knowledge on the burden of HAT in sub-Saharan Africa, with an emphasis on the disability-adjusted life year (DALY), data sources, and methodological issues relating to the use of this metric for assessing the burden of this disease. We highlight areas where data are lacking to properly quantify the impact of these diseases, mainly relating to quantifying under-reporting and disability associated with infection, and challenge the HAT research community to tackle the neglect in data gathering to enable better evidence-based assessments of burden using DALYs or other appropriate measures.	[Fevre, Eric M.] Univ Edinburgh, Ctr Infect Dis, Ashworth Labs, Edinburgh, Midlothian, Scotland; [v. Wissmann, Beatrix; Welburn, Susan C.] Univ Edinburgh, Coll Med & Vet Med, Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Lutumba, Pascal] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; [Lutumba, Pascal] Inst Trop Med, B-2000 Antwerp, Belgium	Fevre, EM (reprint author), Univ Edinburgh, Ctr Infect Dis, Ashworth Labs, Edinburgh, Midlothian, Scotland.	Eric.Fevre@ed.ac.uk		von Wissmann, Beatrix/0000-0002-0980-4545; Fevre, Eric/0000-0001-8931-4986; Welburn, Susan/0000-0002-9903-7086	UK Department for International Development	We thank the UK Department for International Development (DFID) RNRRS and Research into Use Programmes for the benefit of developing countries (EMF, SCW, BvW), the World Health Organization (EMF, SCW, BvW), the independent charity IKARE (SCW, BvW,) and the Wellcome Trust (SCW) for support of our HAT studies. EMF was supported in part by a Wellcome Trust "Value in People'' award, and a DEFRA-VTRI Research Fellowship. PL is supported by the Belgian Directorate General for Development Cooperation. None of the funders had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel PM, 2004, TROP MED INT HEALTH, V9, P141, DOI 10.1046/j.1365-3156.2003.01152.x; Ad Hoc Committee on Health Research Relating to Future Intervention Options, 1996, INV HLTH RES DEV; Arnesen T, 1999, BRIT MED J, V319, P1423, DOI 10.1136/bmj.319.7222.1423; Aroke AH, 1998, ANN TROP MED PARASIT, V92, P829; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Blum J, 2006, ACTA TROP, V97, P55, DOI 10.1016/j.actatropica.2005.08.001; Blum JA, 2007, TROP MED INT HEALTH, V12, P1422, DOI 10.1111/j.1365-3156.2007.01948.x; BOA YF, 1988, B SOC PATHOL EXOT, V81, P427; Bossert TJ, 2002, HEALTH POLICY PLANN, V17, P14, DOI 10.1093/heapol/17.1.14; Braakman HMH, 2006, NEUROLOGY, V66, P1094, DOI 10.1212/01.wnl.0000209306.41647.13; BUDD LT, 1999, DFID FUNDED TSETE TR; Chisi J E, 2004, East Afr Med J, V81, P505; Cramet R, 1982, Med Trop (Mars), V42, P27; Ebeja AK, 2003, TROP MED INT HEALTH, V8, P949, DOI 10.1046/j.1365-3156.2003.01116.x; Engels D, 2006, TRENDS PARASITOL, V22, P363, DOI 10.1016/j.pt.2006.06.004; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Fevre EM, 2005, LANCET, V366, P745, DOI 10.1016/S0140-6736(05)67179-6; Fevre EM, 2005, TROP MED INT HEALTH, V10, P790, DOI 10.1111/j.1365-3156.2005.01447.x; Fevre EM, 2004, EMERG INFECT DIS, V10, P567, DOI 10.3201/eid1003.020626; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; Fevre EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-96; GEIGY R, 1971, ACTA TROP, V18, P221; GINOUX C, 1982, MED TROP-MARSEILLE, V42, P281; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Gooding Ronald H., 2004, P95, DOI 10.1079/9780851994758.0095; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; Gouteux J P, 1987, Med Trop (Mars), V47, P61; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; HEISCH RB, 1958, BRIT MED J, V2, P1203, DOI 10.1136/bmj.2.5106.1203; Hide G, 1996, PARASITOL TODAY, V12, P50, DOI 10.1016/0169-4758(96)80654-5; Hyde E.P., 1906, Bulletin of the Bureau of Standards, V2, P1; Jannin J, 2003, Med Trop (Mars), V63, P219; Jannin J, 2004, CURR OPIN INFECT DIS, V17, P565, DOI 10.1097/00001432-200412000-00009; Jeppsson A, 2004, HEALTH POLICY, V70, P261, DOI 10.1016/j.healthpol.2004.02.009; Jeppsson A, 2001, HEALTH POLICY PLANN, V16, P187, DOI 10.1093/heapol/16.2.187; Kabasa JD, 2007, TRENDS PARASITOL, V23, P191, DOI 10.1016/j.pt.2007.03.006; Kapiriri L, 2003, SOC SCI MED, V56, P2433, DOI 10.1016/S0277-9536(02)00246-0; Kennedy PGE, 2008, T ROY SOC TROP MED H, V102, P306, DOI 10.1016/j.trstmh.2007.11.011; Kennedy PGE, 2006, INT J PARASITOL, V36, P505, DOI 10.1016/j.ijpara.2006.01.012; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; Kinung'hi S M, 2006, Tanzan Health Res Bull, V8, P168; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; Laveissiere C, 1998, B WORLD HEALTH ORGAN, V76, P559; Louis FJ, 2003, B SOC PATHOL EXOT, V95, P331; Lutumba P, 2005, EMERG INFECT DIS, V11, P1382; Lutumba P, 2007, EMERG INFECT DIS, V13, P248, DOI 10.3201/eid1302.060075; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; MEHLITZ D, 1982, TROPENMED PARASITOL, V33, P113; Monath T P, 2006, Bull Soc Pathol Exot, V99, P341; Mulligan HW, 1970, AFRICAN TRYPANOSOMIA, P661; MURRAY CJ, 1996, GLOBAL BURDEN DIS CO, P990; Murray CJL, 2004, BMJ-BRIT MED J, V329, P1096, DOI 10.1136/bmj.329.7474.1096; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Musgrove P, 2000, HEALTH POLICY PLANN, V15, P110, DOI 10.1093/heapol/15.1.110; Odiit M, 2005, TROP MED INT HEALTH, V10, P840, DOI 10.1111/j.1365-3156.2005.01470.x; Odiit M, 2004, ANN TROP MED PARASIT, V98, P339, DOI 10.1179/000349804225003389; ONYANGO RJ, 1966, T ROY SOC TROP MED H, V60, P175, DOI 10.1016/0035-9203(66)90024-1; Paalman M, 1998, HEALTH POLICY PLANN, V13, P13, DOI 10.1093/heapol/13.1.13; Pawlowski ZS, 2008, T ROY SOC TROP MED H, V102, P228, DOI 10.1016/j.trstmh.2007.10.007; Pepin J, 2001, ADV PARASIT, V49, P71, DOI 10.1016/S0065-308X(01)49038-5; Picozzi K, 2005, BMJ-BRIT MED J, V331, P1238, DOI 10.1136/bmj.331.7527.1238; Picozzi K, 2008, EXP PARASITOL, V118, P41, DOI 10.1016/j.exppara.2007.05.014; POLITI C, 1995, HEALTH ECON, V4, P273, DOI 10.1002/hec.4730040404; PULLAN R, 2008, PARASITOLOGY, V1, P12; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; Robays J, 2008, TROP MED INT HEALTH, V13, P265, DOI 10.1111/j.1365-3156.2007.01999.x; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Sassi F, 2006, HEALTH POLICY PLANN, V21, P402, DOI 10.1093/heapol/czl018; Shaw A P, 2001, Med Trop (Mars), V61, P412; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Simo G, 2006, VET PARASITOL, V139, P57, DOI 10.1016/j.vetpar.2006.02.026; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x; Stein C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000161; Swallow BM., 2000, PAAT TECHNICAL SCI S, V2, P52; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; Van Nieuwenhove S, 2001, TROP MED INT HEALTH, V6, P335, DOI 10.1046/j.1365-3156.2001.00731.x; Vega JC, 2007, TROP MED INT HEALTH, V12, P1540, DOI 10.1111/j.1365-3156.2007.01962.x; Welburn SC, 2001, TRENDS PARASITOL, V17, P19, DOI 10.1016/S1471-4922(00)01839-0; *WHO, 2003, GLOB BURD DIS GBD ST; WHO, 2003, WORLD HLTH REP 2003; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P71; WHO, 2008, GLOB BURD DIS; *WORLD BANK, 1993, WORLD DEV REP 1993 I, P329; World Health Organization, 2006, CONTR NEGL ZOON DIS, P65; World Health Organization, 1998, CONTR SURV AFR TRYP, P114; World Health Organization WHO, 2003, GLOB BURD DIS GBD 20; Worrall E, 2004, AM J TROP MED HYG, V71, P136, DOI 10.4269/ajtmh.2004.71.136; Zuckerman JN, 2007, LANCET INFECT DIS, V7, P521, DOI 10.1016/S1473-3099(07)70138-X; Zumla A, 2002, LANCET INFECT DIS, V2, P393, DOI 10.1016/S1473-3099(02)00312-2	96	150	150	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2008	2	12							e333	10.1371/journal.pntd.0000333				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	406NA	WOS:000263301000003	19104653	DOAJ Gold, Green Published			2019-04-02	
J	Bwirire, LD; Fitzgerald, M; Zachariah, R; Chikafa, V; Massaquoi, M; Moens, M; Kamoto, K; Schouten, EJ				Bwirire, L. D.; Fitzgerald, M.; Zachariah, R.; Chikafa, V.; Massaquoi, M.; Moens, M.; Kamoto, K.; Schouten, E. J.			Reasons for loss to follow-up among mothers registered in a prevention-of-mother-to-child transmission program in rural Malawi	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						HIV; Vertical disease transmission; PMTCT; Focus groups; Loss to follow-up; Malawi	WOMEN; HIV-1; DISCLOSURE; COUNTRIES; BARRIERS; VIOLENCE; AFRICA	This study was conducted to identify reasons for a high and progressive toss to follow-up among HIV-positive mothers within a prevention-of-mother-to-child HIV transmission (PMTCT) program in a rural district hospital in Malawi. Three focus group discussions were conducted among a total of 25 antenatal and post-natal mothers as well as nurse midwives (median age 39 years, range 22-55 years). The main reasons for toss to follow-up included: (1) not being prepared for HIV testing and its implications before the antenatal clinic (ANC) visit; (2) fear of stigma, discrimination, household conflict and even divorce on disclosure of HIV status; (3) lack of support from husbands who do not want to undergo HIV testing; (4) the feeling that one is obliged to rely on artificial feeding, which is associated with social and cultural taboos; (5) long waiting times at the ANC; and (6) inability to afford transport costs related to the long distances to the hospital. This study reveals a number of community- and provider-related operational and cultural barriers hindering the overall acceptability of PMTCT that need to be addressed urgently. Mothers attending antenatal services need to be better informed and supported, at both community and health-provider level. (c) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. Ail rights reserved.	[Zachariah, R.] Brussels Operat Ctr, Med Dept Operat Res, L-1617 Luxembourg, Belgium; [Kamoto, K.; Schouten, E. J.] Minist Hlth, HIV Unit, Lilongwe, Malawi; [Schouten, E. J.] Management Sci Hlth, Cambridge, MA USA	Zachariah, R (reprint author), Brussels Operat Ctr, Med Dept Operat Res, 68 Rue Gasperich, L-1617 Luxembourg, Belgium.	zachariah@internet.lu			Medecins Sans Frontieres	This study was funded by Medecins Sans Frontieres, Brussels, Belgium.	Braithwaite RS, 2008, ANN INTERN MED, V148, P178, DOI 10.7326/0003-4819-148-3-200802050-00004; Dawson S, 1993, MANUAL USE FOCUS GRO; GREEN EC, 1988, SOC SCI MED, V27, P1125, DOI 10.1016/0277-9536(88)90341-3; HEYWARD WL, 1993, AIDS, V7, P1633, DOI 10.1097/00002030-199312000-00014; Karamagi CAS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-284; Kiarie JN, 2006, AIDS, V20, P1763, DOI 10.1097/01.aids.0000242823.51754.0c; Kilewo C, 2001, J ACQ IMMUN DEF SYND, V28, P458; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Maman S, 2001, AIDS CARE, V13, P595, DOI 10.1080/09540120120063223; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; MILLS E, 2006, SCIENCE, V20, P417; *MMWR, 2002, MMWR-MORBID MORTAL W, V51, P103; *MOH, 2005, HIV SYPH SER NAT HIV; *MOH, 2002, STAT HUM CAP DEV EFF; Rennie S, 2006, B WORLD HEALTH ORGAN, V84, P52; *UNAIDS, 2005, REP GLOB AIDS EP 200; Zachariah R, 2006, T ROY SOC TROP MED H, V100, P167, DOI 10.1016/j.trstmh.2005.07.008; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	19	85	85	1	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	DEC	2008	102	12					1195	1200		10.1016/j.trstmh.2008.04.002				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	377XK	WOS:000261285500005	18485431				2019-04-02	
J	Coulibaly, Y; Cavalli, A; van Dormael, M; Polman, K; Kegels, G				Coulibaly, Youssouf; Cavalli, Anna; van Dormael, Monique; Polman, Katja; Kegels, Guy			Programme activities: a major burden for district health systems?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						vertical programmes; health systems			[Cavalli, Anna; van Dormael, Monique; Polman, Katja; Kegels, Guy] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium	Cavalli, A (reprint author), Inst Trop Med Prince Leopold, Natl Str 155, B-2000 Antwerp, Belgium.	acavalli@itg.be					Banteyerga H, 2006, SYSTEMWIDE EFFECTS G; CAINES K, 2005, KEY EVIDENCE MAJOR S; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; JOHNS B, 2003, HLTH POLICY PLANNING, V20, P1; SEGALL M, 2003, INT J HEALTH PLAN MA, V18, P5; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Unger JP, 2003, INT J HEALTH PLAN M, V18, pS27, DOI 10.1002/hpm.723; WHO, 2006, 4 WHO	8	16	16	0	0	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	DEC	2008	13	12					1430	1432		10.1111/j.1365-3156.2008.02174.x				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	376UW	WOS:000261209500002	18983273	Bronze			2019-04-02	
J	Protopopoff, N; Verhaeghen, K; Van Bortel, W; Roelants, P; Marcotty, T; Baza, D; D'Alessandro, U; Coosemans, M				Protopopoff, Natacha; Verhaeghen, Katrijn; Van Bortel, Wim; Roelants, Patricia; Marcotty, Tanguy; Baza, Dismas; D'Alessandro, Umberto; Coosemans, Marc			A significant increase in kdr in Anopheles gambiae is associated with an intensive vector control intervention in Burundi highlands	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Anopheles sp; knockdown resistance; insecticide resistance; indoor residual spraying; insecticide treated net; Burundi	INSECTICIDE-TREATED NETS; PYRETHROID RESISTANCE; IMPREGNATED BEDNETS; MALARIA VECTORS; COTE-DIVOIRE; SOUTH-AFRICA; IDENTIFICATION; MUTATION; DDT; POPULATIONS	In Burundi, the occurrence of the knock down resistance (kdr) mutation in Anopheles gambiae sensu lato (s.l.) was determined for six consecutive years within the framework of a vector control programme. Findings were also linked with the insecticide resistance status observed with bioassay in An. gambiae s.l. and An. funestus. The proportion of An. gambiae s.l. carrying the East Leu-Ser kdr mutation was 1% before the spraying intervention in 2002; by 2007 it was 86% in sprayed valleys and 67% in untreated valleys. Multivariate analysis showed that increased risk of carrying the kdr mutation is associated with spraying interventions, location and time. In bioassays conducted between 2005 and 2007 at five sites, An. funestus was susceptible to permethrin, deltamethrin and DDT. Anopheles gambiae s.l. remained susceptible or tolerant to deltamethrin and resistant to DDT and permethrin, but only when kdr allele carriers reached 90% of the population. The cross-resistance against DDT and permethrin in Karuzi suggests a possible kdr resistance mechanism. Nevertheless, the homozygous resistant genotype alone does not entirely explain the bioassay results, and other mechanisms conferring resistance cannot be ruled out. After exposure to all three insecticides, homozygote individuals for the kdr allele dominate among the surviving An. gambiae s.l. This confirms the potential selection pressure of pyrethroids on kdr mutation. However, the high occurrence of the kdr mutation, even at sites far from the sprayed areas, suggests a selection pressure other than that exerted by the vector control programme.	[Protopopoff, Natacha; Verhaeghen, Katrijn; Van Bortel, Wim; Roelants, Patricia; D'Alessandro, Umberto; Coosemans, Marc] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; [Protopopoff, Natacha] Med Sans Frontieres Belgium, Brussels, Belgium; [Marcotty, Tanguy] Inst Trop Med Prince Leopold, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Baza, Dismas] Minist Hlth, Programme Lutte Malad Transmissibles & Carentiell, Bujumbura, Burundi; [Coosemans, Marc] Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, Dept Biomed Sci, B-2020 Antwerp, Belgium	Protopopoff, N (reprint author), Inst Trop Med Prince Leopold, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	nprotopopoff@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Protopopoff, Natacha/0000-0001-6698-4936; Van Bortel, Wim/0000-0002-6644-518X	MSF-Belgium and the Belgian co-operation (DGDC)	The authors thank the Burundian Health authorities for their support and particularly the LMTC staff for their hard work during these 6 years. The authors would like also to thank the provincial administration of Karuzi for their strong collaboration. The authors are grateful to Thierry Backeljau for reading and providing useful comments to this manuscript. This work was financially supported by MSF-Belgium and the Belgian co-operation (DGDC).	Akogbeto M C, 2005, Bull Soc Pathol Exot, V98, P400; BARUTWANAYO M, 1991, ANN SOC BELG MED TR, V71, P113; Bourguet D, 1998, J EVOLUTION BIOL, V11, P103, DOI 10.1046/j.1420-9101.1998.11010103.x; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; COOSEMANS MH, 1985, ANN SOC BELG MED TR, V65, P187; Dabire RK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-12; Darriet F, 2000, B SOC PATHOL EXOT, V93, P131; Diabate A, 2006, TROP MED INT HEALTH, V11, P597, DOI 10.1111/j.1365-3156.2006.01605.x; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Etang J, 2007, J VECTOR ECOL, V32, P123, DOI 10.3376/1081-1710(2007)32[123:SOMRTD]2.0.CO;2; Etang J, 2006, AM J TROP MED HYG, V74, P795, DOI 10.4269/ajtmh.2006.74.795; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Garros C, 2004, AM J TROP MED HYG, V70, P260, DOI 10.4269/ajtmh.2004.70.260; Gillies M, 1987, ANOPHELINAE AFRICA S; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hargreaves K, 2003, MED VET ENTOMOL, V17, P417, DOI 10.1111/j.1365-2915.2003.00460.x; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Lengeler C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Liu Nannan, 2006, Insect Science, V13, P159, DOI 10.1111/j.1744-7917.2006.00078.x; Mahama T, 2007, J MED ENTOMOL, V44, P498, DOI 10.1603/0022-2585(2007)44[498:EOPICD]2.0.CO;2; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; May RM, 1986, PESTICIDE RESISTANCE, P170; McAbee RD, 2004, PEST MANAG SCI, V60, P359, DOI 10.1002/ps.799; MOUCHET J, 1988, INSECT SCI APPL, V9, P297, DOI 10.1017/S1742758400006238; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-158; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Tia E, 2006, Bull Soc Pathol Exot, V99, P278; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; WHO, 1998, TEST PROC INS RES MO; Xu Q, 2006, BIOCHEM BIOPH RES CO, V345, P774, DOI 10.1016/j.bbrc.2006.04.155	37	52	52	1	9	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	DEC	2008	13	12					1479	1487		10.1111/j.1365-3156.2008.02164.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	376UW	WOS:000261209500008	18983277	Bronze			2019-04-02	
J	Schmunis, GA; Rodriguez, G; Coenen, J; Bellorin, EG; Gianella, A				Schmunis, Gabriel A.; Rodriguez, Gloria; Coenen, Jan; Bellorin, Enrique Gil; Gianella, Alberto			Prevention of Blood-borne Diseases in Bolivia, 1993-2002	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							TRANSMITTED INFECTIOUS-DISEASES; HUMAN-IMMUNODEFICIENCY-VIRUS; CHAGAS-DISEASE; TRANSFUSION; RISK; HEPATITIS; ASSAYS; BANKS; CRUZI; 2ND-GENERATION	This report shows the outcome of a coordinated effort by locals, foreign institutions, and an international agency from 1996-2002, aimed at preventing transmission of blood-borne diseases in Santa Cruz, Bolivia. From 2001-2002, testing the donor pool for HIV prevented transfusion of 32 infected units and 29 infections. With 100% screening coverage, 196 hepatitis B virus (HBV)-infected units were discarded, and 177 infections of HBV were prevented between 1999 and 2002. Incomplete screening for hepatitis C virus (HCV) may have tainted nine units of blood and generated eight HCV infections in 1999. On the other hand, 600 units infected with HCV were discarded, and 540 HCV infections were prevented between 1999 and 2002. Screening for Chagas disease prevented transfusion of 10,661 tainted units and 2,133 infections from 1999 to 2002. From 1996-2002, the investment was US$1,108,000.	[Schmunis, Gabriel A.] WHO, Pan Amer Hlth Org, Communicable Dis Unit, Washington, DC 20037 USA; [Rodriguez, Gloria] Banco Reg Santa Cruz, Santa Cruz, Bolivia; [Coenen, Jan] Inst Trop Med, B-2000 Antwerp, Belgium; [Gianella, Alberto] Ctr Nacl Enfermedades Trop, Santa Cruz, Bolivia	Schmunis, GA (reprint author), 4256 Warren St NW, Washington, DC 20016 USA.	gabriel.schmunis@gmail.com; glorihemato@hotmail.com; jcoenen@itg.be; gilenriq@gut.ops-oms.org; algianella@gmail.com					AACH RD, 1991, NEW ENGL J MED, V325, P1325, DOI 10.1056/NEJM199111073251901; ATTIAS A, 1984, B HOSP SAN JUAN DIOS, V31, P301; BOSSUYT M, 2002, BANCO SANGRE REGIONA; CARRASCO R, 1990, MEM I OSWALDO CRUZ, V85, P69, DOI 10.1590/S0074-02761990000100011; CERISOLA DJ, 1972, B OFIC SANIT PANAM, V73, P203; COUROUCE AM, 1994, TRANSFUSION, V34, P790, DOI 10.1046/j.1537-2995.1994.34994378281.x; Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092; DONEGAN E, 1990, ANN INTERN MED, V113, P733, DOI 10.7326/0003-4819-113-10-733; HUGO W, 1992, J INFECT DIS, V166, P1464, DOI 10.1093/infdis/166.6.1464; Lackritz EM, 1995, NEW ENGL J MED, V333, P1721, DOI 10.1056/NEJM199512283332601; LINARES L, 1994, TALLER LATINOAMERICA; LORCA M, 1988, REV MED CHILE, V116, P112; LORCA M, 1992, REV MED CHILE, V120, P420; LORCA M, 1994, REV MED CHILE, V122, P925; *MIN SAN CONS, 1998, EST EST CTR TRANSF B; MIYOSHI C, 1995, COST EFFECTIVENESS B; *ORG PAN SAL, 2003, OPSEVLAB012003; Pan American Health Organization World Health Organization, 2005, TRANSF MED CAR LAT A; QELEMANN WM, 1998, J CLIN MICROBIOL, V36, P2423; Saez-Alquezar A., 1997, Revista de Patologia Tropical, V26, P343; Salles NA, 1996, TRANSFUSION, V36, P969, DOI 10.1046/j.1537-2995.1996.36111297091740.x; Schmunis GA, 1998, EMERG INFECT DIS, V4, P5, DOI 10.3201/eid0401.980102; Schmunis GA, 2000, TRANSFUSION, V40, P1048, DOI 10.1046/j.1537-2995.2000.40091048.x; Schmunis GA, 2005, CLIN MICROBIOL REV, V18, P12, DOI 10.1128/CMR.18.1.12-29.2005; Schmunis GA, 2001, AM J TROP MED HYG, V65, P924, DOI 10.4269/ajtmh.2001.65.924; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; SOOKVIAN S, 1997, MEDICINA B AIRES, V55, P699; *US GEN ACC OFF, 1997, GAOPEMED971; UYTTENDAELE S, 1994, VOX SANG, V66, P122, DOI 10.1111/j.1423-0410.1994.tb00293.x; Vrielink H, 1997, TRANSFUSION, V37, P845, DOI 10.1046/j.1537-2995.1997.37897424409.x; WENDEL S, 1993, VOX SANG, V64, P1, DOI 10.1111/j.1423-0410.1993.tb02507.x; WHO, 2002, CONTR CHAG DIS; *WHO, 2001, 2 WHO; *WHO, 1991, WHO TECH REP SER, V811, P32; *WHO UNAIDS, 1990, 11 WHOUNAIDS; *WHO UNAIDS, 1998, 910 WHOUNAIDS; World Health Organization, 2001, 1 WHO; ZUNA H, 1985, ANN SOC BELG MED TR, V65, P107; ZUNA H, 1991, BOL CIENT CENETROP, V15, P65; ZUNA H, 1991, B CIENT CTR NACL ENF, V15, P60	40	6	6	1	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2008	79	5					803	808		10.4269/ajtmh.2008.79.803				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	373BD	WOS:000260945100034	18981527				2019-04-02	
J	Roger, E; Grunau, C; Pierce, RJ; Hirai, H; Gourbal, B; Galinier, R; Emans, R; Cesari, IM; Cosseau, C; Mitta, G				Roger, Emmanuel; Grunau, Christoph; Pierce, Raymond J.; Hirai, Hirohisa; Gourbal, Benjamin; Galinier, Richard; Emans, Remi; Cesari, Italo M.; Cosseau, Celine; Mitta, Guillaume			Controlled Chaos of Polymorphic Mucins in a Metazoan Parasite (Schistosoma mansoni) Interacting with Its Invertebrate Host (Biomphalaria glabrata)	PLOS NEGLECTED TROPICAL DISEASES			English	Article							COPY NUMBER POLYMORPHISMS; B DNA CONFORMATIONS; HAMMERHEAD RIBOZYMES; COCCIDIOIDES-IMMITIS; CONCERTED EVOLUTION; ANTIGENIC VARIATION; EXON REPETITION; GENE CONVERSION; MESSENGER-RNAS; PLASMODIUM-FALCIPARUM	Invertebrates were long thought to possess only a simple, effective and hence non-adaptive defence system against microbial and parasitic attacks. However, recent studies have shown that invertebrate immunity also relies on immune receptors that diversify ( e. g. in echinoderms, insects and mollusks ( Biomphalaria glabrata)). Apparently, individual or population-based polymorphism-generating mechanisms exists that permit the survival of invertebrate species exposed to parasites. Consequently, the generally accepted arms race hypothesis predicts that molecular diversity and polymorphism also exist in parasites of invertebrates. We investigated the diversity and polymorphism of parasite molecules ( Schistosoma mansoni Polymorphic Mucins, SmPoMucs) that are key factors for the compatibility of schistosomes interacting with their host, the mollusc Biomphalaria glabrata. We have elucidated the complex cascade of mechanisms acting both at the genomic level and during expression that confer polymorphism to SmPoMuc. We show that SmPoMuc is coded by a multigene family whose members frequently recombine. We show that these genes are transcribed in an individual-specific manner, and that for each gene, multiple splice variants exist. Finally, we reveal the impact of this polymorphism on the SmPoMuc glycosylation status. Our data support the view that S. mansoni has evolved a complex hierarchical system that efficiently generates a high degree of polymorphism - a "controlled chaos'' - based on a relatively low number of genes. This contrasts with protozoan parasites that generate antigenic variation from large sets of genes such as Trypanosoma cruzi, Trypanosoma brucei and Plasmodium falciparum. Our data support the view that the interaction between parasites and their invertebrate hosts are far more complex than previously thought. While most studies in this matter have focused on invertebrate host diversification, we clearly show that diversifying mechanisms also exist on the parasite side of the interaction. Our findings shed new light on how and why invertebrate immunity develops.	[Roger, Emmanuel; Grunau, Christoph; Gourbal, Benjamin; Galinier, Richard; Emans, Remi; Cosseau, Celine; Mitta, Guillaume] Univ Perpignan, CNRS, UMR 5244, F-66025 Perpignan, France; [Pierce, Raymond J.] Univ Lille 2, INSERM, U 547, Inst Pasteur Lille,IFR 142, Lille, France; [Hirai, Hirohisa] Kyoto Univ, Primate Res Inst, Aichi, Japan; [Cesari, Italo M.] ULB, Fac Med, Parasitol Lab, Brussels, Belgium	Roger, E (reprint author), Univ Perpignan, CNRS, UMR 5244, F-66025 Perpignan, France.	mitta@univ-perp.fr	GOURBAL, Benjamin/B-3743-2010; ROGER, Emmanuel/B-4226-2012; Cosseau, Celine/G-8240-2011; Galinier, Richard/G-8278-2011; Grunau, Christoph/A-6989-2010; MITTA, Guillaume/A-6489-2010	Grunau, Christoph/0000-0002-2161-412X; mitta, guillaume/0000-0003-1188-1467; Galinier, Richard/0000-0002-4180-9303	ANR [25390]; CNRS, Inserm; UPVD; ECOS- Nord [V06A01]; Global COE Program (A06) of the MEXT, Japan	This work was supported by the ANR ( grant 25390 Schistophepigen), CNRS, Inserm and UPVD, an ECOS- Nord grant ( V06A01), and the Global COE Program (A06) of the MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Brayton KA, 2002, MOL MICROBIOL, V43, P1151, DOI 10.1046/j.1365-2958.2002.02792.x; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Cannon JP, 2004, CURR BIOL, V14, pR465, DOI 10.1016/j.cub.2004.06.009; Canny MD, 2007, BIOCHEMISTRY-US, V46, P3826, DOI 10.1021/bi062077r; Caudevilla C, 1998, P NATL ACAD SCI USA, V95, P12185, DOI 10.1073/pnas.95.21.12185; Cheng GF, 2006, J BIOL CHEM, V281, P733, DOI 10.1074/jbc.M506963200; DAVIS RE, 1995, J BIOL CHEM, V270, P21813, DOI 10.1074/jbc.270.37.21813; De la Pena M, 2003, EMBO J, V22, P5561, DOI 10.1093/emboj/cdg530; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dixon RJ, 2007, BIOINFORMATICS, V23, P150, DOI 10.1093/bioinformatics/btl575; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Doxiadis GGM, 2006, P NATL ACAD SCI USA, V103, P5864, DOI 10.1073/pnas.0600643103; Ebert D, 2008, CURR OPIN MICROBIOL, V11, P290, DOI 10.1016/j.mib.2008.05.012; Edge ASB, 2003, BIOCHEM J, V376, P339, DOI 10.1042/BJ20030673; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Frantz SA, 1999, P NATL ACAD SCI USA, V96, P5400, DOI 10.1073/pnas.96.10.5400; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; HERTEL KJ, 1992, NUCLEIC ACIDS RES, V20, P3252, DOI 10.1093/nar/20.12.3252; HIBNER BL, 1991, GENETICS, V128, P595; Hicks SJ, 2000, PARASITOL TODAY, V16, P476, DOI 10.1016/S0169-4758(00)01773-7; HIRAI H, 1995, PARASITOL TODAY, V11, P310, DOI 10.1016/0169-4758(95)80048-4; HIRAI H, 2004, METHODS MOL BIOL; Hung CY, 2000, INFECT IMMUN, V68, P584, DOI 10.1128/IAI.68.2.584-593.2000; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; Johannesson H, 2005, GENETICS, V171, P109, DOI 10.1534/genetics.105.040923; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kapp K, 2004, MOL BIOCHEM PARASIT, V138, P171, DOI 10.1016/j.molbiopara.2004.07.010; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Le Paslier MC, 2000, GENOMICS, V65, P87, DOI 10.1006/geno.2000.6147; Liao DQ, 1995, GENOMICS, V30, P583, DOI 10.1006/geno.1995.1280; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Linzmeier RM, 2006, GENOMICS, V88, P122, DOI 10.1016/j.ygeno.2006.03.005; Lopez-Rubio JJ, 2007, CURR OPIN MICROBIOL, V10, P560, DOI 10.1016/j.mib.2007.10.003; Loukas A, 2000, J BIOL CHEM, V275, P39600, DOI 10.1074/jbc.M005632200; MARIN MS, 1992, MOL BIOCHEM PARASIT, V55, P155; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mitta G, 1999, J CELL SCI, V112, P4233; Mitta G, 2005, DEV COMP IMMUNOL, V29, P393, DOI 10.1016/j.dci.2004.10.002; Navarro M, 2007, TRENDS MICROBIOL, V15, P263, DOI 10.1016/j.tim.2007.04.004; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pancer Z, 2000, P NATL ACAD SCI USA, V97, P13156, DOI 10.1073/pnas.230096397; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Patton WF, 2002, J CHROMATOGR B, V771, P3, DOI 10.1016/S1570-0232(02)00043-0; Przybilski R, 2007, BIOL CHEM, V388, P737, DOI 10.1515/BC.2007.065; Puchta H, 1999, GENETICS, V152, P1173; RAJKOVIC A, 1990, P NATL ACAD SCI USA, V87, P8879, DOI 10.1073/pnas.87.22.8879; Ralph SA, 2005, CURR OPIN MICROBIOL, V8, P434, DOI 10.1016/j.mib.2005.06.007; REYNAUD CA, 1994, ADV IMMUNOL, V57, P353, DOI 10.1016/S0065-2776(08)60676-8; Rigatti R, 2004, NUCLEIC ACIDS RES, V32, P441, DOI 10.1093/nar/gkh197; Roger E, 2008, MOL BIOCHEM PARASIT, V157, P205, DOI 10.1016/j.molbiopara.2007.11.003; Roger E, 2008, MOL BIOCHEM PARASIT, V157, P217, DOI 10.1016/j.molbiopara.2007.11.015; ROTH C, 1989, P NATL ACAD SCI USA, V86, P9375, DOI 10.1073/pnas.86.23.9375; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TAJIMA F, 1989, GENETICS, V123, P585; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Theodoropoulos G, 2001, TRENDS PARASITOL, V17, P130, DOI 10.1016/S1471-4922(00)01775-X; Theron A, 2005, J HELMINTHOL, V79, P187, DOI 10.1079/JOH2005299; Theron A, 1997, EXP PARASITOL, V85, P1, DOI 10.1006/expr.1996.4106; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; VANVALEN L, 1974, J MOL EVOL, V3, P89, DOI 10.1007/BF01796554; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Vitte C, 2005, CYTOGENET GENOME RES, V110, P91, DOI 10.1159/000084941; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	74	54	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2008	2	11							e330	10.1371/journal.pntd.0000330				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	385IM	WOS:000261807900011	19002242	DOAJ Gold, Green Published			2019-04-02	
J	Deborggraeve, S; Boelaert, M; Rijal, S; Doncker, S; Dujardin, JC; Herdewijn, P; Buscher, P				Deborggraeve, Stijn; Boelaert, Marleen; Rijal, Suman; De Doncker, Simonne; Dujardin, Jean-Claude; Herdewijn, Piet; Buscher, Philippe			Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						visceral leishmaniasis; diagnosis; PCR; sensitivity and specificity; diagnostic accuracy; asymptomatic infection	RK39 STRIP TEST; REAL-TIME PCR; BLOOD; IDENTIFICATION; INFANTUM; SAMPLES; TESTS; AZAR; DNA	To develop a new PCR for Leishmania detection and to estimate its diagnostic accuracy in a visceral leishmaniasis (VL) endemic area. After providing the proof-of-concept, the diagnostic accuracy was estimated on blood from 247 non-endemic control persons and on blood and bone marrow from 173 confirmed VL, 39 probable VL and 87 non-VL patients from south-eastern Nepal. The PCR showed a specificity of 99.64% [95% confidence interval (CI): 98.93-100%) on non-endemic controls and a sensitivity of 92.1% (95% CI: 87.6-96.6%) on blood and 92.9% (95% CI: 89-96.8%) on bone marrow from the confirmed VL patients. Leishmania DNA was detected in blood and bone marrow of 67.6% (95% CI: 50.8-80.9%) and 71.8% (95% CI: 56.2-83.5%) of the probable VL patients, respectively, and of 38.2% (95% CI: 28-49.4%) and 29.9% (95% CI: 21.3-40.2%) of the non-VL patients, respectively. The PCR showed 97% concordance with a positive DAT status while for a negative DAT status this was only 41.3% (kappa-index 0.416, 95% CI: 0.30-0.53). Our findings indicate that PCR alone rather provides a marker for infection than a marker for disease and its role in VL diagnosis in endemic regions is discussed.	[Deborggraeve, Stijn; De Doncker, Simonne; Dujardin, Jean-Claude; Buscher, Philippe] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Deborggraeve, Stijn; Herdewijn, Piet] Katholieke Univ Leuven, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Med, Dharan, Nepal	Deborggraeve, S (reprint author), Inst Trop Med, Dept Parasitol, Nationalestr 155, B-2000 Antwerp, Belgium.	sdeborggraeve@itg.be	Boelaert, Marleen/E-2698-2012; Buscher, Philippe/B-9956-2012	Boelaert, Marleen/0000-0001-8051-6776; Buscher, Philippe/0000-0002-1926-7472; Herdewijn, Piet/0000-0003-3589-8503; Deborggraeve, Stijn/0000-0003-1501-5355	INCO-DEV; TRYLEIDIAG [015379]; Flemish Fund for Scientific Research (FWO)	We kindly acknowledge Dr C. Grevelding, Dr F. Portaels and Dr U. D'Alessandro for providing DNA from Schistosoma mansoni, Mycobacterium tuberculosis and Plasmodium falciparum, respectively. This study received financial support from the commission of the European communities' Sixth Framework Programme, priority INCO-DEV, project TRYLEIDIAG, contract 015379 and from the Flemish Fund for Scientific Research (FWO).	[Anonymous], 1990, World Health Organ Tech Rep Ser, V793, P1; Antinori S, 2007, CLIN INFECT DIS, V44, P1602, DOI 10.1086/518167; ARIAS JR, 1985, AM J TROP MED HYG, V34, P1098, DOI 10.4269/ajtmh.1985.34.1098; Boelaert M, 2008, T ROY SOC TROP MED H, V102, P32, DOI 10.1016/j.trstmh.2007.09.003; Boelaert M, 2004, AM J TROP MED HYG, V70, P72, DOI 10.4269/ajtmh.2004.70.72; Chicharro C, 2003, ANN TROP MED PARASIT, V97, P75, DOI 10.1179/000349803225002552; DEBORGGRAEVE S, J INFECT DI IN PRESS; Dereure J, 2001, ANN TROP MED PARASIT, V95, P157, DOI 10.1080/00034980120045284; HAILU A, 1990, T ROY SOC TROP MED H, V84, P673, DOI 10.1016/0035-9203(90)90141-Z; Kongkaew W., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P8; Lachaud L, 2000, J CLIN MICROBIOL, V38, P236; Le Ray D, 1975, Ann Soc Belg Med Trop, V55, P129; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Maurya R, 2005, J CLIN MICROBIOL, V43, P3038, DOI 10.1128/JCM.43.7.3038-3041.2005; Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005; Reale S, 1999, J CLIN MICROBIOL, V37, P2931; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; *UNICEF UNDP WORLD, 2006, 200405 TDR UNICEF UN, P1; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	20	41	44	0	5	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2008	13	11					1378	1383		10.1111/j.1365-3156.2008.02154.x				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	375AV	WOS:000261085800008	18803611	Bronze			2019-04-02	
J	Mutesa, L; Pierquin, G; Segers, K; Vanbellinghen, JF; Gahimbare, L; Bours, V				Mutesa, Leon; Pierquin, Genevieve; Segers, Karin; Vanbellinghen, Jean Francois; Gahimbare, Laetitia; Bours, Vincent			Spinocerebellar Ataxia Type 2 (SCA2): Clinical Features and Genetic Analysis	JOURNAL OF TROPICAL PEDIATRICS			English	Article						Spinocerebellar ataxia 2; autosomal dominant; CAG repeats; Central African patients	DOMINANT CEREBELLAR-ATAXIA; REPEAT EXPANSION; TRINUCLEOTIDE REPEAT; CAG REPEAT; FAMILIES	Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neurodegenerative disease that results from the expansion of an unstable trinucleotide CAG repeat encoding for a polyglutamine tract. In normal individuals, alleles contain between 14 and 31 CAG repeats, whereas the pathological alleles have more than 35 CAG repeats. The clinical phenotype of SCA2 includes a progressive cerebellar ataxia with additional features such as ophthalmoplegia, extra-pyramidal or pyramidal signs and peripheral neuropathy. We report a SCA2 large African family with several affected individuals. A major pathological allele carrying 43 CAG repeats was identified in the proband. To our knowledge, this is a first report of a SCA disorder described in Central African patients, thus indicating the need to consider this diagnosis in young African ataxic patients.	[Mutesa, Leon; Pierquin, Genevieve; Segers, Karin; Vanbellinghen, Jean Francois; Bours, Vincent] Univ Liege, CHU, Ctr Human Genet, B-4000 Liege, Belgium; [Mutesa, Leon] Natl Univ Rwanda, CHU Butare, Med Genet Lab, Butare, Rwanda; [Gahimbare, Laetitia] Natl Univ Rwanda, CHU Kigali, Dept Biol Clin, Butare, Rwanda	Bours, V (reprint author), Univ Liege, CHU Sart Tilman, Ctr Human Genet, B-4000 Liege, Belgium.	vbours@ulg.ac.be					Babovic-Vuksanovic D, 1998, AM J MED GENET, V79, P383; Burk K, 1996, BRAIN, V119, P1497, DOI 10.1093/brain/119.5.1497; Cancel G, 1997, HUM MOL GENET, V6, P709, DOI 10.1093/hmg/6.5.709; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; Giunti P, 1998, BRAIN, V121, P459, DOI 10.1093/brain/121.3.459; Herman-Bert A, 2000, AM J HUM GENET, V67, P229, DOI 10.1086/302958; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Klockgether T, 1998, TRENDS NEUROSCI, V21, P413, DOI 10.1016/S0166-2236(98)01315-0; Moseley ML, 1998, NEUROLOGY, V51, P1666, DOI 10.1212/WNL.51.6.1666; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Riess O, 1997, NEUROGENETICS, V1, P59, DOI 10.1007/s100480050009; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Yamashita I, 2000, ANN NEUROL, V48, P156, DOI 10.1002/1531-8249(200008)48:2<156::AID-ANA4>3.0.CO;2-9; Zhou YX, 1998, NEUROLOGY, V51, P595, DOI 10.1212/WNL.51.2.595; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	16	8	10	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	OCT	2008	54	5					350	352		10.1093/tropej/fmn034				3	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	359GV	WOS:000259975300013	18499737	Bronze, Green Published			2019-04-02	
J	Grietens, KP; Boock, AU; Peeters, H; Hausmann-Muela, S; Toomer, E; Ribera, JM				Grietens, Koen Peeters; Boock, Alphonse Um; Peeters, Hans; Hausmann-Muela, Susanna; Toomer, Elizabeth; Ribera, Joan Muela			"It Is Me Who Endures but My Family That Suffers": Social Isolation as a Consequence of the Household Cost Burden of Buruli Ulcer Free of Charge Hospital Treatment	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MYCOBACTERIUM-ULCERANS; TUBERCULOSIS; DISEASE	Despite free of charge biomedical treatment, the cost burden of Buruli ulcer disease (Bu) hospitalisation in Central Cameroon accounts for 25% of households' yearly earnings, surpassing the threshold of 10%, which is generally considered catastrophic for the household economy, and calling into question the sustainability of current Bu programmes. The high non-medical costs and productivity loss for Bu patients and their households make household involvement in the healing process unsustainable. 63% of households cease providing social and financial support for patients as a coping strategy, resulting in the patient's isolation at the hospital. Social isolation itself was cited by in-patients as the principal cause for abandonment of biomedical treatment. These findings demonstrate that further research and investment in Bu are urgently needed to evaluate new intervention strategies that are socially acceptable and appropriate in the local context.	[Grietens, Koen Peeters; Hausmann-Muela, Susanna; Toomer, Elizabeth; Ribera, Joan Muela] PASS Int, Louvain, Belgium; [Grietens, Koen Peeters; Boock, Alphonse Um] Inst Trop Med, B-2000 Antwerp, Belgium; [Peeters, Hans] Aide Lepreux Emmaus Suisse, Alphonse Boock, Bern, Switzerland; [Peeters, Hans] Katholieke Univ Leuven, Louvain, Belgium	Grietens, KP (reprint author), PASS Int, Louvain, Belgium.	joanmuela@terra.es		Peeters Grietens, Koen/0000-0001-6570-9887	Aide aux Lepreux Emmaus Suisse (ALES), Berne, Switzerland	The field work was funded by Aide aux Lepreux Emmaus Suisse (ALES), Berne, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJOULAT I, 2003, TROP MED INT HEALTH, V8, P750; American Anthropological Association, 2004, AM ANTHR ASS STAT ET; American Anthropological Association, 2008, COD ETH AM ANTHR ASS; Johnson PDR, 2005, PLOS MED, V2, P282, DOI 10.1371/journal.pmed.00201108; Lonnroth K, 2001, SOC SCI MED, V52, P935, DOI 10.1016/S0277-9536(00)00195-7; Needham DM, 2001, TROP MED INT HEALTH, V6, P256, DOI 10.1046/j.1365-3156.2001.00709.x; Noeske J, 2004, AM J TROP MED HYG, V70, P520, DOI 10.4269/ajtmh.2004.70.520; Portaels F, 2001, REV SCI TECH OIE, V20, P252, DOI 10.20506/rst.20.1.1270; Prescott N, 1999, C SOC PROT POV; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Stienstra Y, 2002, AM J TROP MED HYG, V67, P207, DOI 10.4269/ajtmh.2002.67.207; STIENSTRA Y, 2005, THESIS GRONINGEN U; Um Boock A, 2004, LEPRA AID INTERNAL R; United Nations (UN), 2005, UNDP HUM DEV REP; Wansbrough-Jones M, 2006, LANCET, V367, P1849, DOI 10.1016/S0140-6736(06)68807-7; *WORLD BANK, 2004, CAM GLANC	17	47	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2008	2	10							e321	10.1371/journal.pntd.0000321				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	385IL	WOS:000261807800012	18923711	DOAJ Gold, Green Published			2019-04-02	
J	Walsh, DS; Portaels, F; Meyers, WM				Walsh, Douglas S.; Portaels, Francoise; Meyers, Wayne M.			Buruli ulcer (Mycobacterium ulcerans infection)	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Review						Buruli ulcer; Mycobacterium ulcerans; Mycobacteria; Infection; Emerging diseases; Review	HIV-POSITIVE PATIENT; HOST IMMUNE-RESPONSE; SOUTHEASTERN AUSTRALIA; MACROLIDE TOXIN; SOUTHERN BENIN; SKIN-LESIONS; RISK-FACTORS; DISEASE; MYCOLACTONE; PCR	Mycobacterium ulcerans is an emerging infection that causes indolent, necrotizing skin lesions known as Buruli ulcer (BU). Bone lesions may include reactive osteitis or osteomyelitis beneath skin lesions, or metastatic osteomyelitis from lymphohematogenous spread of M. ulcerans. Pathogenesis is related to a necrotizing and immunosuppressive toxin produced by M. ulcerans, called mycolactone. The incidence of BU is highest in children up to 15 years old, and is a major public health problem in endemic countries due to disabling scarring and destruction of bone. Most patients live in West Africa, but the disease has been confirmed in at least 30 countries. Treatment options for BU are antibiotics and surgery. BCG vaccination provides short-term protection against M. ulcerans infection and prevents osteomyelitis. HIV infection may increase risk for BU, and renders BU highly aggressive. Unlike leprosy and tuberculosis, BU is related to environmental factors and is thus considered non-communicable. The most plausible mode of transmission is by skin trauma at sites contaminated by M. ulcerans. The reemergence of BU around 1980 may be attributable to environmental factors such as deforestation, artificial topographic alterations and increased manual agriculture of wetlands. The first cultivation of M. ulcerans from nature was reported in 2008. (c) Published by Elsevier Ltd on behalf of Royal Society of Tropical Medicine and Hygiene.	[Walsh, Douglas S.] USAMRU K, Walter Reed Project, Kisumu 10400, Kenya; [Portaels, Francoise] Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Meyers, Wayne M.] Armed Forces Inst Pathol, Dept Environm & Infect Dis Sci, Washington, DC 20306 USA	Walsh, DS (reprint author), USAMRU K, Walter Reed Project, POB 54, Kisumu 10400, Kenya.	dwalsh@wrp-ksm.org					Ablordey A, 2005, J CLIN MICROBIOL, V43, P448, DOI 10.1128/JMC.43.1.448-451.2005; Addo P, 2005, Ghana Med J, V39, P86; Adusumilli S, 2005, CELL MICROBIOL, V7, P1295, DOI 10.1111/j.1462-5822.2005.00557.x; Aguiar J, 1997, Med Trop (Mars), V57, P83; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P145; Asiedu K, 1998, AM J TROP MED HYG, V59, P1015, DOI 10.4269/ajtmh.1998.59.1015; Aujoulat I, 2003, TROP MED INT HEALTH, V8, P750, DOI 10.1046/j.1365-3156.2003.01089.x; Chauty A, 2007, ANTIMICROB AGENTS CH, V51, P4029, DOI 10.1128/AAC.00175-07; Coutanceau E, 2005, CELL MICROBIOL, V7, P1187, DOI 10.1111/j.1462-5822.2005.00546.x; DAFFE M, 1992, J GEN MICROBIOL, V138, P131, DOI 10.1099/00221287-138-1-131; Debacker M, 2005, EMERG INFECT DIS, V11, P584, DOI 10.3201/eid1104.041000; Debacker M, 2004, TROP MED INT HEALTH, V9, P1297, DOI 10.1111/j.1365-3156.2004.01339.x; Debacker M, 2004, EMERG INFECT DIS, V10, P1391, DOI 10.3201/eid1008.030886; Debacker M, 2003, CLIN INFECT DIS, V36, pE67, DOI 10.1086/367660; DODGE OG, 1964, J PATHOL BACTERIOL, V88, P167, DOI 10.1002/path.1700880122; DODGE OG, 1962, J TROP MED HYG, V65, P139; Duker AA, 2006, ENVIRON INT, V32, P567, DOI 10.1016/j.envint.2006.01.002; Eddyani M, 2008, J CLIN MICROBIOL, V46, P69, DOI 10.1128/JCM.00301-07; En J, 2008, INFECT IMMUN, V76, P2002, DOI 10.1128/IAI.01588-07; Evans MRW, 2003, BRIT J DERMATOL, V149, P907, DOI 10.1046/j.1365-2133.2003.05562.x; Faber WR, 2000, T ROY SOC TROP MED H, V94, P277, DOI 10.1016/S0035-9203(00)90320-1; Fine PEM, 1996, LANCET, V348, P17; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Guarner J, 2003, EMERG INFECT DIS, V9, P651; GUERRA H, 2008, PERU EMERG INFECT DI, V14, P373; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Johnson RC, 2002, AIDS, V16, P1704, DOI 10.1097/00002030-200208160-00027; Johnson RC, 2008, AIDS, V22, P901, DOI 10.1097/QAD.0b013e3282f7690a; Kiszewski AE, 2006, CLIN EXP IMMUNOL, V143, P445, DOI 10.1111/j.1365-2249.2006.03020.x; KRIEG RE, 1974, ARCH DERMATOL, V110, P783, DOI 10.1001/archderm.110.5.783; MACCALLUM P, 1948, J PATHOL BACTERIOL, V60, P93, DOI 10.1002/path.1700600111; Marsollier L, 2005, CELL MICROBIOL, V7, P935, DOI 10.1111/j.1462-5822.2005.00521.x; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; MARSTON BJ, 1995, AM J TROP MED HYG, V52, P219, DOI 10.4269/ajtmh.1995.52.219; MEYERS WM, 1974, AM J TROP MED HYG, V23, P924, DOI 10.4269/ajtmh.1974.23.924; MEYERS WM, 1974, AM J TROP MED HYG, V23, P919, DOI 10.4269/ajtmh.1974.23.919; Meyers WM, 1996, BRIT J DERMATOL, V134, P1116, DOI 10.1111/j.1365-2133.1996.tb07955.x; MEYERS WM, 1995, TROPICAL PATHOLOGY; Mve-Obiang A, 2003, INFECT IMMUN, V71, P774, DOI 10.1128/IAI.71.2.774-783.2003; Nackers F, 2007, AM J TROP MED HYG, V77, P834, DOI 10.4269/ajtmh.2007.77.834; Nakanaga K, 2007, J CLIN MICROBIOL, V45, P3840, DOI 10.1128/JCM.01041-07; Coloma JNS, 2005, INT J LEPROSY, V73, P5, DOI 10.1489/1544-581X(2005)73[5:UCMDTM]2.0.CO;2; O'Brien DP, 2007, MED J AUSTRALIA, V186, P58; Pahlevan AA, 1999, J IMMUNOL, V163, P3928; Phanzu DM, 2006, AM J TROP MED HYG, V75, P311, DOI 10.4269/ajtmh.2006.75.311; PIMSLER M, 1988, J INFECT DIS, V157, P577, DOI 10.1093/infdis/157.3.577; Portaels F, 2004, INFECT IMMUN, V72, P62, DOI 10.1128/IAI.72.1.62-65.2004; Portaels F, 1999, LANCET, V353, P986, DOI 10.1016/S0140-6736(98)05177-0; Portaels F, 1996, J CLIN MICROBIOL, V34, P962; Portaels F, 2001, REV SCI TECH OIE, V20, P252, DOI 10.20506/rst.20.1.1270; Portaels F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000178; Pouillot R, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000101; Pszolla N, 2003, CLIN INFECT DIS, V37, pE78, DOI 10.1086/377170; Quek TYJ, 2007, EMERG INFECT DIS, V13, P1661, DOI 10.3201/eid1311.061206; READ JK, 1974, INFECT IMMUN, V9, P1114; REVILL WDL, 1970, BRIT MED J, V2, P390; REVILL WDL, 1972, BRIT J PREV SOC MED, V26, P23; Rondini S, 2003, J CLIN MICROBIOL, V41, P4231, DOI 10.1128/JCM.41.9.4231-4237.2003; Ross BC, 1997, APPL ENVIRON MICROB, V63, P4135; Schutte D, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000002; Siegmund V, 2005, J CLIN MICROBIOL, V43, P271, DOI 10.1128/JCM.43.1.271-276.2005; Stienstra Y, 2006, GENES IMMUN, V7, P185, DOI 10.1038/sj.gene.6364281; Stinear T, 1999, J CLIN MICROBIOL, V37, P1018; Stinear T, 2000, APPL ENVIRON MICROB, V66, P3206, DOI 10.1128/AEM.66.8.3206-3213.2000; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Stragier P, 2006, EMERG INFECT DIS, V12, P844, DOI 10.3201/eid1205.051191; Toll A, 2005, CLIN EXP DERMATOL, V30, P649, DOI 10.1111/j.1365-2230.2005.01892.x; Torrado E, 2007, INFECT IMMUN, V75, P977, DOI 10.1128/IAI.00889-06; *UG BUR GROUP, 1969, LANCET, V1, P111; Veitch MGK, 1997, EPIDEMIOL INFECT, V119, P313, DOI 10.1017/S0950268897008273; Walsh DS, 2007, AM J TROP MED HYG, V76, P132, DOI 10.4269/ajtmh.2007.76.132; Walsh DS, 2005, AM J TROP MED HYG, V73, P410, DOI 10.4269/ajtmh.2005.73.410; Walsh DS, 1999, AM J TROP MED HYG, V61, P694, DOI 10.4269/ajtmh.1999.61.694; Walsh GP, 1996, NAT MED, V2, P430, DOI 10.1038/nm0496-430; Wansbrough-Jones M, 2006, LANCET, V367, P1849, DOI 10.1016/S0140-6736(06)68807-7; World Health Organization, 2001, WHOCDSCPEGBUI20013; World Health Organization, 2006, WHOCDSNTDGBUI200612; World Health Organization, 2004, WHOCDSCPEGBUI2004, P10	79	53	53	2	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	OCT	2008	102	10					969	978		10.1016/j.trstmh.2008.06.006				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	360UI	WOS:000260083000004	18657836				2019-04-02	
J	Mahendradhata, Y; Ahmad, RA; Kusuma, TA; Boelaert, M; Van der Werf, MJ; Kimerling, ME; Van der Stuyft, P				Mahendradhata, Yodi; Ahmad, Riris A.; Kusuma, Theodorus A.; Boelaert, Marleen; Van der Werf, Marieke J.; Kimerling, Michael E.; Van der Stuyft, Patrick			Voluntary counselling and testing uptake and HIV prevalence among tuberculosis patients in Jogjakarta, Indonesia	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Tuberculosis; HIV; VCT; Surveillance; Indonesia	RANDOMIZED-TRIAL; RISK BEHAVIOR; UGANDA; SEROPREVALENCE; COINFECTION; PREVENTION; PROGRAM	We aimed to establish HIV prevalence and uptake of unlinked anonymous testing and voluntary counselling and testing (VCT) among tuberculosis (TB) patients in Jogjakarta, Indonesia. We introduced unlinked anonymous HIV testing for TB patients attending directly observed treatment, short-course services between April and December 2006. Patients were additionally offered VCT services. Of 1269 TB patients who were offered unlinked anonymous testing, 989 (77.9%; 95% CI 75.6-80.1%) accepted. HIV prevalence was 1.9% (95% CI 1.6-2.2%). HIV infections were less frequently diagnosed among TB patients who attended a public health centre [odds ratio (OR) 0.15; 95% CI 0.03-0.70] rather than public hospital. They were more frequent in TB patients with a university education background (OR 5.16; 95% CI 1.01-26.63) or a history of HIV testing (OR 57.87; 95% CI 9.42-355.62). Of the 989 patients who accepted unlinked anonymous testing, only 133 (13.4%; 95% CI 11.5-15.7%) expressed interest in VCT Of these, 52 (39.1%; 95% CI 31.2-47.6%) attended VCT but interest was higher among students and those offered VCT by public health centres. The HIV prevalence in Jogjakarta is higher than expected and needs to be monitored cautiously. Unlinked anonymous HIV testing is well accepted and can be implemented with modest additional efforts. (c) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Mahendradhata, Yodi; Boelaert, Marleen; Van der Stuyft, Patrick] Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Mahendradhata, Yodi; Ahmad, Riris A.] Gadjah Mada Univ, Dept Publ Hlth, Fac Med, Sekip Utara 55281, Jogjakarta, Indonesia; [Kusuma, Theodorus A.] Gadjah Mada Univ, Asia Link TB HIV Project, Fac Med, Sekip Utara 55281, Jogjakarta, Indonesia; [Van der Werf, Marieke J.] KNCV TB Fdn, NL-2501 CC The Hague, Netherlands; [Kimerling, Michael E.] UAB, Sch Med, Div Infect Dis, Gorgas TB Initiat, Birmingham, AL 35294 USA	Mahendradhata, Y (reprint author), Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, Notionalestr 155, B-2000 Antwerp, Belgium.	yodi_mahendradhata@yahoo.co.uk	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Mahendradhata, Yodi/0000-0002-4522-1785	NTP; KNCV; USAID; Belgium Directorate-General for Development and Cooperation	This work was jointly funded by the NTP, KNCV and USAID through the TB Coalition of Technical Assistance. Additional funding was provided by the Belgium Directorate-General for Development and Cooperation.	Bock NN, 2008, INT J TUBERC LUNG D, V12, pS69; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Godfrey-Faussett P, 2002, B WORLD HEALTH ORGAN, V80, P939; Haar CH, 2006, INT J TUBERC LUNG D, V10, P768; Irawati SR, 2007, INT J TUBERC LUNG D, V11, P33; Jerene Degu, 2007, BMC Int Health Hum Rights, V7, P4, DOI 10.1186/1472-698X-7-4; Kassler WJ, 1997, AIDS, V11, P1045, DOI 10.1097/00002030-199708000-00014; Kassler WJ, 1998, INT J STD AIDS, V9, P134, DOI 10.1258/0956462981921882; Mahendradhata Y, 2007, TROP MED INT HEALTH, V12, P1218, DOI 10.1111/j.1365-3156.2007.01946.x; Matovu JKB, 2005, AIDS, V19, P503, DOI 10.1097/01.aids.0000162339.43310.33; *MOH ROI, 2006, 2006 EST HIV INF ADU; *MOH ROI, 2003, NAT GUID TUB CONTR; *MOH ROI, 2006, HIV AIDS NAT DAT 200; Mpairwe H, 2005, JAIDS-J ACQ IMM DEF, V39, P354, DOI 10.1097/01.qai.0000148081.38331.92; *NIHRD, 2003, SIT AN HIV TB PROBL; Organization WH, 2008, WHO REP 2008 GLOB TU; Ramachandran R, 2003, INDIAN J MED RES, V118, P147; Siddiqi K, 2006, TROP MED INT HEALTH, V11, P323, DOI 10.1111/j.1365-3156.2006.01559.x; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; TRINH TT, 2007, PLOS ONE, V2, pE507; *UNAIDS WHO, 2006, 2006 REP GLOB AIDS E; van der Werf MJ, 2007, INT J TUBERC LUNG D, V11, P823; van der Werf MJ, 2006, EMERG INFECT DIS, V12, P766; *WHO, 2007, WHO REP 2007 GLOB TU; *WHO, 2007, GUID PROV IN HIV TES; *WHO, 2004, GUID HIV SURV AMONG; WHO, 2006, WHO REP 2006 GLOB TU; Wolff B, 2005, HEALTH POLICY PLANN, V20, P109, DOI 10.1093/heapol/czi013; World Health Organization, 2004, INT POL COLL TB HIV; World Health Organization and Joint United Nations Programme on HIV/AIDS, 2001, GUID US HIV TEST TEC; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P65	32	13	14	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	OCT	2008	102	10					1003	1010		10.1016/j.trstmh.2008.04.042				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	360UI	WOS:000260083000009	18571213				2019-04-02	
J	De Ryck, I; Koole, O; Wanyenze, R; Colebunders, R				De Ryck, Iris; Koole, Olivier; Wanyenze, Rhoda; Colebunders, Robert			Universal access to HIV care: pitfalls and the way forward	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						HIV care; access; resource limited settings	TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; DEVELOPING-COUNTRIES; INCOME COUNTRIES; ADULT PATIENTS; SCALING-UP; MORTALITY; OUTCOMES; MALAWI		[De Ryck, Iris; Koole, Olivier; Colebunders, Robert] Inst Trop Med, B-2000 Antwerp, Belgium; [De Ryck, Iris; Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium; [Wanyenze, Rhoda] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Colebunders, R (reprint author), Inst Trop Med, Natl St 155, B-2000 Antwerp, Belgium.	bcoleb@itg.be		Koole, Olivier/0000-0002-1122-5382; De Ryck, Iris/0000-0003-3044-1117			Braitstein P, 2006, LANCET, V367, P817; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P1083; Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Homsy J, 2006, JAIDS-J ACQ IMM DEF, V42, P149, DOI 10.1097/01.qai.0000225032.52766.c2; *INT LAB OFF, 2004, HIV AIDS WORK GLOB E; Jerene Degu, 2006, AIDS Res Ther, V3, P10, DOI 10.1186/1742-6405-3-10; Jereni BH, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-17; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Luo C, 2007, REPROD HEALTH MATTER, V15, P179, DOI 10.1016/S0968-8080(07)30327-3; *MED SANS FRONT, 2007, HELP WANT CONFR HLTH; Nakanjako Damalie, 2007, Afr Health Sci, V7, P124; Nakanjako D, 2007, AIDS BEHAV, V11, P753, DOI 10.1007/s10461-006-9180-9; Organisation WH, 2007, TASK SHIFT RAT RED T; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Sobhani R, 2007, INDIAN J MED RES, V126, P116; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; Van Damme W, 2006, AIDS, V20, P653, DOI 10.1097/01.aids.0000216364.44409.b1; Waxman MJ, 2007, AIDS PATIENT CARE ST, V21, P981, DOI 10.1089/apc.2007.0075; *WHO, 2008, GUID PROV IN HIV TES; *WHO, 2006, HIV AIDS PROGR UN AC; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	26	0	0	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2008	13	10					1222	1224		10.1111/j.1365-3156.2008.02135.x				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	358JW	WOS:000259914100001	18764816	Bronze			2019-04-02	
J	Ouedraogo, HZ; Dramaix-Wilmet, M; Zeba, AN; Hennart, P; Donnen, P				Ouedraogo, Hermann Z.; Dramaix-Wilmet, Michele; Zeba, Augustin N.; Hennart, Philippe; Donnen, Philippe			Effect of iron or multiple micronutrient supplements on the prevalence of anaemia among anaemic young children of a malaria-endemic area: a randomized double-blind trial	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						iron; multiple micronutrient; malaria; anaemia; children; Burkina Faso	VITAMIN-A SUPPLEMENTATION; PLACEBO-CONTROLLED TRIAL; PAPUA-NEW-GUINEA; ZINC SUPPLEMENTATION; PRESCHOOL-CHILDREN; PLASMODIUM-FALCIPARUM; INDONESIAN INFANTS; CHILDHOOD ANEMIA; BURKINA-FASO; MORBIDITY	Objective To assess the effect of supplementation with iron or multiple micronutrients (MM) on the prevalence of anaemia in a malaria-endemic area. Methods A community-based randomized double-blind trial was conducted in rural Burkina Faso, including children aged 6-23 months with haemoglobin (Hb) concentrations of 70-109 g/l who were randomized into an iron group (Fe, n = 96), an iron and zinc group (IZ, n = 100) or an MM group (MM, n = 100), 5 days/week for 6 months. All children were provided with insecticide-treated bednets; those who had a Plasmodium falciparum (PF) positive-smear at baseline and/or at each monthly checking received antimalarial therapy. Results The mean (SD) endpoint Hb concentration was higher in the MM group [113.2 (13.6) g/l] than in the IZ group [106.3 (15.6) g/l] and the Fe group [107.1 (12.9) g/l] (P = 0.001). Children in the MM group were more likely to recover from anaemia than those in the Fe group [prevalence rate ratios, PRR (95% confidence interval, CI) = 1.62 (1.22-2.15), P < 0.001]. The IZ group did not differ from the Fe group [PRR (95% CI) = 0.94 (0.65-1.35), P = 0.72]. None of the interactions on the effect of supplementation of baseline age (0.13), or baseline height-for-age z-score (P = 0.33), or incident PF parasitemia (P = 0.99), was significant. Conclusion In this malaria-endemic area, in combination with malaria management, the MM supplement was more efficacious than the Fe supplement and the IZ supplement for reducing anaemia. Further investigation into limiting factors and amounts of micronutrients that would be more efficacious for reducing anaemia is recommended.	[Ouedraogo, Hermann Z.; Zeba, Augustin N.] Inst Res Hlth Sci, Biomed & Publ Hlth Dept, Ouagadougou, Burkina Faso; [Dramaix-Wilmet, Michele] Univ Libre Bruxelles, Sch Publ Hlth, Dept Biostat, Brussels, Belgium; [Hennart, Philippe; Donnen, Philippe] Univ Libre Bruxelles, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Brussels, Belgium	Ouedraogo, HZ (reprint author), Inst Res Hlth Sci, Biomed & Publ Hlth Dept, 03 BP 7192, Ouagadougou, Burkina Faso.	ouedher68@yahoo.fr			'Fonds pour la Recherche Scientifique et Medicale' (FRSM) of Belgium [3.4534.03]; David and Alice Van Buuren Foundation	The study was supported by a grant from the 'Fonds pour la Recherche Scientifique et Medicale' (FRSM) of Belgium (convention no. 3.4534.03), and by the David and Alice Van Buuren Foundation.	Allen L, 2005, J NUTR, V135, p666S; ALLEN LH, 1998, MICRONUTRIENT INTERA, P11; BINKA FN, 1995, AM J CLIN NUTR, V61, P853; BRABIN J, 2001, J NUTR, V131, pS636; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; DESAI MR, 2003, J INFECT DIS, V187, P58; Dewey Kathryn G., 2003, Food and Nutrition Bulletin, V24, P5; Dijkhuizen MA, 2001, J NUTR, V131, P2860; DUNN JT, 1990, PRACTICAL GUIDE CORR; Ekvall H, 2000, TROP MED INT HEALTH, V5, P696, DOI 10.1046/j.1365-3156.2000.00626.x; FASO B, 2005, DIRECTIVES NATL PRIS; Fishman SM, 2000, PUBLIC HEALTH NUTR, V3, P125, DOI 10.1017/S1368980000000173; Gentilini M, 1993, MED TROPICALE; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; *IRIS 1 STUD GROUP, 2003, FOOD NUTR B S3, V24, P27; Kamp F., 2003, FOOD NUTR B S3, V24, P20; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Lemeshow S, 1985, World Health Stat Q, V38, P65; Lind T, 2003, AM J CLIN NUTR, V77, P883; LONNERDAL B, 1998, MICRONUTRIENT INTERA, P3; MEASUREDHS, 2004, B FASO ENQUETE DEMOG; MI/ UNICEF, 2004, VIT MIN DEF GLOB PRO; Muller O, 2006, B WORLD HEALTH ORGAN, V84, P120, DOI 10.2471/BLT.05.023150; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Muller O, 2001, BRIT MED J, V322, P1567, DOI 10.1136/bmj.322.7302.1567; OSBORN J, 1995, INT J EPIDEMIOL, V24, P464, DOI 10.1093/ije/24.2.464; OUEDRAOGO HZ, 2004, SCI TECHNIQUE, V1, P27; POWERS HJ, 1998, MICRONUTRIENT INTERA, P36; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; SCHULTINK W, 1998, MICRONUTRIENTS INTER, P28; Semba RD, 2002, EUR J CLIN NUTR, V56, P271, DOI [10.1038/sj.ejcn.1601320, 10.1038/sj/ejcn/1601320]; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2; Shankar AH, 2000, AM J TROP MED HYG, V62, P663, DOI 10.4269/ajtmh.2000.62.663; SMUTS CM, 2005, J NUTR, V135, P631; Stich A, 2006, PARASITOL RES, V98, P596, DOI 10.1007/s00436-005-0104-9; Stoltzfus RJ, 2004, J NUTR, V134, P348; TRAORE C, 2003, EPIDEMIOLOGY MALARIA; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; *WHO, 2007, FOOD NUTR BULL, V28, pS621; WHO, 2000, NEW PERSP MAL DIAGN; WHO, 2002, REP WHO INF CONS US; WHO, 2001, IR DEF AN ASS PREV C; *WHO UNICEF, 2004, FOC AN INT APPR EFF; WHO(World Health Organ.), 1995, PHYS STAT US INT ANT; Wieringa FT, 2007, J NUTR, V137, P466; ZAGRE N, 2000, CAHIERS SANTE, V12, P38	48	13	13	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2008	13	10					1257	1266		10.1111/j.1365-3156.2008.02138.x				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	358JW	WOS:000259914100005	18764815	Bronze			2019-04-02	
J	Gradoni, L; Soteriadou, K; Louzir, H; Dakkak, A; Toz, SO; Jaffe, C; Dedet, JP; Campino, L; Canavate, C; Dujardin, JC				Gradoni, Luigi; Soteriadou, Ketty; Louzir, Hecmi; Dakkak, Allal; Toz, Seray Ozensoy; Jaffe, Charles; Dedet, Jean-Pierre; Campino, Lenea; Canavate, Carmen; Dujardin, Jean-Claude			Drug regimens for visceral leishmaniasis in Mediterranean countries	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Mediterranean visceral leishmaniasis; Leishmania infantum; therapy; pentavalent antimony; amphotericin B; miltefosine	AMPHOTERICIN-B	Until the early 1990s, pentavalent antimony was the only documented first-line drug employed for the treatment of zoonotic visceral leishmaniasis (VL) in the Mediterranean, with reported cure rates exceeding 95% in immunocompetent patients. The emergence of antimony resistance in other endemic settings and the increase in drug options have stimulated re-evaluation of the current therapeutic approaches and outcomes in Mediterranean countries. A scientific consortium ('LeishMed' network) collected updated information from collaborating clinical health centres of 11 endemic countries of Southern Europe, Northern Africa and the Middle East. In contrast with the previous situation, VL is now treated differently in the region, basically through three approaches: (1) In Northern Africa and in part of the Middle East, pentavalent antimony is still the mainstay for therapy, with no alternative drug options for treating relapses; (2) In some European countries and Israel, both pentavalent antimony and lipid-associated amphotericin B (AmB) formulations are used as first-line drugs, although in different patients' categories; (3) In other countries of Europe, mainly liposomal AmB is employed. Importantly, cure rates exhibited by different drugs, including antimonials in areas where they are still in routine use, are similarly high (>= 95%) in immunocompetent patients. Our findings show that antimony resistance is not an emerging problem in the Mediterranean. A country's wealth affects the treatment choice, which represents a balance between drug efficacy, toxicity and cost, and costs associated with patient's care.	[Gradoni, Luigi] Ist Super Sanita, MIPI Dept, Unit Vector Borne Dis & Int Hlth, I-00161 Rome, Italy; [Soteriadou, Ketty] Hellenic Pasteur Inst, Athens, Greece; [Louzir, Hecmi] Inst Pasteur, Tunis, Tunisia; [Dakkak, Allal] Inst Agron & Vet Hassan II, Rabat, Morocco; [Toz, Seray Ozensoy] Ege Univ, Dept Parasitol, Sch Med, Izmir, Turkey; [Jaffe, Charles] Hebrew Univ Jerusalem, Jerusalem, Israel; [Dedet, Jean-Pierre] Univ Montpellier, Lab Parasitol Mycol, F-34059 Montpellier, France; [Campino, Lenea] Inst Higiene & Med Trop, Lisbon, Portugal; [Canavate, Carmen] Inst Salud Carlos III, Madrid, Spain; [Dujardin, Jean-Claude] Inst Trop Med, B-2000 Antwerp, Belgium	Gradoni, L (reprint author), Ist Super Sanita, MIPI Dept, Unit Vector Borne Dis & Int Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	luigi.gradoni@iss.it	Campino, Lenea/J-6835-2012; GRADONI, LUIGI/C-4962-2016; santos, sofia/I-1637-2012; Campino, Lenea/I-6375-2012	Campino, Lenea/0000-0003-4512-9660	EU [INCO-CT-2004509086]	This work was supported by EU grant INCO-CT-2004509086 (LeishMed).	Bern C, 2006, CLIN INFECT DIS, V43, P917, DOI 10.1086/507530; Carrio Jaume, 2002, BMC Pharmacol, V2, P11, DOI 10.1186/1471-2210-2-11; den Boer Margriet, 2006, Expert Rev Anti Infect Ther, V4, P187, DOI 10.1586/14787210.4.2.187; Deray G, 2002, J ANTIMICROB CHEMOTH, V49, P37, DOI 10.1093/jac/49.suppl_1.37; DESJEUX P, 2002, ANN TROP MED PARASIT, V97, pS3; Dujardin JC, 2006, TRENDS PARASITOL, V22, P4, DOI 10.1016/j.pt.2005.11.004; Gradoni L, 2003, EMERG INFECT DIS, V9, P1617, DOI 10.3201/eid0912.030178; GRADONI L, 1995, B WORLD HEALTH ORGAN, V73, P191; GRAMICCIA M, 1992, ANN TROP MED PARASIT, V86, P613, DOI 10.1080/00034983.1992.11812717; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; Kafetzis DA, 2005, INT J ANTIMICROB AG, V25, P26, DOI 10.1016/j.ijantimicag.2004.09.011; Sundar S, 2002, CURR OPIN INFECT DIS, V15, P593, DOI 10.1097/01.qco.0000044778.05458.f9	12	48	49	0	9	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2008	13	10					1272	1276		10.1111/j.1365-3156.2008.02144.x				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	358JW	WOS:000259914100007	18764817				2019-04-02	
J	Gies, S; Coulibaly, SO; Ouattara, FT; Ky, C; Brabin, BJ; D'Alessandro, U				Gies, Sabine; Coulibaly, Sheick Oumar; Ouattara, Florence Tiemegna; Ky, Clotilde; Brabin, Bernard John; D'Alessandro, Umberto			A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso	MALARIA JOURNAL			English	Article							LOW-BIRTH-WEIGHT; PLACENTAL MALARIA; UNCOMPLICATED MALARIA; EFFICACY; CHLOROQUINE; DELIVERY; AFRICA; BURDEN; CARE; CHEMOPROPHYLAXIS	Background: Intermittent preventive treatment with sulphadoxine-pyrimethamine for pregnant women (IPTp-SP) is currently being scaled up in many countries in sub-Saharan Africa. Despite high antenatal clinic (ANC) attendance, coverage with the required two doses of SP remains low. The study investigated whether a targeted community-based promotion campaign to increase ANC attendance and SP uptake could effectively improve pregnancy outcomes in the community. Methods: Between 2004 and 2006 twelve health centres in Boromo Health District, Burkina Faso were involved in this study. Four were strategically assigned to community promotion in addition to IPTp-SP (Intervention A) and eight were randomly allocated to either IPTp-SP (Intervention B) or weekly chloroquine (Control). Primi-and secundigravidae were enrolled at village level and thick films and packed cell volume (PCV) taken at 32 weeks gestation and at delivery. Placental smears were prepared and newborns weighed. Primary outcomes were peripheral parasitaemia during pregnancy and at delivery, placental malaria, maternal anaemia, mean and low birth weight. Secondary outcomes were the proportion of women with = 3 ANC visits and = 2 doses of SP. Intervention groups were compared using logistic and linear regression with linearized variance estimations to correct for the cluster-randomized design. Results: SP uptake (= 2 doses) was higher with (Intervention A: 70%) than without promotion (Intervention B: 49%) (OR 2.45 95% CI 1.25-4.82 p = 0.014). Peripheral (33.3%) and placental (30.3%) parasite rates were significantly higher in the control arm compared to Intervention B (peripheral: 20.1% OR 0.50 95% CI 0.37-0.69 p = 0.001; placental: 20.5% OR 0.59 95% CI 0.44-0.78 p = 0.002) but did not differ between Intervention A (17.4%; 18.1%) and Intervention B (20.1; 20.5%) (peripheral: OR 0.84 95% CI 0.60-1.18 p = 0.280; placental: OR 0.86 95% CI 0.58-1.29 p = 0.430). Mean PCV and birth weight and prevalence of anaemia and low birth weight did not differ between study arms. Conclusion: The promotional campaign resulted in a major increase in IPTp- coverage, with two thirds of women at delivery having received = 2 SP. Despite lower prevalence of malaria infection this did not translate into a significant difference in maternal anaemia or birth weight. This data provides evidence that, as with immunization programmes, extremely high coverage is essential for effectiveness. This critical threshold of coverage needs to be defined, possibly on a regional basis.	[Gies, Sabine; D'Alessandro, Umberto] Inst Trop Med, Dept Parasitol, Epidemiol & Control Parasit Dis Unit, B-2000 Antwerp, Belgium; [Coulibaly, Sheick Oumar] Univ Ouagadougou, UFR Sci Sante, Ouagadougou, Burkina Faso; [Coulibaly, Sheick Oumar; Ky, Clotilde] Lab Natl Sante Publ, Ouagadougou, Burkina Faso; [Brabin, Bernard John] Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England; [Brabin, Bernard John] Univ Amsterdam, Acad Med Ctr, Emma Kinderziekenhuis, NL-1105 AZ Amsterdam, Netherlands	Gies, S (reprint author), Inst Trop Med, Dept Parasitol, Epidemiol & Control Parasit Dis Unit, B-2000 Antwerp, Belgium.	sgies@itg.be; sheickoumar2@yahoo.fr; ouattaraflorence@yahoo.fr; clotildeky@yahoo.fr; B.J.Brabin@liverpool.ac.uk; udalessandro@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009	European Union [IC4-CT-2002-10022]; Belgian co-operation (DGDC)	We thank the participating villages in Boromo Health District, the promoters of the health messages in the communities and the team of women field assistants for their cooperation. Thanks are given to the staff of Boromo Health District, particularly in the study health centres and the laboratory. Thanks also to the data management unit at Centre Muraz for data entry and help with data management. This work was supported by the European Union INCO-DEV programme (contract IC4-CT-2002-10022). SG was partly supported by the Belgian co-operation (DGDC) through the framework agreement ITM, Antwerp-Centre Muraz, Bobo-Dioulasso. Neither funding source had any role in the work described or the decision to submit for publication.	[Anonymous], 1999, COMP MULT SUPPL US P; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Bulatao RA, 2002, B WORLD HEALTH ORGAN, V80, P721; Coulibaly SO, 2007, AM J TROP MED HYG, V77, P56, DOI 10.4269/ajtmh.2007.77.56; Coulibaly SO, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-49; COULIBALY SO, 2006, THESIS U COPENHAGEN; Crawley J, 2007, LANCET INFECT DIS, V7, P145, DOI 10.1016/S1473-3099(07)70026-9; Denoeud L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-27; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Garner P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub2; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Hommerich L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-144; *I NAT STAT DEM, 2004, OUAGADOUGOU; KASEJE D C O, 1987, Annals of Tropical Medicine and Parasitology, V81, P77; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)71145-4; Mbonye AK, 2007, TROP MED INT HEALTH, V12, P519, DOI 10.1111/j.1365-3156.2007.01819.x; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; MEISSNER PE, 2007, ACTA TROP; *MIN SANT, 2006, OUAGADOUGOU; MUTABINGWA TK, 1993, TROP GEOGR MED, V45, P49; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Rogerson SJ, 2003, J CLIN MICROBIOL, V41, P1370, DOI 10.1128/JCM.41.4.1370-1374.2003; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; SCHULTZ LJ, 1994, AM J TROP MED HYG, V51, P515, DOI 10.4269/ajtmh.1994.51.515; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Sirima SB, 2006, AM J TROP MED HYG, V75, P205, DOI 10.4269/ajtmh.2006.75.205; Steketee RW, 1996, AM J TROP MED HYG, V55, P2, DOI 10.4269/ajtmh.1996.55.2; Steketee RW, 1996, AM J TROP MED HYG, V55, P17, DOI 10.4269/ajtmh.1996.55.17; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; ter Kuile FO, 2007, J INFECT DIS, V196, P1574, DOI 10.1086/522233; Tinto H, 2002, TROP MED INT HEALTH, V7, P925, DOI 10.1046/j.1365-3156.2002.00952.x; Tinto H, 2007, AM J TROP MED HYG, V76, P608, DOI 10.4269/ajtmh.2007.76.608; WHO, 2000, 20 WHO; *WHO, 2005, GLOB STRAT PLAN 2005; *WHO, 1986, 18 WHO; WHO, 2004, STRAT FRAM MAL PREV; WHO, 2003, PREGN CHILDB POSTP N	39	29	29	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 18	2008	7								180	10.1186/1475-2875-7-180				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	359UD	WOS:000260012700001	18801158	DOAJ Gold, Green Published			2019-04-02	
J	Culleton, RL; Mita, T; Ndounga, M; Unger, H; Cravo, PVL; Paganotti, GM; Takahashi, N; Kaneko, A; Eto, H; Tinto, H; Karema, C; D'Alessandro, U; do Rosario, V; Kobayakawa, T; Ntoumi, F; Carter, R; Tanabe, K				Culleton, Richard L.; Mita, Toshihiro; Ndounga, Mathieu; Unger, Holger; Cravo, Pedro V. L.; Paganotti, Giacomo M.; Takahashi, Nobuyuki; Kaneko, Akira; Eto, Hideaki; Tinto, Halidou; Karema, Corine; D'Alessandro, Umberto; do Rosario, Virgilio; Kobayakawa, Takatoshi; Ntoumi, Francine; Carter, Richard; Tanabe, Kazuyuki			Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing	MALARIA JOURNAL			English	Article							POLYMERASE-CHAIN-REACTION; RESISTANCE-CONFERRING MUTATIONS; HUMAN MALARIA PARASITES; UNITED-STATES; FALCIPARUM; SURVEILLANCE; SUSCEPTIBILITY; TRANSMISSION; INDIVIDUALS; EXPRESSION	Background: Plasmodium vivax is estimated to affect 75 million people annually. It is reportedly absent, however, from west and central Africa due to the high prevalence of the Duffy negative phenotype in the indigenous populations. Despite this, non-African travellers consistently return to their own countries with P. vivax malaria after visiting this region. An attempt was made, therefore, to detect the presence of P. vivax parasites in blood samples collected from the indigenous populations of west and central Africa. Methods: Parasite species typing (for all four human malaria parasites) was carried out by PCR on 2,588 blood samples collected from individuals from nine African malaria-endemic countries. Results: Most infections (98.5%) were Plasmodium falciparum, Plasmodium malariae was identified in 8.5% of all infections, and Plasmodium ovale in 3.9%. The prevalence of both parasites varied greatly by country. Only one case of P. vivax was detected from Sao Tome, an island off the west coast of Africa, confirming the scarcity of this parasite in Africa. Conclusion: The prevalence of P. vivax in local populations in sub-Saharan Africa is very low, despite the frequent identification of this parasite in non-African travellers.	[Culleton, Richard L.; Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Malariol, Osaka, Japan; [Mita, Toshihiro; Takahashi, Nobuyuki; Eto, Hideaki; Kobayakawa, Takatoshi] Tokyo Womens Med Univ, Tokyo, Japan; [Ndounga, Mathieu] Ctr Etud Resources Vegetales, Brazzaville, Rep Congo; [Unger, Holger] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Cravo, Pedro V. L.; do Rosario, Virgilio] Ctr Malaria & Outras Doencas Tropicais, Lisbon, Portugal; [Kaneko, Akira] Karolinska Univ Hosp, Dept Med, Solna, Sweden; [Paganotti, Giacomo M.] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Ntoumi, Francine] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [Tinto, Halidou] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Karema, Corine] Programme Natl Lutte Integree Paludisme, Kigali, Rwanda; [Culleton, Richard L.] Nagasaki Univ, Inst Trop Med, Dept Protozool, Nagasaki 852, Japan	Culleton, RL (reprint author), Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Malariol, Osaka, Japan.	richard@nagasaki-u.ac.jp; hiro-tm@research.twmu.ac.jp; ngoualandounga@yahoo.fr; hwunger@doctors.org.uk; PCravo@ihmt.unl.pt; Giacomo.Paganotti@uniroma1.it; nobuyuki@research.twmu.ac.jp; akira.kaneko@ki.se; etohide@research.twmu.ac.jp; tintohalidou@yahoo.fr; corine_kk@yahoo.fr; UDAlessandro@itg.be; CMDT@ihmt.unl.pt; taka@research.twmu.ac.jp; ffntoumi@hotmail.com; rcarter@staffmail.ed.ac.uk; kztanabe@bkns01.biken.osaka-u.ac.jp	D'Alessandro, Umberto/D-3457-2015; Cravo, Pedro/G-3532-2012; santos, sofia/I-1637-2012	D'Alessandro, Umberto/0000-0001-6341-5009; Cravo, Pedro/0000-0003-1675-4504; , Akira/0000-0003-2411-3352; Tinto, Halidou/0000-0002-0472-3586; Culleton, Richard/0000-0001-8808-5771	Japanese Ministry of Education, Culture, Sports, Science and Technology [18073013]; Japan Society for the Promotion of Science [17-05495, 18390131, 18GS03140013]; John Scaife Fund, Edinburgh	This study was supported by Grant-in-Aid for Scientific Research on Priority Areas from The Japanese Ministry of Education, Culture, Sports, Science and Technology (18073013) and Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (17-05495, 18390131, 18GS03140013). We are grateful for a travel award to HU from the John Scaife Fund, Edinburgh. We thank Dr. Rikard Dryselius for helpful discussion, and Dr. Naoko Sakihama for technical assistance.	Blossom DB, 2005, AM J TROP MED HYG, V73, P188, DOI 10.4269/ajtmh.2005.73.188; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, P158; CAVASINI CE, 2007, T R SOC TROP MED HYG, V101, P2; ELIADES MJ, 2003, MMWR SURVEILL SUMM, V54, P25; Fernandes N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-35; Ferreira ID, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-1; Filler Scott, 2003, MMWR Surveill Summ, V52, P1; GARNHAM PCC, 1966, MALARIA PARASITES OT, P116; Gautret P, 2001, ACTA TROP, V78, P177, DOI 10.1016/S0001-706X(00)00181-9; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; HADLEY TJ, 1994, J CLIN INVEST, V94, P985, DOI 10.1172/JCI117465; Horuk R, 1997, J IMMUNOL, V158, P2882; Marques PX, 2005, INT J BIOL SCI, V1, P96; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Muhlberger N, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-5; Olsson ML, 1998, TRANSFUSION, V38, P168, DOI 10.1046/j.1537-2995.1998.38298193099.x; Paganotti GM, 2006, PARASITOLOGY, V132, P607, DOI 10.1017/S0031182005009601; Pimentel S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-30; Polski JM, 1998, J CLIN PATHOL-MOL PA, V51, P215, DOI 10.1136/mp.51.4.215; Rosenberg R, 2007, TRENDS PARASITOL, V23, P193, DOI 10.1016/j.pt.2007.02.009; Rubio JM, 1999, AM J TROP MED HYG, V60, P183, DOI 10.4269/ajtmh.1999.60.183; Ryan JR, 2006, AM J TROP MED HYG, V75, P575, DOI 10.4269/ajtmh.2006.75.575; Shah Snehal, 2004, Morbidity and Mortality Weekly Report, V53, P21; Skarbinski Jacek, 2006, Morbidity and Mortality Weekly Report, V55, P23; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Snounou G, 1998, ACTA TROP, V70, P197, DOI 10.1016/S0001-706X(98)00021-7; Thwing Julie, 2007, Morbidity and Mortality Weekly Report, V56, P23; Tinto H, 2006, T ROY SOC TROP MED H, V100, P509, DOI 10.1016/j.trstmh.2005.09.018; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; VANROS G, 1985, ANN SOC BELG MED TR, V65, P45	34	49	50	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 11	2008	7								174	10.1186/1475-2875-7-174				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	351NV	WOS:000259431900001	18783630	DOAJ Gold, Green Published			2019-04-02	
J	Valdes, AFC; Martinez, JM; Lizama, RS; Vermeersch, M; Cos, P; Maes, L				Valdes, Ayme Fernandez-Calienes; Martinez, Judith Mendiola; Lizama, Ramon Scull; Vermeersch, Marieke; Cos, Paul; Maes, Louis			In vitro anti-microbial activity of the Cuban medicinal plants Simarouba glauca DC, Melaleuca leucadendron L and Artemisia absinthium L	MEMORIAS DO INSTITUTO OSWALDO CRUZ			English	Article						plants; antimicrobial activity; cytotoxicity; selectivity	ESSENTIAL OILS; ANTIMALARIAL ACTIVITY; EURYCOMA-LONGIFOLIA; QUASSINOIDS; GUATEMALA; EXTRACTS	In the present study, an extensive in vitro antimicrobial profiling was performed for three medicinal plants grown in Cuba, namely Simarouba glauca, Melaleuca leucadendron and Artemisia absinthium. Ethanol extracts were tested for their antiprotozoal potential against Trypanosoma b. brucei, Trypanosoma cruzi, Leishmania infantum and Plasmodium falciparum. Antifungal activities were evaluated against Microsporum canis and Candida albicans whereas Escherichia coli and Staphylococcus aureus were used as test organisms for antibacterial activity. Cytotoxicity was assessed against human MRC-5 cells. Only M. leucadendron extract showed selective activity against microorganisms tested. Although S. glauca exhibited strong activity against all protozoa, it must be considered non-specific. The value of integrated evaluation of extracts with particular reference to selectivity is discussed.	[Valdes, Ayme Fernandez-Calienes; Martinez, Judith Mendiola] Inst Med Trop Pedro Kouri, Dept Parasitol, Havana, Cuba; [Lizama, Ramon Scull] Univ La Habana, Inst Farm & Alimentos, Dept Farm, Havana, Cuba; [Vermeersch, Marieke; Cos, Paul; Maes, Louis] Univ Antwerp, Lab Microbiol Parasitol & Hyg, B-2020 Antwerp, Belgium; Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium	Valdes, AFC (reprint author), Inst Med Trop Pedro Kouri, Dept Parasitol, Autopista Novia Mediodia Km 61-2,Marianao 13, Havana, Cuba.	ayme@ipk.sld.cu	Maes, Louis/A-2384-2017; Cos, Paul/L-9717-2015	Maes, Louis/0000-0002-2324-9509; Cos, Paul/0000-0003-4361-8911			ABREU J, 2004, PLANTAS MED, P7; Blagojevic P, 2006, J AGR FOOD CHEM, V54, P4780, DOI 10.1021/jf060123o; Budhiraja SS, 1999, J MANIP PHYSIOL THER, V22, P447, DOI 10.1016/S0161-4754(99)70033-3; CACERES A, 1990, J ETHNOPHARMACOL, V30, P55, DOI 10.1016/0378-8741(90)90017-N; Chan KL, 2005, PLANTA MED, V71, P967, DOI 10.1055/s-2005-864188; Cos P, 2006, J ETHNOPHARMACOL, V106, P290, DOI 10.1016/j.jep.2006.04.003; Dua VK, 2004, J ETHNOPHARMACOL, V95, P247, DOI 10.1016/j.jep.2004.07.008; Farag RS, 2004, PHYTOTHER RES, V18, P30, DOI 10.1002/ptr.1348; Franssen FFJ, 1997, ANTIMICROB AGENTS CH, V41, P1500, DOI 10.1128/AAC.41.7.1500; Fukamiya N, 2005, CANCER LETT, V220, P37, DOI 10.1016/j.canlet.2004.04.023; Guerra M., 2001, REV PLANTAS MEDICINA, V2, P48; Guo Z, 2005, CURR MED CHEM, V12, P173, DOI 10.2174/0929867053363351; Hatimi S, 2001, B SOC PATHOL EXOT, V94, P29; Hussein SAM, 2007, PHYTOCHEMISTRY, V68, P1464, DOI 10.1016/j.phytochem.2007.03.010; MENDIOLA J, 1991, T ROY SOC TROP MED H, V85, P78, DOI 10.1016/0035-9203(91)90165-U; Mikus J, 2000, PLANTA MED, V66, P366, DOI 10.1055/s-2000-8548; *MSP, 1991, NORM RAM SAL PUBL NR, V311; Nurhanan MY, 2005, PHYTOTHER RES, V19, P994, DOI 10.1002/ptr.1759; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038//nrd1824; Quinlan MB, 2002, J ETHNOPHARMACOL, V80, P75, DOI 10.1016/S0378-8741(02)00002-8; Rodriguez-Perez M., 2006, Revista de Ciencias Farmaceuticas Basica e Aplicada, V27, P197; Roig J., 1974, PLANTAS MED AROMATIC; Wright CW, 2005, J ETHNOPHARMACOL, V100, P67, DOI 10.1016/j.jep.2005.05.012	23	23	28	0	17	FUNDACO OSWALDO CRUZ	RIO DE JANEIRO, RJ	AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL	0074-0276	1678-8060		MEM I OSWALDO CRUZ	Mem. Inst. Oswaldo Cruz	SEP	2008	103	6					615	618		10.1590/S0074-02762008000600019				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	365DL	WOS:000260386000019	18949336	DOAJ Gold			2019-04-02	
J	Cassimon, D; Renard, R; Verbeke, K				Cassimon, Danny; Renard, Robrecht; Verbeke, Karel			Assessing debt-to-health swaps: A case study on the Global Fund Debt2Health Conversion Scheme	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						development aid; debt relief; debt swaps; vertical funds; Global Fund to fight AIDS; Tuberculosis and Malaria	OVERHANG	The Debt2Health Conversion Scheme of the Global Fund to Fight AIDS, Tuberculosis and Malaria is used to reassess a range of recent initiatives that propose debt relief in exchange for spending in the health sector. The experience with debt swaps in the mid 1990s was far from positive, and recent improved insight in the economics of debt relief suggests extreme caution. We argue that the recent spade of debt swap proposals, even if targeting countries and debt titles that fall outside current major international debt relief mechanisms, share most of the design faults of previous initiatives. Proposals such as Debt2Health do not constitute efficient vehicles to increase net transfers to poor countries, to reduce the economic disadvantages of indebtedness, or to strengthen public health systems of partner countries. For debt relief to constitute a valuable mechanism to provide aid, it should be designed as a large-scale and comprehensive operation, with spending earmarked to broad country-established priorities, and reinforce rather than undermine national implementation systems.	[Cassimon, Danny; Renard, Robrecht; Verbeke, Karel] Univ Antwerp, B-2000 Antwerp, Belgium	Cassimon, D (reprint author), Univ Antwerp, 13 Prinsstr, B-2000 Antwerp, Belgium.	danny.cassimon@ua.ac.be	cassimon, danny/F-4370-2010; Cassimon, Danny/D-8609-2016	Cassimon, Danny/0000-0002-0460-3488	German Federal Ministry for Economic Cooperation and Development (BMZ); German KfW Development Bank	The authors wish to thank, without implicating, Michael Klingberg from the German Federal Ministry for Economic Cooperation and Development (BMZ) and Jurgen Ulrich from the German KfW Development Bank for putting at our disposal the financial details of the debt forgiven in the 2008 Debt2Health operation with Indonesia.	Arslanalp S, 2005, J FINANC, V60, P1017, DOI 10.1111/j.1540-6261.2005.00754.x; Birdsall N, 2003, WORLD BANK ECON REV, V17, P409, DOI 10.1093/wber/lhg029; BULOW J, 1991, Q J ECON, V106, P1219, DOI 10.2307/2937962; Caines K., 2004, ASSESSING IMPACT GLO; CARLSON C, 2004, IMPACT GLOBAL HLTH P; Cassimon D., 2007, EC SYSTEMS, V31, P12; *DAC, 2007, 2006 SURV MON PAR DE; *DAC, 2005, PAR DECL AID EFF; Depetris Chauvin N., 2005, WHAT HAS 100 BILLION; DEVYLDER S, 2004, DEBT FOR AIDS SWAPS; DODD R, 2007, 9 WHO; Garrett L, 2007, FOREIGN AFF, V86, P14; *GLOB FUND FIGHT A, 2007, DEBT2HEALTH DEBT CON; *GLOB FUND FIGHT A, 2007, DEBT CONV IN LAUNCH; Heller PS, 2006, HEALTH POLICY PLANN, V21, P75, DOI 10.1093/heapol/czj013; *ILO, 2001, ILO EXP M ILO GEN; *IMF, 2007, 07272 IMF; Kaiser J., 1996, DEBT SWAPS SUSTAINAB; KRUGMAN P, 1988, J DEV ECON, V29, P253, DOI 10.1016/0304-3878(88)90044-2; LANE C, 2007, HEALTH AFFAIR, V27, P935; Ndikumana L., 2004, INT REV ECON FINANC, V13, P325; Ooms G, 2007, PLOS MED, V4, P605, DOI 10.1371/journal.pmed.0040128; Patillo C, 2004, 0415 IMF; PETTIFOR A, 2005, GLOBAL FUND DEBT CON; ROEMER M, 1989, WORLD DEV, V17, P795, DOI 10.1016/0305-750X(89)90003-X; ROSEN S, 1999, EXCHANGING DEBT HLTH; *UNESCO, 2007, EDEFARP200719; Walford V, 2007, REV HLTH SECTOR WIDE; World Bank, 2007, SPEND DEV MAK MOST I; World Bank, 2007, AID ARCH OV MAIN TRE; World Bank, 2007, GLOB MON REP 2007; *WORLD BANK IEG, 2006, DEBT REL POOR EV UPD	32	9	9	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2008	13	9					1188	1195		10.1111/j.1365-3156.2008.02125.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	339WG	WOS:000258607400011	18664242	Bronze			2019-04-02	
J	Colebunders, R; Worodria, W; Jones-Lopez, E; Joloba, M; Apers, L; Ellner, J				Colebunders, R.; Worodria, W.; Jones-Lopez, E.; Joloba, M.; Apers, L.; Ellner, J.			Drug-resistant TB and HIV in resource-limited settings: what TB/HIV programmes can learn from each other	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						multidrug-resistant tuberculosis; extensive-resistant tuberculosis; multidrug-resistant HIV infection; resource-limited settings	MULTIDRUG-RESISTANT; ANTIRETROVIRAL TREATMENT; INFECTED PATIENTS; TUBERCULOSIS; HEALTH; IMPACT	Although management of drug resistance in tuberculosis (TB) and HIV in poor settings is in its infancy, lessons learned from TB may be relevant to HIV and vice versa. The experience with HIV has shown that rapid scale-up and lower drug pricing are achievable goals. The current prerequisites for obtaining drugs to treat multidrug-resistant TB (MDR-TB) may be too stringent given the immediacy of the MDR-TB problem. We call for a more rapid roll-out of treatment for MDR-TB with fewer administrative encumbrances and a greater sense of urgency in national TB control programmes. On the other hand, antiretroviral roll-out programmes should learn from the genesis of the MDR-TB problem; laboratory monitoring should be enhanced and compliance optimized to avoid the acquisition of additional drug resistance in HIV.	[Colebunders, R.; Apers, L.] Inst Trop Med, B-2000 Antwerp, Belgium; [Colebunders, R.] Univ Antwerp, Fac Med, Antwerp, Belgium; [Worodria, W.; Joloba, M.] Makerere Univ, Kampala, Uganda; [Jones-Lopez, E.; Ellner, J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	Colebunders, R (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	bcoleb@itg.be		Joloba, Moses/0000-0002-0334-9983; Jones Lopez, Edward/0000-0001-6323-286X; Ellner, Jerrold/0000-0001-6150-0082			Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; *CLINT FDN, 2008, LAT ANT PRIC LIST; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Goldman Robert C., 2007, Infectious Disorders - Drug Targets, V7, P73; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Kamwi R, 2006, LANCET, V367, P1978, DOI 10.1016/S0140-6736(06)68879-X; Kazatchkine Michel, 2007, Bull World Health Organ, V85, P742; Matteelli A, 2007, EXPERT REV ANTI-INFE, V5, P857, DOI 10.1586/14787210.5.5.857; Mitnick CD, 2007, PLOS MED, V4, P1730, DOI 10.1371/journal.pmed.0040292; Monno L, 2007, AIDS RES HUM RETROV, V23, P1293, DOI 10.1089/aid.2007.0035; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Padayatchi N, 2007, EXPERT OPIN PHARMACO, V8, P1035, DOI 10.1517/14656566.8.8.1035; Renaud-Thery F, 2007, AIDS, V21, pS89, DOI 10.1097/01.aids.0000279711.54922.f0; Sungkanuparph S, 2007, INT J TUBERC LUNG D, V11, P325; Toni TD, 2007, AIDS RES HUM RETROV, V23, P1155, DOI 10.1089/aid.2007.0072; Vekemans M, 2007, AIDS, V21, P1205, DOI 10.1097/QAD.0b013e3281c617e8; *WHO, 2008, WHOTB94178; WHO, 2007, WHOHTMTB2007376; *WHO, 2008, GREEN LIGHT COMM GLC; *WHO UNAIDS, 2006, PROGR GLOB ACC HIV A; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; World Health Organization, 2008, 4WHOHTMTB2008394	23	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2008	13	9					1204	1207		10.1111/j.1365-3156.2008.02127.x				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	339WG	WOS:000258607400013	18664238	Bronze			2019-04-02	
J	Morel, CM; Thang, ND; Xa, NX; Hung, LX; Thuan, LK; Van Ky, P; Erhart, A; Mills, AJ; D'Alessandro, U				Morel, Chantal M.; Thang, Ngo Duc; Xa, Nguyen Xuan; Hung, Le Xuan; Thuan, Le Khan; Van Ky, Pham; Erhart, Annette; Mills, Anne J.; D'Alessandro, Umberto			The economic burden of malaria on the household in south-central Vietnam	MALARIA JOURNAL			English	Article							PRODUCTIVITY COSTS; FOREST MALARIA; SRI-LANKA; CARE	Background: Each year, several thousand cases of malaria occur in south-central Vietnam. Evidence from elsewhere suggests that malaria can have an economic impact on the household as the illness prevents households from completing their normal, physically demanding, productive duties such as tending crops and animals. The economic impact of malaria on households was explored within the Raglay ethnic minority living in the montainous and forested area of southcentral Vietnam (Ninh Thuan Province). Methods: Two-hundred fifty-one malaria patients were identified and interviewed in an exit survey at Community Health Centres. The same patient sample was then re-interviewed in a household survey two to four weeks later. Survey data were complemented by approximately 40 informal discussions with health workers, vendors, patients, and community leaders. Results: Each episode of malaria was estimated to cost the patient's household an average of 11.79 USD (2005 prices), direct costs for travel and treatment representing 6% of the total while the remainder was loss in annual income. Conclusion: Whilst government provision of malaria treatment keeps the direct costs relatively low, the overall loss in income due to illness can still be significant given the poverty amongst this population, especially when multiple cases of malaria occur annually within the same household.	[Morel, Chantal M.] London Sch Econ, LSE Hlth, London WC2A 2AE, England; [Thang, Ngo Duc; Xa, Nguyen Xuan; Hung, Le Xuan; Thuan, Le Khan] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Van Ky, Pham] Prov Ctr Malariol Parasitol & Entomol, Phan Rang City, Ninh Thuan Prov, Vietnam; [Erhart, Annette; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Mills, Anne J.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England	Morel, CM (reprint author), London Sch Econ, LSE Hlth, Houghton St, London WC2A 2AE, England.	C.M.Morel@lse.ac.uk; thangnimpevn@fpt.vn; ngxxa@yahoo.com; lxhung@netnam.org.vn; nimpe@netnam.org.vn; phamvankynt@hotmail.com; aerhart@itg.be; Anne.Mills@lshtm.ac.uk; udalessandro@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Mills, Anne/0000-0001-9863-9950	Belgium Cooperation	The authors would like to thank the Belgium Cooperation for their support for this project.	Attanayake N, 2000, TROP MED INT HEALTH, V5, P595, DOI 10.1046/j.1365-3156.2000.00612.x; Audibert M, 2003, TROP MED INT HEALTH, V8, P471, DOI 10.1046/j.1365-3156.2003.01051.x; Brouwer WBF, 1997, HEALTH ECON, V6, P511, DOI 10.1002/(SICI)1099-1050(199709)6:5<511::AID-HEC297>3.0.CO;2-K; DUC TN, 2008, MALARIA CENTRAL VIET; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; GOLDSCHMIDTCLER, 1982, WOMEN WORK DEV, P148; JACKSON S, 2002, B WHO, V80; Jacob-Tacken KHM, 2005, HEALTH ECON, V14, P435, DOI 10.1002/hec.948; Konradsen F, 1997, AM J TROP MED HYG, V56, P656, DOI 10.4269/ajtmh.1997.56.656; Liljas B, 1998, PHARMACOECONOMICS, V13, P1, DOI 10.2165/00019053-199813010-00001; NIMPE, 2003, ANN REP NAT MAL CONT; *NIMPE, 2004, ANN REP NAT MAL CONT; PICARD J, 1992, J TROP MED HYG, V95, P382; Pradhan M, 2002, HEALTH ECON, V11, P431, DOI 10.1002/hec.689; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; VONBORTEL W, 2001, AM J TROP MED HYG, V65, P729; OANDA CURRENCY CONVE	18	10	10	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 27	2008	7								166	10.1186/1475-2875-7-166				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	351NK	WOS:000259430800003	18752675	DOAJ Gold, Green Published			2019-04-02	
J	Ashley, EA; Pinoges, L; Turyakira, E; Dorsey, G; Checchi, F; Bukirwa, H; van den Broek, I; Zongo, I; Urruta, PPP; van Herp, M; Balkan, S; Taylor, WR; Olliaro, P; Guthmann, JP				Ashley, Elizabeth A.; Pinoges, Loretxu; Turyakira, Eleanor; Dorsey, Grant; Checchi, Francesco; Bukirwa, Hasifa; van den Broek, Ingrid; Zongo, Issaka; Palma Urruta, Pedro Pablo; van Herp, Michel; Balkan, Suna; Taylor, Walter R.; Olliaro, Piero; Guthmann, Jean-Paul			Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children	MALARIA JOURNAL			English	Article							ARTESUNATE PLUS AMODIAQUINE; SULFADOXINE-PYRIMETHAMINE; CLINICAL-TRIALS; CENTRAL ANGOLA; DRUG EFFICACY; BURKINA-FASO; UGANDA; RESISTANCE; THERAPIES; LUMEFANTRINE	Background: Use of different methods for assessing the efficacy of artemisinin-based combination antimalarial treatments (ACTs) will result in different estimates being reported, with implications for changes in treatment policy. Methods: Data from different in vivo studies of ACT treatment of uncomplicated falciparum malaria were combined in a single database. Efficacy at day 28 corrected by PCR genotyping was estimated using four methods. In the first two methods, failure rates were calculated as proportions with either (la) reinfections excluded from the analysis (standard WHO per-protocol analysis) or (lb) reinfections considered as treatment successes. In the second two methods, failure rates were estimated using the Kaplan-Meier product limit formula using either (2a) WHO (2001) definitions of failure, or (2b) failure defined using parasitological criteria only. Results: Data analysed represented 2926 patients from 17 studies in nine African countries. Three ACTs were studied: artesunate-amodiaquine (AS+ AQ, N = 1702), artesunate-sulphadoxine-pyrimethamine (AS+ SP, N = 706) and artemether-lumefantrine (AL, N = 518). Using method (la), the day 28 failure rates ranged from 0% to 39.3% for AS+ AQ treatment, from 1.0% to 33.3% for AS+ SP treatment and from 0% to 3.3% for AL treatment. The median [ range] difference in point estimates between method la (reference) and the others were: (i) method lb = 1.3% [ 0 to 24.8], (ii) method 2a = 1.1% [ 0 to 21.5], and (iii) method 2b = 0% [-38 to 19.3]. The standard per-protocol method (la) tended to overestimate the risk of failure when compared to alternative methods using the same endpoint definitions (methods lb and 2a). It either overestimated or underestimated the risk when endpoints based on parasitological rather than clinical criteria were applied. The standard method was also associated with a 34% reduction in the number of patients evaluated compared to the number of patients enrolled. Only 2% of the sample size was lost when failures were classified on the first day of parasite recurrence and survival analytical methods were used. Conclusion: The primary purpose of an in vivo study should be to provide a precise estimate of the risk of antimalarial treatment failure due to drug resistance. Use of survival analysis is the most appropriate way to estimate failure rates with parasitological recurrence classified as treatment failure on the day it occurs.	[Ashley, Elizabeth A.; Pinoges, Loretxu; Turyakira, Eleanor; Guthmann, Jean-Paul] Epictr, F-750110 Paris, France; [Dorsey, Grant] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Checchi, Francesco] London Sch Hyg & Trop Med, London WC1, England; [Bukirwa, Hasifa] Uganda Malaria Surveillance Project, Kampala, Uganda; [van den Broek, Ingrid] Med Sans Frontieres, Amsterdam, Netherlands; [van den Broek, Ingrid] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Zongo, Issaka] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Palma Urruta, Pedro Pablo] Med Sans Frontieres, Barcelona, Spain; [van Herp, Michel] Med Sans Frontieres, Brussels, Belgium; [Balkan, Suna] Med Sans Frontieres, Paris, France; [Taylor, Walter R.] Univ Oxford, Clin Res Unit, Natl Inst Infect & Trop Dis, Hanoi, Vietnam; [Taylor, Walter R.] Univ Hosp Geneva, Travel & Migrat Med Unit, CH-1211 Geneva 14, Switzerland; [Olliaro, Piero] WHO, Special Programme Res & Training Trop Dis, World Bank, UNDP,UNICEF, CH-1211 Geneva, Switzerland; [Olliaro, Piero] Univ Oxford, Churchill Hosp, Nuffield Dept Med, Ctr Trop Med & Vaccinol, Oxford OX3 7LJ, England; [Guthmann, Jean-Paul] Inst Veille Sanit, Dept Malad Infect, Unite Malad Prevent Vaccinale, F-94415 St Maurice, France	Ashley, EA (reprint author), Epictr, 8 Rue St Sabin, F-750110 Paris, France.	elizabeth.ashley@epicentre.msf.org; loretxu.pinoges@epicentre.msf.org; eleanor.tk@gmail.com; gdorsey@medsfgh.ucsf.edu; Francesco.Checchi@lshtm.ac.uk; h_bukirwa@yahoo.ca; ingrid.van.den.broek@rivm.nl; zongo_issaka@yahoo.fr; pedro-pablo.palma@barcelona.msf.org; michel.vanherp@msf.be; Suna.balkan@paris.msf.org; bobtaylor@oucru.netnam.vn; olliarop@who.int; jp.guthmann@invs.sante.fr			Medecins sans Frontieres; University of California; National Institutes of Health and Centers for Disease Control (USA); UNICEF/UNDP/World Bank/WHO	We thank all the study team members and participants involved in the original studies which provided the data for this work, especially the lead investigators-Maryline Bonnet, Sandra Cohuet, Anne Denoncin, Evelyn Depoortere, Martine Felix, Filomeno Fortes, Mufuta Gabriel, Valerie Gaboulaud, Francesco Grandesso, Sally Hamour, Moses Kamya, Crista Kitz, Todd Swarthout, Sophie Tobback, Jean-Bosco Ouedraogo, Naawa Sipilanyambe, Fred Wabwire-Mangen and Adoke Yeka. We are grateful to the laboratories which performed the PCR analyses: Mbarara University, Uganda, Epicentre Mbarara, Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium, Shoklo Malaria Research Unit, Thailand, Hopital Avicenne, Bobigny, France, Wellcome Trust/Medical College of Malawi, Blantyre, Malawi, Faculte de Medicine-Pharmacie, Rouen, France and the Genomics Core Facility, Institute for Human Genetics, University of California, San Francisco, California. Thank you to the Ministries of Health who collaborated on the studies, to Salah Ghabri for assistance with data management and especially to Kasia Stepniewska and Pascal Ringwald for critical review of the manuscript.; The funding for the individual studies was provided by Medecins sans Frontieres, the University of California, San Francisco, National Institutes of Health and Centers for Disease Control ( USA). Funding for this data analysis was provided by the UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR) and MSF/Epicentre. PO is a staff member of the WHO; the authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions, policy or views of the WHO.	Bakyaita N, 2005, AM J TROP MED HYG, V72, P573; Bonnet M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-54; Bukirwa H, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010007; Collins WJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-122; Depoortere E, 2005, TROP MED INT HEALTH, V10, P139, DOI 10.1111/j.1365-3156.2004.01363.x; Grandesso F, 2006, TROP MED INT HEALTH, V11, P1017, DOI 10.1111/j.1365-3156.2006.01655.x; Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07; Guthmann JP, 2006, ANTIMICROB AGENTS CH, V50, P3734, DOI 10.1128/AAC.01618-05; Guthmann JP, 2006, AM J TROP MED HYG, V75, P143, DOI 10.4269/ajtmh.2006.75.143; Guthmann JP, 2005, T ROY SOC TROP MED H, V99, P485, DOI 10.1016/j.trstmh.2004.11.010; Hamour S, 2005, T ROY SOC TROP MED H, V99, P548, DOI 10.1016/j.trstmh.2004.10.003; Mugittu K, 2007, TROP MED INT HEALTH, V12, P219, DOI 10.1111/j.1365-3165.2007.01813.x; Mugittu K, 2006, TROP MED INT HEALTH, V11, P1350, DOI 10.1111/j.1365-3156.2006.01688.x; Olliaro P, 2008, TROP MED INT HEALTH, V13, P83, DOI 10.1111/j.1365-3156.2007.01977.x; Price RN, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-119; Sibley CH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-48; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; Swarthout TD, 2006, TROP MED INT HEALTH, V11, P1503, DOI 10.1111/j.1365-3156.2006.01710.x; van den Broek I, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-113; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5; *WHO, 2005, SUSC PLASM FALC ANT; WHO, 2006, GUID TREATM MAL; WHO, 2003, ASS MON ANT DRUG EFF; *WHO, 1996, ASS THER EFF ANT DRU; World Health Organization, 2001, MON ANT DRUG RES REP; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; Zongo I, 2005, AM J TROP MED HYG, V73, P826, DOI 10.4269/ajtmh.2005.73.826; Zongo I, 2007, LANCET, V369, P491, DOI [10.1016/S0140-6736(07)60236-0, 10.1016/S0140-6736(07)60160-3]	30	10	10	1	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 9	2008	7								154	10.1186/1475-2875-7-154				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	344IG	WOS:000258919500001	18691429	DOAJ Gold, Green Published			2019-04-02	
J	Lee, SJ; Stepniewska, K; Anstey, N; Ashley, E; Barnes, K; Binh, TQ; D'Alessandro, U; Day, NP; de Vries, PJ; Dorsey, G; Guthmann, JP; Mayxay, M; Newton, P; Nosten, F; Olliaro, P; Osario, L; Pinoges, L; Price, R; Rowland, M; Smithuis, F; Taylor, R; White, NJ				Lee, Sue J.; Stepniewska, Kasia; Anstey, Nicholas; Ashley, Elizabeth; Barnes, Karen; Binh, Tran Quang; D'Alessandro, Umberto; Day, Nicholas P. J.; de Vries, Peter J.; Dorsey, Grant; Guthmann, Jean-Paul; Mayxay, Mayfong; Newton, Paul; Nosten, Francois; Olliaro, Piero; Osario, Lyda; Pinoges, Loretxu; Price, Ric; Rowland, Mark; Smithuis, Frank; Taylor, Robert; White, Nicholas J.			The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria	MALARIA JOURNAL			English	Article							THREEFOLD CONVERSION; ENDEMIC SETTINGS; ASSESSING ANEMIA	Background: Malaria is a very important cause of anaemia in tropical countries. Anaemia is assessed either by measurement of the haematocrit or the haemoglobin concentration. For comparisons across studies, it is often necessary to derive one measure from the other. Methods: Data on patients with slide- confirmed uncomplicated falciparum malaria were pooled from 85 antimalarial drug trials conducted in 25 different countries, to assess the haemoglobin/ haematocrit relationship at different time points in malaria. Using a linear random effects model, a conversion equation for haematocrit was derived based on 3,254 measurements from various time points ( ranging from day 0 to day 63) from 1,810 patients with simultaneous measurements of both parameters. Haemoglobin was also estimated from haematocrit with the commonly used threefold conversion. Results: A good fit was obtained using Haematocrit = 5.62 + 2.60 * Haemoglobin. On average, haematocrit/ 3 levels were slightly higher than haemoglobin measurements with a mean difference ( +/- SD) of - 0.69 ( +/- 1.3) for children under the age of 5 ( n = 1,440 measurements from 449 patients). Conclusion: Based on this large data set, an accurate and robust conversion factor both in acute malaria and in convalescence was obtained. The commonly used threefold conversion is also valid.	[Lee, Sue J.; Stepniewska, Kasia; Day, Nicholas P. J.; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, Bangkok 10400, Thailand; [Anstey, Nicholas] Menzies Sch Hlth Res, Darwin, NT, Australia; [Anstey, Nicholas] Royal Darwin Hosp, Darwin, NT, Australia; [Ashley, Elizabeth; Nosten, Francois; Price, Ric] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Barnes, Karen] Univ Cape Town, ZA-7700 Rondebosch, South Africa; [Binh, Tran Quang] Choray Hosp, Ho Chi Minh City, Vietnam; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [Day, Nicholas P. J.; Olliaro, Piero; White, Nicholas J.] Ctr Clin Vaccinol & Trop Med, Oxford, England; [de Vries, Peter J.] Univ Amsterdam, Acad Med Ctr, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Dorsey, Grant] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Dorsey, Grant] Inst Rech Sci Sante, Ouagadougou, Burkina Faso; [Mayxay, Mayfong] Natl Univ Laos, Viangchan, Laos; [Mayxay, Mayfong; Newton, Paul] Oxford Univ Trop Med Res Collaborat, Wellcome Trust Mahosot Hosp, Viangchan, Laos; [Olliaro, Piero; Taylor, Robert] WHO TDR, Geneva, Switzerland; [Rowland, Mark] London Sch Hyg Trop Med, London, England	White, NJ (reprint author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, 3rd Floor,60th Anniversary Chalermprakiat Bldg,42, Bangkok 10400, Thailand.	sue@tropmedres.ac; kasia@tropmedres.ac; nick.anstey@menzies.edu.au; Elizabeth.ASHLEY@epicentre.msf.org; kbarnes@uctgsh1.uct.ac.za; binhtq@hcm.vnn.vn; UDAlessandro@itg.be; nickd@tropmedres.ac; p.j.devries@xs4all.nl; gdorsey@medsfgh.ucsf.edu; jp.guthmann@invs.sante.fr; mmayxay@yahoo.com; paul@tropmedres.ac; francois@tropmedres.ac; olliarop@who.int; lydaosorio@cideim.org.co; Loretxu.PINOGES@epicentre.msf.org; ricprice@doctors.org.uk; mark.rowland@lshtm.ac.uk; frank_smithuis@yahoo.com; btaylor@oucru.org; nickw@tropmedres.ac	White, Nicholas/I-4629-2012; D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Price, Richard/0000-0003-2000-2874; Nosten, Francois/0000-0002-7951-0745	UNICEF/UNDP/World Bank/WHO [A50977]	This study was funded by the UNICEF/UNDP/World Bank/WHO Special Programme on Research & Training in Tropical Diseases (TDR) [Grant A50977] and was part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme.	BLAND JM, 1986, LANCET, V1, P307; BREUSCH TS, 1980, REV ECON STUD, V47, P239, DOI 10.2307/2297111; Carneiro IA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-67; Rodriguez-Morales AJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-166	4	18	19	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 2	2008	7								149	10.1186/1475-2875-7-149				4	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	337KZ	WOS:000258436300001	18673575	DOAJ Gold, Green Published			2019-04-02	
J	Antoine-Moussiaux, N; Saerens, D; Desmecht, D				Antoine-Moussiaux, Nicolas; Saerens, Dirk; Desmecht, Daniel			Flow cytometric enumeration of parasitaemia and haematologic changes in trypanosoma-infected mice	ACTA TROPICA			English	Article						Trypanosoma; flow cytometry; C57BL/6; BALB/c; parasitaemia	BLOOD	African trypanosomiasis is a severe parasitic disease affecting both man and livestock. It is crucial to expand our fundamental knowledge of the intimate interactions between trypanosomes and their vertebrate hosts in order to develop new and efficient control strategies. The mouse model of trypanosomiasis is the most popular for research purposes because of all the logistic advantages of using this species. Studies of any aspect of trypanosomiases in the mouse systematically require the quantification of some phenotypic traits which translate its degree of resistance/susceptibility to the disease, as blood cell counts. The present study presents a methodological approach combining everyday microsampling of tail blood and its analysis by flow cytometry. The technical options and conditions permitting a fast, reliable and reproducible daily quantification of erythrocyte, reticulocyte, leucocyte and trypanosome counts in the inoculated mouse were established. The protocol proposed allows the multiplication of blood samplings without being exposed to the time-consuming constraint of visual countings, without causing iatrogenic blood cell alterations in the mouse and without requiring specific anti-trypanosome antibodies. (C) 2008 Elsevier B.V. All rights reserved.	[Antoine-Moussiaux, Nicolas; Desmecht, Daniel] Univ Liege, Fac Vet Med, Dept Anim Pathol, B-4000 Liege, Belgium; [Antoine-Moussiaux, Nicolas] Univ Liege, Fac Vet Med, Dept Anim Prod, B-4000 Liege, Belgium; [Saerens, Dirk] Vrije Univ Brussels, Cellular & Mol Immunol Lab, B-1050 Brussels, Belgium; [Saerens, Dirk] VIB, Dept Mol & Cellular Interact CMIM, B-1050 Brussels, Belgium	Antoine-Moussiaux, N (reprint author), Univ Liege, Fac Vet Med, Dept Anim Pathol, Sart Tilman B43, B-4000 Liege, Belgium.	nantoine@ulg.ac.be	Saerens, Dirk/B-9162-2008	Saerens, Dirk/0000-0001-8894-8039			Hoff J, 2000, LAB ANIMAL, V29, P47; JACKSON PR, 1977, J PARASITOL, V63, P593, DOI 10.2307/3279556; LUMSDEN WHR, 1973, TECHNIQUES TRYPANOSO, P95; MARTIN LK, 1972, AM J TROP MED HYG, V21, P880, DOI 10.4269/ajtmh.1972.21.880; MILLS JN, 1978, TROPENMED PARASITOL, V29, P95; Saerens D, 2008, J IMMUNOL METHODS, V329, P138, DOI 10.1016/j.jim.2007.10.005; MOUSE PHENOME DATABA	7	9	10	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	AUG	2008	107	2					139	144		10.1016/j.actatropica.2008.05.010				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	345AG	WOS:000258967800011	18589393	Green Published			2019-04-02	
J	Ritacco, V; Lopez, B; Cafrune, PI; Ferrazoli, L; Suffys, PN; Candia, N; Vasquez, L; Realpe, T; Fernandez, J; Lima, KV; Zurita, J; Robledo, J; Rossetti, ML; Kritski, AL; Telles, MA; Palomino, JC; Heersma, H; van Soolingen, D; Kremer, K; Barrera, L				Ritacco, Viviana; Lopez, Beatriz; Cafrune, Patricia I.; Ferrazoli, Lucilaine; Suffys, Philip N.; Candia, Norma; Vasquez, Lucy; Realpe, Teresa; Fernandez, Jorge; Lima, Karla V.; Zurita, Jeannete; Robledo, Jaime; Rossetti, Maria L.; Kritski, Afranio L.; Telles, Maria A.; Palomino, Juan C.; Heersma, Herre; van Soolingen, Dick; Kremer, Kristin; Barrera, Lucia			Mycobacterium tuberculosis strains of the Beijing genotype are rarely observed in tuberculosis patients in South America	MEMORIAS DO INSTITUTO OSWALDO CRUZ			English	Article						Mycobacterium tuberculosis; genotype; Beijing; Latin America	MULTIDRUG-RESISTANT TUBERCULOSIS; DRUG-RESISTANCE; BUENOS-AIRES; EPIDEMIOLOGY; COMMUNITY; ARGENTINA; OUTBREAK; LINEAGE	The frequency of the Beijing genotype of Mycobacterium tuberculosis as a cause of tuberculosis (TB) in South America was determined by analyzing genotypes of strains isolated from patients that had been diagnosed with the disease between 1997 and 2003 in seven countries of the subcontinent. In total, 19 of the 1,202 (1.6%) TB cases carried Beijing isolates, including 11 of the 185 patients from Peru (5.9%), five of the 512 patients from Argentina (1.0%), two of the 252 Brazilian cases (0.8%), one of the 166 patients from Paraguay (0.6%) and none of the samples obtained from Chile (35), Colombia (36) and Ecuador (16). Except for two patients that were East Asian immigrants, all cases with Beijing strains were native South Americans. No association was found between carrying a strain with the Beijing genotype and having drug or multi-drug resistant disease. Our data show that presently transmission of M. tuberculosis strains of the Beijing genotype is not frequent in Latin America. In addition, the lack of association of drug resistant TB and infection with M. tuberculosis of the Beijing genotype observed presently demands efforts to define better the contribution of the virulence and lack of response to treatment to the growing spread of Beijing strains observed in other parts of the world.	[Ritacco, Viviana; Lopez, Beatriz; Barrera, Lucia] ANLIS Carlos Malbran, Inst Nacl Enfermedades Infecciosas, RA-1281 Buenos Aires, DF, Argentina; [Cafrune, Patricia I.; Rossetti, Maria L.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Ferrazoli, Lucilaine; Telles, Maria A.] Adolfo Lutz Inst, Sao Paulo, Brazil; [Suffys, Philip N.] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Candia, Norma] Inst Invest Ciencias Salud, Asuncion, Paraguay; [Vasquez, Lucy] Inst Nacl Salud, Lima, Peru; [Realpe, Teresa; Robledo, Jaime] Corp Invest Biol, Medellin, Colombia; [Fernandez, Jorge] Inst Salud Publ Chile, Santiago, Chile; [Lima, Karla V.] Inst Evandro Chagas, Belem, Para, Brazil; [Zurita, Jeannete] Hosp Vozandes, Quito, Ecuador; [Kritski, Afranio L.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Palomino, Juan C.] Inst Trop Med, B-2000 Antwerp, Belgium; [Heersma, Herre; van Soolingen, Dick; Kremer, Kristin] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Ritacco, V (reprint author), ANLIS Carlos Malbran, Inst Nacl Enfermedades Infecciosas, Velez Sarsfield 563, RA-1281 Buenos Aires, DF, Argentina.	vritacco@anlis.gov.ar	suffys, philip/E-3009-2013; Lima, Karla/N-6531-2016	Lima, Karla/0000-0001-5807-0392; kritski, afranio/0000-0002-5900-6007; Ritacco, Viviana/0000-0003-1217-0229			Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Codina G, 1999, INT J TUBERC LUNG D, V3, P82; Diaz R, 1998, INT J TUBERC LUNG D, V2, P743; Garcia de Viedma D, 2006, EMERG INFECT DIS, V12, P169, DOI 10.3201/eid1201.041214; Glynn JR, 2006, EMERG INFECT DIS, V12, P736; Heersma HF, 1998, METH MOL B, V101, P395, DOI 10.1385/0-89603-471-2:395; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Laserson KF, 2000, INT J TUBERC LUNG D, V4, P673; Mancilla E Marcos, 2006, Rev. chil. infectol., V23, P220, DOI 10.4067/S0716-10182006000300004; Morcillo N., 2005, Rev. argent. microbiol., V37, P92; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Palmero D, 2005, INT J TUBERC LUNG D, V9, P1168; Palmero D, 2003, EMERG INFECT DIS, V9, P965; Telles MAS, 2005, INT J TUBERC LUNG D, V9, P970; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234; VASQUEZ L, 2004, INT J TUBERC LUNG S1, V8, pS80; *WHO IUATLD GLOB P, 2003, WHOTB2003216 IUATLD	21	41	42	0	9	FUNDACO OSWALDO CRUZ	RIO DE JANEIRO, RJ	AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL	0074-0276	1678-8060		MEM I OSWALDO CRUZ	Mem. Inst. Oswaldo Cruz	AUG	2008	103	5					489	492		10.1590/S0074-02762008000500014				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	349KH	WOS:000259279200014	18797764	DOAJ Gold			2019-04-02	
J	Delvaux, T; Saeur, S; Rathavy, T; Crabbe, F; Buve, A				Delvaux, Therese; Saeur, Sophal; Rathavy, Tung; Crabbe, Francois; Buve, Anne			Integration of comprehensive abortion-care services in a Maternal and Child Health clinic in Cambodia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						delivery of health care; safe abortion services; contraception; post-abortion contraception; sex workers	SEX WORKERS; WOMEN; WORLDWIDE	OBJECTIVES To document the pilot experience of provision of safe abortion/post-abortion services implemented in 2002 at the Mother Child Health clinic in Sihanoukville, Cambodia, and to profile clients and assess their uptake of post-abortion contraception. METHODS The initial package of safe abortion/post-abortion clinics (SAPAC) services included counselling on family planning and prevention of sexually transmitted infections, pain management, Manual Vacuum Aspiration procedure and standard universal precautions at an affordable price (US$12.5). SAPAC services became operational in August 2002. The data of medical records from 1 August 2002 to 31 December 2005 (2224 clients) were analysed. RESULTS The mean number of clients per month attending SAPAC services ranged from 26 in 2002 to 64 in 2005. Fifty-three per cent were housewives, 24% worked in sales or services, 8% in factories, 11% in bars or karaoke lounges and 3% were brothel-based sex workers. Ninety-three per cent of clients came for induced abortion and 7% sought post-abortion care. Pain management was used in 99% of cases. The overall rate of complications during intervention was 2.1% and dropped from 9.4% in 2002 to 1.3% in 2005. After SAPAC implementation, fewer women in Sihanoukville sought abortion services without any quality control and a safer technique was used. On average, 40% of patients took up contraception after the abortion. CONCLUSIONS Integrating comprehensive abortion-care services at a peripheral government health facility is feasible. There is a demand for such services provided at an affordable price in Sihanoukville, Cambodia.	[Delvaux, Therese] Inst Trop Med, Dept Microbiol, HIV STI Epidemiol & Control Unit, B-2000 Antwerp, Belgium; [Saeur, Sophal] Reprod Hlth Programme, Sihanoukville, Cambodia; [Rathavy, Tung] NMCHC, Reprod Hlth Programme, Phnom Penh, Cambodia	Delvaux, T (reprint author), Inst Trop Med, Dept Microbiol, HIV STI Epidemiol & Control Unit, 155 Nationalestr, B-2000 Antwerp, Belgium.	tdelvaux@itg.be					AbouZahr C., 1998, HLTH DIMENSIONS SEX; ADEWOLE IF, 2002, W AFR J MED, V21, P112; Bankole A, 1999, INT FAM PLAN PERSPEC, V25, P68, DOI 10.2307/2991944; Cisse Cheikh Tidiane, 2004, Sante, V14, P245; Delvaux T, 2003, REPROD HEALTH MATTER, V11, P88, DOI 10.1016/S0968-8080(03)02163-3; FETTERS T, 2008, BRIT J OBST IN PRESS; Goodyear-Smith F., 2003, NZ MED J, V116, P1; Gorbach PM, 2006, JAIDS-J ACQ IMM DEF, V42, P242, DOI 10.1097/01.qai.0000214817.03411.80; Grimes D, 2004, COCHRANE DB SYST REV, V4; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Henshaw SK, 1999, INT FAM PLAN PERSPEC, V25, pS30, DOI 10.2307/2991869; LEMA VM, 2000, MALAWI E AFRICAN MED, V77, P488; LESTER F, 2003, THESIS UC BERKELEY U; LONG C, 2001, EXP ACC ADV ROL MIDL; *NAT I PUBL HLTH, 2006, CAMB DEM HLTH SURV; *NAT I STAT MIN PL, 2000, CAMB DEM HLTH SURV 2; Nguyen T M, 2000, Southeast Asian J Trop Med Public Health, V31, P167; Perera Jennifer, 2004, Ceylon Med J, V49, P14; Rasch V, 2004, TROP MED INT HEALTH, V9, P399, DOI 10.1111/j.1365-3156.2004.01197.x; RATHAVY T, 2007, READY NOT; Warriner IK, 2006, PREVENTING UNSAFE AB; World Health Organization, 2007, UNS AB GLOB REG EST	22	11	12	0	5	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2008	13	8					962	969		10.1111/j.1365-3156.2008.02102.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	332IY	WOS:000258077900001	18564349				2019-04-02	
J	Delvaux, T; Konan, JPD; Ake-Tano, O; Gohou-Kouassi, V; Bosso, PE; Buve, A; Ronsmans, C				Delvaux, Therese; Konan, Jean-Paul Diby; Ake-Tano, Odile; Gohou-Kouassi, Valerie; Bosso, Patrice Emery; Buve, Anne; Ronsmans, Carine			Quality of antenatal and delivery care before and after the implementation of a prevention of mother-to-child HIV transmission programme in Cote d'Ivoire	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						maternal health services; quality of care; human immunodeficiency virus; prevention; mother-to-child transmission	HEALTH-SERVICES; SCALING-UP; NEVIRAPINE; ABIDJAN; ACCEPTABILITY; COUNTRIES; ZAMBIA; WOMEN	OBJECTIVE To assess whether implementation of a prevention of mother-to-child HIV transmission (PMTCT) programme in Cote d'Ivoire improved the quality of antenatal and delivery care services. METHODS Quality of antenatal and delivery care services was assessed in five urban health facilities before (2002-2003) and after (2005) the implementation of a PMTCT programme through review of facility data; observation of antenatal consultations (n = 606 before; n = 591 after) and deliveries (n = 229 before; n = 231 after) and exit interviews of women; and interviews of health facility staff. RESULTS HIV testing was never proposed at baseline and was proposed to 63% of women at the first ANC visit after PMTCT implementation. The overall testing rate was 42% and 83% of tested HIV-infected pregnant women received nevirapine. In addition, inter-personal communication and confidentiality significantly improved in all health facilities. In the maternity ward, quality of obstetrical care at admission, delivery and post-partum care globally improved in all facilities after the implementation of the programme although some indicators remained poor, such as filling in the partograph directly during labour. Episiotomy rates among primiparous women dropped from 64% to 25% (P < 0.001) after PMTCT implementation. Global scores for quality of antenatal and delivery care significantly improved in all facilities after the implementation of the programme. CONCLUSIONS Introducing comprehensive PMTCT services can improve the quality of antenatal and delivery care in general.	[Delvaux, Therese] Inst Trop Med, Dept Microbiol, HIV STI Epidemiol & Control Unit, B-2000 Antwerp, Belgium; [Konan, Jean-Paul Diby; Ake-Tano, Odile; Gohou-Kouassi, Valerie; Bosso, Patrice Emery] Inst Natl St Publ, Abidjan, Cote Ivoire; [Ronsmans, Carine] London Sch Hyg & Trop Med, London WC1, England	Delvaux, T (reprint author), Inst Trop Med, Dept Microbiol, HIV STI Epidemiol & Control Unit, 155 Nationalestr, B-2000 Antwerp, Belgium.	tdelvaux@itg.be					Bulatao RA, 2002, B WORLD HEALTH ORGAN, V80, P721; Burkhalter B, 2006, QUALITY ASSURANCE PR; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P1083; Delva W, 2006, SAMJ S AFR MED J, V96, P706; Delvaux Therese, 2007, Afr J Reprod Health, V11, P22; *DIPE MSP, 2007, RAPP ANN ACT VIH SID; DULOU AD, 2007, SANTE, V17, P133; DUPONCHELL JL, 2001, PROJ EQU ACC SOINS Z; Ekouevi DK, 2004, AIDS, V18, P697, DOI 10.1097/01.aids.0000111452.61782.0d; GOHOU V, 2004, TROP MED INT HEALTH, V9, P106; Graham WJ, 1999, LANCET, V353, P836, DOI 10.1016/S0140-6736(98)12374-7; Grembowski D, 2005, J GEN INTERN MED, V20, P271, DOI 10.1111/j.1525-1497.2005.32127.x; *HOR PROGR, 2002, WORKSH REP JUL 23 27; *INS IMT, 2004, EFF INT PROGR PREV T; *INS MLS, 2006, ENQ IND SID COT IV 2; Israel E., 2003, INTEGRATING PREVENTI; Johnson N, 2004, W INDIAN MED J, V53, P297; Maimbolwa MC, 1997, MIDWIFERY, V13, P125; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Msellati P, 2001, B WORLD HEALTH ORGAN, V79, P641; *MSP, 2000, MAN DIR PAQ MIN ACT; *MSP MLS, 2006, POL NAT PREV TRANSM; PAINTER TM, 2004, BRIT MED J, V319, P1; Perez F, 2004, TROP MED INT HEALTH, V9, P774, DOI 10.1111/j.1365-3156.2004.01264.x; PORTAL JL, 1996, SANTE CAPITALE; *PROJ RETR CI, 2001, PROGR PREV TRANSM ME; Ramon R, 1998, J ACQ IMMUN DEF SYND, V17, P470, DOI 10.1097/00042560-199804150-00013; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058e1; Rutenberg N, 2004, REV FIELD EXPERIENCE; Stekelenburg J, 2004, TROP MED INT HEALTH, V9, P390, DOI 10.1111/j.1365-3156.2004.01202.x; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/01.aids.0000060395.18106.80; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06748.8f; Tarwireyi F, 2004, Cent Afr J Med, V50, P95; *TRAC RWAND, 2006, RAPP ANN 2005 CENTR; Welty TK, 2005, JAIDS-J ACQ IMM DEF, V40, P486, DOI 10.1097/01.qai.0000163196.36199.89; *WHO, 2003, STRAT PREV HIV INF I; *WHO, 1996, SAF MOTH NEEDS ASS; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; *WHO UNFPA, 2004, GLION CALL ACT FAM P; WHO/UNFPA/UNAIDS/IPPF, 2005, SEX REPR HLTH HIV AI; World Health Organization, 2000, MAN COMPL PREG CHILD	41	24	24	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2008	13	8					970	979		10.1111/j.1365-3156.2008.02105.x				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	332IY	WOS:000258077900002	18564353	Bronze			2019-04-02	
J	Caudron, JM; Ford, N; Henkens, M; Mace, C; Kiddle-Monroe, R; Pinel, J				Caudron, J. -M.; Ford, N.; Henkens, M.; Mace, C.; Kiddle-Monroe, R.; Pinel, J.			Substandard medicines in resource-poor settings: a problem that can no longer be ignored	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						substandard medicines; quality assurance; drug export; contamination; quality standards	DEVELOPING-COUNTRIES; QUALITY-CONTROL; DRUGS; COUNTERFEIT; PHARMACIES; AMODIAQUINE; STABILITY; PRODUCTS	The circulation of substandard medicines in the developing world is a serious clinical and public health concern. Problems include under or over concentration of ingredients, contamination, poor quality ingredients, poor stability and inadequate packaging. There are multiple causes. Drugs manufactured for export are not regulated to the same standard as those for domestic use, while regulatory agencies in the less-developed world are poorly equipped to assess and address the problem. A number of recent initiatives have been established to address the problem, most notably the WHO pre-qualification programme. However, much more action is required. Donors should encourage their partners to include more explicit quality requirements in their tender mechanisms, while purchasers should insist that producers and distributors supply drugs that comply with international quality standards. Governments in rich countries should not tolerate the export of substandard pharmaceutical products to poor countries, while developing country governments should improve their ability to detect substandard medicines.	[Caudron, J. -M.; Ford, N.; Henkens, M.; Mace, C.; Kiddle-Monroe, R.; Pinel, J.] Medecins Sans Frontieres, CH-1211 Geneva, Switzerland; [Caudron, J. -M.; Pinel, J.] AEDES Fdn, Brussels, Belgium	Caudron, JM (reprint author), Medecins Sans Frontieres, 78 Rue Lausanne, CH-1211 Geneva, Switzerland.	jean_michelcaudron@hotmail.com					Aldhous P, 2005, NATURE, V434, P132, DOI 10.1038/434132a; Amin AA, 2005, J CLIN PHARM THER, V30, P559, DOI 10.1111/j.1365-2710.2005.00685.x; Andre MP, 1997, INT J IMAG SYST TECH, V8, P137, DOI 10.1002/(SICI)1098-1098(1997)8:1<137::AID-IMA15>3.0.CO;2-#; [Anonymous], 2003, OFFICIAL J L, V262, P22; [Anonymous], 2003, WHO TECHN REP SER, V908; Arya S C, 1995, World Health Forum, V16, P269; Atemnkeng MA, 2007, TROP MED INT HEALTH, V12, P68, DOI 10.1111/j.1365-3156.2006.01769.x; BA A, 2005, STP PHARM PRATIQUES, V15, P213; BAUER M, 2002, STP PHARM PRATIQUES, V12, P76; Behrens RH, 2002, TROP DOCT, V32, P1; CARPENTER J, 2004, REV DRUG QUALITY ASI; Cavenaghi R, 1989, Bull Int Union Tuberc Lung Dis, V64, P36; DONNELLY J, 2005, AIDS DRUGS HIT ROADB; *EUR COMM HUM AID, 2006, REV QUAL ASS QA MECH; FAWAZ F, 2006, REMED, V33, P16; *FDA, 2006, GUID IND TEST GLYC D; Figueras A, 2002, DRUG SAFETY, V25, P485, DOI 10.2165/00002018-200225070-00002; JAYASENA K, 1985, DEV DIALOGUE, V2, P38; KELESIDIS T, 2007, J ANTIMICROB CHEMOTH, V60, P1; KIBWAGE IO, 1992, E AFR MED J, V69, P577; Laserson KF, 2001, INT J TUBERC LUNG D, V5, P448; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; Maponga C, 2003, QUALITY ANTIMALARIAL; Minzi OMS, 2003, J CLIN PHARM THER, V28, P117, DOI 10.1046/j.1365-2710.2003.00470.x; Moride Y, 1997, BRIT J CLIN PHARMACO, V43, P177, DOI 10.1046/j.1365-2125.1997.05417.x; NAZERALI H, 2003, BRIT MED J, V317, P512; Newton PN, 2008, PLOS MED, V5, P209, DOI 10.1371/journal.pmed.0050032; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; O'Brien KL, 1998, JAMA-J AM MED ASSOC, V279, P1175, DOI 10.1001/jama.279.15.1175; OMER AIH, 1990, TROPICAL DOCTOR, V3; ONOJA AL, 1992, VACCINE, V10, P49, DOI 10.1016/0264-410X(92)90419-K; Pinheiro E, 2006, AIDS, V20, P1745, DOI 10.1097/01.aids.0000242821.67001.65; Po ALW, 2001, LANCET, V357, P1904, DOI 10.1016/S0140-6736(00)05092-3; Rassool G Hussein, 2004, J Adv Nurs, V46, P338; *REMED, 1995, QUAL MED MARCH PHARM; Risha P, 2006, J AOAC INT, V89, P1300; Roy J, 1994, World Health Forum, V15, P406; Shakoor O, 1997, TROP MED INT HEALTH, V2, P839, DOI 10.1046/j.1365-3156.1997.d01-403.x; Singh J, 2001, B WORLD HEALTH ORGAN, V79, P88; Singh S, 2003, INT J TUBERC LUNG D, V7, P298; SMINE A, 2002, MALARIA SENTINEL SUR; STENSON B, 1998, INT J RISK SAFETY ME, V11, P243; Syhakhang L, 2004, PHARM WORLD SCI, V26, P333, DOI 10.1007/s11096-004-0558-3; Taylor RB, 2001, LANCET, V357, P1933, DOI 10.1016/S0140-6736(00)05065-0; Verduin-Muttiganzi R, 1998, TROP MED INT HEALTH, V3, P602, DOI 10.1046/j.1365-3156.1998.00269.x; Videau J Y, 2006, Med Trop (Mars), V66, P533; Wertheimer Albert I, 2003, J Am Pharm Assoc (2003), V43, P710; WHO, 2006, WHO TECH REP SER, V936, P1; *WHO, 1999, QUAL ASS PHARM COMP, V2; *WHO, 1999, GUID DEV MEAS COMB C; *WHO, 2006, WHO CONS REG TECHN P; *WHO, 2004, WHO MED STRAT 2004 2; *WHO, 2004, REP PRE XIICDRA SAT; *WHO, 2007, MOD ESS MED; *WHO, 1988, WHA4116 WHO; *WHO, 2006, INT PHARM; *WHO, 1999, WHA5219 WHO; *WHO, 2006, INT MED PROD ANT TAS; *WHO, 2006, INT EM HLTH KIT; *WHO, 2006, TECHN REP SER, V937; *WHO, 2007, SPEC PHARM PREP; *WHO, 1997, QUAL ASS PHARM COMP, V1; *WHO, 1999, FIX DOS COMB TABL TR; *WHO, 2006, DECL ROM CONCL REC W; *WHO, 2004, QUAL ASS PHARM COMP, V2; WONDEMAGEGNEHU E, 1999, COUNTERFEIT SUBSTAND; 2008, US PHARMACOPEIA	67	115	116	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2008	13	8					1062	1072		10.1111/j.1365-3156.2008.02106.x				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	332IY	WOS:000258077900012	18631318				2019-04-02	
J	Ostyn, B; Vanlerberghe, V; Picado, A; Dinesh, DS; Sundar, S; Chappuis, F; Rijal, S; Dujardin, JC; Coosemans, M; Boelaert, M; Davies, C				Ostyn, Bart; Vanlerberghe, Veerle; Picado, Albert; Dinesh, Diwakar Singh; Sundar, Shyam; Chappuis, Francois; Rijal, Suman; Dujardin, Jean-Claude; Coosemans, Marc; Boelaert, Marleen; Davies, Clive			Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						indoor residual spraying; insecticide susceptibility; insecticide-treated nets; Leishmania donovani; Phlebotomus argentipes; vector control; visceral leishmaniasis; review; India; Nepal	IMPREGNATED BED NETS; PHLEBOTOMINE SAND FLIES; ANTHROPONOTIC CUTANEOUS LEISHMANIASIS; KALA-AZAR; PROTECTIVE EFFICACY; DONOVANI INFECTION; SANDFLIES DIPTERA; MALARIA CONTROL; EASTERN SUDAN; MOSQUITO NETS	Visceral leishmaniasis (VL) is a deadly vector-borne disease that causes an estimated 500 000 new cases a year. In India, Nepal and Bangladesh, VL is caused by Leishmania donovani, which is transmitted from man to man by the sandfly Phlebotomus argentipes. In 2005, these three countries signed a memorandum of understanding to eliminate VL from the region. Integrated vector management is one of the pillars of this elimination strategy, alongside early case detection and treatment. We reviewed the evidence of effectiveness of different vector control methods, to examine the potential role of insecticide treated bednets (ITNs). Indoor residual spraying has shown poor impact for various reasons and resistance to DDT is emerging in Bihar. Environmental management performed poorly compared to insecticide based methods. ITNs could give individual protection but this still needs to be proven in randomized trials. Given the constraints of indoor residual spraying, it is worthwhile to further explore the use of ITNs, in particular long lasting ITNs, as an additional tool in the VL elimination initiative.	[Ostyn, Bart; Vanlerberghe, Veerle; Dujardin, Jean-Claude; Coosemans, Marc; Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [Picado, Albert; Davies, Clive] London Sch Hyg & Trop Med, London WC1, England; [Dinesh, Diwakar Singh] Rajendra Mem Res Inst Med Sci, Patna, Bihar, India; [Sundar, Shyam] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India; [Chappuis, Francois] Univ Hosp Geneva, Geneva, Switzerland; [Rijal, Suman] BP Koirala Inst Hlth Sci, Dharan, Nepal	Ostyn, B (reprint author), Inst Trop Med, Nationalestr 155, B-2000 Antwerp, Belgium.	bostyn@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Picado, Albert/0000-0001-7344-628X			ALEXANDER B, 1995, MED VET ENTOMOL, V9, P279, DOI 10.1111/j.1365-2915.1995.tb00134.x; Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x; Alten B, 2003, J VECTOR ECOL, V28, P53; Amalraj D. Dominic, 1999, Journal of Communicable Diseases, V31, P177; [Anonymous], 1998, LIF 21 CENT VIS ALL; [Anonymous], 2000, ANN INTERNAL ASSESSM; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; Basak Basab, 1995, Journal of Communicable Diseases, V27, P122; BASIMIKE M, 1995, J MED ENTOMOL, V32, P428, DOI 10.1093/jmedent/32.4.428; BENZERROUG EH, 1992, ANN SOC BELG MED TR, V72, P5; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2000, AM J TROP MED HYG, V63, P184, DOI 10.4269/ajtmh.2000.63.184; Bern C, 2006, INDIAN J MED RES, V123, P275; Bhattacharya SK, 2006, INDIAN J MED RES, V123, P195; Binka FN, 1997, TROP MED INT HEALTH, V2, P499, DOI 10.1046/j.1365-3156.1997.d01-299.x; Bongiorno Gioia, 2005, Ann Ist Super Sanita, V41, P247; Bora D, 1999, NATL MED J INDIA, V12, P62; Campbell-Lendrum D, 2001, MEM I OSWALDO CRUZ, V96, P159, DOI 10.1590/S0074-02762001000200004; *CDC, 2006, MAL VECT CONTR HOM I; Chandra Goutam, 1995, Journal of Communicable Diseases, V27, P247; CHAVASSE D, 1999, INSECTICIDE TREATED; Choudhury S., 2000, INT WORKSH CROSS BOR; Curtis C.F., 1991, P1; Curtis C. F., 2003, Journal of Vector Borne Diseases, V40, P1; CURTIS CF, 1994, T ROY SOC TROP MED H, V88, P144, DOI 10.1016/0035-9203(94)90268-2; Davies CR, 2000, T ROY SOC TROP MED H, V94, P631, DOI 10.1016/S0035-9203(00)90214-1; Davies CR, 2003, BRIT MED J, V326, P377, DOI 10.1136/bmj.326.7385.377; DEBARJAC H, 1981, B SOC PATHOL EXOT, V74, P485; DHANDA V, 1983, P IND UK WORKSH LEIS, P128; Dhiman R C, 2003, J Commun Dis, V35, P49; DHIMAN RC, 1991, INDIAN J MED RES-A, V93, P155; DHIMAN RC, 1983, INDIAN J MED RES, V77, P29; Dinesh DS, 2000, ANN TROP MED PARASIT, V94, P447, DOI 10.1080/00034983.2000.11813563; Dinesh DS, 2001, ANN TROP MED PARASIT, V95, P197, DOI 10.1080/00034980120041071; Elnaiem DA, 1999, MED VET ENTOMOL, V13, P310, DOI 10.1046/j.1365-2915.1999.00191.x; Elnaiem DA, 1999, MED VET ENTOMOL, V13, P191, DOI 10.1046/j.1365-2915.1999.00183.x; ELNAIEM DA, 1996, L3188147 WHO ID; FALCAO AL, 1991, MEM I OSWALDO CRUZ, V86, P399, DOI 10.1590/S0074-02761991000400004; Feliciangeli MD, 2003, T ROY SOC TROP MED H, V97, P641; Feliciangeli MD, 2003, TROP MED INT HEALTH, V8, P1131; Feliciangeli MD, 1995, B DIRECCION MALARIOL, V35, P127; Gyapong M, 1996, TROP MED INT HEALTH, V1, P328, DOI 10.1046/j.1365-3156.1996.d01-41.x; Hassan MM, 2004, ACTA TROP, V92, P77, DOI 10.1016/j.actatropicaa.2004.06.001; HATI AK, 1983, P INDO UK WORKSHOP L, P84; HOUSTON R, 2003, ENV HLTH PROJECT ACT, V121, P25; Jalouk L, 2007, T ROY SOC TROP MED H, V101, P360, DOI 10.1016/j.trstmh.2006.07.011; Joshi AB, 2003, J NEPAL HLTH RES COU, V1, P1; Joshi Durga Datt, 2006, J Commun Dis, V38, P139; Joshi G. C., 1979, Journal of Communicable Diseases, V11, P209; JOSHI GC, 1994, J COMMUNICABLE DIS, V26, P56; Kakarsulemankhel JK, 2003, J INVERTEBR PATHOL, V84, P63, DOI 10.1016/S0022-2011(03)00103-4; Kaul S. M., 1993, Journal of Communicable Diseases, V25, P101; KAUL SM, 1994, B WORLD HEALTH ORGAN, V72, P79; KAUL SM, 1978, J COMMUNICABLE DIS, V10, P209; Kayedi MH, 2007, ANN TROP MED PARASIT, V101, P449, DOI 10.1179/136485907X176481; Kesari S., 2000, Journal of Communicable Diseases, V32, P284; Kishore K, 2004, Journal of Communicable Diseases, V36, P41; Kishore K, 2006, INDIAN J MED RES, V123, P467; Koirala S, 1998, B WORLD HEALTH ORGAN, V76, P485; KROEGER A, 1995, AM J TROP MED HYG, V53, P313, DOI 10.4269/ajtmh.1995.53.313; Kroeger A, 2002, BRIT MED J, V325, P810, DOI 10.1136/bmj.325.7368.810; KUMAR K, 1995, WHOLEISH9536; Kumar K, 2006, INDIAN J MED RES, V124, P454; Kumar V., 2001, Journal of Communicable Diseases, V33, P102; KUMAR V, 1995, INDIAN J MED RES, V101, P154; LANE RP, 1991, ANN SOC BELG MED TR, V71, P65; LEPONT F, 1989, ANN SOC BELG MED TR, V69, P223; MAJORI G, 1989, MED VET ENTOMOL, V3, P441, DOI 10.1111/j.1365-2915.1989.tb00253.x; Maroli M., 1989, Leishmaniasis: The current status and new strategies for control. Proceedings of a NATO Advanced Study Institute on leishmaniasis: The first centenary (1885-1985), new strategies for control, Zakinthos, Greece, 20-27 September 1987., P217; Mathur P, 2006, J MED MICROBIOL, V55, P919, DOI 10.1099/jmm.0.46574-0; Mittal P.K., 2004, ENV HLTH PROJECT ACT, V129, P44; Moosa-Kazemi SH, 2007, ANN SAUDI MED, V27, P6, DOI 10.4103/0256-4947.51543; Mukhopadhyay A. K., 1996, Journal of Communicable Diseases, V28, P171; MUKHOPADHYAY AK, 1987, INDIAN J MED RES, V86, P475; MUKHOPADHYAY AK, 1992, WHOCDTVBC92996; MUKHOPADHYAY AK, 1992, WHOLEISH9231; MUTINGA MJ, 1993, E AFR MED J, V70, P168; NADIM A, 2000, WHOLEISH9537; NMEP, 1991, ANN REP NAT MAL ER P; PALIT A, 1994, TROPICAL DIS MOL BIO, P495; Pardo Raúl H, 2006, Biomédica, V26, P167; Rao J. S., 2001, Journal of Communicable Diseases, V33, P7; Reithinger R, 1997, J INVERTEBR PATHOL, V70, P131, DOI 10.1006/jipa.1997.4671; Reyburn H, 2000, T ROY SOC TROP MED H, V94, P361, DOI 10.1016/S0035-9203(00)90104-4; RICHARDS FO, 1993, AM J TROP MED HYG, V49, P410, DOI 10.4269/ajtmh.1993.49.410; Ritmeijer K, 2007, TROP MED INT HEALTH, V12, P404, DOI 10.1111/j.1365-3156.2006.01807.x; Robert LL, 1997, J AM MOSQUITO CONTR, V13, P140; Salotra P, 2001, J CLIN MICROBIOL, V39, P849, DOI 10.1128/JCM.39.3.849-854.2001; Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x; Schlein Y, 2001, AM J TROP MED HYG, V65, P300, DOI 10.4269/ajtmh.2001.65.300; Secundino NFC, 2002, J INVERTEBR PATHOL, V80, P35, DOI 10.1016/S0022-2011(02)00046-0; Singh R, 2001, B WORLD HEALTH ORGAN, V79, P793; Singh S, 2002, CLIN DIAGN LAB IMMUN, V9, P568, DOI 10.1128/CDLI.9.3.568-572.2002; Sivagnaname N, 2006, INDIAN J MED RES, V124, P453; Sivagnaname N., 1997, Journal of Communicable Diseases, V29, P153; Sudhakar S., 2006, Journal of Vector Borne Diseases, V43, P115; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; Sundar S, 2006, J CLIN MICROBIOL, V44, P251, DOI 10.1128/JCM.44.1.251-253.2006; SWAMINATH C. S., 1942, Indian Journal of Medical Research, V30, P473; TAYEH A, 1997, WHOLEISH9741; Wahba M. M., 1999, Journal of the Egyptian Society of Parasitology, V29, P587; Wahba Mahmoud M., 2000, Journal of the Egyptian Society of Parasitology, V30, P315; WARBURG A, 1991, J INVERTEBR PATHOL, V58, P189, DOI 10.1016/0022-2011(91)90063-V; WELLS D, 1986, PESTIC SCI, V17, P473, DOI 10.1002/ps.2780170503; *WHO, 2004, WHOCDSWHOPES20048; *WHO, 2002, IMP OLYS LONG LAST N; World Health Organization, 1984, WHO TECHN REP SER, V701; World Health Organization, 2007, WHOCDSNTDWHOPES20071; World Health Organization, 2001, WHOCDSWHOPES20014; World Health Organization (WHO), 1990, WHO TECHN REP SER, V793; Yaghoobi-Ershadi M R, 2006, Bull Soc Pathol Exot, V99, P43, DOI 10.3185/pathexo2818; Yates A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-52; YUKICH J, 2007, OPERATIONS COSTS COS; YUVAL B, 1989, ANN TROP MED PARASIT, V83, P195, DOI 10.1080/00034983.1989.11812331; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x; 1997, ANN INTERNAL ASSESSM	116	52	52	2	21	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2008	13	8					1073	1085		10.1111/j.1365-3156.2008.02110.x				13	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	332IY	WOS:000258077900013	18564350				2019-04-02	
J	Van Geertruyden, JP; Menten, J; Colebunders, R; Korenromp, E; D'Alessandro, U				Van Geertruyden, Jean-Pierre; Menten, Joris; Colebunders, Robert; Korenromp, Eline; D'Alessandro, Umberto			The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance	MALARIA JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMODIUM-FALCIPARUM MALARIA; COTRIMOXAZOLE PROPHYLAXIS; UNCOMPLICATED MALARIA; INCREASED PREVALENCE; CHILDHOOD MALARIA; INFECTED ADULTS; RURAL UGANDA; SOUTH-AFRICA; CELL COUNT	Background: HIV-related immune-suppression increases the risk of malaria (infection, disease and treatment failure) and probably the circulating parasite biomass, favoring the emergence of drug resistance parasites. Methods: The additional malaria parasite biomass related to HIV-1 co-infection in sub-Saharan Africa was estimated by a mathematical model. Parasite biomass was computed as the incidence rate of clinical malaria episodes multiplied by the number of parasites circulating in the peripheral blood of patients at the time symptoms appear. A mathematical model estimated the influence of HIV-1 infection on parasite density in clinical malaria by country and by age group, malaria transmission intensity and urban/rural area. In a multivariate sensitivity analysis, 95% confidence intervals (CIs) were calculated using the Monte Carlo simulation. Results: The model shows that in 2005 HIV-1 increased the overall malaria parasite biomass by 18.0% (95% CI: 11.6-26.9). The largest relative increase (134.9-243.9%) was found in southern Africa where HIV-1 prevalence is the highest and malaria transmission unstable. The largest absolute increase was found in Zambia, Malawi, the Central African Republic and Mozambique, where both malaria and HIV are highly endemic. A univariate sensitivity analysis shows that estimates are sensitive to the magnitude of the impact of HIV-1 infection on the malaria incidence rates and associated parasite densities. Conclusion: The HIV-1 epidemic by increasing the malaria parasite biomass in sub-Saharan Africa may also increase the emergence of antimalarial drug resistance, potentially affecting the health of the whole population in countries endemic for both HIV-1 and malaria.	[Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto] Inst Trop Med Antwerpen, Epidemiol Unit, Dept Parasitol, B-2000 Antwerp, Belgium; [Menten, Joris] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium; [Korenromp, Eline] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Korenromp, Eline] Global Fund Fight AIDS, Performance Evaluat & Policy Unit, Geneva, Switzerland	Van Geertruyden, JP (reprint author), Inst Trop Med Antwerpen, Epidemiol Unit, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	jpvangeertruyden@itg.be; jmenten@itg.be; bcoleb@itg.be; Eline.Korenromp@TheGlobalFund.org; UDAlessandro@itg.be	Van geertruyden, Jean-Pierre/K-6425-2014; D'Alessandro, Umberto/D-3457-2015	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; D'Alessandro, Umberto/0000-0001-6341-5009			Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; ATZORI C, 1993, ANN TROP MED PARASIT, V87, P585, DOI 10.1080/00034983.1993.11812814; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Birku Y, 2002, ETHIOPIAN MED J, V40, P17; Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023; COLEBUNDERS R, 1990, J INFECTION, V21, P167, DOI 10.1016/0163-4453(90)91701-E; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; GREENBERG AE, 1991, NEW ENGL J MED, V325, P105, DOI 10.1056/NEJM199107113250206; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/01.aids.0000096909.73209.14; Grimwade K, 2003, PEDIATR INFECT DIS J, V22, P1057, DOI 10.1097/01.inf.0000101188.95433.60; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Hastings IM, 2006, PARASITOLOGY, V132, P615, DOI 10.1017/S0031182005009790; Hewitt K, 2006, AIDS, V20, P1993, DOI 10.1097/01.aids.0000247572.95880.92; Kalyesubula I, 1997, PEDIATR INFECT DIS J, V16, P876, DOI 10.1097/00006454-199709000-00011; Kamya MR, 2006, J INFECT DIS, V193, P9, DOI 10.1086/498577; Khasnis A A, 2003, J Postgrad Med, V49, P114; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Kitchen SF, 1949, MALARIOLOGY, P996; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Laufer MK, 2006, J INFECT DIS, V193, P872, DOI 10.1086/500245; Law A. M., 1982, SIMULATION MODELING, P400; Marsh K, 1998, LANCET, V352, P924, DOI 10.1016/S0140-6736(05)61510-3; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; MULLER O, 1990, T ROY SOC TROP MED H, V84, P336, DOI 10.1016/0035-9203(90)90306-Y; NATIONS U, 2002, WORLD POPULATION PRO; Nosten F, 2002, DRUGS, V62, P1315, DOI 10.2165/00003495-200262090-00003; Otieno RO, 2006, AIDS, V20, P275, DOI 10.1097/01.aids.0000200533.56490.b7; Patnaik P, 2005, J INFECT DIS, V192, P984, DOI 10.1086/432730; Ross A, 2006, AM J TROP MED HYG, V75, P63, DOI 10.4269/ajtmh.2006.75.63; SHAFFER N, 1990, AIDS, V4, P1231, DOI 10.1097/00002030-199012000-00008; Shah SN, 2006, J INFECT DIS, V194, P1519, DOI 10.1086/508892; SIMOOYA OO, 1988, BRIT MED J, V297, P30, DOI 10.1136/bmj.297.6640.30; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; TAHA TET, 1994, T ROY SOC TROP MED H, V88, P164, DOI 10.1016/0035-9203(94)90277-1; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; TEAM RDC, 2005, LANGUAGE ENV STAT CO; *UNAIDS, 2006, REP GLOB HIV AIDS AP; Van Geertruyden JP, 2006, J INFECT DIS, V194, P917, DOI 10.1086/507310; Van Geertruyden JP, 2006, JAIDS-J ACQ IMM DEF, V43, P363; Verhoeff FH, 1999, TROP MED INT HEALTH, V4, P5, DOI 10.1046/j.1365-3156.1999.00349.x; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI 10.1172/JCI200421682; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; WHO - World Health Organization, 2005, WORLD MAL REP 2005	50	23	23	1	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 22	2008	7								134	10.1186/1475-2875-7-134				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	344HV	WOS:000258918400001	18647387	DOAJ Gold, Green Published			2019-04-02	
J	Akoda, K; Harouna, S; Marcotty, T; De Deken, R; Van den Bossche, P				Akoda, K.; Harouna, S.; Marcotty, T.; De Deken, R.; Van den Bossche, P.			Investigations on the transmissibility of Trypanosoma congolense by the tsetse fly Glossina morsitans morsitans during its development in a mammalian host	ACTA TROPICA			English	Article						Glossina; transmission; Trypanosoma congolense; development	BLOOD-STREAM; BRUCEI; DIFFERENTIATION; FORMS	Experiments were conducted to investigate the effect of the developmental stage of a monomorphic T congolense IL1180 strain, in a vertebrate host, on its transmissibility by the tsetse fly Glossina morsitans morsitans Westwood (Diptera: Glossinidae). Batches of 160 male teneral tsetse flies were given a single bloodmeal on mice infected with this T congolense strain 4,5,6,7 or 10 days post-infection. The proportion of infected flies in each of those batches showed that the stage of development of the trypanosome does affect the proportion of flies that develop a mature or immature infection with immature and mature infection rates of flies infected on days 5 or 10 significantly higher. The proportion of infected flies was not affected by the parasitaemia at the moment of infection. Results show that tsetse flies can become infected at any phase of the development of the T congolense IL1180 strain but the ease with which trypanosomes develop in the fly depends on the phase in the parasite's development in the host. Those observations suggest that in analogy with the pleomorphic T brucei s.l. adaptation of the monomorphic T congolense to development in the fly may also determine the parasite's transmissibility. Moreover, the findings stress the importance of standardising experiments in which the vectorial capacity of tsetse flies is determined and compared. (C) 2008 Elsevier B.V. All rights reserved.	[Akoda, K.; Harouna, S.; Marcotty, T.; De Deken, R.; Van den Bossche, P.] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Van den Bossche, P.] Univ Pretoria, Dept Vet Trop Dis, Onderstepoort, South Africa	Van den Bossche, P (reprint author), Inst Trop Med, Dept Anim Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	pvdbossche@itg.be					Aksoy S, 2003, ADV PARASIT, V53, P1, DOI 10.1016/S0065-308X(03)53002-0; BALBER AE, 1972, EXP PARASITOL, V31, P307, DOI 10.1016/0014-4894(72)90122-1; Breidbach T, 2002, EXP PARASITOL, V101, P223, DOI 10.1016/S0014-4894(02)00133-9; Elsen Pierre, 1993, Journal of African Zoology, V107, P439; GEIGY R, 1973, Acta Tropica, V30, P12; Godfrey D. G., 1960, Annals of Tropical Medicine and Parasitology, V54, P428; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Kubi C, 2006, MED VET ENTOMOL, V20, P388, DOI 10.1111/j.1365-2915.2006.00644.x; LLYOD L, 1924, B ENTOMOL RES, V14, P265; Matthews KR, 1999, PARASITOL TODAY, V15, P76, DOI 10.1016/S0169-4758(98)01381-7; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; MAUDLIN I, 1989, ANN TROP MED PARASIT, V83, P431, DOI 10.1080/00034983.1989.11812368; Morrison W. I., 1985, Immunology and pathogenesis of trypanosomiasis, P103; NANTULYA VM, 1978, ACTA TROP, V35, P329; SEED JR, 2003, KINETOPLASTID BIOL D, V2, P3, DOI DOI 10.1186/1475-9292-2-3; TURNER CMR, 1988, PARASITOL RES, V74, P507, DOI 10.1007/BF00531626; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; Van den Bossche P, 2005, TROP MED INT HEALTH, V10, P833, DOI 10.1111/j.1365-3156.2005.01467.x; VANDENABBEELE J, 2001, THESIS ANTWERP U ANT; Wijers D. J. B., 1960, Annals of Tropical Medicine and Parasitology, V54, P341	20	6	6	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JUL	2008	107	1					17	19		10.1016/j.actatropica.2008.04.002				3	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	326FP	WOS:000257644200004	18485324				2019-04-02	
J	Protopopoff, N; Van Bortel, W; Marcotty, T; Van Herp, M; Maes, P; Baza, D; D'Alessandro, U; Coosemans, M				Protopopoff, Natacha; Van Bortel, Wim; Marcotty, Tanguy; Van Herp, Michel; Maes, Peter; Baza, Dismas; D'Alessandro, Umberto; Coosemans, Marc			Spatial targeted vector control is able to reduce malaria prevalence in the highlands of Burundi	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							PLASMODIUM-FALCIPARUM PARASITEMIA; WESTERN KENYA; CLINICAL MALARIA; TRANSMISSION; EPIDEMIC; AFRICA; IMPACT; INTERVENTIONS; COMBINATION; POPULATION	In a highland province of Burundi, indoor residual spraying and long-lasting insecticidal net distribution were targeted in the valley, aiming also to protect the population living on the hilltops. The impact on malaria indicators was assessed, and the potential additional effect of nets evaluated. After the intervention-and compared with the control valleys-children 1-9 years old in the treated valleys had lower risks of malaria infection (odds ratio, OR: 0.55), high parasite density (OR: 0.48), and clinical malaria (OR: 0.57). The impact on malaria prevalence was even higher in infants (OR: 0.14). Using nets did not confer an additional protective effect to spraying. Targeted vector control had a major impact on malaria in the high-risk valleys but not in the less-exposed hilltops. Investment in targeted and regular control measures associated with effective case management should be able to control malaria in the highlands.	[Protopopoff, Natacha; Van Bortel, Wim; D'Alessandro, Umberto; Coosemans, Marc] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Marcotty, Tanguy] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Van Herp, Michel; Maes, Peter] Med Sans Frontieres Belgium, Dept Med, B-1090 Brussels, Belgium; [Baza, Dismas] Minist Hlth, Programme Lutte Malad Transmissibles & Carentiell, Bujumbura, Burundi; Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, Dept Biomed Sci, B-2020 Antwerp, Belgium	Protopopoff, N (reprint author), Inst Trop Med, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	nprotopopoff@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009			Abeku TA, 2007, EMERG INFECT DIS, V13, P681, DOI 10.3201/eid1305.061333; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; BARNES KI, 2005, PLOS MED, V2, P1123; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Checchi F, 2006, EMERG INFECT DIS, V12, P1477, DOI 10.3201/eid1210.060540; Coosemans M, 1989, Trans R Soc Trop Med Hyg, V83 Suppl, P97, DOI 10.1016/0035-9203(89)90612-3; DRAPER C. C, 1960, TRANS ROY SOC TROP MED AND HYG, V54, P342, DOI 10.1016/0035-9203(60)90115-2; Etchegorry MG, 2001, LANCET, V357, P1046, DOI 10.1016/S0140-6736(05)71623-8; FONTAINE RE, 1961, AM J TROP MED HYG, V10, P795, DOI 10.4269/ajtmh.1961.10.795; GARNHAM PCC, 1945, BRIT MED J, V2, P45, DOI 10.1136/bmj.2.4410.45; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Hay SI, 2002, EMERG INFECT DIS, V8, P543, DOI 10.3201/eid0806.010309; *INS RES ACT COMM, 2006, PREV MAN INS RES VEC; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Malakooti MA, 1998, EMERG INFECT DIS, V4, P671, DOI 10.3201/eid0404.980422; MANGA L, 1993, J MED ENTOMOL, V30, P936, DOI 10.1093/jmedent/30.5.936; MARIMBU J, 1993, B SOC PATHOL EXOT, V86, P399; MCELROY PD, 1994, AM J TROP MED HYG, V51, P523, DOI 10.4269/ajtmh.1994.51.523; McElroy PD, 1997, AM J EPIDEMIOL, V145, P945; *MED SANS FRONT, 2002, MAL CAS WEEKL REP; *MIN HLTH EP STAT, 2002, MONTHL REP MAL CAS; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; NAJERA J, 1998, WHOMAL981084; NAJERA JA, 2001, WHOCDSWHOPES20013, P1; Ndayiragije A, 2004, TROP MED INT HEALTH, V9, P673, DOI 10.1111/j.1365-3156.2004.01255.x; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-93; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-158; Rowland M, 1999, T ROY SOC TROP MED H, V93, P458, DOI 10.1016/S0035-9203(99)90336-X; Shanks GD, 2000, T ROY SOC TROP MED H, V94, P253, DOI 10.1016/S0035-9203(00)90310-9; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; VanBortel W, 1996, TROP MED INT HEALTH, V1, P824; *WHO, 2003, WHOHTMMAL20041098; WHO, 2005, WHOCDSNTDDCE20052A; WHO, 2007, INS TREAT MOSQ NETS; World Health Organization, 2006, WHOHTMMAL20061112	42	48	48	0	11	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUL	2008	79	1					12	18		10.4269/ajtmh.2008.79.12				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	322XD	WOS:000257407700005	18606758	Green Published			2019-04-02	
J	Putnak, JR; de La Barrera, R; Burgess, T; Pardo, J; Dessy, F; Gheysen, D; Lobet, Y; Green, S; Endy, TP; Thomas, SJ; Eckels, KH; Innis, BL; Sun, W				Putnak, J. Robert; de la Barrera, Rafael; Burgess, Timothy; Pardo, Jorge; Dessy, Francis; Gheysen, Dirk; Lobet, Yves; Green, Sharone; Endy, Timothy P.; Thomas, Stephen J.; Eckels, Kenneth H.; Innis, Bruce L.; Sun, Wellington			Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; INFECTION; CELLS	Plaque reduction neutralization tests (PRNTs) are commonly used for measuring levels of dengue virus (DENV) neutralizing antibodies. However, these assays lack a standardized format, generally have a low sample throughput, and are labor-intensive. The objective of the present study was to evaluate two alternative DENY neutralizing antibody assays: an enzyme-linked immunosorbent assay-based microneutralization (MN) assay, and a fluorescent antibody cell sorter-based, DC-SIGN expresser dendritic cell (DC) assay. False-positive rates, serotype specificity, reproducibility, sensitivity, and agreement among the assay methods were assessed using well-characterized but limited numbers of coded test sera. Results showed that all three assays had false-positive rates of less than 10% with titers near the cut-off and generally below the estimated limits of detection. All three methods demonstrated a high degree of specificity and good agreement when used to assay sera and serum mixtures from monovalent vaccinees and sera from patients after primary natural infection, with the only notable exception being moderate-to-high neutralizing antibody titers against DENV 2 measured by PRNT in a mixture containing only DENY 3 and DENV 4 sera. The MN and DC assays demonstrated good reproducibility. All three assays were comparable in their sensitivity, except that the PRNT was less sensitive for measuring DENV 4 antibody, and the MN and DC assays were less sensitive for measuring DENV 2 antibody. However, when used to test sera from persons after tetravalent DENV vaccination or secondary DENY infection, there was poor specificity and poor agreement among the different assays.	[Putnak, J. Robert; Thomas, Stephen J.] Walter Reed Army Inst Res, Div Viral Dis, Silver Spring, MD 20910 USA; [de la Barrera, Rafael; Eckels, Kenneth H.] Walter Reed Army Inst Res, Div Regulated Activ, Pilot Bioprod Facil, Silver Spring, MD 20910 USA; [Burgess, Timothy] USN, Med Res Ctr, Silver Spring, MD USA; [Pardo, Jorge] BD Biosci, San Jose, CA 95131 USA; [Dessy, Francis; Gheysen, Dirk; Lobet, Yves] GlaxoSmithKline Biol, Global Vaccine Dev, B-1330 Rixensart, Belgium; [Green, Sharone] Univ Massachusetts, Sch Med, Ctr Infect Dis & Vaccine Res, Worcester, MA 01655 USA; [Endy, Timothy P.] SUNY Hlth Sci Ctr, Dept Med, Syracuse, NY 13210 USA; [Innis, Bruce L.] N Amer GlaxoSmithKline, Clin R&D & Med Affair Vaccines Virus Dis, King Of Prussia, PA USA; [Sun, Wellington] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Dengue Branch, San Juan, PR 00920 USA	Putnak, JR (reprint author), Walter Reed Army Inst Res, Div Viral Dis, 503 Robert Grant Ave,Suite 3A12, Silver Spring, MD 20910 USA.	robert.putnak@na.amedd.army.mil; rafael.delabarrera@na.amedd.army.mil; burgess.namru2@yahoo.com; Jorge_Pardo@bd.com; francis.dessy@gskbio.com; dirk.gheysen@gskbio.com; yves.lobet@gskbio.com; sharone.green@umassmed.edu; endyt@upstate.edu; stephen.thomas@na.amedd.army.mil; kenneth.eckels@amedd.army.mil; bruce.2.innis@gsk.com; wks4@cdc.gov		Innis, Bruce/0000-0002-1753-7248	NIAID NIH HHS [P01 AI34533]		CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; FEGUSON M, 2002, PREPARATION ANTIDENG; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; Halstead SB, 2003, AM J TROP MED HYG, V69, P5; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; KUNO G, 1991, J VIROL METHODS, V33, P101, DOI 10.1016/0166-0934(91)90011-N; Martin NC, 2006, J VIROL METHODS, V134, P74, DOI 10.1016/j.jviromet.2005.12.002; PEREZ JL, 1995, J CLIN MICROBIOL, V33, P1646; Raengsakulrach B, 2002, J VIROL METHODS, V105, P219, DOI 10.1016/S0166-0934(02)00104-0; RUSSELL PK, 1967, J IMMUNOL, V99, P285; SINGH KRP, 1969, B WORLD HEALTH ORGAN, V40, P982; Sun W, 2003, AM J TROP MED HYG, V69, P24; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Vorndam V, 2002, AM J TROP MED HYG, V66, P208, DOI 10.4269/ajtmh.2002.66.208	16	42	44	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUL	2008	79	1					115	122		10.4269/ajtmh.2008.79.115				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	322XD	WOS:000257407700021	18606774	Green Published			2019-04-02	
J	Graham, WJ; Conombo, SG; Zombre, DS; Meda, N; Byass, P; De Brouwere, V				Graham, Wendy J.; Conombo, S. Ghislaine; Zombre, D. Sosthene; Meda, Nicolas; Byass, Peter; De Brouwere, Vincent			Undertaking a complex evaluation of safe motherhood in rural Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						complex evaluation; safe motherhood strategies; skilled attendance at delivery	REDUCING MATERNAL MORTALITY; SKILLED CARE; STRATEGIES; DELIVERY	Evaluations of composite health interventions, such as those attempting to make motherhood safer, are by definition complex, but nevertheless regarded as essential to informing progress in global health. This paper introduces a series of reports which set out the basis of Family Care International's Skilled Care Initiative in rural Burkina Faso, go on to describe strategies and methods for evaluating it, and present evaluation findings in terms of pregnancy outcomes, utilisation and effects of the intervention and economics. Although there were encouraging findings, no 'magic bullets' emerged from these studies, illustrating the reality that sustained and increasing resources are needed to achieve safe motherhood for all. There is no cheap or short-cut solution.	[Graham, Wendy J.; Byass, Peter] Univ Aberdeen, Immpact, Aberdeen AB25 2ZD, Scotland; [Conombo, S. Ghislaine; Zombre, D. Sosthene] World Hlth Org, Ouagadougou, Burkina Faso; [Meda, Nicolas] Ctr Muraz, Immpact, Bobo Dioulasso, Burkina Faso; [De Brouwere, Vincent] Inst Trop Med, Immpact, B-2000 Antwerp, Belgium	Graham, WJ (reprint author), Univ Aberdeen, Immpact, Hlth Sci Bldg, Aberdeen AB25 2ZD, Scotland.	w.graham@abdn.ac.uk		Byass, Peter/0000-0001-5474-4361			Bell JS, 2008, TROP MED INT HEALTH, V13, P31, DOI 10.1111/j.1365-3156.2008.02085.x; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI94, DOI 10.1093/heapol/czi056; Bullough C, 2005, BJOG-INT J OBSTET GY, V112, P1180, DOI 10.1111/j.1471-0528.2005.00718.x; Byass P, 2008, TROP MED INT HEALTH, V13, P25, DOI 10.1111/j.1365-3156.2008.02084.x; *CAMPB COLL, 2005, J HEALTH SERV RES PO, V10, P1; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; De Brouwere V, 2002, LANCET, V359, P974, DOI 10.1016/S0140-6736(02)07993-X; *DIR SANT FAM, 2003, STRAT NAT MAT MOINDR; Graham W, 2008, TROP MED INT HEALTH, V13, P6, DOI 10.1111/j.1365-3156.2008.02082.x; Graham WJ, 2004, LANCET, V363, P23, DOI 10.1016/S0140-6736(03)15165-3; Hounton S, 2008, TROP MED INT HEALTH, V13, P44, DOI 10.1111/j.1365-3156.2008.02086.x; Hounton S, 2008, TROP MED INT HEALTH, V13, P53, DOI 10.1111/j.1365-3156.2008.02087.x; Hounton S, 2008, TROP MED INT HEALTH, V13, P14, DOI 10.1111/j.1365-3156.2008.02083.x; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; MACDONAGH S, 2005, ACHIEVING SKILLED AT; Meda N, 2008, TROP MED INT HEALTH, V13, P68, DOI 10.1111/j.1365-3156.2008.02089.x; Milne L, 2004, J MIDWIFERY WOM HEAL, V49, P338, DOI 10.1016/j.jmwh.2004.04.002; Moore M., 2002, BEHAV CHANGE APPROAC; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Pawson R., 1997, REALISTIC EVALUATION; RONSMANS C, 2007, MIDWIFE LED CO UNPUB; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S01406736(06)69380-X; SAVEDOFF WD, 2006, WHEN WILL WE EVER LE; World Health Organization, 2005, WORLD HLTH REP 2005	26	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2008	13			1			1	5		10.1111/j.1365-3156.2008.02081.x				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	311SX	WOS:000256621100001	18578806	Bronze			2019-04-02	
J	Graham, W; Themmen, E; Bassane, B; Meda, N; De Brouwere, V				Graham, Wendy; Themmen, Ellen; Bassane, Brahima; Meda, Nicolas; De Brouwere, Vincent			Evaluating skilled care at delivery in Burkina Faso: principles and practice	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						skilled attendance at delivery; conceptual frameworks; outcome evaluation	REDUCING MATERNAL MORTALITY; SAFE MOTHERHOOD; ATTENDANCE; STRATEGIES; ACCESS; WORKS	There are strong expectations of what could be achieved by skilled care at delivery for maternal and newborn survival and health. Meeting these expectations involves the translation of the concepts and principles of skilled attendance into the reality of routine programmes. This process of translation brings to light some of the tensions which lie behind the consensus on the ideal package and particularly the alternative configurations of provider and place necessary in the immediate term. Lessons learnt from the implementation of specific projects and initiatives have a crucial role to play in informing scaling-up and the achievement of universal coverage. The Skilled Care Initiative implemented in Burkina Faso by Family Care International, evaluated and reported here, provides many lessons for moving from concepts to practice. Firstly, there is the crucial issue of local contextual adaptation, as no one-size-fits-all for skilled attendance. Secondly, interventions to achieve skilled care require and imply different levels of intensity of implementation, depending on the functionality of the wider health system in the intervention area. Thirdly, there is the crucial issue of the balance and sequencing of supply- and demand-side interventions. Finally, the concept of skilled attendance at delivery does not exist in a vacuum in space or time, and concurrent health initiatives and cross-sectoral developments, such as transport and road improvements, can strongly influence outcomes. This not only presents challenges for the implementation of specific interventions within health institutions and communities, but also for the evaluation of their effects.	[Graham, Wendy] Univ Aberdeen, Immpact, Aberdeen AB25 2ZD, Scotland; [Themmen, Ellen] Family Care Int, New York, NY USA; [Bassane, Brahima] Family Care Int, Ouagadougou, Burkina Faso; [Meda, Nicolas] Ctr Muraz, Immpact, Bobo Diulasso, Burkina Faso; [De Brouwere, Vincent] Inst Trop Med, Immpact, B-2000 Antwerp, Belgium	Graham, W (reprint author), Univ Aberdeen, Immpact, Hlth Sci Bldg, Aberdeen AB25 2ZD, Scotland.	w.graham@abdn.ac.uk					Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Buttiens H, 2004, TROP MED INT HEALTH, V9, P653, DOI 10.1111/j.1365-3156.2004.01256.x; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; *FAM CAR INT, 2005, SKILL CAR IN WHICH C; *FAM CAR INT, 2007, SKILL CAR IN OV KEY; Freedman LP, 2005, WHOS GOT POWER TRANS; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Gill K, 2007, LANCET, V370, P1347, DOI 10.1016/S0140-6736(07)61577-3; Graham WJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P499; Graham WJ, 2001, STUDIES HLTH SERVICE, V17, P97; Hounton S, 2008, TROP MED INT HEALTH, V13, P14, DOI 10.1111/j.1365-3156.2008.02083.x; Hussein J, 2004, REPROD HEALTH MATTER, V12, P160, DOI 10.1016/S0968-8080(04)24136-2; Jahn A., 2001, STUD HLTH SERVICES O, V17, P229; Koblinsky M, 2003, REDUCING MATERNAL MO; Koblinsky MA, 1999, B WORLD HEALTH ORGAN, V77, P399; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; MACDONAGH S, 2005, ACHIEVING SKILLED AT; Maine D, 2007, LANCET, V370, P1380, DOI 10.1016/S0140-6736(07)61580-3; MCCARTHY J, 1992, STUD FAMILY PLANN, V23, P23, DOI 10.2307/1966825; Moore M., 2002, BEHAV CHANGE APPROAC; Mukuria A, 2005, CONTEXT WOMENS HLTH; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S01406736(06)69380-X; ROSENFIELD A, 1985, LANCET, V2, P83; STANTON C, 2007, J BIOSOC SCI, V39, P102; STARRS A, 2007, LANCET, V370, P1283; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; ten Hoope-Bender P, 2006, INT J GYNECOL OBSTET, V94, P226, DOI 10.1016/j.ijgo.2006.04.003; *UON NETW, 2007, UNM OBST NEEDS NETW; *WHO, 2005, SKILL ATT BIRTH 2005; World Health Organization, 2004, MAK PREGN SAF CRIT R; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2006, WORLD HLTH REP 2006	34	15	15	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2008	13			1			6	13		10.1111/j.1365-3156.2008.02082.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	311SX	WOS:000256621100002	18578807	Bronze			2019-04-02	
J	Hounton, S; Sombie, I; Meda, N; Bassane, B; Byass, P; Stanton, C; De Brouwere, V				Hounton, Sennen; Sombie, Issiaka; Meda, Nicolas; Bassane, Brahima; Byass, Peter; Stanton, Cynthia; De Brouwere, Vincent			Methods for evaluating effectiveness and cost-effectiveness of a Skilled Care Initiative in rural Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						safe motherhood; skilled care initiative; cost-effectiveness; mixed methods; Burkina Faso	MATERNAL MORTALITY; PUBLIC-HEALTH	Introduction This paper aims to describe the design, methods and approaches used to assess the effectiveness and cost-effectiveness of the Skilled Care Initiative in reducing pregnancy-related and perinatal mortality in Ouargaye district, Burkina Faso. Methods The evaluation used a quasi-experimental design, mixed methods and a composite of tools to compare mortality and severe morbidity (near-miss) of women in reproductive age, perinatal mortality, facility functionality, perceived quality of care, utilisation of maternal health services, and costs borne by families and the health care system for maternal health care in Ouargaye and Diapaga districts. Structured questionnaires and interview guides were developed, pre-tested and piloted prior to the main survey. The evaluation was carried out from January to July 2006. A household census was used to retrospectively assess pregnancy-related and perinatal mortality over the previous 5 years, and causes of pregnancy-related death were identified using a newly developed and tested probabilistic model for interpreting verbal autopsy data. Data were directly entered into Personal Digital Assistant devices at the point of interview. Analyses included univariate and multivariate regressions and incremental cost-effectiveness ratios. Results A population census covering over half a million people, three qualitative surveys and facility surveys in 47 health centres have been carried out. Conclusion A partnership with key stakeholders and the use of mixed methods proved feasible for evaluating complex safe motherhood strategies, and the use of hand-held computers proved possible for direct data capture, even in this remote rural environment.	[Hounton, Sennen; Sombie, Issiaka; Meda, Nicolas] Ctr Muraz, Immpact, Bobo Dioulasso, Burkina Faso; [Bassane, Brahima] Family Care Int, Ouagadougou, Burkina Faso; [Byass, Peter] Univ Aberdeen, Immpact, Aberdeen, Scotland; [Stanton, Cynthia] Johns Hopkins Bloomberg Sch Publ Hlth, Immpact, Baltimore, MD USA; [De Brouwere, Vincent] Inst Trop Med, Immpact, B-2000 Antwerp, Belgium	Hounton, S (reprint author), Ctr Muraz, Immpact, POB 298, Bobo Dioulasso, Burkina Faso.	shounton.muraz@fasonet.bf		Byass, Peter/0000-0001-5474-4361			Blackwood B, 2006, J ADV NURS, V54, P612, DOI 10.1111/j.1365-2648.2006.03869.x; BRYCE J, 2005, HLTH POLICY PLANN S1, V20, P5; Byass P, 2006, SCAND J PUBLIC HEALT, V34, P26, DOI 10.1080/14034940510032202; Byass P, 2008, TROP MED INT HEALTH, V13, P25, DOI 10.1111/j.1365-3156.2008.02084.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fottrell Edward, 2007, Popul Health Metr, V5, P1, DOI 10.1186/1478-7954-5-1; Gibson JL, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-25; Graham W, 2008, TROP MED INT HEALTH, V13, P6, DOI 10.1111/j.1365-3156.2008.02082.x; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P173, DOI 10.2471/BLT.05.027714; Hill K., 2001, MEASURE EVALUATION M, V4; Hounton SH, 2005, INT J GYNECOL OBSTET, V91, P97, DOI 10.1016/j.ijgo.2005.06.027; *I NAT STAT DEM, 2001, ENQ PRIOR COND VIE M; *MACR INT, 2004, DEM HLTH SURV BURK F; *MACR INT, 2000, DEM HLTH SURV BURK F; MADI BC, 2007, HLTH POLICY, V83, P91; Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x; *MIN HLTH, 2002, PLAN ACT DISTR SAN D; *MIN HLTH, 2002, PLAN ACT DISTR SAN O; Ovretveit J., 1998, EVALUATING HLTH INTE; *QSR INT, 2007, NVIVO SOFTW; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S01406736(06)69380-X; SASSI F, 2002, HLTH POLICY PLANNING, V63, P141; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stanton C, 2001, B WORLD HEALTH ORGAN, V79, P657; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Victoria C, 2005, HLTH POLICY PLANN S1, V20, P18; WHO (World Health Organization), 1999, WHOFCHRHR9917	28	17	17	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2008	13			1			14	24		10.1111/j.1365-3156.2008.02083.x				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	311SX	WOS:000256621100003	18578808				2019-04-02	
J	Hounton, S; Chapman, G; Menten, J; De Brouwere, V; Ensor, T; Sombie, I; Meda, N; Ronsmans, C				Hounton, Sennen; Chapman, Glyn; Menten, Joris; De Brouwere, Vincent; Ensor, Tim; Sombie, Issiaka; Meda, Nicolas; Ronsmans, Carine			Accessibility and utilisation of delivery care within a Skilled Care Initiative in rural Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						skilled care Initiative; health care access; health care utilisation; delivery care; Burkina Faso	MATERNAL MORTALITY; HEALTH; KENYA	Objectives The Skilled Care Initiative (SCI) was a comprehensive skilled attendance at delivery strategy implemented by the Ministry of Health and Family Care International in Ouargaye district (Burkina Faso) from 2002 to 2005. We aimed to evaluate the relationships between accessibility, functioning of health centres and utilisation of delivery care in the SCI intervention district (Ouargaye) and compare this with another district (Diapaga). Methods Data were collected on staffing, equipment, water and energy supply for all health centres and a functionality index for health centres were constructed. A household census was carried out in 2006 to assess assets of all household members, and document pregnancies lasting more than 6 months between 2001 and 2005, with place of delivery and delivery attendant. Utilisation of delivery care was defined as birth in a health institution or birth by Caesarean section. Analyses included univariate and multivariate logistic regression. Results Distance to health facility, education and asset ownership were major determinants of delivery care utilisation, but no association was found between the functioning of health centres (as measured by infrastructure, energy supply and equipment) and institutional birth rates or births by Caesarean section. The proportion of births in an institution increased more substantially in the SCI district over time but no changes were seen in Caesarean section rates. Conclusion The SCI has increased uptake of institutional deliveries but there is little evidence that it has increased access to emergency obstetric care, at least in terms of uptake of Caesarean sections. Its success is contingent on large-scale coverage and 24-h availability of referral for life saving drugs, skilled personnel and surgery for pregnant women.	[Ronsmans, Carine] Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Immpact, London WC1E 7HT, England; [Hounton, Sennen; Sombie, Issiaka; Meda, Nicolas] Ctr Muraz, Immpact, Bobo Dioulasso, Burkina Faso; [Chapman, Glyn] Univ Aberdeen, Immpact, Aberdeen, Scotland; [Menten, Joris; De Brouwere, Vincent; Ensor, Tim] Inst Trop Med, Immpact, B-2000 Antwerp, Belgium	Ronsmans, C (reprint author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Immpact, Keppel St, London WC1E 7HT, England.	carine.ronsmans@lshtm.ac.uk		Ensor, Timothy/0000-0003-0279-9576			Bell JS, 2008, TROP MED INT HEALTH, V13, P31, DOI 10.1111/j.1365-3156.2008.02085.x; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; CHAPMAN G, 2006, MEASURING FUNCTIONAL; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; DIALLO D, 2002, EVALUATION QUANTITAT; *DIEM, 2004, NORM STAND INFR EQ C, P151; *DIR SANT FAM, 2004, MIN SANT BURK FAS CO; *DIR SANT FAM, 2004, MIN SANT BURK FAS SA; Dubourg D, 2007, UON NETWORK TACKLING; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Graham W, 2008, TROP MED INT HEALTH, V13, P6, DOI 10.1111/j.1365-3156.2008.02082.x; Hardin J. W., 2003, GEN ESTIMATING EQUAT; Hodgkin D, 1996, HEALTH ECON, V5, P333, DOI 10.1002/(SICI)1099-1050(199607)5:4<333::AID-HEC202>3.0.CO;2-K; Hounton S, 2008, TROP MED INT HEALTH, V13, P14, DOI 10.1111/j.1365-3156.2008.02083.x; Hussein J, 2004, REPROD HEALTH MATTER, V12, P160, DOI 10.1016/S0968-8080(04)24136-2; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Leberghe W., 1998, BESOINS OBSTETRICAUX; Magadi M, 2000, SOC BIOL, V47, P164; *NAT I STAT DEM MA, 2004, DEM HLTH SURV BURK F; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S01406736(06)69380-X; Tanser F, 2006, J EPIDEMIOL COMMUN H, V60, P846, DOI 10.1136/jech.2005.043265; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; *WORLD BANK, 2007, MILL DEV GOALS; World Health Organization, 2005, WORLD HLTH REP 2005	25	62	62	0	6	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2008	13			1			44	52		10.1111/j.1365-3156.2008.02086.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	311SX	WOS:000256621100006	18578811	Bronze			2019-04-02	
J	Hounton, S; Menten, J; Ouedraogo, M; Dubourg, D; Meda, N; Ronsmans, C; Byass, P; De Brouwere, V				Hounton, Sennen; Menten, Joris; Ouedraogo, Moctar; Dubourg, Dominique; Meda, Nicolas; Ronsmans, Carine; Byass, Peter; De Brouwere, Vincent			Effects of a skilled care initiative on pregnancy-related mortality in rural burkina faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						maternal mortality; pregnancy-related mortality; skilled attendance at delivery; effectiveness; Burkina Faso		Objective The aim of this paper is to assess to what extent a Skilled Care Initiative (SCI) was associated with pregnancy-related mortality in Ouargaye district, Burkina Faso. Methods We used a quasi-experimental design to compare pregnancy-related mortality within the intervention district (health facility areas covered by the SCI vs. areas not covered) and between the intervention district (Ouargaye) and a comparison district (Diapaga). Population-based data were used to examine differences in pregnancy-related mortality levels, their determinants and how they related to uptake of care, as well as examining contexts and mechanisms of pregnancy-related deaths that occurred. Data analyses included descriptive statistics, univariate and multivariate regression analyses. Results The main risk factors for pregnancy-related mortality in rural Burkina Faso were age (extreme ages of reproductive period), low coverage of antenatal care and low institutional delivery. The introduction of the SCI, as implemented within the study reference period, had no appreciable effect on pregnancy-related mortality. Conclusion Although the SCI was conceptually well designed and implemented, structural constraints may have limited its effectiveness for reducing pregnancy-related mortality within its period of implementation. Lessons have been identified which might enable similar skilled attendance strategies to make their full potential impact on pregnancy-related mortality in remote and rural settings.	[Menten, Joris; Dubourg, Dominique; De Brouwere, Vincent] Inst Trop Med, Dept Publ Hlth, Immpact, B-2000 Antwerp, Belgium; [Hounton, Sennen; Ouedraogo, Moctar; Meda, Nicolas] Ctr Muraz, Immpact, Bobo Dioulasso, Burkina Faso; [Ronsmans, Carine] London Sch Hyg & Trop Med, Immpact, London WC1, England; [Byass, Peter] Univ Aberdeen, Immpact, Aberdeen, Scotland	De Brouwere, V (reprint author), Inst Trop Med, Dept Publ Hlth, Immpact, B-2000 Antwerp, Belgium.	vdbrouw@itg.be		Byass, Peter/0000-0001-5474-4361			Byass P, 2008, TROP MED INT HEALTH, V13, P25, DOI 10.1111/j.1365-3156.2008.02084.x; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; *DGS, 2005, EV PERF DISTR SAN PR; DIALLO D, 2003, EVALUATION QUANTITAT; DIALLO D, 2002, EVALUATION QUANTITAT; DIELTIENS G, 2005, PREGNANCY RELATED MO; *DIR SANT FAM, 2003, STRAT NAT MAT MOINDR; Graham W, 2008, TROP MED INT HEALTH, V13, P6, DOI 10.1111/j.1365-3156.2008.02082.x; Graham WJ, 2004, LANCET, V363, P23, DOI 10.1016/S0140-6736(03)15165-3; Hardin J. W., 2003, GEN ESTIMATING EQUAT; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P173, DOI 10.2471/BLT.05.027714; Hill K., 2001, MEASURE EVALUATION M, V4; Horton R, 2006, LANCET, V368, P1129, DOI 10.1016/S0140-6736(06)69389-6; Hounton S, 2008, TROP MED INT HEALTH, V13, P44, DOI 10.1111/j.1365-3156.2008.02086.x; Hounton S, 2008, TROP MED INT HEALTH, V13, P14, DOI 10.1111/j.1365-3156.2008.02083.x; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; McKnight P. E., 2007, MISSING DATA GENTLE; *MIN EC FIN OUAG B, 2000, RAPP FIN ENQ DEM SAN; NACOULMA D, 2003, 10 JOURN SCI SANT BO; SAS Institute Inc, 2004, SAS STAT 9 1 US GUID; *UONN, 2002, TACKL UNM OBST NEEDS; Van Lerberghe W, 2001, STUDIES HLTH SERVICE, P7; Victoria C, 2005, HLTH POLICY PLANN S1, V20, P18; *WHO UNICEF UNFPA, 2000, MAT MORT 2000 EST DE; World Health Organization, 2005, WORLD HLTH REP 2005	25	23	23	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2008	13			1			53	60		10.1111/j.1365-3156.2008.02087.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	311SX	WOS:000256621100007	18578812				2019-04-02	
J	Meda, N; Hounton, S; De Brouwere, V; Sombie, I; Byass, P				Meda, Nicolas; Hounton, Sennen; De Brouwere, Vincent; Sombie, Issiaka; Byass, Peter		IMMPACT Burkina Evaluation Study	From evaluating a Skilled Care Initiative in rural Burkina Faso to policy implications for safe motherhood in Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						safe motherhood; policy priorities; evaluation research; Burkina Faso; Africa	REDUCING MATERNAL MORTALITY; DEVELOPING-COUNTRIES; STRATEGIES; SURVIVAL; REDUCTION	Evaluation findings from a particular setting need to be generalized into policy implications if they are to find widespread use. Skilled attendance at delivery is widely regarded as one of the most important intervention strategies for safe motherhood in low-resource settings, particularly in Africa, but implementations of such strategies are often not rigorously evaluated or interpreted into future policy. Initiative for Maternal Mortality Programme Assessment (Immpact) has applied a package of research-based monitoring and evaluation tools to assess the Family Care International Skilled Care Initiative in Ouargaye District, Burkina Faso. This evaluation research aimed to generate reliable, evidence-based policies for accelerating safe motherhood programmes in Burkina Faso and elsewhere in Africa. Five policy priorities were identified as representing real chances of improving the safety of motherhood: (1) enhancing national coverage of delivery by professionally skilled attendants; (2) to provide a network of 24-h basic emergency obstetric care within 5 km; (3) to have an effective referral system, equipped and resourced to undertake a reasonable number of Caesarean sections; (4) to promote community mobilization activities as a lever to increasing delivery care utilization; and (5) to implement strategies to remove financial barriers to delivery care. To meet Millennium Development Goal five by 2015, both supply and demand side constraints on the provision of quality maternity care have to be addressed, which in turn need greater political commitment and funding.	[Meda, Nicolas; Hounton, Sennen; Sombie, Issiaka] Ctr Muraz, Immpact Project, Bobo Dioulasso, Burkina Faso; [De Brouwere, Vincent] Inst Trop Med, Immpact, B-2000 Antwerp, Belgium; [Byass, Peter] Univ Aberdeen, Immpact, Aberdeen AB9 1FX, Scotland	Meda, N (reprint author), Ctr Muraz, Immpact Project, POB 298, Bobo Dioulasso, Burkina Faso.	nmeda.muraz@fasonet.bf		Byass, Peter/0000-0001-5474-4361			[Anonymous], 2004, MAK PREGN SAF CRIT R; Bell JS, 2008, TROP MED INT HEALTH, V13, P31, DOI 10.1111/j.1365-3156.2008.02085.x; Bullough C, 2005, BJOG-INT J OBSTET GY, V112, P1180, DOI 10.1111/j.1471-0528.2005.00718.x; Buttiens H, 2004, TROP MED INT HEALTH, V9, P653, DOI 10.1111/j.1365-3156.2004.01256.x; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Costello A, 2005, LANCET, V366, P603, DOI 10.1016/S0140-6736(05)66703-7; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; De Brouwere V, 2001, STUDIES HLTH SERVICE, V17, P1; Haddad S, 2006, TROP MED INT HEALTH, V11, P1889, DOI 10.1111/j.1365-3156.2006.01748.x; Hounton S, 2008, TROP MED INT HEALTH, V13, P44, DOI 10.1111/j.1365-3156.2008.02086.x; Hounton S, 2008, TROP MED INT HEALTH, V13, P53, DOI 10.1111/j.1365-3156.2008.02087.x; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Liljestrand J, 2004, J PUBLIC HEALTH POL, V25, P299, DOI 10.1057/palgrave.jphp.3190030; Mavalankar DV, 2005, AM J PUBLIC HEALTH, V95, P200, DOI 10.2105/AJPH.2003.036715; NEWLANDS S, 2008, TROPICAL MED INT S1, V13, P61; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Pereira C, 1996, BRIT J OBSTET GYNAEC, V103, P508, DOI 10.1111/j.1471-0528.1996.tb09797.x; *POP REF BUR, 2004, HLTH B, V1, P1; Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455; Stanton C, 2007, J BIOSOC SCI, V39, P109, DOI 10.1017/S0021932006001271; Van Lerberghe W, 2001, STUDIES HLTH SERVICE, P7; World Health Organization, 2005, WORLD HLTH REP 2005	23	5	5	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2008	13			1			68	72		10.1111/j.1365-3156.2008.02089.x				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	311SX	WOS:000256621100009	18578814				2019-04-02	
J	Dinesh, DS; Das, P; Picado, A; Davies, C; Speybroeck, N; Ostyn, B; Boelaert, M; Coosemans, M				Dinesh, Diwakar S.; Das, Pradeep; Picado, Albert; Davies, Clive; Speybroeck, Niko; Ostyn, Bart; Boelaert, Marleen; Coosemans, Marc			Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Phlebotomus argentipes; sandfly control; visceral leishmaniasis; long-lasting nets; indoor residual spraying; Indian subcontinent	DELTAMETHRIN-IMPREGNATED BEDNETS; KALA-AZAR; LEISHMANIASIS	OBJECTIVE To determine whether the use of long-lasting insecticidal nets (LLINS) at household level are effective in reducing the abundance of Phlebotomus argentipes, vector of anthroponotic visceral leishmaniasis in India, Nepal and Bangladesh. METHODS The impact of two long-lasting nets (Olyset and PermaNet) on indoor sandfly abundance was evaluated in selected houses of three endemic hamlets in Bihar (India). It was assumed that most sandflies breed inside the houses and that LLINs would progressively reduce the indoor density during the reproduction season. A campaign of indoor spraying with dichloro-diphenyl-trichloroethane (DDT) interfered with the trial but did not affect the sandfly population. RESULTS Only the density of males of P. argentipes was significantly reduced by both the LLINs but not the females. CONCLUSIONS These findings suggest that most female sandflies are coming from outside and that LLINs do not reduce their entry rate.	[Coosemans, Marc] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Dinesh, Diwakar S.; Das, Pradeep] Rajendra Mem Res Inst Med Sci, Indian Council Med Res, Agamkuan Patna, India; [Picado, Albert; Davies, Clive] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Speybroeck, Niko] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Speybroeck, Niko] Univ Catholique Louvain, Ecole Sante Publ, B-1200 Brussels, Belgium; [Ostyn, Bart; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Vet & Biomed Sci, B-2020 Antwerp, Belgium	Coosemans, M (reprint author), Inst Trop Med, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	mcoosemans@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Picado, Albert/0000-0001-7344-628X			ALEXANDER B, 1995, MED VET ENTOMOL, V9, P279, DOI 10.1111/j.1365-2915.1995.tb00134.x; Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x; COOSEMANS M, 1995, ANN SOC BELG MED TR, V75, P13; Courtenay O, 2007, MED VET ENTOMOL, V21, P168, DOI 10.1111/j.1365-2915.2007.00678.x; Curtis C. F., 2003, Journal of Vector Borne Diseases, V40, P1; Dhiman R C, 2003, J Commun Dis, V35, P49; Dinesh DS, 2008, MED VET ENTOMOL, V22, P120, DOI 10.1111/j.1365-2915.2008.00724.x; Dinesh DS, 2001, ANN TROP MED PARASIT, V95, P197, DOI 10.1080/00034980120041071; EMAMI MM, 2005, SGS0476 WHO; Feliciangeli MD, 2004, MED VET ENTOMOL, V18, P71, DOI 10.1111/j.0269-283X.2004.0487.x; Jalouk L, 2007, T ROY SOC TROP MED H, V101, P360, DOI 10.1016/j.trstmh.2006.07.011; KAUL SM, 1994, B WORLD HEALTH ORGAN, V72, P79; Kishore K, 2004, Journal of Communicable Diseases, V36, P41; KUMAR V, 1995, INDIAN J MED RES, V101, P154; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; RAHMAN S J, 1986, Journal of Communicable Diseases, V18, P35; Ritmeijer K, 2007, TROP MED INT HEALTH, V12, P404, DOI 10.1111/j.1365-3156.2006.01807.x; Sivagnaname N., 1997, Journal of Communicable Diseases, V29, P153; Speybroeck N, 2003, EPIDEMIOL INFECT, V131, P991, DOI 10.1017/S095026880300102X; Thakur CP, 2007, INDIAN J MED RES, V126, P447; WHO, 2001, WHA542 WHO, P4; *WHO, 2007, 10 WHOPES WORKSH GRO, P53; *WHO, 2005, SEAVBC85REV1; WHO, 2004, WHOCDSWHOPES20048, P29; WHO, 2007, INS TREAT MOSQ NETS; World Health Organization, 2005, WHOCDSWHOPESGCDPP200; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x	27	35	35	1	5	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2008	13	7					953	958		10.1111/j.1365-3156.2008.02096.x				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	311SW	WOS:000256621000010	18482197	Bronze			2019-04-02	
J	Skovmand, O; Bonnet, J; Pigeon, O; Corbel, V				Skovmand, Ole; Bonnet, Julien; Pigeon, Olivier; Corbel, Vincent			Median knock-down time as a new method for evaluating insecticide-treated textiles for mosquito control	MALARIA JOURNAL			English	Article							NETS	Background: Insecticide treated bed nets are major tools for the Roll Back Malaria campaign. There are two types of Long-Lasting Insecticide-treated Nets (LNs) on the market: coated nets and insecticide-incorporated nets. Nets provided to this market need a recommendation from the World Health Organization to be purchased by donors and NGOs. During laboratory study (phase I), the first step consists in evaluating the wash resistance of a new LN product. When insecticide-incorporated nets are washed, it takes time to regenerate the insecticidal activity, i.e. insecticide must migrate to the net surface to be accessible to mosquitoes. The interval of time required for regeneration must be carefully determined to ensure the accuracy of further results. WHOPES procedures currently recommend the determination of the regeneration time by using mortality data. However, as mortality cannot exceed 100%, a LN that regenerates a surface concentration exceeding the dosage for 100% mortality, will have its regeneration time underestimated. Methods: The Median Knock Down Time (MKDT) was determined as function of insecticide dosage on an inert surface, glass, and on polyester nettings using an acetone solution or a simple emulsion. Dosage response was also established for mortality data. The same method was then applied to a commercially polyethylene netting, currently under WHOPES evaluation, to determine the dynamics of regeneration as function of repeated washings. The deltamethrin content of these nets was estimated by Capillary Gas Chromatography (GC-ECD). Results: MKDT was a linear function of log insecticide dosage on glass as on nettings. Mortality data were either 0 or 100% for most concentrations except for a narrow range. MKDT was log linear function of total deltamethrin content in a commercial polyethylene net exposed to washings. The regeneration time of this net increased with the number of washes and MKDT became higher. A new, easy and rapid method to determine MKDT is suggested. Discussion: The MKDT is linearly correlated to log dosage on a given substrate and shows no saturation as mortality data do. It is suited to determine regeneration time of a product that is exposed to a stress, like washing or heating, where the process impacts on the bio-availability of the insecticide. Mortality data are useful for measuring product efficacy, whereas MKDT are better to measure dynamics of surface concentration like regeneration after a stressing process. Change in MKDT can be used to illustrate the loss of insecticide due to washing, but the slope of the curve is product and surface-dependent.	[Skovmand, Ole] Intelligent Insect Control, F-34170 Castelnau, France; [Bonnet, Julien; Corbel, Vincent] IRD, Lab Lutte Insects Nuisibles, F-34394 Montpellier 5, France; [Pigeon, Olivier] Walloon Agr Res Ctr CRA W, Pesticides Res Dept, B-5030 Gembloux, Belgium	Skovmand, O (reprint author), Intelligent Insect Control, 118 Chem Alouettes, F-34170 Castelnau, France.	ole.skovmand@insectcontrol.net; Julien.Bonnet@mpl.ird.fr; pigeon@cra.wallonie.be; Corbel@mpl.ird.fr	Corbel, VIncent/G-9576-2016				Curtis CF, 1998, TROP MED INT HEALTH, V3, P619, DOI 10.1046/j.1365-3156.1998.00281.x; Graham K, 2005, MED VET ENTOMOL, V19, P72, DOI 10.1111/j.0269-283X.2005.00543.x; Maxwell C. A., 2006, Journal of Vector Borne Diseases, V43, P1; WHO, 1998, WHOCDSCPCMAL9812; *WHO, 1996, WHOCTDWHOPESIC961; World Health Organization, 2005, WHOCDSWHOPESGCDPP200; Yates A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-52	7	12	12	1	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUN 27	2008	7								114	10.1186/1475-2875-7-114				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	325ST	WOS:000257609300001	18582393	DOAJ Gold, Green Published			2019-04-02	
J	Van Bortel, W; Trung, HD; Thuan, LK; Sochantha, T; Socheat, D; Sumrandee, C; Baimai, V; Keokenchanh, K; Samlane, P; Roelants, P; Denis, L; Verhaeghen, K; Obsomer, V; Coosemans, M				Van Bortel, Wim; Trung, Ho Dinh; Thuan, Le Khanh; Sochantha, Tho; Socheat, Duong; Sumrandee, Chalao; Baimai, Visut; Keokenchanh, Kalouna; Samlane, Phompida; Roelants, Patricia; Denis, Leen; Verhaeghen, Katrijn; Obsomer, Valerie; Coosemans, Marc			The insecticide resistance status of malaria vectors in the Mekong region	MALARIA JOURNAL			English	Article							ANOPHELES-DIRUS COMPLEX; PYRETHROID TOLERANCE; SUNDAICUS COMPLEX; SPECIES COMPLEX; MOSQUITO AGE; GAMBIAE; CULICIDAE; DIPTERA; MINIMUS; VIETNAM	Background: Knowledge on insecticide resistance in target species is a basic requirement to guide insecticide use in malaria control programmes. Malaria transmission in the Mekong region is mainly concentrated in forested areas along the country borders, so that decisions on insecticide use should ideally be made at regional level. Consequently, cross-country monitoring of insecticide resistance is indispensable to acquire comparable baseline data on insecticide resistance. Methods: A network for the monitoring of insecticide resistance, MALVECASIA, was set up in the Mekong region in order to assess the insecticide resistance status of the major malaria vectors in Cambodia, Laos, Thailand, and Vietnam. From 2003 till 2005, bioassays were performed on adult mosquitoes using the standard WHO susceptibility test with diagnostic concentrations of permethrin 0.75% and DDT 4%. Additional tests were done with pyrethroid insecticides applied by the different national malaria control programmes. Results: Anopheles dirus s.s., the main vector in forested malaria foci, was susceptible to permethrin. However, in central Vietnam, it showed possible resistance to type II pyrethroids. In the Mekong delta, Anopheles epiroticus was highly resistant to all pyrethroid insecticides tested. It was susceptible to DDT, except near Ho Chi Minh City where it showed possible DDT resistance. In Vietnam, pyrethroid susceptible and tolerant Anopheles minimus s.l. populations were found, whereas An. minimus s.l. from Cambodia, Laos and Thailand were susceptible. Only two An. minimus s.l. populations showed DDT tolerance. Anopheles vagus was found resistant to DDT and to several pyrethroids in Vietnam and Cambodia. Conclusion: This is the first large scale, cross-country survey of insecticide resistance in Anopheles species in the Mekong Region. A unique baseline data on insecticide resistance for the Mekong region is now available, which enables the follow-up of trends in susceptibility status in the region and which will serve as the basis for further resistance management. Large differences in insecticide resistance status were observed among species and countries. In Vietnam, insecticide resistance was mainly observed in low or transmission-free areas, hence an immediate change of malaria vector control strategy is not required. Though, resistance management is important because the risk of migration of mosquitoes carrying resistance genes from non-endemic to endemic areas. Moreover, trends in resistance status should be carefully monitored and the impact of existing vector control tools on resistant populations should be assessed.	[Van Bortel, Wim; Roelants, Patricia; Denis, Leen; Verhaeghen, Katrijn; Obsomer, Valerie; Coosemans, Marc] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Trung, Ho Dinh; Thuan, Le Khanh] Natl Inst Malariol Parasitol & Entomol, Dept Entomol, Hanoi, Vietnam; [Sochantha, Tho; Socheat, Duong] Natl Ctr Malaria Control Parasitol & Entomol, Dept Entomol, Phnom Penh, Cambodia; [Sumrandee, Chalao; Baimai, Visut] Mahidol Univ, Dept Biol, Bangkok 10400, Thailand; [Keokenchanh, Kalouna; Samlane, Phompida] Ctr Malariol Parasitol & Entomol, Dept Entomol, Viangchan, Laos; [Obsomer, Valerie] Catholic Univ Louvain, Dept Environm Sci & Land Use Planning, B-1348 Louvain, Belgium; [Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Vet & Biomed Sci, B-2610 Antwerp, Belgium	Van Bortel, W (reprint author), Inst Trop Med, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	wvbortel@itg.be; entomology@fpt.vn; nimpe@netmam.org.vn; sochanthat@cnm.gov.kh; socheatd@cnm.gov.kh; sumrandee@yahoo.com; scvbm@mahidol.ac.th; cmpelao@gmail.com; p.samlane@gmail.com; proelants@itg.be; ldenis@itg.be; kverhaeghen@itg.be; valerie.obsomer@uclouvain.be; mcoosemans@itg.be		Van Bortel, Wim/0000-0002-6644-518X			Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Chareonviriyahpap Theeraphap, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P184; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Covell G., 1944, JOUR MALARIA INST INDIA, V5, P399; Dusfour I, 2004, AM J TROP MED HYG, V71, P518, DOI 10.4269/ajtmh.2004.71.518; Erhart A, 2004, TROP MED INT HEALTH, V9, P1081, DOI 10.1111/j.1365-3156.2004.01310.x; ERHART A, 2006, MALARIA CONTROL VIET, P1; Etang J, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-46; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; Harbach RE, 2007, ZOOTAXA, P41, DOI 10.11646/zootaxa.1654.1.3; Harbach RE, 2006, P ENTOMOL SOC WASH, V108, P198; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; HINH TD, 2000, MEKONG MALARIA FORUM, V6, P64; Hodjati MH, 1999, B ENTOMOL RES, V89, P329; *IMPE, 1987, KEYS AN VIETN AD PUR; *IMPE LAOS, 1996, MAL ITS CONTR LAO PE; *IMPE VIETN, 1996, MAL ITS CONTR VIETN; Kamau L, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.1101; Kristan M, 2003, MED VET ENTOMOL, V17, P326, DOI 10.1046/j.1365-2915.2003.00449.x; LINES JD, 1991, MED VET ENTOMOL, V5, P261, DOI 10.1111/j.1365-2915.1991.tb00550.x; Linton YM, 2005, B ENTOMOL RES, V95, P329, DOI 10.1079/BER2005364; McCann L, 2005, SOC NATUR RESOUR, V18, P759, DOI 10.1080/08941920591005340; *NMC CAMB, 1996, MAL ITS CONTR CAMB; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Overgaard HJ., 2006, MALARIA MOSQUITO RES, V103, P1; REID JA, 1968, ANOPHELINE MOSQUITOE, P1; Sallum MAM, 2005, MED VET ENTOMOL, V19, P158, DOI 10.1111/j.0269-283X.2005.00551.x; Somboon Pradya, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P87; Stoops CA, 2007, J MED ENTOMOL, V44, P543, DOI 10.1603/0022-2585(2007)44[543:EFAWSA]2.0.CO;2; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; TRUNG HD, 2003, MALARIA VECTORS SE A, P1; Van Bortel W, 2000, INSECT MOL BIOL, V9, P335, DOI 10.1046/j.1365-2583.2000.00192.x; Van Bortel W, 2001, AM J TROP MED HYG, V65, P729, DOI 10.4269/ajtmh.2001.65.729; Walton C, 1999, MED VET ENTOMOL, V13, P24, DOI 10.1046/j.1365-2915.1999.00142.x; WHO, 1998, WHOCDSCPCMAL9812; WHO, 2006, WHOCDSNTDWHOPESGCDPP, P1; WHO Expert Committee, 2007, World Health Organ Tech Rep Ser, P1	38	46	46	0	16	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUN 5	2008	7								102	10.1186/1475-2875-7-102				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	330DU	WOS:000257920500001	18534006	DOAJ Gold, Green Published			2019-04-02	
J	Kayumba, PC; Twagirumukiza, M; Huyghebaert, N; Ntawukuliryayo, JD; Van Bortel, L; Vervaet, C; Remon, JP				Kayumba, P. C.; Twagirumukiza, M.; Huyghebaert, N.; Ntawukuliryayo, J. D.; Van Bortel, L.; Vervaet, C.; Remon, J. P.			Taste-masked quinine sulphate pellets: bio-availability in adults and steady-state plasma concentrations in children with uncomplicated Plasmodium falciparum malaria	ANNALS OF TROPICAL PAEDIATRICS			English	Article							PHARMACOKINETICS; CHLOROQUINE	Background: Quinine sulphate (QS), like most other antimalarials, is in tablet form designed for adults. In children, treatment is based on breaking the tablets to adapt the dose to the child's bodyweight. However, poor breakability owing to the tablet design or the absence of a score line can lead to inaccurate dosage. Furthermore, QS is very bitter which reduces its acceptability to children. QS taste-masked pellets have been developed which offer more flexibility in adapting dosage to a child's weight. Aims: To evaluate the oral bio-availability of QS taste-masked pellets in healthy adult volunteers and to determine steady-state plasma concentrations in children aged,5 years with uncomplicated Plasmodium falciparum malaria. Methods: Healthy adult volunteers at Kigali University Hospital received a single dose of 600 mg QS as taste-masked pellets or as commercially available tablets. A total of 56 children,5 years with uncomplicated P. falciparum malaria were recruited among patients attending Butare University Hospital and nearby health centres and treated with QS taste-masked pellets, 10-12.5 mg/kg every 8 h for 7 days. Quinine steady-state plasma concentrations were assessed on the 4th day of treatment. Results: Following administration of taste-masked pellets to healthy adult volunteers, peak plasma concentration (C-max) and area-under-the-curve (AUC) (C-max 4.7 mu g.ml(-1), AUC(0-24) 63.5 mu g.h.ml(-1)) were significantly higher (p<0.05) than for tablets (C-max 3.7 mu g.ml(-1), AUC(0-24) 52.4 mu g.h.ml(-1)), but still within the limits reported for quinine. The steady-state concentrations in children were in the therapeutic range for quinine. All the children recovered and completed the 14-day follow-up. Conclusion: QS taste-masked pellets offered the possibility to easily adjust the dose to the bodyweight of the child and can be used as an alternative to dividing tablets.	[Kayumba, P. C.; Huyghebaert, N.; Remon, J. P.] Univ Ghent, Pharmaceut Technol Lab, Fac Pharmaceut Sci, B-9000 Ghent, Belgium; [Kayumba, P. C.; Ntawukuliryayo, J. D.] Natl Univ Rwanda, Dept Pharm, Butare, Rwanda; [Twagirumukiza, M.] Natl Univ Rwanda, Fac Med, Butare, Rwanda; [Twagirumukiza, M.; Van Bortel, L.] Univ Ghent, Heymans Inst Pharmacol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Remon, JP (reprint author), Univ Ghent, Pharmaceut Technol Lab, Fac Pharmaceut Sci, Harelbekestr 72, B-9000 Ghent, Belgium.	jeanpaul.remon@ugent.be	Twagirumukiza, Marc/B-5898-2012	Twagirumukiza, Marc/0000-0003-1378-6922			AUPRAYOON P, 1995, BRIT J CLIN PHARMACO, V40, P494, DOI 10.1111/j.1365-2125.1995.tb05795.x; Barennes H, 2003, EUR J CLIN PHARMACOL, V58, P649, DOI 10.1007/s00228-002-0546-2; BLOLAND PB, WHOCDSDRS20014; FDA Guidance for Industry, 2001, BIOAN METH VAL; ICH E11, CPMPICH271199; Kayumba PC, 2007, EUR J PHARM BIOPHARM, V66, P460, DOI 10.1016/j.ejpb.2006.11.018; Kayumba PC, 2006, PHARM AFRIQUE, V193, P11; Krishna S, 1996, CLIN PHARMACOKINET, V30, P263, DOI 10.2165/00003088-199630040-00002; LEBRUNVIGNES B, 1999, MED MAL INFECT S2, V29, P229; McCalley DV, 2002, J CHROMATOGR A, V967, P1, DOI 10.1016/S0021-9673(01)01557-6; Pukrittayakamee S, 2003, ANTIMICROB AGENTS CH, V47, P3458, DOI 10.1128/AAC.47.11.3458-3463.2003; SALAKO LA, 1992, EUR J CLIN PHARMACOL, V42, P171, DOI 10.1007/BF00278479; Samanidou VF, 2005, J PHARMACEUT BIOMED, V38, P21, DOI 10.1016/j.jpba.2004.12.005; vanHensbroek MB, 1996, AM J TROP MED HYG, V54, P237, DOI 10.4269/ajtmh.1996.54.237; WANWIMOLRUK S, 1991, BRIT J CLIN PHARMACO, V32, P617, DOI 10.1111/j.1365-2125.1991.tb03961.x; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; *WHO, WHOFCHCAH001, P139	17	6	6	0	5	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0272-4936			ANN TROP PAEDIATR	Ann. Trop. Paediatr.	JUN	2008	28	2					103	109		10.1179/146532808X302116				7	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	314VP	WOS:000256837600002	18510819				2019-04-02	
J	Sejas, E; Kolsteren, P; Hoeree, T; Roberfroid, D				Sejas, E.; Kolsteren, P.; Hoeree, T.; Roberfroid, D.			Iron supplementation in previously anemic Bolivian children normalized hematologic parameters, but not immunologic parameters	JOURNAL OF TROPICAL PEDIATRICS			English	Article						iron deficiency; CD1a lymphocyte; school children	CELL-MEDIATED-IMMUNITY; SOLUBLE TRANSFERRIN RECEPTOR; MALNOURISHED CHILDREN; DEFICIENCY	Iron deficiency anemia (IDA) is considered to be the most prevalent micronutrient deficiency in the world. Estimates indicate that 1.2 billion people suffer mild to severe forms of anemia and that up to 46% of schoolchildren in developing countries are affected. In 2003, ENDSA, the national demographic and health survey of Bolivia showed that 60% of children under five and 72% of children under 2 years old were anemic. Micronutrient deficiency has been suggested to impair cell-mediated immunity. In particular, iron, zinc and vitamin A deficiencies have an impact on the immune system. In vitro and in vivo laboratory studies indicate a link between iron deficiency and impaired T-lymphocyte proliferation. The exact effects or mechanisms of iron deficiency on maturation and proliferation of T-lymphocytes in vivo are, however, not yet known. This study investigated the effects of iron on the maturation of T-lymphocytes in anemic but otherwise healthy schoolchildren ( no apparent protein-energy deficiency or other morbidity). Anemic children of a poor peri-urban school of Cochabamba city, Bolivia, were given iron treatment for three consecutive months. We chose to look at CD1a+ lymphocytes, which are immature thymocytes. The proportions of CD1a+ lymphocytes in the peripheral circulation measured at baseline and after treatment were compared with a reference group of age-matched non-anemic children controls from the same school. The immunologic parameters, although improved, did not reach the proportions of the control group. Overall, the proportion of circulating immature T-lymphocytes decreased from 18.3% to 9.2% in the treated following iron supplementation in anemic children, compared with 3.4% in non-anemic children.	[Kolsteren, P.; Hoeree, T.; Roberfroid, D.] Inst Trop Med, Nutr & Child Hlth Unit, B-2000 Antwerp, Belgium	Sejas, E (reprint author), Urbanizac FUD N 17, Puntiti Norte, Cochabamba, Bolivia.						Beguin Y, 2003, CLIN CHIM ACTA, V329, P9, DOI 10.1016/S0009-8981(03)00005-6; Berger J, 2000, EUR J CLIN NUTR, V54, P29, DOI 10.1038/sj.ejcn.1600888; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; BOMFORD A, 1986, BIOCHEM J, V236, P243, DOI 10.1042/bj2360243; Brandao M, 2005, HAEMATOLOGICA, V90, P31; Brock JH, 2000, P NUTR SOC, V59, P537, DOI 10.1017/S002966510000077X; Chevalier P, 1998, J TROP PEDIATRICS, V44, P304, DOI 10.1093/tropej/44.5.304; Dalloul AH, 1999, J IMMUNOL, V162, P5821; DHUR A, 1990, ANN NUTR METAB, V34, P280, DOI 10.1159/000177599; FARTHING MJG, 1989, ACTA PAEDIATR SCAND, P44; GOLDING S, 1995, SCAND J IMMUNOL, V41, P229, DOI 10.1111/j.1365-3083.1995.tb03558.x; HO CH, 2002, ZHONGHUA YI XUE ZHI, V65, P61; KRANTMAN HJ, 1982, AM J DIS CHILD, V136, P840, DOI 10.1001/archpedi.1982.03970450082020; Kuvibidila SR, 2001, BRIT J NUTR, V86, P157, DOI 10.1079/BJN2001366; OMARA FO, 1994, BRIT J NUTR, V72, P899, DOI 10.1079/BJN19940094; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; PARENT G, 1994, AM J CLIN NUTR, V60, P274; SOTZIK F, 1993, IMMUNOL LETT, V36, P101, DOI 10.1016/0165-2478(93)90073-B; THIBAULT H, 1993, EUR J PEDIATR, V152, P120, DOI 10.1007/BF02072487; Viteri FE, 1998, BIOMED ENVIRON SCI, V11, P46; Wieringa FT, 2004, EUR J CLIN NUTR, V58, P1498, DOI 10.1038/sj.ejcn.1601998	21	7	9	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	JUN	2008	54	3					164	168		10.1093/tropej/fmm106				5	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	310JP	WOS:000256525200004	18211949	Bronze			2019-04-02	
J	Boraschi, D; Alemayehu, MA; Aseffa, A; Chiodi, F; Chisi, J; Del Prete, G; Doherty, TM; Elhassan, I; Engers, H; Gyan, B; Harandi, AM; Kariuki, T; Kironde, F; Kouriba, B; Langhorne, J; Laskay, T; Medaglini, D; Olesen, O; Onyebujoh, P; Palma, C; Sauerwein, R; Sibanda, E; Steinhoff, U; Tagliabue, A; Thiel, A; Vahedi, M; Troye-Blomberg, M				Boraschi, Diana; Alemayehu, Markos Abebe; Aseffa, Abraham; Chiodi, Francesca; Chisi, John; Del Prete, Gianfranco; Doherty, T. Mark; Elhassan, Ibrahim; Engers, Howard; Gyan, Ben; Harandi, Ali M.; Kariuki, Thomas; Kironde, Fred; Kouriba, Bourema; Langhorne, Jean; Laskay, Tamas; Medaglini, Donata; Olesen, Ole; Onyebujoh, Philip; Palma, Carla; Sauerwein, Robert; Sibanda, Elopy; Steinhoff, Ulrich; Tagliabue, Aldo; Thiel, Andreas; Vahedi, Mahnaz; Troye-Blomberg, Marita			Immunity against HIV/AIDS, Malaria, and Tuberculosis during Co-Infections with Neglected Infectious Diseases: Recommendations for the European Union Research Priorities	PLOS NEGLECTED TROPICAL DISEASES			English	Editorial Material							CHRONIC HELMINTH INFECTIONS; TROPICAL DISEASES; POLYMORPHISMS; IMPACT	Infectious diseases remain a major health and socioeconomic problem in many low-income countries, particularly in sub-Saharan Africa. For many years, the three most devastating diseases, HIV/AIDS, malaria, and tuberculosis ( TB) have received most of the world's attention. However, in rural and impoverished urban areas, a number of infectious diseases remain neglected and cause massive suffering. It has been calculated that a group of 13 neglected infectious diseases affects over one billion people, corresponding to a sixth of the world's population. These diseases include infections with different types of worms and parasites, cholera, and sleeping sickness, and can cause significant mortality and severe disabilities in low-income countries. For most of these diseases, vaccines are either not available, poorly effective, or too expensive. Moreover, these neglected diseases often occur in individuals who are also affected by HIV/AIDS, malaria, or TB, making the problem even more serious and indicating that co-infections are the rule rather than the exception in many geographical areas. To address the importance of combating co-infections, scientists from 14 different countries in Africa and Europe met in Addis Ababa, Ethiopia, on September 9-11, 2007. The message coming from these scientists is that the only possibility for winning the fight against infections in low-income countries is by studying, in the most global way possible, the complex interaction between different infections and conditions of malnourishment. The new scientific and technical tools of the post-genomic era can allow us to reach this goal. However, a concomitant effort in improving education and social conditions will be needed to make the scientific findings effective.	[Boraschi, Diana] CNR, I-56100 Pisa, Italy; [Alemayehu, Markos Abebe; Aseffa, Abraham; Engers, Howard] AHRI ALERT, Addis Ababa, Ethiopia; [Chisi, John] Univ Malawi, Coll Med, Blantyre, Malawi; [Chiodi, Francesca] Karolinska Inst, Stockholm, Sweden; [Del Prete, Gianfranco] Univ Florence, Florence, Italy; [Doherty, T. Mark] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Elhassan, Ibrahim] Univ Khartoum, Khartoum, Sudan; [Gyan, Ben] Noguchi Mem Inst Med Res, Legon, Ghana; [Harandi, Ali M.] Univ Gothenburg, Gothenburg, Sweden; [Kariuki, Thomas] Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya; [Kironde, Fred] Makerere Univ, Kampala, Uganda; [Kouriba, Bourema] Univ Mali, Bamako, Mali; [Langhorne, Jean] Natl Inst Med Res, London NW7 1AA, England; [Laskay, Tamas] Med Univ Lubeck, D-23538 Lubeck, Germany; [Medaglini, Donata] Univ Siena, I-53100 Siena, Italy; [Olesen, Ole] EU Commiss, Brussels, Belgium; [Onyebujoh, Philip; Vahedi, Mahnaz] WHO, CH-1211 Geneva, Switzerland; [Palma, Carla] ISS, Rome, Italy; [Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Sibanda, Elopy] Univ Zimbabwe, Harare, Zimbabwe; [Steinhoff, Ulrich] MPIIB, Berlin, Germany; [Tagliabue, Aldo] ALTA, Siena, Italy; [Thiel, Andreas] Deutsch Rheuma Forsch Zentrum, Berlin, Germany; [Troye-Blomberg, Marita] Stockholm Univ, S-10691 Stockholm, Sweden	Boraschi, D (reprint author), CNR, I-56100 Pisa, Italy.	tagliabue@altaweb.eu	PALMA, CARLA/C-8821-2016; Aseffa, Abraham/J-3248-2016; Laskay, Tamas/E-9190-2013; Medaglini, Donata/R-1149-2018; Sauerwein, Robert/C-8519-2013; Troye-Blomberg, Marita/B-9210-2016; Thiel, Andreas/F-1539-2013	PALMA, CARLA/0000-0003-2583-5306; Aseffa, Abraham/0000-0002-8028-1150; Laskay, Tamas/0000-0002-4212-8366; Medaglini, Donata/0000-0003-1729-7325; Troye-Blomberg, Marita/0000-0002-2804-0325; Steinhoff, Ulrich/0000-0003-2141-7756; Langhorne, Jean/0000-0002-2257-9733	Medical Research Council [MC_U117584248]		[Anonymous], 2007, LANCET, V370, P1880; Dybul M, 2006, LANCET, V368, P1865; Ebensen T, 2008, HUM VACCINES, V4, P13, DOI 10.4161/hv.4.1.5560; Elias D, 2007, EXPERT REV ANTI-INFE, V5, P475, DOI 10.1586/14787210.5.3.475; EPSTEIN MA, 1984, NATURE, V312, P398, DOI 10.1038/312398a0; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2006, LANCET, V368, P1865, DOI 10.1016/S0140-6736(06)69765-1; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Prentice AM, 2007, FOOD NUTR BULL, V28, pS524, DOI 10.1177/15648265070284S406; Ramaswamy M, 2007, EXPERT REV ANTI-INFE, V5, P231, DOI 10.1586/14787210.5.2.231; Reiche EMV, 2007, CURR MED CHEM, V14, P1325; *UNICEF UNDP WORLD, 2007, TDRGENEN071REV1 UNIC; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009	19	18	19	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2008	2	6							e255	10.1371/journal.pntd.0000255				4	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	385ID	WOS:000261807000003	18575596	DOAJ Gold, Green Published			2019-04-02	
J	Sow, S; Polman, K; Vereecken, K; Vercruysse, J; Gryseels, B; de Vlas, SJ				Sow, Seydou; Polman, Katja; Vereecken, Kim; Vercruysse, Jozef; Gryseels, Bruno; de Vlas, Sake J.			The role of hygienic bathing after defecation in the transmission of Schistosoma mansoni	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Schistosoma mansoni; miracidia; water contamination; hygienic washing; disease transmission; Senegal	RICHARD-TOLL; ENDEMIC AREA; PREVALENCE; INFECTION; EGGS; SEASONALITY; POPULATIONS; COMMUNITY; BEHAVIOR; SENEGAL	Transmission of Schistosoma mansoni depends on fecal eggs reaching water, but the way this happens is poorly understood. We studied the role of hygienic bathing after defecation in the contamination of water with S. mansoni eggs. Individuals in an endemic community in Northern Senegal (n = 991) were examined for S. mansoni infection and a random sample (22%) was interviewed about stool disposal practices and hygienic behavior. We assessed the presence and viability of S. mansoni eggs adhering to the peri-anal region of 13 infected volunteers, by counting the miracidia in the water they had used for hygienic washing; for 10 of them (77%) miracidia were demonstrated. From the population infection distribution, average number of defecations per day, proportion of individuals bathing after defecation, and association between miracidial counts and infection intensity, we calculated a daily population miracidial output of similar to 30 000 through hygienic bathing. For comparison, one complete stool reaching the water was calculated to yield similar to 2500 miracidia. Thus, 12 individuals in this population should defecate into the water every day to produce the same number of miracidia as through hygienic bathing. Our results suggest a major role of hygienic bathing after defecation in the transmission of S. mansoni. (C) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Sow, Seydou; de Vlas, Sake J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Sow, Seydou; Polman, Katja; Vereecken, Kim; Gryseels, Bruno] Inst Trop Med, B-2000 Antwerp, Belgium; [Sow, Seydou] Reg Med St Louis, St Louis, Senegal; [Vercruysse, Jozef] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, B-9820 Merelbeke, Belgium	de Vlas, SJ (reprint author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	s.devlas@erasmusmc.nl					ADEWUNMI CO, 1991, TROP MED PARASITOL, V42, P332; ANDERSON RM, 1979, PARASITOLOGY, V79, P63, DOI 10.1017/S0031182000051982; BUNDY DAP, 1987, T ROY SOC TROP MED H, V81, P85, DOI 10.1016/0035-9203(87)90293-8; CHANDIWANA SK, 1986, T ROY SOC TROP MED H, V80, P963, DOI 10.1016/0035-9203(86)90273-7; CHEESMOND AK, 1981, J TROP MED HYG, V84, P101; CHEEVER AW, 1978, J NATL CANCER I, V61, P13, DOI 10.1093/jnci/61.1.13; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Duplantier JM, 2000, J HELMINTHOL, V74, P129; Gryseels B, 1996, AM J TROP MED HYG, V55, P103, DOI 10.4269/ajtmh.1996.55.103; Husting E L, 1965, Cent Afr J Med, V11, P330; KASSIM O, 1976, J PARASITOL, V62, P715, DOI 10.2307/3278948; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; MANSOUR NS, 1973, J PARASITOL, V59, P424, DOI 10.2307/3278762; MERTENS TE, 1992, INT J EPIDEMIOL, V21, P1157, DOI 10.1093/ije/21.6.1157; ROLLINSON D, 1986, PARASITOLOGY, V93, P39, DOI 10.1017/S0031182000049817; Sow S, 2004, Bull Soc Pathol Exot, V97, P12; STURROCK RF, 1979, ANN TROP MED PARASIT, V73, P369, DOI 10.1080/00034983.1979.11687272; Sturrock RF, 2001, PARASITOLOGY, V123, pS77, DOI 10.1017/S0031182001008125; Theron A, 2005, J HELMINTHOL, V79, P187, DOI 10.1079/JOH2005299; UPATHAM ES, 1976, PARASITOLOGY, V73, P253, DOI 10.1017/S0031182000046941; Vercruysse J, 2001, TRENDS PARASITOL, V17, P256, DOI 10.1016/S1471-4922(01)01937-7; VUNGUYEN T, 2006, VIETNAM INT J INFECT, V10, P298; Yu J, 1998, AM J TROP MED HYG, V59, P370, DOI 10.4269/ajtmh.1998.59.370	23	13	13	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUN	2008	102	6					542	547		10.1016/j.trstmh.2008.02.016				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	324KS	WOS:000257518100007	18423504				2019-04-02	
J	Seridi, N; Belkaid, M; Quispe-Tintaya, W; Zidane, C; Dujardin, JC				Seridi, Nabila; Belkaid, Miloud; Quispe-Tintaya, Wilber; Zidane, Charef; Dujardin, Jean Claude			Application of PCR-RFLP for the exploration of the molecular diversity of Leishmania infantum in Algeria	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						leishmaniasis; Leishmania infantum; PCR; RFLP; polymorphism; Algeria	VISCERAL LEISHMANIASIS; DONOVANI COMPLEX; TROPICA; MOROCCO; HUMANS; DOGS	In recent years, new methods have been developed for the molecular typing of Leishmania that need to be extensively validated by studies of clinical isolates in a well defined epidemiological context. The present study is a contribution to this effort. Using PCR-RFLP of gp63 and cpb genes, we analysed 59 isolates of L. (L.) infantum obtained from different regions of Algeria and originating from different clinical forms, hosts and zymodemes. PCR-RFLP identified 15 different genotypes among the four zymodemes analysed, thereby demonstrating a higher discriminatory power than multilocus enzyme electrophoresis. We did not see any significant relationships between PCR-RFLP patterns and host origin. However, cpb polymorphism showed two interesting trends: a possible relationship with the cutaneous origin of the isolates and an association with a West-East cline. We verified the proof of evidence of the direct applicability of gp63 and cpb PCR-RFLP in blood samples from dogs. Further work is needed to compare the sensitivity of pattern detection with cpb and gp63 PCR-RFLP but our results pave the way to future multilocus PCR-RFLP studies of L. (L.) infantum populations. (C) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Seridi, Nabila; Quispe-Tintaya, Wilber; Dujardin, Jean Claude] Inst Trop Med, Mol Parasitol Unit, B-2000 Antwerp, Belgium; [Seridi, Nabila] USTHB, Fac Biol Sci, Genet Lab, Algiers, Algeria; [Seridi, Nabila; Belkaid, Miloud] Inst Pasteur, Serv Parasitol, Algiers, Algeria; [Zidane, Charef] Hop Mustapha Bacha, Ctr Pierre & Marie Curie, Serv Cytol, Algiers, Algeria	Dujardin, JC (reprint author), Inst Trop Med, Mol Parasitol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	jcdujardin@itg.be					Benikhlef R, 2001, B SOC PATHOL EXOT, V94, P14; Botilde Y, 2006, INFECT GENET EVOL, V6, P440, DOI 10.1016/j.meegid.2006.02.003; Dedet J. P., 1969, Archs Inst Pasteur Tunis, V46, P69; DEREURE J, 1991, T ROY SOC TROP MED H, V85, P595, DOI 10.1016/0035-9203(91)90356-4; El Tai NO, 2001, EXP PARASITOL, V97, P35, DOI 10.1006/expr.2001.4592; Gallego M, 2001, T ROY SOC TROP MED H, V95, P269, DOI 10.1016/S0035-9203(01)90231-7; Guerbouj S, 2001, T ROY SOC TROP MED H, V95, P687, DOI 10.1016/S0035-9203(01)90117-8; Guerbouj S, 2001, PARASITOLOGY, V122, P25, DOI 10.1017/S0031182000007125; GuessousIdrissi N, 1997, AM J TROP MED HYG, V57, P172, DOI 10.4269/ajtmh.1997.57.172; Harrat Z, 1995, B SOC PATHOL EXOT, V88, P180; Harrat Z, 1996, T ROY SOC TROP MED H, V90, P625, DOI 10.1016/S0035-9203(96)90410-1; IZRI MA, 1990, ANN PARASIT HUM COMP, V65, P151; IZRI MA, 1993, T ROY SOC TROP MED H, V87, P399, DOI 10.1016/0035-9203(93)90011-E; Lewin S, 2002, INT J PARASITOL, V32, P1267, DOI 10.1016/S0020-7519(02)00091-7; Marlet MVL, 2003, T ROY SOC TROP MED H, V97, P667, DOI 10.1016/S0035-9203(03)80099-8; Mottram JC, 1996, P NATL ACAD SCI USA, V93, P6008, DOI 10.1073/pnas.93.12.6008; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Quispe-Tintaya KW, 2005, J INFECT DIS, V192, P685, DOI 10.1086/432077; QUISPETINTAYA KW, 2004, J INFECT DIS, V189, P1035; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Sambrook J., 1989, MOL CLONING LAB MANU	22	13	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUN	2008	102	6					556	563		10.1016/j.trstmh.2008.03.004				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	324KS	WOS:000257518100009	18407304				2019-04-02	
J	Van Deun, A; Chuquiyauri, R; Torrea, G; Agapito, J; Verdonck, K; Gotuzzo, E				Van Deun, A.; Chuquiyauri, R.; Torrea, G.; Agapito, J.; Verdonck, K.; Gotuzzo, E.			Yield of fluorescence microscopy versus culture for tuberculosis at a middle-income country referral hospital	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						tuberculosis; microscopy; Ziehl-Neelsen; auramine; culture; acid-fast bacilli	SPUTUM SMEAR MICROSCOPY; ACID-FAST BACILLI; ZIEHL-NEELSEN	The aim of this study was to determine the usefulness of fluorescence microscopy (FM) at a referral centre in a middle-income country. Direct Ziehl-Neelsen (ZN) and direct, as well as concentrated, smear FM were performed on 2179 suspect sputa, with Lowenstein-Jensen (LJ) culture as the gold standard. ZN, direct FM and concentration FM detected 36.0, 38.6 and 37.0%, respectively, of 272 culture-positive specimens. Patient-wise, there were 8.1% (126/1553) positives on any smear compared with 12.0% (187/1553) on any culture. ZN, direct FM and concentrated FM smear were positive in 43.3, 46.5 and 45.5%, respectively, of culture-proven cases. All differences between microscopy and culture were significant (P < 0.001), but not those between microscopy techniques. Acid-fast bacilli (AFB) were not rare in 60% of 48 duplicate smears, positive in ZN or FM only. Simple LJ culture, but not FM on direct or concentrated smears, was thus significantly more sensitive than ZN smears. The considerable numbers of AFB found in positive direct smears from discordant microscopy sets suggest that repeating smears can improve microscopy sensitivity more than variations of correctly executed technique, provided that overload is avoided. Thus FM could be particularly useful, as it is time-saving and could protect against the sensitivity loss associated with high workload. (C) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Van Deun, A.; Torrea, G.] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Van Deun, A.] Int Union TB & Lung Dis, F-75006 Paris, France; [Chuquiyauri, R.; Verdonck, K.; Gotuzzo, E.] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima 31, Peru; [Agapito, J.; Gotuzzo, E.] Hosp Nacl Cayetano Heredia, Lima 31, Peru	Van Deun, A (reprint author), Inst Trop Med, Mycobacteriol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	avdeun@itg.be		AGAPITO, JUAN CARLOS/0000-0001-9134-7322			Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Cambanis A, 2007, INT J TUBERC LUNG D, V11, P40; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Habeenzu C, 1998, T ROY SOC TROP MED H, V92, P415, DOI 10.1016/S0035-9203(98)91071-9; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; KUBICA GP, 1980, B INT UNION TUBERC, V55, P117; Mitchison D A, 1974, Trop Doct, V4, P147; Murray SJ, 2003, J CLIN PATHOL, V56, P613, DOI 10.1136/jcp.56.8.613; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rieder H.L., 1998, MINIMUM REQUIREMENTS, P1; *SHO, 1998, LAB SERV TUB CONTR 2, P1; SLOSAREK M, 1977, J HYG EPID MICROB IM, V21, P7; Van Deun A, 2002, INT J TUBERC LUNG D, V6, P222; Van Deun A, 2005, INT J TUBERC LUNG D, V9, P1127; Van Deun A, 2005, INT J TUBERC LUNG D, V9, P355	15	3	3	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUN	2008	102	6					564	569		10.1016/j.trstmh.2008.02.012				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	324KS	WOS:000257518100010	18395235				2019-04-02	
J	Yeung, S; Van Damme, W; Socheat, D; White, NJ; Mills, A				Yeung, Shunmay; Van Damme, Wim; Socheat, Doung; White, Nicholas J.; Mills, Anne			Access to artemisinin combination therapy for malaria in remote areas of Cambodia	MALARIA JOURNAL			English	Article							SUB-SAHARAN AFRICA; FALCIPARUM-MALARIA; SOUTHEAST-ASIA; SELF-TREATMENT; HOME TREATMENT; RURAL KENYA; ANTIMALARIALS; ARTESUNATE; PREVALENCE; ISSUES	Background: Malaria-endemic countries are switching antimalarial drug policy to artemisinin combination therapies (ACTs) and the global community are considering the setting up of a global subsidy mechanism in order to make them accessible and affordable. However, specific interventions may be needed to reach remote at-risk communities and to ensure that they are used appropriately. This analysis documents the coverage with ACTs versus artemisinin monotherapies, and the effectiveness of malaria outreach teams (MOTs) and Village Malaria Workers (VMWs) in increasing access to appropriate diagnosis and treatment with ACTs in Cambodia, the first country to switch national antimalarial drug policy to an ACT of artesunate and mefloquine (A+M) in 2000. Methods: A cross-sectional survey was carried out in three different types of intervention area: with VMWs, MOTs and no specific interventions. Individuals with a history of fever in the last three weeks were included in the study and completed a questionnaire on their treatment seeking and drug usage behaviour. Blood was taken for a rapid diagnostic test (RDT) and data on the household socio-economic status were also obtained. Results: In areas without specific interventions, only 17% (42/251) of respondents received a biological diagnosis, 8% (17/206) of respondents who received modern drug did so from a public health facility, and only 8% of them (17/210) received A+M. Worryingly, 78% (102/131) of all artemisinin use in these areas was as a monotherapy. However, both the VMW scheme and MOT scheme significantly increased the likelihood of being seen by a trained provider ( Adjusted Odds Ratios (AOR) of 148 and 4 respectively) and of receiving A+M (AORs of 2.7 and 7.7 respectively). Conclusion: The coverage rates of appropriate diagnosis and treatment of malaria were disappointingly low and the use of artemisinin monotherapy alarmingly high. This reflects the fragmented nature of Cambodia's health system in remote areas and the reliance placed by these communities on informal vendors from whom artemisinin monotherapies are widely available. However VMWs in particular are an effective means of improving access to malaria diagnosis and treatment. The VMW scheme and the social marketing of RDTS and blister-packaged artesunate and mefloquine have both been scaled up nationally. Case management in the public sector has also reportedly improved. Given recent concerns regarding the development of artemisinin drug resistance on the Thai- Cambodia border, the effectiveness of these measures in reducing the use of artemisinin monotherapy needs to be urgently re-evaluated.	[Yeung, Shunmay; Mills, Anne] London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1E 7HT, England; [Yeung, Shunmay; White, Nicholas J.] Mahidol Univ, Wellcome Trust Mahidol Univ, Fac Trop Med, Oxford Trop Med Res Programme, Bangkok 10400, Thailand; [Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Socheat, Doung] Natl Ctr Parasitol Entomol & Malaria Control, Phonm Penh, Cambodia	Yeung, S (reprint author), London Sch Hyg & Trop Med, Hlth Policy Unit, Keppel St, London WC1E 7HT, England.	shunmay@tropmedres.ac; wvdamme@itg.be; socheatd@cnm.go.kh; nickwdt@tropmedres.ac; anne.mills@lshtm.ac.uk	White, Nicholas/I-4629-2012; Van Damme, Wim/F-7404-2011	Mills, Anne/0000-0001-9863-9950	Wellcome Trust		[Anonymous], 2007, Wkly Epidemiol Rec, V82, P360; ARROW KJ, SAVING LIVES BUYING; Barney K., 2005, CUSTOMS CONCESSIONAI; Brown Ellie, 2002, HLTH BELIEFS PRACTIC; BUNNAG D, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P534; BUNNAG D, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P539; BURY L, 1999, REPORT PILOT STUDY K, P43; BURY L, 1999, MALARIA RISK FACTORS; *CNM, 2006, ANN PROGR REP, P188; DENIS MB, 1994, TREATMENT SEEKING BE, P6; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; DUZEY O, 2003, COMMUNITY DRUG USE P; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 2005, HEALTH POLICY PLANN, V20, P337, DOI 10.1093/heapol/czi043; HASSAN AM, 1996, T R SOC TROP MED HYG, V90, P61; HONG N, 2004, WORKING PAPER SERIES; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Khim N, 2005, ANTIMICROB AGENTS CH, V49, P3147, DOI 10.1128/AAC.49.8.3147-3152.2005; Lim P, 2005, ACTA TROP, V93, P31, DOI 10.1016/j.actatropica.2004.09.002; Luby S, 2002, TROP MED INT HEALTH, V7, P210, DOI 10.1046/j.1365-3156.2002.00859.x; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; McCombie SC, 2002, HEALTH POLICY PLANN, V17, P333, DOI 10.1093/heapol/17.4.333; *MIN HLTH KINGD CA, 2001, ANN PROGR REP; *MINS HLTH KINGD C, 2000, TREATM GUID MAL KING; Newton PN, 2003, LANCET, V362, P169, DOI 10.1016/S0140-6736(03)13872-X; *NIS, 2000, DEM HLTH SURV 2006; ROSE G, 2002, PRIVATE PRACTITIONER, P49; Rozendaal J, 2001, LANCET, V357, P890, DOI 10.1016/S0140-6736(05)71830-4; RUEBUSH TK, 1995, B WORLD HEALTH ORGAN, V73, P229; Sedano E., 2002, VILLAGE MALARIA WORK; SLUTSKER L, 1994, TROP MED PARASITOL, V45, P61; Sochantha T, 2006, TROP MED INT HEALTH, V11, P1166, DOI 10.1111/j.1365-3156.2006.01673.x; VANENGELGEM I, 2001, MALARIA CONTROL PROJ; *WHO, WHO CALLS IMM HALT P; *WHO, 2002, ACH IMP ROLL BACK MA; *WHO, 1996, INT M MAL CONTR EMPH, P37; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; World Health Organization [WHO], 2007, CONT MAL MULT RES CA; YEUNG S, 2007, MALARIA J UNPUB	41	76	77	1	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAY 29	2008	7								96	10.1186/1475-2875-7-96				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	319KU	WOS:000257163300001	18510724	DOAJ Gold, Green Published			2019-04-02	
J	Yeung, S; Van Damme, W; Socheat, D; White, NJ; Mills, A				Yeung, Shunmay; Van Damme, Wim; Socheat, Duong; White, Nicholas J.; Mills, Anne			Cost of increasing access to artemisinin combination therapy: the Cambodian experience	MALARIA JOURNAL			English	Article							UNCOMPLICATED FALCIPARUM-MALARIA; BRAZILIAN AMAZON; SOUTHEAST-ASIA; DRUG POLICY; ANTIMALARIALS; CHLOROQUINE; MANAGEMENT; TANZANIA; EFFICACY; PROGRAM	Background: Malaria-endemic countries are switching antimalarial drug policy from cheap ineffective monotherapies to artemisinin combination therapies (ACTs) for the treatment of Plasmodium falciparum malaria and the global community are considering setting up a global subsidy to fund their purchase. However, in order to ensure that ACTs are correctly used and are accessible to the poor and remote communities who need them, specific interventions will be necessary and the additional costs need to be considered. Methods: This paper presents an incremental cost analysis of some of these interventions in Cambodia, the first country to change national antimalarial drug policy to an ACT of artesunate and mefloquine. These costs include the cost of rapid diagnostic tests (RDTs), the cost of blister-packaging the drugs locally and the costs of increasing access to diagnosis and treatment to remote communities through malaria outreach teams (MOTs) and Village Malaria Workers (VMW). Results: At optimum productive capacity, the cost of blister-packaging cost under $0.20 per package but in reality was significantly more than this because of the low rate of production. The annual fixed cost (exclusive of RDTs and drugs) per capita of the MOT and VMW schemes was $0.44 and $0.69 respectively. However because the VMW scheme achieved a higher rate of coverage than the MOT scheme, the cost per patient treated was substantially lower at $5.14 compared to $12.74 per falciparum malaria patient treated. The annual cost inclusive of the RDTs and drugs was $19.31 for the MOT scheme and $11.28 for the VMW scheme given similar RDT positivity rates of around 22% and good provider compliance to test results. Conclusion: In addition to the cost of ACTs themselves, substantial additional investments are required in order to ensure that they reach the targeted population via appropriate delivery systems and to ensure that they are used appropriately. In addition, differences in local conditions, in particular the prevalence of malaria and the pre-existing infrastructure, need to be considered in choosing appropriate diagnostic and delivery strategies.	[Yeung, Shunmay; Mills, Anne] London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1E 7HT, England; [Yeung, Shunmay; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Wellcome Trust Mahidol Univ Oxford Trop Med Res P, Bangkok 10400, Thailand; [Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Socheat, Duong] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia	Yeung, S (reprint author), London Sch Hyg & Trop Med, Hlth Policy Unit, Keppel St, London WC1E 7HT, England.	shunmay.yeung@lshtm.ac.uk; wvdamme@itg.be; socheatd@cnm.gov.kh; nickwdt@tropmedres.ac; anne.mills@lshtm.ac.uk	Van Damme, Wim/F-7404-2011; White, Nicholas/I-4629-2012	Mills, Anne/0000-0001-9863-9950	Wellcome Trust		Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; Arrow K. J., 2004, SAVING LIVES BUYING; Arrow KJ, 2005, NEW ENGL J MED, V353, P333, DOI 10.1056/NEJMp058168; *CAMB NAT MAL CTR, ANN PROGR REP 2001; *CAMB NAT MAL CTR, ANN PROGR REP 2006; Cunha MLON, 2001, AM J TROP MED HYG, V65, P872, DOI 10.4269/ajtmh.2001.65.872; Denis MB, 2006, TROP MED INT HEALTH, V11, P1800, DOI 10.1111/j.1365-3156.2006.01739.x; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; ETTLING MB, 1991, B WORLD HEALTH ORGAN, V69, P467; *EUR COMM CAMB MAL, 2002, VILL MAL WORK PIL PR; Janssens B, 2007, TROP MED INT HEALTH, V12, P251, DOI 10.1111/j.1365-3165.2006.01786.x; Malik EM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-65; MILLS A, 1992, SOC SCI MED, V34, P965, DOI 10.1016/0277-9536(92)90127-C; Mubyazi GM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-51; Mulligan JA, 2006, TROP MED INT HEALTH, V11, P452, DOI 10.1111/j.1365-3156.2006.01590.x; Mutabingwa TK, 2005, ACTA TROP, V95, P305, DOI 10.1016/j.actatropica.2005.06.009; Newton PN, 2003, LANCET, V362, P169, DOI 10.1016/S0140-6736(03)13872-X; Pang LW, 2001, AM J TROP MED HYG, V65, P883, DOI 10.4269/ajtmh.2001.65.883; Sochantha T, 2006, TROP MED INT HEALTH, V11, P1166, DOI 10.1111/j.1365-3156.2006.01673.x; VANENGELGEM I, 2001, MAL SCI ADV M JAN 22; Whitty CJM, 2004, B WORLD HEALTH ORGAN, V82, P381; *WHO CAMB NAT MAL, 2000, TREATM GUID MAL KING; World Health Organization, 2001, MACR HLTH INV HLTH E; Yeung S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-96; 2002, COUNTRY COORDINATED	25	22	22	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAY 20	2008	7								84	10.1186/1475-2875-7-84				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	309SW	WOS:000256481500002	18492245	DOAJ Gold, Green Published			2019-04-02	
J	Mamoudou, A; Delespaux, V; Chepnda, V; Hachimou, Z; Andrikaye, JP; Zoli, A; Geerts, S				Mamoudou, A.; Delespaux, V.; Chepnda, V.; Hachimou, Z.; Andrikaye, J. P.; Zoli, A.; Geerts, S.			Assessment of the occurrence of trypanocidal drug resistance in trypanosomes of naturally infected cattle in the Adamaoua region of Cameroon using the standard mouse test and molecular tools	ACTA TROPICA			English	Article						Trypanosoma congolense; Trypanosoma brucei; drug resistance; diminazene; isometamidium; PCR-RFLP mouse test; Cameroon	SSU-RDNA AMPLIFICATION; AFRICAN TRYPANOSOMIASIS; TRANSPORTER; DIAGNOSIS; BRUCEI; IDENTIFICATION; CONGOLENSE; GENE	From May to November 2005, a study was carried out to assess the occurrence of trypanocidal drug resistance (DR) in trypanosomes of naturally infected cattle of the Adamaoua region of Cameroon. Two distinct Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) procedures were used together with an Allele specific-PCR (AS-PCR) and the standardized single-dose mouse test. Using the mouse test, 3 of the 13 Trypanosoma brucei isolates and all 14 tested Trypanosoma congolense isolates were resistant to ISM. However, only 11 of the 25 T congolense isolates were diagnosed as resistant to ISM using the MboIl-PCR-RFLP. Resistance to DA was identified in 1 of the 13 T brucei isolates and all 11 T congolense isolates which were tested with the mouse test. Using the AS-PCR or BclI-PCR-RFLP, 3 of the 13 T brucei isolates and all 25 T congolense isolates respectively were found resistant. The data presented in this study prove that DR is widespread in the Adamaoua Department of Cameroon. The problem appears to be more serious in T congolense than in T brucei. Appropriate measures need to be taken in order to control bovine trypanosomosis in this area. (C) 2008 Elsevier B.V. All rights reserved.	[Delespaux, V.; Chepnda, V.; Hachimou, Z.; Geerts, S.] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Mamoudou, A.; Andrikaye, J. P.; Zoli, A.] Univ Dschang, Fac Agron & Sci Agr, Dschang, Cameroon	Delespaux, V (reprint author), Inst Trop Med, Dept Anim Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	vdelespaux@itg.be	DELESPAUX, Vincent/C-3160-2009	Geerts, Stanny/0000-0001-9885-8846			Delespaux V, 2005, INT J PARASITOL, V35, P235, DOI 10.1016/j.ijpara.2004.11.009; Delespaux V, 2006, ACTA TROP, V100, P96, DOI 10.1016/j.actatropica.2006.10.001; Delespaux V, 2003, VET PARASITOL, V117, P185, DOI 10.1016/j.vetpar.2003.08.004; Delespaux V, 2007, DRUG RESIST UPDATE, V10, P30, DOI 10.1016/j.drup.2007.02.004; Eisler MC, 2001, VET PARASITOL, V97, P171, DOI 10.1016/S0304-4017(01)00415-0; GEERTS S, 1998, PAAT TECHNICAL SCI S, V1; Geysen D, 2003, VET PARASITOL, V110, P171, DOI 10.1016/S0304-4017(02)00313-8; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; HOLMES PH, 2004, TRYPANOSOMIASIS; Mamoudou A, 2006, REV ELEV MED VET PAY, V59, P11; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; MURRAY M, 1977, T ROY SOC TROP MED H, V71, P325, DOI 10.1016/0035-9203(77)90110-9; Nerima B, 2007, TROP MED INT HEALTH, V12, P1361, DOI 10.1111/j.1365-3156.2007.01918.x	13	22	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X			ACTA TROP	Acta Trop.	MAY	2008	106	2					115	118		10.1016/j.actatropica.2008.02.003				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	307JQ	WOS:000256315600006	18355771				2019-04-02	
J	Fanello, CI; Karema, C; Ngamije, D; Uwimana, A; Ndahindwa, V; Van Overmeir, C; Van Doren, W; Curtis, J; D'Alessandro, U				Fanello, C. I.; Karema, C.; Ngamije, D.; Uwimana, A.; Ndahindwa, V.; Van Overmeir, C.; Van Doren, W.; Curtis, J.; D'Alessandro, U.			A randomised trial to assess the efficacy and safety of chlorproguanil/dapsone plus artesunate for the treatment of uncomplicated Plasmodium falciparum malaria	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article; Proceedings Paper	Meeting of the Royal-Society-of-Tropical-Medicine-and-Hygiene	2007	London, ENGLAND	Royal Soc Trop Med Hygiene		Plasmodium falciparum; chlorproguanil/dapsone; artesunate; combination drug therapy; drug resistance; Rwanda	PYRIMETHAMINE-SULFADOXINE; DIHYDROFOLATE-REDUCTASE; DAPSONE TREATMENT; CHILDREN; RECRUDESCENCE; COMBINATIONS; AMODIAQUINE; RESISTANCE; PRIMAQUINE; SELECTION	We tested the efficacy and safety of chlorproguanil/dapsone co-administered with artesunate (CD+A) for the treatment of uncomplicated Plasmodium falciparum malaria in children compared with amodiaquine + sulfadoxine/pyrimethamine (AQ+SP) at two different sites in Rwanda. The trial was open label and 800 patients were randomly assigned to AQ+SP (n = 400) or CD+A (n = 400). Patients were hospitalised for 3 days and then followed-up weekly until Day 28 after treatment. Clinical and parasitological outcomes were recorded. Results showed that neither treatment was adequately efficacious. At one site, the adequate clinical and parasitological response (ACPR), PCR-adjusted, was 73.3% in the CD+A arm and 87.8% in the AQ+SP arm (P<0.001), and at the second site the ACPR, PCR-adjusted, was 70.5% in the CD+A arm and 38.1% in the AQ+SP arm (P<0.001). The combination CD+A is considered an alternative to, or replacement for, SP in Africa because CD has been shown to be effective in patients for whom SP treatment has failed and, with its short half-life, it is expected to exert less selection pressure for resistant parasites than SP. However, the results of this trial indicate that in an area of high SP resistance, CD+A may not be the best choice. [ClinicalTrials.gov identifier: NCT004611578] (C) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Fanello, C. I.; Curtis, J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Karema, C.; Ngamije, D.; Uwimana, A.; Van Doren, W.] Natl Malaria Control Program, Kigali, Rwanda; [Ndahindwa, V.] Natl Univ Rwanda, Kigali, Rwanda; [Van Overmeir, C.; D'Alessandro, U.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium	Fanello, CI (reprint author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	caterina.fanello@lshtm.ac.uk	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Fanello, Caterina/0000-0003-1932-9562			BUKIRWA H, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004387.PUB2; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; Chotivanich K, 2006, ANTIMICROB AGENTS CH, V50, P1927, DOI 10.1128/AAC.01472-05; Curtis J, 1998, J INFECT DIS, V177, P1429, DOI 10.1086/517831; Fanello CI, 2007, T ROY SOC TROP MED H, V101, P344, DOI 10.1016/j.trstmh.2006.06.010; Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07; Hastings MD, 2002, T ROY SOC TROP MED H, V96, P674, DOI 10.1016/S0035-9203(02)90349-4; Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001; Krudsood S, 2005, T ROY SOC TROP MED H, V99, P142, DOI 10.1016/j.trstmh.2004.07.001; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Mutabingwa T, 2001, LANCET, V358, P1218, DOI 10.1016/S0140-6736(01)06344-9; Nzila A, 2005, T ROY SOC TROP MED H, V99, P341, DOI 10.1016/j.trstmh.2004.07.002; Nzila AM, 2002, INT J PARASITOL, V32, P1469, DOI 10.1016/S0020-7519(02)00164-9; Pukrittayakamee S, 2004, ANTIMICROB AGENTS CH, V48, P1329, DOI 10.1128/AAC.48.4.1329-1334.2004; Rwagacondo CE, 2004, TROP MED INT HEALTH, V9, P1091, DOI 10.1111/j.1365-3156.2004.01316.x; Rwagacondo CE, 2003, AM J TROP MED HYG, V68, P743, DOI 10.4269/ajtmh.2003.68.743; Sibley CH, 2001, TRENDS PARASITOL, V17, P582, DOI 10.1016/S1471-4922(01)02085-2; Sirawaraporn W, 1997, P NATL ACAD SCI USA, V94, P1124, DOI 10.1073/pnas.94.4.1124; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; WHO, 2003, ASS MON ANT DRUG EFF; *WHO, 2000, T R SOC TROP MED S1, V94; Wilairatana P, 1997, ANN TROP MED PARASIT, V91, P125, DOI 10.1080/00034983.1997.11813121; Winstanley P, 1997, T ROY SOC TROP MED H, V91, P322, DOI 10.1016/S0035-9203(97)90093-6; Winstanley P, 2001, TROP MED INT HEALTH, V6, P952, DOI 10.1046/j.1365-3156.2001.00751.x	25	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAY	2008	102	5					412	420		10.1016/j.trstmh.2008.01.013				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	310VM	WOS:000256558800004	18328518				2019-04-02	
J	Toledo, ME; Baly, A; Vanlerberghe, V; Rodriguez, M; Benitez, JR; Duvergel, J; Van der Stuyft, P				Toledo, Maria E.; Baly, Alberto; Vanlerberghe, Veerle; Rodriguez, Maritza; Benitez, Juan R.; Duvergel, Jacinto; Van der Stuyft, Patrick			The unbearable lightness of technocratic efforts at dengue control	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						aedes aegypti; dengue; control tools; behavioural change; community participation; top-down intervention; Cuba	AEDES-AEGYPTI INFESTATION; COMMUNITY PARTICIPATION; HEMORRHAGIC-FEVER; DISEASE-CONTROL; CUBA; HEALTH; SUSTAINABILITY; LESSONS; PROGRAM; VECTOR	OBJECTIVE To identify key elements that should provide an added value and assure sustainable effects of the deployment of technical tools for Aedes aegypti control. METHODS An observational study was conducted between April 2001 and March 2002 in 30 blocks (1574 houses) in the central zone of Guantanamo city. A trial that combined two complementary technical interventions, the distribution of new ground level water tanks and the intensive use of insecticide, was nested in May 2001. Another 30 blocks (1535 houses) were selected as control area. We assessed community perceptions and household risk behaviour at baseline and after 9 months, and measured the trial's impact through entomological indices. RESULTS Perceived self efficacy to solve A. aegypti infestation and prevent dengue was not modified. We found no changes in behaviour. In the study area the container indices decreased significantly from 0.7% before to 0.1% 1 month after the intervention. Six months later, they had increased to 2.7% and uncovered new water tanks constituted 75.9% of all breeding sites. Over the 9 months after the trial the average monthly house indices were similar in the study and control areas. A technical approach and lack of community involvement in the trial's implementation were the main causes of these short-lived results. CONCLUSION Top-down deployment of technical tools without active involvement of the community has a temporary effect and does not lead to the behavioural changes necessary for sustainable A. aegypti control.	[Toledo, Maria E.; Baly, Alberto] Inst Trop Med Pedro Kouri, Havana, Cuba; [Vanlerberghe, Veerle; Van der Stuyft, Patrick] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Rodriguez, Maritza; Benitez, Juan R.; Duvergel, Jacinto] Unidad Provincial Vigilancia & Lucha Antivectoria, Guantanamo, Cuba	Toledo, ME (reprint author), Inst Trop Med Pedro Kouri, Km 6 La Lisa, Havana, Cuba.	mariaeugeniatoledo@yahoo.es					Arcade J., 1994, STRUCTURAL ANAL MICM; BERMEJO A, 1993, SOC SCI MED, V36, P1145, DOI 10.1016/0277-9536(93)90234-U; BRACHT N, 1994, HEALTH EDUC RES, V9, P243, DOI 10.1093/her/9.2.243; Castle T, 1999, Rev Panam Salud Publica, V5, P100; De Vos P, 2005, INT J HEALTH SERV, V35, P189, DOI 10.2190/M72R-DBKD-2XWV-HJWB; GRATZ NG, 1991, J AM MOSQUITO CONTR, V7, P353; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P282, DOI 10.1590/S1020-49892006000400014; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; JACKSON C, 1994, HEALTH EDUC RES, V9, P385, DOI 10.1093/her/9.3.385; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Kroeger A, 1995, TROP MED PARASITOL, V46, P241; Kroeger A, 2006, LANCET, V368, P2193, DOI 10.1016/S0140-6736(06)69873-5; KUNTZ D, 1994, INT J HEALTH SERV, V24, P161, DOI 10.2190/L6VN-57RR-AFLK-XW90; NATHAN MB, 1991, J AM MOSQUITO CONTR, V7, P400; *PAHO, 1994, DENG DENG HAEM FEV A; Parks W, 2004, PLANNING SOCIAL MOBI; Parks WJ, 2004, DENGUE B S, V28; Patton M. Q., 2001, QUALITATIVE RES EVAL; Pluye P, 2005, EVAL PROGRAM PLANN, V28, P123, DOI 10.1016/j.evalprogplan.2004.10.003; Renganathan E., 2003, Dengue Bulletin, V27, P6; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; ROSENBAUM J, 1995, AM J TROP MED HYG, V53, P111, DOI 10.4269/ajtmh.1995.53.111; Sanchez L, 2005, TROP MED INT HEALTH, V10, P82, DOI 10.1111/j.1365-3156.2004.01347.x; Shediac-Rizkallah MC, 1998, HEALTH EDUC RES, V13, P87, DOI 10.1093/her/13.1.87; SIGRID S, 2003, SEARCH THEORETICAL F; SOTO F, 2000, REV ESP SALUD PUBLIC, V71, P335; Spiegel Jerry, 2005, EcoHealth, V2, P273, DOI 10.1007/s10393-005-8388-x; Spiegel JM, 2007, TROP MED INT HEALTH, V12, P503, DOI 10.1111/j.1365-3156.2007.01818.x; Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942; WINCH P, 1992, HEALTH POLICY PLANN, V7, P342, DOI 10.1093/heapol/7.4.342	32	20	21	1	5	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2008	13	5					728	736		10.1111/j.1365-3156.2008.02046.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	289NW	WOS:000255062200016	18346029	Bronze			2019-04-02	
J	Srour, ML; Watt, B; Phengdy, B; Khansoulivong, K; Harris, J; Bennett, C; Strobel, M; Dupuis, C; Newton, PN				Srour, M. Leila; Watt, Bryan; Phengdy, Bounthom; Khansoulivong, Keutmy; Harris, Jim; Bennett, Christopher; Strobel, Michel; Dupuis, Christian; Newton, Paul N.			Noma in Laos: Stigma of severe poverty in rural Asia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SOUTH INDIAN CHILDREN; NUTRITIONAL-STATUS; CANCRUM ORIS; GANGRENE; PDR	Noma, or cancrum oris, is a debilitating necrotizing ulcerative stomatitis that destroys the mouth and face. It usually starts in early childhood and is associated with severe poverty, malnutrition, and infections. It is most frequently described from sub-Saharan Africa but is under-reported. There have been very few reports from Asia. We describe the clinical and social features of a series of 12 patients with noma from remote poor villages in rural Lao People's Democratic Republic (Laos). Noma is an ominous stigma of severe poverty and the description of this disease emphasizes the importance of poverty reduction and nutritional improvement in Lao development. In the meantime, more awareness of the problem and the importance of early therapy in acute noma by primary health care workers may reduce mortality and prevent progression to severe disfigurement.	[Srour, M. Leila] Hlth Frontiers, Viangchan, Laos; Mahosot Hosp, Dept Ear Nose & Throat, Viangchan, Laos; Phoenix Clearance Ltd, UXO Awareness, Viangchan, Laos; Interplast, Melbourne, Vic, Australia; Amade Fdn, Brussels, Belgium; Francophone Inst Trop Med, Viangchan, Laos; Mahosot Hosp, Wellcome Trust Mahosot Hosp, Oxford Trop Med Res Collaborat, Viangchan, Laos; Univ Oxford, Churchill Hosp, Ctr Trop Med, Nuffield Dept Clin Med, Oxford, England; London Sch Hyg & Trop Med, London WC1, England	Srour, ML (reprint author), POB 2548, Viangchan, Laos.	srourleila@gmail.com			Wellcome Trust		Adelekan DA, 2003, NUTRITION, V19, P179, DOI 10.1016/S0899-9007(02)01101-2; Baratti-Mayer D, 2003, LANCET INFECT DIS, V3, P419, DOI 10.1016/S1473-3099(03)00670-4; BARENNES H, 2007, EUR J CLIN NUTR; Barmes DE, 1997, TROP MED INT HEALTH, V2, P1111, DOI 10.1046/j.1365-3156.1997.d01-220.x; BISWAL N, 1992, Indian Pediatrics, V29, P509; BLACK FO, 1973, SOUTHERN MED J, V66, P308, DOI 10.1097/00007611-197303000-00007; *CLE, 2007, WEEKL EP SURV REP; DAMME PA, 2006, LANCET S1, V368, pS61; DONALD J, 1892, LANCET, P417; Dooley Thomas A., 1960, NIGHT THEY BURNED MO; Enwonwu CO, 2006, NEW ENGL J MED, V354, P221, DOI 10.1056/NEJMp058193; Enwonwu CO, 2005, TROP MED INT HEALTH, V10, P65, DOI 10.1111/j.1365-3156.2004.01351.x; Enwonwu CO, 1999, AM J TROP MED HYG, V60, P223, DOI 10.4269/ajtmh.1999.60.223; Enwonwu CO, 2006, LANCET, V368, P147, DOI 10.1016/S0140-6736(06)69004-1; Fackler M L, 1971, US Navy Med, V58, P12; *GOV LAO PDR MIN H, 2001, HLTH STAT PEOPL LAO; Kuroiwa C, 2001, J Epidemiol, V11, P255; MALDEN N, 1985, ORAL SURG ORAL MED O, V59, P279, DOI 10.1016/0030-4220(85)90167-7; Marck KW, 2003, PLAST RECONSTR SURG, V111, P1702, DOI 10.1097/01.PRS.0000055445.84307.3C; MARCK KW, 2003, NORMA FACE POVERTY; Mayxay M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-193; Mayxay M, 2007, AM J TROP MED HYG, V77, P36, DOI 10.4269/ajtmh.2007.77.36; Mehrotra M C, 1966, J Indian Med Assoc, V47, P555; Miyoshi M, 2005, EUR J CLIN NUTR, V59, P887, DOI 10.1038/sj.ejcn.1602160; Phimmasone K, 1996, J TROP PEDIATRICS, V42, P5, DOI 10.1093/tropej/42.1.5; Phimphachanh C, 2004, AIDS EDUC PREV, V16, P91, DOI 10.1521/aeap.16.3.5.91.35523; PINDBORG JJ, 1967, J PERIODONTOL, V38, P218, DOI 10.1902/jop.1967.38.3.218; PINDBORG JJ, 1966, J PERIODONTOL, V37, P14, DOI 10.1902/jop.1966.37.1.14; REYNAUD J, 1950, Rev Odontostomatol, V6, P125; SISOUPHANTHONG B, 2000, ATLAS LAOS; TUAN PHAN-DINH, 1962, INDIAN JOUR PEDIAT, V29, P367, DOI 10.1007/BF02896752; UNDP, 2005, HUM DEV REP; WHO, 2000, MAN CHILD SER INF SE; *WHO, 1998, WORLD HLTH REP	34	9	10	1	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	APR	2008	78	4					539	542		10.4269/ajtmh.2008.78.539				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	287UZ	WOS:000254943300004	18385344				2019-04-02	
J	Martinez, R; Vivancos, R; Visschers, B; Namatovu, L; Nyangoma, E; Walley, J				Martinez, R.; Vivancos, R.; Visschers, B.; Namatovu, L.; Nyangoma, E.; Walley, J.			Training needs, practices and barriers in the work of community reproductive health workers in Masindi district, Uganda	TROPICAL DOCTOR			English	Article								Community reproductive health workers play a valuable role in family planning counselling and the distribution of contraceptive methods in rural communities. However, they face stigma, misconceptions and a lack of support. Regular supervision by health workers and support from community leaders can help address these issues.	[Martinez, R.] Univ Glasgow, Gartnavel Royal Hosp, Dept Psychol Med, Glasgow G12 OXH, Lanark, Scotland; [Vivancos, R.; Visschers, B.] Univ Ziekenhuis St Rafael, Centrum Reprod Geneeskunde, Ghent, Belgium; [Walley, J.] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England	Martinez, R (reprint author), Univ Glasgow, Gartnavel Royal Hosp, Dept Psychol Med, 1055 Great Western Rd, Glasgow G12 OXH, Lanark, Scotland.	rm129z@clinmed.gla.ac.uk					Flaherty A, 2005, TROP DOCT, V35, P4, DOI 10.1258/0049475053001813; Kipp W, 2003, J HEALTH POPUL NUTR, V21, P103; Meldrum A, 1994, Afr Rep, V39, P47; *MIN HLTH, 2000, REPR HLTH DIV 5 YEAR; Ministry of Health Uganda, 2000, HLTH SECT STRAT PLAN; Okwero M, 1994, Plan Parent Chall, P17; *WHO, 1994, WHO POS PAP HLTH POP; 1995, AFR ALTERN, V2, P6	8	5	5	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0049-4755	1758-1133		TROP DOCT	Trop. Dr.	APR	2008	38	2					93	95		10.1258/td.2007.070116				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	297BL	WOS:000255590900012	18453497				2019-04-02	
J	Siddiqi, K; Volz, A; Armas, L; Otero, L; Ugaz, R; Ochoa, E; Gotuzzo, E; Torrico, F; Newell, JN; Walley, J; Robinson, M; Dieltiens, G; Van der Stuyft, P				Siddiqi, Kamran; Volz, Anna; Armas, L.; Otero, L.; Ugaz, R.; Ochoa, E.; Gotuzzo, E.; Torrico, F.; Newell, James N.; Walley, J.; Robinson, Mike; Dieltiens, G.; Van der Stuyft, P.			TB country profile: Cuba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						clinical audit; tuberculosis; professional behaviour; quality; diagnosis; smear-negative TB	COMPLEX INTERVENTIONS; HEALTH-CARE; QUALITY; AUDIT; TUBERCULOSIS; FRAMEWORK; POLICIES	Objectives To assess the effectiveness of clinical audit in improving the quality of diagnostic care provided to patients suspected of tuberculosis; and to understand the contextual factors which impede or facilitate its success. Methods Twenty-six health centres in Cuba, Peru and Bolivia were recruited. Clinical audit was introduced to improve the diagnostic care for patients attending with suspected TB. Standards were based on the WHO and TB programme guidelines relating to the appropriate use of microscopy, culture and radiological investigations. At least two audit cycles were completed over 2 years. Improvement was determined by comparing the performance between two six-month periods pre- and post-intervention. Qualitative methods were used to ascertain facilitating and limiting contextual factors influencing change among healthcare professionals' clinical behaviour after the introduction of clinical audit. Results We found a significant improvement in 11 of 13 criteria in Cuba, in 2 of 6 criteria in Bolivia and in 2 of 5 criteria in Peru. Twelve out of 24 of the audit criteria in all three countries reached the agreed standards. Barriers to quality improvement included conflicting objectives for clinicians and TB programmes, poor coordination within the health system and patients' attitudes towards illness. Conclusions Clinical audit may drive improvements in the quality of clinical care in resource-poor settings. It is likely to be more effective if integrated within and supported by the local TB programmes. We recommend developing and evaluating an integrated model of quality improvement including clinical audit.	[Siddiqi, Kamran; Newell, James N.; Walley, J.; Robinson, Mike] Univ Leeds, Fac Med & Hlth, Inst Hlth Sci & Publ Hlth Res, Nuffield Ctr Int Hlth & Dev, Leeds LS2 9LP, W Yorkshire, England; [Volz, Anna] Univ Mayor San Simon, Minist Hlth, Dept Hlth Serv, Cochabamba, Bolivia; [Armas, L.; Ochoa, E.] Inst Trop Med Pedro Kouri, Havana, Cuba; [Otero, L.; Ugaz, R.; Gotuzzo, E.] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 100, Peru; [Torrico, F.] Univ Mayor San Simon, Fac Med, IIBISMED, Cochabamba, Bolivia; [Dieltiens, G.; Van der Stuyft, P.] Inst Trop Med, B-2000 Antwerp, Belgium	Siddiqi, K (reprint author), Univ Leeds, Fac Med & Hlth, Inst Hlth Sci & Publ Hlth Res, Nuffield Ctr Int Hlth & Dev, 71-75 Clarendon Rd, Leeds LS2 9LP, W Yorkshire, England.	hssks@leeds.ac.uk		Otero, Larissa/0000-0002-8348-4340; Siddiqi, Kamran/0000-0003-1529-7778			Alemi F, 2000, Jt Comm J Qual Improv, V26, P74; BAKER R, 1999, IMPLEMENTING CHANGE; Bauchner H, 2001, ARCH DIS CHILD, V84, P459, DOI 10.1136/adc.84.6.459; Brown Celia A, 2006, BMC Med Res Methodol, V6, P54; Campbell H, 1998, BMJ-BRIT MED J, V316, P133; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Cook T. D., 1979, QUASI EXPERIMENTATIO; Dick J, 2004, J ADV NURS, V48, P434, DOI 10.1111/j.1365-2648.2004.03226.x; EDDY DM, 1982, NEW ENGL J MED, V307, P343, DOI 10.1056/NEJM198208053070604; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; FLEISS J, 2003, STAT METHODS RATES; Fraser RC, 1997, BRIT J GEN PRACT, V47, P743; FREEMANTLE N, 2000, COCHRANE DB SYST REV, V2; Grol R, 2001, JAMA-J AM MED ASSOC, V286, P2578, DOI 10.1001/jama.286.20.2578; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hawe P, 2004, BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Hearnshaw H, 2002, Health Technol Assess, V6, P1; Hearnshaw HM, 2003, QUAL SAF HEALTH CARE, V12, P24, DOI 10.1136/qhc.12.1.24; Jamtvedt G, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000259.PUB2; KERRISON S, 1993, MONITORING MED AUDIT, P155; Lauzardo M, 2000, CHEST, V117, P1455, DOI 10.1378/chest.117.5.1455; Lord J, 1997, BRIT MED J, V315, P668, DOI 10.1136/bmj.315.7109.668; MAHER D, 1997, TREATMENT TUBERCULOS, P13; ManceyJones M, 1997, HEALTH POLICY PLANN, V12, P183, DOI 10.1093/heapol/12.3.183; MARQUEZ L, 2001, HELPING HEALTHCARE P; *MRC, 2000, FRAM DEV RCTS COMPL; Murphy MK, 1998, HEALTH TECHNOL ASSES, V2, P1, DOI DOI 10.3310/HTA2030; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; OBRIEN MAT, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003030; OBRIEN MAT, 2000, COCHRANE DB SYST REV; Robinson MB, 1998, QUAL HEALTH CARE, V7, P19, DOI 10.1136/qshc.7.1.19; Siddiqi K, 2005, INT J QUAL HEALTH C, V17, P447, DOI 10.1093/intqhc/mzi051; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Silimperi DR, 2002, INT J QUAL HEALTH C, V14, P67, DOI 10.1093/intqhc/14.suppl_1.67; Steinberg EP, 2003, NEW ENGL J MED, V348, P2681, DOI 10.1056/NEJMe030085; Strauss A, 1990, BASICS QUALITATIVE R; *WHO, 2004, COUNTR PROF PERU; WHO, 2003, WORLD HLTH REP 2003; *WHO, 2006, TB COUNTR PROF BOL; *WHO, 2006, WEKKLY EPIDMIOLOGY R, V81, P43; *WHO, 2006, COUNTR PROF CUB; Yin R., 1994, CASE STUDY RES DESIG	42	10	11	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2008	13	4					566	578		10.1111/j.1365-3156.2008.02035.x				13	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	287YY	WOS:000254954600016	18318698				2019-04-02	
J	Kilian, A; Byamukama, W; Pigeon, O; Atieli, F; Duchon, S; Phan, C				Kilian, Albert; Byamukama, Wilson; Pigeon, Olivier; Atieli, Francis; Duchon, Stephan; Phan, Chi			Long-term field performance of a polyester-based long-lasting insecticidal mosquito net in rural Uganda	MALARIA JOURNAL			English	Article							WASH-RESISTANCE; TREATED NETS; MALARIA TRANSMISSION; DISTRIBUTION PROGRAM; IMPREGNATED BEDNET; FORMULATION; PERMETHRIN; INTENSITY; DISTRICT; STRATEGY	Background: In order to evaluate whether criteria for LLIN field performance (phase III) set by the WHO Pesticide Evaluation Scheme are met, first and second generations of one of these products, PermaNet (R), a polyester net using the coating technology were tested. Methods: A randomized, double blinded study design was used comparing LLIN to conventionally treated nets and following LLIN for three years under regular household use in rural conditions. Primary outcome measures were deltamethrin residue and bioassay performance (60 minute knock-down and 24 hour mortality after a three minute exposure) using a strain of Anopheles gambiae s. s. sensitive to pyrethroid insecticides. Results: Baseline concentration of deltamethrin was within targets for all net types but was rapidly lost in conventionally treated nets and first generation PermaNet (R) with median of 0.7 and 2.5 mg/m(2) after six months respectively. In contrast, second generation PermaNet (R) retained insecticide well and had 41.5% of baseline dose after 36 months (28.7 mg/m(2)). Similarly, vector mortality and knockdown dropped to 18% and 70% respectively for first generation LLIN after six months but remained high (88.5% and 97.8% respectively) for second generation PermaNet (R) after 36 months of follow up at which time 90.0% of nets had either a knockdown rate >= 95% or mortality rate >= 80%. Conclusion: Second generation PermaNet r showed excellent results after three years of field use and fulfilled the WHOPES criteria for LLIN. Loss of insecticide on LLIN using coating technology under field conditions was far more influenced by factors associated with handling rather than washing.	[Kilian, Albert] Malaria Consortium, London EC2A 4JX, England; [Kilian, Albert] German Tech Cooperat, Dept Hlth Educ Social Secur, Eschborn, Germany; [Byamukama, Wilson] Dist Hlth Serv Kabarole Dist, Ft Portal, Uganda; [Pigeon, Olivier] Ctr Wallon Rech Agron CRAW, Dept Phytopharm, Gembloux, Belgium; [Atieli, Francis] Ctr Dis Control & Prevent, Div Parasit Dis, Atlanta, GA USA; [Atieli, Francis] Kenya Govt Med Res Ctr, Ctr Vector Biol & Control Res, Kisumu, Kenya; [Duchon, Stephan] IRD, LIN, Montpellier, France; [Phan, Chi] Vestergaard Frandsen Qual Control Labs, Hanoi, Vietnam	Kilian, A (reprint author), Malaria Consortium, Dev House,56-64 Leonard St, London EC2A 4JX, England.	a.kilian@malariaconsortium.org; wilsonbyamukama@yahoo.com; pigeon@cra.wallonie.be; Fatieli@kisian.mimcom.net; Stephane.Duchon@mpl.ird.fr; vfhl1@hn.vnn.vn		DUCHON, STEPHANE/0000-0002-0140-1020			Adams KJ, 2002, MED VET ENTOMOL, V16, P106, DOI 10.1046/j.0269-283x.2002.00341.x; Asidi AN, 2004, MED VET ENTOMOL, V18, P134, DOI 10.1111/j.0269-283X.2004.00485.x; Curtis CF, 1996, MED VET ENTOMOL, V10, P1, DOI 10.1111/j.1365-2915.1996.tb00075.x; Erlanger TE, 2004, MED VET ENTOMOL, V18, P153, DOI 10.1111/j.0269-283X.2004.00491.x; Gimnig J. E., 2003, American Journal of Tropical Medicine and Hygiene, V69, P450; Gimnig JE, 2005, TROP MED INT HEALTH, V10, P1022, DOI 10.1111/j.1365-3156.2005.01481.x; Gonzalez JO, 2002, T ROY SOC TROP MED H, V96, P370, DOI 10.1016/S0035-9203(02)90363-9; Graham K, 2005, MED VET ENTOMOL, V19, P72, DOI 10.1111/j.0269-283X.2005.00543.x; Guillet P, 2001, B WORLD HEALTH ORGAN, V79, P998; *ISO, 1983, 3801 ISO; Jawara M, 2001, TROP MED INT HEALTH, V6, P309, DOI 10.1046/j.1365-3156.2001.00706.x; Kilian AHD, 1999, ACTA TROP, V72, P281, DOI 10.1016/S0001-706X(99)00003-0; Kroeger A, 2004, T ROY SOC TROP MED H, V98, P152, DOI 10.1016/S0035-9203(03)00038-5; Kroeger A, 1997, TROP MED INT HEALTH, V2, P589, DOI 10.1046/j.1365-3156.1997.d01-319.x; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; Miller JE, 1999, TROP MED INT HEALTH, V4, P167, DOI 10.1046/j.1365-3156.1999.43378.x; Miller JE, 1999, TROP MED INT HEALTH, V4, P160, DOI 10.1046/j.1365-3156.1999.43377.x; MILLER JE, 1995, MED VET ENTOMOL, V9, P43, DOI 10.1111/j.1365-2915.1995.tb00115.x; Muller O, 2002, T ROY SOC TROP MED H, V96, P483, DOI 10.1016/S0035-9203(02)90411-6; Muller O, 1997, SOC SCI MED, V44, P1903, DOI 10.1016/S0277-9536(96)00299-7; N'Guessan R, 2001, MED VET ENTOMOL, V15, P97, DOI 10.1046/j.1365-2915.2001.00284.x; *NETMARK, 2001, BAS SURV INS TREAT M; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Ritmeijer K, 2007, TROP MED INT HEALTH, V12, P404, DOI 10.1111/j.1365-3156.2006.01807.x; Snow RW, 1999, HEALTH POLICY PLANN, V14, P18, DOI 10.1093/heapol/14.1.18; Spencer S, 2004, T ROY SOC TROP MED H, V98, P719, DOI 10.1016/j.trstmh.2004.01.012; Talisuna AO, 2002, T ROY SOC TROP MED H, V96, P310, DOI 10.1016/S0035-9203(02)90108-2; Tami A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-19; WHO, 1998, TEST PROC INS RES MO; WHO, 2006, WHO SPEC EV PUBL HLT; *WHO, 2003, REP 7 WHOPES WORK GR; *WHO, 2001, REP 3 WHOPES WORK GR; *WHO, FOURTH UPD LLIN GEN; WHO [World Health Organization], 2005, GUID LAB FIELD TEST; World Health Organization (WHO), 2001, REP 5 WHOPES WORK GR; Yates A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-52	37	76	78	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAR 20	2008	7								49	10.1186/1475-2875-7-49				22	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	292QG	WOS:000255280600001	18355408	DOAJ Gold, Green Published			2019-04-02	
J	Mens, PF; van Overmeir, C; Bonnet, M; Dujardin, JC; d'Alessandro, U				Mens, Petra F.; van Overmeir, Chantal; Bonnet, Maryline; Dujardin, Jean Claude; d'Alessandro, Umberto			Real-time PCR/MCA assay using fluorescence resonance energy transfer for the genotyping of resistance related DHPS-540 mutations in Plasmodium falciparum	MALARIA JOURNAL			English	Article							SULFADOXINE-PYRIMETHAMINE RESISTANCE; DIHYDROPTEROATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; MALARIA; PCR; DRUG; EFFICACY; THERAPY	Background: Sulphadoxine-pyrimethamine has been abandoned as first- or second-line treatment by most African malaria endemic countries in favour of artemisinin-based combination treatments, but the drug is still used as intermittent preventive treatment during pregnancy. However, resistance to sulphadoxine-pyrimethamine has been increasing in the past few years and, although the link between molecular markers and treatment failure has not been firmly established, at least for pregnant women, it is important to monitor such markers. Methods: This paper reports a novel sensitive, semi-quantitative and specific real-time PCR and melting curve analysis (MCA) assay using fluorescence resonance energy transfer (FRET) for the detection of DHPS-540, an important predictor for SP resistance. FRET/MCA was evaluated using 78 clinical samples from malaria patients and compared to PCR-RFLP. Results: Sixty-two samples were in perfect agreement between both assays. One sample showed a small wild type signal with FRET/MCA that indicates a polyclonal infection. Four samples were not able to generate enough material in both assays to distinguish mutant from wild-type infection, six samples gave no signal in PCR-RFLP and five samples gave no amplification in FRET/MCA. Conclusion: FRET/MCA is an effective tool for the identification of SNPs in drug studies and epidemiological surveys on resistance markers in general and DHPS-540 mutation in particular.	[Mens, Petra F.; van Overmeir, Chantal; Dujardin, Jean Claude; d'Alessandro, Umberto] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; [Mens, Petra F.] Royal Trop Inst, Koninklijk Inst Voor De Tropen, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; Epictr, F-75011 Paris, France	Mens, PF (reprint author), Inst Trop Med Prince Leopold, Dept Parasitol, Nationalestr 155, B-2000 Antwerp, Belgium.	pmens.@kit.nl; cvovermeir@itg.be; marylinebonnet@epicentre.msf.org; jcdujard@itg.be; udalessandro@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009			Alker AP, 2004, ANTIMICROB AGENTS CH, V48, P2924, DOI 10.1128/AAC.48.8.2924-2929.2004; Altman DG, 1991, PRACTICAL STAT MED R, P611; CARDULLO RA, 1988, P NATL ACAD SCI USA, V85, P8790, DOI 10.1073/pnas.85.23.8790; Chaparro J, 2001, EXP PARASITOL, V99, P115, DOI 10.1006/expr.2001.4660; Cohuet S, 2006, AM J TROP MED HYG, V75, P152, DOI 10.4269/ajtmh.2006.75.152; Decuypere S, 2003, J INFECT DIS, V188, P1245, DOI 10.1086/378521; Dorsey G, 2004, AM J TROP MED HYG, V71, P758, DOI 10.4269/ajtmh.2004.71.758; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; Juliano JJ, 2007, EMERG INFECT DIS, V13, P873, DOI 10.3201/eid1306.061182; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Le Bras J, 2003, FUND CLIN PHARMACOL, V17, P147, DOI 10.1046/j.1472-8206.2003.00164.x; OMUA P, 2006, PLOS CLIN TRIALS, V1, pE28; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Sibley CH, 2001, TRENDS PARASITOL, V17, P582, DOI 10.1016/S1471-4922(01)02085-2; Talisuna AO, 2004, INFECT GENET EVOL, V4, P321, DOI 10.1016/j.meegid.2004.04.002; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; *WHO REG OFF AFR, 1996, ASS THER EFF ANT DRU; *WHO REG OFF AFR, 2004, STRAG FRAM MAL PREV; Wilson PE, 2005, TRENDS PARASITOL, V21, P278, DOI 10.1016/j.pt.2005.04.007; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6	21	6	7	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAR 17	2008	7								48	10.1186/1475-2875-7-48				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	283MF	WOS:000254639600001	18346279	DOAJ Gold, Green Published			2019-04-02	
J	Simasathien, S; Thomas, SJ; Watanaveeradej, V; Nisalak, A; Barberousse, C; Innis, BL; Sun, W; Putnak, JR; Eckels, KH; Hutagalung, Y; Gibbons, RV; Zhang, C; De La Barrera, R; Jarman, RG; Chawachalasai, W; Mammen, MP				Simasathien, Sriluck; Thomas, Stephen J.; Watanaveeradej, Veerachai; Nisalak, Ananda; Barberousse, Celia; Innis, Bruce L.; Sun, Wellington; Putnak, J. Robert; Eckels, Kenneth H.; Hutagalung, Yanee; Gibbons, Robert V.; Zhang, Chunlin; De La Barrera, Rafael; Jarman, Richard G.; Chawachalasai, Wipa; Mammen, Mammen P., Jr.			Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							JAPANESE ENCEPHALITIS VACCINES; VIRUSES	A live-attenuated tetravalent dengue virus (DENV) vaccine candidate has been well tolerated and immunogenic in healthy, US flavivirus naive adult volunteers. We conducted a pilot, safety, and immunogenicity trial of the vaccine candidate in healthy Thai children (6-7 years of age) to prepare for its eventual evaluation in Thai infants. In an uncontrolled, open clinical trial, the investigational vaccine was administered on study Days 0 and 180 to seven volunteers residing in Bangkok without neutralizing antibodies to DENV1-4 or to Japanese encephalitis virus (JEV). Clinical and laboratory safety assessments were completed during the 30 days after each vaccine dose, and immunogenicity was determined at Day 30. In this study, the vaccine was well tolerated with no serious adverse events or alert laboratory values. One volunteer experienced fever (38.2 degrees C, < 2 days) and associated DENV4 vaccine viremia 7 days after Dose 2. One month after Dose 2, six volunteers in the per-protocol analysis exhibited a tetravalent neutralizing antibody response with DENV1-4 geometric mean titers of 55, 475, 350, and 171, respectively. Ten weeks (similar to 75 days) after Dose 2, five of the six volunteers continued to exhibit a tetravalent neutralizing antibody profile; one volunteer's DENV4 PRNT50 titer fell below the assay cut-off (29 -> < 10); (clinicaltrials.gov NCT00384670).	[Thomas, Stephen J.] USAMC AFRIMS, APO AP, Bangkok 96546, Thailand; [Simasathien, Sriluck; Watanaveeradej, Veerachai] Phramongkutklao Hosp, Dept Pediat, Bangkok, Thailand; [Nisalak, Ananda; Gibbons, Robert V.; Zhang, Chunlin; Jarman, Richard G.; Chawachalasai, Wipa; Mammen, Mammen P., Jr.] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok, Thailand; [Barberousse, Celia] GlaxoSmithKline Biol, Rixensart, Belgium; [Innis, Bruce L.] GlaxoSmithKline Inc, King Of Prussia, PA USA; [Sun, Wellington] Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Infect Dis, San Juan, PR 00920 USA; [Putnak, J. Robert] Walter Reed Army Inst Res, Div Viral Dis, Silver Spring, MD 20910 USA; [Eckels, Kenneth H.; De La Barrera, Rafael] Walter Reed Army Inst Res, Div Regulated Activit, Pilot Bioprod Facil, Silver Spring, MD 20910 USA; [Hutagalung, Yanee] GlaxoSmithKline Inc, Bangkok, Thailand	Thomas, SJ (reprint author), USAMC AFRIMS, APO AP, Bangkok 96546, Thailand.	ssriluck@hotmail.com; stephen.thomas@afrims.org; veerachaiw@yahoo.com; ananda.nisalak@afrims.org; celia.barberousse@gsk.com; bruce.2.innis@gsk.com; WSun@cdc.gov; robert.putnak@amedd.army.mil; kenneth.eckels@amedd.army.mil; yanee.hutagalung@gsk.com; Robert.gibbons@afrims.org; chunlin.zhang@amedd.army.mil; rafael.delabarrera@na.amedd.army.mil; Richard.jarman@afrims.org; Wipac@afrims.org; mammen.mammen@amedd.army.mil		Innis, Bruce/0000-0002-1753-7248			BRANDT WE, 1990, J INFECT DIS, V162, P577, DOI 10.1093/infdis/162.3.577; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Eckels KH, 2003, AM J TROP MED HYG, V69, P12, DOI 10.4269/ajtmh.2003.69.12; Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48; Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Innis BL, 2003, AM J TROP MED HYG, V69, P1; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545; Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356; ROSEN L, 1985, AM J TROP MED HYG, V34, P805, DOI 10.4269/ajtmh.1985.34.805; RUSSELL PK, 1967, J IMMUNOL, V99, P285; Sabchareon A, 2004, PEDIATR INFECT DIS J, V23, P99, DOI 10.1097/01.inf.0000109289.55856.27; Sabchareon A, 2002, AM J TROP MED HYG, V66, P264, DOI 10.4269/ajtmh.2002.66.264; *STATXACT, 2002, CYT SOFTW CORP, V5; TSAI TF, 2000, PRINCIPLES PRACTICES, P1727	19	75	84	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAR	2008	78	3					426	433		10.4269/ajtmh.2008.78.426				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	273KE	WOS:000253928100016	18337339				2019-04-02	
J	Portaels, F; Meyers, WM; Ablordey, A; Castro, AG; Chemlal, K; de Rijk, P; Elsen, P; Fissette, K; Fraga, AG; Lee, R; Mahrous, E; Small, PLC; Stragier, P; Torrado, E; Van Aerde, A; Silva, MT; Pedrosa, J				Portaels, Francoise; Meyers, Wayne M.; Ablordey, Anthony; Castro, Antonio G.; Chemlal, Karim; de Rijk, Pim; Elsen, Pierre; Fissette, Krista; Fraga, Alexandra G.; Lee, Richard; Mahrous, Engy; Small, Pamela L. C.; Stragier, Pieter; Torrado, Egidio; Van Aerde, Anita; Silva, Manuel T.; Pedrosa, Jorge			First Cultivation and Characterization of Mycobacterium ulcerans from the Environment	PLOS NEGLECTED TROPICAL DISEASES			English	Article							BURULI ULCER; AQUATIC INSECTS; PCR; INFECTION; MARINUM; IS2404; IDENTIFICATION; MYCOLACTONE; VIRULENCE; BACTERIA	Background: Mycobacterium ulcerans disease, or Buruli ulcer (BU), is an indolent, necrotizing infection of skin, subcutaneous tissue and, occasionally, bones. It is the third most common human mycobacteriosis worldwide, after tuberculosis and leprosy. There is evidence that M. ulcerans is an environmental pathogen transmitted to humans from aquatic niches; however, well-characterized pure cultures of M. ulcerans from the environment have never been reported. Here we present details of the isolation and characterization of an M. ulcerans strain (00-1441) obtained from an aquatic Hemiptera (common name Water Strider, Gerris sp.) from Benin. Methodology/Principal Findings: One culture from a homogenate of a Gerris sp. in BACTEC became positive for IS2404, an insertion sequence with more than 200 copies in M. ulcerans. A pure culture of M. ulcerans 00-1441 was obtained on Lowenstein-Jensen medium after inoculation of BACTEC culture in mouse footpads followed by two other mouse footpad passages. The phenotypic characteristics of 00-1441 were identical to those of African M. ulcerans, including production of mycolactone A/B. The nucleotide sequence of the 59 end of 16S rRNA gene of 00-1441 was 100% identical to M. ulcerans and M. marinum, and the sequence of the 39 end was identical to that of the African type except for a single nucleotide substitution at position 1317. This mutation in M. ulcerans was recently discovered in BU patients living in the same geographic area. Various genotyping methods confirmed that strain 00-1441 has a profile identical to that of the predominant African type. Strain 00-1441 produced severe progressive infection and disease in mouse footpads with involvement of bone. Conclusion: Strain 00-1441 represents the first genetically and phenotypically identified strain of M. ulcerans isolated in pure culture from the environment. This isolation supports the concept that the agent of BU is a human pathogen with an environmental niche.	[Portaels, Francoise; Ablordey, Anthony; Chemlal, Karim; de Rijk, Pim; Elsen, Pierre; Fissette, Krista; Stragier, Pieter; Van Aerde, Anita] Inst Trop Med, B-2000 Antwerp, Belgium; [Meyers, Wayne M.] Armed Forces Inst Pathol, Washington, DC 20306 USA; [Ablordey, Anthony] Univ Ghana, Noguchi Mem Inst Med Res, Coll Hlth Sci, Legon, Accra, Ghana; [Castro, Antonio G.; Fraga, Alexandra G.; Torrado, Egidio; Pedrosa, Jorge] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Lee, Richard; Mahrous, Engy; Small, Pamela L. C.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Silva, Manuel T.] Univ Porto, Inst Mol & Cell Biol, P-4100 Oporto, Portugal	Portaels, F (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.	portaels@itg.be	Stragier, Pieter/G-9414-2012; Lee, Richard/J-4997-2013; Castro, Gil/T-7584-2018; Pedrosa, Jorge/H-4877-2011; Fraga, Alexandra/T-5174-2018; Castro, Antonio/F-5863-2011; Torrado, Egidio/T-5156-2018	Stragier, Pieter/0000-0002-6369-341X; Lee, Richard/0000-0002-2397-0443; Castro, Gil/0000-0002-4684-4183; Pedrosa, Jorge/0000-0002-8204-4888; Fraga, Alexandra/0000-0003-2029-1629; Castro, Antonio/0000-0002-4684-4183; Torrado, Egidio/0000-0002-7462-8234	Directorate-General for Development Cooperation (DGDC) Brussels (Belgium); Scientific Research, Flanders (Belgium) (FWO) [0301.01]; Damien Foundation, Brussels (Belgium); European Commission [INCO-CT-2005-051476-BURULICO]; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Health Services of Fundacao Calouste Gulbenkian; FCT [SFRH/BD/9757/2003, SFRH/BD/15911/2005]	This work was partly supported by the Directorate-General for Development Cooperation (DGDC) Brussels (Belgium), the Fund for Scientific Research, Flanders (Belgium) (FWO grant nu G. 0301.01), by the Damien Foundation, Brussels (Belgium), by the European Commission, project nr. INCO-CT-2005-051476-BURULICO "Buruli ulcer: multidisciplinary research for improvement of control in Africa'', and by the National Institute of Allergy and Infectious Diseases, National Institutes of Health. This work was also supported by a grant from the Health Services of Fundacao Calouste Gulbenkian and by FCT fellowships Praxis SFRH/BD/9757/2003 and SFRH/BD/15911/2005 to E. Torrado and A. G. Fraga, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablordey A, 2007, CLIN MICROBIOL INFEC, V13, P734, DOI 10.1111/j.1469-0691.2007.01716.x; Ablordey A, 2005, J CLIN MICROBIOL, V43, P448, DOI 10.1128/JMC.43.1.448-451.2005; Barker D J, 1972, East Afr Med J, V49, P667; BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Caro A, 1999, APPL ENVIRON MICROB, V65, P3229; Chemlal K, 2002, J CLIN MICROBIOL, V40, P2370, DOI 10.1128/JCM.40.7.2370-2380.2002; Chemlal K, 2001, J CLIN MICROBIOL, V39, P3272, DOI 10.1128/JCM.39.9.3272-3278.2001; Chemlal K, 2001, AM J TROP MED HYG, V64, P270, DOI 10.4269/ajtmh.2001.64.270; Debacker M, 2006, EMERG INFECT DIS, V12, P1325, DOI 10.3201/eid1209.050598; Duker AA, 2006, ENVIRON INT, V32, P567, DOI 10.1016/j.envint.2006.01.002; Eddyani M, 2007, CLIN MICROBIOL INFEC, V13, P1033, DOI 10.1111/j.1469-0691.2007.01791.x; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; George KM, 2000, INFECT IMMUN, V68, P877, DOI 10.1128/IAI.68.2.877-883.2000; Guimaraes-Peres A, 1999, J CLIN MICROBIOL, V37, P206; HOFER M, 1993, NEW ENGL J MED, V328, P1007, DOI 10.1056/NEJM199304083281405; Imms AD, 1947, INSECT NATURAL HIST; JANSSENS PG, 2005, B SEANCES ACAD R SCI, V51, P165; Keep NH, 2006, TRENDS MICROBIOL, V14, P271, DOI 10.1016/j.tim.2006.04.003; Kotlowski R, 2004, J MED MICROBIOL, V53, P927, DOI 10.1099/jmm.0.45593-0; Leitritz L, 2001, J CLIN MICROBIOL, V39, P3764, DOI 10.1128/JCM.39.10.3764-3767.2001; LEVYFREBAULT VV, 1992, INT J SYST BACTERIOL, V42, P315; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P1097, DOI 10.1128/AEM.70.2.1097-1103.2004; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Merritt RW, 2005, FRONT ECOL ENVIRON, V3, P323, DOI 10.1890/1540-9295(2005)003[0323:UAEDAW]2.0.CO;2; MEYERS WM, 1974, AM J TROP MED HYG, V23, P924, DOI 10.4269/ajtmh.1974.23.924; Mve-Obiang A, 2003, INFECT IMMUN, V71, P774, DOI 10.1128/IAI.71.2.774-783.2003; Oliveira MS, 2005, INFECT IMMUN, V73, P6299, DOI 10.1128/IAI.73.10.6299-6310.2005; Oliver JD, 2005, J MICROBIOL, V43, P93; Palomino JC, 1998, J CLIN MICROBIOL, V36, P402; PATTYN SR, 1965, ANN I PASTEUR PARIS, V109, P309; PORTAELS F, 1989, ANN SOC BELG MED TR, V69, P91; Portaels F, 1973, Ann Soc Belg Med Trop, V53, P373; Portaels F., 2003, Bulletin des Seances, Academie Royale des Sciences d'Outre- Mer, V49, P161; Portaels F, 1999, LANCET, V353, P986, DOI 10.1016/S0140-6736(98)05177-0; PORTAELS F, 1995, CLIN DERMATOL, V13, P207, DOI 10.1016/0738-081X(95)00004-Y; Portaels F, 1996, J CLIN MICROBIOL, V34, P962; Portaels F, 2001, REV SCI TECH OIE, V20, P252, DOI 10.20506/rst.20.1.1270; PORTAELS F, 2006, IMPORTED SKIN DIS, P117; PORTAELS F, 2001, WHOCDSGBUI20014; Robert B, 1997, J CLIN MICROBIOL, V35, P2709; Ross BC, 1997, J CLIN MICROBIOL, V35, P1696; Ross BC, 1997, APPL ENVIRON MICROB, V63, P4135; ROSZAK DB, 1987, MICROBIOL REV, V51, P365; Shepard C C, 1968, Int J Lepr Other Mycobact Dis, V36, P78; Shleeva M, 2004, MICROBIOL-SGM, V150, P1687, DOI 10.1099/mic.0.26893-0; Silva MT, 2007, PLOS MED, V4, P229, DOI 10.1371/journal.pmed.0040063; Stinear T, 2000, APPL ENVIRON MICROB, V66, P3206, DOI 10.1128/AEM.66.8.3206-3213.2000; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Stragier P, 2006, EMERG INFECT DIS, V12, P844, DOI 10.3201/eid1205.051191; Stragier P, 2005, J BACTERIOL, V187, P1639, DOI 10.1128/JB.187.5.1639-1647.2005; Stragier P, 2007, SYST APPL MICROBIOL, V30, P525, DOI 10.1016/j.syapm.2007.06.001; Torrado E, 2007, INFECT IMMUN, V75, P977, DOI 10.1128/IAI.00889-06; Yip MJ, 2007, J BACTERIOL, V189, P2021, DOI 10.1128/JB.01442-06	55	109	110	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2008	2	3							e178	10.1371/journal.pntd.0000178				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	385HZ	WOS:000261806600006	18365032	DOAJ Gold, Green Published			2019-04-02	
J	Tanghe, A; Dangy, JP; Pluschke, G; Huygen, K				Tanghe, Audrey; Dangy, Jean-Pierre; Pluschke, Gerd; Huygen, Kris			Improved Protective Efficacy of a Species-Specific DNA Vaccine Encoding Mycolyl-Transferase Ag85A from Mycobacterium ulcerans by Homologous Protein Boosting	PLOS NEGLECTED TROPICAL DISEASES			English	Article							T-CELL EPITOPES; CULTURE FILTRATE ANTIGENS; BOVIS BCG VACCINATION; BURULI ULCER; IMMUNE-RESPONSE; MACROLIDE TOXIN; TUBERCULOSIS; INFECTION; MYCOLACTONE; DISEASE	Vaccination with plasmid DNA encoding Ag85A from M. bovis BCG can partially protect C57BL/6 mice against a subsequent footpad challenge with M. ulcerans. Unfortunately, this cross-reactive protection is insufficient to completely control the infection. Although genes encoding Ag85A from M. bovis BCG (identical to genes from M. tuberculosis) and from M. ulcerans are highly conserved, minor sequence differences exist, and use of the specific gene of M. ulcerans could possibly result in a more potent vaccine. Here we report on a comparison of immunogenicity and protective efficacy in C57BL/6 mice of Ag85A from M. tuberculosis and M. ulcerans, administered as a plasmid DNA vaccine, as a recombinant protein vaccine in adjuvant or as a combined DNA prime-protein boost vaccine. All three vaccination formulations induced cross-reactive humoral and cell-mediated immune responses, although species-specific Th1 type T cell epitopes could be identified in both the NH(2)-terminal region and the COOH-terminal region of the antigens. This partial species-specificity was reflected in a higher albeit not sustained-protective efficacy of the M. ulcerans than of the M. tuberculosis vaccine, particularly when administered using the DNA prime-protein boost protocol.	[Tanghe, Audrey; Huygen, Kris] IPH Pasteur Inst Brussels, Brussels, Belgium; [Dangy, Jean-Pierre; Pluschke, Gerd] Swiss Trop Inst, Dept Mol Immunol, CH-4002 Basel, Switzerland	Tanghe, A (reprint author), IPH Pasteur Inst Brussels, Brussels, Belgium.	khuygen@pasteur.be		Huygen, Kris/0000-0001-7808-0512	Damiaanaktie-Belgium, from FWO-Vlaanderen (Krediet aan Navorsers) [1.5.144.04]; Research Transversal Programme PTR [212]	This work was partially supported by grants from the Damiaanaktie-Belgium, from FWO-Vlaanderen (Krediet aan Navorsers 1.5.144.04), and from Research Transversal Programme PTR 212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; CHAUTY A, 2007, ANTIMICROB AGENTS CH, V25; Coutanceau E, 2005, CELL MICROBIOL, V7, P1187, DOI 10.1111/j.1462-5822.2005.00546.x; Coutanceau E, 2007, J EXP MED, V204, P1395, DOI 10.1084/jem.20070234; Coutanceau E, 2006, MICROBES INFECT, V8, P2075, DOI 10.1016/j.micinf.2006.03.009; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Daniel AK, 2004, INFECT IMMUN, V72, P123, DOI 10.1128/IAI.72.1.123-132.2004; Denis O, 1998, INFECT IMMUN, V66, P1527; Diaz D, 2006, CLIN VACCINE IMMUNOL, V13, P1314, DOI 10.1128/CVI.00254-06; Dobos KM, 2000, EMERG INFECT DIS, V6, P158, DOI 10.3201/eid0602.000208; Duker AA, 2006, ENVIRON INT, V32, P567, DOI 10.1016/j.envint.2006.01.002; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.; FENNER F, 1957, AM REV TUBERC PULM, V76, P76; FENNER F, 1956, AM REV TUBERC PULM, V73, P650; Gartner T, 2007, IMMUNOL LETT, V111, P26, DOI 10.1016/j.imlet.2007.04.010; Gooding TM, 2002, INFECT IMMUN, V70, P5562, DOI 10.1128/IAI.70.10.5562-5567.2002; Gooding TM, 2001, INFECT IMMUN, V69, P1704, DOI 10.1128/IAI.69.3.1704-1707.2001; HUYGEN K, 1992, INFECT IMMUN, V60, P2880; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; HUYGEN K, 1994, INFECT IMMUN, V62, P363; HUYGEN K, 1990, INFECT IMMUN, V58, P2192; Huygen Kris, 2003, Expert Rev Vaccines, V2, P561, DOI 10.1586/14760584.2.4.561; KAUFMANN SHE, 1990, LUNG, V168, P1025, DOI 10.1007/BF02718240; Kiszewski AE, 2006, CLIN EXP IMMUNOL, V143, P445, DOI 10.1111/j.1365-2249.2006.03020.x; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P6296, DOI 10.1128/AEM.70.10.6296-6298.2004; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Miao J, 2006, VACCINE, V24, P6187, DOI 10.1016/j.vaccine.2006.05.099; Moore QC, 2006, VACCINE, V24, P5755, DOI 10.1016/j.vaccine.2006.04.046; Mve-Obiang A, 2005, INFECT IMMUN, V73, P3307, DOI 10.1128/IAI.73.6.3307-3312.2005; Nackers F, 2006, AM J TROP MED HYG, V75, P768, DOI 10.4269/ajtmh.2006.75.768; Okenu DMN, 2004, CLIN DIAGN LAB IMMUN, V11, P387, DOI 10.1128/CDLI.11.2.387-391.2004; Phillips R, 2006, INFECT IMMUN, V74, P2917, DOI 10.1128/IAI.74.5.2917-2924.2006; Portaels F, 2004, INFECT IMMUN, V72, P62, DOI 10.1128/IAI.72.1.62-65.2004; Portaels F, 2002, CLIN DIAGN LAB IMMUN, V9, P1389, DOI 10.1128/CDLI.9.6.1389-1391.2002; Prevot G, 2004, INFECT IMMUN, V72, P958, DOI 10.1128/IAI.72.2.958-965.2004; Ranger BS, 2006, INFECT IMMUN, V74, P6037, DOI 10.1128/IAI.00970-06; Romano M, 2004, J IMMUNOL, V172, P6913, DOI 10.4049/jimmunol.172.11.6913; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Rosseels V, 2006, INFECT IMMUN, V74, P202, DOI 10.1128/IAI.74.1.202-212.2006; Shu Q, 2001, VET RES COMMUN, V25, P43, DOI 10.1023/A:1026757917968; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; SMITH PG, 1976, T ROY SOC TROP MED H, V70, P449, DOI 10.1016/0035-9203(76)90128-0; Snyder DS, 2003, MICROB PATHOGENESIS, V34, P91, DOI 10.1016/S0882-4010(02)00210-3; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Tanghe A, 2001, INFECT IMMUN, V69, P5403, DOI 10.1128/IAI.69.9.5403-5411.2001; Tanghe A, 2001, INFECT IMMUN, V69, P3041, DOI 10.1128/IAI.69.5.3041-3047.2001; Tanghe A, 2007, INFECT IMMUN, V75, P2642, DOI 10.1128/IAI.01622-06; Torrado E, 2007, INFECT IMMUN, V75, P3979, DOI 10.1128/IAI.00290-07; Torrado E, 2007, INFECT IMMUN, V75, P977, DOI 10.1128/IAI.00889-06; *UG BUR GROUP, 1969, LANCET, V1, P111; WHO, 2006, NEGL TROP DIS HIDD S; Yanagisawa S, 1997, INT IMMUNOL, V9, P227, DOI 10.1093/intimm/9.2.227; Yeboah-Manu D, 2006, J LEUKOCYTE BIOL, V79, P1150, DOI 10.1189/jlb.1005581	55	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2008	2	3							e199	10.1371/journal.pntd.0000199				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	385HZ	WOS:000261806600011	18350112	DOAJ Gold, Green Published			2019-04-02	
J	Zachariah, R; Van Engelgem, I; Massaquoi, M; Kocholla, L; Manzi, M; Suleh, A; Phillips, M; Borgdorff, M				Zachariah, R.; Van Engelgem, I.; Massaquoi, M.; Kocholla, L.; Manzi, M.; Suleh, A.; Phillips, M.; Borgdorff, M.			Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						HIV; AIDS; antiretroviral therapy; payment; loss to follow-up; Kenya	SUB-SAHARAN AFRICA; ADHERENCE; EXPERIENCE; COUNTRIES; COHORT	This retrospective analysis of routine programme data from Mbagathi District Hospital, Nairobi, Kenya shows the difference in rates of toss to follow-up between a cohort that paid 500 shillings/month (approximately US$7) for antiretroviral. drugs (ART) and one that received medication free of charge. A total of 435 individuals (mean age 31.5 years, 65% female) was followed-up for 146 person-years: 265 were in the 'payment' cohort and 170 in the 'free' cohort. The incidence rate for Loss to follow-up per 100 person-years was 47.2 and 20.5, respectively (adjusted hazard ratio 2.27, 95% CI 1.21-4.24, P=0.01). Overall risk reduction attributed to offering ART free of charge was 56.6% (95% CI 20.0-76.5). Five patients diluted their ART regimen to one tablet (instead of two tablets) twice daily in order to reduce the monthly cost of medication by half. ALL these patients were from the payment cohort. Payment for ART is associated with a significantly higher rate of toss to follow-up, as some patients might be unable to sustain payment over time. In resource-limited settings, ART should be offered free of charge in order to promote treatment compliance and prevent the emergence of drug resistance. (c) 2007 Royal Society of Tropical. Medicine and Hygiene. Published by Elsevier Ltd. All. rights reserved.	[Zachariah, R.] Med Sans Frontieres, Brussels, Belgium; [Zachariah, R.] Dept Med, L-1617 Luxembourg, Luxembourg; [Van Engelgem, I.; Massaquoi, M.; Manzi, M.] Med Sans Frontieres, Nairobi, Kenya; [Kocholla, L.] Mbagathi Hosp, Minist Hlth, Nairobi, Kenya; [Suleh, A.] Minist Hlth, Nairobi, Kenya; [Phillips, M.] Brussels Operat Ctr, Anal & Advocacy Unit, Med Sans Frontieres, Brussels, Belgium; [Borgdorff, M.] Univ Amsterdam, The Hague, Netherlands; [Borgdorff, M.] KNCV Tuberculosis Fdn, The Hague, Netherlands	Zachariah, R (reprint author), Med Sans Frontieres, Brussels, Belgium.	zachariah@internet.lu					Ardeshir Sepehri, 2001, Journal of International Development, V13, P183, DOI 10.1002/jid.726; BELL C, 2004, MACROECONOMICS HIV A; BISSON GP, 2006, AIDS, V9, P1333; Braitstein P, 2006, LANCET, V367, P817; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Harries AD, 2001, LANCET, V358, P410, DOI 10.1016/S0140-6736(01)05551-9; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Laniece I, 2003, AIDS, V17, pS103, DOI 10.1097/00002030-200317003-00014; Laurent C, 2005, CLIN INFECT DIS, V41, P108, DOI 10.1086/430712; *MOH, 2004, KENY NAT CLIN MAN AR; *MOH, 2004, STRAT PLAN NAT ART P; OOSTERHOUT VJ, 2005, TROP MED INT HEALTH, V10, P464; Remien RH, 2003, AIDS, V17, P786, DOI 10.1097/01.aids.0000060324.12269.73; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; *UNAIDS, 2007, UN WORLD AIDS KENY; *UNDP, 2007, KENY NAT HUM DEV REP; VENTELOU B, 2003, EC AIDS ACCESS HIV A; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; *WHO, 2003, WHOCDSTB2003321; *WHO, 2005, PROGR GLOB ACC HIV I; *WHO, 2005, WHOHIV200511; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; *WORLD BANK, 2006, KEY DEV DATA STAT; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	25	24	24	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAR	2008	102	3					288	293		10.1016/j.trstmh.2007.12.007				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	276RY	WOS:000254161100020	18258272	Green Published			2019-04-02	
J	Affolabi, D; Tanimomo-Kledjo, B; Anyo, G; Johnson, RC; Anagonou, SY; Portaels, F				Affolabi, Dissou; Tanimomo-Kledjo, Blanche; Anyo, Gladys; Johnson, Roch C.; Anagonou, Severin Y.; Portaels, Francoise			Setting up a national reference laboratory for Buruli ulcer: the case of Benin	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Buruli ulcer; reference laboratory; Benin	MYCOBACTERIUM-ULCERANS; DISEASE; DIAGNOSIS; PCR	OBJECTIVE To report the experience of Benin, where Buruli ulcer (BU) is endemic, in the implementation of diagnostic laboratory services. METHODS AND RESULTS There has been a gradual introduction of biologic diagnostic activities for BU comprising (1) training of a laboratory technician in a highly experienced reference laboratory; (2) acquiring indispensable laboratory start-up materials; (3) progressive development of diagnostic laboratory activities; (4) regular external quality assessment with an experienced reference laboratory and (5) decentralization of activities to various clinical diagnostic and treatment centres for BU in Benin. CONCLUSION Setting up a reference laboratory for BU is a continuous process, which necessitates motivated personnel and the cooperation of an experienced external reference laboratory.	[Affolabi, Dissou; Anyo, Gladys; Portaels, Francoise] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Affolabi, Dissou; Tanimomo-Kledjo, Blanche; Anagonou, Severin Y.] Lab Reference Mycobacteries, Cotonou, Benin; [Johnson, Roch C.] Programme Natl Lutte Contre Ulcere Buruli, Cotonou, Benin	Portaels, F (reprint author), Inst Trop Med, Mycobacteriol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	portaels@itg.be					Aguiar J, 1997, Med Trop (Mars), V57, P83; BOUVIER P, 2004, B SEANCES ACAD ROYAL, V50, P251; Debacker M, 2004, EMERG INFECT DIS, V10, P1391, DOI 10.3201/eid1008.030886; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.; JANSSENS PG, 2005, B SEANCES ACAD R SCI, V51, P165; Johnson RC, 2005, EMERG INFECT DIS, V11, P500, DOI 10.3201/eid1103.040597; Phillips R, 2005, J CLIN MICROBIOL, V43, P3650, DOI 10.1128/JCM.43.8.3650-3656.2005; *PHL CDC IUATLD KN, 2002, EXT QUAL ASS AFB SME; Portaels F., 2004, Bulletin des Seances, Academie Royale des Sciences d'Outre- Mer, V50, P271; Portaels F, 2001, BURULI ULCER DIAGNOS; RIEDER HL, 1998, HLTH SERVICE NATL TU; Stienstra Y, 2003, J CLIN MICROBIOL, V41, P794, DOI 10.1128/JCM.41.2.794-797.2003; van der Werf TS, 2005, B WORLD HEALTH ORGAN, V83, P785; *WHO, 2000, MYC ULC INF; World Health Organization, 1999, LAB SERV TUB CONTR 3	15	6	6	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAR	2008	13	3					365	368		10.1111/j.1365-3156.2008.02011.x				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	284VQ	WOS:000254735300009	18397399	Bronze			2019-04-02	
J	Htwe, K; Yee, KS; Tin, M; Vandenplas, Y				Htwe, Khin; Yee, Khin Saw; Tin, Marlar; Vandenplas, Yvan			Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: A randomized controlled study	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							PREVENTION; PROBIOTICS; EFFICACY; TRIAL	This study was conducted to evaluate the efficacy of Saccharomyces boulardii in acute diarrhea. One hundred hospitalized children in Myanmar (age range = 3 months to 10 years) were included. Fifty were treated with S. boulardii for five days in addition to oral rehydration solution (ORS) and 50 were given ORS alone (control group) in an alternating order. The mean duration of diarrhea was 3.08 days in the S. boulardii group and 4.68 days (P < 0.05) in the control group. Stools had a normal consistency on day 3 in 38 (76%) of 50 patients in the S. boulardii group compared with only 12 (24%) of 50 in the control group (P = 0.019). On day 2, 27 (54%) of 50 had less than three stools per day in the S. boulardii group compared with only 15 (30%) of 50 in the control group (P = 0.019). Saccharomyces boulardii shortens the duration of diarrhea and normalizes stool consistency and frequency. The shortening of the duration of diarrhea results in a social and economic benefits.	[Vandenplas, Yvan] Univ Ziekenhuis Brussel Kinderen, B-1090 Brussels, Belgium; [Htwe, Khin; Yee, Khin Saw; Tin, Marlar] Univ Med, N Okkalapa Gen Hosp, Dept Child Hlth, Yangon, Myanmar	Vandenplas, Y (reprint author), Univ Ziekenhuis Brussel Kinderen, Laarbeeklaan 101, B-1090 Brussels, Belgium.	yvan.vandenplas@uzbrussel.be					Besirbellioglu BA, 2006, SCAND J INFECT DIS, V38, P479, DOI 10.1080/00365540600561769; BHAN MK, 2005, TREATMENT DIARRHEA M, P8; Billoo AG, 2006, WORLD J GASTROENTERO, V12, P4557, DOI 10.3748/wjg.v12.i28.4557; Bleichner G, 1997, INTENS CARE MED, V23, P517, DOI 10.1007/s001340050367; BUTS JP, 1993, J PEDIATR GASTR NUTR, V16, P419, DOI 10.1097/00005176-199305000-00013; BUTS JP, 2006, EXAMPLE MED PROBIOTI, P221; Castaneda Guillot C, 1995, REV MEX PUERICULTURA, V2, P12; CETINASAURI G, 1994, ANN PEDIATR-PARIS, V41, P397; HOCHTER W, 1990, MUNCHEN MED WOCHEN, V132, P188; Kollaritsch H, 1993, Fortschr Med, V111, P152; Kurugol Z, 2005, ACTA PAEDIATR, V94, P44, DOI 10.1080/08035250410022521; Mansour-Ghanaei F, 2003, WORLD J GASTROENTERO, V9, P1832, DOI 10.3748/wjg.v9.i8.1832; NYEIN TMM, 1992, MYANMAR HLTH SCI RES, V4, P45; NYEIN TMM, 1999, MYANM RES C JAN, V8, P7; SAINTMARC T, 1995, SEM HOP PARIS, V71, P735; Salvatore S, 2007, NUTRITION, V23, P498, DOI 10.1016/j.nut.2007.03.008; SURAWICZ CM, 1989, GASTROENTEROLOGY, V96, P981, DOI 10.1016/0016-5085(89)91613-2; SZAJEWSKA H, 2007, ALIMENT PHARM, V25, P287; Vandenplas Y, 2007, EUR J PEDIATR, V166, P1211, DOI 10.1007/s00431-007-0497-9; Villarruel G, 2007, ACTA PAEDIATR, V96, P538, DOI 10.1111/j.1651-2227.2007.00191.x	20	52	57	3	7	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	FEB	2008	78	2					214	216		10.4269/ajtmh.2008.78.214				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	259VP	WOS:000252969300010	18256417				2019-04-02	
J	Hung, CC; Ji, DD; Sun, HY; Lee, YT; Hsu, SY; Chang, SY; Wu, CH; Chan, YH; Hsiao, CF; Liu, WC; Colebunders, R				Hung, Chien-Ching; Ji, Dar-Der; Sun, Hsin-Yun; Lee, Ya-Tien; Hsu, Shui-Yuan; Chang, Sui-Yuan; Wu, Cheng-Hsin; Chan, Yun-Hsien; Hsiao, Chin-Fu; Liu, Wen-Chun; Colebunders, Robert			Increased Risk for Entamoeba histolytica Infection and Invasive Amebiasis in HIV Seropositive Men Who Have Sex with Men in Taiwan	PLOS NEGLECTED TROPICAL DISEASES			English	Article; Proceedings Paper	44th Annual Meeting of the Infectious-Diseases-Society-of-America	OCT 12-15, 2006	Toronto, CANADA	Infect Dis Soc Amer			HUMAN-IMMUNODEFICIENCY-VIRUS; INTESTINAL PARASITIC INFECTIONS; HOMOSEXUAL MEN; LIVER-ABSCESS; AIDS; DISEASE; PREVALENCE; JAPAN; AREA; TRANSMISSION	Background: Incidence of Entamoeba histolytica infection and clinical manifestations and treatment response of invasive amebiasis (IA) in HIV-infected patients have rarely been investigated before. Methodology/Principal Findings: At the National Taiwan University Hospital, medical records of HIV-infected patients who received a diagnosis of IA between 1994 and 2005 were reviewed. The incidence of amebiasis was investigated in serial blood and stool samples from 670 and 264 HIV-infected patients, respectively, using serological and specific amebic antigen assays. DNA extracted from stool samples containing E. histolytica were analyzed by PCR, sequenced, and compared. Sixty-four (5.8%) of 1,109 HIV-infected patients had 67 episodes of IA, and 89.1% of them were men having sex with men (MSM). The CD4 count at diagnosis of IA was significantly higher than that of the whole cohort (215 cells/mu L vs. 96 cells/mu L). Forty episodes (59.7%) were liver abscesses, 52 (77.6%) colitis, and 25 (37.3%) both liver abscesses and colitis. Fever resolved after 3.5 days of metronidazole therapy (range, 1-11 days). None of the patients died. The incidence of E. histolytica infection in MSM was higher than that in other risk groups assessed by serological assays (1.99 per 100 person-years [PY] vs. 0 per 100 PY; p < 0.0001) and amebic antigen assays (3.16 per 100 PY vs. 0.68 per 100 PY; p = 0.12). In multiple logistic regression analysis, only MSM was significantly associated with acquisition of E. histolytica infection (adjusted odds ratio, 14.809; p = 0.01). Clustering of E. histolytica isolates by sequencing analyses from geographically-unrelated patients suggested person-to-person transmission. Conclusions/Significance: HIV-infected MSM were at significantly higher risk of amebiasis than patients from other risk groups. Despite immunosuppression, amebic liver abscesses and colitis responded favorably to treatment.	[Hung, Chien-Ching; Sun, Hsin-Yun; Wu, Cheng-Hsin; Liu, Wen-Chun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium; [Chang, Sui-Yuan] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Ji, Dar-Der; Lee, Ya-Tien; Hsu, Shui-Yuan; Chan, Yun-Hsien] Ctr Dis Control, Res & Diagnost Ctr, Dept Hlth, Taipei, Taiwan; [Hsiao, Chin-Fu] Natl Hlth Res Inst, Div Biostat & Bioinformat, Zhunan Town, Taiwan; [Colebunders, Robert] Inst Trop Med, B-2000 Antwerp, Belgium	Hung, CC (reprint author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	bcoleb@itg.be	Hsiao, Chin-Fu/E-3993-2010	CHANG, SUI-YUAN/0000-0002-6009-6724; Hung, Chien-Ching/0000-0001-7345-0836; Hsiao, Chin-Fu/0000-0003-1284-7260; SUN, HSIN-YUN/0000-0003-0074-7721			ACETI A, 1987, NEW ENGL J MED, V316, P692; Ali IKM, 2005, J CLIN MICROBIOL, V43, P5842, DOI 10.1128/JCM.43.12.5842-5847.2005; ALLASONJONES E, 1986, NEW ENGL J MED, V315, P353, DOI 10.1056/NEJM198608073150603; BLANSHARD C, 1992, AIDS, V6, P1043, DOI 10.1097/00002030-199209000-00023; CDC (Centers for Disease Control and Prevention), 1992, MMWR-MORBID MORTAL W, V41, P1; Fatkenheuer G, 1997, J CLIN MICROBIOL, V35, P2168; Fontanet AL, 2000, ANN TROP MED PARASIT, V94, P269, DOI 10.1080/00034980050006456; GATHIRAM V, 1987, S AFR MED J, V72, P669; Germani Y, 1998, AM J TROP MED HYG, V59, P1008, DOI 10.4269/ajtmh.1998.59.1008; Haghighi A, 2002, J CLIN MICROBIOL, V40, P4081, DOI 10.1128/JCM.40.11.4081-4090.2002; Hailemariam G, 2004, JPN J INFECT DIS, V57, P41; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; Hung CC, 2005, ARCH INTERN MED, V165, P409, DOI 10.1001/archinte.165.4.409; Hung CC, 1999, AIDS, V13, P2421, DOI 10.1097/00002030-199912030-00014; KEYSTONE JS, 1980, CAN MED ASSOC J, V123, P512; Ko NY, 2006, SEX TRANSM DIS, V33, P467, DOI 10.1097/01.olq.0000204512.15297.5f; Liu CJ, 2001, J CLIN GASTROENTEROL, V33, P64, DOI 10.1097/00004836-200107000-00016; Lowther SA, 2000, CLIN INFECT DIS, V30, P955, DOI 10.1086/313811; LUCAS SB, 1990, T ROY SOC TROP MED H, V84, P34, DOI 10.1016/0035-9203(90)90453-L; Mohandas K, 2002, JPN J INFECT DIS, V55, P83; MORALES MAG, 1995, TROP MED PARASITOL, V46, P109; Moran P, 2005, AM J TROP MED HYG, V73, P296, DOI 10.4269/ajtmh.2005.73.296; Nozaki T, 2006, ARCH MED RES, V37, P277, DOI 10.1016/j.arcmed.2005.09.010; Ohnishi K, 1997, EPIDEMIOL INFECT, V119, P363, DOI 10.1017/S0950268897008236; Ohnishi K, 2004, EPIDEMIOL INFECT, V132, P57, DOI 10.1017/S0950268803001389; Park WB, 2007, EMERG INFECT DIS, V13, P516, DOI 10.3201/eid1303.060894; PHILLIPS SC, 1981, NEW ENGL J MED, V305, P603, DOI 10.1056/NEJM198109103051102; QUINN TC, 1983, NEW ENGL J MED, V309, P576, DOI 10.1056/NEJM198309083091002; REED SL, 1991, AM J MED, V90, P269; Sadraei J, 2005, PARASITOL RES, V97, P270, DOI 10.1007/s00436-005-1422-7; Senya C, 2003, INT J STD AIDS, V14, P411, DOI 10.1258/095646203765371312; SMITH PD, 1988, ANN INTERN MED, V108, P328, DOI 10.7326/0003-4819-108-3-328; SORVILLO FJ, 1986, AM J PUBLIC HEALTH, V76, P1137, DOI 10.2105/AJPH.76.9.1137; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Stark DJ, 2006, MED J AUSTRALIA, V185, P417; TAKEUCHI T, 1989, J INFECT DIS, V159, P808, DOI 10.1093/infdis/159.4.808; TAKEUCHI T, 1987, AM J TROP MED HYG, V36, P321, DOI 10.4269/ajtmh.1987.36.321; TAKEUCHI T, 1980, T R SOC TROP MED HYG, V84, P250; Tanyuksel M, 2003, CLIN MICROBIOL REV, V16, P713, DOI 10.1128/CMR.16.4.713-729.2003; Tsai JJ, 2006, AM J TROP MED HYG, V74, P1016, DOI 10.4269/ajtmh.2006.74.1016; Waywa D, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P151; Weber R, 1999, ARCH INTERN MED, V159, P1473, DOI 10.1001/archinte.159.13.1473; Zaki M, 2001, J CLIN MICROBIOL, V39, P897, DOI 10.1128/JCM.39.3.897-905.2001	43	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2008	2	2							e175	10.1371/journal.pntd.0000175				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	385HY	WOS:000261806500004	18301730	DOAJ Gold, Green Published			2019-04-02	
J	ten Hove, RJ; Verweij, JJ; Vereecken, K; Polman, K; Dieye, L; van Lieshout, L				ten Hove, Robert J.; Verweij, Jaco J.; Vereecken, Kim; Polman, Katja; Dieye, Lamin; van Lieshout, Lisette			Multiplex real-time PCR for the detection and quantification of Schistosoma mansoni and S-haematobium infection in stool samples collected in northern Senegal	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Schistosomiasis; Schistosoma mansoni; Schistosoma haematobium; diagnosis; microscopy; real-time PCR	POLYMERASE-CHAIN-REACTION; FECAL SAMPLES; URINE SAMPLES; DNA; AMPLIFICATION	A multiplex real-time PCR assay for the detection and quantification of Schistosoma mansoni and S. hoematobium DNA in faecal samples was developed and evaluated as an alternative diagnostic method to study the epidemiology of schistosomiasis. Primers and probes targeting the cytochrome c oxidase gene were designed for species-specific amplification and were combined with an internal control. Using positive control DNA extracted from adult Schistosoma worms and negative control samples (n = 150) with DNA from a wide range of intestinal microorganisms, the method proved to be sensitive and 100% specific. For further evaluation, duplicate stool specimens with varying S. mansoni egg toads were collected in northern Senegal from pre-selected individuals (n = 88). The PCR cycle threshold values, reflecting parasite-specific DNA toads in faeces, showed significant correlation with microscopic egg counts both for S. mansoni in stool and S. haematobium in urine. The Schistosoma detection rate of PCR (84.1%) was similar to that of microscopy performed on duplicate stool samples (79.5%). The simple faecal sample collection procedure and the high throughput potential of the multiplex real-time PCR provide a powerful diagnostic too[ for epidemiological studies on schistosomiasis in remote areas, with possibilities for extension to other helminths or protozoa using additional molecular targets. (c) 2007 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[ten Hove, Robert J.; Verweij, Jaco J.; van Lieshout, Lisette] Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands; [Vereecken, Kim; Polman, Katja] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Dieye, Lamin] Ctr Sante Richard Toll, Richard Toll, Senegal	ten Hove, RJ (reprint author), Leiden Univ, Med Ctr, Dept Parasitol, POB 9600, NL-2300 RC Leiden, Netherlands.	r.ten_hove@lumc.nt					AZAR J. E., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P562, DOI 10.1016/0035-9203(58)90105-6; De Clercq D, 1999, TROP MED INT HEALTH, V4, P544; Gomes ALD, 2006, MEM I OSWALDO CRUZ, V101, P133, DOI 10.1590/S0074-02762006000900021; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; FELDMEIER H, 1993, ACTA TROP, V52, P205, DOI 10.1016/0001-706X(93)90009-Z; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Le TH, 2000, INT J PARASITOL, V30, P283, DOI 10.1016/S0020-7519(99)00204-0; Morgan JAT, 2005, MOL ECOL, V14, P3889, DOI 10.1111/j.1365-294X.2005.02709.x; NIESTERS HG, 2002, J CLIN VIROL S3, V25, P3; PETERS PA, 1976, B WORLD HEALTH ORGAN, V54, P159; Pontes LA, 2003, AM J TROP MED HYG, V68, P652, DOI 10.4269/ajtmh.2003.68.652; Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157; Sandoval N, 2006, PARASITOLOGY, V133, P581, DOI 10.1017/S0031182006000898; ten Hove R, 2007, CLIN MICROBIOL INFEC, V13, P1001, DOI 10.1111/j.1469-0691.2007.01788.x; van Dam GJ, 2004, J CLIN MICROBIOL, V42, P5458, DOI 10.1128/JCM.42.12.5458-5461.2004; Verweij JJ, 2007, DIAGN MICR INFEC DIS, V57, P163, DOI 10.1016/j.diagmicrobio.2006.08.009; Verweij JJ, 2001, TROP MED INT HEALTH, V6, P726, DOI 10.1046/j.1365-3156.2001.00770.x; Verweij JJ, 2004, J CLIN MICROBIOL, V42, P1220, DOI 10.1128/JCM.42.3.1220-1223.2004; VERWEIJ JJ, 2007, AM J TROP MED HYG, V77, P689	21	107	111	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	FEB	2008	102	2					179	185		10.1016/j.trstmh.2007.10.011				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	269LK	WOS:000253650300014	18177680				2019-04-02	
J	Jacobs, B; Bigdeli, M; van Pelt, M; Ir, P; Salze, C; Criel, B				Jacobs, Bart; Bigdeli, Maryam; van Pelt, Maurits; Ir, Por; Salze, Cedric; Criel, Bart			Bridging community-based health insurance and social protection for health care - a step in the direction of universal coverage?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						health care; community-based health insurance; social protection; universal coverage	LOW-INCOME; IMPROVING ACCESS; HOSPITAL-CARE; MIDDLE-INCOME; COUNTRIES; CAMBODIA; AFRICA; SYSTEM; PERFORMANCE; HOUSEHOLDS		[Ir, Por; Criel, Bart] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Jacobs, Bart] Swiss Red Cross, Phnom Penh, Cambodia; [Bigdeli, Maryam] World Hlth Org, Phnom Penh, Cambodia; [van Pelt, Maurits] MoPoTsyo Patient Informat Ctr, Phnom Penh, Cambodia; [Salze, Cedric] Grp Rech Echanges Technol, Phnom Penh, Cambodia	Criel, B (reprint author), Inst Trop Med, Dept Publ Hlth, 155 Natl Str, B-2000 Antwerp, Belgium.	bcriel@itg.be					Atim C, 1999, SOC SCI MED, V48, P881, DOI 10.1016/S0277-9536(98)00390-6; Barnighausen T, 2002, SOC SCI MED, V54, P1559, DOI 10.1016/S0277-9536(01)00137-X; Bennett S, 2004, HEALTH POLICY PLANN, V19, P147, DOI 10.1093/heapol/czh018; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Carrin G, 2005, TROP MED INT HEALTH, V10, P799, DOI 10.1111/j.1365-3156.2005.01455.x; Criel B, 1997, TROP MED INT HEALTH, V2, P654, DOI 10.1046/j.1365-3156.1997.d01-349.x; Criel B, 2003, SOC SCI MED, V57, P1205, DOI 10.1016/S0277-9536(02)00495-1; CRIEL B, 2006, POGODA BASED COMMUNI; Foster G, 2007, AIDS CARE, V19, pS54, DOI 10.1080/09540120601114469; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Hardeman W, 2004, HEALTH POLICY PLANN, V19, P22, DOI 10.1093/heapol/czh003; Holzmann R., 2000, 6 WORLD BANK; International Labour Organisation, 2002, EXT SOC PROT HLTH CO; Jacobs B, 2006, HEALTH POLICY PLANN, V21, P27, DOI 10.1093/heapol/czj001; Jacobs B, 2007, TROP MED INT HEALTH, V12, P1391, DOI 10.1111/j.1365-3156.2007.01926.x; Jakab M., 2001, COMMUNITY INVOLVEMEN; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Meessen B, 2003, TROP MED INT HEALTH, V8, P581, DOI 10.1046/j.1365-3156.2003.01081.x; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; Ndiaye P, 2007, TROP MED INT HEALTH, V12, P157, DOI 10.1111/j.1365-3156.2007.01814.x; Noirhomme M, 2007, HEALTH POLICY PLANN, V22, P246, DOI 10.1093/heapol/czm015; Palmer N, 2004, LANCET, V364, P1365, DOI 10.1016/S0140-6736(04)17195-X; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; VANGINNEKEN W, 2002, 13 EES INT LAB OFF; WAELKENS MP, 2004, ENS C INT ORG NOU MA	25	17	17	1	12	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2008	13	2					140	143		10.1111/j.1365-3156.2007.01983.x				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	281GM	WOS:000254484900001	18304258				2019-04-02	
J	Wordemann, M; Diaz, RJ; Heredia, LM; Madurga, AMC; Espinosa, AR; Prado, RC; Milian, IA; Escobedo, A; Rivero, LR; Gryseels, B; Gorbea, MB; Polman, K				Wordemann, Meike; Diaz, Raquel Junco; Heredia, Lenina Menocal; Madurga, Ana Maria Collado; Espinosa, Aniran Ruiz; Prado, Raul Cordovi; Milian, Irai Atencio; Escobedo, Angel; Rivero, Lazara Rojas; Gryseels, Bruno; Gorbea, Mariano Bonet; Polman, Katja			Association of atopy, asthma, allergic rhinoconjunctivitis, atopic dermatitis and intestinal helminth infections in Cuban children	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						allergic rhinoconjunctivitis; asthma; atopic dermatitis; atopy; helminth infections	GEOHELMINTH PARASITES; NEGATIVE ASSOCIATION; WORLDWIDE VARIATIONS; HYGIENE HYPOTHESIS; CHILDHOOD ASTHMA; SCHOOL-CHILDREN; RISK-FACTORS; RURAL AREA; PREVALENCE; SYMPTOMS	OBJECTIVE To examine the relationship of past and current intestinal helminth infections with asthma, allergic rhinoconjunctivitis, atopic dermatitis and atopy. METHODS Cross-sectional study of 1320 children aged 4-14 years from two Cuban municipalities. Helminth infections were determined by stool examination and parental questionnaire. Asthma, rhinoconjunctivitis and atopic dermatitis were diagnosed by International Study of Asthma and Allergies in Childhood questionnaire, asthma additionally by spirometry, atopy by skin prick testing. RESULTS Questionnaire-based frequencies were 21% for asthma, 14% for allergic rhinoconjunctivitis and 8% for atopic dermatitis. According to spirometry, 4% had asthma; 20% had a positive skin prick test. A history of infection for Enterobius vermicularis was associated with increased risk of atopic dermatitis (OR 1.88, P = 0.001) and allergic rhinoconjunctivitis (OR 1.34, P = 0.046), and hookworm with increased risk of allergic rhinoconjunctivitis (OR 2.77, P = 0.021). A positive stool examination for Ascaris lumbricoides infection was negatively associated with atopic dermatitis (OR 0.22, P = 0.007). Asthma and atopy were unrelated to helminth infections. CONCLUSION Current A. lumbricoides infection protects against atopic dermatitis in Cuban children, while past infection with E. vermicularis and hookworm are risk factors for allergic rhinoconjunctivitis and/or atopic dermatitis. Apparently, interactions differ depending on the type of helminth and atopic disease and on the time of helminth infestation.	[Wordemann, Meike; Gryseels, Bruno; Polman, Katja] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Diaz, Raquel Junco; Heredia, Lenina Menocal; Madurga, Ana Maria Collado; Gorbea, Mariano Bonet] Natl Inst Hyg Epidemiol & Microbiol, Havana, Cuba; [Espinosa, Aniran Ruiz; Prado, Raul Cordovi; Milian, Irai Atencio; Rivero, Lazara Rojas] Inst Pedro Kouri, Havana, Cuba; [Escobedo, Angel] Pediat Hosp Pedro Borras, Havana, Cuba	Wordemann, M (reprint author), Inst Trop Med, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	mwoerdemann@itg.be					[Anonymous], 1987, AM REV RESPIR DIS, V136, P1285; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bufford JD, 2005, IMMUNOL ALLERGY CLIN, V25, P247, DOI 10.1016/j.iac.2005.03.005; Cooper PJ, 2006, LANCET, V367, P1598, DOI 10.1016/S0140-6736(06)68697-2; Cooper PJ, 2003, J ALLERGY CLIN IMMUN, V111, P995, DOI 10.1067/mai.2003.1348; Cooper PJ, 2004, CLIN EXP ALLERGY, V34, P845, DOI 10.1111/j.1365-2222.2004.01958.x; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Dagoye D, 2003, AM J RESP CRIT CARE, V167, P1369, DOI 10.1164/rccm.200210-1204OC; Davey G, 2005, CLIN EXP ALLERGY, V35, P301, DOI 10.1111/j.1365-2222.2005.02181.x; Demissie K, 1998, ANN EPIDEMIOL, V8, P201, DOI 10.1016/S1047-2797(97)00168-3; Escobedo AA, 2007, TROP DOCT, V37, P236, DOI 10.1258/004947507782332991; Gruchalla RS, 2003, ANN ALLERG ASTHMA IM, V90, P491, DOI 10.1016/S1081-1206(10)61842-X; Hart AL, 2002, ALIMENT PHARM THERAP, V16, P1383, DOI 10.1046/j.1365-2036.2002.01310.x; Huang SL, 2002, CLIN EXP ALLERGY, V32, P1029, DOI 10.1046/j.1365-2745.2002.01424.x; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; KNUDSON RJ, 1976, AM REV RESPIR DIS, V113, P587; Lau S, 2006, LANCET, V367, P1556, DOI 10.1016/S0140-6736(06)68670-4; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Nordenstedt H, 2006, CHEST, V129, P1051, DOI 10.1378/chest.129.4.1051; Nyan OA, 2001, CLIN EXP ALLERGY, V31, P1672, DOI 10.1046/j.1365-2222.2001.00987.x; Palmer LJ, 2002, AM J RESP CRIT CARE, V165, P1489, DOI 10.1164/rccm.2107020; Remes ST, 2002, THORAX, V57, P120, DOI 10.1136/thorax.57.2.120; Schafer T, 2005, ALLERGY, V60, P1014, DOI 10.1111/j.1398-9995.2005.00801.x; Scrivener S, 2001, LANCET, V358, P1493, DOI 10.1016/S0140-6736(01)06579-5; Sharghi N, 2001, CLIN INFECT DIS, V32, P111; Strachan DP, 1997, PEDIAT ALLERG IMM-UK, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Tsibouris P, 2005, DIGEST DIS SCI, V50, P2389, DOI 10.1007/s10620-005-3069-8; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Wordemann M, 2006, TROP MED INT HEALTH, V11, P1813, DOI 10.1111/j.1365-3156.2006.01745.x; Wordemann M, 2006, ALLERGY, V61, P1125, DOI 10.1111/j.1398-9995.2006.01129.x	32	39	43	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2008	13	2					180	186		10.1111/j.1365-3156.2007.01988.x				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	281GM	WOS:000254484900006	18304263	Bronze			2019-04-02	
J	Affolabi, D; Bankole, H; Ablordey, A; Hounnouga, J; Koutchakpo, P; Sopoh, G; Aguiar, J; Dossou, A; Johnson, RC; Anagonou, S; Portaels, F				Affolabi, Dissou; Bankole, Honore; Ablordey, Anthony; Hounnouga, Julie; Koutchakpo, Pierre; Sopoh, Ghislain; Aguiar, Julia; Dossou, Ange; Johnson, Roch Christian; Anagonou, Severin; Portaels, Francoise			Effects of grinding surgical tissue specimens and smear staining methods on Buruli ulcer microscopic diagnosis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Buruli ulcer; smear; staining; tissue	MYCOBACTERIUM-ULCERANS; TUBERCULOSIS; EVOLUTION; DISEASE; MARINUM	To optimize Buruli ulcer (BU) microscopic diagnosis, we compared two smear preparation methods from tissue specimens: smears made with tissue suspension after grinding and smears made directly with unground tissue. We also compared two smear staining methods: auramine and Ziehl-Neelsen (ZN). IS 2404-PCR was used as reference method. One hundred and thirty-one surgical tissue specimens from patients suspected of having BU were analyzed. Both smear preparation methods and both staining methods were equivalent in any combination. Thus we recommend ZN stained smears of unground tissue for peripheral treatment centres.	[Affolabi, Dissou; Anagonou, Severin] Lab Reference Mycobacteries, Cotonou, Benin; [Affolabi, Dissou; Ablordey, Anthony; Portaels, Francoise] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Ablordey, Anthony] Noguchi Mem Inst Med Res, Legon, Ghana; [Johnson, Roch Christian] Programme Natl Lutte Ulcere Buruli, Cotonou, Benin	Portaels, F (reprint author), Inst Trop Med Prince Leopold, Mycobacteriol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	portaels@itg.be		SOPOH, Ghislain Emmanuel/0000-0003-1237-1047			Bretzel G, 2007, TROP MED INT HEALTH, V12, P89, DOI 10.1111/j.1365-3156.2006.01761.x; Chemlal K, 2002, J CLIN MICROBIOL, V40, P2370, DOI 10.1128/JCM.40.7.2370-2380.2002; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376; Guimaraes-Peres A, 1999, J CLIN MICROBIOL, V37, P206; Kent PT, 1985, PUBLIC HLTH MYCOBACT; N'Guessan K, 2001, B SOC PATHOL EXOT, V94, P9; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Shinnick Thomas M., 2005, Morbidity and Mortality Weekly Report, V54, P1; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; van der Werf TS, 2005, B WORLD HEALTH ORGAN, V83, P785; *WHO, 2001, WHOCDSCPEGBUI20014; World Health Organization, 1998, WHOTB98258; Yip MJ, 2007, J BACTERIOL, V189, P2021, DOI 10.1128/JB.01442-06	13	9	9	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2008	13	2					187	190		10.1111/j.1365-3156.2007.01989.x				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	281GM	WOS:000254484900007	18304264				2019-04-02	
J	Tinto, H; Guekoun, L; Zongo, I; Guiguemde, RT; D'Alessandro, U; Ouedraogo, JB				Tinto, Halidou; Guekoun, Lougue; Zongo, Issaka; Guiguemde, Robert Tinga; D'Alessandro, Umberto; Ouedraogo, Jean Bosco			Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-I Y86) and amodiaquine resistance in Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						malaria; Plasmodium falciparum; drug resistance; amodiaquine; Pfcrt; Pfmdr-1	PLASMODIUM-FALCIPARUM; MALARIA; VIVO; TRANSPORTER; MUTATIONS; GENES; SULFADOXINE/PYRIMETHAMINE; PYRIMETHAMINE; POLYMORPHISMS; SURVEILLANCE	We investigated the relationship between the two main molecular markers for chloroquine resistance (Pfcrt T76 and Pfmdr-1 Y86) and the clinical efficacy of amodiaquine in Burkina Faso. Before treatment, the prevalence of Pfcrt T76, Pfmdr-1 Y86 or both mutations in the same infection was significantly higher in patients who experienced a recrudescence than in those who successfully responded to the treatment. Therefore, these two molecular markers could be useful in monitoring amodiaquine resistance, particularly in countries where this drug is used in combination with artesunate as first- or second-line treatment.	[Tinto, Halidou; Zongo, Issaka; Ouedraogo, Jean Bosco] IRSS, Bobo Dioulasso, Burkina Faso; [Tinto, Halidou; Guekoun, Lougue; Guiguemde, Robert Tinga; Ouedraogo, Jean Bosco] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium		tintohalidou@yahoo.fr	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Tinto, Halidou/0000-0002-0472-3586			Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Djimde A, 2001, LANCET, V358, P890, DOI 10.1016/S0140-6736(01)06040-8; Dokomajilar C, 2006, AM J TROP MED HYG, V75, P162, DOI 10.4269/ajtmh.2006.75.162; Dorsey G, 2001, J INFECT DIS, V183, P1417, DOI 10.1086/319865; Gonzalez IJ, 2003, T ROY SOC TROP MED H, V97, P318, DOI 10.1016/S0035-9203(03)90160-X; Gorissen E, 2000, TROP MED INT HEALTH, V5, P459, DOI 10.1046/j.1365-3156.2000.00570.x; Happi CT, 2006, AM J TROP MED HYG, V75, P155, DOI 10.4269/ajtmh.2006.75.155; Holmgren G, 2006, INFECT GENET EVOL, V6, P309, DOI 10.1016/j.meegid.2005.09.001; Ochong EO, 2003, AM J TROP MED HYG, V69, P184, DOI 10.4269/ajtmh.2003.69.184; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Ranford-Cartwright LC, 1997, T ROY SOC TROP MED H, V91, P719, DOI 10.1016/S0035-9203(97)90539-3; Staedke SG, 2001, LANCET, V358, P368, DOI 10.1016/S0140-6736(01)05557-X; Tinto H, 2006, T ROY SOC TROP MED H, V100, P509, DOI 10.1016/j.trstmh.2005.09.018; Tinto H, 2005, AM J TROP MED HYG, V73, P171, DOI 10.4269/ajtmh.2005.73.171; Tinto H, 2003, INFECT GENET EVOL, V3, P287, DOI 10.1016/j.meegid.2003.08.002; WHO, 2003, ASS MON ANT DRUG EFF	16	21	22	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2008	13	2					238	240		10.1111/j.1365-3156.2007.01995.x				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	281GM	WOS:000254484900013	18304270	Bronze			2019-04-02	
J	Robays, J; Raguenaud, ME; Josenando, T; Boelaert, M				Robays, J.; Raguenaud, M. E.; Josenando, T.; Boelaert, M.			Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						human African trypanosomiasis; Trypanosoma brucei gambiense; eflornithine; melarsoprol; cost-effectiveness	MILLENNIUM DEVELOPMENT GOALS; GAMBIENSE SLEEPING SICKNESS; T-B.-GAMBIENSE; LATE-STAGE; DEVELOPING-COUNTRIES; BRUCEI-GAMBIENSE; RISK-FACTORS; UGANDA; TRIAL; STRATEGIES	OBJECTIvE To compare the cost-effectiveness of eflornithine and melarsoprol in the treatment of human African trypanosomiasis. METHOD We used data from a Medecins Sans Frontieres treatment project in Caxito, Angola to do a formal cost-effectiveness analysis, comparing the efficiency of an eflornithine-based approach with melarsoprol. Endpoints calculated were: cost per death avoided; incremental cost per additional life saved; cost per years of life lost (YLL) averted; incremental cost per YLL averted. Sensitivity analysis was done for all parameters for which uncertainty existed over the plausible range. We did an analysis with and without cost of trypanocidal drugs included. RESULTS Effectiveness was 9S.6% for melarsoprol and 98.7% for eflornithine. Cost/patient was 504.6 for melarsoprol and 5S2.3 for eflornithine, cost per life saved was 527.5 USD for melarsoprol and S59.8 USD for eflornithine without cost of trypanocidal drugs but it increases to 600.4 USD and 844.6 USD per patient saved and 627.6 USD and 856.1 USD per life saved when cost of trypanocidal drugs are included. Incremental cost-effectiveness ratio is 1596 USD per additional life saved and 58 USD per additional life year saved in the baseline scenario without cost of trypanocidal drugs but it increases to 8169 USD per additional life saved and 299 USD per additional life year saved if costs of trypanocidal drugs are included. CONCLUSION Eflornithine saves more lives than melarsoprol, but melarsoprol is slightly more cost-effective. Switching from melarsoprol to eflornithine can be considered as a cost-effective option according to the WHO choice criteria.	[Robays, J.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Raguenaud, M. E.] Med San Frontieres, Brussels, Belgium; [Josenando, T.] HAT Natl Program ICCT, Luanda, Angola	Boelaert, M (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	mboelaert@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776			Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Blum J, 2001, TROP MED INT HEALTH, V6, P390, DOI 10.1046/j.1365-3156.2001.00710.x; Burri C, 2000, LANCET, V355, P1419, DOI 10.1016/S0140-6736(00)02141-3; Burri C, 2003, PARASITOL RES, V90, pS49, DOI 10.1007/s00436-002-0766-5; Chappuis F, 2005, CLIN INFECT DIS, V41, P748, DOI 10.1086/432576; Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; Evans DB, 2005, BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Legros D, 1999, B SOC PATHOL EXOT, V92, P171; Louis F J, 2003, Med Trop (Mars), V63, P559; Lutumba P, 2005, EMERG INFECT DIS, V11, P1382; Matovu E, 2001, TROP MED INT HEALTH, V6, P407, DOI 10.1046/j.1365-3156.2001.00712.x; Murray CJ, 1996, GLOBAL BURDEN DIS, V1; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; PEPIN J, 1989, LANCET, V1, P1246, DOI 10.1016/S0140-6736(89)92340-4; PEPIN J, 1994, T ROY SOC TROP MED H, V88, P447, DOI 10.1016/0035-9203(94)90430-8; Pepin J, 2000, B WORLD HEALTH ORGAN, V78, P1284; POLITI C, 1995, HEALTH ECON, V4, P273, DOI 10.1002/hec.4730040404; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Robays J, 2007, TROP MED INT HEALTH, V12, P290, DOI 10.1111/j.1365-3165.2006.01768.x; Schmid C, 2005, J INFECT DIS, V191, P1922, DOI 10.1086/429929; Schmid C, 2004, LANCET, V364, P789, DOI 10.1016/S0140-6736(04)16940-7; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x	24	13	13	0	5	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2008	13	2					265	271		10.1111/j.1365-3156.2007.01999.x				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	281GM	WOS:000254484900017	18304274	Bronze			2019-04-02	
J	Thang, ND; Erhart, A; Speybroeck, N; Hung, LX; Thuan, LK; Hung, CT; Van Ky, P; Coosemans, M; D'Alessandro, U				Thang, Ngo Duc; Erhart, Annette; Speybroeck, Niko; Hung, Le Xuan; Thuan, Le Khanh; Hung, Cong Trinh; Van Ky, Pham; Coosemans, Marc; D'Alessandro, Umberto			Malaria in central Vietnam: analysis of risk factors by multivariate analysis and classification tree models	MALARIA JOURNAL			English	Article							SOUTHEAST-ASIA; FOREST MALARIA; CHALLENGE; INDIA; AREAS; NETS	Background: In Central Vietnam, forest malaria remains difficult to control due to the complex interactions between human, vector and environmental factors. Methods: Prior to a community-based intervention to assess the efficacy of long-lasting insecticidal hammocks, a complete census ( 18,646 individuals) and a baseline cross-sectional survey for determining malaria prevalence and related risk factors were carried out. Multivariate analysis using survey logistic regression was combined to a classification tree model ( CART) to better define the relative importance and inter-relations between the different risk factors. Results: The study population was mostly from the Ra-glai ethnic group ( 88%), with both low education and socio-economic status and engaged mainly in forest activities ( 58%). The multivariate analysis confirmed forest activity, bed net use, ethnicity, age and education as risk factors for malaria infections, but could not handle multiple interactions. The CART analysis showed that the most important risk factor for malaria was the wealth category, the wealthiest group being much less infected ( 8.9%) than the lower and medium wealth category ( 16.6%). In the former, forest activity and bed net use were the most determinant risk factors for malaria, while in the lower and medium wealth category, insecticide treated nets were most important, although the latter were less protective among Ra-glai people. Conclusion: The combination of CART and multivariate analysis constitute a novel analytical approach, providing an accurate and dynamic picture of the main risk factors for malaria infection. Results show that the control of forest malaria remains an extremely complex task that has to address poverty-related risk factors such as education, ethnicity and housing conditions.	[Thang, Ngo Duc; Hung, Le Xuan; Thuan, Le Khanh; Hung, Cong Trinh] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Erhart, Annette; Speybroeck, Niko; Coosemans, Marc; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Speybroeck, Niko] Univ Catholique Louvain, Ecole Sante Publ, B-1200 Brussels, Belgium; [Speybroeck, Niko] Ctr Malariol Parasitol & Entomol, Phan Rang, Ninh Thuan, Vietnam	Thang, ND (reprint author), Natl Inst Malariol Parasitol & Entomol, Luong Vinh St,BC 10200 Tu Liem Dist, Hanoi, Vietnam.	thangnimpevn@yahoo.com; aerhart@itg.be; nspeybroeck@itg.be; lxhung1952@yahoo.com; nimpe@netnam.org.vn; ngxxa@yahoo.com; phamvankynt@hotmail.com; mcoosemans@itg.be; udalessandro@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009			Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; BUTRAPORN P, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P386; Dabire RK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-12; Dang Nghiem Van, 2000, ETHNIC MINORITIES VI; DESMOND MC, 2007, GROWTH COSTS MALARIA; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Gaudart Jean, 2005, BMC Med Res Methodol, V5, P22, DOI 10.1186/1471-2288-5-22; Kitsantas P, 2006, ARTIF INTELL MED, V38, P275, DOI 10.1016/j.artmed.2006.03.008; *NIMPE, 2006, ANN REP NAT MAL CONT; *NIMPE, 2004, ANN REP NAT MAL CONT; *NIMPE, 2005, ANN REP NAT MAL CONT; Saegerman C, 2004, J CLIN MICROBIOL, V42, P172, DOI 10.1128/JCM.42.1.172-178.2004; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Schuftan C., 2000, WHO WPRO GLOBAL ROLL; Speybroeck N, 2004, AGR SYST, V80, P133, DOI 10.1016/j.agsy.2003.06.006; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; WILLIAMS DS, 2005, POVERTY ALLEVIATION; Wise J, 2004, B WORLD HEALTH ORGAN, V82, P884	22	48	48	1	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 30	2008	7								28	10.1186/1475-2875-7-28				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	280WV	WOS:000254458300002	18234102	DOAJ Gold, Green Published			2019-04-02	
J	Garros, C; Van Nguyen, C; Trung, HD; Van Bortel, W; Coosemans, M; Manguin, S				Garros, Claire; Van Nguyen, Cam; Trung, Ho Dinh; Van Bortel, Wim; Coosemans, Marc; Manguin, Sylvie			Distribution of Anopheles in Vietnam, with particular attention to malaria vectors of the Anopheles minimus complex	MALARIA JOURNAL			English	Article							SOUTHEAST-ASIA; SPECIES COMPLEX; IDENTIFICATION; CULICIDAE; DIPTERA; HETEROGENEITY; THAILAND; MEMBERS; ASSAY	Background: The distribution of anopheline mosquitoes in Vietnam was examined, with a particular interest for the two sibling species of the Anopheles minimus complex ( Cellia: Myzomyia), An. minimus and Anopheles harrisoni, respectively former species A and C. Because the morphological identification of both sibling species is difficult and may lead to misidentifications, accurate data on their respective distribution are missing. This is of fundamental importance since the two species seem to exhibit differential vectorial capacities for malaria transmission. Methods: Large entomological surveys based on cattle collections and molecular identifications of An. minimus s.l. were carried out in 23 sites throughout northern, central and south-eastern regions of Vietnam. Results: Based on previous molecular works and our data, the distribution of anopheline species and the relative densities of An. minimus and An. harrisoni were mapped. It is noteworthy that there was a high specific biodiversity at each study site. Anopheles minimus s.l. and Anopheles sinensis were the main anopheline species in the northern region, whereas Anopheles aconitus and Anopheles vagus were the most frequent ones in the central region. The southern limit of An. harrisoni was increased to the latitude of 11 degrees N. Sympatry between both sibling species has been extended to new provinces. Conclusion: Malaria transmission is still high in central Vietnam and along bordering countries. Therefore, it is important to know and map the precise distribution of the main and secondary malaria vectors in Vietnam for applying efficient vector control programmes. Moreover, these maps should be regularly updated and linked to environmental characteristics relative to disease epidemiology, and environmental and climatic changes occurring in southeast Asia.	[Garros, Claire; Manguin, Sylvie] Ctr Biol & Management Populat, IRD, F-34988 Montferrier Sur Lez, France; [Garros, Claire] Univ Catholique Louvain, Unite Ecol & Biogeog, B-1348 Louvain, Belgium; [Van Nguyen, Cam] Inst Geog Vietnam Acad Sci & Technol VAST, Hanoi, Vietnam; [Trung, Ho Dinh] NIMPE, Hanoi, Vietnam; [Van Bortel, Wim; Coosemans, Marc] ITM, Dept Parasitol, B-2000 Antwerp, Belgium; [Coosemans, Marc] Univ Antwerp, Fac Pharmaceut, Dept Biomed Sci, Antwerp, Belgium	Manguin, S (reprint author), Ctr Biol & Management Populat, IRD, Campus Int Baillarguet,CS 30 016, F-34988 Montferrier Sur Lez, France.	clairegarros@uclouvain.be; ngcamvanvn@yahoo.com; hodinhtrung@nimpe.vn; WVBortel@itg.be; MCoosemans@itg.be; manguin@mpl.ird.fr	Garros, Claire/C-2715-2011; Manguin, Sylvie/G-1787-2015	Manguin, Sylvie/0000-0002-5925-7164; Van Bortel, Wim/0000-0002-6644-518X			Chareonviriyaphap Theeraphap, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P225; DUC NH, 1973, ANN SCI WORKS, P134; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Garros C, 2006, TROP MED INT HEALTH, V11, P102, DOI 10.1111/j.1365-3156.2005.01536.x; Garros C, 2005, J AM MOSQUITO CONTR, V21, P139, DOI 10.2987/8756-971X(2005)21[139:FROAMC]2.0.CO;2; Garros C, 2004, AM J TROP MED HYG, V70, P583, DOI 10.4269/ajtmh.2004.70.583; Harbach RE, 2004, B ENTOMOL RES, V94, P537, DOI 10.1079/BER2004321; HARRISON B A, 1980, Contributions of the American Entomological Institute, V17, P1; Jambulingam P, 2005, ACTA TROP, V96, P31, DOI 10.1016/j.actatropica.2005.05.013; Kengne P, 2001, INSECT MOL BIOL, V10, P427, DOI 10.1046/j.0962-1075.2001.00281.x; KIRNOWARDOYO S, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P129; Linton YM, 2001, SYST ENTOMOL, V26, P357, DOI 10.1046/j.1365-3113.2001.00153.x; Maheswary N. P., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P798; Mouchet J., 2004, BIODIVERSITE PALUDIS; *NIMPE, 1987, KEYS ANOPHELES VIETN; *NIMPE, 2006, ANN REP NAT MAL CONT; OBSOMER V, 2007, MALAR J, V6; Phuc HK, 2003, MED VET ENTOMOL, V17, P423, DOI 10.1111/j.1365-2915.2003.00462.x; RAHMAN WA, 1993, ACTA TROP, V55, P263, DOI 10.1016/0001-706X(93)90084-O; Rahman Wahab A., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P599; SCANLON J E, 1968, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale, V6, P237; Somboon P, 2001, J AM MOSQUITO CONTR, V17, P98; Sungvornyothin S, 2006, J VECTOR ECOL, V31, P252, DOI 10.3376/1081-1710(2006)31[252:TBABAO]2.0.CO;2; Sungvornyothin S, 2006, J AM MOSQUITO CONTR, V22, P185, DOI 10.2987/8756-971X(2006)22[185:HRITHP]2.0.CO;2; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; Van Bortel W, 1999, TROP MED INT HEALTH, V4, P257; Van Bortel W, 2000, INSECT MOL BIOL, V9, P335, DOI 10.1046/j.1365-2583.2000.00192.x; Van Bortel W, 2004, J MED ENTOMOL, V41, P366, DOI 10.1603/0022-2585-41.3.366; Van Bortel W, 2001, AM J TROP MED HYG, V65, P729, DOI 10.4269/ajtmh.2001.65.729	30	17	17	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 11	2008	7								11	10.1186/147-2875-7-11				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	267TZ	WOS:000253533400003	18190697	DOAJ Gold			2019-04-02	
J	Adam, I; Elhardello, OA; Elhadi, MO; Abdalla, E; Elmardi, KA; Jansen, FH				Adam, I.; Elhardello, O. A.; Elhadi, M. O.; Abdalla, E.; Elmardi, K. A.; Jansen, F. H.			The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria	ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY			English	Article							SCHISTOSOMA-HAEMATOBIUM INFECTIONS; DOUBLE-BLIND; PRAZIQUANTEL; ARTEMISININS; RESISTANCE; TRIAL; DRUGS	Although artemisinin and its derivatives are widely used for the treatment of malaria, they also have antischistosomal activity. In a small study in eastern Sudan, the effects of the treatment of uncomplicated, Plasmodium falciparum malaria with artesunate-sulfamethoxypyrazine-pyrimethamine (AS-SMP) and artemether-lumefantrine (AT-LU) on co-infections with Schistosoma mansoni were therefore investigated. Faecal samples from 14 of the 306 patients screened on presentation, at the start of a clinical trial of antimalarial treatment, were found to contain Schistosoma mansoni eggs. For the treatment of their malaria, the 14 egg-positive cases, who were aged 640 years (mean= 13.7 years), were each subsequently treated with three tablets of a fixed combination of AS-SMP, with a 12-h (six patients) or 24-h interval (five patients) between each tablet, or with six doses of AT-LU given over 3 days. When checked 28 and 29 days after the initiation of treatment, all 14 patients were found stool-negative for schistosome eggs. These results indicate that AS-SMP and AT-LU are currently very effective treatments not only for uncomplicated, P. falciparum malaria but also for S. mansoni infections.	[Adam, I.] Univ Khartoum, Fac Med, Khartoum, Sudan; [Elhardello, O. A.; Abdalla, E.] New Halfa Teaching Hosp, New Halfa, Sudan; [Elhadi, M. O.] Natl Res Ctr, Khartoum, Sudan; [Elmardi, K. A.] Minist Hlth Sudan, Natl Malaria Control Programme, Khartoum, Sudan; [Jansen, F. H.] Dafra Pharm NV, B-2300 Turnhout, Belgium	Adam, I (reprint author), Univ Khartoum, Fac Med, POB 102, Khartoum, Sudan.	ishagadam@hotmail.com					Adam I, 2004, East Mediterr Health J, V10, P309; Adam I, 2004, ANN TROP MED PARASIT, V98, P661, DOI 10.1179/000349804225021514; Adam Ishag, 2006, Ann Clin Microbiol Antimicrob, V5, P18, DOI 10.1186/1476-0711-5-18; Borrmann S, 2001, J INFECT DIS, V184, P1363, DOI 10.1086/324004; Boulanger D, 2007, T ROY SOC TROP MED H, V101, P113, DOI 10.1016/j.trstmh.2006.03.003; Cioli D, 2000, CURR OPIN INFECT DIS, V13, P659, DOI 10.1097/00001432-200012000-00014; Davis A., 1993, Human schistosomiasis., P367; De Clercq D, 2002, ACTA TROP, V82, P61, DOI 10.1016/S0001-706X(02)00003-7; Himeidan YES, 2005, AM J INFECT DIS, V1, P75, DOI 10.3844/ajidsp.2005.75.78; Inyang-Etoh PC, 2004, ANN TROP MED PARASIT, V98, P491, DOI 10.1179/000349804225003460; Ismail M, 1999, AM J TROP MED HYG, V60, P932, DOI 10.4269/ajtmh.1999.60.932; N'Goran EK, 2003, AM J TROP MED HYG, V68, P24, DOI 10.4269/ajtmh.2003.68.24; Price RN, 2000, EXPERT OPIN INV DRUG, V9, P1815, DOI 10.1517/13543784.9.8.1815; Sagara I, 2006, AM J TROP MED HYG, V75, P630, DOI 10.4269/ajtmh.2006.75.630; TEESDALE CH, 1976, B WORLD HEALTH ORGAN, V54, P703; Utzinger J, 2007, CURR OPIN INVEST DR, V8, P105; *WHO, 1985, TECHN REP SER, V728; WHO, 1996, WHOMAL961077; Xiao SH, 2005, ACTA TROP, V96, P153, DOI 10.1016/j.actatropica.2005.07.010	19	24	25	0	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0003-4983			ANN TROP MED PARASIT	Ann. Trop. Med. Parasitol.	JAN	2008	102	1					39	44		10.1179/136485908X252214				6	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	256QS	WOS:000252745300004	18186976				2019-04-02	
J	Amendezo, E; Twagirumukiza, M; Sebatunzi, O; Kagame, A				Amendezo, Etienne; Twagirumukiza, Marc; Sebatunzi, Osee; Kagame, Abel			Inhospital cardiovascular morbidity and mortality in the department of internal medicine at CHU Kigali (Rwanda)	ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH			English	Article						Cardiovascular disease; cardiomyopathy; HIV/AIDS; morbidity; mortality; Rwanda; sub-Saharan Africa		Cardiovascular diseases (CVD) formerly considered as developed countries pandemic, are becoming nowadays increasingly ubiquitous in developing countries, where in addition to a steady increase in different risk factors, there is substantial inaccessibility to health care. However, data about the burden of CVD is lacking in many sub-Saharan African countries, and their morbimortality characteristics have been poorly described. Authors carried out a descriptive and retrospective study over a 12-month period, to describe the inhospital morbidity and mortality of CVD in the Department of Internal Medicine at University Teaching Hospital in Kigali City. Data were collected from 226 CVD cases (91 males and 135 females). The patients' age ranged from 26 to 94 years (mean age of 47.17 +/- 16.04). The 226 CVD cases account for the 8.2% of hospitalized patients. Hypertension was the principal cause of death (43.1% of deaths) and the predominant cause of patients' admission (42.9%), followed by cardiomyopathies (11.9%) and valvular heart diseases (11.5%). The association between a CVD and HIV/AIDS infection was observed in 23.9% of the total patients, but no causality relationship was investigated. Isolated heart failure takes the first place (33.6%) among the cardiovascular complications, followed by stroke (14.2%) and isolated renal failure (7.5%). Findings of this study confirm the importance of CVD in CHU Kigali, not only by their inhospital frequency but also- and especially by their lethality rate and their complications associated. This study stresses also a real need of CVD community survey in Rwanda.	[Amendezo, Etienne; Twagirumukiza, Marc; Sebatunzi, Osee; Kagame, Abel] Univ Teaching Hosp Kigali, Dept Internal Med, Kigali, Rwanda; [Amendezo, Etienne; Twagirumukiza, Marc; Sebatunzi, Osee; Kagame, Abel] Univ Teaching Hosp Butare, Dept Internal Med, Butare, Rwanda; [Twagirumukiza, Marc; Sebatunzi, Osee; Kagame, Abel] Natl Univ Rwanda, Fac Med, Butare, Rwanda; [Twagirumukiza, Marc] Univ Ghent, Heymans Inst Pharmacol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Twagirumukiza, M (reprint author), Univ Ghent, Heymans Inst Pharmacol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	marc.twagirumukiza@ugent.be		Twagirumukiza, Marc/0000-0003-1378-6922			Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Amoah AGB, 2000, CARDIOLOGY, V93, P11, DOI 10.1159/000006996; Araya MR, 2004, REV PANAM SALUD PUBL, V16, P295, DOI 10.1590/S1020-49892004001100001; Barbaro G, 2003, ADV CARDIOL, V40, P15; Bardgett HP, 2006, TROP DOCT, V36, P129, DOI 10.1258/004947506777978217; Bertrand E, 1997, WORLD HEALTH FORUM, V18, P163; Bertrand E, 1997, ARCH MAL COEUR VAISS, V90, P981; Bradshaw Debbie, 2005, Cardiovasc J S Afr, V16, P140; Brundtland GH, 2002, JAMA-J AM MED ASSOC, V288, P1974, DOI 10.1001/jama.288.16.1974; Chen Hao-zhu, 2003, Zhonghua Nei Ke Za Zhi, V42, P829; Coleman R, 1998, LANCET, V351, P1208, DOI 10.1016/S0140-6736(05)79158-3; Cooper R, 1997, AM J HYPERTENS, V10, P804, DOI 10.1016/S0895-7061(97)00211-2; Cruickshank JK, 2001, J HYPERTENS, V19, P41, DOI 10.1097/00004872-200101000-00006; Etienne U, 1997, PROTIL ETIOPATHOGENI; Gaju S Twagirayezu, 2006, CONTRIBUTION ELECTRO; Gasakure E, 1999, JOURNEES MED BUTARE; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Huiart L, 2005, CHEST, V128, P2640, DOI 10.1378/chest.128.4.2640; Kadiri S, 2005, BRIT MED J, V331, P711, DOI 10.1136/bmj.331.7519.711; Kengne AP, 2005, CIRCULATION, V112, P3592, DOI 10.1161/CIRCULATIONAHA.105.544312; Kingue S., 2005, Annales de Cardiologie et d'Angeiologie, V54, P276, DOI 10.1016/j.ancard.2005.04.014; Kotto R Mboulley, 2000, CARDIOL TROP, V26, P69; LongoMbenza B, 1997, ARCH MAL COEUR VAISS, V90, P1377; Lubega S, 2005, Afr Health Sci, V5, P219; Mackay J, 2004, ATLAS HEART DIS STRO; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Mukagatare I, 2002, COMPLICATIONS CARDI; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nkuba V, 2003, ANTAGONISTES CALCIQU; Ntsekhe M, 2005, CIRCULATION, V112, P3602, DOI 10.1161/CIRCULATIONAHA.105.549220; Opie LH, 2005, CIRCULATION, V112, P3536, DOI 10.1161/CIRCULATIONAHA.105.597765; Pearson TA, 1999, CARDIOVASC DRUG THER, V13, P95, DOI 10.1023/A:1007727924276; Razum O., 1996, Central African Journal of Medicine, V42, P120; Reitsma JB, 1999, HEART, V82, P52, DOI 10.1136/hrt.82.1.52; Rotimi C, 1997, CIRCULATION, V95, P2348, DOI 10.1161/01.CIR.95.10.2348; Smith SM, 2003, ETHNIC DIS, V13, P77; SoRelle R, 1999, CIRCULATION, V100, pE102; Thiam M, 2003, Bull Soc Pathol Exot, V96, P217; Timmermann M, 2004, MMW Fortschr Med, V146 Spec No 1, P10; Twagirumukiza M, 2003, MED AFR NOIRE, V50, P169; Twagirumukiza M, 2007, CURR HIV RES, V5, P129, DOI 10.2174/157016207779316288; Umurungi Y, 1997, MANIFESTATIONS CARDI; Vorster HH, 2002, PUBLIC HEALTH NUTR, V5, P239, DOI 10.1079/PHN2001299; World Health Organisation (WHO), 2005, PREV CHRON DIS VIT I; Yikona J, 2001, LANCET, V357, P74, DOI 10.1016/S0140-6736(05)71579-8; Zareba Karolina M., 2003, Curr Infect Dis Rep, V5, P513, DOI 10.1007/s11908-003-0096-5	46	3	3	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1755-6783	0974-6005		ANN TROP MED PUBLIC	Ann. Trop. Med. Public Health	JAN-JUN	2008	1	1					9	14		10.4103/1755-6783.43071				6	Tropical Medicine	Tropical Medicine	V4B8G	WOS:000218788900003		Other Gold			2019-04-02	
J	Brabin, BJ; Warsame, M; Uddenfeldt-Wort, U; Dellicour, S; Hill, J; Gies, S				Brabin, Bernard J.; Warsame, Marian; Uddenfeldt-Wort, Ulrika; Dellicour, Stephanie; Hill, Jenny; Gies, Sabine			Monitoring and evaluation of malaria in pregnancy - developing a rational basis for control	MALARIA JOURNAL			English	Review							INTERMITTENT PREVENTIVE TREATMENT; SULFADOXINE-PYRIMETHAMINE; BIRTH-WEIGHT; MATERNAL MORTALITY; SOUTHERN MALAWI; WESTERN KENYA; BURKINA-FASO; AFRICA; WOMEN; ANEMIA	Monitoring and evaluation of malaria control in pregnancy is essential for assessing the efficacy and effectiveness of health interventions aimed at reducing the major burden of this disease on women living in endemic areas. Yet there is no currently integrated strategic approach on how this should be achieved. Malaria control in pregnancy is formulated in relation to epidemiological patterns of exposure. Current emphasis is on intermittent preventive treatment (IPTp) during pregnancy with sulphadoxine-pyrimethamine in higher transmission areas, combined with insecticide treated bed nets (ITNs) and case management. Emphasis in lower transmission areas is primarily on case management. This paper discusses a rational basis for monitoring and evaluation based on: assessments of therapeutic and prophylactic drug efficacy; proportional reductions in parasite prevalence; seasonal effects; rapid assessment methodologies; birthweight and/or anaemia nomograms; case-coverage methods; maternal mortality indices; operational and programmatic indicators; and safety and pharmacovigilance of antimalarials in pregnancy. These approaches should be incorporated more effectively within National Programmes in order to facilitate surveillance and improve identification of high-risk women. Systems for utilizing routinely collected data should be strengthened, with greater attention to safety and pharmacovigilance with the advent of artemisinin combination therapies, and prospects of inadvertent exposures to artemisinins in the first trimester. Integrating monitoring activities within malaria control, reproductive health and adolescent-friendly services will be critical for implementation. Large-scale operational research is required to further evaluate the validity of currently proposed indicators, and in order to clarify the breadth and scale of implementation to be deployed.	[Brabin, Bernard J.; Dellicour, Stephanie; Hill, Jenny] Univ Liverpool Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England; [Brabin, Bernard J.] Univ Amsterdam, Global Child Hlth Grp, Emma Kinderziekenhuis, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Warsame, Marian] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Uddenfeldt-Wort, Ulrika] Lund Univ, Lund, Sweden; [Gies, Sabine] Inst Trop Med Prince Leopold, Epidemiol & Control Parasit Dis Unit, Dept Parasitol, B-2000 Antwerp, Belgium	Brabin, BJ (reprint author), Univ Liverpool Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England.	b.j.brabin@liverpool.ac.uk; warsamem@who.int; Ulrika.Uddenfeldt@kane.se; s.dellicour@liverpool.ac.uk; jennyhill@liverpool.ac.uk; sgies@itg.be		hill, jenny/0000-0003-1588-485X			Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Brabin BJ, 1999, ANN TROP MED PARASIT, V93, pS43, DOI 10.1080/00034983.1999.11813503; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Brabin BJ, 2001, J NUTR, V131, p14S; Brabin L, 1998, ACTA OBSTET GYN SCAN, V77, P402, DOI 10.1034/j.1600-0412.1998.770408.x; Crawley J, 2007, LANCET INFECT DIS, V7, P145, DOI 10.1016/S1473-3099(07)70026-9; Dellicour S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-15; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Gies S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-180; GILLES HM, 1969, ANN TROP MED PARASIT, V63, P245, DOI 10.1080/00034983.1969.11686625; Green MD, 2007, J INFECT DIS, V196, P1403, DOI 10.1086/522632; Greenwood B, 2007, LANCET INFECT DIS, V7, P169, DOI 10.1016/S1473-3099(07)70028-2; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Kennedy DL, 2004, DRUG SAFETY, V27, P215, DOI 10.2165/00002018-200427040-00001; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Msyamboza K, 2007, INT J EPIDEMIOL, V36, P406, DOI 10.1093/ije/dyl301; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Parise ME, 2003, B WORLD HEALTH ORGAN, V81, P316; Pirmohamed M, 2007, BRIT MED J, V335, P462, DOI 10.1136/bmj.39323.586123.BE; Savage EJ, 2007, BJOG-INT J OBSTET GY, V114, P1222, DOI 10.1111/j.1471-0528.2007.01420.x; Singh N, 1999, B WORLD HEALTH ORGAN, V77, P567; Sirima SB, 2006, AM J TROP MED HYG, V75, P205, DOI 10.4269/ajtmh.2006.75.205; STOKES E, 2008, BR J OBSTET IN PRESS; Talisuna AO, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-50; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; van den Broek NR, 2000, BRIT J OBSTET GYNAEC, V107, P445; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P630, DOI 10.1111/j.1365-3156.2004.01242.x; Verhoeff FH, 1999, ANN TROP MED PARASIT, V93, P119; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; *WHO, 2005, SUSC PLASM FALC ANT; *WHO AFRO, 2004, STRAT FRAM MAL PREV; World Health Organization, 2007, MAL PREGN GUID MEAS; World Health Organization, 2002, IMP PHARM SAF MON ME; World Health Organization, 2006, SAF MED PUBL HLTH PR; Wort UU, 2008, PUBLIC HEALTH, V122, P923, DOI 10.1016/j.puhe.2007.12.012; Wort UU, 2006, ACTA OBSTET GYN SCAN, V85, P949, DOI 10.1080/00016340600756870; Wort UU, 2004, INT J EPIDEMIOL, V33, P1311, DOI 10.1093/ije/dyh256	43	14	14	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.		2008	7			1					S6	10.1186/1475-2875-7-S1-S6				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	602UG	WOS:000278163700006	19091040	DOAJ Gold, Green Published			2019-04-02	
J	Frederich, M; Tits, M; Angenot, L				Frederich, Michel; Tits, Monique; Angenot, Luc			Potential antimalarial activity of indole alkaloids	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Review						malaria; plasmodium; falciparum; plasmodium berghei; antiplasmodials; indote alkaloids; natural products	TROPICAL PARASITIC DISEASES; IN-VITRO; ANTIPLASMODIAL ACTIVITY; CRYPTOLEPIS-SANGUINOLENTA; STRYCHNOS-USAMBARENSIS; PLASMODIUM MALARIA; NEOCRYPTOLEPINE DERIVATIVES; BIOLOGICAL EVALUATION; MANZAMINE ALKALOIDS; INDONESIAN SPONGE	New antimalarial treatments are now urgently required, following the emergence of resistance to the most used drugs. Natural products contribute greatly to the therapeutic arsenal in this area, including artemisinin and quinine (and atovaquone, semi-synthetic). Among the natural products, indole alkaloids represent an interesting class of compounds. Screening carried out to date has revealed several substances active in vitro under the micromolar range and with a good selectivity index. This review covers the indole alkaloids with high antiplas-modial activity (in vitro and in vivo) isolated from natural sources, and is organized according to the different chemical structures of the alkaloids. (c) 2007 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Frederich, Michel; Tits, Monique; Angenot, Luc] Univ Liege, CIRM, Dept Pharm, B-4000 Liege, Belgium	Frederich, M (reprint author), Univ Liege, CIRM, Dept Pharm, CHU Tour 4 Batiment B36,Ave Hop 1, B-4000 Liege, Belgium.	m.frederich@ulg.ac.be		FREDERICH, Michel/0000-0002-0770-9990			Ang KKH, 2000, ANTIMICROB AGENTS CH, V44, P1645, DOI 10.1128/AAC.44.6.1645-1649.2000; Ansah C, 2005, TOXICOLOGY, V208, P141, DOI 10.1016/j.tox.2004.11.026; Ansah C, 2002, TOXICOL SCI, V70, P245, DOI 10.1093/toxsci/70.2.245; Arzel E, 2001, J MED CHEM, V44, P949, DOI 10.1021/jm0010419; Bhattacharjee AK, 2004, EUR J MED CHEM, V39, P59, DOI 10.1016/j.ejmech.2003.10.004; Bonjean K, 1998, BIOCHEMISTRY-US, V37, P5136, DOI 10.1021/bi972927q; BOURDY G, 2007, INT J PARASIT; Caira MR, 1995, J CHEM CRYSTALLOGR, V25, P725, DOI 10.1007/BF01670325; Chouteau F, 2005, BIOORG MED CHEM LETT, V15, P3024, DOI 10.1016/j.bmcl.2005.04.033; Cimanga K, 1997, J NAT PROD, V60, P688, DOI 10.1021/np9605246; Clinquart E., 1929, B ACAD R MED BELG, V12, P627; Federici E, 2000, PLANTA MED, V66, P93; Fichter F, 1906, CHEM BER, V39, P3932; Frederich M, 1999, J NAT PROD, V62, P619, DOI 10.1021/np980375m; Frederich M, 2000, PLANTA MED, V66, P262, DOI 10.1055/s-2000-8559; Frederich M, 2004, PLANTA MED, V70, P520, DOI 10.1055/s-2004-827151; Frederich M, 2004, PLANTA MED, V70, P72, DOI 10.1055/s-2004-815461; Frederich M, 2002, J NAT PROD, V65, P1381, DOI 10.1021/np020070e; Frederich M, 2001, PLANTA MED, V67, P523, DOI 10.1055/s-2001-16476; Frederich M, 1999, ANTIMICROB AGENTS CH, V43, P2328, DOI 10.1128/AAC.43.9.2328; Frederich M, 2001, J NAT PROD, V64, P12, DOI 10.1021/np000285t; George V., 1996, Fitoterapia, V67, P553; Grellier P, 1996, PHYTOTHER RES, V10, P317, DOI 10.1002/(SICI)1099-1573(199606)10:4<317::AID-PTR858>3.0.CO;2-0; GUNATILAKA AAL, 1980, PLANTA MED, V39, P66; Hamburger Matthias, 2002, Phytochemistry Reviews, V1, P333, DOI 10.1023/A:1026095608691; Ho YL, 2003, AM J CHINESE MED, V31, P61, DOI 10.1142/S0192415X03000783; HONDA G, 1980, PLANTA MED, V38, P275, DOI 10.1055/s-2008-1074877; IWAKI K, 2005, NEW TECHNOLOGIES MED, V6, P550; Jenett-Siems K, 2004, BIOORGAN MED CHEM, V12, P817, DOI 10.1016/j.bmc.2003.10.035; Jonckers THM, 2002, J MED CHEM, V45, P3497, DOI 10.1021/jm011102i; Keawpradub N, 1999, PLANTA MED, V65, P690, DOI 10.1055/s-1999-14043; KEENE AT, 1983, J PHARM PHARMACOL, V35, P20; KEENE AT, 1987, PLANTA MED, V53, P201; KIRBY GC, 1995, PHYTOTHER RES, V9, P359, DOI 10.1002/ptr.2650090510; Lisgarten JN, 2002, NAT STRUCT BIOL, V9, P57, DOI 10.1038/nsb729; MARTINDALE D, 2002, MALARIA DRUG MUDDLE; Mitaine-Offer AC, 2002, PHYTOMEDICINE, V9, P142, DOI 10.1078/0944-7113-00094; Muruganandam AV, 2000, INDIAN J CHEM B, V39, P125; Onyeibor O, 2005, J MED CHEM, V48, P2701, DOI 10.1021/jm040893w; Orellana C, 2003, LANCET INFECT DIS, V3, P61, DOI 10.1016/S1473-3099(03)00528-0; Philippe G, 2006, EUR J PHARMACOL, V530, P15, DOI 10.1016/j.ejphar.2005.11.048; Philippe G, 2005, J ETHNOPHARMACOL, V97, P535, DOI 10.1016/j.jep.2004.12.011; Philippe G, 2007, PLANTA MED, V73, P478, DOI 10.1055/s-2007-967174; Rafatro H, 2000, J MASS SPECTROM, V35, P1112, DOI 10.1002/1096-9888(200009)35:9<1112::AID-JMS39>3.0.CO;2-K; Rafatro H, 2000, J CHROMATOGR B, V744, P121, DOI 10.1016/S0378-4347(00)00238-3; Rafatro H, 2000, BIOCHEM PHARMACOL, V59, P1053, DOI 10.1016/S0006-2952(99)00400-1; Ramanitrahasimbola D, 2006, MOL BIOCHEM PARASIT, V146, P58, DOI 10.1016/j.molbiopara.2005.10.018; Ramanitrahasimbola D, 2001, PHYTOTHER RES, V15, P30, DOI 10.1002/1099-1573(200102)15:1<30::AID-PTR680>3.0.CO;2-T; RAMIALIHARISOA A, 1994, REV MED PHARM AFR, V8, P123; Rao KV, 2004, J NAT PROD, V67, P1314, DOI 10.1021/np0400095; Rao KV, 2003, J NAT PROD, V66, P823, DOI 10.1021/np020592u; Rasoanaivo P, 1996, GAZZ CHIM ITAL, V126, P517; Rasoanaivo P., 1996, Cahiers d'Etudes et de Recherches Francophones/Sante, V6, P249; RASOANAIVO P, 1994, PLANTA MED, V60, P13, DOI 10.1055/s-2006-959398; RASOANAIVO P, 2005, ETHNOPHARMACOLOGIA, V35, P33; RASOANAIVO P, 2002, STUDIES NATURAL PROD, V26, P1029; Sauvain M, 1996, PHYTOTHER RES, V10, P198; SCHINDLER F, 1971, ARCH MIKROBIOL, V79, P187, DOI 10.1007/BF00408783; Van Miert S, 2005, J NAT PROD, V68, P674, DOI 10.1021/np0496284; Van Miert S, 2004, EXP PARASITOL, V108, P163, DOI 10.1016/j.exppara.2004.08.006; *WHO, 2005, WORLD MAL REP; Willcox ML, 2004, BMJ-BRIT MED J, V329, P1156, DOI 10.1136/bmj.329.7475.1156; WRIGHT CW, 1994, PHYTOTHER RES, V8, P149, DOI 10.1002/ptr.2650080306; Wright CW, 1996, PHYTOTHER RES, V10, P361, DOI 10.1002/(SICI)1099-1573(199606)10:4<361::AID-PTR845>3.0.CO;2-N; WRIGHT CW, 1993, J ETHNOPHARMACOL, V40, P41, DOI 10.1016/0378-8741(93)90087-L; WRIGHT CW, 1991, PLANTA MED, V57, P337, DOI 10.1055/s-2006-960112; Wright CW, 2001, J MED CHEM, V44, P3187, DOI 10.1021/jm010929+; Yang SW, 1999, J NAT PROD, V62, P976, DOI 10.1021/np990035g; Zocoler MA, 2005, J BRAZIL CHEM SOC, V16, P1372, DOI 10.1590/S0103-50532005000800011	69	69	71	1	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JAN	2008	102	1					11	19		10.1016/j.trstmh.2007.10.002				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	254RY	WOS:000252606900005	18035385				2019-04-02	
J	Boelaert, M; El-Safi, S; Hailu, A; Mukhtar, M; Rijal, S; Sundar, S; Wasunna, M; Aseffa, A; Mbui, J; Menten, J; Desjeux, P; Peeling, RW				Boelaert, M.; El-Safi, S.; Hailu, A.; Mukhtar, M.; Rijal, S.; Sundar, S.; Wasunna, M.; Aseffa, A.; Mbui, J.; Menten, J.; Desjeux, P.; Peeling, R. W.			Diagnostic tests for kata-azar: a mutti-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						visceral; leishmaniasis; sensitivity and specificity; diagnostic tests; Africa; India; Nepal	DIRECT AGGLUTINATION-TEST; ESTIMATING DISEASE PREVALENCE; LINKED-IMMUNOSORBENT-ASSAY; VISCERAL LEISHMANIASIS; KALA-AZAR; ANTI-K-39 ANTIBODY; SPLENIC ASPIRATION; SEROLOGICAL TESTS; GOLD STANDARD; DIPSTICK TEST	Three diagnostic tests for visceral. leishmaniasis (VL), the freeze-dried direct agglutination test (FD-DAT), the rK39 dipstick and a urine latex antigen test (KAtex), were evaluated for use in primary care in East Africa and the Indian subcontinent. Clinical suspects were prospectively recruited and tissue, blood and urine samples were taken. Direct microscopic examination of tissue smear, and FD-DAT, rK39 and KAtex were performed. Sensitivity and specificity with 95% credible intervals were estimated using Bayesian Latent class analysis. On the Indian subcontinent both the FD-DAT and the rK39 strip test exceeded the 95% sensitivity and 90% specificity target, but not so in East Africa. Sensitivity of the FD-DAT was high in Ethiopia and Kenya but lower in Sudan, white its specificity was below 90% in Kenya. Sensitivity of the rK39 was below 80% in the three countries, and its specificity was only 70% in Ethiopia. KAtex showed moderate to very low sensitivity in all countries. FD-DAT and rK39 can be recommended for clinical practice on the Indian subcontinent. In East Africa, their clinical use should be carefully monitored. More work is needed to improve existing formats, and to develop better VL diagnostics. (c) 2007 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Boelaert, M.; Menten, J.] Inst Trop Med, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [El-Safi, S.; Mukhtar, M.] Univ Khartoum, Fac Med Lab Sci, Dept Microbiol & Parasitol, Khartoum, Sudan; [Hailu, A.] Univ Addis Ababa, Fac Med, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Rijal, S.] BP Koirala Inst Hlth Sci, Dept Med, Dharan, Nepal; [Sundar, S.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Wasunna, M.; Mbui, J.] Clin Res Ctr, Kenya Med Res Inst, Nairobi, Kenya; [Aseffa, A.] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Desjeux, P.] IOWH, F-01220 Divonne, France; [Peeling, R. W.] WHO, Special Programme Res & Training Trop Dis, UNICEF UNDP World Bank, PDE, CH-1211 Geneva, Switzerland	Boelaert, M (reprint author), Inst Trop Med, Epidemiol & Dis Control Unit, Natl Str 155, B-2000 Antwerp, Belgium.	mboelaert@itg.be	Boelaert, Marleen/E-2698-2012; Aseffa, Abraham/J-3248-2016	Boelaert, Marleen/0000-0001-8051-6776; Aseffa, Abraham/0000-0002-8028-1150			Attar ZJ, 2001, ACTA TROP, V78, P11, DOI 10.1016/S0001-706X(00)00155-8; Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Bern C, 2000, AM J TROP MED HYG, V63, P153, DOI 10.4269/ajtmh.2000.63.153; Black MA, 2002, STAT MED, V21, P2653, DOI 10.1002/sim.1178; Boelaert M, 2004, AM J TROP MED HYG, V70, P72, DOI 10.4269/ajtmh.2004.70.72; Boelaert M, 1999, TROP MED INT HEALTH, V4, P31, DOI 10.1046/j.1365-3156.1999.00348.x; Boussery G, 2001, EMERG INFECT DIS, V7, P603; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Bryceson A. D. M., 1996, Manson's tropical diseases., P1213; Chappuis F, 2003, TROP MED INT HEALTH, V8, P277, DOI 10.1046/j.1365-3156.2003.01026.x; Chappuis F, 2006, TROP MED INT HEALTH, V11, P31, DOI 10.1111/j.1365-3156.2005.01533.x; Chappuis F, 2005, J CLIN MICROBIOL, V43, P5973, DOI 10.1128/JCM.43.12.5973-5977.2005; Chappuis F, 2006, BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; DEBEER P, 1991, AM J TROP MED HYG, V44, P283, DOI 10.4269/ajtmh.1991.44.283; Efron B., 1993, INTRO BOOTSTRAP; ELSAFI SH, 1989, T ROY SOC TROP MED H, V83, P334, DOI 10.1016/0035-9203(89)90493-8; Gelman A, 2005, BIOMETRICS, V61, P74, DOI 10.1111/j.0006-341X.2005.031010.x; Gerstl S, 2006, TROP MED INT HEALTH, V11, P167, DOI 10.1111/j.1365-3156.2005.01550.x; Goetghebeur E, 2000, STAT METHODS MED RES, V9, P231, DOI 10.1191/096228000701555127; HAILU A, 1990, T ROY SOC TROP MED H, V84, P673, DOI 10.1016/0035-9203(90)90141-Z; HARITH AE, 1986, T ROY SOC TROP MED H, V80, P583, DOI 10.1016/0035-9203(86)90149-5; Jacquet D, 2006, TROP MED INT HEALTH, V11, P1777, DOI 10.1111/j.1365-3156.2006.01743.x; KAGER PA, 1983, TROP GEOGR MED, V35, P125; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MEREDITH SEO, 1995, J CLIN MICROBIOL, V33, P1742; Peeling RW, 2006, NAT REV MICROBIOL, pS2, DOI [10.1038/nrmicro1568, 10.1038/nrmico1522]; *R DEV COR TEAM, 2005, R FDN STAT COMP; Riera C, 2004, EUR J CLIN MICROBIOL, V23, P899, DOI 10.1007/s10096-004-1249-7; Rijal S, 2004, TROP MED INT HEALTH, V9, P724, DOI 10.1111/j.1365-3156.2004.01251.x; Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76; Ritmeijer K, 2003, T ROY SOC TROP MED H, V97, P609, DOI 10.1016/S0035-9203(03)80047-0; Sarkari B, 2002, ACTA TROP, V82, P339, DOI 10.1016/S0001-706X(02)00043-8; Sarker C B, 2003, Mymensingh Med J, V12, P93; Singh SP, 2006, AM J TROP MED HYG, V75, P505, DOI 10.4269/ajtmh.2006.75.505; SINGLA N, 1993, T ROY SOC TROP MED H, V87, P276, DOI 10.1016/0035-9203(93)90125-A; SINHA R, 1994, J TROP MED HYG, V97, P333; SPIEGELHALTER D, 2006, BAYESIAN INFERENCE U; SPIEGELHALTER D, 2004, IMPERIAL COLL MED RE; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Sundar S, 2007, TROP MED INT HEALTH, V12, P284, DOI 10.1111/j.1356-3156.2006.01775.x; Sundar S, 2006, J CLIN MICROBIOL, V44, P251, DOI 10.1128/JCM.44.1.251-253.2006; Sundar S, 2002, CLIN INFECT DIS, V35, P581, DOI 10.1086/342057; Sundar S, 2002, ANN TROP MED PARASIT, V96, P19, DOI 10.1179/000349802125000466; Thakur CP, 1997, T ROY SOC TROP MED H, V91, P668, DOI 10.1016/S0035-9203(97)90516-2; *WHO, 1999, WHO REC SURV STAND 2; World Health Organization (WHO), 1990, WHO TECHN REP SER, V793; Zhou X-H, 2002, STAT METHODS DIAGNOS; ZIJLSTRA EE, 1992, T ROY SOC TROP MED H, V86, P505, DOI 10.1016/0035-9203(92)90086-R; Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x; Zijlstra EE, 1998, CLIN DIAGN LAB IMMUN, V5, P717; Zijlstra EE, 1997, T ROY SOC TROP MED H, V91, P671, DOI 10.1016/S0035-9203(97)90518-6	54	113	115	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JAN	2008	102	1					32	40		10.1016/j.trstmh.2007.09.003				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	254RY	WOS:000252606900008	17942129				2019-04-02	
J	Buhendwa, L; Zachariah, R; Teck, R; Massaquoi, M; Kazima, J; Firmenich, P; Harries, AD				Buhendwa, L.; Zachariah, R.; Teck, R.; Massaquoi, M.; Kazima, J.; Firmenich, P.; Harries, A. D.			Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmssion programme rural Malawi	TROPICAL DOCTOR			English	Article							TRANSMISSION; INHIBITION	This study shows that cabergoline (single oral-dose) is an acceptable, safe and effective drug for suppressing puerperal lactation. It could be of operational benefit not only for artificial feeding, but also for weaning in those that breast-feed within preventive mother-to-child HIV transmission programmes in resource-limited settings.	[Zachariah, R.] Brussels Operat Ctr, Dept Med, Med Sans Frontieres, B-1090 Brussels, Belgium; [Kazima, J.] Minist Hlth & Populat, Thyolo Dist Hlth Serv, Thyolo, Malawi; [Harries, A. D.] Minist Hlth, HIV Care & Support, Lilongwe, Malawi; [Harries, A. D.] London Sch Hyg & Trop Med, London, England	Zachariah, R (reprint author), Brussels Operat Ctr, Med Sans Frontieres, 68 Rue Gasperich, L-1617 Gasperich, Luxembourg.	zachariah@intemet.lu					CABALLEROGORDO A, 1991, J REPROD MED, V36, P717; Fowler MG, 2002, J ACQ IMMUN DEF SYND, V30, P230, DOI 10.1097/01.QAI.0000018364.28828.14; John-Stewart G, 2004, JAIDS-J ACQ IMM DEF, V35, P196, DOI 10.1097/00126334-200402010-00015; *MOH, 2003, NAT GUID PREV MOTH C; ROLLAND R, 1991, BMJ-BRIT MED J, V302, P1367; Van de Perre P, 2000, ANN NY ACAD SCI, V918, P122; *WHO, 2003, HIV INF FEED GUID DE	7	6	6	0	1	ROYAL SOC MEDICINE PRESS LTD	LONDON	1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND	0049-4755			TROP DOCT	Trop. Dr.	JAN	2008	38	1					30	32		10.1258/td.2007.060091				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	269HF	WOS:000253639400015	18302861	Bronze			2019-04-02	
J	Sundar, S; Mondal, D; Rijal, S; Bhattacharya, S; Ghalib, H; Kroeger, A; Boelaert, M; Desjeux, P; Richter-Airijoki, H; Harms, G				Sundar, Shyam; Mondal, Dinesh; Rijal, Suman; Bhattacharya, Sujit; Ghalib, Hashim; Kroeger, Axel; Boelaert, Marleen; Desjeux, Philippe; Richter-Airijoki, Heide; Harms, Gundel			Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal - the challenges for diagnosis and treatment	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						implementation research; diagnosis; treatment; visceral leishmaniasis; kala azar; elimination; India; Bangladesh; Nepal	VISCERAL LEISHMANIASIS; AMPHOTERICIN-B; MILTEFOSINE; TESTS		[Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Mondal, Dinesh] ICDDR B, Parasitol Lab, Dhaka, Bangladesh; [Rijal, Suman] Koirala Inst Hlth Sci, Dharan, Nepal; [Bhattacharya, Sujit] Indian Council Med Res, New Delhi, India; [Ghalib, Hashim; Kroeger, Axel] WHO, TDR, CH-1211 Geneva, Switzerland; [Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [Desjeux, Philippe] Inst OneWorld Hlth, Divonne, France; [Richter-Airijoki, Heide] GTZ, Deutsch Gesellsch Tech Zusammenarbeit, Eschborn, Germany; [Harms, Gundel] Charite, Inst Trop Med, Berlin, Germany	Sundar, S (reprint author), Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Kroeger, Axel/0000-0001-8438-2904			Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; APARICIO P, 2007, WHO 1 M SUBC EXP COM; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bhattacharya SK, 2007, J INFECT DIS, V196, P591, DOI 10.1086/519690; CERF BJ, 1987, J INFECT DIS, V168, P986; Jha TK, 2006, INDIAN J MED RES, V123, P389; Meheus F, 2006, TROP MED INT HEALTH, V11, P1715, DOI 10.1111/j.1365-3156.2006.01732.x; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Sundar S, 2007, TROP MED INT HEALTH, V12, P284, DOI 10.1111/j.1356-3156.2006.01775.x; Sundar S, 2006, J CLIN MICROBIOL, V44, P251, DOI 10.1128/JCM.44.1.251-253.2006; Sundar S, 2005, B WORLD HEALTH ORGAN, V83, P394; Sundar S, 2004, CLIN INFECT DIS, V38, P377, DOI 10.1086/380971; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2001, BRIT MED J, V323, P419, DOI 10.1136/bmj.323.7310.419; Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536; *WHO, 2002, RED RISKS PROM HLTH, P186	18	47	47	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2008	13	1					2	5		10.1111/j.1365-3156.2007.01974.x				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	281GL	WOS:000254484800001	18290995				2019-04-02	
J	Melo, J; Folgosa, E; Manjate, D; Osman, N; Francois, I; Temmerman, M; Cappuccinelli, P; Colombo, MM				Melo, Josefa; Folgosa, Elena; Manjate, Delfina; Osman, Nafissa; Francois, Isabelle; Temmerman, Marleen; Cappuccinelli, Piero; Colombo, Mauro M.			Low prevalence of HIV and other sexually transmitted infections in young women attending a youth counselling service in Maputo, Mozambique	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						STI; counselling; young women; Mozambique	POPULATION-BASED SURVEY; SOUTH-AFRICA; CONDOM USE; HEALTH; PREVENTION; TANZANIA; DISEASES; ECTOPY	OBJECTIVES To determine the prevalence of sexually transmitted infections (STIs) in a group of young women attending the Adolescent and Youth Friendly Service, in Maputo, Mozambique, and to evaluate their level of knowledge, practices and attitudes about STI. METHODS A total of 445 women voluntarily participated in the study and filled in a self-administered knowledge, practices and attitudes (KAP) questionnaire; 435 of them underwent a laboratory examination for vaginosis, candidiasis, trichomoniasis, gonorrhoea, chlamydiosis, syphilis and HIV infection. RESULTS Women had a high level of awareness and knowledge of STI and HIV. Candidiasis was the most prevalent reproductive tract infection (36%), followed by vaginosis (13%) and trichomoniasis (7.6%), and sexually transmitted diseases. HIV seroprevalence was 4%; 42% were negative in all tests. CONCLUSION The low prevalence of STI and HIV may be related in part to the high level of awareness registered in the group.	[Colombo, Mauro M.] Univ Roma La Sapienza, Dept Dev & Cell Biol, Rome, Italy; [Melo, Josefa; Folgosa, Elena; Manjate, Delfina] Univ E Mondlane, Fac Med, Dept Microbiol, Maputo, Mozambique; [Osman, Nafissa] Minist Hlth, Maputo Cent Hosp, Maputo, Mozambique; [Osman, Nafissa] Fac Med, Dept Obstet & Gynaecol, Maputo, Mozambique; [Francois, Isabelle; Temmerman, Marleen] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Cappuccinelli, Piero] Univ Sassari, Fac Med, Dept Biomed Sci, I-07100 Sassari, Italy	Colombo, MM (reprint author), Univ Roma La Sapienza, Dept Dev & Cell Biol, Rome, Italy.	mauro.colombo@uniroma1.it					Aboyeji A P, 2003, J Obstet Gynaecol, V23, P637, DOI 10.1080/01443610310001604411; Agha S, 2001, HEALTH POLICY PLANN, V16, P144, DOI 10.1093/heapol/16.2.144; ALENE GD, 2004, AIDS CARE, V1, P57; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Hawken MP, 2002, JAIDS, V31, P529, DOI 10.1097/00126334-200212150-00011; Kiapi-Iwa L, 2004, AIDS CARE, V16, P339, DOI 10.1080/09540120410001665349; Mayaud P, 2004, SEX TRANSM INFECT, V80, P174, DOI 10.1136/sti.2002.004101; Mbago MCY, 2003, INT J STD AIDS, V14, P596, DOI 10.1258/095646203322301040; Meyer-Weitz A, 2000, J ADOLESCENCE, V23, P741, DOI 10.1006/jado.2000.0356; Moscicki AB, 2001, J INFECT DIS, V183, P865, DOI 10.1086/319261; Myer L, 2006, SEX TRANSM DIS, V33, P683, DOI 10.1097/01.olq.0000216026.67352.f9; Newman L, 2004, VALIDATION SYNDROMIC; Prata N, 2006, INT FAM PLAN PERSPEC, V32, P192, DOI 10.1363/3219206; Rodriguez MDM, 2002, AIDS, V16, P451; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; Sunmola Adegbenga M, 2003, Afr J Reprod Health, V7, P37, DOI 10.2307/3583344	16	8	8	0	5	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2008	13	1					17	20		10.1111/j-1365-3156.2007.01972.x				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	281GL	WOS:000254484800003	18290997				2019-04-02	
J	Moreira, J; Alarcon, F; Bisoffi, Z; Rivera, J; Salinas, R; Menten, J; Duenas, G; Van den Ende, J				Moreira, Juan; Alarcon, Fernando; Bisoffi, Zeno; Rivera, Jose; Salinas, Robert; Menten, Joris; Duenas, Gonzalo; Van den Ende, Jef			Tuberculous meningitis: dies lowering the treatment treshold result in many more treated patients?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						tuberculous meningitis; decision threshold; medical decision making; latent class analysis; clinical reasoning; Ecuador	DECISION-MAKING; GOLD STANDARD; DIAGNOSIS; CHEMOTHERAPY; THRESHOLD; FEATURES; ADULTS; TESTS	OBJECTIVE To determine how many more patients would be treated when lowering the treatment threshold for tuberculous meningitis. METHODS From 1989 to 2004 findings of patients with symptoms lasting more than 1 week and inflammatory changes of cerebrospinal fluid (CSF) were collected. Several models of latent class analysis were tested. Cumulative numbers of cases were plotted against different cut-offs for post-test probability. RESULTS In a cohort of 232 patients the prevalence of tuberculous meningitis (TBM) was estimated at 79.8% (95% CI. 67,0-88,1); probabilities above 80% were reached in 73% of patients. Lowering this threshold from 80% to 20% would add 14% more patients to be treated, for a total of 87%. A further lowering of the threshold to 5% would imply 5% more patients to be treated, bringing the cumulative number to 92%. The difference of lowering the threshold from 80% to 5% was 19%. CONCLUSION In this setting, at least 75% of patients showing suggestive symptoms for more than a week and CSF changes very probably had TBM. The number of patients that should be treated does not increase linearly when lowering the threshold.	[Alarcon, Fernando; Rivera, Jose; Salinas, Robert] Hosp Eugenio Espejo, Dept Neurol, Quito, Ecuador; [Moreira, Juan; Menten, Joris; Van den Ende, Jef] Inst Trop Med, B-2000 Antwerp, Belgium; [Bisoffi, Zeno] Osped Sacrocuore, Ctr Malattie Trop, Verona, Italy; [Duenas, Gonzalo] Hosp Metropolitano, Serv Radiol, Quito, Ecuador	Alarcon, F (reprint author), Hosp Eugenio Espejo, Dept Neurol, Quito, Ecuador.	alyosha@access.net.ec	Bisoffi, Zeno/B-6438-2013				Alarcon F, 2000, MOVEMENT DISORD, V15, P561, DOI 10.1002/1531-8257(200005)15:3<561::AID-MDS1021>3.0.CO;2-K; ALARCON F, 1990, ARCH NEUROL-CHICAGO, V47, P1313, DOI 10.1001/archneur.1990.00530120057010; Albert PS, 2004, BIOMETRICS, V60, P427, DOI 10.1111/j.0006-341X.2004.00187.x; Baltussen R, 2005, BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Basinga P, 2007, MED DECIS MAKING, V27, P53, DOI 10.1177/0272989X06297104; Clarke P, 2005, NEW ENGL J MED, V352, P919, DOI 10.1056/NEJMcps040804; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Garcia-Monco JC, 1999, NEUROL CLIN, V17, P737, DOI 10.1016/S0733-8619(05)70164-X; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Goetghebeur E, 2000, STAT METHODS MED RES, V9, P231, DOI 10.1191/096228000701555127; Hagenaars Jacques A., 2002, APPL LATENT CLASS AN; Kopelman RI, 1999, NEW ENGL J MED, V341, P435, DOI 10.1056/NEJM199908053410608; Lazarsfeld Paul F., 1968, LATENT STRUCTURE ANA; LIPSKY BA, 1984, REV INFECT DIS, V6, P214; Little R. J. A., 1987, STAT ANAL MISSING DA; MARSHALL G, 1948, LANCET, P582; Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; PAUKER SG, 1975, NEW ENGL J MED, V293, P229, DOI 10.1056/NEJM197507312930505; R Development Core Team, 2006, R LANG ENV STAT COMP; Ritov I, 1999, ORGAN BEHAV HUM DEC, V79, P79, DOI 10.1006/obhd.1999.2839; Sackett D. L., 1991, CLIN EPIDEMIOLOGY BA; SPIEGELHALTER DJ, 2001, WINBUGS USER MANUAL; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P996, DOI 10.1128/JCM.42.3.996-1002.2004; Thwaites GE, 2005, J INFECT DIS, V192, P79, DOI 10.1086/430616; Thwaites GE, 2005, LANCET NEUROL, V4, P160, DOI 10.1016/S1474-4422(05)01013-6; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; UDANI PM, 1971, J NEUROL SCI, V14, P341, DOI 10.1016/0022-510X(71)90222-X; *UNAIDS, 2005, EP UPD DEC 2005; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; Van den Ende J, 2005, LANCET, V366, P548, DOI 10.1016/S0140-6736(05)67096-1; VERMUNT J, 2000, LATENT GOLD USERS MA; Vermunt J. K., 2004, SAGE ENCY SOCIAL SCI, P549; *WHO, 2005, GLOBAL TUBERCULOSIS	37	11	11	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2008	13	1					68	75		10.1111/j.1365-3156.2007.01975.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	281GL	WOS:000254484800010	18291004				2019-04-02	
J	Nahum, A; Erhart, A; Gazard, D; Agbowai, C; Van Overmeir, C; van Loen, H; Menten, J; Akogbeto, M; Coosemans, M; Massougbodji, A; D'Alessandro, U				Nahum, Alain; Erhart, Annette; Gazard, Dorothee; Agbowai, Carine; Van Overmeir, Chantal; van Loen, Harry; Menten, Joris; Akogbeto, Martin; Coosemans, Marc; Massougbodji, Achille; D'Alessandro, Umberto			Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM; CHLOROQUINE RESISTANCE; AMODIAQUINE; MUTATIONS; MEFLOQUINE	Background: Benin has recently shifted its national antimalarial drug policy from monotherapies to combinations containing artemisinin derivatives. When this decision was taken, the available information on alternatives to chloroquine and sulphadoxine-pyrimethamine, the first-and second-line treatment, was sparse. Methods: In 2003-2005, before the drug policy change, a randomized, open-label, clinical trial was carried out on the efficacy of chloroquine, and sulphadoxine-pyrimethamine alone or combined with artesunate, with the aim of providing policy makers with the information needed to formulate a new antimalarial drug policy. Children between six and 59 months of age, with uncomplicated malaria and living in the lagoon costal area in southern Benin, were randomly allocated to one of the three study arms and followed up for 28 days. Results: Treatment failure (PCR corrected) was significantly lower in the artesunate + sulphadoxine-pyrimethamine group (4/77, 5.3%) than in chloroquine group(51/71, 71.8%) or the sulphadoxine-pyrimethamine alone group (30/70, 44.1%) (p < 0.001). Despite high sulphadoxine-pyrimethamine failure, its combination with artesunate greatly improved treatment efficacy. Conclusion: In Benin, artesunate + sulphadoxine-pyrimethamine is efficacious and could be used when the recommended artemisinin-based combinations (artemether-lumefantrine and amodiaquine-artesunate) are not available. However, because sulphadoxine-pyrimethamine is also used in pregnant women as intermittent preventive treatment, its combination with artesunate should not be widely employed in malaria patients as this may compromise the efficacy of intermittent preventive treatment.	[Nahum, Alain; Agbowai, Carine; Akogbeto, Martin] Ctr Rech Entomol Cotonou, Parasitol Lab, Cotonou, Benin; [Erhart, Annette; Van Overmeir, Chantal; van Loen, Harry; Menten, Joris; Coosemans, Marc; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; [Gazard, Dorothee; Massougbodji, Achille] Univ Natl Benin, Fac Sci Sante, Parasitol Lab, Cotonou, Benin	Nahum, A (reprint author), Ctr Rech Entomol Cotonou, Parasitol Lab, Cotonou, Benin.	nahum_alain@yahoo.fr; aerhart@itg.be; kindegazard@yahoo.fr; cagbowai@yahoo.fr; cvoverm@itg.be; hvanloen@itg.be; jmenten@itg.be; akogbeto@leland.bj; mcoosemans@itg.be; massoubdodjiachille@yahoo.fr; udalessandro@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009			AKOGBETO M, 1992, REV EPIDEMIOL SANTE, V40, P233; Akogbeto M., 1992, Parassitologia (Rome), V34, P147; AKOGBETO M, 1992, THESIS U PARIS 11; [Anonymous], 2005, POL NAT LUTT CONTR P; Chanda P, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-21; CHIPPAUX JP, 1990, B SOC PATHOL EXOT, V83, P320; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Dokomajilar C, 2006, AM J TROP MED HYG, V75, P162, DOI 10.4269/ajtmh.2006.75.162; Duraisingh MT, 1997, PARASITOLOGY, V114, P205, DOI 10.1017/S0031182096008487; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(00)00084-8; Happi CT, 2006, AM J TROP MED HYG, V75, P155, DOI 10.4269/ajtmh.2006.75.155; Ibrahium AM, 2007, ANN TROP MED PARASIT, V101, P15, DOI 10.1179/136485907X156924; LEBRAS J, 1986, LANCET, V2, P1043; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; *PROGR NAT LUTT CO, 2003, REPR DEP FICH SUIV I; *PROGR NAT LUTT CO, 2004, AT CONS CHANG POL TR; *PROGR NAT LUTT CO, 2006, INF ESS TRAIT PREV I; RANFORDCARTWRIGHT LC, 1993, PARASITOLOGY, V107, P11, DOI 10.1017/S003118200007935X; ROSENHEIM M, 1987, T ROY SOC TROP MED H, V81, P498, DOI 10.1016/0035-9203(87)90174-X; Sharma YD, 2005, INDIAN J MED RES, V121, P13; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; WHO, 2003, ASS MON ANT DRUG EFF; *WHO, 2002, MON ANT MAL DRUGS RE; *WHO, 2000, T R SOC TROP MED S1, V94, P1; 1996, WHOMAL961077	27	11	11	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	DEC 21	2007	6								170	10.1186/1475-2875-6-170				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	264WE	WOS:000253320300001	18154655	DOAJ Gold, Green Published			2019-04-02	
J	Protopopoff, N; Van Bortel, W; Marcotty, T; Van Herp, M; Maes, P; Baza, D; D'Alessandro, U; Coosemans, M				Protopopoff, Natacha; Van Bortel, Wim; Marcotty, Tanguy; Van Herp, Michel; Maes, Peter; Baza, Dismas; D'Alessandro, Umberto; Coosemans, Marc			Spatial targeted vector control in the highlands of Burundi and its impact on malaria transmission	MALARIA JOURNAL			English	Article							WESTERN KENYA HIGHLANDS; EARLY WARNING SYSTEMS; ANOPHELES-FUNESTUS; EPIDEMIC MALARIA; AFRICA; INSECTICIDE; IDENTIFICATION; INTERVENTIONS; ETHIOPIA; COMPLEX	Background: Prevention of malaria epidemics is a priority for African countries. The 2000 malaria epidemic in Burundi prompted the government to implement measures for preventing future outbreaks. Case management with artemisinin-based combination therapy and malaria surveillance were nationally improved. A vector control programme was initiated in one of the most affected highland provinces. The focal distribution of malaria vectors in the highlands was the starting point for designing a targeted vector control strategy. The objective of this study was to present the results of this strategy on malaria transmission in an African highland region. Methods: In Karuzi, in 2002-2005, vector control activities combining indoor residual spraying and long-lasting insecticidal nets were implemented. The interventions were done before the expected malaria transmission period and targeted the valleys between hills, with the expectation that this would also protect the populations living at higher altitudes. The impact on the Anopheles population and on malaria transmission was determined by nine cross-sectional surveys carried out at regular intervals throughout the study period. Results: Anopheles gambiae s.l. and Anopheles funestus represented 95% of the collected anopheline species. In the valleys, where the vector control activities were implemented, Anopheles density was reduced by 82% ( 95% CI: 69-90). Similarly, transmission was decreased by 90% ( 95% CI: 63%-97%, p = 0.001). In the sprayed valleys, Anopheles density was further reduced by 79.5% ( 95% CI: 51.7-91.3, p < 0.001) in the houses with nets as compared to houses without them. No significant impact on vector density and malaria transmission was observed in the hill tops. However, the intervention focused on the high risk areas near the valley floor, where 93% of the vectors are found and 90% of the transmission occurs. Conclusion: Spatial targeted vector control effectively reduced Anopheles density and transmission in this highland district. Bed nets have an additional effect on Anopheles density though this did not translate in an additional impact on transmission. Though no impact was observed in the hilltops, the programme successfully covered the areas most at risk. Such a targeted strategy could prevent the emergence and spread of an epidemic from these high risk foci.	[Protopopoff, Natacha; Van Bortel, Wim; D'Alessandro, Umberto; Coosemans, Marc] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; [Marcotty, Tanguy] Inst Trop Med Prince Leopold, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Protopopoff, Natacha; Van Herp, Michel; Maes, Peter] Med Sans Frontieres Belgium, Dept Med, Brussels, Belgium; [Baza, Dismas] Minist Hlth, Programme Lutte Contre Malad Transmissibles & Car, Bujumbura, Burundi; [Coosemans, Marc] Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, Dept Biomed Sci, B-2610 Antwerp, Belgium	Protopopoff, N (reprint author), Inst Trop Med Prince Leopold, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	nprotopopoff@itg.be; wvbortel@itg.be; tmarcotty@itg.be; michel.van.herp@msf.be; Peter.Maes@msf.be; bazadismas@yahoo.fr; UDAlessandro@itg.be; mcoosemans@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Van Bortel, Wim/0000-0002-6644-518X; Protopopoff, Natacha/0000-0001-6698-4936			Abeku TA, 2007, EMERG INFECT DIS, V13, P681, DOI 10.3201/eid1305.061333; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Checchi F, 2006, EMERG INFECT DIS, V12, P1477, DOI 10.3201/eid1210.060540; COTICELLI P, 2007, AFRICA FIGHTING MALA; Cox J, 2007, TRENDS PARASITOL, V23, P243, DOI 10.1016/j.pt.2007.03.008; Diabate A, 2006, TROP MED INT HEALTH, V11, P597, DOI 10.1111/j.1365-3156.2006.01605.x; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; Garros C, 2004, AM J TROP MED HYG, V70, P260, DOI 10.4269/ajtmh.2004.70.260; Gillies MT, 1987, SUPPLEMENT ANOPHELIN; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Grover-Kopec E, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-6; Guthmann JP, 2007, EMERG INFECT DIS, V13, P140, DOI 10.3201/eid1301.060546; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P298, DOI 10.1046/j.1365-3156.2002.00874.x; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; JADIN J, 1951, Ann Soc Belg Med Trop (1920), V31, P353; Jambou R, 2001, T ROY SOC TROP MED H, V95, P14, DOI 10.1016/S0035-9203(01)90317-7; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; Malakooti MA, 1998, EMERG INFECT DIS, V4, P671, DOI 10.3201/eid0404.980422; Minakawa N, 2004, MED VET ENTOMOL, V18, P301, DOI 10.1111/j.0269-283X.2004.00503.x; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-93; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; SMITH A, 1959, NATURE, V183, P198, DOI 10.1038/183198a0; Takken W, 1990, ENV MEASURES MALARIA, P90; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; WHO, 1975, MAN PRACT ENT MAL 2; *WHO, 2003, MAL EP FOR PREV EARL; WHO, 2007, INS TREAT MOSQ NETS; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; World Health Organization, 2000, AFR SUMM ROLL BACK M; Zhou GF, 2004, J MED ENTOMOL, V41, P1001, DOI 10.1603/0022-2585-41.6.1001; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29	34	38	38	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	DEC 3	2007	6								158	10.1186/1475-2875-6-158				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	260GK	WOS:000252998600001	18053166	DOAJ Gold, Green Published			2019-04-02	
J	Coulibaly, SO; Gies, S; D'Alessandro, U				Coulibaly, Sheick Oumar; Gies, Sabine; D'Alessandro, Umberto			Malaria burden among pregnant women living in the rural district of Boromo, Burkina Faso	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							LOW BIRTH-WEIGHT; WEST-AFRICAN VILLAGE; SUB-SAHARAN AFRICA; PAPUA-NEW-GUINEA; PLASMODIUM-FALCIPARUM; PLACENTAL MALARIA; ENDEMIC AREA; ANEMIA; INFECTION; EPIDEMIOLOGY	In two cross-sectional surveys carried out in the rural health district of Boromo, Burkina Faso, malaria infection was evaluated in 295 pregnant women in May 2003 and 288 pregnant women in December 2003. Malaria prevalence, all P. falciparum infect ion, was higher in December (32.2%) than in May (11.9%) (P < 0.0001). In both surveys primigravidae had a significantly higher risk of infection than multigravidae (P < 0.0001). Such risk decreased significantly and progressively with gestational age, the highest risk being during the first trimester. Women who had not attended the antenatal clinic had also a significantly higher risk of malaria infection. Despite the high antenatal clinic attendance and the use (or misuse) of chloroquine chemoprophylaxis, malaria remains an important problem for pregnant women living in the rural district of Boromo. This requires a major effort by the health authorities to guarantee all pregnant women have access to and use preventive measures.	[Coulibaly, Sheick Oumar] Lab Natl Sante Publ, Dept Med Biol, Ouagadougou 09, Burkina Faso; Inst Trop Med, B-2000 Antwerp, Belgium	Coulibaly, SO (reprint author), Lab Natl Sante Publ, Dept Med Biol, 09 BP 24, Ouagadougou 09, Burkina Faso.	sheickoumar@hotmail.com	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009			Bouvier P, 1997, AM J TROP MED HYG, V56, P378, DOI 10.4269/ajtmh.1997.56.378; Bouvier P, 1997, AM J TROP MED HYG, V56, P384, DOI 10.4269/ajtmh.1997.56.384; BRABIN BJ, 1990, ANN TROP MED PARASIT, V84, P11, DOI 10.1080/00034983.1990.11812429; BRABIN BJ, 1988, T ROY SOC TROP MED H, V82, P677, DOI 10.1016/0035-9203(88)90192-7; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; BRABIN BJ, 1991, 1 TDR WHO; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; Diagne N, 1997, T ROY SOC TROP MED H, V91, P166, DOI 10.1016/S0035-9203(97)90209-1; Dicko A, 2003, ACTA TROP, V89, P17, DOI 10.1016/j.actatropica.2003.07.001; Gansane A, 2005, ACTA TROP, V95, pS335; GILLES HM, 1969, ANN TROP MED PARASIT, V63, P245, DOI 10.1080/00034983.1969.11686625; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; JELLIFFE EF, 1968, B WORLD HEALTH ORGAN, V38, P69; KEUTER M, 1990, BMJ-BRIT MED J, V301, P466, DOI 10.1136/bmj.301.6750.466; KORTMAN HFC, 1972, THESIS U VANAMSTERDA; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; MIAFFO C, 2004, BMC PREGNANCY CHILDB, V27, P18; *MIN SANT BURK FAS, 2004, ANN STAT; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; MUTABINGWA TK, 1994, ACTA TROP, V57, P239, DOI 10.1016/0001-706X(94)90070-1; Newman RD, 2003, TROP MED INT HEALTH, V8, P488, DOI 10.1046/j.1365-3156.2003.01066.x; NOSTEN F, 1994, J INFECT DIS, V169, P595, DOI 10.1093/infdis/169.3.595; Rogerson SJ, 2000, AM J TROP MED HYG, V62, P335, DOI 10.4269/ajtmh.2000.62.335; Sirima SB, 2003, CLIN INFECT DIS, V36, P1374, DOI 10.1086/375077; STEKETEE RW, 1987, B WORLD HEALTH ORGAN, V65, P885; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; Van Geertruyden JP, 2005, TROP MED INT HEALTH, V10, P681, DOI 10.1111/j.1365-3156.2005.01431.x; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; World Health Organisation, 2006, MAL PREGN GUID MEAS	35	14	14	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2007	77	6		S			56	60		10.4269/ajtmh.2007.77.56				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	249FJ	WOS:000252212600012	18165475				2019-04-02	
J	Talisuna, AO; Okello, PE; Erhart, A; Coosemans, M; D'Alessandro, U				Talisuna, Ambrose O.; Okello, Paul E.; Erhart, Annette; Coosemans, Marc; D'Alessandro, Umberto			Intensity of malaria transmission and the spread of Plasmodium falciparum-resistant malaria: A review of epidemiologic field evidence	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							ANTIMALARIAL-DRUG RESISTANCE; ELIMINATION HALF-LIFE; CHLOROQUINE RESISTANCE; PYRIMETHAMINE-SULFADOXINE; REDUCING TRANSMISSION; COMBINATION THERAPY; BURKINA-FASO; 7 SITES; PARASITES; INFECTIONS	Malaria transmission intensity has been proposed, based on theoretical models, as an important factor for the spread of falciparum-resistant malaria, but the predictions obtained vary according to the assumptions inherent in the model used. We summarized the available field data on transmission intensity and the prevalence of malaria drug resistance. Resistance to chloroquine and sulphadoxine-pyrimethamine monotherapy was invariably higher where transmission was intense. Vector control interventions were associated with a better chloroquine and sulfadoxine-pyrimethamine efficacy. However, high resistance to chloroquine and also to combination therapy (chloroquine plus sulphadoxine-pyrimethamine and amodiaquine plus sulfadoxine-pyrimethamine) was also observed in very low transmission areas. Reducing transmission intensity is likely to slow the spread of drug resistance. Nevertheless, where transmission is extremely low, to limit the unnecessarv use of antimalarials and a consequent paradoxical acceleration of the spread of resistance, patients should be treated only after laboratory confirmation of malaria.	[Talisuna, Ambrose O.] Minist Hlth, Epidemiol Surveillance Div, Kampala, Uganda; [Talisuna, Ambrose O.] E African Network Monitoring Atimalarial Treatmen, Kampala, Uganda; [Erhart, Annette; Coosemans, Marc; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium	Talisuna, AO (reprint author), Minist Hlth, Epidemiol Surveillance Div, POB 7272, Kampala, Uganda.	atalisuna@afsat.com	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009			Alifrangis M, 2003, AM J TROP MED HYG, V69, P238, DOI 10.4269/ajtmh.2003.69.238; Anderson TJC, 2005, ACTA TROP, V94, P269, DOI 10.1016/j.actatropica.2005.04.010; Arnot D, 1998, T ROY SOC TROP MED H, V92, P580, DOI 10.1016/S0035-9203(98)90773-8; Babiker HA, 1997, PARASITOL TODAY, V13, P262, DOI 10.1016/S0169-4758(97)01075-2; Barnes KI, 2005, ACTA TROP, V94, P230, DOI 10.1016/j.actatropica.2005.04.014; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; CATTANNI JA, 1985, PAPUA NEW GUINEA MED, V29, P11; Charlwood JD, 1998, AM J TROP MED HYG, V59, P243, DOI 10.4269/ajtmh.1998.59.243; CROSS AP, 1991, T ROY SOC TROP MED H, V85, P349, DOI 10.1016/0035-9203(91)90286-8; CURTIS CF, 1986, T ROY SOC TROP MED H, V80, P889, DOI 10.1016/0035-9203(86)90248-8; Diallo DA, 2007, AM J TROP MED HYG, V76, P237, DOI 10.4269/ajtmh.2007.76.237; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Drakeley CJ, 2004, TROP MED INT HEALTH, V9, P53, DOI 10.1046/j.1365-3156.2003.01169.x; Farnert A, 1999, J INFECT DIS, V179, P989, DOI 10.1086/314652; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(00)00084-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; Greenwood B, 2002, TROP MED INT HEALTH, V7, P1012, DOI 10.1046/j.1365-3156.2002.00980.x; Hallett RL, 2004, ANTIMICROB AGENTS CH, V48, P3940, DOI 10.1128/AAC.48.10.3940-3943.2004; Hastings IM, 2006, TROP MED INT HEALTH, V11, P1206, DOI 10.1111/j.1365-3156.2006.01668.x; Hastings IM, 1997, PARASITOLOGY, V115, P133, DOI 10.1017/S0031182097001261; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Hastings IM, 2002, PHILOS T ROY SOC B, V357, P505, DOI 10.1098/rstb.2001.1036; Hastings IM, 2001, TROP MED INT HEALTH, V6, P883, DOI 10.1046/j.1365-3156.2001.00800.x; Hastings IM, 2005, ACTA TROP, V94, P218, DOI 10.1016/j.actatropica.2005.04.003; Hastings IM, 1998, PARASITOLOGY, V117, P411, DOI 10.1017/S0031182098003291; Lee SA, 2006, J INFECT DIS, V193, P1160, DOI 10.1086/501473; Mackinnon MJ, 1998, T ROY SOC TROP MED H, V92, P188, DOI 10.1016/S0035-9203(98)90745-3; MBOGO CNM, 1995, AM J TROP MED HYG, V52, P201, DOI 10.4269/ajtmh.1995.52.201; Mharakurwa S, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-35; Molyneux DH, 1999, PARASITOL TODAY, V15, P238, DOI 10.1016/S0169-4758(99)01453-2; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Paganotti GM, 2004, AM J TROP MED HYG, V71, P173, DOI 10.4269/ajtmh.2004.71.173; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; PRUDHOMMEOMEARA W, 2006, PLOS MED, V3, pE141; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Reyburn H, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-4; Rogier C., 1999, Parassitologia (Rome), V41, P255; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; SCHMIDT KF, 1995, SCIENCE, V269, P1670, DOI 10.1126/science.7569890; Sibley CH, 2001, TRENDS PARASITOL, V17, P582, DOI 10.1016/S1471-4922(01)02085-2; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Slater M, 2005, AM J TROP MED HYG, V73, P256, DOI 10.4269/ajtmh.2005.73.256; Smith T, 1998, AM J TROP MED HYG, V59, P252, DOI 10.4269/ajtmh.1998.59.252; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Talisuna AO, 2003, INT J PARASITOL, V33, P1051, DOI 10.1016/S0020-7519(03)00156-5; Talisuna AO, 2002, T ROY SOC TROP MED H, V96, P310, DOI 10.1016/S0035-9203(02)90108-2; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WATKINS WM, 1993, T ROY SOC TROP MED H, V87, P75, DOI 10.1016/0035-9203(93)90431-O; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; WERNSDORFER WH, 1994, ACTA TROP, V56, P143, DOI 10.1016/0001-706X(94)90060-4; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White N. J., 1999, Parassitologia (Rome), V41, P301; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; WHO, 1965, RES MAL PAR DRUGS; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	64	37	37	0	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2007	77	6		S			170	180						11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	249FJ	WOS:000252212600027	18165490				2019-04-02	
J	Ballou, WR; Cahill, CP				Ballou, W. Ripley; Cahill, Conor P.			Two decades of commitment to malaria vaccine development: GlaxoSmithKline biologicals	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CIRCUMSPOROZOITE PROTEIN VACCINE; B SURFACE-ANTIGEN; RANDOMIZED CONTROLLED-TRIAL; INSTITUTE-OF-RESEARCH; SEMI-IMMUNE ADULTS; PHASE-I SAFETY; CD4(+) T-CELL; RECOMBINANT PROTEIN; SPOROZOITE VACCINE	GlaxoSmithKline Biologicals (GSK) is committed to the development of a safe and effective malaria vaccine. Its research program in this field was initiated in 1984 and has been continuously active to this day, making it unparalleled within the vaccine industry. Although it works in partnerships with several leading organizations from the public sector, this effort has required GSK to invest major financial and human resource commitments, and its partners rely heavily con the company's global infrastructure and expertise in research, advanced clinical development, regulatory, large-scale manufacturing, and cornmercialization. Through GSK's pioneering business model and working in partnership with global vaccine funding agencies, the company is committed to seeing that, once approved, a safe and effective malaria vaccine will be available to everyone that needs it.	[Ballou, W. Ripley; Cahill, Conor P.] GlaxoSmithKline Biol, Global Clin Res & Dev, B-1330 Rixensart, Belgium	Ballou, WR (reprint author), GlaxoSmithKline Biol, Global Clin Res & Dev, 89 Rue Inst, B-1330 Rixensart, Belgium.	ripley.ballou@gskbio.com					AGGARWAL A, 1990, J EXP MED, V172, P1083, DOI 10.1084/jem.172.4.1083; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; ARONSON NE, 1991, AM J TROP MED HYG, V45, P548, DOI 10.4269/ajtmh.1991.45.548; BALLOU WR, 1985, SCIENCE, V228, P996, DOI 10.1126/science.2988126; BALLOU WR, 1987, LANCET, V1, P1277; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; BROWN AE, 1991, AM J TROP MED HYG, V44, P21, DOI 10.4269/ajtmh.1991.44.21; BROWN AE, 1994, VACCINE, V12, P102, DOI 10.1016/0264-410X(94)90046-9; CAMPBELL JR, 1988, AM J TROP MED HYG, V39, P232, DOI 10.4269/ajtmh.1988.39.232; CHAROENVIT Y, 1990, B WORLD HEALTH ORGAN, V68, P26; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; COLLINS WE, 1989, AM J TROP MED HYG, V40, P455, DOI 10.4269/ajtmh.1989.40.455; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; Doherty JF, 1999, AM J TROP MED HYG, V61, P865, DOI 10.4269/ajtmh.1999.61.865; Dunachie SJ, 2006, VACCINE, V24, P2850, DOI 10.1016/j.vaccine.2005.12.041; EGAN JE, 1987, SCIENCE, V236, P453, DOI 10.1126/science.3551073; Epstein JE, 2004, VACCINE, V22, P1592, DOI 10.1016/j.vaccine.2004.01.031; FRIES LF, 1992, P NATL ACAD SCI USA, V89, P358, DOI 10.1073/pnas.89.1.358; FRIES LF, 1992, INFECT IMMUN, V60, P1834; Garcon Nathalie, 2003, Expert Rev Vaccines, V2, P231, DOI 10.1586/14760584.2.2.231; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; GORDON DM, 1991, AM J TROP MED HYG, V45, P49, DOI 10.4269/ajtmh.1991.45.49; GORDON DM, 1990, AM J TROP MED HYG, V42, P527, DOI 10.4269/ajtmh.1990.42.527; Heppner DG, 1996, J INFECT DIS, V174, P361, DOI 10.1093/infdis/174.2.361; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; HOCKMEYER WT, 1986, VACCINE 86; HOFFMAN SL, 1989, J IMMUNOL, V142, P3581; HOLLINGDALE MR, 1987, EXP PARASITOL, V63, P345, DOI 10.1016/0014-4894(87)90182-2; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Ling IT, 1997, VACCINE, V15, P1562, DOI 10.1016/S0264-410X(97)00076-5; Macete E, 2007, TROP MED INT HEALTH, V12, P37, DOI 10.1111/j.1365-3156.2006.01754.x; MALIK A, 1993, INFECT IMMUN, V61, P5062; MOELANS IIMD, 1995, MOL BIOCHEM PARASIT, V72, P179, DOI 10.1016/0166-6851(95)00072-9; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Nussenzweig RS, 1970, J PARASITOL, V56, P350; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Pichyangkul S, 2004, VACCINE, V22, P3831, DOI 10.1016/j.vaccine.2004.07.023; Pinder M, 2004, CLIN EXP IMMUNOL, V135, P286, DOI 10.1111/j.1365-2249.2004.02371.x; Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; QUE JU, 1988, INFECT IMMUN, V56, P2645; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; RICKMAN LS, 1991, LANCET, V337, P998, DOI 10.1016/0140-6736(91)92659-P; RUTGERS T, 1988, BIO-TECHNOL, V6, P1065, DOI 10.1038/nbt0988-1065; SADOFF JC, 1988, SCIENCE, V240, P336, DOI 10.1126/science.3281260; SCHOFIELD L, 1987, J IMMUNOL, V139, P2020; Schwenk R, 2003, PARASITE IMMUNOL, V25, P17, DOI 10.1046/j.1365-3024.2003.00495.x; SHERWOOD JA, 1991, T ROY SOC TROP MED H, V85, P336, DOI 10.1016/0035-9203(91)90281-3; Sherwood JA, 1996, VACCINE, V14, P817, DOI 10.1016/0264-410X(95)00221-L; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Stewart VA, 2006, VACCINE, V24, P6493, DOI 10.1016/j.vaccine.2006.06.035; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; VREDEN SGS, 1991, AM J TROP MED HYG, V45, P533, DOI 10.4269/ajtmh.1991.45.533; Walsh DS, 2004, AM J TROP MED HYG, V70, P499, DOI 10.4269/ajtmh.2004.70.499; Wang RB, 2004, J IMMUNOL, V172, P5561, DOI 10.4049/jimmunol.172.9.5561; WIRTZ RA, 1987, EXP PARASITOL, V63, P166, DOI 10.1016/0014-4894(87)90158-5; WITHERS MR, 2006, PLOS CLIN TRIALS, V24, pE32; YOUNG JF, 1987, MICROB PATHOGENESIS, V2, P237, DOI 10.1016/0882-4010(87)90121-5; YOUNG JF, 1985, SCIENCE, V228, P958, DOI 10.1126/science.2988125; YOUNG JF, 1987, P 10 INT CONV IMM ES, P251; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	69	19	23	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2007	77	6		S			289	295		10.4269/ajtmh.2007.77.289				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	249FJ	WOS:000252212600042	18165505				2019-04-02	
J	Jansen, FH; Lesaffre, E; Penali, LK; Zattera, MJG; Die-Kakou, H; Bissagnene, E				Jansen, Frans Herwig; Lesaffre, Emmanuel; Penali, Louis Kone; Zattera, Maria-Jose Garcia; Die-Kakou, Henri; Bissagnene, Emmanuel			Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							PLUS SULFADOXINE-PYRIMETHAMINE; PLASMODIUM-FALCIPARUM MALARIA; PLACEBO-CONTROLLED TRIAL; ARTEMETHER-LUMEFANTRINE; UNCOMPLICATED MALARIA; DOUBLE-BLIND; MEFLOQUINE-ARTESUNATE; ANTIMALARIAL EFFICACY; EASTERN SUDAN; AMODIAQUINE	Over the years, multiple articles on Artemisinin-based Combination Therapies (ACTS) were published, highlighting the relative advantages or drawbacks of these combinations. Many studies were comparative. Because none of the studies compare all combinations and methodology varies between studies, there is no homogeneity. A multi-treatment Bayesian random-effects meta-analysis was designed to assess the relative effect of each combination therapy to artesunate + sulfadoxine-pyrimethamine (4 mg/kg/day for 3 days). By far the most attractive result for the variable adequate clinical and parasitological response at day 28 PCR corrected is given by the combination artemether-lumefantrine. Annual follow-up on the data published is intended to reveal the changes in the relative drug efficacy values of ACTS.	ACT ion Afrique, Brussels, Belgium; Univ Leuven, Biostat Ctr, Louvain, Belgium	Jansen, FH (reprint author), Witte Bremlaan 30, B-2360 Oud Turnhout, Belgium.	fh.jansen@actionafrique.org					Adam I, 2005, ANN TROP MED PARASIT, V99, P449, DOI 10.1179/136485905X36299; Adam I, 2005, ANN TROP MED PARASIT, V99, P111, DOI 10.1179/136485905X19801; Adjuik M, 2004, LANCET, V363, P9; Ashley EA, 2005, CURR OPIN INFECT DIS, V18, P531, DOI 10.1097/01.qco.0000186848.46417.6c; Avila JC, 2004, TROP MED INT HEALTH, V9, P217, DOI 10.1046/j.1365-3156.2003.01184.x; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; CHANDA P, 2006, ASSESSMENT THERAPEUT; Checchi F, 2004, TROP MED INT HEALTH, V9, P445, DOI 10.1111/j.1365-3156.2004.01217.x; Falade C, 2005, T ROY SOC TROP MED H, V99, P459, DOI 10.1016/j.trstmh.2004.09.013; Guthmann JP, 2005, T ROY SOC TROP MED H, V99, P485, DOI 10.1016/j.trstmh.2004.11.010; Hamour S, 2005, T ROY SOC TROP MED H, V99, P548, DOI 10.1016/j.trstmh.2004.10.003; Hutagalung R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-46; Koram KA, 2005, ACTA TROP, V95, P194, DOI 10.1016/j.actatropica.2005.06.018; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Obonyo CO, 2003, T ROY SOC TROP MED H, V97, P585, DOI 10.1016/S0035-9203(03)80038-X; Priotto G, 2003, T ROY SOC TROP MED H, V97, P325, DOI 10.1016/S0035-9203(03)90161-1; Rwagacondo CE, 2004, TROP MED INT HEALTH, V9, P1091, DOI 10.1111/j.1365-3156.2004.01316.x; Rwagacondo CE, 2003, AM J TROP MED HYG, V68, P743, DOI 10.4269/ajtmh.2003.68.743; Sirima SB, 2003, T ROY SOC TROP MED H, V97, P345, DOI 10.1016/S0035-9203(03)90166-0; SPEGELHALTER D, 2003, WINBUGS VERSION 1 4; Toovey S, 2006, TOXICOL LETT, V166, P95, DOI 10.1016/j.toxlet.2006.06.001; van den Broek IV, 2005, T ROY SOC TROP MED H, V99, P727, DOI 10.1016/j.trstmh.2005.02.007; *WHO, 2006, WHOHTMMAL20061108; WHO, 2003, WHOHTMRBM200350; World Health Organization, 2001, WHOCDSRBM200135	28	15	17	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2007	77	6					1005	1009		10.4269/ajtmh.2007.77.1005				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	248AH	WOS:000252123200003	18165512				2019-04-02	
J	Phanzu, DM; Ablordey, A; Imposo, DB; Lefevre, L; Mahema, RL; Suykerbuyk, P; Meyers, WM; Portaels, F				Phanzu, Delphin M.; Ablordey, Anthony; Imposo, Desire B.; Lefevre, Lucien; Mahema, Roger L.; Suykerbuyk, Patrick; Meyers, Wayne M.; Portaels, Francoise			Short report: Edematous Mycobacterium ulcerans infection (Buruli ulcer) on the face: A case report	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							DISEASE; EPIDEMIOLOGY; CONGO	We report a case of a four-year-old Angolan boy with the edematous form of Buruli ulcer on the face and scalp, who was treated at a rural hospital in the Bas-Congo Province, Democratic Republic of Congo. Treatment consisted of a series of surgical interventions and antimycobacterial chemotherapy (rifampin and ciprofloxacin) for two months. This case demonstrates the diagnostic and management difficulties of an edematous lesion of BU on the face and suggests an enhancement of healing and limitation of extent of excision by specific antibiotherapy. The outcome in this patient also underscores the importance of prompt referral of suspected cases and training of health professionals in the early diagnosis of BU.	[Suykerbuyk, Patrick; Portaels, Francoise] Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, Nationalstr 155, B-2000 Antwerp, Belgium; [Phanzu, Delphin M.; Imposo, Desire B.; Mahema, Roger L.] Inst Med Evangelique, Kimpese, DEM REP CONGO; [Lefevre, Lucien] Onze Lieve Vrouw Hosp, Aalst, Belgium	Portaels, F (reprint author), Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, Nationalstr 155, B-2000 Antwerp, Belgium.	portaels@itg.be					ASIEDU K, 2001, BURULI ULCER MYCOBAC; Bafende AE, 2004, TROP DOCT, V34, P82, DOI 10.1177/004947550403400207; Debacker M, 2004, TROP MED INT HEALTH, V9, P1297, DOI 10.1111/j.1365-3156.2004.01339.x; Debacker M, 2004, EMERG INFECT DIS, V10, P1391, DOI 10.3201/eid1008.030886; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.; Janssens P, 2005, B SEANCES ACAD R SCI, V51, P265; Johnson R C, 2004, Med Trop (Mars), V64, P145; Kibadi K, 2007, Med Trop (Mars), V67, P241; KIBADI K, 2004, B SOC PATHOL EXOT, V97, P302; KIBADI K, 2003, CAHIERS SANTE, V13, P39; Meyers W M, 1974, Ann Soc Belg Med Trop, V54, P147; MEYERS WM, 1995, TROPICAL PATHOLOGY, P291; Phanzu DM, 2006, AM J TROP MED HYG, V75, P311, DOI 10.4269/ajtmh.2006.75.311; PORTAELS F, 1989, ANN SOC BELG MED TR, V69, P91; PORTAELS F, 2008, IN PRESS CLIN DERMAT; Portaels F, 2001, BURULI ULCER DIAGNOS; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; *WHO, 2004, WHOCDSCPEGBUI200410; 2004, WKLY EPIDEMIOL REC, V79, P194	19	4	4	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2007	77	6					1099	1102		10.4269/ajtmh.2007.77.1099				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	248AH	WOS:000252123200021	18165530				2019-04-02	
J	Mutesa, L; Muganga, N; Lissens, W; Boemer, F; Schoos, R; Pierquin, G; Bours, V				Mutesa, Leon; Muganga, Narcisse; Lissens, Willy; Boemer, Francois; Schoos, Roland; Pierquin, Genevieve; Bours, Vincent			Molecular analysis in two siblings African patients with severe form of Hunter syndrome: Identification of a novel (p.Y54X) nonsense mutation	JOURNAL OF TROPICAL PEDIATRICS			English	Article						African patients; Hunter syndrome; iduronate-2-sulfatase; nonsense mutation	IDURONATE-2-SULFATASE GENE; DISEASE; DECAY	Hunter syndrome (or Mucopolysaccharidosis type II, MPS II) is an X-linked recessive disorder due to the deficiency of the iduronate-2-sulfatase (IDS) enzyme, resulting in the accumulation of heparan and dermatan sulfates in the lysosomes. The heterogeneity of clinical phenotypes, ranging from mild-to-severe forms, is a result of different mutations in the IDS gene. We report here, a novel nonsense mutation (p.Y54X) in two siblings MPS II African patients affected with a severe form of the disease. We postulated that the p.Y54X mutation which causes a loss of the IDS region highly conserved among sulfatase enzymes, could be predicted as a severe disease-causing mutation for Hunter syndrome.	[Mutesa, Leon; Boemer, Francois; Schoos, Roland; Pierquin, Genevieve; Bours, Vincent] Univ Liege, CHU Sart Tilman, Ctr Human Genet, B-4000 Liege, Belgium; [Muganga, Narcisse] Natl Univ Rwanda, Dept Paediat, Kigali, Rwanda; [Lissens, Willy] Dutch Speaking Free Univ Brussels, Ctr Med Genet, Brussels, Belgium	Bours, V (reprint author), Univ Liege, CHU Sart Tilman, Ctr Human Genet, B-4000 Liege, Belgium.	vbours@ulg.ac.be	Lissens, Willy/B-2892-2013	Lissens, Willy/0000-0003-3875-9955; BOEMER, Francois/0000-0003-4470-9524			FLOMEN RH, 1993, HUM MOL GENET, V2, P5, DOI 10.1093/hmg/2.1.5; JONSSON JJ, 1995, AM J HUM GENET, V56, P597; Li PN, 1996, AM J MED GENET, V64, P531, DOI 10.1002/(SICI)1096-8628(19960906)64:4<531::AID-AJMG1>3.3.CO;2-T; Lissens W, 1997, J INHERIT METAB DIS, V20, P453, DOI 10.1023/A:1005335624386; Lualdi S, 2006, BBA-MOL BASIS DIS, V1762, P478, DOI 10.1016/j.bbadis.2006.01.003; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; NEUFELD EF, 1995, METABOLIC MOL BASES, P2465; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; SUKEGAWA K, 1995, HUM MUTAT, V6, P136, DOI 10.1002/humu.1380060206; Vafiadaki E, 1998, ARCH DIS CHILD, V79, P237, DOI 10.1136/adc.79.3.237; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531	11	3	4	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338			J TROP PEDIATRICS	J. Trop. Pediatr.	DEC	2007	53	6					434	437		10.1093/tropej/fmm056				4	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	246DX	WOS:000251988800014	17616540	Bronze			2019-04-02	
J	Das, ML; Singh, SP; Vanlerberghe, V; Rijal, S; Rai, M; Karki, P; Sundar, S; Boelaert, M				Das, Murari L.; Singh, Shri P.; Vanlerberghe, Veerle; Rijal, Suman; Rai, Madhukar; Karki, Prahlad; Sundar, Shyam; Boelaert, Marleen			Population Preference of Net Texture prior to Bed Net Trial in Kala-Azar-Endemic Areas	PLOS NEGLECTED TROPICAL DISEASES			English	Article							INSECTICIDE-TREATED BEDNETS; VISCERAL LEISHMANIASIS; IMPREGNATED BEDNETS; CUTANEOUS LEISHMANIASIS; PROTECTIVE EFFICACY; VECTOR; NEPAL; SUDAN	Prior to a community-based efficacy trial of long-lasting insecticidal nets (LLINs) in the prevention of visceral leishmaniasis (VL; also called kala-azar), a pilot study on preference of tools was held in endemic areas of India and Nepal in September 2005. LLINs made of polyester and polyethylene were distributed to 60 participants, who used the nets sequentially for 7 d. Acceptability and preference were evaluated via indirect indicators through questionnaires at three defined time points before and after use of the LLINs and through focus group discussions (FGDs). In the latter, preferences for color and size were also assessed. Untreated bed nets were owned by 87% of the households prior to the study. All users liked textures of both LLIN types after 7 d of use, but had a slight preference for those made of polyester if they were to recommend a LLIN to relatives or friends (p<0.05), mainly because of their relatively greater softness in comparison to polyethylene LLINs. Users reported that both net types reduced mosquito bites and number of insects, including sand fly (bhusana; genus Phlebotomus), inside the house. Side effects were minor and disappeared quickly. The large-scale intervention trial considered the preferences of the study population to decide on the best tool of intervention-light-blue, rectangular, polyester LLINs of different sizes.	[Das, Murari L.; Rijal, Suman; Karki, Prahlad] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Singh, Shri P.; Rai, Madhukar; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Vanlerberghe, Veerle; Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium	Das, ML (reprint author), BP Koirala Inst Hlth Sci, Dharan, Nepal.	vvanlerberghe@itg.be		Das, Murari/0000-0001-6816-2389	European Commission; KALANET [INCO-CT 2005-015374]	This study was funded by the European Commission, KALANET (Contract INCO-CT 2005-015374), with thanks to Vestergaard-Frandsen and Sumitomo Chemical for providing the LLINs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDY M, 1992, B WORLD HEALTH ORGAN, V70, P341; Alten B, 2003, J VECTOR ECOL, V28, P53; Bern C, 2000, AM J TROP MED HYG, V63, P184, DOI 10.4269/ajtmh.2000.63.184; Courtenay O, 2007, MED VET ENTOMOL, V21, P168, DOI 10.1111/j.1365-2915.2007.00678.x; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Elnaiem DA, 1999, MED VET ENTOMOL, V13, P310, DOI 10.1046/j.1365-2915.1999.00191.x; Jalouk L, 2007, T ROY SOC TROP MED H, V101, P360, DOI 10.1016/j.trstmh.2006.07.011; Jima D, 2005, ETHIOP J HEALTH DEV, V19, P16; NADIM A, 2000, WHOLEISH9537; Reyburn H, 2000, T ROY SOC TROP MED H, V94, P361, DOI 10.1016/S0035-9203(00)90104-4; Ritmeijer K, 2007, TROP MED INT HEALTH, V12, P404, DOI 10.1111/j.1365-3156.2006.01807.x; Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x; Shrestha S. L., 1994, JNMA, Journal of the Nepal Medical Association, V32, P237	13	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2007	1	3							e100	10.1371/journal.pntd.0000100				4	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	383XK	WOS:000261707500005	18160976	DOAJ Gold, Green Published			2019-04-02	
J	Pouillot, R; Matias, G; Wondje, CM; Portaels, F; Valin, N; Ngos, F; Njikap, A; Marsollier, L; Fontanet, A; Eyangoh, S				Pouillot, Regis; Matias, Goncalo; Wondje, Christelle Mbondji; Portaels, Francoise; Valin, Nadia; Ngos, Francois; Njikap, Adelaide; Marsollier, Laurent; Fontanet, Arnaud; Eyangoh, Sara			Risk Factors for Buruli Ulcer: A Case Control Study in Cameroon	PLOS NEGLECTED TROPICAL DISEASES			English	Article							PERMETHRIN-IMPREGNATED BEDNETS; MYCOBACTERIUM-ULCERANS; BCG VACCINE; INFECTION; GHANA; DISEASE; BENIN; EPIDEMIOLOGY; TRANSMISSION; PROTECTION	Background: Buruli ulcer is an infectious disease involving the skin, caused by Mycobacterium ulcerans. This disease is associated with areas where the water is slow-flowing or stagnant. However, the exact mechanism of transmission of the bacillus and the development of the disease through human activities is unknown. Methodology/Principal Findings: A case-control study to identify Buruli ulcer risk factors in Cameroon compared case-patients with community-matched controls on one hand and family-matched controls on the other hand. Risk factors identified by the community-matched study (including 163 pairs) were: having a low level of education, swamp wading, wearing short, lower-body clothing while farming, living near a cocoa plantation or woods, using adhesive bandages when hurt, and using mosquito coils. Protective factors were: using bed nets, washing clothes, and using leaves as traditional treatment or rubbing alcohol when hurt. The family-matched study (including 118 pairs) corroborated the significance of education level, use of bed nets, and treatment with leaves. Conclusions/Significance: Covering limbs during farming activities is confirmed as a protective factor guarding against Buruli ulcer disease, but newly identified factors including wound treatment and use of bed nets may provide new insight into the unknown mode of transmission of M. ulcerans or the development of the disease.	[Pouillot, Regis; Matias, Goncalo] Ctr Pasteur Cameroun, Lab Epidemiol & Sante Publ, Yaounde, Cameroon; [Matias, Goncalo; Valin, Nadia; Fontanet, Arnaud] Inst Pasteur, Unite Epidemiol Maladies Emergentes, Paris, France; [Wondje, Christelle Mbondji; Eyangoh, Sara] Ctr Pasteur Cameroun, Lab Mycobacteries, Yaounde, Cameroon; [Portaels, Francoise] Inst Trop Med, Mycobacterium Unit, B-2000 Antwerp, Belgium; [Ngos, Francois] Ministere Sante Publ, Hop Dist Akonolinga, Yaounde, Cameroon; [Njikap, Adelaide] Med Sans Frontieres Suisse, Yaounde, Cameroon; [Marsollier, Laurent] Univ Angers, Grp Etude Interact Hotes Parasites, Angers, France; [Marsollier, Laurent] Inst Pasteur, Equipe Avenir Inst Natl Sante & Rech Med, Seoul, South Korea	Pouillot, R (reprint author), Ctr Pasteur Cameroun, Lab Epidemiol & Sante Publ, Yaounde, Cameroon.	pouillot@pasteur-yaounde.org; eyangoh@pasteur-yaounde.org	Marsollier, Laurent/P-6178-2015; Pouillot, Regis/E-8103-2010	Pouillot, Regis/0000-0002-6107-5212	Direction des affaires internationales-Institut Pasteur (Paris); Programme Transversaux de Recherche-Institut Pasteur (Paris); Association Francaise Raoul Follereau; World Health Organization; Global Buruli Ulcer Initiative; French Cooperation in Cameroon	This study was financially supported by Direction des affaires internationales-Institut Pasteur (Paris), Programme Transversaux de Recherche-Institut Pasteur (Paris), Association Francaise Raoul Follereau, the World Health Organization/Global Buruli Ulcer Initiative and the French Cooperation in Cameroon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiga H, 2004, AM J TROP MED HYG, V71, P387, DOI 10.4269/ajtmh.2004.71.387; AMOFAH GK, 1993, T ROY SOC TROP MED H, V87, P644, DOI 10.1016/0035-9203(93)90272-R; Aujoulat I, 2003, TROP MED INT HEALTH, V8, P750, DOI 10.1046/j.1365-3156.2003.01089.x; Barker D J, 1972, East Afr Med J, V49, P260; BARKER DJP, 1973, T ROY SOC TROP MED H, V67, P43, DOI 10.1016/0035-9203(73)90317-9; BARKER DJP, 1971, AM J TROP MED HYG, V74, P260; Debacker M, 2006, EMERG INFECT DIS, V12, P1325, DOI 10.3201/eid1209.050598; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; GREENLAND S, 1982, AM J EPIDEMIOL, V116, P402, DOI 10.1093/oxfordjournals.aje.a113424; Hospers IC, 2005, T ROY SOC TROP MED H, V99, P196, DOI 10.1016/j.trstmh.2004.05.004; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; JANSSENS PG, 2005, B SEANCES ACAD R SCI, V51, P165; Johnson PDR, 2007, MED J AUSTRALIA, V186, P64; Johnson PDR, 2005, PLOS MED, V2, P282, DOI 10.1371/journal.pmed.00201108; LAVENDER C, 2006, 9 ANN M WHO GLOB BUR; LINDSAY SW, 1989, MED VET ENTOMOL, V3, P377, DOI 10.1111/j.1365-2915.1989.tb00244.x; MANDER A, 2005, SAMPSI MCC STAT MOD; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; Marsollier L, 2007, PLOS MED, V4, P288, DOI 10.1371/journal.pmed.0040064; MARSTON BJ, 1995, AM J TROP MED HYG, V52, P219, DOI 10.4269/ajtmh.1995.52.219; MEYERS WM, 1974, AM J TROP MED HYG, V23, P919, DOI 10.4269/ajtmh.1974.23.919; Nackers F, 2006, AM J TROP MED HYG, V75, P768, DOI 10.4269/ajtmh.2006.75.768; Noeske J, 2004, AM J TROP MED HYG, V70, P520, DOI 10.4269/ajtmh.2004.70.520; OLUWASANMI JO, 1976, AM J TROP MED HYG, V25, P122, DOI 10.4269/ajtmh.1976.25.122; PONNIGHAUS JM, 1992, LANCET, V339, P636, DOI 10.1016/0140-6736(92)90794-4; Portaels F, 1999, LANCET, V353, P986, DOI 10.1016/S0140-6736(98)05177-0; Raghunathan PL, 2005, CLIN INFECT DIS, V40, P1445, DOI 10.1086/429623; Ravisse P, 1975, MED TROP, V35, P471; Rowland M, 1996, T ROY SOC TROP MED H, V90, P357, DOI 10.1016/S0035-9203(96)90505-2; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; Stienstra Y, 2002, AM J TROP MED HYG, V67, P207, DOI 10.4269/ajtmh.2002.67.207; Stinear T, 1999, J CLIN MICROBIOL, V37, P1018; Temu EA, 1999, MED VET ENTOMOL, V13, P457, DOI 10.1046/j.1365-2915.1999.00194.x; Uganda Buruli Group, 1971, T R SOC TROP MED HYG, V65, P763; UMBOOCK A, 2004, B MED MUNDI SUISSE, V92, P92; VANDERWERF TS, 1989, T ROY SOC TROP MED H, V83, P410, DOI 10.1016/0035-9203(89)90521-X; Veitch MGK, 1997, EPIDEMIOL INFECT, V119, P313, DOI 10.1017/S0950268897008273; *WHO, 2001, WHOCDSCPEGBUI20014; *WHO, 2000, WHOCDSCPEGBUI20001; *WHO, 2005, 199 WHO	40	50	50	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2007	1	3							e101	10.1371/journal.pntd.0000101				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	383XK	WOS:000261707500006	18160977	DOAJ Gold, Green Published			2019-04-02	
J	Garcia, AL; Tellez, T; Parrado, R; Rojas, E; Bermudez, H; Dujardin, JC				Garcia, Ana Lineth; Tellez, Tatiana; Parrado, Rudy; Rojas, Ernesto; Bermudez, Hernan; Dujardin, Jean-Claude			Epidemiological monitoring of American tegumentary leishmaniasis: molecular characterization of a peridomestic transmission cycle in the Amazonian lowlands of Bolivia	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						leishmania; Lutzomyia; epidemiology; molecular diagnostic techniques; PCR; Bolivia	PHLEBOTOMINE SAND FLIES; CUTANEOUS LEISHMANIASIS; FLAGELLATE INFECTIONS; VECTORIAL COMPETENCE; LUTZOMYIA-PERUENSIS; RISK-FACTORS; PSYCHODIDAE; DIPTERA; BRAZIL; STATE	Human-made and environmental changes constitute a major risk factor for the (re-)emergence and spread of leishmaniasis; surveillance of the transmission cycle is essential in this context. This study integrated entomological and molecular parasitological techniques to document the transmission pattern of a peridomestic focus of Leishmania in the Isiboro Secure area of Bolivia. First the spatial distribution and relative density of phlebotomine sand flies, genus Lutzomyia, were established. Lutzomyia shawi was the predominant species in domestic and peridomestic environments (90% from all collections). Second direct application of the hsp70 PCR to sand fly extracts detected Leishmania infections in Lu. shawi only, and gave an estimated infection rate of 0.21 to 0.38%. The cleavage of the hsp70 amplicon with restriction enzymes (hsp70 PCR-RFLP) allowed identification of Le. (V.) braziliensis and Le. (V.) guyanensis in Lu. shawi captured in the same village. These two parasite species were also found in humans from the study region, supporting the co-existence of two transmission cycles involving the same sand fly species. This study demonstrated the use of PCR-RFLP in the identification of Leishmania in sand fly pools which could lead to the development of methods for screening large sand fly populations in Latin America. (C) 2007 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	[Garcia, Ana Lineth; Tellez, Tatiana; Parrado, Rudy; Rojas, Ernesto; Bermudez, Hernan] Univ San Simon, Fac Med, Ctr Univ Med Trop, Cochabamba, Bolivia; [Garcia, Ana Lineth; Dujardin, Jean-Claude] Inst Trop Geneeskunde, Mol Parasitol Lab, B-2000 Antwerp, Belgium	Dujardin, JC (reprint author), Univ San Simon, Fac Med, Ctr Univ Med Trop, Av Aniceto Arce 0371,POB 3023, Cochabamba, Bolivia.	jcdujard@itg.be					ARIAS JR, 1985, AM J TROP MED HYG, V34, P1098, DOI 10.4269/ajtmh.1985.34.1098; Bermudez H., 1993, Archives de l'Institut Pasteur de Tunis, V70, P455; Brandao SP, 1999, T ROY SOC TROP MED H, V93, P488, DOI 10.1016/S0035-9203(99)90346-2; Caceres AG, 2004, AM J TROP MED HYG, V70, P607, DOI 10.4269/ajtmh.2004.70.607; Campbell-Lendrum D, 2001, MEM I OSWALDO CRUZ, V96, P159, DOI 10.1590/S0074-02762001000200004; *CIPA, 1999, COMP AID ID PHLEB SA; CRONIN T M, 1987, Paleontological Society Memoir, P1; Davies C R, 2000, Cad Saude Publica, V16, P925, DOI 10.1590/S0102-311X2000000400013; de Castro EA, 2005, ACTA TROP, V93, P141, DOI 10.1016/j.actatropica.2004.10.004; Desjeux P, 2001, MED MICROBIOL IMMUN, V190, P77, DOI 10.1007/s004300100085; Dujardin JC, 2006, TRENDS PARASITOL, V22, P4, DOI 10.1016/j.pt.2005.11.004; Feliciangeli MD, 1999, PARASITE, V6, P113, DOI 10.1051/parasite/1999062113; FORATTINI OP, 1960, BRAZIL REV BRAS MALA, V12, P69; Galati EAB, 1996, REV SAUDE PUBL, V30, P115, DOI 10.1590/S0034-89101996000200002; Garcia AL, 2007, T ROY SOC TROP MED H, V101, P368, DOI 10.1016/j.trstmh.2006.06.009; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; Kamhawi S, 2000, PARASITOLOGY, V121, P25, DOI 10.1017/S0031182099006125; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; LAINSON R, 1994, MEM I OSWALDO CRUZ, V89, P435, DOI 10.1590/S0074-02761994000300027; Martinez E, 1999, AM J TROP MED HYG, V61, P846, DOI 10.4269/ajtmh.1999.61.846; Meneses CRV, 2005, MED VET ENTOMOL, V19, P38, DOI 10.1111/j.0269-283X.2005.00535.x; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Montoya-Lerma J, 1999, MEM I OSWALDO CRUZ, V94, P277, DOI 10.1590/S0074-02761999000300001; Muskus C, 1997, J PARASITOL, V83, P671, DOI 10.2307/3284245; Oliveira CCG, 2004, ACTA TROP, V90, P155, DOI 10.1016/j.actatropica.2003.11.011; PEREZ JE, 1991, T ROY SOC TROP MED H, V85, P60, DOI 10.1016/0035-9203(91)90158-U; PIMENTA PFP, 1994, P NATL ACAD SCI USA, V91, P9155, DOI 10.1073/pnas.91.19.9155; Reithinger Richard, 2002, Trends in Parasitology, V18, P289, DOI 10.1016/S1471-4922(02)02296-1; RYAN L, 1987, T ROY SOC TROP MED H, V81, P353, DOI 10.1016/0035-9203(87)90133-7; RYAN L, 1990, T ROY SOC TROP MED H, V84, P786, DOI 10.1016/0035-9203(90)90080-X; Sacks DL, 2001, CELL MICROBIOL, V3, P189, DOI 10.1046/j.1462-5822.2001.00115.x; Soares RPP, 2005, INT J PARASITOL, V35, P245, DOI 10.1016/j.ijpara.2004.12.008; SUDIA WD, 1988, J AM MOSQUITO CONTR, V4, P536; TOLEZANO JE, 1994, MEM I OSWALDO CRUZ, V89, P427, DOI 10.1590/S0074-02761994000300026; Torrez M, 1998, ACTA TROP, V71, P311, DOI 10.1016/S0001-706X(98)00068-0; Travi BL, 2002, J MED ENTOMOL, V39, P451, DOI 10.1603/0022-2585-39.3.451; VILLASECA P, 1993, AM J TROP MED HYG, V49, P260, DOI 10.4269/ajtmh.1993.49.260; Williams CJ, 2001, J AQUAT ANIM HEALTH, V13, P300, DOI 10.1577/1548-8667(2001)013<0300:ACOMOS>2.0.CO;2; WILLIAMS P, 1970, T ROY SOC TROP MED H, V64, P317, DOI 10.1016/0035-9203(70)90171-9; Ximenes MDFD, 2000, J MED ENTOMOL, V37, P162, DOI 10.1603/0022-2585-37.1.162; Yadon ZE, 2003, AM J TROP MED HYG, V68, P519, DOI 10.4269/ajtmh.2003.68.519; Young D. G., 1994, GUIDE IDENTIFICATION	42	26	29	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	DEC	2007	101	12					1208	1213		10.1016/j.trstmh.2007.09.002				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	240QY	WOS:000251603300009	17945322				2019-04-02	
J	Aponte, JJ; Sacarlal, J; Aide, P; Macete, E; Renom, M; Bassat, Q; Mandomando, I; Manaca, MN; Lafuente, S; Leach, A; Ballou, R; Lievens, M; Thonnard, J; Dubois, MC; Demotie, MA; Cohen, J; Dubovsky, F; Millman, J; Sillman, M; Alonso, PL				Aponte, John J.; Sacarlal, Jahit; Aide, Pedro; Macete, Eusebio; Renom, Montse; Bassat, Quique; Mandomando, Inacio; Manaca, Maria N.; Lafuente, Sarah; Leach, Amanda; Ballou, Ripley; Lievens, Marc; Thonnard, Joelle; Dubois, Marie-Claude; Demotie, Marie-Ange; Cohen, Joe; Dubovsky, Filip; Millman, Jessica; Sillman, Marla; Alonso, Pedro L.			A four-year follow-up of the safety, immunogenicity and efficacy of the candidate malaria vaccine RTS,S/AS02A in children vaccinated at aged 1 to 4 years in a malaria-endemic region of Mozambique	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Aponte, John J.; Renom, Montse; Bassat, Quique; Lafuente, Sarah; Alonso, Pedro L.] Univ Barcelona, DIBAPS, Hosp Clin, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Sacarlal, Jahit; Aide, Pedro; Macete, Eusebio; Mandomando, Inacio; Manaca, Maria N.] Manhica Hlth Res Ctr, Manhica, Mozambique; [Leach, Amanda; Ballou, Ripley; Thonnard, Joelle; Dubois, Marie-Claude; Demotie, Marie-Ange; Cohen, Joe] GlaxoSmithKline Biologicals, Rixensart, Belgium; [Dubovsky, Filip; Millman, Jessica; Sillman, Marla] PATH Malaria Vaccine Initiat, Bethesda, MD USA			Bassat, Quique/P-2341-2016	Bassat, Quique/0000-0003-0875-7596				0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		8	2	2						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758200009					2019-04-02	
J	Barbosa, A; Naniche, D; Manaca, MN; Aponte, J; Mandomando, I; Aide, P; Renom, M; Sacarlal, J; Ballou, R; Moris, P; Cohen, J; Dubovsky, F; Millman, J; Alonso, PL				Barbosa, Arnoldo; Naniche, Denise; Manaca, Maria N.; Aponte, John; Mandomando, Inacio; Aide, Pedro; Renom, Montse; Sacarlal, Jahit; Ballou, Ripley; Moris, Philippe; Cohen, Joe; Dubovsky, Filip; Millman, Jessica; Alonso, Pedro L.			Assessment of cellular immune responses in infants participating in a RTS,S/AS02D phase I/IIB trial in Mozambique	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Barbosa, Arnoldo; Naniche, Denise; Manaca, Maria N.; Aponte, John; Renom, Montse; Alonso, Pedro L.] Univ Barcelona, IDIBAPS, Hosp Clin, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Manaca, Maria N.; Mandomando, Inacio; Aide, Pedro; Sacarlal, Jahit] Manhica Hlth Res Ctr, Manhica, Mozambique; [Ballou, Ripley; Moris, Philippe; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Dubovsky, Filip; Millman, Jessica] PATH Malaria Vaccine Initiat, Bethesda, MD USA								0	2	2	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		9	2	3						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758200010					2019-04-02	
J	Lell, B; Agnandjil, S; von Glasenapp, I; Oyakhiromen, S; Haertle, S; Kremsner, PG; Ramboer, I; Lievens, M; Ballou, R; Vekemans, J; Dubois, MC; Demoitie, MA; Cohen, J; Villafana, T; Carter, T; Petersen, C				Lell, Bertand; Agnandjil, Selidji; von Glasenapp, Isabelle; Oyakhiromen, Sunny; Haertle, Sonja; Kremsner, Peter G.; Ramboer, Isabelle; Lievens, Marc; Ballou, Ripley; Vekemans, Johan; Dubois, Marie-Claude; Demoitie, Marie-Ange; Cohen, Joe; Villafana, Tonya; Carter, Terrell; Petersen, Carolyn			A randomized, observer-blind trial to compare safety and immunogenicity of two adjuvanted RTS,S anti-malaria vaccine candidates in gabonese children	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Lell, Bertand; Agnandjil, Selidji; von Glasenapp, Isabelle; Oyakhiromen, Sunny; Haertle, Sonja; Kremsner, Peter G.] Albert Schweitzer Hosp, Med Res Unit, Gabon, Guinea; [Ramboer, Isabelle; Lievens, Marc; Ballou, Ripley; Vekemans, Johan; Dubois, Marie-Claude; Demoitie, Marie-Ange; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Villafana, Tonya; Carter, Terrell; Petersen, Carolyn] PATH Malaria Vaccine Initiat, Bethesda, MD USA								0	1	1	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		10	3	3						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758200011					2019-04-02	
J	Angov, E; Bergmann-Leitner, ES; Duncan, EH; Brent-Kirk, A; McCasland, M; Mease, R; Soisson, LS; Demoitie, MA; Ogutu, B; Heppner, DG; Lyon, JA				Angov, Evelina; Bergmann-Leitner, Elke S.; Duncan, Elizabeth H.; Brent-Kirk, Afiya; McCasland, Michael; Mease, Ryan; Soisson, Lorraine S.; Demoitie, Marie-Ange; Ogutu, Bernhards; Heppner, D. Gray; Lyon, Jeffrey A.			Measurement of antibody fine specificities induced by malaria vaccine FMP1/AS02A from a pediatric phase 2b trial in Western Kenya	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Angov, Evelina; Bergmann-Leitner, Elke S.; Duncan, Elizabeth H.; Brent-Kirk, Afiya; McCasland, Michael; Mease, Ryan; Heppner, D. Gray; Lyon, Jeffrey A.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Soisson, Lorraine S.] US Agcy Int Dev, Washington, DC USA; [Demoitie, Marie-Ange] GlaxoSmithKline Biol, Rixensart, Belgium; [Ogutu, Bernhards] Kenya Govt Med Res Ctr, Kisumu, Kenya			Bergmann-Leitner, Elke/B-3548-2011	Bergmann-Leitner, Elke/0000-0002-8571-8956				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		12	4	4						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758200013					2019-04-02	
J	Castillo, Y; Pierre, D; Arias, P; Portocarrero, M; Rodriguez, S; Victor, B; Kanobana, K; Gilman, R; Armando, G; Brandt, J; Garcia, H				Castillo, Yesenia; Pierre, Dorny; Arias, Patricia; Portocarrero, Milagrytos; Rodriguez, Silvia; Victor, Bjorn; Kanobana, Kirezi; Gilman, Robert; Armando, Gonzalez; Brandt, Jef; Garcia, Hector			Antigen-detection in neurocysticercosis: Sensitivity and specificity according to parasite stage and number of lesions	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Castillo, Yesenia; Arias, Patricia; Portocarrero, Milagrytos; Garcia, Hector] UPCH, Dept Microbiol, Lima, Peru; [Pierre, Dorny; Victor, Bjorn; Kanobana, Kirezi; Brandt, Jef] Inst Trop Med, Antwerp, Belgium; [Rodriguez, Silvia] Inst Ciencias Neurol, Lima, Peru; [Gilman, Robert] Johns Hopkins Univ, Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Armando, Gonzalez] Univ Mayor San Marcos, Sch Vet Med, Lima, Peru								0	2	2	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S			10	10						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758200034					2019-04-02	
J	Stewart, VA; McGrath, SM; Pau, MG; Mettens, P; Dubois, PM; Shott, J; Demoitie, MA; Custers, JH; Weverling, GJ; Bayat, B; Donner, MN; Dubois, MC; Cohen, J; Goudsmit, J; Heppner, DG				Stewart, V. Ann; McGrath, Shannon M.; Pau, Maria Grazia; Mettens, Pascal; Dubois, Patrice M.; Shott, Joseph; Demoitie, Maria-Ange; Custers, Jerome H. H. V.; Weverling, Gerrit-Jan; Bayat, Babak; Donner, Marie-Noelle; Dubois, Marie-Claude; Cohen, Joe; Goudsmit, Jaap; Heppner, D. Gray			Comparison of the immunogenicity of adenovirus 35-PFCS alone and in heterologous combination with an adenovirus 5-PFCS construct	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Stewart, V. Ann; McGrath, Shannon M.; Shott, Joseph; Heppner, D. Gray] Walter Reed Army Inst Res, Silver Spring, MD USA; [Pau, Maria Grazia; Custers, Jerome H. H. V.; Weverling, Gerrit-Jan; Goudsmit, Jaap] Crucell Holland BV, Leiden, Netherlands; [Mettens, Pascal; Demoitie, Maria-Ange; Bayat, Babak; Donner, Marie-Noelle; Dubois, Marie-Claude; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Dubois, Patrice M.] ImmunoVacc Consulting, Brussels, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		44	13	14						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758200045					2019-04-02	
J	Delgado, RC; Gamboa, D; Torres, K; Grande, T; Llanos, A; Carcamo, C; D'Alessandro, U				Delgado, Richard C.; Gamboa, Dionicia; Torres, Katherine; Grande, Tanilu; Llanos, Alejandro; Carcamo, Cesar; D'Alessandro, Umberto			High genetic diversity of Plasmodium falciparum and low complexity of infection in the Peruvian Amazon	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Delgado, Richard C.; Gamboa, Dionicia; Torres, Katherine; Grande, Tanilu; Llanos, Alejandro] Univ Peruana Cayetano Heredia, Inst Trop Med, Lima, Peru; [Carcamo, Cesar] Univ Peruana Cayetano Heredia, Lima, Peru; [D'Alessandro, Umberto] Inst Trop Med Prince Leopold, Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		206	60	60						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758200206					2019-04-02	
J	Pichyangkul, S; Kum-Arb, U; Yongvanitchit, K; Limsalakpetch, A; Gettayacamin, M; Lanar, DE; Ware, LA; Stewart, VA; Heppner, DG; Mettens, P; Cohen, JD; Ballou, WR; Fukuda, MM				Pichyangkul, Sathit; Kum-Arb, Utaiwan; Yongvanitchit, Kosol; Limsalakpetch, Amporn; Gettayacamin, Monthip; Lanar, David E.; Ware, Lisa A.; Stewart, V. A.; Heppner, D. Gray; Mettens, Pascal; Cohen, Joe D.; Ballou, W. R.; Fukuda, Mark M.			Pre-clinical evaluation of safety and immunogenicity of Plasmodium falciparum LSA1/AS01B when administered separately or concurrently with RTS,S/AS01B in rhesus primates	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Pichyangkul, Sathit; Kum-Arb, Utaiwan; Yongvanitchit, Kosol; Limsalakpetch, Amporn; Gettayacamin, Monthip; Fukuda, Mark M.] USA, Med Component Armed Forces Res Inst Med Sci, Bangkok, Thailand; [Lanar, David E.; Ware, Lisa A.; Stewart, V. A.; Heppner, D. Gray] Walter Reed Army Inst Res, Silver Spring, MD USA; [Mettens, Pascal; Cohen, Joe D.; Ballou, W. R.] GlaxoSmithKline Biol, Rixensart, Belgium			Lanar, David/B-3560-2011					0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		218	63	64						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758200218					2019-04-02	
J	Lutumba, PPL; Meheus, F; Robays, J; Miaka, C; Kande, V; Buscher, P; Dujardin, B; Boelaert, M				Lutumba, Pascal P. L.; Meheus, Filip; Robays, Jo; Miaka, Constantin; Kande, Victor; Buescher, Philippe; Dujardin, Bruno; Boelaert, Marleen			Cost-effectiveness of algorithms for population screening of human African trypanosomiasis	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Lutumba, Pascal P. L.; Robays, Jo; Buescher, Philippe; Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [Meheus, Filip] Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands; [Miaka, Constantin] Minist Hlth, Kinshasa, DEM REP CONGO; [Kande, Victor] Natl Control Program Against Human African Trypan, Kinshasa, DEM REP CONGO; [Dujardin, Bruno] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium			Boelaert, Marleen/E-2698-2012; Buscher, Philippe/B-9956-2012	Boelaert, Marleen/0000-0001-8051-6776; Buscher, Philippe/0000-0002-1926-7472				0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		481	138	138						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758200479					2019-04-02	
J	Aponte, JJ; Aide, P; Renom, M; Mandomando, I; Bassat, Q; Sacarlal, J; Manaca, MN; Lafuente, S; Macete, E; Leach, A; Ballou, R; Lievens, M; Vekemans, J; Dubois, MC; Demotie, MA; Cohen, J; Dubovsky, F; Millman, J; Sillman, M; Alonso, PL				Aponte, John J.; Aide, Pedro; Renom, Montse; Mandomando, Inacio; Bassat, Quique; Sacarlal, Jahit; Manaca, Maria N.; Lafuente, Sarah; Macete, Eusebici; Leach, Amanda; Ballou, Ripley; Lievens, Marc; Vekemans, Johan; Dubois, Marie-Claude; Demotie, Marie-Ange; Cohen, Joe; Dubovsky, Filip; Millman, Jessica; Sillman, Marla; Alonso, Pedro L.			A phase I/IIB randomized, double-blind, controlled clinical trial of the safety, immunogenicity and efficacy of RTS,S/AS02D, a candidate malaria vaccine in Mozambican infants	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Aponte, John J.; Renom, Montse; Bassat, Quique; Lafuente, Sarah; Alonso, Pedro L.] Univ Barcelona, Hosp Clin IDIPAS, Barcelona Ctr Int Hlth Res, CRESIB, E-08007 Barcelona, Spain; [Aide, Pedro; Mandomando, Inacio; Sacarlal, Jahit; Manaca, Maria N.; Macete, Eusebici] Manhica Hlth Res Ctr, CISM, Manhica, Mozambique; [Leach, Amanda; Ballou, Ripley; Lievens, Marc; Vekemans, Johan; Dubois, Marie-Claude; Demotie, Marie-Ange; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Dubovsky, Filip; Millman, Jessica; Sillman, Marla] PATH Malaria Vaccine Initiat, Bethesda, MD USA			Bassat, Quique/P-2341-2016	Bassat, Quique/0000-0003-0875-7596				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		572	164	164						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758201034					2019-04-02	
J	Anyona, SB; Hunja, CW; Kifude, CM; Polhemus, ME; Heppner, DG; Leach, A; Lievens, M; Ballou, R; Cohen, J; Sutherland, C; Waitumbi, JN				Anyona, Samuel B.; Hunja, Carol W.; Kifude, Carolyne M.; Polhemus, Mark E.; Heppner, D. Gray; Leach, Amanda; Lievens, Marc; Ballou, Ripley; Cohen, Joe; Sutherland, Colin; Waitumbi, John N.			Impact of RTS,S/AS02A and RTS,S/AS01B on multiplicity of infections and CSP t-cell epitopes of Plasmodium falciparum in adults participating in a malaria vaccine clinical trial	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Anyona, Samuel B.; Hunja, Carol W.; Kifude, Carolyne M.; Polhemus, Mark E.; Waitumbi, John N.] Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya; [Heppner, D. Gray] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA; [Leach, Amanda; Lievens, Marc; Ballou, Ripley; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Sutherland, Colin] London Sch Hyg & Trop Med, London, England								0	1	1	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		578	166	166						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758201040					2019-04-02	
J	Jarman, RG; Klungthong, C; Thaisomboonsuk, B; Nisalak, A; Rothman, A; Green, S; Thomas, S; Toussaint, JF; Kalanarooj, S; Gibbons, R				Jarman, Rick G.; Klungthong, Chonticha; Thaisomboonsuk, Butsaya; Nisalak, Ananda; Rothman, Alan; Green, Sharone; Thomas, Stephen; Toussaint, Jean Francois; Kalanarooj, Siripen; Gibbons, Robert			Analysis of ns-1 antigen and viremia in hospitalized dengue hemorrhagic fever and dengue fever patients in Thailand	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Jarman, Rick G.; Klungthong, Chonticha; Thaisomboonsuk, Butsaya; Nisalak, Ananda; Gibbons, Robert] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; Univ Massachusetts, Sch Med, Worcester, MA USA; [Rothman, Alan; Green, Sharone; Thomas, Stephen] Walter Reed Army Inst Res, Silver Spring, MD USA; [Toussaint, Jean Francois] GlaxoSmithKline Inc, Rixensart, Belgium; [Kalanarooj, Siripen] Queen Sirikit Inst Child Hlth, Bangkok, Thailand								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		765	220	220						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758201226					2019-04-02	
J	Lutumba, P; Makieya, E; Shaw, A; Meheus, F; Boelaert, M				Lutumba, Pascal; Makieya, Eric; Shaw, Alexandra; Meheus, Filip; Boelaert, Marleen			Impact of human African trypanosomiasis in a rural community in Democratic Republic of Congo	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Lutumba, Pascal; Boelaert, Marleen] Inst Trop Med, Antwerp, Belgium; [Makieya, Eric] Kinshasa Univ, Kinshasa, DEM REP CONGO; [Meheus, Filip] Royal Trop Inst, Amsterdam, Netherlands			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		794	228	228						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758201254					2019-04-02	
J	Tiintol, H; Lougue, G; Zongo, I; Guiguemde, RT; D'Alessandro, U; Oudraogo, JB				Tiintol, Haliclou; Lougue, Guekoun; Zongo, Issaka; Guiguemde, Robert Tinga; D'Alessandro, Umberto; Oudraogo, Jean Bosco			Chloroquine - Resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Tiintol, Haliclou; Oudraogo, Jean Bosco] IRSS, Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Lougue, Guekoun; Guiguemde, Robert Tinga] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5				833	238	239						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758201292					2019-04-02	
J	Van Geertruyden, JP; Menten, J; Colebunders, R; Korenromp, E; D'Alessandro, U				Van Geertruyden, Jean-Pierre; Menten, Joris; Colebunders, Robert; Korenromp, Eline; D'Alessandro, Umberto			The impact of HIV-1 on the malaria parasite biomass in sub-Saharan Africa and its possible contribution to the emergence and spread of antimalarial drug resistance	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Van Geertruyden, Jean-Pierre; Menten, Joris; Colebunders, Robert; D'Alessandro, Umberto] Prince Leopold Inst Trop Geneeskunde, Antwerp, Belgium; [Korenromp, Eline] Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands			D'Alessandro, Umberto/D-3457-2015; Van geertruyden, Jean-Pierre/K-6425-2014	D'Alessandro, Umberto/0000-0001-6341-5009; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		937	268	268						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758201396					2019-04-02	
J	Guthmann, JP; Checchi, F; Van den Broek, I; Balkan, S; Van Herp, M; Comte, E; Bernal, O; Kindermans, JM; Ashley, E; Legros, D; Guerin, PJ				Guthmann, Jean-Paul; Checchi, Francesco; Van den Broek, Ingrid; Balkan, Suna; Van Herp, Michel; Comte, Eric; Bernal, Oscar; Kindermans, Jean-Marie; Ashley, Elizabeth; Legros, Dominique; Guerin, Philippe J.			The contribution of Medecins Sans Frontieres to the assessment of efficacy of antimalarial treatment, 1996-2004	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene	NOV 04-08, 2007	Philadelphia, PA	Amer Soc Trop Med & Hyg					[Guthmann, Jean-Paul; Checchi, Francesco; Ashley, Elizabeth; Legros, Dominique; Guerin, Philippe J.] Epictr, Paris, France; [Van den Broek, Ingrid] Med San Frontieres, Amsterdam, Netherlands; [Balkan, Suna] Med San Frontieres, Paris, France; [Van Herp, Michel; Kindermans, Jean-Marie] Med San Frontieres, Brussels, Belgium; [Comte, Eric] Med San Frontieres, Genoa, Italy; [Bernal, Oscar] Med San Frontieres, Barcelona, Spain				Bernal, oscar/0000-0003-2514-3318				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5		S		974	278	279						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228UN	WOS:000250758201432					2019-04-02	
J	Nackers, F; Johnson, RC; Glynn, JR; Zinsou, C; Tonglet, R; Portaels, F				Nackers, Fabienne; Johnson, Roch C.; Glynn, Judith R.; Zinsou, Claude; Tonglet, Rene; Portaels, Francoise			Environmental and health-related risk factors for Mycobacterium ulcerans disease (Buruli ulcer) in Benin	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							GHANA	We conducted a case-control study to investigate the association between Buruli ulcer (BU) and environmental- and health-related behaviors in southern Benin. Hospital BU cases (N = 324) and sex- and age-matched neighborhood controls (N = 1,173) answered a questionnaire. Regular use of soap for washing, treating injuries with soap or antibiotic powder, and frequent contact with flowing water appeared protective against BU.	Catholic Univ Louvain, Epidemiol Unit, Brussels, Belgium; Programme Natl Lutte Ctr Ulcere Buruli, Cotonou, Benin; London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; Ctr Sanitaire & Nutr Gbemonten, Zagnanado, Benin; Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium	Portaels, F (reprint author), Natl Str 155, B-2000 Antwerp, Belgium.	portaels@itg.be					Aiga H, 2004, AM J TROP MED HYG, V71, P387, DOI 10.4269/ajtmh.2004.71.387; Barker D J, 1972, East Afr Med J, V49, P260; Debacker M, 2006, EMERG INFECT DIS, V12, P1325, DOI 10.3201/eid1209.050598; Marsollier L, 2007, PLOS MED, V4, P288, DOI 10.1371/journal.pmed.0040064; MARSTON BJ, 1995, AM J TROP MED HYG, V52, P219, DOI 10.4269/ajtmh.1995.52.219; Nackers F, 2006, AM J TROP MED HYG, V75, P768, DOI 10.4269/ajtmh.2006.75.768; Raghunathan PL, 2005, CLIN INFECT DIS, V40, P1445, DOI 10.1086/429623; *WHO, 2001, MAN HLTH CAR PROV	8	27	27	3	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2007	77	5					834	836		10.4269/ajtmh.2007.77.834				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228MW	WOS:000250735000011	17984337	Green Published			2019-04-02	
J	Lynen, L; Jacobs, J; Colebunders, R				Lynen, Lut; Jacobs, Jan; Colebunders, Robert			Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough?	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Review						HIV; co-trimoxazole; HAART; chemoprophylaxis; drug tolerance; toxicity		Co-trimoxazole prophytaxis in HIV-infected persons is beyond doubt one of the cheapest and most important interventions, next to antiretroviral. therapy (ART), to improve survival. However, many questions, ranging from programme coverage and public health impact to individual tolerance and compliance, remain unanswered. Together with the need for more research to identify optimal ART regimens for resource-poor settings, research regarding optimal chemoprophytaxis against opportunistic infections should also remain high on the agenda. (C) 2007 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium	Lynen, L (reprint author), Inst Trop Med Prince Leopold, Natl Str 155, B-2000 Antwerp, Belgium.	llynen@itg.be	Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895			GOLUB JE, 2006, AIDS 2006 16 INT AID; LOWRANCE D, 2007, 14 ANN C RETR OPP IN; Malamba SS, 2006, AM J TROP MED HYG, V75, P375, DOI 10.4269/ajtmh.2006.75.375; Thera MA, 2005, J INFECT DIS, V192, P1823, DOI 10.1086/498249; World Health Organization, 2006, GUID COTR PROPH HIV	5	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	NOV	2007	101	11					1059	1060		10.1016/j.trstmh.2007.07.001				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	228KV	WOS:000250729700001	17662321				2019-04-02	
J	Guha-Sapir, D; van Panhuis, WG; Lagoutte, J				Guha-Sapir, Debarati; van Panhuis, Willem Gijsbert; Lagoutte, Joel			Short communication: Patterns of chronic and acute diseases after natural disasters - a study from the International Committee of the Red Cross field hospital in Banda Aceh after the 2004 Indian Ocean tsunami	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						natural disasters; chronic diseases; humanitarian aid; Indonesia	SRI-LANKA; EXPERIENCE	OBJECTIVE To assess the pattern of diseases in a natural disaster, which are not necessarily a direct consequence of the event but can impact on the way health assistance is to be provided. METHODS Cross-sectional, record-based study in the International Committee of the Red Cross field hospital in Aceh, Indonesia, established immediately after the tsunami in 2004. Patients who presented to hospital from January 15 to 31, and whose diagnoses were available, were included in the study. RESULTS One thousand one hundred and eighty-eight residents of Aceh participated. 43.5% of the diagnoses was chronic diseases. The odds of chronic vs. acute diseases increased by 16.4% per day up to January 23 [95% confidence interval (CI): 7.8-25.6%] and decreased thereafter by 13.1% (95% CI: 6.6-19.1%) per day. The odds of acute diseases were 34% lower among females than males (95% CI: 16-49%) and 4.3 times higher among children than the rest of the population (95% CI: 2.4-7.6). There were relatively few trauma cases among females and children. CONCLUSIONS Medical teams providing relief after acute disasters should be prepared to provide healthcare for chronic diseases too. A delay in the presentation of many acute conditions has implications for long-term health consequences of disasters, such as disability.	[Guha-Sapir, Debarati] Catholic Univ Louvain, Sch Publ Hlth, Ctr Res Epidemiol Disasters, Brussels, Belgium; [van Panhuis, Willem Gijsbert] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lagoutte, Joel] Int Comm Red Cross, Hlth Serv Unit, Geneva, Switzerland	Guha-Sapir, D (reprint author), Catholic Univ Louvain, Sch Publ Hlth, Ctr Res Epidemiol Disasters, Brussels, Belgium.	sapir@esp.ucl.ac.be		Van Panhuis, Willem/0000-0002-7278-9982			*CTR RES EP DIS, 2006, EM DAT EM DIS DAT; Guha-Sapir D, 2005, BMJ-BRIT MED J, V331, P50, DOI 10.1136/bmj.331.7507.50; Guha-Sapir D., 2006, RISK FACTORS MORTALI; Kwak YH, 2006, J KOREAN MED SCI, V21, P143, DOI 10.3346/jkms.2006.21.1.143; Lim JH, 2005, FAM MED, V37, P422; MOKDAD AH, 2005, PREVENTION CHRONIC D, V2; Nishikiori N, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-73; Redwood-Campbell LJ, 2006, PREHOSP DISASTER MED, V21, pS1, DOI 10.1017/S1049023X00015806; Somasundaram DJ, 2006, J CLIN PSYCHIAT, V67, P64; *WHO, 1999, MAN CHILDH ILLN DEV	10	21	22	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2007	12	11					1338	1341		10.1111/j.1365-3156.2007.01932.x				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	242HT	WOS:000251716900010	18045260				2019-04-02	
J	Raguenaud, ME; Jansson, A; Vanlerberghe, V; Van der Auwera, G; Deborggraeve, S; Dujardin, JC; Orfanos, G; Reid, T; Boelaert, M				Raguenaud, Marie-Eve; Jansson, Anna; Vanlerberghe, Veerle; Van der Auwera, Geert; Deborggraeve, Stijn; Dujardin, Jean-Claude; Orfanos, Giannos; Reid, Tony; Boelaert, Marleen			Epidemiology and Clinical Features of Patients with Visceral Leishmaniasis Treated by an MSF Clinic in Bakool Region, Somalia, 2004-2006	PLOS NEGLECTED TROPICAL DISEASES			English	Article							BARINGO DISTRICT; KALA-AZAR; DONOVANI COMPLEX; SOUTHERN SUDAN; KENYA; DIAGNOSIS; ETHIOPIA; VILLAGE; UGANDA; GENES	Background: There are few reports describing the epidemiology of visceral leishmaniasis (VL) in Somalia. Over the years 2002 to 2005, a yearly average of 140 patients were reported from the Huddur centre in Bakool region, whereas in 2006, this number rose to 1002 patients. Given the limited amount of information on VL and the opportunity to compare features with the studies done in 2000 in this part of Somalia, we describe the epidemiologic and clinical features of patients who presented to the Huddur treatment centre of Bakool region, Somalia, using data routinely collected over a five-year observation period (2002-2006). Methodology: Methods used included the analysis of routine data on VL cases treated in the Huddur treatment centre, a retrospective study of records of patients admitted between 2004 and 2006, community leaders interviews, and analysis of blood specimens taken for parasite species identification in Antwerp Institute of Tropical Medicine. Principal Findings: A total of 1671 VL patients were admitted to the Huddur centre from January 2002 until December 2006. Nearly all patients presented spontaneously to the health centre. Since 2002, the average patient load was stable, with an average of 140 admissions per year. By the end of 2005, the number of admissions dramatically increased to reach a 7-fold increase in 2006. The genotype of L. donovani identified in 2006 was similar to the one reported in 2002. 82% of total patients treated for VL originated from two districts of Bakool region, Huddur and Tijelow districts. Clinical recovery rate was 93.2% and case fatality rate 3.9%. Conclusions: After four years of low but constant VL case findings, a major increase in VL was observed over a 16-month period in the Huddur VL centre. The profile of the patients was pediatric and mortality relatively low. Decentralized treatment centers, targeted active screening, and community sensitization will help decrease morbidity and mortality from VL in this endemic area. The true magnitude of VL in Somalia remains unknown. Further documentation to better understand transmission dynamics and thus define appropriate control measures will depend on the stability of the context and safe access to the Somali population.	[Raguenaud, Marie-Eve; Reid, Tony] Med Sans Frontieres, Dept Med, Brussels, Belgium; [Jansson, Anna; Orfanos, Giannos] Med Sans Frontieres, Somalia Mission, Nairobi, Kenya; [Vanlerberghe, Veerle; Boelaert, Marleen] Inst Trop Med, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Van der Auwera, Geert; Deborggraeve, Stijn; Dujardin, Jean-Claude] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium	Raguenaud, ME (reprint author), Med Sans Frontieres, Dept Med, Brussels, Belgium.	eve_raguenaud@hotmail.com	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Deborggraeve, Stijn/0000-0003-1501-5355			Boelaert M, 2004, AM J TROP MED HYG, V70, P72, DOI 10.4269/ajtmh.2004.70.72; CAMPINO L, 2006, LEISHMED TRAINING CO; Chappuis F, 2005, J CLIN MICROBIOL, V43, P5973, DOI 10.1128/JCM.43.12.5973-5977.2005; CHIN J, 2000, CONTROL COMMUNICABLE, P287; Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; El-Safi SH, 2002, MICROBES INFECT, V4, P1439, DOI 10.1016/S1286-4579(02)00026-6; Hide M, 2007, PARASITOLOGY, V134, P379, DOI 10.1017/S0031182006001600; Kolaczinski JH, 2007, EMERG INFECT DIS, V13, P507, DOI 10.3201/eid1303.060706; Lyons S, 2003, TROP MED INT HEALTH, V8, P733, DOI 10.1046/j.1365-3156.2003.01088.x; Marlet MVL, 2003, T ROY SOC TROP MED H, V97, P515, DOI 10.1016/S0035-9203(03)80012-3; MARLET MVL, 2003, T R SOC TROP MED HYG, V97, P1; Moise R, 1955, ANN MED NAVALE TROPI, V68, P481; Ngumbi P M, 1998, Afr J Health Sci, V5, P28; Penso G, 1934, B ATTI RICERCA ACCAD, V60, P292; ROBERT LL, 1994, ANN TROP MED PARASIT, V88, P649, DOI 10.1080/00034983.1994.11812917; Ryan JR, 2006, AM J TROP MED HYG, V74, P308; SCHAEFER KU, 1995, T ROY SOC TROP MED H, V89, P471, DOI 10.1016/0035-9203(95)90070-5; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; SHIDDO SA, 1995, T ROY SOC TROP MED H, V89, P361, DOI 10.1016/0035-9203(95)90008-X; Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133; Veeken H, 2003, TROP MED INT HEALTH, V8, P164, DOI 10.1046/j.1365-3156.2003.00996.x; *WHO, 1995, MAN VISC LEISHM CONT; WOODHEAD A, 1995, ANN TROP MED PARASIT, V89, P687	25	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2007	1	1							e85	10.1371/journal.pntd.0000085				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	383XH	WOS:000261707200014	17989791	DOAJ Gold, Green Published			2019-04-02	
J	Mahendradhata, Y; Utarini, A; Lazuardi, U; Boelaert, M; Van der Stuyft, P				Mahendradhata, Yodi; Utarini, Adi; Lazuardi, Upiek; Boelaert, Marleen; Van der Stuyft, Patrick			Private practitioners and tuberculosis case detection in Jogjakarta, Indonesia: actual role and potential	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article							TB CONTROL; INDIA; PARTNERSHIP; HEALTH; NEPAL; DOTS	BACKGROUND Indonesia has a high tuberculosis (TB) prevalence and a large private health sector. OBJECTIVES To explore the potential of private practitioners (PP) in TB control in Jogjakarta by assessing their load of TB suspects and case-management practices. METHODS We conducted a cross-sectional telephone survey of a random sample of 164 PP, weighted to the local proportions of specialists, general practitioners (GP), nurses and midwives. We investigated their knowledge of directly observed treatment, short-course (DOTS), whether they see TB suspects, whether they refer such patients and how they possibly diagnose and treat TB. RESULTS We sampled 174 PP, of which 164 (94.3%) completed the interview. Most PP (63.4%) reported to have seen TB suspects in their private practice, and 62.8% were also employed in a DOTS facility. Specialists saw on average 18 suspects, GP 11 suspects, and nurses-midwives three suspects in a year. Many PP (45.2%) always relied on National Tuberculosis Control Programme (NTP) services for diagnosis. Fewer PP (41.5%) used, by themselves, diagnostic procedures complying with the NTP guidelines. The majority (63.6%) always referred confirmed cases for treatment, mainly (71.4%) to NTP services. Most PP (72.7%) who treated TB patients themselves did not prescribe the NTP standard regimen. CONCLUSION The study shows that the TB case load per PP is low in Jogjakarta, where the NTP already involves public and private hospitals besides public health centres. Initiatives to engage all PP might only marginally contribute in increasing the TB case detection.	Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; Gadjah Mada Univ, Dept Publ Hlth, Fac Med, Yogyakarta, Indonesia; Gadjah Mada Univ, Ctr Hlth Serv Management, Fac Med, Yogyakarta, Indonesia	Mahendradhata, Y (reprint author), Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, Natl Str 155, B-2000 Antwerp, Belgium.	yodi_mahendradhata@yahoo.co.uk	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Mahendradhata, Yodi/0000-0002-4522-1785			[Anonymous], 2006, INT STAND TUB CAR IS; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P501; Chakaya JM, 2005, INT J TUBERC LUNG D, V9, P403; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; *DOH ROI, 2003, NAT GUID TUB CONTR; DWIPRAHASTO I, 1992, ANTIBIOTIC UTLIZATIO; IDRIS F, 2003, PARTNERSHIP MODEL TB; Lambert ML, 2005, TROP MED INT HEALTH, V10, P246, DOI 10.1111/j.1365-3156.2004.01383.x; Lambert ML, 2005, TROP MED INT HEALTH, V10, P945, DOI 10.1111/j.1365-3156.2005.01485.x; Lonnroth K, 2004, B WORLD HEALTH ORGAN, V82, P580; Mahendradhata Y, 2003, INT J HEALTH PLAN M, V18, pS53, DOI 10.1002/hpm.724; Murthy KJR, 2001, INT J TUBERC LUNG D, V5, P354; NEWELL J, 2002, B WORLD HEALTH ORGAN, V10, P836; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Newell JN, 2005, INT J TUBERC LUNG D, V9, P1013; *NIHRD, 2005, TUB PRE SURV IND 200; NSUTHI L, 2001, INT J TUBERC LUNG D, V11, P1006; Portero JL, 2003, TROP MED INT HEALTH, V8, P329, DOI 10.1046/j.1365-3156.2003.01032.x; Stop TB Partnership. The Stop TB Strategy, 2006, STOP TB STRAT BUILD; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; WHO, 2006, ENG ALL HLTH CAR PRO; *WHO, 2003, INV PRIV PRACT TUB C; World Health Organization, 2006, GLOB TUB CONTR SURV	24	11	11	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2007	12	10					1218	1224		10.1111/j.1365-3156.2007.01946.x				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	231BB	WOS:000250920300011	17956504	Bronze			2019-04-02	
J	Muffler, N; Trabelssi, MEH; De Brouwere, V				Muffler, Nathalie; Trabelssi, Mohammed El Hassane; De Brouwere, Vincent			Scaling up clinical audits of obstetric cases in Morocco	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						clinical audits; Morocco; hospitals; quality of care; maternal health; obstetrics	SETTINGS	OBJECTIVES To follow-up on the process of implementing clinical audits of obstetric cases in Morocco as recommended by the Ministry of Health (2001) and to explore both the barriers to and factors facilitating sustainability of clinical audits. METHOD Questionnaires were sent to heads of all 61 Moroccan health provinces (response rate 69%) to ask if their maternity units had implemented clinical audits between 1998 and 2003. Twenty of the 42 public maternities which responded had performed so. Thirteen of these 20 hospitals were visited and 56 semi-structured interviews held with administrators and health professionals. Locally available audit registers were consulted to triangulate data. RESULTs Eleven of 13 maternities visited conducted an average of 6.8 case reviews per year with a total average of 16.7 cases per hospital (range 4-38). Although interviewees confirmed that audits resulted in better quality of care, five hospitals had ceased performing audits altogether and the remainder did them less frequently, because of audit teams encountering staff resistance, insufficient understanding of the audit concept, difficulties in organizing sessions, and lack of administrative support. Insufficient training and external assistance hindered the implementation of complete audit loops, resulting in a loss of staff motivation. CONCLUSION Implementing clinical audits as a means to improving quality of care requires a significant investment in training and various kinds of on-going assistance - factors which decision-makers should be aware of.	Inst Trop Med, Berlin, Germany; Direct Hop & Soins Ambulatoires, Ministere Sante, Serv Suivi & Evaluat, Div Hop, Rabat, Morocco; Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Muffler, N (reprint author), Pasteurstr 17, D-10407 Berlin, Germany.	nmuffler@gmx.net					AZELMAT M, 1993, ENQUETTE NATL POPULA; BULLOUGH C, 2004, BEYOND NUMBERS, P124; Filippi V, 2004, HEALTH POLICY PLANN, V19, P57, DOI 10.1093/heapol/czh007; Healy K, 1998, BMJ-BRIT MED J, V316, P1906; *JHU CCP, 2000, COMM SAF MOTH MOR FA; Johnston G, 2000, QUAL HEALTH CARE, V9, P23, DOI 10.1136/qhc.9.1.23; Miller E, 1998, BRIT MED J, V316, P875, DOI 10.1136/bmj.316.7135.875; *NICE, 2002, PRINC BEST PRACT CLI; *PAPCHILD, 1997, ENQ NAT SANT MER ENF; Pechevis M, 1999, Sante Publique, V11, P211; Ronsmans C, 2004, NUMBERS REV MATERNAL, P103; Siddiqi K, 2005, B WORLD HEALTH ORGAN, V83, P882; Wagaarachchi PT, 2001, INT J GYNECOL OBSTET, V74, P119, DOI 10.1016/S0020-7292(01)00427-1	13	16	17	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2007	12	10					1248	1257		10.1111/j.1365-3156.2007.01911.x				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	231BB	WOS:000250920300015	17956508	Bronze			2019-04-02	
J	Gomez-Elipe, A; Otero, A; van Herp, M; Aguirre-Jaime, A				Gomez-Elipe, Alberto; Otero, Angel; van Herp, Michel; Aguirre-Jaime, Armando			Forecasting malaria incidence based on monthly case reports and environmental factors in Karuzi, Burundi, 1997-2003	MALARIA JOURNAL			English	Article							EPIDEMIC MALARIA; RAINFALL; ETHIOPIA; AFRICA	Background: The objective of this work was to develop a model to predict malaria incidence in an area of unstable transmission by studying the association between environmental variables and disease dynamics. Methods: The study was carried out in Karuzi, a province in the Burundi highlands, using time series of monthly notifications of malaria cases from local health facilities, data from rain and temperature records, and the normalized difference vegetation index (NDVI). Using autoregressive integrated moving average (ARIMA) methodology, a model showing the relation between monthly notifications of malaria cases and the environmental variables was developed. Results: The best forecasting model (R-adj(2) = 82%, p < 0.0001 and 93% forecasting accuracy in the range +/- 4 cases per 100 inhabitants) included the NDVI, mean maximum temperature, rainfall and number of malaria cases in the preceding month. Conclusion: This model is a simple and useful tool for producing reasonably reliable forecasts of the malaria incidence rate in the study area.	Univ Autonoma Madrid, Dept Publ Hlth, Madrid 28029, Spain; Med Sans Frontieres, Dept Epidemiol, B-1090 Brussels, Belgium; NS Candelaria Univ Hosp, Res Support Serv, Santa Cruz de Tenerife 38010, Spain	Gomez-Elipe, A (reprint author), Univ Autonoma Madrid, Dept Publ Hlth, C Arzobispo Morcillo 2, Madrid 28029, Spain.	agomez.elipe@gmail.com; angel.otero@uam.es; michel.van.herp@brussels.msf.org; aaguirre@canarias.org					Abeku TA, 2004, PARASITOLOGY, V128, P585, DOI 10.1017/S003182004005013; Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; *AFR DAT DISS SERV, DEK NORM DIFF VEG IN; Craig MH, 2004, TROP MED INT HEALTH, V9, P1247, DOI 10.1111/j.1365-3156.2004.01340.x; Grover-Kopec E, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-6; Guthmann JP, 2007, EMERG INFECT DIS, V13, P140, DOI 10.3201/eid1301.060546; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Hay SI, 2003, LANCET, V361, P1705, DOI 10.1016/S0140-6736(03)13366-1; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; LEGROS D, 2001, EPIDEMIE PALUDISME B; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; NAJERA JA, 1998, WHO MAL198 1084; Teklehaimanot HD, 2004, EMERG INFECT DIS, V10, P1220, DOI 10.3201/eid1007.030722; Thompson J, 1997, ANTI-CANCER DRUG, V8, P313, DOI 10.1097/00001813-199704000-00002; Thomson MC, 2005, AM J TROP MED HYG, V73, P214, DOI 10.4269/ajtmh.2005.73.214; United Nations Population Division, WORLD POP PROSP 2006; *WHO, 2002, FIN REP 3 M RBM TECH; *WHO UNICEF, 2005, WORLD MAL REP 2005; WHO - World Health Organization, 2001, MAL EARL WARN SYST C; World Health Organization, 2004, MAL EPID FOR PREV EA; World Health Organization, 2004, WORLD HLTH REP 2004; WORRAL E, 2004, AM J TROP MED HYG, P136; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	25	64	68	0	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 24	2007	6								129	10.1186/1475-2875-6-129				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	230JM	WOS:000250872800001	17892540	DOAJ Gold, Green Published			2019-04-02	
J	Kindermans, JM; Pilloy, J; Olliaro, P; Gomes, M				Kindermans, Jean-Marie; Pilloy, Jacques; Olliaro, Piero; Gomes, Melba			Ensuring sustained ACT production and reliable artemisinin supply	MALARIA JOURNAL			English	Editorial Material							MALARIA; AFRICA	Introduction: This paper reviews recent trends in the production, supply and price of the active ingredients as well as finished ACT products. Production and cost data provided in this paper are based on an ongoing project (Artepal). Stability data are derived from a development project on rectal artesunate. Discussion: The artemisinin raw material and its derivatives appear to be very stable compared to the finished products. Supply of artemisinin changed in May 2004 when the Global Fund shifted financial support to qualified countries from chloroquine or sulphadoxine-pyrimethamine to an ACT for treatment of malaria. First, there was a sudden shortage of the starting material, and short term scarcity led to a steep rise in API price: it increased dramatically in 2004, from $350 per kg to more than $1000. Second, there was a parallel increase in the number of companies extracting artemisinin from 10 to 80 between 2003 and 2005 in China, and from 3 to 20 in Vietnam. Commercial cultivation began also in East Africa and Madagascar. A steady and predictable demand for the crop can eliminate such wide fluctuations and indirectly contribute to price stability of the herb, the API and ACT. With appropriate mechanisms to reduce those fluctuations, the cost of artemisinin might decrease sustainably to US$ 250-300 per kg. Conclusion: Today the global health community is facing the risk of another cyclical swing with lower demand feeding into reduced planting of A. annua and, thereafter, a new shortage of the raw material and higher API prices. International donors, the largest purchasers for ACTs could better coordinate their activities, in order to guarantee purchase of ACTs and consequently of API with manufacturers. In parallel, the base of quality producers of APIs and finished ACT products needs to be broadened. While the ACT programme is still in its early stages, the consequences of another wave of artemisinin and ACT shortages would permanently discredit it and impede any progress in rolling malaria back.	AEDES Fdn, B-1000 Brussels, Belgium; OTECI, F-75009 Paris, France; WHO Special Programme Res & Training Trop Dis TDR, UNICEF UNPD WB, CH-1211 Geneva 27, Switzerland; Univ Oxford, Ctr Trop Med & Vaccinol, Oxford, England	Kindermans, JM (reprint author), AEDES Fdn, 34 Rue Joseph 2, B-1000 Brussels, Belgium.	jmkindermans@aedes.be; pilloyj@aol.com; olliarop@who.int; gomesm@who.int					DONALD GJM, 2005, NY TIMES        0125; Kindermans JM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-91; Korenromp E, 2011, MALARIA INCIDENCE ES; LAUGHLIN JC, 2001, ARTEMISIA, P159; Snow RW, 2003, TRENDS PARASITOL, V19, P363, DOI 10.1016/S1471-4922(03)00168-5; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; *WHO, 2006, WHOHTMMAL20061108; World Health Organization, 2001, WHOCDSRBM200135	8	45	46	0	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 15	2007	6								125	10.1186/1475-2875-6-125				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	224RJ	WOS:000250463800002	17868471	DOAJ Gold, Green Published			2019-04-02	
J	Price, RN; Dorsey, G; Ashley, EA; Barnes, KI; Baird, JK; d'Alessandro, U; Guerin, PJ; Laufer, MK; Naidoo, I; Nosten, F; Olliaro, P; Plowe, CV; Ringwald, P; Sibley, CH; Stepniewska, K; White, NJ				Price, Ric N.; Dorsey, Grant; Ashley, Elizabeth A.; Barnes, Karen I.; Baird, J. Kevin; d'Alessandro, Umberto; Guerin, Philippe J.; Laufer, Miriam K.; Naidoo, Inbarani; Nosten, Francois; Olliaro, Piero; Plowe, Christopher V.; Ringwald, Pascal; Sibley, Carol H.; Stepniewska, Kasia; White, Nicholas J.			World antimalarial resistance network I: Clinical efficacy of antimalarial drugs	MALARIA JOURNAL			English	Review							FALCIPARUM-MALARIA; TRIALS	The proliferation of antimalarial drug trials in the last ten years provides the opportunity to launch a concerted global surveillance effort to monitor antimalarial drug efficacy. The diversity of clinical study designs and analytical methods undermines the current ability to achieve this. The proposed World Antimalarial Resistance Network (WARN) aims to establish a comprehensive clinical database from which standardised estimates of antimalarial efficacy can be derived and monitored over time from diverse geographical and endemic regions. The emphasis of this initiative is on five key variables which define the therapeutic response. Ensuring that these data are collected at the individual patient level in a consistent format will facilitate better data management and analytical practices, and ensure that clinical data can be readily collated and made amenable for pooled analyses. Such an approach, if widely adopted will permit accurate and timely recognition of trends in drug efficacy. This will guide not only appropriate interventions to deal with established multidrug resistant strains of malaria, but also facilitate prompt action when new strains of drug resistant plasmodia first emerge. A comprehensive global database incorporating the key determinants of the clinical response with in vitro, molecular and pharmacokinetic parameters will bring together relevant data on host, drug and parasite factors that are fundamental contributors to treatment efficacy. This resource will help guide rational drug policies that optimize antimalarial drug use, in the hope that the emergence and spread of resistance to new drugs can be, if not prevented, at least delayed.	Menzies Sch Hlth Res, Int Hlth Program, Darwin, NT, Australia; Charles Darwin Univ, Darwin, NT, Australia; Churchill Hosp, Nuffield Dept Clin Med, Ctr Vaccinol & Trop Med, Oxford OX3 7LJ, England; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Epictr, F-75011 Paris, France; Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; Div Clin Pharmacol, Jakarta 10430, Indonesia; Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; MRC, Malaria Res Programme, Kwa Zulu, Natal, South Africa; Shoklo Malaria Res Unit, Mae Sot, Thailand; WHO, World Bank, UNICEF, WHO Special Programme Res & Training Trop Dis TDR, CH-1211 Geneva, Switzerland; WHO, GMP, CH-1211 Geneva, Switzerland; Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand	Price, RN (reprint author), Menzies Sch Hlth Res, Int Hlth Program, Darwin, NT, Australia.	ricprice@doctors.org.uk; grantd@itsa.ucsf.edu; e.ashley@another.com; karenb@ctnet.co.za; kbaird@alertasia.org; udalessandro@itg.be; philippe.guerin@epicentre.msf.org; mlaufer@medicine.umaryland.edu; inaidoo@mrc.ac.za; francois@tropmedres.ac; olliarop@who.int; cplowe@medicine.umaryland.edu; ringwaldp@who.int; sibley@u.washington.edu; kasia@tropmedres.ac; nickwdt@tropmedres.ac	D'Alessandro, Umberto/D-3457-2015; White, Nicholas/I-4629-2012	D'Alessandro, Umberto/0000-0001-6341-5009; Nosten, Francois/0000-0002-7951-0745; Price, Richard/0000-0003-2000-2874; Naidoo, Inbarani/0000-0001-7590-0618; Guerin, Philippe/0000-0002-6008-2963; Laufer, Miriam/0000-0001-8300-9593	NIAID NIH HHS [K23 AI059316]		Adjuik M, 2004, LANCET, V363, P9; BAIRD JK, 1995, J INFECT DIS, V171, P1678, DOI 10.1093/infdis/171.6.1678; Collins WJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-122; Guthmann JP, 2006, ANTIMICROB AGENTS CH, V50, P3734, DOI 10.1128/AAC.01618-05; Hyde JE, 2005, TRENDS PARASITOL, V21, P494, DOI 10.1016/j.pt.2005.08.020; Myint HY, 2004, T ROY SOC TROP MED H, V98, P73, DOI 10.1016/S0035-9203(03)00014-2; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5; *WHO, 2005, SUSC PLASM FALC ANT; WHO, 2003, WHOHTMRBM200350	12	45	45	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 6	2007	6								119	10.1186/1475-2875-6-119				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	224RH	WOS:000250463600001	17822532	DOAJ Gold, Green Published			2019-04-02	
J	Diggle, PJ; Thomson, MC; Christensen, OF; Rowlingson, B; Obsomer, V; Gardon, J; Wanji, S; Takougang, I; Enyong, P; Kamgno, J; Remme, JH; Boussinesq, M; Molyneux, DH				Diggle, P. J.; Thomson, M. C.; Christensen, O. F.; Rowlingson, B.; Obsomer, V.; Gardon, J.; Wanji, S.; Takougang, I.; Enyong, P.; Kamgno, J.; Remme, J. H.; Boussinesq, M.; Molyneux, D. H.			Spatial modelling and the prediction of Loa loa risk: Decision making under uncertainty	ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY			English	Article							INFORMATION-SYSTEMS; CHRYSOPS-SILACEA; PREVALENCE; CAMEROON; INFECTION; INTENSITY; AFRICA; WEST; MAP; TEMPERATURE	Health decision-makers working in Africa often need to act for millions of people over large geographical areas on little and uncertain information. Spatial statistical modelling and Bayesian inference have now been used to quantify the uncertainty in the predictions of a regional, environmental risk map for Loa loa ( a map that is currently being used as an essential decision tool by the African Programme for Onchocerciasis Control). The methodology allows the expression of the probability that, given the data, a particular location does or does not exceed a predefined high-risk threshold for which a change in strategy for the delivery of the antihelmintic ivermectin is required.	Univ Lancaster, Dept Med, Lancaster LA1 4YF, England; Columbia Univ, Earth Inst, Int Res Inst Climate & Soc, Palisades, NY 10964 USA; Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus, Denmark; Inst Trop Med, Dept Parasitol, Entomol Unit, B-2000 Antwerp, Belgium; Ctr Pasteur Cameroon Epidemiol & Sante Publ, Lab Mixte, IRD, UR 024, F-34000 Montpellier, France; Univ Buea, Fac Sci, Dept Life Sci, Buea, Cameroon; Univ Yaounde, Fac Med & Biomed Sci, Dept Publ Hlth, Yaounde, Cameroon; Trop Med Res Stn, Kumba, Cameroon; WHO, Special Programme Res & Training Trop Dis, World Bank, UNDP, CH-1211 Geneva, Switzerland; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Diggle, PJ (reprint author), Univ Lancaster, Dept Med, Lancaster LA1 4YF, England.	p.diggle@lancaster.ac.uk	Diggle, Peter/A-3025-2009; Boussinesq, Michel/J-7256-2016; Gardon, Jacques/J-8022-2016	Boussinesq, Michel/0000-0001-6312-0681; Gardon, Jacques/0000-0002-0570-634X; Rowlingson, Barry/0000-0002-8586-6625; Diggle, Peter/0000-0003-3521-5020			Anyamba A, 2002, PHOTOGRAMM ENG REM S, V68, P137; Boussinesq M, 2001, ANN TROP MED PARASIT, V95, P495, DOI 10.1080/00034980120073184; Brooker S, 2002, TRENDS PARASITOL, V18, P70, DOI 10.1016/S1471-4922(01)02223-1; Brooker S, 2000, B WORLD HEALTH ORGAN, V78, P1456; Ceccato P., 2005, Parassitologia (Rome), V47, P81; Christensen O.F., 2002, R NEWS, V2, P26; CREWE W, 1961, ANN TROP MED PARASIT, V55, P211, DOI 10.1080/00034983.1961.11686039; DALE WE, 1975, J MED ENTOMOL, V12, P551, DOI 10.1093/jmedent/12.5.551; DIGGLE P. J., 2003, SPATIAL STAT COMPUTA, P43; DIGGLE PJ, 1998, APPL STAT, V47, P299; Gonfiantini R, 2001, CHEM GEOL, V181, P147, DOI 10.1016/S0009-2541(01)00279-0; Hafez M., 1970, Bulletin de la Societe Entomologique d'Egypte, V54, P465; Kamgno J, 1997, B SOC PATHOL EXOT, V90, P327; Kamgno J, 2001, B SOC PATHOL EXOT, V94, P342; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; Malone JB, 1997, PARASITOL TODAY, V13, P112, DOI 10.1016/S0169-4758(97)01009-0; Mayaux P, 2004, J BIOGEOGR, V31, P861, DOI 10.1111/j.1365-2699.2004.01073.x; Molesworth AM, 2003, EMERG INFECT DIS, V9, P1287; PINDER M, 1991, ACTA TROP, V49, P305, DOI 10.1016/0001-706X(91)90081-T; Takougang I, 2002, B WORLD HEALTH ORGAN, V80, P852; Thomson MC, 1999, TROP MED INT HEALTH, V4, P105, DOI 10.1046/j.1365-3156.1999.00368.x; Thomson MC, 2000, MED VET ENTOMOL, V14, P227, DOI 10.1046/j.1365-2915.2000.00250.x; Thomson MC, 2000, LANCET, V356, P1077, DOI 10.1016/S0140-6736(00)02733-1; Thomson MC, 2004, FILARIA J, V3, P7, DOI DOI 10.1186/1475-2883-3-7; Wanji S, 2003, T ROY SOC TROP MED H, V97, P182, DOI 10.1016/S0035-9203(03)90114-3	25	64	64	1	7	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0003-4983			ANN TROP MED PARASIT	Ann. Trop. Med. Parasitol.	SEP	2007	101	6					499	509		10.1179/136485907X229121				11	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	211WN	WOS:000249554100007	17716433				2019-04-02	
J	Diro, E; Techane, Y; Tefera, T; Assefa, Y; Kebede, T; Genetu, A; Kebede, Y; Tesfaye, A; Ergicho, B; Gebre-Yohannes, A; Mengistu, G; Engers, H; Aseffa, A; Desjeuxe, P; Boelaert, M; Hailu, A				Diro, Ermias; Techane, Yoseph; Tefera, Tedros; Assefa, Yibeltal; Kebede, Tadesse; Genetu, Abebe; Kebede, Yenew; Tesfaye, Abiye; Ergicho, Bahiru; Gebre-Yohannes, Asfawesen; Mengistu, Getahun; Engers, Howard; Aseffa, Abraham; Desjeuxe, Philippe; Boelaert, Marleen; Hailu, Asrat			Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						visceral; leishmaniasis; diagnostic tests; latex agglutination test; leishmania k39 antigen; serotogy; Ethiopia	KALA-AZAR; ANTIGEN; NEPAL; TESTS; SUDAN; SERODIAGNOSIS; PERFORMANCE; VALIDITY; ANTIBODY; CHAGASI	Three novel diagnostic tests for viscera leishmaniasis (VL), namely FD-DAT, rK39 dipstick and KATEX, were evaluated under field conditions using 101 clinical cases suspected of having VL enrolled in a trial. either by active (63 patients) or passive (38 patients) surveillance. VL was confirmed in 49 patients: 35 by both aspirate smear microscopy and NNN culture, 10 by NNN culture atone and 4 by aspirate smear microscopy atone. Based on tests performed the field, sensitivity for FD-DAT, rK39 dipstick and KATEX was determined to be 95.3% (95% Cl 82.9-99.2%), 71.7% (95% Cl 56.3-83.5%) and 57.4% (95% Cl 42.3-71.4%), respectively. Similarly, the specificity was determined to be 62.7% (95% Cl 48.1-75.5%), 82.4% (95% Cl 68.6-91.1%) and 84.3% (95% Cl 70.9-92.5%), respectively. A higher sensitivity of KATEX (73.9% vs. 41.7%) and higher specificity of FD-DAT (100.0% vs. 48.6%) were demonstrated under passive case detection compared with active case detection. FD-DAT is recommended for confirmation of VL diagnosis in hospital settings, whereas its use in the field will be Limited to exclude VL in clinical suspects. The sensitivity of KATEX and rK39 dipstick tests needs to be improved to promote their use as first-line diagnostic tests in the field setting of northwestern Ethiopia. (c) 2007 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	Univ Addis Ababa, Fac Med, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; Gondar Univ, Amhara Reg State, Gondar, Ethiopia; Kahsay Abera Hosp, Tigray Reg State, Humera, Ethiopia; Univ Addis Ababa, Fac Med, Biomed Res & Training Program, Addis Ababa, Ethiopia; Armauer Hansen Res Inst, Addis Ababa, Ethiopia; Cluster Communicable Dis, WHO, Dept Control Prevent & Eliminat, CDS CPE, Geneva, Switzerland; Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Hailu, A (reprint author), Univ Addis Ababa, Fac Med, Dept Microbiol Immunol & Parasitol, POB 9086, Addis Ababa, Ethiopia.	haitu_a2004@yahoo.com	Aseffa, Abraham/J-3248-2016; Boelaert, Marleen/E-2698-2012	Aseffa, Abraham/0000-0002-8028-1150; Boelaert, Marleen/0000-0001-8051-6776			Attar ZJ, 2001, ACTA TROP, V78, P11, DOI 10.1016/S0001-706X(00)00155-8; Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758; Boelaert M, 2004, AM J TROP MED HYG, V70, P72, DOI 10.4269/ajtmh.2004.70.72; Boelaert M, 1999, TROP MED INT HEALTH, V4, P395, DOI 10.1046/j.1365-3156.1999.00421.x; BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775; Carvalho SFG, 2003, AM J TROP MED HYG, V68, P321; Chappuis F, 2003, TROP MED INT HEALTH, V8, P277, DOI 10.1046/j.1365-3156.2003.01026.x; Chappuis F, 2006, TROP MED INT HEALTH, V11, P31, DOI 10.1111/j.1365-3156.2005.01533.x; Chappuis F, 2005, J CLIN MICROBIOL, V43, P5973, DOI 10.1128/JCM.43.12.5973-5977.2005; El-Safi S H, 2003, East Mediterr Health J, V9, P844; Hailu A, 2002, ANN TROP MED PARASIT, V96, P25, DOI 10.1179/000349802125000475; Hailu A, 2002, ACTA TROP, V83, P93, DOI 10.1016/S0001-706X(02)00063-3; HAILU A, 1990, T ROY SOC TROP MED H, V84, P673, DOI 10.1016/0035-9203(90)90141-Z; HARITH AE, 1986, T ROY SOC TROP MED H, V80, P583, DOI 10.1016/0035-9203(86)90149-5; HARITH AE, 1988, J CLIN MICROBIOL, V26, P1321; Lyons S, 2003, TROP MED INT HEALTH, V8, P733, DOI 10.1046/j.1365-3156.2003.01088.x; MEREDITH SEO, 1995, J CLIN MICROBIOL, V33, P1742; Rijal S, 2004, TROP MED INT HEALTH, V9, P724, DOI 10.1111/j.1365-3156.2004.01251.x; Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76; Sarker C B, 2003, Mymensingh Med J, V12, P93; Schallig HDFH, 2002, MEM I OSWALDO CRUZ, V97, P1015, DOI 10.1590/S0074-02762002000700015; Sundar S, 2005, AM J TROP MED HYG, V73, P269, DOI 10.4269/ajtmh.2005.73.269; Veeken H, 2003, TROP MED INT HEALTH, V8, P164, DOI 10.1046/j.1365-3156.2003.00996.x; Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x; ZIJLSTRA EE, 1991, T ROY SOC TROP MED H, V85, P474, DOI 10.1016/0035-9203(91)90224-M	25	36	36	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	SEP	2007	101	9					908	914		10.1016/j.trstmh.2007.05.002				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	207BX	WOS:000249227700011	17624385				2019-04-02	
J	Roberfroid, D; Pelto, GH; Kolsteren, P				Roberfroid, D.; Pelto, G. H.; Kolsteren, P.			Plot and see! Maternal comprehension of growth charts worldwide	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						growth charts; comprehension; maternal education; programme theory; communication; review	DIRECT RECORDING SCALES; MONITORING PROGRAM; CONTROLLED-TRIAL; HEALTH-SERVICES; WEIGHT-GAIN; NUTRITION; MOTHERS; PROMOTION; CHILDREN; CARE	OBJECTIVE To evaluate maternal comprehension of growth charts used in growth monitoring and promotion (GMP), a worldwide programme with important budgets but contrasting results. METHODS Systematic literature review through MEDLINE, POPLINE, Global Health, ERIC and the Cochrane Library with the keywords 'growth monitoring' or 'growth chart' limited to the title/abstract field and to the 0-5 years age range. RESULTS Twenty studies from Asia (8), Africa (8) and Latin America/Caribbean (3) were included in the review. The results of the 14 non-intervention, cross-sectional studies provide convincing evidence that a third to three-fourths of carers in developing countries do not understand the growth charts. Literacy had a strong effect on women's ability to interpret the cards. Appropriate training and educational activities also increased substantially maternal comprehension as demonstrated in five of the six intervention trials. CONCLUSIONS Many carers have poor comprehension of growth charts, but their comprehension increases not only with literacy, but also with training. Activities aimed at improving communication skills of health staff and at empowering parents to practice responsive parenting could greatly improve GMP outcomes.	Inst Trop Med Prince Leopold, Dept Publ Hlth, Nutr & Child Hlth Unit, B-2000 Antwerp, Belgium; Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Roberfroid, D (reprint author), Inst Trop Med Prince Leopold, Dept Publ Hlth, Nutr & Child Hlth Unit, 155 Natl Str, B-2000 Antwerp, Belgium.	droberfroid@itg.be					Aden A S, 1990, Paediatr Perinat Epidemiol, V4, P340, DOI 10.1111/j.1365-3016.1990.tb00656.x; BROWN R, 1993, J TROP PEDIATRICS, V39, P55, DOI 10.1093/tropej/39.1.55; De Onis M, 2004, J PEDIATR-US, V144, P461, DOI 10.1016/j.jpeds.2003.12.034; de Souza ACT, 1999, B WORLD HEALTH ORGAN, V77, P895; Dicken K., 1997, DESIGNING DIALOGUE P; DIXON RA, 1991, ANN TROP PAEDIATR, V11, P3, DOI 10.1080/02724936.1991.11747471; FAGBULE D O, 1991, African Journal of Medicine and Medical Sciences, V20, P41; FAGBULE DO, 1990, E AFR MED J, V67, P69; Forsyth S. J., 1984, Food and Nutrition Bulletin, V6, P22; FREED GL, 1995, PEDIATRICS, V96, P490; Glanz K, 1997, AM J CLIN NUTR, V65, P2016; GOPALDAS T, 1990, J TROP PEDIATRICS, V36, P322, DOI 10.1093/tropej/36.6.322; Gouws E, 2005, SOC SCI MED, V61, P613, DOI 10.1016/j.socscimed.2004.12.019; GRANT K, 1986, J TROP PEDIATRICS, V32, P255, DOI 10.1093/tropej/32.5.255; GRIFFITHS M, 1988, Indian Journal of Pediatrics, V55, pS59, DOI 10.1007/BF02810391; Griffiths M, 1996, PROMOTING GROWTH CHI, P1; Hossain SMM, 2005, HEALTH POLICY PLANN, V20, P35, DOI 10.1093/heapol/czi004; HUGHSON H C, 1988, Journal of the Medical Association of Thailand, V71, P666; Karim Fazlul, 1994, Food and Nutrition Bulletin, V15, P192; LEFEVRE P, 1999, COMPREHENSIVE PARTIC; Loechl C., 2004, OPERATIONS EVALUATIO; LOTFI M, 1997, FOOD NUTR BULL, V10, P3; MCAULIFFE JF, 1993, J TROP PEDIATRICS, V39, P370, DOI 10.1093/tropej/39.6.370; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; MEEGAN M, 1994, T ROY SOC TROP MED H, V88, P635, DOI 10.1016/0035-9203(94)90202-X; Meegan M, 1999, TROP DOCT, V29, P23, DOI 10.1177/004947559902900109; MITCHELMAN DF, 1990, AM J HEALTH PROMOT, V4, P181; MORLEY DC, 1988, THEY GROW MONITORING; MORLEY DC, 1994, S AFR MED J, V7, P15; Musaiger AO, 2001, TROP DOCT, V31, P161, DOI 10.1177/004947550103100316; NABARRO D, 1988, SOC SCI MED, V26, P941, DOI 10.1016/0277-9536(88)90414-5; OWEN MR, 1983, W INDIAN MED J, V32, P176; Owusu W. B., 1992, Food and Nutrition Bulletin, V14, P97; Pelto GH, 2004, J NUTR, V134, P357; Penny ME, 2005, LANCET, V365, P1863, DOI 10.1016/S0140-6736(05); QAZI SA, 2002, INDIAN PEDIATR, V40, P1043; Rasheed P, 1996, SAUDI MED J, V17, P195; Roberfroid D, 2005, TROP MED INT HEALTH, V10, P1121, DOI 10.1111/j.1365-3156.2005.01498.x; Roberfroid D, 2005, J HEALTH POPUL NUTR, V23, P207; Robert RC, 2006, J NUTR, V136, P634; ROHDE J E, 1988, Indian Journal of Pediatrics, V55, pS3, DOI 10.1007/BF02810383; Ross A, 2005, TROP MED INT HEALTH, V10, P404, DOI 10.1111/j.1365-3156.2005.01405.x; Rossi PH, 2004, EVALUATION SYSTEMATI; RUEL MT, 1990, B WORLD HEALTH ORGAN, V68, P483; RUEL MT, 1992, INT J EPIDEMIOL, V21, P59, DOI 10.1093/ije/21.1.59; RUEL MT, 1995, CHILD GROWTH NUTR DE, P78; Santos I, 2001, J NUTR, V131, P2866; Senanayake MP, 1997, ARCH DIS CHILD, V76, P359, DOI 10.1136/adc.76.4.359; SHEKAR M, 1992, Indian Journal of Pediatrics, V59, P5, DOI 10.1007/BF02760889; Sohal H, 1998, TROP DOCT, V28, P160, DOI 10.1177/004947559802800311; Vasundhara M K, 1993, Indian J Matern Child Health, V4, P25; WIT JM, 1984, TROP DOCT, V14, P34, DOI 10.1177/004947558401400118; World Health Organization, 1986, GROWTH CHART TOOL US	53	16	17	0	4	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2007	12	9					1074	1086		10.1111/j.1365-3156.2007.01890.x				13	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213KF	WOS:000249665000008	17875018	Bronze			2019-04-02	
J	Simukoko, H; Marcotty, T; Phiri, I; Vercruysse, J; Van den Bossche, P				Simukoko, H.; Marcotty, T.; Phiri, I.; Vercruysse, J.; Van den Bossche, P.			Heterogeneity in the trypanosomosis incidence in Zebu cattle of different ages and sex on the plateau of eastern Zambia	ACTA TROPICA			English	Article						trypanosomosis; incidence; endemic; cattle heterogeneity; Zambia	GLOSSINA-MORSITANS-MORSITANS; TSETSE; DIPTERA; FLIES	On the plateau of eastern Zambia, trypanosomosis is endemic. Glossina morsitans morsitans Westwood (Diptera: Glossinidae), the only tsetse species present, is almost entirely dependent on livestock as its source of food with cattle being the most preferred host. To determine if tsetse challenge is distributed equally over the various age categories and sexes within a cattle herd, a longitudinal study of trypanosomosis incidence was conducted during the rainy season. A total of 354 head of cattle consisting of 40% oxen, 30% cows, 15% young stock, 13% calves and 2% bulls were sampled for three consecutive months and their infection statuses determined using the PCR-RFLP technique as diagnostic method. Results indicated that there were significant differences (P<0.001) in the proportion of infected animals between the various categories. In oxen, the risk of infection was 5.6 times higher than in calves. Those results suggest heterogeneity in the challenge by tsetse flies and are in line with entomological observations on the feeding preference of tsetse on cattle. The implications of these results for the control of trypanosomosis in Eastern Province and other epidemiologically related areas are discussed. (c) 2007 Elsevier B.V. All rights reserved.	Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; Univ Zambia, Sch Vet Med, Lusaka, Zambia; Univ Ghent, Vakgroep Virol Parasitol & Immunol, B-9820 Merelbeke, Belgium; Univ Pretoria, Dept Vet Trop Dis, Onderstepoort, South Africa	Van den Bossche, P (reprint author), Inst Trop Med, Dept Anim Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	pvdbossche@itg.be			Wellcome Trust [07824/B/04/Z]		Cannon R. M., 1982, LIVESTOCK DIS SURVEY; Doran M., 2000, SOCIO EC TRYPANOSOMO, V3, P156; FIENNES RNT, 1970, PATHOGENESIS PATHOLO, P729; Geysen D, 2003, VET PARASITOL, V110, P171, DOI 10.1016/S0304-4017(02)00313-8; HOLMES PH, 1997, VET PARASITOL, V110, P117; Kelly DW, 2001, TRENDS PARASITOL, V17, P578, DOI 10.1016/S1471-4922(01)02116-X; Rowlands GJ, 2001, ACTA TROP, V79, P149, DOI 10.1016/S0001-706X(01)00068-7; Stata Corporation, 2003, STAT STAT SOFTW REL; SWALLOW BM, 1998, IMPACTS AFRICAN ANIM, P19; Torr SJ, 2000, MED VET ENTOMOL, V14, P400, DOI 10.1046/j.1365-2915.2000.00257.x; Torr SJ, 2006, B ENTOMOL RES, V96, P71, DOI 10.1079/BER2005404; TORR SJ, 1994, B ENTOMOL RES, V84, P411, DOI 10.1017/S0007485300032545; TRAIL JCM, 1994, VET PARASITOL, V55, P175, DOI 10.1016/0304-4017(94)00647-U; Van den Bossche P, 2002, MED VET ENTOMOL, V16, P170, DOI 10.1046/j.1365-2915.2002.00360.x; VandenBossche P, 1997, ACTA TROP, V65, P105, DOI 10.1016/S0001-706X(97)00658-X; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	16	10	10	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	AUG	2007	103	2					98	101		10.1016/j.actatropica.2007.05.011				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	213QD	WOS:000249681300003	17618594	Green Published, Other Gold			2019-04-02	
J	van Griensven, J; De Naeyer, L; Mushi, T; Ubarijoro, S; Gashumba, D; Gazille, C; Zachariah, R				van Griensven, Johan; De Naeyer, Ludwig; Mushi, Thomas; Ubarijoro, Sowaf; Gashumba, Diane; Gazille, Claire; Zachariah, Rony			High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						HIV; antiretroviral therapy; lipoatrophy; lipodystrophy; stavudine; Africa	HIV-INFECTED ADULTS; LIPODYSTROPHY; ABNORMALITIES; COHORT	This study was conducted among individuals placed on WHO-recommended first-line antiretroviral therapy (ART) at two urban health centres in Kigali, Rwanda, in order to determine (a) the overall prevalence of lipodystrophy and (b) the risk factors for lipoatropy. Consecutive individuals on ART for > 1 year were systematically subjected to a stanclardised case definition-based questionnaire and clinical assessment. Of a total of 409 individuals, 370 (90%) were on an ART regimen containing stavudine (d4T), whilst the rest were receiving a zidovudine (AZT)-containing regimen. Lipodystrophy was apparent in 140 individuals (34%), of whom 40 (9.8%) had isolated lipoatrophy, 20 (4.9%) had isolated lipohypertrophy and 80 (19.6%) had mixed patterns. Fifty-six percent of patients reported the effects as disturbing. The prevalence of lipoatrophy was more than three times higher when taking d4T compared with AZT-containing regimens (31.4% vs. 10.3%). Being female, d4T-based ART, baseline body mass index >= 25 kg/m(2) or baseline CD4 count >= 150 cells/mu l and increasing duration of ART were all significantly associated with lipoatrophy. Lipoatrophy appears to be an important tong-term complication of WHO-recommended first-line ART regimens. These data highlight the urgent need for access to more affordable and less toxic ART regimens in resource-limited settings. (c) 2007 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	Med Sans Frontieres, Kacyiru 1361, Kigali, Rwanda; Minist Hlth, Kigali, Rwanda; Med Sans Frontieres, Brussels Operat Ctr, Dept Med Operat Res, B-1090 Brussels, Belgium	van Griensven, J (reprint author), Med Sans Frontieres, Kacyiru 1361, Kigali, Rwanda.	jvgrie@yahoo.com					Bacchetti P, 2006, JAIDS-J ACQ IMM DEF, V42, P562; BOULLE A, 2006, REGIMEN DURABILITY T; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; FORNA F, 2006, 13 C RETR OPP INF 5; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; KIM A, 2006, 13 C RETR OPP INF 5; Lichtenstein KA, 2005, JAIDS-J ACQ IMM DEF, V39, P395, DOI 10.1097/01.qai.0000167478.28051.3a; MCCOMSEY G, 2006, 13 C RETR OPP INF 5; Palella FJ, 2004, CLIN INFECT DIS, V38, P903; Pujari SN, 2005, JAIDS-J ACQ IMM DEF, V39, P199; Spacek LA, 2006, CLIN INFECT DIS, V42, P252, DOI 10.1086/499044; VANGRIENSVEN J, 2006, 13 C RETR OPP INF 5; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; *WHO, 2006, ANT TREATM HIV INF A	15	74	75	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	AUG	2007	101	8					793	798		10.1016/j.trstmh.2007.02.020				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	192LW	WOS:000248204300010	17467756	Green Published			2019-04-02	
J	Richard, F; Ouedraogo, C; Compaore, J; Dubourg, D; De Brouwere, V				Richard, F.; Ouedraogo, C.; Compaore, J.; Dubourg, D.; De Brouwere, V.			Reducing financial barriers to emergency obstetric care: experience of cost-sharing mechanism in a district hospital in Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						emergency obstetric care; access to health care; financing; equity; urban health; Burkina Faso	HEALTH-SERVICES	Objective To describe the implementation of a cost- sharing system for emergency obstetric care in an urban health district of Ouagadougou, Burkina Faso and analyse its results after 1 year of activity. methods Service availability and use, service quality, knowledge of the cost- sharing system in the community and financial viability of the system were measured before and after the system was implemented. Different sources of data were used: community survey, anthropological study, routine data from hospital files and registers and specific data collected on major obstetric interventions (MOI) in all the hospitals utilized by the district population. Direct costs of MOI were collected for each patient through an individual form and monitored during the year 2005. Rates of MOI for absolute maternal indications (AMI) were calculated for the period 2003 - 2005. Results The direct cost of a MOI was on average 136US$, including referral cost. Through the costsharing system this amount was shared between families (46US$), health centres (15US$), Ministry of Health (38US$) and local authority (37US$). The scheme was started in January 2005. The rate of cost recovery was 91.3% and the balance at the end of 2005 was slightly positive (4.7% of the total contribution). The number of emergency referrals by health centres increased from 84 in 2004 to 683 in 2005. MOI per 100 expected births increased from 1.95% in 2003 to 3.56% in 2005 and MOI for AMI increased from 0.75% to 1.42%. conclusions The dramatic increase in MOI suggests that the cost- sharing scheme decreased financial and geographical barriers to emergency obstetric care. Other positive effects on quality of care were documented but the sustainability of such a system remains uncertain in the dynamic context of Burkina Faso (decentralization).	Inst Trop Med, Dept Publ Hlth, Human Resources & Qual Unit, B-2000 Antwerp, Belgium; Secteur Dist Hosp 30, Obstet & Gynaecol Unit, Ouagadougou, Burkina Faso; ASMADE, Ouagadougou, Burkina Faso	De Brouwere, V (reprint author), Inst Trop Med, Dept Publ Hlth, Human Resources & Qual Unit, B-2000 Antwerp, Belgium.	vdbrouw@itg.be					ABELSMITH B, 1992, HEALTH POLICY PLANN, V7, P329, DOI 10.1093/heapol/7.4.329; AbouZahr C, 2001, B WORLD HEALTH ORGAN, V79, P561; BEAUCHEMIN C, 2004, MIGRATION GRANDES BU; BERE Y, 2005, WORKSH 72 MUT BURK F; BICABA A, 2003, GOUVERNANCE EQUITE S; Ensor T, 2005, HEALTH POLICY, V75, P49, DOI 10.1016/j.healthpol.2005.02.002; *GTZ, 2001, URB HLTH PART CHALL; *INSD, 2003, ENQ BURK COND MEN; *INSD, 1998, ENQ PRIOR DEP MEN OU; Jewkes R, 1998, SOC SCI MED, V46, P843, DOI 10.1016/S0277-9536(97)00209-8; KAKAMBEGA M, 2005, WORKSH 72 MUT BURK F; KOBIANE JF, 1998, ESSAI CONSTRUCTION P, P117; *MIN EC DEV, 2004, CADR STRAT LUTT PAUV; *MIN SANT, 2005, PLAN ACT DISTR SAN S; Murray SF, 2006, SOC SCI MED, V62, P2205, DOI 10.1016/j.socscimed.2005.10.025; NACOULMA D, 2003, 10 JOURN SCI SANT BO; Nahar S, 1998, HEALTH POLICY PLANN, V13, P417, DOI 10.1093/heapol/13.4.417; OUATTTARA F, 2006, CLOS S AQUASOU PROJ; RIDDE V, 2006, QUESTION EQUITE ACCE; SEN A., 2000, NOUVEAU MODELE EC; Stierle F, 1999, INT J HEALTH PLAN M, V14, P81, DOI 10.1002/(SICI)1099-1751(199904/06)14:2<81::AID-HPM543>3.0.CO;2-P; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21; *UN STAT DIV, 2005, WORLD REG TRENDS MIL; UNDP, 2003, HUM DEV REP; *UON NETW, 1998, TACKL UNM OBST NEEDS; Waelkens M.-P., 2004, MUTUELLES SANTE AFRI; WHO UNICEF UNFPA, 2004, MAT MORT 2000 EST DE; ZONGO S, 2005, APPR ANTHR ACC DOM D; 2004, VENTAIRE SYSTEMS ASS	29	17	17	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2007	12	8					972	981		10.1111/j.1365-3156.2007.01877.x				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	206RL	WOS:000249200500009	17697092				2019-04-02	
J	Protopopoff, N; van Herp, M; Maes, P; Reid, T; Baza, D; D'Alessandro, U; van Bortel, W; Coosemans, M				Protopopoff, Natacha; van Herp, Michel; Maes, Peter; Reid, Tony; Baza, Dismas; D'Alessandro, Umberto; van Bortel, Wim; Coosemans, Marc			Vector control in a malaria epidemic occurring within a complex emergency situation in Burundi: a case study	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM GAMETOCYTAEMIA; INSECTICIDE-TREATED BEDNETS; WESTERN KENYA; CHILDREN; HIGHLANDS; IMPACT; MORBIDITY; ETHIOPIA; AFRICA	Background: African highlands often suffer of devastating malaria epidemics, sometimes in conjunction with complex emergencies, making their control even more difficult. In 2000, Burundian highlands experienced a large malaria outbreak at a time of civil unrest, constant insecurity and nutritional emergency. Because of suspected high resistance to the first and second line treatments, the provincial health authority and Medecins Sans Frontieres ( Belgium) decided to implement vector control activities in an attempt to curtail the epidemic. There are few reported interventions of this type to control malaria epidemics in complex emergency contexts. Here, decisions and actions taken to control this epidemic, their impact and the lessons learned from this experience are reported. Case description: Twenty nine hills ( administrative areas) were selected in collaboration with the provincial health authorities for the vector control interventions combining indoor residual spraying with deltamethrin and insecticide-treated nets. Impact was evaluated by entomological and parasitological surveys. Almost all houses ( 99%) were sprayed and nets use varied between 48% and 63%. Anopheles indoor resting density was significantly lower in treated as compared to untreated hills, the latter taken as controls. Despite this impact on the vector, malaria prevalence was not significantly lower in treated hills except for people sleeping under a net. Discussion: Indoor spraying was feasible and resulted in high coverage despite being a logistically complex intervention in the Burundian context ( scattered houses and emergency situation). However, it had little impact on the prevalence of malaria infection, possibly because it was implemented after the epidemic's peak. Nevertheless, after this outbreak the Ministry of Health improved the surveillance system, changed its policy with introduction of effective drugs and implementation of vector control to prevent new malaria epidemics. Conclusion: In the absence of effective drugs and sufficient preparedness, present study failed to demonstrate any impact of vector control activities upon the course of a short-duration malaria epidemic. However, the experience gained lead to increased preparedness and demonstrated the feasibility of vector control measures in this specific context.	Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; Med Sans Frontieres Belgium, Dept Med, Brussels, Belgium; Minist Hlth, Programme Lutte Malad Transmissibles & Carentiell, Bujumbura, Burundi; Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Vet & Biomed Sci, B-2610 Antwerp, Belgium	Protopopoff, N (reprint author), Inst Trop Med Prince Leopold, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	nprotopopoff@itg.be; michel.van.herp@msf.be; Peter.maes@msf.be; Tony.Reid@msf.be; bazadismas@yahoo.fr; UDAlessandro@itg.be; wvbortel@itg.be; mcoosemans@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Protopopoff, Natacha/0000-0001-6698-4936; Van Bortel, Wim/0000-0002-6644-518X			Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bousema JT, 2003, TROP MED INT HEALTH, V8, P427, DOI 10.1046/j.1365-3156.2003.01047.x; Checchi F, 2006, EMERG INFECT DIS, V12, P1477, DOI 10.3201/eid1210.060540; GARNHAM PCC, 1945, BRIT MED J, V2, P45, DOI 10.1136/bmj.2.4410.45; Gillies MT, 1987, SUPPLEMENT ANOPHELIN; Guthmann JP, 2007, EMERG INFECT DIS, V13, P140, DOI 10.3201/eid1301.060546; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P298, DOI 10.1046/j.1365-3156.2002.00874.x; Hay SI, 2002, EMERG INFECT DIS, V8, P543, DOI 10.3201/eid0806.010309; JADIN J, 1951, Ann Soc Belg Med Trop (1920), V31, P353; LACARIN CJ, 1999, EMERGENCY VECTOR CON; Malakooti MA, 1998, EMERG INFECT DIS, V4, P671, DOI 10.3201/eid0404.980422; MEYUS H., 1962, ANN SOC BEIGE MED TROP, V42, P771; *MIN SANT PUB BUR, 2004, PLAN LUTT CONTR EP P; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Ndayiragije A, 2004, TROP MED INT HEALTH, V9, P673, DOI 10.1111/j.1365-3156.2004.01255.x; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Romi R, 2002, AM J TROP MED HYG, V66, P2, DOI 10.4269/ajtmh.2002.66.2; SNOW RW, 1988, T ROY SOC TROP MED H, V82, P838, DOI 10.1016/0035-9203(88)90011-9; Sowunmi A, 2003, TROP MED INT HEALTH, V8, P783, DOI 10.1046/j.1365-3156.2003.01093.x; VanBortel W, 1996, TROP MED INT HEALTH, V1, P824; Vincke IH, 1946, ANN SOC BELG MED TR, V26, P483; WEBSTER J, 2001, RBM COMPLEX EMERGENC, P1; WHO, 1975, MAN PRACT ENT MAL 2; *WHO, 2003, MAL EP FOR PREV EARL; *WHO, 2004, GUID PRINC MAL CONTR; WHO, 2005, MAL CONTR COMPL EM I	27	18	18	1	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 16	2007	6								93	10.1186/1475-2875-6-93				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	208DO	WOS:000249300200001	17634116	DOAJ Gold, Green Published			2019-04-02	
J	Kindermans, JM; Vandenbergh, D; Vreeke, E; Olliaro, P; D'Altilia, JP				Kindermans, Jean-Marie; Vandenbergh, Daniel; Vreeke, Ed; Olliaro, Piero; D'Altilia, Jean-Pierre			Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs)	MALARIA JOURNAL			English	Article							MALARIA	Background: Having reliable forecasts is critical now for producers, malaria-endemic countries and agencies in order to adapt production and procurement of the artemisinin-based combination treatments (ACTs), the new first-line treatments of malaria. There is no ideal method to quantify drug requirements for malaria. Morbidity data give uncertain estimations. This study uses drug consumption to provide elements to help estimate quantities and financial requirements of ACTs. Methods: The consumption of chloroquine, sulphadoxine/pyrimethamine and quinine both through the private and public sector was assessed in five sub-Saharan Africa countries with different epidemiological patterns (Senegal, Rwanda, Tanzania, Malawi, Zimbabwe). From these data the number of adult treatments per capita was calculated and the volumes and financial implications derived for the whole of Africa. Results: Identifying and obtaining data from the private sector was difficult. The quality of information on drug supply and distribution in countries must be improved. The number of adult treatments per capita and per year in the five countries ranged from 0.18 to 0.50. Current adult treatment prices for ACTs range US$ 1-1.8. Taking the upper range for both volumes and costs, the highest number of adult treatments consumed for Africa was estimated at 314.5 million, corresponding to an overall maximum annual need for financing ACT procurement of US$ 566.1 million. In reality, both the number of cases treated and the cost of treatment are likely to be lower (projections for the lowest consumption estimate with the least expensive ACT would require US $ 113 million per annum). There were substantial variations in the market share between public and private sources among these countries (the public sector share ranging from 98% in Rwanda to 33% in Tanzania). Conclusion: Additional studies are required to build a more robust methodology, and to assess current consumptions more accurately in order to better quantify volumes and finances for production and procurement of ACTs.	AEDES Fdn, B-1000 Brussels, Belgium; WHO, UNICEF UNDP WB, Special Programme Res & Training Trop Dis TDR, CH-1211 Geneva 27, Switzerland	Kindermans, JM (reprint author), AEDES Fdn, 34 Rue Joseph 2, B-1000 Brussels, Belgium.	jmkindermans@aedes.be; dvandenbergh@aedes.be; dir@asrames.org; olliarop@who.int; jpdaltilia@aedes.be					Breman JG, 2001, AM J TROP MED HYG, V64, P1; *I MED NAT AC, 2004, SAV LIV BUY TIM; Korenromp E, 2011, MALARIA INCIDENCE ES; McCombie SC, 2002, HEALTH POLICY PLANN, V17, P333, DOI 10.1093/heapol/17.4.333; *RBM UNICEF WHO, 2005, WHOHTMMAL20051102, P80; SHRETTA R, 2003, FLOW ANTIMALARIAL DR; Snow RW, 2003, TRENDS PARASITOL, V19, P363, DOI 10.1016/S1471-4922(03)00168-5; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tavrow P, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-10; *UN POP DIV, WORLD POP PROSP 2002; *WHO, 2006, WHOHTMMAL20061108; *WHO, 2003, POS WHOS ROLL BACK M; World Health Organization, WHOCDSRBM200135; World Health Organization, AFR MAL REP 2003; World Health Organization, WHO VACC PREV DIS MO; World Health Organization, 2000, WHOCDSRBM200133; MALARIA GLANCE 2001	17	9	9	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 10	2007	6								91	10.1186/1475-2875-6-91				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	198UA	WOS:000248651800001	17623092	DOAJ Gold, Green Published			2019-04-02	
J	Virreira, M; Truyens, C; Alonso-Vega, C; Brutus, L; Jijena, J; Torrico, F; Carlier, Y; Svoboda, M				Virreira, Myrna; Truyens, Carine; Alonso-Vega, Cristina; Brutus, Laurent; Jijena, Juan; Torrico, Faustino; Carlier, Yves; Svoboda, Michal			Comparison of Trypanosoma cruzi lineages and levels of parasitic DNA in infected mothers and their newborns	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							CONGENITAL CHAGAS-DISEASE; POLYMERASE-CHAIN-REACTION; BOLIVIA	To better understand the factors involved in maternal-fetal transmission of Trypanosoma cruzi, we compared DNA levels-obtained by use of quantitative real-time PCR and parasitic genotypes determined by PCR amplification followed by hybridization-in Bolivian mothers and their congenitally infected newborns. Mothers and their neonates displayed markedly different parasitic DNA levels, as most maternal estimated parasitemias (> 90%) were < 10 parasites/mL, whereas those of 76% of their newborns were > 1,000 parasites/mL. Comparison of T cruzi TeII sublineages infecting mothers and newborns showed identity, without evidence of mixed infection in mothers or neonates. Analysis of minor variants of TcIId-genotyped parasites using sequence class probes hybridizing with hypervariable domains of kDNA minicircles showed discrepancies in half of mother/newborn pairs.	Univ Libre Bruxelles, Fac Med, Chim Biol Lab, B-1070 Brussels, Belgium; Univ Libre Bruxelles, Fac Med, Parasitol Lab, Brussels, Belgium; Univ Mayor San Simon, Fac Med, Cochabamba, Bolivia; IRD, Mother & Child Hlth Res Unit UR010, La Paz, Bolivia; Hosp Univ San Juan de Dios, Unidad Neonatol, Tarija, Bolivia	Svoboda, M (reprint author), Univ Libre Bruxelles, Fac Med, Chim Biol Lab, 808 Route Lennik CP 611, B-1070 Brussels, Belgium.	msvobod@ulb.ac.be	Brutus, Laurent/A-7430-2011	Brutus, Laurent/0000-0002-9967-0666			ALVES AMB, 1994, J EUKARYOT MICROBIOL, V41, P415, DOI 10.1111/j.1550-7408.1994.tb06099.x; Carlier Yves, 2003, Rev. Soc. Bras. Med. Trop., V36, P767, DOI 10.1590/S0037-86822003000600024; Breniere SF, 2002, MEM I OSWALDO CRUZ, V97, P289, DOI 10.1590/S0074-02762002000300002; CARLIER Y, 2002, 8505120 SAS; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; Fernandez-Aguilar S, 2005, REV SOC BRAS MED TRO, V38, P84; Hermann E, 2004, J INFECT DIS, V189, P1274, DOI 10.1086/382511; Hermann E, 2002, BLOOD, V100, P2153; Schenone Hugo, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P231, DOI 10.1590/S0036-46652001000400011; Schijman AG, 2003, J ANTIMICROB CHEMOTH, V52, P441, DOI 10.1093/jac/dkg338; Torrico F, 2004, AM J TROP MED HYG, V70, P201, DOI 10.4269/ajtmh.2004.70.201; Torrico MC, 2005, REV SOC BRAS MED TRO, V38, P58; Vago AR, 1996, AM J PATHOL, V149, P2153; Vekemans J, 2000, INFECT IMMUN, V68, P5430, DOI 10.1128/IAI.68.9.5430-5434.2000; Virreira M, 2003, AM J TROP MED HYG, V68, P574, DOI 10.4269/ajtmh.2003.68.574; Virreira M, 2006, AM J TROP MED HYG, V75, P871, DOI 10.4269/ajtmh.2006.75.871; Virreira M, 2006, AM J TROP MED HYG, V75, P1082, DOI 10.4269/ajtmh.2006.75.1082	17	44	46	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUL	2007	77	1					102	106		10.4269/ajtmh.2007.77.102				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	189HK	WOS:000247979800017	17620638	Green Published			2019-04-02	
J	Siwila, J; Phiri, IGK; Vercruysse, J; Goma, F; Gabriel, S; Claerebout, E; Geurden, T				Siwila, Joyce; Phiri, Isaac G. K.; Vercruysse, Jozef; Goma, Fusya; Gabriel, Sarah; Claerebout, Edwin; Geurden, Thomas			Asymptomatic cryptosporidiosis in Zambian dairy farm workers and their household members	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Cryptosporidium; zoonosis; disease transmission; genotyping; Zambia		The prevalence of Cryptosporidium and the possibility of zoonotic transmission on dairy farms were examined. Eighteen cases of cryptosporidiosis (prevalence 6%) were identified in 82 farm workers and 207 household members. Furthermore, 70 (34%) of 207 calf samples were positive. Based on the 70 kDa heat shock protein and the 18S rDNA gene, Cryptosporidium parvum was identified in 75% of the positive farm workers and in 60% of the household members. Of the positive calves, 62% were infected with C. parvum, indicating a possible zoonotic transmission on these farms. (C) 2007 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	Univ Ghent, Lab Vet Parasitol, Fac Vet Med, B-9820 Merelbeke, Belgium; Univ Zambia, Dept Clin Studies, Sch Vet Med, Lusaka, Zambia	Geurden, T (reprint author), Univ Ghent, Lab Vet Parasitol, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.	thomas.geurden@ugent.be		GABRIEL, SARAH/0000-0002-2523-233X			Gatei W, 2003, J CLIN MICROBIOL, V41, P1458, DOI 10.1128/JCM.41.4.1458-1462.2003; Geurden T, 2006, VET PARASITOL, V138, P217, DOI 10.1016/j.vetpar.2006.02.009; Kelly P, 1997, J INFECT DIS, V176, P1120, DOI 10.1086/516528; Morgan UM, 2001, INT J PARASITOL, V31, P289, DOI 10.1016/S0020-7519(00)00164-8; Ryan U, 2003, APPL ENVIRON MICROB, V69, P4302, DOI 10.1128/AEM.69.7.4302-4307.2003	5	23	23	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUL	2007	101	7					733	734		10.1016/j.trstmh.2007.01.006				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	184TR	WOS:000247665700019	17368697				2019-04-02	
J	Macq, J; Torfoss, T; Getahun, H				Macq, Jean; Torfoss, Ted; Getahun, Haileyesus			Patient empowerment in tuberculosis control: reflecting on past documented experiences	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						tuberculosis; patient empowerment; evaluation	RANDOMIZED CONTROLLED-TRIAL; EDUCATIONAL INTERVENTION; ENHANCE ADHERENCE; SOCIAL STIGMA; BURKINA-FASO; SOUTH-AFRICA; TB CLUBS; CARE; COMMUNITY; BARRIERS	Objectives To review the available published and non-published literature on patient empowerment in tuberculosis (TB) control, describe what it entails, identify possible trends and conclusions, and suggest areas both for informing policy makers and for orienting further research. Methods We searched MEDLINE and PSYCINFO databases, used World Wide Web research tools and included conference abstracts and specific project reports. Results Experience shows that operational definitions, potential barriers towards empowerment and contextual issues need to be considered. Four types of experiences were reported: (1) enabling patients to take more responsibility for their health, especially regarding adherence to treatment, (2) organizing TB patients into groups and clubs, (3) building patient-centred care in TB and general health services, and (4) using TB patients' advocacy skills to improve TB control. Conclusions Patient empowerment conceptions through interventions and studies should primarily involve TB patients themselves. Patients' activism - their role, the shape it takes and resulting effects - is insufficiently documented.	Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; Norwegian Assoc Heart & Lung Patients, Nydalen, Norway; WHO, STOP TB Dept, CH-1211 Geneva, Switzerland	Macq, J (reprint author), Univ Libre Bruxelles, Sch Publ Hlth, CP 597,Route Lennik 808, Brussels, Belgium.	jmacq@ulb.ac.be					Akramul I, 2005, INT J TUBERC LUNG D, V9, p0S37; Allen S, 2003, INT J TUBERC LUNG D, V7, pS190; Alvarez Gordillo GC, 2003, REV PANAM SALUD PUBL, V14, P402; Alvarez-Gordillo GD, 2000, SALUD PUBLICA MEXICO, V42, P520, DOI 10.1590/S0036-36342000000600008; Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P1; *ASET, 2005, EXP AP LUCH CONTR TU; Atre SR, 2004, TROP MED INT HEALTH, V9, P1228, DOI 10.1111/j.1365-3156.2004.01321.x; AUGLAND K, 2005, TB PATIENT EVALUATIO, P1; BAM DS, 2004, SAARC J TUBERCULOSIS, V1, P43; BAM DS, 2004, INT J TUBERC LUNG D, V8, pS176; Banerjee A, 1997, TROP DOCT, V27, P240, DOI 10.1177/004947559702700421; Bond VA, 2005, INT J TUBERC LUNG D, V9, P282; Cabrera DM, 2002, PATIENT EDUC COUNS, V46, P117, DOI 10.1016/S0738-3991(01)00156-2; CASE G, 2005, INT J TUBERC LUNG D, V9, pS46; CASE G, 2006, PATIENTS CHARTER TUB; Cass AD, 2005, INT J TUBERC LUNG D, V9, P415; Chaisson RE, 2001, AM J MED, V110, P610, DOI 10.1016/S0002-9343(01)00695-7; CHESIRE L, 2006, TBTV IS GREATEST THI; Dandona R, 2004, NATL MED J INDIA, V17, P292; DATTA M, 2006, INTRO CULTURALLY SEN, P1; DEMBELE M, 2003, INT J TUBERC LUNG D, V7, pS128; DEMBELE M, 2003, INT J TUBERC LUNG D, V7, pS192; Demissie M, 2003, SOC SCI MED, V56, P2009, DOI 10.1016/S0277-9536(02)00182-X; Dick J, 2004, J ADV NURS, V48, P434, DOI 10.1111/j.1365-2648.2004.03226.x; Dick J, 1997, INT J TUBERC LUNG D, V1, P181; Dick J, 1996, TUBERCLE LUNG DIS, V77, P173, DOI 10.1016/S0962-8479(96)90034-9; Drabo KM, 2006, INT J TUBERC LUNG D, V10, P93; DUTTON D, 1986, SOC SCI MED, V23, P721, DOI 10.1016/0277-9536(86)90121-8; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; El Saadr W, 2006, PATHWAYS COMPLETION; Franson JD, 2005, ADV SCI TECH SEC APP, P1; Getahun H, 1998, Afr Health, V21, P20; Getahun H, 2000, INT J TUBERC LUNG D, V4, P174; GIE V, 2001, 129 ANN M APHA NEW Y; HAMPTON G, 2006, SURVIVOR AFRICAS TWI; HARRIES A, 2001, LESS LEARN M HAR ZIM, P1; He GX, 2005, INT J TUBERC LUNG D, V9, pS135; Houston HR, 2002, ETHNIC HEALTH, V7, P255, DOI 10.1080/1355785022000060718; Hovell MF, 2003, AM J PUBLIC HEALTH, V93, P1871, DOI 10.2105/AJPH.93.11.1871; Hurtig AK, 1999, INT J TUBERC LUNG D, V3, P553; JARAMILLO E, 2002, WHOCDSTB2002304S, P1; Johansson E, 2002, QUAL HEALTH RES, V12, P473, DOI 10.1177/104973202129120025; Karim F, 2003, GENDER BARRIERS TUBE; Kironde S, 2002, INT J TUBERC LUNG D, V6, P104; Lawn SD, 2000, INT J TUBERC LUNG D, V4, P1190; Lewin S, 2005, B WORLD HEALTH ORGAN, V83, P250; Liefooghe R, 1997, TROP MED INT HEALTH, V2, P809, DOI 10.1046/j.1365-3156.1997.d01-380.x; Lienhardt C, 2004, TROP MED INT HEALTH, V9, P833, DOI 10.1111/j.1365-3156.2004.01273.x; MACEDO CE, 2003, INT J TUBERC LUNG D, V7, pS230; Macq J, 2006, Psychol Health Med, V11, P346, DOI 10.1080/13548500600595277; Macq J, 2005, HEALTH POLICY, V74, P205, DOI 10.1016/j.healthpol.2005.01.003; Macq J, 2004, INT J TUBERC LUNG D, V8, P1330; MACQ J, 2004, INT J TUBERC LUNG D, V8, pS89; MACQ J, 2005, INT J TUBERC LUNG D, V9, pS70; MACQ J, 2005, JOINT M DOTS EXP TB; Macq JCM, 2003, INT J TUBERC LUNG D, V7, P103; Manders AJE, 2001, INT J TUBERC LUNG D, V5, P838; Martin M, 2005, INT J TUBERC LUNG D, V9, P550; Morisky DE, 2001, PUBLIC HEALTH REP, V116, P568, DOI 10.1093/phr/116.6.568; *MSH, 2001, RESP DAM FDN SURV SE; MYRSETH S, 2006, HUMAN RIGHTS TB CONT; NATPRATAN C, 2005, INT J TUBERC LUNG D, V9, pS46; Needham DM, 2004, HEALTH POLICY, V67, P93, DOI 10.1016/S0168-8510(03)00065-4; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; New South Wales Treasury, 2004, TB CULT COMP NOT FIE, P1; NGAMTRAIRAI N, 2004, INT J TUBERC LUNG D, V8, pS174; Ogden J, 1999, INT J TUBERC LUNG D, V3, P855; Paton NI, 2004, AM J CLIN NUTR, V80, P460; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; Rangan S, 2003, TUBERCULOSIS, V83, P165, DOI 10.1016/S1472-9792(02)00070-7; Rangan S, 2003, HLTH ADM, V15, P72; RAYE S, 2005, INT J TUBERC LUNG D, V9, pS122; RAYE S, 2005, INT J TUBERC LUNG D, V8, pS210; ROSAS F, 2005, INT J TUBERC LUNG D, V9, pS20; SALIM H, 2003, INT J TUBERC LUNG D, V7, pS255; Sanou A, 2004, INT J TUBERC LUNG D, V8, P1479; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; SIDDHI A, 2005, INT J TUBERC LUNG D, V9, pS20; Sok T, 2004, INT J TUBERC LUNG D, V8; *STOP TB PARTN WHO, 2006, GLOB PLAN STOP TB 20, V35, P1; TAVORA E, 2004, INT J TUBERC LUNG D, V8, pS90; TORFOSS T, 2006, FRONTLINE HLTH WORKE; *UNDP, 2004, INVOLVEMENT EMPOWERM, P1; UPLEKAR M, 1999, WHOCDSTB2000280, P1; van der Oest Clif, 2005, N Z Med J, V118, pU1496; Wallerstein N., 2006, WHAT IS EVIDENCE EFF, P1; Wandwalo E, 2004, INT J TUBERC LUNG D, V8, P1248; Wandwalo E, 2006, HEALTH POLICY, V78, P284, DOI 10.1016/j.healthpol.2005.11.010; WHO, 2002, EXP DOTS FRAM EFF TU; World Health Organization (WHO), 2005, ADDR POV TB CONTR OP	90	31	33	1	4	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2007	12	7					873	885		10.1111/j.1365-3156.2007.01858.x				13	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	183GZ	WOS:000247562000011	17596255	Bronze			2019-04-02	
J	Prado-Jean, A; Kanobana, K; Druet-Cabanac, M; Nsengyiumva, G; Dorny, P; Preux, PM; Geerts, S				Prado-Jean, A.; Kanobana, K.; Druet-Cabanac, M.; Nsengyiumva, G.; Dorny, P.; Preux, P. M.; Geerts, S.			Combined use of an antigen and antibody detection enzyme-linked immunosorbent assay for cysticercosis as tools in an epidemiological study of epilepsy in Burundi	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						burundi; cysticercosis; diagnosis; enzyme-linked immunosorbent assay; epilepsy; case-control study	TAENIA-SOLIUM CYSTICERCOSIS; DEVELOPING-COUNTRIES; CEREBRAL MALARIA; NEUROCYSTICERCOSIS; SEROPREVALENCE; PREVALENCE; GUIDELINES; DIAGNOSIS; AFRICA; AREA	Objective To evaluate the benefits of the detection of both circulating antibodies (Ab) and antigens (Ag) for the diagnosis of cysticercosis in people with epilepsy. Neurocysticercosis is a cause of neurological diseases world-wide, especially epilepsy. The clinical symptoms of neurocysticercosis are non-specific and diagnosis is often difficult. Methods Serum samples were collected from subjects in a matched case-control study for epilepsy in the Kiremba area, Burundi, between March and April 2001 (epileptic cases = 303; controls without epilepsy = 606). The enzyme-linked immunosorbent assay (ELISA) was used for the detection of antibodies (Ab-ELISA) and circulating Ag (Ag-ELISA). Resluts The Ab-ELISA revealed 58.7% positivity in epilepsy cases and 31.4% in healthy controls; and Ag-ELISA revealed 38.3% positivity in epilepsy cases and 20.0% in controls. The matched odds ratios were 3.6 (95%CI: 2.5-4.9) for Ab-ELISA, and 2.9 (95%CI: 2.1-4.3) for Ag-ELISA. Conclusions Both Ag- and Ab-ELISA detected a significantly higher number of seropositives among people with epilepsy than among controls. The risk of epilepsy was high in cases with a positive Ag-ELISA, although less important than in cases with positivity for Ab-ELISA. Dead or degenerating cysticerci appear to be more frequently associated with epilepsy than living cysts. The high number of people with circulating Ag of Taenia solium suggests that the study area is a focus of active transmission of the parasite.	Inst Trop Med, B-2000 Antwerp, Belgium; Inst Epidemiol & Trop Neurol, EA 3174, Lab Neuroparasitol & Neuroepidemiol, Limoges, France; Ctr Natl Reference Matiere VIH SIDA Burundi, Bujumbura, Burundi	Geerts, S (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	sgeerts@itg.be	PREUX, Pierre-Marie/B-8393-2014	PREUX, Pierre-Marie/0000-0002-2171-2977; Geerts, Stanny/0000-0001-9885-8846; Druet-Cabanac, Michel/0000-0001-5711-3346			Carpio A, 2002, NEUROLOGY, V59, P1730, DOI 10.1212/01.WNL.0000036320.69823.EA; Commission on classification and terminology of the International League Against Epilepsy (ILAE), 1989, EPILEPSIA, V30, P389, DOI DOI 10.1111/J.1528-1157.1989.TB05316.X; Correa D, 1999, ANN TROP MED PARASIT, V93, P69; Del Brutto OH, 2001, NEUROLOGY, V57, P177, DOI 10.1212/WNL.57.2.177; Dorny P, 2004, TRENDS PARASITOL, V20, P259, DOI 10.1016/j.pt.2004.04.001; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Dorny P, 2000, VET PARASITOL, V88, P43, DOI 10.1016/S0304-4017(99)00196-X; Erhart A, 2002, T ROY SOC TROP MED H, V96, P270, DOI 10.1016/S0035-9203(02)90095-7; Garcia HH, 2000, T ROY SOC TROP MED H, V94, P673, DOI 10.1016/S0035-9203(00)90228-1; Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; Garcia HH, 2002, CLIN MICROBIOL REV, V15, P747, DOI 10.1128/CMR.15.4.747-756.2002; Guerra G., 1982, P437; Houinato D, 1998, T ROY SOC TROP MED H, V92, P621, DOI 10.1016/S0035-9203(98)90785-4; *ILAE, 1993, EPILEPSIA, V34, P592; Ito A, 2003, ACTA TROP, V87, P95, DOI 10.1016/S0001-706X(03)00024-X; Newell E, 1997, T ROY SOC TROP MED H, V91, P389, DOI 10.1016/S0035-9203(97)90251-0; Newell ED, 1997, T ROY SOC TROP MED H, V91, P525, DOI 10.1016/S0035-9203(97)90009-2; Ngoungou EB, 2006, EPILEPSIA, V47, P873, DOI 10.1111/j.1528-1167.2006.00524.x; Ngoungou EB, 2006, EPILEPSIA, V47, P2147, DOI 10.1111/j.1528-1167.2006.00890.x; Nguekam, 2003, PARASITE, V10, P65, DOI 10.1051/parasite/2003101p65; Nguekam A, 2003, VET PARASITOL, V111, P323, DOI 10.1016/S0304-4017(02)00391-6; Nguekam JP, 2003, TROP MED INT HEALTH, V8, P144, DOI 10.1046/j.1365-3156.2003.01000.x; Nicoletti A, 2002, NEUROLOGY, V58, P1256, DOI 10.1212/WNL.58.8.1256; Nsengiyumva G, 2003, EPILEPSIA, V44, P950, DOI 10.1046/j.1528-1157.2003.55302.x; NZISABIRA L, 1992, B SOC PATHOL EXOT, V85, P374; Pal DK, 2000, J NEUROL NEUROSUR PS, V68, P137, DOI 10.1136/jnnp.68.2.137; PAWLOWSKI ZS, 2001, FOODBORNE DIS HDB, V2, P217; Preux PM, 2000, B SOC PATHOL EXOT, V93, P276; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; PREUX PM, 1996, NEUROL INFECT EPIDEM, V1, P63; Sciutto E, 2000, MICROBES INFECT, V2, P1875, DOI 10.1016/S1286-4579(00)01336-8; Sokal RR, 1981, BIOMETRY, P859; Sotelo J, 1997, CNS DRUGS, V7, P17, DOI 10.2165/00023210-199707010-00003; WHO Expert Committee, 2002, COMM LANG FUNCT DIS, P1; Zoli AP, 2003, T ROY SOC TROP MED H, V97, P683, DOI 10.1016/S0035-9203(03)80103-7	35	16	16	0	4	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2007	12	7					895	901		10.1111/j.1365-3156.2007.01860.x				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	183GZ	WOS:000247562000013	17596257	Bronze			2019-04-02	
J	Baly, A; Toledo, ME; Boelaert, M; Reyes, A; Vanlerberghe, V; Ceballos, E; Carvajal, M; Maso, R; La Rosa, M; Denis, O; Van der Stuyft, P				Baly, A.; Toledo, M. E.; Boelaert, M.; Reyes, A.; Vanlerberghe, V.; Ceballos, E.; Carvajal, M.; Maso, R.; La Rosa, M.; Denis, O.; Van der Stuyft, P.			Cost effectiveness of Aedes aegypti control programmes: participatory versus vertical	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						dengue; Aedes aegypti; control; community-based programme; cost-effectiveness analysis; Cuba	BORNE DISEASE-CONTROL; COMMUNITY PARTICIPATION; DENGUE-3 EPIDEMIC; LESSONS; CUBA	We conducted an economic appraisal of two strategies for Aedes aegypti control: a vertical versus a community-based approach. Costs were calculated for the period 2000-2002 in three pilot areas of Santiago de Cuba where a community intervention was implemented and compared with three control areas with routine vertical programme activities. Reduction in A. aegypti foci was chosen as the measure of effectiveness. The pre-intervention number of foci (614 vs. 632) and economical costs for vector control (US$243 746 vs. US$263 486) were comparable in the intervention and control areas. During the intervention period (2001-2002), a 13% decrease in recurrent costs for the health system was observed. Within the control areas, these recurrent relative costs remained stable. The number of A. aegypti foci in the pilot areas and the control areas fell by 459 and 467, respectively. The community-based approach was more cost effective from a health system perspective (US$964 vs. US$1406 per focus) as well as from society perspective (US$1508 vs. US$1767 per focus). (C) 2007 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	Inst Med Trop Pedro Kouri, Dept Epidemiol, Havana, Cuba; Inst Trop Med, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; Prov Ctr Surveillance & Vector Control, Santiago De Cuba, Cuba	Baly, A (reprint author), Inst Med Trop Pedro Kouri, Dept Epidemiol, Autopista Novia Mediodia Km 6 1-2, Havana, Cuba.	baty@ipk.std.cu	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776			*COM EC AM LAT CAR, 2004, EV EC DUR 2003 PERSP; Cruz Rodolfo Rodriguez, 2002, Rev Cubana Med Trop, V54, P189; de la Cruz A M, 1999, Rev Cubana Med Trop, V51, P135; Gubler D J, 1991, Bull Pan Am Health Organ, V25, P237; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571; Guzman M G, 1992, Rev Cubana Med Trop, V44, P13; Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P282, DOI 10.1590/S1020-49892006000400014; HADDIX A, 1996, PRACTICAL GUIDE PREV, P1100; HADDIX A, 2003, PRACTICAL GUIDE PREV, P162; JOHNS B, 2003, COST EFF RESOUR ALLO, P1; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; LIBORIO M, 2004, REV BRAS EPIDEMIOL, V7, P311; McConnell K. John, 2003, Rev Panam Salud Publica, V14, P9, DOI 10.1590/S1020-49892003000600003; *PAHO, 1994, REP SCI PUB PAHO, V548; *PAHO, 1999, BLUEPR ACT NEXT GEN; PARKS W, 2004, WHOCDSWMC20042 PLANN; Pelaez O, 2004, EMERG INFECT DIS, V10, P719, DOI 10.3201/eid1004.030271; REYNOLDS J, 1986, PRICOR MONOGRAPH SER, V2; Sanchez L, 2006, EMERG INFECT DIS, V12, P800; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Toledo ME, 2007, T ROY SOC TROP MED H, V101, P56, DOI 10.1016/j.trstmh.2006.03.006; TOLEDO ME, 2006, REV SALUD PUBLICA ME, V48; UGALDE A, 1985, SOC SCI MED, V21, P41, DOI 10.1016/0277-9536(85)90286-2; Valdes L, 1999, Rev Panam Salud Publica, V6, P16, DOI 10.1590/S1020-49891999000600003; Valdés G Luis, 2002, Rev Cubana Med Trop, V54, P220; WINCH P, 1992, HEALTH POLICY PLANN, V7, P342, DOI 10.1093/heapol/7.4.342	27	26	28	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUN	2007	101	6					578	586		10.1016/j.trstmh.2007.01.002				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	172WE	WOS:000246834400010	17368696				2019-04-02	
J	Zachariah, R; Reid, T; Harries, AD				Zachariah, Rony; Reid, Tony; Harries, A. D.			Reply to comment on: Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district of Malawi	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Letter									Med Sans Frontieres, Brussels Operat Ctr, Luxembourg 1617, Belgium; Minist Hlth, HIV Care & Support, Lilongwe, Malawi	Zachariah, R (reprint author), Med Sans Frontieres, Brussels Operat Ctr, 68 Rue Gasperich, Luxembourg 1617, Belgium.	zachariah@internet.lu					MUULA AS, 2007, T R SOC TROP MED HYG, P101; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	2	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUN	2007	101	6					627	628		10.1016/j.trstmh.2007.02.016				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	172WE	WOS:000246834400019					2019-04-02	
J	Dorny, P; Somers, R; Vercruysse, J				Dorny, Pierre; Somers, Raf; Vercruysse, Jozef			Response to comment on: Human tapeworms in north Vietnam	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Letter							CYSTICERCOSIS; TAENIASIS		Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; Univ Ghent, Fac Vet Med, Parasitol Lab, B-9820 Merelbeke, Belgium	Dorny, P (reprint author), Inst Trop Med, Dept Anim Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	pdorny@itg.be					De NV, 2001, J MALARIA PARAS DIS, V3, P80; Ito A, 2003, LANCET, V362, P1918, DOI 10.1016/S0140-6736(03)14965-3; Nakao M, 2002, PARASITOLOGY, V124, P657, DOI 10.1017/S0031182002001725; Somers R, 2006, TROP MED INT HEALTH, V11, P65, DOI 10.1111/j.1365-3156.2005.01537.x; Willingham A Lee 3rd, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 1, P35	5	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUN	2007	101	6					629	630		10.1016/j.trstmh.2007.01.001				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	172WE	WOS:000246834400021					2019-04-02	
J	Perez, D; Lefevre, P; Sanchez, L; Van der Stuyft, P				Perez, Dennis; Lefevre, Pierre; Sanchez, Lizet; Van der Stuyft, Patrick			Comment on: What do community-based dengue control programmes achieve? A systematic review of published evaluations	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Letter									Inst Trop Med Pedro Kouri, Div Epidemiol, Havana, Cuba; Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, Antwerp, Belgium	Perez, D (reprint author), Inst Trop Med Pedro Kouri, Div Epidemiol, Havana, Cuba.	dennis@ipk.sld.cu					de Oliveira R M, 2001, Cad Saude Publica, V17 Suppl, P77, DOI 10.1590/S0102-311X2001000700016; EINTZE C, 2007, T R SOC TROP MED HYG, V101, P317; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; PEREZ D, IN PRESS TROP MED IN; Rifkin SB, 1996, ACTA TROP, V61, P79, DOI 10.1016/0001-706X(95)00105-N	6	7	9	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUN	2007	101	6					630	631		10.1016/j.trstmh.2007.02.010				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	172WE	WOS:000246834400022	17399754				2019-04-02	
J	Shamputa, IC; Van Deun, A; Salim, AH; Hossain, A; Fissette, K; de Rijk, P; Rigouts, L; Portaels, F				Shamputa, Isdore Chola; Van Deun, Armand; Salim, Abdul Hamid; Hossain, Anwar; Fissette, Krista; de Rijk, Pim; Rigouts, Leen; Portaels, Francoise			Endogenous reactivation and true treatment failure as causes of recurrent tuberculosis in a high incidence setting with a low HIV infection	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						tuberculosis; reinfection; reactivation; treatment failure; DNA fingerprinting	HUMAN-IMMUNODEFICIENCY-VIRUS; RESISTANT MYCOBACTERIUM-TUBERCULOSIS; EXOGENOUS REINFECTION; PULMONARY TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; DRUG SUSCEPTIBILITY; MIXED INFECTION; STRAIN; HETEROGENEITY; PROGRAM	Objective To determine the relative frequencies of reinfection vs. reactivation or treatment failure in patients from a high tuberculosis incidence setting with a low prevalence of HIV infection. Method We performed DNA fingerprinting on serial isolates from one and multiple TB episodes from 97 retreatment patients; 35 patients had been previously cured, whereas 62 had not. Results DNA fingerprinting patterns of recurrence Mycobacterium tuberculosis isolates of 5 of the 35 previously cured patients did not match with those of the corresponding initial isolates, indicating reinfection. We did not document reinfection during treatment. Isolates from each of the remaining 30 previously cured patients had identical DNA fingerprinting results, indicating reactivation. DNA fingerprinting patterns of isolates from the 62 patients with persistently positive sputum smears were identical, suggesting treatment failure. Conclusion These findings suggest that reinfection is not a common cause of relapse and treatment failure in this rural predominantly HIV-free population despite the high incidence of TB.	Inst Trop Med Prince Leopold, Mycobacteriol Unit, B-2000 Antwerp, Belgium; Damien Fdn Bangladesh, Dhaka, Bangladesh; Trop Dis Res Ctr, Dept Biomed Sci, Ndola, Zambia	Shamputa, IC (reprint author), Inst Trop Med Prince Leopold, Mycobacteriol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	icshamputa@itg.be		Shamputa, Isdore Chola/0000-0003-1888-8936			[Anonymous], 1997, TREATM TUB GUID NAT; Bandera A, 2001, J CLIN MICROBIOL, V39, P2213, DOI 10.1128/JCM.39.6.2213-2218.2001; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chaves F, 1999, AIDS, V13, P615, DOI 10.1097/00002030-199904010-00011; Das S, 1995, TUBERCLE LUNG DIS, V76, P550, DOI 10.1016/0962-8479(95)90533-2; de Boer AS, 2000, J CLIN MICROBIOL, V38, P4478; DEVIEDMA DG, 2002, ARCH INTERN MED, V162, P1873; Fitzpatrick L, 2004, CLIN INFECT DIS, V38, pE52, DOI 10.1086/382076; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Glynn JR, 2004, J INFECT DIS, V190, P1158, DOI 10.1086/423144; Johnson JL, 2000, INT J TUBERC LUNG D, V4, P1032; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907; KATZ HL, 1958, T 17 C CHEM TUB, P214; Kruuner A, 2002, CLIN INFECT DIS, V35, P146, DOI 10.1086/340980; Laszlo A, 2002, INT J TUBERC LUNG D, V6, P748; March F, 1997, CLIN INFECT DIS, V25, P1044, DOI 10.1086/516065; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; NARDELL E, 1986, NEW ENGL J MED, V315, P1570, DOI 10.1056/NEJM198612183152502; PORTAELS F, 2006, REICHMAN HERSHFIELDS; SALIM AH, 2001, ANN ACTIVITIES REPOR; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Strassle A, 1997, J CLIN MICROBIOL, V35, P374; Telenti A, 1997, J CLIN MICROBIOL, V35, P719; THEISEN A, 1995, LANCET, V345, P1512, DOI 10.1016/S0140-6736(95)91073-5; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P23; Van Deun A, 2001, INT J TUBERC LUNG D, V5, P329; Van Deun A, 1999, INT J TUBERC LUNG D, V3, P143; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; van Rie A, 1999, J INFECT DIS, V180, P1608, DOI 10.1086/315054; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; *WHO, 2004, WHO IUATLD GLOB PROJ	38	8	9	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JUN	2007	12	6					700	708		10.1111/j.1365-3156.2007.01840.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	177TI	WOS:000247175000002	17550467	Bronze			2019-04-02	
J	Felu, C; Pasture, J; Pays, E; Perez-Morga, D				Felu, Cecile; Pasture, Julie; Pays, Etienne; Perez-Morga, David			Diagnostic potential of a conserved genomic rearrangement in the Trypanosoma brucei gambiense-specific TGSGP locus	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							POLYMERASE-CHAIN-REACTION; SLEEPING-SICKNESS SUSPECTS; ANTIGEN GENE; FOLLOW-UP; EXPRESSION; UGANDA; CATT; ELECTROPHORESIS; TRANSPOSITION; INDIVIDUALS	We have previously identified TGSGP as a gene specific to the Trypanosoma brucei gambiense subspecies. TGSGP is a truncated VSG-like telomeric gene transcribed by RNA polymerase II. The TGSGP protein localizes to the flagellar pocket, and exhibits features compatible with a role as surface receptor. Here we show that TGSGP is physically linked to a truncation of a gene homologous to yeast AUT1 (APG3), a gene involved in internal vesicular formation. Further analysis indicated that T. b. gambiense is heterozygous for AUT1 (AUT1/aut1), with each allele located on independent chromosome 11 homologues. In IS T b. gambiense isolates from distinct geographical origins and different hosts, this genomic rearrangement was conserved. The size of the intergenic region between TGSGP and truncated aut1 varied among isolates but was similar in isolates of the same geographical area, and this observation may be used in epidemiology to trace the geographical origin of T b. gambiense isolates.	Univ Libre Bruxelles, IBMM, Mol Parasitol Lab, Gosselies, Belgium	Perez-Morga, D (reprint author), Univ Libre Bruxelles, IBMM, Mol Parasitol Lab, Gosselies, Belgium.	David.Perez-Morga@ulb.ac.be					Bagnall RD, 2005, GENOME RES, V15, P214, DOI 10.1101/gr.2946205; Berberof M, 2001, MOL BIOCHEM PARASIT, V113, P127, DOI 10.1016/S0166-6851(01)00208-0; BERNARDS A, 1986, GENE, V42, P313, DOI 10.1016/0378-1119(86)90235-0; CAMPBELL DA, 1984, NUCLEIC ACIDS RES, V12, P2759, DOI 10.1093/nar/12.6.2759; CARRINGTON M, 1989, MOL BIOCHEM PARASIT, V33, P289, DOI 10.1016/0166-6851(89)90091-1; DERO B, 1987, MOL BIOCHEM PARASIT, V26, P247, DOI 10.1016/0166-6851(87)90077-6; El-Sayed NMA, 2003, NUCLEIC ACIDS RES, V31, P4856, DOI 10.1093/nar/gkg673; Enyaru JCK, 1998, ANN TROP MED PARASIT, V92, P845; Garcia A, 2000, TROP MED INT HEALTH, V5, P786, DOI 10.1046/j.1365-3156.2000.00623.x; Gibson W, 2001, TROP MED INT HEALTH, V6, P401, DOI 10.1046/j.1365-3156.2001.00711.x; GIBSON W C, 1986, Parasitology Today, V2, P255, DOI 10.1016/0169-4758(86)90011-6; GRAY AR, 1972, T ROY SOC TROP MED H, V66, P263, DOI 10.1016/0035-9203(72)90158-7; Kabiri M, 1999, TROP MED INT HEALTH, V4, P658, DOI 10.1046/j.1365-3156.1999.00465.x; Kanmogne GD, 1997, ACTA TROP, V63, P75, DOI 10.1016/S0001-706X(96)00600-6; Kanmogne GD, 1996, ANN TROP MED PARASIT, V90, P475, DOI 10.1080/00034983.1996.11813072; Kyambadde JW, 2000, B WORLD HEALTH ORGAN, V78, P119; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; LIU AYC, 1983, J MOL BIOL, V167, P57, DOI 10.1016/S0022-2836(83)80034-5; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Melville SE, 2000, MOL BIOCHEM PARASIT, V111, P261, DOI 10.1016/S0166-6851(00)00316-9; PAINDAVOINE P, 1986, PARASITOLOGY, V92, P31, DOI 10.1017/S0031182000063435; PAYS E, 1983, MOL BIOCHEM PARASIT, V7, P63, DOI 10.1016/0166-6851(83)90117-2; PAYS E, 1983, CELL, V34, P371, DOI 10.1016/0092-8674(83)90371-9; Penchenier L, 2000, T ROY SOC TROP MED H, V94, P392, DOI 10.1016/S0035-9203(00)90116-0; Picozzi K, 2005, BMJ-BRIT MED J, V331, P1238, DOI 10.1136/bmj.331.7527.1238; Radwanska M, 2002, AM J TROP MED HYG, V67, P684, DOI 10.4269/ajtmh.2002.67.684; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schlumpberger M, 1997, J BACTERIOL, V179, P1068, DOI 10.1128/jb.179.4.1068-1076.1997; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Simarro PP, 1999, TROP MED INT HEALTH, V4, P858, DOI 10.1046/j.1365-3156.1999.00494.x; Truc P, 1999, B WORLD HEALTH ORGAN, V77, P745; Xong HV, 1998, CELL, V95, P839; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	34	11	12	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAY	2007	76	5					922	929		10.4269/ajtmh.2007.76.922				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	165SR	WOS:000246326300027	17488917				2019-04-02	
J	Odusanya, OO; Meurice, FP; Hoet, B				Odusanya, O. O.; Meurice, F. P.; Hoet, B.			Nigerian medical students are at risk for hepatitis B infection	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						hepatitis B virus; blood-borne pathogens; medical students; needlestick injuries; vaccination; Nigeria			Lagos State Univ, Coll Med, Dept Community Hlth & Primary Hlth Care, Lagos, Nigeria; GlaxoSmithKline Biol, B-1330 Rixensart, Belgium	Odusanya, OO (reprint author), Lagos State Univ, Coll Med, Dept Community Hlth & Primary Hlth Care, PMB 21266, Lagos, Nigeria.							0	15	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAY	2007	101	5					465	468		10.1016/j.trstmh.2006.08.001				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	158IN	WOS:000245785200009	17011004				2019-04-02	
J	Van den Ende, J; Bisoffi, Z; Van Hauwe, R				Van den Ende, J.; Bisoffi, Z.; Van Hauwe, R.			The Kabisa computer program for tropical medicine: introduction of a threshold driven panoramic logic	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van den Ende, J.] Inst Trop Med, B-2000 Antwerp, Belgium; [Bisoffi, Z.] Ctr Malattie Tropicali, Verona, Italy; [Van Hauwe, R.] AR Software, Antwerp, Belgium								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			7	8						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500023					2019-04-02	
J	Colebunders, R				Colebunders, R.			The control of Filovirus infections	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Colebunders, R.] Inst Trop Med, B-2000 Antwerp, Belgium								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			9	10						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500030					2019-04-02	
J	Unger, JP				Unger, J. -P.			International policies, primary health care, disease control and integration	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Unger, J. -P.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium								0	0	0	0	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			16	17						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500050					2019-04-02	
J	Geerts, S; Delespaux, V				Geerts, S.; Delespaux, V.			Drug resistance in human and animal African trypanosomes	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Geerts, S.; Delespaux, V.] Inst Trop Med, B-2000 Antwerp, Belgium			DELESPAUX, Vincent/C-3160-2009					0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			23	23						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500071					2019-04-02	
J	Le, H; Nguyen, QT; Erhart, A; Le, KT; D'Alessandro, U; Coosemans, M				Le, H.; Nguyen, Q. T.; Erhart, A.; Le, K. T.; D'Alessandro, U.; Coosemans, M.			Border malaria in Vietnam: a regional problem calling for a regional solution	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Erhart, A.; D'Alessandro, U.; Coosemans, M.] Inst Trop Med, B-2000 Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			34	35						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500102					2019-04-02	
J	Gies, S; Coulibaly, SO; D'Alessandro, U				Gies, S.; Coulibaly, S. O.; D'Alessandro, U.			Controlling malaria in pregnant women living in Boromo health district, Burkina Faso, through intermittent preventive treatment with sulfadoxine-pyrimethamine	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gies, S.; D'Alessandro, U.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Coulibaly, S. O.] Univ Ouagadougou, UFR Sci Sante, Ouagadougou, Burkina Faso			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			35	35						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500103					2019-04-02	
J	Ahmad, RA; Mahendradhata, Y; de Vlas, SJ				Ahmad, R. A.; Mahendradhata, Y.; de Vlas, S. J.			Improving the national TB control program in Indonesia: explorations with a health systems model	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ahmad, R. A.] Erasmus MC, Univ Med Ctr, Yogyakarta, Indonesia; [Mahendradhata, Y.] Inst Trop Med, B-2000 Antwerp, Belgium; [de Vlas, S. J.] Erasmus MC, Univ Med Ctr, Rotterdam, Netherlands								0	1	1	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			39	40						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500116					2019-04-02	
J	Tuyisenge, L; Ndimubanzi, P; Ndayisaba, G; Muganga, N; Van den Ende, J				Tuyisenge, L.; Ndimubanzi, P.; Ndayisaba, G.; Muganga, N.; Van den Ende, J.			Predictors of tuberculosis in a national reference paediatric ward in sub-Saharan Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Tuyisenge, L.; Ndimubanzi, P.; Muganga, N.] Ctr Hosp Univ Kigalil, Kigali, Rwanda; [Ndayisaba, G.] Ctr Hosp Univ Kigalil, Kigali, Rwanda; [Van den Ende, J.] Inst Trop Med, B-2000 Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			40	40						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500118					2019-04-02	
J	Zinnen, V; Porignon, D; Paul, C; Robert, A				Zinnen, V.; Porignon, D.; Paul, C.; Robert, A.			Evaluation of the health sector-wide approach (SWAp) at district level. pilot case study: Kwimba district, Tanzania	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Zinnen, V.; Robert, A.] Univ Catholique Louvain, Ecole Sante Publ, B-1200 Brussels, Belgium; [Porignon, D.; Paul, C.] Univ Liege, Liege, Belgium								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			41	42						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500122					2019-04-02	
J	Paehler, J				Paehler, J.			The 7th European Framework Programme for Research - opportunities for international cooperation in health systems research	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Paehler, J.] Commiss European Communities, DG Res, B-1049 Brussels, Belgium								0	0	0	0	6	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			42	43						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500125					2019-04-02	
J	Van den Ende, J; Demeester, R; Bottieau, E; Van Laethem, Y; Van Hauwe, R				Van den Ende, J.; Demeester, R.; Bottieau, E.; Van Laethem, Y.; Van Hauwe, R.			Evaluation of the performance of the KABISA expert system in diagnosing febrile illnesses occurring after a stay in the tropics	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van den Ende, J.; Demeester, R.; Bottieau, E.; Van Hauwe, R.] Inst Trop Med, B-2000 Antwerp, Belgium; [Van Laethem, Y.] Hop Univ St Pierre, B-1000 Brussels, Belgium								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			59	60						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500173					2019-04-02	
J	Protopopoff, N; D'Alessandro, U; Coosemans, M				Protopopoff, N.; D'Alessandro, U.; Coosemans, M.			Prevention of malaria epidemics by vector control in Burundi highlands	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Protopopoff, N.; D'Alessandro, U.; Coosemans, M.] Inst Trop Med, B-2000 Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			63	63						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500183					2019-04-02	
J	Verhaeghen, K; Van Bortel, W; Trung, HD; Sochantha, T; Backeljau, T; Coosemans, M				Verhaeghen, K.; Van Bortel, W.; Trung, H. D.; Sochantha, T.; Backeljau, T.; Coosemans, M.			Role of knockdown resistance in conferring pyrethroid and DDT resistance in the Southeast Asian Anopheles species	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Verhaeghen, K.; Van Bortel, W.; Coosemans, M.] Inst Trop Med, Unit Entomol, B-2000 Antwerp, Belgium; [Trung, H. D.] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Sochantha, T.] Natl Ctr Malaria Control Parasitol & Entomol, Phnom Penh, Cambodia; [Backeljau, T.] Royal Belgian Inst Nat Sci, Brussels, Belgium								0	0	0	0	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			64	64						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500186					2019-04-02	
J	Maug, A; Salim, MAH; Declercq, E; Van Deun, A; Blok, L				Maug, A.; Salim, M. A. H.; Declercq, E.; Van Deun, A.; Blok, L.			Does an intermittent regimen increase the risk of MDR-TB?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Maug, A.; Salim, M. A. H.] Damien Fdn Bangladesh, Dhaka, Bangladesh; [Van Deun, A.] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Blok, L.] Royal Trop Inst, KIT, NL-1105 AZ Amsterdam, Netherlands; [Declercq, E.] Damien Fdn Belgium, Brussels, Belgium								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			74	74						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500214					2019-04-02	
J	Canales, MA; Polman, K; Pekelharing, J; van Hoogdalem, A; Terashima, A; Gotuzzo, E; Verweij, JJ				Canales, M. A.; Polman, K.; Pekelharing, J.; van Hoogdalem, A.; Terashima, A.; Gotuzzo, E.; Verweij, J. J.			Serologic diagnosis of Strongyloides stercoralis in La Merced, a Peruvian Rainforest City	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Canales, M. A.; Terashima, A.; Gotuzzo, E.] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima, Peru; [Polman, K.] Inst Trop Med, B-2000 Antwerp, Belgium; [Pekelharing, J.; van Hoogdalem, A.; Verweij, J. J.] Leiden Univ, Med Ctr, Leiden, Netherlands								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			76	76						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500220					2019-04-02	
J	Van den Eede, P; Van der Auwera, G; Van Overmeir, C; Duc, TN; Erhart, A; Hung, LX; Anne, J; D'Alessandro, U				Van den Eede, P.; Van der Auwera, G.; Van Overmeir, C.; Duc, T. Ngo; Erhart, A.; Hung, L. X.; Anne, J.; D'Alessandro, U.			Genotyping of Plasmodium vivax infections using microsatellite markers and MSP1	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van den Eede, P.; Van der Auwera, G.; Van Overmeir, C.; Erhart, A.; D'Alessandro, U.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Duc, T. Ngo; Hung, L. X.] Natl Inst Malariol, Hanoi, Vietnam; [Anne, J.] Catholic Univ Leuven, Louvain, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			77	77						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500222					2019-04-02	
J	Deckers, N; Conrath, K; Kanobana, K; Victor, B; Vercruysse, J; Dorny, P				Deckers, N.; Conrath, K.; Kanobana, K.; Victor, B.; Vercruysse, J.; Dorny, P.			Use of recombinant camelid single domain antibodies for the diagnosis of Taenia solium cysticercosis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Deckers, N.; Kanobana, K.; Victor, B.; Dorny, P.] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Conrath, K.] Free Univ Brussels, Dept Cellular & Mol Immunol, Etterbeek, Belgium; [Vercruysse, J.] Univ Ghent, Fac Vet Med, Parasitol Lab, Merelbeke, Belgium								0	0	0	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			89	90						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500254					2019-04-02	
J	Unger, JP; Soors, W; De Paepe, P				Unger, J. -P.; Soors, W.; De Paepe, P.			Are international health policies evidence based? A light shed from Latin America	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Unger, J. -P.; Soors, W.; De Paepe, P.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium								0	0	0	0	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			92	92						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500262					2019-04-02	
J	Alarcon, F; Moreira, J; Rivera, J; Salinas, R; Duenas, G; Van den Ende, J				Alarcon, F.; Moreira, J.; Rivera, J.; Salinas, R.; Duenas, G.; Van den Ende, J.			Outcome of central nervous system tuberculosis: an alternative scoring system	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract							MENINGITIS		[Alarcon, F.; Rivera, J.; Salinas, R.] Hosp Eugenio Espejo, Quito, Ecuador; [Moreira, J.; Van den Ende, J.] Inst Trop Med, B-2000 Antwerp, Belgium; [Duenas, G.] Hosp Metropolitano, Quito, Ecuador							KENNEDY DH, 1979, JAMA-J AM MED ASSOC, V241, P264, DOI 10.1001/jama.241.3.264; MARSHALL G, 1948, LANCET, V17, P582; SMITH AL, 1975, MED J AUSTRALIA, V1, P57; SPIEGELHALTER DJ, 1984, J R STAT SOC A STAT, V147, P35, DOI 10.2307/2981737	4	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			96	96						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500272					2019-04-02	
J	De Paepe, P; Unger, JP; Soors, W				De Paepe, P.; Unger, J. -P.; Soors, W.			PPM DOTS for TB control: panacea to reach the Millennium Development Goals?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Paepe, P.; Unger, J. -P.; Soors, W.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium							DEPAEPE P, 2006, BR MED J; Mahendradhata Y, 2007, TROP MED INT HEALTH, V12, P315, DOI 10.1111/j.1365-3156.2007.01816.x; WHO (World Health Organization), 2006, GLOB PLAN STOP TB 20	3	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			106	106						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500299					2019-04-02	
J	Boelaert, M; El-Safi, S; Hailu, A; Mukhtar, M; Rijal, S; Sundar, S; Wasunna, M; Aseffa, A; Mbui, J; Menten, J; Desjeux, P; Peeling, R				Boelaert, M.; El-Safi, S.; Hailu, A.; Mukhtar, M.; Rijal, S.; Sundar, S.; Wasunna, M.; Aseffa, A.; Mbui, J.; Menten, J.; Desjeux, P.; Peeling, R.			Diagnostic tests for kala-azar at primary care level: a multi-centre study of the frieze-dried DAT, rK39 strip test and katex in east Africa and the Indian subcontinent	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Boelaert, M.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [El-Safi, S.; Mukhtar, M.] Univ Khartoum, Dept Microbiol & Parasitol, Khartoum, Sudan; [Hailu, A.] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Rijal, S.] BP Koirala Inst Hlth Sci, Dept Med, Dharan, Nepal; [Sundar, S.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Wasunna, M.; Mbui, J.] Clin Res Ctr, Kenya Med Res Inst, Nairobi, Kenya; [Aseffa, A.] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Menten, J.] Inst Trop Med, Clin Trial Unit, B-2000 Antwerp, Belgium; [Desjeux, P.] Inst One World Hlth, Divonne, France; [Peeling, R.] UNICEF UNDP World Bank WHO, Special Programme Res & Training Trop Dis, Diag R&D, Geneva, Switzerland			Boelaert, Marleen/E-2698-2012; Aseffa, Abraham/J-3248-2016	Boelaert, Marleen/0000-0001-8051-6776; Aseffa, Abraham/0000-0002-8028-1150				0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			107	107						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500302					2019-04-02	
J	Zerbo, R; Huygens, P; Drabo, KM; Kafando, B; Assogba, F; Macq, J; Ouedraogo, JB; Dujardin, B				Zerbo, R.; Huygens, P.; Drabo, K. M.; Kafando, B.; Assogba, F.; Macq, J.; Ouedraogo, J. -B.; Dujardin, B.			Definition and implementation of actors map for TB patient care (PC) in peripheral health services in Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Zerbo, R.; Drabo, K. M.; Assogba, F.; Ouedraogo, J. -B.] CNRST IRSS DRO FORESA, Ouagadougou, Burkina Faso; [Huygens, P.; Macq, J.; Dujardin, B.] Univ Libre Bruxelles, ESP Polit Syst Sante, Brussels, Belgium; [Kafando, B.] Direct Reg Sante Plateau Cent, Ouagodougou, Burkina Faso								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			112	112						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500314					2019-04-02	
J	Goodwin, F				Goodwin, F.			Achieving the health Millennium Development Goals (MDGS) through improved health financing and policy	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Goodwin, F.] European Publ Hlth Alliance, Brussels, Belgium								0	0	0	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			115	116						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500324					2019-04-02	
J	Dujardin, B; Paul, E; Laokri, S; Samake, S				Dujardin, B.; Paul, E.; Laokri, S.; Samake, S.			Analysis of the health sector-wide approach (SWAp) dynamics in Mali	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dujardin, B.; Laokri, S.] Univ Libre Bruxelles, Brussels, Belgium; [Paul, E.] Univ Liege, Dept Sante Publ, Liege, Belgium; [Samake, S.] Minist de la Sante, Bamako, Mali								0	1	1	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			116	117						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500326					2019-04-02	
J	Erhart, A; D'Alessandro, U; Bernasconi, A; Grande, T; Gamboa, D; Llanos-Cuentas, A				Erhart, A.; D'Alessandro, U.; Bernasconi, A.; Grande, T.; Gamboa, D.; Llanos-Cuentas, A.			Efficacy, safety, and tolerability of dihydroartemisinin/piperaquine (Artekint (R)) for the treatment of uncomplicated falciparum malaria in the Peruvian Amazon region	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Erhart, A.; D'Alessandro, U.; Bernasconi, A.] Inst Trop Med, B-2000 Antwerp, Belgium; [Grande, T.; Gamboa, D.; Llanos-Cuentas, A.] Inst Trop Med Alexandor von Humboldt, Lima, Peru			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			118	118						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500331					2019-04-02	
J	Mahendradhata, Y; Ahmad, RA; Lefevre, P; Boelaert, M; Van der Stuyft, P				Mahendradhata, Y.; Ahmad, R. A.; Lefevre, P.; Boelaert, M.; Van der Stuyft, P.			Barriers and opportunities for introducing HIV testing among TB patients in Jogjakarta, Indonesia: Barriers and Enablers	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mahendradhata, Y.; Lefevre, P.; Boelaert, M.; Van der Stuyft, P.] Inst Trop Med, B-2000 Antwerp, Belgium; [Ahmad, R. A.] Gadjah Mada Univ, Yogyakarta, Indonesia			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			126	126						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500354					2019-04-02	
J	Van den Ende, J; Lodesani, C; Angheben, A; Pharm, TH; Sirima, SB; Van den Ende, K; Gobbi, F; Baracca, G; Bisoffi, Z				Van den Ende, J.; Lodesani, C.; Angheben, A.; Pharm, T. Halidou; Sirima, S. Bienvenu; Van den Ende, K.; Gobbi, F.; Baracca, G.; Bisoffi, Z.			Does the introduction of malaria antigen tests improve clinical care? results from a randomized study in Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van den Ende, J.] Inst Trop Med, B-2000 Antwerp, Belgium; [Lodesani, C.; Angheben, A.; Bisoffi, Z.] S Cuore Hosp, Ctr Trop Dis, Verona, Italy; [Pharm, T. Halidou] RSS Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Sirima, S. Bienvenu; Van den Ende, K.; Baracca, G.] MLAL Unidea An Ka Here So, Bobo Dioulasso, Burkina Faso; [Gobbi, F.] Amedeo Savoia Hosp, Clin Infect Dis, Turin, Italy			Bisoffi, Zeno/B-6438-2013					0	1	1	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			128	128						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500360					2019-04-02	
J	Huygens, P; Macq, J; Laokri, S; Dujardin, B				Huygens, P.; Macq, J.; Laokri, S.; Dujardin, B.			Challenging health systems with community's perceptions and expectations through socioanthropological feed-back data	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Huygens, P.; Macq, J.; Laokri, S.; Dujardin, B.] Univ Libre Bruxelles, Brussels, Belgium								0	0	0	1	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			132	132						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500371					2019-04-02	
J	Soors, W; De Paepe, P; Unger, JP				Soors, W.; De Paepe, P.; Unger, J. -P.			Performance agreements in Costa Rica's primary care	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Soors, W.; De Paepe, P.; Unger, J. -P.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium								0	0	0	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			134	135						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500379					2019-04-02	
J	ten Hove, R; Verweij, J; Vereecken, K; Polman, K; Dieve, L; Van Lieshout, L				ten Hove, R.; Verweij, J.; Vereecken, K.; Polman, K.; Dieve, L.; Van Lieshout, L.			Multiplex real-time PCR for the (semi)-quantitative detection of Schistosoma mansoni and S-haematobium in stool samples collected in northern Senegal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[ten Hove, R.; Verweij, J.; Van Lieshout, L.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Vereecken, K.; Polman, K.] Inst Trop Med, B-2000 Antwerp, Belgium; [Dieve, L.] Ctr Sante Richard Toll, Richard Toll, Senegal								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			136	137						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500385					2019-04-02	
J	Van Geertruyden, JP; Mulenga, M; Chalwe, V; Nambozi, M; Mukwamataba, D; Colebunders, R; D'Alessandro, U				Van Geertruyden, J. -P.; Mulenga, M.; Chalwe, V.; Nambozi, M.; Mukwamataba, D.; Colebunders, R.; D'Alessandro, U.			Impact of HIV-I infection on the hematological recovery after a clinical malaria attack	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van Geertruyden, J. -P.; D'Alessandro, U.] Inst Trop Geneeskunde, Antwerp, Belgium; [Mulenga, M.; Chalwe, V.; Nambozi, M.; Mukwamataba, D.] Trop Dis Res Ctr, Ndola, Zambia; [Colebunders, R.] Univ Antwerp, B-2020 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014; D'Alessandro, Umberto/D-3457-2015	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			137	137						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500387					2019-04-02	
J	Ponnet, M; Bottieau, E; Ngove, T; Alface, B; Montanoh, R; Biot, M; Huyst, V; Lynen, L				Ponnet, M.; Bottieau, E.; Ngove, T.; Alface, B.; Montanoh, R.; Biot, M.; Huyst, V.; Lynen, L.			Improvement of HIV care in the medical wards of the provincial hospital of Tete, Mozambique, through enhancement of clinical awareness and strengthening of HIV testing capacity	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ponnet, M.; Bottieau, E.; Huyst, V.; Lynen, L.] Inst Trop Med, B-2000 Antwerp, Belgium; [Ngove, T.; Alface, B.] PHT, Tete, Mozambique			Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895				0	0	0	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			161	161						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500457					2019-04-02	
J	Ngo, T; Erhart, A; Le, H; Coosemans, M; D'Alessandro, U				Ngo, T.; Erhart, A.; Le, H.; Coosemans, M.; D'Alessandro, U.			Long-lasting insecticidal hammock nets (LLIHN) for controlling forest malaria in Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ngo, T.; Erhart, A.; Coosemans, M.; D'Alessandro, U.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Le, H.] Natl Inst Malariol, Hanoi, Vietnam			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			168	168						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500478					2019-04-02	
J	Drabo, M; Ouedraogo, H; Zerbo, R; Frank, A; Ouedraogo, JB; Dujardin, B; Macq, J				Drabo, M.; Ouedraogo, H.; Zerbo, R.; Frank, A.; Ouedraogo, J. B.; Dujardin, B.; Macq, J.			Does community involvement into the case management systems lead to meeting the expectations of tuberculosis patients? Literature review	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Drabo, M.; Ouedraogo, H.; Zerbo, R.; Frank, A.; Ouedraogo, J. B.] Inst Rech Sci Sante, Ouagadougou, Burkina Faso; [Dujardin, B.; Macq, J.] Univ Libre Bruxelles, ESP Polit & Syst Sante, Brussels, Belgium								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			172	172						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500489					2019-04-02	
J	Assogba, F; Drabo, KM; Ouedraogo, H; Kafando, B; Zerbo, R; Ouedraogo, JB; Dujardin, B; Macq, J				Assogba, F.; Drabo, K. M.; Ouedraogo, H.; Kafando, B.; Zerbo, R.; Ouedraogo, J. B.; Dujardin, B.; Macq, J.			Pulmonary tuberculosis detection rate evolution in three health districts of Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Assogba, F.; Drabo, K. M.; Ouedraogo, H.; Zerbo, R.; Ouedraogo, J. B.] Hlth Res Sci Inst, Ouagadougou, Burkina Faso; [Kafando, B.] Hlth Res Direct, Ouagadougou, Burkina Faso; [Dujardin, B.; Macq, J.] ULB, EPS, Brussels, Belgium								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			173	173						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500493					2019-04-02	
J	Gies, S; Coulibaly, SO; Peeters, K; D'Alessandro, U				Gies, S.; Coulibaly, S. O.; Peeters, K.; D'Alessandro, U.			Community involvement to reduce the malaria burden in pregnancy in Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gies, S.; D'Alessandro, U.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Coulibaly, S. O.] Univ Ouagadougou, UFR Sci Sante, Ouagadougou, Burkina Faso; [Peeters, K.] PASS Int, Tessenderlo, Belgium			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			173	173						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500492					2019-04-02	
J	Baly, A; Rodriguez, K; Toledo, ME; Benitez, JR; Rodriguez, M; Vanlerberghe, V; Boelaert, M; Van der Stuyft, P				Baly, A.; Rodriguez, K.; Toledo, M. E.; Benitez, J. R.; Rodriguez, M.; Vanlerberghe, V.; Boelaert, M.; Van der Stuyft, P.			Cost of a large scale vertical control programme to control Aedes aegypti and prevent dengue	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Baly, A.; Toledo, M. E.] Inst Trop Med Pedro Kouri, Havana, Cuba; [Rodriguez, K.; Benitez, J. R.; Rodriguez, M.] Unidad Provincial Vigilancia & Lucha Antivectoria, Guantanamo, Cuba; [Vanlerberghe, V.; Boelaert, M.; Van der Stuyft, P.] Inst Trop Med, B-2000 Antwerp, Belgium			Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776				0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			177	177						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500505					2019-04-02	
J	Toledo, ME; Vanlerberghe, V; Perez, D; Benitez, JR; Rodriguez, M; Gomez, D; Baly, A; Van der Stuyft, P				Toledo, M. E.; Vanlerberghe, V.; Perez, D.; Benitez, J. R.; Rodriguez, M.; Gomez, D.; Baly, A.; Van der Stuyft, P.			Getting research into practice: facilitators and effectiveness of vector control program for dengue prevention in Cuba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Toledo, M. E.; Perez, D.; Baly, A.] Inst Trop Med Pedro Kouri, Havana, Cuba; [Vanlerberghe, V.; Van der Stuyft, P.] Inst Trop Med, B-2000 Antwerp, Belgium; [Benitez, J. R.] Unidad Provincial Vigilancia & Lucha Antivectoria, Guantanamo, Cuba; [Gomez, D.] Ctr Provincial Higiene & Epidemiol, Guantanamo, Cuba								0	0	0	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			177	178						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500506					2019-04-02	
J	Collado, A; Junco, R; Menocal, L; Alfonso, K; Escobedo, A; Hernandez, A; Wordemann, M; Polman, K; Gryseels, B; Bonet, M				Collado, A.; Junco, R.; Menocal, L.; Alfonso, K.; Escobedo, A.; Hernandez, A.; Wordemann, M.; Polman, K.; Gryseels, B.; Bonet, M.			Learning ability is associated with delayed psychomotor development in Cuban schoolchildren	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Collado, A.; Junco, R.; Menocal, L.; Alfonso, K.; Hernandez, A.; Bonet, M.] Natl Inst Hyg, Havana, Cuba; [Escobedo, A.] Acad Paediat Hosp Pedro Borras, Havana, Cuba; [Wordemann, M.; Polman, K.; Gryseels, B.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			207	208						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500595					2019-04-02	
J	Escobedo, A; Betancourt, M; Menocal, L; Junco, R; Collado, A; Woerdemann, M; Polman, K; Bonet, M				Escobedo, A.; Betancourt, M.; Menocal, L.; Junco, R.; Collado, A.; Woerdemann, M.; Polman, K.; Bonet, M.			Soil-transmitted helminths related perceptions among mothers and children in San Juan y Martinez, Cuba: implications for control	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Escobedo, A.] Acad Paediat Hosp Pedro Borras, Havana, Cuba; [Betancourt, M.; Menocal, L.; Junco, R.; Collado, A.; Bonet, M.] Natl Inst Hyg, Havana, Cuba; [Woerdemann, M.; Polman, K.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			207	207						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500594					2019-04-02	
J	Clerinx, J; Bottieau, E; Colebunders, R; Ende, EV; Demey, H; Wouters, R; Van Esbroeck, M; Vervoort, T; Van Gompel, A; Van den Ende, J				Clerinx, J.; Bottieau, E.; Colebunders, R.; Ende, E. Vanden; Demey, H.; Wouters, R.; Van Esbroeck, M.; Vervoort, T.; Van Gompel, A.; Van den Ende, J.			Criteria for safe outpatient treatment of falciparum malaria	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Clerinx, J.; Bottieau, E.; Colebunders, R.; Ende, E. Vanden; Wouters, R.; Van Esbroeck, M.; Vervoort, T.; Van Gompel, A.; Van den Ende, J.] ITMA, Antwerp, Belgium; [Demey, H.] UZA, Antwerp, Belgium								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			223	224						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500642					2019-04-02	
J	Dujardi, B; Kanoute, A; Traore, L; Mugisho, E; Sangare, F; Godin, I; Nacko, A				Dujardi, B.; Kanoute, A.; Traore, L.; Mugisho, E.; Sangare, F.; Godin, I.; Nacko, A.			A new strategy for the diagnosis of pulmonary tuberculosis: the FORESA3 project	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dujardi, B.; Godin, I.] Univ Libre Bruxelles, Brussels, Belgium; [Kanoute, A.; Nacko, A.] Programme Natl Lutte TB, Bamako, Mali; [Traore, L.; Sangare, F.] Ctr Natl Appui Lutte Malad, Bamako, Mali; [Mugisho, E.] Univ Libre Bruxelles, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			223	223						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500641					2019-04-02	
J	Fall, S; Diop, AH; Ndoye, T; Huygens, P; Dujardin, B				Fall, S.; Diop, A. H.; Ndoye, T.; Huygens, P.; Dujardin, B.			Tuberculosis patient centered approach (PCA): methodological approach and first results in Senegal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Fall, S.; Diop, A. H.; Ndoye, T.] Programme Natl Lutte Tuberculose, Dakar, Senegal; [Huygens, P.; Dujardin, B.] Univ Libre Bruxelles, Brussels, Belgium								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			229	230						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500660					2019-04-02	
J	Chatterjee, S; Panis, T; Bernat, A; Bridts, C; Stevens, W; Van Marck, E				Chatterjee, S.; Panis, T.; Bernat, A.; Bridts, C.; Stevens, W.; Van Marck, E.			Cytokine profiles after somatostatin therapy in Schistosoma mansoni infected high pathology mice	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Chatterjee, S.; Panis, T.; Bernat, A.; Van Marck, E.] Univ Antwerp, Pathol Lab, B-2020 Antwerp, Belgium; [Bridts, C.; Stevens, W.] Univ Antwerp, Immunol Lab, B-2020 Antwerp, Belgium			BRIDTS, Chris/M-7933-2016	BRIDTS, Chris/0000-0002-3324-7320				0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			234	235						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500675					2019-04-02	
J	Van den Ende, J; Mugabekazi, J; Moreira, J; Seryange, E; Basinga, P; Bisoffi, Z; Boelaert, M				Van den Ende, J.; Mugabekazi, J.; Moreira, J.; Seryange, E.; Basinga, P.; Bisoffi, Z.; Boelaert, M.			Effect of decision thresholds on blackstone like error ratio in pulmonary tuberculosis: an example from a national reference level in Rwanda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									Univ Kigali, Ctr Hosp, Inst Trop Med Antwerp, Antwerp, Belgium; [Van den Ende, J.; Moreira, J.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Mugabekazi, J.; Seryange, E.] Ctr Hosp Univ, Kigali, Rwanda; [Basinga, P.] Natl Univ Rwanda, Sch Publ Hlth, Kigali, Rwanda; [Bisoffi, Z.] Ctr Malattie Trop, Negrar Verona, Italy			Boelaert, Marleen/E-2698-2012; Bisoffi, Zeno/B-6438-2013	Boelaert, Marleen/0000-0001-8051-6776; 			Basinga P, 2007, MED DECIS MAKING, V27, P53, DOI 10.1177/0272989X06297104; DEKAY ML, 1996, LAW SOCIAL INQUIRY, V21, P5; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003	3	0	0	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			242	243						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500697					2019-04-02	
J	Moreira, J; Alarcon, F; Bisoffi, Z; Rivera, J; Salinas, R; Menten, J; Duenas, G; Van den Ende, J				Moreira, J.; Alarcon, F.; Bisoffi, Z.; Rivera, J.; Salinas, R.; Menten, J.; Duenas, G.; Van den Ende, J.			Tuberculous meningitis: does lowering the treatment threshold result in many more treated patients?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Moreira, J.; Menten, J.; Van den Ende, J.] Inst Trop Med, B-2000 Antwerp, Belgium; [Alarcon, F.; Rivera, J.; Salinas, R.] Hosp Eugenio Espejo, Quito, Ecuador; [Bisoffi, Z.] Osped Sacrocuore, Ctr Malattie Trop, Negrar, VR, Italy; [Duenas, G.] Hosp Metropolitano, Quito, Ecuador								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			243	243						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500698					2019-04-02	
J	Traore, LF; Maguiraga, F; Godin, I; Dujardin, B				Traore, L. F.; Maguiraga, F.; Godin, I.; Dujardin, B.			How to give an impulse to women's health care seeking through popular theatre - experience of Mopti health district on tuberculosis control in Mali	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Traore, L. F.; Maguiraga, F.] Ctr Natl Appui Lutte Maladie FORESA3, Bamako, Mali; [Godin, I.] Univ Libre Bruxelles, Polit & Syst Sante, Brussels, Belgium								0	0	0	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			244	244						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500702					2019-04-02	
J	Huygens, P; Alami, K; Semini, I; Tawil, O				Huygens, P.; Alami, K.; Semini, I.; Tawil, O.			External review of outreach work with commercial sex workers (CSWs): an exploratory study on HIV/AIDS in Morocco	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Huygens, P.] Univ Libre Bruxelles, Polit & Syst Sante, Brussels, Belgium; [Alami, K.] Programme ONUSIDA Maroc, Rabat, Morocco; [Semini, I.; Tawil, O.] UNAIDS Reg Support Team Middle E & N Africa MENA, Cairo, Egypt								0	0	0	0	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12			1			247	247						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	302FP	WOS:000255954500710					2019-04-02	
J	Perez, D; Lefevre, P; Sanchez, L; Sanchez, LM; Boelaert, M; Kouri, G; Van der Stuyft, P				Perez, D.; Lefevre, P.; Sanchez, L.; Sanchez, L. M.; Boelaert, M.; Kouri, G.; Van der Stuyft, P.			Community participation in Aedes aegypti control: a sociological perspective on five years of research in the health area "26 de Julio", Havana, Cuba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						community participation; sociology; Aedes aegypti control; dengue; Cuba	DENGUE HEMORRHAGIC-FEVER; CONTROL PROGRAM; EPIDEMIC; LESSONS	Objective: Effective dengue prevention and Aedes aegypti control is a priority for the Cuban health authorities. To enhance effectiveness, strategies oriented towards a more active involvement of communities in control activities are being tested. This paper presents a sociological perspective on a pilot project conducted in the health area ''26 de Julio'' (La Havana) in 1999-2004. Methods: Instrumental case study based on an exhaustive content analysis of project documents and on observations of a sociologist. Results: The context and the pilot project are systematically described and an analysis of the evolution of the underlying concept of community participation is provided. The pilot experience was a dynamic process influenced by self-reflection of the research team, feedback from research partners and changes in the epidemiological context (provoked by two dengue outbreaks during the study period). Community participation evolved from being just one component in Aedes aegypti control directed by the health staff into a learning and empowering process for the people. This change in the concept of participation was reflected in different aspects of the pilot project such as the learning and evaluation processes. Conclusion: Empirical evidence from 5 years of research in the particular context of Cuba showed that moves towards community-based Aedes aegypti control are feasible. However, in order to be successful, community-based dengue prevention should be a social learning process, implying a transfer of power and responsibilities to local people. Actions undertaken must be oriented towards creating local capabilities, strengthening existing structures and organizations and promoting group work for learning participation from participation itself.	Inst Trop Med Pedro Kouri, Havana, Cuba; Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; Hlth Area 26 Julio, Havana, Cuba	Perez, D (reprint author), Inst Trop Med Pedro Kouri, Autopista Novia Mediodia Km 61-2, Havana, Cuba.	dennis@ipk.sld.cu	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776			Chiaravalloti Neto F, 2003, CAD SAUDE PUBLICA, V19, P1739; de Oliveira R M, 2001, Cad Saude Publica, V17 Suppl, P77, DOI 10.1590/S0102-311X2001000700016; deKoning K., 1996, PARTICIPATORY RES HL, P1; ESPINO F, 2004, SPECIAL TOPICS UNICE, V2; Freire P., 1972, PEDAGOGY OPPRESSED; Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Kemmis S., 2000, HDB QUALITATIVE RES, P567; Khanlou N, 2005, SOC SCI MED, V60, P2333, DOI 10.1016/j.socscimed.2004.10.004; Kouri G, 1998, EMERG INFECT DIS, V4, P89; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; LEONTSINI E, 1993, T ROY SOC TROP MED H, V87, P267, DOI 10.1016/0035-9203(93)90120-F; LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635; Lysack C., 1996, ACTIONAID DISABILITY, V7, P43; Morgan LM, 2001, HEALTH POLICY PLANN, V16, P221, DOI 10.1093/heapol/16.3.221; *PAHO, 2000, NUMB REP CAS DENG DE; *PAHO, 1994, SCI PUBL PAHO, V548; Pelaez O, 2004, EMERG INFECT DIS, V10, P719, DOI 10.3201/eid1004.030271; PEREZ D, 2004, THESIS I TROPICAL ME; PREISSWERK M, 2004, CONCEPCION METODOLOG, V2, P115; Rifkin SB, 1996, ACTA TROP, V61, P79, DOI 10.1016/0001-706X(95)00105-N; Sanchez L, 2004, REV PANAM SALUD PUBL, V15, P19, DOI 10.1590/S1020-49892004000100004; Sanchez L, 2005, TROP MED INT HEALTH, V10, P82, DOI 10.1111/j.1365-3156.2004.01347.x; Stake R., 1995, ART CASE STUDY RES; Suarez MR, 2005, SOC SCI MED, V61, P495, DOI 10.1016/j.socscimed.2004.11.069; Uphoff A., 1997, REASONS HOPE INSTRUC; WINCH P, 1992, HEALTH POLICY PLANN, V7, P342, DOI 10.1093/heapol/7.4.342; Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363; Zakus JDL, 1998, HEALTH POLICY PLANN, V13, P1, DOI 10.1093/heapol/13.1.1	31	23	24	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2007	12	5					664	672		10.1111/j.1365-3156.2007.01833.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	157UG	WOS:000245745900011	17445134	Bronze			2019-04-02	
J	Tinto, H; Ouedraogo, JB; Zongo, I; Van Overmeir, C; Van Marck, E; Guiguemde, TR; D'Alessandro, U				Tinto, Halidou; Ouedraogo, Jean Bosco; Zongo, Issaka; Van Overmeir, Chantal; Van Marck, Eric; Guiguemde, Tinga Robert; D'Alessandro, Umberto			Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina faso before its introduction as intermittent preventive treatment for pregnant women	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							THYMIDYLATE SYNTHASE GENE; POLYMERASE-CHAIN-REACTION; DIHYDROFOLATE-REDUCTASE; DIHYDROPTEROATE SYNTHASE; UNCOMPLICATED MALARIA; PROGUANIL RESISTANCE; MOLECULAR ANALYSIS; SEQUENCE-ANALYSIS; DRUG EFFICACY; CHILDREN	Sulfadoxine-pyrimethamine efficacy was determined with a 28-day follow-up in 97 children between 6 months and 15 years of age. The polymerase chain reaction (PCR)-corrected treatment failure was 8.2% and the uncorrected was 21.6%. The presence of the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) mutations linked to sulfadoxine-pyrimethamine resistance before and after treatment was determined by PCR-restriction fragment length polymorphism (RFLP) and by a fluorogenic PCR assay. Before treatment, the prevalence of the triple DHFR mutations was higher among the patients having had a recurrent parasitemia (either recrudescence or new infection; 28.6% versus 9.3%), although the difference was not significant (P = 0.1). The double mutation Ala436/Gly-437 was observed in 67% of samples, whereas no Glu-540 mutation was found. After treatment, the triple DHFR mutation was found in 76.2% of patients with recurrent parasiternia, recrudescence, and new infection alike. Such high prevalence of mutant parasites indicates that sulfadoxine-pyrimethamine should not be used as monotherapy.	Ctr Muraz, Bobo Dioulasso, Burkina Faso; INst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; Univ Antwerp, B-2020 Antwerp, Belgium; Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium	D'Alessandro, U (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	tintohalidou@yahoo.fr; udalessandro@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Tinto, Halidou/0000-0002-0472-3586			Aubouy A, 2003, J ANTIMICROB CHEMOTH, V52, P43, DOI 10.1093/jac/dkg294; Basco LK, 1998, AM J TROP MED HYG, V58, P369, DOI 10.4269/ajtmh.1998.58.369; Basco LK, 2000, J INFECT DIS, V182, P624, DOI 10.1086/315731; Bates SJ, 2004, J INFECT DIS, V190, P1783, DOI 10.1086/425078; BISWAS S, 2000, TROP MED INT HEALTH, V10, P773; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; BZIK DJ, 1987, P NATL ACAD SCI USA, V84, P8360, DOI 10.1073/pnas.84.23.8360; Curtis J, 1996, T ROY SOC TROP MED H, V90, P678, DOI 10.1016/S0035-9203(96)90432-0; Decuypere S, 2003, J INFECT DIS, V188, P1245, DOI 10.1086/378521; Deloron P, 2000, T ROY SOC TROP MED H, V94, P188, DOI 10.1016/S0035-9203(00)90272-4; Diourte Y, 1999, AM J TROP MED HYG, V60, P475, DOI 10.4269/ajtmh.1999.60.475; Doumbo OK, 2000, J INFECT DIS, V182, P993, DOI 10.1086/315787; Driessen GJA, 2002, TROP MED INT HEALTH, V7, P577, DOI 10.1046/j.1365-3156.2002.00910.x; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; FOOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014, DOI 10.1073/pnas.87.8.3014; GUIGUEMDE TR, 1994, AM J TROP MED HYG, V50, P699, DOI 10.4269/ajtmh.1994.50.699; Henry M C, 2002, Med Trop (Mars), V62, P55; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Mawili-Mboumba DP, 2001, ACTA TROP, V78, P231, DOI 10.1016/S0001-706X(01)00084-5; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; Parzy D, 1997, AM J TROP MED HYG, V57, P646, DOI 10.4269/ajtmh.1997.57.646; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; *PNLP, 2005, RAPP REUN CONS CHANG; Ranford-Cartwright LC, 1997, T ROY SOC TROP MED H, V91, P719, DOI 10.1016/S0035-9203(97)90539-3; Ranford-Cartwright LC, 2002, T ROY SOC TROP MED H, V96, P568, DOI 10.1016/S0035-9203(02)90446-3; Shretta R, 2000, TROP MED INT HEALTH, V5, P755, DOI 10.1046/j.1365-3156.2000.00643.x; Sirawaraporn W, 1997, P NATL ACAD SCI USA, V94, P1124, DOI 10.1073/pnas.94.4.1124; Sirima SB, 2003, CLIN INFECT DIS, V36, P1374, DOI 10.1086/375077; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Talisuna AO, 2004, INFECT GENET EVOL, V4, P321, DOI 10.1016/j.meegid.2004.04.002; Tinto H, 2002, TROP MED INT HEALTH, V7, P925, DOI 10.1046/j.1365-3156.2002.00952.x; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X; Wang P, 1997, MOL BIOCHEM PARASIT, V89, P161, DOI 10.1016/S0166-6851(97)00114-X; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; *WHO, 1996, ASS THER EFF ANT DRU; World Health Organization, 2002, MON ANT RES	40	22	24	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	APR	2007	76	4					608	613		10.4269/ajtmh.2007.76.608				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	155UV	WOS:000245604800002	17426157	Green Published			2019-04-02	
J	Mansiangi, P; Kiyombo, G; Mulumba, P; Josens, G; Krueger, A				Mansiangi, P.; Kiyombo, G.; Mulumba, P.; Josens, G.; Krueger, A.			Molecular systematics of Simulium squamosum, the vector in the Kinsuka onchocerciasis focus (Kinshasa, Democratic Republic of Congo)	ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY			English	Article							DAMNOSUM THEOBALD DIPTERA; COMPLEX; CYTOTAXONOMY; EDWARDSELLUM; BLACKFLIES; CAMEROON; ZAIRE		Univ Kinshasa, Ecole Sante Publ, Fac Med, Kinshasa, Zaire; Univ Libre Bruxelles, Lab Ecol & Systemat Anim, B-1050 Brussels, Belgium; Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, D-20359 Hamburg, Germany; Bernhard Nocht Inst Trop Med, FB Tropenmed Bundeswehr, D-20359 Hamburg, Germany	Krueger, A (reprint author), Univ Kinshasa, Ecole Sante Publ, Fac Med, Kinshasa, Zaire.	krueger@bni-hamburg.de					DUNBAR RW, 1966, NATURE, V209, P597, DOI 10.1038/209597a0; ELSEN P, 1988, Revue de Zoologie Africaine, V102, P455; Elsen P., 1983, Revue de Zoologie Africaine, V97, P653; ELSEN P, 1989, ANN TROP MED PARASIT, V83, P85, DOI 10.1080/00034983.1989.11812315; FAIN A, 1980, Revue de Zoologie Africaine, V94, P811; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; HENRY MC, 1990, ANN TROP MED PARASIT, V84, P369, DOI 10.1080/00034983.1990.11812482; Krueger A, 2006, MED VET ENTOMOL, V20, P60, DOI 10.1111/j.1365-2915.2006.00606.x; Krueger A, 2006, MOL PHYLOGENET EVOL, V39, P83, DOI 10.1016/j.ympev.2005.11.007; Kruger A, 2003, ANN TROP MED PARASIT, V97, P657, DOI 10.1179/000349803225002336; Mustapha M, 2004, MED VET ENTOMOL, V18, P296, DOI 10.1111/j.0269-283X.2004.00501.x; Post RJ, 2003, B ENTOMOL RES, V93, P145, DOI 10.1079/BER2003228; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Traore-Lamizana M, 2001, MED VET ENTOMOL, V15, P219, DOI 10.1046/j.0269-283x.2001.00300.x; VAJIME CG, 1990, ACT LEIDENS, V59, P235; VAJIME CG, 1975, TROPENMED PARASITOL, V26, P111	16	3	3	0	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0003-4983			ANN TROP MED PARASIT	Ann. Trop. Med. Parasitol.	APR	2007	101	3					275	279		10.1179/136485907X157013				5	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	155QK	WOS:000245592800010	17362602				2019-04-02	
J	Fanello, CI; Karema, C; van Doren, W; van Overmeir, C; Ngamije, D; D'Alessandro, U				Fanello, C. I.; Karema, C.; van Doren, W.; van Overmeir, Chantal; Ngamije, D.; D'Alessandro, U.			A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem (R)) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Plasmodium falciparum; artemether; lumefantrine; drug resistance; treatment outcome; Rwanda	ANTIMALARIAL-DRUG; CO-ARTEMETHER; PHARMACOKINETICS; PHARMACODYNAMICS; BENFLUMETOL; CHILDREN	Coartem(R) is a fixed-dose combination of artemether-lumefantrine that, given in six doses, provides effective treatment for children with uncomplicated Plasmodium falciparum infection in areas with highly endemic and multidrug-resistant malaria. In Rwanda since 2001, amodiaquine + sulfadoxine-pyrimethamine (AQ + SP) has been the first-Line treatment, but resistance to this combination has rapidly emerged and spread. Coartem was considered as a possible alternative, and a randomised, open-label, clinical trial to test its safety, tolerability and efficacy was carried out in 2004-2005. Five hundred children aged 12-59 months with uncomplicated P. falciparum malaria were randomly allocated to AQ + SP or Coartem. Patients were followed up until day 28 after treatment. Adverse events and clinical and parasitological outcomes were recorded. Adequate clinical and parasitological response (ACPR) was significantly higher in children treated with Coartem than in those treated with AQ + SP: the PCR-adjusted 28-day ACPR was 96.68% for Coartem and 79.35% for AQ + SP. Both treatments rapidly cleared parasitaemia and fever, although parasite clearance was significantly faster in children treated with Coartem. Mean packed cell volume increased in all patients, with no significant differences between treatments. Coartem proved to be more efficacious than AQ + SP, with a good safety and tolerability profile. (C) 2006 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Natl Malaria Control Program, Kigali, Rwanda; Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; Belgian Tech Cooperat, Kigali, Rwanda	Fanello, CI (reprint author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	caterina.fanello@lshtm.ac.uk	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Fanello, Caterina/0000-0003-1932-9562			Bakshi R, 2000, T ROY SOC TROP MED H, V94, P419, DOI 10.1016/S0035-9203(00)90126-3; Bindschedler M, 2002, AM J TROP MED HYG, V66, P293, DOI 10.4269/ajtmh.2002.66.293; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Ezzet F, 1998, BRIT J CLIN PHARMACO, V46, P553, DOI 10.1046/j.1365-2125.1998.00830.x; Gil JP, 2005, J INFECT DIS, V192, P1304, DOI 10.1086/432555; Haynes RK, 2001, CURR OPIN INFECT DIS, V14, P719, DOI 10.1097/00001432-200112000-00010; Irion A, 1998, TROP MED INT HEALTH, V3, P490, DOI 10.1046/j.1365-3156.1998.00253.x; KAREMA C, 2006, T R SOC TROP MED HYG, V100; Omari AAA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005564; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; Rwagacondo CE, 2003, AM J TROP MED HYG, V68, P743, DOI 10.4269/ajtmh.2003.68.743; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Von Seidlein L, 1998, AM J TROP MED HYG, V58, P638; Wernsdorfer Walther H, 2004, Expert Rev Anti Infect Ther, V2, P181, DOI 10.1586/14787210.2.2.181; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; WHO, 2003, ASS MON ANT DRUG EFF	19	37	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	APR	2007	101	4					344	350		10.1016/j.trstmh.2006.06.010				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	148FD	WOS:000245059100005	17005222				2019-04-02	
J	Garcia, AL; Parrado, R; De Doncker, S; Bermudez, H; Dujardin, JC				Garcia, Ana Lineth; Parrado, Rudy; De Doncker, Simonne; Bermudez, Hernan; Dujardin, Jean-Claude			American tegumentary leishmaniasis: direct species identification of Leishmania in non-invasive clinical samples	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						cutaneous leishmaniasis; Leishmania (Viannia) braziliensis; Leishmania (Viannia) lainsoni; diagnosis; PCR; Bolivia	CUTANEOUS LEISHMANIASIS; PCR-DIAGNOSIS; VIANNIA	Species identification is highly relevant for improved prognosis and adequate treatment of American tegumentary leishmaniasis (ATL). PCR-based methods are available for this purpose but should be simplified to improve accessibility. As a first step in this process, this paper describes a simplified protocol for collection of clinical samples. Using samples from 44 Bolivian patients with confirmed ATL, we demonstrated that hsp70 PCR-RFLP on skin scrapings collected with a tooth pick allowed identification of the parasite species with a sensitivity of 95% and specificity of 100%. Our method should greatly facilitate individual patient management and epidemiological surveillance of ATL. (C) 2006 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	Inst Trop Geneeskunde, Mol Parasitol Lab, B-2000 Antwerp, Belgium; Univ San Simon, Fac Med, Ctr Univ Med Trop, Cochabamba, Bolivia	Dujardin, JC (reprint author), Inst Trop Geneeskunde, Mol Parasitol Lab, Natl Str 155, B-2000 Antwerp, Belgium.	jcdujard@itg.be					Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; Cupolillo E, 2003, J CLIN MICROBIOL, V41, P3126, DOI 10.1128/JCM.41.7.3126-3132.2003; CUPOLILLO E, 1995, MOL BIOCHEM PARASIT, V73, P145, DOI 10.1016/0166-6851(95)00108-D; Davies CR, 1997, CLIN INFECT DIS, V25, P302, DOI 10.1086/514535; ESCOBAR MA, 1992, TROP DOCT, V22, P69, DOI 10.1177/00494755920220S110; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; Lachaud L, 2001, J CLIN MICROBIOL, V39, P613, DOI 10.1128/JCM.39.2.613-617.2001; Marsden P D, 1994, Rev Soc Bras Med Trop, V27, P93; Matsumoto T, 1999, T ROY SOC TROP MED H, V93, P606, DOI 10.1016/S0035-9203(99)90065-2; MERTENS P, 2004, CLIN MICROBIOL INFEC, V10, P526; Mimori T, 2002, ACTA TROP, V81, P197, DOI 10.1016/S0001-706X(01)00215-7; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; RODRIGUEZ N, 1994, J CLIN MICROBIOL, V32, P2246; Victoir K, 1998, PARASITOLOGY, V117, P1	14	31	35	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	APR	2007	101	4					368	371		10.1016/j.trstmh.2006.06.009				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	148FD	WOS:000245059100008	17011005				2019-04-02	
J	Nackers, F; Tonglet, R; Slachmuylder, V; Johnson, RC; Robert, A; Zinsou, C; Glynn, JR; Portaels, F; Gala, JL				Nackers, Fabienne; Tonglet, Ren; Slachmuylder, Vronique; Johnson, Roch C.; Robert, Annie; Zinsou, Claude; Glynn, Judith R.; Portaels, Francoise; Gala, Jean-Luc			Association between haemoglobin variants S and C and Mycobacterium ulcerans disease (Buruli ulcer): a case-control study in Benin	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						case-control studies; Mycobacterium ulcerans; Benin; haemoglobin S; haemoglobin C; osteomyelitis	HIV-POSITIVE PATIENT; AQUATIC INSECTS; INFECTION	Risk factors for Buruli ulcer (BU) are poorly understood. We conducted a case-control study in southern Benin to investigate the association between haemoglobin variants S or C and BU, and particularly the association between haernoglobinopathies HbSS/SC and BU osteomyelitis. We compared the haemoglobin genotype of 179 patients with BU and 44 with BU osteomyelitis to that of 242 community controls. We found no evidence of an increased risk of BU according to the presence of haemoglobin variants S and/or C [odds ratio adjusted for sex, age, region of residence and ethnicity: 1.24 (95%CI: 0.80-1.93), P = 0.34]. Haemoglobin variants S and C are unlikely to play a role in the BU burden. However, haemoglobinopathies HbSS/SC were more frequent among BU osteomyelitis patients than among controls (6.8% vs. 1.0%, Fisher's exact P-value = 0.045), which may suggest that those disorders facilitate growth of Mycobacterium ulcerans in the bone matrix.	Univ Catholique Louvain, Ecole Sante Publ, Unite Epidemiol, B-1200 Brussels, Belgium; Univ Catholique Louvain, Lab Appl Mol Technol, Ctr Human Genet, B-1200 Brussels, Belgium; Programme Natl Lutte Contre Ulcere Buruli, Cotonou, Benin; Ctr Depistage & Traitement Ulcere, Lalo, Benin; Ctr Sanitaire & Nutr Gbemoten, Zagnanado, Benin; London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium; Belgian Armed Forces, Def Labs Dept, Brussels, Belgium	Nackers, F (reprint author), Univ Catholique Louvain, Ecole Sante Publ, Unite Epidemiol, Clos Chapelle aux Champs,30 EPID 3058, B-1200 Brussels, Belgium.	fabienne.nackers@epid.ucl.ac.be					Amofah G, 2002, EMERG INFECT DIS, V8, P167, DOI 10.3201/eid0802.010119; [Anonymous], 2004, Wkly Epidemiol Rec, V79, P194; BARKER DJP, 1973, T ROY SOC TROP MED H, V67, P43, DOI 10.1016/0035-9203(73)90317-9; CHIPPAUX JP, 1992, REV EPIDEMIOL SANTE, V40, P246; Debacker M, 2004, TROP MED INT HEALTH, V9, P1297, DOI 10.1111/j.1365-3156.2004.01339.x; Debacker M, 2004, EMERG INFECT DIS, V10, P1391, DOI 10.3201/eid1008.030886; Debacker M, 2002, LANCET, V360, P1830, DOI 10.1016/S0140-6736(02)11771-5; Duker AA, 2006, ENVIRON INT, V32, P567, DOI 10.1016/j.envint.2006.01.002; Embury SH, 1994, SICKLE CELL DIS BASI; Johnson RC, 2005, TROP MED INT HEALTH, V10, P863, DOI 10.1111/j.1365-3156.2005.01465.x; Johnson RC, 2005, EMERG INFECT DIS, V11, P500, DOI 10.3201/eid1103.040597; Johnson RC, 2002, AIDS, V16, P1704, DOI 10.1097/00002030-200208160-00027; Kotlowski R, 2004, J MED MICROBIOL, V53, P927, DOI 10.1099/jmm.0.45593-0; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; MARSTON BJ, 1995, AM J TROP MED HYG, V52, P219, DOI 10.4269/ajtmh.1995.52.219; MEYERS WM, 1974, AM J TROP MED HYG, V23, P919, DOI 10.4269/ajtmh.1974.23.919; Nackers F, 2006, AM J TROP MED HYG, V75, P768, DOI 10.4269/ajtmh.2006.75.768; Nagel RL, 2003, BLOOD REV, V17, P167, DOI 10.1016/S0268-960X(03)00003-1; Palomino JC, 1998, J CLIN MICROBIOL, V36, P3420; Portaels F., 2003, Bulletin des Seances, Academie Royale des Sciences d'Outre- Mer, V49, P161; Portaels F, 1999, LANCET, V353, P986, DOI 10.1016/S0140-6736(98)05177-0; Pszolla N, 2003, CLIN INFECT DIS, V37, P78; ROTHMAN K, 1998, MODERN EPIDEMIOLOGY, P609; Scott JT, 2004, EMERG INFECT DIS, V10, P551, DOI 10.3201/eid1003.020514; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; Stienstra Y, 2004, AM J TROP MED HYG, V71, P318, DOI 10.4269/ajtmh.2004.71.318; Stoffel V, 2005, Sante Publique, V17, P191; Toll A, 2005, CLIN EXP DERMATOL, V30, P649, DOI 10.1111/j.1365-2230.2005.01892.x; Weatherall DJ, 1997, BRIT MED J, V314, P492, DOI 10.1136/bmj.314.7079.492; *WHO, 2001, BUR ULC DIAGN MYC UL, P27	30	5	5	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2007	12	4					511	518		10.1111/j.1365-3156.2006.01808.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	162CY	WOS:000246065600006	17445142	Bronze			2019-04-02	
J	Obsomer, V; Defourny, P; Coosemans, M				Obsomer, Valerie; Defourny, Pierre; Coosemans, Marc			The Anopheles dirus complex: spatial distribution and environmental drivers	MALARIA JOURNAL			English	Review							MALARIA TRANSMISSION; SOUTHEAST-ASIA; FOREST MALARIA; PLASMODIUM-FALCIPARUM; NORTHWESTERN THAILAND; HYPERENDEMIC MALARIA; BALABACENSIS COMPLEX; POPULATION-STRUCTURE; SPECIES-A; LAO PDR	Background: The Anopheles dirus complex includes efficient malaria vectors of the Asian forested zone. Studies suggest ecological and biological differences between the species of the complex but variations within species suggest possible environmental influences. Behavioural variation might determine vector capacity and adaptation to changing environment. It is thus necessary to clarify the species distributions and the influences of environment on behavioural heterogeneity. Methods: A literature review highlights variation between species, influences of environmental drivers, and consequences on vector status and control. The localisation of collection sites from the literature and from a recent project ( MALVECASIA) produces detailed species distributions maps. These facilitate species identification and analysis of environmental influences. Results: The maps give a good overview of species distributions. If species status partly explains behavioural heterogeneity, occurrence and vectorial status, some environmental drivers have at least the same importance. Those include rainfall, temperature, humidity, shade, soil type, water chemistry and moon phase. Most factors are probably constantly favourable in forest. Biological specificities, behaviour and high human-vector contact in the forest can explain the association of this complex with high malaria prevalence, multi-drug resistant Plasmodium falciparum and partial control failure of forest malaria in Southeast Asia. Conclusion: Environmental and human factors seem better than species specificities at explaining behavioural heterogeneity. Although forest seems essential for mosquito survival, adaptations to orchards and wells have been recorded. Understanding the relationship between landscape components and mosquito population is a priority in foreseeing the influence of land-cover changes on malaria occurrence and in shaping control strategies for the future.	Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium; Univ Catholique Louvain, Dept Environm Sci & Land Use Planning, B-1348 Louvain, Belgium	Obsomer, V (reprint author), Inst Trop Med Prince Leopold, Dept Parasitol, Natl Str 155, B-2000 Antwerp, Belgium.	obsomer@enge.ucl.ac.be; defourny@enge.ucl.ac.be; mcoosemans@itg.be					AUDTHO M, 1995, J MED ENTOMOL, V32, P107, DOI 10.1093/jmedent/32.2.107; AUNG H, 1999, SE ASIAN J TROP MED, V30, P447; BAIMAI V, 1981, GENETICA, V57, P81, DOI 10.1007/BF00131231; BAIMAI V, 1988, J AM MOSQUITO CONTR, V4, P333; BAIMAI V, 1984, Southeast Asian Journal of Tropical Medicine and Public Health, V15, P536; Baimai V, 1998, ZOOL STUD, V37, P75; BAIMAI V, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P151; BAIMAI V, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P661; BAIMAI V, 1987, P ENTOMOL SOC WASH, V89, P157; BAKER EZ, 1987, J MED ENTOMOL, V24, P536, DOI 10.1093/jmedent/24.5.536; BHAT H R, 1988, Indian Journal of Malariology, V25, P103; CHEONG WH, 1965, SCIENCE, V150, P1314, DOI 10.1126/science.150.3701.1314; DARSIE R F JR, 1990, Mosquito Systematics, V22, P69; DAS S C, 1985, Indian Journal of Malariology, V22, P53; DAVIS JR, 1995, MED VET ENTOMOL, V9, P249, DOI 10.1111/j.1365-2915.1995.tb00130.x; Dutta P., 1993, Indian Journal of Malariology, V30, P135; DUTTA P, 1991, Indian Journal of Malariology, V28, P121; Dutta P., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P378; DUTTA P, 1989, Indian Journal of Malariology, V26, P95; DUTTA P, 1989, Indian Journal of Malariology, V26, P149; DUTTA P, 1992, INDIAN J MED RES-A, V95, P245; Elias M, 1982, J PREVENTIVE SOCIAL, V1, P20; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; EYLES DON E., 1964, BULL WORLD HEALTH ORGAN, V30, P7; GINGRICH JB, 1990, J MED ENTOMOL, V27, P1016, DOI 10.1093/jmedent/27.6.1016; Gould D.J., 1966, ARMY SCI C P, P361; GOULD DJ, 1967, T ROY SOC TROP MED H, V61, P441, DOI 10.1016/0035-9203(67)90024-7; GREEN CA, 1992, MED VET ENTOMOL, V6, P29, DOI 10.1111/j.1365-2915.1992.tb00031.x; Harbach RE, 2004, B ENTOMOL RES, V94, P537, DOI 10.1079/BER2004321; HARBACH RE, 1987, J AM MOSQUITO CONTR, V3, P296; Ichimori K., 1989, Japanese Journal of Sanitary Zoology, V40, P81; ISMAIL IAH, 1975, WHOVBC75515; ISMAIL IAH, 1975, WHOMAL75847; Kengluechal Ampornpan, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P46; Khan S. A., 1998, Indian Journal of Malariology, V35, P131; Kitthawee S., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P143; KITTHAWEE S, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P128; KITTHAWEE S, 1992, J MED ENTOMOL, V29, P921, DOI 10.1093/jmedent/29.6.921; KLEIN J M, 1977, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V15, P107; Kobayashi J, 2000, TROP MED INT HEALTH, V5, P17, DOI 10.1046/j.1365-3156.2000.00516.x; Kobayashi Jun, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P615; KULKARNI S M, 1989, Indian Journal of Malariology, V26, P41; KYI KM, 1970, UNION BURMA J LIFE S, V3, P217; Lin TY, 2000, ENG APPL ARTIF INTEL, V13, P3, DOI 10.1016/S0952-1976(99)00045-7; Manguin S, 2002, MED VET ENTOMOL, V16, P46, DOI 10.1046/j.0269-283x.2002.00344.x; MARCHAND RP, 2004, 40 ANN SCI SEM MAL S, V10; MARCHAND RP, 1997, MED COMITE NEDERLAND, P1; MATHENGE EM, 2005, MALARIA J, V4; MAY K, 1987, GENOME, V29, P886, DOI 10.1139/g87-151; MENDIS K N, 1983, Mosquito Systematics, V15, P318; Misra S. P., 1993, Journal of Communicable Diseases, V25, P62; Moore S. J., 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P282; Nandi J., 1993, Journal of Communicable Diseases, V25, P18; Nandi J., 1996, Journal of Communicable Diseases, V28, P279; Oo TT, 2004, J VECTOR ECOL, V29, P21; Oo TT, 2003, J VECTOR ECOL, V28, P175; Oo TT, 2002, J VECTOR ECOL, V27, P44; Overgaard HJ, 2003, LANDSCAPE ECOL, V18, P605, DOI 10.1023/A:1026074910038; Paing M, 1989, MYANMAR HLTH SCI RES, V1, P122; PAING M, 1989, BURMA HLTH SCI RES J, V1, P52; PEYTON E L, 1989, Mosquito Systematics, V21, P197; PEYTON E L, 1979, Mosquito Systematics, V11, P40; PEYTON E L, 1980, Mosquito Systematics, V12, P335; PEYTON EL, 1988, MOSQ SYST, V20, P273; PHAN VT, 1998, EPIDEMIOLOGIE PALUDI; PRAKASH A, 1997, MOSQ BORNE DIS B, V4, P31; Prakash Anil, 1997, Indian Journal of Malariology, V34, P117; Prakash A, 2001, VECTOR-BORNE ZOONOT, V1, P231, DOI 10.1089/153036601753552594; Prakash Anil, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P610; Rahman Wahab A., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P599; Rajavel A. R., 1998, Journal of Communicable Diseases, V30, P57; Rattanarithikul R, 1995, J AM MOSQUITO CONTR, V11, P428; Rattanarithikul R, 1996, AM J TROP MED HYG, V54, P114, DOI 10.4269/ajtmh.1996.54.114; Rattanarithikul R, 1996, J AM MOSQUITO CONTR, V12, P75; Rattanarithikul R, 1996, J AM MOSQUITO CONTR, V12, P52; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P29, DOI 10.1016/0035-9203(90)90369-P; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P22; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P175, DOI 10.4269/ajtmh.1982.31.175; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P192, DOI 10.4269/ajtmh.1982.31.192; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P14, DOI 10.1016/0035-9203(90)90366-M; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P183, DOI 10.4269/ajtmh.1982.31.183; Sallum MAM, 2005, MED VET ENTOMOL, V19, P158, DOI 10.1111/j.0269-283X.2005.00551.x; SAWADIPANICH Y, 1990, J AM MOSQUITO CONTR, V6, P477; Scanlon J E, 1967, Proc Pap Annu Conf Calif Mosq Control Assoc, V35, P78; SCANLON JOHN E., 1965, J MED ENTOMOL, V2, P61; Sidavong B., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P309; Sithiprasasna R, 2004, J MED ENTOMOL, V41, P151, DOI 10.1603/0022-2585-41.2.151; Socheath S, 2000, Southeast Asian J Trop Med Public Health, V31 Suppl 1, P106; SOMBOON P, 1995, T ROY SOC TROP MED H, V89, P248, DOI 10.1016/0035-9203(95)90525-1; Somboon Pradya, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P3; Srivastava A, 2001, CURR SCI INDIA, V80, P1129; STIBIG HJ, 2003, GLC2000 DAT EUR COMM; SUWONKERD W, 1990, Tropical Medicine, V32, P1; Suwonkerd Wannapa, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P316; Suwonkerd Wannapa, 1995, Japanese Journal of Tropical Medicine and Hygiene, V23, P183; Tang L.-h., 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P467; TANG LH, 1991, CHINESE J PARASITIC, V4, P163; Teng T., 1974, Acta Entomologica Sinica, V17, P463; TEWARI S C, 1987, Indian Journal of Malariology, V24, P21; THU MM, 1985, JPN J GENET, V60, P313; Toma Takako, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P532; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; TRUNG HD, 2003, MALARIA VECTORS SE A; Tun-Lin W., 1988, Journal of Communicable Diseases, V19, P291; TunLin W, 1995, J AM MOSQUITO CONTR, V11, P401; TUNLIN W, 1986, MOSQ BORNE DIS B, P1; Uza Miyoko, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P246; Vythilingam I, 2003, TROP MED INT HEALTH, V8, P525, DOI 10.1046/j.1365-3156.2003.01052.x; Vythilingam Indra, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P83; Walton C, 1999, MED VET ENTOMOL, V13, P24, DOI 10.1046/j.1365-2915.1999.00142.x; Walton C, 2001, MOL ECOL, V10, P569, DOI 10.1046/j.1365-294x.2001.01201.x; Walton C, 2000, MOL BIOL EVOL, V17, P962, DOI 10.1093/oxfordjournals.molbev.a026377; WILKINSON RN, 1978, J MED ENTOMOL, V14, P666, DOI 10.1093/jmedent/14.6.666; WILKINSON RN, 1972, P HELM SOC WASH, V39, P423; Xu JN, 1997, MED VET ENTOMOL, V11, P134, DOI 10.1111/j.1365-2915.1997.tb00302.x; YANG TH, 1983, WHOMAL83999, P30; Yu Y., 1984, Entomotaxonomia, V6, P323; GLOBAL GAZETTEER VER	119	87	90	1	15	BIOMED CENTRAL LTD	LONDON	MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAR 6	2007	6								26	10.1186/1475-2875-6-26				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	151YW	WOS:000245328200001	17341297	DOAJ Gold, Green Published			2019-04-02	
J	Erhart, A; Thang, ND; Xa, NX; Thieu, NQ; Hung, LX; Hung, NQ; Nam, NV; Toi, LV; Tung, NM; Bien, TH; Tuy, TQ; Cong, LD; Thuan, LK; Coosemans, M; D'Alessandro, U				Erhart, A.; Thang, N. D.; Xa, N. X.; Thieu, N. Q.; Hung, L. X.; Hung, N. Q.; Nam, N. V.; Toi, L. V.; Tung, N. M.; Bien, T. H.; Tuy, T. Q.; Cong, L. D.; Thuan, L. K.; Coosemans, M.; D'Alessandro, U.			Accuracy of the health information system on malaria surveillance in Vietnam	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						malaria; surveillance; morbidity; private health system; disease management; self medication; Vietnam	FOREST MALARIA; EPIDEMIOLOGY; COMPLEX	The health information system (HIS) is a key component of control programs and its accuracy is necessary for the assessment of disease risks, the formulation of priorities and the evaluation of the cost-effectiveness of different interventions. In order to assess the quality of the HIS in estimating malaria morbidity in Vietnam, we compared data obtained by a 2-year active (ACD) and passive case detection (PCD) study with those routinely collected at the local commune health centres (CHC) at three sites having different malaria epidemiology. The majority of malaria cases (80-95%) detected by ACD were missed by the HIS. Similarly, most malaria cases (50-90%) detected by PCD were also missed by the HIS, and this was proportional to the number of active private practitioners. Reasons for this low sensitivity are low CHC attendance, high attendance at private health facilities, widespread self-medication and attendance at central health facilities. In conclusion, although malaria has sharply decreased in Vietnam over the past 10 years, the current HIS greatly underestimates the malaria burden. Involvement of the private sector and the establishment of sentinel sites might improve the quality of data and the relevance of HIS in malaria control. (c) 2006 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; Inst Malariol Parasitol & Entomol, Ho Chi Minh City, Vietnam; Malaria & Goitre Control Ctr Binh Thuan Prov, Phan Thiet, Vietnam; Prov Malaria Stn Bac Lieu Prov, Bac Lieu, Vietnam	Erhart, A (reprint author), Inst Trop Med Prince Leopold, Natl Str 155, B-2000 Antwerp, Belgium.	aerhart@itg.be	Alkhalawi, Mohammed/C-6111-2012; D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009			Abeysekera T, 1997, TROP MED INT HEALTH, V2, P1057, DOI 10.1046/j.1365-3156.1997.d01-183.x; Chang FR, 2003, HEALTH ECON, V12, P721, DOI 10.1002/hec.841; CONG L, 1998, MEKONG MALARIA FORUM, P9; DEMEDTS P, 1985, ANN SOC BELG MED TR, V65, P89; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart A, 2004, TROP MED INT HEALTH, V9, P1081, DOI 10.1111/j.1365-3156.2004.01310.x; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; ERHART A, 1999, RETROSPECTIVE STUDY; KRICKEBERG K, 1999, HLTH INFORM SYSTEM V; Linton YM, 2005, B ENTOMOL RES, V95, P329, DOI 10.1079/BER2005364; NGUYEN THH, 2002, HLTH POLICY PLAN, V17, P61; NGUYEN THH, 1999, MEKONG MALARIA FORUM, P33; *NIMPE, 2004, ANN REP NATL MAL CON; *NIMPE, 2003, ANN REP NATL MAL CON; *NIMPE, 2002, ANN REP NATL MAL CON; *NIMPE, 2005, ANN REP NATL MAL CON; Oum S, 2005, TROP MED INT HEALTH, V10, P689, DOI 10.1111/j.1365-3156.2005.01445.x; PHAN VT, 1998, EPIDEMIOLOGIE PALUDI; PHAN VT, 1998, EPIDEMIOLOGICAL CHAR, P22; Sallum MAM, 2005, MED VET ENTOMOL, V19, P158, DOI 10.1111/j.0269-283X.2005.00551.x; Schuftan C, 2000, STORY BE SHARED SUCC; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tran Tuan, 2005, Health Policy and Planning, V20, P319, DOI 10.1093/heapol/czi037; Trivedi P. K., 2002, PATTERNS HLTH CARE U; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; TRUNG HD, 2005, TROP MED INT HEALTH, V10, P1; Van Bortel W, 1999, TROP MED INT HEALTH, V4, P257; Verle P., 1998, Research and Reviews in Parasitology, V58, P169; *WHO WPRO, 2005, VIETN HLTH SIT; World Bank, 2001, GROW HLTH REV VIETN	30	26	26	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAR	2007	101	3					216	225		10.1016/j.trstmh.2006.07.003				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	135CE	WOS:000244130600002	16979202				2019-04-02	
J	Somers, R; Dorny, P; Geysen, D; Nguyen, LA; Thach, DC; Vercruysse, J; Nguyen, VK				Somers, Raf; Dorny, Pierre; Geysen, Dirk; Nguyen, Lan Anh; Thach, Dang Cam; Vercruysse, Jozef; Nguyen, Viet Khong			Human tapeworms in north Vietnam	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Taenia; morphology; PCR; RFLP; Vietnam	DIFFERENTIAL-DIAGNOSIS; SOLIUM CYSTICERCOSIS; TAENIASIS; ASIATICA; PCR	Sixty-five Toenia samples were collected from patients in a referral hospital in Hanoi, north Vietnam, for species identification by morphological and molecular techniques. PCR-RFLP of a mitochondrial 12S rDNA fragment, developed for this study, allowed direct differentiation between all Taenia spp., overcoming the disadvantages of classical morphological examination, which failed on disintegrated samples. Taenia saginata asiatica was the most common species (55.4%) followed by T. saginata (38.5%) and T. solium (6.2%). This report demonstrates the complexity of the epidemiology of Taenia spp. in Vietnam and the need for further work to reveal transmission patterns of these species. (c) 2006 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; Univ Ghent, Fac Med Vet, Parasitol Lab, B-9820 Merelbeke, Belgium; Natl Inst Vet Res, Hanoi, Vietnam; Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam	Dorny, P (reprint author), Inst Trop Med, Dept Anim Hlth, Nationalestr 155, B-2000 Antwerp, Belgium.	pdorny@itg.be					BOOM R, 1990, J CLIN MICROBIOL, V28, P495; De NV, 2001, J MALARIA PARAS DIS, V3, P80; Dorny P, 2004, SE ASIAN J TROP MED, V35, P223; EOM K, 2002, KOREAN J PARASITOL, V40, P32; Eom Keeseon S., 2001, Korean Journal of Parasitology, V39, P267; Eom KS, 2002, J PARASITOL, V88, P758, DOI 10.1645/0022-3395(2002)088[0758:IOTAIC]2.0.CO;2; Erhart A, 2002, T ROY SOC TROP MED H, V96, P270, DOI 10.1016/S0035-9203(02)90095-7; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Gonzalez LM, 2004, DIAGN MICR INFEC DIS, V49, P183, DOI 10.1016/j.diagmicrobio.2004.03.013; MORGAN BB, 1949, VET HELMINTHOLOGY; Rodriguez V, 2002, PHYSICA E, V12, P88, DOI 10.1016/S1386-9477(01)00249-1; Rodriguez-Hidalgo R, 2003, VET PARASITOL, V118, P51, DOI 10.1016/j.vetpar.2003.09.019; Somers R, 2006, TROP MED INT HEALTH, V11, P65, DOI 10.1111/j.1365-3156.2005.01537.x; Willingham A Lee 3rd, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 1, P35; Yamasaki H, 2004, J CLIN MICROBIOL, V42, P548, DOI 10.1128/JCM.42.2.548-553.2004	15	27	29	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAR	2007	101	3					275	277		10.1016/j.trstmh.2006.04.007				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	135CE	WOS:000244130600010	16806333				2019-04-02	
J	Mahendradhata, Y; Lambert, ML; Boelaert, M; Van der Stuyft, P				Mahendradhata, Yodi; Lambert, Marie-Laurence; Boelaert, Marleen; Van der Stuyft, Patrick			Engaging the private sector for tuberculosis control: much advocacy on a meagre evidence base	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						tuberculosis; tuberculosis control; private sector; DOTS; public-private mix			Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium; Gadjah Mada Univ, Ctr Hlth Serv Management, Fac Med, Yogyakarta, Indonesia	Mahendradhata, Y (reprint author), Inst Trop Med, Epidemiol & Dis Control Unit, Dept Publ Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	yodi_mahendradhata@yahoo.co.uk	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Mahendradhata, Yodi/0000-0002-4522-1785			DEWAN PK, 2006, BRIT MED J, V7541, P574; FLOYD K, 2006, B WORLD HEALTH ORGAN, V6, P437; Huong NT, 2005, INT J TUBERC LUNG D, V9, P151; LONNROTH K, 2006, B WORLD HEALTH ORGAN, V11, P876; LONNROTH K, 2004, B WORLD HEALTH ORGAN, V8, P580; Maher B, 2003, MIND LANG, V18, P1, DOI 10.1111/1468-0017.00212; SINGH V, 2002, TROP MED INT HEALTH, V8, P693; Stop TB Partnership. The Stop TB Strategy, 2006, STOP TB STRAT BUILD; SUAREZ P, 2001, J INFECT DIS, V184, P437; Tang SL, 2005, HEALTH POLICY, V72, P93, DOI 10.1016/j.healthpol.2004.06.009; WHO, 2006, ENG ALL HLTH CAR PRO; World Health Organization, 2006, GLOB TUB CONTR SURV	12	17	17	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAR	2007	12	3					315	316		10.1111/j.1365-3156.2007.01816.x				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	138CU	WOS:000244341500001	17286621				2019-04-02	
J	Vereecken, K; Naus, CWA; Polman, K; Scott, JT; Diop, M; Gryseels, B; Kestens, L				Vereecken, Kim; Naus, Cynthia W. A.; Polman, Katja; Scott, Janet T.; Diop, Mamadou; Gryseels, Bruno; Kestens, Luc			Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						schistosomiasis; Schistosoma mansoni; antibody responses; senegal; treatment; reinfection	ISOTYPE RESPONSES; HUMAN EOSINOPHILS; NORTHERN SENEGAL; IMMUNE-RESPONSES; HUMAN IGE; INFECTION; AGE; HAEMATOBIUM; ANTIGENS; JAPONICUM	We examined associations between schistosome-specific antibody responses and reinfection in Senegalese individuals recently exposed to Schistosoma mansoni. The effects of treatment, age, intensity of infection and duration of exposure on schistosome-specific antibody responses were also investigated by comparing immune responses in individuals exposed for less than 3 years with responses in people exposed for more than 8 years. All individuals were bled before treatment as well as 6 and 12 weeks after. We used a statistical model that included interaction terms between time, age, infection intensity and duration of exposure. The overall patterns of most specific antibody responses by age were similar to those previously published for S. mansoni, Schistosoma japonicum and Schistosoma haematobium infections in different endemic areas. In general, a boost in specific antibody responses against adult worm antigen (SWA) was observed at 6 weeks after treatment whereas the majority of isotype responses against egg antigen (SEA) were not affected by treatment. Our analysis showed that the effect of treatment on schistosome-specific antibody responses is influenced by age, infection intensity and duration of exposure. We found no evidence that treatment matures the specific antibody response of children recently infected with S. mansoni. Our results indicate that the build-up of potentially protective immunoglobulin E (IgE) responses was associated with duration of exposure, or, in other words, experience of infection. Interestingly, in recently exposed individuals there was a significant association between IgA responses to SWA and resistance to reinfection. Resistance to reinfection and production of IgA-SWA was associated with adulthood independently of exposure patterns, suggesting that susceptibility to S. mansoni and the development of protective immune responses is age-dependent.	Prince Leopold Inst Trop Med, B-2000 Antwerp, Belgium; Programme ESPOIR, Reg Med, St Louis, Senegal	Kestens, L (reprint author), Prince Leopold Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	lkestens@itg.be					ABUGHAZALEH RI, 1989, J IMMUNOL, V142, P2393; Ali A. E., 1994, Journal of the Egyptian Society of Parasitology, V24, P505; AURIAULT C, 1990, J CLIN MICROBIOL, V28, P1918; BUTTERWORTH A, 1988, BIOCHIMIE, V70, P1053, DOI 10.1016/0300-9084(88)90268-4; BUTTERWORTH AE, 1994, PARASITOL TODAY, V10, P378, DOI 10.1016/0169-4758(94)90225-9; BUTTERWORTH AE, 1977, J IMMUNOL, V118, P2230; Caldas IR, 2000, AM J TROP MED HYG, V62, P57, DOI 10.4269/ajtmh.2000.62.57; CAPRON M, 1995, ALLERGY, V50, P20, DOI 10.1111/j.1398-9995.1995.tb04270.x; CAPRON M, 1988, CR ACAD SCI III-VIE, V307, P397; CAPRON M, 1984, J IMMUNOL, V132, P462; DUNNE DW, 1992, EUR J IMMUNOL, V22, P1483, DOI 10.1002/eji.1830220622; ERNOULD JC, 1996, EPIDEMIOLOGIE SCHIST; GIBODA M, 1994, J TROP MED HYG, V97, P98; Grogan JL, 1996, J INFECT DIS, V173, P1242, DOI 10.1093/infdis/173.5.1242; GRYSEELS B, 1994, PARASITOL TODAY, V10, P380, DOI 10.1016/0169-4758(94)90226-7; GRZYCH JM, 1993, J IMMUNOL, V150, P527; HAGAN P, 1991, NATURE, V349, P243, DOI 10.1038/349243a0; HARNETT W, 1986, PARASITOLOGY, V93, P401, DOI 10.1017/S0031182000051568; Kabatereine NB, 1999, PARASITOLOGY, V118, P101, DOI 10.1017/S0031182098003576; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; KHALIFE J, 1989, J IMMUNOL, V142, P4422; Lemke H, 2004, TRENDS IMMUNOL, V25, P180, DOI 10.1016/j.it.2004.02.007; Li X, 2002, T ROY SOC TROP MED H, V96, P210, DOI 10.1016/S0035-9203(02)90310-X; Mutapi F, 1997, PARASITE IMMUNOL, V19, P255, DOI 10.1046/j.1365-3024.1997.d01-206.x; Mutapi F, 1998, J INFECT DIS, V178, P289, DOI 10.1086/517456; Naus CWA, 1999, INFECT IMMUN, V67, P3444; Naus CWA, 2003, TROP MED INT HEALTH, V8, P561, DOI 10.1046/j.1365-3156.2003.01056.x; Naus CWA, 1998, CLIN INFECT DIS, V26, P1142, DOI 10.1086/520310; Ndhlovu P, 1996, PARASITE IMMUNOL, V18, P181, DOI 10.1046/j.1365-3024.1996.d01-78.x; POULSEN LK, 1993, ALLERGY, V48, P207, DOI 10.1111/j.1398-9995.1993.tb00715.x; Scott JT, 2003, TROP MED INT HEALTH, V8, P100, DOI 10.1046/j.1365-3156.2003.00993.x; Shen L, 2002, CLIN EXP IMMUNOL, V129, P339, DOI 10.1046/j.1365-2249.2002.01914.x; SPIEGELBERG HL, 1989, INT ARCH ALLER A IMM, V90, P22, DOI 10.1159/000235071; STELMA FF, 1993, AM J TROP MED HYG, V49, P701, DOI 10.4269/ajtmh.1993.49.701; van den Biggelaar AHJ, 2002, J INFECT DIS, V186, P1474, DOI 10.1086/344352; vanDam GJ, 1996, J INFECT DIS, V173, P1232, DOI 10.1093/infdis/173.5.1232; Webster M, 1997, PARASITOLOGY, V114, P383, DOI 10.1017/S003118209600858X; Webster M, 1996, INFECT IMMUN, V64, P4042; Woolhouse MEJ, 1999, NAT MED, V5, P1225, DOI 10.1038/15169; Zhang ZS, 1997, T ROY SOC TROP MED H, V91, P606, DOI 10.1016/S0035-9203(97)90047-X	40	25	25	0	3	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	MAR	2007	12	3					431	444		10.1111/j.1365-3156.2006.01805.x				14	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	138CU	WOS:000244341500015	17313515	Bronze			2019-04-02	
J	Orach, CG; Dubourg, D; De Brouwere, V				Orach, Christopher Garimoi; Dubourg, Dominique; De Brouwere, Vincent			Costs and coverage of reproductive health interventions in three rural refugee-affected districts, Uganda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Reproductive health interventions (antenatal care, vaginal delivery; caesarean section,family planning, sexually transmitted infections) costs; coverage; refugee; host; Uganda	INTERNALLY DISPLACED PERSONS; ASSISTANCE PROGRAM; WEST-NILE; SERVICES; GUINEA	BACKGROUND Uganda has hosted an estimated 200 000 refugees in post-emergency phase settlements interspersed within host communities since 1990. However, refugee health service runs parallel to host in most refugee-affected districts. The process of integration of health services began in 1999. OBJECTIVE To estimate and compare the costs and coverage of reproductive health (RH) interventions in refugee and host populations in three rural West Nile refugee-affected districts of Uganda. METHODS Data on costs of RH interventions were collected through a survey in 38/116 (33%) health facilities (3 public hospitals and 35 health centres). Data on coverage of RH interventions were collected from all 116 health facilities in the three rural refugee-affected districts for 2 years, 2003 and 2004. RESULTS The costs and coverage of RH interventions significantly varied between population categories and among levels of refugee and host health facilities. Per capita cost of health care is 2.7 times higher for the refugee than the host population (US$13.12 vs. US$4.85). The cost per RH intervention is higher in the refugee than in the host health system (US$3.02 vs. US$2.73). Significantly more refugees attend antenatal care [99.4% (95% CI, 97.5-100) vs. 53.5% (53.22-53.78); P < 0.0001]. The proportion of births in health facilities was significantly greater among refugees [37.3% (36.12-38.48) vs. 15.2% (15.01-15.39); P < 0.05]. Major obstetrical interventions for absolute maternal indications were significantly more frequent among refugees than the host population living in the same region [1.02% (0.79-1.25) vs. 0.85% (0.80-0.90); P < 0.05]. CONCLUSIONS Our study has shown higher costs and coverage in refugee than host health services. The findings suggest policy recommendations for improving the capacity, financing, organization and the performance of host health system in the refugee-affected settings.	Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Inst Trop Med, B-2000 Antwerp, Belgium; Vrije Univ Brussels, Brussels, Belgium	Orach, CG (reprint author), Makerere Univ, Inst Publ Hlth, POB 7072, Kampala, Uganda.	cgarimoi@itg.be					*ADJ DISTR PLANN O, 2005, REP ADJ DISTR LOC GO; *AFR HUM ACT, 2002, ANN FIELD REP 1999 2; *AR DISTR PLANN OF, 2005, REP AR DISTR LOC GOV; Belghiti A, 1998, TROP MED INT HEALTH, V3, P584; Borghi J, 2001, SAFE MOTHERHOOD STRA, P247; Burnham GM, 2003, DISASTERS, V27, P54, DOI 10.1111/1467-7717.00219; COSSA HA, 1994, INT J STD AIDS, V5, P117, DOI 10.1177/095646249400500208; Daly CC, 1998, HEALTH POLICY PLANN, V13, P87, DOI 10.1093/heapol/13.1.87; De Brouwere V, 1996, SEM INN APPR ASS REP, P1; DICK B, 1985, DISASTERS, V9, P259, DOI 10.1111/j.1467-7717.1985.tb00948.x; *DISTR DIR HLTH SE, 2002, ADJ DISTR DEV PLAN 1; Girard F, 2000, INT FAM PLAN PERSPEC, V26, P167, DOI 10.2307/2648254; *GOU, 1999, SELF REL REF HOST AR, P10; *GOU, 1994, EQ VULN SIT AN WOM A, P13; Hynes M, 2002, JAMA-J AM MED ASSOC, V288, P595, DOI 10.1001/jama.288.5.595; *JMS, 2003, CAT PRIC IND, P31; Lawrie N, 2003, LANCET, V362, P575, DOI 10.1016/S0140-6736(03)14124-4; Levin A, 2003, INT J HEALTH PLAN M, V18, P3, DOI 10.1002/hpm.690; *MIN HLTH, 2003, UGANDA HLTH B, V9, P5; *MOYO DISTR PLANN, 2005, REP MOYO DISTR LOC G; *NAT MED STOR, 2001, PRIC IND STOCK INF C; Orach CG, 1998, LANCET, V352, P327, DOI 10.1016/S0140-6736(05)60308-X; Orach CG, 2006, HEALTH POLICY PLANN, V21, P53, DOI 10.1093/hepaol/czj007; Orach CG, 2004, LANCET, V364, P611, DOI 10.1016/S0140-6736(04)16854-2; PORIGNON D, 1995, DISASTERS, V19, P356, DOI 10.1111/j.1467-7717.1995.tb00356.x; *UBOS ORC MACR, 2001, UG DEM HLTH SURV UDS; *UNHCR, 1999, REPR HLTH REF SIT IN; *UNHCR, 2005, REF SIT UG; *UNHCR, 2004, SELF REL STRAT 1999; *UONN, 2005, TACKL UNM NEED MAJ O; Van Damme W, 1998, LANCET, V351, P1609, DOI 10.1016/S0140-6736(97)10348-8; VANDAMME W, 1998, STUDIES HLTH SERVICE, P139; WEISSMAN E, 1999, WHOCHSRHR999; WHO (World Health Organization), 1999, WHOFCHRHR9917; Wynd S, 2004, LANCET, V364, P562, DOI 10.1016/S0140-6736(04)16865-7	35	5	5	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAR	2007	12	3					459	469		10.1111/j.1365-3156.2006.01788.x				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	138CU	WOS:000244341500017	17313517				2019-04-02	
J	Ndiaye, P; Soors, W; Criel, B				Ndiaye, Pascal; Soors, Werner; Criel, Bart			Editorial: A view from beneath: Community health insurance in africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						community health insurance; access; financing; user empowerment; sub-Saharan Africa	SCHEMES; GUINEA	This paper presents an overview of the development of Community Health Insurance (CHI) in sub-Saharan Africa. In 2003, nearly 600 CHI initiatives were registered in a dozen countries of francophone West Africa alone. At regional level, coordination networks have been created in Africa with the aim to support and monitor the developments of this innovative model of health care financing. At national level, governments are preparing the necessary legal frameworks for CHI implementation. CHI is increasingly seen as a strategy to meet other development goals than only health. It constitutes an interesting model to finance health care, to pool financial resources in a fair way and to empower health care users. The CHI movement however still faces many challenges. The relevance of more professional inputs in the management of CHI and the need for careful subsidy of CHI schemes are increasingly recognized. There is also need to optimize the relationship of CHI with the other actors in the health system and to scale-up CHI so as to gain in effectiveness and efficiency. The boom in the number of schemes in Africa during the last years is an indicator of the increasing attractiveness of the model. In practice however, enrolment rates per scheme remain low or are only slowly increasing. Context-specific research is needed on the reasons that prevent people from enrolling in larger numbers. On that basis, relevant action to be taken locally can be identified.	Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; ICODES Afrique, Dakar, Senegal	Criel, B (reprint author), Inst Trop Med, Dept Publ Hlth, 155 Natl Str, B-2000 Antwerp, Belgium.	bcriel@itg.be					Atim C, 1999, SOC SCI MED, V48, P881, DOI 10.1016/S0277-9536(98)00390-6; ATIM C, 2000, CONTRIBUTION MUTUELL; BROUILLET P, 1997, ENFANT MILIEU TROPIC, V228, P40; *CONC ACT DEV MUT, 2004, INV SYST ASS MAL AFR; *CONC ACT DEV MUT, 2000, BAS DONN MUT SANT AF; Criel B, 2003, SOC SCI MED, V57, P1205, DOI 10.1016/S0277-9536(02)00495-1; CRIEL B, 1998, TROP MED INT HEALTH, V4, P155; Criel B., 1998, STUDIES HLTH SERVICE, V<IT>9</IT>; Dror D., 1999, INT SOCIAL SECURITY, V52, P71, DOI DOI 10.1111/1468-246X.00034; GRUAT JV, 1990, INT LABOUR REV, V129, P405; LevyBruhl D, 1997, INT J HEALTH PLAN M, V12, pS49, DOI 10.1002/(SICI)1099-1751(199706)12:1+<S49::AID-HPM466>3.3.CO;2-G; NDIAYE P, 2006, DEV MUTUELLES SANTE; NORMAND C, 1996, SOCIAL HLTH INSURANC; *PROJ PRIMA GUIN C, 2002, EXP ORG MUT SANT AFR; Waelkens M.-P., 2004, MUTUELLES SANTE AFRI; WAELKENS MP, 2005, 22 STEP INT LAB ORG	16	27	27	0	4	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2007	12	2					157	161		10.1111/j.1365-3156.2007.01814.x				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	132KQ	WOS:000243942100001	17300621	Bronze			2019-04-02	
J	Wang, Y; Collins, C; Vergis, M; Gerein, N; Macq, J				Wang, Yan; Collins, Charles; Vergis, Mercy; Gerein, Nancy; Macq, Jean			HIV/AIDS and TB: contextual issues and policy choice in programme relationships	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						HIV; AIDS; tuberculosis; programme integration; policy; organizational issues	HEALTH SECTOR REFORM; DISEASE-CONTROL PROGRAMS; SUB-SAHARAN AFRICA; REPRODUCTIVE HEALTH; SOUTH-AFRICA; TUBERCULOSIS PROGRAMS; CARE; SERVICES; INTEGRATION; DECENTRALIZATION	Tuberculosis (TB) and HIV/AIDS affect each other closely. Given the rapid spread of the HIV-driven TB epidemic worldwide, the case for establishing some form of relationship between control activities for HIV/AIDS and TB is clear. However, the question 'how' has not been resolved satisfactorily. TB and HIV/AIDS programmes have traditionally maintained their own management, supervision, funding flows and specialist boundaries. This article explores opportunities and challenges for collaboration between the two, through drawing on the expertise in organization and management, policy analysis and disease control of both TB and HIV/AIDS. Based on an extensive literature review, the article investigates how contextual issues affect the design of a collaboration; what the organizational options are; and what impact a collaboration would have. A universal model for organizational change is unlikely and changes may present as both solutions and contradictions. Careful planning and consultation are required before implementing the changes, in order to avoid jeopardizing the function and effectiveness of both disease control programmes and the health service system.	Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Independent Acad, Wirral, Merseyside, England; Calderdale Primary Care Trust, Halifax, NS, Canada; Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds LS2 9JT, W Yorkshire, England; Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium	Wang, Y (reprint author), Univ Liverpool, Liverpool Sch Trop Med, Pembrooke Pl, Liverpool L3 5QA, Merseyside, England.	yan.wang@liverpool.ac.uk					Askew I, 2002, INT FAM PLAN PERSPEC, V28, P77, DOI 10.2307/3088239; Balogun MA, 1996, INT J STD AIDS, V7, P58, DOI 10.1258/0956462961917087; Buve A, 2003, INT J HEALTH PLAN M, V18, pS41, DOI 10.1002/hpm.725; Charalambous S, 2004, AIDS CARE, V16, P47, DOI 10.1080/09540120310001633967; Chimzizi RB, 2004, INT J TUBERC LUNG D, V8, P938; Coetzee D, 2004, TROP MED INT HEALTH, V9, pA11, DOI 10.1111/j.1365-3156.2004.01259.x; Collins C, 1999, HEALTH POLICY, V47, P69, DOI 10.1016/S0168-8510(99)00003-2; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Criel B, 2004, TROP MED INT HEALTH, V9, pA1, DOI 10.1111/j.1365-3156.2004.01257.x; Escott S, 2005, SOC SCI MED, V61, P1701, DOI [10.1016/j.socscimed.2005.03.040, 10.1016/j.socsimed.2005.03.040]; Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8; Forsythe S, 2002, HEALTH POLICY PLANN, V17, P187, DOI 10.1093/heapol/17.2.187; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Godfrey-Faussett P, 2003, TUBERCULOSIS, V83, P68, DOI 10.1016/S1472-9792(02)00083-5; Godfrey-Faussett R, 2002, INT J TUBERC LUNG D, V6, P796; Hanson S, 2000, INT J HEALTH PLAN M, V15, P341, DOI 10.1002/hpm.602; Harries AD, 2005, INT J TUBERC LUNG D, V9, P128; Harries AD, 2004, TB HIV CLIN MANUAL; HELLBERG H, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90570-7; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Kumaresan JA, 2000, INT J TUBERC LUNG D, V4, P615; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; Lienhardt C, 1997, INT J TUBERC LUNG D, V1, P196; Macq J, 2005, HEALTH POLICY, V74, P205, DOI 10.1016/j.healthpol.2005.01.003; MACQ J, 2004, INT J TURBERCULOSIS, V8, P330; Macq JCM, 2003, INT J TUBERC LUNG D, V7, P103; Maher D, 2005, INT J TUBERC LUNG D, V9, P17; Mayhew SH, 2000, STUD FAMILY PLANN, V31, P151, DOI 10.1111/j.1728-4465.2000.00151.x; Mayhew SH, 2003, REPROD HEALTH MATTER, V11, P74, DOI 10.1016/S0968-8080(03)02171-2; McIntyre D, 2003, REPROD HEALTH MATTER, V11, P108, DOI 10.1016/S0968-8080(03)02166-9; Needham DM, 2004, HEALTH POLICY, V67, P93, DOI 10.1016/S0168-8510(03)00065-4; Oliff M, 2003, REPROD HEALTH MATTER, V11, P37; Paone D, 1998, J SUBST ABUSE TREAT, V15, P229, DOI 10.1016/S0740-5472(97)00193-1; Rajeswari R, 2002, INT J TUBERC LUNG D, V6, P789; RIEL B, 1997, INTEGRATION VERTICAL; ROGERS DL, 1982, INTERORGANISATIONAL; Sanou A, 2004, INT J TUBERC LUNG D, V8, P1479; SCHNEIDER H, 2004, HLTH SYSTEMS STRENGT; *STOP TB PARTN WHO, 2006, WHOHTMSTB200635; Unger JP, 2003, INT J HEALTH PLAN M, V18, pS27, DOI 10.1002/hpm.723; Visschedijk Jan, 2003, Cad. Saúde Pública, V19, P1567; *WHO, 2003, GUID IMPL COLL TB HI; *WHO, 2005, WHO 2005 REP GLOB TU; *WHO UNAIDS, 2005, 3 5 PROGR REP DEC 20; World Health Organization, 2004, INT POL COLL TB HIV; World Health Organization, 2005, WORLD HLTH REP 2005	46	10	10	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2007	12	2					183	194		10.1111/j.1365-3156.2006.01783.x				12	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	132KQ	WOS:000243942100004	17300624	Bronze			2019-04-02	
J	Janssens, B; van Herp, M; Goubert, L; Chan, S; Uong, S; Nong, S; Socheat, D; Brockman, A; Ashley, EA; Van Damme, W				Janssens, B.; van Herp, M.; Goubert, L.; Chan, S.; Uong, S.; Nong, S.; Socheat, D.; Brockman, A.; Ashley, E. A.; Van Damme, W.			A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						efficacy; tolerability; dihydroartemisinin-piperaquine; falciparum malaria	PLASMODIUM-FALCIPARUM; MEFLOQUINE RESISTANCE; ARTESUNATE-MEFLOQUINE; THAILAND; COMBINATION	Objectives To compare the efficacy and tolerability of dihydroartemisinin-piperaquine (DHA-PQP) with that of a 3-day regimen of mefloquine and artesunate (MAS3) for the treatment of uncomplicated falciparum malaria in Cambodia. Method Randomized open-label non-inferiority study over 64 days. Results Four hundred and sixty-four patients were included in the study. The polymerase chain reaction genotyping-adjusted cure rates on day 63 were 97.5% (95% confidence interval, CI, 93.8-99.3) for DHA-PQP and 97.5% (95% CI, 93.8-99.3) for MAS3, P = 1. There were no serious adverse events, but significantly more episodes of vomiting (P = 0.03), dizziness (P = 0.002), palpitations (P = 0.04), and sleep disorders (P = 0.03) reported in the MAS3 treatment group, consistent with the side-effect profile of mefloquine. Conclusions DHA-PQP was as efficacious as MAS3, but much better tolerated, making it more appropriate for use in a routine programme setting. This highly efficacious, safe and more affordable fixed-dose combination could become the treatment of choice for Plasmodium falciparum malaria in Cambodia.	Med Sans Frontieres, Phnom Penh, Cambodia; Operat Ctr Brussels, Med Sans Frontieres, Brussels, Belgium; Inst Trop Med, B-2000 Antwerp, Belgium; Natl Ctr Paratisiol Entomol & Malaria Control, Minist Hlth, Phnom Penh, Cambodia; Shoklo Malaria Res Unit, Mae Sot, Thailand; Menizies Sch Hlth Res, Casuarina, Australia	Janssens, B (reprint author), Grotebeerstr 52, B-2018 Antwerp, Belgium.	b.janssens@bigfoot.com	Van Damme, Wim/F-7404-2011				Ashley EA, 2005, CLIN INFECT DIS, V41, P425, DOI 10.1086/432011; Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Chatterjee P, 2005, LANCET, V366, P191, DOI 10.1016/S0140-6736(05)66890-0; Denis MB, 2002, CLIN INFECT DIS, V35, P1469, DOI 10.1086/344647; Ezedinachi ENU, 1999, AM J TROP MED HYG, V61, P114, DOI 10.4269/ajtmh.1999.61.114; Karunajeewa H, 2004, BRIT J CLIN PHARMACO, V57, P93, DOI 10.1046/j.1365-2125.2003.01962.x; Krudsood S, 2002, AM J TROP MED HYG, V67, P465, DOI 10.4269/ajtmh.2002.67.465; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; terKuile FO, 1995, B WORLD HEALTH ORGAN, V73, P631; Tran Tinh Hien, 2004, Lancet (North American Edition), V363, P18; *WHO, 2006, WHOHTMMAL20061108; *WHO, 2003, POS WHOS ROLL BACK M; Yeung S, 2004, AM J TROP MED HYG, V71, P179, DOI 10.4269/ajtmh.2004.71.179	18	46	48	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2007	12	2					251	259		10.1111/j.1365-3165.2006.01786.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	132KQ	WOS:000243942100013	17300633				2019-04-02	
J	Vanlerberghe, V; Diap, G; Guerin, PJ; Meheus, F; Gerstl, S; Van der Stuyft, P; Boelaert, M				Vanlerberghe, V.; Diap, G.; Guerin, P. J.; Meheus, F.; Gerstl, S.; Van der Stuyft, P.; Boelaert, M.			Drug policy for visceral leishmaniasis: a cost-effectiveness analysis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						visceral leishmaniasis; drug policy; cost-effectiveness analysis	LIPOSOMAL AMPHOTERICIN-B; PLUS SODIUM STIBOGLUCONATE; ORAL MILTEFOSINE; KALA-AZAR; PAROMOMYCIN AMINOSIDINE; MEGLUMINE ANTIMONIATE; NEGLECTED DISEASES; INFECTED PATIENTS; DIAGNOSTIC-TESTS; RANDOMIZED-TRIAL	Objectives To facilitate the choice of the best visceral leishmaniasis (VL) treatment strategy for first-line health services in (VL)-endemic areas, we compared in a formal decision analysis the cost and the cost-effectiveness of the different available options. Method We selected four drug regimens for VL on the basis of frequency of use, feasibility and reported efficacy studies. The point estimates and the range of plausible values of effectiveness and cost were retrieved from a literature review. A decision tree was constructed and the strategy minimizing the cost per death averted was selected. Results Treatment with amphotericin B deoxycholate was the most effective approach in the baseline analysis and averted 87.2% of all deaths attributable to VL. The least expensive and the most cost-effective treatment was the miltefosine regimen, and the most expensive and the least cost-effective was AmBisome((R)) treatment. The cost of drug and medical care are the main determinants of the cost-effectiveness ranking of the alternative schemes. Sensitivity analysis showed that antimonial was competitive with miltefosine in the low-resistance regions. Conclusions In areas with > 94% response rates to antimonials, generic sodium stibogluconate remains the most cost-effective option for VL treatment, mainly due to low drug cost. In other regions, miltefosine is the most cost-effective option of treatment, but its use as a first-line drug is limited by its teratogenicity and rapid resistance development. AmBisome in mono- or combination therapy is too expensive to compete in cost-effectiveness with the other regimens.	Inst Trop Med Prince Leopold, Epidemiol & Dis Unit, B-2000 Antwerp, Belgium; Medecins Sans Frontieres, Campaign Access Essential Med, Geneva, Switzerland; EPICTR, Paris, France; Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands	Vanlerberghe, V (reprint author), Inst Trop Med Prince Leopold, Epidemiol & Dis Unit, Natl Str 155, B-2000 Antwerp, Belgium.	vvanlerberghe@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Guerin, Philippe/0000-0002-6008-2963			Adhikari SR, 2003, ACTA TROP, V88, P1, DOI 10.1016/S0001-706X(03)00156-6; ALI A, 1994, ANN TROP MED PARASIT, V88, P43, DOI 10.1080/00034983.1994.11812833; Berman JD, 1998, B WORLD HEALTH ORGAN, V76, P25; Bhattacharya SK, 2004, CLIN INFECT DIS, V38, P217, DOI 10.1086/380638; Boelaert M, 2004, AM J TROP MED HYG, V70, P72, DOI 10.4269/ajtmh.2004.70.72; Boelaert M, 2002, TROP MED INT HEALTH, V7, P955, DOI 10.1046/j.1365-3156.2002.00959.x; Boelaert M, 1999, B WORLD HEALTH ORGAN, V77, P667; Boelaert M, 2000, T ROY SOC TROP MED H, V94, P465, DOI 10.1016/S0035-9203(00)90055-5; Bryceson A, 2001, TROP MED INT HEALTH, V6, P928, DOI 10.1046/j.1365-3156.2001.00795.x; Chappuis F, 2006, TROP MED INT HEALTH, V11, P31, DOI 10.1111/j.1365-3156.2005.01533.x; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2001, TROP MED INT HEALTH, V6, P899, DOI 10.1046/j.1365-3156.2001.00754.x; Delgado J, 1999, AM J TROP MED HYG, V61, P766, DOI 10.4269/ajtmh.1999.61.766; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; GASSER RA, 1994, CLIN INFECT DIS, V18, P83, DOI 10.1093/clinids/18.1.83; Ghislain Pierre-Dominique, 2002, Dermatol Online J, V8, P5; Griekspoor A, 1999, HEALTH POLICY PLANN, V14, P70, DOI 10.1093/heapol/14.1.70; Jha TK, 1998, BRIT MED J, V316, P1200, DOI 10.1136/bmj.316.7139.1200; Laguna F, 2003, ANN TROP MED PARASIT, V97, P135, DOI 10.1179/000349803225002606; Laguna F, 1999, AIDS, V13, P1063, DOI 10.1097/00002030-199906180-00009; Meyerhoff A, 1999, CLIN INFECT DIS, V28, P42, DOI 10.1086/515085; Morel CM, 2003, EMBO REP, V4, pS35, DOI 10.1038/sj.embor.embor851; Murray  H W, 2000, Int J Infect Dis, V4, P158, DOI 10.1016/S1201-9712(00)90078-X; Murray HW, 2001, ANTIMICROB AGENTS CH, V45, P2185, DOI 10.1128/AAC.45.8.2185-2197.2001; Olliaro PL, 2005, LANCET INFECT DIS, V5, P763, DOI 10.1016/S1473-3099(05)70296-6; Pagliano P, 2003, J ANTIMICROB CHEMOTH, V52, P264, DOI 10.1093/jac/dkg340; Rijal S, 2003, T ROY SOC TROP MED H, V97, P597, DOI 10.1016/S0035-9203(03)80043-3; Ritmeijer K, 2001, T ROY SOC TROP MED H, V95, P668, DOI 10.1016/S0035-9203(01)90110-5; SCHAEFER KU, 1995, T ROY SOC TROP MED H, V89, P471, DOI 10.1016/0035-9203(95)90070-5; SCHOPF E, 1991, ARCH DERMATOL, V127, P839, DOI 10.1001/archderm.127.6.839; SEAMAN J, 1993, J INFECT DIS, V168, P715, DOI 10.1093/infdis/168.3.715; Sindermann H, 2004, CLIN INFECT DIS, V39, P1520, DOI 10.1086/425359; Singh S, 2000, Int J Infect Dis, V4, P203, DOI 10.1016/S1201-9712(00)90110-3; Sundar S, 1998, LANCET, V352, P1821, DOI 10.1016/S0140-6736(98)04367-0; Sundar S, 1998, AM J TROP MED HYG, V59, P139, DOI 10.4269/ajtmh.1998.59.139; Sundar S, 2004, CLIN INFECT DIS, V38, P377, DOI 10.1086/380971; Sundar S, 2003, PEDIATR INFECT DIS J, V22, P434; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2002, AM J TROP MED HYG, V66, P143, DOI 10.4269/ajtmh.2002.66.143; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2001, BRIT MED J, V323, P419, DOI 10.1136/bmj.323.7310.419; Sundar S, 1997, ANN INTERN MED, V127, P133, DOI 10.7326/0003-4819-127-2-199707150-00007; Sundar S, 2000, T ROY SOC TROP MED H, V94, P200, DOI 10.1016/S0035-9203(00)90277-3; Sundar S, 1998, ANN TROP MED PARASIT, V92, P755; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Syriopoulou V, 2003, CLIN INFECT DIS, V36, P560, DOI 10.1086/367843; Thakur CP, 2000, T ROY SOC TROP MED H, V94, P429, DOI 10.1016/S0035-9203(00)90130-5; Thakur CP, 2000, T ROY SOC TROP MED H, V94, P432, DOI 10.1016/S0035-9203(00)90131-7; Thakur CP, 1998, ANN TROP MED PARASIT, V92, P561, DOI 10.1080/00034983.1998.11813313; Thakur CP, 2000, T ROY SOC TROP MED H, V94, P156, DOI 10.1016/S0035-9203(00)90255-4; Thakur CP, 2004, ANN TROP MED PARASIT, V98, P129, DOI 10.1179/000349804225003154; Thakur CP, 1999, T ROY SOC TROP MED H, V93, P319, DOI 10.1016/S0035-9203(99)90037-8; *UNDP WORLD BANK W, 1997, 102 UNDP WORLD BANKW; Veeken H, 2000, TROP MED INT HEALTH, V5, P312, DOI 10.1046/j.1365-3156.2000.00555.x; Weinstein M, 1980, CLIN DECISION ANAL; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176; Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	58	37	39	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2007	12	2					274	283		10.1111/j.1365-3156.2006.01782.x				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	132KQ	WOS:000243942100016	17300636	Bronze			2019-04-02	
J	Sundar, S; Singh, RK; Bimal, SK; Gidwani, K; Mishra, A; Maurya, R; Singh, SK; Manandhar, KD; Boelaert, M; Rai, M				Sundar, S.; Singh, R. K.; Bimal, S. K.; Gidwani, K.; Mishra, A.; Maurya, R.; Singh, S. K.; Manandhar, K. D.; Boelaert, M.; Rai, M.			Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						visceral leishmaniasis; direct agglutination test; rK-39 strip test; rK-26 strip test; KAtex; diagnostic accuracy	DIRECT AGGLUTINATION-TEST; KALA-AZAR; FIELD DIAGNOSIS; STRIP TEST; ASPIRATION; ANTIGENS; DONOVANI; SUDAN	In this phase III trial for diagnostics for visceral leishmaniasis (VL) in India, we compared parasitological diagnosis with several serological tests: direct agglutination test (freeze dried; DAT-FD), rK-39 strip test, rK-26 strip test and a latex agglutination test for antigen detection in urine (KAtex) in 452 subjects from the endemic regions of Bihar, India. The subjects were segregated into four categories: 230 confirmed patients, 52 probable cases, 70 non-cases and 100 healthy endemic controls. The first two groups were used for estimating sensitivity, the latter two for specificity. Sensitivity of DAT-FD was 98.9%, rK-39: 98.9%, KAtex: 67.0% and rK-26: 21.3%. Sensitivity of DAT-FD on blood taken on filter paper (DAT-FDF) was 99.3%, which was comparable with that using serum. Specificity of serological tests was comparable and high (DAT-FD and DAT-FDF: 94%, rK-39 strip test: 97%, KAtex: 99% and rK-26 strip test: 100%). The classical 'gold standard' parasitological demonstration in splenic smear performed poorly as it missed 18.4% of cases that benefited from VL treatment. Reproducibility of the serological tests between field and central laboratories was excellent (kappa = 1.0, 0.99, 0.96 and 0.94 respectively for microscopy, DAT-FD, rK-39 strip test and rK-26 strip test). A high degree of agreement was observed between DAT-FD and rK-39 strip test (kappa = 0.986). Although DAT-FD and rK-39 strip test were highly sensitive with excellent specificity, the ease of use of the latter makes it most suitable for the diagnosis of VL in the field conditions.	Banaras Hindu Univ, Inst Med Sci, Infect Dis Res Lab, Varanasi 221005, Uttar Pradesh, India; Rajendra Mem Res Inst Med Sci, Patna, Bihar, India; Inst Trop Med, B-2000 Antwerp, Belgium	Sundar, S (reprint author), 6 SK Gupra Nagra, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Maurya, Radheshyam/0000-0003-3157-7147			Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Attar ZJ, 2001, ACTA TROP, V78, P11, DOI 10.1016/S0001-706X(00)00155-8; Bhatia A, 1999, MOL BIOCHEM PARASIT, V102, P249, DOI 10.1016/S0166-6851(99)00098-5; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Gatti S, 2004, ANN TROP MED PARASIT, V98, P667, DOI 10.1179/000349804225011488; Goswami R P, 2003, J Assoc Physicians India, V51, P759; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Hailu A, 2002, ANN TROP MED PARASIT, V96, P25, DOI 10.1179/000349802125000475; HAQUE I, 1993, ACTA CYTOL, V37, P73; Hommel M, 2001, Med Trop (Mars), V61, P503; LANDIS JR, 1977, BIOMETRICS, V33, P174; LIGHTNER LK, 1983, AM J TROP MED HYG, V32, P296, DOI 10.4269/ajtmh.1983.32.296; MEREDITH SEO, 1995, J CLIN MICROBIOL, V33, P1742; Rijal S, 2004, TROP MED INT HEALTH, V9, P724, DOI 10.1111/j.1365-3156.2004.01251.x; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; Sundar S, 2006, J CLIN MICROBIOL, V44, P251, DOI 10.1128/JCM.44.1.251-253.2006; Sundar S, 1998, LANCET, V352, P1821, DOI 10.1016/S0140-6736(98)04367-0; Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002; Sundar S, 1991, J Assoc Physicians India, V39, P651; SUNDAR S, 2006, J ROYAL SOC TROPICAL, V100, P533; Veeken H, 2003, TROP MED INT HEALTH, V8, P164, DOI 10.1046/j.1365-3156.2003.00996.x; Zhou X-H, 2002, STAT METHODS DIAGNOS; ZIJLSTRA EE, 1992, T ROY SOC TROP MED H, V86, P505, DOI 10.1016/0035-9203(92)90086-R; ZIJLSTRA EE, 1991, T ROY SOC TROP MED H, V85, P474, DOI 10.1016/0035-9203(91)90224-M	25	48	49	0	6	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2007	12	2					284	289		10.1111/j.1356-3156.2006.01775.x				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	132KQ	WOS:000243942100017	17300637				2019-04-02	
J	Robays, J; Lefevre, P; Lutumba, P; Lubanza, S; Mesu, VKBK; Van der Stuyft, P; Boelaert, M				Robays, J.; Lefevre, P.; Lutumba, P.; Lubanza, S.; Mesu, V. Kande Betu Ku; Van der Stuyft, P.; Boelaert, M.			Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Human African Trypanosomiasis; accessibility; acceptability; community participation; perception; T.b. gambiense; Democratic Republic of Congo	SLEEPING-SICKNESS; TSETSE CONTROL; HEALTH-CARE; UGANDA; TRYPANOSOMIASIS; GAMBIENSE; RECOVERY; SERVICES; DISTRICT; AFRICA	Introduction Active case-finding programmes by mobile teams are the cornerstone of West African Human African Trypanosomiasis (HAT) control. Low attendance rates of screening and low uptake of treatment after diagnosis are major problems. The objectives of this survey were to explore community perception of HAT, to assess acceptability of control activities and to identify barriers amenable to intervention. Methods In September 2004, we conducted 33 focus group discussions with beneficiaries of the HAT control programme among various ethnic groups in two ecological settings (savannah and fluvial) of the Democratic Republic of Congo. Results The population had a very detailed knowledge and understanding of HAT transmission, utility of screening, symptoms and treatment. Melarsoprol treatment was feared for its side effects. The sudden death of previously asymptomatic people during treatment was attributed to witchcraft, to which one becomes more vulnerable when the diagnosis is disclosed in public. Lack of confidentiality was also a problem because HAT carries a stigma as a mental disease. Lumbar punctures, especially when performed in public, were disliked but less feared. Financial barriers were a major obstacle for many patients. Conclusions Less toxic drugs, lowering financial barriers and improving confidentiality would have considerable impact on the participation in population screening for HAT.	Inst Trop Med, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; Programme Natl Lutte Contre Trypanosomiase Humain, Kinshasa, Zaire; Univ Kinshasa, Kinshasa, Zaire	Robays, J (reprint author), Inst Trop Med, Epidemiol & Dis Control Unit, Natl Str 155, B-2000 Antwerp, Belgium.	jrobays@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776			[Anonymous], 1998, WHO TECH REP SER, V881, P1; BURKE J, 1971, Annales des Societes Belges de Medecine Tropicale de Parasitologie et de Mycologie, V51, P465; BURRI C, 2003, MANSONS TROPICAL DIS, P1303; Dawson S, 1993, MANUAL USE FOCUS GRO; Gilson L, 1997, HEALTH POLICY PLANN, V12, P273; Gouteux J P, 1987, Med Trop (Mars), V47, P61; Gouteux J P, 1985, Med Trop (Mars), V45, P259; HAGENBUCHERSACR.F, 1981, CAH ORSTOM SER SCI H, V18, P445; HAGENBUCHERSACR.F, 1983, CAHIERS ORSTOM SCI H, V19, P203; Krueger R.A., 2000, FOCUS GROUPS PRACTIC; LEYGUES M, 1989, SOC SCI MED, V28, P1255, DOI 10.1016/0277-9536(89)90344-4; Lutumba P, 2005, EMERG INFECT DIS, V11, P1382; LUTUMBA P, 2005, UNPUB IMPACT HUMAN A; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Merton R. K., 1956, FOCUSED INTERVIEW MA; Meuwissen LE, 2002, HEALTH POLICY PLANN, V17, P304, DOI 10.1093/heapol/17.3.304; Moore A, 1999, AM J TROP MED HYG, V61, P315, DOI 10.4269/ajtmh.1999.61.315; Moore A, 2001, TROP MED INT HEALTH, V6, P342, DOI 10.1046/j.1365-3156.2001.00714.x; Nabyonga J, 2005, HEALTH POLICY PLANN, V20, P100, DOI 10.1093/heapol/czi012; Odiit M, 2004, ANN TROP MED PARASIT, V98, P339, DOI 10.1179/000349804225003389; OKOTH JO, 1991, ANN TROP MED PARASIT, V85, P315, DOI 10.1080/00034983.1991.11812567; PAQUET C, 1995, B SOC PATHOL EXOT, V88, P38; Ridde V, 2003, B WORLD HEALTH ORGAN, V81, P532; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; TEMPELS, 1945, BANTOE FILOSOFIE; Wilkinson D, 2001, B WORLD HEALTH ORGAN, V79, P665	26	31	31	0	9	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2007	12	2					290	298		10.1111/j.1365-3165.2006.01768.x				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	132KQ	WOS:000243942100018	17300638				2019-04-02	
J	Agha, S; Van Rossem, R; Stallworthy, G; Kusanthan, T				Agha, Sohail; Van Rossem, Ronan; Stallworthy, Guy; Kusanthan, Thankian			The impact of a hybrid social marketing intervention on inequities in access, ownership and use of insecticide-treated nets	MALARIA JOURNAL			English	Article							MOSQUITO NETS; MALARIA; INEQUALITIES; DISTRICT; MALAWI; KENYA	Background: An ITN intervention was initiated in three predominantly rural districts of Eastern Province, Zambia, that lacked commercial distribution and communication infrastructures. Social marketing techniques were used for product and message development. Public sector clinics and village-based volunteers promoted and distributed subsidized ITNs priced at $2.5 per net. A study was conducted to assess the effects of the intervention on inequities in knowledge, access, ownership and use of ITNs. Methods: A post-test only quasi-experimental study design was used to compare intervention and comparison districts. A total of 2,986 respondents were interviewed. Survey respondents were grouped into four socio-economic (SES) categories: low, medium-low, medium and high. Knowledge, access, ownership and use indicators are compared. Concentration index scores are calculated. Interactions between intervention status and SES help determine how different SES groups benefited from the intervention. Results: Although overall use of nets remained relatively low, post-test data show that knowledge, access, ownership and use of mosquito nets was higher in intervention districts. A decline in SES inequity in access to nets occurred in intervention districts, resulting from a disproportionately greater increase in access among the low SES group. Declines in SES inequities in net ownership and use of nets were associated with the intervention. The largest increases in net ownership and use occurred among medium and high SES categories. Conclusion: Increasing access to nets among the poorest respondents in rural areas may not lead to increases in net use unless the price of nets is no longer a barrier to their purchase.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, New Orleans, LA 70118 USA; Univ Ghent, Dept Sociol, B-9000 Ghent, Belgium; PSI Myanmar, Kamaryut Township Yangon, Myanmar; Univ Zambia, Dept Gender Studies, Lusaka, Zambia	Agha, S (reprint author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, New Orleans, LA 70118 USA.	sagha@tulane.edu; Ronan.VanRossem@UGent.be; guy@psimyanmar.org.mm; kusanth@sfh.org.zm					Baume C, 2000, SOC SCI MED, V51, P1491, DOI 10.1016/S0277-9536(00)00049-6; *CENTR STAT OFF, 2001, 2000 CENS POP HOUS R; Central Statistical Office [Zambia] MoHZ and Macro International Inc, 1997, ZAMB DEM HLTH SURV 1; Holtz TH, 2002, TROP MED INT HEALTH, V7, P220, DOI 10.1046/j.1365-3156.2002.00846.x; Kolaczinski J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-37; KORENROMP LE, 2003, TROP MED INT HEALTH, V8, P693; *NAT MAL CONTR CTR, 2000, MAL ZAMB SIT AN; *NAT STAT OFF ORC, 2001, MAL DEM HLTH SURV 20; *NAT STAT OFF ORC, 2005, MAL DEM HLTH SURV 20; Nathan R, 2004, TROP MED INT HEALTH, V9, P1121, DOI 10.1111/j.1365-3156.2004.01309.x; Noor AM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-5; Onwujekwe O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-62; Onwujekwe O, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-6; SHELLEY K, 1998, FORMATIVE RES MALARI; Snow RW, 1999, HEALTH POLICY PLANN, V14, P18, DOI 10.1093/heapol/14.1.18; Stevens W, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-22; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Worrall E, 2005, TROP MED INT HEALTH, V10, P19, DOI 10.1111/j.1365-3156.2004.01355.x; WORRALL E, 2002, TROP MED INT HEALTH, V10, P1047	19	16	16	2	8	BIOMED CENTRAL LTD	LONDON	MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 29	2007	6								13	10.1186/1475-2875-6-13				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	133NZ	WOS:000244020900001	17261185	DOAJ Gold, Green Published			2019-04-02	
J	Atemnkeng, MA; De Cock, K; Plaizier-Vercammen, J				Atemnkeng, Magnus A.; De Cock, Katelijne; Plaizier-Vercammen, Jacqueline			Post-marketing assessment of content and efficacy of preservatives in artemisinin-derived antimalarial dry suspensions for paediatric use	MALARIA JOURNAL			English	Article							SAFETY	Background: Artemisinin-derivative formulations are now widely used to treat falciparum malaria. However, the dry powder suspensions developed for children are few and/or are of poor quality. In addition to the active compound, the presence of a suitable preservative in these medicines is essential. In this study, an evaluation of the preservative content and efficacy in some dry suspensions available on the Kenyan market was performed. Method: UV spectrophotometry was used to identify the preservatives in each sample while HPLC-UV was used for quantification. After reconstitution of the powders in water, the dissolution of the preservatives was followed for 7 days. Antimicrobial efficacy of the preservatives was assessed by conducting a preservative efficacy test ( PET) following the European pharmacopoeia standards. Results: Four different preservatives were identified namely methylparahydroxybenzoate ( MP), propylparahydroxybenzoate ( PP), benzoic acid and sorbic acid. MP and PP were identified in Artesiane(R) ( artemether 300 mg/100 ml), Alaxin(R) ( dihydroartemisinin 160 mg/80 ml) andGvither(R) ( artemether 300 mg/100 ml) respectively. Sorbic acid was presentin Artenam(R) ( artemether 180 mg/60 ml) while benzoic acid was identified in Santecxin(R) ( dihydroartemisinin 160 mg/80 ml) andArtexin(R) ( dihydroartemisinin 160 mg/80 ml) respectively. Cotecxin(R) ( dihydroartemisinin 160 mg/80 ml) did not contain any of the above preservatives. After reconstitution in water, preservativesin 50%(3/6) of the products did not completely dissolve and the PET results revealed that only Artenam(R) and Gvither(R) met the requirements for antimicrobial efficacy. The other products did not conform. Conclusion: These results show that paediatric antimalarial dry powder formulations on the market may contain ineffective or incorrect amounts of preservatives. This is a potential risk to the patient. Studies conducted on the dry powder suspensions should include the analysis of both the active ingredient and the preservative, including the efficacy of the latter.	Vrije Univ Brussels, Dept Pharmaceut Technol & Phys Pharm, Fac Med & Pharm, B-1090 Brussels, Belgium	Plaizier-Vercammen, J (reprint author), Vrije Univ Brussels, Dept Pharmaceut Technol & Phys Pharm, Fac Med & Pharm, Laarbeeklaan 103, B-1090 Brussels, Belgium.	matemnke@vub.ac.be; kdecock@vub.ac.be; jplaizie@vub.ac.be					ANGER CB, 1996, PHARM DOSAGE FORMS, V2, P377; Atemnkeng MA, 2007, TROP MED INT HEALTH, V12, P68, DOI 10.1111/j.1365-3156.2006.01769.x; *EUR DIR QUAL MED, 2003, EUR PHARM, V4; Haines A, 1997, BRIT MED J, V314, P529, DOI 10.1136/bmj.314.7080.529; *INT COMM HARM, 1992, 75318EEC INT COMM HA; Klocker N, 2004, EUR J PHARM BIOPHARM, V57, P489, DOI 10.1016/j.ejpb.2003.12.005; Koundourellis JE, 2000, J PHARMACEUT BIOMED, V23, P469, DOI 10.1016/S0731-7085(00)00318-6; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; Martin A, 1983, PHYS PHARM PHYS CHEM; MARTINDALE, 1999, COMPL DRUG REF; Newton PN, 2003, LANCET, V362, P169, DOI 10.1016/S0140-6736(03)13872-X; OFNER CM, 1996, PHARM DOSAGE FORMS, V2, P243; Rowe RC, 2005, HDB PHARM EXCIPIENTS; *SOC JAP PHARM, 1984, JAP STAND COSM INGR; Soni MG, 2001, FOOD CHEM TOXICOL, V39, P513, DOI 10.1016/S0278-6915(00)00162-9; Van der Meersch H, 2005, J Pharm Belg, V60, P23; WILSON LA, 1971, AM J OPHTHALMOL, V71, P1298, DOI 10.1016/0002-9394(71)90979-2	17	8	8	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 26	2007	6								12	10.1186/1475-2875-6-12				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	138JU	WOS:000244359700002	17257400	DOAJ Gold, Green Published			2019-04-02	
J	Walsh, DS; Dela Cruz, EC; Abalos, RM; Tan, EV; Walsh, GP; Portaels, F; Meyers, WM				Walsh, Douglas S.; Dela Cruz, Eduardo C.; Abalos, Rodolfo M.; Tan, Esterlina V.; Walsh, Gerald P.; Portaels, Francoise; Meyers, Wayne M.			Short report: Clinical and histologic features of skin lesions in a cynomolgus monkey experimentally infected with Mycobacterium ulcerans (Buruli ulcer) by intradermal inoculation	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							MYCOLACTONES; APOPTOSIS; DISEASE; TOXIN; MODEL	Buruli ulcer, caused by Mycobacterium ulcerans, is a destructive infection that most commonly affects the skin. Animal models for Buruli ulcer include guinea pigs, rats, mice, and armadillos, but each is limited in replicating the spectrum of human disease. Here, a cynomolgus monkey was infected with two concentrations of M. ulcerans (1.0 and 2.2 x 10(8)) by intradermal inoculation, 3 months apart. All injection sites developed papules that progressed to ulcers with undermined borders within 2-4 weeks. The rate of progression and size of the ulcers were proportional to the numbers of organisms inoculated. Biopsies from ulcer edges showed ulceration, robust inflammatory cell infiltrates, granulomatous-like responses, mild edema, and extracellular acid-fast bacilli. The ulcers healed spontaneously between Weeks 8 and 12, with no signs of systemic infection. This report, the first to describe a non-human primate experimentally infected with M. ulcerans, suggests that cynomolgus monkeys are modestly susceptible and develop some of the clinical and histologic features of Buruli ulcer.	AFRIMS, USA Med Component, Dept Immunol & Med, Bangkok, Thailand; Mycobacteriol Unit, Inst Trop Med, Antwerp, Belgium; Leonard Wood Mem Ctr Leprosy Res, Cebu, Philippines; Armed Forces Inst Pathol, Dept Environm & Infect Dis Sci, Washington, DC 20306 USA	Walsh, DS (reprint author), USAMRUK, Unit 64109, APO, AE USA.	dwalsh@wrp-ksm.org; lwmrectr@cvis.net.ph; portaels@itg.be; wmekmeyers@comcast.com					George KM, 2000, INFECT IMMUN, V68, P877, DOI 10.1128/IAI.68.2.877-883.2000; Guarner J, 2003, EMERG INFECT DIS, V9, P651; KRIEG RE, 1974, ARCH DERMATOL, V110, P783, DOI 10.1001/archderm.110.5.783; Mve-Obiang A, 2003, INFECT IMMUN, V71, P774, DOI 10.1128/IAI.71.2.774-783.2003; PATTYN S R, 1965, Ann Soc Belges Med Trop Parasitol Mycol, V45, P31; READ JK, 1974, INFECT IMMUN, V9, P1114; SINGH NB, 1984, INDIAN J EXP BIOL, V22, P393; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; Stinear T, 1999, J CLIN MICROBIOL, V37, P1018; van der Werf TS, 2003, LANCET, V362, P1062, DOI 10.1016/S0140-6736(03)14417-0; Walsh DS, 2005, AM J TROP MED HYG, V73, P410, DOI 10.4269/ajtmh.2005.73.410; Walsh DS, 1999, AM J TROP MED HYG, V61, P694, DOI 10.4269/ajtmh.1999.61.694; Walsh GP, 1996, NAT MED, V2, P430, DOI 10.1038/nm0496-430; Wansbrough-Jones M, 2006, LANCET, V367, P1849, DOI 10.1016/S0140-6736(06)68807-7; World Health Organization, 2004, PROV GUID ROL SPEC A	15	10	10	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JAN	2007	76	1					132	134		10.4269/ajtmh.2007.76.132				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	127GP	WOS:000243573800022	17255241				2019-04-02	
J	Toledo, ME; Vanlerberghe, V; Baly, A; Ceballos, E; Valdes, L; Searret, M; Boelaert, M; Van der Stuyft, P				Toledo, M. E.; Vanlerberghe, V.; Baly, A.; Ceballos, E.; Valdes, L.; Searret, M.; Boelaert, M.; Van der Stuyft, P.			Towards active community participation in dengue vector control: results from action research in Santiago de Cuba, Cuba	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						dengue; Aedes aegypti; vector control; prevention; community participation; Cuba	AEDES-AEGYPTI CONTROL; HEMORRHAGIC-FEVER; CONTROL PROGRAM; PREVENTION; EPIDEMIC; LESSONS; HEALTH; INTERVENTION; KNOWLEDGE; DISEASE	Community participation is advocated as essential for attaining effective dengue prevention, but knowledge of how to foster this is limited. In Santiago de Cuba, multiple small. task forces were created at the neighbourhood level that included all. stakeholders in the control of Aedes aegypti. The task forces assessed the perceived needs and elaborated action plans to promote specific behavioural change and to reduce environmental risks through social communication strategies and intersectoral local government activities. We monitored five dimensions of the participation process and assessed behavioural and environmental results and entomological outcomes. Participation was weak to good. At the household Level, uncovered water storage containers decreased from 49.3% to 2.6% between 2000 and 2002, and removing larvicide from them dropped from 45.5% to 1%. There was a reduction of 75% in the absolute number of positive containers and a significant decrease from 1.23% to 0.35% in the house index. Local task forces, in which the interests of householders as well as vector control workers are directly represented, can lead to effective government-community partnerships that resolve problems of mutual concern. (C) 2006 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	Inst Med Trop Pedro Kouri, Dept Epidemiol, Havana, Cuba; Inst Trop Med, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; Unidad Prov Vigilancia & Lucha Antivectorial, Santiago De Cuba, Cuba	Toledo, ME (reprint author), Inst Med Trop Pedro Kouri, Dept Epidemiol, Autopista Novia Mediodia Km 6 1-2 La Lisa, Havana, Cuba.	mariaeugeniatoledo@yahoo.es	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776			BOS R, 1988, PARASITOL TODAY, V4, P295, DOI 10.1016/0169-4758(88)90029-4; BRYAN RT, 1994, AM J TROP MED HYG, V50, P61, DOI 10.4269/ajtmh.1994.50.61; Chan AST, 1998, ANN TROP MED PARASIT, V92, P317, DOI 10.1080/00034983.1998.11813296; CHIARAVALLOTI NF, 1998, CAD SAUDE PUBLICA S2, V14, P101; de la Cruz A M, 1999, Rev Cubana Med Trop, V51, P135; GUBLER DJ, 1994, AM J TROP MED HYG, V50, P50, DOI 10.4269/ajtmh.1994.50.50; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; KITTAYAPONG P, 1992, P INT C DENG AED AEG, P169; Kouri G, 1998, EMERG INFECT DIS, V4, P89; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Lardeux F, 2002, ANN TROP MED PARASIT, V96, pS105, DOI 10.1179/000349802125002455; LEONTSINI E, 1993, T ROY SOC TROP MED H, V87, P267, DOI 10.1016/0035-9203(93)90120-F; LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635; MCKINLAY JB, 1995, PREPARATION AGING; Parks W., 2004, WHOCDSWMC20042; Patton M. Q., 2001, QUALITATIVE RES EVAL; Pelaez O, 2004, EMERG INFECT DIS, V10, P719, DOI 10.3201/eid1004.030271; Rifkin SB, 1996, ACTA TROP, V61, P79, DOI 10.1016/0001-706X(95)00105-N; RIFKIN SB, 1988, SOC SCI MED, V26, P931, DOI 10.1016/0277-9536(88)90413-3; Rodriguez-Roche R, 2005, EMERG INFECT DIS, V11, P773; ROSENBAUM J, 1995, AM J TROP MED HYG, V53, P111, DOI 10.4269/ajtmh.1995.53.111; Roussos ST, 2000, ANNU REV PUBL HEALTH, V21, P369, DOI 10.1146/annurev.publhealth.21.1.369; Sanchez L, 2005, TROP MED INT HEALTH, V10, P82, DOI 10.1111/j.1365-3156.2004.01347.x; Sorensen G, 1998, ANNU REV PUBL HEALTH, V19, P379, DOI 10.1146/annurev.publhealth.19.1.379; Stemler S, 2001, OVERVIEW CONTENT ANA, V7; Toledo-Romani ME, 2006, SALUD PUBLICA MEXICO, V48, P39, DOI 10.1590/s0036-36342006000100007; Valdés G Luis, 2002, Rev Cubana Med Trop, V54, P220; Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363; World Health Organization, 2000, INF CONS 18 20 OCT 1	32	51	58	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0035-9203			T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JAN	2007	101	1					56	63		10.1016/j.trstmh.2006.03.006				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	115UN	WOS:000242759400008	16824565				2019-04-02	
J	Arendt, V; Mossong, J; Zachariah, R; Inwani, C; Farah, B; Robert, I; Waelbrouck, A; Fonck, K				Arendt, V.; Mossong, J.; Zachariah, R.; Inwani, C.; Farah, B.; Robert, I.; Waelbrouck, A.; Fonck, K.			Clinical screening for HIV in a health centre setting in urban Kenya: an entry point for voluntary counselling, HIV testing and early diagnosis of HIV infection?	TROPICAL DOCTOR			English	Article							TUBERCULOSIS; MORTALITY; TANZANIA; EFFICACY; MALAWI; TRIAL	A study was conducted among patients attending a public health centre in Nairobi, Kenya in order to (a) verify the prevalence of HIV, (b) identify clinical risk factors associated with HIV and W determine clinical markers for clinical screening of HIV infection at the health centre level. Of 304 individuals involved in the study, 107(35%) were HIV positive. A clinical screening algorithm based on four clinical markers, namely oral thrush, past or present TB, past or present herpes zoster and prurigo would pick out 61 (57%) of the 107 HIV-positive individuals. In a resource-poor setting, introducing a clinical screening algorithm for HIV at the health centre level could provide an opportunity for targeting voluntary counselling and HIV testing, and early access to a range of prevention and care interventions.	Lab Natl Sante, L-1011 Luxembourg, Luxembourg; CRP Sante Retrovirol Lab, Luxembourg, Luxembourg; Brussels Operat Ctr, Mission Kenya, Med Sans Frontieres, Brussels, Belgium; Med Sans Frontieres, Med Dept Operat Res, Brussels, Belgium; Univ Ghent, B-9000 Ghent, Belgium; Univ Nairobi, Nairobi, Kenya; Nairobi City Council STD Programme, Nairobi, Kenya	Mossong, J (reprint author), Lab Natl Sante, POB 1102, L-1011 Luxembourg, Luxembourg.	joel.mossong@lns.etat.lu	Mossong, Joel/D-4998-2009	Mossong, Joel/0000-0003-0717-9835			Coates TJ, 2000, LANCET, V356, P103; Lewis DK, 2003, T ROY SOC TROP MED H, V97, P91, DOI 10.1016/S0035-9203(03)90035-6; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; TEMBO G, 1994, AIDS, V8, P1169, DOI 10.1097/00002030-199408000-00021; *UNAIDS, 2000, PROV WHO UNAIDS SECR; *UNAIDS WHO, 1997, WKLY EPIDEMIOL REC, V72, P81; *WHO, 2002, QV2685 WHO; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization & UNAIDS, 1998, WHOTB98255; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/01.aids.0000060355.78202.b7	10	2	2	0	3	ROYAL SOC MEDICINE PRESS LTD	LONDON	1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND	0049-4755			TROP DOCT	Trop. Dr.	JAN	2007	37	1					45	47		10.1258/004947507779951899				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	138EK	WOS:000244345700018	17326892				2019-04-02	
J	Macete, E; Aponte, JJ; Guinovart, C; Sacarlal, J; Ofori-Anyinam, O; Mandomando, I; Espasa, M; Bevilacqua, C; Leach, A; Dubois, MC; Heppner, DG; Tello, L; Milman, J; Cohen, J; Dubovsky, F; Tornieporth, N; Thompson, R; Alonso, PL				Macete, E.; Aponte, J. J.; Guinovart, C.; Sacarlal, J.; Ofori-Anyinam, O.; Mandomando, I.; Espasa, M.; Bevilacqua, C.; Leach, A.; Dubois, M. C.; Heppner, D. G.; Tello, L.; Milman, J.; Cohen, J.; Dubovsky, F.; Tornieporth, N.; Thompson, R.; Alonso, P. L.			Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in Mozambique	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						RTS,S; safety; malaria vaccine	PLASMODIUM-FALCIPARUM MALARIA; CIRCUMSPOROZOITE PROTEIN VACCINE; RANDOMIZED CONTROLLED-TRIAL; EFFICACY; INFECTION; DISEASE; GAMBIA	BACKGROUND The development of a malaria vaccine remains a public health priority for sub-Saharan Africa. RTS,S/AS02A candidate malaria vaccine has been shown to be safe and immunogenic in previous studies in adults and staggered dose-escalation studies in children in The Gambia. However, genetic features and the intensity of malaria transmission may modify the safety and immune response of a vaccine. OBJECTIVE We carried out a phase I, double-blind randomized controlled trial in 60 children aged 1-4 in Mozambique to evaluate the safety, reactogenicity and immunogenicity of the paediatric vaccine dose (fixed 25 mu g RTS,S in 0.25 ml) of RTS,S/AS02A, prior to undertaking a planned larger phase IIb proof-of-concept of efficacy study in the same population. METHOD Children were randomized to receive either RTS,S/AS02A or Engerix-B-(R) vaccine. Monitoring of safety and reactogenicity included detailed clinical and laboratory analyses and assessment of adverse events (AEs). RESULTS The RTS,S/AS02A was found to be safe and well tolerated. Serious adverse events were balanced between both groups and none was related to vaccination. The frequency of adverse events reported with RTS, S/AS02A was comparable to previous studies in children. Grade 3 AEs were infrequent (one case of pain, one of fever in each group and some swelling greater than 20 mm in diameter), transient and resolved without sequelae. RTS,S/AS02A was highly immunogenic for anti-circumsporozoite protein antibody response and induced a strong anti-hepatitis-B surface antigen response.	Univ Barcelona, Hosp Clin Barcelona, Ctr Salud Int, IDIBAPS, E-08036 Barcelona, Spain; CISM, Manhica, Mozambique; Minist Saude, Direccao Nacl Saude, Maputo, Mozambique; Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; GlaxoSmithKline Biol, Rixensart, Belgium; Minist Saude, Inst Nacl Saude, Maputo, Mozambique; Walter Reed Army Inst Res, Silver Spring, MD USA	Alonso, PL (reprint author), Univ Barcelona, Hosp Clin Barcelona, Ctr Salud Int, IDIBAPS, C Villarroel 170, E-08036 Barcelona, Spain.	palonso@clinic.ub.es	ESPASA, MATEU/L-4587-2014	Sacarlal, Jahit/0000-0003-1059-217X			ALONSO P, 2002, POPULATION HLTH DEV, P189; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Doherty JF, 1999, AM J TROP MED HYG, V61, P865, DOI 10.4269/ajtmh.1999.61.865; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; Saute F, 2003, T ROY SOC TROP MED H, V97, P655, DOI 10.1016/S0035-9203(03)80097-4; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657	13	46	48	0	3	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2007	12	1					37	46		10.1111/j.1365-3156.2006.01754.x				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	123LS	WOS:000243298000005	17207146	Bronze			2019-04-02	
J	Atemnkeng, MA; De Cock, K; Plaizier-Vercammen, J				Atemnkeng, Magnus A.; De Cock, Katelijne; Plaizier-Vercammen, Jacqueline			Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						antimalarials; artemisinin derivatives; quality control; counterfeit; reversed-phase HPLC	SOUTHEAST-ASIA; DRUGS; ARTESUNATE; MALARIA; RESISTANCE	OBJECTIVES Artemisinin-derivative drugs are widely used to treat Plasmodium falciparum malaria and very few studies have investigated the quality of these medicines in Africa. We analysed the active ingredient contents of artemisinin-derivative drugs marketed in Kenya and DR Congo. METHODS We analysed tablets, capsules, dry suspensions and injections (IM) containing either artemether (AM), arteether (AE), artesunate (ARS) or dihydroartemisinin (DHA). The content of active ingredients and preservatives was determined quantitatively using validated HPLC-UV methods. All analyses were done according to European pharmacopoeia requirements. RESULTS Labelled active ingredients were identified in all samples, however with varying dosages. Nine of the 24 drug samples analysed did not comply with the pharmacopoeial requirements of 95-105%: seven samples were underdosed and two were slightly overdosed. DHA was the active ingredient in 57% of the underdosed samples. AE injections had the lowest drug content (77%). Two-thirds of the dry powder suspensions were either substandard or fake. Tablets were up to 23% out of range. Unidentified peaks were observed on the chromatograms of AE IM injections and a DHA dry powder. CONCLUSIONS Counterfeit or substandard artemisinin-derivative drugs are being sold in parts of Africa, presenting a potential route for resistance development in the future. Appropriate measures need to be taken to maintain proper and safe use of these medicines.	Vrije Univ Brussels, Dept Pharmaceut Technol & Phys Pharm, B-1090 Brussels, Belgium	Plaizier-Vercammen, J (reprint author), Vrije Univ Brussels, Dept Pharmaceut Technol & Phys Pharm, Laarbeeklaan 103, B-1090 Brussels, Belgium.	jplaizie@vub.ac.be					ABDI YA, 1995, LANCET, V346, P116; Aka E, 2005, BRIT MED J, V331, P358, DOI 10.1136/bmj.331.7512.358; Basco LK, 2004, AM J TROP MED HYG, V70, P245, DOI 10.4269/ajtmh.2004.70.245; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; Green MD, 2001, TROP MED INT HEALTH, V6, P980, DOI 10.1046/j.1365-3156.2001.00793.x; HOGERZEIL HV, 1992, BRIT MED J, V304, P210, DOI 10.1136/bmj.304.6821.210; *INT PHARM, 2003, MON ANT DRUGS WHO, V5, P185; MAPONGA C, 2003, WHOEDMPAR20034; NAVARATMAN V, 2000, CLIN PHARMACOKINET, V39, P254; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2003, LANCET, V362, P169, DOI 10.1016/S0140-6736(03)13872-X; PETRALANDA I, 1995, LANCET, V345, P1433, DOI 10.1016/S0140-6736(95)92620-8; *PH EUR, 2003, EUR PHARM, V4; Price RN, 2001, DRUG RESIST UPDATE, V4, P187, DOI 10.1054/drup.2001.0195; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Rozendaal J, 2001, LANCET, V357, P890, DOI 10.1016/S0140-6736(05)71830-4; Shakoor O, 1997, TROP MED INT HEALTH, V2, P839, DOI 10.1046/j.1365-3156.1997.d01-403.x; Taylor RB, 2001, LANCET, V357, P1933, DOI 10.1016/S0140-6736(00)05065-0; WHITE NJ, 1992, J ANTIMICROB CHEMOTH, V30, P571, DOI 10.1093/jac/30.5.571; 2001, MARKETLETTER, P55604	20	62	62	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2007	12	1					68	74		10.1111/j.1365-3156.2006.01769.x				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	123LS	WOS:000243298000009	17207150	Bronze			2019-04-02	
J	Virreira, M; Seffano, G; Maldonado, L; Svoboda, M				Virreira, Myrna; Seffano, Geovanka; Maldonado, Luis; Svoboda, Michal			Trypanosoma cruzi: Typing of genotype (sub)lineages in megacolon samples from bolivian patients	ACTA TROPICA			English	Article						Trypanosoma cruzi; genotyping; megacolon	POLYMERASE-CHAIN-REACTION; CHAGAS-DISEASE; GENE-SEQUENCES; RIBOSOMAL-RNA; CLONES; IDENTIFICATION; EPIDEMIOLOGY; REGION	Visceral dystrophy, a clinical complication of Chagas' disease, is more frequent in southern cone countries in South America, where Trypanosoma cruzi II (TcII) lineage predominates in human infection. As this major TcII lineage is not homogeneous population and its (sub)lineages are not geographically distributed evenly, therefore, we investigated the possible relationship between parasite (sub)lineages in megacolon patients. We typified the T cruzi lineages and (sub)lineages in megacolon samples from 18 patients using kDNA probes specific of lineage TcI, TcIIb, TcIId and TcIIe. The majority of the samples (16/18) were (sub)lineage TcIId positive. However, two samples were positive for (sub)lineage TcIIb. Two synthetic probes discriminated variants of lineage TeIId. Proportion of TcIId variants encountered were 6/16, 6/16 and 4/16, similar to the distribution of Chagasic populations in Bolivia. Our data suggest that there is no preferential tropism of one particular lineage or variant of T cruzi II in megacolon pathology. (c) 2006 Elsevier B.V. All rights reserved.	Univ Libre Bruxelles, Fac Med, Chim Biol Lab, B-1070 Brussels, Belgium; Univ Mayor San Simon, Fac Med, Cochabamba, Bolivia	Svoboda, M (reprint author), Univ Libre Bruxelles, Fac Med, Chim Biol Lab, 808 Route Lennik,CP611, B-1070 Brussels, Belgium.	msvobod@ulb.ac.be					Andrade LO, 1999, MOL BIOCHEM PARASIT, V100, P163, DOI 10.1016/S0166-6851(99)90035-X; Breniere SF, 2002, MEM I OSWALDO CRUZ, V97, P289, DOI 10.1590/S0074-02762002000300002; BRENIERE SF, 1992, AM J TROP MED HYG, V46, P335, DOI 10.4269/ajtmh.1992.46.335; Brisse S, 2000, MOL BIOCHEM PARASIT, V111, P95, DOI 10.1016/S0166-6851(00)00302-9; Buscaglia CA, 2003, MICROBES INFECT, V5, P419, DOI 10.1016/S1286-4579(03)00050-9; CUTAIT DE, 1991, WORLD J SURG, V15, P188, DOI 10.1007/BF01659052; Da Silveira P.A., 2000, INT J PARASITOL, V30, P843; Kawashita SY, 2001, MOL BIOL EVOL, V18, P2250, DOI 10.1093/oxfordjournals.molbev.a003771; Kirchhoff LV, 1996, J CLIN MICROBIOL, V34, P1171; Lages-Silva E, 2001, AM J TROP MED HYG, V65, P435, DOI 10.4269/ajtmh.2001.65.435; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; MILES MA, 1981, LANCET, V1, P1338; Telleria J, 2006, EXP PARASITOL, V114, P279, DOI 10.1016/j.exppara.2006.04.005; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; VEAS F, 1991, CELL MOL BIOL, V37, P73; Virreira M, 2003, AM J TROP MED HYG, V68, P574, DOI 10.4269/ajtmh.2003.68.574; VIRREIRA M, 2006, IN PRESS AM J TROP M; *WHO, 2002, 905 WHO; Zingales B, 1998, INT J PARASITOL, V28, P105, DOI 10.1016/S0020-7519(97)00178-1	19	24	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X			ACTA TROP	Acta Trop.	DEC	2006	100	3					252	255		10.1016/j.actatropica.2006.11.005				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	141IU	WOS:000244572800013	17157796				2019-04-02	
J	Virreira, M; Martinez, S; Alonso-Vega, C; Torrico, F; Solano, M; Torrico, MC; Parrado, R; Truyens, C; Carlier, Y; Svoboda, M				Virreira, Myrna; Martinez, Sabrina; Alonso-Vega, Cristina; Torrico, Faustino; Solano, Marco; Torrico, Mary Cruz; Parrado, Rudy; Truyens, Carine; Carlier, Yves; Svoboda, Michal			Short report: Amniotic fluid is not useful for diagnosis of congenital Trypanosoma cruzi infection	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							PRENATAL-DIAGNOSIS; PCR	Although Trypanosoma cruzi can be transmitted transplacentally and induce congenital infection, no data are available about the presence of this parasite in human amniotic fluid. We examined 8, 19, and 4 amniotic fluid samples (collected at delivery or by aspiration of gastric content of neonates) from control uninfected mothers (M-B-), infected mothers delivering uninfected newborns (M+B-), and mothers of confirmed congenital cases (M+B+), respectively. Polymerase chain reaction (PCR), using nuclear and kinetoplastic DNA primers (Tcz1-Tcz2 and 121-122), were negative for all control M-B- samples, but positive for 5 of 19 M+B- and 2 of 4 M+B+ samples. To determine the number of parasites in the positive samples, real-time PCR using S35/S36 kinetoplastic DNA was performed. Only one M+B+ sample presented a high parasitic DNA amount, whereas the other six PCR-positive samples displayed traces of T. cruzi DNA. In conclusion, the release of parasites in amniotic fluid is probably a rare event that cannot be helpful for the routine diagnosis of congenital Chagas disease.	Univ Libre Bruxelles, Fac Med, Chim Biol Lab, B-1070 Brussels, Belgium; Univ Mayor San Simon, Fac Med, Cochabamba, Bolivia; Univ Libre Bruxelles, Fac Med, Parasitol Lab, Brussels, Belgium	Svoboda, M (reprint author), Univ Libre Bruxelles, Fac Med, Chim Biol Lab, 808 Route de Lennik,CP 611, B-1070 Brussels, Belgium.	msvobod@ulb.ac.be					Carlier Yves, 2003, Rev. Soc. Bras. Med. Trop., V36, P767, DOI 10.1590/S0037-86822003000600024; Carlier Y, 2002, TRYPANOSOMIASE AM MA; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; Fernandez-Aguilar S, 2005, REV SOC BRAS MED TRO, V38, P84; Mace M, 2004, J CLIN MICROBIOL, V42, P4818, DOI 10.1128/JCM.42.10.4818-4820.2004; McIver CJ, 2005, J CLIN MICROBIOL, V43, P5102, DOI 10.1128/JCM.43.10.5102-5110.2005; Moya P R, 1979, Rev Fac Cien Med Univ Nac Cordoba, V37, P21; Revello MG, 2003, J CLIN MICROBIOL, V41, P1772, DOI 10.1128/JCM.41.4.1772-1774.2003; Thalib L, 2005, BJOG-INT J OBSTET GY, V112, P567, DOI 10.1111/j.1471-0528.2005.00486.x; Torrico F, 2004, AM J TROP MED HYG, V70, P201, DOI 10.4269/ajtmh.2004.70.201; Virreira M, 2003, AM J TROP MED HYG, V68, P574, DOI 10.4269/ajtmh.2003.68.574	11	21	21	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637			AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2006	75	6					1082	1084		10.4269/ajtmh.2006.75.1082				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	117OC	WOS:000242881600011	17172370				2019-04-02	
J	Karema, C; Fanello, CI; Van Overmeir, C; Van Geertruyden, JP; van Doren, W; Ngamije, D; D'Alessandro, U				Karema, Corine; Fanello, Caterina I.; Van Overmeir, Chantal; Van geertruyden, Jean-Pierre; van Doren, Walli; Ngamije, Daniel; D'Alessandro, Umberto			Safety and efficacy of dihydroartemisinin/piperaquine (Artekin (R)) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						malaria; Plasmodium falciparum; piperaquine; amodiaquine; sulfadoxine/pyrimethamine; Rwanda	PIPERAQUINE; AMODIAQUINE; PHARMACOKINETICS; PYRIMETHAMINE; CHLOROQUINE; SULFADOXINE; ARTESUNATE; PLASMA	In Rwanda, amodiaquine + sulfadoxine/pyrimethamine (AQ+SP) is the current first-line treatment for malaria, introduced in 2001 as an interim strategy before the future deployment of an artemisinin-based combination treatment (ACT). Dihydroartemisinin/piperaquine (DHA-PQP) is a new co-formulated and well tolerated ACT increasingly used in Southeast Asia where it has proved to be highly effective against Plasmodium falciparum malaria. We tested the efficacy, safety and tolerability of DHA-PQP in children with uncomplicated P falciparum malaria. A randomised, open trial was carried out in 2003-2004. Seven hundred and sixty-two children aged 12-59 months with uncomplicated P falciparum malaria were randomly allocated to one of the following treatments: amodiaquine+artesunate; AQ+SP; or DHA-PQP. Patients were followed-up until Day 28 after treatment. Adverse events and clinical and parasitological outcomes were recorded. Children treated with DHA-PQP or AQ+AS had a significantly higher cure rate compared with those treated with amodiaquine+sulfadoxine/pyrimethamine (95.2% and 92.0% vs. 84.7%, respectively). Parasite clearance was significantly faster in children treated with DHA-PQP and AQ+AS compared with those treated with amodiaquine+sulfadoxine/pyrimethamine. The frequency of adverse events was significantly lower in patients treated with DHA-PQP than in those treated with combinations containing amodiaquine. A 3-day treatment with DHA-PQP proved to be efficacious with a good safety and tolerability profile and could be a good candidate for the next first-line treatment. (C) 2006 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Natl Malaria Control Program, Kigali, Rwanda; Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; Belgian Tech Cooperat, Kigali, Rwanda	Fanello, CI (reprint author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	caterina.fanello@lshtm.ac.uk	Van geertruyden, Jean-Pierre/K-6425-2014; D'Alessandro, Umberto/D-3457-2015	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; D'Alessandro, Umberto/0000-0001-6341-5009; Fanello, Caterina/0000-0003-1932-9562			Ashley EA, 2005, CLIN INFECT DIS, V41, P425, DOI 10.1086/432011; Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Basco LK, 2003, ANTIMICROB AGENTS CH, V47, P1391, DOI 10.1128/AAC.47.4.1391-1394.2003; Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004; Denis MB, 2002, CLIN INFECT DIS, V35, P1469, DOI 10.1086/344647; Fan Bo, 1998, Chinese Journal of Parasitology & Parasitic Diseases, V16, P460; FANELLO CI, 2006, TROP MED INT HEALTH, V11, P1; Guo X B, 1993, Zhonghua Yi Xue Za Zhi, V73, P602; GUO XB, 1993, ZHONGHUA YI XUE ZA Z, V73, P638; Hien TT, 2004, LANCET, V363, P18, DOI 10.1016/S0140-6736(03)15163-X; Hung TY, 2004, BRIT J CLIN PHARMACO, V57, P253, DOI [10.1046/j.1365-2125.2003.02004.x, 10.1111/j.1365-2125.2003.02004.x]; Hung TY, 2003, J CHROMATOGR B, V791, P93, DOI 10.1016/S1570-0232(03)00209-5; Irion A, 1998, TROP MED INT HEALTH, V3, P490, DOI 10.1046/j.1365-3156.1998.00253.x; Krishna S, 1996, CLIN PHARMACOKINET, V30, P263, DOI 10.2165/00003088-199630040-00002; Rwagacondo CE, 2004, TROP MED INT HEALTH, V9, P1091, DOI 10.1111/j.1365-3156.2004.01316.x; Rwagacondo CE, 2003, AM J TROP MED HYG, V68, P743, DOI 10.4269/ajtmh.2003.68.743; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; WEIDEKAMM E, 1982, B WORLD HEALTH ORGAN, V60, P115; WHO, 2003, ASS MON ANT DRUG EFF; Yang H, 1999, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V17, P43; Yang H, 1995, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V13, P111; Yang H L, 1992, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V10, P198	23	83	84	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	DEC	2006	100	12					1105	1111		10.1016/j.trstmh.2006.01.001				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	105DM	WOS:000242009500003	16766006				2019-04-02	
J	Jacquet, D; Boelaert, M; Seaman, J; Rijal, S; Sundar, S; Menten, J; Magnus, E				Jacquet, Diane; Boelaert, Marleen; Seaman, Jill; Rijal, Suman; Sundar, Shyam; Menten, Joris; Magnus, Eddy			Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						visceral leishmaniasis; direct agglutination test; freeze-dried antigen; liquid antigen	AGREEMENT	The direct agglutination test (DAT) for visceral leishmaniasis (VL) with liquid (LQ) antigen is known to be only moderately reproducible because of inter-observer and batch-to-batch variability as well as its sensitivity to temperature and shaking during transport. We evaluated a DAT with freeze-dried (FD) antigen and compared it with the LQ antigen version. Blood samples of clinical VL suspects and healthy endemic controls were collected in Sudan, Nepal and India. Both test versions were performed in duplicate in the respective countries and in the reference laboratory. Interbatch variability and stability tests were conducted and agreement was examined within and between centres on a dichotomic scale by Cohen's kappa as well as on a continuous scale through Bland-Altman plots. The FD antigen remains fully active even after storage at 45 degrees C for 24 months. Using a cut-off titre of 1:6400, the agreement between the FD and the LQ formats was excellent. The major advantages of FD antigen are its better stability at higher temperatures and its longer shelf life, which make it much more suitable than the LQ version for use in the field.	Inst Trop Med, Appl Technol & Prod Unit, B-2000 Antwerp, Belgium; Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; Int Med Relief Fund, Watsonville, CA USA; BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India	Jacquet, D (reprint author), Inst Trop Geneeskunde Prins Leopold, Eenheild Toegepaste Technol & Prod, Natl Str 155, B-2000 Antwerp, Belgium.	djacquet@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776			BLAND JM, 1986, LANCET, V1, P307; Boelaert M, 1999, TROP MED INT HEALTH, V4, P31, DOI 10.1046/j.1365-3156.1999.00348.x; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; CONGER AJ, 1980, PSYCHOL BULL, V88, P322, DOI 10.1037//0033-2909.88.2.322; Efron B., 1993, INTRO BOOTSTRAP; HARITH AE, 1986, T ROY SOC TROP MED H, V80, P583, DOI 10.1016/0035-9203(86)90149-5; HARITH AE, 1988, J CLIN MICROBIOL, V26, P1321; LANDIS JR, 1977, BIOMETRICS, V33, P174; Marlet MVL, 2003, T ROY SOC TROP MED H, V97, P667, DOI 10.1016/S0035-9203(03)80099-8; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; MEREDITH SEO, 1995, J CLIN MICROBIOL, V33, P1742; Oskam L, 1999, T ROY SOC TROP MED H, V93, P275, DOI 10.1016/S0035-9203(99)90021-4; R Development Core Team, 2005, R LANG ENV STAT COMP; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; ZIJLSTRA EE, 1992, T ROY SOC TROP MED H, V86, P505, DOI 10.1016/0035-9203(92)90086-R	15	24	24	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	DEC	2006	11	12					1777	1784		10.1111/j.1365-3156.2006.01743.x				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	108LP	WOS:000242241600002	17176341				2019-04-02	
